https://www.pharmasources.com/industryinsights/ 0.8 daily https://www.pharmasources.com/industryinsights/list/pharmaexperts/ 0.8 daily https://www.pharmasources.com/industryinsights/list/cate-768/ 0.6 daily https://www.pharmasources.com/industryinsights/list/cate-769/ 0.6 daily https://www.pharmasources.com/industryinsights/list/cate-790/ 0.6 daily https://www.pharmasources.com/industryinsights/list/cate-791/ 0.6 daily https://www.pharmasources.com/industryinsights/list/cate-792/ 0.6 daily https://www.pharmasources.com/industryinsights/2016-sees-lowest-number-of-drug-approval-291810.html 0.6 2025-11-25T04:50:08+08:00 daily https://www.pharmasources.com/industryinsights/shire-sells-mrna-therapy-platform-to-ran-291811.html 0.6 2026-02-15T13:05:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-priority-review-to-bayers-fil-291812.html 0.6 2026-06-08T20:04:41+08:00 daily https://www.pharmasources.com/industryinsights/cadila-arm-acquires-six-brands-from-msd--291813.html 0.6 2026-08-06T21:58:54+08:00 daily https://www.pharmasources.com/industryinsights/clovis-oncology-announces-upsizing-and-p-291814.html 0.6 2026-08-08T19:39:39+08:00 daily https://www.pharmasources.com/industryinsights/m-pharmaceutical-inc-enters-into-exclusi-291815.html 0.6 2026-08-07T14:42:13+08:00 daily https://www.pharmasources.com/industryinsights/versant-ventures-closes-sixth-healthcare-291816.html 0.6 2026-08-06T23:32:02+08:00 daily https://www.pharmasources.com/industryinsights/custopharm-acquires-two-anda-pharmaceuti-291817.html 0.6 2026-08-07T02:40:28+08:00 daily https://www.pharmasources.com/industryinsights/national-institute-for-health-and-care-e-291818.html 0.6 2026-08-07T03:04:08+08:00 daily https://www.pharmasources.com/industryinsights/vtesse-appoints-jason-meyenburg-as-chief-291819.html 0.6 2026-08-06T23:47:05+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-insulin-injection-soliqua-10033--291820.html 0.6 2026-08-07T00:22:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-bayers-li-291821.html 0.6 2026-08-03T01:08:56+08:00 daily https://www.pharmasources.com/industryinsights/lonza-concludes-divestment-of-peptides-b-291822.html 0.6 2026-08-06T22:05:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-for-filing-snda-for-liletta--291823.html 0.6 2026-08-06T23:36:14+08:00 daily https://www.pharmasources.com/industryinsights/amorsa-to-collaborate-with-jj-on-treatme-291824.html 0.6 2026-08-06T22:53:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-3-new-diabetes-drugs-that--291825.html 0.6 2026-08-06T22:20:54+08:00 daily https://www.pharmasources.com/industryinsights/enterome-starts-phase-i-crohns-disease-t-291826.html 0.6 2026-08-06T23:54:01+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-adjust-organization-and-leaders-291827.html 0.6 2026-08-01T10:53:31+08:00 daily https://www.pharmasources.com/industryinsights/shripad-naik-inaugurates-international-c-291828.html 0.6 2026-08-10T00:46:11+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-supplemental-new-drug-ap-291829.html 0.6 2026-06-20T08:32:27+08:00 daily https://www.pharmasources.com/industryinsights/elanco-animal-health-completes-acquisiti-291830.html 0.6 2026-08-08T01:10:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-says-philippine-fdas-demand-to-st-291831.html 0.6 2026-08-06T21:58:31+08:00 daily https://www.pharmasources.com/industryinsights/fundacin-medina-will-use-dotmatics-solut-291832.html 0.6 2026-08-06T22:08:18+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-innovation-effort-yield-291833.html 0.6 2026-08-06T21:38:20+08:00 daily https://www.pharmasources.com/industryinsights/arvinas-appoints-president-of-research-a-291834.html 0.6 2026-08-09T01:49:43+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-announces-immunothe-291835.html 0.6 2026-08-08T23:54:50+08:00 daily https://www.pharmasources.com/industryinsights/xigens-brimapitide-an-innovative-jnk-inh-291836.html 0.6 2026-08-06T21:54:20+08:00 daily https://www.pharmasources.com/industryinsights/want-a-sharper-brain-as-you-age-voluntee-291837.html 0.6 2026-08-06T22:08:25+08:00 daily https://www.pharmasources.com/industryinsights/study-casts-doubt-on-long-used-morning-s-291838.html 0.6 2026-02-09T03:26:18+08:00 daily https://www.pharmasources.com/industryinsights/vomiting-disorder-on-rise-in-weed-friend-291839.html 0.6 2026-05-06T22:39:16+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-abcellera-in-multi-target-researc-291840.html 0.6 2026-08-06T22:53:54+08:00 daily https://www.pharmasources.com/industryinsights/halozyme-announces-phase-2-study-in-adva-291841.html 0.6 2026-08-06T22:54:23+08:00 daily https://www.pharmasources.com/industryinsights/janssen-and-bristol-myers-squibb-to-eval-291842.html 0.6 2026-08-06T22:14:26+08:00 daily https://www.pharmasources.com/industryinsights/synthetic-genomics-janssen-ink-rna-techn-291843.html 0.6 2026-08-06T23:48:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-supplemental-new-drug-appli-291844.html 0.6 2026-08-06T23:33:35+08:00 daily https://www.pharmasources.com/industryinsights/prokarium-probiomed-initiate-scale-up-of-291845.html 0.6 2026-08-08T23:32:40+08:00 daily https://www.pharmasources.com/industryinsights/spark-therapeutics-earns-15m-pfizer-mile-291846.html 0.6 2026-08-06T20:06:05+08:00 daily https://www.pharmasources.com/industryinsights/synpromics-ge-healthcare-enter-biologics-291847.html 0.6 2025-11-15T13:14:23+08:00 daily https://www.pharmasources.com/industryinsights/albumedix-appoints-chief-medical-officer-291848.html 0.6 2026-08-06T23:33:33+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-appoints-christi-shaw-to-head--291849.html 0.6 2026-08-06T23:36:04+08:00 daily https://www.pharmasources.com/industryinsights/allergan-guides-for-mid-single-digit-rev-291850.html 0.6 2026-08-06T23:46:05+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-innovations-global-pursu-291851.html 0.6 2026-08-06T23:45:37+08:00 daily https://www.pharmasources.com/industryinsights/pieris-pharmaceuticals-and-servier-forge-291852.html 0.6 2026-08-06T23:46:38+08:00 daily https://www.pharmasources.com/industryinsights/how-would-gilead-keep-its-status-with-th-291853.html 0.6 2026-08-08T22:58:47+08:00 daily https://www.pharmasources.com/industryinsights/three-chinese-pharmaceutical-enterprises-291854.html 0.6 2026-08-06T23:37:35+08:00 daily https://www.pharmasources.com/industryinsights/noxxon-pharma-licenses-and-assigns-precl-291855.html 0.6 2026-08-06T23:47:35+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-janssen-to-collaborate-to-evalua-291856.html 0.6 2026-08-06T23:55:11+08:00 daily https://www.pharmasources.com/industryinsights/novartis-invests-in-next-generation-ther-291857.html 0.6 2026-08-06T22:08:35+08:00 daily https://www.pharmasources.com/industryinsights/110-students-graduate-from-biocon-academ-291858.html 0.6 2026-08-06T21:54:08+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-yeliva-abc29-291859.html 0.6 2026-08-09T22:45:58+08:00 daily https://www.pharmasources.com/industryinsights/hub-and-dutch-health-insurance-companies-291860.html 0.6 2026-08-10T00:26:04+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-sucampo-pharmaceuticals--291861.html 0.6 2025-11-10T18:57:16+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-northern-biologics-sumitom-291862.html 0.6 2026-08-07T03:21:33+08:00 daily https://www.pharmasources.com/industryinsights/new-research-shows-how-cancer-cells-brea-291863.html 0.6 2026-08-07T13:16:03+08:00 daily https://www.pharmasources.com/industryinsights/fortress-biotech-forms-new-subsidiary-291864.html 0.6 2026-03-19T12:24:47+08:00 daily https://www.pharmasources.com/industryinsights/flu-season-starting-to-peak-291865.html 0.6 2026-08-07T13:16:26+08:00 daily https://www.pharmasources.com/industryinsights/superbug-infections-down-30-percent-at-v-291866.html 0.6 2026-08-06T21:46:52+08:00 daily https://www.pharmasources.com/industryinsights/technology-and-strategies-of-the-immunod-291867.html 0.6 2026-08-09T21:45:32+08:00 daily https://www.pharmasources.com/industryinsights/merus-and-irb-barcelona-form-research-co-291868.html 0.6 2026-08-10T00:52:29+08:00 daily https://www.pharmasources.com/industryinsights/neovacs-to-collaborate-with-the-sunnybro-291869.html 0.6 2026-08-08T23:19:12+08:00 daily https://www.pharmasources.com/industryinsights/double-blind-study-validates-memeds-bloo-291870.html 0.6 2026-08-09T00:58:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-invests-in-next-generation-ther-291871.html 0.6 2026-08-09T18:56:16+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-sanofi-to-appeal-us-distri-291872.html 0.6 2026-08-06T21:54:16+08:00 daily https://www.pharmasources.com/industryinsights/oncogenex-to-merge-with-achieve-life-sci-291873.html 0.6 2026-08-06T22:08:22+08:00 daily https://www.pharmasources.com/industryinsights/biotime-establishes-cell-therapy-mnfg-ce-291874.html 0.6 2026-08-07T05:30:53+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-fda-clearance-for-18-minute-a-291875.html 0.6 2026-08-07T13:19:27+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-pvp-biologics-form-35m-gi-pac-291876.html 0.6 2026-08-07T13:19:05+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-acquires-villapharma-in-spain-291877.html 0.6 2026-07-05T09:44:05+08:00 daily https://www.pharmasources.com/industryinsights/amyris-names-kathleen-valiasek-cfo-291878.html 0.6 2026-08-06T21:47:23+08:00 daily https://www.pharmasources.com/industryinsights/mast-therapeutics-and-savara-sign-merger-291879.html 0.6 2026-08-09T01:46:07+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-gets-us-fda-nod-for-its-291880.html 0.6 2026-08-06T23:55:18+08:00 daily https://www.pharmasources.com/industryinsights/interview-roche-discusses-the-importance-291881.html 0.6 2026-08-06T22:01:05+08:00 daily https://www.pharmasources.com/industryinsights/synthetic-genomics-announces-collaborati-291884.html 0.6 2026-08-08T23:51:50+08:00 daily https://www.pharmasources.com/industryinsights/amgen-davita-enter-new-sourcing-and-supp-291910.html 0.6 2026-07-01T23:42:37+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-evaluate-jotrol-for-softgel--291911.html 0.6 2026-08-06T23:47:08+08:00 daily https://www.pharmasources.com/industryinsights/study-casts-more-doubt-on-value-of-mammo-291912.html 0.6 2026-08-09T03:20:27+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-to-buy-cancer-drugs-from-merrimack-291913.html 0.6 2026-08-06T21:47:10+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-acquire-ariad-pharmaceuticals-291914.html 0.6 2026-01-25T06:00:10+08:00 daily https://www.pharmasources.com/industryinsights/ibm-watson-health-illumina-partner-to-ex-291915.html 0.6 2026-08-06T22:00:01+08:00 daily https://www.pharmasources.com/industryinsights/amgen-immatics-ink-deal-potentially-wort-291916.html 0.6 2026-08-07T05:05:53+08:00 daily https://www.pharmasources.com/industryinsights/celgene-raises-profit-revenue-forecasts--291917.html 0.6 2026-08-06T23:56:45+08:00 daily https://www.pharmasources.com/industryinsights/macrophage-pharma-raises-9-million-in-se-291918.html 0.6 2026-08-08T20:02:25+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-develop-softgel-capsules-for-291919.html 0.6 2026-08-09T02:22:34+08:00 daily https://www.pharmasources.com/industryinsights/cardinal-health-reaches-20-million-settl-291920.html 0.6 2026-07-07T21:00:48+08:00 daily https://www.pharmasources.com/industryinsights/novartis-invests-in-ionis-therapies-to-r-291921.html 0.6 2026-08-07T02:40:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-roches-assay-to-assess-ovar-291922.html 0.6 2026-08-06T23:47:01+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-sees-huge-potential-in-c-291923.html 0.6 2026-08-06T23:37:17+08:00 daily https://www.pharmasources.com/industryinsights/kite-pharma-joins-hands-with-daiichi-san-291924.html 0.6 2026-08-06T23:45:05+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-destroys-expired-medicine-worth-291925.html 0.6 2026-08-06T23:47:47+08:00 daily https://www.pharmasources.com/industryinsights/genocea-armed-with-positive-phase-2b-dat-291926.html 0.6 2026-08-06T23:36:52+08:00 daily https://www.pharmasources.com/industryinsights/us-armys-planned-zika-vax-license-to-san-291927.html 0.6 2026-08-06T22:18:47+08:00 daily https://www.pharmasources.com/industryinsights/paxvax-joins-chikungunya-vaccine-quest-w-291928.html 0.6 2026-08-07T05:30:49+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-acquire-ariad-pharmaceuticals-291929.html 0.6 2026-08-06T23:47:50+08:00 daily https://www.pharmasources.com/industryinsights/sanpower-group-to-acquire-dendreon-from--291930.html 0.6 2026-08-08T18:34:56+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-genecentric-dia-291931.html 0.6 2026-08-09T00:51:32+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-first-dosing-291932.html 0.6 2026-08-07T04:31:09+08:00 daily https://www.pharmasources.com/industryinsights/bionet-received-thai-fda-approval-of-the-291933.html 0.6 2026-08-06T22:00:11+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-updates-segment-reporting-struct-291934.html 0.6 2026-08-06T19:59:44+08:00 daily https://www.pharmasources.com/industryinsights/honeywell-launches-scanpal-eda50hc-mobil-291935.html 0.6 2026-08-06T20:05:47+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-expands-end-to-end-biodev-291936.html 0.6 2026-04-13T14:48:16+08:00 daily https://www.pharmasources.com/industryinsights/japans-takeda-to-acquire-us-cancer-drug--291937.html 0.6 2026-08-06T23:47:44+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-roches-supplemental-biolo-291938.html 0.6 2026-04-28T05:41:54+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-to-acquire-global-oncology-assets--291939.html 0.6 2026-08-06T21:59:07+08:00 daily https://www.pharmasources.com/industryinsights/valeant-to-sell-cerave-acnefree-and-ambi-291940.html 0.6 2026-08-06T23:48:16+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-signs-collaboration-agreement--291941.html 0.6 2026-08-06T20:05:26+08:00 daily https://www.pharmasources.com/industryinsights/extend-deadline-for-tb-drug-regimen-sc-291942.html 0.6 2026-08-06T20:06:41+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-to-buy-portugals-generi-291943.html 0.6 2026-08-06T22:09:07+08:00 daily https://www.pharmasources.com/industryinsights/non-invasive-screening-method-reveals-im-291944.html 0.6 2026-08-09T20:12:25+08:00 daily https://www.pharmasources.com/industryinsights/high-blood-pressure-increasing-worldwide-291945.html 0.6 2026-08-06T23:46:40+08:00 daily https://www.pharmasources.com/industryinsights/brisk-walk-may-help-sidestep-heart-disea-291946.html 0.6 2026-08-06T23:33:29+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-eternygen-to-develop-metaboli-291947.html 0.6 2026-08-08T20:44:57+08:00 daily https://www.pharmasources.com/industryinsights/indicia-production-acquires-metis-biotec-291948.html 0.6 2026-08-08T22:22:51+08:00 daily https://www.pharmasources.com/industryinsights/sgs-unveils-virus-agent-for-clinical-tri-291949.html 0.6 2025-10-28T21:11:54+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-expands-biodevelopment-ce-291950.html 0.6 2026-08-08T23:52:55+08:00 daily https://www.pharmasources.com/industryinsights/valeant-to-sell-dendreon-cancer-business-291951.html 0.6 2026-08-06T21:58:38+08:00 daily https://www.pharmasources.com/industryinsights/philips-illumina-partner-to-offer-integr-291952.html 0.6 2026-08-07T02:31:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bla-for-mylan-and-biocons-pr-291953.html 0.6 2026-08-09T00:50:49+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-merck-expand-immuno-oncology-c-291954.html 0.6 2026-08-06T20:03:36+08:00 daily https://www.pharmasources.com/industryinsights/piqur-and-pierre-fabre-announce-partners-291955.html 0.6 2026-08-06T20:06:55+08:00 daily https://www.pharmasources.com/industryinsights/stellar-biotechnologies-advances-strateg-291956.html 0.6 2026-08-06T22:08:57+08:00 daily https://www.pharmasources.com/industryinsights/us-court-of-appeals-rules-in-lillys-favo-291957.html 0.6 2026-08-06T22:53:26+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-aghast-as-trump-taps-vaccines--291958.html 0.6 2026-08-09T18:40:15+08:00 daily https://www.pharmasources.com/industryinsights/trump-to-pharma-youre-getting-away-with--291959.html 0.6 2026-08-06T22:08:20+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-qidp-fast-tr-291960.html 0.6 2026-08-06T22:07:58+08:00 daily https://www.pharmasources.com/industryinsights/huntingtons-disease-hd-opportunity-analy-291961.html 0.6 2026-08-06T22:08:31+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-allowance-of-291962.html 0.6 2026-08-06T23:47:45+08:00 daily https://www.pharmasources.com/industryinsights/chilterns-thought-leader-to-speak-on-ris-291963.html 0.6 2026-08-07T21:28:40+08:00 daily https://www.pharmasources.com/industryinsights/scorr-marketing-wins-28-marketing-awards-291964.html 0.6 2026-08-07T03:33:43+08:00 daily https://www.pharmasources.com/industryinsights/idt-biologika-establishes-animal-health--291965.html 0.6 2026-08-07T13:17:09+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-immatics-enter-strategic-colla-291966.html 0.6 2026-06-30T20:40:11+08:00 daily https://www.pharmasources.com/industryinsights/maverick-therapeutics-and-takeda-announc-291967.html 0.6 2026-08-06T22:28:27+08:00 daily https://www.pharmasources.com/industryinsights/close-to-half-of-adults-and-one-quarter--291968.html 0.6 2026-08-07T05:07:18+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-yoga-may-help-children-wit-291969.html 0.6 2026-08-06T22:14:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-biologics-license-applicatio-291970.html 0.6 2026-08-07T13:15:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-roches-cancer-immunotherapy-t-291971.html 0.6 2026-08-06T23:46:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-licenses-four-oncology-research-an-291972.html 0.6 2026-08-09T19:40:12+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-to-re-audit-dr-reddys-three-plant-291973.html 0.6 2026-07-04T00:29:36+08:00 daily https://www.pharmasources.com/industryinsights/piqur-and-pierre-fabre-announce-partners-291974.html 0.6 2026-06-27T07:29:57+08:00 daily https://www.pharmasources.com/industryinsights/measles-rubella-vaccine-to-roll-out-in-f-291975.html 0.6 2026-08-06T23:54:48+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-announces-positive-top-line-res-291976.html 0.6 2026-08-06T23:48:02+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-nod-to-market-its-skin-291977.html 0.6 2026-08-08T22:03:49+08:00 daily https://www.pharmasources.com/industryinsights/nhs-confederation-appoints-niall-dickson-291978.html 0.6 2026-08-06T22:21:14+08:00 daily https://www.pharmasources.com/industryinsights/govt-to-soon-come-out-with-clarification-291979.html 0.6 2026-08-08T22:39:22+08:00 daily https://www.pharmasources.com/industryinsights/new-study-finds-antidepressant-use-incre-291980.html 0.6 2026-08-08T23:25:48+08:00 daily https://www.pharmasources.com/industryinsights/phase-ii-trial-for-f2gs-antifungal-drug--291981.html 0.6 2026-08-09T13:04:55+08:00 daily https://www.pharmasources.com/industryinsights/pitt-and-bayer-to-advance-research-for-h-291982.html 0.6 2026-08-06T21:54:29+08:00 daily https://www.pharmasources.com/industryinsights/zambon-and-seqirus-partner-for-parkinson-291983.html 0.6 2026-03-19T23:22:32+08:00 daily https://www.pharmasources.com/industryinsights/ec-ratifies-positive-opinion-for-ptcs-tr-291984.html 0.6 2026-08-09T00:55:01+08:00 daily https://www.pharmasources.com/industryinsights/valeant-to-sell-dendreon-to-chinas-sanpo-291985.html 0.6 2026-08-06T20:06:24+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-roches-supplemental-biolo-291986.html 0.6 2026-08-05T19:49:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-former-cdf-kidney-cancer-d-291987.html 0.6 2026-08-09T23:38:38+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-leaders-call-for-gender-divers-291988.html 0.6 2026-08-06T21:58:49+08:00 daily https://www.pharmasources.com/industryinsights/ablynx-initiates-phase-iib-anti-rsv-nano-291989.html 0.6 2026-08-06T22:12:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-mylan-and-biocons-biosimilar-291990.html 0.6 2026-08-09T13:08:12+08:00 daily https://www.pharmasources.com/industryinsights/which-biosimilars-will-upend-the-global--291991.html 0.6 2026-08-06T22:08:20+08:00 daily https://www.pharmasources.com/industryinsights/how-were-the-blockbuster-product-depende-291992.html 0.6 2026-08-06T22:08:43+08:00 daily https://www.pharmasources.com/industryinsights/new-generation-mealtime-insulin-approved-291993.html 0.6 2026-08-07T02:41:17+08:00 daily https://www.pharmasources.com/industryinsights/vivagel-bv-granted-qidp-and-fast-track-d-291994.html 0.6 2026-08-06T23:56:16+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-opens-a-new-val-291995.html 0.6 2026-08-06T23:55:13+08:00 daily https://www.pharmasources.com/industryinsights/merck-licenses-four-oncology-rd-programs-291996.html 0.6 2026-08-06T23:46:30+08:00 daily https://www.pharmasources.com/industryinsights/flashback-2016-291997.html 0.6 2026-08-06T23:46:36+08:00 daily https://www.pharmasources.com/industryinsights/australia-approves-drug-that-can-melt-aw-291998.html 0.6 2026-08-02T19:51:59+08:00 daily https://www.pharmasources.com/industryinsights/frontier-biotech-gets-43m-from-huaxin-ce-291999.html 0.6 2026-08-06T23:46:42+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-all-set-to-buy-portugal-292000.html 0.6 2026-08-06T22:14:54+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-darmstadt-germany-and-palanti-292001.html 0.6 2026-01-31T10:51:04+08:00 daily https://www.pharmasources.com/industryinsights/abbott-announces-us-launch-and-first-com-292002.html 0.6 2026-08-09T01:17:04+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-extends-review-period-for-baricit-292003.html 0.6 2026-08-08T23:29:22+08:00 daily https://www.pharmasources.com/industryinsights/first-us-service-members-treated-with-th-292004.html 0.6 2026-08-06T20:05:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-cancer-patients-not-to-use-pnc-292005.html 0.6 2026-08-08T21:47:48+08:00 daily https://www.pharmasources.com/industryinsights/a-skin-secures-patent-for-groundbreaking-292006.html 0.6 2026-08-09T00:11:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-final-guidance-for-nonpropr-292007.html 0.6 2026-08-08T20:01:02+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-biotech-receives-en-iso-13485-cer-292008.html 0.6 2026-08-06T22:53:18+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-lilly-to-develop-second--292009.html 0.6 2025-10-23T04:29:48+08:00 daily https://www.pharmasources.com/industryinsights/merck-drives-business-opportunities-in-t-292010.html 0.6 2026-03-29T02:37:02+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-ms-contin-er-tabl-292011.html 0.6 2026-06-12T13:54:45+08:00 daily https://www.pharmasources.com/industryinsights/orthocell-collaborates-with-jjs-depuy-sy-292012.html 0.6 2026-05-30T18:46:29+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-mylans-bla-for-proposed-t-292013.html 0.6 2026-08-08T16:58:14+08:00 daily https://www.pharmasources.com/industryinsights/meningococcal-vaccines-global-drug-forec-292014.html 0.6 2026-08-10T01:25:29+08:00 daily https://www.pharmasources.com/industryinsights/attention-deficit-hyperactivity-disorder-292015.html 0.6 2026-08-06T23:36:45+08:00 daily https://www.pharmasources.com/industryinsights/new-zika-virus-monoclonal-antibodies-292016.html 0.6 2026-08-06T23:33:09+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-immunext-enter-into-agreement-292017.html 0.6 2026-08-07T12:16:20+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-opens-a-new-val-292018.html 0.6 2026-08-06T23:36:05+08:00 daily https://www.pharmasources.com/industryinsights/us-supreme-court-agrees-to-hear-novartis-292019.html 0.6 2026-08-06T23:46:24+08:00 daily https://www.pharmasources.com/industryinsights/vwr-acquires-seastar-292020.html 0.6 2026-08-06T23:35:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-to-deploy-palantir-data-analy-292021.html 0.6 2026-08-09T00:55:20+08:00 daily https://www.pharmasources.com/industryinsights/pci-suvoda-in-clinical-irt-alliance-292022.html 0.6 2026-08-06T23:46:17+08:00 daily https://www.pharmasources.com/industryinsights/aptevo-spin-off-receives-20m-emergent-pa-292023.html 0.6 2026-08-06T23:38:16+08:00 daily https://www.pharmasources.com/industryinsights/pediatricians-offer-heads-up-for-prevent-292024.html 0.6 2026-08-07T03:33:42+08:00 daily https://www.pharmasources.com/industryinsights/leon-nanodrugs-partners-with-bionpharma--292025.html 0.6 2026-06-10T08:30:16+08:00 daily https://www.pharmasources.com/industryinsights/new-study-examines-the-health-benefits-o-292026.html 0.6 2026-08-09T00:00:56+08:00 daily https://www.pharmasources.com/industryinsights/for-a-colicky-baby-you-might-give-acupun-292027.html 0.6 2026-08-08T21:39:29+08:00 daily https://www.pharmasources.com/industryinsights/james-bond-has-kicked-butts-but-his-co-s-292028.html 0.6 2026-08-07T00:36:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-review-period-for-eli-lillys-292029.html 0.6 2026-08-07T05:05:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-partners-with-palantir-technologie-292030.html 0.6 2026-08-09T19:15:22+08:00 daily https://www.pharmasources.com/industryinsights/pharma-in-south-east-asia-wins-through-i-292031.html 0.6 2026-06-09T23:42:12+08:00 daily https://www.pharmasources.com/industryinsights/tesaro-receives-crl-for-rolapitant-iv-fr-292032.html 0.6 2026-08-07T05:37:04+08:00 daily https://www.pharmasources.com/industryinsights/can-hiv-drugs-boost-syphilis-risk-292033.html 0.6 2026-08-07T05:37:11+08:00 daily https://www.pharmasources.com/industryinsights/synpromics-and-ge-healthcare-to-collabor-292034.html 0.6 2026-08-06T22:26:18+08:00 daily https://www.pharmasources.com/industryinsights/new-nice-ultra-rare-disease-proposals-no-292035.html 0.6 2026-08-06T22:27:10+08:00 daily https://www.pharmasources.com/industryinsights/merck-in-230-million-swoop-for-vertex-ca-292036.html 0.6 2026-08-06T22:54:07+08:00 daily https://www.pharmasources.com/industryinsights/asbm-statement-on-final-guidance-for-ind-292037.html 0.6 2026-08-06T22:53:23+08:00 daily https://www.pharmasources.com/industryinsights/prokarium-and-probiomed-in-uk-mexico-col-292038.html 0.6 2026-08-06T22:08:22+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-leverage-palantirs-data-analyti-292039.html 0.6 2026-08-09T17:16:41+08:00 daily https://www.pharmasources.com/industryinsights/novo-strikes-up-personalised-diabetes-tr-292040.html 0.6 2026-08-08T23:33:01+08:00 daily https://www.pharmasources.com/industryinsights/benzodiazepines-increase-stroke-risk-in--292041.html 0.6 2026-08-09T01:46:45+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-extends-review-period-for-eli-lil-292042.html 0.6 2026-08-06T22:13:04+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-reveal-drug-price-increases-next-m-292043.html 0.6 2026-08-08T22:04:54+08:00 daily https://www.pharmasources.com/industryinsights/m-pharmaceutical-to-develop-new-topical--292044.html 0.6 2026-08-07T02:40:14+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-licences-immunext-autoimmune-dise-292045.html 0.6 2026-08-09T03:44:58+08:00 daily https://www.pharmasources.com/industryinsights/gps-not-offering-extended-hours-could-fa-292046.html 0.6 2026-08-06T23:36:28+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-test-fracture-prevention-combo--292047.html 0.6 2026-08-08T22:51:46+08:00 daily https://www.pharmasources.com/industryinsights/think-strategically-for-design-of-experi-292048.html 0.6 2026-08-07T07:14:23+08:00 daily https://www.pharmasources.com/industryinsights/introducing-imeds-a-public-private-resou-292049.html 0.6 2026-07-11T13:33:10+08:00 daily https://www.pharmasources.com/industryinsights/after-automobiles-trump-targets-the-phar-292050.html 0.6 2026-08-07T03:02:33+08:00 daily https://www.pharmasources.com/industryinsights/aptuit-and-chiesi-initiate-integrated-di-292051.html 0.6 2026-08-06T23:36:17+08:00 daily https://www.pharmasources.com/industryinsights/common-heart-drug-repurposed-to-treat-ra-292052.html 0.6 2026-08-06T23:33:25+08:00 daily https://www.pharmasources.com/industryinsights/selonterra-publishes-novel-proprietary-m-292053.html 0.6 2026-08-06T23:37:44+08:00 daily https://www.pharmasources.com/industryinsights/smc-rejects-two-indications-of-myeloma-d-292054.html 0.6 2026-08-07T05:27:54+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-opens-production-facility-292055.html 0.6 2026-08-06T22:54:15+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-gedeon-richter-announce-pos-292056.html 0.6 2026-08-06T22:08:08+08:00 daily https://www.pharmasources.com/industryinsights/brunn-to-lead-bayers-pharmaceuticals-bus-292057.html 0.6 2026-08-06T23:55:55+08:00 daily https://www.pharmasources.com/industryinsights/harris-poll-only-nine-percent-of-us-cons-292058.html 0.6 2026-08-07T13:16:04+08:00 daily https://www.pharmasources.com/industryinsights/smith-joins-emd-serono-as-senior-vice-pr-292059.html 0.6 2026-08-06T23:48:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-review-period-for-baricitini-292060.html 0.6 2026-08-07T02:40:07+08:00 daily https://www.pharmasources.com/industryinsights/second-call-for-proposals-under-grand-ch-292061.html 0.6 2026-08-07T05:28:06+08:00 daily https://www.pharmasources.com/industryinsights/cadila-settles-patent-litigation-related-292062.html 0.6 2026-08-09T02:52:01+08:00 daily https://www.pharmasources.com/industryinsights/ec-amends-marketing-authorisation-for-ph-292063.html 0.6 2026-08-06T21:52:14+08:00 daily https://www.pharmasources.com/industryinsights/new-study-finds-benzodiazepines-use-incr-292064.html 0.6 2026-08-06T22:00:30+08:00 daily https://www.pharmasources.com/industryinsights/dalton-cerium-ink-development-mfg-agreem-292065.html 0.6 2026-08-06T22:53:30+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-opens-production-facility-292066.html 0.6 2026-08-06T22:08:24+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-genomics-expands-express-oligo--292067.html 0.6 2026-08-07T13:18:32+08:00 daily https://www.pharmasources.com/industryinsights/ani-appoints-regulatory-affairs-vp-292068.html 0.6 2025-12-30T11:44:53+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-to-support-promabs-car-t-servic-292069.html 0.6 2026-08-09T05:08:05+08:00 daily https://www.pharmasources.com/industryinsights/adents-ramps-up-us-ops-292070.html 0.6 2026-08-06T22:20:58+08:00 daily https://www.pharmasources.com/industryinsights/higher-risk-of-heart-disease-for-blacks--292071.html 0.6 2026-08-06T22:20:50+08:00 daily https://www.pharmasources.com/industryinsights/ticks-carrying-lyme-disease-confirmed-in-292072.html 0.6 2026-08-07T03:34:54+08:00 daily https://www.pharmasources.com/industryinsights/working-out-dont-bring-your-cellphone-292073.html 0.6 2026-08-06T20:06:48+08:00 daily https://www.pharmasources.com/industryinsights/even-a-little-daily-activity-may-boost-c-292074.html 0.6 2026-05-05T21:26:47+08:00 daily https://www.pharmasources.com/industryinsights/biogen-reaches-125-billion-settlement-li-292075.html 0.6 2026-08-07T02:30:56+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-broadens-first-line-immuno-o-292076.html 0.6 2026-08-06T23:50:42+08:00 daily https://www.pharmasources.com/industryinsights/alcobra-halts-development-of-metadoxine--292077.html 0.6 2026-08-06T23:48:40+08:00 daily https://www.pharmasources.com/industryinsights/oncurious-announces-european-commission--292078.html 0.6 2026-08-07T16:56:49+08:00 daily https://www.pharmasources.com/industryinsights/new-natural-molecule-better-than-morphin-292079.html 0.6 2026-08-07T05:05:32+08:00 daily https://www.pharmasources.com/industryinsights/microject-reactor-technology-to-take-cen-292080.html 0.6 2026-08-06T23:36:18+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-to-acquire-oncology-assets-from-me-292081.html 0.6 2026-08-09T02:02:35+08:00 daily https://www.pharmasources.com/industryinsights/a-skin-secures-patent-for-groundbreaking-292082.html 0.6 2026-08-07T13:18:53+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-colucid-pharmaceuticals-announ-292083.html 0.6 2026-08-06T22:53:53+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-supports-mainst-292084.html 0.6 2026-08-06T21:47:27+08:00 daily https://www.pharmasources.com/industryinsights/successful-antibody-trial-in-hiv-infecte-292085.html 0.6 2026-08-06T23:47:05+08:00 daily https://www.pharmasources.com/industryinsights/biocon-foundation-holds-free-cancer-scre-292086.html 0.6 2026-08-06T21:54:11+08:00 daily https://www.pharmasources.com/industryinsights/ministry-of-skill-development-led-life-s-292087.html 0.6 2026-08-09T20:28:27+08:00 daily https://www.pharmasources.com/industryinsights/whitehouse-labs-amri-increase-el-experti-292088.html 0.6 2026-08-09T08:01:12+08:00 daily https://www.pharmasources.com/industryinsights/servier-selects-masthercell-for-car-t-ce-292089.html 0.6 2026-08-06T23:56:02+08:00 daily https://www.pharmasources.com/industryinsights/eag-labs-adds-dermal-absorption-testing--292090.html 0.6 2026-08-06T23:47:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vantrela-er-292091.html 0.6 2026-08-06T22:08:19+08:00 daily https://www.pharmasources.com/industryinsights/know-the-risks-warning-signs-of-ovarian--292092.html 0.6 2026-08-08T19:43:02+08:00 daily https://www.pharmasources.com/industryinsights/forward-thinking-tips-for-back-pain-292093.html 0.6 2026-08-06T22:08:33+08:00 daily https://www.pharmasources.com/industryinsights/men-here-are-ways-to-healthier-younger-l-292094.html 0.6 2026-08-06T23:37:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ceo-suggests-that-trump-tax-cut-292095.html 0.6 2026-08-06T23:45:21+08:00 daily https://www.pharmasources.com/industryinsights/drugmakers-partner-to-tackle-non-communi-292096.html 0.6 2026-08-06T23:39:04+08:00 daily https://www.pharmasources.com/industryinsights/takeda-ovid-to-co-develop-tak-935-for-pa-292097.html 0.6 2026-08-06T23:36:29+08:00 daily https://www.pharmasources.com/industryinsights/hikma-receives-approval-for-sodium-oxyba-292098.html 0.6 2026-08-06T23:33:53+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-biosimilar-candidat-292099.html 0.6 2026-08-06T23:32:53+08:00 daily https://www.pharmasources.com/industryinsights/zydus-receives-final-approval-from-the-u-292100.html 0.6 2026-04-27T06:33:27+08:00 daily https://www.pharmasources.com/industryinsights/allergan-gedeons-fibroid-drug-hits-phiii-292101.html 0.6 2026-08-06T22:08:36+08:00 daily https://www.pharmasources.com/industryinsights/experts-propose-ebola-champion-group-to--292102.html 0.6 2026-08-06T22:21:01+08:00 daily https://www.pharmasources.com/industryinsights/smc-oks-four-new-therapies-for-nhs-use-i-292103.html 0.6 2026-08-06T22:08:00+08:00 daily https://www.pharmasources.com/industryinsights/investigators-line-up-keytruda-cancer-va-292104.html 0.6 2026-08-09T20:14:13+08:00 daily https://www.pharmasources.com/industryinsights/researchers-financed-by-pharma-more-like-292105.html 0.6 2026-08-06T21:47:26+08:00 daily https://www.pharmasources.com/industryinsights/with-flublok-at-a-standstill-in-japan-as-292106.html 0.6 2026-08-06T22:53:19+08:00 daily https://www.pharmasources.com/industryinsights/pm-may-announces-brexit-plan-bioindustry-292107.html 0.6 2026-08-09T02:13:08+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-positive-topline-re-292108.html 0.6 2026-08-06T23:48:07+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-biosciences-cx-4945-granted-orpha-292109.html 0.6 2026-08-06T23:36:45+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-crt-and-mrc-to-target-292110.html 0.6 2026-08-06T22:21:00+08:00 daily https://www.pharmasources.com/industryinsights/malecare-launches-new-mobile-application-292111.html 0.6 2026-08-07T06:08:01+08:00 daily https://www.pharmasources.com/industryinsights/eisai-acquires-manufacturing-rights-for--292112.html 0.6 2026-08-06T21:47:07+08:00 daily https://www.pharmasources.com/industryinsights/8-protected-tcm-varieties-exceeding-rmb--292113.html 0.6 2026-07-15T18:45:05+08:00 daily https://www.pharmasources.com/industryinsights/cfda-chemical-drug-process-change-issue--292114.html 0.6 2026-08-07T13:15:41+08:00 daily https://www.pharmasources.com/industryinsights/allergans-rhofade-cream-1-for-persistent-292115.html 0.6 2026-08-06T23:32:44+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-demonstrated-efficacy-and-improve-292116.html 0.6 2026-08-06T23:47:20+08:00 daily https://www.pharmasources.com/industryinsights/many-with-mental-illness-miss-out-on-hiv-292117.html 0.6 2026-08-08T01:33:59+08:00 daily https://www.pharmasources.com/industryinsights/food-stamp-use-linked-to-raised-early-de-292118.html 0.6 2026-08-06T23:46:35+08:00 daily https://www.pharmasources.com/industryinsights/uspto-issues-notice-of-allowance-for-mit-292119.html 0.6 2026-04-06T05:37:25+08:00 daily https://www.pharmasources.com/industryinsights/swedens-amra-receives-funding-to-redefin-292120.html 0.6 2026-08-09T18:12:57+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-find-new-method-to-protec-292121.html 0.6 2026-08-06T23:56:10+08:00 daily https://www.pharmasources.com/industryinsights/brain-training-may-help-ease-ringing-in--292122.html 0.6 2026-03-22T03:49:04+08:00 daily https://www.pharmasources.com/industryinsights/study-ties-inflammation-gut-bacteria-to--292123.html 0.6 2026-08-06T23:55:16+08:00 daily https://www.pharmasources.com/industryinsights/milner-therapeutics-institute-announces--292124.html 0.6 2026-08-06T22:53:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-imbruvica-as-first-treatmen-292125.html 0.6 2026-08-06T22:20:01+08:00 daily https://www.pharmasources.com/industryinsights/cipla-arm-to-sell-stake-in-four-m-propac-292126.html 0.6 2026-08-06T22:05:51+08:00 daily https://www.pharmasources.com/industryinsights/ethypharm-acquires-martindale-pharma-in--292127.html 0.6 2026-08-06T23:36:31+08:00 daily https://www.pharmasources.com/industryinsights/skill-development-programme-on-pv-launch-292128.html 0.6 2026-08-06T23:32:31+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-and-ftc-resolve-questcor-ma-292129.html 0.6 2026-08-06T23:54:11+08:00 daily https://www.pharmasources.com/industryinsights/panacea-inks-pact-with-unicef-292130.html 0.6 2026-08-06T23:47:52+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-biosimilar-candidat-292131.html 0.6 2026-08-06T23:36:03+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-acquire-colucid-292132.html 0.6 2026-08-06T22:08:01+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-supports-mainst-292133.html 0.6 2026-08-06T23:33:43+08:00 daily https://www.pharmasources.com/industryinsights/international-symposium-on-drafting-a-na-292134.html 0.6 2026-08-06T23:32:53+08:00 daily https://www.pharmasources.com/industryinsights/octoplus-renamed-dr-reddys-rd-292135.html 0.6 2026-08-09T20:51:23+08:00 daily https://www.pharmasources.com/industryinsights/evotec-asahi-kasei-enter-drug-discovery--292136.html 0.6 2026-08-09T18:17:19+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-biosimilar-candidat-292137.html 0.6 2026-08-06T22:54:03+08:00 daily https://www.pharmasources.com/industryinsights/better-early-nutrition-better-brains-stu-292138.html 0.6 2026-08-08T21:59:05+08:00 daily https://www.pharmasources.com/industryinsights/osteoarthritis-opportunity-analysis-and--292139.html 0.6 2026-08-08T00:49:32+08:00 daily https://www.pharmasources.com/industryinsights/panacea-initiates-phase-i-prostate-cance-292140.html 0.6 2026-08-09T01:01:48+08:00 daily https://www.pharmasources.com/industryinsights/eu-approval-for-cs-type-2-diabetes-treat-292141.html 0.6 2026-08-07T14:48:48+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-aquire-pain-biotech-colucid-292142.html 0.6 2026-08-06T19:59:33+08:00 daily https://www.pharmasources.com/industryinsights/gsk-snatches-az-europe-vp-to-replace-exi-292143.html 0.6 2026-08-06T20:06:50+08:00 daily https://www.pharmasources.com/industryinsights/ucb-dermira-plan-psoriasis-filing-for-ci-292144.html 0.6 2026-08-06T21:46:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-trulance-for-chronic-idiopa-292145.html 0.6 2026-08-06T21:38:13+08:00 daily https://www.pharmasources.com/industryinsights/novel-drugs-summary-2016-292146.html 0.6 2026-08-08T07:17:08+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-names-senior-vp-of-mfg-292147.html 0.6 2026-08-06T22:20:32+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-acquires-hd-biosciences-292148.html 0.6 2026-08-06T22:31:50+08:00 daily https://www.pharmasources.com/industryinsights/amatsigroup-acquires-disposable-lab-292149.html 0.6 2026-08-09T02:35:33+08:00 daily https://www.pharmasources.com/industryinsights/researchers-discover-severe-side-effects-292150.html 0.6 2026-08-08T22:20:27+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-extends-collaborati-292151.html 0.6 2026-08-08T19:34:25+08:00 daily https://www.pharmasources.com/industryinsights/rats-take-african-health-facilities-for--292152.html 0.6 2026-08-09T01:51:10+08:00 daily https://www.pharmasources.com/industryinsights/antinuclear-antibody-testing-market-wort-292153.html 0.6 2026-08-07T07:26:37+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-orphan-drug-designation-to-292154.html 0.6 2026-08-06T23:56:56+08:00 daily https://www.pharmasources.com/industryinsights/too-much-sitting-too-little-exercise-may-292155.html 0.6 2026-08-06T23:41:22+08:00 daily https://www.pharmasources.com/industryinsights/hester-biosciences-posts-net-profit-of-r-292156.html 0.6 2026-08-06T23:45:17+08:00 daily https://www.pharmasources.com/industryinsights/australias-telix-completes-product-colla-292157.html 0.6 2026-08-06T23:46:35+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-shenzhen-kangtai-biologi-292158.html 0.6 2026-08-08T21:35:49+08:00 daily https://www.pharmasources.com/industryinsights/ebola-blood-test-may-help-predict-surviv-292159.html 0.6 2026-08-09T00:20:14+08:00 daily https://www.pharmasources.com/industryinsights/flu-cases-starting-to-spread-cdc-292160.html 0.6 2026-08-09T22:55:57+08:00 daily https://www.pharmasources.com/industryinsights/stress-may-explain-digestive-issues-in-k-292161.html 0.6 2026-08-08T20:05:05+08:00 daily https://www.pharmasources.com/industryinsights/best-ways-to-steer-clear-of-the-flu-292162.html 0.6 2026-08-08T22:02:07+08:00 daily https://www.pharmasources.com/industryinsights/pharma-joins-gates-foundation-internatio-292163.html 0.6 2026-08-07T02:40:45+08:00 daily https://www.pharmasources.com/industryinsights/ceva-completes-deal-to-acquire-portfolio-292164.html 0.6 2026-08-08T19:38:20+08:00 daily https://www.pharmasources.com/industryinsights/kalo-announces-us-availability-and-prici-292165.html 0.6 2026-07-16T16:21:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-trulance-for-chronic-idiopa-292166.html 0.6 2026-08-07T13:17:45+08:00 daily https://www.pharmasources.com/industryinsights/gsk-announces-winners-of-2016-discovery--292167.html 0.6 2026-08-06T22:00:12+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-provides-regulatory-292168.html 0.6 2026-08-06T23:33:12+08:00 daily https://www.pharmasources.com/industryinsights/verastem-announces-executive-leadership--292169.html 0.6 2026-07-05T09:18:27+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-ono-settle-patent-l-292170.html 0.6 2026-08-06T23:45:19+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-wont-seek-accelerat-292171.html 0.6 2026-08-06T23:35:49+08:00 daily https://www.pharmasources.com/industryinsights/chemocentryx-announces-presentation-of-d-292172.html 0.6 2026-08-06T23:56:24+08:00 daily https://www.pharmasources.com/industryinsights/first-of-its-kind-cancer-stem-cell-resea-292173.html 0.6 2026-06-08T09:37:48+08:00 daily https://www.pharmasources.com/industryinsights/asia-pacific-flu-market-to-hit-171bn-by--292174.html 0.6 2026-08-07T13:14:56+08:00 daily https://www.pharmasources.com/industryinsights/shire-refiles-adhd-drug-292175.html 0.6 2026-08-06T22:20:51+08:00 daily https://www.pharmasources.com/industryinsights/3-biotechs-that-could-peak-in-2017-292176.html 0.6 2026-08-06T22:08:17+08:00 daily https://www.pharmasources.com/industryinsights/ultragenyx-and-kyowa-kirin-international-292177.html 0.6 2026-08-07T05:05:53+08:00 daily https://www.pharmasources.com/industryinsights/smokers-unleash-harms-on-their-pets-292178.html 0.6 2026-08-07T03:06:44+08:00 daily https://www.pharmasources.com/industryinsights/imbruvica-gets-us-nod-for-marginal-zone--292179.html 0.6 2026-08-06T23:41:02+08:00 daily https://www.pharmasources.com/industryinsights/abpi-slams-new-plans-for-drug-appraisals-292180.html 0.6 2026-08-09T02:48:56+08:00 daily https://www.pharmasources.com/industryinsights/stemline-therapeutics-prices-45-million--292181.html 0.6 2026-08-08T20:57:24+08:00 daily https://www.pharmasources.com/industryinsights/biggest-leap-in-decades-for-prostate-can-292182.html 0.6 2026-08-07T12:03:32+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-creates-new-warrant-plan-292183.html 0.6 2026-08-09T03:01:28+08:00 daily https://www.pharmasources.com/industryinsights/walgreens-said-to-face-ftc-concerns-over-292184.html 0.6 2026-08-06T23:47:19+08:00 daily https://www.pharmasources.com/industryinsights/cytovation-announces-appointment-of-ole--292185.html 0.6 2026-06-08T22:26:48+08:00 daily https://www.pharmasources.com/industryinsights/jjs-imbruvica-scores-fifth-fda-lymphoma--292186.html 0.6 2026-08-07T11:05:04+08:00 daily https://www.pharmasources.com/industryinsights/seven-pharma-trends-for-2017-292187.html 0.6 2026-08-06T23:37:09+08:00 daily https://www.pharmasources.com/industryinsights/servier-appoints-masthercell-for-the-dev-292188.html 0.6 2026-08-06T21:59:22+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-rd-tax-credit-regulatory--292189.html 0.6 2026-08-06T23:57:06+08:00 daily https://www.pharmasources.com/industryinsights/mylan-acquires-cold-eeze-brand-to-furthe-292190.html 0.6 2026-07-16T12:16:06+08:00 daily https://www.pharmasources.com/industryinsights/ema-validates-gileads-maa-for-investigat-292191.html 0.6 2026-08-06T23:32:12+08:00 daily https://www.pharmasources.com/industryinsights/concert-pharmaceuticals-receives-fda-orp-292192.html 0.6 2026-08-06T23:54:31+08:00 daily https://www.pharmasources.com/industryinsights/bms-ono-pharma-and-merck-resolve-pd-1-an-292193.html 0.6 2026-08-07T16:58:41+08:00 daily https://www.pharmasources.com/industryinsights/enamine-actelion-expand-drug-discovery-c-292194.html 0.6 2026-08-06T22:09:26+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-inovalon-enter-cloud-platform-292195.html 0.6 2026-08-09T19:02:49+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-domain-explore-new-immuno-onc-292196.html 0.6 2026-06-11T08:55:03+08:00 daily https://www.pharmasources.com/industryinsights/early-family-deaths-may-create-grief-gap-292197.html 0.6 2026-08-06T23:36:28+08:00 daily https://www.pharmasources.com/industryinsights/obamacare-boosted-coverage-for-the-chron-292198.html 0.6 2026-08-06T23:33:13+08:00 daily https://www.pharmasources.com/industryinsights/when-loved-one-has-breast-cancer-partner-292199.html 0.6 2026-08-07T04:25:02+08:00 daily https://www.pharmasources.com/industryinsights/exercise-rates-often-decline-after-cance-292200.html 0.6 2026-08-08T01:17:49+08:00 daily https://www.pharmasources.com/industryinsights/french-drug-developer-ethypharm-acquires-292201.html 0.6 2026-08-07T13:16:23+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-research-collaboration-w-292202.html 0.6 2026-08-09T09:43:08+08:00 daily https://www.pharmasources.com/industryinsights/synpromics-announces-research-collaborat-292203.html 0.6 2026-08-07T13:15:21+08:00 daily https://www.pharmasources.com/industryinsights/xigens-brimapitide-an-innovative-jnk-inh-292204.html 0.6 2026-06-15T03:00:01+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--292205.html 0.6 2026-08-06T22:28:00+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-settlement-and-license-a-292206.html 0.6 2026-08-06T22:21:07+08:00 daily https://www.pharmasources.com/industryinsights/merck-agrees-to-resolve-keytruda-patent--292207.html 0.6 2026-08-06T23:47:44+08:00 daily https://www.pharmasources.com/industryinsights/canadas-abcellera-receives-grant-from-ga-292208.html 0.6 2026-08-06T23:47:36+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-abbvies-imbruvica-to-tre-292209.html 0.6 2026-08-06T23:33:21+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-resubmits-dextenza-to-292210.html 0.6 2026-08-06T20:02:35+08:00 daily https://www.pharmasources.com/industryinsights/actelions-opsumit-fails-in-late-stage-st-292211.html 0.6 2026-08-06T20:07:07+08:00 daily https://www.pharmasources.com/industryinsights/us-pharmaceutical-industry-launches-medi-292212.html 0.6 2026-08-06T22:05:48+08:00 daily https://www.pharmasources.com/industryinsights/neuropore-therapies-announces-appointmen-292213.html 0.6 2026-08-08T22:03:19+08:00 daily https://www.pharmasources.com/industryinsights/therabron-therapeutics-receives-orphan-d-292214.html 0.6 2026-08-06T22:01:01+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-initiative-improves--292215.html 0.6 2026-08-08T22:41:27+08:00 daily https://www.pharmasources.com/industryinsights/kymab-appoints-dr-arndt-schottelius-as-e-292216.html 0.6 2026-04-06T19:17:56+08:00 daily https://www.pharmasources.com/industryinsights/enteris-biopharma-enters-agreement-with--292217.html 0.6 2026-08-07T04:33:52+08:00 daily https://www.pharmasources.com/industryinsights/hope-biosciences-licenses-nuc-gemcitabin-292218.html 0.6 2026-08-07T23:06:00+08:00 daily https://www.pharmasources.com/industryinsights/herantis-pharma-plc-publishes-introducto-292219.html 0.6 2026-08-07T01:06:48+08:00 daily https://www.pharmasources.com/industryinsights/bms-receives-625-million-patent-settleme-292220.html 0.6 2026-08-08T22:25:08+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-partners-with-cambridge-matchmake-292221.html 0.6 2026-08-06T20:06:44+08:00 daily https://www.pharmasources.com/industryinsights/working-together-to-reduce-the-devastati-292222.html 0.6 2026-08-06T20:02:18+08:00 daily https://www.pharmasources.com/industryinsights/immune-pharma-enters-a-research-partners-292223.html 0.6 2026-08-09T03:09:11+08:00 daily https://www.pharmasources.com/industryinsights/aptuit-enters-drug-discovery-collaborati-292224.html 0.6 2026-08-07T05:05:43+08:00 daily https://www.pharmasources.com/industryinsights/ropack-selects-serialization-partner-292225.html 0.6 2026-08-08T20:24:40+08:00 daily https://www.pharmasources.com/industryinsights/vwr-receives-excipact-certifications-292226.html 0.6 2026-08-06T23:57:11+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-supports-mainstream-adoption-o-292227.html 0.6 2026-08-06T22:53:14+08:00 daily https://www.pharmasources.com/industryinsights/paragon-niaid-in-preclinical-drug-develo-292228.html 0.6 2026-08-06T23:47:17+08:00 daily https://www.pharmasources.com/industryinsights/expert-apprehensive-about-trumps-vaccine-292229.html 0.6 2026-08-08T23:39:37+08:00 daily https://www.pharmasources.com/industryinsights/chinas-illegal-vaccine-sales-culprit-get-292230.html 0.6 2026-08-07T13:17:18+08:00 daily https://www.pharmasources.com/industryinsights/novavax-hopes-to-revive-rsv-vaccine-with-292231.html 0.6 2026-08-07T00:24:32+08:00 daily https://www.pharmasources.com/industryinsights/vendors-favour-platform-monitoring-as-no-292232.html 0.6 2026-06-06T10:02:17+08:00 daily https://www.pharmasources.com/industryinsights/albumedix-appoints-chief-medical-officer-292233.html 0.6 2026-08-06T23:32:06+08:00 daily https://www.pharmasources.com/industryinsights/biosimilars-market-is-expected-to-worth--292234.html 0.6 2026-08-06T23:47:23+08:00 daily https://www.pharmasources.com/industryinsights/new-genital-herpes-vaccine-candidate-pro-292235.html 0.6 2026-08-06T22:54:14+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-wants-budget-to-offer-ta-292236.html 0.6 2026-08-06T22:20:55+08:00 daily https://www.pharmasources.com/industryinsights/innovate-uk-grants-funding-to-cypralis-t-292237.html 0.6 2026-08-07T13:17:04+08:00 daily https://www.pharmasources.com/industryinsights/new-research-reveals-caspase-2-enzyme-de-292238.html 0.6 2026-08-06T23:57:47+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-maa-for-chronic-hepatiti-292239.html 0.6 2026-08-07T03:33:57+08:00 daily https://www.pharmasources.com/industryinsights/body-cooling-little-help-to-kids-when-he-292240.html 0.6 2026-08-06T23:55:07+08:00 daily https://www.pharmasources.com/industryinsights/fitter-seniors-may-have-healthier-brains-292241.html 0.6 2026-08-06T20:08:14+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccine-doesnt-eliminate-need-for-pa-292242.html 0.6 2026-08-06T19:23:59+08:00 daily https://www.pharmasources.com/industryinsights/could-a-therapy-for-irregular-heartbeat--292243.html 0.6 2026-08-06T20:06:49+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-q4-sales-boosted-by-new-292244.html 0.6 2026-01-31T08:43:48+08:00 daily https://www.pharmasources.com/industryinsights/nuvox-pharma-and-jiangsu-nhwa-pharmaceut-292245.html 0.6 2026-08-06T22:00:18+08:00 daily https://www.pharmasources.com/industryinsights/cue-biopharma-debuts-with-26-million-in--292246.html 0.6 2026-08-06T23:47:56+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-revlimid-plus-dex-292247.html 0.6 2026-08-08T19:31:53+08:00 daily https://www.pharmasources.com/industryinsights/tg-therapeutics-announces-orphan-drug-de-292248.html 0.6 2026-08-06T21:34:41+08:00 daily https://www.pharmasources.com/industryinsights/connect-biopharmaceuticals-completes-25--292249.html 0.6 2026-06-18T05:46:38+08:00 daily https://www.pharmasources.com/industryinsights/viracyte-receives-orphan-drug-designatio-292250.html 0.6 2026-03-17T22:33:40+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-announces-pricing-of--292251.html 0.6 2026-08-06T21:47:15+08:00 daily https://www.pharmasources.com/industryinsights/ironshore-pharmaceuticals-announces-clos-292252.html 0.6 2026-08-07T05:05:49+08:00 daily https://www.pharmasources.com/industryinsights/keneric-healthcare-and-angelini-pharma-p-292253.html 0.6 2026-08-06T22:53:27+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-grants-orphan-drug-d-292254.html 0.6 2026-08-06T21:47:07+08:00 daily https://www.pharmasources.com/industryinsights/intrexon-to-acquire-genvec-to-expand-ind-292255.html 0.6 2026-08-09T22:29:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-beyondspring-ind-application-292256.html 0.6 2026-08-09T03:14:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-perrigos-ab-rated-generic-v-292257.html 0.6 2026-08-06T22:53:38+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-reports-2016-fourth-quar-292258.html 0.6 2026-08-06T23:47:11+08:00 daily https://www.pharmasources.com/industryinsights/endo-announces-agreement-to-resolve-fede-292259.html 0.6 2026-08-10T01:14:15+08:00 daily https://www.pharmasources.com/industryinsights/phrma-launches-multi-year-advertising-an-292260.html 0.6 2026-08-06T22:21:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-genentech-292261.html 0.6 2026-08-07T13:14:52+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-worlds-lung-cancer-targe-292262.html 0.6 2026-08-06T22:12:31+08:00 daily https://www.pharmasources.com/industryinsights/the-new-king-of-cancer-drugs-can-you-gue-292263.html 0.6 2026-08-06T14:41:26+08:00 daily https://www.pharmasources.com/industryinsights/hub-and-dutch-health-insurance-companies-292264.html 0.6 2026-08-07T02:40:38+08:00 daily https://www.pharmasources.com/industryinsights/orexigen-therapeutics-announces-publicat-292265.html 0.6 2026-08-07T13:16:35+08:00 daily https://www.pharmasources.com/industryinsights/abbott-reports-fourth-quarter-2016-resul-292266.html 0.6 2026-08-09T20:57:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-delivered-solid-2016-performanc-292267.html 0.6 2026-08-06T23:32:42+08:00 daily https://www.pharmasources.com/industryinsights/vetter-starts-operations-in-its-center-f-292268.html 0.6 2026-08-06T23:32:41+08:00 daily https://www.pharmasources.com/industryinsights/biocon-wins-myr-300-m-contract-for-insul-292269.html 0.6 2026-08-06T22:53:52+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-ortho-cyclen-28-t-292270.html 0.6 2026-08-07T12:07:29+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-genentech-actemras-sbla-f-292271.html 0.6 2025-11-08T13:24:53+08:00 daily https://www.pharmasources.com/industryinsights/merus-closes-global-strategic-research-c-292272.html 0.6 2026-08-06T23:38:29+08:00 daily https://www.pharmasources.com/industryinsights/bedrocan-recognised-as-worlds-first-gmp--292273.html 0.6 2026-04-24T06:25:09+08:00 daily https://www.pharmasources.com/industryinsights/should-pregnant-women-always-be-treated--292274.html 0.6 2026-08-08T21:33:45+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-may-affect-chances-against-292275.html 0.6 2026-08-09T01:26:18+08:00 daily https://www.pharmasources.com/industryinsights/1-in-4-us-adults-1-in-10-teens-use-tobac-292276.html 0.6 2026-08-08T18:41:26+08:00 daily https://www.pharmasources.com/industryinsights/rates-of-early-deaths-rise-for-whites-dr-292277.html 0.6 2026-02-15T13:30:32+08:00 daily https://www.pharmasources.com/industryinsights/the-medicines-patent-pool-announces-firs-292278.html 0.6 2026-06-22T10:57:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-says-court-battle-will-delay-it-292279.html 0.6 2026-04-08T21:50:40+08:00 daily https://www.pharmasources.com/industryinsights/narcan-naloxone-hcl-nasal-spray-2mg-appr-292280.html 0.6 2025-12-01T23:17:56+08:00 daily https://www.pharmasources.com/industryinsights/depuy-synthes-announces-exclusive-co-pro-292281.html 0.6 2026-08-06T23:32:11+08:00 daily https://www.pharmasources.com/industryinsights/uniqure-appoints-alexander-kuta-as-senio-292282.html 0.6 2026-08-06T21:47:02+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-takes-ownership-of-hq-for-720m-292283.html 0.6 2026-08-06T23:47:56+08:00 daily https://www.pharmasources.com/industryinsights/mhra-accepts-roches-tecentriq-into-early-292284.html 0.6 2026-08-06T22:08:08+08:00 daily https://www.pharmasources.com/industryinsights/voyager-therapeutics-announces-publicati-292285.html 0.6 2026-08-10T01:02:47+08:00 daily https://www.pharmasources.com/industryinsights/reach-separations-celebrates-5th-birthda-292286.html 0.6 2026-08-06T21:47:30+08:00 daily https://www.pharmasources.com/industryinsights/japan-ip-high-court-rules-in-lillys-favo-292287.html 0.6 2026-08-06T20:05:48+08:00 daily https://www.pharmasources.com/industryinsights/merck-gets-the-thumbs-up-in-europe-for-k-292288.html 0.6 2026-08-05T07:30:18+08:00 daily https://www.pharmasources.com/industryinsights/allergan-successfully-completes-lifecell-292289.html 0.6 2026-08-06T21:47:21+08:00 daily https://www.pharmasources.com/industryinsights/biogen-completes-separation-of-global-he-292290.html 0.6 2026-08-07T03:03:00+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-xyzal-allergy-24hr-approved-for--292291.html 0.6 2026-08-09T19:00:30+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-releases-full-year-and-q4-20-292292.html 0.6 2026-08-09T19:02:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-votubia-receives-eu-approval-to-292293.html 0.6 2026-08-06T22:08:17+08:00 daily https://www.pharmasources.com/industryinsights/phrma-statement-following-meeting-with-p-292294.html 0.6 2026-08-07T12:14:33+08:00 daily https://www.pharmasources.com/industryinsights/kevzara-receives-first-approval-in-canad-292295.html 0.6 2026-08-07T05:30:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-xyzal-allergy-24hr-approved-for--292296.html 0.6 2026-08-06T23:35:44+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-grants-priority-review-to--292297.html 0.6 2026-08-09T03:00:11+08:00 daily https://www.pharmasources.com/industryinsights/epo-upholds-decision-regarding-sprycel-292298.html 0.6 2026-08-07T02:40:04+08:00 daily https://www.pharmasources.com/industryinsights/allergan-completes-lifecell-acquisition-292299.html 0.6 2026-08-09T20:59:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-bristol-myers-squibbs-opdiv-292300.html 0.6 2026-08-06T22:26:36+08:00 daily https://www.pharmasources.com/industryinsights/scientists-use-large-data-to-map-links-b-292301.html 0.6 2026-08-06T22:21:52+08:00 daily https://www.pharmasources.com/industryinsights/genomedx-collaborates-with-astellas-to-i-292302.html 0.6 2026-08-06T22:20:53+08:00 daily https://www.pharmasources.com/industryinsights/patheon-acquires-roches-manufacturing-fa-292303.html 0.6 2026-08-08T20:50:01+08:00 daily https://www.pharmasources.com/industryinsights/meridian-lab-and-apobiologix-to-develop--292304.html 0.6 2026-08-07T04:30:54+08:00 daily https://www.pharmasources.com/industryinsights/janssen-human-microbiome-institute-annou-292305.html 0.6 2026-08-06T21:58:31+08:00 daily https://www.pharmasources.com/industryinsights/onxeo-and-institut-curie-to-study-benefi-292306.html 0.6 2026-08-06T23:47:21+08:00 daily https://www.pharmasources.com/industryinsights/mylan-wins-court-ruling-for-copaxone-40m-292307.html 0.6 2026-08-08T22:54:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-abbott-the-first-commercial-a-292308.html 0.6 2026-08-06T23:57:05+08:00 daily https://www.pharmasources.com/industryinsights/teva-confirms-generic-victoza-patent-cha-292309.html 0.6 2026-08-06T23:35:50+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-fourth-quarter-and-full--292310.html 0.6 2026-08-07T13:16:30+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-to-acquire-primary-care-platform-i-292311.html 0.6 2026-08-08T20:48:11+08:00 daily https://www.pharmasources.com/industryinsights/victorian-government-receives-funding-fo-292312.html 0.6 2026-08-09T01:39:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-abbotts-molecular-zika-viru-292313.html 0.6 2026-08-06T22:54:26+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-breast-cancer-drug-too-expensive-292314.html 0.6 2026-08-06T22:21:13+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-treatment-fast-tracked-und-292315.html 0.6 2026-08-06T22:08:00+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-qidp-fast-tr-292316.html 0.6 2026-08-09T00:06:41+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-growth-continues-to-set-t-292317.html 0.6 2026-08-08T23:39:10+08:00 daily https://www.pharmasources.com/industryinsights/endpoint-selected-as-sole-irt-provider-f-292318.html 0.6 2026-08-08T20:03:04+08:00 daily https://www.pharmasources.com/industryinsights/ttp-ventus-formed-to-commercialise-micro-292319.html 0.6 2026-08-06T20:06:20+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-expands-end-to-end-biodev-292320.html 0.6 2026-07-02T16:54:27+08:00 daily https://www.pharmasources.com/industryinsights/icagen-announces-distribution-agreement--292321.html 0.6 2026-08-07T02:40:36+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-experts-make-pharma-predi-292322.html 0.6 2026-08-06T23:23:06+08:00 daily https://www.pharmasources.com/industryinsights/co-formulate-strengthens-relationship-wi-292323.html 0.6 2026-08-06T23:46:21+08:00 daily https://www.pharmasources.com/industryinsights/innova-biosciences-introduces-the-conjug-292324.html 0.6 2026-07-04T06:35:04+08:00 daily https://www.pharmasources.com/industryinsights/taiwan-china-recorded-new-hiv-cases-in-2-292325.html 0.6 2026-08-06T22:26:38+08:00 daily https://www.pharmasources.com/industryinsights/aerie-pharmaceuticals-appoints-barry-ivi-292326.html 0.6 2026-07-04T11:00:33+08:00 daily https://www.pharmasources.com/industryinsights/the-safelia-autoinjector-wins-the-exhibi-292327.html 0.6 2026-08-06T22:13:38+08:00 daily https://www.pharmasources.com/industryinsights/south-korea-approves-commercialization-o-292328.html 0.6 2026-06-22T03:29:51+08:00 daily https://www.pharmasources.com/industryinsights/chinas-vincent-medical-holdings-invests--292329.html 0.6 2026-08-06T19:59:37+08:00 daily https://www.pharmasources.com/industryinsights/malaria-superbugs-spreading-across-asia--292330.html 0.6 2026-08-06T21:54:38+08:00 daily https://www.pharmasources.com/industryinsights/sio2-medical-products-receives-marketing-292331.html 0.6 2026-08-06T22:00:14+08:00 daily https://www.pharmasources.com/industryinsights/orbusneich-expands-portfolio-with-a-next-292332.html 0.6 2026-08-06T22:00:13+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-biologics-license-applica-292333.html 0.6 2026-08-08T23:49:26+08:00 daily https://www.pharmasources.com/industryinsights/nuts-can-inhibit-the-growth-of-cancer-ce-292334.html 0.6 2026-08-06T22:21:12+08:00 daily https://www.pharmasources.com/industryinsights/potential-new-cancer-treatment-activates-292335.html 0.6 2026-06-09T04:52:12+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-registers-net-profit-of-rs-605-cr-292336.html 0.6 2026-08-06T23:46:32+08:00 daily https://www.pharmasources.com/industryinsights/vav-life-sciences-launches-indias-first--292337.html 0.6 2026-08-09T18:41:19+08:00 daily https://www.pharmasources.com/industryinsights/piramal-enterprises-to-acquire-portfolio-292338.html 0.6 2026-08-08T21:42:46+08:00 daily https://www.pharmasources.com/industryinsights/south-koreas-mezzion-pharma-files-suit-a-292339.html 0.6 2026-08-09T03:58:16+08:00 daily https://www.pharmasources.com/industryinsights/sta-pharma-expands-changzhou-site-292340.html 0.6 2026-06-08T00:41:35+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-receives-biothrax--292341.html 0.6 2026-08-06T21:54:34+08:00 daily https://www.pharmasources.com/industryinsights/quotient-clinical-acquires-seaview-resea-292342.html 0.6 2026-08-06T22:09:05+08:00 daily https://www.pharmasources.com/industryinsights/swedens-sobi-debates-sale-of-partner-pro-292343.html 0.6 2026-07-10T09:18:03+08:00 daily https://www.pharmasources.com/industryinsights/myoderm-appoints-coo-292344.html 0.6 2026-08-07T13:17:55+08:00 daily https://www.pharmasources.com/industryinsights/cytokinetics-and-royalty-pharma-sign-agr-292345.html 0.6 2026-08-06T23:33:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-airduo-respiclick-292346.html 0.6 2026-08-08T23:11:44+08:00 daily https://www.pharmasources.com/industryinsights/parexel-international-to-acquire-us-comp-292347.html 0.6 2026-08-06T22:54:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-armonair-respiclick-292348.html 0.6 2026-08-06T23:36:17+08:00 daily https://www.pharmasources.com/industryinsights/us-teens-lag-on-recommended-vaccinations-292349.html 0.6 2026-08-06T23:36:51+08:00 daily https://www.pharmasources.com/industryinsights/e-cigarettes-may-be-less-toxic-than-toba-292350.html 0.6 2026-08-06T23:33:35+08:00 daily https://www.pharmasources.com/industryinsights/molecular-devices-and-mimetas-present-ne-292351.html 0.6 2026-08-06T23:36:52+08:00 daily https://www.pharmasources.com/industryinsights/terminally-ill-obese-people-less-likely--292352.html 0.6 2026-06-08T21:10:48+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-and-leukocare-announce-strate-292353.html 0.6 2026-08-06T23:47:46+08:00 daily https://www.pharmasources.com/industryinsights/agendia-co-founder-laura-van-t-veer-wins-292354.html 0.6 2026-08-06T22:08:19+08:00 daily https://www.pharmasources.com/industryinsights/express-scripts-says-cost-of-branded-dru-292355.html 0.6 2026-08-08T08:12:32+08:00 daily https://www.pharmasources.com/industryinsights/mylan-reaches-965-million-settlement-reg-292356.html 0.6 2026-08-08T19:31:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-confirms-elevated-levels-of-belladon-292357.html 0.6 2026-08-07T15:17:31+08:00 daily https://www.pharmasources.com/industryinsights/trumps-vaccine-hesitant-views-run-agains-292358.html 0.6 2026-08-07T03:33:58+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-to-announce-fourth-quarter--292359.html 0.6 2026-08-09T14:28:20+08:00 daily https://www.pharmasources.com/industryinsights/medical-marijuana-market-size-to-reach-u-292360.html 0.6 2026-07-19T14:10:40+08:00 daily https://www.pharmasources.com/industryinsights/amgens-repatha-significantly-reduced-the-292361.html 0.6 2026-08-06T23:56:33+08:00 daily https://www.pharmasources.com/industryinsights/nanobiotix-appoints-oncology-industry-ve-292362.html 0.6 2026-06-22T00:22:39+08:00 daily https://www.pharmasources.com/industryinsights/the-austrian-center-of-industrial-biotec-292363.html 0.6 2026-08-07T03:34:03+08:00 daily https://www.pharmasources.com/industryinsights/biotech-firm-seeks-to-expand-organ-on-a--292364.html 0.6 2026-08-07T04:03:05+08:00 daily https://www.pharmasources.com/industryinsights/optibrium-and-emolecules-collaborate-on--292365.html 0.6 2026-08-09T00:42:48+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-two-si-292366.html 0.6 2026-08-09T21:01:12+08:00 daily https://www.pharmasources.com/industryinsights/regorafenib-granted-priority-review-in-t-292367.html 0.6 2026-08-06T21:38:23+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-in-cancer-development-pact-292368.html 0.6 2026-08-09T20:47:20+08:00 daily https://www.pharmasources.com/industryinsights/q-laboratories-names-chief-executive-292369.html 0.6 2026-08-09T21:49:30+08:00 daily https://www.pharmasources.com/industryinsights/amri-in-drug-discovery-alliance-292370.html 0.6 2026-08-06T20:06:35+08:00 daily https://www.pharmasources.com/industryinsights/study-links-immune-system-genetic-varian-292371.html 0.6 2026-08-06T20:07:15+08:00 daily https://www.pharmasources.com/industryinsights/cc-abhi-funds-early-stage-innovations-in-292372.html 0.6 2026-08-07T10:04:18+08:00 daily https://www.pharmasources.com/industryinsights/belgiums-ablynx-submits-marketing-author-292373.html 0.6 2026-08-09T01:18:59+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-confirms-patent-challenge-for-ge-292374.html 0.6 2026-08-09T02:14:19+08:00 daily https://www.pharmasources.com/industryinsights/could-night-shifts-heavy-lifting-impair--292375.html 0.6 2026-08-06T23:33:47+08:00 daily https://www.pharmasources.com/industryinsights/screening-hpv-vaccine-can-prevent-cervic-292376.html 0.6 2026-08-06T23:47:30+08:00 daily https://www.pharmasources.com/industryinsights/charleston-labs-and-daiichi-sankyo-recei-292377.html 0.6 2026-08-06T23:45:43+08:00 daily https://www.pharmasources.com/industryinsights/teva-appoints-interim-chief-executive-of-292378.html 0.6 2026-08-06T22:08:13+08:00 daily https://www.pharmasources.com/industryinsights/aerie-pharmaceuticals-names-director-of--292379.html 0.6 2026-08-06T23:47:43+08:00 daily https://www.pharmasources.com/industryinsights/winters-no-reason-to-hibernate-head-outs-292380.html 0.6 2026-08-06T21:54:14+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-third-quarter-and-ni-292381.html 0.6 2026-08-09T20:39:55+08:00 daily https://www.pharmasources.com/industryinsights/many-hospital-workers-are-an-unhealthy-l-292382.html 0.6 2026-08-07T13:19:09+08:00 daily https://www.pharmasources.com/industryinsights/zika-vaccine-for-women-of-childbearing-a-292383.html 0.6 2026-08-09T01:23:54+08:00 daily https://www.pharmasources.com/industryinsights/galena-moves-neuvax-herceptin-combo-stud-292384.html 0.6 2026-08-07T13:19:35+08:00 daily https://www.pharmasources.com/industryinsights/mercks-gardasil-faces-negative-impact-of-292385.html 0.6 2026-08-06T23:47:25+08:00 daily https://www.pharmasources.com/industryinsights/teva-ceo-erez-vigodman-steps-down-from-r-292386.html 0.6 2026-08-07T13:16:17+08:00 daily https://www.pharmasources.com/industryinsights/gilead-announces-lower-than-expected-201-292387.html 0.6 2026-08-07T08:45:12+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-reaches-deal-with-investor-to-re-292388.html 0.6 2026-08-06T23:47:37+08:00 daily https://www.pharmasources.com/industryinsights/prexton-therapeutics-series-b-financing--292389.html 0.6 2026-08-06T23:33:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-ang-292390.html 0.6 2026-08-06T22:53:10+08:00 daily https://www.pharmasources.com/industryinsights/lillys-trulicity-dulaglutide-label-updat-292391.html 0.6 2026-08-06T22:53:18+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-creates-vaccine-growth-in-2016-de-292392.html 0.6 2026-08-08T21:19:15+08:00 daily https://www.pharmasources.com/industryinsights/pharmapack-europe-award-winners-2017-20--292393.html 0.6 2026-08-06T23:33:06+08:00 daily https://www.pharmasources.com/industryinsights/smart-pill-bottle-receives-the-good-desi-292394.html 0.6 2026-08-06T23:35:48+08:00 daily https://www.pharmasources.com/industryinsights/keele-researchers-create-biosensor-to-be-292395.html 0.6 2026-08-07T05:31:10+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-targeted-breast-cancer-r-292396.html 0.6 2026-08-08T19:16:11+08:00 daily https://www.pharmasources.com/industryinsights/x-ray-inspection-and-metal-detection-a-f-292397.html 0.6 2026-08-06T23:47:04+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-announces-positive-top-line-res-292398.html 0.6 2026-08-06T23:46:07+08:00 daily https://www.pharmasources.com/industryinsights/in-vitro-diagnostics-ivd-quality-control-292399.html 0.6 2026-08-06T23:37:22+08:00 daily https://www.pharmasources.com/industryinsights/trod-medical-receives-us-patent-allowanc-292400.html 0.6 2026-08-07T13:15:58+08:00 daily https://www.pharmasources.com/industryinsights/mercks-parents-of-fertility-initiative-s-292401.html 0.6 2026-08-09T08:01:07+08:00 daily https://www.pharmasources.com/industryinsights/sex-drugs-and-rock-and-roll-chemistry-in-292402.html 0.6 2026-08-06T22:54:11+08:00 daily https://www.pharmasources.com/industryinsights/poly-medicure-announces-results-for-the--292403.html 0.6 2026-08-07T05:05:12+08:00 daily https://www.pharmasources.com/industryinsights/gilead-names-gm-for-canada-ops-292404.html 0.6 2026-08-06T22:20:57+08:00 daily https://www.pharmasources.com/industryinsights/genmab-appoints-cdo-292405.html 0.6 2026-08-06T23:36:25+08:00 daily https://www.pharmasources.com/industryinsights/vyome-biosciences-announces-phase-1-stud-292406.html 0.6 2026-08-06T23:32:53+08:00 daily https://www.pharmasources.com/industryinsights/wellcome-trust-grants-funding-to-exonate-292407.html 0.6 2026-08-07T05:05:19+08:00 daily https://www.pharmasources.com/industryinsights/renova-takes-over-rights-to-heart-failur-292408.html 0.6 2026-06-10T18:39:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-parsabiv-292409.html 0.6 2026-08-09T14:12:05+08:00 daily https://www.pharmasources.com/industryinsights/espero-acquires-global-rights-to-durlaza-292410.html 0.6 2026-08-06T21:47:07+08:00 daily https://www.pharmasources.com/industryinsights/smoke-free-public-housing-cuts-secondhan-292411.html 0.6 2026-08-06T23:36:15+08:00 daily https://www.pharmasources.com/industryinsights/gym-membership-makes-your-heart-fitter-t-292412.html 0.6 2026-08-06T22:53:25+08:00 daily https://www.pharmasources.com/industryinsights/is-it-parkinsons-or-something-else-blood-292413.html 0.6 2026-08-06T22:42:32+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-fourth-quarter-profit-more-than--292414.html 0.6 2026-08-06T22:54:33+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-posts-q4-profit-as-sales-292415.html 0.6 2026-08-06T22:21:05+08:00 daily https://www.pharmasources.com/industryinsights/lundbecks-experimental-alzheimers-diseas-292416.html 0.6 2026-08-09T03:11:20+08:00 daily https://www.pharmasources.com/industryinsights/allergans-fourth-quarter-revenue-climbs--292417.html 0.6 2026-08-06T23:32:14+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-continues-to-show-solid-revenue-292418.html 0.6 2026-08-07T07:21:05+08:00 daily https://www.pharmasources.com/industryinsights/blake-insomnia-therapeutics-enters-a-joi-292419.html 0.6 2026-08-06T22:08:30+08:00 daily https://www.pharmasources.com/industryinsights/astellas-names-linda-friedman-general-co-292420.html 0.6 2026-08-06T23:32:29+08:00 daily https://www.pharmasources.com/industryinsights/meiragtx-provides-clinical-trial-updates-292421.html 0.6 2026-08-06T23:37:37+08:00 daily https://www.pharmasources.com/industryinsights/galena-biopharma-announces-pricing-of-pu-292422.html 0.6 2026-08-06T22:01:14+08:00 daily https://www.pharmasources.com/industryinsights/carolyn-r-bertozzi-phd-elected-to-lilly--292423.html 0.6 2026-08-06T23:57:07+08:00 daily https://www.pharmasources.com/industryinsights/european-policy-response-to-rare-cancers-292424.html 0.6 2026-08-06T23:33:26+08:00 daily https://www.pharmasources.com/industryinsights/orthosera-closes-series-b-financing-roun-292425.html 0.6 2026-08-10T00:53:38+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-awards-grants-for-new-progra-292426.html 0.6 2026-08-06T23:56:53+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-amgens-parsabiv-to-treat-292427.html 0.6 2026-08-07T05:05:16+08:00 daily https://www.pharmasources.com/industryinsights/prexton-to-fund-two-phase-ii-studies-of--292428.html 0.6 2026-08-07T02:40:54+08:00 daily https://www.pharmasources.com/industryinsights/australian-research-receives-a125-mn-fun-292429.html 0.6 2026-04-04T09:08:26+08:00 daily https://www.pharmasources.com/industryinsights/amgen-vs-sanofi-appeals-court-suspend-pa-292430.html 0.6 2026-08-08T03:13:49+08:00 daily https://www.pharmasources.com/industryinsights/bioflo-120-newly-launched-bioprocess-con-292431.html 0.6 2026-08-06T22:21:15+08:00 daily https://www.pharmasources.com/industryinsights/applied-photophysics-appoints-louise-mad-292432.html 0.6 2026-08-06T22:54:02+08:00 daily https://www.pharmasources.com/industryinsights/medivir-ab-names-new-ceo-292433.html 0.6 2026-08-09T19:47:00+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-to-evaluate-afatini-292434.html 0.6 2026-08-10T00:07:25+08:00 daily https://www.pharmasources.com/industryinsights/china-will-continue-to-rise-as-a-key-bas-292435.html 0.6 2026-08-09T02:24:05+08:00 daily https://www.pharmasources.com/industryinsights/universal-healthcare-enrolment-to-see-gr-292436.html 0.6 2026-08-08T20:49:18+08:00 daily https://www.pharmasources.com/industryinsights/leon-nanodrugs-partners-with-bionpharma--292437.html 0.6 2026-04-21T02:35:17+08:00 daily https://www.pharmasources.com/industryinsights/an-alternative-theory-on-how-aspirin-may-292438.html 0.6 2026-04-02T01:05:08+08:00 daily https://www.pharmasources.com/industryinsights/astellas-names-friedman-general-counsel--292439.html 0.6 2026-08-06T23:32:46+08:00 daily https://www.pharmasources.com/industryinsights/allergan-reports-strong-2016-finish-with-292440.html 0.6 2026-08-09T21:14:27+08:00 daily https://www.pharmasources.com/industryinsights/lillys-trulicity-label-updated-to-includ-292441.html 0.6 2026-08-06T22:55:59+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-expands-commercial-operations--292442.html 0.6 2026-08-07T03:06:33+08:00 daily https://www.pharmasources.com/industryinsights/cladribine-tablets-significantly-reduced-292443.html 0.6 2026-08-06T23:46:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-emflaza-292444.html 0.6 2026-08-08T19:58:49+08:00 daily https://www.pharmasources.com/industryinsights/space-reshapes-astronauts-brains-study-292445.html 0.6 2026-08-06T20:06:49+08:00 daily https://www.pharmasources.com/industryinsights/college-students-seem-to-take-longer-to--292446.html 0.6 2026-08-06T20:04:51+08:00 daily https://www.pharmasources.com/industryinsights/naps-may-sharpen-a-preschoolers-language-292447.html 0.6 2026-08-06T22:08:18+08:00 daily https://www.pharmasources.com/industryinsights/do-older-guys-always-prefer-younger-wome-292448.html 0.6 2026-08-09T01:17:14+08:00 daily https://www.pharmasources.com/industryinsights/us-appeals-court-allows-sanofi-regeneron-292449.html 0.6 2026-08-06T22:21:10+08:00 daily https://www.pharmasources.com/industryinsights/acordas-experimental-parkinsons-disease--292450.html 0.6 2026-08-06T22:08:07+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-annual-outlook-for-eylea-sale-292451.html 0.6 2026-08-06T21:58:38+08:00 daily https://www.pharmasources.com/industryinsights/xo1-founding-management-team-re-unite-to-292452.html 0.6 2026-03-24T01:04:06+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biotherapeutics-strengthens-board-292453.html 0.6 2026-08-06T23:35:56+08:00 daily https://www.pharmasources.com/industryinsights/gw-planing-to-test-its-cannabinoids-in-c-292454.html 0.6 2026-08-07T13:15:37+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-leukemia-targeting-drugs-in--292455.html 0.6 2026-08-07T02:41:12+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-giants-issued-2016-financ-292456.html 0.6 2026-08-06T23:46:21+08:00 daily https://www.pharmasources.com/industryinsights/think-strategically-for-design-of-experi-292457.html 0.6 2026-06-13T05:00:10+08:00 daily https://www.pharmasources.com/industryinsights/afatinib-to-be-evaluated-in-combination--292458.html 0.6 2026-08-06T23:35:50+08:00 daily https://www.pharmasources.com/industryinsights/appeals-court-grants-stay-of-permanent-i-292459.html 0.6 2026-08-06T23:32:32+08:00 daily https://www.pharmasources.com/industryinsights/wittys-bet-on-vaccines-pays-off-in-gsk-c-292460.html 0.6 2026-08-06T23:54:57+08:00 daily https://www.pharmasources.com/industryinsights/3e-and-dotmatics-establish-strategic-all-292461.html 0.6 2026-08-08T20:43:50+08:00 daily https://www.pharmasources.com/industryinsights/global-pharmaceutical-packaging-market-e-292462.html 0.6 2026-04-17T02:30:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-to-treat-duchenne-musc-292463.html 0.6 2026-01-24T13:34:42+08:00 daily https://www.pharmasources.com/industryinsights/owlstone-medical-commences-1400-patient--292464.html 0.6 2026-07-08T02:19:08+08:00 daily https://www.pharmasources.com/industryinsights/armetheon-to-conduct-a-1000-patient-sing-292465.html 0.6 2026-08-08T23:22:13+08:00 daily https://www.pharmasources.com/industryinsights/sta-pharma-changzhou-site-expands-rd-tea-292466.html 0.6 2026-03-08T20:44:54+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-reports-fourth-quarter-and-ful-292467.html 0.6 2026-08-06T23:33:33+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-announces-agreement-wit-292468.html 0.6 2026-08-07T13:18:32+08:00 daily https://www.pharmasources.com/industryinsights/aveo-announces-clinical-and-regulatory-u-292469.html 0.6 2026-08-06T21:54:28+08:00 daily https://www.pharmasources.com/industryinsights/avanzcare-quickly-becoming-a-significant-292470.html 0.6 2026-08-07T13:15:22+08:00 daily https://www.pharmasources.com/industryinsights/merck-foundation-announces-six-program-g-292471.html 0.6 2026-08-06T23:34:09+08:00 daily https://www.pharmasources.com/industryinsights/1000-patient-phase-iii-study-required-fo-292472.html 0.6 2026-08-06T23:37:10+08:00 daily https://www.pharmasources.com/industryinsights/natural-cycles-fertility-tracking-app-ap-292473.html 0.6 2026-08-06T23:47:16+08:00 daily https://www.pharmasources.com/industryinsights/newlink-genetics-selects-cevecs-cap-tech-292474.html 0.6 2026-08-04T01:06:40+08:00 daily https://www.pharmasources.com/industryinsights/werum-it-eis-in-pas-x-service-partnershi-292475.html 0.6 2026-08-06T22:54:06+08:00 daily https://www.pharmasources.com/industryinsights/cocoon-biotech-teams-up-with-camargo-292476.html 0.6 2026-08-06T22:53:50+08:00 daily https://www.pharmasources.com/industryinsights/impel-partners-with-camargo-for-developm-292477.html 0.6 2026-08-06T23:55:38+08:00 daily https://www.pharmasources.com/industryinsights/zenith-technologies-strengthens-managed--292478.html 0.6 2026-08-09T01:28:35+08:00 daily https://www.pharmasources.com/industryinsights/be-your-childs-valentine-292479.html 0.6 2026-07-17T11:44:14+08:00 daily https://www.pharmasources.com/industryinsights/how-to-stay-on-your-feet-during-slippery-292480.html 0.6 2026-08-06T21:47:09+08:00 daily https://www.pharmasources.com/industryinsights/flu-cases-spiking-across-the-united-stat-292481.html 0.6 2026-08-06T23:33:24+08:00 daily https://www.pharmasources.com/industryinsights/cancer-survivors-gain-from-web-based-hea-292482.html 0.6 2026-08-07T13:02:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-az-daxas-for-copd-292483.html 0.6 2026-08-09T19:27:06+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-awards-71m-to-first-grand-challeng-292484.html 0.6 2026-08-06T21:59:03+08:00 daily https://www.pharmasources.com/industryinsights/relationship-expert-teams-up-with-pfizer-292485.html 0.6 2026-08-06T21:47:24+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-gains-rights-to-immunom-292486.html 0.6 2026-08-06T20:06:25+08:00 daily https://www.pharmasources.com/industryinsights/stada-receives-two-takeover-proposals-in-292487.html 0.6 2026-08-06T20:03:12+08:00 daily https://www.pharmasources.com/industryinsights/3-biotech-stocks-able-to-weather-an-unst-292488.html 0.6 2026-08-06T23:36:43+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-once-daily--292489.html 0.6 2026-08-07T13:17:44+08:00 daily https://www.pharmasources.com/industryinsights/qa-on-strategies-for-earlier-diagnosis-o-292490.html 0.6 2026-08-06T21:48:59+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-enrollment-o-292491.html 0.6 2026-08-06T23:47:39+08:00 daily https://www.pharmasources.com/industryinsights/chinasavvy-lands-13-million-engineering--292492.html 0.6 2026-08-06T23:45:11+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-enrolled-in-phase-ii-study-292493.html 0.6 2025-12-14T06:54:49+08:00 daily https://www.pharmasources.com/industryinsights/pharma-exhibitors-at-cphi-south-east-asi-292494.html 0.6 2026-08-07T05:05:26+08:00 daily https://www.pharmasources.com/industryinsights/aquarium-to-bedside-drug-shows-promise-i-292495.html 0.6 2026-08-06T23:36:24+08:00 daily https://www.pharmasources.com/industryinsights/selonterra-publishes-novel-proprietary-m-292496.html 0.6 2026-08-06T23:46:57+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-pcpa-sign-agree-292497.html 0.6 2026-08-06T23:56:06+08:00 daily https://www.pharmasources.com/industryinsights/ttp-labtech-introduces-dragonfly-discove-292498.html 0.6 2026-08-09T01:25:36+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-buys-four-biosimilar-pr-292499.html 0.6 2026-08-08T22:36:38+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-emflaza-tablets-to-treat-292500.html 0.6 2026-08-06T21:47:06+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-incytes-leukaemia-drug-for-292501.html 0.6 2026-08-06T22:01:10+08:00 daily https://www.pharmasources.com/industryinsights/the-cancer-drugs-fund-292502.html 0.6 2026-08-08T20:06:31+08:00 daily https://www.pharmasources.com/industryinsights/10th-annual-clinical-research-conference-292503.html 0.6 2026-08-06T23:32:20+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-acquire-zeltiq-for-247b-292504.html 0.6 2026-08-10T00:38:55+08:00 daily https://www.pharmasources.com/industryinsights/india-pharma-2017-india-medical-device-2-292505.html 0.6 2026-08-09T21:23:27+08:00 daily https://www.pharmasources.com/industryinsights/how-eating-less-can-slow-the-aging-proce-292506.html 0.6 2026-08-09T23:01:27+08:00 daily https://www.pharmasources.com/industryinsights/inducing-an-identity-crisis-in-liver-cel-292507.html 0.6 2026-08-06T22:20:59+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-pharmaceuticals-q3-net-s-292508.html 0.6 2026-08-06T22:20:45+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-teva-292509.html 0.6 2026-08-09T02:02:37+08:00 daily https://www.pharmasources.com/industryinsights/symbiosis-opens-north-america-office-292510.html 0.6 2026-08-09T00:11:15+08:00 daily https://www.pharmasources.com/industryinsights/antares-moves-hq-to-moorestown-nj-292511.html 0.6 2026-08-06T22:53:32+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-announces-plans-to-purs-292512.html 0.6 2026-08-06T22:53:42+08:00 daily https://www.pharmasources.com/industryinsights/mediterranean-diet-plus-olive-oil-a-boos-292513.html 0.6 2026-08-07T02:40:08+08:00 daily https://www.pharmasources.com/industryinsights/the-best-place-to-find-your-valentine-292514.html 0.6 2026-08-09T02:36:05+08:00 daily https://www.pharmasources.com/industryinsights/tevas-fourth-quarter-sales-jump-33-perce-292515.html 0.6 2026-08-09T22:41:17+08:00 daily https://www.pharmasources.com/industryinsights/galena-biopharma-announces-closing-of-pu-292516.html 0.6 2026-08-06T20:47:43+08:00 daily https://www.pharmasources.com/industryinsights/us-lawmakers-question-price-of-marathons-292517.html 0.6 2026-03-01T07:38:38+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-agrees-to-sell-five-otc-products--292518.html 0.6 2026-08-09T15:39:03+08:00 daily https://www.pharmasources.com/industryinsights/uks-acacia-to-file-rescue-ponv-drug-in-t-292519.html 0.6 2026-08-06T23:35:55+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-reports-fourth-quarter-and--292520.html 0.6 2026-08-07T06:07:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-drug-trials-snapshots-and-diversity--292521.html 0.6 2026-01-03T16:49:48+08:00 daily https://www.pharmasources.com/industryinsights/janssen-says-two-drug-combination-of-dol-292522.html 0.6 2026-08-08T18:54:39+08:00 daily https://www.pharmasources.com/industryinsights/ionis-earns-75m-from-bayer-for-advancing-292523.html 0.6 2026-08-08T21:43:16+08:00 daily https://www.pharmasources.com/industryinsights/scottish-cmo-opens-us-office-292524.html 0.6 2026-08-06T22:08:15+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-once-daily--292525.html 0.6 2026-08-06T22:09:39+08:00 daily https://www.pharmasources.com/industryinsights/top-pharmacovigilance-trend-in-2017-292526.html 0.6 2026-08-06T22:08:57+08:00 daily https://www.pharmasources.com/industryinsights/hikmas-exclusive-licensing-agreement-wit-292527.html 0.6 2026-08-07T02:30:53+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-announces-plans-to-purs-292528.html 0.6 2026-08-06T21:59:08+08:00 daily https://www.pharmasources.com/industryinsights/ferring-backs-foresees-sif-platform-for--292529.html 0.6 2026-06-20T19:33:41+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-to-acquire-a-portfolio-of-select-c-292530.html 0.6 2026-08-06T23:32:58+08:00 daily https://www.pharmasources.com/industryinsights/endpoints-500th-irt-trial-has-them-looki-292531.html 0.6 2026-08-06T23:48:07+08:00 daily https://www.pharmasources.com/industryinsights/hitachi-announces-integration-and-expans-292532.html 0.6 2026-08-07T13:15:02+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-to-support-promab-biotechnologi-292533.html 0.6 2026-08-06T23:36:58+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-compass-study-with-bayers-riva-292534.html 0.6 2026-08-06T23:33:46+08:00 daily https://www.pharmasources.com/industryinsights/350-medical-and-patient-groups-write-to--292535.html 0.6 2026-08-06T21:58:52+08:00 daily https://www.pharmasources.com/industryinsights/case-grande-inks-pact-with-coldman-logis-292536.html 0.6 2026-08-08T01:45:49+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-posts-consolidated-revenue--292537.html 0.6 2026-08-09T02:11:16+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-posts-rs-7683-crs-sales-in-q3-292538.html 0.6 2026-08-08T20:19:51+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-acquire-us-medical-technolog-292539.html 0.6 2026-08-07T01:20:17+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-to-acquire-five-consumer-healthcar-292540.html 0.6 2026-08-10T01:21:21+08:00 daily https://www.pharmasources.com/industryinsights/novimmune-and-legochem-evaluate-antibody-292541.html 0.6 2026-08-06T22:54:05+08:00 daily https://www.pharmasources.com/industryinsights/5-ways-women-can-cut-their-heart-attack--292542.html 0.6 2026-08-06T23:35:50+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-not-a-quick-fix-for-hay-fe-292543.html 0.6 2026-08-06T22:08:10+08:00 daily https://www.pharmasources.com/industryinsights/zika-lingers-in-semen-for-less-time-than-292544.html 0.6 2026-08-06T23:33:49+08:00 daily https://www.pharmasources.com/industryinsights/gilead-reports-positive-mid-stage-data-f-292545.html 0.6 2026-07-20T17:49:39+08:00 daily https://www.pharmasources.com/industryinsights/actelions-fourth-quarter-sales-profit-ri-292546.html 0.6 2026-08-09T03:21:31+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-seen-as-takeover-ba-292547.html 0.6 2026-08-09T12:11:57+08:00 daily https://www.pharmasources.com/industryinsights/rcsi-and-almac-discovery-enter-research--292548.html 0.6 2026-08-06T20:07:55+08:00 daily https://www.pharmasources.com/industryinsights/incyte-and-agenus-amend-collaboration-ag-292549.html 0.6 2026-06-02T06:43:39+08:00 daily https://www.pharmasources.com/industryinsights/additional-results-from-pivotal-ra-beam--292550.html 0.6 2026-08-06T22:54:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-gsk-targeted-for-vaccine-pricing--292551.html 0.6 2026-08-06T23:56:15+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-once-daily-olumiant-tablets--292552.html 0.6 2026-08-06T23:54:49+08:00 daily https://www.pharmasources.com/industryinsights/alzheon-to-present-new-clinical-data-and-292553.html 0.6 2026-08-06T23:45:20+08:00 daily https://www.pharmasources.com/industryinsights/msds-alzheimers-drug-failure-undermines--292554.html 0.6 2026-08-06T23:54:45+08:00 daily https://www.pharmasources.com/industryinsights/us-panel-endorses-human-embryo-gene-edit-292555.html 0.6 2026-08-06T22:21:25+08:00 daily https://www.pharmasources.com/industryinsights/new-cancer-drug-could-give-hope-to-non-r-292556.html 0.6 2026-08-06T22:08:55+08:00 daily https://www.pharmasources.com/industryinsights/stada-encourages-bidding-war-with-figure-292557.html 0.6 2026-08-06T21:59:40+08:00 daily https://www.pharmasources.com/industryinsights/x-chem-janssen-biotech-expand-discovery--292558.html 0.6 2026-08-09T20:03:24+08:00 daily https://www.pharmasources.com/industryinsights/almac-diagnostics-appoints-vp-of-uk-ops-292559.html 0.6 2026-08-09T11:07:12+08:00 daily https://www.pharmasources.com/industryinsights/mammatyper-enables-more-precise-predicti-292560.html 0.6 2026-08-09T19:24:29+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-elemental-analysis-capabilit-292561.html 0.6 2026-08-09T19:54:44+08:00 daily https://www.pharmasources.com/industryinsights/ubm-india-announces-cphis-5th-annual-pha-292562.html 0.6 2026-08-06T22:53:50+08:00 daily https://www.pharmasources.com/industryinsights/some-docs-may-help-fuel-opioid-abuse-epi-292563.html 0.6 2026-08-08T23:19:31+08:00 daily https://www.pharmasources.com/industryinsights/weight-loss-surgery-may-help-obese-patie-292564.html 0.6 2026-08-07T05:37:25+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-bags-apac-mass-spectrometry-com-292565.html 0.6 2026-08-06T23:56:30+08:00 daily https://www.pharmasources.com/industryinsights/viiv-study-shows-efficacy-of-two-drug-hi-292566.html 0.6 2026-08-06T22:00:10+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-alexions-rare-disease-thera-292567.html 0.6 2026-08-06T21:47:28+08:00 daily https://www.pharmasources.com/industryinsights/ritter-and-ubc-to-study-role-of-microbio-292568.html 0.6 2026-04-05T17:51:45+08:00 daily https://www.pharmasources.com/industryinsights/delivering-stps-will-need-capital-fundin-292569.html 0.6 2026-01-12T23:15:18+08:00 daily https://www.pharmasources.com/industryinsights/vifor-pharma-gains-commercialisation-rig-292570.html 0.6 2026-08-07T00:02:01+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-and-incyte-receive-ecs-marketi-292571.html 0.6 2026-08-07T05:36:56+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-weill-cornell-m-292572.html 0.6 2026-08-06T22:31:48+08:00 daily https://www.pharmasources.com/industryinsights/the-fda-has-approved-tirosint-sol-levoth-292573.html 0.6 2026-08-06T23:32:26+08:00 daily https://www.pharmasources.com/industryinsights/pra-health-sciences-and-takeda-partnersh-292574.html 0.6 2026-08-06T23:32:26+08:00 daily https://www.pharmasources.com/industryinsights/versant-ventures-launches-jecure-therape-292575.html 0.6 2026-08-06T23:32:39+08:00 daily https://www.pharmasources.com/industryinsights/cytori-completes-acquisition-of-azaya-th-292576.html 0.6 2026-08-06T23:37:30+08:00 daily https://www.pharmasources.com/industryinsights/us-patent-office-rules-in-favour-of-broa-292577.html 0.6 2026-08-09T14:33:15+08:00 daily https://www.pharmasources.com/industryinsights/zika-virus-vaccines-global-market-expect-292578.html 0.6 2026-08-10T01:24:20+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-initiates-study-of-u3-140-292579.html 0.6 2026-06-10T10:02:35+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-supports-mainst-292580.html 0.6 2026-08-06T23:32:28+08:00 daily https://www.pharmasources.com/industryinsights/astellas-announces-participation-in-acce-292581.html 0.6 2026-08-06T20:47:54+08:00 daily https://www.pharmasources.com/industryinsights/immune-cell-study-prompts-rethink-on-how-292582.html 0.6 2026-08-06T23:56:13+08:00 daily https://www.pharmasources.com/industryinsights/amag-pharmaceuticals-signs-us-licence-ag-292583.html 0.6 2026-08-06T21:53:04+08:00 daily https://www.pharmasources.com/industryinsights/siliq-approved-by-the-fda-for-adult-pati-292584.html 0.6 2026-08-07T10:21:38+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-siliq-to-treat-plaque-ps-292585.html 0.6 2026-08-06T22:09:39+08:00 daily https://www.pharmasources.com/industryinsights/charleston-laboratories-announces-senior-292586.html 0.6 2026-08-09T00:51:21+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-and-helsinn-expand-licensing-292587.html 0.6 2026-08-09T05:18:26+08:00 daily https://www.pharmasources.com/industryinsights/shire-reports-full-year-2016-results-wit-292588.html 0.6 2026-08-06T22:55:09+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-extends-collaborati-292589.html 0.6 2026-08-06T21:59:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-biologics-license-applicatio-292590.html 0.6 2026-08-07T02:41:16+08:00 daily https://www.pharmasources.com/industryinsights/ensuring-content-and-package-quality-wit-292591.html 0.6 2026-07-19T06:48:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-spiriva-respimat-292592.html 0.6 2026-08-06T22:00:14+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-presents-thought-le-292593.html 0.6 2026-08-06T21:54:28+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-to-acquire-multipli-292594.html 0.6 2026-08-06T23:33:36+08:00 daily https://www.pharmasources.com/industryinsights/the-female-health-companyveru-healthcare-292595.html 0.6 2026-08-06T22:08:17+08:00 daily https://www.pharmasources.com/industryinsights/trumps-not-going-to-back-down-from-vacci-292596.html 0.6 2026-08-06T23:54:30+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-siliq-brodalumab-approved-by-292597.html 0.6 2026-08-06T22:08:40+08:00 daily https://www.pharmasources.com/industryinsights/generic-and-biosimilar-manufacturers-lau-292598.html 0.6 2026-08-06T22:08:49+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-elemental-impurity-testing-s-292599.html 0.6 2026-08-08T23:14:22+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-eli-lillys-rheumatoid-arthri-292600.html 0.6 2026-06-09T19:14:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-does-not-recommend-abbvies-leukaemi-292601.html 0.6 2026-08-07T00:02:45+08:00 daily https://www.pharmasources.com/industryinsights/sophia-ai-becomes-the-technology-of-choi-292602.html 0.6 2026-06-14T06:30:31+08:00 daily https://www.pharmasources.com/industryinsights/polyganics-stop-neuroma-study-interim-da-292603.html 0.6 2026-08-08T21:08:12+08:00 daily https://www.pharmasources.com/industryinsights/mammatyper-enables-more-precise-predicti-292604.html 0.6 2026-08-07T13:18:01+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-centreone-expands-fill-finish-ser-292605.html 0.6 2026-08-06T23:32:52+08:00 daily https://www.pharmasources.com/industryinsights/lonza-and-selecta-biosciences-in-mfg-pac-292606.html 0.6 2026-08-06T23:47:51+08:00 daily https://www.pharmasources.com/industryinsights/x-chem-janssen-biotech-expand-discovery--292607.html 0.6 2026-08-06T22:08:41+08:00 daily https://www.pharmasources.com/industryinsights/working-together-to-fight-tb-and-drug-re-292608.html 0.6 2026-08-06T23:36:38+08:00 daily https://www.pharmasources.com/industryinsights/flu-vaccine-a-pretty-good-match-for-viru-292609.html 0.6 2026-08-06T23:45:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-valeants-siliq-for-plaque-p-292610.html 0.6 2026-08-07T03:33:28+08:00 daily https://www.pharmasources.com/industryinsights/shires-fourth-quarter-sales-more-than-do-292611.html 0.6 2026-08-09T12:47:16+08:00 daily https://www.pharmasources.com/industryinsights/alexion-forecasts-soliris-growth-for-201-292612.html 0.6 2026-04-18T20:41:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-spiriva-respimat-292613.html 0.6 2026-08-06T23:55:44+08:00 daily https://www.pharmasources.com/industryinsights/prospects-of-fda-technical-guidance-work-292614.html 0.6 2026-08-06T22:53:11+08:00 daily https://www.pharmasources.com/industryinsights/prospects-of-fda-technical-guidance-work-292615.html 0.6 2026-08-06T22:18:53+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn2017217-292616.html 0.6 2026-08-06T22:26:16+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-enters-into-a-corporate-partne-292617.html 0.6 2026-04-03T21:06:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-spiriva-respimat-292618.html 0.6 2026-08-06T22:09:18+08:00 daily https://www.pharmasources.com/industryinsights/catalent-completes-accucaps-acquisition-292619.html 0.6 2026-08-06T22:54:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bla-for-mylan-and-biocons-pr-292620.html 0.6 2026-01-29T16:23:43+08:00 daily https://www.pharmasources.com/industryinsights/valeants-treatment-for-plaque-psoriasis--292621.html 0.6 2026-08-06T22:00:01+08:00 daily https://www.pharmasources.com/industryinsights/is-digital-disruption-of-heart-disease-m-292622.html 0.6 2026-08-06T22:07:59+08:00 daily https://www.pharmasources.com/industryinsights/cutting-costs-but-not-quality-heart-fail-292623.html 0.6 2026-08-06T23:36:09+08:00 daily https://www.pharmasources.com/industryinsights/japans-takeda-acquires-us-cancer-drug-ma-292624.html 0.6 2026-08-07T02:31:15+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-meets-primary-endpoint-in-phase-292625.html 0.6 2026-08-09T12:42:56+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-closure-of-its-australi-292626.html 0.6 2026-05-08T06:43:56+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-expands-oncology-portfolio-292627.html 0.6 2026-08-06T22:08:39+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-pharmaceuticals-appoints-chief-ex-292628.html 0.6 2026-08-06T23:55:26+08:00 daily https://www.pharmasources.com/industryinsights/mclinica-raises-63-million-series-a-fund-292629.html 0.6 2026-03-12T17:56:26+08:00 daily https://www.pharmasources.com/industryinsights/ionis-and-akcea-to-collaborate-with-nova-292630.html 0.6 2026-08-06T23:46:22+08:00 daily https://www.pharmasources.com/industryinsights/takeda-completes-acquisition-of-ariad-ph-292631.html 0.6 2026-08-08T19:21:00+08:00 daily https://www.pharmasources.com/industryinsights/merck-launches-ilm-health-solutions-292632.html 0.6 2026-08-08T22:26:55+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-partners-with-the-european-mol-292633.html 0.6 2026-08-06T22:06:10+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-to-acquire-multipli-292634.html 0.6 2026-08-07T13:15:59+08:00 daily https://www.pharmasources.com/industryinsights/optibrium-signs-agreement-with-zastra-in-292635.html 0.6 2026-08-06T22:13:04+08:00 daily https://www.pharmasources.com/industryinsights/reach-separations-celebrates-fifth-birth-292636.html 0.6 2026-08-10T00:50:27+08:00 daily https://www.pharmasources.com/industryinsights/heptares-therapeutics-enters-a-new-resea-292637.html 0.6 2026-04-22T23:32:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-psoriasis-drug-that-ind-292638.html 0.6 2026-07-06T12:54:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-mylan-and-biocons-biosimil-292639.html 0.6 2026-08-07T13:19:08+08:00 daily https://www.pharmasources.com/industryinsights/your-computer-can-help-scientists-search-292640.html 0.6 2026-08-08T01:17:32+08:00 daily https://www.pharmasources.com/industryinsights/dna-computer-brings-intelligent-drugs-a--292641.html 0.6 2026-08-06T21:47:06+08:00 daily https://www.pharmasources.com/industryinsights/spider-web-of-cancer-proteins-reveals-ne-292642.html 0.6 2026-08-06T21:52:27+08:00 daily https://www.pharmasources.com/industryinsights/siliq-brodalumab-approved-by-the-us-fda--292643.html 0.6 2026-07-24T01:22:46+08:00 daily https://www.pharmasources.com/industryinsights/anti-addiction-meds-given-in-er-can-help-292644.html 0.6 2026-08-07T13:16:32+08:00 daily https://www.pharmasources.com/industryinsights/chinese-affordable-lung-cancer-drug-hits-292645.html 0.6 2026-08-06T20:05:58+08:00 daily https://www.pharmasources.com/industryinsights/indian-biosimilar-market-likely-to-touch-292646.html 0.6 2026-08-06T19:23:08+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-announces-fda-final-approval-for-292647.html 0.6 2026-08-06T20:01:31+08:00 daily https://www.pharmasources.com/industryinsights/baxalta-buy-drives-huge-leap-in-shires-q-292648.html 0.6 2026-08-06T21:54:06+08:00 daily https://www.pharmasources.com/industryinsights/trends-in-pharmaceutical-mergers-and-acq-292649.html 0.6 2026-06-13T16:57:17+08:00 daily https://www.pharmasources.com/industryinsights/dbt-to-jointly-fund-global-research-to-a-292650.html 0.6 2026-08-06T23:33:35+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-in-fortunes-2017-list-of-wo-292651.html 0.6 2026-08-06T21:48:57+08:00 daily https://www.pharmasources.com/industryinsights/phase-ii-study-supports-potential-for-ge-292652.html 0.6 2026-08-08T22:32:04+08:00 daily https://www.pharmasources.com/industryinsights/foresee-pharmaceuticals-announces-top-li-292653.html 0.6 2026-08-06T22:08:56+08:00 daily https://www.pharmasources.com/industryinsights/frutarom-health-increases-phytopharmaceu-292654.html 0.6 2026-08-06T23:36:16+08:00 daily https://www.pharmasources.com/industryinsights/almac-group-launches-next-generation-tem-292655.html 0.6 2026-08-06T23:32:29+08:00 daily https://www.pharmasources.com/industryinsights/vectura-achieves-9-million-royalty-cap-f-292656.html 0.6 2026-08-09T02:12:03+08:00 daily https://www.pharmasources.com/industryinsights/amygdala-neurosciences-to-acquire-gs-663-292657.html 0.6 2026-08-07T05:05:29+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-weill-cornell-m-292658.html 0.6 2026-08-09T03:28:09+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-nhs-ayrshire-arran-launch-n-292659.html 0.6 2026-08-09T03:18:42+08:00 daily https://www.pharmasources.com/industryinsights/vivo-healthcare-received-investment-from-292660.html 0.6 2026-08-09T19:37:59+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-find-vitamin-b3-prevents--292661.html 0.6 2026-08-06T23:46:39+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-health-monitoring-system-in-292662.html 0.6 2026-08-06T23:55:58+08:00 daily https://www.pharmasources.com/industryinsights/sustainable-development-indicators-can-s-292663.html 0.6 2026-08-06T22:21:02+08:00 daily https://www.pharmasources.com/industryinsights/malaria-control-efforts-can-benefit-from-292664.html 0.6 2026-08-06T22:31:56+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-healthcares-biosimilar-shows-p-292665.html 0.6 2026-08-06T22:08:09+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-enters-agreement-with-terser-292666.html 0.6 2026-08-08T19:23:11+08:00 daily https://www.pharmasources.com/industryinsights/kids-born-to-older-moms-score-higher-on--292667.html 0.6 2026-08-06T23:45:34+08:00 daily https://www.pharmasources.com/industryinsights/the-short--and-long-term-prognosis-for-o-292668.html 0.6 2026-08-06T23:45:54+08:00 daily https://www.pharmasources.com/industryinsights/dont-skip-veggies-in-winter-292669.html 0.6 2026-08-06T23:48:40+08:00 daily https://www.pharmasources.com/industryinsights/cancer-survivors-skip-prescription-drugs-292670.html 0.6 2026-05-29T02:42:56+08:00 daily https://www.pharmasources.com/industryinsights/nordic-nanovector-sees-interest-from-buy-292671.html 0.6 2026-08-07T04:24:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-plans-india-bio-production-plant-292672.html 0.6 2026-08-06T23:57:02+08:00 daily https://www.pharmasources.com/industryinsights/karolinska-development-company-modus-the-292673.html 0.6 2026-08-06T23:33:03+08:00 daily https://www.pharmasources.com/industryinsights/hospitals-to-buy-cancer-drugs-collective-292674.html 0.6 2026-08-06T23:37:24+08:00 daily https://www.pharmasources.com/industryinsights/hikma-announces-exclusive-licensing-agre-292675.html 0.6 2026-08-09T01:37:42+08:00 daily https://www.pharmasources.com/industryinsights/sobi-expands-haemophilia-b-development-p-292676.html 0.6 2026-08-06T22:14:11+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lynparza-hits-breast-cancer-292677.html 0.6 2026-08-09T01:12:40+08:00 daily https://www.pharmasources.com/industryinsights/company-funded-studies-of-approved-drugs-292678.html 0.6 2026-08-06T22:05:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-nhs-joint-working-pact-delivers-292679.html 0.6 2026-08-06T21:55:23+08:00 daily https://www.pharmasources.com/industryinsights/amygdala-acquires-gileads-candidate-for--292680.html 0.6 2026-08-06T22:08:34+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-and-embl-join-forces-to-offer--292681.html 0.6 2026-08-06T22:00:08+08:00 daily https://www.pharmasources.com/industryinsights/takeda-completes-acquisition-of-ariad-ph-292682.html 0.6 2026-02-23T13:15:01+08:00 daily https://www.pharmasources.com/industryinsights/cellprothera-raises-83-million-euros-292683.html 0.6 2026-08-07T06:06:58+08:00 daily https://www.pharmasources.com/industryinsights/ferring-pharmaceuticals-and-enteris-biop-292684.html 0.6 2026-08-07T06:06:54+08:00 daily https://www.pharmasources.com/industryinsights/amptec-and-cmc-pharma-close-consulting-a-292685.html 0.6 2026-08-07T05:31:08+08:00 daily https://www.pharmasources.com/industryinsights/cellgenix-headquarters-expands-to-meet-t-292686.html 0.6 2026-08-06T23:47:32+08:00 daily https://www.pharmasources.com/industryinsights/new-mid-infrared-laser-system-could-dete-292687.html 0.6 2026-08-06T23:33:05+08:00 daily https://www.pharmasources.com/industryinsights/scientists-developed-a-miniature-gas-sen-292688.html 0.6 2026-08-06T23:57:03+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-enters-agreement-with-terser-292689.html 0.6 2026-08-08T22:07:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-perrigos-hydrocodone-bitart-292690.html 0.6 2026-08-08T23:08:52+08:00 daily https://www.pharmasources.com/industryinsights/valeant-pharmaceuticals-and-eyegate-ente-292691.html 0.6 2026-08-09T00:55:40+08:00 daily https://www.pharmasources.com/industryinsights/paresthesias-nerve-problems-linked-to-wo-292692.html 0.6 2026-08-09T01:51:49+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-otsuka-and-lundbe-292693.html 0.6 2026-08-06T23:47:42+08:00 daily https://www.pharmasources.com/industryinsights/mayne-pharma-launches-methylphenidate-ex-292694.html 0.6 2026-08-06T21:46:11+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-appoints-three-new--292695.html 0.6 2026-08-06T21:03:01+08:00 daily https://www.pharmasources.com/industryinsights/online-pharmacies-could-fuel-antibiotic--292696.html 0.6 2026-08-07T05:05:25+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-protects-against-colds-and-flu-292697.html 0.6 2026-08-07T13:18:46+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-opens-first-production-unit-i-292698.html 0.6 2026-08-07T02:40:46+08:00 daily https://www.pharmasources.com/industryinsights/neurodegenerative-drugs-market-to-reach--292699.html 0.6 2026-06-12T06:12:33+08:00 daily https://www.pharmasources.com/industryinsights/sciex-launches-new-x500b-qtof-mass-spect-292700.html 0.6 2026-08-06T22:53:55+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-acquires-kemwells-pharmaceutic-292701.html 0.6 2026-08-06T22:26:19+08:00 daily https://www.pharmasources.com/industryinsights/mereo-biopharmas-bps-804-drug-accepted-f-292702.html 0.6 2026-08-06T22:18:59+08:00 daily https://www.pharmasources.com/industryinsights/us-life-expectancy-may-rise-to-over-80-b-292703.html 0.6 2026-08-06T22:53:45+08:00 daily https://www.pharmasources.com/industryinsights/no-your-cat-isnt-a-threat-to-your-mental-292704.html 0.6 2026-08-06T23:31:59+08:00 daily https://www.pharmasources.com/industryinsights/scientists-shed-light-on-possible-cause--292705.html 0.6 2026-08-08T19:42:21+08:00 daily https://www.pharmasources.com/industryinsights/loneliness-often-plagues-black-women-at--292706.html 0.6 2026-08-08T22:28:32+08:00 daily https://www.pharmasources.com/industryinsights/sanaria-works-to-tweak-malaria-vaccine-d-292707.html 0.6 2026-08-08T22:32:08+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-sells-fda-priority-review-vouche-292708.html 0.6 2026-08-09T12:38:20+08:00 daily https://www.pharmasources.com/industryinsights/carl-icahn-purchases-stake-in-bristol-my-292709.html 0.6 2026-08-06T21:58:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-amphastars-filing-for-intran-292710.html 0.6 2026-08-07T02:40:08+08:00 daily https://www.pharmasources.com/industryinsights/ibm-watson-being-trained-to-identify-abn-292711.html 0.6 2026-08-08T00:55:06+08:00 daily https://www.pharmasources.com/industryinsights/think-strategically-for-design-of-experi-292712.html 0.6 2026-06-22T22:11:22+08:00 daily https://www.pharmasources.com/industryinsights/apollo-therapeutics-launched-the-first-d-292713.html 0.6 2026-08-06T22:53:32+08:00 daily https://www.pharmasources.com/industryinsights/agilent-receives-dows-western-canada-sci-292714.html 0.6 2026-04-04T23:26:04+08:00 daily https://www.pharmasources.com/industryinsights/apollo-therapeutics-funding-of-four-init-292715.html 0.6 2026-08-06T23:35:44+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-announces-offering-of-senio-292716.html 0.6 2026-08-08T02:17:04+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-fast-track-designation-to--292717.html 0.6 2026-08-06T22:12:48+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-tersera-sign-agreement-t-292718.html 0.6 2026-08-07T13:15:24+08:00 daily https://www.pharmasources.com/industryinsights/can-yeast-rise-to-the-challenge-of-curin-292719.html 0.6 2026-08-08T19:50:16+08:00 daily https://www.pharmasources.com/industryinsights/neovacs-and-biosense-partner-to-develop--292720.html 0.6 2026-08-07T14:23:35+08:00 daily https://www.pharmasources.com/industryinsights/2016-leaves-pharma-facing-stormy-waters-292721.html 0.6 2026-08-09T00:13:49+08:00 daily https://www.pharmasources.com/industryinsights/regenerative-medicine-market-worth-us387-292722.html 0.6 2026-08-07T13:16:08+08:00 daily https://www.pharmasources.com/industryinsights/mohfw-undertakes-drug-survey-for-determi-292723.html 0.6 2026-08-06T23:36:22+08:00 daily https://www.pharmasources.com/industryinsights/sciex-launches-new-fast-glycan-labeling--292724.html 0.6 2026-08-06T23:37:36+08:00 daily https://www.pharmasources.com/industryinsights/successful-insomnia-treatment-may-requir-292725.html 0.6 2026-08-06T23:44:54+08:00 daily https://www.pharmasources.com/industryinsights/ayush-minister-to-inaugurate-world-integ-292726.html 0.6 2026-08-06T23:36:17+08:00 daily https://www.pharmasources.com/industryinsights/apitopes-phase-ii-multiple-sclerosis-tri-292727.html 0.6 2026-08-06T23:47:18+08:00 daily https://www.pharmasources.com/industryinsights/celerion-appoints-cmo-292728.html 0.6 2026-08-10T01:05:18+08:00 daily https://www.pharmasources.com/industryinsights/ppd-frenova-in-nephrology-services-colla-292729.html 0.6 2026-08-06T22:54:16+08:00 daily https://www.pharmasources.com/industryinsights/flu-vaccines-48-effective-so-far-this-se-292730.html 0.6 2026-08-06T23:23:23+08:00 daily https://www.pharmasources.com/industryinsights/an-all-in-one-mosquito-borne-diseases-va-292731.html 0.6 2026-08-07T13:15:44+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-remicade-biosimilar-displays-sim-292732.html 0.6 2026-08-06T23:48:02+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-discuva-extend-agreement-to-de-292733.html 0.6 2026-08-09T22:14:13+08:00 daily https://www.pharmasources.com/industryinsights/rabbit-virus-proves-effective-in-treatme-292734.html 0.6 2026-08-06T21:52:27+08:00 daily https://www.pharmasources.com/industryinsights/testosterone-gel-trials-reveal-mixed-res-292735.html 0.6 2026-07-05T07:03:54+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-for-pfizers-all-drug-292736.html 0.6 2026-08-09T00:33:50+08:00 daily https://www.pharmasources.com/industryinsights/msd-wayra-unveil-velocity-health-winners-292737.html 0.6 2026-08-07T13:15:17+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-roches-lung-cancer-drug-alece-292738.html 0.6 2026-03-27T12:20:53+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-yes-for-amicus-fabry-disease--292739.html 0.6 2026-08-09T19:36:26+08:00 daily https://www.pharmasources.com/industryinsights/bma-report-highlights-nhs-bed-crisis-292740.html 0.6 2026-08-09T18:38:11+08:00 daily https://www.pharmasources.com/industryinsights/is-need-for-more-sleep-a-sign-of-pending-292741.html 0.6 2026-08-06T23:36:49+08:00 daily https://www.pharmasources.com/industryinsights/unhealthy-in-middle-age-dementia-in-old--292742.html 0.6 2026-08-06T23:37:30+08:00 daily https://www.pharmasources.com/industryinsights/mris-can-be-safe-for-people-with-heart-d-292743.html 0.6 2026-08-09T17:03:52+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-announces-pricing-of-senior-292744.html 0.6 2026-08-06T22:32:59+08:00 daily https://www.pharmasources.com/industryinsights/lawmakers-decry-armys-planned-zika-vacci-292745.html 0.6 2026-08-09T18:52:12+08:00 daily https://www.pharmasources.com/industryinsights/repatha-receives-ec-approval-for-new-420-292746.html 0.6 2026-03-19T09:07:30+08:00 daily https://www.pharmasources.com/industryinsights/cell-lines-and-media-for-difficult-to-cu-292747.html 0.6 2026-01-16T03:43:37+08:00 daily https://www.pharmasources.com/industryinsights/nih-begins-study-of-vaccine-to-protect-a-292748.html 0.6 2026-08-06T22:09:04+08:00 daily https://www.pharmasources.com/industryinsights/jan-medical-and-university-of-wyoming-jo-292749.html 0.6 2026-08-06T21:55:12+08:00 daily https://www.pharmasources.com/industryinsights/china-updates-list-of-key-reimbursable-m-292750.html 0.6 2026-08-06T23:37:20+08:00 daily https://www.pharmasources.com/industryinsights/minoryx-therapeutics-receives-orphan-dru-292751.html 0.6 2026-08-06T23:41:13+08:00 daily https://www.pharmasources.com/industryinsights/werum-it-solutions-and-eis-agree-on-serv-292752.html 0.6 2026-08-06T23:47:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-phase-iii-breast-cancer-tria-292753.html 0.6 2026-08-06T22:13:13+08:00 daily https://www.pharmasources.com/industryinsights/novartis-drug-zykadia-receives-fda-prior-292754.html 0.6 2026-03-17T21:01:41+08:00 daily https://www.pharmasources.com/industryinsights/first-biosimilar-mab-in-oncology-granted-292755.html 0.6 2026-08-06T23:45:32+08:00 daily https://www.pharmasources.com/industryinsights/phrma-foundation-announces-awards-of-up--292756.html 0.6 2026-08-08T20:07:57+08:00 daily https://www.pharmasources.com/industryinsights/lannett-announces-addition-to-management-292757.html 0.6 2026-08-06T22:32:47+08:00 daily https://www.pharmasources.com/industryinsights/another-record-year-for-bayer---good-pro-292758.html 0.6 2026-08-09T17:19:46+08:00 daily https://www.pharmasources.com/industryinsights/santen-and-twoxar-announce-strategic-res-292759.html 0.6 2026-08-08T19:51:35+08:00 daily https://www.pharmasources.com/industryinsights/novartis-drug-zykadia-receives-fda-prior-292760.html 0.6 2026-08-06T22:43:52+08:00 daily https://www.pharmasources.com/industryinsights/courtagen-receives-notice-of-allowance-f-292761.html 0.6 2026-08-07T05:31:07+08:00 daily https://www.pharmasources.com/industryinsights/drugs-similar-to-aspirin-ibuprofen-could-292762.html 0.6 2026-06-08T19:13:50+08:00 daily https://www.pharmasources.com/industryinsights/puretech-health-appoints-former-gsk-svp--292763.html 0.6 2026-08-06T20:09:00+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-offers-fully-integrated-a-292764.html 0.6 2026-08-06T20:08:31+08:00 daily https://www.pharmasources.com/industryinsights/roquette-celebrates-10-years-of-operatio-292765.html 0.6 2026-08-06T21:11:56+08:00 daily https://www.pharmasources.com/industryinsights/msf-calls-on-japan-and-south-korea-to-dr-292766.html 0.6 2026-08-09T15:04:10+08:00 daily https://www.pharmasources.com/industryinsights/biolabex-opens-rd-laboratory-in-biopark--292767.html 0.6 2026-08-07T00:01:15+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-regulatory-submission-for-292768.html 0.6 2026-08-07T00:03:19+08:00 daily https://www.pharmasources.com/industryinsights/valeant-and-eyegate-sign-licensing-agree-292769.html 0.6 2026-04-12T04:22:38+08:00 daily https://www.pharmasources.com/industryinsights/northwell-health-and-ge-ventures-collabo-292770.html 0.6 2026-08-06T23:36:18+08:00 daily https://www.pharmasources.com/industryinsights/many-opioid-addicts-in-treatment-take-na-292771.html 0.6 2026-08-08T23:35:58+08:00 daily https://www.pharmasources.com/industryinsights/could-parkinsons-disease-raise-stroke-ri-292772.html 0.6 2026-08-08T20:21:57+08:00 daily https://www.pharmasources.com/industryinsights/study-links-psychiatric-disorders-to-str-292773.html 0.6 2026-04-12T22:50:33+08:00 daily https://www.pharmasources.com/industryinsights/nhl-veterans-pledge-their-brains-to-rese-292774.html 0.6 2026-08-08T21:48:44+08:00 daily https://www.pharmasources.com/industryinsights/allergan-ceo-says-everybody-likely-looki-292775.html 0.6 2026-08-09T03:04:50+08:00 daily https://www.pharmasources.com/industryinsights/warm-atmosphere-on-the-site-of-the-6th-c-292776.html 0.6 2026-08-09T03:51:54+08:00 daily https://www.pharmasources.com/industryinsights/humira-had-a-big-lead-among-the-50-hotte-292777.html 0.6 2026-08-09T00:59:13+08:00 daily https://www.pharmasources.com/industryinsights/global-bio-medicine-proceeded-in-hardshi-292778.html 0.6 2026-08-10T01:01:30+08:00 daily https://www.pharmasources.com/industryinsights/sgs-platform-provides-modeling-and-simul-292779.html 0.6 2026-08-06T22:05:50+08:00 daily https://www.pharmasources.com/industryinsights/updated-phase-i-data-show-bavarian-nordi-292780.html 0.6 2026-08-06T22:08:40+08:00 daily https://www.pharmasources.com/industryinsights/tillotts-pharma-in-germany-dedicated-to--292781.html 0.6 2026-08-06T20:07:53+08:00 daily https://www.pharmasources.com/industryinsights/taipei-firm-works-to-cure-cancer-through-292782.html 0.6 2026-08-06T20:02:27+08:00 daily https://www.pharmasources.com/industryinsights/health-literacy-practices-improve-pediat-292783.html 0.6 2026-08-07T13:18:28+08:00 daily https://www.pharmasources.com/industryinsights/acceliant-awarded-who-drug-medical-codin-292784.html 0.6 2026-08-06T21:27:28+08:00 daily https://www.pharmasources.com/industryinsights/ivig-market-is-expected-to-reach-us12632-292785.html 0.6 2026-08-06T23:47:42+08:00 daily https://www.pharmasources.com/industryinsights/endo-pharmaceuticals-issues-voluntary-na-292786.html 0.6 2026-08-07T04:27:44+08:00 daily https://www.pharmasources.com/industryinsights/zenith-technologies-strengthens-managed--292787.html 0.6 2025-12-19T04:03:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-test-to-help-manage-antibioti-292788.html 0.6 2025-10-19T18:36:05+08:00 daily https://www.pharmasources.com/industryinsights/ani-pharmaceuticals-acquires-inderal-xl--292789.html 0.6 2026-08-09T00:23:52+08:00 daily https://www.pharmasources.com/industryinsights/ronald-e-blaylock-elected-to-pfizers-boa-292790.html 0.6 2026-08-06T22:08:58+08:00 daily https://www.pharmasources.com/industryinsights/santhera-pharmaceuticals-opens-us-office-292791.html 0.6 2026-08-06T22:00:12+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-to-launch-influenza-fightin-292792.html 0.6 2026-08-06T22:08:45+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-receives-positive-chmp-opinion--292793.html 0.6 2026-08-06T22:20:56+08:00 daily https://www.pharmasources.com/industryinsights/revlimid-approved-by-the-european-commis-292794.html 0.6 2026-08-07T02:30:54+08:00 daily https://www.pharmasources.com/industryinsights/fusion-pharmaceuticals-launches-to-devel-292795.html 0.6 2026-08-07T12:12:14+08:00 daily https://www.pharmasources.com/industryinsights/executive-moves-at-celgene-292796.html 0.6 2026-08-06T23:37:26+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-awards-orphan-drug-designation-to-292797.html 0.6 2026-05-14T17:53:12+08:00 daily https://www.pharmasources.com/industryinsights/abivax-to-screen-new-antiviral-molecules-292798.html 0.6 2026-08-07T13:19:21+08:00 daily https://www.pharmasources.com/industryinsights/prison-time-can-be-deadly-to-health-292799.html 0.6 2026-08-08T21:46:29+08:00 daily https://www.pharmasources.com/industryinsights/the-brain-can-produce-its-own-sugar-repo-292800.html 0.6 2026-08-07T12:13:13+08:00 daily https://www.pharmasources.com/industryinsights/manchester-to-explore-new-ways-of-paying-292801.html 0.6 2026-08-07T05:05:45+08:00 daily https://www.pharmasources.com/industryinsights/better-diabetic-foot-care-could-save-nhs-292802.html 0.6 2026-08-08T23:49:44+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-hyperkalaemia-treatment-reb-292803.html 0.6 2026-08-08T20:36:22+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-drug-prescribed-off-label-for-292804.html 0.6 2026-08-06T22:12:44+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-sun-pharma-resets-goals-to-fo-292805.html 0.6 2026-08-07T02:40:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-subpoenaed-in-doj-investigation-o-292806.html 0.6 2026-08-07T05:31:00+08:00 daily https://www.pharmasources.com/industryinsights/mercks-letermovir-an-investigational-ant-292807.html 0.6 2026-08-06T23:47:32+08:00 daily https://www.pharmasources.com/industryinsights/endo-pharmaceuticals-issues-voluntary-na-292808.html 0.6 2026-08-07T09:56:15+08:00 daily https://www.pharmasources.com/industryinsights/stada-opens-structured-bidding-process-i-292809.html 0.6 2026-08-07T12:10:37+08:00 daily https://www.pharmasources.com/industryinsights/teva-freezes-plans-to-build-new-raanana--292810.html 0.6 2026-08-06T21:58:50+08:00 daily https://www.pharmasources.com/industryinsights/top-10-us-patent-losses-of-2017-292811.html 0.6 2026-06-25T05:28:11+08:00 daily https://www.pharmasources.com/industryinsights/barriers-to-integrated-care-and-how-to-o-292812.html 0.6 2026-08-06T22:08:50+08:00 daily https://www.pharmasources.com/industryinsights/real-world-data-show-lower-risk-of-strok-292813.html 0.6 2025-12-12T18:18:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-positive-chmp-opinion--292814.html 0.6 2026-08-06T23:33:34+08:00 daily https://www.pharmasources.com/industryinsights/lupin-inks-pact-to-distribute-antidepres-292815.html 0.6 2026-08-09T22:53:15+08:00 daily https://www.pharmasources.com/industryinsights/chugai-receives-taiwan-china-nod-for-ale-292816.html 0.6 2026-08-07T06:10:06+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-positive-chmp-opinion--292817.html 0.6 2026-08-07T12:03:56+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-expands-internation-292818.html 0.6 2026-08-06T22:08:38+08:00 daily https://www.pharmasources.com/industryinsights/antibe-signs-distribution-agreement-with-292819.html 0.6 2026-03-29T01:55:43+08:00 daily https://www.pharmasources.com/industryinsights/santen-and-twoxar-to-identify-new-drug-c-292820.html 0.6 2026-08-07T15:29:10+08:00 daily https://www.pharmasources.com/industryinsights/researchers-initiate-new-non-invasive-ur-292821.html 0.6 2026-08-06T22:20:56+08:00 daily https://www.pharmasources.com/industryinsights/report-japanese-pharmaceutical-market-to-292822.html 0.6 2026-08-06T22:54:24+08:00 daily https://www.pharmasources.com/industryinsights/valium-may-be-useless-for-acute-lower-ba-292823.html 0.6 2026-08-06T22:21:30+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-receives-chmp-positive-opinion-fo-292824.html 0.6 2026-08-06T23:32:11+08:00 daily https://www.pharmasources.com/industryinsights/active-pharmaceutical-ingredients-api-ma-292825.html 0.6 2026-08-06T23:47:10+08:00 daily https://www.pharmasources.com/industryinsights/arsanis-and-adimab-enter-into-license-ag-292826.html 0.6 2026-08-06T23:36:32+08:00 daily https://www.pharmasources.com/industryinsights/hip-fractures-link-to-early-death-may-la-292827.html 0.6 2026-08-06T23:36:45+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-expands-internation-292828.html 0.6 2026-08-09T00:32:32+08:00 daily https://www.pharmasources.com/industryinsights/astellas-and-lupins-subsidiary-kyowa-ent-292829.html 0.6 2026-08-07T03:02:29+08:00 daily https://www.pharmasources.com/industryinsights/government-funding-could-save-canadians--292830.html 0.6 2026-08-07T04:31:58+08:00 daily https://www.pharmasources.com/industryinsights/nhs-funding-cleared-for-new-specialised--292831.html 0.6 2026-08-07T19:21:32+08:00 daily https://www.pharmasources.com/industryinsights/six-new-medicines-endorsed-for-eu-approv-292832.html 0.6 2026-08-06T21:46:07+08:00 daily https://www.pharmasources.com/industryinsights/eu-expands-use-of-revlimid-to-include-po-292833.html 0.6 2026-08-06T23:46:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-gears-up-to-file-antiviral-letermo-292834.html 0.6 2026-08-08T20:28:08+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-expanded-indication-for-j-292835.html 0.6 2026-08-08T20:30:22+08:00 daily https://www.pharmasources.com/industryinsights/msds-investigational-cytomegalovirus-tre-292836.html 0.6 2026-08-09T01:56:07+08:00 daily https://www.pharmasources.com/industryinsights/la-jolla-finds-potential-jewel-in-succes-292837.html 0.6 2026-08-08T22:30:38+08:00 daily https://www.pharmasources.com/industryinsights/assay-opens-way-to-autoantibodies-treatm-292838.html 0.6 2026-08-06T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-lonza-form-monoclonal-antibody-pr-292839.html 0.6 2026-08-08T20:40:11+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-says-net-price-increase--292840.html 0.6 2026-08-06T23:37:07+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-to-sell-tysabri-royalty-stream-t-292841.html 0.6 2026-08-06T23:33:14+08:00 daily https://www.pharmasources.com/industryinsights/novel-barcode-tracking-of-t-cells-in-imm-292842.html 0.6 2026-08-06T21:47:11+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-cancer-research-uks-mancheste-292843.html 0.6 2026-08-06T21:58:49+08:00 daily https://www.pharmasources.com/industryinsights/2016-a-record-setting-year-for-generic-d-292844.html 0.6 2026-08-06T22:08:54+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-present-new-data-for-taltz-ixek-292845.html 0.6 2026-08-07T02:40:00+08:00 daily https://www.pharmasources.com/industryinsights/merck-launches-integrity-test-system-for-292846.html 0.6 2026-08-07T05:31:06+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-eu-conditional-marketing-292847.html 0.6 2026-08-08T14:20:24+08:00 daily https://www.pharmasources.com/industryinsights/astellas-affinivax-team-up-on-next-gen-p-292848.html 0.6 2026-08-03T19:42:12+08:00 daily https://www.pharmasources.com/industryinsights/inovios-first-in-human-zika-mers-vaccine-292849.html 0.6 2026-04-20T23:27:00+08:00 daily https://www.pharmasources.com/industryinsights/novavax-still-gunning-for-first-to-marke-292850.html 0.6 2026-08-05T22:13:45+08:00 daily https://www.pharmasources.com/industryinsights/janssens-monoclonal-antibody-receives-po-292851.html 0.6 2026-08-07T02:52:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-once-daily-qtern-dapagliflo-292852.html 0.6 2026-07-20T12:02:00+08:00 daily https://www.pharmasources.com/industryinsights/molecule-stops-fatal-pediatric-brain-tum-292853.html 0.6 2026-08-09T21:40:44+08:00 daily https://www.pharmasources.com/industryinsights/baxter-scinopharm-in-strategic-generic-i-292854.html 0.6 2026-08-06T23:33:24+08:00 daily https://www.pharmasources.com/industryinsights/new-comprehensive-lc-ms-workflow-provide-292855.html 0.6 2026-03-13T03:10:41+08:00 daily https://www.pharmasources.com/industryinsights/ttp-labtech-partners-with-genedata-to-pr-292856.html 0.6 2026-08-06T21:47:13+08:00 daily https://www.pharmasources.com/industryinsights/mayne-pharma-enters-licensesupply-pact-292857.html 0.6 2026-08-09T05:30:05+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-biologics-names-bioprocess-dev-292858.html 0.6 2026-08-07T20:41:45+08:00 daily https://www.pharmasources.com/industryinsights/biolabex-opens-rd-laboratory-in-biopark--292859.html 0.6 2026-08-06T23:47:20+08:00 daily https://www.pharmasources.com/industryinsights/injectable-drug-delivery-market-worth-us-292860.html 0.6 2026-06-08T20:34:16+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-launches-cobra-index-292861.html 0.6 2026-08-08T16:30:15+08:00 daily https://www.pharmasources.com/industryinsights/ppd-establishes-rare-disease-and-pediatr-292862.html 0.6 2026-08-09T23:57:11+08:00 daily https://www.pharmasources.com/industryinsights/parexel-appoints-svp-cfo-292863.html 0.6 2026-03-28T21:45:34+08:00 daily https://www.pharmasources.com/industryinsights/who-publishes-a-list-of-priority-pathoge-292864.html 0.6 2025-11-27T06:56:22+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-lonza-join-hands-to-build-biologi-292865.html 0.6 2026-02-08T11:19:06+08:00 daily https://www.pharmasources.com/industryinsights/liquidia-develops-technology-to-design-d-292866.html 0.6 2025-11-27T06:58:33+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-and-eisai-partner-to-offer-hala-292867.html 0.6 2026-02-28T13:11:21+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-viekirax-exviera-receives-positi-292868.html 0.6 2025-11-27T07:00:40+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-lonza-to-build-270m-mammalian-292869.html 0.6 2026-06-15T12:22:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-qtern-292870.html 0.6 2026-08-07T10:09:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xermelo-292871.html 0.6 2026-06-14T14:02:09+08:00 daily https://www.pharmasources.com/industryinsights/what-guides-docs-sleeping-pill-picks-sam-292872.html 0.6 2026-06-14T06:36:00+08:00 daily https://www.pharmasources.com/industryinsights/many-smokers-switch-to-e-cigs-after-toba-292873.html 0.6 2026-04-09T03:24:51+08:00 daily https://www.pharmasources.com/industryinsights/valeants-fourth-quarter-loss-widens-as-s-292874.html 0.6 2026-04-13T23:30:19+08:00 daily https://www.pharmasources.com/industryinsights/kite-pharma-reports-positive-six-month-d-292875.html 0.6 2026-01-29T22:50:59+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-says-partner-roche-to-start-se-292876.html 0.6 2026-06-03T20:26:14+08:00 daily https://www.pharmasources.com/industryinsights/concussions-more-likely-in-female-athlet-292877.html 0.6 2026-06-04T01:57:36+08:00 daily https://www.pharmasources.com/industryinsights/lilly-completes-acquisition-of-colucid-p-292878.html 0.6 2026-04-13T13:38:13+08:00 daily https://www.pharmasources.com/industryinsights/trialscope-launches-trial-results-summar-292879.html 0.6 2025-11-27T07:12:33+08:00 daily https://www.pharmasources.com/industryinsights/ligand-expands-sermonix-license-to-oral--292880.html 0.6 2026-04-05T18:26:02+08:00 daily https://www.pharmasources.com/industryinsights/bms-grail-in-precision-medicine-pact-292881.html 0.6 2026-07-13T16:07:44+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-bioanalytical-service-unit-p-292882.html 0.6 2026-08-09T21:22:57+08:00 daily https://www.pharmasources.com/industryinsights/malvern-launches-microcal-peaq-dsc-for-f-292883.html 0.6 2026-07-05T02:41:41+08:00 daily https://www.pharmasources.com/industryinsights/pharmas-most-innovative-companies-the-20-292884.html 0.6 2025-11-27T07:15:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bla-for-avelumab-for-the-tre-292885.html 0.6 2026-04-27T17:18:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-odactra-for-house-dust-mite-292886.html 0.6 2026-01-30T19:20:29+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-completes-acquisition-of-292887.html 0.6 2026-06-30T15:32:07+08:00 daily https://www.pharmasources.com/industryinsights/richmond-unveils-new-clinical-research-c-292888.html 0.6 2026-08-01T00:18:12+08:00 daily https://www.pharmasources.com/industryinsights/foresee-announces-successful-completion--292889.html 0.6 2026-03-25T10:32:35+08:00 daily https://www.pharmasources.com/industryinsights/inhaler-users-get-about-half-as-much-med-292890.html 0.6 2026-03-20T12:51:46+08:00 daily https://www.pharmasources.com/industryinsights/regenerative-medicine-market-growing-at--292891.html 0.6 2026-02-28T15:29:40+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-sanofi-close-bu-292892.html 0.6 2026-07-18T10:51:07+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-day-2017-addresses-growing--292893.html 0.6 2026-07-08T10:39:38+08:00 daily https://www.pharmasources.com/industryinsights/how-much-melatonin-is-really-in-that-sup-292894.html 0.6 2026-07-19T23:59:12+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-a-breakthrough-for-sickle-c-292895.html 0.6 2026-06-29T18:42:41+08:00 daily https://www.pharmasources.com/industryinsights/mildly-low-thyroid-function-in-pregnancy-292896.html 0.6 2026-04-17T18:45:58+08:00 daily https://www.pharmasources.com/industryinsights/immune-disorders-such-as-ms-psoriasis-ma-292897.html 0.6 2026-08-09T06:59:46+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-to-sell-tysabri-drug-royalty-to--292898.html 0.6 2026-08-08T08:25:23+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-msds-keytruda-in-first-line-292899.html 0.6 2026-04-07T12:21:06+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-crt-and-hitgen-to-dev-292900.html 0.6 2026-08-08T07:01:25+08:00 daily https://www.pharmasources.com/industryinsights/genentech-to-launch-second-phiii-trial-o-292901.html 0.6 2026-08-08T05:07:12+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-priority-review-for-emd-s-292902.html 0.6 2026-08-07T13:14:51+08:00 daily https://www.pharmasources.com/industryinsights/ucl-research-team-bags-35m-mrc-grant-292903.html 0.6 2026-08-06T23:54:41+08:00 daily https://www.pharmasources.com/industryinsights/promising-anti-cocaine-treatment-aims-fo-292904.html 0.6 2026-08-06T23:48:14+08:00 daily https://www.pharmasources.com/industryinsights/asthma-drugs-may-have-alternative-functi-292905.html 0.6 2026-08-06T22:54:21+08:00 daily https://www.pharmasources.com/industryinsights/kite-pharma-climbs-on-strong-data-showin-292906.html 0.6 2026-08-06T22:19:50+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-for-merck-pfizers-avelum-292907.html 0.6 2026-08-06T23:32:20+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-head-of-north-american-ope-292908.html 0.6 2026-08-06T21:54:09+08:00 daily https://www.pharmasources.com/industryinsights/trump-targets-slow-and-burdensome-fda-ap-292909.html 0.6 2026-08-06T23:32:14+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-hitgen-work-together-on-new-lung-c-292910.html 0.6 2026-08-06T22:09:43+08:00 daily https://www.pharmasources.com/industryinsights/lexicons-xermelo-garners-fda-approval-fo-292911.html 0.6 2026-08-06T23:37:16+08:00 daily https://www.pharmasources.com/industryinsights/gsk-confirms-closure-of-agreement-to-div-292912.html 0.6 2026-08-07T12:13:03+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-to-sell-tysabri-drug-royalty-to--292913.html 0.6 2026-08-07T13:18:07+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-lonza-to-build-270m-mammalian-292914.html 0.6 2026-08-07T13:57:58+08:00 daily https://www.pharmasources.com/industryinsights/amicus-kicks-off-launch-of-galafold-in-t-292915.html 0.6 2026-03-24T20:32:35+08:00 daily https://www.pharmasources.com/industryinsights/us-approval-for-alks-house-dust-mite-pil-292916.html 0.6 2025-11-21T03:18:44+08:00 daily https://www.pharmasources.com/industryinsights/new-remote-monitoring-app-being-trialled-292917.html 0.6 2026-04-30T09:06:54+08:00 daily https://www.pharmasources.com/industryinsights/nhs-on-burning-platform-warns-chief-hosp-292918.html 0.6 2026-06-24T09:25:34+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-biotechnologies-launch-292919.html 0.6 2026-02-28T14:25:39+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-launches-bio-cdmo-division-292920.html 0.6 2026-07-31T13:25:54+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-acquires-colucid-pharmaceutica-292921.html 0.6 2026-08-08T01:38:16+08:00 daily https://www.pharmasources.com/industryinsights/cmo-bushu-and-takeda-form-partnership-292922.html 0.6 2026-08-09T16:51:39+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-changes-in-senior-manage-292923.html 0.6 2026-04-13T03:41:51+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-and-evestra-inc-292924.html 0.6 2026-07-30T15:26:19+08:00 daily https://www.pharmasources.com/industryinsights/drug-importation-101-292925.html 0.6 2026-04-28T11:07:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-odactra-for-house-dust-mite-292926.html 0.6 2026-04-27T23:07:43+08:00 daily https://www.pharmasources.com/industryinsights/mutual-recognition-promises-new-framewor-292927.html 0.6 2026-04-30T12:13:20+08:00 daily https://www.pharmasources.com/industryinsights/cypralis-to-develop-new-cyclophilin-inhi-292928.html 0.6 2026-04-28T17:30:21+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-names-executive-vice-president-and-292929.html 0.6 2026-08-06T23:00:12+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-launch-of-generic-pristiq-292930.html 0.6 2026-07-01T12:08:15+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-expands-focus-on-pr-292931.html 0.6 2026-06-08T21:40:22+08:00 daily https://www.pharmasources.com/industryinsights/aslan-collaborates-with-csi-ncis-to-inve-292932.html 0.6 2026-06-25T00:41:58+08:00 daily https://www.pharmasources.com/industryinsights/revive-is-a-daily-supplement-to-combat-a-292933.html 0.6 2026-06-08T06:48:40+08:00 daily https://www.pharmasources.com/industryinsights/russias-pharmaceutical-market-to-double--292934.html 0.6 2026-07-02T06:12:58+08:00 daily https://www.pharmasources.com/industryinsights/cphi-expands-in-middle-east-africa-with--292935.html 0.6 2025-11-25T07:38:44+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-and-evestra-ann-292936.html 0.6 2026-06-09T18:15:39+08:00 daily https://www.pharmasources.com/industryinsights/nice-expands-reach-of-erbitux-in-colorec-292937.html 0.6 2026-06-18T03:17:32+08:00 daily https://www.pharmasources.com/industryinsights/scientists-stimulate-immune-system-stop--292938.html 0.6 2026-06-19T02:25:30+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-receives-chmp-positive-opinion-fo-292939.html 0.6 2026-07-27T06:26:05+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-xermelo-with-ssa-therapy-292940.html 0.6 2026-06-18T15:19:01+08:00 daily https://www.pharmasources.com/industryinsights/nice-does-not-recommend-mercks-lung-canc-292941.html 0.6 2026-06-06T02:07:55+08:00 daily https://www.pharmasources.com/industryinsights/quotient-clinical-expands-into-usa-throu-292942.html 0.6 2026-04-13T23:42:49+08:00 daily https://www.pharmasources.com/industryinsights/polyganics-stop-neuroma-study-interim-da-292943.html 0.6 2026-04-08T17:03:54+08:00 daily https://www.pharmasources.com/industryinsights/exercise-helps-counter-cancer-linked-fat-292944.html 0.6 2026-06-08T17:44:54+08:00 daily https://www.pharmasources.com/industryinsights/rising-number-of-kids-ill-from-drinking--292945.html 0.6 2026-08-07T00:14:44+08:00 daily https://www.pharmasources.com/industryinsights/combination-of-roches-perjeta-herceptin--292946.html 0.6 2026-06-12T15:36:23+08:00 daily https://www.pharmasources.com/industryinsights/juno-ends-development-of-car-t-therapy-j-292947.html 0.6 2026-03-17T20:58:00+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-first-biliary-cholangitis--292948.html 0.6 2026-03-17T23:04:26+08:00 daily https://www.pharmasources.com/industryinsights/with-shrinking-of-usd-5-billion-how-can--292949.html 0.6 2026-07-12T07:59:43+08:00 daily https://www.pharmasources.com/industryinsights/interpretation-of-the-diabetes-drug-mark-292950.html 0.6 2026-05-03T18:49:35+08:00 daily https://www.pharmasources.com/industryinsights/new-head-to-head-data-shows-significantl-292951.html 0.6 2026-08-09T08:01:54+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-pasteur-and-medimmune-collaborate-292952.html 0.6 2026-08-05T23:03:01+08:00 daily https://www.pharmasources.com/industryinsights/lilly-diabetes-becomes-official-diabetes-292953.html 0.6 2026-08-09T14:59:47+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-betta-pharmaceuticals-eli--292954.html 0.6 2026-07-03T21:14:09+08:00 daily https://www.pharmasources.com/industryinsights/essen-bioscience-to-be-acquired-by-sarto-292955.html 0.6 2026-08-07T02:40:15+08:00 daily https://www.pharmasources.com/industryinsights/cvs-health-names-executive-vice-presiden-292956.html 0.6 2026-08-06T22:08:23+08:00 daily https://www.pharmasources.com/industryinsights/crb-appoints-new-president-292957.html 0.6 2026-08-06T21:58:35+08:00 daily https://www.pharmasources.com/industryinsights/mithra-signs-agreement-with-fuji-pharma--292958.html 0.6 2026-08-07T08:36:15+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-hybio-pharmaceutical-pfi-292959.html 0.6 2026-07-02T06:20:12+08:00 daily https://www.pharmasources.com/industryinsights/ekg-labs-expands-analytical-lab-capacity-292960.html 0.6 2026-08-09T16:48:00+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-pharmaceutical-to-acquire-neurova-292961.html 0.6 2026-08-09T10:45:27+08:00 daily https://www.pharmasources.com/industryinsights/cannimed-therapeutics-and-pharmachoice-e-292962.html 0.6 2026-07-12T11:14:47+08:00 daily https://www.pharmasources.com/industryinsights/synthon-and-sanquin-to-develop-immuno-on-292963.html 0.6 2026-07-13T10:52:07+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-to-acquire-essen-bioscience-292964.html 0.6 2026-07-20T11:10:18+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-medimmune-in-rsv-alliance-292965.html 0.6 2026-08-08T02:16:53+08:00 daily https://www.pharmasources.com/industryinsights/ppd-awarded-nih-contract-for-hiv-researc-292966.html 0.6 2025-11-18T10:53:06+08:00 daily https://www.pharmasources.com/industryinsights/nemus-catalent-to-advance-nb1222-for-cli-292967.html 0.6 2026-06-08T17:17:54+08:00 daily https://www.pharmasources.com/industryinsights/new-research-reveals-asia-as-preferred-d-292968.html 0.6 2026-03-18T02:24:00+08:00 daily https://www.pharmasources.com/industryinsights/postnatal-assay-for-detection-of-genetic-292969.html 0.6 2026-02-01T04:41:46+08:00 daily https://www.pharmasources.com/industryinsights/allergopharma-opens-new-biopharmaceutica-292970.html 0.6 2026-08-06T00:34:29+08:00 daily https://www.pharmasources.com/industryinsights/regulators-warn-public-on-dangers-of-web-292971.html 0.6 2026-06-24T11:36:55+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-biologics-license-applica-292972.html 0.6 2026-06-21T06:06:17+08:00 daily https://www.pharmasources.com/industryinsights/az-and-sanofi-link-on-rsv-vaccine-292973.html 0.6 2026-06-13T22:43:45+08:00 daily https://www.pharmasources.com/industryinsights/pharma-in-indonesia-competing-for-higher-292974.html 0.6 2026-07-08T12:31:57+08:00 daily https://www.pharmasources.com/industryinsights/chronic-obstructive-pulmonary-disease-co-292975.html 0.6 2026-07-24T10:19:26+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-new-treatment-for-chronic-liv-292976.html 0.6 2026-07-20T18:56:17+08:00 daily https://www.pharmasources.com/industryinsights/ema-fda-form-transatlantic-pact-on-site--292977.html 0.6 2026-04-04T05:06:52+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-membrane-filtration-marke-292978.html 0.6 2026-06-06T15:46:30+08:00 daily https://www.pharmasources.com/industryinsights/janssen-announces-two-drug-combination-o-292979.html 0.6 2026-08-06T10:21:15+08:00 daily https://www.pharmasources.com/industryinsights/european-and-us-regulators-agree-on-mutu-292980.html 0.6 2026-04-06T21:38:32+08:00 daily https://www.pharmasources.com/industryinsights/herbalife-nutrition-partners-with-syngen-292981.html 0.6 2026-06-29T18:59:11+08:00 daily https://www.pharmasources.com/industryinsights/national-drug-surveys-and-who-benchmarks-292982.html 0.6 2026-06-11T09:12:09+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-enrollment-o-292983.html 0.6 2026-05-27T04:43:26+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-introduces-postnata-292984.html 0.6 2026-04-16T18:18:28+08:00 daily https://www.pharmasources.com/industryinsights/quotient-clinical-announces-second-us-ac-292985.html 0.6 2026-02-09T08:14:13+08:00 daily https://www.pharmasources.com/industryinsights/volkswagens-excess-emissions-will-lead-t-292986.html 0.6 2026-03-01T01:13:23+08:00 daily https://www.pharmasources.com/industryinsights/mutual-recognition-promises-new-framewor-292987.html 0.6 2026-02-28T14:35:49+08:00 daily https://www.pharmasources.com/industryinsights/cipla-to-divest-its-animal-health-busine-292988.html 0.6 2025-11-27T07:44:29+08:00 daily https://www.pharmasources.com/industryinsights/rentokil-partners-with-pci-292989.html 0.6 2026-03-01T08:30:46+08:00 daily https://www.pharmasources.com/industryinsights/the-5-drug-giants-that-could-snap-up-a-s-292990.html 0.6 2026-08-09T03:28:20+08:00 daily https://www.pharmasources.com/industryinsights/dr-igor-matushansky-appointed-global-hea-292991.html 0.6 2026-08-01T19:20:59+08:00 daily https://www.pharmasources.com/industryinsights/pci-pharma-services-triples-serializatio-292992.html 0.6 2026-02-23T15:23:06+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-lonza-in-285mn-biologics-pact-292993.html 0.6 2026-06-02T08:30:51+08:00 daily https://www.pharmasources.com/industryinsights/hemispherx-meets-ampligen-milestone-292994.html 0.6 2026-06-27T13:39:10+08:00 daily https://www.pharmasources.com/industryinsights/alcami-expands-analytical-capabilities-292995.html 0.6 2026-05-03T10:14:15+08:00 daily https://www.pharmasources.com/industryinsights/medday-boosts-its-research-capabilities-292996.html 0.6 2026-08-08T07:53:00+08:00 daily https://www.pharmasources.com/industryinsights/lsne-completes-two-fda-inspections-292997.html 0.6 2026-08-09T05:02:07+08:00 daily https://www.pharmasources.com/industryinsights/first-ever-biosimilar-of-interferon-beta-292998.html 0.6 2026-07-24T11:34:59+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-invests-in-system-to-boost-pharmace-292999.html 0.6 2026-02-28T18:32:08+08:00 daily https://www.pharmasources.com/industryinsights/qatar-airways-cargo-introduces-additiona-293000.html 0.6 2026-03-23T04:51:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-excessi-293001.html 0.6 2026-03-30T09:49:31+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-enters-into-a-corporate-partne-293002.html 0.6 2026-04-13T16:07:56+08:00 daily https://www.pharmasources.com/industryinsights/blood-cancer-drugs-leading-growth-in-glo-293003.html 0.6 2026-04-25T10:43:15+08:00 daily https://www.pharmasources.com/industryinsights/lilly-posts-impressive-psoriasis-results-293004.html 0.6 2026-04-14T14:54:18+08:00 daily https://www.pharmasources.com/industryinsights/new-access-to-vaccines-index-reveals-fir-293005.html 0.6 2026-06-22T00:42:39+08:00 daily https://www.pharmasources.com/industryinsights/vermont-senators-call-for-restraints-on--293006.html 0.6 2026-06-25T05:29:14+08:00 daily https://www.pharmasources.com/industryinsights/rentokil-partners-with-pci-293007.html 0.6 2026-03-12T14:54:30+08:00 daily https://www.pharmasources.com/industryinsights/cipla-to-divest-its-animal-health-busine-293008.html 0.6 2026-03-12T09:30:35+08:00 daily https://www.pharmasources.com/industryinsights/cipla-halts-hiv-drug-production-due-to-d-293009.html 0.6 2026-06-08T15:20:10+08:00 daily https://www.pharmasources.com/industryinsights/emerging-markets-better-bet-than-develop-293010.html 0.6 2026-03-18T03:34:37+08:00 daily https://www.pharmasources.com/industryinsights/how-molecular-machines-may-drive-the-fut-293011.html 0.6 2026-04-08T15:42:03+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-pasteur-and-medimmune-to-develop--293012.html 0.6 2026-03-21T23:11:06+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-aphinity-study-shows-roches-pe-293013.html 0.6 2026-04-12T02:50:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-serenitys-noctiva-nasal-spr-293014.html 0.6 2026-06-29T05:07:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-frequen-293015.html 0.6 2026-02-09T07:58:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-intercepts-ocaliva-for-use-293016.html 0.6 2026-02-28T15:34:40+08:00 daily https://www.pharmasources.com/industryinsights/major-pharmaceutical-companies-collabora-293017.html 0.6 2026-08-08T03:01:12+08:00 daily https://www.pharmasources.com/industryinsights/uk-high-court-rules-against-abbvies-humi-293018.html 0.6 2026-06-16T09:51:07+08:00 daily https://www.pharmasources.com/industryinsights/phase-3-data-for-janssen-psoriasis-drug--293019.html 0.6 2026-03-19T02:20:19+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-and-hill-dermaceuticals-ann-293020.html 0.6 2026-03-18T02:28:16+08:00 daily https://www.pharmasources.com/industryinsights/report-french-pharmaceutical-market-to-s-293021.html 0.6 2026-02-15T13:30:43+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-announce-fda-and-ema-fi-293022.html 0.6 2026-05-11T23:16:00+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-to-acquire-neurovance-in-potentia-293023.html 0.6 2026-03-27T09:14:56+08:00 daily https://www.pharmasources.com/industryinsights/valeant-pharmaceuticals-completes-sale-o-293024.html 0.6 2025-11-29T15:46:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-new-drug-application-and-gra-293025.html 0.6 2026-08-06T14:08:09+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-announces-fda-acknowled-293026.html 0.6 2026-06-13T17:46:46+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn201737-293027.html 0.6 2026-06-08T15:24:28+08:00 daily https://www.pharmasources.com/industryinsights/new-research-reveals-asia-as-preferred-d-293028.html 0.6 2026-04-16T04:20:58+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharmaceuticals-appoints-cfo-adds-uk--293029.html 0.6 2026-06-08T18:27:31+08:00 daily https://www.pharmasources.com/industryinsights/cros-nt-acquires-pm-clinical-ltd-293030.html 0.6 2026-04-01T03:26:46+08:00 daily https://www.pharmasources.com/industryinsights/ab-biotechnologies-adds-bd-director-293031.html 0.6 2025-11-27T07:03:49+08:00 daily https://www.pharmasources.com/industryinsights/gsks-vaccines-access-leads-the-pack-repo-293032.html 0.6 2026-06-30T16:23:51+08:00 daily https://www.pharmasources.com/industryinsights/director-upheaval-threatens-brazilian-de-293033.html 0.6 2026-03-01T04:21:30+08:00 daily https://www.pharmasources.com/industryinsights/the-end-of-chinas-vaccine-scandal-some-c-293034.html 0.6 2026-06-28T00:11:17+08:00 daily https://www.pharmasources.com/industryinsights/cdc-works-on-new-bird-flu-vaccine-amid-c-293035.html 0.6 2026-08-08T07:55:58+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-proposed-biosimilar-adalimumab-de-293036.html 0.6 2026-08-07T13:16:09+08:00 daily https://www.pharmasources.com/industryinsights/gsk-study-shows-nucala-significantly-imp-293037.html 0.6 2026-08-06T23:56:10+08:00 daily https://www.pharmasources.com/industryinsights/vertex-to-acquire-ctp-656-from-concert-p-293038.html 0.6 2026-08-06T23:47:17+08:00 daily https://www.pharmasources.com/industryinsights/singapore-strengthens-digital-health-inn-293039.html 0.6 2026-08-06T22:53:52+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-appoints-new-executive-vice-293040.html 0.6 2026-08-06T20:07:47+08:00 daily https://www.pharmasources.com/industryinsights/vela-genomics-launches-solution-for-ngs--293041.html 0.6 2026-08-06T21:58:35+08:00 daily https://www.pharmasources.com/industryinsights/artificial-mouse-embryo-created-from-ste-293042.html 0.6 2026-08-06T23:54:35+08:00 daily https://www.pharmasources.com/industryinsights/scotlands-npsc-and-mrc-sign-mou-to-accel-293043.html 0.6 2026-08-07T13:18:39+08:00 daily https://www.pharmasources.com/industryinsights/new-triple-quadrupole-icp-ms-launched-by-293044.html 0.6 2026-08-09T07:56:30+08:00 daily https://www.pharmasources.com/industryinsights/second-international-ayurveda-congress-t-293045.html 0.6 2026-06-24T00:56:19+08:00 daily https://www.pharmasources.com/industryinsights/uk-life-sciences-sector-productivity-dou-293046.html 0.6 2026-03-25T13:51:15+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-industry-continues-to-face-293047.html 0.6 2026-03-11T18:04:02+08:00 daily https://www.pharmasources.com/industryinsights/price-drops-make-more-cancer-drugs-routi-293048.html 0.6 2026-03-23T21:15:46+08:00 daily https://www.pharmasources.com/industryinsights/beigene-to-develop-330-million-biologics-293049.html 0.6 2026-06-13T06:55:58+08:00 daily https://www.pharmasources.com/industryinsights/vertex-to-acquire-concert-pharmaceutical-293050.html 0.6 2026-07-05T05:46:55+08:00 daily https://www.pharmasources.com/industryinsights/cancer-immunotherapy-market-to-hit-14-pe-293051.html 0.6 2026-06-15T02:24:59+08:00 daily https://www.pharmasources.com/industryinsights/vernalis-and-servier-sign-oncology-drug--293052.html 0.6 2026-08-07T22:15:17+08:00 daily https://www.pharmasources.com/industryinsights/medimmune-and-sanofi-pasteur-form-allian-293053.html 0.6 2026-06-26T15:23:39+08:00 daily https://www.pharmasources.com/industryinsights/researchers-discover-worrying-new-antibi-293054.html 0.6 2026-08-08T01:48:09+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-shows-almost-all-psori-293055.html 0.6 2026-05-03T21:29:12+08:00 daily https://www.pharmasources.com/industryinsights/cadila-and-supernus-settle-patent-disput-293056.html 0.6 2026-04-30T19:21:14+08:00 daily https://www.pharmasources.com/industryinsights/sulforaphane-a-phytochemical-in-broccoli-293057.html 0.6 2026-07-23T17:16:42+08:00 daily https://www.pharmasources.com/industryinsights/mercks-allergopharma-opens-42m-biopharma-293058.html 0.6 2026-02-03T23:31:45+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizers-diabetes-therapy-under-293059.html 0.6 2026-07-25T16:15:15+08:00 daily https://www.pharmasources.com/industryinsights/gene-test-needed-before-using-alzheimers-293060.html 0.6 2026-07-24T17:26:05+08:00 daily https://www.pharmasources.com/industryinsights/study-casts-doubt-on-a-brain-cancers-lin-293061.html 0.6 2026-04-07T08:52:52+08:00 daily https://www.pharmasources.com/industryinsights/gsks-asthma-biologic-hits-quality-of-lif-293062.html 0.6 2026-04-03T02:43:06+08:00 daily https://www.pharmasources.com/industryinsights/five-additional-leading-physicians-to-jo-293063.html 0.6 2026-03-19T10:57:39+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-promising-new-strategy-to--293064.html 0.6 2026-06-08T06:23:46+08:00 daily https://www.pharmasources.com/industryinsights/china-to-optimize-approval-procedures-fo-293065.html 0.6 2025-11-27T06:33:23+08:00 daily https://www.pharmasources.com/industryinsights/french-biotech-medday-acquires-profilomi-293066.html 0.6 2026-05-02T12:14:10+08:00 daily https://www.pharmasources.com/industryinsights/epo-2016-report-shows-european-patent-fi-293067.html 0.6 2026-04-08T15:32:14+08:00 daily https://www.pharmasources.com/industryinsights/german-community-of-gynecological-oncolo-293068.html 0.6 2026-07-21T10:35:24+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-marketing-authorisation-for-ac-293069.html 0.6 2026-07-07T13:37:52+08:00 daily https://www.pharmasources.com/industryinsights/cphi-north-america-debuts-in-philadelphi-293070.html 0.6 2026-04-04T19:20:41+08:00 daily https://www.pharmasources.com/industryinsights/keapstone-therapeutics-created-out-of-sh-293071.html 0.6 2026-02-28T13:57:56+08:00 daily https://www.pharmasources.com/industryinsights/apotex-announces-184m-investment-to-grow-293072.html 0.6 2026-08-07T07:27:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-supplemental-new-drug-applic-293073.html 0.6 2026-08-07T09:57:46+08:00 daily https://www.pharmasources.com/industryinsights/teligent-receives-fda-approval-of-clobet-293074.html 0.6 2026-02-01T04:41:33+08:00 daily https://www.pharmasources.com/industryinsights/apotex-spends-184mn-to-grow-us-mfg-prese-293075.html 0.6 2025-12-29T15:45:57+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-combination-gives-hope-for-acut-293076.html 0.6 2026-05-14T10:00:19+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-names-executive-vic-293077.html 0.6 2026-06-15T06:55:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-sbla-filing-of-soliris-as-a--293078.html 0.6 2026-08-04T01:42:26+08:00 daily https://www.pharmasources.com/industryinsights/cook-pharmica-teams-up-with-ivy-tech-blo-293079.html 0.6 2026-03-25T00:16:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-and-nice-approve-of-first-new-hyperp-293080.html 0.6 2026-08-07T14:39:47+08:00 daily https://www.pharmasources.com/industryinsights/japans-taiho-pharmaceutical-announces-ex-293081.html 0.6 2026-02-28T00:13:17+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-could-be-key-to-treating-a-293082.html 0.6 2026-01-29T11:55:23+08:00 daily https://www.pharmasources.com/industryinsights/ab-biotechnologies-expands-sterile-injec-293083.html 0.6 2026-07-04T07:24:59+08:00 daily https://www.pharmasources.com/industryinsights/research-gives-hope-of-potential-treatme-293084.html 0.6 2026-03-31T21:48:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-shows-almost-all-psori-293085.html 0.6 2026-04-04T21:56:43+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-uk-sheffield-university-launc-293086.html 0.6 2026-04-20T23:07:04+08:00 daily https://www.pharmasources.com/industryinsights/bosch-underlines-line-competence-for-liq-293087.html 0.6 2026-07-01T08:10:59+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-to-launch-china-pharma-week-293088.html 0.6 2026-08-04T01:57:38+08:00 daily https://www.pharmasources.com/industryinsights/ae-departments-under-resourced-mps-belie-293089.html 0.6 2026-08-05T23:27:46+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharma-unveils-new-financial-head-293090.html 0.6 2026-04-07T15:53:12+08:00 daily https://www.pharmasources.com/industryinsights/centauri-therapeutics-closes-25-million--293091.html 0.6 2025-11-27T06:08:28+08:00 daily https://www.pharmasources.com/industryinsights/horizon-discovery-launches-multiplex-i-c-293092.html 0.6 2026-06-08T17:59:23+08:00 daily https://www.pharmasources.com/industryinsights/number-of-women-in-management-positions--293093.html 0.6 2026-07-18T21:14:10+08:00 daily https://www.pharmasources.com/industryinsights/head-and-neck-cancer-market-fertile-for--293094.html 0.6 2026-03-21T15:14:50+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-expands-collaborati-293095.html 0.6 2026-02-28T15:36:02+08:00 daily https://www.pharmasources.com/industryinsights/antioxidants-and-lung-cancer-risk-293096.html 0.6 2026-02-09T13:06:38+08:00 daily https://www.pharmasources.com/industryinsights/dr-ajaz-hussain-appointed-as-senior-advi-293097.html 0.6 2026-06-09T01:44:16+08:00 daily https://www.pharmasources.com/industryinsights/obamacares-medicaid-expansion-cut-medica-293098.html 0.6 2026-08-06T22:07:18+08:00 daily https://www.pharmasources.com/industryinsights/gleevec-keeps-a-leukemia-in-check-for-mo-293099.html 0.6 2026-07-19T02:36:17+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-combination-targets-aggressive--293100.html 0.6 2026-02-27T19:06:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-cs-293101.html 0.6 2026-07-06T08:01:11+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-actelions-rare-immune-system--293102.html 0.6 2026-07-16T03:35:54+08:00 daily https://www.pharmasources.com/industryinsights/8-biotechs-that-could-be-taken-out-soon-293103.html 0.6 2026-07-06T12:18:45+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-2016-antitumor-drug-market-c-293104.html 0.6 2026-08-08T02:44:28+08:00 daily https://www.pharmasources.com/industryinsights/latest-rankings-global-top-10-pharmaceut-293105.html 0.6 2026-06-08T20:39:34+08:00 daily https://www.pharmasources.com/industryinsights/the-value-of-innovation-in-oncology-293106.html 0.6 2026-03-17T21:38:46+08:00 daily https://www.pharmasources.com/industryinsights/mrida-greens-expands-its-plant-extracts--293107.html 0.6 2026-04-13T18:32:12+08:00 daily https://www.pharmasources.com/industryinsights/womens-leadership-in-stem-293108.html 0.6 2026-02-15T13:43:43+08:00 daily https://www.pharmasources.com/industryinsights/cadila-healthcare-in-pact-with-supernus--293109.html 0.6 2026-03-19T23:30:20+08:00 daily https://www.pharmasources.com/industryinsights/why-americans-need-tax-reform-293110.html 0.6 2026-08-07T21:17:22+08:00 daily https://www.pharmasources.com/industryinsights/trumps-tweet-causes-pharmaceutical-compa-293111.html 0.6 2026-04-22T16:17:56+08:00 daily https://www.pharmasources.com/industryinsights/university-of-sheffield-and-parkinsons-u-293112.html 0.6 2026-01-22T05:38:15+08:00 daily https://www.pharmasources.com/industryinsights/bms-names-evp-cso-293113.html 0.6 2026-08-08T02:09:18+08:00 daily https://www.pharmasources.com/industryinsights/ferring-pharmaceuticals-acquires-apricus-293114.html 0.6 2026-02-15T13:36:35+08:00 daily https://www.pharmasources.com/industryinsights/13-fda-observations-on-dr-reddys-plant-s-293115.html 0.6 2026-02-28T14:25:33+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-eyes-acquisition-of-global--293116.html 0.6 2026-06-08T19:48:54+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-university-announces-world-lea-293117.html 0.6 2026-01-14T06:26:45+08:00 daily https://www.pharmasources.com/industryinsights/basi-appoints-preclinical-services-svp-293118.html 0.6 2026-08-09T13:45:59+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-lps-division-names-marketing-s-293119.html 0.6 2026-08-09T14:45:00+08:00 daily https://www.pharmasources.com/industryinsights/mayne-pharma-acquires-pars-generic-pain--293120.html 0.6 2026-06-14T06:30:44+08:00 daily https://www.pharmasources.com/industryinsights/amgen-accuses-biosimilar-producer-of-mas-293121.html 0.6 2026-07-23T00:58:06+08:00 daily https://www.pharmasources.com/industryinsights/mixed-response-to-uk-budget-293122.html 0.6 2026-04-16T14:56:06+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-launches-new-resear-293123.html 0.6 2026-04-07T15:43:34+08:00 daily https://www.pharmasources.com/industryinsights/number-of-people-quitting-smoking-hits-r-293124.html 0.6 2025-12-02T19:25:23+08:00 daily https://www.pharmasources.com/industryinsights/columbia-pacific-acquires-serene-senior--293125.html 0.6 2026-06-16T18:08:36+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-uni-launches-new-industryacade-293126.html 0.6 2026-06-08T11:40:36+08:00 daily https://www.pharmasources.com/industryinsights/cancer-experts-urge-reform-of-paediatric-293127.html 0.6 2026-02-09T08:07:01+08:00 daily https://www.pharmasources.com/industryinsights/pci-pharma-expands-its-serialization-cap-293128.html 0.6 2026-03-29T15:55:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-snda-for-vraylar-293129.html 0.6 2026-04-14T06:30:14+08:00 daily https://www.pharmasources.com/industryinsights/global-trade-bodies-issue-guidance-on-bi-293130.html 0.6 2026-06-10T20:37:34+08:00 daily https://www.pharmasources.com/industryinsights/amptec-and-cmc-pharma-close-consulting-a-293131.html 0.6 2026-07-02T18:47:03+08:00 daily https://www.pharmasources.com/industryinsights/bms-appoints-dr-thomas-j-lynch-jr-execut-293132.html 0.6 2026-03-21T20:56:24+08:00 daily https://www.pharmasources.com/industryinsights/anemia-drugs-market-projected-to-rise-ov-293133.html 0.6 2026-04-04T20:23:51+08:00 daily https://www.pharmasources.com/industryinsights/cellgenix-headquarters-expands-to-meet-t-293134.html 0.6 2026-07-19T05:25:27+08:00 daily https://www.pharmasources.com/industryinsights/potential-drug-candidates-halt-prostate--293135.html 0.6 2026-04-13T02:32:49+08:00 daily https://www.pharmasources.com/industryinsights/the-union-for-international-cancer-contr-293136.html 0.6 2026-07-27T17:46:32+08:00 daily https://www.pharmasources.com/industryinsights/heart-disease-kicks-in-earlier-for-obese-293137.html 0.6 2026-04-16T04:37:38+08:00 daily https://www.pharmasources.com/industryinsights/sickle-cell-trait-tied-to-higher-kidney--293138.html 0.6 2026-04-13T06:50:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-bo-293139.html 0.6 2026-07-17T07:44:35+08:00 daily https://www.pharmasources.com/industryinsights/amring-pharmaceuticals-acquires-six-anda-293140.html 0.6 2026-06-02T21:48:48+08:00 daily https://www.pharmasources.com/industryinsights/with-nyc-hackathon-mdecins-sans-frontire-293141.html 0.6 2026-08-06T02:03:44+08:00 daily https://www.pharmasources.com/industryinsights/tris-pharma-appoints-new-chief-commercia-293142.html 0.6 2026-04-07T18:07:22+08:00 daily https://www.pharmasources.com/industryinsights/servier-and-pfizer-announce-fda-clearanc-293143.html 0.6 2026-01-18T21:29:37+08:00 daily https://www.pharmasources.com/industryinsights/i-holland-to-showcase-its-most-innovativ-293144.html 0.6 2026-04-06T19:57:30+08:00 daily https://www.pharmasources.com/industryinsights/endocyte-and-seattle-childrens-research--293145.html 0.6 2026-04-09T18:34:44+08:00 daily https://www.pharmasources.com/industryinsights/horizon-discovery-enters-into-rd-and-lic-293146.html 0.6 2026-06-23T13:45:11+08:00 daily https://www.pharmasources.com/industryinsights/apotex-to-invest-184-million-to-grow-us--293147.html 0.6 2025-11-27T05:12:40+08:00 daily https://www.pharmasources.com/industryinsights/mayne-pharma-acquires-rights-to-generic--293148.html 0.6 2026-03-27T02:32:07+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-receives-scientists-293149.html 0.6 2026-07-07T12:39:18+08:00 daily https://www.pharmasources.com/industryinsights/european-experts-meet-with-afican-regula-293150.html 0.6 2026-02-28T15:29:19+08:00 daily https://www.pharmasources.com/industryinsights/clintec-marks-20th-year-of-global-clinic-293151.html 0.6 2026-06-09T09:17:59+08:00 daily https://www.pharmasources.com/industryinsights/bi-drug-gets-orphan-status-for-mds-293152.html 0.6 2026-04-29T21:36:56+08:00 daily https://www.pharmasources.com/industryinsights/nhs-performance-takes-another-downturn-293153.html 0.6 2026-02-28T16:11:52+08:00 daily https://www.pharmasources.com/industryinsights/treat-severe-cases-of-sepsis-within-one--293154.html 0.6 2026-03-25T22:13:24+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-shutter-west-lothian-plant-293155.html 0.6 2026-07-02T11:48:49+08:00 daily https://www.pharmasources.com/industryinsights/new-england-journal-of-medicine-publishe-293156.html 0.6 2026-04-08T18:21:40+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-a-new-way-to-promot-293157.html 0.6 2026-03-13T20:25:57+08:00 daily https://www.pharmasources.com/industryinsights/international-yoga-fest-concludes-in-new-293158.html 0.6 2026-01-31T00:49:51+08:00 daily https://www.pharmasources.com/industryinsights/bergenbio-and-merck-to-evaluate-bgb324-w-293159.html 0.6 2026-07-08T18:56:35+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-ataxion-kasten-heat-biolog-293160.html 0.6 2026-06-20T17:25:41+08:00 daily https://www.pharmasources.com/industryinsights/pharnext-and-galapagos-partner-to-genera-293161.html 0.6 2026-06-22T11:52:15+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-sichuan-kelun-pharma-asc-293162.html 0.6 2025-11-27T04:56:49+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-showcases-its-products-at-pu-tec-293163.html 0.6 2026-03-05T07:07:53+08:00 daily https://www.pharmasources.com/industryinsights/branded-heart-diabetes-drugs-much-costli-293164.html 0.6 2026-06-16T21:00:45+08:00 daily https://www.pharmasources.com/industryinsights/indian-investors-encouraged-to-invest-in-293165.html 0.6 2026-07-18T15:28:58+08:00 daily https://www.pharmasources.com/industryinsights/your-dna-may-determine-how-you-handle-th-293166.html 0.6 2026-07-08T18:14:36+08:00 daily https://www.pharmasources.com/industryinsights/severe-low-blood-sugar-episode-may-up-de-293167.html 0.6 2026-04-12T22:33:02+08:00 daily https://www.pharmasources.com/industryinsights/radius-health-receives-notification-of-p-293168.html 0.6 2026-01-23T11:27:16+08:00 daily https://www.pharmasources.com/industryinsights/nicox-resubmits-ac-170-zerviate-nda-to-t-293169.html 0.6 2026-03-17T22:57:40+08:00 daily https://www.pharmasources.com/industryinsights/cure-found-for-cancer-killing-endangered-293170.html 0.6 2026-03-17T23:12:31+08:00 daily https://www.pharmasources.com/industryinsights/former-fda-deputy-commissioner-scott-got-293171.html 0.6 2026-06-22T02:26:49+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-fosun-comments-on-media-reports-293172.html 0.6 2026-06-14T08:22:04+08:00 daily https://www.pharmasources.com/industryinsights/valeant-receives-lender-consent-for-refi-293173.html 0.6 2026-06-14T06:38:43+08:00 daily https://www.pharmasources.com/industryinsights/future-hta-cooperation-in-europe-293174.html 0.6 2026-06-14T14:34:31+08:00 daily https://www.pharmasources.com/industryinsights/selvita-to-present-new-data-from-its-onc-293175.html 0.6 2026-03-22T00:15:52+08:00 daily https://www.pharmasources.com/industryinsights/trumps-fda-pick-gottlieb-calls-vaccine-a-293176.html 0.6 2026-07-16T20:20:30+08:00 daily https://www.pharmasources.com/industryinsights/gsk-consolidates-dt-and-tt-vax-productio-293177.html 0.6 2025-12-26T14:31:38+08:00 daily https://www.pharmasources.com/industryinsights/duran-group-launches-new-corporate-ident-293178.html 0.6 2026-04-21T06:11:41+08:00 daily https://www.pharmasources.com/industryinsights/duran-wheaton-kimble-appoints-executives-293179.html 0.6 2026-01-26T14:05:59+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-chiesi-extend-drug-discove-293180.html 0.6 2026-03-28T16:57:38+08:00 daily https://www.pharmasources.com/industryinsights/hikma-launches-desvenlafaxine-succinate--293181.html 0.6 2026-07-07T03:23:23+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-announces-collaboration--293182.html 0.6 2025-11-27T04:36:32+08:00 daily https://www.pharmasources.com/industryinsights/proclara-biosciences-australia-awarded-g-293183.html 0.6 2026-01-03T12:40:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-ind-clearance-for-serviers-uc-293184.html 0.6 2026-03-01T18:55:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-bo-293185.html 0.6 2026-07-17T15:53:23+08:00 daily https://www.pharmasources.com/industryinsights/toxicological-risk-evaluation-of-extract-293186.html 0.6 2026-08-04T07:58:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kisqali-receives-fda-approval-a-293187.html 0.6 2026-07-04T07:21:07+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-roche-to-test-bladder-ca-293188.html 0.6 2026-08-05T21:27:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-the-biologics-license-applic-293189.html 0.6 2026-07-03T03:43:17+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-submits-snda-to-fda-for-use-of--293190.html 0.6 2026-06-08T17:30:07+08:00 daily https://www.pharmasources.com/industryinsights/phage-therapy-shown-to-kill-drug-resista-293191.html 0.6 2026-06-21T00:49:48+08:00 daily https://www.pharmasources.com/industryinsights/cancer-clinic-turns-to-crowdfunding-to-b-293192.html 0.6 2026-08-07T02:07:46+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-announces-winners-of-inaugural-he-293193.html 0.6 2026-04-05T21:38:27+08:00 daily https://www.pharmasources.com/industryinsights/forma-therapeutics-achieves-first-clinic-293194.html 0.6 2026-06-23T12:33:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kisqali-293195.html 0.6 2026-02-15T10:50:17+08:00 daily https://www.pharmasources.com/industryinsights/cystic-fibrosis-survival-better-in-canad-293196.html 0.6 2026-03-03T02:41:16+08:00 daily https://www.pharmasources.com/industryinsights/hodgkin-lymphoma-survivors-face-risk-of--293197.html 0.6 2026-06-09T19:34:37+08:00 daily https://www.pharmasources.com/industryinsights/roche-reaches-global-settlement-licensin-293198.html 0.6 2026-06-27T20:39:15+08:00 daily https://www.pharmasources.com/industryinsights/ackman-unloads-entire-stake-in-valeant-293199.html 0.6 2026-08-09T08:09:59+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-partnership-with-uk-uni-293200.html 0.6 2026-04-07T04:34:41+08:00 daily https://www.pharmasources.com/industryinsights/trump-makes-choice-on-new-fda-head-293201.html 0.6 2025-12-27T19:35:10+08:00 daily https://www.pharmasources.com/industryinsights/bma-rcn-warn-immigration-charge-will-cos-293202.html 0.6 2026-03-08T00:58:21+08:00 daily https://www.pharmasources.com/industryinsights/tigenix-announces-success-of-novel-heart-293203.html 0.6 2026-01-31T10:05:52+08:00 daily https://www.pharmasources.com/industryinsights/bad-start-to-month-for-karyopharm-gets-w-293204.html 0.6 2026-03-03T02:40:01+08:00 daily https://www.pharmasources.com/industryinsights/scottish-gov-to-stream-extra-71m-into-ge-293205.html 0.6 2026-03-01T13:04:05+08:00 daily https://www.pharmasources.com/industryinsights/combination-immunotherapy-shows-promise--293206.html 0.6 2026-02-06T22:32:26+08:00 daily https://www.pharmasources.com/industryinsights/fish-oil-pills-may-help-after-heart-atta-293207.html 0.6 2026-01-17T09:23:09+08:00 daily https://www.pharmasources.com/industryinsights/failed-fertility-treatments-poorer-heart-293208.html 0.6 2026-04-07T20:12:49+08:00 daily https://www.pharmasources.com/industryinsights/bracing-for-the-biosimilar-wave-293209.html 0.6 2026-08-09T09:50:07+08:00 daily https://www.pharmasources.com/industryinsights/keapstone-therapeutics-and-sygnature-dis-293210.html 0.6 2026-05-07T02:04:34+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-hospital-clinical-pharmacolo-293211.html 0.6 2026-08-07T22:26:02+08:00 daily https://www.pharmasources.com/industryinsights/amo-pharma-ranedis-pharmaceuticals-form--293212.html 0.6 2026-04-20T18:27:13+08:00 daily https://www.pharmasources.com/industryinsights/vedantra-forms-research-collaboration-wi-293213.html 0.6 2026-07-07T16:50:44+08:00 daily https://www.pharmasources.com/industryinsights/oral-otezla-demonstrated-significant-imp-293214.html 0.6 2026-06-29T06:11:06+08:00 daily https://www.pharmasources.com/industryinsights/global-obesity-has-reached-pandemic-leve-293215.html 0.6 2026-06-24T22:32:03+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-names-winners-of-first-a-293216.html 0.6 2026-03-29T02:14:39+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-editas-medicine-enter-to-di-293217.html 0.6 2026-08-06T03:00:19+08:00 daily https://www.pharmasources.com/industryinsights/amo-pharma-enters-into-collaboration-agr-293218.html 0.6 2025-12-27T16:26:10+08:00 daily https://www.pharmasources.com/industryinsights/new-study-results-may-lead-to-a-new-stan-293219.html 0.6 2026-07-07T22:51:51+08:00 daily https://www.pharmasources.com/industryinsights/ta-associates-announces-investment-in-id-293220.html 0.6 2026-07-17T04:33:55+08:00 daily https://www.pharmasources.com/industryinsights/mylan-announces-global-settlement-and-li-293221.html 0.6 2026-04-09T16:39:21+08:00 daily https://www.pharmasources.com/industryinsights/repatha-demonstrates-reduced-need-for-ap-293222.html 0.6 2026-08-07T22:15:56+08:00 daily https://www.pharmasources.com/industryinsights/gsk-consumer-healthcare-launches-new-too-293223.html 0.6 2026-03-12T16:06:42+08:00 daily https://www.pharmasources.com/industryinsights/boehringers-investigational-anti-cd33-mo-293224.html 0.6 2026-03-18T09:39:17+08:00 daily https://www.pharmasources.com/industryinsights/new-economic-data-finds-novo-nordisks-in-293225.html 0.6 2026-07-17T17:01:24+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-biosimilar-adalimumab-study-shows-293226.html 0.6 2026-06-11T12:39:56+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-airway-disease-portfolio-w-293227.html 0.6 2026-03-17T23:22:51+08:00 daily https://www.pharmasources.com/industryinsights/luxcel-biosciences-and-hd-biosciences-en-293228.html 0.6 2026-04-22T22:17:37+08:00 daily https://www.pharmasources.com/industryinsights/cooking-at-home-tonight-its-likely-cheap-293229.html 0.6 2026-03-05T09:13:37+08:00 daily https://www.pharmasources.com/industryinsights/leo-innovation-lab-ceo-wins-eyeforpharma-293230.html 0.6 2026-03-01T00:12:56+08:00 daily https://www.pharmasources.com/industryinsights/roche-annual-general-meeting-2017-293231.html 0.6 2026-04-12T19:39:57+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-based-astex-pharmaceuticals-ce-293232.html 0.6 2026-07-06T23:17:05+08:00 daily https://www.pharmasources.com/industryinsights/skill-development-project-for-life-scien-293233.html 0.6 2026-04-15T11:24:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mercks-keytruda-pembrolizum-293234.html 0.6 2026-08-03T20:52:53+08:00 daily https://www.pharmasources.com/industryinsights/gene-variant-from-africa-linked-to-black-293235.html 0.6 2026-04-18T04:56:06+08:00 daily https://www.pharmasources.com/industryinsights/is-radiation-therapy-overused-in-breast--293236.html 0.6 2026-04-02T01:03:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kisqali-garners-fda-approval-as-293237.html 0.6 2026-04-17T10:44:12+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-ovarian-cancer-drug-lynparz-293238.html 0.6 2025-11-27T03:39:46+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharmaceutical-says-fda-to-lift-impo-293239.html 0.6 2026-08-07T12:01:13+08:00 daily https://www.pharmasources.com/industryinsights/allergan-editas-medicine-partner-to-deve-293240.html 0.6 2026-08-07T05:01:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-voluntis-expand-agreement-to-deli-293241.html 0.6 2026-08-07T04:25:44+08:00 daily https://www.pharmasources.com/industryinsights/swansea-university-scientists-participat-293242.html 0.6 2026-08-07T20:25:51+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dupilumab-joins-uks-early-access-293243.html 0.6 2026-08-07T03:55:42+08:00 daily https://www.pharmasources.com/industryinsights/pharma-firms-fall-foul-of-abpi-code-293244.html 0.6 2026-08-07T03:34:22+08:00 daily https://www.pharmasources.com/industryinsights/smc-welcomes-roches-gazyvaro-but-rejects-293245.html 0.6 2026-08-07T03:25:09+08:00 daily https://www.pharmasources.com/industryinsights/poor-sleep-in-preschool-years-could-mean-293246.html 0.6 2026-08-07T03:03:01+08:00 daily https://www.pharmasources.com/industryinsights/us-nod-for-novartis-breast-cancer-drug-k-293247.html 0.6 2026-08-07T03:14:04+08:00 daily https://www.pharmasources.com/industryinsights/its-a-bad-deal-sanders-says-of-us-armys--293248.html 0.6 2026-08-07T00:02:58+08:00 daily https://www.pharmasources.com/industryinsights/roche-lines-up-bavarian-nordic-vaccine-f-293249.html 0.6 2026-08-07T00:40:24+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-research-uk-report-reveals-do-293250.html 0.6 2026-08-07T01:19:43+08:00 daily https://www.pharmasources.com/industryinsights/enterprise-system-partners-werum-it-rene-293251.html 0.6 2026-08-07T01:11:01+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-patients-in-uk-wait-average-293252.html 0.6 2026-08-07T01:27:31+08:00 daily https://www.pharmasources.com/industryinsights/envigo-expands-rd-capabilities-293253.html 0.6 2026-08-07T01:31:53+08:00 daily https://www.pharmasources.com/industryinsights/japans-mhlw-grants-priority-review-for-a-293254.html 0.6 2026-08-08T07:58:16+08:00 daily https://www.pharmasources.com/industryinsights/lallemand-health-solutions-quality-probi-293255.html 0.6 2026-08-08T08:59:45+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-editas-medicine-all-set-to--293256.html 0.6 2026-08-09T04:40:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-launches-new-antibiotic-in-the-uk-293257.html 0.6 2026-01-06T06:34:10+08:00 daily https://www.pharmasources.com/industryinsights/colorado-unapproved-drug-and-dietary-sup-293258.html 0.6 2026-06-14T17:44:45+08:00 daily https://www.pharmasources.com/industryinsights/basf-inorganic-specialties-divestiture-c-293259.html 0.6 2026-03-17T18:14:09+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-announces-positive-results-fr-293260.html 0.6 2026-08-08T08:24:25+08:00 daily https://www.pharmasources.com/industryinsights/nice-gets-go-ahead-to-fast-track-more-dr-293261.html 0.6 2026-07-14T06:14:39+08:00 daily https://www.pharmasources.com/industryinsights/nice-expands-positive-recommendation-for-293262.html 0.6 2026-04-28T12:55:34+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-mercks-keytruda-for-hodgkin--293263.html 0.6 2026-08-09T03:44:43+08:00 daily https://www.pharmasources.com/industryinsights/angsanas-rna-based-fusions-cancer-panel--293264.html 0.6 2026-06-13T18:47:43+08:00 daily https://www.pharmasources.com/industryinsights/allergan-signs-up-to-editas-genome-editi-293265.html 0.6 2025-11-27T03:10:04+08:00 daily https://www.pharmasources.com/industryinsights/uks-mrc-tech-licenses-antibody-to-chines-293266.html 0.6 2026-06-25T21:25:34+08:00 daily https://www.pharmasources.com/industryinsights/nice-asks-for-more-data-on-opdivo-293267.html 0.6 2026-04-03T17:47:23+08:00 daily https://www.pharmasources.com/industryinsights/developing-nanopreparation-properties-fo-293268.html 0.6 2026-03-20T01:51:25+08:00 daily https://www.pharmasources.com/industryinsights/biocartis-and-merck-partnership-launch-s-293269.html 0.6 2026-02-05T14:15:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-shows-almost-all-psori-293270.html 0.6 2026-08-03T05:42:23+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-reports-that-investigati-293271.html 0.6 2026-08-06T18:05:43+08:00 daily https://www.pharmasources.com/industryinsights/drug-combination-delivered-by-nanopartic-293272.html 0.6 2026-06-07T16:57:23+08:00 daily https://www.pharmasources.com/industryinsights/jp-nadda-addresses-who-regional-health-m-293273.html 0.6 2026-08-08T11:57:00+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-to-lift-import-alert-on-mohali-pl-293274.html 0.6 2026-02-28T21:11:11+08:00 daily https://www.pharmasources.com/industryinsights/smartphone-based-asthma-study-highlights-293275.html 0.6 2026-06-07T01:18:35+08:00 daily https://www.pharmasources.com/industryinsights/study-links-diclofenac-ibuprofen-with-in-293276.html 0.6 2026-08-03T14:46:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-says-benefits-of-endos-opana-e-293277.html 0.6 2026-03-10T02:24:37+08:00 daily https://www.pharmasources.com/industryinsights/decade-lifespan-difference-in-americans--293278.html 0.6 2026-08-05T15:44:54+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-against-opdivo-for-class-293279.html 0.6 2025-11-27T02:54:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approved-preterm-birth-drug-has-no-b-293280.html 0.6 2026-08-05T22:13:47+08:00 daily https://www.pharmasources.com/industryinsights/seniors-with-brain-cancer-may-have-bette-293281.html 0.6 2026-06-21T13:18:28+08:00 daily https://www.pharmasources.com/industryinsights/stem-cells-hold-promise-peril-in-treatin-293282.html 0.6 2026-06-08T11:35:20+08:00 daily https://www.pharmasources.com/industryinsights/fantastic-returns-on-rare-disease-drug-d-293283.html 0.6 2026-07-17T10:30:57+08:00 daily https://www.pharmasources.com/industryinsights/gsk-submits-application-to-fda-for-expan-293284.html 0.6 2026-05-22T23:45:08+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dupilumab-receives-eams-positive-293285.html 0.6 2026-08-03T01:48:48+08:00 daily https://www.pharmasources.com/industryinsights/uk-nice-to-deny-nhs-access-to-bmss-blood-293286.html 0.6 2026-03-17T20:33:25+08:00 daily https://www.pharmasources.com/industryinsights/nice-oks-20m-budget-impact-limit-for-new-293287.html 0.6 2026-03-19T08:17:02+08:00 daily https://www.pharmasources.com/industryinsights/tencent-changing-medical-field-requires--293288.html 0.6 2026-07-21T00:49:19+08:00 daily https://www.pharmasources.com/industryinsights/study-links-nsaids-with-higher-risk-of-c-293289.html 0.6 2026-03-13T21:06:43+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-biogens-zinbryta-for-m-293290.html 0.6 2026-06-11T20:09:38+08:00 daily https://www.pharmasources.com/industryinsights/teva-launches-authorized-generic-of-mina-293291.html 0.6 2026-03-13T08:41:59+08:00 daily https://www.pharmasources.com/industryinsights/shire-receives-european-approval-for-lab-293292.html 0.6 2026-02-25T21:45:28+08:00 daily https://www.pharmasources.com/industryinsights/natoli-engineering-company-opens-facilit-293293.html 0.6 2026-07-15T17:42:08+08:00 daily https://www.pharmasources.com/industryinsights/az-lynparza-hits-targets-in-ovarian-canc-293294.html 0.6 2026-04-07T03:55:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-says-viberzi-eluxadoline-has-an-incr-293295.html 0.6 2026-07-19T02:44:44+08:00 daily https://www.pharmasources.com/industryinsights/trinity-health-and-pacira-pharmaceutical-293296.html 0.6 2026-07-19T10:17:42+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-to-acquire-emflaza-for--293297.html 0.6 2025-11-27T02:33:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mercks-keytruda-for-adult-a-293298.html 0.6 2026-07-25T22:09:20+08:00 daily https://www.pharmasources.com/industryinsights/endo-releases-statement-on-fda-advisory--293299.html 0.6 2025-11-27T02:31:40+08:00 daily https://www.pharmasources.com/industryinsights/gsk-seeks-expanded-indication-for-fluari-293300.html 0.6 2026-03-03T00:32:01+08:00 daily https://www.pharmasources.com/industryinsights/metrion-and-concept-introduce-integrated-293301.html 0.6 2026-08-06T11:37:03+08:00 daily https://www.pharmasources.com/industryinsights/100-billion-of-revenues-up-for-grabs-for-293302.html 0.6 2026-02-28T14:22:23+08:00 daily https://www.pharmasources.com/industryinsights/pharmajet-partners-with-serum-to-launch--293303.html 0.6 2026-06-15T16:52:17+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-to-grow-overseas-sales--293304.html 0.6 2026-07-20T16:13:34+08:00 daily https://www.pharmasources.com/industryinsights/pharmapack-europe-2017-highlights-new-de-293305.html 0.6 2026-04-15T11:17:31+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-announces-first-293306.html 0.6 2026-06-08T19:40:58+08:00 daily https://www.pharmasources.com/industryinsights/takeda-off-loads-some-drug-development-t-293307.html 0.6 2026-07-06T10:09:10+08:00 daily https://www.pharmasources.com/industryinsights/human-antibody-for-zika-virus-promising--293308.html 0.6 2026-04-17T07:04:08+08:00 daily https://www.pharmasources.com/industryinsights/dietary-anti-cancer-compound-may-work-by-293309.html 0.6 2026-08-09T02:39:31+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-india-launches-humalog-200uml--293310.html 0.6 2026-07-19T02:12:17+08:00 daily https://www.pharmasources.com/industryinsights/dsm-sinochem-pharmaceuticals-in-agreemen-293311.html 0.6 2026-05-15T17:51:52+08:00 daily https://www.pharmasources.com/industryinsights/govt-gets-rs-672-crs-fine-from-pharma-co-293312.html 0.6 2026-06-09T14:07:09+08:00 daily https://www.pharmasources.com/industryinsights/opioid-dependence-can-start-in-just-a-fe-293313.html 0.6 2026-07-02T06:38:11+08:00 daily https://www.pharmasources.com/industryinsights/new-nice-rules-designed-to-speed-access--293314.html 0.6 2025-12-03T07:51:05+08:00 daily https://www.pharmasources.com/industryinsights/proposed-us-budget-for-2018-sees-rise-in-293315.html 0.6 2026-04-04T22:20:12+08:00 daily https://www.pharmasources.com/industryinsights/stada-gives-suitors-more-time-to-raise-b-293316.html 0.6 2026-04-07T10:10:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-chinas-lumis-over-misbranded-a-293317.html 0.6 2026-08-07T14:31:41+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-centreone-expands-service-portfol-293318.html 0.6 2026-08-09T03:12:31+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-cphi-barcelona-2016an-encoun-293319.html 0.6 2026-07-28T02:19:36+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-innopharmax-aurinia-phar-293320.html 0.6 2026-06-08T09:28:05+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biodynamics-joins-collaboration-t-293321.html 0.6 2026-04-07T18:28:31+08:00 daily https://www.pharmasources.com/industryinsights/diurnal-and-clinigen-to-introduce-patien-293322.html 0.6 2026-06-14T23:10:14+08:00 daily https://www.pharmasources.com/industryinsights/uk-nice-board-approves-changes-to-drug-e-293323.html 0.6 2026-04-20T18:37:03+08:00 daily https://www.pharmasources.com/industryinsights/first-dedicated-outcome-trials-of-empagl-293324.html 0.6 2026-03-26T17:23:00+08:00 daily https://www.pharmasources.com/industryinsights/ta-associates-invests-in-ideal-cures-293325.html 0.6 2026-02-05T07:27:52+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-appreciates-mohfws-move--293326.html 0.6 2026-03-26T19:23:46+08:00 daily https://www.pharmasources.com/industryinsights/idx-and-ibm-watson-health-forge-alliance-293327.html 0.6 2026-03-17T21:34:30+08:00 daily https://www.pharmasources.com/industryinsights/bellus-health-sells-subsidiary-thallion--293328.html 0.6 2026-08-09T12:55:04+08:00 daily https://www.pharmasources.com/industryinsights/threshold-pharmaceuticals-and-molecular--293329.html 0.6 2026-02-28T07:59:55+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-receives-complete-response-l-293330.html 0.6 2026-03-27T10:47:29+08:00 daily https://www.pharmasources.com/industryinsights/research-paper-slams-deepmindroyal-free--293331.html 0.6 2026-06-17T19:08:41+08:00 daily https://www.pharmasources.com/industryinsights/myeloma-uk-launches-world-first-immunoth-293332.html 0.6 2026-03-07T13:36:28+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-circassia-enter-strategi-293333.html 0.6 2026-04-18T20:32:28+08:00 daily https://www.pharmasources.com/industryinsights/cost-of-prescriptions-to-rise-20p-in-eng-293334.html 0.6 2026-07-20T21:38:39+08:00 daily https://www.pharmasources.com/industryinsights/nice-set-to-reject-janssens-darzalex-for-293335.html 0.6 2026-03-08T06:40:12+08:00 daily https://www.pharmasources.com/industryinsights/finalists-for-international-clinical-res-293336.html 0.6 2026-04-06T23:39:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novartis-kisqali-as-first-l-293337.html 0.6 2026-07-29T10:03:36+08:00 daily https://www.pharmasources.com/industryinsights/growing-market-for-generics-and-liberali-293338.html 0.6 2025-11-13T01:46:41+08:00 daily https://www.pharmasources.com/industryinsights/landmark-outcomes-study-shows-that-repat-293339.html 0.6 2026-04-06T08:19:58+08:00 daily https://www.pharmasources.com/industryinsights/wns-acquires-healthhelp-293340.html 0.6 2026-03-26T23:57:56+08:00 daily https://www.pharmasources.com/industryinsights/genomic-health-unveils-data-for-the-onco-293341.html 0.6 2026-04-08T14:29:37+08:00 daily https://www.pharmasources.com/industryinsights/study-using-biocartis-liquid-biopsy-assa-293342.html 0.6 2026-06-28T12:13:32+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-phase-iii-data-demonstrates-pro-293343.html 0.6 2026-08-08T07:49:33+08:00 daily https://www.pharmasources.com/industryinsights/xw-labs-announces-exclusive-licensing-ag-293344.html 0.6 2026-03-28T20:04:29+08:00 daily https://www.pharmasources.com/industryinsights/pharma-can-learn-from-other-sectors-293345.html 0.6 2025-12-25T07:51:07+08:00 daily https://www.pharmasources.com/industryinsights/biogen-appoints-red-svp-293346.html 0.6 2026-02-28T16:39:59+08:00 daily https://www.pharmasources.com/industryinsights/crown-bioscience-appoints-gm-293347.html 0.6 2026-06-15T16:53:30+08:00 daily https://www.pharmasources.com/industryinsights/camargo-plans-to-expand-and-develop-new--293348.html 0.6 2026-07-17T05:06:47+08:00 daily https://www.pharmasources.com/industryinsights/hitachi-chemical-acquires-remaining-stak-293349.html 0.6 2026-06-22T09:13:57+08:00 daily https://www.pharmasources.com/industryinsights/selvita-announces-first-patient-dosed-in-293350.html 0.6 2026-03-13T05:16:18+08:00 daily https://www.pharmasources.com/industryinsights/remote-amazon-tribe-may-have-healthiest--293351.html 0.6 2026-06-19T20:43:42+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-bayers-xarelto-superior--293352.html 0.6 2026-06-22T06:10:59+08:00 daily https://www.pharmasources.com/industryinsights/new-cholesterol-drugs-may-beat-statins-b-293353.html 0.6 2026-06-17T19:58:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-api-manufacturer-about-river-w-293354.html 0.6 2026-08-04T02:11:23+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20172003-293355.html 0.6 2026-06-08T15:24:29+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-phase-3-monarch-2-breast-293356.html 0.6 2026-03-19T22:05:22+08:00 daily https://www.pharmasources.com/industryinsights/finding-solutions-for-patients-293357.html 0.6 2026-07-20T04:40:39+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-completes-sale-of-its-intra-293358.html 0.6 2026-07-03T06:10:46+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-cytomx-therapeu-293359.html 0.6 2026-03-01T00:02:07+08:00 daily https://www.pharmasources.com/industryinsights/x-chem-announces-strategic-collaboration-293360.html 0.6 2026-04-06T13:33:54+08:00 daily https://www.pharmasources.com/industryinsights/bellus-health-agrees-to-sell-thallion-to-293361.html 0.6 2026-06-18T20:44:36+08:00 daily https://www.pharmasources.com/industryinsights/circassia-to-acquire-us-rights-to-tudorz-293362.html 0.6 2026-01-10T13:18:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-use-of-daratumumab-darzalex-293363.html 0.6 2026-08-03T07:09:36+08:00 daily https://www.pharmasources.com/industryinsights/arena-pharmaceuticals-appoints-executive-293364.html 0.6 2026-01-30T23:24:57+08:00 daily https://www.pharmasources.com/industryinsights/bayers-xarelto-beats-aspirin-in-preventi-293365.html 0.6 2026-02-06T11:33:39+08:00 daily https://www.pharmasources.com/industryinsights/lga-public-health-england-issue-countrys-293366.html 0.6 2025-11-17T08:37:22+08:00 daily https://www.pharmasources.com/industryinsights/second-us-rejection-for-az-potassium-bin-293367.html 0.6 2026-01-31T10:21:59+08:00 daily https://www.pharmasources.com/industryinsights/new-analysis-shows-novartis-entresto-imp-293368.html 0.6 2026-08-08T13:36:12+08:00 daily https://www.pharmasources.com/industryinsights/dementia-consortium-funds-manchester-bas-293369.html 0.6 2026-08-05T23:34:26+08:00 daily https://www.pharmasources.com/industryinsights/merck-introduces-millipore-express-high--293370.html 0.6 2026-07-28T08:32:05+08:00 daily https://www.pharmasources.com/industryinsights/korea-to-inaugurate-countrys-first-biosa-293371.html 0.6 2026-01-02T04:20:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-heart-failure-med-entresto-cuts-293372.html 0.6 2026-07-07T15:29:03+08:00 daily https://www.pharmasources.com/industryinsights/fixed-dose-combination-of-drugs-versus-s-293373.html 0.6 2026-06-08T06:30:02+08:00 daily https://www.pharmasources.com/industryinsights/re-formulation-of-microbicidal-lubricant-293374.html 0.6 2026-06-08T17:46:55+08:00 daily https://www.pharmasources.com/industryinsights/debiopharms-triptorelin-6-month-formulat-293375.html 0.6 2026-06-25T07:32:34+08:00 daily https://www.pharmasources.com/industryinsights/bioversys-ag-and-aptuit-announce-collabo-293376.html 0.6 2026-03-28T21:41:48+08:00 daily https://www.pharmasources.com/industryinsights/owlstone-medical-to-provide-breath-bioma-293377.html 0.6 2026-03-22T03:44:41+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-appoints-cco-293378.html 0.6 2026-01-21T05:27:29+08:00 daily https://www.pharmasources.com/industryinsights/bms-cytomx-expand-probody-pact-293379.html 0.6 2026-06-26T14:33:54+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-bioanalytical-services-at-po-293380.html 0.6 2026-03-17T20:05:35+08:00 daily https://www.pharmasources.com/industryinsights/piramal-buys-mallinckrodts-pain-drug-por-293381.html 0.6 2026-03-17T20:32:09+08:00 daily https://www.pharmasources.com/industryinsights/taro-pharmaceuticals-in-agreement-with-t-293382.html 0.6 2026-05-03T08:43:10+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-commends-edevice-for-sett-293383.html 0.6 2025-11-24T05:33:45+08:00 daily https://www.pharmasources.com/industryinsights/lowering-ldl-levels-with-repathar-evoloc-293384.html 0.6 2026-07-21T02:52:23+08:00 daily https://www.pharmasources.com/industryinsights/eyeforpharma-philadelphia-2017-be-the-tr-293385.html 0.6 2026-04-13T02:53:02+08:00 daily https://www.pharmasources.com/industryinsights/new-analysis-shows-novartis-entresto-imp-293386.html 0.6 2026-08-06T15:18:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-juvderm-vollure-xc-293387.html 0.6 2026-07-31T11:54:31+08:00 daily https://www.pharmasources.com/industryinsights/new-hepatitis-c-drugs-might-eliminate-th-293388.html 0.6 2026-06-05T15:55:38+08:00 daily https://www.pharmasources.com/industryinsights/cspc-pharmaceutical-announces-2016-annua-293389.html 0.6 2026-07-16T11:30:36+08:00 daily https://www.pharmasources.com/industryinsights/truth-or-myth-global-survey-for-world-or-293390.html 0.6 2026-01-30T20:01:06+08:00 daily https://www.pharmasources.com/industryinsights/former-congressman-speaks-against-drug-i-293391.html 0.6 2025-11-04T08:42:21+08:00 daily https://www.pharmasources.com/industryinsights/mylan-receives-tentative-approval-for-tl-293392.html 0.6 2026-08-09T01:58:03+08:00 daily https://www.pharmasources.com/industryinsights/bausch-lomb-and-nicox-announce-pdufa-dat-293393.html 0.6 2026-07-07T01:38:18+08:00 daily https://www.pharmasources.com/industryinsights/divis-labs-gets-us-fda-import-alert-293394.html 0.6 2026-06-12T00:09:55+08:00 daily https://www.pharmasources.com/industryinsights/merck-accelerator-hits-new-peak-of-appli-293395.html 0.6 2026-06-08T09:10:23+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-msd-enter-research-collaborat-293396.html 0.6 2026-08-09T03:16:24+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-cured-of-rare-blood-disord-293397.html 0.6 2026-02-28T15:38:39+08:00 daily https://www.pharmasources.com/industryinsights/sutrovax-reels-in-64m-with-plans-to-take-293398.html 0.6 2026-06-30T13:55:33+08:00 daily https://www.pharmasources.com/industryinsights/geovax-pushes-ahead-in-zika-vaccine-real-293399.html 0.6 2026-04-06T16:06:45+08:00 daily https://www.pharmasources.com/industryinsights/us-government-tasks-protein-sciences-wit-293400.html 0.6 2026-04-09T15:47:01+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-study-shows-sglt-2-inhibitor-293401.html 0.6 2026-08-09T22:12:05+08:00 daily https://www.pharmasources.com/industryinsights/essentica-is-the-largest-high-technology-293402.html 0.6 2026-04-23T23:28:13+08:00 daily https://www.pharmasources.com/industryinsights/apogenix-presents-data-on-novel-hexavale-293403.html 0.6 2026-07-10T10:36:57+08:00 daily https://www.pharmasources.com/industryinsights/uninterrupted-pradaxa-showed-less-major--293404.html 0.6 2026-02-11T22:10:32+08:00 daily https://www.pharmasources.com/industryinsights/icco-netherlands-invests-in-vivo-healthc-293405.html 0.6 2026-06-09T20:27:24+08:00 daily https://www.pharmasources.com/industryinsights/ntu-singapore-partners-with-chinese-and--293406.html 0.6 2026-07-07T00:52:33+08:00 daily https://www.pharmasources.com/industryinsights/potential-early-warning-signs-of-osteopo-293407.html 0.6 2026-03-17T23:56:12+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-liver-disease-drug-293408.html 0.6 2026-07-02T13:12:18+08:00 daily https://www.pharmasources.com/industryinsights/russian-government-drive-to-increase-dom-293409.html 0.6 2026-06-16T12:30:51+08:00 daily https://www.pharmasources.com/industryinsights/envigos-fully-validated-highly-sensitive-293410.html 0.6 2026-03-19T22:58:17+08:00 daily https://www.pharmasources.com/industryinsights/merck-launches-mobius-myway-portfolio-293411.html 0.6 2025-12-15T16:23:02+08:00 daily https://www.pharmasources.com/industryinsights/marken-awarded-two-new-operating-license-293412.html 0.6 2026-03-31T09:27:56+08:00 daily https://www.pharmasources.com/industryinsights/european-group-on-tumour-markers-egtm-up-293413.html 0.6 2026-08-07T18:02:25+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-first-patien-293414.html 0.6 2026-04-27T08:23:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xadago-293415.html 0.6 2025-12-05T08:40:31+08:00 daily https://www.pharmasources.com/industryinsights/many-doctors-get-payments-from-drug-comp-293416.html 0.6 2026-06-17T04:25:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-newron-zambon-us-worldmeds-xa-293417.html 0.6 2026-01-09T10:36:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-says-cosentyx-can-potentially-m-293418.html 0.6 2026-07-22T11:19:59+08:00 daily https://www.pharmasources.com/industryinsights/us-patent-office-upholds-biogens-patent--293419.html 0.6 2026-05-12T19:56:17+08:00 daily https://www.pharmasources.com/industryinsights/adaptimmune-therapeutics-proposes-public-293420.html 0.6 2026-07-09T18:30:51+08:00 daily https://www.pharmasources.com/industryinsights/argenx-announces-collaboration-with-brot-293421.html 0.6 2026-07-16T21:20:43+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-and-h-immune-announce-strat-293422.html 0.6 2026-04-02T10:52:02+08:00 daily https://www.pharmasources.com/industryinsights/3d-printing-applications-for-healthcare--293423.html 0.6 2026-08-09T05:10:08+08:00 daily https://www.pharmasources.com/industryinsights/international-medical-group-rolls-out-ne-293424.html 0.6 2026-08-09T01:08:11+08:00 daily https://www.pharmasources.com/industryinsights/digital-flexible-and-open---cerec-a-comp-293425.html 0.6 2026-06-17T04:04:54+08:00 daily https://www.pharmasources.com/industryinsights/pcc-acquires-intrathecal-therapy-busines-293426.html 0.6 2026-04-07T03:24:12+08:00 daily https://www.pharmasources.com/industryinsights/emergent-signs-100m-barda-contract-to-de-293427.html 0.6 2026-02-28T14:36:38+08:00 daily https://www.pharmasources.com/industryinsights/cannrx-and-icanisrael-cannabis-form-jv-t-293428.html 0.6 2026-01-22T14:49:38+08:00 daily https://www.pharmasources.com/industryinsights/come-back-for-lillys-breast-cancer-drug-293429.html 0.6 2026-08-10T01:20:53+08:00 daily https://www.pharmasources.com/industryinsights/16-years-of-cultivation-in-the-pharma-in-293430.html 0.6 2026-08-07T11:38:38+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-novartis-cosentyx-may-modify-293431.html 0.6 2026-08-07T15:39:07+08:00 daily https://www.pharmasources.com/industryinsights/arix-links-with-ldc-leeds-uni-in-metabol-293432.html 0.6 2026-02-15T00:09:55+08:00 daily https://www.pharmasources.com/industryinsights/govt-plans-to-expand-protection-for-nhs--293433.html 0.6 2026-03-19T08:55:52+08:00 daily https://www.pharmasources.com/industryinsights/wnif-combating-alzheimers-together-293434.html 0.6 2026-07-07T22:26:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-to-treat-parkinsons-di-293435.html 0.6 2026-04-09T20:38:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-is-first-and-only-il-1-293436.html 0.6 2026-07-22T11:19:58+08:00 daily https://www.pharmasources.com/industryinsights/sglt-2-inhibitors-significantly-reduce-d-293437.html 0.6 2026-03-16T09:11:14+08:00 daily https://www.pharmasources.com/industryinsights/china-proposes-new-fda-rules-to-speed-up-293438.html 0.6 2026-08-08T20:48:58+08:00 daily https://www.pharmasources.com/industryinsights/jj-chief-gorsky-in-china-for-official-su-293439.html 0.6 2026-05-15T04:31:33+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-exec-fires-back-amid-fight-over-z-293440.html 0.6 2026-01-12T12:16:38+08:00 daily https://www.pharmasources.com/industryinsights/gsk-starts-175m-plant-to-boost-productio-293441.html 0.6 2026-06-08T16:04:45+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-partners-with-sato-to-manufact-293442.html 0.6 2026-07-06T23:43:03+08:00 daily https://www.pharmasources.com/industryinsights/mylan-receives-tentative-approval-for-tl-293443.html 0.6 2026-07-02T18:41:15+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-to-invest-millions-in-new-uk-fa-293444.html 0.6 2026-06-07T15:03:17+08:00 daily https://www.pharmasources.com/industryinsights/minoryx-therapeutics-completes-phase-1-c-293445.html 0.6 2026-01-31T09:22:18+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-and-h-immune-to-develop-new-293446.html 0.6 2026-07-06T20:47:59+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-dosing-of-fi-293447.html 0.6 2026-06-26T03:50:16+08:00 daily https://www.pharmasources.com/industryinsights/ferrier-research-institute-and-bcfnz-to--293448.html 0.6 2026-05-03T10:34:32+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-xadago-to-treat-patients-293449.html 0.6 2025-12-10T08:30:27+08:00 daily https://www.pharmasources.com/industryinsights/verona-signs-up-quintilesims-for-respira-293450.html 0.6 2025-12-10T08:28:25+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-enhances-exome-sequ-293451.html 0.6 2026-07-03T01:11:58+08:00 daily https://www.pharmasources.com/industryinsights/novartis-heart-drug-serelaxin-fails-in-k-293452.html 0.6 2026-06-08T16:53:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-first-novel-treatment-for-parkin-293453.html 0.6 2026-02-28T14:12:58+08:00 daily https://www.pharmasources.com/industryinsights/success-for-renowns-phase-i-study-to-tre-293454.html 0.6 2026-06-30T15:46:21+08:00 daily https://www.pharmasources.com/industryinsights/contraceptive-pill-reduces-cancer-risk-l-293455.html 0.6 2026-06-13T14:43:35+08:00 daily https://www.pharmasources.com/industryinsights/high-efficacy-0-adverse-effects-in-hemp--293456.html 0.6 2026-02-09T04:52:24+08:00 daily https://www.pharmasources.com/industryinsights/drug-no-better-than-placebo-for-lower-ba-293457.html 0.6 2026-07-06T11:39:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-serelaxin-fails-to-meet-goals-o-293458.html 0.6 2026-08-07T11:52:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-permits-akashi-therapeutics-to-resum-293459.html 0.6 2026-07-27T11:01:17+08:00 daily https://www.pharmasources.com/industryinsights/british-columbia-lists-epclusa-on-public-293460.html 0.6 2026-07-09T08:58:36+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-receives-orphan-drug-designati-293461.html 0.6 2025-12-14T13:44:53+08:00 daily https://www.pharmasources.com/industryinsights/opko-receives-fda-orphan-drug-status-for-293462.html 0.6 2026-03-29T04:09:24+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-and-h-immune-announce-strat-293463.html 0.6 2025-12-10T08:32:31+08:00 daily https://www.pharmasources.com/industryinsights/eagle-pharmaceuticals-announces-three-ne-293464.html 0.6 2026-08-08T03:16:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xadago-for-parkinsons-disea-293465.html 0.6 2026-07-04T04:52:06+08:00 daily https://www.pharmasources.com/industryinsights/upsher-smith-launches-generic-clomiprami-293466.html 0.6 2026-06-09T16:22:25+08:00 daily https://www.pharmasources.com/industryinsights/shire-receives-fda-fast-track-designatio-293467.html 0.6 2026-02-28T23:34:25+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-ceo-olivier-brandicourts-2017-chi-293468.html 0.6 2026-04-04T00:14:56+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-innovation-launches-sing-293469.html 0.6 2026-05-07T06:51:36+08:00 daily https://www.pharmasources.com/industryinsights/pharmapack-europe-2017-293470.html 0.6 2026-03-29T13:19:05+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-industry-outlook-2030-at--293471.html 0.6 2026-06-24T12:53:59+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-industry-outlook-2030-at--293472.html 0.6 2026-07-03T06:13:29+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-wins-cmo-leadership-awar-293473.html 0.6 2026-04-26T05:29:00+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharmas-preservative-free-multidos-293474.html 0.6 2026-06-15T11:31:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-approval-for-bavencio-aveluma-293475.html 0.6 2026-03-21T18:39:31+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-unveils-top-50-multi-bill-293476.html 0.6 2026-06-09T08:34:14+08:00 daily https://www.pharmasources.com/industryinsights/clobetasol-propionate-is-used-for-treati-293477.html 0.6 2026-06-08T14:32:47+08:00 daily https://www.pharmasources.com/industryinsights/a-smart-way-to-screen-male-infertility-293478.html 0.6 2026-06-12T12:05:31+08:00 daily https://www.pharmasources.com/industryinsights/silicone-saline-breast-implants-linked-t-293479.html 0.6 2026-08-09T03:20:00+08:00 daily https://www.pharmasources.com/industryinsights/argenx-and-broteio-pharma-partner-to-dev-293480.html 0.6 2026-04-17T06:24:37+08:00 daily https://www.pharmasources.com/industryinsights/new-formulation-of-fda-approved-drug-may-293481.html 0.6 2026-07-09T13:17:01+08:00 daily https://www.pharmasources.com/industryinsights/british-columbia-to-provide-public-acces-293482.html 0.6 2025-11-10T08:49:29+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-fast-track-designation-for-293483.html 0.6 2026-04-17T19:17:38+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-drugs-for-breast-cance-293484.html 0.6 2026-04-02T05:28:10+08:00 daily https://www.pharmasources.com/industryinsights/akcea-and-ionis-familial-chylomicronaemi-293485.html 0.6 2026-06-19T10:20:12+08:00 daily https://www.pharmasources.com/industryinsights/nhs-trusts-under-growing-pressure-to-mak-293486.html 0.6 2026-04-07T07:52:03+08:00 daily https://www.pharmasources.com/industryinsights/mrc-technology-licenses-antibody-to-news-293487.html 0.6 2026-08-07T03:33:58+08:00 daily https://www.pharmasources.com/industryinsights/three-quarters-of-ccgs-failing-to-improv-293488.html 0.6 2026-04-09T19:40:05+08:00 daily https://www.pharmasources.com/industryinsights/shires-rare-blood-disorder-drug-gets-us--293489.html 0.6 2026-03-19T23:36:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-drug-as-add-on-treatmen-293490.html 0.6 2026-04-09T16:34:18+08:00 daily https://www.pharmasources.com/industryinsights/mylan-recalls-81000-epipens-after-report-293491.html 0.6 2026-06-08T11:31:38+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-gsk-to-sequence-uk-genetic-293492.html 0.6 2025-10-19T01:18:14+08:00 daily https://www.pharmasources.com/industryinsights/trumps-budget-cuts-will-be-disastrous-fo-293493.html 0.6 2026-01-30T21:57:21+08:00 daily https://www.pharmasources.com/industryinsights/about-17-million-children-die-each-year--293494.html 0.6 2026-03-19T11:01:17+08:00 daily https://www.pharmasources.com/industryinsights/the-20-percent-duty-on-imported-medicine-293495.html 0.6 2026-07-02T14:31:44+08:00 daily https://www.pharmasources.com/industryinsights/novartis-laterals-two-phii-anti-aging-dr-293496.html 0.6 2026-06-24T07:19:19+08:00 daily https://www.pharmasources.com/industryinsights/will-the-nhs-force-doctors-to-prescribe--293497.html 0.6 2026-07-04T05:19:44+08:00 daily https://www.pharmasources.com/industryinsights/protein-hints-at-a-fountain-of-youth-in--293498.html 0.6 2026-06-21T16:27:49+08:00 daily https://www.pharmasources.com/industryinsights/major-breakthrough-in-the-manufacture-of-293499.html 0.6 2026-04-20T22:08:52+08:00 daily https://www.pharmasources.com/industryinsights/bayers-rivaroxaban-demonstrated-superior-293500.html 0.6 2026-08-07T13:51:45+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-disease-linked-to-the-metabol-293501.html 0.6 2026-02-15T00:30:08+08:00 daily https://www.pharmasources.com/industryinsights/could-nektar-therapeutics-be-worth-more-293502.html 0.6 2026-06-13T11:21:47+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-the-william-sansum-diabetes-ce-293503.html 0.6 2026-06-12T10:26:29+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-850-million-investment-i-293504.html 0.6 2026-06-20T07:41:51+08:00 daily https://www.pharmasources.com/industryinsights/the-power-of-unexpected-connection-293505.html 0.6 2026-01-17T11:18:28+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharmaceuticals-observes-world-tb-293506.html 0.6 2026-03-24T06:11:35+08:00 daily https://www.pharmasources.com/industryinsights/almirall-and-sun-pharma-announce-regulat-293507.html 0.6 2026-07-19T11:17:00+08:00 daily https://www.pharmasources.com/industryinsights/tb-alliance-sublicenses-promising-anti-t-293508.html 0.6 2026-04-13T14:36:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-rare-fo-293509.html 0.6 2026-03-29T09:30:03+08:00 daily https://www.pharmasources.com/industryinsights/rgc-uk-biobank-and-gsk-launch-new-initia-293510.html 0.6 2026-02-10T16:50:03+08:00 daily https://www.pharmasources.com/industryinsights/alexion-submits-application-to-japans-mh-293511.html 0.6 2026-06-15T20:09:46+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-ascend-therapeutics-us-t-293512.html 0.6 2026-04-07T00:30:03+08:00 daily https://www.pharmasources.com/industryinsights/korea-plastic-surgery-tl-plastic-surgery-293513.html 0.6 2026-04-03T05:26:52+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-to-support-precision--293514.html 0.6 2026-02-28T13:45:43+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-sun-moral-international-hk-293515.html 0.6 2026-06-16T09:56:49+08:00 daily https://www.pharmasources.com/industryinsights/biomedical-institute-for-global-health-r-293516.html 0.6 2026-03-20T15:17:53+08:00 daily https://www.pharmasources.com/industryinsights/shangpharma-announces-strategic-corporat-293517.html 0.6 2026-07-23T20:35:54+08:00 daily https://www.pharmasources.com/industryinsights/first-humira-biosimilar-approved-in-euro-293518.html 0.6 2026-06-28T04:42:00+08:00 daily https://www.pharmasources.com/industryinsights/nhs-speeds-up-publication-of-hospital-ep-293519.html 0.6 2026-07-08T05:24:21+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-amgevita-bi-293520.html 0.6 2025-11-13T12:24:40+08:00 daily https://www.pharmasources.com/industryinsights/emas-chmp-recommends-approval-of-mercks--293521.html 0.6 2026-06-08T22:33:17+08:00 daily https://www.pharmasources.com/industryinsights/bms-receives-positive-chmp-opinion-recom-293522.html 0.6 2026-06-22T02:48:44+08:00 daily https://www.pharmasources.com/industryinsights/paratek-pharmaceuticals-opens-new-office-293523.html 0.6 2026-06-14T23:02:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-293524.html 0.6 2026-08-03T18:24:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-parkinsons-disease-drug-293525.html 0.6 2026-06-08T23:18:03+08:00 daily https://www.pharmasources.com/industryinsights/uk-biobank-attracts-backing-from-gsk-and-293526.html 0.6 2026-06-29T08:30:37+08:00 daily https://www.pharmasources.com/industryinsights/dementia-consortium-funds-manchester-bas-293527.html 0.6 2026-06-02T15:57:42+08:00 daily https://www.pharmasources.com/industryinsights/cphi-expands-in-middle-east-africa-with--293528.html 0.6 2026-02-28T15:34:24+08:00 daily https://www.pharmasources.com/industryinsights/mrc-technology-licenses-antibody-to-news-293529.html 0.6 2026-06-08T19:37:17+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-granted-priority-review-in-japan--293530.html 0.6 2026-08-09T15:49:39+08:00 daily https://www.pharmasources.com/industryinsights/is-mri-the-mammography-of-prostate-cance-293531.html 0.6 2026-03-13T20:14:27+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-announces-10m-pancrea-293532.html 0.6 2026-08-07T23:06:33+08:00 daily https://www.pharmasources.com/industryinsights/a-patent-analytics-study-of-the-australi-293533.html 0.6 2026-02-01T04:43:52+08:00 daily https://www.pharmasources.com/industryinsights/research-found-to-reverse-signs-of-agein-293534.html 0.6 2026-04-22T15:23:22+08:00 daily https://www.pharmasources.com/industryinsights/xenon-pharmaceuticals-acne-drug-xen801-f-293535.html 0.6 2026-06-29T15:46:42+08:00 daily https://www.pharmasources.com/industryinsights/fipb-defers-gland-pharmas-acquisition-by-293536.html 0.6 2026-04-04T04:28:15+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-looks-to-close-1-billion-deal-fle-293537.html 0.6 2026-07-30T13:29:32+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn2017327-293538.html 0.6 2026-06-08T15:24:30+08:00 daily https://www.pharmasources.com/industryinsights/manufacture-of-red-blood-cells-possible--293539.html 0.6 2026-07-07T18:35:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receive-european-approval-for-art-293540.html 0.6 2026-04-09T16:49:38+08:00 daily https://www.pharmasources.com/industryinsights/treatment-combating-multi-drug-resistant-293541.html 0.6 2026-04-19T04:07:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-medicine-approved-under-chi-293542.html 0.6 2026-04-28T16:20:13+08:00 daily https://www.pharmasources.com/industryinsights/usana-subsidiary-babycare-holds-grand-op-293543.html 0.6 2026-06-06T13:03:22+08:00 daily https://www.pharmasources.com/industryinsights/karolinska-development-company-enrols-fi-293544.html 0.6 2025-11-10T07:23:02+08:00 daily https://www.pharmasources.com/industryinsights/a-spinach-leaf-turned-into-a-functional--293545.html 0.6 2025-10-28T13:22:55+08:00 daily https://www.pharmasources.com/industryinsights/new-lab-on-a-chip-platform-for-pathogen--293546.html 0.6 2026-02-13T08:10:14+08:00 daily https://www.pharmasources.com/industryinsights/asean-pharma-packaging-conference-conclu-293547.html 0.6 2026-07-08T18:20:06+08:00 daily https://www.pharmasources.com/industryinsights/leukaemia-cares-research-finds-inequalit-293548.html 0.6 2026-03-13T04:04:56+08:00 daily https://www.pharmasources.com/industryinsights/puretech-health-and-novartis-to-advance--293549.html 0.6 2026-05-12T18:50:08+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-secure-us-fda-approval--293550.html 0.6 2026-06-23T03:53:18+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-bags-approval-for-ra-drug-xeljanz-293551.html 0.6 2026-01-31T11:38:04+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-closer-to-classical-hodgki-293552.html 0.6 2026-06-05T23:23:19+08:00 daily https://www.pharmasources.com/industryinsights/six-new-medicines-backed-for-eu-approval-293553.html 0.6 2026-05-12T18:43:55+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-mechanism-that-cause-293554.html 0.6 2026-07-02T03:32:09+08:00 daily https://www.pharmasources.com/industryinsights/xeljanz-tofacitinib-citrate-receives-mar-293555.html 0.6 2026-01-31T00:49:31+08:00 daily https://www.pharmasources.com/industryinsights/chemotherapy-as-a-tablet-instead-of-an-i-293556.html 0.6 2026-07-21T02:00:30+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-extends-partnership-with-sato--293557.html 0.6 2026-05-06T07:04:29+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-inaugurates-congers-site-ex-293558.html 0.6 2026-07-03T19:13:28+08:00 daily https://www.pharmasources.com/industryinsights/biostem-expands-services-293559.html 0.6 2026-01-20T16:53:55+08:00 daily https://www.pharmasources.com/industryinsights/drl-in-agreement-with-integra-lifescienc-293560.html 0.6 2026-07-07T18:52:12+08:00 daily https://www.pharmasources.com/industryinsights/eprex-marketing-authorisation-extended-t-293561.html 0.6 2026-07-06T21:00:26+08:00 daily https://www.pharmasources.com/industryinsights/encouraging-results-of-phase-iia-study-w-293562.html 0.6 2026-07-07T03:18:59+08:00 daily https://www.pharmasources.com/industryinsights/invivotek-completes-solar-farm-and-facil-293563.html 0.6 2026-04-04T18:46:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receives-positive-chmp-opinion-fo-293564.html 0.6 2026-03-12T00:40:30+08:00 daily https://www.pharmasources.com/industryinsights/new-cdisc-data-standard-aids-development-293565.html 0.6 2026-03-29T00:50:11+08:00 daily https://www.pharmasources.com/industryinsights/symproic-once-daily-tablets-c-ii-for-the-293566.html 0.6 2026-04-22T15:50:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-eagle-pha-293567.html 0.6 2026-07-27T19:54:36+08:00 daily https://www.pharmasources.com/industryinsights/peterson-joins-sienna-biopharmaceuticals-293568.html 0.6 2026-03-31T16:35:27+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-paratek-announce-positive-r-293569.html 0.6 2026-06-14T14:05:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zejula-293570.html 0.6 2026-08-03T17:01:21+08:00 daily https://www.pharmasources.com/industryinsights/what-you-need-to-know-about-cholesterol-293571.html 0.6 2026-07-04T12:12:34+08:00 daily https://www.pharmasources.com/industryinsights/plenty-of-iv-fluids-may-make-childbirth--293572.html 0.6 2026-03-28T06:52:13+08:00 daily https://www.pharmasources.com/industryinsights/smoking-slows-recovery-from-drug-abuse-293573.html 0.6 2026-08-08T20:55:02+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lung-cancer-therapy-tagriss-293574.html 0.6 2026-08-07T06:04:29+08:00 daily https://www.pharmasources.com/industryinsights/dishman-pharma-shares-hit-all-time-high--293575.html 0.6 2026-03-24T19:57:43+08:00 daily https://www.pharmasources.com/industryinsights/a-new-cost-effective-vaccine-against-rot-293576.html 0.6 2026-08-06T22:57:14+08:00 daily https://www.pharmasources.com/industryinsights/licensing-agreement-announced-for-sutezo-293577.html 0.6 2026-01-05T08:50:37+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-says-next-plant-in-us--293578.html 0.6 2026-08-07T04:41:30+08:00 daily https://www.pharmasources.com/industryinsights/a-computer-program-for-diagnosing-and-lo-293579.html 0.6 2026-04-13T21:21:10+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-hepatitis-drug-patent-fa-293580.html 0.6 2026-04-21T05:19:57+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-sanofi-announce-fda-approv-293581.html 0.6 2026-08-09T07:15:11+08:00 daily https://www.pharmasources.com/industryinsights/bms-receives-positive-chmp-opinion-recom-293582.html 0.6 2026-07-27T06:26:00+08:00 daily https://www.pharmasources.com/industryinsights/fiasp---a-new-ultra-fast-acting-mealtime-293583.html 0.6 2026-02-01T04:42:12+08:00 daily https://www.pharmasources.com/industryinsights/athenex-announces-the-us-fda-allowance-o-293584.html 0.6 2026-08-08T02:47:21+08:00 daily https://www.pharmasources.com/industryinsights/genewiz-to-launch-single-cell-rna-seq-se-293585.html 0.6 2026-04-17T21:01:16+08:00 daily https://www.pharmasources.com/industryinsights/nektars-opioid-analgesic-meets-endpoints-293586.html 0.6 2025-11-26T15:22:10+08:00 daily https://www.pharmasources.com/industryinsights/butterworth-laboratories-ltd-is-delighte-293587.html 0.6 2026-02-09T15:43:30+08:00 daily https://www.pharmasources.com/industryinsights/single-cell-technology-company-dolomite--293588.html 0.6 2026-07-06T23:41:30+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-announces-first-293589.html 0.6 2026-07-10T10:44:17+08:00 daily https://www.pharmasources.com/industryinsights/lonza-reveals-new-portfolio-of-high-qual-293590.html 0.6 2026-07-07T14:20:58+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-pfizers-xeljanz-to-treat-rhe-293591.html 0.6 2025-11-12T11:25:45+08:00 daily https://www.pharmasources.com/industryinsights/athenex-announces-the-us-fda-allowance-o-293592.html 0.6 2026-05-02T20:55:02+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-completes-sale-of-tysabri-drug-r-293593.html 0.6 2026-06-20T07:11:13+08:00 daily https://www.pharmasources.com/industryinsights/icr-scientists-uncover-information-about-293594.html 0.6 2026-06-05T10:37:58+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-share-its-robust-early-sc-293595.html 0.6 2025-11-21T20:30:50+08:00 daily https://www.pharmasources.com/industryinsights/parker-institute-for-cancer-immunotherap-293596.html 0.6 2026-04-14T00:18:04+08:00 daily https://www.pharmasources.com/industryinsights/entries-for-sales-manager-of-the-year-ar-293597.html 0.6 2026-02-10T13:55:00+08:00 daily https://www.pharmasources.com/industryinsights/patients-call-for-halt-to-nice-changes-293598.html 0.6 2026-04-08T15:27:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-eczema-drug-dupixent-293599.html 0.6 2026-03-17T19:49:56+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-plans-cull-of-low-value-pres-293600.html 0.6 2026-04-01T23:00:22+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-no-for-shires-pancreatic-canc-293601.html 0.6 2026-07-19T13:01:41+08:00 daily https://www.pharmasources.com/industryinsights/human-insulin-market-worth-3913-billion--293602.html 0.6 2026-07-20T03:44:50+08:00 daily https://www.pharmasources.com/industryinsights/allergan-reports-success-in-late-stage-a-293603.html 0.6 2026-07-07T00:18:30+08:00 daily https://www.pharmasources.com/industryinsights/just-55-of-healthcare-professionals-disc-293604.html 0.6 2026-06-09T14:01:01+08:00 daily https://www.pharmasources.com/industryinsights/selvita-and-menarini-group-announce-glob-293605.html 0.6 2026-02-06T21:40:41+08:00 daily https://www.pharmasources.com/industryinsights/calithera-earns-12m-incyte-milestone-293606.html 0.6 2025-11-28T17:46:16+08:00 daily https://www.pharmasources.com/industryinsights/ligand-earns-janssen-milestone-293607.html 0.6 2026-03-05T13:36:09+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-joins-orien-research-exchange-293608.html 0.6 2026-06-15T10:00:58+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-pfizers-xeljanz-to-treat-rhe-293609.html 0.6 2026-01-13T08:26:18+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-completes-sale-of-tysabri-drug-r-293610.html 0.6 2026-07-08T09:08:53+08:00 daily https://www.pharmasources.com/industryinsights/numab-and-ono-pharmaceutical-enter-into--293611.html 0.6 2025-11-27T20:18:50+08:00 daily https://www.pharmasources.com/industryinsights/icagen-announces-collaboration-with-baye-293612.html 0.6 2026-08-07T04:52:56+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-m2gen-announce-new-collaborat-293613.html 0.6 2026-08-07T04:19:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-maintenance-treatment-for-r-293614.html 0.6 2026-08-07T03:54:57+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-completes-divestiture-of-tysabri-293615.html 0.6 2026-08-07T03:27:37+08:00 daily https://www.pharmasources.com/industryinsights/brain-computer-link-restores-some-moveme-293616.html 0.6 2026-08-07T03:18:43+08:00 daily https://www.pharmasources.com/industryinsights/more-older-women-hitting-the-bottle-hard-293617.html 0.6 2026-08-07T03:06:47+08:00 daily https://www.pharmasources.com/industryinsights/knee-replacement-doesnt-always-pay-resea-293618.html 0.6 2026-08-07T02:59:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ocrevus-293619.html 0.6 2026-08-07T02:53:22+08:00 daily https://www.pharmasources.com/industryinsights/five-worrying-facts-about-fake-medicine-293620.html 0.6 2026-08-07T02:40:22+08:00 daily https://www.pharmasources.com/industryinsights/the-rising-threat-of-antibiotic-resistan-293621.html 0.6 2026-08-07T01:27:54+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-the-three-major-treatments-293622.html 0.6 2026-08-07T01:19:25+08:00 daily https://www.pharmasources.com/industryinsights/charities-unite-to-oppose-nice-rare-dise-293623.html 0.6 2026-08-07T01:10:48+08:00 daily https://www.pharmasources.com/industryinsights/health-insurer-spots-potential-of-owlsto-293624.html 0.6 2026-08-07T00:52:48+08:00 daily https://www.pharmasources.com/industryinsights/the-mikey-czech-foundation-contributes-1-293625.html 0.6 2026-08-07T01:14:32+08:00 daily https://www.pharmasources.com/industryinsights/deltahealth-hospital-shanghai-live-broad-293626.html 0.6 2026-08-09T22:01:15+08:00 daily https://www.pharmasources.com/industryinsights/fdas-commitment-to-womens-heart-health-r-293627.html 0.6 2026-08-08T21:54:25+08:00 daily https://www.pharmasources.com/industryinsights/ema-issues-positive-opinion-for-eusa-pha-293628.html 0.6 2026-08-09T01:01:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-in-india-championing-a-culture-of-qu-293629.html 0.6 2026-08-07T14:20:45+08:00 daily https://www.pharmasources.com/industryinsights/bial-and-eisai-receive-positive-opinion--293630.html 0.6 2026-03-20T17:44:04+08:00 daily https://www.pharmasources.com/industryinsights/novo-to-buy-20-stake-in-uks-convatec-293631.html 0.6 2026-02-22T10:01:11+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-new-treatments-for-ms-atopic-d-293632.html 0.6 2026-01-12T15:38:41+08:00 daily https://www.pharmasources.com/industryinsights/az-neuromyelitis-drug-picks-up-orphan-st-293633.html 0.6 2026-04-16T19:32:21+08:00 daily https://www.pharmasources.com/industryinsights/pew-letter-raises-concerns-about-drug-im-293634.html 0.6 2026-03-24T19:17:31+08:00 daily https://www.pharmasources.com/industryinsights/regulator-ponders-otc-availability-of-vi-293635.html 0.6 2026-06-18T23:23:12+08:00 daily https://www.pharmasources.com/industryinsights/how-a-personal-journey-shaped-lilly-tria-293636.html 0.6 2026-07-06T14:13:05+08:00 daily https://www.pharmasources.com/industryinsights/nice-does-not-recommend-janssens-multipl-293637.html 0.6 2026-06-25T11:33:40+08:00 daily https://www.pharmasources.com/industryinsights/merrimack-initiates-phase-1-study-of-mm--293638.html 0.6 2026-07-05T08:33:57+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-nanoassemblr-chose-293639.html 0.6 2026-02-28T12:52:58+08:00 daily https://www.pharmasources.com/industryinsights/rainins-pipette-service-puts-the-custome-293640.html 0.6 2026-06-13T10:20:55+08:00 daily https://www.pharmasources.com/industryinsights/neurological-diseases-cost-the-us-nearly-293641.html 0.6 2026-07-06T23:11:32+08:00 daily https://www.pharmasources.com/industryinsights/how-to-get-adults-to-eat-their-vegetable-293642.html 0.6 2025-11-27T04:07:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-roches-ocrevus-ocrelizumab--293643.html 0.6 2026-06-08T18:38:45+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-and-advanco-form-serialization-293644.html 0.6 2026-03-18T02:36:59+08:00 daily https://www.pharmasources.com/industryinsights/cmc-expands-to-offer-cgmp-processing-293645.html 0.6 2026-06-10T08:08:35+08:00 daily https://www.pharmasources.com/industryinsights/plasticell-signs-stem-cell-research-coll-293646.html 0.6 2026-07-07T05:38:35+08:00 daily https://www.pharmasources.com/industryinsights/mankind-forays-into-diagnostics-with-pat-293647.html 0.6 2026-06-09T02:40:21+08:00 daily https://www.pharmasources.com/industryinsights/bial-and-eisai-receive-positive-opinion--293648.html 0.6 2026-06-18T10:24:07+08:00 daily https://www.pharmasources.com/industryinsights/got-the-hpv-vaccine-before-you-knew-you--293649.html 0.6 2026-03-14T01:38:21+08:00 daily https://www.pharmasources.com/industryinsights/could-electromagnetic-fields-raise-a-wor-293650.html 0.6 2025-12-26T23:39:09+08:00 daily https://www.pharmasources.com/industryinsights/senator-probes-opioid-makers-role-in-us--293651.html 0.6 2026-04-06T20:04:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-genentechs-ocrevus-for-rela-293652.html 0.6 2026-08-08T17:08:40+08:00 daily https://www.pharmasources.com/industryinsights/tesaro-announces-fda-approval-of-zejula--293653.html 0.6 2026-06-30T20:19:27+08:00 daily https://www.pharmasources.com/industryinsights/evolution-of-korean-surgery-motiva-recom-293654.html 0.6 2026-06-21T11:32:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-mylans-generic-version-of-gl-293655.html 0.6 2026-08-05T13:00:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-commissioner-nominee-scott-gottlieb--293656.html 0.6 2025-11-17T22:01:37+08:00 daily https://www.pharmasources.com/industryinsights/depomed-replaces-ceo-board-members-under-293657.html 0.6 2026-07-04T13:05:48+08:00 daily https://www.pharmasources.com/industryinsights/cara-therapeutics-announces-proposed-off-293658.html 0.6 2026-03-18T07:04:38+08:00 daily https://www.pharmasources.com/industryinsights/replica-reproductive-tract-could-aid-dru-293659.html 0.6 2026-04-09T21:42:49+08:00 daily https://www.pharmasources.com/industryinsights/novartis-investigational-car-t-therapy-g-293660.html 0.6 2026-06-18T00:39:27+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-therapy-reverses-diabetes-in-mi-293661.html 0.6 2026-04-13T01:36:50+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-nasal-spray-to-preve-293662.html 0.6 2026-06-08T07:56:16+08:00 daily https://www.pharmasources.com/industryinsights/fibre-supplement-offers-hope-for-asthmat-293663.html 0.6 2026-01-30T19:27:21+08:00 daily https://www.pharmasources.com/industryinsights/colorectal-cancer-on-the-increase-among--293664.html 0.6 2026-04-01T01:14:38+08:00 daily https://www.pharmasources.com/industryinsights/bosch-launches-new-klv-series-for-contai-293665.html 0.6 2026-03-27T15:09:30+08:00 daily https://www.pharmasources.com/industryinsights/capsugel-expands-late-stage-inhalation-p-293666.html 0.6 2025-11-13T16:40:11+08:00 daily https://www.pharmasources.com/industryinsights/symetis-and-boston-scientific-reach-usd--293667.html 0.6 2026-03-17T22:35:44+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-wins-approval-for-antineopla-293668.html 0.6 2026-04-05T17:05:47+08:00 daily https://www.pharmasources.com/industryinsights/france-discover-mydiabby-293669.html 0.6 2026-02-19T00:45:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-helping-small-businesses-get-big-res-293670.html 0.6 2026-04-18T02:38:44+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-potential-drug-for-neuromye-293671.html 0.6 2026-04-13T19:57:03+08:00 daily https://www.pharmasources.com/industryinsights/merck-advances-rd-strategy-through-uniqu-293672.html 0.6 2026-03-12T10:04:11+08:00 daily https://www.pharmasources.com/industryinsights/anti-cancer-drug-gets-a-boost-when-combi-293673.html 0.6 2026-04-13T23:49:42+08:00 daily https://www.pharmasources.com/industryinsights/merck-introduces-mobius-myway-portfolio--293674.html 0.6 2026-06-25T18:23:54+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-announces-collaborative-r-293675.html 0.6 2026-06-19T20:37:45+08:00 daily https://www.pharmasources.com/industryinsights/tesaro-announces-fda-approval-of-zejula--293676.html 0.6 2026-06-05T15:40:52+08:00 daily https://www.pharmasources.com/industryinsights/butterworth-labs-to-expand-operations-by-293677.html 0.6 2026-07-18T16:40:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-genentechs-ocrevus-for-rela-293678.html 0.6 2026-08-06T07:24:12+08:00 daily https://www.pharmasources.com/industryinsights/analytical-protein-aggregate-separation--293679.html 0.6 2026-03-24T22:04:42+08:00 daily https://www.pharmasources.com/industryinsights/tris-pharma-selects-adents-serialization-293680.html 0.6 2026-08-09T00:31:08+08:00 daily https://www.pharmasources.com/industryinsights/takeda-pharmaceuticals-names-emerging-ma-293681.html 0.6 2025-11-03T17:46:17+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-sanofi-announce-fda-approv-293682.html 0.6 2026-08-03T03:12:24+08:00 daily https://www.pharmasources.com/industryinsights/ampac-quadruples-analytical-services-cap-293683.html 0.6 2026-06-11T15:51:52+08:00 daily https://www.pharmasources.com/industryinsights/diteba-develops-iv-approach-to-achieve-b-293684.html 0.6 2026-07-04T09:20:09+08:00 daily https://www.pharmasources.com/industryinsights/worldwide-clinical-trials-names-evp-of-g-293685.html 0.6 2026-06-13T01:24:06+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-orphan-drug-designation-to-gw-293686.html 0.6 2026-06-09T06:32:02+08:00 daily https://www.pharmasources.com/industryinsights/nosopharm-raises-funds-to-accelerate-dev-293687.html 0.6 2026-04-04T13:38:29+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-enters-collaboratio-293688.html 0.6 2026-07-23T16:09:00+08:00 daily https://www.pharmasources.com/industryinsights/mylan-completes-acquisition-of-cold-eeze-293689.html 0.6 2026-03-21T22:32:30+08:00 daily https://www.pharmasources.com/industryinsights/halozyme-provides-update-on-swog-collabo-293690.html 0.6 2026-01-22T10:57:51+08:00 daily https://www.pharmasources.com/industryinsights/novozymes-and-boehringer-ingelheim-to-de-293691.html 0.6 2025-11-11T04:12:03+08:00 daily https://www.pharmasources.com/industryinsights/weight-gender-appear-to-play-part-in-kid-293692.html 0.6 2026-07-30T14:27:03+08:00 daily https://www.pharmasources.com/industryinsights/global-top-10-pharmaceutical-enterprises-293693.html 0.6 2026-04-09T19:24:37+08:00 daily https://www.pharmasources.com/industryinsights/drug-tied-to-dementia-risk-overprescribe-293694.html 0.6 2026-04-06T05:58:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-addition-of-moderate-to-sev-293695.html 0.6 2026-03-11T16:10:01+08:00 daily https://www.pharmasources.com/industryinsights/corbus-unveils-mid-stage-study-data-for--293696.html 0.6 2026-02-28T18:06:52+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-the-policy-signals-in-the-20-293697.html 0.6 2026-03-17T23:28:19+08:00 daily https://www.pharmasources.com/industryinsights/israeli-biotech-biondvax-gets-government-293698.html 0.6 2025-10-30T08:08:39+08:00 daily https://www.pharmasources.com/industryinsights/asia-becomes-the-preferred-destination-f-293699.html 0.6 2026-08-09T08:47:25+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-men-b-shot-trumenba-wins-eu-commi-293700.html 0.6 2026-07-16T03:11:33+08:00 daily https://www.pharmasources.com/industryinsights/serums-heat-stable-rotavirus-vaccine-shi-293701.html 0.6 2026-01-31T08:29:11+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-protext-mobility-yichang-h-293702.html 0.6 2026-06-12T01:24:02+08:00 daily https://www.pharmasources.com/industryinsights/trumps-fda-pick-vows-to-sever-past-pharm-293703.html 0.6 2025-12-24T09:08:46+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-mesoblast-orexigen-thera-293704.html 0.6 2026-07-21T16:06:08+08:00 daily https://www.pharmasources.com/industryinsights/phe-sets-sugar-targets-to-help-fight-obe-293705.html 0.6 2025-11-11T07:58:18+08:00 daily https://www.pharmasources.com/industryinsights/majority-of-patients-with-depression-get-293706.html 0.6 2026-06-07T14:00:34+08:00 daily https://www.pharmasources.com/industryinsights/biosimilar-brenzys-etanercept-available--293707.html 0.6 2026-06-01T14:23:17+08:00 daily https://www.pharmasources.com/industryinsights/breathing-space-for-gsk-as-mylans-advair-293708.html 0.6 2026-06-15T11:41:04+08:00 daily https://www.pharmasources.com/industryinsights/orphan-status-for-gws-rare-epilepsy-drug-293709.html 0.6 2026-03-25T00:51:01+08:00 daily https://www.pharmasources.com/industryinsights/quality-by-design----experimental-strate-293710.html 0.6 2026-08-02T13:49:59+08:00 daily https://www.pharmasources.com/industryinsights/first-female-ceo-of-gsk-to-be-paid-25-le-293711.html 0.6 2026-03-22T13:04:47+08:00 daily https://www.pharmasources.com/industryinsights/cherwell-makes-an-impact-with-new-contin-293712.html 0.6 2026-06-07T02:01:49+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-board-of-directors--293713.html 0.6 2026-03-19T09:10:17+08:00 daily https://www.pharmasources.com/industryinsights/athenex-announces-the-promotion-of-jeffr-293714.html 0.6 2026-08-07T07:35:42+08:00 daily https://www.pharmasources.com/industryinsights/tagrisso-osimertinib-receives-us-fda-ful-293715.html 0.6 2026-02-24T04:39:01+08:00 daily https://www.pharmasources.com/industryinsights/high-doses-of-vitamin-c-to-improve-cance-293716.html 0.6 2026-06-23T15:34:33+08:00 daily https://www.pharmasources.com/industryinsights/vetters-dr-claudia-roth-is-appointed-to--293717.html 0.6 2026-06-08T04:07:35+08:00 daily https://www.pharmasources.com/industryinsights/calypso-biotech-licenses-caly-001-best-i-293718.html 0.6 2026-08-08T07:57:56+08:00 daily https://www.pharmasources.com/industryinsights/number-of-shares-and-votes-in-neurovive--293719.html 0.6 2026-08-07T04:27:56+08:00 daily https://www.pharmasources.com/industryinsights/inc-research-makes-executive-appointment-293720.html 0.6 2026-08-07T13:18:46+08:00 daily https://www.pharmasources.com/industryinsights/strand-life-sciences-releases-version-30-293721.html 0.6 2026-08-07T04:18:58+08:00 daily https://www.pharmasources.com/industryinsights/prometic-and-sram-jv-to-develop-and-comm-293722.html 0.6 2026-08-07T04:33:42+08:00 daily https://www.pharmasources.com/industryinsights/g-ba-confirms-additional-benefit-of-eisa-293723.html 0.6 2026-08-07T04:04:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-indication-for-qud-293724.html 0.6 2026-08-07T04:16:21+08:00 daily https://www.pharmasources.com/industryinsights/acadia-pharmaceuticals-appoints-executiv-293725.html 0.6 2026-08-07T04:27:49+08:00 daily https://www.pharmasources.com/industryinsights/incyte-and-merck-provide-additional-deta-293726.html 0.6 2026-08-07T04:53:07+08:00 daily https://www.pharmasources.com/industryinsights/impax-announces-favorable-ruling-regardi-293727.html 0.6 2026-08-07T05:28:39+08:00 daily https://www.pharmasources.com/industryinsights/dupont-announces-agreement-with-fmc-293728.html 0.6 2026-04-05T14:37:45+08:00 daily https://www.pharmasources.com/industryinsights/self-harm-can-be-a-harbinger-of-suicide-293729.html 0.6 2026-04-08T16:57:03+08:00 daily https://www.pharmasources.com/industryinsights/us-thyroid-cancer-cases-continue-to-rise-293730.html 0.6 2026-04-13T19:39:11+08:00 daily https://www.pharmasources.com/industryinsights/teens-who-are-lazy-bones-have-weaker-ske-293731.html 0.6 2026-04-18T05:20:32+08:00 daily https://www.pharmasources.com/industryinsights/sleepless-nights-unhealthy-hearts-293732.html 0.6 2026-07-07T12:32:00+08:00 daily https://www.pharmasources.com/industryinsights/tauopathies-market-entry-requires-shrewd-293733.html 0.6 2026-01-12T15:57:08+08:00 daily https://www.pharmasources.com/industryinsights/who-issues-ethics-guidance-to-protect-ri-293734.html 0.6 2026-05-07T22:13:12+08:00 daily https://www.pharmasources.com/industryinsights/on-the-trail-of-parkinsons-disease-293735.html 0.6 2026-06-15T08:09:32+08:00 daily https://www.pharmasources.com/industryinsights/pharmas-most-valuable-brands-jj-pfizer-a-293736.html 0.6 2026-07-29T00:05:35+08:00 daily https://www.pharmasources.com/industryinsights/investigational-compound-for-treating-in-293737.html 0.6 2026-08-02T20:23:36+08:00 daily https://www.pharmasources.com/industryinsights/aurinia-pharmaceuticals-where-to-from-he-293738.html 0.6 2026-07-08T03:28:15+08:00 daily https://www.pharmasources.com/industryinsights/heres-how-much-johnson-johnson-will-prob-293739.html 0.6 2026-07-09T16:20:05+08:00 daily https://www.pharmasources.com/industryinsights/takeda-lays-off-more-than-half-of-ariads-293740.html 0.6 2026-08-07T11:09:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-ever-atopic-dermatiti-293741.html 0.6 2026-08-07T03:55:09+08:00 daily https://www.pharmasources.com/industryinsights/sharp-announces-9-million-investment-293742.html 0.6 2026-02-04T04:49:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-drug-combination-tafinlar-mekin-293743.html 0.6 2026-07-23T08:25:17+08:00 daily https://www.pharmasources.com/industryinsights/launch-of-utibron-neohaler-in-the-us-293744.html 0.6 2026-06-08T00:44:48+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-incyte-to-advance-the-combinatio-293745.html 0.6 2026-06-29T00:16:38+08:00 daily https://www.pharmasources.com/industryinsights/tackling-inequality-in-psoriasis-293746.html 0.6 2026-06-13T06:32:56+08:00 daily https://www.pharmasources.com/industryinsights/medicare-part-d-and-negotiation-293747.html 0.6 2026-06-14T19:12:44+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-ohio-university-heritage-colle-293748.html 0.6 2026-01-14T10:20:42+08:00 daily https://www.pharmasources.com/industryinsights/australia-slashes-prescription-drug-pric-293749.html 0.6 2026-02-28T18:36:42+08:00 daily https://www.pharmasources.com/industryinsights/new-technology-promises-rare-disease-det-293750.html 0.6 2026-07-06T22:59:35+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-showcases-cancer-re-293751.html 0.6 2026-06-10T00:01:03+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-announce-fda-approv-293752.html 0.6 2025-12-28T19:21:42+08:00 daily https://www.pharmasources.com/industryinsights/korea-announces-100-mn-fund-for-bio-star-293753.html 0.6 2026-03-28T02:24:32+08:00 daily https://www.pharmasources.com/industryinsights/phase-ii-lymphoma-study-of-daratumumab-w-293754.html 0.6 2026-07-30T14:34:53+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-lung-cancer-drug-receives-fd-293755.html 0.6 2026-06-30T17:26:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sanofi-and-regenerons-new-e-293756.html 0.6 2026-07-23T12:48:34+08:00 daily https://www.pharmasources.com/industryinsights/nice-does-not-recommend-shires-pancreati-293757.html 0.6 2025-11-09T17:58:15+08:00 daily https://www.pharmasources.com/industryinsights/aahrpp-accredits-nine-more-research-orga-293758.html 0.6 2026-04-12T03:45:09+08:00 daily https://www.pharmasources.com/industryinsights/selvita-announces-first-patient-dosed-in-293759.html 0.6 2026-02-24T23:43:19+08:00 daily https://www.pharmasources.com/industryinsights/new-shigella-monoclonal-antibodies-293760.html 0.6 2026-03-27T01:33:43+08:00 daily https://www.pharmasources.com/industryinsights/the-first-overall-survival-data-from-the-293761.html 0.6 2026-08-03T16:05:33+08:00 daily https://www.pharmasources.com/industryinsights/once-weekly-semaglutide-demonstrated-con-293762.html 0.6 2026-02-28T14:15:24+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-receives-fda-orphan-dr-293763.html 0.6 2026-02-15T13:33:56+08:00 daily https://www.pharmasources.com/industryinsights/nbe-therapeutics-expands-board-of-direct-293764.html 0.6 2026-08-03T14:55:50+08:00 daily https://www.pharmasources.com/industryinsights/imanova-receives-1m-award-from-the-mrc-t-293765.html 0.6 2026-04-06T09:41:24+08:00 daily https://www.pharmasources.com/industryinsights/australias-bionic-vision-technologies-ra-293766.html 0.6 2026-08-04T12:15:10+08:00 daily https://www.pharmasources.com/industryinsights/catalent-expands-cold-chain-capabilities-293767.html 0.6 2026-04-02T09:31:08+08:00 daily https://www.pharmasources.com/industryinsights/shangpharma-restructures-cro-and-cmo-ops-293768.html 0.6 2026-07-09T19:28:48+08:00 daily https://www.pharmasources.com/industryinsights/astellas-names-president-of-astellas-us--293769.html 0.6 2026-04-08T15:44:36+08:00 daily https://www.pharmasources.com/industryinsights/essen-bioscience-launches-incucyte-s3-li-293770.html 0.6 2026-06-08T07:36:47+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-introduces-next-gen-high--293771.html 0.6 2025-12-03T16:56:00+08:00 daily https://www.pharmasources.com/industryinsights/sherpa-expands-capacity-293772.html 0.6 2026-07-07T16:01:36+08:00 daily https://www.pharmasources.com/industryinsights/morphotek-launches-adc-services-business-293773.html 0.6 2025-11-01T04:39:41+08:00 daily https://www.pharmasources.com/industryinsights/envigo-launches-r2g2-research-model-293774.html 0.6 2026-08-09T06:59:25+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-launches-oncology-research-293775.html 0.6 2026-08-08T15:51:58+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-acquires-umetrics-completes-es-293776.html 0.6 2026-08-08T10:50:37+08:00 daily https://www.pharmasources.com/industryinsights/astellas-to-acquire-ogeda-sa-293777.html 0.6 2026-08-07T22:01:28+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn2017405-293778.html 0.6 2026-08-07T15:25:49+08:00 daily https://www.pharmasources.com/industryinsights/ku-leuven-to-develop-dual-vaccine-agains-293779.html 0.6 2026-08-09T06:59:54+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-us-fda-approval-for-gener-293780.html 0.6 2026-06-08T02:45:44+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-agrees-to-abridged-clinical-phase-293781.html 0.6 2025-12-13T10:04:44+08:00 daily https://www.pharmasources.com/industryinsights/sayre-therapeutics-in-agreement-with-gp--293782.html 0.6 2026-03-23T14:34:36+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-tevas-austedo-tablets-to-293783.html 0.6 2026-02-28T13:15:24+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-meiji-to-commercialise-safinam-293784.html 0.6 2026-04-17T07:22:28+08:00 daily https://www.pharmasources.com/industryinsights/mundipharmas-mundesine-receives-approval-293785.html 0.6 2026-04-09T18:49:04+08:00 daily https://www.pharmasources.com/industryinsights/sucampo-pharmaceuticals-acquires-rare-di-293786.html 0.6 2026-03-30T10:48:54+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-mmv-launch-new-programme-to-f-293787.html 0.6 2026-04-09T07:10:04+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-develop-new-approach-to-i-293788.html 0.6 2026-01-17T07:35:01+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-announces-new-five-year-forw-293789.html 0.6 2026-07-11T16:32:39+08:00 daily https://www.pharmasources.com/industryinsights/mylan-provides-update-on-expanded-volunt-293790.html 0.6 2026-04-05T20:09:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-kitov-a-waiver-for-new-drug-a-293791.html 0.6 2026-07-21T17:04:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-for-review-the-application-o-293792.html 0.6 2026-08-05T10:56:37+08:00 daily https://www.pharmasources.com/industryinsights/pda-recognized-as-an-ansi-accredited-sta-293793.html 0.6 2026-02-01T04:39:46+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-completes-rolling-s-293794.html 0.6 2026-07-20T14:52:12+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-intends-to-file-nda-wit-293795.html 0.6 2026-04-27T18:19:07+08:00 daily https://www.pharmasources.com/industryinsights/ibrance-palbociclib-receives-fda-regular-293796.html 0.6 2026-02-28T13:16:49+08:00 daily https://www.pharmasources.com/industryinsights/tagrisso-osimertinib-receives-fda-full-a-293797.html 0.6 2026-07-09T21:40:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-addition-of-moderate-to-sev-293798.html 0.6 2026-06-03T09:58:22+08:00 daily https://www.pharmasources.com/industryinsights/nihs-zika-vaccine-enters-phase-2-unscath-293799.html 0.6 2026-03-21T02:42:36+08:00 daily https://www.pharmasources.com/industryinsights/with-7m-nih-grant-inovio-set-to-test-hiv-293800.html 0.6 2026-03-25T01:06:17+08:00 daily https://www.pharmasources.com/industryinsights/activist-parents-rally-in-dc-hoping-trum-293801.html 0.6 2026-04-01T15:26:39+08:00 daily https://www.pharmasources.com/industryinsights/amgen-submits-applications-in-the-us-and-293802.html 0.6 2025-11-24T06:35:59+08:00 daily https://www.pharmasources.com/industryinsights/innova-biosciences-introduces-biotin-che-293803.html 0.6 2026-04-06T23:33:40+08:00 daily https://www.pharmasources.com/industryinsights/envirotainer-increases-e-technology-capa-293804.html 0.6 2026-06-13T03:27:34+08:00 daily https://www.pharmasources.com/industryinsights/sirius-acquires-armadaglobal-293805.html 0.6 2026-06-08T19:33:34+08:00 daily https://www.pharmasources.com/industryinsights/novartis-lung-cancer-drug-combination-re-293806.html 0.6 2026-08-03T08:17:02+08:00 daily https://www.pharmasources.com/industryinsights/new-report-reveals-little-progress-on-20-293807.html 0.6 2026-06-20T23:20:11+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-exclusive-us-293808.html 0.6 2026-07-08T04:54:09+08:00 daily https://www.pharmasources.com/industryinsights/growing-market-for-generics-and-liberali-293809.html 0.6 2026-06-19T23:58:52+08:00 daily https://www.pharmasources.com/industryinsights/plasticell-signs-stem-cell-research-coll-293810.html 0.6 2026-06-19T23:34:41+08:00 daily https://www.pharmasources.com/industryinsights/first-collaborative-definition-of-patien-293811.html 0.6 2026-06-13T08:35:52+08:00 daily https://www.pharmasources.com/industryinsights/deep-learning-algorithm-could-boost-drug-293812.html 0.6 2026-03-25T19:01:40+08:00 daily https://www.pharmasources.com/industryinsights/btg-receives-ce-mark-certification-for-r-293813.html 0.6 2026-04-08T12:10:13+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-reduces-daily-menopausal-hot-fl-293814.html 0.6 2026-04-08T02:43:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-kitov-waiver-for-new-drug-app-293815.html 0.6 2026-08-07T11:11:55+08:00 daily https://www.pharmasources.com/industryinsights/envigo-launches-r2g2-double-knockout-mou-293816.html 0.6 2026-07-21T12:28:19+08:00 daily https://www.pharmasources.com/industryinsights/customized-automation-for-laboratory-app-293817.html 0.6 2026-06-11T03:45:20+08:00 daily https://www.pharmasources.com/industryinsights/dematic-announces-egemin-automation-inte-293818.html 0.6 2026-05-03T18:11:04+08:00 daily https://www.pharmasources.com/industryinsights/intent-on-vaccine-growth-takeda-clinches-293819.html 0.6 2026-05-03T18:11:55+08:00 daily https://www.pharmasources.com/industryinsights/asceneuron-receives-regulatory-approval--293820.html 0.6 2026-07-04T03:43:23+08:00 daily https://www.pharmasources.com/industryinsights/evotec-achieves-sanofi-diabetes-mileston-293821.html 0.6 2026-06-08T18:27:32+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-althea-bolsters-regulatory-aff-293822.html 0.6 2026-04-20T18:39:12+08:00 daily https://www.pharmasources.com/industryinsights/dhl-in-leipzig-gets-iata-ceiv-pharma-cer-293823.html 0.6 2026-07-17T13:42:03+08:00 daily https://www.pharmasources.com/industryinsights/francois-hollande-inaugurates-martin-dow-293824.html 0.6 2026-03-18T02:12:53+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-expands-biopharma-testing-opera-293825.html 0.6 2026-03-24T17:45:19+08:00 daily https://www.pharmasources.com/industryinsights/ligand-licenses-captisol-enabled-ganaxol-293826.html 0.6 2026-04-03T07:05:56+08:00 daily https://www.pharmasources.com/industryinsights/nimbus-therapeutics-charles-river-in-str-293827.html 0.6 2026-04-07T15:37:12+08:00 daily https://www.pharmasources.com/industryinsights/dr-chirag-trivedi-appointed-as-president-293828.html 0.6 2026-04-13T23:01:02+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-posts-financial-yea-293829.html 0.6 2025-11-16T01:15:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-in-license-ecf843-for-ophtha-293830.html 0.6 2026-08-05T12:42:34+08:00 daily https://www.pharmasources.com/industryinsights/evinacumab-gets-fda-breakthrough-therapy-293831.html 0.6 2026-02-09T02:41:20+08:00 daily https://www.pharmasources.com/industryinsights/phrma-launches-new-share-the-savings-cam-293832.html 0.6 2026-06-14T16:06:40+08:00 daily https://www.pharmasources.com/industryinsights/imprimis-pharmaceuticals-acquires-licens-293833.html 0.6 2026-07-02T11:49:17+08:00 daily https://www.pharmasources.com/industryinsights/indian-fda-approves-the-first-autologous-293834.html 0.6 2026-04-24T13:33:51+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-reaches-settlement--293835.html 0.6 2026-07-30T14:36:05+08:00 daily https://www.pharmasources.com/industryinsights/biotime-forms-new-subsidiary-agex-therap-293836.html 0.6 2026-06-12T03:28:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-marketing-of-first-direct-to--293837.html 0.6 2026-08-03T07:00:12+08:00 daily https://www.pharmasources.com/industryinsights/men-more-prone-to-severe-psoriasis-study-293838.html 0.6 2026-01-31T10:23:05+08:00 daily https://www.pharmasources.com/industryinsights/syphilis-rates-spike-among-us-gay-bisexu-293839.html 0.6 2025-12-12T00:35:47+08:00 daily https://www.pharmasources.com/industryinsights/family-history-may-magnify-your-hangover-293840.html 0.6 2026-01-03T05:15:45+08:00 daily https://www.pharmasources.com/industryinsights/holmusk-using-data-to-improve-clinical-o-293841.html 0.6 2026-01-29T12:31:43+08:00 daily https://www.pharmasources.com/industryinsights/indian-fda-approves-the-first-autologous-293842.html 0.6 2026-07-01T01:39:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-hands-over-full-approval-to-az-tagri-293843.html 0.6 2025-11-07T14:47:09+08:00 daily https://www.pharmasources.com/industryinsights/verona-pharma-doses-first-patient-in-cys-293844.html 0.6 2026-08-07T18:29:26+08:00 daily https://www.pharmasources.com/industryinsights/uk-launch-for-nordics-novel-methotrexate-293845.html 0.6 2026-08-09T11:39:59+08:00 daily https://www.pharmasources.com/industryinsights/tevas-austedo-wins-us-nod-for-huntington-293846.html 0.6 2026-06-18T04:15:37+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-shown-to-improve-five-year-lu-293847.html 0.6 2026-06-18T06:06:51+08:00 daily https://www.pharmasources.com/industryinsights/lords-request-new-body-to-lead-nhs-susta-293848.html 0.6 2026-06-18T07:11:02+08:00 daily https://www.pharmasources.com/industryinsights/speedy-review-for-bms-opdivo-in-colorect-293849.html 0.6 2026-06-21T12:28:37+08:00 daily https://www.pharmasources.com/industryinsights/abbviejanssens-imbruvica-filed-for-graft-293850.html 0.6 2026-08-09T22:03:48+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-move-botox-into-phiii-for-de-293851.html 0.6 2026-06-14T01:29:21+08:00 daily https://www.pharmasources.com/industryinsights/cqc-takes-action-against-web-pharmacies-293852.html 0.6 2026-06-08T18:29:20+08:00 daily https://www.pharmasources.com/industryinsights/ulster-university-research-to-tackle-sup-293853.html 0.6 2026-06-23T02:36:45+08:00 daily https://www.pharmasources.com/industryinsights/antibiotics-overuse-could-boost-bowel-ca-293854.html 0.6 2026-06-08T17:03:35+08:00 daily https://www.pharmasources.com/industryinsights/rmb14975-trillion-chinese-pharmaceutical-293855.html 0.6 2026-06-08T09:12:00+08:00 daily https://www.pharmasources.com/industryinsights/space-of-me-too-pharmaceutical-products--293856.html 0.6 2026-07-06T14:20:24+08:00 daily https://www.pharmasources.com/industryinsights/orphan-drugs-become-the-new-favorite-of--293857.html 0.6 2026-08-07T19:21:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-commissioners-oppose-drug-importatio-293858.html 0.6 2026-07-05T01:22:16+08:00 daily https://www.pharmasources.com/industryinsights/life-with-type-1-diabetes-made-a-little--293859.html 0.6 2026-01-18T15:01:24+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-strengthen-rd-pipeline-by-in-293860.html 0.6 2026-07-18T22:14:59+08:00 daily https://www.pharmasources.com/industryinsights/hikma-enters-into-settlement-agreement-w-293861.html 0.6 2026-06-29T09:58:19+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-crl-from-the-fda-for-teco-293862.html 0.6 2026-07-04T06:42:43+08:00 daily https://www.pharmasources.com/industryinsights/japans-astellas-pharma-to-acquire-belgiu-293863.html 0.6 2026-07-16T08:03:07+08:00 daily https://www.pharmasources.com/industryinsights/zuellig-pharma-launches-new-innovation-i-293864.html 0.6 2026-06-08T04:44:56+08:00 daily https://www.pharmasources.com/industryinsights/medivir-completes-phase-ii-clinical-stud-293865.html 0.6 2026-04-30T22:15:49+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-in-licence-ecf843-for-ophtha-293866.html 0.6 2025-10-22T18:04:07+08:00 daily https://www.pharmasources.com/industryinsights/hyundai-pharm-files-for-marketing-approv-293867.html 0.6 2025-11-07T21:50:59+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-capital-international-apol-293868.html 0.6 2026-06-29T08:11:37+08:00 daily https://www.pharmasources.com/industryinsights/supernus-sndas-receive-final-fda-approva-293869.html 0.6 2026-07-03T20:13:26+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-hutchison-china-meditech-293870.html 0.6 2026-08-08T23:44:47+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-submits-fda-applica-293871.html 0.6 2026-07-20T06:23:42+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharmas-yeliva-obtains-orphan-293872.html 0.6 2026-08-07T07:08:02+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-packaging-c-worth-us9493--293873.html 0.6 2026-08-08T23:13:23+08:00 daily https://www.pharmasources.com/industryinsights/allied-minds-cuts-funding-to-seven-subsi-293874.html 0.6 2026-06-08T17:09:00+08:00 daily https://www.pharmasources.com/industryinsights/3rd-global-endotoxin-testing-summit-293875.html 0.6 daily https://www.pharmasources.com/industryinsights/cn-bio-licences-hepatitis-b-drug-discove-293876.html 0.6 2026-04-01T01:12:28+08:00 daily https://www.pharmasources.com/industryinsights/gp-closures-at-record-levels-293877.html 0.6 2025-10-18T16:38:33+08:00 daily https://www.pharmasources.com/industryinsights/towards-a-safe-and-scalable-cell-therapy-293878.html 0.6 2026-04-23T03:05:49+08:00 daily https://www.pharmasources.com/industryinsights/novartis-takes-home-rights-to-lubris-eye-293879.html 0.6 2026-08-06T20:10:32+08:00 daily https://www.pharmasources.com/industryinsights/us-beats-eu-on-drug-review-times-approva-293880.html 0.6 2025-11-11T02:14:14+08:00 daily https://www.pharmasources.com/industryinsights/a-one-two-punch-hits-pancreatic-cancer-w-293881.html 0.6 2026-07-27T20:56:24+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-invests-100-million-euro-in-its--293882.html 0.6 2026-03-18T04:30:28+08:00 daily https://www.pharmasources.com/industryinsights/cipla-usa-in-collaboration-with-medrx-293883.html 0.6 2026-08-08T10:32:53+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-alembic-pharmas-generic--293884.html 0.6 2026-03-28T08:21:16+08:00 daily https://www.pharmasources.com/industryinsights/allergan-names-senior-vice-president-of--293885.html 0.6 2026-03-12T17:56:46+08:00 daily https://www.pharmasources.com/industryinsights/ibm-patents-machine-learning-models-for--293886.html 0.6 2026-03-20T00:36:21+08:00 daily https://www.pharmasources.com/industryinsights/vwr-acquires-mesm-ltd-293887.html 0.6 2026-06-13T03:16:00+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-2017-energy-star-sustaine-293888.html 0.6 2026-03-26T17:12:46+08:00 daily https://www.pharmasources.com/industryinsights/isomeric-pharmacy-solutions-issues-volun-293889.html 0.6 2026-06-18T06:33:08+08:00 daily https://www.pharmasources.com/industryinsights/ge-analytical-instruments-manufacturing--293890.html 0.6 2026-08-09T07:56:23+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170410-293891.html 0.6 2026-08-08T07:49:58+08:00 daily https://www.pharmasources.com/industryinsights/novartis-takes-on-dry-eye-market-with-dr-293892.html 0.6 2026-08-08T08:38:41+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-confirms-takeover-talks-with-a-293893.html 0.6 2026-08-09T06:59:17+08:00 daily https://www.pharmasources.com/industryinsights/improving-and-extending-the-lives-of-pat-293894.html 0.6 2026-07-08T05:40:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-two-hepatitis-c-drugs-for-p-293895.html 0.6 2026-07-20T03:47:30+08:00 daily https://www.pharmasources.com/industryinsights/argentinas-sinergium-turns-to-cell-based-293896.html 0.6 2026-07-31T16:45:32+08:00 daily https://www.pharmasources.com/industryinsights/heptares-gets-12mn-astrazeneca-milestone-293897.html 0.6 2026-08-06T19:31:01+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-heptares-in-immuno-oncology--293898.html 0.6 2026-07-02T14:43:03+08:00 daily https://www.pharmasources.com/industryinsights/china-fda-accepts-jhls-first-clinical-tr-293899.html 0.6 2026-08-09T16:11:44+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-signs-53-million-b-293900.html 0.6 2026-05-01T21:21:03+08:00 daily https://www.pharmasources.com/industryinsights/allergan-reports-topline-phase-ii-data-s-293901.html 0.6 2026-06-29T04:06:01+08:00 daily https://www.pharmasources.com/industryinsights/the-connected-factory---a-reality-for-th-293902.html 0.6 2026-08-03T20:44:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-indications-for-harvoni-293903.html 0.6 2026-06-18T16:36:46+08:00 daily https://www.pharmasources.com/industryinsights/therapix-signs-license-with-yissum-for-c-293904.html 0.6 2026-06-14T09:19:34+08:00 daily https://www.pharmasources.com/industryinsights/sumitomo-dainippon-pharma-selected-hitac-293905.html 0.6 2026-04-23T05:03:22+08:00 daily https://www.pharmasources.com/industryinsights/median-technologies-partners-with-invent-293906.html 0.6 2026-03-29T16:04:06+08:00 daily https://www.pharmasources.com/industryinsights/an-improved-way-of-diagnosing-fatty-live-293907.html 0.6 2026-03-25T14:27:11+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approval-for-alembic-pharma-293908.html 0.6 2026-06-29T08:42:01+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-alecensa-superior-to-crizotin-293909.html 0.6 2026-05-03T19:42:27+08:00 daily https://www.pharmasources.com/industryinsights/the-first-live-attenuated-vaccine-candid-293910.html 0.6 2026-08-05T19:51:13+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-study-shows-roches-alecensa-wa-293911.html 0.6 2026-06-11T10:08:42+08:00 daily https://www.pharmasources.com/industryinsights/dr-markus-wyss-ceo-camag-to-talk-about-h-293912.html 0.6 2026-07-07T03:21:37+08:00 daily https://www.pharmasources.com/industryinsights/world-homeopathy-day-concludes-successfu-293913.html 0.6 2026-06-22T23:15:41+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--293914.html 0.6 2026-06-20T00:14:40+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-feno-293915.html 0.6 2026-06-13T05:43:21+08:00 daily https://www.pharmasources.com/industryinsights/hikma-signs-settlement-agreement-over-ja-293916.html 0.6 2026-07-14T19:40:58+08:00 daily https://www.pharmasources.com/industryinsights/immune-onc-and-ut-system-to-develop-new--293917.html 0.6 2026-04-26T03:34:41+08:00 daily https://www.pharmasources.com/industryinsights/synergy-pharmaceuticals-launches-new-poo-293918.html 0.6 2026-02-28T14:09:05+08:00 daily https://www.pharmasources.com/industryinsights/roches-alecensa-beats-pfizers-xalkori-in-293919.html 0.6 2026-08-10T00:28:53+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-bms-opdivo-for-head-and--293920.html 0.6 2026-04-20T00:59:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-two-antiviral-hep-c-d-293921.html 0.6 2026-08-03T11:32:08+08:00 daily https://www.pharmasources.com/industryinsights/virus-fixes-dna-mutations-for-possible-h-293922.html 0.6 2026-01-21T19:21:51+08:00 daily https://www.pharmasources.com/industryinsights/ema-green-lights-actelions-drug-after-pa-293923.html 0.6 2026-06-18T05:07:14+08:00 daily https://www.pharmasources.com/industryinsights/roches-lung-cancer-c-beats-pfizer-rival--293924.html 0.6 2026-06-29T08:30:40+08:00 daily https://www.pharmasources.com/industryinsights/what-happens-if-gilead-gild-went-bigger--293925.html 0.6 2026-07-07T11:52:17+08:00 daily https://www.pharmasources.com/industryinsights/themis-live-attenuated-recombinant-zika--293926.html 0.6 2026-06-19T19:41:19+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-calls-for-phase-4-dengvaxia-stu-293927.html 0.6 2025-11-07T23:06:16+08:00 daily https://www.pharmasources.com/industryinsights/gsk-vaccine-rd-exec-get-to-work-now-on-t-293928.html 0.6 2026-04-25T10:58:29+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-prevnar-conundrum-how-to-convinc-293929.html 0.6 2026-04-11T17:07:37+08:00 daily https://www.pharmasources.com/industryinsights/lilly-confirms-date-and-conference-call--293930.html 0.6 2026-05-29T16:27:03+08:00 daily https://www.pharmasources.com/industryinsights/ldc-and-sotio-enter-license-and-collabor-293931.html 0.6 2026-04-07T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/lifecodexx-and-charit-to-form-research-a-293932.html 0.6 2026-05-10T11:34:27+08:00 daily https://www.pharmasources.com/industryinsights/court-orders-olive-lifesciences-to-pay-s-293933.html 0.6 2026-03-23T18:04:17+08:00 daily https://www.pharmasources.com/industryinsights/strand-life-sciences-launches-liquid-bio-293934.html 0.6 2026-03-01T05:37:12+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-partners-with-kolon-life-sci-293935.html 0.6 2026-06-23T22:13:37+08:00 daily https://www.pharmasources.com/industryinsights/novogen-awarded-grant-of-up-to-a3-millio-293936.html 0.6 2026-05-03T14:53:51+08:00 daily https://www.pharmasources.com/industryinsights/evonik-health-care-expands-local-presenc-293937.html 0.6 2026-06-22T06:55:19+08:00 daily https://www.pharmasources.com/industryinsights/patientslikeme-and-shire-pharmaceuticals-293938.html 0.6 2026-06-24T08:13:29+08:00 daily https://www.pharmasources.com/industryinsights/health-risk-assessments-shed-light-on-ea-293939.html 0.6 2026-04-30T05:03:36+08:00 daily https://www.pharmasources.com/industryinsights/adapt-pharma-expands-free-narcan-nasal-s-293940.html 0.6 2026-06-28T18:33:23+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-apexigen-to-evaluate-opdivo-in-c-293941.html 0.6 2026-06-23T17:37:17+08:00 daily https://www.pharmasources.com/industryinsights/aerie-pharmaceuticals-expands-commercial-293942.html 0.6 2026-06-23T17:33:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-nanobiosym-diagnostics-emerge-293943.html 0.6 2026-06-12T16:29:22+08:00 daily https://www.pharmasources.com/industryinsights/repros-names-dillaha-its-permanent-presi-293944.html 0.6 2026-05-09T03:37:35+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-invests-in-zenith-technolo-293945.html 0.6 2026-02-28T15:39:27+08:00 daily https://www.pharmasources.com/industryinsights/is-desktop-medicine-chipping-away-at-pat-293946.html 0.6 2025-10-31T13:58:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ingrezza-293947.html 0.6 2026-07-01T20:21:57+08:00 daily https://www.pharmasources.com/industryinsights/submission-of-application-for-marketing--293948.html 0.6 2026-06-18T18:39:41+08:00 daily https://www.pharmasources.com/industryinsights/cbmg-and-ge-to-co-develop-control-proces-293949.html 0.6 2026-08-08T01:20:12+08:00 daily https://www.pharmasources.com/industryinsights/zambon-launches-xadago-in-portugal-to-tr-293950.html 0.6 2026-06-28T11:55:44+08:00 daily https://www.pharmasources.com/industryinsights/austrian-scientists-modify-and-reinforce-293951.html 0.6 2026-07-04T18:57:30+08:00 daily https://www.pharmasources.com/industryinsights/smc-u-turn-backs-roches-kadcyla-for-brea-293952.html 0.6 2026-08-06T23:11:19+08:00 daily https://www.pharmasources.com/industryinsights/scotland-first-uk-nation-to-routinely-of-293953.html 0.6 2026-04-21T07:17:19+08:00 daily https://www.pharmasources.com/industryinsights/nhs-head-and-neck-cancer-patients-barred-293954.html 0.6 2026-06-09T19:15:04+08:00 daily https://www.pharmasources.com/industryinsights/janssen-inks-mega-deal-with-japans-pepti-293955.html 0.6 2026-06-30T05:10:01+08:00 daily https://www.pharmasources.com/industryinsights/sbri-comp-awards-21m-for-primary-care-pr-293956.html 0.6 2026-07-09T04:00:28+08:00 daily https://www.pharmasources.com/industryinsights/eu-safety-review-backs-continued-use-upt-293957.html 0.6 2026-06-18T01:47:41+08:00 daily https://www.pharmasources.com/industryinsights/hilleman-labs-partners-with-indian-gover-293958.html 0.6 2026-06-18T02:48:38+08:00 daily https://www.pharmasources.com/industryinsights/jj-acquires-neuravi-to-bolster-neuro-bus-293959.html 0.6 2026-07-15T04:51:36+08:00 daily https://www.pharmasources.com/industryinsights/scotland-recommends-janssens-imbruvica-f-293960.html 0.6 2026-08-06T01:02:14+08:00 daily https://www.pharmasources.com/industryinsights/egypt-and-india-ties-in-pharmaceuticals--293961.html 0.6 2026-06-20T05:35:33+08:00 daily https://www.pharmasources.com/industryinsights/from-bench-to-bedside-and-back-293962.html 0.6 2026-03-20T01:55:09+08:00 daily https://www.pharmasources.com/industryinsights/the-truth-behind-ordering-from-canadian--293963.html 0.6 2026-07-03T18:21:59+08:00 daily https://www.pharmasources.com/industryinsights/another-downside-to-unemployment-stroke--293964.html 0.6 2026-07-06T17:14:54+08:00 daily https://www.pharmasources.com/industryinsights/kidney-disease-a-big-contributor-to-hear-293965.html 0.6 2026-07-09T07:05:59+08:00 daily https://www.pharmasources.com/industryinsights/seniors-brain-changes-could-make-them-vu-293966.html 0.6 2026-02-28T15:36:39+08:00 daily https://www.pharmasources.com/industryinsights/report-southeast-asian-breast-cancer-mar-293967.html 0.6 2026-06-18T19:13:16+08:00 daily https://www.pharmasources.com/industryinsights/agendia-appoints-patrick-j-balthrop-sr-a-293968.html 0.6 2026-06-21T17:30:29+08:00 daily https://www.pharmasources.com/industryinsights/recordati-launches-recordati-rare-diseas-293969.html 0.6 2026-06-21T07:25:21+08:00 daily https://www.pharmasources.com/industryinsights/d-methadone-for-adjunctive-treatment-of--293970.html 0.6 2026-08-08T19:31:25+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-announces-kuvan-patent-challeng-293971.html 0.6 2026-07-09T09:48:03+08:00 daily https://www.pharmasources.com/industryinsights/roche-launches-antibody-test-to-aid-in-d-293972.html 0.6 2026-08-06T10:21:50+08:00 daily https://www.pharmasources.com/industryinsights/agendia-appoints-patrick-j-balthrop-sr-f-293973.html 0.6 2026-06-21T21:30:02+08:00 daily https://www.pharmasources.com/industryinsights/uks-innovation-agency-backs-plasticell-293974.html 0.6 2026-06-25T08:13:49+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-omnichem-launches-flow-chemist-293975.html 0.6 2026-07-09T07:35:31+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-bolsters-executive-team-293976.html 0.6 2026-04-04T14:57:29+08:00 daily https://www.pharmasources.com/industryinsights/abl-awarded-barda-contract-293977.html 0.6 2026-03-16T05:50:05+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-helps-alligator-bio-comp-293978.html 0.6 2026-01-13T11:48:12+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-apexigen-collaborate-to-evaluate-293979.html 0.6 2026-06-09T20:12:45+08:00 daily https://www.pharmasources.com/industryinsights/regen-biopharma-sees-success-in-its-pre--293980.html 0.6 2026-06-08T17:28:48+08:00 daily https://www.pharmasources.com/industryinsights/bosch-launches-new-wfi-system-at-interpa-293981.html 0.6 2026-06-08T05:58:35+08:00 daily https://www.pharmasources.com/industryinsights/hitachi-elected-by-sumitomo-dainippon-ph-293982.html 0.6 2026-07-02T11:54:29+08:00 daily https://www.pharmasources.com/industryinsights/narendra-modi-australian-pm-inaugurate-t-293983.html 0.6 2026-06-14T18:29:13+08:00 daily https://www.pharmasources.com/industryinsights/a-new-sensitive-technique-for-detecting--293984.html 0.6 2026-01-07T08:43:32+08:00 daily https://www.pharmasources.com/industryinsights/shangpharma-innovation-appoints-new-ceo-293985.html 0.6 2026-05-20T09:52:28+08:00 daily https://www.pharmasources.com/industryinsights/dhl-strengthens-in-china-293986.html 0.6 2026-04-16T17:17:29+08:00 daily https://www.pharmasources.com/industryinsights/indias-torrent-pharma-inks-deal-with-nov-293987.html 0.6 2026-06-18T01:18:33+08:00 daily https://www.pharmasources.com/industryinsights/cancer-can-be-diagnosed-by-googles-artif-293988.html 0.6 2026-06-29T15:49:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-to-treat-tardive-293989.html 0.6 2026-02-03T22:02:23+08:00 daily https://www.pharmasources.com/industryinsights/best-practice-guide-on-leachables-risk-p-293990.html 0.6 2026-07-02T11:02:22+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-genetic-basis-for-drug-respo-293991.html 0.6 2026-06-05T11:22:59+08:00 daily https://www.pharmasources.com/industryinsights/horizon-discovery-enters-into-rd-and-lic-293992.html 0.6 2025-11-21T09:40:31+08:00 daily https://www.pharmasources.com/industryinsights/evonik-health-care-expands-local-presenc-293993.html 0.6 2026-06-26T07:38:05+08:00 daily https://www.pharmasources.com/industryinsights/novogen-awarded-grant-of-up-to-a3-millio-293994.html 0.6 2025-11-17T14:03:59+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-new-drug-approval-of-fda-in--293995.html 0.6 2026-08-08T01:00:09+08:00 daily https://www.pharmasources.com/industryinsights/donkey-hide-gelatin-prices-surging-the-w-293996.html 0.6 2026-06-23T12:32:35+08:00 daily https://www.pharmasources.com/industryinsights/appili-to-develop-new-antibiotic-to-trea-293997.html 0.6 2026-07-02T05:26:02+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-neurocrines-ingrezza-cap-293998.html 0.6 2026-06-08T13:01:10+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-unitedhealth-stada-arzneim-293999.html 0.6 2026-04-03T01:30:52+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-nubiyota-to-develop-microbial-294000.html 0.6 2026-03-01T01:26:44+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-frequency-therapeutics-e-294001.html 0.6 2026-07-04T03:08:03+08:00 daily https://www.pharmasources.com/industryinsights/smc-approves-anti-hiv-drug-prep-294002.html 0.6 2026-02-16T16:27:18+08:00 daily https://www.pharmasources.com/industryinsights/nices-draft-guidance-ignores-recommendat-294003.html 0.6 2026-03-28T13:54:53+08:00 daily https://www.pharmasources.com/industryinsights/gp-practices-to-get-in-house-pharmacists-294004.html 0.6 2026-07-01T14:11:15+08:00 daily https://www.pharmasources.com/industryinsights/stroke-patients-in-england-to-get-revolu-294005.html 0.6 2025-11-07T16:52:09+08:00 daily https://www.pharmasources.com/industryinsights/trail-blazing-trusts-to-invest-70m-in-di-294006.html 0.6 2026-06-24T01:26:47+08:00 daily https://www.pharmasources.com/industryinsights/bms-links-with-apexigen-to-test-cancer-i-294007.html 0.6 2026-07-06T23:08:37+08:00 daily https://www.pharmasources.com/industryinsights/one-in-five-south-west-gps-planning-to-q-294008.html 0.6 2026-07-04T07:39:16+08:00 daily https://www.pharmasources.com/industryinsights/boots-launches-hpv-vaccination-service-294009.html 0.6 2026-01-27T20:09:08+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-first-drug-for-tardive-dyskine-294010.html 0.6 2026-02-28T16:02:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-warning-slams-st-judes-inadequate-re-294011.html 0.6 2026-03-14T00:30:38+08:00 daily https://www.pharmasources.com/industryinsights/rebiotix-delivers-a-gut-bug-punch-in-c-d-294012.html 0.6 2026-06-30T22:46:29+08:00 daily https://www.pharmasources.com/industryinsights/antiparasitic-drug-repurposed-for-treatm-294013.html 0.6 2026-07-17T19:02:00+08:00 daily https://www.pharmasources.com/industryinsights/new-supermolecule-seeks-and-removes-harm-294014.html 0.6 2026-06-14T18:43:23+08:00 daily https://www.pharmasources.com/industryinsights/love-it-or-hate-it-vitamin-b12-may-give--294015.html 0.6 2026-03-26T17:07:42+08:00 daily https://www.pharmasources.com/industryinsights/uk-heading-towards-gp-crisis-as-40-consi-294016.html 0.6 2026-08-08T01:44:40+08:00 daily https://www.pharmasources.com/industryinsights/discovery-of-predictive-protein-signatur-294017.html 0.6 2026-08-06T20:23:50+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-issues-complete-response-letter-f-294018.html 0.6 2026-01-17T14:28:31+08:00 daily https://www.pharmasources.com/industryinsights/ispe-releases-guidance-document-294019.html 0.6 2026-04-06T23:27:19+08:00 daily https://www.pharmasources.com/industryinsights/multisorb-appoints-subham-singh-as-busin-294020.html 0.6 2026-02-15T04:30:57+08:00 daily https://www.pharmasources.com/industryinsights/mohfw-dcgi-grants-approval-to-rms-regrow-294021.html 0.6 2026-07-03T17:20:38+08:00 daily https://www.pharmasources.com/industryinsights/bcpl-posts-net-profit-of-rs-4-crore-294022.html 0.6 2026-06-08T21:53:42+08:00 daily https://www.pharmasources.com/industryinsights/technology-is-key-to-improve-rd-efficacy-294023.html 0.6 2026-05-01T17:18:30+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-appoints-nikhilesh-kalra-to-lead--294024.html 0.6 2026-04-19T03:26:46+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-pfizer-enter-research-collabo-294025.html 0.6 2026-04-15T23:46:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-determines-erythropoiesis-stimulatin-294026.html 0.6 2025-11-13T08:33:04+08:00 daily https://www.pharmasources.com/industryinsights/statistical-approach-to-clinical-trials--294027.html 0.6 2026-04-30T01:33:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-nationwide-voluntary-recal-294028.html 0.6 2026-03-01T01:27:30+08:00 daily https://www.pharmasources.com/industryinsights/casi-pharmaceuticals-reports-on-enrollme-294029.html 0.6 2026-08-07T01:05:40+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-appoints-dr-alexandre-lebeaut-as-e-294030.html 0.6 2025-11-19T17:36:14+08:00 daily https://www.pharmasources.com/industryinsights/arch-biopartners-lead-anti-bacterial-dru-294031.html 0.6 2026-04-20T10:28:45+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-enters-into-separat-294032.html 0.6 2026-04-16T17:35:06+08:00 daily https://www.pharmasources.com/industryinsights/brain-tissue-from-a-petri-dish-294033.html 0.6 2026-04-11T23:29:42+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-honors-island-hospital-wi-294034.html 0.6 2026-03-28T15:00:01+08:00 daily https://www.pharmasources.com/industryinsights/china-cord-blood-corporation-announces-t-294035.html 0.6 2026-07-03T11:25:33+08:00 daily https://www.pharmasources.com/industryinsights/biopharmaceutical-analytical-instrumenta-294036.html 0.6 2026-07-17T16:18:45+08:00 daily https://www.pharmasources.com/industryinsights/science-china-life-sciences-english-edit-294037.html 0.6 2026-06-26T14:51:11+08:00 daily https://www.pharmasources.com/industryinsights/prenetics-launches-onedna-in-partnership-294038.html 0.6 2025-11-26T01:50:23+08:00 daily https://www.pharmasources.com/industryinsights/merrimack-appoints-head-of-research-294039.html 0.6 2026-07-03T00:28:15+08:00 daily https://www.pharmasources.com/industryinsights/foresee-pharma-adds-two-rd-executives-294040.html 0.6 2026-06-27T01:15:20+08:00 daily https://www.pharmasources.com/industryinsights/pboa-praises-action-on-fda-reauthorizati-294041.html 0.6 2026-05-08T17:42:33+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-inspects-alembic-pharmas-vadodara-294042.html 0.6 2026-02-05T07:07:53+08:00 daily https://www.pharmasources.com/industryinsights/unichem-laboratories-receives-anda-appro-294043.html 0.6 2026-08-07T14:11:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-nuvox-pharma-to-run-a-phase-i-294044.html 0.6 2026-08-08T01:22:12+08:00 daily https://www.pharmasources.com/industryinsights/amarantus-forms-subsidiaries-elto-pharma-294045.html 0.6 2026-02-28T14:35:19+08:00 daily https://www.pharmasources.com/industryinsights/janssen-receives-health-canada-approval--294046.html 0.6 2026-04-28T01:53:32+08:00 daily https://www.pharmasources.com/industryinsights/genentech-announces-positive-interim-res-294047.html 0.6 2026-03-20T14:34:31+08:00 daily https://www.pharmasources.com/industryinsights/epilepsy-another-potential-zika-threat-t-294048.html 0.6 2026-04-03T06:01:43+08:00 daily https://www.pharmasources.com/industryinsights/new-bowel-disorder-treatments-needed-fda-294049.html 0.6 2026-04-08T19:12:12+08:00 daily https://www.pharmasources.com/industryinsights/malaysias-island-hospital-gets-frost-sul-294050.html 0.6 2026-04-19T15:24:57+08:00 daily https://www.pharmasources.com/industryinsights/nuhs-discovers-novel-link-between-unheal-294051.html 0.6 2026-04-18T04:06:19+08:00 daily https://www.pharmasources.com/industryinsights/medical-institutes-in-china-planning-par-294052.html 0.6 2026-07-31T13:22:28+08:00 daily https://www.pharmasources.com/industryinsights/biomedical-institute-for-global-health-r-294053.html 0.6 2026-02-28T21:00:32+08:00 daily https://www.pharmasources.com/industryinsights/takeda-enters-into-strategic-collaborati-294054.html 0.6 2026-01-04T05:07:49+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-expands-commercial-operations--294055.html 0.6 2026-06-08T17:40:02+08:00 daily https://www.pharmasources.com/industryinsights/novartis-collaborates-with-allergan-on-n-294056.html 0.6 2026-08-07T21:22:45+08:00 daily https://www.pharmasources.com/industryinsights/roches-hemophilia-a-drug-positive-in-sec-294057.html 0.6 2026-07-28T14:51:29+08:00 daily https://www.pharmasources.com/industryinsights/biotech-standout-juno-plans-bay-area-off-294058.html 0.6 2026-06-17T22:42:45+08:00 daily https://www.pharmasources.com/industryinsights/grifols-donates-140-million-internationa-294059.html 0.6 2026-08-09T23:49:10+08:00 daily https://www.pharmasources.com/industryinsights/deltahealth-and-harvard-global-health-in-294060.html 0.6 2026-06-23T20:55:12+08:00 daily https://www.pharmasources.com/industryinsights/5-things-you-should-expect-when-johnson--294061.html 0.6 2026-08-08T01:12:34+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-industry-its-refreshing-t-294062.html 0.6 2026-07-17T07:30:24+08:00 daily https://www.pharmasources.com/industryinsights/how-pfizer-inc-makes-most-of-its-money-294063.html 0.6 2026-01-12T17:54:46+08:00 daily https://www.pharmasources.com/industryinsights/with-new-online-tool-msf-invites-pfizer--294064.html 0.6 2026-03-01T01:30:23+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-to-produce-vaccines-with-294065.html 0.6 2026-01-04T13:02:53+08:00 daily https://www.pharmasources.com/industryinsights/parent-and-child-vaccination-decisions-r-294066.html 0.6 2026-06-13T20:43:17+08:00 daily https://www.pharmasources.com/industryinsights/california-immunization-rates-hit-new-hi-294067.html 0.6 2026-04-28T21:45:20+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-receives-notice-of-all-294068.html 0.6 2026-03-18T00:50:00+08:00 daily https://www.pharmasources.com/industryinsights/mergermarket-releases-global-pmb-trend-r-294069.html 0.6 2026-08-08T09:06:34+08:00 daily https://www.pharmasources.com/industryinsights/orchid-pharma-receives-eir-from-us-fda-f-294070.html 0.6 2026-06-26T00:29:07+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-raises-rs-100-cr-by-issue--294071.html 0.6 2026-04-08T15:23:56+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-novartis-in-clinical-collab-294072.html 0.6 2026-08-09T01:57:55+08:00 daily https://www.pharmasources.com/industryinsights/altor-bioscience-and-cmc-biologics-team--294073.html 0.6 2026-08-10T01:22:15+08:00 daily https://www.pharmasources.com/industryinsights/ametek-buys-mocon-for-182m-294074.html 0.6 2026-07-01T04:09:23+08:00 daily https://www.pharmasources.com/industryinsights/vantage-consulting-is-first-systems-inte-294075.html 0.6 2026-04-24T03:41:40+08:00 daily https://www.pharmasources.com/industryinsights/inoviem-scientific-raises-800k-to-broade-294076.html 0.6 2026-01-12T16:35:47+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-invests-19m-in-gene-ther-294077.html 0.6 2026-05-03T10:45:41+08:00 daily https://www.pharmasources.com/industryinsights/defibtech-selects-robert-reinhardt-as-ne-294078.html 0.6 2026-07-09T07:00:19+08:00 daily https://www.pharmasources.com/industryinsights/rigel-submits-new-drug-application-to-fd-294079.html 0.6 2026-04-06T17:54:26+08:00 daily https://www.pharmasources.com/industryinsights/amarantus-forms-elto-pharma-for-cns-diso-294080.html 0.6 2026-04-03T17:47:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-cell-therapy-ctl019-recei-294081.html 0.6 2026-04-05T10:18:46+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-establishes-ins-294082.html 0.6 2026-05-02T06:52:46+08:00 daily https://www.pharmasources.com/industryinsights/pipeline-drug-offers-promise-in-treatmen-294083.html 0.6 2026-06-14T08:19:22+08:00 daily https://www.pharmasources.com/industryinsights/roches-bags-new-us-approvals-for-tecentr-294084.html 0.6 2026-04-06T22:42:55+08:00 daily https://www.pharmasources.com/industryinsights/circassia-abandons-allergy-programme-aft-294085.html 0.6 2026-08-09T21:27:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-doubles-its-aid-for-neglected-tropica-294086.html 0.6 2026-04-13T12:16:45+08:00 daily https://www.pharmasources.com/industryinsights/eu-expands-approval-of-alks-house-dust-m-294087.html 0.6 2026-01-31T04:27:02+08:00 daily https://www.pharmasources.com/industryinsights/bma-urges-nhs-focus-in-snap-general-elec-294088.html 0.6 2026-04-23T11:44:26+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-crt-pioneer-fund-and-the-nci-link--294089.html 0.6 2026-06-08T22:04:46+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-novartis-cosentyx-in-psa-294090.html 0.6 2026-04-29T19:43:29+08:00 daily https://www.pharmasources.com/industryinsights/allergan-novartis-sign-nash-clinical-tri-294091.html 0.6 2026-07-17T05:02:53+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-novartis-join-forces-to-dev-294092.html 0.6 2026-02-14T23:35:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-dangers-of-hylands-homeopat-294093.html 0.6 2026-06-23T01:18:27+08:00 daily https://www.pharmasources.com/industryinsights/circassia-stumbles-with-allergy-treatmen-294094.html 0.6 2026-04-13T13:10:01+08:00 daily https://www.pharmasources.com/industryinsights/roches-drug-scores-expanded-fda-indicati-294095.html 0.6 2026-08-06T11:33:10+08:00 daily https://www.pharmasources.com/industryinsights/smart-bandages-could-offer-real-time-wou-294096.html 0.6 2026-06-12T10:47:57+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-tecentriq-receives-fda-accele-294097.html 0.6 2026-04-28T09:48:12+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-declines-approval-of-eli-lilly-an-294098.html 0.6 2026-03-12T04:12:13+08:00 daily https://www.pharmasources.com/industryinsights/reinhard-kandera-appointed-chief-financi-294099.html 0.6 2026-01-03T05:22:58+08:00 daily https://www.pharmasources.com/industryinsights/piramal-enterprises-partners-with-ipa-294100.html 0.6 2026-02-28T15:56:46+08:00 daily https://www.pharmasources.com/industryinsights/clarivate-analytics-unveils-india-innova-294101.html 0.6 2026-04-06T20:58:47+08:00 daily https://www.pharmasources.com/industryinsights/plant-protein-may-protect-against-type-i-294102.html 0.6 2026-03-01T03:04:04+08:00 daily https://www.pharmasources.com/industryinsights/rusan-pharma-launches-anti-tobaccosmokin-294103.html 0.6 2026-06-16T01:07:13+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-tentative-us-fda-nod-for-a-294104.html 0.6 2026-07-31T09:36:11+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-johnson-johnson-294105.html 0.6 2025-12-22T07:04:21+08:00 daily https://www.pharmasources.com/industryinsights/transcelerate-selects-veeva-vault-siteex-294106.html 0.6 2026-08-10T00:41:40+08:00 daily https://www.pharmasources.com/industryinsights/plasticell-kings-college-partner-on-bloo-294107.html 0.6 2026-08-09T23:37:47+08:00 daily https://www.pharmasources.com/industryinsights/ionis-ribo-in-rna-targeted-drug-alliance-294108.html 0.6 2026-06-27T22:27:51+08:00 daily https://www.pharmasources.com/industryinsights/advaxis-appoints-cbo-294109.html 0.6 2026-08-09T08:31:11+08:00 daily https://www.pharmasources.com/industryinsights/cold-chain-technologies-opens-new-hq-294110.html 0.6 2026-05-10T22:54:29+08:00 daily https://www.pharmasources.com/industryinsights/amag-submits-supplemental-new-drug-appli-294111.html 0.6 2026-08-08T22:14:52+08:00 daily https://www.pharmasources.com/industryinsights/cardinal-health-to-acquire-patient-produ-294112.html 0.6 2026-07-03T16:32:51+08:00 daily https://www.pharmasources.com/industryinsights/ametek-to-acquire-mocon-294113.html 0.6 2026-02-28T14:01:07+08:00 daily https://www.pharmasources.com/industryinsights/cdisc-announces-new-standard-for-major-d-294114.html 0.6 2026-03-01T05:10:46+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-nordic-bioscien-294115.html 0.6 2026-04-15T08:06:26+08:00 daily https://www.pharmasources.com/industryinsights/geneuro-initiates-phase-2a-study-in-aust-294116.html 0.6 2026-03-18T02:29:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-lymphoma-treatment-receives-fda-294117.html 0.6 2026-08-03T16:09:57+08:00 daily https://www.pharmasources.com/industryinsights/enzyvant-receives-fda-designation-for-in-294118.html 0.6 2026-08-04T14:36:10+08:00 daily https://www.pharmasources.com/industryinsights/oral-contraceptives-reduce-general-well--294119.html 0.6 2026-06-22T05:38:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-device-to-help-curb-cluster-294120.html 0.6 2025-11-19T23:38:52+08:00 daily https://www.pharmasources.com/industryinsights/new-prognostic-tool-accurately-predicts--294121.html 0.6 2026-06-10T14:34:28+08:00 daily https://www.pharmasources.com/industryinsights/cannabidiol-reduces-seizures-by-half-in--294122.html 0.6 2026-01-18T17:18:04+08:00 daily https://www.pharmasources.com/industryinsights/frog-mucus-may-offer-protection-against--294123.html 0.6 2026-04-19T01:58:29+08:00 daily https://www.pharmasources.com/industryinsights/behavioural-intervention-reduces-need-fo-294124.html 0.6 2026-01-31T08:17:57+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-launches-healthcare-hub-to-suppor-294125.html 0.6 2026-07-16T08:29:21+08:00 daily https://www.pharmasources.com/industryinsights/rigel-pharmaceuticals-submits-nda-to-fda-294126.html 0.6 2026-05-05T13:28:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-294127.html 0.6 2026-03-12T20:43:40+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-cpf-and-nci-partner-t-294128.html 0.6 2025-12-27T11:28:32+08:00 daily https://www.pharmasources.com/industryinsights/ibm-and-hejia-launch-blockchain-based-su-294129.html 0.6 2026-07-23T19:31:02+08:00 daily https://www.pharmasources.com/industryinsights/uks-innovation-agency-backs-plasticell-t-294130.html 0.6 2026-08-08T03:02:06+08:00 daily https://www.pharmasources.com/industryinsights/grifols-donates-140-million-internationa-294131.html 0.6 2026-06-14T07:55:51+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-present-data-for-galcanezumab-f-294132.html 0.6 2026-06-22T05:20:24+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expands-development-programs-fo-294133.html 0.6 2026-07-02T09:22:03+08:00 daily https://www.pharmasources.com/industryinsights/nih-study-shows-novartis-drug-eltrombopa-294134.html 0.6 2026-06-27T10:15:01+08:00 daily https://www.pharmasources.com/industryinsights/targovax-initiates-clinical-immunotherap-294135.html 0.6 2026-04-09T12:22:03+08:00 daily https://www.pharmasources.com/industryinsights/many-targeting-abbvies-top-selling-drug--294136.html 0.6 2026-04-16T18:59:55+08:00 daily https://www.pharmasources.com/industryinsights/what-kind-of-drug-can-be-called-miracle--294137.html 0.6 2026-07-30T17:03:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-genentechs-lucentis-for-dia-294138.html 0.6 2026-08-09T06:08:32+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-embarks-on-15-m-gene-the-294139.html 0.6 2026-05-03T23:08:09+08:00 daily https://www.pharmasources.com/industryinsights/cardinal-health-to-acquire-leading-patie-294140.html 0.6 2026-06-15T23:21:26+08:00 daily https://www.pharmasources.com/industryinsights/polyganics-announces-enrollment-of-the-f-294141.html 0.6 2026-03-07T10:46:09+08:00 daily https://www.pharmasources.com/industryinsights/irisys-doubles-contract-with-nci-for-mfg-294142.html 0.6 2026-06-17T15:11:04+08:00 daily https://www.pharmasources.com/industryinsights/ani-launches-indapamide-tablets-294143.html 0.6 2026-04-09T18:44:53+08:00 daily https://www.pharmasources.com/industryinsights/edge-pharmacy-services-investing-15-mill-294144.html 0.6 2026-04-13T20:22:20+08:00 daily https://www.pharmasources.com/industryinsights/fungi-have-enormous-potential-for-new-an-294145.html 0.6 2026-03-17T20:46:52+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-gets-six-observations-f-294146.html 0.6 2026-02-28T15:40:21+08:00 daily https://www.pharmasources.com/industryinsights/immune-based-therapy-shows-early-promise-294147.html 0.6 2026-01-30T21:10:28+08:00 daily https://www.pharmasources.com/industryinsights/brain-may-be-organized-by-functions-not--294148.html 0.6 2026-01-12T12:08:07+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-in-talks-with-nice-over-cabometyx--294149.html 0.6 2026-07-19T02:17:16+08:00 daily https://www.pharmasources.com/industryinsights/gws-epidiolex-on-track-for-lgs-filing-mi-294150.html 0.6 2026-06-23T09:35:48+08:00 daily https://www.pharmasources.com/industryinsights/novartis-eltrombopag-in-saa-294151.html 0.6 2025-11-27T16:08:15+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-parp-inhibitor-fails-in-phiii-tr-294152.html 0.6 2026-01-05T10:19:45+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-experimental-cancer-drug-hits-wa-294153.html 0.6 2026-07-17T14:05:16+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-study-successfully-halts-neurod-294154.html 0.6 2025-12-18T15:57:49+08:00 daily https://www.pharmasources.com/industryinsights/alpine-immune-sciences-boosts-prospects--294155.html 0.6 2025-11-27T16:03:56+08:00 daily https://www.pharmasources.com/industryinsights/investigational-immunogen-drug-gives-hop-294156.html 0.6 2025-11-27T16:02:52+08:00 daily https://www.pharmasources.com/industryinsights/world-hemophilia-day-marked-by-release-o-294157.html 0.6 2026-02-01T04:45:05+08:00 daily https://www.pharmasources.com/industryinsights/plx-pharma-merges-with-dipexium-pharmace-294158.html 0.6 2026-06-02T10:35:54+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-daiichi-sankyo-jv-submits-nda-fo-294159.html 0.6 2026-02-10T16:12:21+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-pfizer-partner-to-build-and-s-294160.html 0.6 2025-11-08T23:29:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-renflexis-294161.html 0.6 2025-11-27T15:57:40+08:00 daily https://www.pharmasources.com/industryinsights/atara-bio-merck-in-clinical-combo-allian-294162.html 0.6 2026-08-09T01:00:22+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-new-phase-2-data-on-inve-294163.html 0.6 2026-07-05T02:16:14+08:00 daily https://www.pharmasources.com/industryinsights/volition-opens-new-rd-facility-in-belgiu-294164.html 0.6 2026-08-04T13:56:02+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-launches-first-augmented-rea-294165.html 0.6 2026-04-19T08:42:17+08:00 daily https://www.pharmasources.com/industryinsights/cannimed-therapeutics-commences-cannabis-294166.html 0.6 2026-04-19T06:35:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-vernalis-cough-cold-treatmen-294167.html 0.6 2026-04-28T13:15:25+08:00 daily https://www.pharmasources.com/industryinsights/aberdeen-uni-leads-11m-study-on-bleeding-294168.html 0.6 2026-07-07T01:45:22+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-ban-sugary-drinks-in-hospitals-294169.html 0.6 2025-12-13T06:32:28+08:00 daily https://www.pharmasources.com/industryinsights/worlds-largest-society-for-regulatory-pr-294170.html 0.6 2026-08-03T21:35:19+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-reports-99-cure-rate-for-pan-geno-294171.html 0.6 2025-12-10T14:23:07+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-present-data-for-galcanezumab-f-294172.html 0.6 2025-12-18T10:58:28+08:00 daily https://www.pharmasources.com/industryinsights/applied-dna-sciences-agrees-deal-for-bul-294173.html 0.6 2026-07-16T11:19:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-restricts-administration-of-strong-p-294174.html 0.6 2026-03-01T07:40:24+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-expands-manufacturing-facility-294175.html 0.6 2026-06-10T09:44:22+08:00 daily https://www.pharmasources.com/industryinsights/teva-launches-competitors-to-gsks-advair-294176.html 0.6 2026-04-13T21:34:53+08:00 daily https://www.pharmasources.com/industryinsights/pharma-deal-making-in-the-pink-of-health-294177.html 0.6 2026-06-17T13:08:16+08:00 daily https://www.pharmasources.com/industryinsights/allergan-partners-with-target-pharmasolu-294178.html 0.6 2026-03-25T19:13:17+08:00 daily https://www.pharmasources.com/industryinsights/cannabis-based-medicine-may-cut-number-o-294179.html 0.6 2026-06-22T17:41:05+08:00 daily https://www.pharmasources.com/industryinsights/lhasa-and-optibrium-enter-research-and-p-294180.html 0.6 2026-06-15T07:19:09+08:00 daily https://www.pharmasources.com/industryinsights/foresee-pharmaceuticals-announces-key-ex-294181.html 0.6 2025-11-27T15:36:48+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-receives-11-observations-from-294182.html 0.6 2026-04-05T08:12:52+08:00 daily https://www.pharmasources.com/industryinsights/cliantha-research-acquires-inflamax-rese-294183.html 0.6 2026-05-29T19:28:07+08:00 daily https://www.pharmasources.com/industryinsights/avantor-acquires-puritan-products-294184.html 0.6 2026-06-15T23:41:19+08:00 daily https://www.pharmasources.com/industryinsights/plx-pharma-and-dipexium-pharmaceuticals--294185.html 0.6 2026-08-08T02:15:20+08:00 daily https://www.pharmasources.com/industryinsights/co-truxton-issues-voluntary-nationwide-r-294186.html 0.6 2026-07-20T13:43:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-restricts-use-of-prescription-codein-294187.html 0.6 2026-08-03T05:46:22+08:00 daily https://www.pharmasources.com/industryinsights/merck-donates-300000-to-support-neglecte-294188.html 0.6 2026-07-18T13:50:57+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-announces-hire-of-carrie-c-294189.html 0.6 2025-11-27T15:28:25+08:00 daily https://www.pharmasources.com/industryinsights/bruker-introduces-new-clinical-microbiol-294190.html 0.6 2026-02-09T08:44:14+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-grifols-cellesce-arena-p-294191.html 0.6 2025-11-27T15:26:14+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-livzon-pharmaceutical-grou-294192.html 0.6 2026-08-05T19:00:16+08:00 daily https://www.pharmasources.com/industryinsights/novartis-obtains-rights-to-use-parvus-na-294193.html 0.6 2026-02-28T16:08:42+08:00 daily https://www.pharmasources.com/industryinsights/ionis-and-ribo-partner-to-commercialise--294194.html 0.6 2026-08-03T07:41:33+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-announces-drug-discovery-collabor-294195.html 0.6 2026-06-08T16:22:05+08:00 daily https://www.pharmasources.com/industryinsights/hkstp-welcomes-maz-world-to-hong-kong-sa-294196.html 0.6 2026-06-08T22:08:43+08:00 daily https://www.pharmasources.com/industryinsights/insightec-first-patient-with-benign-brai-294197.html 0.6 2026-02-05T04:38:24+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170424-294198.html 0.6 2026-06-08T15:24:42+08:00 daily https://www.pharmasources.com/industryinsights/solidsoft-reply-to-operate-the-irish-nat-294199.html 0.6 2026-07-28T15:46:55+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-hcv-compensated-cirrhosis-drug-a-294200.html 0.6 2026-07-20T05:22:19+08:00 daily https://www.pharmasources.com/industryinsights/bms-phase-ii-study-in-non-alcoholic-stea-294201.html 0.6 2026-07-31T12:01:41+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-phase-3-monarch-3-breast-294202.html 0.6 2026-02-15T13:23:54+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-to-announce-first-quarter-2-294203.html 0.6 2026-08-07T23:37:41+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-opens-gmp-suite-for-clinical-t-294204.html 0.6 2026-04-23T08:00:45+08:00 daily https://www.pharmasources.com/industryinsights/bms-presents-promising-data-for-nash-dru-294205.html 0.6 2026-06-15T01:22:53+08:00 daily https://www.pharmasources.com/industryinsights/pharma-heads-call-for-decision-on-ema-re-294206.html 0.6 2025-11-28T21:40:59+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-obtains-first-drug-appro-294207.html 0.6 2026-06-20T19:57:55+08:00 daily https://www.pharmasources.com/industryinsights/us-green-light-for-remicade-biosimilar-294208.html 0.6 2026-06-18T01:04:46+08:00 daily https://www.pharmasources.com/industryinsights/chmp-backs-11-medicines-for-european-app-294209.html 0.6 2026-06-12T10:39:38+08:00 daily https://www.pharmasources.com/industryinsights/sucampo-acquires-vtesse-for-200mn-294210.html 0.6 2026-04-24T08:39:11+08:00 daily https://www.pharmasources.com/industryinsights/paratek-pharmaceuticals-and-zai-lab-team-294211.html 0.6 2026-04-23T04:48:53+08:00 daily https://www.pharmasources.com/industryinsights/psoriasis-drug-siliq-will-be-cheapest-in-294212.html 0.6 2026-05-03T06:37:26+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-multiple-sclerosis-research-294213.html 0.6 2026-08-06T18:06:26+08:00 daily https://www.pharmasources.com/industryinsights/janssen-acquires-over-90-of-actelion-294214.html 0.6 2026-08-08T23:23:37+08:00 daily https://www.pharmasources.com/industryinsights/eu-recommendation-for-sanofi-and-regener-294215.html 0.6 2026-08-07T03:07:27+08:00 daily https://www.pharmasources.com/industryinsights/england-really-is-not-a-good-place-to-ge-294216.html 0.6 2026-07-18T13:12:20+08:00 daily https://www.pharmasources.com/industryinsights/espero-pharma-and-armetheon-merge-294217.html 0.6 2026-03-17T09:07:25+08:00 daily https://www.pharmasources.com/industryinsights/mpp-signs-licence-and-technology-transfe-294218.html 0.6 2026-03-17T19:39:38+08:00 daily https://www.pharmasources.com/industryinsights/valeant-pharmaceuticals-lists-price-of-p-294219.html 0.6 2026-04-12T03:47:46+08:00 daily https://www.pharmasources.com/industryinsights/oxford-cancer-biomarkers-licenses-rights-294220.html 0.6 2026-01-13T04:17:26+08:00 daily https://www.pharmasources.com/industryinsights/biomarins-brineura-receives-positive-opi-294221.html 0.6 2026-04-14T02:05:37+08:00 daily https://www.pharmasources.com/industryinsights/bacteriophages-natural-drugs-to-combat-s-294222.html 0.6 2026-04-19T21:02:11+08:00 daily https://www.pharmasources.com/industryinsights/philips-and-pathai-team-up-to-improve-br-294223.html 0.6 2026-03-21T16:07:41+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-delivers-first-serialised-batc-294224.html 0.6 2026-04-26T18:42:12+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-proposed-biosimilars-rituximab-an-294225.html 0.6 2026-04-13T18:11:40+08:00 daily https://www.pharmasources.com/industryinsights/bms-986036-shows-consistent-improvement--294226.html 0.6 2026-08-07T19:38:17+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-unveils-atlas-an-interactive-webs-294227.html 0.6 2025-11-27T14:50:14+08:00 daily https://www.pharmasources.com/industryinsights/drl-launches-of-progesterone-capsules-in-294228.html 0.6 2026-06-28T01:08:56+08:00 daily https://www.pharmasources.com/industryinsights/acg-pharmapack-gets-gmp-accreditation-fo-294229.html 0.6 2026-08-09T11:56:23+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-malaria-shot-set-for-wh-294230.html 0.6 2025-12-25T13:45:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-real-world-data-at-aan-confirms-294231.html 0.6 2026-07-06T17:16:41+08:00 daily https://www.pharmasources.com/industryinsights/research-moves-closer-to-unraveling-myst-294232.html 0.6 2026-08-06T19:48:25+08:00 daily https://www.pharmasources.com/industryinsights/khaled-el-gendy-joins-pilatus-clinical-s-294233.html 0.6 2026-01-25T11:52:03+08:00 daily https://www.pharmasources.com/industryinsights/stretta-for-gerd-receives-strong-grade-r-294234.html 0.6 2025-11-27T14:53:24+08:00 daily https://www.pharmasources.com/industryinsights/lilly-reports-first-quarter-2017-results-294235.html 0.6 2026-03-25T19:54:43+08:00 daily https://www.pharmasources.com/industryinsights/pubertys-onset-may-depend-on-dna-294236.html 0.6 2026-08-06T21:09:29+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-picks-up-czech-vaccine-f-294237.html 0.6 2026-01-14T06:57:05+08:00 daily https://www.pharmasources.com/industryinsights/us-army-cant-add-a-pricing-safeguard-to--294238.html 0.6 2026-04-24T00:54:29+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-bms-kick-off-phase-2-tes-294239.html 0.6 2026-05-10T07:19:02+08:00 daily https://www.pharmasources.com/industryinsights/one-third-of-cancer-cases-in-england-dia-294240.html 0.6 2026-02-28T09:00:20+08:00 daily https://www.pharmasources.com/industryinsights/bms-transgene-to-test-new-lung-cancer-co-294241.html 0.6 2026-04-03T02:43:27+08:00 daily https://www.pharmasources.com/industryinsights/united-biopharma-selects-ges-flexfactory-294242.html 0.6 2026-03-17T22:40:10+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-asdera-enter-licensing-agreemen-294243.html 0.6 2026-06-23T19:03:59+08:00 daily https://www.pharmasources.com/industryinsights/domain-pfizer-in-biosensall-alliance-294244.html 0.6 2026-08-09T16:09:54+08:00 daily https://www.pharmasources.com/industryinsights/merck-sells-biosimilars-business-to-fres-294245.html 0.6 2026-02-22T13:44:19+08:00 daily https://www.pharmasources.com/industryinsights/amag-appoints-pharmacovigilance-vp-294246.html 0.6 2026-01-04T14:55:20+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-labcentral-to-foster-biot-294247.html 0.6 2026-08-09T01:07:15+08:00 daily https://www.pharmasources.com/industryinsights/lilly-reports-positive-data-for-breast-c-294248.html 0.6 2025-12-08T22:53:47+08:00 daily https://www.pharmasources.com/industryinsights/oncomed-cuts-workforce-in-half-294249.html 0.6 2026-08-08T13:29:11+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-calls-for-ema-relocation-294250.html 0.6 2026-02-15T13:40:19+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-enrollment-o-294251.html 0.6 2026-06-23T06:06:43+08:00 daily https://www.pharmasources.com/industryinsights/indian-government-goes-to-war-over-75-st-294252.html 0.6 2026-03-17T22:18:39+08:00 daily https://www.pharmasources.com/industryinsights/web-monitoring-for-capturing-real-world--294253.html 0.6 2025-11-27T15:12:28+08:00 daily https://www.pharmasources.com/industryinsights/sanner-passes-60-million-euro-mark-294254.html 0.6 2026-03-12T18:24:20+08:00 daily https://www.pharmasources.com/industryinsights/becton-dickinson-to-acquire-bard-for-24--294255.html 0.6 2026-07-18T04:33:28+08:00 daily https://www.pharmasources.com/industryinsights/united-biopharma-inc-selects-ge-healthca-294256.html 0.6 2026-07-27T05:45:31+08:00 daily https://www.pharmasources.com/industryinsights/1drop-diagnostics-joins-hands-with-massa-294257.html 0.6 2026-01-30T10:40:13+08:00 daily https://www.pharmasources.com/industryinsights/orexigen-therapeutics-announces-new-drug-294258.html 0.6 2026-04-25T01:17:31+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-initiates-clinical-inves-294259.html 0.6 2026-04-08T13:35:26+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-buys-polio-vacc-294260.html 0.6 2026-06-08T20:58:21+08:00 daily https://www.pharmasources.com/industryinsights/ema-gives-positive-opinion-on-biogens-sp-294261.html 0.6 2026-07-05T02:40:03+08:00 daily https://www.pharmasources.com/industryinsights/quarter-of-cancer-patients-visit-gp-thre-294262.html 0.6 2026-06-08T07:05:36+08:00 daily https://www.pharmasources.com/industryinsights/japanese-pharma-expects-17-growth-throug-294263.html 0.6 2026-03-11T08:27:32+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-anti-hy-294264.html 0.6 2026-04-15T18:41:17+08:00 daily https://www.pharmasources.com/industryinsights/fdec-commences-roll-out-of-malaria-demon-294265.html 0.6 2026-07-10T02:29:44+08:00 daily https://www.pharmasources.com/industryinsights/japanese-pharma-companies-predict-17-per-294266.html 0.6 2026-04-06T01:54:08+08:00 daily https://www.pharmasources.com/industryinsights/paratek-and-zai-lab-sign-deal-to-commerc-294267.html 0.6 2026-08-03T05:36:33+08:00 daily https://www.pharmasources.com/industryinsights/merck-divests-biosimilars-business-to-fr-294268.html 0.6 2026-01-13T09:35:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-against-14-companies-fo-294269.html 0.6 2026-02-09T14:22:19+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-receives-fda-approval-fo-294270.html 0.6 2025-11-27T15:29:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-novel-inhaled-lung-cancer-tre-294271.html 0.6 2026-06-13T15:13:14+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-phase-iii-study-to-treat-hospita-294272.html 0.6 2026-08-05T23:47:47+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-proposed-biosimilars-recommended--294273.html 0.6 2026-04-18T10:04:54+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regenerons-kevzara-receives-c-294274.html 0.6 2026-03-09T12:33:56+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-topping-out-of-glo-294275.html 0.6 2025-11-27T15:35:47+08:00 daily https://www.pharmasources.com/industryinsights/britannia-pharmaceuticals-landmark-apomo-294276.html 0.6 2026-06-19T10:59:58+08:00 daily https://www.pharmasources.com/industryinsights/epivax-signs-first-commercial-license-fo-294277.html 0.6 2026-03-16T22:01:45+08:00 daily https://www.pharmasources.com/industryinsights/novartis-reports-1st-quarter-results-294278.html 0.6 2026-01-02T17:36:22+08:00 daily https://www.pharmasources.com/industryinsights/hospira-issues-voluntary-nationwide-reca-294279.html 0.6 2026-04-06T19:50:44+08:00 daily https://www.pharmasources.com/industryinsights/servier-and-cti-biopharma-expand-pixuvri-294280.html 0.6 2026-04-04T00:33:36+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-collaborates-with-labcent-294281.html 0.6 2026-08-07T15:04:57+08:00 daily https://www.pharmasources.com/industryinsights/domain-therapeutics-and-pfizer-enter-int-294282.html 0.6 2026-04-16T00:44:54+08:00 daily https://www.pharmasources.com/industryinsights/ghana-kenya-and-malawi-to-pilot-malaria--294283.html 0.6 2026-03-25T19:52:47+08:00 daily https://www.pharmasources.com/industryinsights/nice-green-light-for-lillys-psoriasis-dr-294284.html 0.6 2025-11-27T15:46:13+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-acquires-akorn-in-43bn-de-294285.html 0.6 2026-02-05T03:23:02+08:00 daily https://www.pharmasources.com/industryinsights/sawai-pays-1bn-for-generics-biz-of-upshe-294286.html 0.6 2026-03-19T22:46:33+08:00 daily https://www.pharmasources.com/industryinsights/eu-issues-full-approval-for-az-tagrisso-294287.html 0.6 2026-01-10T08:18:40+08:00 daily https://www.pharmasources.com/industryinsights/ms-trusts-names-first-sites-for-speciali-294288.html 0.6 2026-04-05T06:09:05+08:00 daily https://www.pharmasources.com/industryinsights/uniqures-haemophilia-b-therapy-picks-up--294289.html 0.6 2026-04-07T19:26:07+08:00 daily https://www.pharmasources.com/industryinsights/azs-tagrisso-continues-successes-with-eu-294290.html 0.6 2026-04-13T19:11:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-condemns-14-companies-selling-fraudu-294291.html 0.6 2026-08-03T02:23:23+08:00 daily https://www.pharmasources.com/industryinsights/research-identifies-marker-for-aggressiv-294292.html 0.6 2026-04-07T20:40:03+08:00 daily https://www.pharmasources.com/industryinsights/pharmatek-adds-cgmp-spray-drying-capacit-294293.html 0.6 2026-04-01T12:56:10+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-launches-lawsuit-against-mylan-ov-294294.html 0.6 2026-03-12T11:00:17+08:00 daily https://www.pharmasources.com/industryinsights/prosolus-expands-transdermal-drug-delive-294295.html 0.6 2025-11-27T15:56:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-amgen-expand-global-collabo-294296.html 0.6 2026-07-29T20:14:44+08:00 daily https://www.pharmasources.com/industryinsights/new-study-confirms-effectiveness-of-bcm--294297.html 0.6 2026-01-21T09:20:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-ncri-introduces-five-year-strategy-to-294298.html 0.6 2025-11-27T16:00:47+08:00 daily https://www.pharmasources.com/industryinsights/ip-the-fuel-for-innovation-294299.html 0.6 2025-12-12T19:51:22+08:00 daily https://www.pharmasources.com/industryinsights/scientists-create-artificial-womb-that-c-294300.html 0.6 2026-07-06T23:03:24+08:00 daily https://www.pharmasources.com/industryinsights/cphi-research-shows-positive-growth-in-b-294301.html 0.6 2026-07-07T21:45:14+08:00 daily https://www.pharmasources.com/industryinsights/philip-morris-drives-toxicology-data-sha-294302.html 0.6 2026-07-04T09:45:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xatmep-294303.html 0.6 2026-05-11T15:46:03+08:00 daily https://www.pharmasources.com/industryinsights/grieving-friends-often-find-support-onli-294304.html 0.6 2026-04-12T03:35:37+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-disease-may-originate-in-gut--294305.html 0.6 2026-06-13T10:21:09+08:00 daily https://www.pharmasources.com/industryinsights/unity-denticare-joining-bookdoc-platform-294306.html 0.6 2026-07-06T20:12:35+08:00 daily https://www.pharmasources.com/industryinsights/seegene-unlocks-the-door-to-the-next-lev-294307.html 0.6 2026-03-10T10:52:10+08:00 daily https://www.pharmasources.com/industryinsights/ima-condemns-the-west-bengal-clinical-es-294308.html 0.6 2026-08-05T22:49:11+08:00 daily https://www.pharmasources.com/industryinsights/cci-orders-detailed-probe-against-pharma-294309.html 0.6 2026-01-13T23:10:58+08:00 daily https://www.pharmasources.com/industryinsights/fipb-refers-gland-pharma-proposal-to-cce-294310.html 0.6 2026-03-01T00:19:43+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-in-alliance-with-salesforce-294311.html 0.6 2026-03-17T22:08:46+08:00 daily https://www.pharmasources.com/industryinsights/cphi-expert-says-quicker-approvals-for-a-294312.html 0.6 2026-03-19T23:19:58+08:00 daily https://www.pharmasources.com/industryinsights/gileads-phase-ii-study-showed-99-hcv-cur-294313.html 0.6 2026-08-08T00:19:07+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-receives-positive-chmp-opinion--294314.html 0.6 2026-07-01T00:34:59+08:00 daily https://www.pharmasources.com/industryinsights/shire-granted-eu-conditional-marketing-a-294315.html 0.6 2026-02-15T09:32:19+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-sanofi-receive-fda-approva-294316.html 0.6 2026-07-19T07:45:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-drug-safety-communication-fda-approv-294317.html 0.6 2026-03-28T22:35:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-amgen-expand-agreement-to-comme-294318.html 0.6 2026-08-05T12:02:17+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-named-best-bio-product-294319.html 0.6 2026-03-25T23:34:41+08:00 daily https://www.pharmasources.com/industryinsights/resmed-unveils-worlds-smallest-cpap-desi-294320.html 0.6 2026-04-01T14:12:13+08:00 daily https://www.pharmasources.com/industryinsights/astellas-reports-fy2016-financial-result-294321.html 0.6 2026-08-04T13:18:02+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-reports-first-quart-294322.html 0.6 2026-02-28T21:16:01+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-harrington-discovery-institut-294323.html 0.6 2025-12-13T22:27:41+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-announces-manufacturing-i-294324.html 0.6 2025-12-13T22:28:43+08:00 daily https://www.pharmasources.com/industryinsights/midazolam-nasal-spray-phase-3-trial-meet-294325.html 0.6 2026-08-08T11:25:35+08:00 daily https://www.pharmasources.com/industryinsights/insphero-pfizer-to-develop-assays-for-di-294326.html 0.6 2026-06-08T18:33:15+08:00 daily https://www.pharmasources.com/industryinsights/ht-presspart-hovione-technology-enter-dp-294327.html 0.6 2026-08-08T02:29:59+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-roche-294328.html 0.6 2026-06-15T20:48:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approved-use-of-stivarga-reg-294329.html 0.6 2026-02-08T19:15:20+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-may-be-bad-for-brain-hea-294330.html 0.6 2025-12-13T22:35:10+08:00 daily https://www.pharmasources.com/industryinsights/opioid-use-by-iraq-afghanistan-war-vets--294331.html 0.6 2026-01-16T03:35:34+08:00 daily https://www.pharmasources.com/industryinsights/repeat-teen-births-still-a-problem-in-un-294332.html 0.6 2026-03-17T21:48:18+08:00 daily https://www.pharmasources.com/industryinsights/money-pressures-mount-when-a-spouse-gets-294333.html 0.6 2026-07-19T03:53:13+08:00 daily https://www.pharmasources.com/industryinsights/mixed-first-quarter-fortunes-for-gsk-az-294334.html 0.6 2026-08-07T02:48:01+08:00 daily https://www.pharmasources.com/industryinsights/abpi-unveils-its-post-election-wish-list-294335.html 0.6 2026-08-08T22:53:54+08:00 daily https://www.pharmasources.com/industryinsights/takedas-ninlaro-rejected-by-nice-for-mul-294336.html 0.6 2026-06-29T08:51:31+08:00 daily https://www.pharmasources.com/industryinsights/ocalvia-gets-nhs-green-light-for-rare-ch-294337.html 0.6 2026-03-27T00:42:15+08:00 daily https://www.pharmasources.com/industryinsights/pharmatek-adds-further-cgmp-spray-drying-294338.html 0.6 2026-02-14T11:56:34+08:00 daily https://www.pharmasources.com/industryinsights/clinical-researcher-of-the-year---its-fi-294339.html 0.6 2026-04-03T02:40:36+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-able-to-detect-cancer-a-year--294340.html 0.6 2026-08-07T23:28:04+08:00 daily https://www.pharmasources.com/industryinsights/new-data-at-aan-reinforce-clinical-benef-294341.html 0.6 2026-06-12T17:50:30+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-spending-to-sink-by-45-mil-294342.html 0.6 2026-01-31T01:35:53+08:00 daily https://www.pharmasources.com/industryinsights/cheap-drug-could-prevent-thousands-of-ma-294343.html 0.6 2026-03-17T22:37:09+08:00 daily https://www.pharmasources.com/industryinsights/italian-style-coffee-reduces-the-risk-of-294344.html 0.6 2025-12-13T22:49:10+08:00 daily https://www.pharmasources.com/industryinsights/abpi-calls-for-a-world-class-nhs-with-20-294345.html 0.6 2026-07-07T15:01:48+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-ixekizumab-taltz-to-trea-294346.html 0.6 2026-07-19T21:03:53+08:00 daily https://www.pharmasources.com/industryinsights/studying-unstable-chromosomes-can-help-p-294347.html 0.6 2026-08-05T20:44:21+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-serum-institute-of-india-f-294348.html 0.6 2026-04-13T00:22:11+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-contravir-pharmaceutical-294349.html 0.6 2026-08-06T17:31:40+08:00 daily https://www.pharmasources.com/industryinsights/acg-inspection-systems-acquires-croatian-294350.html 0.6 2026-06-21T14:37:41+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lung-cancer-drug-receives-f-294351.html 0.6 2026-06-19T08:48:25+08:00 daily https://www.pharmasources.com/industryinsights/protein-targeting-antibiotics-bring-new--294352.html 0.6 2026-04-08T23:00:25+08:00 daily https://www.pharmasources.com/industryinsights/volition-makes-progress-with-its-colorec-294353.html 0.6 2026-04-14T20:41:49+08:00 daily https://www.pharmasources.com/industryinsights/which-pharmaceutical-products-have-enter-294354.html 0.6 2026-08-09T01:20:21+08:00 daily https://www.pharmasources.com/industryinsights/deloitte-multinational-pharmaceutical-en-294355.html 0.6 2026-06-08T17:29:59+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170428-294356.html 0.6 2026-06-08T18:02:59+08:00 daily https://www.pharmasources.com/industryinsights/lilly-declares-second-quarter-2017-divid-294357.html 0.6 2026-05-02T23:33:13+08:00 daily https://www.pharmasources.com/industryinsights/working-to-raise-awareness-and-reduce-he-294358.html 0.6 2026-03-20T11:04:43+08:00 daily https://www.pharmasources.com/industryinsights/bexsero-gains-propel-gsks-vaccines-unit--294359.html 0.6 2026-02-07T11:16:28+08:00 daily https://www.pharmasources.com/industryinsights/rondo-pak-adds-sales-and-marketing-svp-294360.html 0.6 2026-03-30T12:31:25+08:00 daily https://www.pharmasources.com/industryinsights/dragonfly-therapeutics-appoints-head-of--294361.html 0.6 2026-04-12T19:57:59+08:00 daily https://www.pharmasources.com/industryinsights/astellas-appoints-three-senior-developme-294362.html 0.6 2026-07-28T02:31:35+08:00 daily https://www.pharmasources.com/industryinsights/shire-licenses-parions-dry-eye-drug-294363.html 0.6 2026-06-08T22:24:50+08:00 daily https://www.pharmasources.com/industryinsights/avid-bioservices-expands-manufacturing-c-294364.html 0.6 2026-08-09T22:58:28+08:00 daily https://www.pharmasources.com/industryinsights/astellas-announces-leadership-promotions-294365.html 0.6 2026-08-07T17:31:31+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-genzyme-announces-approval-of-cer-294366.html 0.6 2026-08-09T23:45:34+08:00 daily https://www.pharmasources.com/industryinsights/shire-and-parion-sciences-enter-into-col-294367.html 0.6 2026-06-08T12:30:25+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-announces-zoptec-phase--294368.html 0.6 2026-06-27T06:14:36+08:00 daily https://www.pharmasources.com/industryinsights/takeda-announces-fda-accelerated-approva-294369.html 0.6 2026-04-25T12:29:42+08:00 daily https://www.pharmasources.com/industryinsights/china-fda-approves-countrys-first-all-or-294370.html 0.6 2026-08-05T07:10:54+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-introduces-new-biostat-str-bio-294371.html 0.6 2026-08-04T09:06:26+08:00 daily https://www.pharmasources.com/industryinsights/allergan-successfully-completes-zeltiq-a-294372.html 0.6 2026-07-30T22:11:43+08:00 daily https://www.pharmasources.com/industryinsights/learn-from-change-making-pharmaceutical--294373.html 0.6 2026-08-05T12:21:25+08:00 daily https://www.pharmasources.com/industryinsights/antidepressant-may-enhance-drug-delivery-294374.html 0.6 2026-04-12T11:29:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-a-form--294375.html 0.6 2026-03-21T18:00:53+08:00 daily https://www.pharmasources.com/industryinsights/englands-cancer-drugs-fund-failed-to-del-294376.html 0.6 2026-06-10T10:29:17+08:00 daily https://www.pharmasources.com/industryinsights/marksans-pharma-receives-gmp-certificate-294377.html 0.6 2026-07-01T06:32:57+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-science-foundation-recognises-294378.html 0.6 2026-06-08T17:41:20+08:00 daily https://www.pharmasources.com/industryinsights/syngene-posts-fy17-results-registers-a-r-294379.html 0.6 2026-06-08T17:02:34+08:00 daily https://www.pharmasources.com/industryinsights/vyome-biosciences-completes-clinical-stu-294380.html 0.6 2026-03-01T22:16:54+08:00 daily https://www.pharmasources.com/industryinsights/drugs-to-watch-2017-294381.html 0.6 2025-12-26T17:34:55+08:00 daily https://www.pharmasources.com/industryinsights/next-generation-diabetes-therapy-and-dru-294382.html 0.6 2026-03-31T17:28:52+08:00 daily https://www.pharmasources.com/industryinsights/bric-over-the-counter-pharmaceuticals-ma-294383.html 0.6 2025-12-13T15:46:46+08:00 daily https://www.pharmasources.com/industryinsights/first-new-promising-treatment-in-a-decad-294384.html 0.6 2026-03-19T14:23:08+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-receive-chmp-positi-294385.html 0.6 2025-12-20T00:37:30+08:00 daily https://www.pharmasources.com/industryinsights/novartis-real-world-data-confirms-benefi-294386.html 0.6 2025-12-13T15:22:47+08:00 daily https://www.pharmasources.com/industryinsights/skinceuticals-announces-partnership-with-294387.html 0.6 2026-07-02T21:05:08+08:00 daily https://www.pharmasources.com/industryinsights/yisheng-biopharma-starts-enrollment-in-p-294388.html 0.6 2026-01-05T08:42:15+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-new-option-for-crohns-disease-294389.html 0.6 2026-07-06T20:13:25+08:00 daily https://www.pharmasources.com/industryinsights/cancer-drugs-fund-poor-value-for-money-s-294390.html 0.6 2026-01-18T11:03:15+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-first-therapy-for-batten-disea-294391.html 0.6 2026-02-28T13:08:33+08:00 daily https://www.pharmasources.com/industryinsights/our-tax-code-is-stuck-in-the-80s-294392.html 0.6 2026-01-03T16:39:32+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-pfizer-294393.html 0.6 2026-03-07T18:38:04+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-merck-294394.html 0.6 2026-05-31T11:43:56+08:00 daily https://www.pharmasources.com/industryinsights/gsk-invests-139m-to-expand-benlysta-capa-294395.html 0.6 2026-03-24T14:40:13+08:00 daily https://www.pharmasources.com/industryinsights/amri-wins-five-year-nih-contract-294396.html 0.6 2026-07-01T06:43:58+08:00 daily https://www.pharmasources.com/industryinsights/corvus-genentech-expand-clinical-collabo-294397.html 0.6 daily https://www.pharmasources.com/industryinsights/secretive-moderna-reveals-first-in-human-294398.html 0.6 2026-08-02T02:31:42+08:00 daily https://www.pharmasources.com/industryinsights/gardasil-posts-big-q1-beat-to-push-merck-294399.html 0.6 2026-07-12T19:24:57+08:00 daily https://www.pharmasources.com/industryinsights/us-supplies-of-sanofi-pasteurs-yellow-fe-294400.html 0.6 2026-03-27T23:48:29+08:00 daily https://www.pharmasources.com/industryinsights/despite-foundering-dengvaxia-launch-sano-294401.html 0.6 2026-03-23T20:28:07+08:00 daily https://www.pharmasources.com/industryinsights/india-has-at-least-60-million-to-80-mill-294402.html 0.6 2026-06-08T18:35:49+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-marks-a-key-milestone-with-t-294403.html 0.6 2026-06-19T12:44:43+08:00 daily https://www.pharmasources.com/industryinsights/englands-cancer-drugs-fund-failed-to-del-294404.html 0.6 2026-03-17T21:41:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-sanofi-and-regenerons-biolog-294405.html 0.6 2026-03-18T01:12:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approved-use-of-bayers-liver-294406.html 0.6 2026-06-19T12:15:51+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-janssens-crohns-disease--294407.html 0.6 2026-07-30T22:55:52+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-in-partnership-with-yungjin-ph-294408.html 0.6 2026-03-19T20:52:41+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-nextcode-closes-a-75-million-series-294409.html 0.6 2026-07-17T03:20:53+08:00 daily https://www.pharmasources.com/industryinsights/mpeg-la-invites-crispr-cas9-patents-to-b-294410.html 0.6 2026-04-06T20:23:45+08:00 daily https://www.pharmasources.com/industryinsights/biodelivery-sciences-announces-approval--294411.html 0.6 2026-04-09T19:01:08+08:00 daily https://www.pharmasources.com/industryinsights/camurus-and-braeburn-announce-positive-t-294412.html 0.6 2026-07-06T14:42:27+08:00 daily https://www.pharmasources.com/industryinsights/foamix-pharmaceuticals-announces-additio-294413.html 0.6 2025-12-02T01:13:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-roche-high-volume-immunoassay-294414.html 0.6 2026-04-17T18:28:28+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-receives-fda-accele-294415.html 0.6 2026-05-02T03:09:15+08:00 daily https://www.pharmasources.com/industryinsights/usana-celebrates-longevity-and-success-i-294416.html 0.6 2026-04-06T10:16:40+08:00 daily https://www.pharmasources.com/industryinsights/us-molecular-imaging-companies-leverage--294417.html 0.6 2026-04-09T21:12:10+08:00 daily https://www.pharmasources.com/industryinsights/cml-patients-in-england-win-access-to-in-294418.html 0.6 2026-04-19T06:23:03+08:00 daily https://www.pharmasources.com/industryinsights/takedas-lung-cancer-drug-approved-in-the-294419.html 0.6 2026-06-05T10:00:39+08:00 daily https://www.pharmasources.com/industryinsights/eu-expands-use-of-janssens-darzalex-294420.html 0.6 2026-02-14T18:56:07+08:00 daily https://www.pharmasources.com/industryinsights/bioindustry-association-calls-for-govern-294421.html 0.6 2026-04-03T20:09:01+08:00 daily https://www.pharmasources.com/industryinsights/potential-blockbuster-az-immunotherapy-s-294422.html 0.6 2026-04-28T08:02:12+08:00 daily https://www.pharmasources.com/industryinsights/researchers-control-blood-sugar-levels-i-294423.html 0.6 2026-02-15T04:34:14+08:00 daily https://www.pharmasources.com/industryinsights/janssen-scores-eu-approval-for-blood-can-294424.html 0.6 2026-08-07T21:51:13+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-reports-first-quarter-2017--294425.html 0.6 2026-02-28T15:42:22+08:00 daily https://www.pharmasources.com/industryinsights/namodenoson-enters-phase-ii-trial-for-tr-294426.html 0.6 2025-12-27T10:58:54+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-initiates-phase-3-study-with-b-294427.html 0.6 2026-06-23T03:34:04+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-receives-fda-protocol-clearanc-294428.html 0.6 2026-06-18T16:24:51+08:00 daily https://www.pharmasources.com/industryinsights/stainwei-granted-patent-for-anti-vegf-mo-294429.html 0.6 2026-06-21T10:23:08+08:00 daily https://www.pharmasources.com/industryinsights/mayo-clinic-gets-brain-tumor-research-gr-294430.html 0.6 2026-07-10T05:16:58+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-collaborates-with-labcent-294431.html 0.6 2026-07-25T21:59:29+08:00 daily https://www.pharmasources.com/industryinsights/swedish-3d-printing-technique-opens-the--294432.html 0.6 2026-05-22T13:11:31+08:00 daily https://www.pharmasources.com/industryinsights/ec-extends-approval-for-janssens-daratum-294433.html 0.6 2026-06-10T13:38:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-bladder-cancer-treatment-re-294434.html 0.6 2026-03-18T07:39:23+08:00 daily https://www.pharmasources.com/industryinsights/health-ministry-to-launch-pneumonia-vacc-294435.html 0.6 2026-03-24T20:37:16+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-partners-with-kali-care-294436.html 0.6 2026-04-12T11:54:38+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-boosts-early-respiratory-med-294437.html 0.6 2026-04-16T17:20:33+08:00 daily https://www.pharmasources.com/industryinsights/ajanta-pharma-posts-rs-114-crore-profit--294438.html 0.6 2025-11-14T14:48:07+08:00 daily https://www.pharmasources.com/industryinsights/pathways-leading-to-beta-cell-division-i-294439.html 0.6 2026-08-07T05:15:53+08:00 daily https://www.pharmasources.com/industryinsights/arthritis-drug-shows-promise-for-ulcerat-294440.html 0.6 2026-08-07T05:05:24+08:00 daily https://www.pharmasources.com/industryinsights/too-many-people-still-ignore-heart-attac-294441.html 0.6 2026-08-07T12:51:24+08:00 daily https://www.pharmasources.com/industryinsights/gene-mutation-may-speed-alzheimers-decli-294442.html 0.6 2026-08-07T00:42:40+08:00 daily https://www.pharmasources.com/industryinsights/us-authorities-search-perrigos-offices-a-294443.html 0.6 2026-08-07T13:18:23+08:00 daily https://www.pharmasources.com/industryinsights/pillsy-launches-bluetooth-enable-bottle--294444.html 0.6 2026-08-07T13:56:00+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-posts-5-percent-rise-in-q1-294445.html 0.6 2026-08-09T02:38:48+08:00 daily https://www.pharmasources.com/industryinsights/impact-received-imp4297-chinese-ind-appr-294446.html 0.6 2026-08-09T11:20:10+08:00 daily https://www.pharmasources.com/industryinsights/getinge-announces-results-of-study-of-co-294447.html 0.6 2026-02-28T14:27:59+08:00 daily https://www.pharmasources.com/industryinsights/az-imfinzi-gets-accelerated-nod-for-blad-294448.html 0.6 2026-03-29T00:25:23+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-amgens-rare-leukaemia-drug-294449.html 0.6 2026-05-03T10:12:53+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-endometrial-cancer-drug-294450.html 0.6 2026-07-28T00:07:21+08:00 daily https://www.pharmasources.com/industryinsights/uk-gps-lacking-in-psoriasis-training-war-294451.html 0.6 2026-04-08T14:18:03+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-key-trigger-in-mela-294452.html 0.6 2026-07-09T04:32:32+08:00 daily https://www.pharmasources.com/industryinsights/study-discovers-origin-of-cancer-metasta-294453.html 0.6 2026-06-24T13:30:46+08:00 daily https://www.pharmasources.com/industryinsights/first-large-scale-study-gives-hope-for-k-294454.html 0.6 2026-06-22T20:15:23+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-janssens-first-of-its-ki-294455.html 0.6 2026-06-13T04:50:28+08:00 daily https://www.pharmasources.com/industryinsights/uk-must-prioritise-17bn-medtech-sector-i-294456.html 0.6 2026-06-10T12:41:00+08:00 daily https://www.pharmasources.com/industryinsights/us-court-of-appeals-reverses-district-co-294457.html 0.6 2026-07-08T15:34:56+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-receives-fda-accele-294458.html 0.6 2026-06-13T14:23:18+08:00 daily https://www.pharmasources.com/industryinsights/quay-pharmaceuticals-receives-permission-294459.html 0.6 2026-03-27T01:42:33+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-regeneron-294460.html 0.6 2026-06-24T14:54:18+08:00 daily https://www.pharmasources.com/industryinsights/sgs-completes-phase-i-flu-trial-294461.html 0.6 2026-06-09T22:03:27+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-completes-gmp-mfg-plant-in-suzh-294462.html 0.6 2026-06-12T13:43:44+08:00 daily https://www.pharmasources.com/industryinsights/alcami-invests-5m-to-expand-sc-ops-294463.html 0.6 2026-08-09T00:18:55+08:00 daily https://www.pharmasources.com/industryinsights/epizyme-earns-10m-gsk-milestone-294464.html 0.6 2026-06-18T07:23:33+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-chemis-294465.html 0.6 2026-06-13T00:43:56+08:00 daily https://www.pharmasources.com/industryinsights/alzprotect-the-american-food-and-drug-ad-294466.html 0.6 2026-04-07T05:54:00+08:00 daily https://www.pharmasources.com/industryinsights/hookipa-biotech-presents-positive-data-f-294467.html 0.6 2026-08-07T23:15:13+08:00 daily https://www.pharmasources.com/industryinsights/native-antigen-company-expands-into-new--294468.html 0.6 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-receives-fda-accele-294469.html 0.6 2026-06-09T19:14:34+08:00 daily https://www.pharmasources.com/industryinsights/concert-pharmaceuticals-initiates-ctp-54-294470.html 0.6 2026-01-11T09:08:42+08:00 daily https://www.pharmasources.com/industryinsights/brinton-pharma-raises-4-mn-from-tata-cap-294471.html 0.6 2026-01-03T14:24:36+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-announces-new-b-294472.html 0.6 2026-01-05T03:42:13+08:00 daily https://www.pharmasources.com/industryinsights/first-ever-evidence-of-treatment-induced-294473.html 0.6 2026-08-07T16:38:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-roches-high-volume-immunoas-294474.html 0.6 2026-08-08T08:02:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-combination-treatment-f-294475.html 0.6 2026-06-09T13:57:24+08:00 daily https://www.pharmasources.com/industryinsights/epizyme-earns-10-million-payment-from-gs-294476.html 0.6 2026-08-05T09:22:48+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-therapeutics-announces-special-r-294477.html 0.6 2026-08-07T23:27:50+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-starts-phase-3-clinical-trial-of--294478.html 0.6 2026-08-09T01:08:49+08:00 daily https://www.pharmasources.com/industryinsights/spero-therapeutics-receives-grant-from-n-294479.html 0.6 2026-08-07T05:45:20+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-doxycycline-may-offer-hope-fo-294480.html 0.6 2026-08-05T13:25:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-exercises-exclusive-option-agre-294481.html 0.6 2026-01-03T08:24:36+08:00 daily https://www.pharmasources.com/industryinsights/the-push-towards-pure-generics-impact-on-294482.html 0.6 2026-07-21T09:00:58+08:00 daily https://www.pharmasources.com/industryinsights/veeva-releases-survey-on-digitalisation--294483.html 0.6 2026-08-06T00:41:18+08:00 daily https://www.pharmasources.com/industryinsights/4-in-10-people-will-suffer-arthritic-han-294484.html 0.6 2026-04-07T17:17:51+08:00 daily https://www.pharmasources.com/industryinsights/bystander-cpr-not-only-saves-lives-it-le-294485.html 0.6 2026-08-06T19:39:06+08:00 daily https://www.pharmasources.com/industryinsights/az-and-pieris-link-in-21bn-respiratory-d-294486.html 0.6 2026-01-04T10:31:52+08:00 daily https://www.pharmasources.com/industryinsights/39-pharmaceutical-products-to-be-checked-294487.html 0.6 2026-07-26T09:12:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-scoops-up-rights-to-nash-drug-294488.html 0.6 2026-05-03T18:35:18+08:00 daily https://www.pharmasources.com/industryinsights/50-blood-test-could-predict-prostate-can-294489.html 0.6 2026-04-27T12:33:17+08:00 daily https://www.pharmasources.com/industryinsights/exercise-pill-boosts-endurance-by-70-in--294490.html 0.6 2026-04-24T01:43:43+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-warns-uk-over-drug-a-294491.html 0.6 2025-12-15T02:02:39+08:00 daily https://www.pharmasources.com/industryinsights/myth-of-the-mouse-nerve-growth-factor-in-294492.html 0.6 2026-08-09T20:53:39+08:00 daily https://www.pharmasources.com/industryinsights/who-aims-to-increase-uptake-of-biosimila-294493.html 0.6 2026-04-16T18:27:49+08:00 daily https://www.pharmasources.com/industryinsights/roche-denies-its-acne-treatment-led-to-s-294494.html 0.6 2026-01-04T14:29:10+08:00 daily https://www.pharmasources.com/industryinsights/cheap-blood-test-may-help-tailor-prostat-294495.html 0.6 2026-08-06T19:44:24+08:00 daily https://www.pharmasources.com/industryinsights/gsk-invests-139m-to-increase-benlysta-be-294496.html 0.6 2026-07-07T11:16:34+08:00 daily https://www.pharmasources.com/industryinsights/servier-and-miragen-extend-research-coll-294497.html 0.6 2026-01-22T05:56:38+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-offices-searched-by-us-justice-d-294498.html 0.6 2026-04-09T12:31:58+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170508-294499.html 0.6 2026-08-06T15:06:53+08:00 daily https://www.pharmasources.com/industryinsights/patients-waiting-more-than-18-weeks-for--294500.html 0.6 2026-08-09T00:40:12+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-offers-ibrance-free-to-the-nhs-du-294501.html 0.6 2026-08-07T05:03:55+08:00 daily https://www.pharmasources.com/industryinsights/next-govt-must-get-to-grips-with-obesity-294502.html 0.6 2026-08-08T18:34:10+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-offers-breast-cancer-drug-for-fre-294503.html 0.6 2026-04-12T22:56:06+08:00 daily https://www.pharmasources.com/industryinsights/regulus-ceo-heads-to-exit-as-company-str-294504.html 0.6 2026-04-15T11:16:47+08:00 daily https://www.pharmasources.com/industryinsights/gsk-boosts-benlysta-production-with-139--294505.html 0.6 2026-06-19T11:31:40+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-huapont-life-sciences-sose-294506.html 0.6 2026-03-31T23:30:20+08:00 daily https://www.pharmasources.com/industryinsights/new-collaborative-project-launched-to-en-294507.html 0.6 2026-08-09T00:09:50+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-amag-pharmaceuticals-nox-294508.html 0.6 2026-08-06T22:54:39+08:00 daily https://www.pharmasources.com/industryinsights/first-approval-for-keytruda-in-a-hematol-294509.html 0.6 2026-04-18T06:13:11+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-bounces-back-gains-us-approv-294510.html 0.6 2026-08-09T22:46:29+08:00 daily https://www.pharmasources.com/industryinsights/biolytical-partners-with-pasante-on-uk-d-294511.html 0.6 2026-06-03T08:10:40+08:00 daily https://www.pharmasources.com/industryinsights/braeburn-achieves-endpoints-in-implant-s-294512.html 0.6 2026-06-23T08:07:26+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-kali-care-to-develop-medica-294513.html 0.6 2026-06-14T14:25:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-to-treat-als-294514.html 0.6 2026-03-18T23:41:55+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-a-deficiency-is-detrimental-to-b-294515.html 0.6 2025-12-15T01:37:29+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-seeks-shareholders-nod-to-rais-294516.html 0.6 2026-03-25T20:46:53+08:00 daily https://www.pharmasources.com/industryinsights/withdraw-trips-plus-proposals-msf-to-jap-294517.html 0.6 2026-03-08T10:24:19+08:00 daily https://www.pharmasources.com/industryinsights/norgine-presents-new-post-hoc-data-analy-294518.html 0.6 2026-07-16T23:06:58+08:00 daily https://www.pharmasources.com/industryinsights/elekta-unity-transformative-magnetic-res-294519.html 0.6 2026-04-10T01:25:22+08:00 daily https://www.pharmasources.com/industryinsights/avantor-to-acquire-vwr-for-64b-294520.html 0.6 2026-06-26T16:19:40+08:00 daily https://www.pharmasources.com/industryinsights/dalton-to-start-gmp-mfg-for-inhalation-d-294521.html 0.6 2026-05-31T22:53:53+08:00 daily https://www.pharmasources.com/industryinsights/ppd-creates-real-world-research-unit-294522.html 0.6 2026-08-08T08:33:17+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-sillajen-in-clinical-and-suppl-294523.html 0.6 2026-08-07T15:14:31+08:00 daily https://www.pharmasources.com/industryinsights/patheon-completes-nc-sterile-expansion-294524.html 0.6 2025-12-15T01:27:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-ec-approval-for-keytruda--294525.html 0.6 2026-04-19T01:12:24+08:00 daily https://www.pharmasources.com/industryinsights/immunocore-and-gsk-identify-second-new-i-294526.html 0.6 2026-08-09T02:17:42+08:00 daily https://www.pharmasources.com/industryinsights/proterris-and-alfama-complete-merger-to--294527.html 0.6 2026-04-30T22:35:03+08:00 daily https://www.pharmasources.com/industryinsights/teva-and-active-biotech-announce-concert-294528.html 0.6 2026-07-24T16:29:33+08:00 daily https://www.pharmasources.com/industryinsights/valeant-announces-leadership-changes-294529.html 0.6 2026-04-14T00:18:26+08:00 daily https://www.pharmasources.com/industryinsights/oncolytics-biotech-announces-fda-fast-tr-294530.html 0.6 2026-07-10T07:44:35+08:00 daily https://www.pharmasources.com/industryinsights/roche-receives-fda-approval-for-compleme-294531.html 0.6 2026-06-07T08:03:16+08:00 daily https://www.pharmasources.com/industryinsights/judit-h-nyirady-joins-leo-pharma-as-vp-o-294532.html 0.6 2026-03-01T05:51:20+08:00 daily https://www.pharmasources.com/industryinsights/california-life-sciences-association-add-294533.html 0.6 2026-08-08T10:59:45+08:00 daily https://www.pharmasources.com/industryinsights/us-drug-spending-growth-of-48-percent-in-294534.html 0.6 2026-07-05T13:35:32+08:00 daily https://www.pharmasources.com/industryinsights/achaogen-receives-investment-from-gates--294535.html 0.6 2026-07-01T08:50:30+08:00 daily https://www.pharmasources.com/industryinsights/abbott-announces-ce-mark-and-first-use-o-294536.html 0.6 2026-06-25T12:20:55+08:00 daily https://www.pharmasources.com/industryinsights/public-skeptical-of-research-if-tied-to--294537.html 0.6 2026-06-20T18:08:12+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-advisory-board-inducts-fi-294538.html 0.6 2026-08-10T00:08:41+08:00 daily https://www.pharmasources.com/industryinsights/hetero-receives-generic-sofosbuvirvelpat-294539.html 0.6 2026-06-21T17:43:10+08:00 daily https://www.pharmasources.com/industryinsights/hester-biosciences-net-profit-up-by-29-p-294540.html 0.6 2026-04-26T09:00:20+08:00 daily https://www.pharmasources.com/industryinsights/sonova-opens-global-hearing-institute-in-294541.html 0.6 2026-06-16T16:07:32+08:00 daily https://www.pharmasources.com/industryinsights/new-real-world-analyses-support-effectiv-294542.html 0.6 2026-04-09T15:40:58+08:00 daily https://www.pharmasources.com/industryinsights/catalent-manufactures-lexicons-xermelo-f-294543.html 0.6 2026-07-30T14:02:05+08:00 daily https://www.pharmasources.com/industryinsights/carmell-therapeutics-expands-mfg-capabil-294544.html 0.6 2026-08-09T11:00:10+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-exscientia-pen-250m-drug-disc-294545.html 0.6 2026-07-26T12:54:40+08:00 daily https://www.pharmasources.com/industryinsights/takeda-inks-100m-pact-with-gammadelta-294546.html 0.6 2026-06-28T14:39:26+08:00 daily https://www.pharmasources.com/industryinsights/crown-bioscience-enters-antibody-collabo-294547.html 0.6 2026-08-09T10:31:30+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-acquires-grzybowski-scien-294548.html 0.6 2026-06-17T17:23:57+08:00 daily https://www.pharmasources.com/industryinsights/endo-reports-first-quarter-2017-financia-294549.html 0.6 2026-06-14T01:51:28+08:00 daily https://www.pharmasources.com/industryinsights/grunenthal-names-new-coo-294550.html 0.6 2026-08-09T07:32:15+08:00 daily https://www.pharmasources.com/industryinsights/durect-and-sandoz-sign-293m-deal-to-comm-294551.html 0.6 2026-05-23T23:17:22+08:00 daily https://www.pharmasources.com/industryinsights/mt-pharma-americas-radicava-secures-fda--294552.html 0.6 2026-05-04T18:43:42+08:00 daily https://www.pharmasources.com/industryinsights/gsk-ends-vaxem-hib-production-costing-ta-294553.html 0.6 2026-05-02T04:22:09+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-merck-kgaa-join-with-cancer-vacci-294554.html 0.6 2026-07-21T15:27:31+08:00 daily https://www.pharmasources.com/industryinsights/tangle-of-global-regs-adds-to-risk-of-va-294555.html 0.6 2026-04-23T11:13:40+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-doubles-capacity-a-294556.html 0.6 2026-04-16T20:25:25+08:00 daily https://www.pharmasources.com/industryinsights/optibrium-and-goldfinch-bio-sign-agreeme-294557.html 0.6 2026-06-27T02:25:57+08:00 daily https://www.pharmasources.com/industryinsights/biopharmaspec-announces-expansion-of-in--294558.html 0.6 2026-05-30T05:22:31+08:00 daily https://www.pharmasources.com/industryinsights/cartiheal-raises-183-million-294559.html 0.6 2026-05-30T05:28:45+08:00 daily https://www.pharmasources.com/industryinsights/ireland-reiterates-bid-to-host-the-europ-294560.html 0.6 2026-05-01T07:01:33+08:00 daily https://www.pharmasources.com/industryinsights/inducing-protein-aggregation-by-extensio-294561.html 0.6 2025-12-15T02:05:57+08:00 daily https://www.pharmasources.com/industryinsights/rajasthan-antibiotics-to-raise-rs-50-cro-294562.html 0.6 2026-05-04T04:11:25+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-makes-eight-observations-at-lupin-294563.html 0.6 2026-06-10T02:37:02+08:00 daily https://www.pharmasources.com/industryinsights/torrent-completes-acquisition-of-novarti-294564.html 0.6 2026-06-11T18:46:57+08:00 daily https://www.pharmasources.com/industryinsights/allow-co-prescription-of-brands-and-gene-294565.html 0.6 2026-06-29T01:19:01+08:00 daily https://www.pharmasources.com/industryinsights/zika-risk-may-be-lower-than-thought-for--294566.html 0.6 2026-07-19T21:39:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-baven-294567.html 0.6 2026-07-01T22:27:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-bavencior-avelumab-approval-f-294568.html 0.6 2026-07-12T17:33:29+08:00 daily https://www.pharmasources.com/industryinsights/studies-further-validate-safety-efficacy-294569.html 0.6 2026-01-07T18:13:30+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-limited-announces-final-resul-294570.html 0.6 2026-03-20T14:07:00+08:00 daily https://www.pharmasources.com/industryinsights/duchenne-drug-poised-to-cost-35000-but-w-294571.html 0.6 2026-01-12T10:36:03+08:00 daily https://www.pharmasources.com/industryinsights/university-of-oxford-gains-access-to-bio-294572.html 0.6 2026-03-20T08:15:01+08:00 daily https://www.pharmasources.com/industryinsights/leigh-ann-pusey-joins-lilly-as-senior-vi-294573.html 0.6 2026-06-05T19:00:13+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-signs-collaboration-deal-with-294574.html 0.6 2025-12-15T02:20:11+08:00 daily https://www.pharmasources.com/industryinsights/eusa-pharma-receives-ec-approval-for-din-294575.html 0.6 2026-01-14T11:30:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-fda-approval-for-kisqa-294576.html 0.6 2026-07-20T09:09:25+08:00 daily https://www.pharmasources.com/industryinsights/halo-pharma-forms-pediatric-center-of-ex-294577.html 0.6 2026-08-09T22:26:41+08:00 daily https://www.pharmasources.com/industryinsights/bms-calithera-biosciences-expand-clinica-294578.html 0.6 2026-04-07T10:07:47+08:00 daily https://www.pharmasources.com/industryinsights/inc-research-inventiv-health-to-merge-294579.html 0.6 2026-03-18T01:38:45+08:00 daily https://www.pharmasources.com/industryinsights/kcr-expands-us-presence-294580.html 0.6 2026-02-28T14:32:33+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-amri-294581.html 0.6 2026-08-09T07:34:21+08:00 daily https://www.pharmasources.com/industryinsights/3-indian-scientists-elected-fellows-of-r-294582.html 0.6 2026-03-24T14:09:07+08:00 daily https://www.pharmasources.com/industryinsights/claris-sells-stake-to-otsuka-for-20-m-294583.html 0.6 2026-08-07T16:16:27+08:00 daily https://www.pharmasources.com/industryinsights/malarias-genetic-poker-playing-could-thr-294584.html 0.6 2026-08-09T23:28:52+08:00 daily https://www.pharmasources.com/industryinsights/nearly-1-in-3-drugs-found-to-have-safety-294585.html 0.6 2026-07-03T19:56:31+08:00 daily https://www.pharmasources.com/industryinsights/high-levels-of-exercise-linked-to-nine-y-294586.html 0.6 2026-07-10T17:32:52+08:00 daily https://www.pharmasources.com/industryinsights/merck-acquires-grzybowski-scientific-inv-294587.html 0.6 2026-02-28T06:34:58+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-updates-stratos-1-phase-iii--294588.html 0.6 2026-06-09T09:41:16+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-and-merck-to-evaluate-combinatio-294589.html 0.6 2026-08-07T22:36:16+08:00 daily https://www.pharmasources.com/industryinsights/phrma-board-of-directors-establishes-new-294590.html 0.6 2026-03-28T15:53:17+08:00 daily https://www.pharmasources.com/industryinsights/initial-pre-emergency-use-authorization--294591.html 0.6 2026-01-16T03:32:54+08:00 daily https://www.pharmasources.com/industryinsights/life-expectancy-with-hiv-nears-normal-wi-294592.html 0.6 2026-08-06T21:33:25+08:00 daily https://www.pharmasources.com/industryinsights/groundbreaking-strides-made-in-zika-vacc-294593.html 0.6 2026-03-17T21:12:39+08:00 daily https://www.pharmasources.com/industryinsights/transplant-of-insulin-producing-cells-of-294594.html 0.6 2026-04-16T10:09:43+08:00 daily https://www.pharmasources.com/industryinsights/grnenthal-opens-innovation-hub-in-boston-294595.html 0.6 2026-03-23T14:23:11+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-fails-to-increase-survi-294596.html 0.6 2026-02-26T20:13:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-approval-to-merck-cos-keytrud-294597.html 0.6 2026-08-07T10:34:07+08:00 daily https://www.pharmasources.com/industryinsights/mylans-first-quarter-profit-rises-but-sa-294598.html 0.6 2026-07-06T23:16:41+08:00 daily https://www.pharmasources.com/industryinsights/takeda-posts-full-year-profit-growth-des-294599.html 0.6 2025-11-08T10:46:45+08:00 daily https://www.pharmasources.com/industryinsights/echosens-wins-in-germany-a-major-trial-f-294600.html 0.6 2026-01-03T10:34:44+08:00 daily https://www.pharmasources.com/industryinsights/leica-biosystems-applauds-fda-primary-di-294601.html 0.6 2026-06-20T14:32:44+08:00 daily https://www.pharmasources.com/industryinsights/mundipharmas-raman-singh-ranked-among-wo-294602.html 0.6 2026-06-18T23:23:36+08:00 daily https://www.pharmasources.com/industryinsights/new-licensing-program-facilitates-adopti-294603.html 0.6 2026-06-14T08:45:27+08:00 daily https://www.pharmasources.com/industryinsights/croda-celebrates-excipact-certification--294604.html 0.6 2026-06-30T14:37:19+08:00 daily https://www.pharmasources.com/industryinsights/gyros-protein-technologies-introduces-ne-294605.html 0.6 2026-04-04T21:00:56+08:00 daily https://www.pharmasources.com/industryinsights/norgine-buys-merus-labs-for-342m-294606.html 0.6 2026-06-08T16:52:51+08:00 daily https://www.pharmasources.com/industryinsights/delmar-collaborates-with-pra-health-scie-294607.html 0.6 2026-06-12T08:18:32+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-inks-deal-with-sangmo-for-heamoph-294608.html 0.6 2026-07-28T11:53:07+08:00 daily https://www.pharmasources.com/industryinsights/new-technology-could-dramatically-shorte-294609.html 0.6 2026-06-08T23:47:16+08:00 daily https://www.pharmasources.com/industryinsights/european-medicines-agencys-2016-annual-r-294610.html 0.6 2026-04-09T17:19:36+08:00 daily https://www.pharmasources.com/industryinsights/bioreactors-and-fermenters-market-to-rea-294611.html 0.6 2026-04-07T03:29:13+08:00 daily https://www.pharmasources.com/industryinsights/ebmt-to-upgrade-patient-registry-with-el-294612.html 0.6 2026-06-09T13:45:28+08:00 daily https://www.pharmasources.com/industryinsights/sermo-unveils-first-global-physician-to--294613.html 0.6 2026-04-07T00:06:08+08:00 daily https://www.pharmasources.com/industryinsights/bayer-wins-best-employer-in-india-2017-a-294614.html 0.6 2026-06-18T01:04:32+08:00 daily https://www.pharmasources.com/industryinsights/syn-004-receives-breakthrough-therapy-de-294615.html 0.6 2026-04-13T00:14:23+08:00 daily https://www.pharmasources.com/industryinsights/lexicon-reports-additional-positive-data-294616.html 0.6 2026-01-12T14:01:29+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-receives-expanded-fda-breakthroug-294617.html 0.6 2026-04-05T19:18:55+08:00 daily https://www.pharmasources.com/industryinsights/xencors-xmab5871-receives-orphan-drug-de-294618.html 0.6 2026-03-01T21:01:31+08:00 daily https://www.pharmasources.com/industryinsights/astellas-discontinues-asp8273-treatment--294619.html 0.6 2026-07-20T02:33:22+08:00 daily https://www.pharmasources.com/industryinsights/rowan-rutgers-announce-launch-of-alzheim-294620.html 0.6 2026-03-20T15:35:38+08:00 daily https://www.pharmasources.com/industryinsights/modernizing-the-way-drugs-are-made-a-tra-294621.html 0.6 2026-02-19T19:04:00+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-innovation-announces-res-294622.html 0.6 2026-07-04T00:20:32+08:00 daily https://www.pharmasources.com/industryinsights/icr-track-cancer-to-carbon-date-progress-294623.html 0.6 2026-06-08T00:47:12+08:00 daily https://www.pharmasources.com/industryinsights/bodys-natural-defence-mechanism-against--294624.html 0.6 2026-02-05T04:05:24+08:00 daily https://www.pharmasources.com/industryinsights/hikma-says-low-likelihood-of-us-approval-294625.html 0.6 2026-04-28T02:55:18+08:00 daily https://www.pharmasources.com/industryinsights/uk-patients-get-early-access-to-abbvies--294626.html 0.6 2026-04-09T19:37:06+08:00 daily https://www.pharmasources.com/industryinsights/zeiss-significant-growth-in-revenue-and--294627.html 0.6 2026-04-08T16:46:48+08:00 daily https://www.pharmasources.com/industryinsights/shineco-inc-retains-ascent-investor-rela-294628.html 0.6 2026-06-30T13:34:13+08:00 daily https://www.pharmasources.com/industryinsights/darling-ingredients-inc-reports-first-qu-294629.html 0.6 2025-11-08T14:10:56+08:00 daily https://www.pharmasources.com/industryinsights/2017-fiscal-year-q1-interpretation-of-fe-294630.html 0.6 2026-03-20T07:53:46+08:00 daily https://www.pharmasources.com/industryinsights/is-pfizer-to-buy-bms-ceo-read-hinted-at--294631.html 0.6 2026-03-21T13:25:01+08:00 daily https://www.pharmasources.com/industryinsights/artemisinin-has-become-the-worlds-most-p-294632.html 0.6 2026-07-08T16:26:38+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-positive-results-for-thr-294633.html 0.6 2026-03-01T02:50:18+08:00 daily https://www.pharmasources.com/industryinsights/neurodigm-uses-tissue-repair-in-an-innov-294634.html 0.6 2026-03-26T21:04:27+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-positive-results-for-thr-294635.html 0.6 2026-04-02T01:45:44+08:00 daily https://www.pharmasources.com/industryinsights/ardelyx-reports-successful-phase-3-t3mpo-294636.html 0.6 2026-04-09T15:52:27+08:00 daily https://www.pharmasources.com/industryinsights/milestone-pharmaceuticals-announces-etri-294637.html 0.6 2026-04-13T19:02:22+08:00 daily https://www.pharmasources.com/industryinsights/capricor-therapeutics-provides-update-on-294638.html 0.6 2026-04-18T03:43:01+08:00 daily https://www.pharmasources.com/industryinsights/astellas-names-senior-vice-president-hea-294639.html 0.6 2026-07-22T22:59:36+08:00 daily https://www.pharmasources.com/industryinsights/teva-reports-first-quarter-2017-financia-294640.html 0.6 2026-08-08T20:24:55+08:00 daily https://www.pharmasources.com/industryinsights/genentech-to-present-new-data-on-persona-294641.html 0.6 2026-03-30T21:43:37+08:00 daily https://www.pharmasources.com/industryinsights/avastin-as-effective-as-eylea-for-treati-294642.html 0.6 2026-01-29T14:01:16+08:00 daily https://www.pharmasources.com/industryinsights/gsk-real-world-drug-test-has-second-succ-294643.html 0.6 2026-06-29T03:41:16+08:00 daily https://www.pharmasources.com/industryinsights/surprising-link-between-blood-sugar-brai-294644.html 0.6 2026-02-28T14:05:07+08:00 daily https://www.pharmasources.com/industryinsights/milann-hospital-receives-approval-from-i-294645.html 0.6 2026-04-30T18:21:53+08:00 daily https://www.pharmasources.com/industryinsights/ifc-to-sell-entire-stake-for-65-mn-in-ma-294646.html 0.6 2026-02-14T11:28:26+08:00 daily https://www.pharmasources.com/industryinsights/amitabh-bachchan-appointed-who-goodwill--294647.html 0.6 2026-06-13T13:08:19+08:00 daily https://www.pharmasources.com/industryinsights/funds-for-new-stroke-research-294648.html 0.6 2026-06-19T01:45:42+08:00 daily https://www.pharmasources.com/industryinsights/st-jude-childrens-research-hospital-to-c-294649.html 0.6 2026-06-23T15:12:02+08:00 daily https://www.pharmasources.com/industryinsights/the-continuum-of-hiv-care-what-does-it-m-294650.html 0.6 2026-08-05T23:32:15+08:00 daily https://www.pharmasources.com/industryinsights/genericisation-evokes-fierce-debate-at-t-294651.html 0.6 2026-07-04T00:35:01+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-experts-call-for-changes-in-f-294652.html 0.6 2026-06-28T13:52:37+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-posts-q4-and-fy17-financial-re-294653.html 0.6 2026-07-04T22:16:53+08:00 daily https://www.pharmasources.com/industryinsights/gnh-india-clears-kenyan-pharmacy-and-poi-294654.html 0.6 2026-01-08T05:09:30+08:00 daily https://www.pharmasources.com/industryinsights/merck-expands-m-lab-collaboration-center-294655.html 0.6 2026-07-04T06:32:43+08:00 daily https://www.pharmasources.com/industryinsights/indoco-receives-uk-mhra-approval-294656.html 0.6 2026-04-22T03:28:24+08:00 daily https://www.pharmasources.com/industryinsights/new-hepatitis-c-infections-hit-15-year-h-294657.html 0.6 2026-03-11T15:37:17+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-significantly-reduces-the-risk-o-294658.html 0.6 2026-04-14T02:07:19+08:00 daily https://www.pharmasources.com/industryinsights/china-pharma-holdings-inc-reports-first--294659.html 0.6 2025-11-14T02:05:15+08:00 daily https://www.pharmasources.com/industryinsights/blitzresultscom-ergonomic-office---5-eas-294660.html 0.6 2026-04-15T16:39:18+08:00 daily https://www.pharmasources.com/industryinsights/malaria-expected-to-be-eradicated-from-1-294661.html 0.6 2026-07-05T05:56:06+08:00 daily https://www.pharmasources.com/industryinsights/india-to-immunise-five-million-using-pfi-294662.html 0.6 2026-04-05T08:17:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-green-lights-alembics-cholesterol-dr-294663.html 0.6 2026-07-03T01:13:28+08:00 daily https://www.pharmasources.com/industryinsights/china-threatens-prison-time-and-death-pe-294664.html 0.6 2026-08-08T00:48:06+08:00 daily https://www.pharmasources.com/industryinsights/brazil-declares-end-to-zika-virus-emerge-294665.html 0.6 2026-08-07T20:54:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-signs-drug-access-deal-with-pak-294666.html 0.6 2026-06-24T03:09:43+08:00 daily https://www.pharmasources.com/industryinsights/how-merck-co-mrk-could-have-lucked-into--294667.html 0.6 2026-04-07T18:01:49+08:00 daily https://www.pharmasources.com/industryinsights/4-cheapest-drug-stocks-in-the-world-294668.html 0.6 2026-07-27T07:18:23+08:00 daily https://www.pharmasources.com/industryinsights/size-matters-why-a-biotechs-size-can-aff-294669.html 0.6 2026-07-27T09:59:38+08:00 daily https://www.pharmasources.com/industryinsights/cooey-rolls-out-its-enterprise-platform--294670.html 0.6 2026-06-11T12:35:48+08:00 daily https://www.pharmasources.com/industryinsights/what-lies-ahead-for-the-pharmaceutical-s-294671.html 0.6 2025-12-19T13:46:21+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-issues-crl-to-hikmas-generic-vers-294672.html 0.6 2026-01-03T16:53:41+08:00 daily https://www.pharmasources.com/industryinsights/dendreon-eyes-real-world-data-boost-for--294673.html 0.6 2026-04-30T21:14:20+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-13-valent-pcv-selected-in-indias-294674.html 0.6 2025-11-07T10:31:49+08:00 daily https://www.pharmasources.com/industryinsights/synthetic-biologics-syn-004-secures-fda--294675.html 0.6 2026-02-15T13:34:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-pakistan-sign-deal-to-provi-294676.html 0.6 2026-03-01T14:54:07+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-to-buy-patheon-for-72b-294677.html 0.6 2026-04-15T21:38:44+08:00 daily https://www.pharmasources.com/industryinsights/pci-begins-move-in-phase-of-european-cli-294678.html 0.6 2026-04-19T04:51:25+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharmas-electronic-lockout-device--294679.html 0.6 2026-05-27T15:27:32+08:00 daily https://www.pharmasources.com/industryinsights/catalent-biologics-collaborates-with-the-294680.html 0.6 2026-08-08T03:33:05+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-initiates-clinical-study-for-gb-294681.html 0.6 2026-02-21T20:34:28+08:00 daily https://www.pharmasources.com/industryinsights/nuvo-announces-results-from-european-ank-294682.html 0.6 2026-06-08T18:26:32+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-to-acquire-path-294683.html 0.6 2026-01-11T06:04:28+08:00 daily https://www.pharmasources.com/industryinsights/biohavens-trigriluzole-receives-fast-tra-294684.html 0.6 2025-11-17T10:44:40+08:00 daily https://www.pharmasources.com/industryinsights/biogen-acquires-remedy-pharmaceuticals-c-294685.html 0.6 2026-07-16T18:06:16+08:00 daily https://www.pharmasources.com/industryinsights/ionis-announces-phase-3-neuro-ttr-study--294686.html 0.6 2026-01-17T14:25:15+08:00 daily https://www.pharmasources.com/industryinsights/clintec-secures-queens-award-for-enterpr-294687.html 0.6 2026-02-10T15:36:01+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-announces-expanded--294688.html 0.6 2026-02-25T06:36:15+08:00 daily https://www.pharmasources.com/industryinsights/biontech-announces-positive-results-of-a-294689.html 0.6 2026-08-03T18:07:00+08:00 daily https://www.pharmasources.com/industryinsights/cellgenix-appoints-leading-experts-to-sc-294690.html 0.6 2026-02-28T16:46:37+08:00 daily https://www.pharmasources.com/industryinsights/drl-launches-hepatitis-c-drug-in-india-294691.html 0.6 2026-07-26T13:05:52+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-to-launch-global-pharma-m-294692.html 0.6 2026-07-28T05:56:40+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-launches-anti-hypertensiv-294693.html 0.6 2026-03-20T08:41:39+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-anti-myeloma-drug-gets-clinical-294694.html 0.6 2026-06-05T16:07:54+08:00 daily https://www.pharmasources.com/industryinsights/stable-economy-will-drive-german-pharmac-294695.html 0.6 2026-04-05T19:49:48+08:00 daily https://www.pharmasources.com/industryinsights/eu-grants-marketing-approval-for-childre-294696.html 0.6 2026-06-11T02:09:30+08:00 daily https://www.pharmasources.com/industryinsights/cphis-6th-annual-innopack-pharma-confex--294697.html 0.6 2026-06-07T03:25:05+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmas-cholesterol-drug-gets-us-294698.html 0.6 2026-06-11T20:44:57+08:00 daily https://www.pharmasources.com/industryinsights/resverlogix-receives-approval-from-the-f-294699.html 0.6 2026-06-13T14:57:06+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-completes-acquisition-of-hd--294700.html 0.6 2026-07-22T12:02:16+08:00 daily https://www.pharmasources.com/industryinsights/merck-launches-industrys-first-off-the-s-294701.html 0.6 2026-08-09T05:58:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-use-of-new-device-to-trea-294702.html 0.6 2026-07-04T16:24:21+08:00 daily https://www.pharmasources.com/industryinsights/antalis-packaging-warns-of-quality-contr-294703.html 0.6 2026-03-28T04:06:01+08:00 daily https://www.pharmasources.com/industryinsights/market-pressures-and-inadequate-producti-294704.html 0.6 2026-07-07T13:59:29+08:00 daily https://www.pharmasources.com/industryinsights/a-path-toward-ending-aids-epidemic-in-th-294705.html 0.6 2026-07-02T13:27:47+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-launches-probe-into--294706.html 0.6 2026-07-02T09:29:45+08:00 daily https://www.pharmasources.com/industryinsights/actelion-announces-changes-to-its-execut-294707.html 0.6 2026-06-21T17:58:07+08:00 daily https://www.pharmasources.com/industryinsights/cuba-looks-to-begin-trials-of-new-neurop-294708.html 0.6 2026-06-21T13:56:21+08:00 daily https://www.pharmasources.com/industryinsights/research-reveals-manufacturers-and-contr-294709.html 0.6 2026-06-21T17:58:10+08:00 daily https://www.pharmasources.com/industryinsights/bacteria-can-form-living-materials-with--294710.html 0.6 2026-06-26T13:09:33+08:00 daily https://www.pharmasources.com/industryinsights/belgian-scientists-turn-polluted-air-int-294711.html 0.6 2026-07-01T20:13:47+08:00 daily https://www.pharmasources.com/industryinsights/pain-management-drugs-market-to-grow-at--294712.html 0.6 2026-07-12T11:45:39+08:00 daily https://www.pharmasources.com/industryinsights/relocating-the-ema-an-open-letter-from-e-294713.html 0.6 2026-07-13T12:58:14+08:00 daily https://www.pharmasources.com/industryinsights/lessons-from-ebola-how-to-improve-diseas-294714.html 0.6 2026-01-02T03:32:15+08:00 daily https://www.pharmasources.com/industryinsights/first-in-class-innovation-a-key-strategy-294715.html 0.6 2025-12-03T11:28:55+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-drug-monitoring-market-to-gr-294716.html 0.6 2026-08-06T18:11:27+08:00 daily https://www.pharmasources.com/industryinsights/india-pharma-survey-reveals-digital-tran-294717.html 0.6 2026-06-12T05:30:05+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-in-licenses-a-genetic-mitochon-294718.html 0.6 2026-06-29T20:45:05+08:00 daily https://www.pharmasources.com/industryinsights/qiagen-partners-with-maccura-to-localize-294719.html 0.6 2026-02-08T19:26:51+08:00 daily https://www.pharmasources.com/industryinsights/camurus-and-braeburn-pharmaceuticals-ann-294720.html 0.6 2026-06-15T18:01:25+08:00 daily https://www.pharmasources.com/industryinsights/orexigen-therapeutics-and-navamedic-asa--294721.html 0.6 2026-06-07T20:30:32+08:00 daily https://www.pharmasources.com/industryinsights/the-native-antigen-company-expands-into--294722.html 0.6 2026-04-06T21:41:31+08:00 daily https://www.pharmasources.com/industryinsights/3d-printing-in-science-294723.html 0.6 2026-04-12T23:43:14+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-packaging-equipment-marke-294724.html 0.6 2026-04-16T06:00:17+08:00 daily https://www.pharmasources.com/industryinsights/beactica-announces-glioblastoma-research-294725.html 0.6 2026-06-19T14:17:29+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-inaugurates-world-c-294726.html 0.6 2026-08-07T14:36:38+08:00 daily https://www.pharmasources.com/industryinsights/lupin-and-lilly-expand-partnership-in-in-294727.html 0.6 2026-06-22T23:58:14+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-systimmune-partner-for-bi-294728.html 0.6 2026-08-05T10:54:37+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-invests-to-increase-pilot-scale--294729.html 0.6 2026-06-13T10:01:39+08:00 daily https://www.pharmasources.com/industryinsights/saneca-pharma-expands-services-in-russia-294730.html 0.6 2026-03-24T22:57:30+08:00 daily https://www.pharmasources.com/industryinsights/actress-angela-bassett-joins-for-your-sw-294731.html 0.6 2026-04-14T04:50:49+08:00 daily https://www.pharmasources.com/industryinsights/eu-nations-urge-funding-to-research-new--294732.html 0.6 2026-04-26T20:38:36+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-receives-fast-track-designation--294733.html 0.6 2026-01-31T10:54:16+08:00 daily https://www.pharmasources.com/industryinsights/lannett-announces-approval-for-levocetir-294734.html 0.6 2026-03-18T00:29:14+08:00 daily https://www.pharmasources.com/industryinsights/eagle-pharmaceuticals-appoints-new-cfo-294735.html 0.6 2026-02-01T04:41:28+08:00 daily https://www.pharmasources.com/industryinsights/longeveron-announces-phase-1-safety-effi-294736.html 0.6 2026-07-12T15:26:30+08:00 daily https://www.pharmasources.com/industryinsights/nls-pharma-announces-phase-2-study-of-nl-294737.html 0.6 2026-06-08T19:38:15+08:00 daily https://www.pharmasources.com/industryinsights/regen-biopharma-sees-additional-positive-294738.html 0.6 2026-03-28T16:55:27+08:00 daily https://www.pharmasources.com/industryinsights/mouse-gives-birth-to-pups-using-3-d-prin-294739.html 0.6 2025-11-12T18:54:04+08:00 daily https://www.pharmasources.com/industryinsights/heart-attack-risk-spikes-after-respirato-294740.html 0.6 2026-07-04T02:58:11+08:00 daily https://www.pharmasources.com/industryinsights/for-inflamed-pancreas-eating-right-away--294741.html 0.6 2026-08-08T00:09:19+08:00 daily https://www.pharmasources.com/industryinsights/common-treatment-for-ms-revealed-to-have-294742.html 0.6 2026-05-29T16:42:36+08:00 daily https://www.pharmasources.com/industryinsights/new-fda-commissioner-gottlieb-restructur-294743.html 0.6 2026-03-26T23:07:10+08:00 daily https://www.pharmasources.com/industryinsights/patient-death-sparks-safety-worries-in-i-294744.html 0.6 2025-12-10T12:42:14+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-biotech-announces-receipt-of-nas-294745.html 0.6 2026-06-08T18:36:22+08:00 daily https://www.pharmasources.com/industryinsights/quality-by-design----experimental-strate-294746.html 0.6 2026-08-06T20:52:09+08:00 daily https://www.pharmasources.com/industryinsights/mercks-ebola-vaccine-candidate-could-see-294747.html 0.6 2026-07-03T23:24:00+08:00 daily https://www.pharmasources.com/industryinsights/limited-domestic-vaccine-manufacturing-e-294748.html 0.6 2026-07-02T03:17:25+08:00 daily https://www.pharmasources.com/industryinsights/cdc-recommends-paxvaxs-vaxchora-for-trav-294749.html 0.6 2026-07-10T06:35:21+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-opens-biopharmaceutical-manuf-294750.html 0.6 2026-08-07T15:41:32+08:00 daily https://www.pharmasources.com/industryinsights/vifor-pharma-and-akebia-to-sell-vadadust-294751.html 0.6 2026-04-08T01:07:13+08:00 daily https://www.pharmasources.com/industryinsights/cytokinetics-receives-fda-orphan-drug-st-294752.html 0.6 2026-03-30T15:38:45+08:00 daily https://www.pharmasources.com/industryinsights/ensuring-universal-access-is-a-political-294753.html 0.6 2026-08-07T02:52:06+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-partners-with-n-294754.html 0.6 2026-08-07T02:36:52+08:00 daily https://www.pharmasources.com/industryinsights/emergent-unveils-expanded-facility-in-ba-294755.html 0.6 2026-08-07T05:12:26+08:00 daily https://www.pharmasources.com/industryinsights/dow-offers-new-technology-to-solve-pharm-294756.html 0.6 2026-08-06T23:56:42+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-stability-capacity-at-missis-294757.html 0.6 2026-08-06T23:45:52+08:00 daily https://www.pharmasources.com/industryinsights/upm-celebrates-100-years-of-mfg-at-tenne-294758.html 0.6 2026-08-06T20:01:09+08:00 daily https://www.pharmasources.com/industryinsights/gamlen-tableting-changes-its-name-to-gam-294759.html 0.6 2026-08-06T22:08:38+08:00 daily https://www.pharmasources.com/industryinsights/virus-study-targets-infection-linked-to--294760.html 0.6 2026-08-06T23:45:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-bayer-priority-review-for-inv-294761.html 0.6 2026-08-08T16:29:32+08:00 daily https://www.pharmasources.com/industryinsights/merck-develops-alternative-crispr-genome-294762.html 0.6 2025-12-11T09:07:06+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-expands-phase-2-clinical-trials-o-294763.html 0.6 2026-08-03T11:41:25+08:00 daily https://www.pharmasources.com/industryinsights/abon-received-approval-from-fda-for-clof-294764.html 0.6 2026-07-12T05:34:09+08:00 daily https://www.pharmasources.com/industryinsights/pharmadax-receives-fda-approval-for-gene-294765.html 0.6 2026-01-31T13:28:18+08:00 daily https://www.pharmasources.com/industryinsights/can-crab-shells-provide-a-green-solution-294766.html 0.6 2026-03-24T03:35:53+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-and-pfizer-to-collaborate-on-hae-294767.html 0.6 2026-03-21T15:29:15+08:00 daily https://www.pharmasources.com/industryinsights/ec-opens-formal-investigation-into-aspen-294768.html 0.6 2025-11-10T21:37:41+08:00 daily https://www.pharmasources.com/industryinsights/govt-approves-rs-1500-cr-investment-to-d-294769.html 0.6 2026-06-22T16:38:12+08:00 daily https://www.pharmasources.com/industryinsights/indegene-and-microsoft-in-alliance-294770.html 0.6 2026-04-21T15:32:18+08:00 daily https://www.pharmasources.com/industryinsights/investing-in-drug-safety-monitoring-coul-294771.html 0.6 2026-04-02T09:57:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approved-use-of-kalydeco-to--294772.html 0.6 2026-02-21T21:34:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-americans-about-risk-of-inaccu-294773.html 0.6 2026-02-15T07:46:51+08:00 daily https://www.pharmasources.com/industryinsights/500-staff-face-the-axe-as-teva-cans-hung-294774.html 0.6 2026-08-08T10:16:16+08:00 daily https://www.pharmasources.com/industryinsights/az-launches-lawsuit-against-former-execu-294775.html 0.6 2026-01-22T05:50:57+08:00 daily https://www.pharmasources.com/industryinsights/t-cells-found-to-acquire-knowledge-to-ta-294776.html 0.6 2025-10-28T09:40:00+08:00 daily https://www.pharmasources.com/industryinsights/video-surveillance-could-support-dementi-294777.html 0.6 2026-03-11T09:59:13+08:00 daily https://www.pharmasources.com/industryinsights/nhs-risks-missed-opportunity-to-put-ment-294778.html 0.6 2025-11-15T01:47:44+08:00 daily https://www.pharmasources.com/industryinsights/peripheral-vascular-procedure-volumes-gl-294779.html 0.6 2026-05-01T12:18:28+08:00 daily https://www.pharmasources.com/industryinsights/mercks-glucophage-sr-receives-label-exte-294780.html 0.6 2026-03-06T09:20:00+08:00 daily https://www.pharmasources.com/industryinsights/a-first-full-length-class-b-gpcr-crystal-294781.html 0.6 2025-11-07T13:48:15+08:00 daily https://www.pharmasources.com/industryinsights/cfda-consecutively-issued-new-policies-t-294782.html 0.6 2026-07-20T06:04:16+08:00 daily https://www.pharmasources.com/industryinsights/which-is-to-become-the-savior-of-alzheim-294783.html 0.6 2026-06-22T17:57:27+08:00 daily https://www.pharmasources.com/industryinsights/offense-and-defense-change-of-spear-and--294784.html 0.6 2026-07-19T14:54:48+08:00 daily https://www.pharmasources.com/industryinsights/star-rd-duo-nabs-65-million-for-iterum-t-294785.html 0.6 2026-06-12T20:00:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-slaps-clinical-hold-on-concert-pharm-294786.html 0.6 2026-02-28T17:54:57+08:00 daily https://www.pharmasources.com/industryinsights/apple-aapl-ceo-spotted-wearing-a-prototy-294787.html 0.6 2026-04-01T00:43:48+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170523-294788.html 0.6 2026-06-08T15:24:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kevzara-for-the-treatment-o-294789.html 0.6 2026-06-20T17:24:31+08:00 daily https://www.pharmasources.com/industryinsights/new-analyses-reinforce-the-potential-of--294790.html 0.6 2026-06-21T19:25:44+08:00 daily https://www.pharmasources.com/industryinsights/spiriva-respimat-inhalation-spray-improv-294791.html 0.6 2026-07-28T02:15:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-genentechs-actemra-for-gian-294792.html 0.6 2026-06-21T02:20:24+08:00 daily https://www.pharmasources.com/industryinsights/ema-validates-application-for-bmss-spryc-294793.html 0.6 2026-06-12T17:40:59+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-inaugurates-biophar-294794.html 0.6 2026-07-20T14:20:12+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-to-acquire-path-294795.html 0.6 2026-06-22T00:28:42+08:00 daily https://www.pharmasources.com/industryinsights/inovios-nih-backed-hiv-vaccine-shows-nea-294796.html 0.6 2026-08-06T17:42:34+08:00 daily https://www.pharmasources.com/industryinsights/shareholder-suit-targets-newlink-managem-294797.html 0.6 2026-06-25T09:16:56+08:00 daily https://www.pharmasources.com/industryinsights/mercks-gardasil-preps-for-head-to-head-w-294798.html 0.6 2026-07-11T04:45:34+08:00 daily https://www.pharmasources.com/industryinsights/japan-ratifies-nagoya-protocol-on-use-of-294799.html 0.6 2025-10-30T00:04:39+08:00 daily https://www.pharmasources.com/industryinsights/a-palm-sized-medical-gamma-ray-camera-in-294800.html 0.6 2026-01-12T12:39:04+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-expands-global-patent-portfolio-f-294801.html 0.6 2026-02-09T07:21:21+08:00 daily https://www.pharmasources.com/industryinsights/innova-biosciences-introduces-the-flexli-294802.html 0.6 2025-11-27T07:55:01+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-gammadelta-therapeutics-annou-294803.html 0.6 2026-07-08T13:38:14+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-receives-japanese-patent-294804.html 0.6 2026-07-03T13:07:16+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-announces-eur250-million-coll-294805.html 0.6 2026-07-04T11:23:26+08:00 daily https://www.pharmasources.com/industryinsights/thermo-scientific-refrigerated-incubator-294806.html 0.6 2026-08-07T22:12:31+08:00 daily https://www.pharmasources.com/industryinsights/bosch-presents-xelum-platform-excelling--294807.html 0.6 2026-08-06T20:02:04+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-chemis-294808.html 0.6 2026-08-06T23:36:05+08:00 daily https://www.pharmasources.com/industryinsights/i-holland-offers-free-trial-of-innovativ-294809.html 0.6 2026-08-06T23:46:18+08:00 daily https://www.pharmasources.com/industryinsights/norwegian-study-confirms-the-potential-h-294810.html 0.6 2026-08-07T12:03:53+08:00 daily https://www.pharmasources.com/industryinsights/new-high-performance-filtration-plates-f-294811.html 0.6 2026-08-07T13:17:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mercks-bladder-cancer-drug-294812.html 0.6 2026-08-07T13:56:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-cancer-treatment-for--294813.html 0.6 2026-01-11T20:55:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-enters-agreement-with-record-294814.html 0.6 2026-07-09T05:44:49+08:00 daily https://www.pharmasources.com/industryinsights/tablet-helps-heart-failure-patients-mana-294815.html 0.6 2026-08-08T21:48:30+08:00 daily https://www.pharmasources.com/industryinsights/better-cheaper-healthcare-with-dry-blood-294816.html 0.6 2026-08-08T20:01:14+08:00 daily https://www.pharmasources.com/industryinsights/athenex-and-its-partner-guangzhou-xiangx-294817.html 0.6 2026-08-08T18:18:08+08:00 daily https://www.pharmasources.com/industryinsights/shangpharma-innovation-appoints-mohamad--294818.html 0.6 2026-08-08T16:50:21+08:00 daily https://www.pharmasources.com/industryinsights/preventing-cancer-and-autism-new-functio-294819.html 0.6 2026-06-09T12:17:01+08:00 daily https://www.pharmasources.com/industryinsights/jellagen-launches-jellyfish-collagen-man-294820.html 0.6 2026-06-24T20:01:42+08:00 daily https://www.pharmasources.com/industryinsights/brilique-ticagrelor-new-formulation-gain-294821.html 0.6 2026-06-29T11:29:20+08:00 daily https://www.pharmasources.com/industryinsights/motor-neurone-disease-onset-delayed-by-a-294822.html 0.6 2026-07-04T14:34:30+08:00 daily https://www.pharmasources.com/industryinsights/zika-virus-assay-for-screening-blood-don-294823.html 0.6 2026-07-09T12:57:53+08:00 daily https://www.pharmasources.com/industryinsights/patent-library-will-be-founded-in-lithua-294824.html 0.6 2026-02-07T07:24:28+08:00 daily https://www.pharmasources.com/industryinsights/biosimilar-medicines-dramatic-increase-i-294825.html 0.6 2026-07-27T01:04:48+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-therapy-for-nearly-1-in-4-adu-294826.html 0.6 2026-01-30T19:45:23+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-collaboration-to-reduce-injectabl-294827.html 0.6 2026-02-28T21:07:18+08:00 daily https://www.pharmasources.com/industryinsights/bonesupport-enrols-first-patient-in-inje-294828.html 0.6 2026-01-03T16:12:00+08:00 daily https://www.pharmasources.com/industryinsights/uks-first-cancer-fighting-proton-beam-th-294829.html 0.6 2026-04-07T05:15:10+08:00 daily https://www.pharmasources.com/industryinsights/more-needs-to-be-done-in-cancer-preventi-294830.html 0.6 2026-06-22T23:30:33+08:00 daily https://www.pharmasources.com/industryinsights/a-strong-eu-ip-framework-guarantees-futu-294831.html 0.6 2026-03-17T22:31:37+08:00 daily https://www.pharmasources.com/industryinsights/early-mri-may-lower-costs-for-prostate-c-294832.html 0.6 2026-04-20T22:00:38+08:00 daily https://www.pharmasources.com/industryinsights/akebia-therapeutics-names-cmo-294833.html 0.6 2026-04-27T13:49:44+08:00 daily https://www.pharmasources.com/industryinsights/merck-stelis-open-first-joint-process-sc-294834.html 0.6 2026-04-27T21:55:25+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-develops-new-crispr-genom-294835.html 0.6 2026-01-30T21:24:46+08:00 daily https://www.pharmasources.com/industryinsights/lsne-selecta-biosciences-form-mfg-pact-294836.html 0.6 2026-07-21T02:13:13+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-buys-igenica-immuno-oncolog-294837.html 0.6 2026-06-19T12:13:47+08:00 daily https://www.pharmasources.com/industryinsights/selexis-sa-and-ose-immunotherapeutics-en-294838.html 0.6 2026-07-02T21:29:52+08:00 daily https://www.pharmasources.com/industryinsights/kbi-biopharma-invests-30m-in-facility-up-294839.html 0.6 2026-04-23T09:10:21+08:00 daily https://www.pharmasources.com/industryinsights/recro-gainesville-expands-mfg-capabiliti-294840.html 0.6 2026-03-17T22:23:25+08:00 daily https://www.pharmasources.com/industryinsights/cros-nt-expands-medidata-pact-294841.html 0.6 2026-03-19T13:08:10+08:00 daily https://www.pharmasources.com/industryinsights/tekni-plex-acquires-brunaseals-294842.html 0.6 2026-01-31T00:15:37+08:00 daily https://www.pharmasources.com/industryinsights/worldwide-clinical-trials-appoints-clini-294843.html 0.6 2026-03-18T01:31:12+08:00 daily https://www.pharmasources.com/industryinsights/pci-biotech-rxi-pharma-extend-research-c-294844.html 0.6 2026-06-12T08:13:22+08:00 daily https://www.pharmasources.com/industryinsights/nektar-and-takeda-in-research-collaborat-294845.html 0.6 2026-08-05T11:46:58+08:00 daily https://www.pharmasources.com/industryinsights/the-angiogenesis-foundation-mourns-the-p-294846.html 0.6 2026-06-20T18:53:03+08:00 daily https://www.pharmasources.com/industryinsights/hovione-starts-phase-1-clinical-trial-of-294847.html 0.6 2025-10-26T00:25:24+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-makes-appointment-in-the-uk-ir-294848.html 0.6 2026-08-07T19:23:09+08:00 daily https://www.pharmasources.com/industryinsights/evotec-opens-us-hq-in-nj-294849.html 0.6 2026-03-16T05:57:47+08:00 daily https://www.pharmasources.com/industryinsights/bioverativ-to-purchase-true-north-therap-294850.html 0.6 2026-06-13T14:44:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sun-pharmas-tildrakizumab-f-294851.html 0.6 2026-06-08T20:34:18+08:00 daily https://www.pharmasources.com/industryinsights/unisys-unveils-pharmatrack-software-to-m-294852.html 0.6 2026-03-17T18:37:00+08:00 daily https://www.pharmasources.com/industryinsights/uk-cma-accuses-merck-of-breaking-competi-294853.html 0.6 2026-06-22T20:58:05+08:00 daily https://www.pharmasources.com/industryinsights/ardelyxs-first-in-class-nhe3-blocker-ten-294854.html 0.6 2026-03-23T04:14:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sanofi-and-regenerons-kevza-294855.html 0.6 2026-08-03T04:10:26+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-and-essex-to-develop-biologica-294856.html 0.6 2026-01-31T10:03:17+08:00 daily https://www.pharmasources.com/industryinsights/singapore-edevelopment-subsidiary-starts-294857.html 0.6 2026-06-15T10:37:01+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-signs-deal-to-sell-commercia-294858.html 0.6 2026-06-15T10:26:21+08:00 daily https://www.pharmasources.com/industryinsights/mercks-isentress-receives-chmp-positive--294859.html 0.6 2026-08-08T14:21:09+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-insulin-lispro-receives-chmp-pos-294860.html 0.6 2026-08-06T20:00:31+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-funded-scientists-to--294861.html 0.6 2026-04-03T00:20:08+08:00 daily https://www.pharmasources.com/industryinsights/sobi-receives-sfda-approval-for-orfadin--294862.html 0.6 2026-03-25T15:45:56+08:00 daily https://www.pharmasources.com/industryinsights/nppa-issues-notice-to-pharmaceutical-fir-294863.html 0.6 2026-04-01T05:43:24+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-fosun-pharmaceutical-group-shan-294864.html 0.6 2026-03-23T22:01:05+08:00 daily https://www.pharmasources.com/industryinsights/shareholder-suit-targets-newlink-managem-294865.html 0.6 2026-04-20T14:41:22+08:00 daily https://www.pharmasources.com/industryinsights/inovios-nih-backed-hiv-vaccine-shows-nea-294866.html 0.6 2026-01-30T20:45:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-executive-lays-out-case-for-taxpa-294867.html 0.6 2025-12-07T18:50:50+08:00 daily https://www.pharmasources.com/industryinsights/making-biological-drugs-with-spider-silk-294868.html 0.6 2026-06-27T09:01:44+08:00 daily https://www.pharmasources.com/industryinsights/isolated-greek-villages-reveal-genetic-s-294869.html 0.6 2026-03-29T04:07:17+08:00 daily https://www.pharmasources.com/industryinsights/one-in-3-high-blood-pressure-patients-fa-294870.html 0.6 2025-12-14T21:26:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-committee-recommends-approv-294871.html 0.6 2026-04-19T02:56:10+08:00 daily https://www.pharmasources.com/industryinsights/noted-experts-critically-evaluate-benefi-294872.html 0.6 2026-02-15T13:43:59+08:00 daily https://www.pharmasources.com/industryinsights/new-data-at-ats-add-to-the-body-of-evide-294873.html 0.6 2026-07-03T18:30:25+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-parkinsons-and-huntingtons-di-294874.html 0.6 2026-06-26T19:17:17+08:00 daily https://www.pharmasources.com/industryinsights/sirius-acquires-international-medical-gr-294875.html 0.6 2026-06-13T09:46:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-for-priority-review-bmss-app-294876.html 0.6 2026-02-28T15:54:02+08:00 daily https://www.pharmasources.com/industryinsights/inovio-hiv-vaccine-elicits-nearly-100-im-294877.html 0.6 2026-08-06T23:38:32+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-case-studies-illustrating-294878.html 0.6 2026-06-14T06:31:35+08:00 daily https://www.pharmasources.com/industryinsights/pda-initiative-connecting-drug-manufactu-294879.html 0.6 2026-03-11T04:02:36+08:00 daily https://www.pharmasources.com/industryinsights/asias-first-bot-aided-implant-for-parkin-294880.html 0.6 2025-12-16T02:44:09+08:00 daily https://www.pharmasources.com/industryinsights/genae-invests-in-meditrix-294881.html 0.6 2026-03-23T19:06:59+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-ltd-announces-manuf-294882.html 0.6 2026-06-08T16:12:09+08:00 daily https://www.pharmasources.com/industryinsights/stago-group-acquires-hemosonics-294883.html 0.6 2026-07-16T08:30:36+08:00 daily https://www.pharmasources.com/industryinsights/fertility-specialist-clinic-open-in-beij-294884.html 0.6 2026-01-13T00:26:59+08:00 daily https://www.pharmasources.com/industryinsights/japans-maz-world-opens-lab-in-hong-kong--294885.html 0.6 2026-04-09T22:11:37+08:00 daily https://www.pharmasources.com/industryinsights/yaskawa-midea-launching-nursing-care-rob-294886.html 0.6 2026-08-05T18:51:46+08:00 daily https://www.pharmasources.com/industryinsights/following-global-tour-zika-virus-knocks--294887.html 0.6 2026-03-27T23:35:20+08:00 daily https://www.pharmasources.com/industryinsights/university-researchers-in-hong-kong-sar--294888.html 0.6 2026-04-06T05:59:23+08:00 daily https://www.pharmasources.com/industryinsights/paper-test-strip-designed-for-heart-pati-294889.html 0.6 2026-04-06T21:12:14+08:00 daily https://www.pharmasources.com/industryinsights/new-medicine-shows-potential-to-reduce-o-294890.html 0.6 2026-04-08T18:10:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-use-of-novartis-lu-294891.html 0.6 2026-08-07T12:01:49+08:00 daily https://www.pharmasources.com/industryinsights/biologics-before-triple-therapy-not-cost-294892.html 0.6 2026-06-17T17:16:16+08:00 daily https://www.pharmasources.com/industryinsights/abeona-therapeutics-receives-fda-orphan--294893.html 0.6 2026-04-11T02:07:08+08:00 daily https://www.pharmasources.com/industryinsights/wirb-copernicus-group-wcg-acquires-medav-294894.html 0.6 2026-06-16T13:26:55+08:00 daily https://www.pharmasources.com/industryinsights/astellas-announces-decision-to-discontin-294895.html 0.6 2026-03-18T00:36:56+08:00 daily https://www.pharmasources.com/industryinsights/mundipharmas-ceo-ranked-among-pharma-bus-294896.html 0.6 2026-02-01T04:39:50+08:00 daily https://www.pharmasources.com/industryinsights/inc-research-and-inventiv-health-to-merg-294897.html 0.6 2026-04-08T13:31:23+08:00 daily https://www.pharmasources.com/industryinsights/new-report-states-growth-in-pharmacy-man-294898.html 0.6 2026-01-13T00:12:38+08:00 daily https://www.pharmasources.com/industryinsights/new-analyses-support-the-effectiveness-a-294899.html 0.6 2026-08-07T21:53:03+08:00 daily https://www.pharmasources.com/industryinsights/cell-penetrating-antibodies-to-oncogenic-294900.html 0.6 2026-07-04T14:30:04+08:00 daily https://www.pharmasources.com/industryinsights/cros-nt-appoints-president-of-north-amer-294901.html 0.6 2026-01-13T00:09:38+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-expands-capacity-and-capabilites-294902.html 0.6 2026-01-13T00:08:36+08:00 daily https://www.pharmasources.com/industryinsights/array-bms-in-opdivo-clinical-combo-allia-294903.html 0.6 2026-02-09T03:09:19+08:00 daily https://www.pharmasources.com/industryinsights/janssen-biotech-protagonist-in-exclusive-294904.html 0.6 2026-06-25T15:33:08+08:00 daily https://www.pharmasources.com/industryinsights/quotient-clinical-appoints-chief-commerc-294905.html 0.6 2026-08-06T21:52:22+08:00 daily https://www.pharmasources.com/industryinsights/lupin-pharmaceuticals-announces-nationwi-294906.html 0.6 2026-01-13T00:04:33+08:00 daily https://www.pharmasources.com/industryinsights/hookipa-biotech-announces-data-showing-t-294907.html 0.6 2026-01-20T14:09:55+08:00 daily https://www.pharmasources.com/industryinsights/government-approves-baxter-pharmas-fdi-p-294908.html 0.6 2026-06-19T20:29:20+08:00 daily https://www.pharmasources.com/industryinsights/bayer-receives-fda-approval-of-mybetaapp-294909.html 0.6 2026-08-01T15:13:57+08:00 daily https://www.pharmasources.com/industryinsights/chris-peetz-joins-frazier-healthcare-par-294910.html 0.6 2026-06-19T20:54:17+08:00 daily https://www.pharmasources.com/industryinsights/orphomed-secures-39-million-series-a-fin-294911.html 0.6 2026-04-13T07:33:42+08:00 daily https://www.pharmasources.com/industryinsights/moh-to-ramp-up-use-of-apps-robotics-to-i-294912.html 0.6 2026-08-07T08:18:03+08:00 daily https://www.pharmasources.com/industryinsights/42gears-solves-alkems-field-device-misus-294913.html 0.6 2026-03-18T01:17:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-strattera-for-294914.html 0.6 2026-04-07T16:02:47+08:00 daily https://www.pharmasources.com/industryinsights/studying-century-old-drug-as-potential-n-294915.html 0.6 2026-04-03T20:55:24+08:00 daily https://www.pharmasources.com/industryinsights/heptares-fiona-marshall-receives-2017-jo-294916.html 0.6 2026-03-26T21:32:55+08:00 daily https://www.pharmasources.com/industryinsights/domainex-signs-multi-year-agreement-with-294917.html 0.6 2026-06-03T02:05:33+08:00 daily https://www.pharmasources.com/industryinsights/merck-opens-first-joint-bioprocess-scale-294918.html 0.6 2026-08-06T01:59:42+08:00 daily https://www.pharmasources.com/industryinsights/chiltern-acquires-japanese-cro-294919.html 0.6 2026-03-30T19:41:42+08:00 daily https://www.pharmasources.com/industryinsights/vetter-microdermics-enter-strategic-drug-294920.html 0.6 2026-02-09T08:54:14+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-trumenba-to-challenge-glaxosmith-294921.html 0.6 2026-04-06T21:48:44+08:00 daily https://www.pharmasources.com/industryinsights/mercks-experimental-ebola-vaccine-poised-294922.html 0.6 2026-08-08T19:06:48+08:00 daily https://www.pharmasources.com/industryinsights/anyone-can-become-more-curious-is-that-t-294923.html 0.6 2026-08-07T05:23:22+08:00 daily https://www.pharmasources.com/industryinsights/it-transformation-and-cloud-content-mana-294924.html 0.6 2026-06-16T05:08:26+08:00 daily https://www.pharmasources.com/industryinsights/array-biopharma-and-bristol-myers-squibb-294925.html 0.6 2026-04-01T07:08:01+08:00 daily https://www.pharmasources.com/industryinsights/some-heart-attack-patients-may-not-benef-294926.html 0.6 2026-02-28T13:16:33+08:00 daily https://www.pharmasources.com/industryinsights/green-light-given-for-new-eudravigilance-294927.html 0.6 2026-07-31T16:22:24+08:00 daily https://www.pharmasources.com/industryinsights/ce-mark-for-implandatas-eyemate-system-f-294928.html 0.6 2026-06-22T17:34:33+08:00 daily https://www.pharmasources.com/industryinsights/inthera-bioscience-raises-chf-105-millio-294929.html 0.6 2026-06-30T21:32:10+08:00 daily https://www.pharmasources.com/industryinsights/rohto-pharmaceutical-japan-forges-capita-294930.html 0.6 2026-08-07T23:55:11+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-posts-consolidated-total-re-294931.html 0.6 2026-03-25T17:00:00+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-us-fda-nod-for-adhd-drug-294932.html 0.6 2026-08-08T01:49:20+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-recalls-13000-bottles-of-chew-294933.html 0.6 2026-03-11T19:50:05+08:00 daily https://www.pharmasources.com/industryinsights/china-aid-the-best-gateway-into-the-chin-294934.html 0.6 2026-03-21T23:09:31+08:00 daily https://www.pharmasources.com/industryinsights/nls-pharma-unveils-positive-phase-2-data-294935.html 0.6 2026-04-04T22:56:47+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-signs-manufacturing-294936.html 0.6 2026-06-08T18:04:22+08:00 daily https://www.pharmasources.com/industryinsights/sanner-acquisition-strengthens-companys--294937.html 0.6 2026-07-20T03:26:52+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-available-in-singapore-followin-294938.html 0.6 2026-03-20T09:26:19+08:00 daily https://www.pharmasources.com/industryinsights/taigen-biotechnology-announces-the-submi-294939.html 0.6 2026-03-31T03:47:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-approval-for-roches-alk-test--294940.html 0.6 2026-08-09T15:11:29+08:00 daily https://www.pharmasources.com/industryinsights/asia-preferred-destination-for-clinical--294941.html 0.6 2026-08-08T03:20:35+08:00 daily https://www.pharmasources.com/industryinsights/climate-change--biggest-healthcare-chall-294942.html 0.6 2026-08-05T22:10:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-novo-nordisk-treatment--294943.html 0.6 2026-04-07T20:33:26+08:00 daily https://www.pharmasources.com/industryinsights/what-revolutionary-changes-the-new-draft-294944.html 0.6 2026-07-22T10:44:58+08:00 daily https://www.pharmasources.com/industryinsights/ohio-suit-will-be-tough-to-win-for-opioi-294945.html 0.6 2026-06-17T00:05:18+08:00 daily https://www.pharmasources.com/industryinsights/trends-in-drug-discovery-outsourcing-a-p-294946.html 0.6 2026-07-24T06:11:32+08:00 daily https://www.pharmasources.com/industryinsights/the-biobanking-boom-294947.html 0.6 2026-05-04T15:54:56+08:00 daily https://www.pharmasources.com/industryinsights/cro-industry-continues-to-expand-294948.html 0.6 2026-03-17T06:43:57+08:00 daily https://www.pharmasources.com/industryinsights/saratha-rajeswaran-joins-abpi-as-executi-294949.html 0.6 2026-01-12T23:21:22+08:00 daily https://www.pharmasources.com/industryinsights/esmo-welcomes-the-adoption-of-the-2017-w-294950.html 0.6 2026-04-25T08:20:01+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-review-sandoz-biosimilars-adalimu-294951.html 0.6 2026-06-24T04:30:43+08:00 daily https://www.pharmasources.com/industryinsights/kemwell-biopharma-supplies-biologics-dru-294952.html 0.6 2026-02-01T04:45:22+08:00 daily https://www.pharmasources.com/industryinsights/atum-licenses-to-thermo-fisher-scientifi-294953.html 0.6 2026-04-18T19:42:19+08:00 daily https://www.pharmasources.com/industryinsights/pelicanbiothermal-unveils-new-series-22--294954.html 0.6 2026-04-03T02:43:05+08:00 daily https://www.pharmasources.com/industryinsights/irvine-scientific-launches-new-xeno-free-294955.html 0.6 2026-01-12T23:15:15+08:00 daily https://www.pharmasources.com/industryinsights/bacteria-used-as-factories-to-produce-ca-294956.html 0.6 2026-03-10T08:06:30+08:00 daily https://www.pharmasources.com/industryinsights/amgen-showcases-a-legacy-of-science-inno-294957.html 0.6 2026-08-07T22:01:33+08:00 daily https://www.pharmasources.com/industryinsights/synthetic-genomics-launches-cgmp-synthet-294958.html 0.6 2026-08-06T22:05:50+08:00 daily https://www.pharmasources.com/industryinsights/protalix-wins-fda-approval-as-multi-prod-294959.html 0.6 2026-08-07T13:16:37+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-antidep-294960.html 0.6 2026-08-09T00:31:28+08:00 daily https://www.pharmasources.com/industryinsights/biocon-appoints-pratima-rao-as-mission-d-294961.html 0.6 2026-01-31T10:16:35+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-launches-new-analytical-balance-294962.html 0.6 2026-03-07T07:37:19+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-in-agreement-with-phytronix-294963.html 0.6 2026-01-14T14:48:06+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-to-continue-neurostat-clinical-294964.html 0.6 2026-06-30T21:12:01+08:00 daily https://www.pharmasources.com/industryinsights/quotient-clinical-appoints-azhar-kalim-294965.html 0.6 2026-01-12T23:05:08+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-announces-new-colla-294966.html 0.6 2026-06-03T18:37:48+08:00 daily https://www.pharmasources.com/industryinsights/mikart-compliant-with-dscsa-mandates-294967.html 0.6 2026-01-16T19:57:15+08:00 daily https://www.pharmasources.com/industryinsights/ips-expands-leadership-team-294968.html 0.6 2026-04-20T11:33:31+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-services-completes-3-fda-inspe-294969.html 0.6 2026-01-12T23:01:07+08:00 daily https://www.pharmasources.com/industryinsights/orchard-inks-mfg-agreement-with-pct-cell-294970.html 0.6 2026-03-19T12:24:05+08:00 daily https://www.pharmasources.com/industryinsights/new-nih-study-reveals-mutations-in-gene--294971.html 0.6 2026-03-11T04:08:36+08:00 daily https://www.pharmasources.com/industryinsights/surface-oncology-enters-licence-agreemen-294972.html 0.6 2026-01-12T22:58:09+08:00 daily https://www.pharmasources.com/industryinsights/innate-pharma-acquires-anti-c5ar-antibod-294973.html 0.6 2026-01-12T22:57:08+08:00 daily https://www.pharmasources.com/industryinsights/ibm-announces-partnership-with-baheal-to-294974.html 0.6 2026-08-07T17:55:52+08:00 daily https://www.pharmasources.com/industryinsights/dendreon-touts-t-cell-response-data-for--294975.html 0.6 2026-01-12T22:55:05+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-scores-eighth-approval-in-eur-294976.html 0.6 2026-07-05T00:26:16+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-expands-in-india-294977.html 0.6 2026-03-19T20:32:28+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-signs-potential-1-billion-dea-294978.html 0.6 2026-03-20T15:44:14+08:00 daily https://www.pharmasources.com/industryinsights/latest-prostate-cancer-research-could-pr-294979.html 0.6 2026-04-01T16:28:40+08:00 daily https://www.pharmasources.com/industryinsights/combination-therapy-shown-to-shrink-tumo-294980.html 0.6 2026-01-12T22:51:02+08:00 daily https://www.pharmasources.com/industryinsights/new-targeted-therapy-promises-strong-res-294981.html 0.6 2026-02-15T07:12:54+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-treatment-for-ovarian-cance-294982.html 0.6 2026-03-17T22:02:49+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-opdivo-for-bladder-cancer-294983.html 0.6 2026-06-22T06:13:28+08:00 daily https://www.pharmasources.com/industryinsights/az-lynparza-cuts-risk-of-breast-cancer-p-294984.html 0.6 2026-01-12T22:45:00+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-ambr-1-294985.html 0.6 2026-04-17T04:03:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-ground-breaking-colla-294986.html 0.6 2026-07-23T13:34:38+08:00 daily https://www.pharmasources.com/industryinsights/precision-ovarian-cancer-drug-shows-earl-294987.html 0.6 2026-03-17T22:37:18+08:00 daily https://www.pharmasources.com/industryinsights/spinraza-approved-in-the-eu-as-first-tre-294988.html 0.6 2026-06-08T00:00:32+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-submits-regulatory-appli-294989.html 0.6 2026-03-01T01:32:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-roches-lung-cancer-companio-294990.html 0.6 2026-04-25T05:03:06+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-boehringer-ingelheim-confirm--294991.html 0.6 2026-01-30T15:21:57+08:00 daily https://www.pharmasources.com/industryinsights/unisys-launches-activeinsights-pharmatra-294992.html 0.6 2026-08-06T00:52:20+08:00 daily https://www.pharmasources.com/industryinsights/nanomite-pump-ideal-for-targeted-brain-i-294993.html 0.6 2026-01-12T22:36:56+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-receives-research-grant-from-v-294994.html 0.6 2026-08-05T12:53:58+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-us-fda-filing-accep-294995.html 0.6 2026-02-26T13:52:25+08:00 daily https://www.pharmasources.com/industryinsights/dsm-sinochem-pharmaceuticals-wins-indian-294996.html 0.6 2026-04-02T08:26:49+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receives-fda-fast-track-designati-294997.html 0.6 2026-07-06T06:40:11+08:00 daily https://www.pharmasources.com/industryinsights/natco-plans-to-launch-8-10-branded-formu-294998.html 0.6 2026-03-01T04:58:22+08:00 daily https://www.pharmasources.com/industryinsights/seven-new-research-parks-to-be-set-up-in-294999.html 0.6 2026-07-18T13:58:25+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-looks-to-file-100-andas-i-295000.html 0.6 2026-01-12T22:29:50+08:00 daily https://www.pharmasources.com/industryinsights/veloxis-pharma-signs-agreements-to-comme-295001.html 0.6 2026-03-19T11:57:57+08:00 daily https://www.pharmasources.com/industryinsights/novartis-bristol-myers-squibb-to-evaluat-295002.html 0.6 2026-06-14T15:04:19+08:00 daily https://www.pharmasources.com/industryinsights/sevion-therapeutics-eloxx-pharmaceutical-295003.html 0.6 2026-01-12T22:25:47+08:00 daily https://www.pharmasources.com/industryinsights/guardant-health-in-long-term-association-295004.html 0.6 2026-03-25T20:00:55+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-opdivo-for-previously-treate-295005.html 0.6 2026-03-28T02:37:03+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-launches-new-analytical-balance-295006.html 0.6 2026-01-12T22:23:44+08:00 daily https://www.pharmasources.com/industryinsights/now-india-has-a-balanced-scientific-regu-295007.html 0.6 2026-01-12T22:22:45+08:00 daily https://www.pharmasources.com/industryinsights/zuellig-pharma-cambodia-appointed-vice-c-295008.html 0.6 2026-07-01T10:16:14+08:00 daily https://www.pharmasources.com/industryinsights/bd-receives-fda-510k-clearance-for-molec-295009.html 0.6 2026-01-31T01:06:53+08:00 daily https://www.pharmasources.com/industryinsights/china-to-conduct-first-human-trials-on-e-295010.html 0.6 2026-06-30T14:44:30+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-announces-the-expansion-of-295011.html 0.6 2026-01-22T06:16:47+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-initiates-recall-of-brilinta-295012.html 0.6 2026-05-06T05:50:46+08:00 daily https://www.pharmasources.com/industryinsights/e-clinical-trials-move-towards-personali-295013.html 0.6 2026-01-12T22:16:43+08:00 daily https://www.pharmasources.com/industryinsights/new-paradigm-of-pharma-industry-295014.html 0.6 2026-06-30T15:32:10+08:00 daily https://www.pharmasources.com/industryinsights/apac-market-is-gaining-pace-on-par-with--295015.html 0.6 2026-04-21T18:56:09+08:00 daily https://www.pharmasources.com/industryinsights/path-research-institutes-to-test-novel-m-295016.html 0.6 2026-06-08T06:13:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zerviate-295017.html 0.6 2026-07-29T14:10:05+08:00 daily https://www.pharmasources.com/industryinsights/bms-novartis-to-test-mekinistopdivo-comb-295018.html 0.6 2026-03-23T19:26:58+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-ambr-1-295019.html 0.6 2026-01-12T22:10:37+08:00 daily https://www.pharmasources.com/industryinsights/genomic-health-new-data-show-important-r-295020.html 0.6 2026-06-26T21:21:11+08:00 daily https://www.pharmasources.com/industryinsights/novartis-bms-in-opdivo-clinical-collabor-295021.html 0.6 2026-07-28T01:29:05+08:00 daily https://www.pharmasources.com/industryinsights/bayer-adds-oncology-leadership-295022.html 0.6 2026-08-08T20:47:40+08:00 daily https://www.pharmasources.com/industryinsights/chesapeake-irb-acquires-institutional-bi-295023.html 0.6 2026-08-07T06:54:18+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-services-completes-3-fda-inspe-295024.html 0.6 2026-04-18T17:26:44+08:00 daily https://www.pharmasources.com/industryinsights/ips-expands-leadership-team-295025.html 0.6 2026-06-16T15:43:41+08:00 daily https://www.pharmasources.com/industryinsights/lonza-acquires-pharmacell-295026.html 0.6 2026-04-12T12:05:47+08:00 daily https://www.pharmasources.com/industryinsights/recording-artist-sir-ivan-releases-new-a-295027.html 0.6 2026-06-17T22:38:22+08:00 daily https://www.pharmasources.com/industryinsights/orbusneich-announces-fda-clearance-launc-295028.html 0.6 2026-07-18T02:19:12+08:00 daily https://www.pharmasources.com/industryinsights/activate-and-firstbeat-collaboration-mak-295029.html 0.6 2026-04-20T16:34:54+08:00 daily https://www.pharmasources.com/industryinsights/ibm-announces-partnership-with-baheal-gr-295030.html 0.6 2026-08-06T20:41:37+08:00 daily https://www.pharmasources.com/industryinsights/f-star-expands-relationship-with-merck-t-295031.html 0.6 2026-03-01T02:58:23+08:00 daily https://www.pharmasources.com/industryinsights/iso-guide-34-and-isoiec-17025-and-the-va-295032.html 0.6 2026-07-17T15:16:42+08:00 daily https://www.pharmasources.com/industryinsights/chikungunya-vaccines-themis-bharat-biote-295033.html 0.6 2026-08-06T05:45:21+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-novo-takeda-take-home-honors-in-p-295034.html 0.6 2026-06-17T11:08:27+08:00 daily https://www.pharmasources.com/industryinsights/chinese-car-t-results-offer-hope-of-myel-295035.html 0.6 2026-06-13T14:16:46+08:00 daily https://www.pharmasources.com/industryinsights/1-in-6-us-patients-are-given-wrong-dose--295036.html 0.6 2026-02-01T04:44:02+08:00 daily https://www.pharmasources.com/industryinsights/puma-gains-as-roche-breast-cancer-combo--295037.html 0.6 2026-04-14T03:00:46+08:00 daily https://www.pharmasources.com/industryinsights/takeda-launches-construction-of-40-milli-295038.html 0.6 2026-06-06T05:03:19+08:00 daily https://www.pharmasources.com/industryinsights/unprecedented-car-t-data-shows-100-respo-295039.html 0.6 2026-06-17T01:34:53+08:00 daily https://www.pharmasources.com/industryinsights/asco-round-up-zytiga-shines-in-frontline-295040.html 0.6 2026-03-27T01:42:17+08:00 daily https://www.pharmasources.com/industryinsights/acasti-pharma-and-cordenpharma-announce--295041.html 0.6 2026-06-23T03:27:05+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-contract-manufacturingcon-295042.html 0.6 2026-08-07T12:01:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-expanded-use-of-sapien-3-arti-295043.html 0.6 2026-06-17T04:18:12+08:00 daily https://www.pharmasources.com/industryinsights/acasti-pharma-and-cordenpharma-team-up-295044.html 0.6 2026-04-09T15:47:11+08:00 daily https://www.pharmasources.com/industryinsights/bilcares-footprint-grows-in-mexico-295045.html 0.6 2026-06-11T04:10:05+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-introduces-new-eu-fmd-complian-295046.html 0.6 2026-07-17T06:07:13+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-expands-agreement-with-sanaria-295047.html 0.6 2026-04-14T02:44:40+08:00 daily https://www.pharmasources.com/industryinsights/tapemark-passes-regulatory-hurdle-295048.html 0.6 2026-07-05T11:14:50+08:00 daily https://www.pharmasources.com/industryinsights/costs-for-generic-hepatitis-c-drugs-in-i-295049.html 0.6 2026-02-01T04:41:15+08:00 daily https://www.pharmasources.com/industryinsights/lubrizol-unveils-60m-expansion-plan-295050.html 0.6 2026-01-12T21:40:20+08:00 daily https://www.pharmasources.com/industryinsights/amri-bought-for-922m-295051.html 0.6 2026-01-12T21:38:22+08:00 daily https://www.pharmasources.com/industryinsights/biosimilar-trastuzumab-candidate-shown-s-295052.html 0.6 2026-08-06T08:57:42+08:00 daily https://www.pharmasources.com/industryinsights/aptuit-announces-strategic-provider-agre-295053.html 0.6 2026-06-13T19:06:04+08:00 daily https://www.pharmasources.com/industryinsights/shangpharma-innovation-names-new-executi-295054.html 0.6 2026-03-19T23:24:54+08:00 daily https://www.pharmasources.com/industryinsights/new-who-designation-for-oxygen-could-sav-295055.html 0.6 2026-01-12T21:34:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zerviate-295056.html 0.6 2026-06-19T18:33:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-two-month-aristada-for-trea-295057.html 0.6 2026-06-04T10:33:45+08:00 daily https://www.pharmasources.com/industryinsights/could-us-election-results-be-harmful-to--295058.html 0.6 2026-04-25T10:04:05+08:00 daily https://www.pharmasources.com/industryinsights/study-confirms-link-between-sglt2-inhibi-295059.html 0.6 2026-07-26T13:01:32+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-blocks-drug-heroin-high-in-tests-295060.html 0.6 2026-05-02T02:52:04+08:00 daily https://www.pharmasources.com/industryinsights/horizon-discovery-introduces-four-braf-r-295061.html 0.6 2026-05-07T18:49:32+08:00 daily https://www.pharmasources.com/industryinsights/vanrx-pharmasystems-appoints-shreedhar-i-295062.html 0.6 2026-03-17T18:26:55+08:00 daily https://www.pharmasources.com/industryinsights/bone-metastasis-therapeutic-pipeline-rev-295063.html 0.6 2026-03-09T03:35:35+08:00 daily https://www.pharmasources.com/industryinsights/waters-collaborates-withwyatt-295064.html 0.6 2026-03-17T20:23:53+08:00 daily https://www.pharmasources.com/industryinsights/unichem-laboratories-gets-eir-for-ghazia-295065.html 0.6 2026-06-19T05:54:26+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-to-distribute-helsinns-cin-295066.html 0.6 2026-02-01T04:41:06+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-secures-rights-to-ibcs-research-295067.html 0.6 2026-04-20T07:04:13+08:00 daily https://www.pharmasources.com/industryinsights/taking-the-initiative-for-a-healthy-work-295068.html 0.6 2026-04-16T15:21:13+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gets-creative-in-pricing-next-g-295069.html 0.6 2026-08-03T06:54:16+08:00 daily https://www.pharmasources.com/industryinsights/inu-launches-joint-masters-program-in-pu-295070.html 0.6 2026-07-09T18:55:00+08:00 daily https://www.pharmasources.com/industryinsights/sleep-scratcher-nestl-skin-healths-got-a-295071.html 0.6 2026-04-05T08:42:54+08:00 daily https://www.pharmasources.com/industryinsights/japans-sawai-gets-us-production-with-1b--295072.html 0.6 2026-06-30T02:57:06+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-significantly-reduces-risk-of-d-295073.html 0.6 2026-07-01T16:37:30+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-june-7-2017-295074.html 0.6 2026-04-17T04:16:15+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-blocks-drug-heroin-high-in-tests-295075.html 0.6 2026-04-13T06:37:03+08:00 daily https://www.pharmasources.com/industryinsights/ich-flooded-the-screen-chinas-joining-of-295076.html 0.6 2026-06-17T23:39:13+08:00 daily https://www.pharmasources.com/industryinsights/chinese-pharmaceutical-enterprises-liste-295077.html 0.6 2026-07-07T13:22:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-requests-removal-of-certain-prescrip-295078.html 0.6 2026-06-22T14:25:48+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-extends-its-child-resistant-295079.html 0.6 2026-06-08T18:39:31+08:00 daily https://www.pharmasources.com/industryinsights/zuellig-pharma-invests-in-healthtech-sta-295080.html 0.6 2026-03-15T09:46:40+08:00 daily https://www.pharmasources.com/industryinsights/3d-heart-tissue-created-for-drug-testing-295081.html 0.6 2026-07-09T16:01:00+08:00 daily https://www.pharmasources.com/industryinsights/korean-drugs-to-hit-the-market-295082.html 0.6 2026-01-12T21:06:56+08:00 daily https://www.pharmasources.com/industryinsights/ace-swimmer-micheal-phelps-joins-austral-295083.html 0.6 2026-01-31T01:31:32+08:00 daily https://www.pharmasources.com/industryinsights/taiwan-china-pharma-association-opens-ne-295084.html 0.6 2026-07-19T08:43:06+08:00 daily https://www.pharmasources.com/industryinsights/a-translational-research-collaboration-295085.html 0.6 2026-06-29T07:36:35+08:00 daily https://www.pharmasources.com/industryinsights/an-improved-tool-to-detect-cancer-295086.html 0.6 2026-01-12T21:02:55+08:00 daily https://www.pharmasources.com/industryinsights/vaginal-bacteria-may-affect-herpes-and-z-295087.html 0.6 2026-01-22T04:04:24+08:00 daily https://www.pharmasources.com/industryinsights/experimental-zika-vaccine-protects-mice--295088.html 0.6 2026-04-03T03:56:06+08:00 daily https://www.pharmasources.com/industryinsights/switching-to-tresiba-provides-significan-295089.html 0.6 2026-01-30T18:23:37+08:00 daily https://www.pharmasources.com/industryinsights/patient-blood-management-landmark-study--295090.html 0.6 2026-03-01T04:39:20+08:00 daily https://www.pharmasources.com/industryinsights/msd-investment-confirms-thriving-biophar-295091.html 0.6 2026-03-29T13:57:39+08:00 daily https://www.pharmasources.com/industryinsights/vertex-in-long-term-reimbursement-agreem-295092.html 0.6 2026-06-24T08:12:52+08:00 daily https://www.pharmasources.com/industryinsights/asia-pacific-asthma-market-will-hit-6-bi-295093.html 0.6 2026-07-25T13:57:32+08:00 daily https://www.pharmasources.com/industryinsights/global-study-sets-new-standard-to-person-295094.html 0.6 2026-04-09T18:18:02+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-significantly-reduces-risk-of-d-295095.html 0.6 2026-02-28T13:18:15+08:00 daily https://www.pharmasources.com/industryinsights/vetter-and-microdermics-in-strategic-coo-295096.html 0.6 2026-07-05T08:27:39+08:00 daily https://www.pharmasources.com/industryinsights/successful-aaalac-accreditation-for-envi-295097.html 0.6 2026-04-12T03:41:04+08:00 daily https://www.pharmasources.com/industryinsights/sciex-launches-swath-data-independent-ac-295098.html 0.6 2026-04-05T20:25:01+08:00 daily https://www.pharmasources.com/industryinsights/fdas-move-could-mean-endo-suffers-from-o-295099.html 0.6 2026-03-29T04:58:21+08:00 daily https://www.pharmasources.com/industryinsights/shp465-back-in-front-of-the-fda-and-data-295100.html 0.6 2026-08-08T02:40:58+08:00 daily https://www.pharmasources.com/industryinsights/snippet-roundup-shires-lialda-goes-gener-295101.html 0.6 2026-04-20T21:21:25+08:00 daily https://www.pharmasources.com/industryinsights/ozone-pharma-introduces-dfo-4x-gel-295102.html 0.6 2026-01-12T20:54:49+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-extends-its-cr-nasal-pump-m-295103.html 0.6 2026-06-28T13:27:52+08:00 daily https://www.pharmasources.com/industryinsights/copd-market-set-to-hit-141-billion-by-20-295104.html 0.6 2026-08-05T21:38:28+08:00 daily https://www.pharmasources.com/industryinsights/top-ten-most-read-pages-on-pharmafilecom-295105.html 0.6 2026-08-07T02:24:11+08:00 daily https://www.pharmasources.com/industryinsights/continuous-manufacturing-novartis-experi-295106.html 0.6 2026-07-04T08:04:33+08:00 daily https://www.pharmasources.com/industryinsights/lilly-bolsters-diabetes-assets-with-55m--295107.html 0.6 2026-08-08T01:14:19+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-loses-15-million-depakote-birth-d-295108.html 0.6 2026-06-13T20:43:03+08:00 daily https://www.pharmasources.com/industryinsights/actelion-spin-off-hit-by-blow-shortly-be-295109.html 0.6 2026-04-08T17:12:59+08:00 daily https://www.pharmasources.com/industryinsights/sawai-pharmaceutical-completes-acquisiti-295110.html 0.6 2026-04-13T04:52:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-makes-unprecedented-move-asks-endo-t-295111.html 0.6 2026-08-08T01:33:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-requests-removal-of-opana-er-for-ris-295112.html 0.6 2026-04-22T18:34:59+08:00 daily https://www.pharmasources.com/industryinsights/top-10-diabetes-drugs-by-2016-sales-295113.html 0.6 2026-07-06T11:57:24+08:00 daily https://www.pharmasources.com/industryinsights/mindbeagle-the-first-eeg-based-bci-syste-295114.html 0.6 2026-04-30T16:19:51+08:00 daily https://www.pharmasources.com/industryinsights/tresiba-demonstrated-no-increased-risk-o-295115.html 0.6 2026-06-16T15:04:40+08:00 daily https://www.pharmasources.com/industryinsights/new-leukemia-treatment-outperforms-stand-295116.html 0.6 2026-05-23T23:31:15+08:00 daily https://www.pharmasources.com/industryinsights/adherium-appoints-new-ceo-to-drive-globa-295117.html 0.6 2026-01-12T21:09:57+08:00 daily https://www.pharmasources.com/industryinsights/what-does-a-hung-parliament-mean-for-uk--295118.html 0.6 2026-01-12T21:11:03+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-hikes-us-prices-of-91-drugs-295119.html 0.6 2026-06-08T10:04:38+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-extends-nasal-pump-manufact-295120.html 0.6 2026-06-08T09:38:09+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-to-commercialise-non-narcotic-m-295121.html 0.6 2026-08-07T23:11:39+08:00 daily https://www.pharmasources.com/industryinsights/celgene-dragonfly-enter-strategic-trinke-295122.html 0.6 2026-01-12T21:15:03+08:00 daily https://www.pharmasources.com/industryinsights/interview-german-merck-doubles-down-on-d-295123.html 0.6 2026-01-31T02:40:53+08:00 daily https://www.pharmasources.com/industryinsights/kamada-receives-additional-shire-milesto-295124.html 0.6 2026-01-31T10:11:51+08:00 daily https://www.pharmasources.com/industryinsights/risk-benefit-or-cost-what-stops-patients-295125.html 0.6 2026-07-02T21:57:23+08:00 daily https://www.pharmasources.com/industryinsights/biontech-brings-antibody-production-into-295126.html 0.6 2026-03-13T20:35:28+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-ambr-1-295127.html 0.6 2026-04-23T09:47:03+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-requests-endo-pharmaceuticals-to--295128.html 0.6 2026-04-08T06:04:45+08:00 daily https://www.pharmasources.com/industryinsights/aptuit-regulus-in-strategic-provider-pac-295129.html 0.6 2026-01-12T21:20:07+08:00 daily https://www.pharmasources.com/industryinsights/atum-and-horizon-discovery-announce-coll-295130.html 0.6 2026-04-21T13:06:32+08:00 daily https://www.pharmasources.com/industryinsights/interview-german-merck-doubles-down-on-d-295131.html 0.6 2026-04-01T07:00:38+08:00 daily https://www.pharmasources.com/industryinsights/xencor-appoints-biology-vp-295132.html 0.6 2026-06-12T02:28:40+08:00 daily https://www.pharmasources.com/industryinsights/canvas-paints-a-mixed-picture-for-jjs-in-295133.html 0.6 2026-04-07T18:27:49+08:00 daily https://www.pharmasources.com/industryinsights/veloxis-pharmaceuticals-as-announces-agr-295134.html 0.6 2026-03-27T00:03:36+08:00 daily https://www.pharmasources.com/industryinsights/precision-medicine-data-on-ds-8201-295135.html 0.6 2026-04-13T06:40:55+08:00 daily https://www.pharmasources.com/industryinsights/lexicon-pharma-goes-three-for-three-with-295136.html 0.6 2026-06-12T02:24:58+08:00 daily https://www.pharmasources.com/industryinsights/nemametrix-introduces-fluorescent-staini-295137.html 0.6 2026-06-28T19:19:38+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-builds-digital-lab--295138.html 0.6 2026-06-08T01:22:09+08:00 daily https://www.pharmasources.com/industryinsights/drug-costs-vary-by-more-than-600-in-stud-295139.html 0.6 2026-08-06T00:25:49+08:00 daily https://www.pharmasources.com/industryinsights/flypharma-conference-2017---collaboratio-295140.html 0.6 2026-06-05T11:44:43+08:00 daily https://www.pharmasources.com/industryinsights/smc-reverses-decision-on-opdivo-for-kidn-295141.html 0.6 2026-06-16T08:17:00+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-directly-linked-to-bmi-295142.html 0.6 2026-04-13T23:27:13+08:00 daily https://www.pharmasources.com/industryinsights/oppi-hosted-its-sixth-healthcare-accesss-295143.html 0.6 2026-03-25T02:09:55+08:00 daily https://www.pharmasources.com/industryinsights/teva-conducts-boardroom-shuffle-with-fou-295144.html 0.6 2026-04-20T01:09:00+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-posts-positive-pral-295145.html 0.6 2026-08-06T02:57:25+08:00 daily https://www.pharmasources.com/industryinsights/ecron-acunova-to-offer-end-to-end-capabi-295146.html 0.6 2026-04-13T22:18:51+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-loses-15-million-depakote-birth-d-295147.html 0.6 2026-01-12T21:40:22+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-keybioscience-collaborate-to-d-295148.html 0.6 2026-03-11T18:44:55+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-june-12-2017-295149.html 0.6 2026-03-20T01:55:08+08:00 daily https://www.pharmasources.com/industryinsights/a-monkeys-smile-may-not-be-sweet-295150.html 0.6 2026-01-12T21:44:23+08:00 daily https://www.pharmasources.com/industryinsights/could-your-breakfast-cloud-your-judgment-295151.html 0.6 2026-01-12T21:45:26+08:00 daily https://www.pharmasources.com/industryinsights/beans-or-sizzlin-beans-words-get-people--295152.html 0.6 2026-08-06T00:58:27+08:00 daily https://www.pharmasources.com/industryinsights/valeant-pharmaceuticals-to-sell-inova-bu-295153.html 0.6 2026-01-15T22:03:58+08:00 daily https://www.pharmasources.com/industryinsights/stay-safe-as-summer-temps-soar-295154.html 0.6 2026-08-07T00:51:42+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biotechnologie-and-rentschler-295155.html 0.6 2026-01-17T11:59:54+08:00 daily https://www.pharmasources.com/industryinsights/centogene-raises-a-eur-25-million-series-295156.html 0.6 2026-02-14T23:24:04+08:00 daily https://www.pharmasources.com/industryinsights/zytoprotecs-novel-dialysis-product-meets-295157.html 0.6 2026-06-16T15:27:45+08:00 daily https://www.pharmasources.com/industryinsights/genomic-health-new-data-show-important-r-295158.html 0.6 2026-01-12T21:51:28+08:00 daily https://www.pharmasources.com/industryinsights/one-footprint-multiple-set-ups-with-syrr-295159.html 0.6 2026-07-06T23:17:10+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-to-usher-in-new--295160.html 0.6 2026-06-06T09:10:35+08:00 daily https://www.pharmasources.com/industryinsights/ashfield-appoints-new-regional-president-295161.html 0.6 2026-06-15T11:42:56+08:00 daily https://www.pharmasources.com/industryinsights/bayer-grants4apps-dealmaker-berlin-2017-295162.html 0.6 2026-06-22T12:24:51+08:00 daily https://www.pharmasources.com/industryinsights/lillys-galcanezumab-significantly-reduce-295163.html 0.6 2026-04-15T20:50:49+08:00 daily https://www.pharmasources.com/industryinsights/tekni-plex-announces-15-million-investme-295164.html 0.6 2026-02-28T11:47:08+08:00 daily https://www.pharmasources.com/industryinsights/major-boost-for-combatting-drug-addictio-295165.html 0.6 2026-06-24T09:01:24+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-lilly-receive-fda-fast-track--295166.html 0.6 2026-08-03T19:21:20+08:00 daily https://www.pharmasources.com/industryinsights/new-funding-for-phiskin-295167.html 0.6 2026-06-28T19:47:03+08:00 daily https://www.pharmasources.com/industryinsights/new-who-designation-for-oxygen-295168.html 0.6 2026-01-12T22:01:32+08:00 daily https://www.pharmasources.com/industryinsights/eur-25-million-series-a-financing-raised-295169.html 0.6 2026-07-18T11:42:24+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gilead-eyeing-the-takeover-of-tes-295170.html 0.6 2026-04-14T02:35:19+08:00 daily https://www.pharmasources.com/industryinsights/snake-venom-may-replace-aspirin-295171.html 0.6 2026-02-28T13:21:47+08:00 daily https://www.pharmasources.com/industryinsights/mindbeagle-the-first-eeg-based-bci-syste-295172.html 0.6 2026-08-09T10:21:01+08:00 daily https://www.pharmasources.com/industryinsights/new-long-acting-insulin-therapy-demonstr-295173.html 0.6 2026-01-12T22:06:39+08:00 daily https://www.pharmasources.com/industryinsights/university-of-maryland-team-lands-6m-in--295174.html 0.6 2026-01-12T22:07:37+08:00 daily https://www.pharmasources.com/industryinsights/cancer-vaccine-developer-targovax-pulls--295175.html 0.6 2026-01-12T22:08:36+08:00 daily https://www.pharmasources.com/industryinsights/response-to-mercks-ebola-vaccine-lasts-a-295176.html 0.6 2026-06-27T13:55:43+08:00 daily https://www.pharmasources.com/industryinsights/irvine-scientific-expands-in-southern-ca-295177.html 0.6 2026-07-03T14:25:48+08:00 daily https://www.pharmasources.com/industryinsights/corerx-aimmune-unveil-joint-expansion-295178.html 0.6 2026-03-03T11:13:13+08:00 daily https://www.pharmasources.com/industryinsights/olon-spa-acquires-part-of-ricerca-biosci-295179.html 0.6 2026-04-07T00:33:08+08:00 daily https://www.pharmasources.com/industryinsights/numerate-and-takeda-enter-drug-discovery-295180.html 0.6 2026-06-16T00:33:34+08:00 daily https://www.pharmasources.com/industryinsights/uhlmann-acquires-cremer-speciaalmachines-295181.html 0.6 2026-04-07T18:40:24+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biotechnologie-and-rentschler-295182.html 0.6 2026-06-16T04:40:23+08:00 daily https://www.pharmasources.com/industryinsights/croma-pharma-announces-two-major-milesto-295183.html 0.6 2026-06-19T04:19:28+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-is-officially-listed-on-t-295184.html 0.6 2026-07-20T13:00:19+08:00 daily https://www.pharmasources.com/industryinsights/new-leader-analysis-shows-victozar-reduc-295185.html 0.6 2026-04-01T00:40:31+08:00 daily https://www.pharmasources.com/industryinsights/astar-scientists-discovery-on-gastric-ca-295186.html 0.6 2026-07-01T08:18:55+08:00 daily https://www.pharmasources.com/industryinsights/iil-to-expand-its-protozoan-vaccineportf-295187.html 0.6 2026-04-03T13:59:12+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-industry-scores-poorly-on--295188.html 0.6 2026-06-09T06:35:50+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-certain-genetic-faults-help--295189.html 0.6 2026-04-13T20:41:39+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-johnson-joh-295190.html 0.6 2025-12-11T07:28:57+08:00 daily https://www.pharmasources.com/industryinsights/teva-pharmaceutical-launches-generic-all-295191.html 0.6 2026-05-28T17:57:49+08:00 daily https://www.pharmasources.com/industryinsights/csl-to-acquire-majority-stake-in-chinese-295192.html 0.6 2026-07-19T12:59:21+08:00 daily https://www.pharmasources.com/industryinsights/ibbr-awarded-6m-nih-grant-for-structure--295193.html 0.6 2026-05-10T11:31:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-provides-update-on-multiple-myelom-295194.html 0.6 2026-04-17T17:56:21+08:00 daily https://www.pharmasources.com/industryinsights/amgens-myeloma-treatment-kyprolis-gains--295195.html 0.6 2026-06-18T11:25:30+08:00 daily https://www.pharmasources.com/industryinsights/insulet-has-a-challenger-for-medtronic-o-295196.html 0.6 2026-07-01T05:13:53+08:00 daily https://www.pharmasources.com/industryinsights/starpharma-sells-crop-chemical-business--295197.html 0.6 2026-06-27T03:43:23+08:00 daily https://www.pharmasources.com/industryinsights/first-crispr-patent-for-milliporesigma-295198.html 0.6 2026-03-13T20:11:30+08:00 daily https://www.pharmasources.com/industryinsights/nyc-center-receives-75-million-nih-funds-295199.html 0.6 2026-04-22T06:19:28+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approves-the-generic-version-of-li-295200.html 0.6 2025-12-14T20:51:26+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-used-for-treatme-295201.html 0.6 2025-12-14T20:53:38+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-lillys-olaratumab-lartru-295202.html 0.6 2026-06-17T07:10:34+08:00 daily https://www.pharmasources.com/industryinsights/csl-acquires-major-stake-in-ruide-china-295203.html 0.6 2026-01-07T18:31:26+08:00 daily https://www.pharmasources.com/industryinsights/scotland-approves-ipsens-cabozantinib-to-295204.html 0.6 2026-02-15T11:28:43+08:00 daily https://www.pharmasources.com/industryinsights/qiagens-quantiferon-tb-gold-plus-gains-u-295205.html 0.6 2026-08-08T00:53:58+08:00 daily https://www.pharmasources.com/industryinsights/leading-european-health-start-ups-join-f-295206.html 0.6 2026-07-04T19:07:17+08:00 daily https://www.pharmasources.com/industryinsights/aptuit-announces-agreement-with-regulus--295207.html 0.6 2026-04-26T03:10:08+08:00 daily https://www.pharmasources.com/industryinsights/bosch-launches-a-pilot-fermenter-for-man-295208.html 0.6 2026-04-07T03:03:57+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-pharmacists-knew-more-about--295209.html 0.6 2026-07-07T00:09:20+08:00 daily https://www.pharmasources.com/industryinsights/thornhill-medicals-portable-emergency-li-295210.html 0.6 2026-03-13T14:30:33+08:00 daily https://www.pharmasources.com/industryinsights/roches-employee-driven-philanthropic-cam-295211.html 0.6 2026-03-28T16:02:18+08:00 daily https://www.pharmasources.com/industryinsights/jardiance-empagliflozin-analysis-reinfor-295212.html 0.6 2026-06-25T17:04:54+08:00 daily https://www.pharmasources.com/industryinsights/numerate-to-develop-ai-driven-clinical-c-295213.html 0.6 2025-12-31T22:00:16+08:00 daily https://www.pharmasources.com/industryinsights/csl-to-purchase-80-stake-in-chinese-firm-295214.html 0.6 2026-05-31T18:06:14+08:00 daily https://www.pharmasources.com/industryinsights/sienna-biopharmaceuticals-appoints-erle--295215.html 0.6 2026-06-08T19:46:03+08:00 daily https://www.pharmasources.com/industryinsights/baxter-announces-agreement-with-dorizoe--295216.html 0.6 2025-12-14T21:08:51+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-awarded-its-first-crispr--295217.html 0.6 2025-12-14T21:09:55+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-voluntarily-recalls-295218.html 0.6 2026-07-20T23:46:27+08:00 daily https://www.pharmasources.com/industryinsights/biotech-vtv-believes-small-molecule-glp--295219.html 0.6 2025-12-14T21:12:09+08:00 daily https://www.pharmasources.com/industryinsights/sex-specific-cardiovascular-drug-dosages-295220.html 0.6 2026-08-03T22:11:22+08:00 daily https://www.pharmasources.com/industryinsights/nk-ingredients-singapore-site-receives-e-295221.html 0.6 2026-07-07T06:59:17+08:00 daily https://www.pharmasources.com/industryinsights/aspen-fined-r737m-by-italian-competition-295222.html 0.6 2026-06-24T10:10:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-shows-improvements-in--295223.html 0.6 2026-01-03T16:49:12+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-extractables-and-leachables--295224.html 0.6 2025-12-14T21:17:34+08:00 daily https://www.pharmasources.com/industryinsights/new-chemoprevention-trial-hopes-to-stop--295225.html 0.6 2025-12-14T21:18:38+08:00 daily https://www.pharmasources.com/industryinsights/florida-congressional-members-want-us-ar-295226.html 0.6 2026-02-15T14:18:37+08:00 daily https://www.pharmasources.com/industryinsights/nhs-pharma-industry-and-others-form-brex-295227.html 0.6 2026-06-03T18:28:10+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-spends-keytruda-cash-on-rd-ignor-295228.html 0.6 2026-01-18T15:19:43+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-expands-european-hq-to-accommo-295229.html 0.6 2026-03-26T15:26:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-pfizers-all-drug-besponsa-295230.html 0.6 2026-06-17T20:10:07+08:00 daily https://www.pharmasources.com/industryinsights/multiple-myeloma-patients-to-get-nhs-acc-295231.html 0.6 2026-03-17T19:39:58+08:00 daily https://www.pharmasources.com/industryinsights/oral-insulin-could-still-be-a-reality-sa-295232.html 0.6 2026-07-06T01:20:22+08:00 daily https://www.pharmasources.com/industryinsights/crowdsourcing-campaign-looks-to-improve--295233.html 0.6 2026-02-06T08:10:22+08:00 daily https://www.pharmasources.com/industryinsights/four-new-medicines-win-nod-for-nhs-scotl-295234.html 0.6 2026-01-12T21:38:33+08:00 daily https://www.pharmasources.com/industryinsights/az-unveils-new-data-on-farxiga-backing-e-295235.html 0.6 2026-03-07T08:33:43+08:00 daily https://www.pharmasources.com/industryinsights/smc-rejects-perjeta-pertuzumab-for-nhs-u-295236.html 0.6 2025-12-14T21:30:37+08:00 daily https://www.pharmasources.com/industryinsights/pharma-heads-launch-alliance-for-transpa-295237.html 0.6 2026-02-28T10:35:13+08:00 daily https://www.pharmasources.com/industryinsights/ccdc-selects-dotmatics-to-support-2d-que-295238.html 0.6 2026-04-02T06:52:54+08:00 daily https://www.pharmasources.com/industryinsights/chr-hansen-expands-strain-library-295239.html 0.6 2026-01-31T09:57:56+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-presents-phase-iii--295240.html 0.6 2026-06-08T16:59:59+08:00 daily https://www.pharmasources.com/industryinsights/tresiba-demonstrated-no-increased-risk-o-295241.html 0.6 2025-12-14T21:36:04+08:00 daily https://www.pharmasources.com/industryinsights/roches-employee-driven-philanthropic-cam-295242.html 0.6 2025-12-14T21:37:09+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-confirmatory-295243.html 0.6 2025-12-14T21:38:13+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-grants-a-license-for-human-lym-295244.html 0.6 2026-08-04T15:20:47+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-initiates-promotion-of-295245.html 0.6 2026-08-07T21:52:02+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-parexel-collaborate-on-wearable-d-295246.html 0.6 2026-08-08T16:45:20+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-expands-public-health-eng-295247.html 0.6 2026-04-15T09:45:55+08:00 daily https://www.pharmasources.com/industryinsights/the-big-era-for-investment-of-rnai-drugs-295248.html 0.6 2026-03-03T05:16:26+08:00 daily https://www.pharmasources.com/industryinsights/mikart-presents-serialization-from-bottl-295249.html 0.6 2026-01-20T14:59:27+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-capabilities-in-china-295250.html 0.6 2025-12-14T21:45:56+08:00 daily https://www.pharmasources.com/industryinsights/biopharmx-invited-to-present-at-world-pr-295251.html 0.6 2025-12-14T21:47:05+08:00 daily https://www.pharmasources.com/industryinsights/15-million-investment-by-tekni--plex-295252.html 0.6 2025-12-14T21:48:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-biomarins-manufacturing-fac-295253.html 0.6 2026-03-17T20:33:09+08:00 daily https://www.pharmasources.com/industryinsights/initial-successes-in-treating-a-hitherto-295254.html 0.6 2026-03-18T23:35:47+08:00 daily https://www.pharmasources.com/industryinsights/is-the-finger-stick-blood-test-necessary-295255.html 0.6 2026-02-11T23:08:01+08:00 daily https://www.pharmasources.com/industryinsights/smc-rejects-perjetapertuzumab-for-nhs-us-295256.html 0.6 2026-01-02T01:51:04+08:00 daily https://www.pharmasources.com/industryinsights/pharma-heads-launch-alliance-for-transpa-295257.html 0.6 2026-07-09T08:43:26+08:00 daily https://www.pharmasources.com/industryinsights/gilead-submits-drug-application-to-fda-f-295258.html 0.6 2026-08-03T13:44:18+08:00 daily https://www.pharmasources.com/industryinsights/waters-and-andrew-alliance-sign-co-marke-295259.html 0.6 2026-04-09T18:46:38+08:00 daily https://www.pharmasources.com/industryinsights/f-star-expands-its-relationship-with-mer-295260.html 0.6 2026-07-23T23:51:37+08:00 daily https://www.pharmasources.com/industryinsights/trutag-to-showcase-on-dose-authenticatio-295261.html 0.6 2026-05-07T10:29:08+08:00 daily https://www.pharmasources.com/industryinsights/globaldata-study-reveals-decline-in-roi--295262.html 0.6 2026-08-09T10:58:15+08:00 daily https://www.pharmasources.com/industryinsights/rd-leaders-congregate-at-fdd-conclave201-295263.html 0.6 2026-04-27T10:03:10+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-wellbutrin-xl-tab-295264.html 0.6 2026-07-02T18:17:36+08:00 daily https://www.pharmasources.com/industryinsights/neurotoxin-in-cigarette-smoke-worsens-pa-295265.html 0.6 2026-07-04T22:39:58+08:00 daily https://www.pharmasources.com/industryinsights/integral-molecular-begins-immuno-oncolog-295266.html 0.6 2026-04-06T23:09:22+08:00 daily https://www.pharmasources.com/industryinsights/eco-petroleum-acquires-immunotech-labora-295267.html 0.6 2026-04-12T04:43:47+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-carma-therapeutics-vecto-295268.html 0.6 2026-04-01T07:33:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-adamis-cheaper-rival-to-epi-295269.html 0.6 2026-06-17T10:53:10+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-is-game-changer-in-deliver-295270.html 0.6 2026-07-04T20:24:28+08:00 daily https://www.pharmasources.com/industryinsights/bia-report-shows-uk-on-track-to-be-world-295271.html 0.6 2026-03-01T01:36:33+08:00 daily https://www.pharmasources.com/industryinsights/valeant-announces-sale-of-inova-pharmace-295272.html 0.6 2026-04-05T12:46:11+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-at-the-bio-interna-295273.html 0.6 2026-04-09T03:09:52+08:00 daily https://www.pharmasources.com/industryinsights/endpoint-and-smartaction-partner-to-auto-295274.html 0.6 2026-01-12T01:01:23+08:00 daily https://www.pharmasources.com/industryinsights/new-industry-forum-to-advance-clinical-t-295275.html 0.6 2026-06-22T11:27:35+08:00 daily https://www.pharmasources.com/industryinsights/aam-praises-supreme-court-ruling-grantin-295276.html 0.6 2026-07-09T02:44:20+08:00 daily https://www.pharmasources.com/industryinsights/ema-action-plan-supports-smes-as-drivers-295277.html 0.6 2026-08-09T11:26:42+08:00 daily https://www.pharmasources.com/industryinsights/ema-issues-guidance-document-in-preparat-295278.html 0.6 2026-02-25T11:20:03+08:00 daily https://www.pharmasources.com/industryinsights/new-testing-helps-medical-device-manufac-295279.html 0.6 2025-12-14T22:16:31+08:00 daily https://www.pharmasources.com/industryinsights/switching-to-tresiba-295280.html 0.6 2026-04-14T18:53:49+08:00 daily https://www.pharmasources.com/industryinsights/orum-therapeutics-raises-8-million-serie-295281.html 0.6 2026-07-04T02:27:16+08:00 daily https://www.pharmasources.com/industryinsights/leader-analysis-shows-victozar-reduces-c-295282.html 0.6 2026-08-06T21:59:58+08:00 daily https://www.pharmasources.com/industryinsights/merck-ventures-creates-new-immuno-oncolo-295283.html 0.6 2026-08-06T22:12:29+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-that-lowers-cholesterol-offers-h-295284.html 0.6 2026-08-06T22:20:56+08:00 daily https://www.pharmasources.com/industryinsights/gene-variant-protecting-against-alzheime-295285.html 0.6 2026-08-06T23:54:50+08:00 daily https://www.pharmasources.com/industryinsights/roche-pfizer-and-aspen-under-investigati-295286.html 0.6 2026-08-07T00:02:03+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-sandozs-rixathon-for-blood-c-295287.html 0.6 2026-06-08T00:56:39+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-halts-trials-of-latest--295288.html 0.6 2026-08-07T00:53:14+08:00 daily https://www.pharmasources.com/industryinsights/emas-brexit-relocation-decision-date-ann-295289.html 0.6 2026-08-07T01:19:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-files-migraine-drug-with-ema-295290.html 0.6 2026-08-07T01:27:57+08:00 daily https://www.pharmasources.com/industryinsights/shire-long-acting-adhd-drug-finally-appr-295291.html 0.6 2026-08-07T01:43:00+08:00 daily https://www.pharmasources.com/industryinsights/gsks-new-pharma-chief-miels-to-join-in-s-295292.html 0.6 2026-08-07T01:52:00+08:00 daily https://www.pharmasources.com/industryinsights/smartphone-mental-health-company-mindstr-295293.html 0.6 2026-08-07T02:05:15+08:00 daily https://www.pharmasources.com/industryinsights/novartis-next-generation-eye-drug-outper-295294.html 0.6 2026-08-07T02:15:41+08:00 daily https://www.pharmasources.com/industryinsights/clovis-looks-for-new-drugs-after-rubraca-295295.html 0.6 2026-08-07T12:03:47+08:00 daily https://www.pharmasources.com/industryinsights/alvogen-issues-voluntary-nationwide-reca-295296.html 0.6 2026-08-07T13:16:34+08:00 daily https://www.pharmasources.com/industryinsights/victoza-receives-positive-vote-from-fda--295297.html 0.6 2026-08-07T19:39:20+08:00 daily https://www.pharmasources.com/industryinsights/tazemetostat-granted-orphan-drug-designa-295298.html 0.6 2026-08-07T22:00:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-rigels-new-drug-application--295299.html 0.6 2026-08-07T22:34:54+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-announces-advancement-in-cell-ba-295300.html 0.6 2026-08-08T07:54:41+08:00 daily https://www.pharmasources.com/industryinsights/report-global-immunology-drugs-market-to-295301.html 0.6 2026-08-08T23:09:53+08:00 daily https://www.pharmasources.com/industryinsights/kadimastem-receives-approval-for-als-pat-295302.html 0.6 2026-08-09T07:56:37+08:00 daily https://www.pharmasources.com/industryinsights/aveo-oncology-announces-phase-3-tivo-3-s-295303.html 0.6 2025-12-14T22:42:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-amgens-supplemental-biologic-295304.html 0.6 2026-04-17T21:35:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-on-pfizer-drug-shortages-295305.html 0.6 2026-06-29T09:31:47+08:00 daily https://www.pharmasources.com/industryinsights/jj-completes-acquisition-of-actelion-295306.html 0.6 2026-05-27T09:51:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-amgens-sbla-to-expand-indica-295307.html 0.6 2026-06-16T11:45:37+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-licenses-small--295308.html 0.6 2026-08-09T23:52:06+08:00 daily https://www.pharmasources.com/industryinsights/merck-ventures-creates-new-immuno-oncolo-295309.html 0.6 2026-03-28T04:58:09+08:00 daily https://www.pharmasources.com/industryinsights/novartis-achieves-regulatory-milestone-f-295310.html 0.6 2026-06-15T15:06:25+08:00 daily https://www.pharmasources.com/industryinsights/takeda-completes-new-manufacturing-facil-295311.html 0.6 2026-02-14T22:21:19+08:00 daily https://www.pharmasources.com/industryinsights/quva-pharma-announces-availability-of-so-295312.html 0.6 2026-06-11T19:15:37+08:00 daily https://www.pharmasources.com/industryinsights/zuellig-pharma-invests-in-healthcare-sta-295313.html 0.6 2026-03-17T21:52:32+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-announces-the-launc-295314.html 0.6 2026-07-05T17:57:03+08:00 daily https://www.pharmasources.com/industryinsights/discovery-of-protein-mutations-may-lead--295315.html 0.6 2026-03-01T01:11:03+08:00 daily https://www.pharmasources.com/industryinsights/plant-based-medicine-to-treat-alzheimers-295316.html 0.6 2025-12-14T22:56:54+08:00 daily https://www.pharmasources.com/industryinsights/a-type-2-diabetes-drug-found-to-reduce-h-295317.html 0.6 2026-08-07T23:33:35+08:00 daily https://www.pharmasources.com/industryinsights/sunless-tan-now-a-reality-295318.html 0.6 2025-12-14T22:59:05+08:00 daily https://www.pharmasources.com/industryinsights/intake-of-aspirin-increases-bleeding-ris-295319.html 0.6 2026-06-26T04:12:33+08:00 daily https://www.pharmasources.com/industryinsights/new-antibody-for-effective-blood-cancer--295320.html 0.6 2026-06-23T20:26:11+08:00 daily https://www.pharmasources.com/industryinsights/oncoarendi-therapeutics-announces-select-295321.html 0.6 2026-06-30T15:26:58+08:00 daily https://www.pharmasources.com/industryinsights/immune-system-attacks-the-brain-in-alzhe-295322.html 0.6 2025-12-14T23:03:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pulls-off-surprise-success-in-c-295323.html 0.6 2026-02-26T19:43:59+08:00 daily https://www.pharmasources.com/industryinsights/charity-sets-eight-new-grand-challenges--295324.html 0.6 2026-01-16T06:10:51+08:00 daily https://www.pharmasources.com/industryinsights/parexel-to-go-private-in-5bn-deal-295325.html 0.6 2026-02-28T14:10:17+08:00 daily https://www.pharmasources.com/industryinsights/novartis-eye-drug-on-par-with-eylea-but--295326.html 0.6 2026-06-29T12:26:34+08:00 daily https://www.pharmasources.com/industryinsights/dmd-patients-in-the-uk-win-early-access--295327.html 0.6 2025-12-17T19:56:10+08:00 daily https://www.pharmasources.com/industryinsights/shire-secures-us-nod-for-once-daily-adhd-295328.html 0.6 2026-07-23T15:08:12+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-review-novartis-migraine-d-295329.html 0.6 2026-05-03T11:04:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-drug-cuts-cardiovascular-risk-i-295330.html 0.6 2026-06-20T17:53:39+08:00 daily https://www.pharmasources.com/industryinsights/communications-teams---seize-the-opportu-295331.html 0.6 2026-04-24T14:13:33+08:00 daily https://www.pharmasources.com/industryinsights/theranos-reaches-tentative-settlement-wi-295332.html 0.6 2026-04-20T20:42:57+08:00 daily https://www.pharmasources.com/industryinsights/novartis-lung-cancer-combo-receives-fda--295333.html 0.6 2026-04-16T19:38:39+08:00 daily https://www.pharmasources.com/industryinsights/hiv-cases-in-gay-men-fall-for-the-first--295334.html 0.6 2026-04-13T09:16:57+08:00 daily https://www.pharmasources.com/industryinsights/rare-cancers-through-the-looking-glass-295335.html 0.6 2025-12-14T23:17:38+08:00 daily https://www.pharmasources.com/industryinsights/experts-set-out-plan-to-tackle-questiona-295336.html 0.6 2026-04-06T11:48:13+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-introduces-sart-295337.html 0.6 2025-12-14T23:20:00+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-biosimilar-gets-a-second-knock-b-295338.html 0.6 2026-06-29T06:40:10+08:00 daily https://www.pharmasources.com/industryinsights/report-calls-for-action-to-prevent-confu-295339.html 0.6 2026-01-03T17:26:43+08:00 daily https://www.pharmasources.com/industryinsights/uk-among-top-performers-in-access-to-hea-295340.html 0.6 2026-04-04T20:06:48+08:00 daily https://www.pharmasources.com/industryinsights/microfluidics-offers-superior-drug-encap-295341.html 0.6 2026-04-15T19:00:58+08:00 daily https://www.pharmasources.com/industryinsights/rare-cancers-through-the-looking-glass-295342.html 0.6 2026-04-06T02:57:58+08:00 daily https://www.pharmasources.com/industryinsights/abpi-suspends-astellas-uk-for-a-further--295343.html 0.6 2026-01-30T20:17:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-turnaround-for-astrazenecas-copd-dr-295344.html 0.6 2025-12-06T03:40:20+08:00 daily https://www.pharmasources.com/industryinsights/kadcyla-new-deal-means-nice-positive-rec-295345.html 0.6 2025-11-11T22:29:06+08:00 daily https://www.pharmasources.com/industryinsights/pharma-research-firm-apc-has-just-the-ri-295346.html 0.6 2026-04-06T22:15:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-application-for-generic-vers-295347.html 0.6 2026-06-23T10:18:58+08:00 daily https://www.pharmasources.com/industryinsights/genentech-emicizumab-phase-iii-studies-s-295348.html 0.6 2026-06-18T12:00:23+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-trial-needs-to-widen-parti-295349.html 0.6 2026-07-30T14:15:06+08:00 daily https://www.pharmasources.com/industryinsights/merck-awarded-its-first-crispr-patent-295350.html 0.6 2026-06-06T04:46:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rituxan-hycela-rituximab-an-295351.html 0.6 2026-07-06T23:11:54+08:00 daily https://www.pharmasources.com/industryinsights/does-the-emperor-have-clothes-295352.html 0.6 2026-06-02T18:27:12+08:00 daily https://www.pharmasources.com/industryinsights/novos-saxenda-label-to-include-cardio-da-295353.html 0.6 2026-07-17T21:46:48+08:00 daily https://www.pharmasources.com/industryinsights/long-term-consumption-of-caffeine-free-h-295354.html 0.6 2026-08-08T02:48:00+08:00 daily https://www.pharmasources.com/industryinsights/dop-sets-up-facilitation-cell-to-help-co-295355.html 0.6 2026-04-05T20:29:46+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-topicort-lp-emoll-295356.html 0.6 2026-03-03T01:10:40+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-receives-tentative-anda--295357.html 0.6 2026-07-18T03:32:35+08:00 daily https://www.pharmasources.com/industryinsights/cancer-immunotherapy-may-work-in-unexpec-295358.html 0.6 2026-07-17T03:56:37+08:00 daily https://www.pharmasources.com/industryinsights/cruk-launches-next-phase-of-cancer-grand-295359.html 0.6 2026-04-25T11:13:41+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-ceo-supports-childrens-eye--295360.html 0.6 2026-04-18T05:36:27+08:00 daily https://www.pharmasources.com/industryinsights/onoff-group-partners-werum-it-solutions-295361.html 0.6 2026-04-25T11:23:52+08:00 daily https://www.pharmasources.com/industryinsights/irvine-scientific-expands-in-southern-ca-295362.html 0.6 2026-04-02T03:45:53+08:00 daily https://www.pharmasources.com/industryinsights/drrons-insight-robust-experimental-strat-295363.html 0.6 2026-08-06T21:47:18+08:00 daily https://www.pharmasources.com/industryinsights/dear-heller-joins-the-list-of-four-other-295364.html 0.6 2026-06-20T19:13:32+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-projects-best-results-in-company-295365.html 0.6 2026-04-25T11:47:07+08:00 daily https://www.pharmasources.com/industryinsights/rituxan-hycela-approved-by-fda-for-subcu-295366.html 0.6 2026-02-28T15:34:35+08:00 daily https://www.pharmasources.com/industryinsights/gsk-wins-235mn-patent-infringement-case--295367.html 0.6 2026-06-09T12:29:19+08:00 daily https://www.pharmasources.com/industryinsights/sartobind-cassettes-introduced-by-sartor-295368.html 0.6 2026-06-08T20:06:35+08:00 daily https://www.pharmasources.com/industryinsights/baheal-pharma-brings-watson-for-genomics-295369.html 0.6 2026-06-22T13:55:06+08:00 daily https://www.pharmasources.com/industryinsights/bioauxilium-completes-development-of-its-295370.html 0.6 2026-03-08T10:50:53+08:00 daily https://www.pharmasources.com/industryinsights/major-advancement-in-cell-based-influenz-295371.html 0.6 2026-02-25T15:10:44+08:00 daily https://www.pharmasources.com/industryinsights/canopy-biosciences-announces-distributio-295372.html 0.6 2026-04-19T16:07:01+08:00 daily https://www.pharmasources.com/industryinsights/cladribine-tablets-receives-positive-chm-295373.html 0.6 2026-07-11T05:49:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receives-expanded-health-canada-a-295374.html 0.6 2026-07-21T13:33:19+08:00 daily https://www.pharmasources.com/industryinsights/tampered-evidence-and-serialization-295375.html 0.6 2026-08-06T19:30:34+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-introduces-sart-295376.html 0.6 2026-06-12T18:34:51+08:00 daily https://www.pharmasources.com/industryinsights/nutrition-the-microbiome-and-autism-spec-295377.html 0.6 2026-07-06T20:16:51+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-from-bacteria-found-on-kenyan-295378.html 0.6 2026-06-23T15:43:34+08:00 daily https://www.pharmasources.com/industryinsights/wickham-laboratories-expands-sterility-t-295379.html 0.6 2026-06-23T11:30:19+08:00 daily https://www.pharmasources.com/industryinsights/biogens-imraldi-an-adalimumab-biosimilar-295380.html 0.6 2026-08-08T14:37:18+08:00 daily https://www.pharmasources.com/industryinsights/shire-on-haemophilia-how-to-treat-a-blee-295381.html 0.6 2026-07-04T11:54:23+08:00 daily https://www.pharmasources.com/industryinsights/cancer-hijacks-natural-cell-process-to-s-295382.html 0.6 2026-07-09T03:32:55+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-becollaborate-295383.html 0.6 2026-07-17T12:33:09+08:00 daily https://www.pharmasources.com/industryinsights/doctors-without-borders-urges-narendra-m-295384.html 0.6 2026-08-07T18:25:21+08:00 daily https://www.pharmasources.com/industryinsights/juniper-pharma-services-brings-psd-1-spr-295385.html 0.6 2026-08-10T01:58:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mydayis-a-once-daily-option-295386.html 0.6 2026-08-07T05:01:22+08:00 daily https://www.pharmasources.com/industryinsights/dr-desh-bandhu-gupta-founder-and-chairma-295387.html 0.6 2026-06-10T21:41:31+08:00 daily https://www.pharmasources.com/industryinsights/cardiome-pharmas-xydalba-treatment-for-a-295388.html 0.6 2026-08-06T23:47:14+08:00 daily https://www.pharmasources.com/industryinsights/mhra-grants-positive-eams-scientific-opi-295389.html 0.6 2026-08-06T23:33:41+08:00 daily https://www.pharmasources.com/industryinsights/arcinova-investment-reduces-rd-and-manuf-295390.html 0.6 2026-08-06T23:56:00+08:00 daily https://www.pharmasources.com/industryinsights/roche-receives-fda-approval-for-fourth-g-295391.html 0.6 2026-08-06T22:53:37+08:00 daily https://www.pharmasources.com/industryinsights/submission-of-proposed-recommendations-f-295392.html 0.6 2026-08-06T20:28:59+08:00 daily https://www.pharmasources.com/industryinsights/semnur-announces-successful-phase-1-2-tr-295393.html 0.6 2026-08-06T23:33:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-conatus-orphan-drug-designati-295394.html 0.6 2026-08-07T04:31:39+08:00 daily https://www.pharmasources.com/industryinsights/boston-biomedical-announces-unblinding-o-295395.html 0.6 2026-08-07T05:02:10+08:00 daily https://www.pharmasources.com/industryinsights/breckenridge-announces-final-anda-approv-295396.html 0.6 2026-08-07T13:19:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-subcutaneous-c1-esterase-in-295397.html 0.6 2026-08-07T13:57:36+08:00 daily https://www.pharmasources.com/industryinsights/active-dashboard-2-allows-easy-access-to-295398.html 0.6 2026-08-07T16:21:16+08:00 daily https://www.pharmasources.com/industryinsights/oncoarendi-therapeutics-announces-select-295399.html 0.6 2026-08-09T07:36:20+08:00 daily https://www.pharmasources.com/industryinsights/singapores-healthcare-leaders-will-gathe-295400.html 0.6 2026-04-06T23:45:06+08:00 daily https://www.pharmasources.com/industryinsights/lianluo-smart-attends-7th-academic-confe-295401.html 0.6 2026-07-15T11:26:47+08:00 daily https://www.pharmasources.com/industryinsights/abi-research-b2b-healthcare-survey-finds-295402.html 0.6 2026-08-08T20:28:47+08:00 daily https://www.pharmasources.com/industryinsights/wayward-astellas-comes-close-to-uk-indus-295403.html 0.6 2026-08-07T13:30:39+08:00 daily https://www.pharmasources.com/industryinsights/spry-health-raises-funds-for-clinical-gr-295404.html 0.6 2026-06-08T17:43:56+08:00 daily https://www.pharmasources.com/industryinsights/regulators-finally-back-merck-kgaa-oral--295405.html 0.6 2026-03-19T22:45:54+08:00 daily https://www.pharmasources.com/industryinsights/biogeneration-ventures-fund-iii-secures--295406.html 0.6 2026-02-15T07:54:29+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-niv-sign-agreement-to-fight-z-295407.html 0.6 2025-11-23T07:17:27+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-biological-e-collaborate-295408.html 0.6 2026-08-07T03:53:52+08:00 daily https://www.pharmasources.com/industryinsights/study-roches-emicizumab-cuts-bleed-rate--295409.html 0.6 2026-06-28T16:03:01+08:00 daily https://www.pharmasources.com/industryinsights/takeda-seattle-genetics-adcetris-hits-ma-295410.html 0.6 2026-06-05T11:57:27+08:00 daily https://www.pharmasources.com/industryinsights/tackling-dementia---multipronged-collabo-295411.html 0.6 2026-01-13T16:42:49+08:00 daily https://www.pharmasources.com/industryinsights/83-of-life-science-leaders-believe-block-295412.html 0.6 2026-06-17T01:43:00+08:00 daily https://www.pharmasources.com/industryinsights/ema-approves-janssens-prezista-continuou-295413.html 0.6 2026-03-01T05:48:30+08:00 daily https://www.pharmasources.com/industryinsights/lilly-diabetes-brings-an-extra-splash-of-295414.html 0.6 2026-01-13T20:26:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-cryopreserved-formulation-o-295415.html 0.6 2026-06-20T12:12:28+08:00 daily https://www.pharmasources.com/industryinsights/new-single-quadrupole-mass-spectrometer--295416.html 0.6 2026-03-28T16:22:46+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-therapeutics-opens-research-and--295417.html 0.6 2026-02-15T10:11:14+08:00 daily https://www.pharmasources.com/industryinsights/what-makes-stem-cells-into-perfect-allro-295418.html 0.6 2025-12-03T11:53:53+08:00 daily https://www.pharmasources.com/industryinsights/qs-pharma-gains-ema-approval-for-commerc-295419.html 0.6 2026-06-12T18:51:36+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-receives-approval-for-in-295420.html 0.6 2025-11-23T10:45:33+08:00 daily https://www.pharmasources.com/industryinsights/ppd-appoints-lab-evp-295421.html 0.6 2026-04-14T18:17:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-announce-ec-approva-295422.html 0.6 2025-12-06T23:42:38+08:00 daily https://www.pharmasources.com/industryinsights/ablynx-initiates-ind-enabling-tox-study--295423.html 0.6 2026-03-28T23:14:42+08:00 daily https://www.pharmasources.com/industryinsights/ipca-laboratories-appoints-createid8-for-295424.html 0.6 2026-04-15T19:31:02+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-and-niv-sign-agreement-to-fig-295425.html 0.6 2026-01-31T10:05:55+08:00 daily https://www.pharmasources.com/industryinsights/swissmedic-accepts-review-of-takeda-and--295426.html 0.6 2026-06-08T17:17:13+08:00 daily https://www.pharmasources.com/industryinsights/biogeneration-ventures-fund-iii-secures--295427.html 0.6 2026-06-09T22:42:49+08:00 daily https://www.pharmasources.com/industryinsights/indias-glenmark-signs-license-agreement--295428.html 0.6 2026-03-17T20:29:09+08:00 daily https://www.pharmasources.com/industryinsights/axis-biotec-to-begin-construction-on-bio-295429.html 0.6 2026-08-08T01:30:02+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-new-type-of-immune-c-295430.html 0.6 2026-01-31T10:17:38+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-and-science-magazine-to-award--295431.html 0.6 2026-02-01T02:55:36+08:00 daily https://www.pharmasources.com/industryinsights/alma-and-delphi-genetics-expand-alliance-295432.html 0.6 2026-01-29T23:21:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-510k-clearance-to-orthos-vi-295433.html 0.6 2026-06-22T13:23:29+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-premier-collaborate-to-enhance-295434.html 0.6 2026-05-23T21:04:43+08:00 daily https://www.pharmasources.com/industryinsights/takeda-biological-e-ink-pact-to-develop--295435.html 0.6 2026-06-20T12:37:41+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-biological-e-collaborate-to-d-295436.html 0.6 2026-04-10T07:44:00+08:00 daily https://www.pharmasources.com/industryinsights/ikang-launches-healthcare-initiatives-295437.html 0.6 2026-07-04T20:05:51+08:00 daily https://www.pharmasources.com/industryinsights/nantcell-to-acquire-altor-bioscience-295438.html 0.6 2026-04-19T06:15:04+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-biosimilar-gets-another-fda-reje-295439.html 0.6 2025-11-28T19:33:21+08:00 daily https://www.pharmasources.com/industryinsights/jjs-type-2-diabetes-drug-invokana-signif-295440.html 0.6 2026-06-23T10:19:49+08:00 daily https://www.pharmasources.com/industryinsights/teva-xenon-announce-phase-ii-study-of-to-295441.html 0.6 2026-07-27T22:15:10+08:00 daily https://www.pharmasources.com/industryinsights/novotech-and-sonic-clinical-trials-signs-295442.html 0.6 2026-02-10T19:25:41+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-submits-investigational-nda-to-295443.html 0.6 2026-02-09T18:42:35+08:00 daily https://www.pharmasources.com/industryinsights/what-makes-biogen-biib-and-bristol-myers-295444.html 0.6 2026-03-09T13:00:58+08:00 daily https://www.pharmasources.com/industryinsights/a-look-at-the-deaths-that-plagued-juno-j-295445.html 0.6 2026-07-13T07:31:46+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-commends-impinj-for-aidin-295446.html 0.6 2026-07-03T06:56:54+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-limited-corrects-an-earlier-a-295447.html 0.6 2026-04-02T00:53:46+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-and-yungjin-pharm-start-clinic-295448.html 0.6 2026-04-07T16:14:52+08:00 daily https://www.pharmasources.com/industryinsights/uk-trial-for-new-bladder-cancer-therapy-295449.html 0.6 2026-08-08T00:25:28+08:00 daily https://www.pharmasources.com/industryinsights/most-adults-worried-about-the-future-of--295450.html 0.6 2026-04-18T04:28:39+08:00 daily https://www.pharmasources.com/industryinsights/us-approval-for-portolas-bevyxxa-295451.html 0.6 2026-02-28T13:48:44+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-dstl-and-cdrd-collaborate-to-ide-295452.html 0.6 2026-08-08T01:40:45+08:00 daily https://www.pharmasources.com/industryinsights/allergan-introduces-refresh-optive-mega--295453.html 0.6 2026-07-07T12:16:32+08:00 daily https://www.pharmasources.com/industryinsights/bioconjugation-specialist-innova-bioscie-295454.html 0.6 2026-03-17T23:33:13+08:00 daily https://www.pharmasources.com/industryinsights/chinas-icarbonx-invests-in-funding-healt-295455.html 0.6 2026-04-13T03:40:00+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-expands-joint-research-in-china-295456.html 0.6 2026-06-14T05:26:39+08:00 daily https://www.pharmasources.com/industryinsights/natco-receives-fda-approval-for-vidaza-f-295457.html 0.6 2026-04-06T20:30:47+08:00 daily https://www.pharmasources.com/industryinsights/japans-z--works-raises-funding-295458.html 0.6 2026-07-08T19:27:15+08:00 daily https://www.pharmasources.com/industryinsights/strategic-alliance-between-alma-bio-ther-295459.html 0.6 2026-07-03T08:54:53+08:00 daily https://www.pharmasources.com/industryinsights/pda-issues-essential-new-guidance-for-vi-295460.html 0.6 2026-07-09T11:13:55+08:00 daily https://www.pharmasources.com/industryinsights/rise-in-product-recalls-prompts-fda-to-w-295461.html 0.6 2026-04-11T08:48:19+08:00 daily https://www.pharmasources.com/industryinsights/microneedle-patches-for-flu-vaccination--295462.html 0.6 2026-02-16T16:57:02+08:00 daily https://www.pharmasources.com/industryinsights/particle-measuring-systems-celebrates-45-295463.html 0.6 2026-05-14T02:00:57+08:00 daily https://www.pharmasources.com/industryinsights/amber-warning-for-the-uks-access-to-new--295464.html 0.6 2026-03-26T01:02:01+08:00 daily https://www.pharmasources.com/industryinsights/dhl-opens-new-state-of-the-art-life-scie-295465.html 0.6 2026-07-17T15:43:16+08:00 daily https://www.pharmasources.com/industryinsights/trials-show-unique-stem-cells-a-potentia-295466.html 0.6 2026-07-02T16:19:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-tackles-drug-competition-to-improve--295467.html 0.6 2026-08-06T19:52:34+08:00 daily https://www.pharmasources.com/industryinsights/what-makes-stem-cells-into-perfect-allro-295468.html 0.6 2026-06-27T02:14:13+08:00 daily https://www.pharmasources.com/industryinsights/cancer-hijacks-natural-cell-process-to-s-295469.html 0.6 2026-06-16T01:30:58+08:00 daily https://www.pharmasources.com/industryinsights/merlion-and-dstl-awarded-dtra-grant-to-e-295470.html 0.6 2026-01-10T19:42:33+08:00 daily https://www.pharmasources.com/industryinsights/eyeing-a-6b-market-bavarian-nordic-posts-295471.html 0.6 2026-06-07T11:54:51+08:00 daily https://www.pharmasources.com/industryinsights/cadila-gets-board-approval-to-raise-rs-1-295472.html 0.6 2026-01-30T21:14:23+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-to-market-oxybutynin-chlori-295473.html 0.6 2026-07-04T18:22:33+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-natcos-anda-for-generic--295474.html 0.6 2026-06-08T18:35:28+08:00 daily https://www.pharmasources.com/industryinsights/qs-pharma-receives-ema-approval-for-medi-295475.html 0.6 2026-05-06T08:19:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-syn-295476.html 0.6 2026-04-30T21:06:16+08:00 daily https://www.pharmasources.com/industryinsights/senators-lay-into-sanofi-for-zika-vaccin-295477.html 0.6 2026-05-03T20:29:51+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-struggling-flumist-loses-ou-295478.html 0.6 2026-04-27T16:28:36+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-secures-series-c-financing-295479.html 0.6 2026-04-26T07:51:27+08:00 daily https://www.pharmasources.com/industryinsights/to-fight-against-the-behavior-between-si-295480.html 0.6 2026-07-06T05:01:05+08:00 daily https://www.pharmasources.com/industryinsights/cancer-moonshot-initiatives-unlock-techn-295481.html 0.6 2026-06-22T06:19:16+08:00 daily https://www.pharmasources.com/industryinsights/dhl-opens-new-life-sciences-facility-in--295482.html 0.6 2026-05-30T02:43:35+08:00 daily https://www.pharmasources.com/industryinsights/adicet-bio-appoints-chief-medical-office-295483.html 0.6 2026-05-30T02:46:28+08:00 daily https://www.pharmasources.com/industryinsights/armo-biosciences-appoints-naiyer-a-rizvi-295484.html 0.6 2026-05-30T02:43:51+08:00 daily https://www.pharmasources.com/industryinsights/mabvax-starts-patient-dosing-in-mvt-1075-295485.html 0.6 2026-08-06T19:18:35+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-indo-295486.html 0.6 2026-05-30T02:49:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-miltefosine-orphan-drug-desig-295487.html 0.6 2026-05-30T02:52:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-of-10-mg-xare-295488.html 0.6 2026-08-07T20:45:12+08:00 daily https://www.pharmasources.com/industryinsights/alder-shares-slump-despite-migraine-succ-295489.html 0.6 2026-04-28T16:39:01+08:00 daily https://www.pharmasources.com/industryinsights/stroke-prevention-device-wins-healthtech-295490.html 0.6 2026-08-07T13:23:57+08:00 daily https://www.pharmasources.com/industryinsights/merck-co-hit-by-goldeneye-ransomware-295491.html 0.6 2026-01-18T12:42:57+08:00 daily https://www.pharmasources.com/industryinsights/millions-will-be-affected-by-stp-health--295492.html 0.6 2026-07-03T20:20:10+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-sanofis-gaucher-treatmen-295493.html 0.6 2026-05-26T11:06:11+08:00 daily https://www.pharmasources.com/industryinsights/experimental-sickle-cell-disease-drug-ge-295494.html 0.6 2026-08-07T09:41:09+08:00 daily https://www.pharmasources.com/industryinsights/basf-plans-significant-investment-in-ibu-295495.html 0.6 2026-07-08T06:39:18+08:00 daily https://www.pharmasources.com/industryinsights/mercks-anacetrapib-meets-primary-endpoin-295496.html 0.6 2026-01-14T08:46:36+08:00 daily https://www.pharmasources.com/industryinsights/patheon-to-invest-45m-to-expand-capabili-295497.html 0.6 2026-03-19T13:08:33+08:00 daily https://www.pharmasources.com/industryinsights/inc-research-expands-in-japan-295498.html 0.6 2026-08-10T01:59:16+08:00 daily https://www.pharmasources.com/industryinsights/china-us-investors-fund-vivace-therapeut-295499.html 0.6 2026-03-01T02:50:13+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-announce-approval-o-295500.html 0.6 2026-03-31T23:39:27+08:00 daily https://www.pharmasources.com/industryinsights/versiti-introduces-new-hematology-test-p-295501.html 0.6 2026-03-16T09:34:28+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-breaks-ground-on-new-rd-facility--295502.html 0.6 2026-08-03T03:13:03+08:00 daily https://www.pharmasources.com/industryinsights/diasorin-and-tecan-to-collaborate-in-new-295503.html 0.6 2025-12-20T23:31:43+08:00 daily https://www.pharmasources.com/industryinsights/personalised-medicine-batch-size-of-one--295504.html 0.6 2026-06-30T10:08:39+08:00 daily https://www.pharmasources.com/industryinsights/pharmaleads-reports-positive-phase-i-dat-295505.html 0.6 2026-06-27T14:36:10+08:00 daily https://www.pharmasources.com/industryinsights/cannabinoids-suitable-for-migraine-preve-295506.html 0.6 2025-11-28T18:15:31+08:00 daily https://www.pharmasources.com/industryinsights/new-second-generation-solvent-evaporator-295507.html 0.6 2026-02-25T21:49:16+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gains-first-line-approval-for-z-295508.html 0.6 2026-06-08T22:36:44+08:00 daily https://www.pharmasources.com/industryinsights/sayre-therapeutics-in-license-and-distri-295509.html 0.6 2026-04-14T05:25:49+08:00 daily https://www.pharmasources.com/industryinsights/nppa-revised-ceiling-price-of-761-drugs--295510.html 0.6 2025-11-28T18:10:54+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-nod-for-sanofis-gaucher-thera-295511.html 0.6 2026-04-14T02:40:28+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-teams-up-with-uk-defence-lab-and-295512.html 0.6 2026-04-09T16:12:35+08:00 daily https://www.pharmasources.com/industryinsights/vectura-links-with-novartis-for-inhaled--295513.html 0.6 2026-08-06T17:49:52+08:00 daily https://www.pharmasources.com/industryinsights/experimental-sickle-cell-disease-drug-ge-295514.html 0.6 2026-06-08T18:26:31+08:00 daily https://www.pharmasources.com/industryinsights/gsk-tests-mepolizumab-for-nasal-polyps-295515.html 0.6 2026-07-03T10:33:33+08:00 daily https://www.pharmasources.com/industryinsights/mercks-cetp-inhibitor-lowers-risk-of-car-295516.html 0.6 2026-04-06T12:10:39+08:00 daily https://www.pharmasources.com/industryinsights/heat-deaths-in-us-cities-could-jump-10-f-295517.html 0.6 2026-04-03T21:42:15+08:00 daily https://www.pharmasources.com/industryinsights/many-women-mistaken-on-side-effects-of-b-295518.html 0.6 2026-04-07T00:17:28+08:00 daily https://www.pharmasources.com/industryinsights/experimental-drug-shows-promise-against--295519.html 0.6 2026-08-07T14:34:51+08:00 daily https://www.pharmasources.com/industryinsights/novartis-zykadia-gains-expanded-approval-295520.html 0.6 2026-08-08T00:20:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-creates-team-to-tackle-backlog-of-or-295521.html 0.6 2026-07-17T05:08:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vectibix-panitumumab-for-us-295522.html 0.6 2025-12-06T23:47:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-g-295523.html 0.6 2026-06-08T18:03:03+08:00 daily https://www.pharmasources.com/industryinsights/acorda-submits-new-drug-application-to-u-295524.html 0.6 2026-07-31T13:59:38+08:00 daily https://www.pharmasources.com/industryinsights/abcam-holds-first-international-epigenet-295525.html 0.6 2026-01-04T11:37:36+08:00 daily https://www.pharmasources.com/industryinsights/merlion-and-dstl-awarded-dtra-grant-to-e-295526.html 0.6 2026-08-05T22:15:33+08:00 daily https://www.pharmasources.com/industryinsights/zytoprotecs-novel-dialysis-product-meets-295527.html 0.6 2026-06-07T21:40:52+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-introduces-sart-295528.html 0.6 2026-02-28T13:46:41+08:00 daily https://www.pharmasources.com/industryinsights/genomic-health-new-data-show-important-r-295529.html 0.6 2026-06-14T06:46:15+08:00 daily https://www.pharmasources.com/industryinsights/new-single-quadrupole-mass-spectrometer--295530.html 0.6 2026-06-16T03:59:22+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-raises-30-million-funding-295531.html 0.6 2026-03-18T01:07:45+08:00 daily https://www.pharmasources.com/industryinsights/tampered-evidence-and-serialization-295532.html 0.6 2026-06-18T09:02:52+08:00 daily https://www.pharmasources.com/industryinsights/grupo-ngeles-servicios-de-salud-implemen-295533.html 0.6 2026-04-01T12:00:43+08:00 daily https://www.pharmasources.com/industryinsights/mydx-supports-product-sales-and-torontos-295534.html 0.6 2026-07-16T00:40:44+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-announces-construction-o-295535.html 0.6 2026-07-20T04:01:51+08:00 daily https://www.pharmasources.com/industryinsights/chinese-legend-talking-about-the-starry--295536.html 0.6 2026-03-13T15:20:25+08:00 daily https://www.pharmasources.com/industryinsights/data-analysis-of-relevant-warning-letter-295537.html 0.6 2026-08-09T01:21:31+08:00 daily https://www.pharmasources.com/industryinsights/microneedle-patches-for-flu-vaccination--295538.html 0.6 2026-06-03T08:44:38+08:00 daily https://www.pharmasources.com/industryinsights/rise-in-product-recalls-prompts-fda-to-w-295539.html 0.6 2026-02-28T05:31:25+08:00 daily https://www.pharmasources.com/industryinsights/bioverativ-completes-acquisition-of-true-295540.html 0.6 2026-08-07T05:19:50+08:00 daily https://www.pharmasources.com/industryinsights/metrohm-camo-software-are-announcing-a-g-295541.html 0.6 2026-06-07T22:30:53+08:00 daily https://www.pharmasources.com/industryinsights/62-of-medicines-dispensed-in-europe-are--295542.html 0.6 2026-04-18T02:51:39+08:00 daily https://www.pharmasources.com/industryinsights/first-prostate-cancer-patients-treated-w-295543.html 0.6 2026-07-03T18:14:43+08:00 daily https://www.pharmasources.com/industryinsights/looking-for-life-sciences-opportunities--295544.html 0.6 2026-07-05T02:11:27+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-biotechnologies-announ-295545.html 0.6 2026-04-25T12:34:10+08:00 daily https://www.pharmasources.com/industryinsights/older-americans-dont-get---or-seek---eno-295546.html 0.6 2026-04-29T17:28:28+08:00 daily https://www.pharmasources.com/industryinsights/researchers-refute-textbook-knowledge-in-295547.html 0.6 2026-05-04T04:07:42+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-to-market-a-295548.html 0.6 2026-05-06T04:32:27+08:00 daily https://www.pharmasources.com/industryinsights/unichem-gets-eir-from-us-fda-for-goaplan-295549.html 0.6 2026-04-03T11:19:43+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-starts-construction-of-new-rd-fac-295550.html 0.6 2026-08-09T07:58:41+08:00 daily https://www.pharmasources.com/industryinsights/fuji-pharma-to-market-mithras-hormone-th-295551.html 0.6 2026-05-05T16:34:11+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-roches-new--295552.html 0.6 2026-05-03T05:07:59+08:00 daily https://www.pharmasources.com/industryinsights/crt-and-merck-extend-partnership-to-disc-295553.html 0.6 2026-08-05T03:25:17+08:00 daily https://www.pharmasources.com/industryinsights/arrien-pharmaceuticals-signs-license-agr-295554.html 0.6 2026-06-24T11:08:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-eu-approval-for-first--295555.html 0.6 2026-06-22T11:52:12+08:00 daily https://www.pharmasources.com/industryinsights/japans-z--works-raises-funding-295556.html 0.6 2026-04-17T18:56:04+08:00 daily https://www.pharmasources.com/industryinsights/scientists-successfully-erase-different--295557.html 0.6 2026-07-02T01:09:30+08:00 daily https://www.pharmasources.com/industryinsights/singapore-startup-caregiver-asia-launche-295558.html 0.6 2026-06-20T20:01:38+08:00 daily https://www.pharmasources.com/industryinsights/horizon-discovery-announces-progress-295559.html 0.6 2026-03-25T20:02:04+08:00 daily https://www.pharmasources.com/industryinsights/looking-for-life-sciences-opportunities--295560.html 0.6 2026-03-20T23:45:10+08:00 daily https://www.pharmasources.com/industryinsights/steven-baertschi-joins-epr-advisory-boar-295561.html 0.6 2026-03-17T21:39:34+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-biotechnologies-announ-295562.html 0.6 2026-04-23T14:59:45+08:00 daily https://www.pharmasources.com/industryinsights/62-of-medicines-dispensed-in-europe-are--295563.html 0.6 2026-04-18T03:07:34+08:00 daily https://www.pharmasources.com/industryinsights/metrohm-camo-software-are-announcing-a-g-295564.html 0.6 2026-04-13T20:48:15+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-receives-eu-approval-for-erelzi-b-295565.html 0.6 2026-03-20T09:46:03+08:00 daily https://www.pharmasources.com/industryinsights/older-americans-dont-get---or-seek---eno-295566.html 0.6 2026-03-28T11:39:55+08:00 daily https://www.pharmasources.com/industryinsights/unichem-gets-eir-from-us-fda-for-goa-pla-295567.html 0.6 2026-03-31T20:30:45+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-to-market-a-295568.html 0.6 2026-04-13T09:52:54+08:00 daily https://www.pharmasources.com/industryinsights/researchers-refute-textbook-knowledge-in-295569.html 0.6 2026-07-06T23:16:03+08:00 daily https://www.pharmasources.com/industryinsights/to-acquire-sinovac-biotech-nasnaq-sva-si-295570.html 0.6 2026-06-08T02:58:44+08:00 daily https://www.pharmasources.com/industryinsights/china-aid-one-of-the-most-authoritative--295571.html 0.6 2026-06-30T17:59:47+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-to-install-proton-therap-295572.html 0.6 2026-04-12T03:56:02+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-therapeutics-joins-the-alliance--295573.html 0.6 2026-04-14T02:00:07+08:00 daily https://www.pharmasources.com/industryinsights/tuv-rheinland-greater-china-opens-first--295574.html 0.6 2026-04-19T07:48:18+08:00 daily https://www.pharmasources.com/industryinsights/abpi-reveals-10-increase-in-hcp-payment--295575.html 0.6 2025-12-02T06:41:14+08:00 daily https://www.pharmasources.com/industryinsights/outsourcing-current-trends-in-the-cdmo-s-295576.html 0.6 2026-08-09T08:12:21+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-astrazenecas-copd-drug-295577.html 0.6 2025-11-28T16:56:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vectibix-for-use-in-wild-ty-295578.html 0.6 2026-04-05T18:05:36+08:00 daily https://www.pharmasources.com/industryinsights/gyros-protein-technologies-introduces-ne-295579.html 0.6 2025-11-28T16:54:09+08:00 daily https://www.pharmasources.com/industryinsights/impact-resistant-plastic-stands-up-295580.html 0.6 2025-11-28T16:55:13+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-at-its-shanghai-facility-295581.html 0.6 2025-12-06T06:22:16+08:00 daily https://www.pharmasources.com/industryinsights/artificial-t-cell-receptors-market-295582.html 0.6 2026-01-31T10:14:31+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-successful-p-295583.html 0.6 2026-02-28T13:48:34+08:00 daily https://www.pharmasources.com/industryinsights/roche-acquires-mysugr-to-form-a-leading--295584.html 0.6 2026-03-18T01:38:16+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-receives-us-fda-approval-for-o-295585.html 0.6 2026-04-07T09:51:55+08:00 daily https://www.pharmasources.com/industryinsights/domino-printech-india-to-launchax-series-295586.html 0.6 2026-04-22T03:54:38+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-enters-strategic-drug-discove-295587.html 0.6 2026-08-04T08:33:49+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-and-saol-partner-to-co-promote-dys-295588.html 0.6 2026-03-09T07:41:32+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-novartiss-z-295589.html 0.6 2026-07-02T20:55:36+08:00 daily https://www.pharmasources.com/industryinsights/patheon-to-invest-45-million-expanding-c-295590.html 0.6 2026-03-24T04:16:38+08:00 daily https://www.pharmasources.com/industryinsights/valeant-completes-sale-of-dendreon-to-sa-295591.html 0.6 2026-06-24T00:02:03+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-gsk-enter-into-drug-discovery-295592.html 0.6 2026-07-26T10:32:05+08:00 daily https://www.pharmasources.com/industryinsights/cnu-launches-five-new-research-institute-295593.html 0.6 2026-08-09T02:31:12+08:00 daily https://www.pharmasources.com/industryinsights/japan-ministry-of-health-labor-and-welfa-295594.html 0.6 2026-01-31T10:17:31+08:00 daily https://www.pharmasources.com/industryinsights/ferring-appoints-evp-cpo-and-new-executi-295595.html 0.6 2026-03-11T15:27:37+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-announces-fda-acceptance-for-re-295596.html 0.6 2026-01-12T20:44:24+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-new-technology-obtains-health-ca-295597.html 0.6 2026-03-19T14:36:09+08:00 daily https://www.pharmasources.com/industryinsights/tissuegene-awarded-750000-maryland-stem--295598.html 0.6 2025-11-28T16:34:25+08:00 daily https://www.pharmasources.com/industryinsights/promethazine-by-strides-shasun-approved--295599.html 0.6 2026-07-16T10:41:50+08:00 daily https://www.pharmasources.com/industryinsights/amgens-uncontrolled-ldl-cholesterol-lowe-295600.html 0.6 2026-08-05T11:56:17+08:00 daily https://www.pharmasources.com/industryinsights/australian-researchers-offer-hope-for-bo-295601.html 0.6 2026-03-01T06:23:34+08:00 daily https://www.pharmasources.com/industryinsights/artificial-t-cell-receptors-market-295602.html 0.6 2026-08-07T04:18:47+08:00 daily https://www.pharmasources.com/industryinsights/impact-resistant-plastic-stands-up-295603.html 0.6 2026-06-08T23:32:55+08:00 daily https://www.pharmasources.com/industryinsights/baheal-group-brings-watson-for-genomics--295604.html 0.6 2026-04-07T15:52:23+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-successful-p-295605.html 0.6 2026-06-17T11:45:28+08:00 daily https://www.pharmasources.com/industryinsights/outsourcing-current-trends-in-the-cdmo-s-295606.html 0.6 2026-07-19T16:54:48+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-astrazenecas-copd-drug-295607.html 0.6 2026-03-20T03:45:40+08:00 daily https://www.pharmasources.com/industryinsights/roche-acquires-mysugr-to-form-a-leading--295608.html 0.6 2025-11-28T16:23:26+08:00 daily https://www.pharmasources.com/industryinsights/umit---private-university-for-health-sci-295609.html 0.6 2026-06-23T09:58:53+08:00 daily https://www.pharmasources.com/industryinsights/convergence-of-blockchain-with-emerging--295610.html 0.6 2026-02-28T19:21:40+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-receives-us-fda-approval-for-o-295611.html 0.6 2026-02-01T04:41:17+08:00 daily https://www.pharmasources.com/industryinsights/domino-printech-india-to-launch-ax-serie-295612.html 0.6 2025-11-28T16:19:02+08:00 daily https://www.pharmasources.com/industryinsights/dr-tedros-adhanom-ghebreyesus-takes-offi-295613.html 0.6 2026-06-22T03:57:26+08:00 daily https://www.pharmasources.com/industryinsights/big-success-and-even-bigger-failure-for--295614.html 0.6 2025-12-06T11:02:51+08:00 daily https://www.pharmasources.com/industryinsights/new-pfizer-eu-approval-offers-first-trea-295615.html 0.6 2026-07-08T01:15:28+08:00 daily https://www.pharmasources.com/industryinsights/mps-keen-for-close-collaboration-with-em-295616.html 0.6 2026-06-27T14:40:05+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-lillys-baricitinib-olumi-295617.html 0.6 2026-08-03T10:02:55+08:00 daily https://www.pharmasources.com/industryinsights/abpi-respond-to-statement-of-uk-governme-295618.html 0.6 2026-06-21T13:44:54+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-tanabe-pharma-gets-approval-f-295619.html 0.6 2026-07-30T19:11:24+08:00 daily https://www.pharmasources.com/industryinsights/supply-chains-key-to-life-sciences-trans-295620.html 0.6 2025-12-28T13:42:31+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-to-expand-into-eu-us-over-next-295621.html 0.6 2026-06-10T15:20:41+08:00 daily https://www.pharmasources.com/industryinsights/alembic-gets-us-fda-nod-for-erectile-dys-295622.html 0.6 2026-07-18T20:25:07+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-mhra-uk-approval-for-m-295623.html 0.6 2026-06-24T01:15:09+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-ties-up-with-samsungbiologics-295624.html 0.6 2026-06-08T17:41:35+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-pfizers-acute-lymphoblastic--295625.html 0.6 2026-06-08T17:45:29+08:00 daily https://www.pharmasources.com/industryinsights/lillys-olumiant-gets-the-thumbs-up-in-ja-295626.html 0.6 2026-08-06T23:29:36+08:00 daily https://www.pharmasources.com/industryinsights/gsk-selects-third-oncology-target-in-dis-295627.html 0.6 2026-06-30T20:37:33+08:00 daily https://www.pharmasources.com/industryinsights/silence-therapeutics-takes-rival-alnylam-295628.html 0.6 2026-03-04T22:29:46+08:00 daily https://www.pharmasources.com/industryinsights/immunocore-and-gsk-pick-third-cancer-imm-295629.html 0.6 2026-03-29T07:49:40+08:00 daily https://www.pharmasources.com/industryinsights/common-antimicrobials-help-patients-reco-295630.html 0.6 2026-07-19T12:26:18+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-facing-nice-showdown-over-leukaem-295631.html 0.6 2026-07-20T13:50:52+08:00 daily https://www.pharmasources.com/industryinsights/uk-ministers-seek-a-soft-brexit-for-phar-295632.html 0.6 2026-03-19T07:17:59+08:00 daily https://www.pharmasources.com/industryinsights/deepmind-access-breached-nhs-data-privac-295633.html 0.6 2026-07-15T03:24:53+08:00 daily https://www.pharmasources.com/industryinsights/marken-expands-into-new-facilities-295634.html 0.6 2026-06-29T04:33:45+08:00 daily https://www.pharmasources.com/industryinsights/abpi-respond-to-statement-of-uk-governme-295635.html 0.6 2026-01-14T10:43:42+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-receives-eu-approval-in-europe-fo-295636.html 0.6 2026-04-13T23:04:12+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-lillys-baricitinib-olumi-295637.html 0.6 2026-03-28T12:01:22+08:00 daily https://www.pharmasources.com/industryinsights/the-most-efficient-option-for-treating-u-295638.html 0.6 2026-07-19T04:02:50+08:00 daily https://www.pharmasources.com/industryinsights/cancer-researchers-overestimate-reproduc-295639.html 0.6 2026-04-23T21:53:53+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-to-expand-into-eu-us-over-next-295640.html 0.6 2026-04-12T03:48:25+08:00 daily https://www.pharmasources.com/industryinsights/alembic-gets-us-fda-nod-for-erectile-dys-295641.html 0.6 2026-06-08T20:58:55+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-mhra-uk-approval-for-m-295642.html 0.6 2026-07-20T18:19:54+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-ties-up-with-samsung-biologic-295643.html 0.6 2026-06-22T03:23:46+08:00 daily https://www.pharmasources.com/industryinsights/stada-ceo-and-cfo-tumble-in-takeover-tur-295644.html 0.6 2025-11-28T15:44:01+08:00 daily https://www.pharmasources.com/industryinsights/researchers-boost-existing-antibiotic-to-295645.html 0.6 2026-07-26T08:34:12+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-signs-55m-manufacturing-deal--295646.html 0.6 2026-04-20T20:23:10+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-face-major-lawsuit-over--295647.html 0.6 2026-03-13T13:48:35+08:00 daily https://www.pharmasources.com/industryinsights/merck-moves-up-sales-rankings-in-vaccine-295648.html 0.6 2026-08-07T11:00:30+08:00 daily https://www.pharmasources.com/industryinsights/helomics-creates-flexible-wet-lab-space--295649.html 0.6 2026-04-03T05:44:16+08:00 daily https://www.pharmasources.com/industryinsights/alphabet-executive-chairman-eric-schmidt-295650.html 0.6 2026-03-19T08:42:31+08:00 daily https://www.pharmasources.com/industryinsights/zebra-boosts-healthcare-portfolio-with-n-295651.html 0.6 2026-06-08T19:45:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-a-strategic-plan-to-elimin-295652.html 0.6 2026-03-31T12:52:33+08:00 daily https://www.pharmasources.com/industryinsights/japanese-regulators-grant-additional-app-295653.html 0.6 2026-06-30T05:23:51+08:00 daily https://www.pharmasources.com/industryinsights/guanzhou-international-bio-forum-permane-295654.html 0.6 2026-08-04T10:57:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-awards-125-million-to-research-pro-295655.html 0.6 2026-07-02T21:01:06+08:00 daily https://www.pharmasources.com/industryinsights/study-predicts-12-million-people-in-uk-w-295656.html 0.6 2026-04-21T04:48:26+08:00 daily https://www.pharmasources.com/industryinsights/wickham-laboratories-now-offering-full-s-295657.html 0.6 2026-06-29T13:06:38+08:00 daily https://www.pharmasources.com/industryinsights/heart-failure-market-worth-16-billion-by-295658.html 0.6 2026-02-09T08:27:35+08:00 daily https://www.pharmasources.com/industryinsights/biocads-rituximab-biosimilar-to-receive--295659.html 0.6 2026-03-16T05:32:51+08:00 daily https://www.pharmasources.com/industryinsights/patheon-to-invest-45-million-in-spray-dr-295660.html 0.6 2026-03-17T23:51:12+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-samsung-biologics-announce-st-295661.html 0.6 2026-04-12T20:22:02+08:00 daily https://www.pharmasources.com/industryinsights/invokana-reduces-the-risk-of-cv-mi-and-s-295662.html 0.6 2026-06-23T19:37:09+08:00 daily https://www.pharmasources.com/industryinsights/first-patients-treated-in-phase-iii-tria-295663.html 0.6 2026-08-07T17:12:09+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-and-parkinsons-spurred-by-sam-295664.html 0.6 2026-07-19T14:19:52+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-vigamox-ophthalmi-295665.html 0.6 2026-03-27T19:10:09+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-board-nod-to-raise-f-295666.html 0.6 2026-06-19T22:49:28+08:00 daily https://www.pharmasources.com/industryinsights/a-new-highly-innovative-approach-for-tac-295667.html 0.6 2026-01-03T14:02:39+08:00 daily https://www.pharmasources.com/industryinsights/zydus-starts-phase-ii-trial-of-zyan1-for-295668.html 0.6 2026-04-06T11:50:15+08:00 daily https://www.pharmasources.com/industryinsights/scientists-generate-human-embryonic-colo-295669.html 0.6 2026-06-23T13:25:15+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-secures-uk-mhra-approval-for-an-295670.html 0.6 2026-08-02T16:59:37+08:00 daily https://www.pharmasources.com/industryinsights/ema-and-fda-propose-new-approach-for-gau-295671.html 0.6 2026-04-13T23:31:48+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-incyte-receive-marketing-appro-295672.html 0.6 2025-11-08T14:20:54+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-launches-hygiene-products-in-295673.html 0.6 2026-07-07T19:07:29+08:00 daily https://www.pharmasources.com/industryinsights/phase-3-study-of-adjuvant-opdivo-in-rese-295674.html 0.6 2025-10-27T01:47:01+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-launches-generic-version-of-axir-295675.html 0.6 2026-01-04T05:37:42+08:00 daily https://www.pharmasources.com/industryinsights/nih-grants-3-million-to-bring-precision--295676.html 0.6 2026-07-08T07:16:54+08:00 daily https://www.pharmasources.com/industryinsights/endo-announces-divestiture-of-grupo-farm-295677.html 0.6 2026-07-03T08:59:24+08:00 daily https://www.pharmasources.com/industryinsights/cardiome-antibiotic-could-reduce-pressur-295678.html 0.6 2026-04-15T21:32:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-expanded-use-of-cooling-cap-t-295679.html 0.6 2026-08-06T03:58:18+08:00 daily https://www.pharmasources.com/industryinsights/ema-and-fda-aim-to-slash-gaucher-disease-295680.html 0.6 2026-06-16T22:22:10+08:00 daily https://www.pharmasources.com/industryinsights/brain-training-app-reduces-symptoms-of-p-295681.html 0.6 2026-02-15T08:06:48+08:00 daily https://www.pharmasources.com/industryinsights/alexion-price-cut-opens-up-strensiq-to-m-295682.html 0.6 2026-06-24T00:47:29+08:00 daily https://www.pharmasources.com/industryinsights/invokana-reduces-the-risk-of-cv-mi-and-s-295683.html 0.6 2026-07-06T23:37:09+08:00 daily https://www.pharmasources.com/industryinsights/nature-publication-for-cellmids-midkine--295684.html 0.6 2026-07-09T06:39:50+08:00 daily https://www.pharmasources.com/industryinsights/study-predicts-12-million-people-in-uk-w-295685.html 0.6 2025-12-24T22:30:12+08:00 daily https://www.pharmasources.com/industryinsights/wickham-laboratories-now-offering-full-s-295686.html 0.6 2026-08-08T07:53:40+08:00 daily https://www.pharmasources.com/industryinsights/heart-failure-market-worth-16-billion-by-295687.html 0.6 2026-07-02T21:28:34+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-and-parkinsons-spurred-by-sam-295688.html 0.6 2026-02-28T13:18:12+08:00 daily https://www.pharmasources.com/industryinsights/merck-awards-125-million-to-research-pro-295689.html 0.6 2026-03-17T21:40:24+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-vigamox-ophthalmi-295690.html 0.6 2026-06-08T22:35:24+08:00 daily https://www.pharmasources.com/industryinsights/zydus-starts-phase-ii-trial-of-zyan1-for-295691.html 0.6 2026-03-21T03:08:03+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-board-nod-to-raise-f-295692.html 0.6 2026-04-26T05:20:04+08:00 daily https://www.pharmasources.com/industryinsights/pain-free-microneedle-patch-could-help-b-295693.html 0.6 2026-06-21T08:00:48+08:00 daily https://www.pharmasources.com/industryinsights/ema-and-fda-harmonise-over-development-o-295694.html 0.6 2026-04-03T13:36:14+08:00 daily https://www.pharmasources.com/industryinsights/googles-deepmind-app-deal-with-nhs-broug-295695.html 0.6 2026-06-23T02:19:43+08:00 daily https://www.pharmasources.com/industryinsights/nice-agrees-approval-deal-for-ultra-rare-295696.html 0.6 2026-03-21T17:10:20+08:00 daily https://www.pharmasources.com/industryinsights/nda-of-fda-in-2017-q2-total-number-of-ne-295697.html 0.6 2026-06-13T18:47:41+08:00 daily https://www.pharmasources.com/industryinsights/embarrassing-two-different-worlds-in-con-295698.html 0.6 2026-07-17T18:00:45+08:00 daily https://www.pharmasources.com/industryinsights/mindfulness-based-therapy-may-reduce-str-295699.html 0.6 2026-08-08T11:41:50+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-may-improve-sunburn-says-new-t-295700.html 0.6 2026-06-21T11:44:03+08:00 daily https://www.pharmasources.com/industryinsights/supply-chains-key-to-life-sciences-trans-295701.html 0.6 2025-12-12T17:46:08+08:00 daily https://www.pharmasources.com/industryinsights/novartis-combination-targeted-therapy-re-295702.html 0.6 2026-06-21T23:18:44+08:00 daily https://www.pharmasources.com/industryinsights/almac-discovery-granted-orphan-drug-desi-295703.html 0.6 2026-06-18T08:09:10+08:00 daily https://www.pharmasources.com/industryinsights/lonza-completes-acquisition-of-capsugel-295704.html 0.6 2026-06-18T07:26:04+08:00 daily https://www.pharmasources.com/industryinsights/brain-training-app-improves-memory-in-pe-295705.html 0.6 2026-06-12T19:30:53+08:00 daily https://www.pharmasources.com/industryinsights/who-appoints-saima-hossain-its-goodwill--295706.html 0.6 2026-03-19T23:11:16+08:00 daily https://www.pharmasources.com/industryinsights/jardiance-empagliflozin-analysis-reinfor-295707.html 0.6 2026-02-15T13:10:38+08:00 daily https://www.pharmasources.com/industryinsights/guardian--mydocs-partnership-an-answer-t-295708.html 0.6 2026-01-21T08:55:41+08:00 daily https://www.pharmasources.com/industryinsights/researchers-publish-new-findings-on-infl-295709.html 0.6 2026-08-07T00:12:37+08:00 daily https://www.pharmasources.com/industryinsights/new-personalized-vaccines-promise-to-kee-295710.html 0.6 2026-06-22T01:12:34+08:00 daily https://www.pharmasources.com/industryinsights/uk-mrc-researchers-reveal-structures-of--295711.html 0.6 2026-01-24T09:59:19+08:00 daily https://www.pharmasources.com/industryinsights/englands-chief-medical-officer-calls-for-295712.html 0.6 2026-06-23T07:31:35+08:00 daily https://www.pharmasources.com/industryinsights/neovacs-and-centurion-sign-licence-agree-295713.html 0.6 2026-06-23T06:04:53+08:00 daily https://www.pharmasources.com/industryinsights/celgene-to-acquire-rights-to-beigenes-pd-295714.html 0.6 2026-07-15T03:37:58+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-valeant-pharmaceuticals--295715.html 0.6 2026-06-23T05:41:04+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-acino-pharma-oriola-kd-cor-295716.html 0.6 2026-06-23T05:34:22+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-alexions-strensiq-for-hy-295717.html 0.6 2026-06-23T03:26:16+08:00 daily https://www.pharmasources.com/industryinsights/nppa-asks-cos-to-provide-ptr-mat-data-of-295718.html 0.6 2026-03-11T23:18:39+08:00 daily https://www.pharmasources.com/industryinsights/india-israel-ceos-forum-organised-intel--295719.html 0.6 2026-06-11T06:22:06+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-fund-life-science-research--295720.html 0.6 2026-08-06T22:12:12+08:00 daily https://www.pharmasources.com/industryinsights/iil-organises-vaccination-camps-in-100ce-295721.html 0.6 2026-07-09T05:47:02+08:00 daily https://www.pharmasources.com/industryinsights/adents-urges-pharma-cos-to-take-advantag-295722.html 0.6 2026-06-24T19:24:59+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-sciences-receives-us-fda-a-295723.html 0.6 2026-08-07T05:07:36+08:00 daily https://www.pharmasources.com/industryinsights/impact-of-gst-on-pharmaindustry-295724.html 0.6 2026-08-07T04:56:59+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170710-295725.html 0.6 2026-08-07T04:49:05+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-cabozantinib-for-advance-295726.html 0.6 2026-08-07T04:57:11+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-acquires-raman-spec-295727.html 0.6 2026-08-09T19:42:06+08:00 daily https://www.pharmasources.com/industryinsights/drug-and-alcohol-testing-an-expanding-ma-295728.html 0.6 2026-04-07T05:07:28+08:00 daily https://www.pharmasources.com/industryinsights/oramed-granted-japanese-patent-295729.html 0.6 2026-06-09T03:00:00+08:00 daily https://www.pharmasources.com/industryinsights/numerous-manufacturing-and-process-indus-295730.html 0.6 2026-08-07T02:07:36+08:00 daily https://www.pharmasources.com/industryinsights/us-health-regulator-to-soon-lift-import--295731.html 0.6 2026-06-12T02:49:04+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--295732.html 0.6 2026-06-22T07:05:43+08:00 daily https://www.pharmasources.com/industryinsights/gnh-india-clears-audit-to-trade-orphan-d-295733.html 0.6 2026-05-18T11:37:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-bristol-myers-squibbs-orenc-295734.html 0.6 2026-03-11T09:22:24+08:00 daily https://www.pharmasources.com/industryinsights/g-ba-confirms-tevas-cinqaero-gives-minor-295735.html 0.6 2026-03-12T20:44:21+08:00 daily https://www.pharmasources.com/industryinsights/shire-submits-ind-application-for-shp654-295736.html 0.6 2026-07-28T22:05:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-i-295737.html 0.6 2026-07-28T22:04:22+08:00 daily https://www.pharmasources.com/industryinsights/dermavant-sciences-appoints-executive-ch-295738.html 0.6 2026-07-03T01:20:20+08:00 daily https://www.pharmasources.com/industryinsights/biogen-ms-drug-hit-by-eu-safety-restrict-295739.html 0.6 2026-06-13T02:27:41+08:00 daily https://www.pharmasources.com/industryinsights/endo-gives-way-and-withdraws-opioid-pain-295740.html 0.6 2026-04-07T14:53:23+08:00 daily https://www.pharmasources.com/industryinsights/pharma-launches-legal-action-against-eng-295741.html 0.6 2026-06-11T14:54:16+08:00 daily https://www.pharmasources.com/industryinsights/shire-injunction-blocks-roches-misleadin-295742.html 0.6 2026-06-08T23:18:50+08:00 daily https://www.pharmasources.com/industryinsights/brenda-fitzgerald-appointed-as-new-cdc-d-295743.html 0.6 2026-06-12T12:42:13+08:00 daily https://www.pharmasources.com/industryinsights/with-brexit-we-hope-to-see-more-companie-295744.html 0.6 2026-02-18T17:39:34+08:00 daily https://www.pharmasources.com/industryinsights/india-and-israel-launch-innovation-bridg-295745.html 0.6 2026-06-24T13:10:51+08:00 daily https://www.pharmasources.com/industryinsights/solasia-announces-episil-approval-in-jap-295746.html 0.6 2026-06-18T07:26:33+08:00 daily https://www.pharmasources.com/industryinsights/26-winners-recognized-at-the-asian-scien-295747.html 0.6 2026-06-18T08:09:16+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-minister-gives-out-regulatory-a-295748.html 0.6 2026-08-09T10:31:15+08:00 daily https://www.pharmasources.com/industryinsights/according-to-who-untreatable-gonorrhea-s-295749.html 0.6 2026-08-07T01:18:52+08:00 daily https://www.pharmasources.com/industryinsights/gene-mutation-discovered-that-can-preven-295750.html 0.6 2026-08-07T01:10:51+08:00 daily https://www.pharmasources.com/industryinsights/barbra-wells-appointed-president-and-ceo-295751.html 0.6 2026-08-07T13:17:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-endari-for-sickle-cell-dise-295752.html 0.6 2026-08-09T06:59:36+08:00 daily https://www.pharmasources.com/industryinsights/philips-and-sam-to-open-oncology-center--295753.html 0.6 2026-08-08T03:30:55+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-becomes-official-healthcare--295754.html 0.6 2026-04-09T05:26:55+08:00 daily https://www.pharmasources.com/industryinsights/dutch-mag45-appointed-bd-asia-mro-suppli-295755.html 0.6 2026-06-16T08:05:56+08:00 daily https://www.pharmasources.com/industryinsights/professor-brian-wilson-receives-ipa-exce-295756.html 0.6 2026-01-03T09:31:25+08:00 daily https://www.pharmasources.com/industryinsights/top-innovative-health-and-wellness-techn-295757.html 0.6 2025-11-27T17:52:14+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-to-host-nanomedici-295758.html 0.6 2026-03-28T13:35:10+08:00 daily https://www.pharmasources.com/industryinsights/innovation-with-a-purpose-at-agilent-295759.html 0.6 2026-06-06T19:04:43+08:00 daily https://www.pharmasources.com/industryinsights/how-thermal-fluid-maintenance-maximises--295760.html 0.6 2026-08-09T18:59:59+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-still-searching-for-ans-295761.html 0.6 2026-01-05T07:26:38+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-dstl-and-cdrd-collaborates-295762.html 0.6 2026-03-17T20:13:53+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-qb3953-announce-winners-of-the-295763.html 0.6 2026-06-25T18:22:38+08:00 daily https://www.pharmasources.com/industryinsights/treatment-rapidly-reverses-the-effect-of-295764.html 0.6 2026-08-08T14:46:53+08:00 daily https://www.pharmasources.com/industryinsights/antares-vision-receives-ecgrant-295765.html 0.6 2025-11-08T13:31:42+08:00 daily https://www.pharmasources.com/industryinsights/maharashtra-launches-injectable-contrace-295766.html 0.6 2025-11-14T22:06:54+08:00 daily https://www.pharmasources.com/industryinsights/american-academy-of-ophthalmology-and-lu-295767.html 0.6 2026-02-10T14:21:34+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-opens-entries-for-pharma--295768.html 0.6 2026-07-27T07:01:23+08:00 daily https://www.pharmasources.com/industryinsights/ignytas-cancer-drug-entrectinib-receives-295769.html 0.6 2025-11-02T21:27:57+08:00 daily https://www.pharmasources.com/industryinsights/race-and-targimmune-to-develop-new-cance-295770.html 0.6 2026-04-14T23:42:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-emmaus-endari-to-treat-sick-295771.html 0.6 2026-03-31T22:17:18+08:00 daily https://www.pharmasources.com/industryinsights/judicial-review-unhelpful-suggests-biote-295772.html 0.6 2026-06-21T05:38:08+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-750m-acquisition-gives-it-edge-in-295773.html 0.6 2026-07-04T12:46:34+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-still-searching-for-ans-295774.html 0.6 2026-06-20T22:24:23+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-to-host-nanomedici-295775.html 0.6 2026-06-18T16:36:39+08:00 daily https://www.pharmasources.com/industryinsights/innovation-with-a-purpose-at-agilent-295776.html 0.6 2026-06-19T09:45:40+08:00 daily https://www.pharmasources.com/industryinsights/how-thermal-fluid-maintenance-maximises--295777.html 0.6 2026-07-23T05:42:47+08:00 daily https://www.pharmasources.com/industryinsights/numerous-manufacturing-and-process-indus-295778.html 0.6 2026-06-13T00:17:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-safety-in-fda-spotlight-295779.html 0.6 2026-06-09T21:01:51+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-acquires-raman-spec-295780.html 0.6 2026-06-13T03:42:30+08:00 daily https://www.pharmasources.com/industryinsights/government-funds-dwindle-for-cardiac-arr-295781.html 0.6 2026-04-04T18:37:31+08:00 daily https://www.pharmasources.com/industryinsights/study-examines-link-between-marijuana-an-295782.html 0.6 2026-06-12T08:03:46+08:00 daily https://www.pharmasources.com/industryinsights/tai-chi-for-people-with-dementia-295783.html 0.6 2026-07-03T18:57:09+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-and-yungjin-pharm-start-clinic-295784.html 0.6 2026-04-07T16:39:48+08:00 daily https://www.pharmasources.com/industryinsights/cancer-survivors-get-a-taste-for-kefir-a-295785.html 0.6 2026-03-30T18:18:34+08:00 daily https://www.pharmasources.com/industryinsights/shortcut-method-in-drug-development-295786.html 0.6 2026-06-12T04:36:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-cell-therapy-ctl019-unani-295787.html 0.6 2026-02-28T12:59:46+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-invest-rs-1000-cr-inkarnataka-295788.html 0.6 2026-06-22T07:21:35+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-launches-skincare-range--295789.html 0.6 2026-08-08T23:38:36+08:00 daily https://www.pharmasources.com/industryinsights/piramal-to-expand-pharma-presence-in-us--295790.html 0.6 2026-08-07T11:46:42+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-and-yungjin-pharm-start-clinic-295791.html 0.6 2026-06-20T17:21:19+08:00 daily https://www.pharmasources.com/industryinsights/abzena-and-obi-pharma-sign-licence-deal--295792.html 0.6 2026-08-08T20:29:37+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-agrees-to-buy-protein-sciences-fo-295793.html 0.6 2026-08-06T16:45:22+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-dstl-and-cdrd-collaborates-295794.html 0.6 2026-06-08T16:14:57+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-max-planck-and-lead-disco-295795.html 0.6 2026-08-08T03:20:30+08:00 daily https://www.pharmasources.com/industryinsights/sanpower-group-completes-acquisition-of--295796.html 0.6 2026-07-20T07:01:22+08:00 daily https://www.pharmasources.com/industryinsights/google-launches-ai-venture-fund-295797.html 0.6 2026-06-19T12:42:36+08:00 daily https://www.pharmasources.com/industryinsights/gyros-protein-technologies-introduces-ne-295798.html 0.6 2026-07-07T11:46:12+08:00 daily https://www.pharmasources.com/industryinsights/amicus-to-file-fabry-drug-after-fda-chan-295799.html 0.6 2026-08-07T16:31:24+08:00 daily https://www.pharmasources.com/industryinsights/the-curious-case-of-mylotarg-pfizers-leu-295800.html 0.6 2026-03-28T16:53:08+08:00 daily https://www.pharmasources.com/industryinsights/oramed-granted-japanese-patent-295801.html 0.6 2026-04-26T15:05:01+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-acquire-protein-sciences-295802.html 0.6 2026-04-20T02:38:25+08:00 daily https://www.pharmasources.com/industryinsights/new-data-reinforce-the-effectiveness-of--295803.html 0.6 2026-04-18T04:52:32+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-max-planck-innovation-and-295804.html 0.6 2026-04-13T16:24:38+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-identify-breath-biomarkers-to-i-295805.html 0.6 2026-04-07T08:06:25+08:00 daily https://www.pharmasources.com/industryinsights/bmss-orencia-receives-fda-approval-for-t-295806.html 0.6 2026-04-05T03:18:05+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-opens-entries-for-largest-295807.html 0.6 2026-06-08T00:53:25+08:00 daily https://www.pharmasources.com/industryinsights/disappointment-for-scottish-patients-wit-295808.html 0.6 2026-04-27T22:03:40+08:00 daily https://www.pharmasources.com/industryinsights/uk-supreme-court-rules-in-lillys-favour--295809.html 0.6 2026-08-02T16:10:17+08:00 daily https://www.pharmasources.com/industryinsights/shire-submits-ind-application-to-fda-for-295810.html 0.6 2026-04-07T20:08:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-cell-therapy-ctl019-unani-295811.html 0.6 2026-07-17T22:45:52+08:00 daily https://www.pharmasources.com/industryinsights/shortcut-method-in-drug-development-295812.html 0.6 2026-04-21T18:34:31+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-qb3953-announce-winners-of-the-295813.html 0.6 2026-07-18T09:01:39+08:00 daily https://www.pharmasources.com/industryinsights/treatment-rapidly-reverses-the-effect-of-295814.html 0.6 2026-07-23T10:57:25+08:00 daily https://www.pharmasources.com/industryinsights/positive-phase-iii-results-for-roches-em-295815.html 0.6 2026-07-23T14:18:41+08:00 daily https://www.pharmasources.com/industryinsights/type-1-diabetes-risk-linked-to-intestina-295816.html 0.6 2026-07-13T09:25:50+08:00 daily https://www.pharmasources.com/industryinsights/besponsa-approved-in-the-eu-for-adult-pa-295817.html 0.6 2026-08-07T17:43:16+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-expected-tim-295818.html 0.6 2026-08-09T20:15:08+08:00 daily https://www.pharmasources.com/industryinsights/genomic-health-updated-st-gallen-interna-295819.html 0.6 2026-04-02T13:10:16+08:00 daily https://www.pharmasources.com/industryinsights/oncology-drug-market-size-to-approach-us-295820.html 0.6 2026-08-06T00:57:28+08:00 daily https://www.pharmasources.com/industryinsights/when-will-chinese-rituxan-be-marketed-in-295821.html 0.6 2026-08-08T07:12:07+08:00 daily https://www.pharmasources.com/industryinsights/humiras-patent-protection-lawsuit-lost-a-295822.html 0.6 2026-04-11T13:23:12+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biocons-breast-cancer-biosimilar-g-295823.html 0.6 2026-07-27T15:39:25+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharmacovigilance-day-2017-confer-295824.html 0.6 2026-04-21T15:50:17+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-issues-warning-letter-to-hyderaba-295825.html 0.6 2026-06-25T15:29:22+08:00 daily https://www.pharmasources.com/industryinsights/pharmexcil-to-meet-commerce-ministry-off-295826.html 0.6 2026-05-16T08:36:58+08:00 daily https://www.pharmasources.com/industryinsights/shaheen-majeed-promoted-as-president-of--295827.html 0.6 2026-04-13T04:16:01+08:00 daily https://www.pharmasources.com/industryinsights/pankaj-patel-steps-down-as-cadila-md-295828.html 0.6 2026-04-07T19:18:56+08:00 daily https://www.pharmasources.com/industryinsights/bioascent-appoints-new-ceo-295829.html 0.6 2026-04-21T20:13:23+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-launches-skincare-range--295830.html 0.6 2026-06-08T06:53:44+08:00 daily https://www.pharmasources.com/industryinsights/unicity-international-launches-genomeceu-295831.html 0.6 2026-06-09T18:28:49+08:00 daily https://www.pharmasources.com/industryinsights/pharma-market-posts-75-growth-in-june-295832.html 0.6 2026-06-24T18:32:34+08:00 daily https://www.pharmasources.com/industryinsights/new-report-shows-decrease-in-app-launch--295833.html 0.6 2026-06-30T17:05:17+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-invest-100m-to-expand-syd-295834.html 0.6 2026-07-12T11:03:28+08:00 daily https://www.pharmasources.com/industryinsights/erytech-and-queens-university-collaborat-295835.html 0.6 2026-07-13T12:58:20+08:00 daily https://www.pharmasources.com/industryinsights/could-a-menb-vaccine-protect-against-gon-295836.html 0.6 2026-07-08T02:26:00+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gets-a-flu-vaccines-booster-with--295837.html 0.6 2026-07-12T11:18:33+08:00 daily https://www.pharmasources.com/industryinsights/trump-administration-picks-pro-vaccine-c-295838.html 0.6 2026-07-16T21:14:36+08:00 daily https://www.pharmasources.com/industryinsights/senate-proposal-would-tie-dod-research-b-295839.html 0.6 2026-07-27T04:36:03+08:00 daily https://www.pharmasources.com/industryinsights/australias-cochlear-plans-expansion-in-c-295840.html 0.6 2026-04-20T18:30:45+08:00 daily https://www.pharmasources.com/industryinsights/shangpharma-innovation-enters-into-partn-295841.html 0.6 2026-08-06T18:14:01+08:00 daily https://www.pharmasources.com/industryinsights/new-research-offers-insights-into-how-ad-295842.html 0.6 2026-04-13T19:54:16+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-settles-us-opioid-drug-prob-295843.html 0.6 2026-07-09T05:49:39+08:00 daily https://www.pharmasources.com/industryinsights/new-study-finds-no-additional-benefit-fr-295844.html 0.6 2026-07-14T12:27:28+08:00 daily https://www.pharmasources.com/industryinsights/dhl-is-prepared-to-tackle-emerging-deman-295845.html 0.6 2026-06-12T19:33:53+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-announces-agreement-with-novog-295846.html 0.6 2026-06-23T01:17:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-snda-for-xeljanz-for-the-tre-295847.html 0.6 2026-06-23T14:08:38+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-refines-western-european-life-295848.html 0.6 2026-08-05T15:25:45+08:00 daily https://www.pharmasources.com/industryinsights/lilly-reaches-settlement-agreement-in-us-295849.html 0.6 2026-06-24T03:45:15+08:00 daily https://www.pharmasources.com/industryinsights/yaron-turpaz-appointed-as-new-chief-data-295850.html 0.6 2026-06-23T23:48:54+08:00 daily https://www.pharmasources.com/industryinsights/novita-healthcare-ltd-to-acquire-technol-295851.html 0.6 2026-06-23T23:47:26+08:00 daily https://www.pharmasources.com/industryinsights/australias-cochlear-plans-expansion-in-c-295852.html 0.6 2026-06-20T13:23:13+08:00 daily https://www.pharmasources.com/industryinsights/industry-standards-group-align-biopharma-295853.html 0.6 2026-06-19T00:54:58+08:00 daily https://www.pharmasources.com/industryinsights/society-collaboration-release-management-295854.html 0.6 2026-06-19T22:57:22+08:00 daily https://www.pharmasources.com/industryinsights/antalis-drives-forward-with-new-vehicle--295855.html 0.6 2026-06-12T19:30:12+08:00 daily https://www.pharmasources.com/industryinsights/wickham-laboratories-announces-successfu-295856.html 0.6 2026-08-07T02:36:27+08:00 daily https://www.pharmasources.com/industryinsights/particle-measuring-systems-releases-new--295857.html 0.6 2026-03-17T19:39:56+08:00 daily https://www.pharmasources.com/industryinsights/a-remedy-for-humans-a-challenge-for-tech-295858.html 0.6 2026-02-01T04:41:57+08:00 daily https://www.pharmasources.com/industryinsights/importance-of-standardized-label-managem-295859.html 0.6 2026-03-01T18:22:35+08:00 daily https://www.pharmasources.com/industryinsights/novartis-confirms-5-year-data-for-first--295860.html 0.6 2026-02-28T15:29:06+08:00 daily https://www.pharmasources.com/industryinsights/cancer-cells-force-normal-cells-to-mimic-295861.html 0.6 2026-06-08T03:54:48+08:00 daily https://www.pharmasources.com/industryinsights/aiocd-urges-gst-council-to-introduce-uni-295862.html 0.6 2026-02-09T17:40:01+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-opens-rs-300-cr-facility--295863.html 0.6 2026-06-08T22:11:19+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biocons-breast-cancer-biosimilar-g-295864.html 0.6 2026-07-27T16:42:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-recommends-approval-for-novartis-ctl-295865.html 0.6 2026-08-01T10:04:33+08:00 daily https://www.pharmasources.com/industryinsights/bnf-and-bnfc-launch-new-app-for-health-a-295866.html 0.6 2026-01-15T08:39:25+08:00 daily https://www.pharmasources.com/industryinsights/ema-validates-gilead-sciences-marketing--295867.html 0.6 2026-06-16T14:50:41+08:00 daily https://www.pharmasources.com/industryinsights/amid-dustup-over-taxpayer-funded-researc-295868.html 0.6 2026-03-29T07:11:44+08:00 daily https://www.pharmasources.com/industryinsights/what-brexit-means-for-drug-regulation-295869.html 0.6 2026-06-16T19:11:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-unanimously-recommends-mylan-and-bio-295870.html 0.6 2026-02-15T13:36:23+08:00 daily https://www.pharmasources.com/industryinsights/gileads-new-hiv-therapy-under-eu-review-295871.html 0.6 2026-07-02T08:12:14+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-humira-enbrel-and-stelara-for-295872.html 0.6 2026-06-23T17:11:25+08:00 daily https://www.pharmasources.com/industryinsights/amgens-blincyto-wins-full-us-approval-295873.html 0.6 2026-08-07T05:15:40+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170717-295874.html 0.6 2026-08-07T04:53:08+08:00 daily https://www.pharmasources.com/industryinsights/bgi-genomics-announces-pricing-of-initia-295875.html 0.6 2026-03-23T00:19:06+08:00 daily https://www.pharmasources.com/industryinsights/bookdoc-mims-reliable-healthcare-develop-295876.html 0.6 2026-07-07T21:57:52+08:00 daily https://www.pharmasources.com/industryinsights/5-drug-stocks-that-could-be-big-winners--295877.html 0.6 2026-06-19T07:25:44+08:00 daily https://www.pharmasources.com/industryinsights/gsk-ships-2017-18-seasonal-influenza-vac-295878.html 0.6 2026-07-23T19:57:42+08:00 daily https://www.pharmasources.com/industryinsights/singapore-based-radiation-oncology-speci-295879.html 0.6 2026-06-08T06:16:26+08:00 daily https://www.pharmasources.com/industryinsights/taipei-hosts-biotaiwan-china-2017-with-6-295880.html 0.6 2026-04-05T23:15:04+08:00 daily https://www.pharmasources.com/industryinsights/quadria-capital-invests-in-two-hospital--295881.html 0.6 2026-04-01T18:33:14+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-janssens-tremfya-for-the-295882.html 0.6 2026-03-25T19:28:34+08:00 daily https://www.pharmasources.com/industryinsights/verily-to-release-20-million-sterile-mal-295883.html 0.6 2025-11-23T00:51:38+08:00 daily https://www.pharmasources.com/industryinsights/pamlico-invests-in-beckers-healthcare-295884.html 0.6 2026-07-09T09:21:27+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-eyes-product-and-sales-expansi-295885.html 0.6 2026-04-22T15:58:13+08:00 daily https://www.pharmasources.com/industryinsights/kolon-life-science-wins-license-for-gene-295886.html 0.6 2026-04-13T01:46:10+08:00 daily https://www.pharmasources.com/industryinsights/siloam-opens-second-greenfield-hospital--295887.html 0.6 2026-07-03T16:52:38+08:00 daily https://www.pharmasources.com/industryinsights/japan-mhlw-grants-marketing-approval-295888.html 0.6 2026-08-05T15:07:18+08:00 daily https://www.pharmasources.com/industryinsights/merck-biopharma-innovation-cup-2017-295889.html 0.6 2026-06-12T10:35:21+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-last-patient-295890.html 0.6 2026-06-12T17:21:15+08:00 daily https://www.pharmasources.com/industryinsights/new-study-presented-at-alzheimers-associ-295891.html 0.6 2026-06-28T12:22:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-refuses-approval-of-amgen-osteoporos-295892.html 0.6 2026-07-18T12:05:40+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-secures-italian-distributio-295893.html 0.6 2026-06-25T10:10:34+08:00 daily https://www.pharmasources.com/industryinsights/research-may-unlock-statins-cancer-fight-295894.html 0.6 2026-06-23T09:26:00+08:00 daily https://www.pharmasources.com/industryinsights/impax-announces-fda-approval-of-ab-rated-295895.html 0.6 2026-06-23T13:30:13+08:00 daily https://www.pharmasources.com/industryinsights/gsk-ships-2017-18-seasonal-influenza-vac-295896.html 0.6 2026-08-08T14:11:17+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-divests-asthma-and-allergy-prod-295897.html 0.6 2026-02-10T14:45:28+08:00 daily https://www.pharmasources.com/industryinsights/valeant-agrees-to-sell-obagi-medical-pro-295898.html 0.6 2026-01-22T09:58:07+08:00 daily https://www.pharmasources.com/industryinsights/heatwurx-announces-letter-of-intent-with-295899.html 0.6 2026-02-10T15:06:34+08:00 daily https://www.pharmasources.com/industryinsights/janssen-announces-fda-approval-of-tremfy-295900.html 0.6 2026-02-01T04:41:25+08:00 daily https://www.pharmasources.com/industryinsights/horiba-scientific-introduces-new-uvisel--295901.html 0.6 2025-12-27T20:01:22+08:00 daily https://www.pharmasources.com/industryinsights/brexit-health-alliance-welcomes-collabor-295902.html 0.6 2025-12-08T00:47:17+08:00 daily https://www.pharmasources.com/industryinsights/new-improved-bnf-and-bnfc-app-launched-295903.html 0.6 2026-06-12T11:46:08+08:00 daily https://www.pharmasources.com/industryinsights/dr-lilly-xu-joins-chempartner-as-vice-pr-295904.html 0.6 2026-07-01T11:39:02+08:00 daily https://www.pharmasources.com/industryinsights/japan-mhlw-grants-marketing-approval-295905.html 0.6 2025-11-18T08:33:08+08:00 daily https://www.pharmasources.com/industryinsights/novartis-confirms-5-year-data-for-first--295906.html 0.6 2026-02-09T08:46:09+08:00 daily https://www.pharmasources.com/industryinsights/pmu-birac-partners-with-dbt-bmgf-and-ikp-295907.html 0.6 2026-02-15T09:01:40+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-to-buy-sanofis-sma-295908.html 0.6 2026-02-15T09:34:30+08:00 daily https://www.pharmasources.com/industryinsights/janssen-biotechs-tremfya-receives-fda-ap-295909.html 0.6 2026-03-01T05:26:40+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-pfizers-snda-for-xeljanz--295910.html 0.6 2025-10-28T17:37:38+08:00 daily https://www.pharmasources.com/industryinsights/life-sciences-moves-to-unify-clinical-op-295911.html 0.6 2025-11-24T06:34:01+08:00 daily https://www.pharmasources.com/industryinsights/breathable-wearable-electronics-on-skin--295912.html 0.6 2025-11-28T21:17:15+08:00 daily https://www.pharmasources.com/industryinsights/cyber-attacks-top-digital-risk-for-life--295913.html 0.6 2026-06-10T06:00:59+08:00 daily https://www.pharmasources.com/industryinsights/uk-trails-behind-eu-in-cancer-diagnosis--295914.html 0.6 2026-02-01T04:40:34+08:00 daily https://www.pharmasources.com/industryinsights/oramed-appoints-dr-simon-bruce-as-vice-p-295915.html 0.6 2025-12-31T09:46:48+08:00 daily https://www.pharmasources.com/industryinsights/falsified-medicines-directive-dont-lose--295916.html 0.6 2026-07-05T17:24:20+08:00 daily https://www.pharmasources.com/industryinsights/one-minute-of-running-per-day-associated-295917.html 0.6 2026-07-06T19:45:49+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-array-biopharma-announce-precl-295918.html 0.6 2026-03-19T07:24:24+08:00 daily https://www.pharmasources.com/industryinsights/drl-commercialises-vozet-tabs-in-india-295919.html 0.6 2025-10-25T09:54:02+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-sciences-posts-q1-fy18-con-295920.html 0.6 2026-06-27T22:49:59+08:00 daily https://www.pharmasources.com/industryinsights/icici-securities-posts-preview-of-q1fy18-295921.html 0.6 2026-04-18T03:57:31+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-exports-to-us-may-go-up-in-295922.html 0.6 2026-06-16T23:51:27+08:00 daily https://www.pharmasources.com/industryinsights/technology-adoption-fuels-growth-for-pha-295923.html 0.6 2026-04-08T08:03:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-impaxs-ab-rated-generic-con-295924.html 0.6 2026-04-13T21:45:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-asks-for-additional-data-to-approve--295925.html 0.6 2026-08-06T22:22:29+08:00 daily https://www.pharmasources.com/industryinsights/roches-ocrevus-receives-tga-approval-for-295926.html 0.6 2026-07-18T22:57:24+08:00 daily https://www.pharmasources.com/industryinsights/udg-healthcare-to-acquire-cambridge-biom-295927.html 0.6 2026-03-11T21:22:49+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-japan-ink-deal-to-promote-uhc-295928.html 0.6 2025-12-15T11:17:28+08:00 daily https://www.pharmasources.com/industryinsights/nihr-awards-7-million-for-the-establishm-295929.html 0.6 2026-01-17T06:43:37+08:00 daily https://www.pharmasources.com/industryinsights/people-with-higher-levels-of-dkk3-less-l-295930.html 0.6 2026-08-08T02:31:16+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-expand-production-at-its--295931.html 0.6 2026-04-18T01:15:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-to-reduce-the-295932.html 0.6 2026-06-08T09:47:50+08:00 daily https://www.pharmasources.com/industryinsights/oramed-appoints-dr-simon-bruce-as-vice-p-295933.html 0.6 2026-06-08T18:31:05+08:00 daily https://www.pharmasources.com/industryinsights/uk-trails-behind-eu-in-cancer-diagnosis--295934.html 0.6 2026-08-06T11:54:45+08:00 daily https://www.pharmasources.com/industryinsights/cyber-attacks-top-digital-risk-for-life--295935.html 0.6 2026-01-31T10:15:46+08:00 daily https://www.pharmasources.com/industryinsights/breathable-wearable-electronics-on-skin--295936.html 0.6 2026-04-07T09:39:51+08:00 daily https://www.pharmasources.com/industryinsights/life-sciences-moves-to-unify-clinical-op-295937.html 0.6 2026-02-07T10:00:56+08:00 daily https://www.pharmasources.com/industryinsights/influenza-vaccines-and-drugs-market-to-g-295938.html 0.6 2026-08-09T14:06:43+08:00 daily https://www.pharmasources.com/industryinsights/new-report-states-growth-in-pharmacy-man-295939.html 0.6 2026-02-14T21:02:57+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-array-biopharma-announce-precl-295940.html 0.6 2026-06-21T00:15:39+08:00 daily https://www.pharmasources.com/industryinsights/one-minute-of-running-per-day-associated-295941.html 0.6 2026-02-28T21:29:42+08:00 daily https://www.pharmasources.com/industryinsights/drug-combinations-can-boost-weight-loss--295942.html 0.6 2025-12-27T08:00:33+08:00 daily https://www.pharmasources.com/industryinsights/27-phase-iii-and-8-phase-ii-alzheimers-d-295943.html 0.6 2026-07-18T04:17:21+08:00 daily https://www.pharmasources.com/industryinsights/anti-infective-vaccine-market-to-grow-at-295944.html 0.6 2026-03-29T04:21:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vosevi-for-hepatitis-c-295945.html 0.6 2026-04-11T23:46:08+08:00 daily https://www.pharmasources.com/industryinsights/new-way-found-to-boost-immunity-in-fight-295946.html 0.6 2026-01-17T15:07:35+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-in-agreement-with-cyndea-295947.html 0.6 2026-02-28T14:39:26+08:00 daily https://www.pharmasources.com/industryinsights/lupin-recalls-12480-bottles-of-anti-depr-295948.html 0.6 2026-06-13T01:26:46+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-receives-approval-for-s-295949.html 0.6 2026-06-21T14:37:19+08:00 daily https://www.pharmasources.com/industryinsights/maiden-biopharma-mission-innovate-in-ind-295950.html 0.6 2026-01-24T11:15:09+08:00 daily https://www.pharmasources.com/industryinsights/research-team-discovers-epithelial-cells-295951.html 0.6 2025-12-15T10:48:59+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-prana-to-research-neurodegene-295952.html 0.6 2025-12-15T10:47:52+08:00 daily https://www.pharmasources.com/industryinsights/valeant-to-sell-obagi-medical-products-b-295953.html 0.6 2026-05-06T06:32:08+08:00 daily https://www.pharmasources.com/industryinsights/sleepcogni-receives-continued-funding-fo-295954.html 0.6 2025-12-15T10:55:34+08:00 daily https://www.pharmasources.com/industryinsights/brainstorm-announces-nurown-phase-3-tria-295955.html 0.6 2026-08-05T19:22:35+08:00 daily https://www.pharmasources.com/industryinsights/bioniz-reports-top-line-phase-1-clinical-295956.html 0.6 2026-08-08T15:23:39+08:00 daily https://www.pharmasources.com/industryinsights/transfer-technology-expert-expands-us-pr-295957.html 0.6 2026-03-17T20:58:32+08:00 daily https://www.pharmasources.com/industryinsights/shire-expands-broad-monoclonal-antibody--295958.html 0.6 2026-03-19T06:42:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vosevi-for-hepatitis-c-295959.html 0.6 2026-06-30T00:05:06+08:00 daily https://www.pharmasources.com/industryinsights/new-way-found-to-boost-immunity-in-fight-295960.html 0.6 2026-02-15T01:04:41+08:00 daily https://www.pharmasources.com/industryinsights/27-phase-iii-and-8-phase-ii-alzheimers-d-295961.html 0.6 2026-05-09T22:40:34+08:00 daily https://www.pharmasources.com/industryinsights/arvato-systems-signs-deal-with-securmed--295962.html 0.6 2026-02-05T04:41:39+08:00 daily https://www.pharmasources.com/industryinsights/kitov-announces-results-of-study-demonst-295963.html 0.6 2026-01-10T05:15:06+08:00 daily https://www.pharmasources.com/industryinsights/cost-cutting-not-the-way-to-drive-value--295964.html 0.6 2026-08-10T00:56:55+08:00 daily https://www.pharmasources.com/industryinsights/novel-assay-detects-zika-differentiates--295965.html 0.6 2026-08-07T19:39:16+08:00 daily https://www.pharmasources.com/industryinsights/next-generation-sequencing-is-it-fulfill-295966.html 0.6 2026-06-16T01:08:17+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-products-to-report-second-295967.html 0.6 2026-06-16T00:19:01+08:00 daily https://www.pharmasources.com/industryinsights/mr-stephen-ooi-former-zimmer-executive-n-295968.html 0.6 2026-06-08T06:08:07+08:00 daily https://www.pharmasources.com/industryinsights/scale-matrix-teams-up-with-onramp-and-cl-295969.html 0.6 2026-06-06T11:15:07+08:00 daily https://www.pharmasources.com/industryinsights/abbott-diabetes-care-teams-up-with-bigfo-295970.html 0.6 2026-06-08T18:33:53+08:00 daily https://www.pharmasources.com/industryinsights/start-up-embark-veterinary-raises-anothe-295971.html 0.6 2026-06-11T11:48:37+08:00 daily https://www.pharmasources.com/industryinsights/integrated-fes-combined-with-robotics-im-295972.html 0.6 2026-06-14T22:38:36+08:00 daily https://www.pharmasources.com/industryinsights/partnering-cells-turn-off-immune-attack--295973.html 0.6 2026-06-19T07:27:21+08:00 daily https://www.pharmasources.com/industryinsights/c-bridge-capital-closes-second-healthcar-295974.html 0.6 2026-06-20T15:26:17+08:00 daily https://www.pharmasources.com/industryinsights/q2i-launches-healthcare-management-softw-295975.html 0.6 2025-12-15T10:23:36+08:00 daily https://www.pharmasources.com/industryinsights/subra-suresh-named-as-ntu-president-295976.html 0.6 2025-12-15T10:22:28+08:00 daily https://www.pharmasources.com/industryinsights/drrons-insight-robust-experimental-strat-295977.html 0.6 2026-07-21T06:15:11+08:00 daily https://www.pharmasources.com/industryinsights/drrons-insight-robust-experimental-strat-295978.html 0.6 2026-06-22T00:25:25+08:00 daily https://www.pharmasources.com/industryinsights/emids-acquires-healthcare-it-firm-encore-295979.html 0.6 2026-06-07T21:59:46+08:00 daily https://www.pharmasources.com/industryinsights/philips-new-ultrasound-solution-compatib-295980.html 0.6 2026-01-31T09:59:33+08:00 daily https://www.pharmasources.com/industryinsights/do-not-leave-the-town-without-passing-a--295981.html 0.6 2025-12-15T10:19:12+08:00 daily https://www.pharmasources.com/industryinsights/south-korean-pharma-emerging-as-manufact-295982.html 0.6 2026-04-27T22:30:51+08:00 daily https://www.pharmasources.com/industryinsights/robots-and-carbon-targets-may-signal-the-295983.html 0.6 2026-07-08T01:44:40+08:00 daily https://www.pharmasources.com/industryinsights/codes-of-ethics-cause-problems-for-overs-295984.html 0.6 2026-08-05T21:52:20+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-cinqaero-reslizumab-for--295985.html 0.6 2026-05-05T17:15:35+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-collaborate-with-cornin-295986.html 0.6 2026-04-07T04:37:02+08:00 daily https://www.pharmasources.com/industryinsights/27-phase-iii-and-8-phase-ii-alzheimers-d-295987.html 0.6 2026-06-09T05:38:27+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-leo-pharmas-psoriasis-biolog-295988.html 0.6 2026-03-27T00:01:04+08:00 daily https://www.pharmasources.com/industryinsights/final-nhs-green-light-for-amgens-kyproli-295989.html 0.6 2026-08-07T18:43:55+08:00 daily https://www.pharmasources.com/industryinsights/compelling-mid-stage-data-for-vertex-cf--295990.html 0.6 2026-07-16T23:54:19+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-cut-320-jobs-amid-manufacturing-r-295991.html 0.6 2026-07-09T05:10:19+08:00 daily https://www.pharmasources.com/industryinsights/biondvax-reports-positive-phase-2b-clini-295992.html 0.6 2026-04-13T23:12:53+08:00 daily https://www.pharmasources.com/industryinsights/ablynx-sanofi-enter-into-a-collaboration-295993.html 0.6 2026-04-29T06:34:02+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-lidds-establish-industrial-man-295994.html 0.6 2026-08-07T04:06:12+08:00 daily https://www.pharmasources.com/industryinsights/positive-results-from-12-month-phase-iii-295995.html 0.6 2026-06-19T16:55:15+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-and-lidds-establish-industrial-295996.html 0.6 2026-01-02T17:44:11+08:00 daily https://www.pharmasources.com/industryinsights/akorn-shareholders-approve-merger-agreem-295997.html 0.6 2026-01-05T11:57:29+08:00 daily https://www.pharmasources.com/industryinsights/catalent-and-academia-on-quest-to-better-295998.html 0.6 2026-01-03T08:30:42+08:00 daily https://www.pharmasources.com/industryinsights/churchill-pharmaceuticals-announces-nda--295999.html 0.6 2026-06-01T03:09:20+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-negotiates-exclusive-licence-dea-296000.html 0.6 2026-07-30T09:28:26+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-drug-cuts-hallmark-inflammati-296001.html 0.6 2025-12-23T22:35:09+08:00 daily https://www.pharmasources.com/industryinsights/china-fda-us-fda-and-industry-leaders-co-296002.html 0.6 2026-07-07T00:02:39+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-receives-eir-from-us-fda-296003.html 0.6 2026-04-07T10:52:44+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-invest-additional-140m-at-uk-manu-296004.html 0.6 2026-04-04T12:58:23+08:00 daily https://www.pharmasources.com/industryinsights/elsalys-biotech-and-dkfz-collaborate-to--296005.html 0.6 2026-01-30T16:01:52+08:00 daily https://www.pharmasources.com/industryinsights/oxygen-therapy-revives-brain-of-toddler--296006.html 0.6 2026-04-06T01:52:15+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-offers-ablynx-billions-of-biobuck-296007.html 0.6 2026-03-31T17:21:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sanofi-backed-neurovia-closes-1-296008.html 0.6 2026-02-28T16:58:36+08:00 daily https://www.pharmasources.com/industryinsights/theravance-copd-drug-clears-safety-study-296009.html 0.6 2026-06-08T11:51:58+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-speeds-its-i-o-market-sh-296010.html 0.6 2025-12-15T09:47:14+08:00 daily https://www.pharmasources.com/industryinsights/how-did-johnson-johnson-beat-back-remica-296011.html 0.6 2026-06-05T11:20:37+08:00 daily https://www.pharmasources.com/industryinsights/discount-helps-nice-flip-flop-on-tevas-s-296012.html 0.6 2026-03-19T09:12:34+08:00 daily https://www.pharmasources.com/industryinsights/despite-scoring-an-fda-nod-mercks-biosim-296013.html 0.6 2026-08-05T18:32:34+08:00 daily https://www.pharmasources.com/industryinsights/puma-to-price-new-cancer-med-nerlynx-at--296014.html 0.6 2026-03-28T05:18:41+08:00 daily https://www.pharmasources.com/industryinsights/csl-launches-cinryze-rival-haegarda-desp-296015.html 0.6 2026-03-31T23:31:39+08:00 daily https://www.pharmasources.com/industryinsights/is-2017-set-to-be-the-year-we-see-a-car--296016.html 0.6 2026-04-04T13:00:00+08:00 daily https://www.pharmasources.com/industryinsights/the-lancet-commission-one-third-of-demen-296017.html 0.6 2026-06-19T04:27:50+08:00 daily https://www.pharmasources.com/industryinsights/cenegermin-eye-drops-receive-european-un-296018.html 0.6 2026-06-29T22:14:20+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ctl-019-unanimously-passed-by-f-296019.html 0.6 2026-06-09T09:40:42+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-the-global-vaccine-market-wi-296020.html 0.6 2026-06-30T14:52:21+08:00 daily https://www.pharmasources.com/industryinsights/nus-launches-additive-manufacturing-faci-296021.html 0.6 2026-03-29T00:36:51+08:00 daily https://www.pharmasources.com/industryinsights/korean-scientists-create-first-nanoparti-296022.html 0.6 2026-02-28T13:01:25+08:00 daily https://www.pharmasources.com/industryinsights/aids-related-deaths-decline-claims-un-re-296023.html 0.6 2026-06-22T11:24:30+08:00 daily https://www.pharmasources.com/industryinsights/aptevo-alligator-in-bispecific-antibody--296024.html 0.6 2026-08-09T10:00:38+08:00 daily https://www.pharmasources.com/industryinsights/low-cost-drugs-package-saves-lives-of-pe-296025.html 0.6 2026-07-07T11:53:06+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-new-parkinsons-clinical-g-296026.html 0.6 2026-07-04T15:12:48+08:00 daily https://www.pharmasources.com/industryinsights/the-scoop-on-avoiding-brain-freeze-296027.html 0.6 2026-07-13T11:27:58+08:00 daily https://www.pharmasources.com/industryinsights/tessa-therapeutics-appoints-cco-296028.html 0.6 2026-08-07T14:04:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-first-neonatal-magnetic-reson-296029.html 0.6 2026-06-26T14:50:31+08:00 daily https://www.pharmasources.com/industryinsights/ispe-updates-guidance-on-risk-based-manu-296030.html 0.6 2026-06-23T14:58:32+08:00 daily https://www.pharmasources.com/industryinsights/a-reminder-that-meds-and-grapefruit-dont-296031.html 0.6 2026-08-09T17:15:56+08:00 daily https://www.pharmasources.com/industryinsights/paragon-bioservices-appoints-quality-vp-296032.html 0.6 2026-08-09T16:09:31+08:00 daily https://www.pharmasources.com/industryinsights/how-physical-exercise-prevents-dementia-296033.html 0.6 2026-06-11T18:21:39+08:00 daily https://www.pharmasources.com/industryinsights/toward-a-systematic-approach-to-producti-296034.html 0.6 2026-06-14T12:10:33+08:00 daily https://www.pharmasources.com/industryinsights/trump-throws-weight-behind-pharmaceutica-296035.html 0.6 2026-08-08T00:12:48+08:00 daily https://www.pharmasources.com/industryinsights/gsk-continues-restructure-by-axing-350m--296036.html 0.6 2026-06-26T19:48:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-backs-use-of-tevas-asthma-bi-296037.html 0.6 2026-07-02T18:33:48+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-vifors-veltassa-296038.html 0.6 2026-07-07T14:56:58+08:00 daily https://www.pharmasources.com/industryinsights/tentative-us-approval-for-mercks-diabete-296039.html 0.6 2026-01-05T09:04:10+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-ablynx-sign-27bn-research-licensi-296040.html 0.6 2026-08-08T00:22:16+08:00 daily https://www.pharmasources.com/industryinsights/do-you-love-your-team-296041.html 0.6 2026-01-03T17:17:58+08:00 daily https://www.pharmasources.com/industryinsights/raising-the-dose-and-raising-the-cost-th-296042.html 0.6 2026-08-08T22:55:35+08:00 daily https://www.pharmasources.com/industryinsights/mercks-new-keytruda-flat-dose-could-add--296043.html 0.6 2026-07-30T02:27:44+08:00 daily https://www.pharmasources.com/industryinsights/new-3-year-data-supports-kite-cure-hopes-296044.html 0.6 2026-08-07T10:35:10+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-anticoagulant-gains-eu-la-296045.html 0.6 2026-06-22T13:10:47+08:00 daily https://www.pharmasources.com/industryinsights/tevas-cinqaero-to-challenge-nucala-after-296046.html 0.6 2026-06-16T16:31:20+08:00 daily https://www.pharmasources.com/industryinsights/vifors-hyperkalaemia-drug-veltassa-appro-296047.html 0.6 2026-03-26T21:11:32+08:00 daily https://www.pharmasources.com/industryinsights/livongos-diabetes-solution-impresses-in--296048.html 0.6 2026-04-01T13:05:36+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170724-296049.html 0.6 2026-06-08T15:24:53+08:00 daily https://www.pharmasources.com/industryinsights/sta-signs-supply-agreement-with-tesaro-296050.html 0.6 2026-03-23T15:53:19+08:00 daily https://www.pharmasources.com/industryinsights/emas-chmp-issues-positive-opinion-for-av-296051.html 0.6 2026-02-25T13:38:54+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-associations-seek-clari-296052.html 0.6 2025-12-15T09:01:04+08:00 daily https://www.pharmasources.com/industryinsights/government-issues-demand-notice-to-pharm-296053.html 0.6 2026-01-31T10:18:14+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-tevas-cinqaero-to-treat--296054.html 0.6 2026-03-18T02:29:23+08:00 daily https://www.pharmasources.com/industryinsights/ablynx-and-sanofi-collaborate-for-nanobo-296055.html 0.6 2026-08-02T22:49:24+08:00 daily https://www.pharmasources.com/industryinsights/chmp-issues-positive-opinion-for-aveluma-296056.html 0.6 2026-07-07T01:03:41+08:00 daily https://www.pharmasources.com/industryinsights/endo-to-restructure-manufacturing-networ-296057.html 0.6 2026-08-07T00:23:49+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-positive-chmp-opinion--296058.html 0.6 2025-12-15T08:53:23+08:00 daily https://www.pharmasources.com/industryinsights/korean-pharma-association-mulls-on-use-o-296059.html 0.6 2026-03-31T09:47:11+08:00 daily https://www.pharmasources.com/industryinsights/gsk-receives-fda-approval-for-a-new-self-296060.html 0.6 2026-02-28T23:50:07+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-breaks-ground-on-21-296061.html 0.6 2026-04-21T16:28:50+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-collaborate-with-cornin-296062.html 0.6 2026-08-07T01:02:48+08:00 daily https://www.pharmasources.com/industryinsights/biomedic-consulting-inks-strategic-deal--296063.html 0.6 2026-06-10T05:04:12+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-that-otl--296064.html 0.6 2026-08-06T00:56:57+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-appoints-director-296065.html 0.6 2026-08-09T03:12:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gsks-new-self-injectable-fo-296066.html 0.6 2025-12-17T05:12:04+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-completes-fda-inspection-at-ok-296067.html 0.6 2026-01-31T06:13:15+08:00 daily https://www.pharmasources.com/industryinsights/avacens-innovation-expected-to-dramatica-296068.html 0.6 2026-04-05T14:54:45+08:00 daily https://www.pharmasources.com/industryinsights/gileads-fixed-dose-bicftctaf-combination-296069.html 0.6 2026-04-23T23:01:22+08:00 daily https://www.pharmasources.com/industryinsights/keeping-the-us-prescription-drug-supply--296070.html 0.6 2026-03-11T15:04:10+08:00 daily https://www.pharmasources.com/industryinsights/uk-bioscience-companies-form-rare-diseas-296071.html 0.6 2026-02-28T15:43:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-unveils-plan-to-eliminate-orphan-des-296072.html 0.6 2026-06-03T21:52:15+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-biosimilar-wins-tentativ-296073.html 0.6 2026-05-24T23:09:53+08:00 daily https://www.pharmasources.com/industryinsights/merck-co-samsung-bioepis-introduce-remic-296074.html 0.6 2026-08-01T21:34:15+08:00 daily https://www.pharmasources.com/industryinsights/future-has-never-been-brighter-for-us-bi-296075.html 0.6 2025-12-15T08:37:57+08:00 daily https://www.pharmasources.com/industryinsights/tv-sd-south-asia-accredited-by-nabcb-296076.html 0.6 2026-05-24T19:00:46+08:00 daily https://www.pharmasources.com/industryinsights/basf-plans-significant-investment-in-ger-296077.html 0.6 2026-06-08T08:27:19+08:00 daily https://www.pharmasources.com/industryinsights/tata-consultancy-services-recognised-296078.html 0.6 2026-08-07T20:44:21+08:00 daily https://www.pharmasources.com/industryinsights/canopy-biosciences-announces-agreement-w-296079.html 0.6 2026-06-30T17:10:50+08:00 daily https://www.pharmasources.com/industryinsights/antidepressant-use-in-pregnant-women-lin-296080.html 0.6 2026-06-25T11:46:28+08:00 daily https://www.pharmasources.com/industryinsights/us-food-and-drug-administration-expands--296081.html 0.6 2026-06-21T15:49:34+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-takes-tough-stance-on-homeop-296082.html 0.6 2026-07-28T13:24:34+08:00 daily https://www.pharmasources.com/industryinsights/monthly-injectable-hiv-treatment-proves--296083.html 0.6 2026-07-18T16:50:24+08:00 daily https://www.pharmasources.com/industryinsights/over-3-of-all-drugs-in-indian-market-not-296084.html 0.6 2026-08-07T20:18:28+08:00 daily https://www.pharmasources.com/industryinsights/teva-to-cut-over-300-production-jobs-in--296085.html 0.6 2026-07-05T06:32:27+08:00 daily https://www.pharmasources.com/industryinsights/gsk-files-for-extended-use-of-relvar-ell-296086.html 0.6 2026-04-20T18:55:22+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-consults-on-blocking-wastefu-296087.html 0.6 2026-07-20T21:39:04+08:00 daily https://www.pharmasources.com/industryinsights/merck-pfizers-avelumab-clears-first-hurd-296088.html 0.6 2026-07-27T22:03:40+08:00 daily https://www.pharmasources.com/industryinsights/eleven-medicines-leap-closer-to-eu-appro-296089.html 0.6 2026-08-08T22:20:01+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-receives-anda-a-296090.html 0.6 2026-05-09T04:12:52+08:00 daily https://www.pharmasources.com/industryinsights/regional-comprehensive-economic-partners-296091.html 0.6 2026-04-08T10:12:47+08:00 daily https://www.pharmasources.com/industryinsights/acg-appoints-richard-stedman-as-group-ce-296092.html 0.6 2026-05-17T12:44:13+08:00 daily https://www.pharmasources.com/industryinsights/who-prequalifies-first-generic-hepatitis-296093.html 0.6 2026-07-16T00:25:21+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-receives-us-fda-approval--296094.html 0.6 2026-07-03T01:28:40+08:00 daily https://www.pharmasources.com/industryinsights/amfar-the-foundation-for-aids-research-a-296095.html 0.6 2026-06-23T05:12:39+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-and-lidds-set-up-prostate-canc-296096.html 0.6 2026-03-28T05:00:45+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-new-tolerable-drug-carfliz-296097.html 0.6 2026-02-15T14:16:15+08:00 daily https://www.pharmasources.com/industryinsights/emas-chmp-recommends-merck-and-pfizers-c-296098.html 0.6 2026-03-29T01:35:24+08:00 daily https://www.pharmasources.com/industryinsights/gsk-receives-fda-approval-for-new-self-i-296099.html 0.6 2026-08-03T11:24:03+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-us-launch-of-renflexis-296100.html 0.6 2026-06-08T20:00:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-yervoy-296101.html 0.6 2026-05-07T21:03:32+08:00 daily https://www.pharmasources.com/industryinsights/hiv-vaccine-shows-encouraging-early-resu-296102.html 0.6 2026-05-03T03:27:11+08:00 daily https://www.pharmasources.com/industryinsights/europe-recommends-tecentriq-in-bladder-c-296103.html 0.6 2026-04-27T01:07:35+08:00 daily https://www.pharmasources.com/industryinsights/amazon-looks-set-to-enter-healthcare-mar-296104.html 0.6 2025-12-15T08:03:58+08:00 daily https://www.pharmasources.com/industryinsights/nhs-should-pay-for-medicines-based-on-ou-296105.html 0.6 2026-04-29T05:12:47+08:00 daily https://www.pharmasources.com/industryinsights/swine-flu-raises-its-ugly-head-again-in--296106.html 0.6 2026-06-08T10:00:57+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-china-expands-consumer-healt-296107.html 0.6 2026-06-15T16:10:05+08:00 daily https://www.pharmasources.com/industryinsights/gis-introduces-customized-cancer-treatme-296108.html 0.6 2026-06-21T16:08:46+08:00 daily https://www.pharmasources.com/industryinsights/novellusdx-collaborates-with-gene-editin-296109.html 0.6 2026-06-26T14:16:08+08:00 daily https://www.pharmasources.com/industryinsights/sema4-announces-the-launch-of-carrierche-296110.html 0.6 2026-08-06T13:11:17+08:00 daily https://www.pharmasources.com/industryinsights/us-ophthalmic-drugs-market-set-to-pass-3-296111.html 0.6 2026-07-18T11:19:56+08:00 daily https://www.pharmasources.com/industryinsights/influenza-virus-mutations-prevented-duri-296112.html 0.6 2026-07-13T11:54:52+08:00 daily https://www.pharmasources.com/industryinsights/growth-in-next-generation-sequencing-inf-296113.html 0.6 2026-08-09T00:16:29+08:00 daily https://www.pharmasources.com/industryinsights/lilly-backs-nektar-therapeutics-novel-im-296114.html 0.6 2026-07-02T22:14:36+08:00 daily https://www.pharmasources.com/industryinsights/long-acting-injection-to-remove-daily-do-296115.html 0.6 2026-05-04T20:23:55+08:00 daily https://www.pharmasources.com/industryinsights/further-evidence-of-nhs-recruitment-cris-296116.html 0.6 2026-08-07T02:18:27+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-hits-rare-snag-floundering-296117.html 0.6 2026-04-30T06:28:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-chief-plans-regulatory-overhaul-to-t-296118.html 0.6 2026-04-20T18:25:41+08:00 daily https://www.pharmasources.com/industryinsights/merck-launches-remicade-biosimilar-for-a-296119.html 0.6 2026-05-02T02:12:03+08:00 daily https://www.pharmasources.com/industryinsights/sta-signs-5-year-supply-agreement-with-t-296120.html 0.6 2026-07-07T12:28:25+08:00 daily https://www.pharmasources.com/industryinsights/chinas-distribution-changes-force-major--296121.html 0.6 2026-07-19T02:56:51+08:00 daily https://www.pharmasources.com/industryinsights/biogenes-celebrates-25-years-of-excellen-296122.html 0.6 2026-07-02T18:11:57+08:00 daily https://www.pharmasources.com/industryinsights/unicyte-ag-regenerative-medicine-unit-of-296123.html 0.6 2026-07-13T12:58:52+08:00 daily https://www.pharmasources.com/industryinsights/lilly-nektar-to-co-develop-new-immunothe-296124.html 0.6 2026-07-07T12:29:23+08:00 daily https://www.pharmasources.com/industryinsights/rcgp-warns-that-gp-access-is-set-to-wors-296125.html 0.6 2025-12-15T07:39:53+08:00 daily https://www.pharmasources.com/industryinsights/antabio-awarded-up-to-usd89m-from-carb-x-296126.html 0.6 2026-08-03T13:51:06+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-backed-for-bladder-cancer-296127.html 0.6 2026-06-15T15:10:18+08:00 daily https://www.pharmasources.com/industryinsights/lilly-reports-second-quarter-results-296128.html 0.6 2026-06-04T21:39:52+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-incyte-provide-update-on-baric-296129.html 0.6 2026-03-13T08:41:17+08:00 daily https://www.pharmasources.com/industryinsights/viivs-long-acting-two-drug-hiv-regimen-h-296130.html 0.6 2026-06-14T12:33:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-yervoy-ipilimuma-296131.html 0.6 2026-03-07T09:19:18+08:00 daily https://www.pharmasources.com/industryinsights/merck-cos-keytruda-fails-to-improve-over-296132.html 0.6 2026-07-30T16:18:18+08:00 daily https://www.pharmasources.com/industryinsights/stadas-boards-recommend-shareholders-acc-296133.html 0.6 2025-12-15T07:32:10+08:00 daily https://www.pharmasources.com/industryinsights/amgen-posts-higher-q2-profit-and-sales-l-296134.html 0.6 2026-08-08T03:16:39+08:00 daily https://www.pharmasources.com/industryinsights/china-cord-blood-corporation-files-its-a-296135.html 0.6 2026-08-05T11:01:51+08:00 daily https://www.pharmasources.com/industryinsights/resverlogix-receives-approval-pathway-fr-296136.html 0.6 2026-07-27T15:43:45+08:00 daily https://www.pharmasources.com/industryinsights/frontier-biotech-licenses-3bnc117-a-nove-296137.html 0.6 2026-07-30T07:16:54+08:00 daily https://www.pharmasources.com/industryinsights/sta-signs-5-year-supply-agreement-with-t-296138.html 0.6 2026-06-10T04:00:32+08:00 daily https://www.pharmasources.com/industryinsights/klinify-is-a-gamechanger-and-will-change-296139.html 0.6 2026-06-23T14:33:53+08:00 daily https://www.pharmasources.com/industryinsights/the-vaccine-debate-296140.html 0.6 2026-08-09T16:09:52+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-gets-ec-nod-for-its-first-and-296141.html 0.6 2026-03-02T19:26:46+08:00 daily https://www.pharmasources.com/industryinsights/from-traditional-to-advanced-drug-delive-296142.html 0.6 2026-03-12T14:52:24+08:00 daily https://www.pharmasources.com/industryinsights/asia-emerging-healthcare-startup-hub-296143.html 0.6 2026-08-09T03:05:27+08:00 daily https://www.pharmasources.com/industryinsights/merck-wins-tentative-us-fda-approval-for-296144.html 0.6 2026-07-15T20:59:29+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-tanabe-pharma-to-buy-neuroder-296145.html 0.6 2026-02-28T13:36:22+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-expands-partnership-with-world-ch-296146.html 0.6 2026-08-07T18:59:12+08:00 daily https://www.pharmasources.com/industryinsights/patients-at-risk-as-uk-plans-to-leave-eu-296147.html 0.6 2026-07-05T10:14:30+08:00 daily https://www.pharmasources.com/industryinsights/uncovering-the-cause-of-immunotherapy-re-296148.html 0.6 2026-01-20T10:59:35+08:00 daily https://www.pharmasources.com/industryinsights/new-research-highlights-lack-of-confiden-296149.html 0.6 2026-01-14T08:47:45+08:00 daily https://www.pharmasources.com/industryinsights/double-network-hydrogels-make-drug-relea-296150.html 0.6 2026-04-13T00:08:20+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-johnson-johnson-296151.html 0.6 2026-08-09T14:25:21+08:00 daily https://www.pharmasources.com/industryinsights/cardiovascular-outcomes-trial-of-anti-ob-296152.html 0.6 2025-12-17T02:46:59+08:00 daily https://www.pharmasources.com/industryinsights/novacap-announces-the-launch-of-sodium-b-296153.html 0.6 2026-04-18T19:08:47+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announced-first-in-human-296154.html 0.6 2026-06-09T15:26:02+08:00 daily https://www.pharmasources.com/industryinsights/tocilizumab-beats-steroids-for-controlli-296155.html 0.6 2026-04-18T13:36:01+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-expands-partnership-with-world-ch-296156.html 0.6 2026-02-28T15:31:14+08:00 daily https://www.pharmasources.com/industryinsights/gsk-chief-reassured-over-pragmatic-brexi-296157.html 0.6 2026-04-13T21:01:46+08:00 daily https://www.pharmasources.com/industryinsights/noninvasive-brain-test-may-pinpoint-type-296158.html 0.6 2026-02-15T13:40:04+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-gene-therapy-shows-promise--296159.html 0.6 2026-07-05T08:41:25+08:00 daily https://www.pharmasources.com/industryinsights/roche-antibody-becomes-first-of-its-kind-296160.html 0.6 2026-06-15T16:52:19+08:00 daily https://www.pharmasources.com/industryinsights/janssen-single-tablet-regimen-shows-phas-296161.html 0.6 2026-06-22T23:32:39+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-to-cut-30-drug-developme-296162.html 0.6 2026-04-06T07:50:28+08:00 daily https://www.pharmasources.com/industryinsights/shire-targeted-by-potential-buyers-in-eu-296163.html 0.6 2026-06-19T22:36:27+08:00 daily https://www.pharmasources.com/industryinsights/gileads-q2-results-outpace-analyst-expec-296164.html 0.6 2025-12-03T19:54:27+08:00 daily https://www.pharmasources.com/industryinsights/have-your-marketers-entered-marketer-of--296165.html 0.6 2026-07-30T14:28:09+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-chiesis-copd-therapy-296166.html 0.6 2026-03-21T00:24:45+08:00 daily https://www.pharmasources.com/industryinsights/us-senate-rejects-plan-to-repeal-afforda-296167.html 0.6 2026-01-14T07:57:55+08:00 daily https://www.pharmasources.com/industryinsights/us-eu-filings-for-eisais-lenvatinib-in-l-296168.html 0.6 2026-03-08T03:55:28+08:00 daily https://www.pharmasources.com/industryinsights/verona-pharma-begins-dosing-rpl554-in-ph-296169.html 0.6 2026-06-27T11:54:39+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-roches-blood-cancer-drug-296170.html 0.6 2026-03-19T22:30:34+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-roches-gazyvaro-for-follicula-296171.html 0.6 2026-03-13T18:01:49+08:00 daily https://www.pharmasources.com/industryinsights/scd-patients-to-greet-the-first-new-drug-296172.html 0.6 2026-06-08T19:58:04+08:00 daily https://www.pharmasources.com/industryinsights/new-findings-in-ovarian-cancer-treatment-296173.html 0.6 2026-03-27T10:09:10+08:00 daily https://www.pharmasources.com/industryinsights/years-after-the-restriction-order-of-ant-296174.html 0.6 2026-06-27T00:53:04+08:00 daily https://www.pharmasources.com/industryinsights/indoco-to-conduct-early-detection-of-ora-296175.html 0.6 2025-11-20T19:42:45+08:00 daily https://www.pharmasources.com/industryinsights/conference-on-integrative-ayurveda-and-a-296176.html 0.6 2025-11-08T19:24:22+08:00 daily https://www.pharmasources.com/industryinsights/carb-x-to-fund-scientists-for-new-antibi-296177.html 0.6 2025-12-19T01:37:58+08:00 daily https://www.pharmasources.com/industryinsights/gsk-pharma-strengthens-vaccine-portfolio-296178.html 0.6 2026-06-23T22:15:00+08:00 daily https://www.pharmasources.com/industryinsights/antabio-to-develop-treatment-for-pseudom-296179.html 0.6 2025-10-29T14:57:09+08:00 daily https://www.pharmasources.com/industryinsights/gsk-files-supplementary-nda-for-asthma-t-296180.html 0.6 2025-11-11T23:57:45+08:00 daily https://www.pharmasources.com/industryinsights/sta-pharmaceutical-signs-deal-with-tesar-296181.html 0.6 2026-08-08T02:54:47+08:00 daily https://www.pharmasources.com/industryinsights/janssen-receives-ema-committee-recommend-296182.html 0.6 2026-07-02T03:27:06+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-tanabe-pharma-to-buy-neuroder-296183.html 0.6 2026-06-13T14:02:52+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-nektar-partner-to-develop-new--296184.html 0.6 2026-06-09T00:03:33+08:00 daily https://www.pharmasources.com/industryinsights/blow-for-astrazeneca-as-cancer-combinati-296185.html 0.6 2026-06-13T05:25:09+08:00 daily https://www.pharmasources.com/industryinsights/walmsley-cuts-back-pipeline-calls-for-gr-296186.html 0.6 2026-06-18T20:41:35+08:00 daily https://www.pharmasources.com/industryinsights/roche-hails-4-year-nice-access-deal-for--296187.html 0.6 2026-06-03T07:11:22+08:00 daily https://www.pharmasources.com/industryinsights/roche-joins-quest-to-create-closed-loop--296188.html 0.6 2026-02-15T14:19:09+08:00 daily https://www.pharmasources.com/industryinsights/ra-pill-setback-spoils-lillys-growth-sto-296189.html 0.6 2026-06-17T19:42:34+08:00 daily https://www.pharmasources.com/industryinsights/celgene-hopes-device-drug-can-tackle-agg-296190.html 0.6 2025-11-24T20:56:56+08:00 daily https://www.pharmasources.com/industryinsights/novel-device-shows-promise-for-early-ide-296191.html 0.6 2026-07-09T01:17:12+08:00 daily https://www.pharmasources.com/industryinsights/astellas-announces-wind-down-of-agensys--296192.html 0.6 2026-02-15T09:59:13+08:00 daily https://www.pharmasources.com/industryinsights/lonzanews-pall-corporation-introduces-pr-296193.html 0.6 2026-03-10T08:43:10+08:00 daily https://www.pharmasources.com/industryinsights/lonza-pharmabiotech-launches-ibex-soluti-296194.html 0.6 2026-04-18T06:16:40+08:00 daily https://www.pharmasources.com/industryinsights/is-extended-release-guanfacine-effective-296195.html 0.6 2026-03-13T17:49:59+08:00 daily https://www.pharmasources.com/industryinsights/new-workflow-is-first-end-to-end-solutio-296196.html 0.6 2026-04-02T12:58:15+08:00 daily https://www.pharmasources.com/industryinsights/multi-million-funding-for-cryo-em-to-boo-296197.html 0.6 2026-04-05T22:16:29+08:00 daily https://www.pharmasources.com/industryinsights/global-research-programme-to-tackle-huma-296198.html 0.6 2026-06-23T15:41:31+08:00 daily https://www.pharmasources.com/industryinsights/c-difficile-infections-market-to-hit-17b-296199.html 0.6 2026-07-23T13:03:12+08:00 daily https://www.pharmasources.com/industryinsights/technology-selection-identified-as-bigge-296200.html 0.6 2026-08-09T11:04:41+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-merck-establish-strategi-296201.html 0.6 2026-04-24T21:31:40+08:00 daily https://www.pharmasources.com/industryinsights/az-attempts-to-clear-dust-of-mystic-tria-296202.html 0.6 2026-07-07T22:26:48+08:00 daily https://www.pharmasources.com/industryinsights/new-research-reveals-genetic-mutations-i-296203.html 0.6 2025-11-20T14:50:38+08:00 daily https://www.pharmasources.com/industryinsights/essentra-packaging-facility-co-funded-by-296204.html 0.6 2026-06-08T20:15:57+08:00 daily https://www.pharmasources.com/industryinsights/azs-blockbuster-lung-cancer-drug-fails-q-296205.html 0.6 2026-02-28T08:18:55+08:00 daily https://www.pharmasources.com/industryinsights/dh-creates-new-role-to-streamline-pharma-296206.html 0.6 2025-11-07T21:48:36+08:00 daily https://www.pharmasources.com/industryinsights/eu-oks-first-line-use-of-az-faslodex-296207.html 0.6 2026-02-09T03:48:04+08:00 daily https://www.pharmasources.com/industryinsights/final-nhs-nod-for-allergans-ozurdex-abbv-296208.html 0.6 2026-06-09T09:40:49+08:00 daily https://www.pharmasources.com/industryinsights/az-merck-link-to-develop-and-commerciali-296209.html 0.6 2025-10-28T21:08:04+08:00 daily https://www.pharmasources.com/industryinsights/researchers-create-a-unique-system-for-d-296210.html 0.6 2026-04-27T23:09:12+08:00 daily https://www.pharmasources.com/industryinsights/life-sciences-industry-lagging-in-women--296211.html 0.6 2026-07-02T23:06:55+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-launches-its-new-nexis-gc-296212.html 0.6 2025-11-14T02:53:33+08:00 daily https://www.pharmasources.com/industryinsights/uk-biobank-releases-genetic-data-on-05m--296213.html 0.6 2026-08-04T15:36:18+08:00 daily https://www.pharmasources.com/industryinsights/glenmarks-consolidated-revenue-increases-296214.html 0.6 2026-08-06T19:24:51+08:00 daily https://www.pharmasources.com/industryinsights/the-return-of-the-ft-global-pharmaceutic-296215.html 0.6 2026-04-13T16:45:52+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-myhep-all-in-india-296216.html 0.6 2026-04-06T19:32:03+08:00 daily https://www.pharmasources.com/industryinsights/biocad-does-its-sums-for-growth-296217.html 0.6 2026-04-09T19:44:17+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-fidson-healthcare-sarept-296218.html 0.6 2026-04-09T13:34:37+08:00 daily https://www.pharmasources.com/industryinsights/eisai-seeks-marketing-authorisation-for--296219.html 0.6 2026-03-31T21:55:17+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-faslodex-receives-eu-approv-296220.html 0.6 2026-02-28T19:21:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-supply-chain-security-toolk-296221.html 0.6 2026-04-13T17:14:58+08:00 daily https://www.pharmasources.com/industryinsights/viiv-reaches-another-milestone-in-the-de-296222.html 0.6 2025-11-25T16:08:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-status-for-ablynxs-296223.html 0.6 2026-02-28T21:33:11+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-to-improve-treatment-access-to-ch-296224.html 0.6 2026-03-17T15:07:40+08:00 daily https://www.pharmasources.com/industryinsights/puration-announces-strategy-to-become-ca-296225.html 0.6 2026-07-02T19:15:44+08:00 daily https://www.pharmasources.com/industryinsights/new-study-discovers-faulty-genes-underly-296226.html 0.6 2026-04-09T21:26:16+08:00 daily https://www.pharmasources.com/industryinsights/asian-manufacturing-awards-2017-celebrat-296227.html 0.6 2026-03-28T04:43:41+08:00 daily https://www.pharmasources.com/industryinsights/new-constant-pressure-valve-maintenance--296228.html 0.6 2026-06-25T00:50:02+08:00 daily https://www.pharmasources.com/industryinsights/green-tea-ingredient-may-ameliorate-memo-296229.html 0.6 2025-11-25T11:24:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-comprehensive-regulatory-p-296230.html 0.6 2026-07-09T11:32:35+08:00 daily https://www.pharmasources.com/industryinsights/research-into-clinical-trial-transparenc-296231.html 0.6 2026-04-07T17:35:09+08:00 daily https://www.pharmasources.com/industryinsights/shooting-for-the-moon-the-national-cance-296232.html 0.6 2026-03-25T14:01:50+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-cv-benefit-claim-for-novos-v-296233.html 0.6 2026-06-25T11:13:20+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-allergans-truberzi-for-ibs--296234.html 0.6 2026-01-31T10:16:23+08:00 daily https://www.pharmasources.com/industryinsights/revlimid-boosts-survival-in-myeloma-pati-296235.html 0.6 2025-11-02T17:48:17+08:00 daily https://www.pharmasources.com/industryinsights/cruk-brings-commercialisation-arm-in-hou-296236.html 0.6 2026-03-17T22:23:14+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170731-296237.html 0.6 2026-06-08T15:24:54+08:00 daily https://www.pharmasources.com/industryinsights/wuxis-pharmaceutical-development-service-296238.html 0.6 2026-07-21T04:03:43+08:00 daily https://www.pharmasources.com/industryinsights/cardinal-health-completes-acquisition-of-296239.html 0.6 2026-07-23T13:13:10+08:00 daily https://www.pharmasources.com/industryinsights/cphi-annual-reports---how-accurate-were--296240.html 0.6 2025-12-26T18:39:37+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-starts-clinical-study-on-inte-296241.html 0.6 2026-03-23T15:33:38+08:00 daily https://www.pharmasources.com/industryinsights/resurgence-of-swine-flu-in-india-296242.html 0.6 2026-07-05T14:59:31+08:00 daily https://www.pharmasources.com/industryinsights/pall-corporation-introduces-proprietary--296243.html 0.6 2026-08-06T22:49:22+08:00 daily https://www.pharmasources.com/industryinsights/novotech-signs-mou-with-south-koreas-sci-296244.html 0.6 2026-01-31T09:24:48+08:00 daily https://www.pharmasources.com/industryinsights/largest-body-of-evidence-on-clinical-ben-296245.html 0.6 2026-03-01T07:39:33+08:00 daily https://www.pharmasources.com/industryinsights/peg-ioncs-show-potential-as-next-generat-296246.html 0.6 2026-03-31T23:55:58+08:00 daily https://www.pharmasources.com/industryinsights/consortium-established-to-support-ich-m7-296247.html 0.6 2026-01-29T11:47:14+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-wins-breakthrough-therapy-design-296248.html 0.6 2026-04-17T04:30:29+08:00 daily https://www.pharmasources.com/industryinsights/googles-verily-opens-cancer-testing-lab-296249.html 0.6 2025-11-25T07:04:45+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-continuation-296250.html 0.6 2026-02-28T15:32:43+08:00 daily https://www.pharmasources.com/industryinsights/bioconjugation-specialist-innova-bioscie-296251.html 0.6 2026-07-06T18:31:04+08:00 daily https://www.pharmasources.com/industryinsights/deadline-looms-for-ema-host-city-bids-296252.html 0.6 2026-03-28T07:03:07+08:00 daily https://www.pharmasources.com/industryinsights/obamacare-repeal-dealt-huge-blow-as-mcca-296253.html 0.6 2026-04-09T09:53:45+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-clovis-oncology-296254.html 0.6 2026-06-08T03:44:59+08:00 daily https://www.pharmasources.com/industryinsights/study-backs-hiv-testing-in-gp-surgeries--296255.html 0.6 2026-03-19T08:57:08+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-reputations-nosediving--296256.html 0.6 2025-11-07T15:06:35+08:00 daily https://www.pharmasources.com/industryinsights/sta-pharma-merges-with-wuxi-apptecs-pds--296257.html 0.6 2026-06-25T21:30:26+08:00 daily https://www.pharmasources.com/industryinsights/hiv-screening-by-gps-could-reduce-incide-296258.html 0.6 2025-12-21T00:05:11+08:00 daily https://www.pharmasources.com/industryinsights/az-immunotherapy-gets-fda-boost-in-early-296259.html 0.6 2026-02-26T20:19:03+08:00 daily https://www.pharmasources.com/industryinsights/azs-imfinzi-scores-fda-breakthrough-ther-296260.html 0.6 2026-07-10T00:05:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-wants-to-reduce-the-amount-of-nicoti-296261.html 0.6 2025-12-07T11:12:36+08:00 daily https://www.pharmasources.com/industryinsights/alembics-doxycycline-capsules-receives-u-296262.html 0.6 2026-07-02T14:14:12+08:00 daily https://www.pharmasources.com/industryinsights/dr-rao-vsv-vadlamudi-elected-as-presiden-296263.html 0.6 2026-02-15T13:43:51+08:00 daily https://www.pharmasources.com/industryinsights/nice-bars-obesity-pill-from-routine-nhs--296264.html 0.6 2026-01-31T06:24:42+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-concludes-inspection-of-lupins-fa-296265.html 0.6 2026-01-30T23:03:42+08:00 daily https://www.pharmasources.com/industryinsights/baxter-completes-acquisition-of-claris-i-296266.html 0.6 2026-01-10T11:50:13+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-and-janssen-to-develop-v-296267.html 0.6 2026-02-10T00:38:25+08:00 daily https://www.pharmasources.com/industryinsights/new-hepatitis-c-therapies-approved-in-eu-296268.html 0.6 2026-06-19T06:28:15+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-astrazeneca-to-develop-and-mar-296269.html 0.6 2025-10-27T21:35:28+08:00 daily https://www.pharmasources.com/industryinsights/gp-leaders-warn-of-break-point-for-the-p-296270.html 0.6 2026-01-19T15:58:51+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-status-for-az-lung-cancer-d-296271.html 0.6 2025-11-07T20:30:03+08:00 daily https://www.pharmasources.com/industryinsights/the-creative-floor-winners-announced-296272.html 0.6 2026-06-10T09:07:27+08:00 daily https://www.pharmasources.com/industryinsights/amgen-submits-sbla-for-prolia-in-glucoco-296273.html 0.6 2026-07-21T10:57:40+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-clovis-oncology-announce-a-broad-296274.html 0.6 2025-12-14T12:04:59+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-unanimous-po-296275.html 0.6 2026-01-31T00:28:51+08:00 daily https://www.pharmasources.com/industryinsights/bioscience-managers-appoints-elizabeth-k-296276.html 0.6 2026-07-02T16:30:52+08:00 daily https://www.pharmasources.com/industryinsights/evotec-to-pay-300m-for-aptuit-296277.html 0.6 2026-04-18T03:13:35+08:00 daily https://www.pharmasources.com/industryinsights/baxter-completes-625m-purchase-of-claris-296278.html 0.6 2026-04-13T16:57:52+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-expands-services-296279.html 0.6 2026-06-08T02:56:15+08:00 daily https://www.pharmasources.com/industryinsights/lonza-pharma-biotech-launches-ibex-solut-296280.html 0.6 2026-05-31T19:00:21+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-lilly-to-suppor-296281.html 0.6 2026-02-15T00:06:27+08:00 daily https://www.pharmasources.com/industryinsights/colleen-goggins-joins-quintilesims-board-296282.html 0.6 2026-07-09T00:47:26+08:00 daily https://www.pharmasources.com/industryinsights/dynavax-announces-fda-advisory-committee-296283.html 0.6 2026-03-17T23:56:11+08:00 daily https://www.pharmasources.com/industryinsights/india-set-to-block-13-bn-gland-pharma-fo-296284.html 0.6 2026-04-05T22:29:19+08:00 daily https://www.pharmasources.com/industryinsights/takeda-tesaro-ink-strategic-deal-to-co-d-296285.html 0.6 2026-07-18T19:47:28+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-reports-positive-data-in-phase--296286.html 0.6 2026-04-20T10:48:04+08:00 daily https://www.pharmasources.com/industryinsights/arch-biopartners-gmp-manufacturing-of-ab-296287.html 0.6 2026-07-17T15:17:38+08:00 daily https://www.pharmasources.com/industryinsights/torrent-pharmas-revenue-dips-in-q1-fy-20-296288.html 0.6 2026-07-02T05:17:05+08:00 daily https://www.pharmasources.com/industryinsights/siemens-launches-digitalization-hub-in-s-296289.html 0.6 2026-04-06T13:34:53+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-extension-for-meronem-w-296290.html 0.6 2026-05-29T19:10:32+08:00 daily https://www.pharmasources.com/industryinsights/apotex-to-expand-footprint-in-india-296291.html 0.6 2026-08-03T16:55:09+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-concludes-lupins-aurangabad-facil-296292.html 0.6 2026-06-06T06:29:46+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-announces-revolutio-296293.html 0.6 2026-02-28T13:47:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-idhifa-296294.html 0.6 2026-03-06T09:32:54+08:00 daily https://www.pharmasources.com/industryinsights/medical-reality-catches-up-to-science-fi-296295.html 0.6 2025-11-16T01:20:12+08:00 daily https://www.pharmasources.com/industryinsights/janssen-enters-collaboration-with-bavari-296296.html 0.6 2026-01-04T05:22:40+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-nivolumab-receives-1st-august-pbs-296297.html 0.6 2026-02-28T14:28:15+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-to-buy-chiltern-for-approximatel-296298.html 0.6 2026-02-15T09:36:23+08:00 daily https://www.pharmasources.com/industryinsights/lonza-starts-construction-of-biological--296299.html 0.6 2026-07-19T08:27:21+08:00 daily https://www.pharmasources.com/industryinsights/ema-unveils-business-continuity-plan-ahe-296300.html 0.6 2026-04-17T14:48:21+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-receives-ec-grant-to-market-hcv-t-296301.html 0.6 2025-11-28T18:41:31+08:00 daily https://www.pharmasources.com/industryinsights/start-up-helix-launches-the-first-genomi-296302.html 0.6 2025-11-20T17:49:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kalydeco-ivacaftor-for-more-296303.html 0.6 2026-01-06T03:37:29+08:00 daily https://www.pharmasources.com/industryinsights/carb-x-announces-funding-to-speed-treatm-296304.html 0.6 2026-04-15T13:31:24+08:00 daily https://www.pharmasources.com/industryinsights/okayama-university-researchers-identify--296305.html 0.6 2026-01-30T13:40:10+08:00 daily https://www.pharmasources.com/industryinsights/biosimilar-renflexis-infliximab-availabl-296306.html 0.6 2026-06-08T05:28:28+08:00 daily https://www.pharmasources.com/industryinsights/mt-pharma-america-announces-corporate-na-296307.html 0.6 2026-08-09T07:12:34+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-second-quarter-sales-fall-2-perc-296308.html 0.6 2026-04-13T04:43:22+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-signs-agreement-to-acquire-disc-296309.html 0.6 2026-08-07T19:36:15+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-granted-breakthrough-therapy-des-296310.html 0.6 2026-08-06T18:37:19+08:00 daily https://www.pharmasources.com/industryinsights/cardinal-health-completes-acquisition-of-296311.html 0.6 2026-06-30T13:01:24+08:00 daily https://www.pharmasources.com/industryinsights/indian-govt-may-turn-down-fosuns-offer-t-296312.html 0.6 2026-03-13T13:38:58+08:00 daily https://www.pharmasources.com/industryinsights/amgen-allergan-submit-biosimilar-biologi-296313.html 0.6 2026-07-27T08:53:58+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-teva-announce-fda-acceptance-o-296314.html 0.6 2026-07-22T13:27:08+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-may-slow-progression-of-parkins-296315.html 0.6 2026-03-17T20:02:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-296316.html 0.6 2026-01-20T03:55:51+08:00 daily https://www.pharmasources.com/industryinsights/active-dashboard-2-allows-easy-access-296317.html 0.6 2026-07-20T22:37:05+08:00 daily https://www.pharmasources.com/industryinsights/south-korean-pharma-becoming-manufacturi-296318.html 0.6 2026-06-08T19:56:27+08:00 daily https://www.pharmasources.com/industryinsights/roche-reports-strong-performance-in-the--296319.html 0.6 2026-04-06T19:13:22+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-major-drug-gains-doubles-sales-b-296320.html 0.6 2026-06-17T23:04:25+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-scores-second-accelerated-fd-296321.html 0.6 2026-07-18T22:26:10+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-break-ground-on-217-296322.html 0.6 2026-04-17T19:15:00+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-commends-credence-ids-rol-296323.html 0.6 2026-06-09T23:40:30+08:00 daily https://www.pharmasources.com/industryinsights/uk-babies-to-be-routinely-immunised-agai-296324.html 0.6 2026-03-02T18:03:22+08:00 daily https://www.pharmasources.com/industryinsights/kite-first-to-submit-car-t-therapy-in-eu-296325.html 0.6 2026-03-05T05:16:25+08:00 daily https://www.pharmasources.com/industryinsights/amgen-allergans-herceptin-biosimilar-fil-296326.html 0.6 2026-06-18T09:00:38+08:00 daily https://www.pharmasources.com/industryinsights/patients-at-risk-in-brexit-negotiations--296327.html 0.6 2026-03-05T13:30:32+08:00 daily https://www.pharmasources.com/industryinsights/govt-unveils-plans-to-create-21000-new-m-296328.html 0.6 2026-04-05T14:13:15+08:00 daily https://www.pharmasources.com/industryinsights/gsk-announces-new-priorities-plans-to-of-296329.html 0.6 2026-04-15T12:31:48+08:00 daily https://www.pharmasources.com/industryinsights/new-targeted-treatment-for-relapsed-or-r-296330.html 0.6 2026-03-17T23:19:21+08:00 daily https://www.pharmasources.com/industryinsights/comprehensive-regulatory-plan-by-fda-for-296331.html 0.6 2026-07-07T02:55:35+08:00 daily https://www.pharmasources.com/industryinsights/who-partners-with-mrf-to-work-on-meningi-296332.html 0.6 2026-03-01T03:10:11+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-expands-offering-with-roc-it-s-296333.html 0.6 2026-02-28T20:38:22+08:00 daily https://www.pharmasources.com/industryinsights/tecan-launches-new-range-of-clear-dispos-296334.html 0.6 2025-10-28T05:30:22+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-for-human-age-re-296335.html 0.6 2026-03-20T11:11:51+08:00 daily https://www.pharmasources.com/industryinsights/sterigenics-expands-capacity-296336.html 0.6 2026-08-06T00:26:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-targeted-treatment-for--296337.html 0.6 2026-04-18T04:52:26+08:00 daily https://www.pharmasources.com/industryinsights/advantapure-announces-its-iso-90012015-c-296338.html 0.6 2025-10-20T16:35:49+08:00 daily https://www.pharmasources.com/industryinsights/new-imaging-technique-allows-early-asses-296339.html 0.6 2026-02-28T16:09:51+08:00 daily https://www.pharmasources.com/industryinsights/lupin-posts-net-profit-at-rs-3581-mn-in--296340.html 0.6 2026-01-14T10:39:03+08:00 daily https://www.pharmasources.com/industryinsights/merck-adds-chemical-products-to-reaxys-c-296341.html 0.6 2026-06-14T05:15:33+08:00 daily https://www.pharmasources.com/industryinsights/european-medicines-agency-prepares-for-b-296342.html 0.6 2026-03-17T21:38:34+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-priority-review-good-news-p-296343.html 0.6 2026-03-05T07:58:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-celgene-and-agios-acute-mye-296344.html 0.6 2025-10-20T21:35:01+08:00 daily https://www.pharmasources.com/industryinsights/zydus-receives-us-fda-approval-for-temoz-296345.html 0.6 2026-01-30T18:19:01+08:00 daily https://www.pharmasources.com/industryinsights/record-number-of-drug-related-deaths-as--296346.html 0.6 2025-11-07T06:43:20+08:00 daily https://www.pharmasources.com/industryinsights/glenmarks-acyclovir-ointment-usp-5-recei-296347.html 0.6 2026-07-28T16:28:40+08:00 daily https://www.pharmasources.com/industryinsights/ema-reveals-business-continuity-plan-for-296348.html 0.6 2026-02-28T15:27:40+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-prescriptions-rocket-80-percent-296349.html 0.6 2026-06-15T22:47:14+08:00 daily https://www.pharmasources.com/industryinsights/piramal-enterprises-net-profit-up-by-31--296350.html 0.6 2026-01-20T07:40:36+08:00 daily https://www.pharmasources.com/industryinsights/green-light-for-celgenes-targeted-aml-dr-296351.html 0.6 2026-08-08T03:07:34+08:00 daily https://www.pharmasources.com/industryinsights/fast-track-pancreatic-cancer-surgery-boo-296352.html 0.6 2025-11-07T13:59:40+08:00 daily https://www.pharmasources.com/industryinsights/neuroderm-bought-for-11b-296353.html 0.6 2025-11-28T02:12:59+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-and-breakthrough-status--296354.html 0.6 2026-01-31T10:22:23+08:00 daily https://www.pharmasources.com/industryinsights/grantham-hospital-extends-overnight-clos-296355.html 0.6 2026-02-28T23:55:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-imbruvica-ibrutinib-for-chr-296356.html 0.6 2026-03-01T21:36:35+08:00 daily https://www.pharmasources.com/industryinsights/is-infant-drug-withdrawal-likelier-when--296357.html 0.6 2025-10-21T21:33:44+08:00 daily https://www.pharmasources.com/industryinsights/nice-draft-guidance-rejects-roches-tecen-296358.html 0.6 2026-06-18T19:34:29+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-reaches-300-million-deal--296359.html 0.6 2026-08-09T20:58:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-panel-votes-against-approva-296360.html 0.6 2026-08-07T21:15:09+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-boehringer-ingelheims-prescript-296361.html 0.6 2026-08-10T01:39:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-astrazenec-296362.html 0.6 2026-08-03T05:01:05+08:00 daily https://www.pharmasources.com/industryinsights/pacs-vendors-in-southeast-asia-focus-on--296363.html 0.6 2026-03-19T08:51:19+08:00 daily https://www.pharmasources.com/industryinsights/a-delegation-led-by-director-li-weimin-o-296364.html 0.6 2026-07-31T17:19:05+08:00 daily https://www.pharmasources.com/industryinsights/sta-pharmaceutical-merges-with-wuxis-pha-296365.html 0.6 2026-07-17T19:38:30+08:00 daily https://www.pharmasources.com/industryinsights/kite-pharma-submits-maa-for-axicabtagene-296366.html 0.6 2026-03-31T14:52:03+08:00 daily https://www.pharmasources.com/industryinsights/aprea-announces-first-patient-enrolled-i-296367.html 0.6 2026-07-23T20:55:11+08:00 daily https://www.pharmasources.com/industryinsights/theranos-settles-with-walgreens-but-is-l-296368.html 0.6 2026-06-21T23:18:54+08:00 daily https://www.pharmasources.com/industryinsights/roches-herceptin-facing-further-biosimil-296369.html 0.6 2026-08-05T10:43:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-review-to-az-cancer-drug-296370.html 0.6 2026-03-23T01:04:15+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-trial-investigates-genetic-caus-296371.html 0.6 2026-04-06T17:46:12+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-tecentriq-in-bladder-can-296372.html 0.6 2026-06-14T07:56:12+08:00 daily https://www.pharmasources.com/industryinsights/express-scripts-hobbles-new-synergy-med--296373.html 0.6 2026-06-22T13:18:50+08:00 daily https://www.pharmasources.com/industryinsights/ubm-and-restec-discontinue-russia-partne-296374.html 0.6 2026-06-13T09:32:03+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-merck-in-85b-oncology-pact-296375.html 0.6 2026-08-03T17:34:48+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-clovis-oncology-enter-clinical-c-296376.html 0.6 2026-06-06T23:45:16+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-cardurion-form-cardiovascular-296377.html 0.6 2026-07-13T13:32:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mavyret-296378.html 0.6 2026-04-07T06:43:16+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-rosuvast-296379.html 0.6 2026-08-02T12:02:41+08:00 daily https://www.pharmasources.com/industryinsights/the-vaccine-debate-296380.html 0.6 2026-08-09T17:50:57+08:00 daily https://www.pharmasources.com/industryinsights/pharmasafe-india-conference-to-be-held-i-296381.html 0.6 2026-06-28T02:05:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vyxeos-296382.html 0.6 2026-08-09T14:33:06+08:00 daily https://www.pharmasources.com/industryinsights/basf-expands-technical-lab-for-pharma-ap-296383.html 0.6 2026-07-07T17:56:37+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-to-acquire-chiltern-for-12-billi-296384.html 0.6 2025-12-15T04:20:26+08:00 daily https://www.pharmasources.com/industryinsights/biofluidica-pumps-41m-funding-to-back-it-296385.html 0.6 2026-06-28T11:09:44+08:00 daily https://www.pharmasources.com/industryinsights/philips-and-sam-to-open-first-of-its-kin-296386.html 0.6 2026-08-09T03:27:16+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-breakthrough-therapy-desig-296387.html 0.6 2026-07-01T17:14:53+08:00 daily https://www.pharmasources.com/industryinsights/parkway-pantai-introduces-new-3-d-mammog-296388.html 0.6 2026-07-06T01:09:41+08:00 daily https://www.pharmasources.com/industryinsights/national-supercomputing-centre-singapore-296389.html 0.6 2026-08-09T02:47:59+08:00 daily https://www.pharmasources.com/industryinsights/top-10-prescription-drugs-by-ad-expendit-296390.html 0.6 2026-07-19T22:00:25+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-eurofins-scientific-baxter-296391.html 0.6 2026-07-19T09:15:53+08:00 daily https://www.pharmasources.com/industryinsights/uk-nice-invites-roche-to-submit-cancer-d-296392.html 0.6 2026-04-13T03:44:01+08:00 daily https://www.pharmasources.com/industryinsights/noninvasive-technique-for-probing-cells--296393.html 0.6 2026-03-19T10:43:49+08:00 daily https://www.pharmasources.com/industryinsights/collidion-to-buy-80-stake-in-plex-pharma-296394.html 0.6 2026-04-07T15:45:30+08:00 daily https://www.pharmasources.com/industryinsights/see-new-products-first-at-lab-innovation-296395.html 0.6 2026-04-17T17:47:29+08:00 daily https://www.pharmasources.com/industryinsights/new-injectable-antiretroviral-treatment--296396.html 0.6 2026-03-27T21:25:08+08:00 daily https://www.pharmasources.com/industryinsights/latest-progress-of-pd-1-inhibitors-keytr-296397.html 0.6 2025-12-15T04:28:03+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-innoviva-seattle-genetic-296398.html 0.6 2026-08-06T19:24:49+08:00 daily https://www.pharmasources.com/industryinsights/qs-pharma-receives-approval-from-europea-296399.html 0.6 2026-04-07T04:44:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-chronic-graft-versus-host-d-296400.html 0.6 2025-12-15T04:34:38+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-announces-settlement-agre-296401.html 0.6 2026-03-24T15:09:52+08:00 daily https://www.pharmasources.com/industryinsights/takeda-molecular-templates-announce-mult-296402.html 0.6 2026-08-07T03:01:37+08:00 daily https://www.pharmasources.com/industryinsights/essentra-wins-editors-choice-award-at-as-296403.html 0.6 2026-03-25T20:12:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-turns-down-janssens-sirukumab-for-rh-296404.html 0.6 2026-06-16T12:08:38+08:00 daily https://www.pharmasources.com/industryinsights/msds-biosimilar-of-lantus-obtained-tenta-296405.html 0.6 2026-08-05T19:52:26+08:00 daily https://www.pharmasources.com/industryinsights/existing-arthritis-drug-could-save-thous-296406.html 0.6 2025-12-15T04:41:16+08:00 daily https://www.pharmasources.com/industryinsights/the-common-cold-cured-296407.html 0.6 2026-07-08T18:06:59+08:00 daily https://www.pharmasources.com/industryinsights/communications-team-of-the-year-internat-296408.html 0.6 2025-12-15T04:43:28+08:00 daily https://www.pharmasources.com/industryinsights/nice-invites-roche-to-submit-tecentriq-f-296409.html 0.6 2025-12-15T04:44:32+08:00 daily https://www.pharmasources.com/industryinsights/mrc-links-with-ucb-in-antibody-initiativ-296410.html 0.6 2026-06-08T21:33:16+08:00 daily https://www.pharmasources.com/industryinsights/janssens-plivensia-given-thumbs-down-by--296411.html 0.6 2026-02-15T13:35:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-green-lights-first-treatment-for-chr-296412.html 0.6 2026-08-05T19:23:21+08:00 daily https://www.pharmasources.com/industryinsights/ex-google-exec-jeff-huber-steps-down-as--296413.html 0.6 2026-03-12T23:40:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisers-reject-jj-rheumatoid-arthri-296414.html 0.6 2025-12-18T12:42:52+08:00 daily https://www.pharmasources.com/industryinsights/scottish-firm-gets-eu-funding-for-off-th-296415.html 0.6 2026-01-12T02:47:21+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-hits-trouble-with-nice--296416.html 0.6 2026-01-03T16:06:45+08:00 daily https://www.pharmasources.com/industryinsights/australia-announces-new-skill-list-296417.html 0.6 2026-05-27T01:07:38+08:00 daily https://www.pharmasources.com/industryinsights/rpg-life-sciences-posts-reduction-in-pro-296418.html 0.6 2026-05-29T23:19:45+08:00 daily https://www.pharmasources.com/industryinsights/takeda-partners-with-cardurion-pharma-296419.html 0.6 2025-12-15T04:55:29+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-to-buy-ifm-therapeutics-296420.html 0.6 2025-12-19T16:53:39+08:00 daily https://www.pharmasources.com/industryinsights/takeda-pharma-partners-with-cardurion-ph-296421.html 0.6 2026-07-14T12:23:23+08:00 daily https://www.pharmasources.com/industryinsights/infoholics-reports-growth-for-polymerase-296422.html 0.6 2025-12-22T01:15:57+08:00 daily https://www.pharmasources.com/industryinsights/arthritis-drug-may-treat-blood-cancer-pa-296423.html 0.6 2026-08-07T22:57:31+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-to-detect-brain-metastases-296424.html 0.6 2026-06-08T04:56:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-abbvies-mavyret-for-hepatit-296425.html 0.6 2025-12-15T05:02:03+08:00 daily https://www.pharmasources.com/industryinsights/despite-benefits-mercks-keytruda-falls-s-296426.html 0.6 2026-02-25T21:02:53+08:00 daily https://www.pharmasources.com/industryinsights/botox-fillers-steal-the-show-as-allergan-296427.html 0.6 2026-02-28T12:59:02+08:00 daily https://www.pharmasources.com/industryinsights/airmaker-revolutionising-smart-cities-di-296428.html 0.6 2026-07-03T10:17:46+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-accuses-ex-ceo-of-secret-plot-to-296429.html 0.6 2026-07-10T00:17:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-snubs-johnson-johnsons-rheumat-296430.html 0.6 2026-07-04T21:58:30+08:00 daily https://www.pharmasources.com/industryinsights/asia-lung-cancer-summit-in-hong-kong-sar-296431.html 0.6 2026-02-05T02:37:26+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-sells-clinical-manufacturi-296432.html 0.6 2026-01-04T12:37:33+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-23-billion-gamble--296433.html 0.6 2026-04-22T13:25:15+08:00 daily https://www.pharmasources.com/industryinsights/india-pharma-incs-tryst-with-destiny-con-296434.html 0.6 2026-06-23T06:04:21+08:00 daily https://www.pharmasources.com/industryinsights/india-has-recognised-the-need-for-strong-296435.html 0.6 2026-04-18T18:18:55+08:00 daily https://www.pharmasources.com/industryinsights/nice-greenlights-celgene-pancreatic-canc-296436.html 0.6 2026-03-19T22:43:22+08:00 daily https://www.pharmasources.com/industryinsights/second-edition-of-healthcare-senate-to-b-296437.html 0.6 2026-04-22T08:44:25+08:00 daily https://www.pharmasources.com/industryinsights/evolution-of-indian-pharma-regulatory-fr-296438.html 0.6 2026-08-07T08:31:13+08:00 daily https://www.pharmasources.com/industryinsights/upgradation-of-gmp-since-independence-296439.html 0.6 2026-08-01T06:54:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-genentechs-alecensa-priority--296440.html 0.6 2026-06-19T20:41:34+08:00 daily https://www.pharmasources.com/industryinsights/pharma-medical-and-biotech-witness-290-d-296441.html 0.6 2026-01-20T08:03:55+08:00 daily https://www.pharmasources.com/industryinsights/chan-zuckerberg-initiative-injects-10-mi-296442.html 0.6 2026-03-19T23:10:40+08:00 daily https://www.pharmasources.com/industryinsights/global-clostridium-difficile-infections--296443.html 0.6 2026-06-08T20:13:05+08:00 daily https://www.pharmasources.com/industryinsights/apac-colorectal-cancer-therapeutics-mark-296444.html 0.6 2025-12-15T05:25:04+08:00 daily https://www.pharmasources.com/industryinsights/nice-leans-towards-a-no-for-keytruda-in--296445.html 0.6 2026-08-07T06:16:11+08:00 daily https://www.pharmasources.com/industryinsights/biocon-foundations-elaj-project-wins-awa-296446.html 0.6 2026-06-08T18:17:33+08:00 daily https://www.pharmasources.com/industryinsights/pancreatic-cancer-patients-in-england-ge-296447.html 0.6 2026-03-20T11:10:32+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-presents-thought-le-296448.html 0.6 2026-03-19T13:14:22+08:00 daily https://www.pharmasources.com/industryinsights/shire-mulls-over-separation-of-neuroscie-296449.html 0.6 2026-03-26T04:11:30+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-abbvies-imbruvica-for-tr-296450.html 0.6 2026-07-14T16:20:09+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-pan-genotypic-hep-c-therapy-clea-296451.html 0.6 2026-04-06T06:51:29+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-innoviva-seattle-genetic-296452.html 0.6 2026-04-19T09:09:52+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-eurofins-scientific-baxter-296453.html 0.6 2025-12-15T05:33:47+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-stages-a-strong-recovery-over--296454.html 0.6 2026-08-09T17:54:08+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-q1-profit-up-97-pc-at-rs-93-296455.html 0.6 2026-04-21T08:29:24+08:00 daily https://www.pharmasources.com/industryinsights/cams-partners-with-cams-296456.html 0.6 2026-08-10T01:01:44+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-bags-us-fda-approval-for-antib-296457.html 0.6 2026-04-29T17:32:56+08:00 daily https://www.pharmasources.com/industryinsights/new-cancer-therapy-eliminates-toxic-deli-296458.html 0.6 2026-07-23T17:28:19+08:00 daily https://www.pharmasources.com/industryinsights/tokyo-tech-joins-hands-with-kawasaki-cit-296459.html 0.6 2026-06-21T18:26:39+08:00 daily https://www.pharmasources.com/industryinsights/australia-announces-new-skill-list-for-t-296460.html 0.6 2026-05-07T18:10:55+08:00 daily https://www.pharmasources.com/industryinsights/drugs-taken-before-surgery-may-reduce-me-296461.html 0.6 2026-01-30T20:38:46+08:00 daily https://www.pharmasources.com/industryinsights/new-research-shows-drug-used-for-arthrit-296462.html 0.6 2026-06-28T04:00:25+08:00 daily https://www.pharmasources.com/industryinsights/gold-nanoparticles-raise-hopes-for-cance-296463.html 0.6 2025-12-15T05:42:35+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-to-buy-infacare-and-its-pae-296464.html 0.6 2026-07-16T16:14:27+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-to-buy-ifm-therapeu-296465.html 0.6 2026-03-07T17:27:01+08:00 daily https://www.pharmasources.com/industryinsights/compound-derived-from-marijuana-interact-296466.html 0.6 2026-06-08T10:38:18+08:00 daily https://www.pharmasources.com/industryinsights/federal-judge-enters-consent-decree-agai-296467.html 0.6 2026-02-15T08:52:48+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170808-296468.html 0.6 2026-06-08T15:24:55+08:00 daily https://www.pharmasources.com/industryinsights/sta-signs-5-year-supply-agreement-with-t-296469.html 0.6 2026-01-30T18:02:25+08:00 daily https://www.pharmasources.com/industryinsights/bayer-secures-one-two-treatment-for-live-296470.html 0.6 2026-04-18T18:40:14+08:00 daily https://www.pharmasources.com/industryinsights/stomach-acid-drugs-do-not-increase-alzhe-296471.html 0.6 2026-07-18T08:30:20+08:00 daily https://www.pharmasources.com/industryinsights/poor-conditions-leads-isomeric-pharmacy--296472.html 0.6 2026-07-18T05:43:04+08:00 daily https://www.pharmasources.com/industryinsights/hiv-preventing-drug-to-be-trialed-across-296473.html 0.6 2025-12-15T05:55:43+08:00 daily https://www.pharmasources.com/industryinsights/vernalis-cough-and-cold-drug-knocked-bac-296474.html 0.6 2026-03-18T00:38:31+08:00 daily https://www.pharmasources.com/industryinsights/kite-begins-eu-trial-of-cart-therapy-296475.html 0.6 2026-04-15T18:30:46+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-completes-randomization-in-phas-296476.html 0.6 2025-12-15T05:48:04+08:00 daily https://www.pharmasources.com/industryinsights/smc-recommends-three-new-medicines-296477.html 0.6 2025-12-15T05:59:01+08:00 daily https://www.pharmasources.com/industryinsights/rebiotix-announces-first-patient-enrolle-296478.html 0.6 2025-12-15T06:00:07+08:00 daily https://www.pharmasources.com/industryinsights/teva-gets-fda-approval-for-easier-to-use-296479.html 0.6 2026-06-17T13:03:45+08:00 daily https://www.pharmasources.com/industryinsights/shire-reports-q2-2017-operating-results-296480.html 0.6 2026-04-07T15:28:41+08:00 daily https://www.pharmasources.com/industryinsights/cmp-pharma-announces-fda-approval-of-car-296481.html 0.6 2026-03-04T22:39:05+08:00 daily https://www.pharmasources.com/industryinsights/videoryan-riboldi-explains-role-of-new-s-296482.html 0.6 2026-06-08T01:51:13+08:00 daily https://www.pharmasources.com/industryinsights/how-much-will-teva-need-to-pay-to-land-t-296483.html 0.6 2026-06-04T12:51:28+08:00 daily https://www.pharmasources.com/industryinsights/first-oral-liquid-dosage-cmp-pharmas-car-296484.html 0.6 2026-02-03T22:59:03+08:00 daily https://www.pharmasources.com/industryinsights/cellular-garbage-disposal-units-fingered-296485.html 0.6 2026-08-09T01:19:41+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-new-treatment-option-for-psor-296486.html 0.6 2026-03-13T20:43:59+08:00 daily https://www.pharmasources.com/industryinsights/mannkind-one-drop-to-study-afrezza-app-c-296487.html 0.6 2026-06-24T09:33:19+08:00 daily https://www.pharmasources.com/industryinsights/myokardia-transforms-inherited-heart-dis-296488.html 0.6 2026-04-16T04:07:55+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-expects-europe-as-first-mar-296489.html 0.6 2026-07-06T14:24:17+08:00 daily https://www.pharmasources.com/industryinsights/lillys-novel-migraine-drug-hits-phiii-ta-296490.html 0.6 2026-03-26T22:32:50+08:00 daily https://www.pharmasources.com/industryinsights/news-of-noteglaxosmithklines-rd-fix-leo--296491.html 0.6 2026-03-22T15:49:42+08:00 daily https://www.pharmasources.com/industryinsights/zynerba-sinks-after-total-failure-in-pha-296492.html 0.6 2026-02-28T23:25:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-second-vernalis-coughcold-tr-296493.html 0.6 2026-04-06T10:27:46+08:00 daily https://www.pharmasources.com/industryinsights/gemphire-stock-sinks-as-ex-pfizer-ldl-dr-296494.html 0.6 2026-04-07T17:02:54+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-launches-trial-to-assess-pre-296495.html 0.6 2026-04-03T12:02:41+08:00 daily https://www.pharmasources.com/industryinsights/activist-pushes-acorda-to-sell-figuring--296496.html 0.6 2026-06-02T10:10:02+08:00 daily https://www.pharmasources.com/industryinsights/allergan-ceo-whats-the-worlds-best-pharm-296497.html 0.6 2026-03-19T23:42:32+08:00 daily https://www.pharmasources.com/industryinsights/studyblood-pressure-fluctuations-linked--296498.html 0.6 2026-07-03T06:56:50+08:00 daily https://www.pharmasources.com/industryinsights/eu-approved-bayers-stivarga-for-the-seco-296499.html 0.6 2026-03-19T02:42:25+08:00 daily https://www.pharmasources.com/industryinsights/nsf-international-provides-pharma-biotec-296500.html 0.6 2026-03-18T01:56:50+08:00 daily https://www.pharmasources.com/industryinsights/under-new-collaboration-valneva-and-emer-296501.html 0.6 2026-02-28T13:49:55+08:00 daily https://www.pharmasources.com/industryinsights/karius-reels-in-50m-to-ramp-up-infectiou-296502.html 0.6 2026-03-12T19:32:14+08:00 daily https://www.pharmasources.com/industryinsights/new-novartis-rival-kisqali-hasnt-slowed--296503.html 0.6 2026-04-27T12:12:48+08:00 daily https://www.pharmasources.com/industryinsights/look-back-at-10-years-of-industry-watchi-296504.html 0.6 2025-12-28T16:18:24+08:00 daily https://www.pharmasources.com/industryinsights/spoiler-alert-ibd-superheroes-prevail-as-296505.html 0.6 2026-03-28T22:07:36+08:00 daily https://www.pharmasources.com/industryinsights/fdas-generic-competition-push-hits-valea-296506.html 0.6 2026-01-12T19:37:16+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-enters-into-research-collaboratio-296507.html 0.6 2026-08-07T23:50:15+08:00 daily https://www.pharmasources.com/industryinsights/penny-sized-nanochip-pad-can-regrow-orga-296508.html 0.6 2026-03-26T20:50:42+08:00 daily https://www.pharmasources.com/industryinsights/vistamed-expands-manufacturing-facility--296509.html 0.6 2026-06-08T06:31:00+08:00 daily https://www.pharmasources.com/industryinsights/synbio-unlocking-the-commercial-potentia-296510.html 0.6 2026-06-22T17:00:16+08:00 daily https://www.pharmasources.com/industryinsights/indias-pharmaceutical-market-set-to-hit--296511.html 0.6 2026-06-07T11:04:08+08:00 daily https://www.pharmasources.com/industryinsights/viavi-micronir-tablet-probe-unlocks-acce-296512.html 0.6 2026-03-02T19:34:58+08:00 daily https://www.pharmasources.com/industryinsights/bayer-receives-eu-approval-for-regorafen-296513.html 0.6 2026-01-22T03:36:49+08:00 daily https://www.pharmasources.com/industryinsights/research-by-nci-determines-necessary-gen-296514.html 0.6 2025-12-26T13:18:00+08:00 daily https://www.pharmasources.com/industryinsights/research-highlights-lack-of-confidence-i-296515.html 0.6 2026-07-03T03:44:43+08:00 daily https://www.pharmasources.com/industryinsights/herbal-medicine-shows-potential-to-treat-296516.html 0.6 2026-02-10T17:47:37+08:00 daily https://www.pharmasources.com/industryinsights/anti-inflammatory-anti-stress-drugs-take-296517.html 0.6 2026-06-24T12:43:16+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-that-women-have-more-active--296518.html 0.6 2026-02-28T14:02:39+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-sites-capacity-at-lincolnshi-296519.html 0.6 2026-06-10T23:00:55+08:00 daily https://www.pharmasources.com/industryinsights/takeda-reveals-collaboration-aimed-at-bo-296520.html 0.6 2025-12-20T21:57:27+08:00 daily https://www.pharmasources.com/industryinsights/merck-scores-expanded-nice-recommendatio-296521.html 0.6 2025-12-15T06:47:19+08:00 daily https://www.pharmasources.com/industryinsights/shire-shifts-vaccine-facility-from-baxal-296522.html 0.6 2026-02-15T13:48:10+08:00 daily https://www.pharmasources.com/industryinsights/9-companies-will-play-a-huge-role-in-sha-296523.html 0.6 2026-06-04T02:34:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-medicines360s-snda-for-lile-296524.html 0.6 2026-01-18T14:58:38+08:00 daily https://www.pharmasources.com/industryinsights/first-fda-approved-treatment-for-als-in--296525.html 0.6 2026-02-28T09:28:30+08:00 daily https://www.pharmasources.com/industryinsights/struggling-endos-write-downs-pass-5b-for-296526.html 0.6 2026-04-14T05:47:25+08:00 daily https://www.pharmasources.com/industryinsights/tokyo-tech-and-kawasaki-city-to-cooperat-296527.html 0.6 2026-03-25T02:15:10+08:00 daily https://www.pharmasources.com/industryinsights/bookdoc-battles-cancer-with-singapore-ca-296528.html 0.6 2026-08-09T01:52:25+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-baylor-college-of-medicine-adv-296529.html 0.6 2025-12-15T06:56:11+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-erbituxr-in-combination--296530.html 0.6 2026-04-16T05:22:38+08:00 daily https://www.pharmasources.com/industryinsights/australian-medical-technology-company-lb-296531.html 0.6 2026-08-08T00:51:00+08:00 daily https://www.pharmasources.com/industryinsights/hangzhou-just-biotherapeutics-ltd-secure-296532.html 0.6 2026-07-14T23:53:34+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-immunotherapy-for-chronic-h-296533.html 0.6 2026-04-16T12:35:32+08:00 daily https://www.pharmasources.com/industryinsights/valeant-cuts-full-year-sales-forecast-as-296534.html 0.6 2026-06-25T10:29:06+08:00 daily https://www.pharmasources.com/industryinsights/invitrouce-and-gis-launch-innovations-la-296535.html 0.6 2026-06-21T02:22:22+08:00 daily https://www.pharmasources.com/industryinsights/mdv-assigns-57-million-to-support-new-hi-296536.html 0.6 2025-11-07T23:08:56+08:00 daily https://www.pharmasources.com/industryinsights/bookdoc-associates-with-singapore-cancer-296537.html 0.6 2026-04-19T09:35:04+08:00 daily https://www.pharmasources.com/industryinsights/global-shortage-of-hepatitis-b-vaccines--296538.html 0.6 2026-04-14T07:12:57+08:00 daily https://www.pharmasources.com/industryinsights/experts-urge-adoption-of-integrative-med-296539.html 0.6 2026-08-06T20:15:17+08:00 daily https://www.pharmasources.com/industryinsights/ajanta-pharmas-total-comprehensive-incom-296540.html 0.6 2026-04-05T11:34:22+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-collaborates-with-kyukyu--296541.html 0.6 2026-05-08T22:26:44+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-nod-to-market-hi-296542.html 0.6 2026-07-02T03:52:40+08:00 daily https://www.pharmasources.com/industryinsights/biotaiwan-chinas-growth-is-a-reflection--296543.html 0.6 2026-06-07T14:27:48+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-host-first-cannatech-summit-in-oct-296544.html 0.6 2025-11-09T13:05:36+08:00 daily https://www.pharmasources.com/industryinsights/smc-approves-amgens-carfilzomib-for-mult-296545.html 0.6 2026-04-27T13:38:13+08:00 daily https://www.pharmasources.com/industryinsights/new-study-shows-anti-ulcer-drugs-do-not--296546.html 0.6 2026-01-31T01:06:45+08:00 daily https://www.pharmasources.com/industryinsights/biggest-challenges-of-multi-region-clini-296547.html 0.6 2025-11-13T22:12:36+08:00 daily https://www.pharmasources.com/industryinsights/risky-endeavours-for-biosimilars-market-296548.html 0.6 2026-06-21T16:29:24+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-glaxosmithkline-production-iss-296549.html 0.6 2026-07-07T00:15:31+08:00 daily https://www.pharmasources.com/industryinsights/pharmamar-starts-quadruple-combination-s-296550.html 0.6 2026-04-05T00:50:07+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-receives-fda-ocugen-receives-fda--296551.html 0.6 2026-06-08T17:12:53+08:00 daily https://www.pharmasources.com/industryinsights/promising-therapeutic-approach-for-impro-296552.html 0.6 2026-08-06T16:17:21+08:00 daily https://www.pharmasources.com/industryinsights/data-integrity-for-endotoxin-testing-faq-296553.html 0.6 2026-01-03T07:48:11+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-drugs-market-is-expected-to-r-296554.html 0.6 2026-01-17T06:30:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-expand-public-education-campaign--296555.html 0.6 2026-03-24T22:49:30+08:00 daily https://www.pharmasources.com/industryinsights/silverstein-backed-startup-will-test-gen-296556.html 0.6 2025-12-16T10:47:20+08:00 daily https://www.pharmasources.com/industryinsights/stimwaves-mri-safe-injectable-neurostimu-296557.html 0.6 2026-04-13T03:31:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-orphan-status-to-new-brain-ca-296558.html 0.6 2026-04-12T03:06:13+08:00 daily https://www.pharmasources.com/industryinsights/chronic-kidney-disease-player-osprey-med-296559.html 0.6 2026-03-25T19:44:03+08:00 daily https://www.pharmasources.com/industryinsights/valeant-focused-on-bringing-new-products-296560.html 0.6 2026-04-09T19:26:32+08:00 daily https://www.pharmasources.com/industryinsights/chemotherapy-can-spread-breast-cancer-to-296561.html 0.6 2026-02-14T23:37:01+08:00 daily https://www.pharmasources.com/industryinsights/roivant-sciences-in-mega-11b-raise-looks-296562.html 0.6 2026-04-01T18:20:34+08:00 daily https://www.pharmasources.com/industryinsights/global-shortage-of-hep-b-vaccine-hits-uk-296563.html 0.6 2026-05-12T18:44:24+08:00 daily https://www.pharmasources.com/industryinsights/esperion-hits-goal-in-ldl-trial-pulls-fo-296564.html 0.6 2026-07-28T08:02:05+08:00 daily https://www.pharmasources.com/industryinsights/struggling-ardelyx-cuts-staff-as-it-plac-296565.html 0.6 2026-03-19T23:26:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-files-patent-infringement-suit-ag-296566.html 0.6 2026-01-13T00:30:39+08:00 daily https://www.pharmasources.com/industryinsights/judge-rules-against-nhs-in-kuvan-funding-296567.html 0.6 2026-08-07T13:21:41+08:00 daily https://www.pharmasources.com/industryinsights/news-of-noteaeterna-review-allegro-eye-t-296568.html 0.6 2026-08-07T21:25:29+08:00 daily https://www.pharmasources.com/industryinsights/roche-out-licneses-lebrikizumab-to-dermi-296569.html 0.6 2026-08-08T02:11:08+08:00 daily https://www.pharmasources.com/industryinsights/melinta-merges-with-faltering-cempra-bag-296570.html 0.6 2026-04-14T09:13:16+08:00 daily https://www.pharmasources.com/industryinsights/humira-may-spend-most-on-tv-but-xeljanz--296571.html 0.6 2026-06-24T07:44:52+08:00 daily https://www.pharmasources.com/industryinsights/new-hampshire-ground-zero-of-addiction-e-296572.html 0.6 2026-08-06T10:34:25+08:00 daily https://www.pharmasources.com/industryinsights/testing-the-safety-of-immunotherapy-in-d-296573.html 0.6 2025-12-16T10:37:21+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-doubles-down-on-cns-resear-296574.html 0.6 2026-03-27T16:19:37+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-ceo-dont-scapegoat-pricing--296575.html 0.6 2026-04-05T03:49:05+08:00 daily https://www.pharmasources.com/industryinsights/mylan-points-finger-at-fda-for-failure-t-296576.html 0.6 2026-06-23T19:53:35+08:00 daily https://www.pharmasources.com/industryinsights/cvs-walgreens-and-pbms-worked-together-t-296577.html 0.6 2026-04-13T22:15:11+08:00 daily https://www.pharmasources.com/industryinsights/teva-puts-medisand-maybe-moreon-the-bloc-296578.html 0.6 2026-06-21T16:17:23+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-nixes-58-marketing--296579.html 0.6 2026-01-05T16:01:07+08:00 daily https://www.pharmasources.com/industryinsights/what-do-kids-think-of-their-parents-ra-a-296580.html 0.6 2026-04-05T21:04:35+08:00 daily https://www.pharmasources.com/industryinsights/payer-coverage-in-place-allergan-gets-re-296581.html 0.6 2026-06-18T08:21:42+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-baylor-college-of-medicine-sig-296582.html 0.6 2026-06-18T08:13:55+08:00 daily https://www.pharmasources.com/industryinsights/cphi-india-report-identifies-two-tier-ma-296583.html 0.6 2026-06-18T08:21:45+08:00 daily https://www.pharmasources.com/industryinsights/zydus-pharma-recalls-331-lakh-bottles-of-296584.html 0.6 2026-07-07T06:26:31+08:00 daily https://www.pharmasources.com/industryinsights/numerate-receives-nih-funding-to-discove-296585.html 0.6 2026-07-08T18:11:27+08:00 daily https://www.pharmasources.com/industryinsights/galena-biopharma-merges-sellas-to-form-n-296586.html 0.6 2026-06-23T21:12:27+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-mercks-erbitux-to-treat--296587.html 0.6 2026-06-21T13:40:18+08:00 daily https://www.pharmasources.com/industryinsights/sutro-celgene-to-refocus-2014-immuno-onc-296588.html 0.6 2026-06-25T00:20:47+08:00 daily https://www.pharmasources.com/industryinsights/abbott-launches-trial-of-transcatheter-t-296589.html 0.6 2025-10-29T12:05:49+08:00 daily https://www.pharmasources.com/industryinsights/speeding-up-drug-discovery-process-with--296590.html 0.6 2025-10-22T05:35:03+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-three-generic-antiretrovi-296591.html 0.6 2026-07-04T23:24:36+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-appoints-mark-rothe-296592.html 0.6 2026-03-01T05:26:15+08:00 daily https://www.pharmasources.com/industryinsights/regen-addresses-potential-impact-of-bris-296593.html 0.6 2026-07-12T13:24:37+08:00 daily https://www.pharmasources.com/industryinsights/sk-capital-acquires-perrigo-companys-api-296594.html 0.6 2026-06-19T12:40:01+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-promotes-prospects-of-immuno-296595.html 0.6 2026-07-10T20:16:53+08:00 daily https://www.pharmasources.com/industryinsights/effector-therapeutics-completes-386-mill-296596.html 0.6 2025-11-17T07:59:22+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-acclaims-cgis-advanced-ge-296597.html 0.6 2026-06-20T13:23:48+08:00 daily https://www.pharmasources.com/industryinsights/takeda-shattuck-labs-announce-research-c-296598.html 0.6 2026-07-26T10:00:31+08:00 daily https://www.pharmasources.com/industryinsights/ehs-signs-agreement-with-gci-296599.html 0.6 daily https://www.pharmasources.com/industryinsights/teva-announces-fda-approval-of-qvar-redi-296600.html 0.6 2026-06-13T11:32:04+08:00 daily https://www.pharmasources.com/industryinsights/just-china-secures-closing-of-series-b-f-296601.html 0.6 2026-06-08T16:10:33+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-biggest-big-pharmas-new--296602.html 0.6 2025-12-10T08:48:22+08:00 daily https://www.pharmasources.com/industryinsights/feds-pull-mylan-a-small-time-opioid-drug-296603.html 0.6 2026-06-09T16:56:42+08:00 daily https://www.pharmasources.com/industryinsights/rna-targeting-crispr-could-yield-treatme-296604.html 0.6 2026-08-05T18:24:20+08:00 daily https://www.pharmasources.com/industryinsights/report-identifies-two-tier-pharmaceutica-296605.html 0.6 2026-07-02T16:18:58+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-to-take-ipf-drug-into-late-sta-296606.html 0.6 2026-08-07T18:58:22+08:00 daily https://www.pharmasources.com/industryinsights/imagine-a-time-of-early-diagnostic-of-ch-296607.html 0.6 2026-03-18T00:03:23+08:00 daily https://www.pharmasources.com/industryinsights/small-biotechs-will-drive-biggest-develo-296608.html 0.6 2025-11-24T13:47:10+08:00 daily https://www.pharmasources.com/industryinsights/celgene-drops-sutro-buyout-option-and-re-296609.html 0.6 2026-01-04T01:33:23+08:00 daily https://www.pharmasources.com/industryinsights/nexavar-receives-final-appraisal-for-pri-296610.html 0.6 2026-03-18T00:18:36+08:00 daily https://www.pharmasources.com/industryinsights/could-a-trump-mandated-cash-repatriation-296611.html 0.6 2026-06-24T08:29:01+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-offloading-its-ingredient-busine-296612.html 0.6 2026-06-21T13:17:01+08:00 daily https://www.pharmasources.com/industryinsights/the-2017-report-so-far-big-biotechs-spen-296613.html 0.6 2026-07-08T20:30:00+08:00 daily https://www.pharmasources.com/industryinsights/addressing-the-safety-and-risk-managemen-296614.html 0.6 2026-05-13T20:59:30+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-files-suit-in-the-us-to-defend-it-296615.html 0.6 2026-04-08T23:15:43+08:00 daily https://www.pharmasources.com/industryinsights/japanese-telecom-giant-injects-11bn-into-296616.html 0.6 2026-06-20T20:25:13+08:00 daily https://www.pharmasources.com/industryinsights/bayers-liver-cancer-drug-availability-sp-296617.html 0.6 2026-06-10T14:34:26+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-that-one-in-twelve-us-doctor-296618.html 0.6 2026-05-03T00:28:32+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-partners-with-biotecn-296619.html 0.6 2026-04-27T23:57:40+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-and-biotecnol-to-tria-296620.html 0.6 2026-04-23T13:33:05+08:00 daily https://www.pharmasources.com/industryinsights/biotech-to-drive-biggest-cancer-advancem-296621.html 0.6 2026-06-09T21:12:40+08:00 daily https://www.pharmasources.com/industryinsights/positive-outlook-for-biotech-ma-and-fund-296622.html 0.6 2026-04-22T15:08:24+08:00 daily https://www.pharmasources.com/industryinsights/bayers-nexavar-approved-for-primary-live-296623.html 0.6 2026-08-09T02:52:38+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-biomarin-pharmaceutical--296624.html 0.6 2026-08-09T00:10:07+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-sun-pharmaceutical-industr-296625.html 0.6 2026-08-08T21:27:04+08:00 daily https://www.pharmasources.com/industryinsights/blockbuster-zikv-drug-research-published-296626.html 0.6 2026-08-08T08:00:01+08:00 daily https://www.pharmasources.com/industryinsights/half-brine-half-flame-two-different-worl-296627.html 0.6 2026-08-07T13:18:31+08:00 daily https://www.pharmasources.com/industryinsights/the-hottest-pk-between-pd-1pd-l1-antibod-296628.html 0.6 2026-06-19T11:10:31+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-close-it-neuroscience-rd-center-i-296629.html 0.6 2026-04-14T02:25:06+08:00 daily https://www.pharmasources.com/industryinsights/milkha-singh-appointed-who-goodwill-amba-296630.html 0.6 2026-05-04T00:27:18+08:00 daily https://www.pharmasources.com/industryinsights/able-firm-announce-industry-and-research-296631.html 0.6 2026-07-19T19:25:41+08:00 daily https://www.pharmasources.com/industryinsights/professor-teo-yik-ying-joins-nus-296632.html 0.6 2026-05-09T08:46:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-drafts-guidance-on-post-approval-man-296633.html 0.6 2025-11-27T16:57:09+08:00 daily https://www.pharmasources.com/industryinsights/smc-suggests-three-new-medicines-for-rou-296634.html 0.6 2026-03-27T19:34:13+08:00 daily https://www.pharmasources.com/industryinsights/pharmalytica-2017-kickstarts-in-hyderaba-296635.html 0.6 2026-01-05T08:19:18+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-posts-q1fy18-results-296636.html 0.6 2025-11-07T22:15:27+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-launches-avio-500-icp-oes-296637.html 0.6 2026-01-05T04:22:03+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharmacovigilance-day-2017-confer-296638.html 0.6 2026-07-06T18:10:55+08:00 daily https://www.pharmasources.com/industryinsights/internet-of-medical-things-providers-tap-296639.html 0.6 2025-12-21T04:51:28+08:00 daily https://www.pharmasources.com/industryinsights/tabuk-pharmaceuticals-signs-exclusive-in-296640.html 0.6 2026-01-04T11:09:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-alarms-of-possible-contamination-in--296641.html 0.6 2026-06-15T11:17:27+08:00 daily https://www.pharmasources.com/industryinsights/celgene-opts-not-to-acquire-sutro-biopha-296642.html 0.6 2026-01-04T13:45:04+08:00 daily https://www.pharmasources.com/industryinsights/early-stage-study-gives-hope-for-rare-an-296643.html 0.6 2026-01-31T02:29:43+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-expected-to-keep-battlin-296644.html 0.6 2026-04-24T05:07:07+08:00 daily https://www.pharmasources.com/industryinsights/fiercepharmaasiasuns-quarterly-loss-beig-296645.html 0.6 2026-04-12T14:37:59+08:00 daily https://www.pharmasources.com/industryinsights/ending-the-era-when-cancer-drugs-cost-10-296646.html 0.6 2026-04-03T07:18:48+08:00 daily https://www.pharmasources.com/industryinsights/suns-profit-crushed-as-it-pays-150m-to-s-296647.html 0.6 2026-06-08T20:35:11+08:00 daily https://www.pharmasources.com/industryinsights/teva-kept-silence-for-weeks-on-upcoming--296648.html 0.6 2026-08-05T23:51:52+08:00 daily https://www.pharmasources.com/industryinsights/nhs-unsustainable-says-confederation-chi-296649.html 0.6 2026-06-18T18:11:52+08:00 daily https://www.pharmasources.com/industryinsights/kalo-maker-of-epipen-rival-auvi-q-teams--296650.html 0.6 2026-06-12T13:58:05+08:00 daily https://www.pharmasources.com/industryinsights/amgen-falls-short-in-epogen-patent-appea-296651.html 0.6 2026-06-21T00:19:23+08:00 daily https://www.pharmasources.com/industryinsights/2m-uk-consortium-to-tackle-gene-therapy-296652.html 0.6 2026-06-19T05:47:21+08:00 daily https://www.pharmasources.com/industryinsights/whats-next-after-crispr-succeed-in-quest-296653.html 0.6 2026-04-06T20:04:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-gastric-balloon-warning-afte-296654.html 0.6 2026-06-23T19:41:34+08:00 daily https://www.pharmasources.com/industryinsights/alexion-and-sema4-partner-in-rare-diseas-296655.html 0.6 2026-07-22T12:57:13+08:00 daily https://www.pharmasources.com/industryinsights/neuromodulation-player-neosync-grabs-13m-296656.html 0.6 2026-04-20T17:14:34+08:00 daily https://www.pharmasources.com/industryinsights/for-parkinsons-patients-singing-may-be-g-296657.html 0.6 2026-06-18T16:48:27+08:00 daily https://www.pharmasources.com/industryinsights/gsk-jilts-ionis-rare-disease-drug-as-fda-296658.html 0.6 2026-06-20T20:26:16+08:00 daily https://www.pharmasources.com/industryinsights/takeda-allies-with-austin-for-double-wha-296659.html 0.6 2026-02-28T13:53:12+08:00 daily https://www.pharmasources.com/industryinsights/international-laboratories-issues-volunt-296660.html 0.6 2026-07-16T04:46:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-alerts-hcps-patients-not-to-use-ster-296661.html 0.6 2026-07-18T09:09:09+08:00 daily https://www.pharmasources.com/industryinsights/achieve-announces-fda-acceptance-of-ind--296662.html 0.6 2026-06-20T16:23:08+08:00 daily https://www.pharmasources.com/industryinsights/c4-therapeutics-appoints-vp-of-business--296663.html 0.6 2026-08-07T22:09:17+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170814-296664.html 0.6 2026-06-08T15:24:56+08:00 daily https://www.pharmasources.com/industryinsights/zydus-settles-patent-case-over-aptalis-d-296665.html 0.6 2026-06-12T01:57:44+08:00 daily https://www.pharmasources.com/industryinsights/natco-gets-us-fda-nod-to-market-renal-di-296666.html 0.6 2025-11-10T13:44:42+08:00 daily https://www.pharmasources.com/industryinsights/more-than-1000-jan-aushadhi-kendras-to-o-296667.html 0.6 2026-06-13T08:19:11+08:00 daily https://www.pharmasources.com/industryinsights/repeated-regulatory-reprimands-will-erod-296668.html 0.6 2026-06-10T07:28:12+08:00 daily https://www.pharmasources.com/industryinsights/divis-labs-bags-green-nod-296669.html 0.6 2026-06-12T09:49:41+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-shattuck-labs-partner-to-deve-296670.html 0.6 2026-06-12T14:06:04+08:00 daily https://www.pharmasources.com/industryinsights/sk-capital-to-buy-api-business-from-perr-296671.html 0.6 2026-07-07T14:48:52+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-pharma-partner-with-dhl-to-buil-296672.html 0.6 2026-08-07T06:51:44+08:00 daily https://www.pharmasources.com/industryinsights/asia-the-fastest-growing-vaccine-market--296673.html 0.6 2026-06-04T21:07:17+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-three-generic-anti-retrov-296674.html 0.6 2026-06-09T06:40:38+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-reports-second-quarter-2017-res-296675.html 0.6 2026-04-27T16:29:37+08:00 daily https://www.pharmasources.com/industryinsights/swift-announces-the-highest-throughput-s-296676.html 0.6 2026-01-03T14:43:50+08:00 daily https://www.pharmasources.com/industryinsights/renovis-surgical-receives-fda-clearance--296677.html 0.6 2026-03-22T15:51:54+08:00 daily https://www.pharmasources.com/industryinsights/experimental-treatment-for-niemann-pick--296678.html 0.6 2026-03-25T19:13:45+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-three-quarters-of-the-canc-296679.html 0.6 2026-03-13T22:58:11+08:00 daily https://www.pharmasources.com/industryinsights/drug-approval-harmonisation-shows-saving-296680.html 0.6 2026-03-20T09:32:16+08:00 daily https://www.pharmasources.com/industryinsights/inc-research-and-inventiv-health-announc-296681.html 0.6 2026-04-17T14:50:35+08:00 daily https://www.pharmasources.com/industryinsights/enrollment-of-first-human-subject-for-lu-296682.html 0.6 2026-05-19T14:08:33+08:00 daily https://www.pharmasources.com/industryinsights/experimental-treatment-for-niemann-pick--296683.html 0.6 2026-05-27T08:01:57+08:00 daily https://www.pharmasources.com/industryinsights/vaccines-market-to-reach-4927-billion-us-296684.html 0.6 2026-04-30T17:40:04+08:00 daily https://www.pharmasources.com/industryinsights/nice-knocks-back-advanced-kidney-cancer--296685.html 0.6 2026-05-03T07:09:02+08:00 daily https://www.pharmasources.com/industryinsights/insulin-pumps-market-up-to-95507-million-296686.html 0.6 2026-04-27T15:28:41+08:00 daily https://www.pharmasources.com/industryinsights/takeda-strikes-partnership-to-develop-si-296687.html 0.6 2026-04-23T19:55:47+08:00 daily https://www.pharmasources.com/industryinsights/over-1000-currently-active-cancer-trials-296688.html 0.6 2026-05-08T16:14:19+08:00 daily https://www.pharmasources.com/industryinsights/hugely-disturbing-rise-in-uk-children-wi-296689.html 0.6 2026-06-30T16:03:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-potential-contamination-in--296690.html 0.6 2026-07-17T18:23:47+08:00 daily https://www.pharmasources.com/industryinsights/suptavumab-does-not-meet-primary-endpoin-296691.html 0.6 2026-07-18T23:28:00+08:00 daily https://www.pharmasources.com/industryinsights/a-vaccine-for-addiction-dont-get-your-ho-296692.html 0.6 2026-06-09T19:21:12+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-kidney-cancer-drugs-296693.html 0.6 2026-06-09T19:23:30+08:00 daily https://www.pharmasources.com/industryinsights/ophthotech-completes-clean-sweep-of-phas-296694.html 0.6 2025-12-29T15:26:02+08:00 daily https://www.pharmasources.com/industryinsights/gsk-walks-away-from-ionis-antisense-drug-296695.html 0.6 2026-07-06T10:16:57+08:00 daily https://www.pharmasources.com/industryinsights/james-mullen-backs-vicarius-22m-series-a-296696.html 0.6 2026-05-28T18:16:44+08:00 daily https://www.pharmasources.com/industryinsights/repairing-broken-hearts-with-injectable--296697.html 0.6 2026-03-17T19:21:38+08:00 daily https://www.pharmasources.com/industryinsights/councils-plea-for-more-cash-to-combat-ch-296698.html 0.6 2026-03-19T23:28:46+08:00 daily https://www.pharmasources.com/industryinsights/audit-shows-drop-in-hospital-heart-failu-296699.html 0.6 2026-02-09T09:43:23+08:00 daily https://www.pharmasources.com/industryinsights/merck-ceo-frazier-draws-trumps-ire-for-t-296700.html 0.6 2025-10-29T20:54:28+08:00 daily https://www.pharmasources.com/industryinsights/amazon-could-partner-with-a-pbm-to-blaze-296701.html 0.6 2026-03-22T07:53:20+08:00 daily https://www.pharmasources.com/industryinsights/chinas-fosun-shanghai-pharma-circle-geor-296702.html 0.6 2026-07-19T18:00:30+08:00 daily https://www.pharmasources.com/industryinsights/has-the-brent-saunders-price-hike-limit--296703.html 0.6 2026-06-29T21:17:42+08:00 daily https://www.pharmasources.com/industryinsights/aka-what-fanapt-maker-vanda-puts-antipsy-296704.html 0.6 2026-06-14T19:22:35+08:00 daily https://www.pharmasources.com/industryinsights/mannkind-plots-trial-pairing-inhaled-ins-296705.html 0.6 2026-02-28T15:24:15+08:00 daily https://www.pharmasources.com/industryinsights/mercks-frazier-joins-top-paid-pharma-ceo-296706.html 0.6 2026-01-30T15:31:42+08:00 daily https://www.pharmasources.com/industryinsights/the-great-hall-of-china-double-digit-gro-296707.html 0.6 2026-07-18T22:04:03+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-acquires-global-rights-for-c-296708.html 0.6 2026-02-15T00:33:47+08:00 daily https://www.pharmasources.com/industryinsights/3-in-4-of-cdf-treatments-now-approved-on-296709.html 0.6 2026-04-05T23:31:36+08:00 daily https://www.pharmasources.com/industryinsights/amneal-issues-voluntary-nationwide-recal-296710.html 0.6 2026-08-07T01:00:39+08:00 daily https://www.pharmasources.com/industryinsights/metacrine-collaborates-on-fgf1-variants--296711.html 0.6 2026-08-01T11:50:24+08:00 daily https://www.pharmasources.com/industryinsights/lexicon-reports-additional-positive-data-296712.html 0.6 2026-06-06T18:21:58+08:00 daily https://www.pharmasources.com/industryinsights/endothelial-cell-application-centre-expa-296713.html 0.6 2026-04-01T05:23:11+08:00 daily https://www.pharmasources.com/industryinsights/injectable-tissue-patch-may-help-repair--296714.html 0.6 2025-12-02T22:34:17+08:00 daily https://www.pharmasources.com/industryinsights/new-library-to-help-companies-implement--296715.html 0.6 2026-07-07T02:19:22+08:00 daily https://www.pharmasources.com/industryinsights/scorr-applied-clinical-trials-release-re-296716.html 0.6 2026-07-06T03:24:59+08:00 daily https://www.pharmasources.com/industryinsights/mt-pharma-america-announces-corporate-na-296717.html 0.6 2026-02-06T17:22:48+08:00 daily https://www.pharmasources.com/industryinsights/horizon-discovery-releases-cho-genome-se-296718.html 0.6 2026-06-12T03:23:33+08:00 daily https://www.pharmasources.com/industryinsights/light-to-moderate-alcohol-consumption-ma-296719.html 0.6 2026-04-03T22:03:56+08:00 daily https://www.pharmasources.com/industryinsights/shire-files-dry-eye-drug-lifitegrast-for-296720.html 0.6 2026-02-15T13:41:49+08:00 daily https://www.pharmasources.com/industryinsights/gilead-set-to-open-250m-23-acre-campus-296721.html 0.6 2026-07-18T07:24:26+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-abandons-respiratory-syncytial-296722.html 0.6 2026-08-05T21:41:57+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-agrees-250m-smart-chemothera-296723.html 0.6 2026-04-12T08:14:53+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-drops-rsv-therapy-on-trial-fai-296724.html 0.6 2026-08-06T01:55:01+08:00 daily https://www.pharmasources.com/industryinsights/atlas-awarded-2m-grant-for-infectious-di-296725.html 0.6 2026-08-09T02:02:15+08:00 daily https://www.pharmasources.com/industryinsights/shire-submits-dry-eye-drug-in-europe-296726.html 0.6 2026-02-15T08:21:58+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-support-for-researchers-wi-296727.html 0.6 2026-05-27T21:54:42+08:00 daily https://www.pharmasources.com/industryinsights/takeda-announces-alliance-with-stanford--296728.html 0.6 2026-01-31T10:28:41+08:00 daily https://www.pharmasources.com/industryinsights/data-shows-slump-in-uk-bowel-cancer-deat-296729.html 0.6 2026-08-09T12:05:16+08:00 daily https://www.pharmasources.com/industryinsights/alvogen-announces-acquisition-of-omega-b-296730.html 0.6 2026-03-28T17:47:29+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-gets-new-funds-from-niaid-to-d-296731.html 0.6 2026-02-14T23:02:58+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-opens-new-566m-vaccines--296732.html 0.6 2025-12-02T22:14:00+08:00 daily https://www.pharmasources.com/industryinsights/lilly-backed-cavion-poaches-teva-executi-296733.html 0.6 2026-03-27T20:02:56+08:00 daily https://www.pharmasources.com/industryinsights/chinese-biotech-hitgen-inks-new-drug-dis-296734.html 0.6 2026-05-12T11:41:28+08:00 daily https://www.pharmasources.com/industryinsights/cerecor-ceo-retires-after-scoring-johnso-296735.html 0.6 2026-01-10T21:03:23+08:00 daily https://www.pharmasources.com/industryinsights/lexicon-builds-case-for-sanofi-partnered-296736.html 0.6 2025-12-26T18:37:57+08:00 daily https://www.pharmasources.com/industryinsights/ros1-cancer-patients-team-up-to-build-di-296737.html 0.6 2026-03-01T05:24:27+08:00 daily https://www.pharmasources.com/industryinsights/will-more-pharmas-oppose-trump-after-mer-296738.html 0.6 2026-06-18T14:40:28+08:00 daily https://www.pharmasources.com/industryinsights/suvens-revenue-declines-by-21-per-cent-296739.html 0.6 2026-06-20T08:43:15+08:00 daily https://www.pharmasources.com/industryinsights/which-ma-made-our-best-and-worst-ballot--296740.html 0.6 2026-07-29T08:08:49+08:00 daily https://www.pharmasources.com/industryinsights/dark-money-and-drugs-ohio-pricing-activi-296741.html 0.6 2026-07-29T23:00:28+08:00 daily https://www.pharmasources.com/industryinsights/gilead-set-to-open-california-production-296742.html 0.6 2026-08-09T04:15:11+08:00 daily https://www.pharmasources.com/industryinsights/after-a-slow-start-novartis-finally-gain-296743.html 0.6 2026-07-31T18:55:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-status-to-h3-biom-296744.html 0.6 2026-08-03T23:31:47+08:00 daily https://www.pharmasources.com/industryinsights/amicus-galafold-receives-tga-approval-fo-296745.html 0.6 2026-03-20T09:06:26+08:00 daily https://www.pharmasources.com/industryinsights/aradigm-secures-sbir-grant-to-investigat-296746.html 0.6 2026-03-28T13:12:29+08:00 daily https://www.pharmasources.com/industryinsights/dop-observes-swachhta-pakhwada-296747.html 0.6 2026-08-07T07:24:41+08:00 daily https://www.pharmasources.com/industryinsights/softbank-invests-11-billion-in-roivant-s-296748.html 0.6 2026-08-01T16:18:57+08:00 daily https://www.pharmasources.com/industryinsights/dr-yin-zhongchao-named-singapores-outsta-296749.html 0.6 2026-08-02T04:48:55+08:00 daily https://www.pharmasources.com/industryinsights/biocon-withdraws-application-for-eu-appr-296750.html 0.6 2026-07-31T18:56:52+08:00 daily https://www.pharmasources.com/industryinsights/top-korean-pharma-companies-increase-the-296751.html 0.6 2026-07-30T15:30:00+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-us-fda-approval-fo-296752.html 0.6 2026-03-21T10:19:26+08:00 daily https://www.pharmasources.com/industryinsights/gsk-inaugurates-its-new-facility-in-scot-296753.html 0.6 2026-08-03T15:53:21+08:00 daily https://www.pharmasources.com/industryinsights/suvens-revenue-declines-by-21-per-cent-296754.html 0.6 2026-03-26T18:55:14+08:00 daily https://www.pharmasources.com/industryinsights/ankon-raises-100-m-from-sbcvc-296755.html 0.6 2026-07-31T15:10:28+08:00 daily https://www.pharmasources.com/industryinsights/vista-to-provide-high-end-health-care-se-296756.html 0.6 2026-08-06T21:29:17+08:00 daily https://www.pharmasources.com/industryinsights/accelerated-drugs-approval-evaluated-296757.html 0.6 2026-08-07T08:19:06+08:00 daily https://www.pharmasources.com/industryinsights/plk1-inhibitor-pcm-075-enhances-efficacy-296758.html 0.6 2026-06-27T12:48:24+08:00 daily https://www.pharmasources.com/industryinsights/new-molecule-may-foresee-the-spread-of-b-296759.html 0.6 2026-08-06T19:35:21+08:00 daily https://www.pharmasources.com/industryinsights/spotlight-enters-into-research-agreement-296760.html 0.6 2026-07-16T11:28:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-medivirs-ind-application-for-296761.html 0.6 2026-08-07T22:32:47+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivering-micromotors-treat-bacter-296762.html 0.6 2026-07-10T20:23:34+08:00 daily https://www.pharmasources.com/industryinsights/commercial-application-segment-to-domina-296763.html 0.6 2026-08-07T12:11:24+08:00 daily https://www.pharmasources.com/industryinsights/news-of-noteseqirus-fujifilm-and-more-296764.html 0.6 2026-08-06T23:48:43+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-metrion-to-support-neuroscience--296765.html 0.6 2026-08-06T23:56:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-under-fire-over-accelerated-approval-296766.html 0.6 2026-08-06T23:46:06+08:00 daily https://www.pharmasources.com/industryinsights/innovative-paperless-manufacturing-in-th-296767.html 0.6 2026-08-06T20:06:22+08:00 daily https://www.pharmasources.com/industryinsights/takeda-rd-reboot-continues-with-stanford-296768.html 0.6 2026-08-06T21:48:48+08:00 daily https://www.pharmasources.com/industryinsights/chinas-zai-lab-files-for-115m-nasdaq-ipo-296769.html 0.6 2026-08-07T16:28:32+08:00 daily https://www.pharmasources.com/industryinsights/new-personalised-molecular-blood-test-co-296770.html 0.6 2026-06-09T13:54:50+08:00 daily https://www.pharmasources.com/industryinsights/new-target-could-yield-treatment-for-alz-296771.html 0.6 2026-05-22T22:54:45+08:00 daily https://www.pharmasources.com/industryinsights/massive-increase-in-uk-care-home-places--296772.html 0.6 2026-04-07T18:21:04+08:00 daily https://www.pharmasources.com/industryinsights/venturemed-nets-15m-for-pad-catheter-296773.html 0.6 2026-04-01T02:54:16+08:00 daily https://www.pharmasources.com/industryinsights/bms-left-red-faced-as-opdivoyervoy-fails-296774.html 0.6 2026-06-04T05:17:24+08:00 daily https://www.pharmasources.com/industryinsights/tandem-to-trial-insulin-pump-that-automa-296775.html 0.6 2026-06-30T13:45:42+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-taps-baltimores-insilico-296776.html 0.6 2026-06-19T23:35:06+08:00 daily https://www.pharmasources.com/industryinsights/jj-ceo-alex-gorsky-leaves-trump-council--296777.html 0.6 2026-07-07T10:24:33+08:00 daily https://www.pharmasources.com/industryinsights/less-sleep-in-children-relevant-to-highe-296778.html 0.6 2026-02-03T18:47:35+08:00 daily https://www.pharmasources.com/industryinsights/health-officials-urge-young-people-to-ge-296779.html 0.6 2026-06-18T08:11:00+08:00 daily https://www.pharmasources.com/industryinsights/vectura-allows-dynavax-access-to-smart-i-296780.html 0.6 2026-06-25T08:56:06+08:00 daily https://www.pharmasources.com/industryinsights/gsk-opens-new-aluminium-salts-facility-i-296781.html 0.6 2026-06-18T08:20:22+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-puts-up-opdivo-plus-yervoy-296782.html 0.6 2026-06-29T10:12:20+08:00 daily https://www.pharmasources.com/industryinsights/pharmas-social-status-linkedin-and-fb-up-296783.html 0.6 2026-07-06T05:06:17+08:00 daily https://www.pharmasources.com/industryinsights/mixed-results-for-bms-opdivo-yervoy-comb-296784.html 0.6 2026-06-21T13:28:53+08:00 daily https://www.pharmasources.com/industryinsights/biocon-pulls-eu-herceptin-biosim-app-but-296785.html 0.6 2026-07-19T01:58:50+08:00 daily https://www.pharmasources.com/industryinsights/payers-line-up-to-back-mitsubishi-tanabe-296786.html 0.6 2026-06-23T15:39:48+08:00 daily https://www.pharmasources.com/industryinsights/alexion-wins-3-new-soliris-patents-as-am-296787.html 0.6 2026-07-17T14:46:28+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-in-partnership-with-csir-296788.html 0.6 2026-07-20T09:45:49+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-nutrition-metabolic-formulas-to--296789.html 0.6 2026-06-21T21:29:36+08:00 daily https://www.pharmasources.com/industryinsights/suven-life-sciences-granted-patent-for-n-296790.html 0.6 2026-07-03T10:18:35+08:00 daily https://www.pharmasources.com/industryinsights/piramal-arm-drg-acquires-us-firm-context-296791.html 0.6 2026-06-13T00:05:24+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-india-opens-centre-of-excell-296792.html 0.6 2026-06-18T07:19:16+08:00 daily https://www.pharmasources.com/industryinsights/evotec-buys-aptuit-for-nearly-300m-296793.html 0.6 2026-06-20T03:35:11+08:00 daily https://www.pharmasources.com/industryinsights/shire-submits-marketing-application-for--296794.html 0.6 2026-04-12T23:12:08+08:00 daily https://www.pharmasources.com/industryinsights/achieve-life-sciences-initiates-cytisine-296795.html 0.6 2026-06-10T15:27:54+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-partners-with-n-296796.html 0.6 2026-06-20T15:19:00+08:00 daily https://www.pharmasources.com/industryinsights/calculus-capital-invests-in-biotech-comp-296797.html 0.6 2026-06-25T01:09:33+08:00 daily https://www.pharmasources.com/industryinsights/biocept-ut-southwestern-medical-center-a-296798.html 0.6 2026-03-22T02:01:10+08:00 daily https://www.pharmasources.com/industryinsights/study-reports-encouraging-preclinical-re-296799.html 0.6 2026-04-03T20:40:40+08:00 daily https://www.pharmasources.com/industryinsights/shuttle-pharmaceuticals-and-pola-pharma--296800.html 0.6 2026-04-22T14:22:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-besponsa-for-relapsed-or-re-296801.html 0.6 2026-08-06T18:48:39+08:00 daily https://www.pharmasources.com/industryinsights/biondvax-receives-additional-grant-fundi-296802.html 0.6 2026-02-14T12:25:39+08:00 daily https://www.pharmasources.com/industryinsights/making-stem-cells-from-fibroblasts-comba-296803.html 0.6 2026-06-07T09:28:15+08:00 daily https://www.pharmasources.com/industryinsights/china-pledged-to-promote-ayurvedic-with--296804.html 0.6 2026-08-07T15:44:29+08:00 daily https://www.pharmasources.com/industryinsights/native-mass-spectrometry-uesed-to-help-d-296805.html 0.6 2026-07-03T11:54:05+08:00 daily https://www.pharmasources.com/industryinsights/multicolour-mris-could-aid-disease-detec-296806.html 0.6 2026-04-08T13:39:06+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-program-shows-promise-f-296807.html 0.6 2026-07-18T07:05:34+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-myhep-all-in-india-296808.html 0.6 2026-07-03T22:10:16+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-people-focus-acknowledged-by-296809.html 0.6 2026-08-08T02:39:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-adults-wi-296810.html 0.6 2026-04-27T13:11:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-entices-ucsf-director-to-senior-296811.html 0.6 2026-06-18T09:14:41+08:00 daily https://www.pharmasources.com/industryinsights/gene-variant-activity-is-notably-variabl-296812.html 0.6 2026-08-07T02:46:23+08:00 daily https://www.pharmasources.com/industryinsights/big-pharma-ally-atreca-scoops-35m-as-i-o-296813.html 0.6 2026-06-09T03:00:15+08:00 daily https://www.pharmasources.com/industryinsights/nanoparticle-imaging-startup-alzeca-reel-296814.html 0.6 2026-04-03T00:35:02+08:00 daily https://www.pharmasources.com/industryinsights/independent-research-may-change-the-immu-296815.html 0.6 2026-04-14T05:08:02+08:00 daily https://www.pharmasources.com/industryinsights/leading-transatlantic-cancer-teams-form--296816.html 0.6 2025-11-14T19:03:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-recalls-liquid-pharma-products-after-296817.html 0.6 2026-04-08T04:43:51+08:00 daily https://www.pharmasources.com/industryinsights/cancer-genetics-pays-12m-for-australian--296818.html 0.6 2025-11-10T03:16:19+08:00 daily https://www.pharmasources.com/industryinsights/alexion-moves-to-bolster-patent-protecti-296819.html 0.6 2025-11-08T17:43:07+08:00 daily https://www.pharmasources.com/industryinsights/lawmakers-dig-into-skyrocketing-ms-costs-296820.html 0.6 2025-11-13T14:08:36+08:00 daily https://www.pharmasources.com/industryinsights/novo-diabetes-drug-outperforms-lilly-riv-296821.html 0.6 2026-03-22T14:58:23+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-new-semaglutide-trounces-l-296822.html 0.6 2026-04-15T23:33:10+08:00 daily https://www.pharmasources.com/industryinsights/world-copd-deaths-rise-12-percent-in-15--296823.html 0.6 2026-03-30T08:57:40+08:00 daily https://www.pharmasources.com/industryinsights/valeant-says-it-is-getting-on-top-of-sit-296824.html 0.6 2026-08-06T19:04:32+08:00 daily https://www.pharmasources.com/industryinsights/a-10-years-top-10-patent-losses-worth-a--296825.html 0.6 2026-03-21T08:32:17+08:00 daily https://www.pharmasources.com/industryinsights/novos-semaglutide-superior-to-lillys-tru-296826.html 0.6 2026-03-27T20:13:41+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-tip-ends-in-465m-settlement-betwe-296827.html 0.6 2026-01-19T13:12:54+08:00 daily https://www.pharmasources.com/industryinsights/shkreli-thinks-he-will-escape-prison-whi-296828.html 0.6 2026-08-05T22:14:38+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-wins-approval-for-blood-cancer-dr-296829.html 0.6 2026-08-05T20:12:54+08:00 daily https://www.pharmasources.com/industryinsights/valeant-denies-bypassing-eye-device-make-296830.html 0.6 2026-08-06T22:54:31+08:00 daily https://www.pharmasources.com/industryinsights/hiv-vaccine-to-come-play-without-scruple-296831.html 0.6 2026-08-06T22:08:00+08:00 daily https://www.pharmasources.com/industryinsights/prospects-of-vb6-are-promising-with-incr-296832.html 0.6 2026-08-06T21:45:53+08:00 daily https://www.pharmasources.com/industryinsights/draft-pharmaceutical-policy-2017-calls-f-296833.html 0.6 2026-08-06T21:38:22+08:00 daily https://www.pharmasources.com/industryinsights/ispe-2017-europe-pharma-40-conference-to-296834.html 0.6 2026-08-06T20:05:09+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-observes-swachhta-pakhwada-296835.html 0.6 2026-08-07T12:03:05+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-guanhao-biotech-cancer-gen-296836.html 0.6 2026-08-07T13:17:45+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-and-newcastle-univers-296837.html 0.6 2026-08-09T07:56:30+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-kadmon-holdings-antares--296838.html 0.6 2026-01-30T17:54:44+08:00 daily https://www.pharmasources.com/industryinsights/sillajen-and-nci-partner-to-develop-new--296839.html 0.6 2025-12-16T13:34:45+08:00 daily https://www.pharmasources.com/industryinsights/hikma-and-takeda-sign-new-licensing-agre-296840.html 0.6 2026-03-19T02:25:03+08:00 daily https://www.pharmasources.com/industryinsights/mimetas-collaborates-with-roche-to-devel-296841.html 0.6 2026-07-24T16:41:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-new-tools-for-tests-to-dete-296842.html 0.6 2025-10-26T09:30:54+08:00 daily https://www.pharmasources.com/industryinsights/acf-bioservices-completes-cgmp-compliant-296843.html 0.6 2026-06-29T06:19:49+08:00 daily https://www.pharmasources.com/industryinsights/new-treatment-for-adults-with-relapsed-o-296844.html 0.6 2026-04-06T23:43:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-approval-of-besponsa-for-acut-296845.html 0.6 2026-08-06T15:24:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-two-orphan-drug-designations--296846.html 0.6 2026-07-22T13:47:49+08:00 daily https://www.pharmasources.com/industryinsights/latency-of-seizures-determined-by-diet-296847.html 0.6 2026-06-19T15:41:52+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-partners-with-csir-imtec-296848.html 0.6 2026-07-23T20:01:30+08:00 daily https://www.pharmasources.com/industryinsights/the-pendulum-swing-of-generic-drug-price-296849.html 0.6 2026-07-24T00:19:34+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-leukaemia-drug-gets-opposing-reg-296850.html 0.6 2026-08-06T18:56:27+08:00 daily https://www.pharmasources.com/industryinsights/az-and-msd-secure-three-bits-of-good-new-296851.html 0.6 2026-03-26T22:21:59+08:00 daily https://www.pharmasources.com/industryinsights/govt-streams-5m-into-obesity-research-un-296852.html 0.6 2026-01-31T03:58:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-use-of-azmercks-lynparza-in--296853.html 0.6 2026-08-09T20:21:25+08:00 daily https://www.pharmasources.com/industryinsights/medivir-initiates-study-of-birinapant-in-296854.html 0.6 2026-03-29T16:43:41+08:00 daily https://www.pharmasources.com/industryinsights/mylan-agrees-to-pay-465-million-for-unde-296855.html 0.6 2026-08-09T22:55:55+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-receives-additional-and-broad-a-296856.html 0.6 2026-04-06T19:09:35+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-dovonex-psoriasis-ointment-296857.html 0.6 2026-08-07T18:27:40+08:00 daily https://www.pharmasources.com/industryinsights/protalex-awarded-grant-from-fda-office-o-296858.html 0.6 2026-04-23T10:29:43+08:00 daily https://www.pharmasources.com/industryinsights/biondvax-receives-additional-grant-fundi-296859.html 0.6 2026-03-20T20:08:22+08:00 daily https://www.pharmasources.com/industryinsights/us-regulators-wave-through-pfizers-leuka-296860.html 0.6 2026-06-21T01:45:43+08:00 daily https://www.pharmasources.com/industryinsights/hikma-announces-expanded-licensing-agree-296861.html 0.6 2026-06-20T09:16:29+08:00 daily https://www.pharmasources.com/industryinsights/ibm-jdrf-to-unravel-type-1-diabetes-risk-296862.html 0.6 2026-03-30T15:03:02+08:00 daily https://www.pharmasources.com/industryinsights/chutes-laddersnovartis-lures-ucsf-cardio-296863.html 0.6 2025-10-22T15:47:41+08:00 daily https://www.pharmasources.com/industryinsights/five-prime-names-ex-genentech-i-o-specia-296864.html 0.6 2026-02-28T13:59:25+08:00 daily https://www.pharmasources.com/industryinsights/deals-of-biotech-down-by-half-possibly-m-296865.html 0.6 2026-06-14T00:30:13+08:00 daily https://www.pharmasources.com/industryinsights/arcus-adds-wuxi-biologics-developed-pd-1-296866.html 0.6 2026-02-28T21:05:00+08:00 daily https://www.pharmasources.com/industryinsights/thank-you-ken-frazier-for-making-pharma--296867.html 0.6 2026-07-08T09:47:23+08:00 daily https://www.pharmasources.com/industryinsights/zai-labs-115m-ipo-takeda-stanford-rd-dea-296868.html 0.6 2026-07-19T17:57:22+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lynparza-armed-with-new-fda-296869.html 0.6 2026-04-14T03:46:57+08:00 daily https://www.pharmasources.com/industryinsights/duponts-expands-probiotics-facility-in-m-296870.html 0.6 2026-07-03T09:05:33+08:00 daily https://www.pharmasources.com/industryinsights/icmr-department-of-health-and-family-wel-296871.html 0.6 2026-07-01T15:43:47+08:00 daily https://www.pharmasources.com/industryinsights/cipla-launches-nicotex-nicotine-patch-296872.html 0.6 2026-06-27T17:11:13+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-mmv-launches-patient-trial--296873.html 0.6 2026-06-24T22:36:11+08:00 daily https://www.pharmasources.com/industryinsights/fdc-seeks-opportunities-in-untapped-mark-296874.html 0.6 2026-06-22T15:47:39+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-besponsa-gets-fda-approval-for-t-296875.html 0.6 2026-06-20T04:50:54+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-medimmune-and-ethris-to-deve-296876.html 0.6 2026-08-07T02:09:49+08:00 daily https://www.pharmasources.com/industryinsights/champions-oncology-to-collaborate-with-a-296877.html 0.6 2026-08-10T01:25:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-medicines-for-malaria-ventu-296878.html 0.6 2026-06-16T08:41:08+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-lion-tcr-two-orphan-drug-d-296879.html 0.6 2026-06-24T17:20:36+08:00 daily https://www.pharmasources.com/industryinsights/medivir-offloads-china-rights-for-hepati-296880.html 0.6 2026-08-07T21:58:13+08:00 daily https://www.pharmasources.com/industryinsights/new-research-finds-self-healing-heart-ce-296881.html 0.6 2026-04-17T00:04:44+08:00 daily https://www.pharmasources.com/industryinsights/momentum-biosciences-etga-technology-hel-296882.html 0.6 2026-07-08T11:57:31+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-takeda-sign-agreement-to-296883.html 0.6 2026-07-24T11:36:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-bags-usfda-approval-for-besponsa-296884.html 0.6 2026-06-14T16:54:44+08:00 daily https://www.pharmasources.com/industryinsights/shire-director-and-senior-management-cha-296885.html 0.6 2026-06-13T13:50:14+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-joins-hands-with-takeda--296886.html 0.6 2026-03-05T07:15:03+08:00 daily https://www.pharmasources.com/industryinsights/pcm-075-demonstrates-synergy-with-hdac-i-296887.html 0.6 2026-04-01T01:25:09+08:00 daily https://www.pharmasources.com/industryinsights/amgen-collaborates-with-humana-to-improv-296888.html 0.6 2026-03-20T12:14:20+08:00 daily https://www.pharmasources.com/industryinsights/gamida-cell-announces-first-patient-tran-296889.html 0.6 2026-06-08T15:29:05+08:00 daily https://www.pharmasources.com/industryinsights/samsung-jumps-into-novel-drug-rd-through-296890.html 0.6 2026-06-19T18:34:34+08:00 daily https://www.pharmasources.com/industryinsights/wild-mussels-inspire-superstrong-glue-fo-296891.html 0.6 2026-03-17T21:14:40+08:00 daily https://www.pharmasources.com/industryinsights/lasers-used-to-detect-risk-of-heart-atta-296892.html 0.6 2026-06-14T09:03:03+08:00 daily https://www.pharmasources.com/industryinsights/nitrogen-clearing-enzyme-a-new-target-fo-296893.html 0.6 2026-08-09T18:00:57+08:00 daily https://www.pharmasources.com/industryinsights/venture-launched-for-a-novel-compound-ag-296894.html 0.6 2026-08-07T02:51:38+08:00 daily https://www.pharmasources.com/industryinsights/new-ceo-takes-the-helm-at-akari-as-it-tr-296895.html 0.6 2026-08-07T02:36:47+08:00 daily https://www.pharmasources.com/industryinsights/will-third-trial-be-the-charm-for-alkerm-296896.html 0.6 2026-08-07T02:30:53+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-inks-respiratory-disease-mrn-296897.html 0.6 2026-08-07T02:18:30+08:00 daily https://www.pharmasources.com/industryinsights/upstart-blade-nabs-bristol-myers-squibb--296898.html 0.6 2026-08-07T02:31:04+08:00 daily https://www.pharmasources.com/industryinsights/fullerton-health-expands-australian-medi-296899.html 0.6 2026-08-07T02:40:10+08:00 daily https://www.pharmasources.com/industryinsights/amid-fda-competition-push-hikma-jacks-up-296900.html 0.6 2026-03-27T19:14:15+08:00 daily https://www.pharmasources.com/industryinsights/openeye-announces-pfizer-to-adopt-orion--296901.html 0.6 2026-06-08T16:13:27+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-revives-ex-novartis-otc-brands-296902.html 0.6 2026-04-08T15:38:30+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-medicines-for-malaria-ventu-296903.html 0.6 2026-01-31T12:39:56+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-lashes-out-at-frustrating-nice-de-296904.html 0.6 2026-03-27T22:49:54+08:00 daily https://www.pharmasources.com/industryinsights/ironwoods-gout-franchise-gets-a-lift-wit-296905.html 0.6 2025-12-12T22:43:43+08:00 daily https://www.pharmasources.com/industryinsights/siri-alexa-as-hands-free-tech-use-grows--296906.html 0.6 2026-04-17T17:06:28+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ceo-opens-door-to-cancer-patien-296907.html 0.6 2026-04-20T07:58:10+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-shakes-up-agency-team-adding-wpp--296908.html 0.6 2026-06-14T06:37:31+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-eir-from-us-fda-296909.html 0.6 2026-04-30T04:55:38+08:00 daily https://www.pharmasources.com/industryinsights/eisai-pharma-to-cater-to-the-japanese-ma-296910.html 0.6 2026-05-05T06:38:13+08:00 daily https://www.pharmasources.com/industryinsights/studyshorter-painkiller-prescriptions-ma-296911.html 0.6 2026-05-02T11:32:58+08:00 daily https://www.pharmasources.com/industryinsights/drl-out-licenses-dfd-06-to-encore-dermat-296912.html 0.6 2026-05-07T10:51:52+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-us-fda-nod-for-p-296913.html 0.6 2025-12-30T13:18:24+08:00 daily https://www.pharmasources.com/industryinsights/indian-patent-office-grants-patent-to-pf-296914.html 0.6 2026-06-07T14:51:30+08:00 daily https://www.pharmasources.com/industryinsights/novartis-launches-multiple-sclerosis-stu-296915.html 0.6 2026-06-18T00:41:14+08:00 daily https://www.pharmasources.com/industryinsights/sandozs-erelzi-available-for-multiple-in-296916.html 0.6 2026-02-28T12:52:41+08:00 daily https://www.pharmasources.com/industryinsights/mimedx-to-divest-stability-biologics-bus-296917.html 0.6 2026-02-09T04:44:32+08:00 daily https://www.pharmasources.com/industryinsights/takeda-submits-nda-for-vedolizumab-to-tr-296918.html 0.6 2026-06-22T02:20:46+08:00 daily https://www.pharmasources.com/industryinsights/grid-therapeutics-signs-exclusive-agreem-296919.html 0.6 2025-12-12T22:28:10+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-announces-submission-of-phase--296920.html 0.6 2026-01-12T15:59:52+08:00 daily https://www.pharmasources.com/industryinsights/hr-2430-of-the-fdara-signed-into-law-296921.html 0.6 2026-05-14T14:48:31+08:00 daily https://www.pharmasources.com/industryinsights/pharmakea-announces-successful-completio-296922.html 0.6 2026-06-16T11:41:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-launches-ms-study-that-allows-p-296923.html 0.6 2025-12-16T19:58:30+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-announces-the-out-296924.html 0.6 2026-01-21T20:13:34+08:00 daily https://www.pharmasources.com/industryinsights/eu-commission-grants-new-indication-for--296925.html 0.6 2026-06-08T19:59:01+08:00 daily https://www.pharmasources.com/industryinsights/alliance-foundation-opens-trial-investig-296926.html 0.6 2026-01-10T03:03:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-chief-gottlieb-backs-vaccinesagainto-296927.html 0.6 2026-06-21T17:27:17+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-partners-with-alibaba-fo-296928.html 0.6 2026-01-30T20:01:41+08:00 daily https://www.pharmasources.com/industryinsights/news-of-noteseqirus-vbi-and-altimmune-296929.html 0.6 2026-04-04T04:19:43+08:00 daily https://www.pharmasources.com/industryinsights/hong-kong-sar-china-doctor-found-giving--296930.html 0.6 2026-01-14T00:29:10+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-taking-heat-in-its-uk-ho-296931.html 0.6 2026-03-25T17:33:51+08:00 daily https://www.pharmasources.com/industryinsights/encore-makes-pipeline-play-licensing-pso-296932.html 0.6 2026-03-13T16:12:30+08:00 daily https://www.pharmasources.com/industryinsights/encore-makes-pipeline-play-licensing-pso-296933.html 0.6 2026-02-27T16:38:59+08:00 daily https://www.pharmasources.com/industryinsights/krystal-files-for-ipo-to-move-gene-thera-296934.html 0.6 2026-03-22T02:48:01+08:00 daily https://www.pharmasources.com/industryinsights/livongo-recruits-former-23andme-presiden-296935.html 0.6 2026-02-27T08:19:41+08:00 daily https://www.pharmasources.com/industryinsights/lilly-pens-deal-for-evotec-spinouts-immu-296936.html 0.6 2026-04-01T00:52:56+08:00 daily https://www.pharmasources.com/industryinsights/parexel-osaka-international-cancer-insti-296937.html 0.6 2026-07-03T15:42:30+08:00 daily https://www.pharmasources.com/industryinsights/microbiome-startup-axial-gains-depomed-e-296938.html 0.6 2026-06-08T14:14:26+08:00 daily https://www.pharmasources.com/industryinsights/small-growth-for-big-pharmas-workforce-a-296939.html 0.6 2026-06-15T10:36:48+08:00 daily https://www.pharmasources.com/industryinsights/bidders-line-up-for-tevas-womens-health--296940.html 0.6 2026-03-17T20:51:47+08:00 daily https://www.pharmasources.com/industryinsights/shire-cfo-along-with-analysts-tries-to-p-296941.html 0.6 2026-07-05T19:17:03+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-hit-with-417m-verdict-as-296942.html 0.6 2026-04-08T13:59:31+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-objects-to-a-janssen-dev-296943.html 0.6 2026-04-13T04:02:40+08:00 daily https://www.pharmasources.com/industryinsights/eisai-introduces-first-in-class-epilepsy-296944.html 0.6 2026-04-16T22:20:21+08:00 daily https://www.pharmasources.com/industryinsights/prometic-and-shenzen-royal-asset-managem-296945.html 0.6 2025-12-06T20:12:09+08:00 daily https://www.pharmasources.com/industryinsights/cancer-genetics-acquires-vivopharm-for-1-296946.html 0.6 2026-07-17T07:16:29+08:00 daily https://www.pharmasources.com/industryinsights/indian-manufacturers-account-for-60-of-v-296947.html 0.6 2026-07-21T11:17:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-evaluates-prescription-opioid-medica-296948.html 0.6 2026-01-15T09:15:49+08:00 daily https://www.pharmasources.com/industryinsights/superbug-squashed-by-super-team-of-antib-296949.html 0.6 2026-07-06T03:45:46+08:00 daily https://www.pharmasources.com/industryinsights/biochemical-fingerprints-reveal-diabetes-296950.html 0.6 2026-02-28T23:23:30+08:00 daily https://www.pharmasources.com/industryinsights/ligand-to-receive-us2mn-from-wuxi-biolog-296951.html 0.6 2026-07-09T01:00:56+08:00 daily https://www.pharmasources.com/industryinsights/reference-pricing-encourages-patients-to-296952.html 0.6 2026-03-28T05:17:27+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-humana-partner-for-improved-he-296953.html 0.6 2025-12-12T21:54:46+08:00 daily https://www.pharmasources.com/industryinsights/ultragenyx-stumbles-in-p3-trial-for-seve-296954.html 0.6 2026-08-07T20:10:50+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-strikes-mrna-based-partnersh-296955.html 0.6 2026-02-28T20:42:05+08:00 daily https://www.pharmasources.com/industryinsights/new-flu-vaccine-approved-for-uk-use-296956.html 0.6 2026-08-08T01:37:01+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2017082-296957.html 0.6 2026-07-20T08:33:08+08:00 daily https://www.pharmasources.com/industryinsights/prega-news-partners-with-spicejet-296958.html 0.6 2026-02-28T21:27:56+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-seroquel-xr-tabs--296959.html 0.6 2026-02-27T11:37:25+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-tria-296960.html 0.6 2026-07-17T16:07:27+08:00 daily https://www.pharmasources.com/industryinsights/topas-and-lilly-sign-deal-to-focus-on-im-296961.html 0.6 2026-04-09T17:03:58+08:00 daily https://www.pharmasources.com/industryinsights/orchards-otl-101-receives-promising-medi-296962.html 0.6 2026-04-13T18:34:26+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-finds-new-antibodies-targeting-296963.html 0.6 2026-08-07T11:39:56+08:00 daily https://www.pharmasources.com/industryinsights/teikoku-pharma-announces-positive-result-296964.html 0.6 2026-06-21T01:47:17+08:00 daily https://www.pharmasources.com/industryinsights/viracyte-announces-positive-phase-2-tria-296965.html 0.6 2026-04-26T17:47:27+08:00 daily https://www.pharmasources.com/industryinsights/fosun-pharma-inks-deal-with-medidata-296966.html 0.6 2026-03-28T18:04:19+08:00 daily https://www.pharmasources.com/industryinsights/researchers-in-us-successfully-developed-296967.html 0.6 2026-05-05T11:21:35+08:00 daily https://www.pharmasources.com/industryinsights/jupiter-receives-orphan-drug-designation-296968.html 0.6 2026-04-29T21:44:47+08:00 daily https://www.pharmasources.com/industryinsights/forage-genetics-conducts-a-field-trial-f-296969.html 0.6 2026-06-12T13:31:41+08:00 daily https://www.pharmasources.com/industryinsights/symic-bio-enrolls-first-patient-in-modif-296970.html 0.6 2026-05-06T21:09:15+08:00 daily https://www.pharmasources.com/industryinsights/cambricon-raises-100-m-funding-296971.html 0.6 2026-05-03T16:46:57+08:00 daily https://www.pharmasources.com/industryinsights/japanese-researchers-use-brain-imaging-t-296972.html 0.6 2026-04-30T17:55:56+08:00 daily https://www.pharmasources.com/industryinsights/biotronik-us-launches-smallest-mr-condit-296973.html 0.6 2026-08-09T10:01:22+08:00 daily https://www.pharmasources.com/industryinsights/steroids-not-effective-for-chest-infecti-296974.html 0.6 2025-12-12T21:33:06+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-predicts-dementi-296975.html 0.6 2026-04-19T05:25:24+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-launches-trial-to-tes-296976.html 0.6 2026-04-12T23:04:05+08:00 daily https://www.pharmasources.com/industryinsights/vascular-dynamics-receives-approval-to-e-296977.html 0.6 2026-07-18T08:15:37+08:00 daily https://www.pharmasources.com/industryinsights/parexel-osaka-international-cancer-insti-296978.html 0.6 2026-04-05T17:28:20+08:00 daily https://www.pharmasources.com/industryinsights/self-powered-paper-based-speds-may-lead--296979.html 0.6 2026-04-16T16:13:19+08:00 daily https://www.pharmasources.com/industryinsights/alliance-foundation-trials-opens-global--296980.html 0.6 2026-08-05T20:34:46+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-between-lilly-and-cruk-pro-296981.html 0.6 2026-04-07T18:34:42+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-achilles-heel-of-oes-296982.html 0.6 2026-04-13T18:08:13+08:00 daily https://www.pharmasources.com/industryinsights/how-roche-fine-tuned-an-old-drug-to-keep-296983.html 0.6 2026-06-14T00:46:42+08:00 daily https://www.pharmasources.com/industryinsights/amid-dwindling-cash-and-a-nasdaq-warning-296984.html 0.6 2026-04-23T15:35:33+08:00 daily https://www.pharmasources.com/industryinsights/paratek-rising-fast-after-bloomberg-says-296985.html 0.6 2026-06-21T18:28:49+08:00 daily https://www.pharmasources.com/industryinsights/elligo-health-research-allscripts-team-u-296986.html 0.6 2026-07-29T13:54:31+08:00 daily https://www.pharmasources.com/industryinsights/longevity-fund-raises-cash-to-back-anti--296987.html 0.6 2026-05-03T18:17:43+08:00 daily https://www.pharmasources.com/industryinsights/phase-3-fail-prompts-ultragenyx-to-can-m-296988.html 0.6 2026-08-07T22:08:26+08:00 daily https://www.pharmasources.com/industryinsights/no-need-for-60-plus-discounts-on-repatha-296989.html 0.6 2026-05-03T07:16:20+08:00 daily https://www.pharmasources.com/industryinsights/nice-looks-to-toss-sanofi-and-ipsen-thyr-296990.html 0.6 2026-03-19T22:54:29+08:00 daily https://www.pharmasources.com/industryinsights/amerisourcebergen-agrees-to-134m-settlem-296991.html 0.6 2025-12-12T21:15:19+08:00 daily https://www.pharmasources.com/industryinsights/with-ibd-market-set-for-major-growth-abb-296992.html 0.6 2026-01-31T00:56:19+08:00 daily https://www.pharmasources.com/industryinsights/digital-minded-novartis-taps-apples-rese-296993.html 0.6 2026-02-10T13:55:05+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-zeroes-in-on-primary-care-docto-296994.html 0.6 2026-06-04T05:27:31+08:00 daily https://www.pharmasources.com/industryinsights/how-an-eye-test-could-detect-alzheimers-296995.html 0.6 2026-02-07T01:01:54+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-eucrisa-beats-dupixent-to-the-dt-296996.html 0.6 2026-06-21T13:34:15+08:00 daily https://www.pharmasources.com/industryinsights/columbia-china-initiates-its-next-hospit-296997.html 0.6 2026-07-29T03:07:51+08:00 daily https://www.pharmasources.com/industryinsights/japanese-researchers-develop-a-long-last-296998.html 0.6 2026-06-10T16:39:51+08:00 daily https://www.pharmasources.com/industryinsights/generic-seroquel-xr-tablets-launched-by--296999.html 0.6 2026-08-09T05:05:35+08:00 daily https://www.pharmasources.com/industryinsights/choosing-alternative-cancer-treatment-do-297000.html 0.6 2026-04-02T03:53:53+08:00 daily https://www.pharmasources.com/industryinsights/amrit-pharmacy-opens-its-100th-outlet-297001.html 0.6 2026-04-05T20:46:22+08:00 daily https://www.pharmasources.com/industryinsights/metal-simplifies-synthesis-of-antibody-d-297002.html 0.6 2026-06-02T23:07:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-eu-approval-for-riboci-297003.html 0.6 2026-06-09T13:08:40+08:00 daily https://www.pharmasources.com/industryinsights/infrared-spectroscopy-could-reduce-depen-297004.html 0.6 2026-01-10T03:07:11+08:00 daily https://www.pharmasources.com/industryinsights/new-study-offers-detailed-insights-on-bi-297005.html 0.6 2026-06-08T19:39:06+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-sells-formulations-manufa-297006.html 0.6 2026-04-19T04:01:03+08:00 daily https://www.pharmasources.com/industryinsights/dsm-nutritional-products-appoints-new-as-297007.html 0.6 2026-06-12T13:35:59+08:00 daily https://www.pharmasources.com/industryinsights/ministry-of-law-and-justice-rejects-phar-297008.html 0.6 2026-07-03T20:43:08+08:00 daily https://www.pharmasources.com/industryinsights/extended-treatment-with-brilinta-reduces-297009.html 0.6 2026-04-19T15:44:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-appoints-bertrand-bodson-as-chi-297010.html 0.6 2026-06-17T13:05:57+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-to-market-anti-psychotic-dr-297011.html 0.6 2026-04-21T15:12:43+08:00 daily https://www.pharmasources.com/industryinsights/crispr-and-massachusetts-general-hospita-297012.html 0.6 2026-05-04T22:57:37+08:00 daily https://www.pharmasources.com/industryinsights/umi3-gives-exclusive-licence-for-sentrag-297013.html 0.6 2026-04-19T05:16:28+08:00 daily https://www.pharmasources.com/industryinsights/icr-researchers-discover-use-of-ibrutini-297014.html 0.6 2026-04-13T18:45:45+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-mylan-to-commercialize-delamanid-297015.html 0.6 2026-04-07T09:31:00+08:00 daily https://www.pharmasources.com/industryinsights/aspen-pharmacare-completes-transfer-of-a-297016.html 0.6 2026-06-30T15:24:33+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-initiates-phase-iia-297017.html 0.6 2026-08-08T01:19:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-genentechs-297018.html 0.6 2026-08-07T02:05:10+08:00 daily https://www.pharmasources.com/industryinsights/novartis-appoints-chief-digital-officer-297019.html 0.6 2026-08-07T01:59:02+08:00 daily https://www.pharmasources.com/industryinsights/kisqali-receives-eu-approval-as-first-li-297020.html 0.6 2026-08-07T01:52:27+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-wins-indian-patent-to-prevnar-13--297021.html 0.6 2026-08-07T01:42:57+08:00 daily https://www.pharmasources.com/industryinsights/omeros-defends-drug-data-vows-to-unmask--297022.html 0.6 2026-08-07T01:28:04+08:00 daily https://www.pharmasources.com/industryinsights/roche-receives-fda-priority-review-for-d-297023.html 0.6 2026-08-07T01:10:59+08:00 daily https://www.pharmasources.com/industryinsights/extended-use-of-astrazenecas-brilinta-re-297024.html 0.6 2026-08-07T00:41:39+08:00 daily https://www.pharmasources.com/industryinsights/chutes-laddersshire-cfos-abrupt-exit-wor-297025.html 0.6 2026-08-07T01:19:37+08:00 daily https://www.pharmasources.com/industryinsights/ionis-urges-investors-to-reject-trc-capi-297026.html 0.6 2026-08-06T23:55:54+08:00 daily https://www.pharmasources.com/industryinsights/gsk-propeller-expand-digital-health-coll-297027.html 0.6 2026-08-07T00:01:54+08:00 daily https://www.pharmasources.com/industryinsights/hiv-home-tests-seized-from-market-over-p-297028.html 0.6 2026-08-07T00:03:01+08:00 daily https://www.pharmasources.com/industryinsights/envigo-merges-with-avista-to-be-listed-o-297029.html 0.6 2026-08-07T00:40:57+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-priority-review-for-hyped-hem-297030.html 0.6 2026-08-07T01:14:00+08:00 daily https://www.pharmasources.com/industryinsights/accelerated-pharma-puts-the-brakes-on-ip-297031.html 0.6 2026-08-07T02:05:17+08:00 daily https://www.pharmasources.com/industryinsights/bioverativ-taps-patient-social-network-f-297032.html 0.6 2026-08-07T02:18:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-ema-and-ec-sign-new-confidentiality--297033.html 0.6 2026-08-07T01:10:47+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-clinigen-group-mekong-capi-297034.html 0.6 2026-08-09T23:07:00+08:00 daily https://www.pharmasources.com/industryinsights/researchers-repurpose-diabetes-drug-for--297035.html 0.6 2026-01-10T15:43:45+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-jazz-pharmaceuticals-kan-297036.html 0.6 2026-04-09T16:04:34+08:00 daily https://www.pharmasources.com/industryinsights/merck-sees-promise-in-macrophage-pharma-297037.html 0.6 2025-12-12T20:28:49+08:00 daily https://www.pharmasources.com/industryinsights/michigan-joins-wave-of-states-trying-to--297038.html 0.6 2026-04-07T07:27:00+08:00 daily https://www.pharmasources.com/industryinsights/can-novartis-kisqali-beat-pfizers-market-297039.html 0.6 2026-03-31T22:13:21+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-propeller-widen-respirat-297040.html 0.6 2026-06-08T12:02:01+08:00 daily https://www.pharmasources.com/industryinsights/with-two-new-uses-kaput-astrazeneca-tout-297041.html 0.6 2025-10-27T04:48:31+08:00 daily https://www.pharmasources.com/industryinsights/extended-use-of-az-brilinta-cuts-cv-deat-297042.html 0.6 2026-02-15T13:38:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-breast-cancer-drug-kisqali-wins-297043.html 0.6 2026-02-15T09:16:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-roches-bla-for-emicizumab-to-297044.html 0.6 2026-08-07T03:31:45+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-jazz-pharmaceuticals-kan-297045.html 0.6 2026-08-07T03:18:52+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-novartis-breast-cancer-drug--297046.html 0.6 2026-08-07T03:06:21+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-clinigen-group-mekong-capi-297047.html 0.6 2026-08-07T02:52:05+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-pfizer-announce-first-patient-re-297048.html 0.6 2026-02-28T15:34:03+08:00 daily https://www.pharmasources.com/industryinsights/titan-pharmaceuticals-receives-fda-clear-297049.html 0.6 2026-02-15T07:02:22+08:00 daily https://www.pharmasources.com/industryinsights/victoza-indicated-to-reduce-the-risk-of--297050.html 0.6 2026-07-07T15:28:07+08:00 daily https://www.pharmasources.com/industryinsights/chinese-scientists-use-nanoparticles-as--297051.html 0.6 2026-01-10T03:03:26+08:00 daily https://www.pharmasources.com/industryinsights/mdr-tb-drug-by-otsuka-made-its-way-to-in-297052.html 0.6 2026-08-06T05:21:12+08:00 daily https://www.pharmasources.com/industryinsights/achievements-of-5-transnational-pharmace-297053.html 0.6 2026-08-09T21:41:08+08:00 daily https://www.pharmasources.com/industryinsights/rigel-announces-new-appointment-to-board-297054.html 0.6 2026-07-21T07:56:15+08:00 daily https://www.pharmasources.com/industryinsights/althea-announces-new-aseptic-fill-finish-297055.html 0.6 2026-08-08T02:23:08+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-grants-approval-for--297056.html 0.6 2026-04-01T02:50:17+08:00 daily https://www.pharmasources.com/industryinsights/columbia-china-initiates-its-next-hospit-297057.html 0.6 2026-03-01T01:53:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-297058.html 0.6 2026-01-18T07:12:45+08:00 daily https://www.pharmasources.com/industryinsights/researchers-in-japan-work-on-next-genera-297059.html 0.6 2026-03-18T13:46:48+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discovers-cancer-drug-that-ca-297060.html 0.6 2026-03-31T19:20:26+08:00 daily https://www.pharmasources.com/industryinsights/protagonist-announces-closing-of-janssen-297061.html 0.6 2026-06-28T09:02:28+08:00 daily https://www.pharmasources.com/industryinsights/micro-sphere-to-invest-eur19mn-in-gmp-fa-297062.html 0.6 2026-04-12T19:11:29+08:00 daily https://www.pharmasources.com/industryinsights/express-scripts-research-shows-significa-297063.html 0.6 2026-04-13T18:25:23+08:00 daily https://www.pharmasources.com/industryinsights/astar-discovers-elabela-protects-against-297064.html 0.6 2026-05-07T13:46:20+08:00 daily https://www.pharmasources.com/industryinsights/this-is-how-belly-fat-could-increase-you-297065.html 0.6 2026-04-20T22:14:48+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-initiates-phase-iia-297066.html 0.6 2026-05-01T11:04:14+08:00 daily https://www.pharmasources.com/industryinsights/lithium-levels-in-water-supply-could-pre-297067.html 0.6 2026-06-08T21:52:59+08:00 daily https://www.pharmasources.com/industryinsights/after-7-years-ec-grants-approval-for-mer-297068.html 0.6 2025-12-12T19:55:33+08:00 daily https://www.pharmasources.com/industryinsights/insights-into-fat-signaling-could-boost--297069.html 0.6 2026-02-09T04:05:21+08:00 daily https://www.pharmasources.com/industryinsights/exosome-diagnostics-carefirst-partner-to-297070.html 0.6 2026-02-28T14:22:06+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-to-buy-battered-dimension-for--297071.html 0.6 2026-07-04T11:04:54+08:00 daily https://www.pharmasources.com/industryinsights/new-method-identifies-potential-targets--297072.html 0.6 2026-04-01T03:30:41+08:00 daily https://www.pharmasources.com/industryinsights/apellis-sets-up-another-phase-3-program--297073.html 0.6 2025-12-12T19:50:26+08:00 daily https://www.pharmasources.com/industryinsights/second-nasdaq-compliance-notice-adds-to--297074.html 0.6 2026-08-06T05:05:23+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-hunt-for-new-manhattan-hq-lands--297075.html 0.6 2026-04-13T18:49:54+08:00 daily https://www.pharmasources.com/industryinsights/adamas-scores-orphan-approval-for-tweake-297076.html 0.6 2026-04-09T20:49:31+08:00 daily https://www.pharmasources.com/industryinsights/funds-80b-valeant-losses-prompt-lawsuit--297077.html 0.6 2026-08-04T17:18:36+08:00 daily https://www.pharmasources.com/industryinsights/nice-flip-flops-on-takedas-adcetriswith--297078.html 0.6 2026-06-26T20:53:48+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-to-take-on-biogen-novartis-wi-297079.html 0.6 2026-06-10T09:36:55+08:00 daily https://www.pharmasources.com/industryinsights/samsung-takeda-rd-pact-gsk-alibaba-vacci-297080.html 0.6 2026-07-12T20:00:39+08:00 daily https://www.pharmasources.com/industryinsights/biogen-samsung-humira-copy-wins-eu-appro-297081.html 0.6 2026-06-14T20:11:38+08:00 daily https://www.pharmasources.com/industryinsights/drrons-insights-statistics-roundtable-ra-297082.html 0.6 2026-07-09T21:26:24+08:00 daily https://www.pharmasources.com/industryinsights/drrons-insights-statistics-roundtable-ra-297083.html 0.6 2026-06-18T14:09:16+08:00 daily https://www.pharmasources.com/industryinsights/drrons-insights-statistics-roundtable-ra-297084.html 0.6 2026-08-05T23:11:59+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-gets-us-fda-nod-for-anti-i-297085.html 0.6 2026-03-03T01:10:40+08:00 daily https://www.pharmasources.com/industryinsights/drl-announces-the-launch-of-cefixime-in--297086.html 0.6 2026-06-19T22:36:38+08:00 daily https://www.pharmasources.com/industryinsights/danone-india-launches-neocate-in-india-297087.html 0.6 2026-07-18T12:26:51+08:00 daily https://www.pharmasources.com/industryinsights/growth-hungry-gilead-acquires-kite-at-12-297088.html 0.6 2026-04-19T02:00:18+08:00 daily https://www.pharmasources.com/industryinsights/law-firm-drops-suit-alleging-cvs-gouged--297089.html 0.6 2026-01-11T10:27:04+08:00 daily https://www.pharmasources.com/industryinsights/the-top-10-cardiovascular-drugs-in-the-w-297090.html 0.6 2026-01-31T10:17:11+08:00 daily https://www.pharmasources.com/industryinsights/esc-novartis-faces-an-uphill-battle-turn-297091.html 0.6 2026-02-15T00:35:51+08:00 daily https://www.pharmasources.com/industryinsights/victozas-triple-play-cv-nod-sharpens-nov-297092.html 0.6 2026-03-23T20:17:08+08:00 daily https://www.pharmasources.com/industryinsights/shire-launches-new-adhd-drug-mydayis-as--297093.html 0.6 2026-06-24T07:24:06+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-propeller-expand-digital-health--297094.html 0.6 2026-02-15T13:38:45+08:00 daily https://www.pharmasources.com/industryinsights/esc-jjs-xarelto-combo-tops-aspirin-in-ar-297095.html 0.6 2026-06-13T14:41:20+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-to-buy-battered-dimension-for--297096.html 0.6 2026-02-15T13:30:01+08:00 daily https://www.pharmasources.com/industryinsights/exosome-diagnostics-partners-with-carefi-297097.html 0.6 2026-03-01T05:33:59+08:00 daily https://www.pharmasources.com/industryinsights/praava-builds-first-family-health-centre-297098.html 0.6 2026-03-01T01:46:37+08:00 daily https://www.pharmasources.com/industryinsights/japanese-researchers-design-device-for-d-297099.html 0.6 2026-04-07T02:43:21+08:00 daily https://www.pharmasources.com/industryinsights/protea-expands-clinical-study-for-new-me-297100.html 0.6 2025-12-12T19:24:43+08:00 daily https://www.pharmasources.com/industryinsights/dual-antithrombotic-therapy-cuts-bleedin-297101.html 0.6 2026-06-21T22:54:39+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-market-expected-to-grow-at-a-cag-297102.html 0.6 2026-06-09T18:37:58+08:00 daily https://www.pharmasources.com/industryinsights/anti-inflammatory-therapy-cuts-risk-of-l-297103.html 0.6 2026-08-09T07:18:27+08:00 daily https://www.pharmasources.com/industryinsights/victoza-reduces-the-risk-of-major-cardio-297104.html 0.6 2026-04-07T05:27:26+08:00 daily https://www.pharmasources.com/industryinsights/lumosa-therapeutics-partners-with-camarg-297105.html 0.6 2026-07-10T15:01:19+08:00 daily https://www.pharmasources.com/industryinsights/boosting-immunotherapy-by-targeting-cell-297106.html 0.6 2026-02-09T00:13:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tandems-insulin-pump-with-d-297107.html 0.6 2026-01-22T09:05:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-bards-lutonix-drug-coated-balloo-297108.html 0.6 2026-07-05T03:42:42+08:00 daily https://www.pharmasources.com/industryinsights/csl-behring-buys-calimmune-for-early-ste-297109.html 0.6 2026-04-10T02:04:36+08:00 daily https://www.pharmasources.com/industryinsights/aveos-phoenix-drug-tivozanib-rises-up-in-297110.html 0.6 2025-12-31T16:32:11+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-takeda-establish-collaborati-297111.html 0.6 2026-02-28T13:35:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-acts-to-remove-unproven-potentially--297112.html 0.6 2026-03-19T02:46:03+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-collaborates-with-angiex--297113.html 0.6 2026-01-04T14:32:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-297114.html 0.6 2025-12-12T19:10:18+08:00 daily https://www.pharmasources.com/industryinsights/ccm-duopharma-inks-deal-with-govt-for-sa-297115.html 0.6 2026-04-19T07:54:26+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-enters-worldwide-licensin-297116.html 0.6 2026-08-08T07:10:18+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-to-acquire-natrix-separat-297117.html 0.6 2026-06-29T20:44:15+08:00 daily https://www.pharmasources.com/industryinsights/vyome-biosciences-appoints-angelo-secci--297118.html 0.6 2026-06-08T19:10:46+08:00 daily https://www.pharmasources.com/industryinsights/abbott-introduces-heartmate-3-left-ventr-297119.html 0.6 2026-02-18T23:49:20+08:00 daily https://www.pharmasources.com/industryinsights/berg-work-with-astrazeneca-to-identify-n-297120.html 0.6 2026-08-08T02:52:56+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-to-buy-kite-pharma-for-1-297121.html 0.6 2025-12-12T19:03:48+08:00 daily https://www.pharmasources.com/industryinsights/victoza-reduces-the-risk-of-major-cardio-297122.html 0.6 2026-06-08T21:59:22+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-completes-acquisition-of-protein--297123.html 0.6 2026-06-24T13:14:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-genentechs-sbla-for-gazyva-t-297124.html 0.6 2026-06-09T10:33:50+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-to-acquire-kite-pharma-f-297125.html 0.6 2026-08-04T09:51:23+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-propeller-expand-digital-health--297126.html 0.6 2026-06-12T16:03:41+08:00 daily https://www.pharmasources.com/industryinsights/economic-incentives-and-research-quality-297127.html 0.6 2025-12-30T00:58:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-targets-rogue-clinic-using-sanofis-s-297128.html 0.6 2026-08-08T02:08:43+08:00 daily https://www.pharmasources.com/industryinsights/offshore-human-testing-of-herpes-vaccine-297129.html 0.6 2026-07-02T17:07:13+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccination-rates-ticking-upward-cdc-297130.html 0.6 2026-08-03T08:05:11+08:00 daily https://www.pharmasources.com/industryinsights/anacetrapib-reduces-risk-of-serious-card-297131.html 0.6 2026-04-18T03:20:12+08:00 daily https://www.pharmasources.com/industryinsights/combination-of-conventional-drugs-enhanc-297132.html 0.6 2026-03-18T01:26:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-anounces-gdufa-rates-for-fiscal-year-297133.html 0.6 2026-06-05T15:14:58+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-out-licenses-dfd--297135.html 0.6 2026-07-04T13:46:20+08:00 daily https://www.pharmasources.com/industryinsights/cf-pharmtech-raises-us65mn-to-develop-in-297136.html 0.6 2026-08-05T22:39:50+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-takeda-establish-collabo-297137.html 0.6 2026-05-04T20:14:14+08:00 daily https://www.pharmasources.com/industryinsights/merck-collaborates-with-angiex-to-speed--297138.html 0.6 2026-08-03T05:36:37+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-unloads-another-drug-for-400-297139.html 0.6 2026-06-09T01:44:16+08:00 daily https://www.pharmasources.com/industryinsights/new-research-claims-first-response-of-ne-297140.html 0.6 2026-04-13T05:06:34+08:00 daily https://www.pharmasources.com/industryinsights/more-canadians-have-access-to-humira-for-297141.html 0.6 2026-01-10T03:57:10+08:00 daily https://www.pharmasources.com/industryinsights/novartis-drug-prevents-heart-attacks-and-297142.html 0.6 2026-04-18T11:23:51+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-assess-data-recording-insulin-pen-297143.html 0.6 2026-04-05T22:57:53+08:00 daily https://www.pharmasources.com/industryinsights/biostar-announces-receipt-of-nasdaq-cont-297144.html 0.6 2025-12-12T18:55:36+08:00 daily https://www.pharmasources.com/industryinsights/allergan-heads-to-federal-court-to-defen-297145.html 0.6 2026-08-07T05:05:16+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-oldie-faslodex-nets-another--297146.html 0.6 2026-02-20T16:46:13+08:00 daily https://www.pharmasources.com/industryinsights/allergan-hits-its-already-battered-irvin-297147.html 0.6 2026-02-15T06:59:50+08:00 daily https://www.pharmasources.com/industryinsights/how-will-gilead-price-car-t-with-kite-bu-297148.html 0.6 2026-01-10T03:05:16+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-veteran-peter-guenter-exits-top-d-297149.html 0.6 2026-06-03T16:07:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-refuses-acorda-nda-for-parkinsons-dr-297150.html 0.6 2025-12-12T19:01:44+08:00 daily https://www.pharmasources.com/industryinsights/merck-still-mulling-over-filing-cetp-med-297151.html 0.6 2026-06-16T21:03:08+08:00 daily https://www.pharmasources.com/industryinsights/harvard-health-outcome-health-team-up-to-297152.html 0.6 2026-03-24T17:04:59+08:00 daily https://www.pharmasources.com/industryinsights/meyer-leaves-troubled-uniqure-for-rd-pos-297153.html 0.6 2025-12-12T19:04:52+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pays-75m-for-chance-to-buy-into-imm-297154.html 0.6 2026-05-02T20:18:35+08:00 daily https://www.pharmasources.com/industryinsights/five-prime-cuts-loose-from-inhibrx-immun-297155.html 0.6 2026-08-06T19:15:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-granted-first-ever-fda-approval-297156.html 0.6 2026-07-18T15:59:10+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-exercises-option-to-co--297157.html 0.6 2026-03-17T22:38:58+08:00 daily https://www.pharmasources.com/industryinsights/immunogen-and-jazz-collaborate-to-develo-297158.html 0.6 2026-07-04T08:08:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-astrazenecas-faslodex-for-e-297159.html 0.6 2026-08-07T22:22:30+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-receives-fda-approv-297160.html 0.6 2026-06-15T06:38:02+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-file-baricitinib-resubmission-t-297161.html 0.6 2026-04-16T21:12:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-pegvaliase-bla-grants-priori-297162.html 0.6 2026-06-25T19:18:11+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-launches-new-treatment-for-l-297163.html 0.6 2026-06-02T23:53:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-us-treatment-for-chag-297164.html 0.6 2026-08-09T21:17:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-antibacterial-drug-297165.html 0.6 2026-05-23T23:47:52+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-completes-acqui-297166.html 0.6 2026-04-29T21:40:23+08:00 daily https://www.pharmasources.com/industryinsights/sa-signs-mou-with-zimbabwe-for-highway-c-297167.html 0.6 2026-05-05T19:20:49+08:00 daily https://www.pharmasources.com/industryinsights/metformin-may-help-in-parkinsons-disease-297168.html 0.6 2026-04-23T19:20:49+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-combination-effective-at-k-297169.html 0.6 2026-04-19T05:47:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-antibacterial-drug-297170.html 0.6 2026-08-08T03:28:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-medicines-for-malaria-venture-l-297171.html 0.6 2026-03-27T18:06:02+08:00 daily https://www.pharmasources.com/industryinsights/researchers-discover-new-immunotherapy-c-297172.html 0.6 2025-12-12T19:25:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-us-treatment-for-chag-297173.html 0.6 2025-12-12T19:26:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approval-brings-first-gene-therapy-t-297174.html 0.6 2026-03-14T00:32:00+08:00 daily https://www.pharmasources.com/industryinsights/uks-post-brexit-strategy-looks-to-life-s-297175.html 0.6 2026-06-16T13:02:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-tracks-recreational-drug-mdma-f-297176.html 0.6 2025-12-12T19:29:50+08:00 daily https://www.pharmasources.com/industryinsights/boehringers-humira-biosimilar-wins-us-gr-297177.html 0.6 2026-02-22T04:49:38+08:00 daily https://www.pharmasources.com/industryinsights/a-selfie-and-a-smartphone-app-could-help-297178.html 0.6 2026-04-26T15:29:24+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-avillion-file-for-bosulif-expansi-297179.html 0.6 2026-03-18T04:28:00+08:00 daily https://www.pharmasources.com/industryinsights/hit-and-run-gene-therapy-nanoparticles-c-297180.html 0.6 2026-01-17T16:43:42+08:00 daily https://www.pharmasources.com/industryinsights/msds-cetp-inhibitor-cuts-heart-risk-by-9-297181.html 0.6 2026-02-15T00:35:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-incyte-reveal-earlier-than-expecte-297182.html 0.6 2026-04-20T18:21:05+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-and-autm-partner-for-tech-transf-297183.html 0.6 2026-04-08T15:40:43+08:00 daily https://www.pharmasources.com/industryinsights/mazor-robotics-to-collect-another-40m-fr-297184.html 0.6 2026-04-17T17:40:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-takeda-sign-400m-deal-for-pa-297185.html 0.6 2025-11-15T16:41:23+08:00 daily https://www.pharmasources.com/industryinsights/industry-puts-building-big-biotechs-attr-297186.html 0.6 2025-12-12T19:39:08+08:00 daily https://www.pharmasources.com/industryinsights/stealthy-torque-powers-through-with-21m--297187.html 0.6 2026-02-06T17:22:18+08:00 daily https://www.pharmasources.com/industryinsights/fdi-releases-chairside-guide-for-dentist-297188.html 0.6 2026-07-06T11:43:56+08:00 daily https://www.pharmasources.com/industryinsights/armo-taps-celgene-gv-for-67m-to-fuel-lat-297189.html 0.6 2026-04-18T07:35:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-crosses-fda-finish-line-with-mo-297190.html 0.6 2026-08-03T09:52:42+08:00 daily https://www.pharmasources.com/industryinsights/snl-veteran-vanessa-bayer-joins-allergan-297191.html 0.6 2026-02-28T18:17:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-meeting-before-car-t-approval-l-297192.html 0.6 2026-06-10T02:51:06+08:00 daily https://www.pharmasources.com/industryinsights/havas-health-quietly-picks-up-bristol-my-297193.html 0.6 2025-12-12T19:46:19+08:00 daily https://www.pharmasources.com/industryinsights/the-medicines-co-nets-400m-nod-for-uti-a-297194.html 0.6 2026-07-01T11:04:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-blesses-nonprofit-backed-chagas-drug-297195.html 0.6 2025-12-12T19:48:22+08:00 daily https://www.pharmasources.com/industryinsights/shire-disputes-employee-dissatisfaction--297196.html 0.6 2026-08-06T21:14:45+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-shire-vertex-and-more-back-first--297197.html 0.6 2026-07-07T17:00:09+08:00 daily https://www.pharmasources.com/industryinsights/lupins-bipresso-listed-in-nhi-drug-price-297198.html 0.6 2026-08-05T13:31:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-car-t-cell-therapy-for-kids-297199.html 0.6 2026-08-07T20:02:12+08:00 daily https://www.pharmasources.com/industryinsights/with-fdas-approval-of-the-second-biosimi-297200.html 0.6 2026-06-27T11:21:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-camber-spine-technologies-3d--297201.html 0.6 2026-07-10T06:23:53+08:00 daily https://www.pharmasources.com/industryinsights/ihi-partners-with-health-department-in-s-297202.html 0.6 2026-06-08T18:37:10+08:00 daily https://www.pharmasources.com/industryinsights/nobel-laureate-honoured-by-japan-for-con-297203.html 0.6 2026-04-02T00:37:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-car-t-cell-therapy-for-chil-297204.html 0.6 2026-04-07T18:54:26+08:00 daily https://www.pharmasources.com/industryinsights/z-endoxifen-to-become-a-new-treatment-of-297205.html 0.6 2026-04-13T10:45:03+08:00 daily https://www.pharmasources.com/industryinsights/mri-can-detect-kidney-damage-and-predict-297206.html 0.6 2026-04-18T03:58:55+08:00 daily https://www.pharmasources.com/industryinsights/ambrosus-trek-therapeutics-to-develop-bl-297207.html 0.6 2026-06-17T08:54:00+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-enters-licencing-agreemen-297208.html 0.6 2026-04-29T19:06:56+08:00 daily https://www.pharmasources.com/industryinsights/abbott-and-the-abbott-fund-donate-1-mill-297209.html 0.6 2026-05-02T20:56:06+08:00 daily https://www.pharmasources.com/industryinsights/lilly-gets-second-shot-at-application-fo-297210.html 0.6 2026-03-21T02:36:35+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-hikes-fee-for-processing-anda-by--297211.html 0.6 2026-01-03T12:31:59+08:00 daily https://www.pharmasources.com/industryinsights/teva-scores-expanded-indication-for-aust-297212.html 0.6 2026-06-08T15:55:13+08:00 daily https://www.pharmasources.com/industryinsights/nhs-will-pay-80bn-for-pfi-contracts-297213.html 0.6 2026-06-17T04:00:25+08:00 daily https://www.pharmasources.com/industryinsights/cma-clears-birmingham-hospitals-merger-297214.html 0.6 2026-06-19T00:44:53+08:00 daily https://www.pharmasources.com/industryinsights/final-nhs-green-light-for-allergans-ibs--297215.html 0.6 2026-03-19T22:15:19+08:00 daily https://www.pharmasources.com/industryinsights/nppa-nada-app-to-help-athletes-identify--297216.html 0.6 2026-06-08T23:32:08+08:00 daily https://www.pharmasources.com/industryinsights/paradigm-shifts-in-asia-healthcare-ecosy-297217.html 0.6 2026-07-01T16:28:23+08:00 daily https://www.pharmasources.com/industryinsights/ajanta-pharma-launches-eletriptan-hydrob-297218.html 0.6 2026-08-06T20:37:07+08:00 daily https://www.pharmasources.com/industryinsights/igmpi-wins-assocham-services-excellence--297219.html 0.6 2026-04-05T09:41:45+08:00 daily https://www.pharmasources.com/industryinsights/new-study-reveals-role-of-proteins-in-tr-297220.html 0.6 2026-01-20T12:50:48+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-pfizers-bosulif-type-ii-vari-297221.html 0.6 2026-04-20T01:11:48+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-licences-eusas-advan-297222.html 0.6 2026-08-06T22:08:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approval-brings-first-gene-therapy-t-297223.html 0.6 2026-06-10T18:32:29+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-announces-positive-top-li-297224.html 0.6 2026-08-06T21:54:22+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-terminates-agreement-with-297225.html 0.6 2026-08-06T20:07:07+08:00 daily https://www.pharmasources.com/industryinsights/phrma-announces-new-chief-medical-office-297226.html 0.6 2026-08-06T18:36:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-personalized-cellular-thera-297227.html 0.6 2026-08-06T19:23:37+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-japan-selects-scibite-se-297228.html 0.6 2026-08-06T20:01:36+08:00 daily https://www.pharmasources.com/industryinsights/abbott-initiates-us-pivotal-study-of-amp-297229.html 0.6 2026-08-06T23:46:32+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-submits-nda-for-dasotraline-for-297230.html 0.6 2026-08-07T02:42:03+08:00 daily https://www.pharmasources.com/industryinsights/symcel-sverige-ab-appointment-jesper-eri-297231.html 0.6 2026-08-07T02:51:56+08:00 daily https://www.pharmasources.com/industryinsights/korean-companies-to-advance-drug-discove-297232.html 0.6 2026-07-04T11:50:16+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-subsidiary-arrow-pharma-a-297233.html 0.6 2026-03-16T14:44:28+08:00 daily https://www.pharmasources.com/industryinsights/polyu-discovers-a-new-superbug---hyper-r-297234.html 0.6 2026-08-07T20:03:20+08:00 daily https://www.pharmasources.com/industryinsights/lakewood-amedex-strengthens-board-of-dir-297235.html 0.6 2026-07-03T18:05:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approved-revolutionary-immunotherapy-297236.html 0.6 2026-04-17T04:31:37+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-chemo-groups-benznidazol-297237.html 0.6 2026-04-14T02:08:26+08:00 daily https://www.pharmasources.com/industryinsights/beta-blockers-have-positive-effect-in-pu-297238.html 0.6 2026-07-15T03:47:39+08:00 daily https://www.pharmasources.com/industryinsights/asthma-medicine-reduses-risk-of-parkinso-297239.html 0.6 2026-08-05T21:50:35+08:00 daily https://www.pharmasources.com/industryinsights/lyophilization-usa-conference-2017-297240.html 0.6 2026-01-14T05:34:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mylotarg-for-treatment-of-a-297241.html 0.6 2026-06-28T17:25:27+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-astrazenecas-breast-cancer--297242.html 0.6 2026-07-29T17:08:23+08:00 daily https://www.pharmasources.com/industryinsights/nhs-pumps-100m-into-gp-recruitment-as-nu-297243.html 0.6 2025-12-12T20:38:07+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-az-faslodex-for-breast-c-297244.html 0.6 2025-12-12T20:39:08+08:00 daily https://www.pharmasources.com/industryinsights/heptares-doses-first-subject-in-alzheime-297245.html 0.6 2026-02-28T15:29:20+08:00 daily https://www.pharmasources.com/industryinsights/wales-sees-patients-waiting-more-than-a--297246.html 0.6 2026-01-10T02:58:05+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-new-antibiotic-for-utis-297247.html 0.6 2026-01-10T03:13:50+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-pharma-buys-us-radiopharmacy-bu-297248.html 0.6 2025-12-28T12:07:42+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-nod-for-injectio-297249.html 0.6 2026-03-29T03:18:22+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20170904-297250.html 0.6 2026-08-06T23:45:14+08:00 daily https://www.pharmasources.com/industryinsights/tpg-capital-asia-acquires-major-stake-in-297251.html 0.6 2025-12-13T19:43:30+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-benicar-tablets-i-297252.html 0.6 2026-08-07T00:39:38+08:00 daily https://www.pharmasources.com/industryinsights/australian-digital-health-and-life-scien-297253.html 0.6 2026-08-07T00:03:04+08:00 daily https://www.pharmasources.com/industryinsights/targeted-therapy-for-acute-myeloid-leuke-297254.html 0.6 2026-08-06T23:55:54+08:00 daily https://www.pharmasources.com/industryinsights/ontario-canada-partners-with-apotex-inct-297255.html 0.6 2026-08-06T23:45:55+08:00 daily https://www.pharmasources.com/industryinsights/scientists-devise-breakthrough-therapy-f-297256.html 0.6 2026-08-06T23:36:13+08:00 daily https://www.pharmasources.com/industryinsights/singapore-biotech-startup-focuses-on-fib-297257.html 0.6 2026-08-07T05:05:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-new-ceo-297258.html 0.6 2026-04-05T05:19:59+08:00 daily https://www.pharmasources.com/industryinsights/driving-innovation-at-esmo-2017-with-new-297259.html 0.6 2026-08-05T22:55:18+08:00 daily https://www.pharmasources.com/industryinsights/australian-cancer-specialists-may-hold-k-297260.html 0.6 2026-02-28T02:21:34+08:00 daily https://www.pharmasources.com/industryinsights/nhs-needs-emergency-350-million-to-survi-297261.html 0.6 2026-03-19T16:16:29+08:00 daily https://www.pharmasources.com/industryinsights/takeda-partners-up-to-develop-next-gener-297262.html 0.6 2026-04-01T06:35:57+08:00 daily https://www.pharmasources.com/industryinsights/roches-alecensa-gets-green-light-for-ear-297263.html 0.6 2026-06-29T22:08:22+08:00 daily https://www.pharmasources.com/industryinsights/withdrawn-7-years-ago-pfizers-mylotarg-i-297264.html 0.6 2025-12-12T21:00:46+08:00 daily https://www.pharmasources.com/industryinsights/one-in-ten-men-have-older-hearts-than-th-297265.html 0.6 2026-04-13T05:25:10+08:00 daily https://www.pharmasources.com/industryinsights/mercks-erbitux-backed-by-nice-for-head-a-297266.html 0.6 2026-04-17T00:22:59+08:00 daily https://www.pharmasources.com/industryinsights/new-steps-to-strengthen-fdas-inspection--297267.html 0.6 2026-08-06T20:06:41+08:00 daily https://www.pharmasources.com/industryinsights/working-to-improve-information-on-medica-297268.html 0.6 2025-12-12T21:03:51+08:00 daily https://www.pharmasources.com/industryinsights/3sbio-speed-up-expanding-its-global-biol-297269.html 0.6 2026-04-12T04:25:51+08:00 daily https://www.pharmasources.com/industryinsights/novartis-appoints-vasant-narasimhan-as-c-297270.html 0.6 2026-03-01T06:19:50+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-acquire-kite-pharma-for-119b-297271.html 0.6 2026-07-18T21:42:45+08:00 daily https://www.pharmasources.com/industryinsights/indian-institute-of-science-alumna-named-297272.html 0.6 2026-04-03T00:08:22+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-mylotarg-receives-fda-approval-f-297273.html 0.6 2026-06-19T19:14:03+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-submits-nda-for-dasotraline-to--297274.html 0.6 2026-04-02T10:02:29+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-completes-acquisition-of-chilter-297275.html 0.6 2026-05-06T01:01:40+08:00 daily https://www.pharmasources.com/industryinsights/irst-subject-dosed-in-phase-1-clinical-s-297276.html 0.6 2025-12-12T21:12:13+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-pulls-out-of-zika-vaccine-collabo-297277.html 0.6 2026-05-05T00:46:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-adheriums-usage-tracker-for-a-297278.html 0.6 2026-07-21T14:51:26+08:00 daily https://www.pharmasources.com/industryinsights/ionis-spinout-akcea-files-for-approval-o-297279.html 0.6 2026-04-16T21:21:54+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-biocon-herceptin-biosimilar-de-297280.html 0.6 2025-12-12T21:16:21+08:00 daily https://www.pharmasources.com/industryinsights/nightstar-files-for-86m-ipo-to-fund-gene-297281.html 0.6 2026-08-07T00:25:25+08:00 daily https://www.pharmasources.com/industryinsights/apollo-bags-ce-mark-for-longer-term-obes-297282.html 0.6 2026-08-06T08:35:43+08:00 daily https://www.pharmasources.com/industryinsights/world-psychiatric-association-wpa-only-4-297283.html 0.6 2026-04-07T14:09:54+08:00 daily https://www.pharmasources.com/industryinsights/rising-star-award-in-addiction-research--297284.html 0.6 2026-04-13T05:23:14+08:00 daily https://www.pharmasources.com/industryinsights/taiwan-china-sees-large-extent-of-growth-297285.html 0.6 2026-06-09T17:27:11+08:00 daily https://www.pharmasources.com/industryinsights/swine-flu-raises-its-ugly-head-again-in--297286.html 0.6 2026-06-08T17:58:44+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-disease-greatest-threat-to-he-297287.html 0.6 2026-03-16T15:55:31+08:00 daily https://www.pharmasources.com/industryinsights/noile-immune-signs-car-t-collaboration-w-297288.html 0.6 2026-06-09T01:52:21+08:00 daily https://www.pharmasources.com/industryinsights/avella-introduces-app-for-pain-managemen-297289.html 0.6 2026-08-07T01:06:45+08:00 daily https://www.pharmasources.com/industryinsights/amal-therapeutics-raises-series-b-fundin-297290.html 0.6 2026-08-07T01:06:44+08:00 daily https://www.pharmasources.com/industryinsights/brainscope-bags-16m-funding-for-its-head-297291.html 0.6 2026-08-07T05:07:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-appointed-vasant-narasimhan-as--297292.html 0.6 2026-07-31T04:36:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-status-to-cellect-297293.html 0.6 2026-04-20T19:07:53+08:00 daily https://www.pharmasources.com/industryinsights/hygienic-pharma-sieve-for-paracetamol-in-297294.html 0.6 2026-03-19T23:33:21+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-launches-difolta-for-relapse-297295.html 0.6 2026-08-06T11:30:21+08:00 daily https://www.pharmasources.com/industryinsights/amal-therapeutics-raises-eur-8-million-c-297296.html 0.6 2026-07-04T06:45:30+08:00 daily https://www.pharmasources.com/industryinsights/3sbio-acquires-therapure-for-290m-297297.html 0.6 2026-05-25T21:00:17+08:00 daily https://www.pharmasources.com/industryinsights/amatsigroup-manufactures-injectable-clin-297298.html 0.6 2026-06-08T06:30:15+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-opens-new-technology-services-l-297299.html 0.6 2026-08-06T18:42:01+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-commits-to-continued-partners-297300.html 0.6 2026-07-06T23:17:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-drug-back-on-the-market-after-pr-297301.html 0.6 2026-08-06T08:48:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-celebrates-success-of-gilenya-i-297302.html 0.6 2026-01-31T09:55:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gilenya-hits-targets-in-paediat-297303.html 0.6 2026-03-29T01:24:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-holds-trials-of-cellectis-cell-thera-297304.html 0.6 2026-02-28T19:21:33+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-noile-immune-to-jointly-devel-297305.html 0.6 2026-03-17T19:00:11+08:00 daily https://www.pharmasources.com/industryinsights/janssen-and-mundipharma-sign-distributio-297306.html 0.6 2026-03-19T23:11:07+08:00 daily https://www.pharmasources.com/industryinsights/therapure-biopharma-to-divest-cdmo-busin-297307.html 0.6 2026-03-01T01:54:21+08:00 daily https://www.pharmasources.com/industryinsights/news-of-notevbi-vaccines-biondvax-and-mo-297308.html 0.6 2026-08-06T05:08:33+08:00 daily https://www.pharmasources.com/industryinsights/gavi-to-save-20m-lives-350b-with-vaccine-297309.html 0.6 2026-02-28T18:35:22+08:00 daily https://www.pharmasources.com/industryinsights/smith-nephew-imperial-college-to-develop-297310.html 0.6 2025-12-12T21:47:32+08:00 daily https://www.pharmasources.com/industryinsights/us-pharma-companies-fired-fewer-employee-297311.html 0.6 2026-01-21T10:19:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-status-to-apograf-297312.html 0.6 2026-03-01T00:00:31+08:00 daily https://www.pharmasources.com/industryinsights/lannett-receives-approval-for-esomeprazo-297313.html 0.6 2026-03-18T00:55:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-ceo-joseph-jimenez-to-297314.html 0.6 2026-05-03T05:56:56+08:00 daily https://www.pharmasources.com/industryinsights/csa-group-korean-lab-now-accredited-as-a-297315.html 0.6 2026-07-16T13:01:46+08:00 daily https://www.pharmasources.com/industryinsights/first-israeli-company-sisram-announces-p-297316.html 0.6 2025-11-30T12:24:53+08:00 daily https://www.pharmasources.com/industryinsights/singapores-pips-program-to-give-pharma-s-297317.html 0.6 2025-12-12T21:54:45+08:00 daily https://www.pharmasources.com/industryinsights/zika-virus-could-be-used-to-treat-brain--297318.html 0.6 2026-02-28T14:35:25+08:00 daily https://www.pharmasources.com/industryinsights/smith-nephew-partners-with-imperial-coll-297319.html 0.6 2026-07-08T05:09:44+08:00 daily https://www.pharmasources.com/industryinsights/singapore-to-boost-community-care-sector-297320.html 0.6 2026-01-14T12:48:43+08:00 daily https://www.pharmasources.com/industryinsights/swedish-startup-raises-51-million-fundin-297321.html 0.6 2026-03-24T05:37:56+08:00 daily https://www.pharmasources.com/industryinsights/speeding-up-drug-discovery-with-artifici-297322.html 0.6 2026-02-28T14:56:50+08:00 daily https://www.pharmasources.com/industryinsights/new-app-replaces-ultrasound-to-measure-h-297323.html 0.6 2025-11-14T11:48:43+08:00 daily https://www.pharmasources.com/industryinsights/antidepressant-could-slow-parkinsons-dis-297324.html 0.6 2026-02-28T13:36:17+08:00 daily https://www.pharmasources.com/industryinsights/multichannel-pipetting-to-make-you-smile-297325.html 0.6 2026-03-01T06:25:30+08:00 daily https://www.pharmasources.com/industryinsights/rampant-technological-advancements-will--297326.html 0.6 2026-03-28T15:19:53+08:00 daily https://www.pharmasources.com/industryinsights/tezepelumab-significantly-reduced-asthma-297327.html 0.6 2026-06-12T13:54:43+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-employees-ride-acro-297328.html 0.6 2026-03-18T01:43:53+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-settles-lawsuit-over-illega-297329.html 0.6 2026-01-04T03:17:49+08:00 daily https://www.pharmasources.com/industryinsights/anti-hiv-drug-prep-proves-safety-in-gay--297330.html 0.6 2026-04-17T07:28:36+08:00 daily https://www.pharmasources.com/industryinsights/real-world-data-prove-efficacy-of-eisai--297331.html 0.6 2026-02-14T20:17:02+08:00 daily https://www.pharmasources.com/industryinsights/bioverativ-and-bicycle-therapeutics-team-297332.html 0.6 2026-06-08T18:45:52+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-resolves-us-federal-investi-297333.html 0.6 2026-06-18T08:55:06+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-for-mercks-keytruda-for-blad-297334.html 0.6 2026-08-05T13:28:55+08:00 daily https://www.pharmasources.com/industryinsights/clintec-expands-uk-hq-297335.html 0.6 2026-08-09T09:23:38+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-looks-to-sell-consumer-health-297336.html 0.6 2026-06-17T04:21:46+08:00 daily https://www.pharmasources.com/industryinsights/acceliant-partners-with-qed-clinical-ser-297337.html 0.6 2026-07-08T01:41:24+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-recognises-ul-2900-for-cybersecur-297338.html 0.6 2026-07-04T01:22:04+08:00 daily https://www.pharmasources.com/industryinsights/drl-launches-bupropion-hydrochloride-and-297339.html 0.6 2026-06-29T11:18:25+08:00 daily https://www.pharmasources.com/industryinsights/sayre-therapeutics-raises-funds-from-acc-297340.html 0.6 2026-07-02T05:51:34+08:00 daily https://www.pharmasources.com/industryinsights/biocon-collaborates-with-jdrf-297341.html 0.6 2026-07-03T09:21:48+08:00 daily https://www.pharmasources.com/industryinsights/draft-pharma-policy-old-wine-in-a-new-bo-297342.html 0.6 2026-08-10T01:39:05+08:00 daily https://www.pharmasources.com/industryinsights/tigenix-obtains-production-licence-for-e-297343.html 0.6 2026-01-22T22:54:35+08:00 daily https://www.pharmasources.com/industryinsights/uk-nice-issues-second-draft-no-on-ninlar-297344.html 0.6 2026-01-10T18:00:57+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-awarded-fast-track-designation-f-297345.html 0.6 2026-07-06T02:13:18+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-submits-nda-for-elagolix-297346.html 0.6 2025-12-12T22:25:01+08:00 daily https://www.pharmasources.com/industryinsights/actelion-receives-fda-approval-of-tracle-297347.html 0.6 2026-01-14T04:36:19+08:00 daily https://www.pharmasources.com/industryinsights/gates-foundation-commits-120m-for-nonpro-297348.html 0.6 2025-12-12T22:27:10+08:00 daily https://www.pharmasources.com/industryinsights/borderless-access-launches-healthsight---297349.html 0.6 2026-02-28T16:13:07+08:00 daily https://www.pharmasources.com/industryinsights/tips-on-successful-liposuctions-revealed-297350.html 0.6 2026-08-08T20:19:55+08:00 daily https://www.pharmasources.com/industryinsights/notable-labs-nets-10m-funding-for-person-297351.html 0.6 2026-08-07T05:27:32+08:00 daily https://www.pharmasources.com/industryinsights/proprietary-firm-launches-healthcare-fun-297352.html 0.6 2026-08-09T04:01:57+08:00 daily https://www.pharmasources.com/industryinsights/world-bank-provides-funds-for-healthcare-297353.html 0.6 2026-02-28T13:01:08+08:00 daily https://www.pharmasources.com/industryinsights/cbd-may-protect-against-psychiatric-risk-297354.html 0.6 2025-12-27T11:07:56+08:00 daily https://www.pharmasources.com/industryinsights/improved-vaccine-protects-against-nine-t-297355.html 0.6 2026-07-02T23:22:38+08:00 daily https://www.pharmasources.com/industryinsights/biotech-hub-outsources-rd-to-marketplace-297356.html 0.6 2026-08-08T00:43:56+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-combination-safe-and-62-pe-297357.html 0.6 2026-07-14T19:29:06+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-completes-previousl-297358.html 0.6 2026-06-18T00:57:24+08:00 daily https://www.pharmasources.com/industryinsights/antidepressants-polluting-rivers-buildin-297359.html 0.6 2026-03-29T04:18:35+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-astrazenecas-experimental-drug-297360.html 0.6 2026-02-03T21:09:45+08:00 daily https://www.pharmasources.com/industryinsights/nhs-negligence-bill-set-to-double-297361.html 0.6 2026-01-25T07:51:42+08:00 daily https://www.pharmasources.com/industryinsights/3-uk-wins-in-practice-to-policy-health-a-297362.html 0.6 2026-01-30T10:02:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-puts-bristol-myers-squibb-opdivo-tri-297363.html 0.6 2026-01-30T18:36:56+08:00 daily https://www.pharmasources.com/industryinsights/congenicas-sapientia-selected-by-coimbra-297364.html 0.6 2026-08-05T19:40:29+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-rigontec-rig-i-therapeu-297365.html 0.6 2026-07-22T18:14:29+08:00 daily https://www.pharmasources.com/industryinsights/new-pen-device-identifies-cancerous-tiss-297366.html 0.6 2026-02-22T13:36:07+08:00 daily https://www.pharmasources.com/industryinsights/pharma-education-in-need-of-a-revamp-297367.html 0.6 2026-07-05T06:50:43+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharmaceuticals-concludes-swachht-297368.html 0.6 2026-02-28T13:19:49+08:00 daily https://www.pharmasources.com/industryinsights/biocons-malaysia-facility-receives-eu-gm-297369.html 0.6 2026-03-17T23:22:41+08:00 daily https://www.pharmasources.com/industryinsights/gibs-2017-held-in-mumbai-297370.html 0.6 2026-01-10T04:09:02+08:00 daily https://www.pharmasources.com/industryinsights/jenburkt-pharma-to-consider-share-buybac-297371.html 0.6 2025-12-12T22:50:59+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-mundipharma-medical-comp-297372.html 0.6 2026-03-18T02:32:48+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-jhl-biotech-bio-techne-met-297373.html 0.6 2026-03-05T05:12:27+08:00 daily https://www.pharmasources.com/industryinsights/gsk-exercises-option-over-spear-t-cell-t-297374.html 0.6 2026-08-06T01:12:41+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-shutter-us-china-rd-centers-297375.html 0.6 2026-06-24T02:08:24+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-amgen-severe-asthma-drug-297376.html 0.6 2026-06-29T04:04:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-slams-pfizer-unit-that-made-epipens--297377.html 0.6 2026-08-08T01:53:30+08:00 daily https://www.pharmasources.com/industryinsights/picarro-introduces-a-hydrogen-peroxide-g-297378.html 0.6 2026-06-08T18:01:43+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-applauds-stanley-healthca-297379.html 0.6 2026-03-06T08:58:03+08:00 daily https://www.pharmasources.com/industryinsights/the-most-valuable-unsold-assets-of-the-p-297380.html 0.6 2026-04-27T08:42:30+08:00 daily https://www.pharmasources.com/industryinsights/anticoagulant-clopidogrel-hot-on-chinese-297381.html 0.6 2026-07-24T05:32:32+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-invest-more-in-new-medicine-297382.html 0.6 2026-03-31T23:54:23+08:00 daily https://www.pharmasources.com/industryinsights/japans-icure-gets-associated-with-inter--297383.html 0.6 2026-03-08T06:57:47+08:00 daily https://www.pharmasources.com/industryinsights/john-fowler-appointed-as-the-chief-opera-297384.html 0.6 2026-07-06T03:35:15+08:00 daily https://www.pharmasources.com/industryinsights/maldives-host-seventieth-regional-commit-297385.html 0.6 2026-01-22T10:29:50+08:00 daily https://www.pharmasources.com/industryinsights/tabula-rasa-healthcare-acquires-sinfonar-297386.html 0.6 2026-08-08T00:02:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-designation-to-c-297387.html 0.6 2025-12-18T08:24:28+08:00 daily https://www.pharmasources.com/industryinsights/pembrolizumab-shows-promise-in-pretreate-297388.html 0.6 2026-07-20T18:56:18+08:00 daily https://www.pharmasources.com/industryinsights/new-method-for-producing-malaria-treatme-297389.html 0.6 2026-04-21T13:34:19+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-announce-that-cemip-297390.html 0.6 2026-07-19T10:17:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-rigontec-rig-i-therapeu-297391.html 0.6 2025-12-12T23:11:46+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-may-be-a-cost-effective-alternat-297392.html 0.6 2026-03-20T14:20:43+08:00 daily https://www.pharmasources.com/industryinsights/lily-announces-massive-staff-cuts-of-350-297393.html 0.6 2026-08-05T02:50:43+08:00 daily https://www.pharmasources.com/industryinsights/roche-blood-test-can-accurately-predict--297394.html 0.6 2026-04-12T00:35:02+08:00 daily https://www.pharmasources.com/industryinsights/gsk-makes-t-cell-move-297395.html 0.6 2026-06-22T19:25:25+08:00 daily https://www.pharmasources.com/industryinsights/robust-performance-of-oncobeam-ras-crc-l-297396.html 0.6 2026-04-16T21:06:37+08:00 daily https://www.pharmasources.com/industryinsights/piramal-appoints-coo-297397.html 0.6 2026-08-09T03:50:55+08:00 daily https://www.pharmasources.com/industryinsights/nih-awards-100m-in-funding-for-research--297398.html 0.6 2025-12-12T23:18:59+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-and-gubra-collaborate-to-disc-297399.html 0.6 2026-06-08T13:17:51+08:00 daily https://www.pharmasources.com/industryinsights/bioverativ-and-bicycle-therapeutics-to-d-297400.html 0.6 2026-01-10T18:25:56+08:00 daily https://www.pharmasources.com/industryinsights/explore-the-research-progress-of-over-24-297401.html 0.6 2026-07-20T03:31:42+08:00 daily https://www.pharmasources.com/industryinsights/british-biologicals-organises-nutrition--297402.html 0.6 2026-07-06T09:13:19+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-warns-of-problems-with-epipen-man-297403.html 0.6 2026-04-01T13:02:44+08:00 daily https://www.pharmasources.com/industryinsights/purdue-university-scientists-find-breakt-297404.html 0.6 2026-07-09T02:23:29+08:00 daily https://www.pharmasources.com/industryinsights/drls-visakhapatnam-unit-gets-six-observa-297405.html 0.6 2026-04-05T19:34:37+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-names-john-fowl-297406.html 0.6 2026-04-03T06:58:52+08:00 daily https://www.pharmasources.com/industryinsights/blocking-two-proteins-could-improve-stem-297407.html 0.6 2026-06-24T11:55:34+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-preps-jak-atopic-dermatitis-candi-297408.html 0.6 2025-12-12T23:29:26+08:00 daily https://www.pharmasources.com/industryinsights/boosting-a-mitochondria-targeting-protei-297409.html 0.6 2026-04-20T20:45:56+08:00 daily https://www.pharmasources.com/industryinsights/esmo-mercks-keytruda-extends-survival-ed-297410.html 0.6 2026-04-17T10:41:38+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-opdivo-yervoy-cocktail-sla-297411.html 0.6 2026-05-09T14:04:53+08:00 daily https://www.pharmasources.com/industryinsights/merck-grant-for-oncology-innovation-awar-297412.html 0.6 2026-01-05T07:52:35+08:00 daily https://www.pharmasources.com/industryinsights/janssen-to-discontinue-hepatitis-c-devel-297413.html 0.6 2026-08-03T04:46:06+08:00 daily https://www.pharmasources.com/industryinsights/michigan-third-most-preferred-destinatio-297414.html 0.6 2026-07-02T16:30:22+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-collaborates-with-gubra-to-de-297415.html 0.6 2026-07-16T23:29:54+08:00 daily https://www.pharmasources.com/industryinsights/quest-diagnostics-moves-to-more-accurate-297416.html 0.6 2026-03-01T05:20:48+08:00 daily https://www.pharmasources.com/industryinsights/who-urges-member-nations-to-step-up-effo-297417.html 0.6 2026-03-23T18:15:35+08:00 daily https://www.pharmasources.com/industryinsights/merck-joins-forces-to-pioneer-global-onc-297418.html 0.6 2025-12-13T04:29:12+08:00 daily https://www.pharmasources.com/industryinsights/tecan-introduces-new-solution-for-walkaw-297419.html 0.6 2026-03-23T03:57:43+08:00 daily https://www.pharmasources.com/industryinsights/taselisib-boosts-breast-tumour-shrinkage-297420.html 0.6 2026-03-24T03:19:46+08:00 daily https://www.pharmasources.com/industryinsights/prestigious-scientific-organisations-sup-297421.html 0.6 2026-04-05T16:32:37+08:00 daily https://www.pharmasources.com/industryinsights/ingenza-invests-in-faster-fermentation-d-297422.html 0.6 2025-12-08T06:56:04+08:00 daily https://www.pharmasources.com/industryinsights/nivolumab-cuts-relapse-by-one-third-comp-297423.html 0.6 2026-07-19T23:43:57+08:00 daily https://www.pharmasources.com/industryinsights/merck-set-to-join-forces-with-project-da-297424.html 0.6 2026-04-22T09:27:44+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-crisis-as-uk-struggles-wit-297425.html 0.6 2026-04-27T16:35:56+08:00 daily https://www.pharmasources.com/industryinsights/lillys-cyramza-combo-boasts-strong-resul-297426.html 0.6 2026-04-30T10:03:48+08:00 daily https://www.pharmasources.com/industryinsights/melanoma-treatment-novartis-posts-succes-297427.html 0.6 2025-12-02T19:44:52+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-tagrisso-beats-standard-of--297428.html 0.6 2026-05-07T16:32:15+08:00 daily https://www.pharmasources.com/industryinsights/new-migraine-results-for-both-allergan-a-297429.html 0.6 2026-01-30T20:51:49+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-co-lead-big-data-alliance-297430.html 0.6 2026-03-19T10:55:58+08:00 daily https://www.pharmasources.com/industryinsights/new-analysis-from-german-study-group-pro-297431.html 0.6 2026-07-10T03:28:58+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-usfda-nod-to-market-anti-infe-297432.html 0.6 2026-06-12T08:38:34+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-launches-combiflam-icyhot-297433.html 0.6 2026-06-24T12:38:49+08:00 daily https://www.pharmasources.com/industryinsights/laurus-infosystems-launches-smart-mes-so-297434.html 0.6 2026-02-28T15:54:49+08:00 daily https://www.pharmasources.com/industryinsights/gufic-biosciences-to-tap-generics-life-s-297435.html 0.6 2026-07-03T21:05:50+08:00 daily https://www.pharmasources.com/industryinsights/merck-in-agreement-with-natrix-separatio-297436.html 0.6 2025-12-21T00:00:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-project-data-sphere-to-join-fo-297437.html 0.6 2026-02-05T04:15:55+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-sanofi-receive-fdas-breakt-297438.html 0.6 2026-03-29T15:25:58+08:00 daily https://www.pharmasources.com/industryinsights/gsk-exercises-global-licence-option-for--297439.html 0.6 2026-06-21T03:40:15+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-sanofi-announce-positive-dupil-297440.html 0.6 2026-06-09T01:53:24+08:00 daily https://www.pharmasources.com/industryinsights/walter-reed-path-to-test-modified-regime-297441.html 0.6 2026-07-28T14:51:32+08:00 daily https://www.pharmasources.com/industryinsights/depuy-synthes-rolls-out-3d-printed-facia-297442.html 0.6 2026-06-21T22:45:31+08:00 daily https://www.pharmasources.com/industryinsights/dupixent-severe-asthma-results-should-pr-297443.html 0.6 2025-11-07T01:24:42+08:00 daily https://www.pharmasources.com/industryinsights/hanall-biopharma-and-harbour-biomed-sign-297444.html 0.6 2026-04-21T18:29:51+08:00 daily https://www.pharmasources.com/industryinsights/australia-brazil-china-join-forces-to-ad-297445.html 0.6 2026-01-15T03:25:09+08:00 daily https://www.pharmasources.com/industryinsights/bio-techne-introduces-zika-virus-detecti-297446.html 0.6 2026-07-03T00:39:48+08:00 daily https://www.pharmasources.com/industryinsights/japan-mhlw-approves-medtronics-latest-de-297447.html 0.6 2026-01-30T19:02:05+08:00 daily https://www.pharmasources.com/industryinsights/teva-pharma-strikes-11-b-deal-for-paraga-297448.html 0.6 2025-12-10T14:15:10+08:00 daily https://www.pharmasources.com/industryinsights/cancer-drug-stimulates-tripolar-mode-of--297449.html 0.6 2026-06-24T13:34:05+08:00 daily https://www.pharmasources.com/industryinsights/nivolumab-superior-to-ipilimumab-for-adj-297450.html 0.6 2026-03-18T02:26:18+08:00 daily https://www.pharmasources.com/industryinsights/paul-royall-joins-european-pharmaceutica-297451.html 0.6 2026-04-18T04:30:27+08:00 daily https://www.pharmasources.com/industryinsights/eisai-merck-co-to-expand-enrolment-of-st-297452.html 0.6 2026-06-16T21:52:03+08:00 daily https://www.pharmasources.com/industryinsights/congenica-selected-by-coimbra-paediatric-297453.html 0.6 2026-04-09T02:50:32+08:00 daily https://www.pharmasources.com/industryinsights/narayana-health-city-to-introduce-advanc-297454.html 0.6 2026-04-03T17:52:03+08:00 daily https://www.pharmasources.com/industryinsights/polyu-discovers-newly-emerged-hyper-resi-297455.html 0.6 2026-04-04T20:22:36+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-japan-selects-scibite-se-297456.html 0.6 2026-07-24T13:35:48+08:00 daily https://www.pharmasources.com/industryinsights/qed-clinical-services-chooses-acceliant--297457.html 0.6 2025-11-12T18:25:44+08:00 daily https://www.pharmasources.com/industryinsights/more-people-treated-with-once-weekly-sem-297458.html 0.6 2026-07-31T14:46:37+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-presents-new-results-identif-297459.html 0.6 2026-01-13T04:14:55+08:00 daily https://www.pharmasources.com/industryinsights/newly-adopted-flu-vaccine-could-save-170-297460.html 0.6 2025-11-08T22:36:14+08:00 daily https://www.pharmasources.com/industryinsights/jj-backs-out-of-11-billion-hep-c-deal-wi-297461.html 0.6 2026-04-21T20:11:16+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-sale-of-paragard-for-11-b-297462.html 0.6 2026-03-20T23:33:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-license-application-for-nova-297463.html 0.6 2026-08-03T02:00:56+08:00 daily https://www.pharmasources.com/industryinsights/key-process-to-be-modernised-in-producti-297464.html 0.6 2025-12-23T15:13:55+08:00 daily https://www.pharmasources.com/industryinsights/ayush-minister-inaugurates-indias-first--297465.html 0.6 2025-11-14T16:28:25+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-global-medicines-developmen-297466.html 0.6 2026-03-03T13:40:18+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-receives-usfda-approval-f-297467.html 0.6 2026-02-28T20:16:55+08:00 daily https://www.pharmasources.com/industryinsights/integra-to-sell-neurosurgery-assets-to-n-297468.html 0.6 2026-06-11T00:28:18+08:00 daily https://www.pharmasources.com/industryinsights/summit-therapeutics-secures-62m-contract-297469.html 0.6 2026-07-09T08:43:25+08:00 daily https://www.pharmasources.com/industryinsights/trial-shows-jardiance-reduced-cardiovasc-297470.html 0.6 2026-04-06T23:43:43+08:00 daily https://www.pharmasources.com/industryinsights/prevnar-13-among-blockbusters-industry-w-297471.html 0.6 2026-04-17T13:57:56+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-adjuvanted-quadrivalent-flu-vacc-297472.html 0.6 2026-04-17T18:32:07+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-could-mean-earlier-diagnosis--297473.html 0.6 2026-04-20T17:22:11+08:00 daily https://www.pharmasources.com/industryinsights/techcode-showcases-chinas-capabilities-a-297474.html 0.6 2026-06-16T11:06:15+08:00 daily https://www.pharmasources.com/industryinsights/new-gates-foundation-report-highlights-r-297475.html 0.6 2026-05-07T17:36:32+08:00 daily https://www.pharmasources.com/industryinsights/singapore-leads-the-world-in-progress-to-297476.html 0.6 2026-03-28T01:32:51+08:00 daily https://www.pharmasources.com/industryinsights/arthritis-act-before-it-gets-late-297477.html 0.6 2026-05-04T16:11:39+08:00 daily https://www.pharmasources.com/industryinsights/it-is-quite-possible-to-slow-aging-and-e-297478.html 0.6 2026-06-07T16:13:38+08:00 daily https://www.pharmasources.com/industryinsights/eisai-announces-combined-clinical-trial--297479.html 0.6 2026-02-28T22:52:29+08:00 daily https://www.pharmasources.com/industryinsights/australian-researchers-develop-novel-the-297480.html 0.6 2026-01-15T08:01:27+08:00 daily https://www.pharmasources.com/industryinsights/road-map-to-modernized-production-of-lif-297481.html 0.6 2026-07-08T08:03:42+08:00 daily https://www.pharmasources.com/industryinsights/new-microchip-technology-could-be-used-t-297482.html 0.6 2026-03-17T20:22:51+08:00 daily https://www.pharmasources.com/industryinsights/bc-platforms-launches-global-genomics-an-297483.html 0.6 2026-07-16T23:47:59+08:00 daily https://www.pharmasources.com/industryinsights/magnetic-cellular-legos-for-the-regenera-297484.html 0.6 2026-02-15T00:34:41+08:00 daily https://www.pharmasources.com/industryinsights/merck-project-data-sphere-to-pioneer-glo-297485.html 0.6 2025-11-07T04:54:03+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-names-john-fowl-297486.html 0.6 2026-06-02T08:59:32+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-is-a-reversible-conditio-297487.html 0.6 2025-11-10T21:30:48+08:00 daily https://www.pharmasources.com/industryinsights/uk-collaboration-presents-promising-data-297488.html 0.6 2026-06-22T01:01:32+08:00 daily https://www.pharmasources.com/industryinsights/sanofiregeneron-new-asthma-data-bolstere-297489.html 0.6 2026-01-13T19:28:55+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-proves-long-term-effic-297490.html 0.6 2026-05-29T08:20:20+08:00 daily https://www.pharmasources.com/industryinsights/23andme-raises-250m-in-financing-researc-297491.html 0.6 2026-07-06T15:35:06+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-nod-to-market-generic--297492.html 0.6 2026-08-08T01:08:36+08:00 daily https://www.pharmasources.com/industryinsights/ministry-of-ayush-conducts-online-articl-297493.html 0.6 2026-06-09T01:51:13+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-findings-from-phase-iii--297494.html 0.6 2026-03-08T19:53:57+08:00 daily https://www.pharmasources.com/industryinsights/aurigene-curis-to-expand-ca-170-clinical-297495.html 0.6 2025-12-28T14:16:07+08:00 daily https://www.pharmasources.com/industryinsights/janssen-to-stop-further-development-of-j-297496.html 0.6 2026-08-09T01:55:20+08:00 daily https://www.pharmasources.com/industryinsights/pascal-biosciences-acquires-stc-technolo-297497.html 0.6 2026-08-07T12:17:51+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-to-develop-and-commercial-297498.html 0.6 2026-08-08T20:42:35+08:00 daily https://www.pharmasources.com/industryinsights/neuraltus-university-of-hawaii-initiate--297499.html 0.6 2026-08-07T03:18:15+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-treated-in-expansion-cohor-297500.html 0.6 2026-01-30T15:20:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-unanimously-endorses-glaxos-sh-297501.html 0.6 2026-08-08T14:53:05+08:00 daily https://www.pharmasources.com/industryinsights/can-the-culprit-for-cancer-spreading-als-297502.html 0.6 2026-07-08T07:17:19+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-matching-platform-raises--297503.html 0.6 2026-06-21T06:55:22+08:00 daily https://www.pharmasources.com/industryinsights/easd-boehringer-ingelheim-lillys-jardian-297504.html 0.6 2026-06-20T17:56:26+08:00 daily https://www.pharmasources.com/industryinsights/flight-training-to-provide-continuing-ed-297505.html 0.6 2026-06-21T08:00:10+08:00 daily https://www.pharmasources.com/industryinsights/gsks-shingles-vaccine-gets-unanimous-rec-297506.html 0.6 2026-06-25T20:55:22+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-cut-3500-jobs-globally-shut-297507.html 0.6 2026-07-10T16:03:40+08:00 daily https://www.pharmasources.com/industryinsights/india-and-japan-join-hands-for-stem-cell-297508.html 0.6 2026-07-20T11:50:27+08:00 daily https://www.pharmasources.com/industryinsights/researchers-design-a-paper-based-test-fo-297509.html 0.6 2026-06-21T00:44:31+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-joins-the-abpi-as-a-full-me-297510.html 0.6 2026-06-21T10:58:23+08:00 daily https://www.pharmasources.com/industryinsights/cci-to-study-pricing-issue-in-pharma-hea-297511.html 0.6 2026-06-21T13:08:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approved-drug-may-block-resistance-t-297512.html 0.6 2026-06-22T02:53:35+08:00 daily https://www.pharmasources.com/industryinsights/lupin-pharmaceuticals-recalls-12888-bott-297513.html 0.6 2025-12-11T21:50:44+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-drug-provides-significan-297514.html 0.6 2026-06-22T18:42:15+08:00 daily https://www.pharmasources.com/industryinsights/idma-nsf-programme-to-inaugurate-on-sept-297515.html 0.6 2026-06-21T10:39:57+08:00 daily https://www.pharmasources.com/industryinsights/concept-life-sciences-expands-into-alder-297516.html 0.6 2026-06-22T07:49:25+08:00 daily https://www.pharmasources.com/industryinsights/jesper-ericsson-appointed-new-ceo-of-sym-297517.html 0.6 2026-06-21T13:14:37+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-opens-new-cell-culture-process--297518.html 0.6 2026-08-08T10:58:49+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-halozyme-enter--297519.html 0.6 2025-11-11T11:25:37+08:00 daily https://www.pharmasources.com/industryinsights/monopar-receives-licence-to-develop-onxe-297520.html 0.6 2026-06-21T01:00:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-forxiga-displays-potential--297521.html 0.6 2026-06-21T08:49:53+08:00 daily https://www.pharmasources.com/industryinsights/agenebio-receives-nih-grant-for-mild-cog-297522.html 0.6 2026-06-20T22:15:00+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-aspen-enter-agreement-for-re-297523.html 0.6 2026-06-20T23:44:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-gives-gsks-shingrix-unanimous--297524.html 0.6 2026-06-21T04:53:37+08:00 daily https://www.pharmasources.com/industryinsights/oncolytics-biotech-announces-first-patie-297525.html 0.6 2026-06-21T05:11:11+08:00 daily https://www.pharmasources.com/industryinsights/novos-xultophy-beats-basal-insulin-in-cu-297526.html 0.6 2026-07-10T00:11:26+08:00 daily https://www.pharmasources.com/industryinsights/pharma-bro-shkreli-heads-to-jail-297527.html 0.6 2026-06-22T03:45:24+08:00 daily https://www.pharmasources.com/industryinsights/moderna-initiates-chikungunya-vaccine-hu-297528.html 0.6 2026-07-08T18:28:35+08:00 daily https://www.pharmasources.com/industryinsights/how-seaweed-could-help-heal-traumatic-br-297529.html 0.6 2026-05-27T03:13:28+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-lexicon-trot-out-more-data-backin-297530.html 0.6 2026-06-20T21:53:36+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-intelligence-firm-launches-int-297531.html 0.6 2026-08-04T14:13:52+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-allergan-win-fda-nod-for-biosi-297532.html 0.6 2026-06-21T10:24:13+08:00 daily https://www.pharmasources.com/industryinsights/efficacy-of-philips-stellarex-035-low-do-297533.html 0.6 2026-06-20T18:19:57+08:00 daily https://www.pharmasources.com/industryinsights/volition-granted-four-additional-patents-297534.html 0.6 2026-06-22T20:58:03+08:00 daily https://www.pharmasources.com/industryinsights/csl-behring-announces-fda-approval-of-pr-297535.html 0.6 2026-06-22T11:12:48+08:00 daily https://www.pharmasources.com/industryinsights/startup-antidote-raises-11m-297536.html 0.6 2026-06-21T23:57:45+08:00 daily https://www.pharmasources.com/industryinsights/bridgebio-pharma-gets-135m-for-genetic-d-297537.html 0.6 2026-06-21T05:03:42+08:00 daily https://www.pharmasources.com/industryinsights/golden-equator-launches-healthcare-incub-297538.html 0.6 2026-06-20T14:20:03+08:00 daily https://www.pharmasources.com/industryinsights/mydoc-receives-investment-from-ust-globa-297539.html 0.6 2026-07-09T19:22:04+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-collaborates-with-e-297540.html 0.6 2026-07-20T05:25:20+08:00 daily https://www.pharmasources.com/industryinsights/mri-succeed-in-detecting-breast-cancers--297541.html 0.6 2026-06-20T14:47:04+08:00 daily https://www.pharmasources.com/industryinsights/new-method-allows-one-vaccine-injection--297542.html 0.6 2026-06-22T05:30:47+08:00 daily https://www.pharmasources.com/industryinsights/mvasi-approved-as-the-first-biosimilar-i-297543.html 0.6 2026-06-22T06:54:43+08:00 daily https://www.pharmasources.com/industryinsights/concept-life-sciences-expands-into-alder-297544.html 0.6 2026-08-06T00:08:43+08:00 daily https://www.pharmasources.com/industryinsights/md-anderson-daiichi-sankyo-collaborate-t-297545.html 0.6 2026-06-21T21:49:59+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-medical-care-unveils-malaysias-297546.html 0.6 2026-08-02T00:04:27+08:00 daily https://www.pharmasources.com/industryinsights/exciting-discovery-on-path-to-develop-ne-297547.html 0.6 2026-06-23T08:42:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-sets-new-benchmark-in--297548.html 0.6 2026-08-07T13:55:49+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receives-prostate-cancer-drug-boo-297549.html 0.6 2026-08-07T13:15:17+08:00 daily https://www.pharmasources.com/industryinsights/gsk-receives-positive-opinion-for-triple-297550.html 0.6 2026-08-07T00:02:26+08:00 daily https://www.pharmasources.com/industryinsights/five-firms-named-in-breaches-of-abpi-cod-297551.html 0.6 2026-08-06T23:55:34+08:00 daily https://www.pharmasources.com/industryinsights/most-hcps-not-aware-of-accelerated-acces-297552.html 0.6 2026-08-06T23:47:34+08:00 daily https://www.pharmasources.com/industryinsights/ispe-launches-new-website-297553.html 0.6 2026-08-06T20:00:18+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-bayers-drug-for-follicul-297554.html 0.6 2026-08-06T22:08:29+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astellas-prostate-cancer-drug-pro-297555.html 0.6 2026-08-06T22:20:46+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-silver-falcon-adcock-ingra-297556.html 0.6 2026-08-06T22:28:15+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-pivot-pharmaceuticals-in-297557.html 0.6 2026-08-07T13:19:39+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-and-halozyme-to-develop-su-297558.html 0.6 2026-06-22T07:02:47+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-mars-innovation-launch-new-dr-297559.html 0.6 2026-07-19T12:13:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-adults-wi-297560.html 0.6 2026-08-03T15:19:27+08:00 daily https://www.pharmasources.com/industryinsights/baricitinib-meets-primary-endpoint-in-ph-297561.html 0.6 2026-06-22T13:05:07+08:00 daily https://www.pharmasources.com/industryinsights/lillyincytes-baricitinib-musters-mixed-d-297562.html 0.6 2026-06-20T22:16:21+08:00 daily https://www.pharmasources.com/industryinsights/cash-strapped-teva-closes-in-on-womens-h-297563.html 0.6 2026-06-20T23:15:04+08:00 daily https://www.pharmasources.com/industryinsights/samsung-wins-first-chmp-backing-for-a-he-297564.html 0.6 2026-06-20T14:59:13+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-recipients-of-the-grant--297565.html 0.6 2026-07-07T18:05:29+08:00 daily https://www.pharmasources.com/industryinsights/india-and-japan-sign-15-agreements-inclu-297566.html 0.6 2026-06-22T10:01:49+08:00 daily https://www.pharmasources.com/industryinsights/ageing-population-in-asia-to-provide-new-297567.html 0.6 2026-06-20T19:48:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-puts-clinical-hold-on-cellectis-car--297568.html 0.6 2026-06-22T22:07:00+08:00 daily https://www.pharmasources.com/industryinsights/india-and-japan-sign-mou-for-the-expansi-297569.html 0.6 2026-06-23T01:24:50+08:00 daily https://www.pharmasources.com/industryinsights/mustang-bio-and-fred-hutchinson-cancer-r-297570.html 0.6 2026-06-22T06:44:43+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-announce-results-fo-297571.html 0.6 2026-08-05T10:44:45+08:00 daily https://www.pharmasources.com/industryinsights/chemotherapy-pain-may-be-eased-by-jet-la-297572.html 0.6 2026-06-20T20:55:46+08:00 daily https://www.pharmasources.com/industryinsights/cypralis-granted-new-innovate-uk-feasibi-297573.html 0.6 2026-04-13T02:51:23+08:00 daily https://www.pharmasources.com/industryinsights/novel-combination-therapy-for-cancer-ide-297574.html 0.6 2026-06-21T03:14:52+08:00 daily https://www.pharmasources.com/industryinsights/ineos-styrolution-presents-innovative-so-297575.html 0.6 2026-07-04T17:28:07+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-collaboration--297576.html 0.6 2026-07-19T10:45:06+08:00 daily https://www.pharmasources.com/industryinsights/cells-programmed-like-computers-to-fight-297577.html 0.6 2026-06-21T13:05:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-xolair-shows-strong-retreatment-297578.html 0.6 2026-08-09T16:58:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-medical-app-for-use-i-297579.html 0.6 2026-06-21T15:01:47+08:00 daily https://www.pharmasources.com/industryinsights/chinas-fosun-group-acquired-74-stake-in--297580.html 0.6 2026-08-05T00:57:21+08:00 daily https://www.pharmasources.com/industryinsights/bayer-lymphoma-treatment-speeds-to-fda-a-297581.html 0.6 2026-06-22T23:07:59+08:00 daily https://www.pharmasources.com/industryinsights/chmp-backs-13-treatments-for-eu-approval-297582.html 0.6 2026-06-27T03:51:44+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-hit-by-cancer-immunother-297583.html 0.6 2026-06-30T22:25:49+08:00 daily https://www.pharmasources.com/industryinsights/bayers-rare-cancer-drug-aliqopa-bags-spe-297584.html 0.6 2026-07-31T12:02:40+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-first-line-use-of-roches-ga-297585.html 0.6 2026-08-08T01:14:45+08:00 daily https://www.pharmasources.com/industryinsights/fosun-pharma-to-acquire-74-per-cent-stak-297586.html 0.6 2026-03-22T15:27:51+08:00 daily https://www.pharmasources.com/industryinsights/zydus-nesher-pharma-gets-us-fda-nods-for-297587.html 0.6 2026-06-21T12:59:31+08:00 daily https://www.pharmasources.com/industryinsights/lupin-appoints-jim-loerop-as-chief-corpo-297588.html 0.6 2026-06-20T23:55:37+08:00 daily https://www.pharmasources.com/industryinsights/advanced-gmp-workshops-2017-to-be-held-a-297589.html 0.6 2026-06-20T17:47:00+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-allergans-anti-cancer-biosimil-297590.html 0.6 2026-07-01T16:26:20+08:00 daily https://www.pharmasources.com/industryinsights/aspen-to-acquire-remaining-rights-to-ast-297591.html 0.6 2026-01-04T12:01:11+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-innoviva-receive-positive-opinio-297592.html 0.6 2026-07-28T14:00:28+08:00 daily https://www.pharmasources.com/industryinsights/delmar-receives-ind-allowance-from-fda-t-297593.html 0.6 2026-06-21T10:04:11+08:00 daily https://www.pharmasources.com/industryinsights/study-memeds-blood-test-distinguishes-be-297594.html 0.6 2026-07-02T00:24:31+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regenerons-dupixent-scores-a--297595.html 0.6 2026-06-27T14:15:49+08:00 daily https://www.pharmasources.com/industryinsights/doctor-evidence-to-be-subscription-softw-297596.html 0.6 2026-06-20T17:51:19+08:00 daily https://www.pharmasources.com/industryinsights/summary-of-development-process-of-antibo-297597.html 0.6 2026-06-23T14:45:31+08:00 daily https://www.pharmasources.com/industryinsights/review-of-2017-h1-of-the-biological-phar-297598.html 0.6 2026-07-07T19:10:15+08:00 daily https://www.pharmasources.com/industryinsights/nacimbio-signs-agreement-with-mylan-labo-297599.html 0.6 2026-06-20T21:40:15+08:00 daily https://www.pharmasources.com/industryinsights/jim-loerop-appointed-as-chief-corporate--297600.html 0.6 2026-06-21T17:51:57+08:00 daily https://www.pharmasources.com/industryinsights/fosun-pharma-cuts-stake-to-74-in-gland-p-297601.html 0.6 2026-06-20T23:11:10+08:00 daily https://www.pharmasources.com/industryinsights/teva-to-sell-its-remaining-women-health--297602.html 0.6 2026-06-21T06:21:16+08:00 daily https://www.pharmasources.com/industryinsights/orion-health-joins-hand-with-singapores--297603.html 0.6 2026-06-21T19:18:50+08:00 daily https://www.pharmasources.com/industryinsights/siemens-collaborates-with-tsinghua-for-r-297604.html 0.6 2026-06-20T17:45:06+08:00 daily https://www.pharmasources.com/industryinsights/alere-and-find-introduce-new-diagnostic--297605.html 0.6 2026-06-21T23:04:46+08:00 daily https://www.pharmasources.com/industryinsights/hiv-epidemic-control-to-be-achieved-by-2-297606.html 0.6 2026-06-22T05:48:25+08:00 daily https://www.pharmasources.com/industryinsights/fluorescent-cells-grown-using-cmos-image-297607.html 0.6 2026-06-21T09:10:14+08:00 daily https://www.pharmasources.com/industryinsights/beta-blocker-therapy-after-heart-attack--297608.html 0.6 2026-06-21T02:03:38+08:00 daily https://www.pharmasources.com/industryinsights/epivax-to-use-immune-history-to-protect--297609.html 0.6 2026-07-07T18:09:01+08:00 daily https://www.pharmasources.com/industryinsights/winners-of-the-first-asia-proper-johnson-297610.html 0.6 2026-06-21T03:59:46+08:00 daily https://www.pharmasources.com/industryinsights/ipf-world-week-2017-boehringer-ingelheim-297611.html 0.6 2026-06-21T10:10:13+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-abbvies-leukaemia-combo-smashe-297612.html 0.6 2026-06-21T09:59:11+08:00 daily https://www.pharmasources.com/industryinsights/janssen-reveals-positive-chmp-opinion-lo-297613.html 0.6 2026-08-06T23:31:55+08:00 daily https://www.pharmasources.com/industryinsights/roche-added-to-the-hold-group-by-fda-for-297614.html 0.6 2026-08-06T20:22:38+08:00 daily https://www.pharmasources.com/industryinsights/janssens-guselkumab-shows-long-term-bene-297615.html 0.6 2026-06-21T07:16:10+08:00 daily https://www.pharmasources.com/industryinsights/gsk-innoviva-announce-us-nod-for-trelegy-297616.html 0.6 2026-06-22T00:02:45+08:00 daily https://www.pharmasources.com/industryinsights/aplagon-partners-with-cadila-pharmaceuti-297617.html 0.6 2026-06-20T21:51:33+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-acquire-cook-pharmica-for-95-297618.html 0.6 2026-01-10T03:59:45+08:00 daily https://www.pharmasources.com/industryinsights/nominations-open-for-two-prestigious-pha-297619.html 0.6 2026-06-21T09:08:18+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-laboratory-free-297620.html 0.6 2026-06-20T22:17:24+08:00 daily https://www.pharmasources.com/industryinsights/gates-foundation-supports-development-of-297621.html 0.6 2026-06-20T15:10:26+08:00 daily https://www.pharmasources.com/industryinsights/teva-to-sell-assets-in-global-womens-hea-297622.html 0.6 2026-08-08T01:19:41+08:00 daily https://www.pharmasources.com/industryinsights/nus-study-shows-artemisinin-ala-co-treat-297623.html 0.6 2026-06-30T06:43:49+08:00 daily https://www.pharmasources.com/industryinsights/dolcas-bcm-95-anti-chemoresistance-study-297624.html 0.6 2026-06-21T16:02:22+08:00 daily https://www.pharmasources.com/industryinsights/walgreens-boots-alliance-secures-clearan-297625.html 0.6 2026-07-03T06:36:52+08:00 daily https://www.pharmasources.com/industryinsights/new-investigation-advises-doctors-to-rec-297626.html 0.6 2026-06-30T16:27:13+08:00 daily https://www.pharmasources.com/industryinsights/inovio-geneone-to-test-mers-vaccine-in-s-297627.html 0.6 2026-06-20T17:56:33+08:00 daily https://www.pharmasources.com/industryinsights/aerie-raids-alcon-again-returning-this-t-297628.html 0.6 2026-06-22T03:56:43+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-needing-a-sales-surge-wi-297629.html 0.6 2026-06-26T03:50:16+08:00 daily https://www.pharmasources.com/industryinsights/activate-and-firstbeat-ink-multimillion--297630.html 0.6 2026-06-20T14:45:36+08:00 daily https://www.pharmasources.com/industryinsights/the-world-is-running-out-of-antibiotics--297631.html 0.6 2026-06-20T14:51:13+08:00 daily https://www.pharmasources.com/industryinsights/symbio-receives-licensing-rights-from-ea-297632.html 0.6 2026-06-21T04:08:49+08:00 daily https://www.pharmasources.com/industryinsights/andrew-witty-joins-hatteras-venture-part-297633.html 0.6 2026-06-21T08:54:13+08:00 daily https://www.pharmasources.com/industryinsights/australia-launches-national-cancer-progr-297634.html 0.6 2026-06-20T15:10:23+08:00 daily https://www.pharmasources.com/industryinsights/cwcf-introduces-app-for-ovarian-cancer-p-297635.html 0.6 2026-07-07T01:14:38+08:00 daily https://www.pharmasources.com/industryinsights/medtronics-next-generation-spinal-cord-s-297636.html 0.6 2026-06-21T21:01:42+08:00 daily https://www.pharmasources.com/industryinsights/quality-control-method-to-select-effecti-297637.html 0.6 2026-06-20T18:05:31+08:00 daily https://www.pharmasources.com/industryinsights/proposed-guidelines-for-handling-car-t-c-297638.html 0.6 2026-06-23T05:54:21+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccine-associated-with-improved-fer-297639.html 0.6 2026-06-20T15:55:26+08:00 daily https://www.pharmasources.com/industryinsights/second-successful-fda-inspection-for-hum-297640.html 0.6 2026-06-21T04:56:47+08:00 daily https://www.pharmasources.com/industryinsights/fujitsus-world-first-hands-free-speech-t-297641.html 0.6 2026-07-17T11:12:31+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-way-to-convert-bad-body--297642.html 0.6 2026-06-21T17:50:15+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-goes-to-court-to-allow-competitio-297643.html 0.6 2026-06-21T06:00:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-scores-eu-approval-in-acute-mye-297644.html 0.6 2026-07-20T13:50:24+08:00 daily https://www.pharmasources.com/industryinsights/gates-foundation-invest-in-immunocore-wa-297645.html 0.6 2026-07-17T02:25:11+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-development-is-inadequate-to--297646.html 0.6 2026-06-21T09:00:57+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-to-finally-be-made-available--297647.html 0.6 2026-06-21T00:57:48+08:00 daily https://www.pharmasources.com/industryinsights/uk-firms-link-to-develop-adcs-for-cancer-297648.html 0.6 2026-07-07T02:07:37+08:00 daily https://www.pharmasources.com/industryinsights/shires-intuniv-hits-targets-in-adult-adh-297649.html 0.6 2026-06-21T12:06:17+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-opdivo-for-lung-cancer-297650.html 0.6 2026-06-21T05:00:44+08:00 daily https://www.pharmasources.com/industryinsights/krber-plans-takeover-of-systec-services--297651.html 0.6 2026-08-08T02:09:47+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-receives-anda-approval-f-297652.html 0.6 2026-06-21T09:34:18+08:00 daily https://www.pharmasources.com/industryinsights/russia-and-india-embark-on-the-transfer--297653.html 0.6 2026-06-22T07:01:51+08:00 daily https://www.pharmasources.com/industryinsights/turacoz-healthcare-solutions-acceliant-p-297654.html 0.6 2026-08-08T18:14:33+08:00 daily https://www.pharmasources.com/industryinsights/zydus-and-pharm-aid-enter-deal-for-varic-297655.html 0.6 2026-06-21T01:01:51+08:00 daily https://www.pharmasources.com/industryinsights/new-study-suggests-jet-lag-drug-benefits-297656.html 0.6 2026-07-01T10:07:39+08:00 daily https://www.pharmasources.com/industryinsights/catalent-signs-agreement-to-buy-cook-pha-297657.html 0.6 2026-06-20T20:58:34+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-announces-nidcr-sbir-grant-awa-297658.html 0.6 2026-08-07T19:12:48+08:00 daily https://www.pharmasources.com/industryinsights/how-poliovirus-unleashes-an-attack-on-gl-297659.html 0.6 2026-06-20T23:17:59+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-leads-big-pharmas-emerging-market-297660.html 0.6 2026-08-07T01:18:51+08:00 daily https://www.pharmasources.com/industryinsights/terumo-bct-expands-collaboration-with-ma-297661.html 0.6 2026-08-07T01:10:40+08:00 daily https://www.pharmasources.com/industryinsights/dr-james-ostell-appointed-as-the-directo-297662.html 0.6 2026-08-07T01:06:43+08:00 daily https://www.pharmasources.com/industryinsights/inverness-campus-to-get-new-45million-li-297663.html 0.6 2026-08-07T01:14:22+08:00 daily https://www.pharmasources.com/industryinsights/indian-oil-and-lanza-tech-to-construct-w-297664.html 0.6 2026-08-07T05:37:07+08:00 daily https://www.pharmasources.com/industryinsights/esr-plans-investment-in-biotech-start-up-297665.html 0.6 2026-08-07T05:39:38+08:00 daily https://www.pharmasources.com/industryinsights/hku-researchers-connect-liver-cancer-wit-297666.html 0.6 2026-08-07T05:45:48+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-raises-series-b-funding-297667.html 0.6 2026-08-07T05:49:08+08:00 daily https://www.pharmasources.com/industryinsights/romosozumab-provides-protection-against--297668.html 0.6 2026-08-07T05:59:18+08:00 daily https://www.pharmasources.com/industryinsights/tecan-offers-walkaway-automation-for-bio-297669.html 0.6 2026-06-21T18:11:33+08:00 daily https://www.pharmasources.com/industryinsights/poliovirus-therapy-induces-immune-respon-297670.html 0.6 2026-06-12T22:22:33+08:00 daily https://www.pharmasources.com/industryinsights/steroid-inhalers-increase-the-risk-of-ha-297671.html 0.6 2026-06-20T15:13:27+08:00 daily https://www.pharmasources.com/industryinsights/acceliant-turacoz-healthcare-solutions-e-297672.html 0.6 2026-06-21T22:09:53+08:00 daily https://www.pharmasources.com/industryinsights/aplagon-and-cadila-pharmaceuticals-to-de-297673.html 0.6 2026-03-21T18:58:00+08:00 daily https://www.pharmasources.com/industryinsights/new-scholarships-worth-eur-417000-awarde-297674.html 0.6 2026-06-19T23:46:48+08:00 daily https://www.pharmasources.com/industryinsights/danish-discovery-can-pave-the-way-for-mo-297675.html 0.6 2026-08-05T20:09:12+08:00 daily https://www.pharmasources.com/industryinsights/weight-loss-drugs-could-be-used-to-treat-297676.html 0.6 2026-07-20T13:28:58+08:00 daily https://www.pharmasources.com/industryinsights/witty-ex-ceo-of-gsk-keeps-busy-with-two--297677.html 0.6 2026-06-21T04:14:54+08:00 daily https://www.pharmasources.com/industryinsights/report-finds-variation-in-quality-of-car-297678.html 0.6 2026-06-22T07:54:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizers-joint-skin-cancer-drug-297679.html 0.6 2026-02-06T17:22:23+08:00 daily https://www.pharmasources.com/industryinsights/mercks-ms-pill-mavenclad-launched-in-the-297680.html 0.6 2026-08-06T17:55:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-alnylams-rnai-therapeutic-smashes-297681.html 0.6 2026-07-27T08:44:47+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-files-lawsuit-against-jjs-exclusi-297682.html 0.6 2026-06-21T01:00:45+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-and-roche-sign-agreement-to-ma-297683.html 0.6 2026-06-22T12:22:55+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-bristol-myers-squibbs-ni-297684.html 0.6 2026-07-18T17:42:42+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-nih-researchers-develop-three-in--297685.html 0.6 2026-07-24T06:44:23+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-bavencio-297686.html 0.6 2026-06-22T18:16:47+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-announces-licensing-agree-297687.html 0.6 2026-06-20T07:10:36+08:00 daily https://www.pharmasources.com/industryinsights/audentes-therapeutics-announces-dosing-o-297688.html 0.6 2026-07-03T23:26:52+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-reverses-symptoms-slows-pro-297689.html 0.6 2026-06-21T04:11:55+08:00 daily https://www.pharmasources.com/industryinsights/janssen-deal-gives-new-kid-in-town-prove-297690.html 0.6 2026-04-06T17:57:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-merck-kgaa-grab-eu-approval-for-p-297691.html 0.6 2026-08-06T04:50:58+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-announces-construction-o-297692.html 0.6 2026-08-01T08:59:23+08:00 daily https://www.pharmasources.com/industryinsights/arkis-biosciences-receives-fda-clearance-297693.html 0.6 2026-08-06T02:24:08+08:00 daily https://www.pharmasources.com/industryinsights/indivumed-partners-with-cancer-research--297694.html 0.6 2026-03-19T09:43:55+08:00 daily https://www.pharmasources.com/industryinsights/nektar-therapeutics-appoints-mr-jeff-aje-297695.html 0.6 2026-07-18T02:49:13+08:00 daily https://www.pharmasources.com/industryinsights/ucb-receives-eu-approval-for-paediatric--297696.html 0.6 2026-06-23T21:46:04+08:00 daily https://www.pharmasources.com/industryinsights/tlr-agonists-suppress-tumour-growth-297697.html 0.6 2026-06-21T05:12:52+08:00 daily https://www.pharmasources.com/industryinsights/cycle-pharmaceuticals-ketorolac-trometha-297698.html 0.6 2026-06-20T14:13:38+08:00 daily https://www.pharmasources.com/industryinsights/activate-and-firstbeat-enter-multimillio-297699.html 0.6 2025-11-11T04:59:05+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-bristol-myers-squibb-announce-297700.html 0.6 2026-06-21T11:20:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-the-max-foundation-transfor-297701.html 0.6 2026-06-21T01:14:56+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-soars-on-likely-first-rnai-treat-297702.html 0.6 2026-06-20T18:16:46+08:00 daily https://www.pharmasources.com/industryinsights/19-deaths-from-liver-drug-causes-interce-297703.html 0.6 2025-11-10T12:59:34+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-bayers-eylea-for-myopic--297704.html 0.6 2026-07-09T15:12:13+08:00 daily https://www.pharmasources.com/industryinsights/eu-allows-use-of-ucbs-anti-epileptic-vim-297705.html 0.6 2026-07-06T03:43:07+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-new-eylea-indication-297706.html 0.6 2026-07-02T14:03:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-kevzara-will-be-funded-for-nhs-u-297707.html 0.6 2026-06-22T00:43:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-warning-on-intercepts-ocaliva-after--297708.html 0.6 2026-06-22T03:48:32+08:00 daily https://www.pharmasources.com/industryinsights/labcentral-pfizer-to-open-next-stage-fac-297709.html 0.6 2026-06-21T12:45:32+08:00 daily https://www.pharmasources.com/industryinsights/werum-it-solutions-and-sarla-technologie-297710.html 0.6 2026-06-20T16:53:25+08:00 daily https://www.pharmasources.com/industryinsights/nci-awards-contract-to-pact-health-of-br-297711.html 0.6 2026-06-21T08:00:06+08:00 daily https://www.pharmasources.com/industryinsights/oncoqr-mls-vaccine-platform-closes-the-f-297712.html 0.6 2026-06-21T03:42:29+08:00 daily https://www.pharmasources.com/industryinsights/zydus-pharma-recalls-44800-bottles-of-an-297713.html 0.6 2026-06-20T19:18:57+08:00 daily https://www.pharmasources.com/industryinsights/orchid-pharma-gets-eir-from-us-fda-for-i-297714.html 0.6 2026-06-20T19:33:27+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-launches-triple-qua-297715.html 0.6 2026-06-20T14:53:04+08:00 daily https://www.pharmasources.com/industryinsights/gsk-joins-astrazeneca-and-labcyte-to-dev-297716.html 0.6 2026-06-20T15:53:25+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-aspen-global-incorporate-297717.html 0.6 2026-06-20T20:18:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-rydapt-receives-approval-for-tw-297718.html 0.6 2026-06-20T14:57:13+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-catalent-ultragenyx-pharma-297719.html 0.6 2026-08-03T06:34:42+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-bristol-myers-squibb-announce-cli-297720.html 0.6 2026-06-21T07:17:34+08:00 daily https://www.pharmasources.com/industryinsights/natera-selected-for-circulating-tumor-dn-297721.html 0.6 2026-06-21T08:57:02+08:00 daily https://www.pharmasources.com/industryinsights/250-million-plant-breaks-ground-in-melro-297722.html 0.6 2026-06-21T04:17:29+08:00 daily https://www.pharmasources.com/industryinsights/shineco-inc-enters-into-strategic-cooper-297723.html 0.6 2026-06-22T00:48:58+08:00 daily https://www.pharmasources.com/industryinsights/researchers-from-the-duke-university-say-297724.html 0.6 2026-06-20T22:01:39+08:00 daily https://www.pharmasources.com/industryinsights/cphi-korea-reveals-growth-of-domestic-ph-297725.html 0.6 2026-06-20T21:06:51+08:00 daily https://www.pharmasources.com/industryinsights/merck-opens-bio-development-centre-in-sh-297726.html 0.6 2026-06-30T03:33:24+08:00 daily https://www.pharmasources.com/industryinsights/angptl4-patch-may-improve-hard-to-heal-s-297727.html 0.6 2026-06-21T03:16:57+08:00 daily https://www.pharmasources.com/industryinsights/national-physical-laboratory-re-launched-297728.html 0.6 2026-04-18T17:26:33+08:00 daily https://www.pharmasources.com/industryinsights/glythera-and-iontas-to-collaborate-for-d-297729.html 0.6 2026-06-21T01:12:55+08:00 daily https://www.pharmasources.com/industryinsights/merck-milliporesigma-announces-opening-o-297730.html 0.6 2026-06-20T14:48:05+08:00 daily https://www.pharmasources.com/industryinsights/amgen-foundation-pledges-up-to-5-million-297731.html 0.6 2026-06-20T22:53:37+08:00 daily https://www.pharmasources.com/industryinsights/bevespi-aerosphere-demonstrates-statisti-297732.html 0.6 2026-07-20T08:21:02+08:00 daily https://www.pharmasources.com/industryinsights/allergan-posts-disappointing-data-in-nas-297733.html 0.6 2026-06-21T05:14:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-arthritis-treatment-kevzara-secu-297734.html 0.6 2026-06-20T21:12:47+08:00 daily https://www.pharmasources.com/industryinsights/super-malaria-sweeps-south-east-asia-297735.html 0.6 2026-06-20T19:59:40+08:00 daily https://www.pharmasources.com/industryinsights/indivior-reaches-settlement-with-mylan-o-297736.html 0.6 2026-06-21T19:54:31+08:00 daily https://www.pharmasources.com/industryinsights/eu-green-light-for-roches-tecentriq-297737.html 0.6 2026-06-21T05:11:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-janssens-plivensia-297738.html 0.6 2026-06-20T15:09:20+08:00 daily https://www.pharmasources.com/industryinsights/aegerion-pleads-guilty-to-us-marketing-v-297739.html 0.6 2026-06-20T17:15:29+08:00 daily https://www.pharmasources.com/industryinsights/bayer-backs-new-mobile-eye-unit-in-hamps-297740.html 0.6 2026-06-21T01:56:39+08:00 daily https://www.pharmasources.com/industryinsights/claris-completes-sale-of-its-stake-in-jv-297741.html 0.6 2026-06-20T20:59:42+08:00 daily https://www.pharmasources.com/industryinsights/bioascent-discovery-in-agreement-with-pi-297742.html 0.6 2026-06-22T08:14:03+08:00 daily https://www.pharmasources.com/industryinsights/a-vaidheesh-elected-president-of-oppi-297743.html 0.6 2026-08-08T01:06:07+08:00 daily https://www.pharmasources.com/industryinsights/suven-life-science-gets-neuro-patent-fro-297744.html 0.6 2026-06-21T12:52:17+08:00 daily https://www.pharmasources.com/industryinsights/gsk-pharma-to-sell-land-in-thane-to-ober-297745.html 0.6 2026-04-26T18:57:04+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-receives-accelerated-fda-297746.html 0.6 2026-06-21T07:02:59+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-roches-toci-297747.html 0.6 2026-06-20T20:56:42+08:00 daily https://www.pharmasources.com/industryinsights/oncoqrs-s-tir-vaccine-technology-helps-i-297748.html 0.6 2026-06-21T12:54:32+08:00 daily https://www.pharmasources.com/industryinsights/allergan-receives-refusal-to-file-letter-297749.html 0.6 2026-04-16T23:23:03+08:00 daily https://www.pharmasources.com/industryinsights/criminal-and-civil-actions-filed-against-297750.html 0.6 2026-06-22T11:53:53+08:00 daily https://www.pharmasources.com/industryinsights/the-inaugural-fiercemedtech-fierce-15a-c-297751.html 0.6 2026-06-21T20:58:43+08:00 daily https://www.pharmasources.com/industryinsights/what-pledge-abbvie-executives-may-back-o-297752.html 0.6 2026-08-10T01:23:00+08:00 daily https://www.pharmasources.com/industryinsights/epivax-launches-precision-cancer-immunot-297753.html 0.6 2026-06-20T14:51:04+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-spins-out-biotech-firm-with-103-m-297754.html 0.6 2026-06-20T18:05:25+08:00 daily https://www.pharmasources.com/industryinsights/lintec-announces-ultra-low-migration-lab-297755.html 0.6 2026-07-04T00:56:36+08:00 daily https://www.pharmasources.com/industryinsights/shandong-to-acquire-argon-medical-device-297756.html 0.6 2026-06-20T14:33:31+08:00 daily https://www.pharmasources.com/industryinsights/suven-gets-product-patent-from-india-and-297757.html 0.6 2026-06-21T04:13:50+08:00 daily https://www.pharmasources.com/industryinsights/brammer-bio-expands-cell-and-gene-therap-297758.html 0.6 2026-06-21T12:02:11+08:00 daily https://www.pharmasources.com/industryinsights/ntu-scientists-develop-gel-patch-to-spee-297759.html 0.6 2026-06-20T22:47:59+08:00 daily https://www.pharmasources.com/industryinsights/antimicrobial-test-may-combat-drug-resis-297760.html 0.6 2026-06-21T17:50:17+08:00 daily https://www.pharmasources.com/industryinsights/medtech-sales-to-reach-522bn-by-2022-297761.html 0.6 2026-06-23T20:11:48+08:00 daily https://www.pharmasources.com/industryinsights/prostaglandin-ei-inhibits-leukaemia-stem-297762.html 0.6 2026-06-20T19:01:37+08:00 daily https://www.pharmasources.com/industryinsights/japan-approves-opdivo-the-first-ever-imm-297763.html 0.6 2026-07-17T11:07:13+08:00 daily https://www.pharmasources.com/industryinsights/gymnemic-acid-found-to-battle-sugar-crav-297764.html 0.6 2026-06-21T07:07:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-conducts-major-global-operation-to-p-297765.html 0.6 2026-08-07T09:12:54+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-announces-taneds-global-2-297766.html 0.6 2026-08-07T04:35:16+08:00 daily https://www.pharmasources.com/industryinsights/axovant-shares-capitulate-after-alzheime-297767.html 0.6 2026-06-22T06:58:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-pointedly-rejects-intellipharmas-opi-297768.html 0.6 2026-06-21T09:12:13+08:00 daily https://www.pharmasources.com/industryinsights/cancer-trials-underrepresent-minorities--297769.html 0.6 2026-06-21T06:16:01+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-janssens-symtuza-297770.html 0.6 2026-07-03T00:54:55+08:00 daily https://www.pharmasources.com/industryinsights/allergan-embarks-on-2-billion-share-repu-297771.html 0.6 2026-06-23T10:17:50+08:00 daily https://www.pharmasources.com/industryinsights/glythera-teams-with-cancer-research-uk-297772.html 0.6 2026-06-20T14:58:06+08:00 daily https://www.pharmasources.com/industryinsights/msd-launches-once-daily-isentress-in-the-297773.html 0.6 2026-07-01T16:54:21+08:00 daily https://www.pharmasources.com/industryinsights/idma-nsf-uk-launch-advanced-programme-in-297774.html 0.6 2026-07-09T06:01:29+08:00 daily https://www.pharmasources.com/industryinsights/clariant-launches-amideamine-free-anti-s-297775.html 0.6 2026-06-20T22:09:45+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--297776.html 0.6 2026-06-26T19:08:00+08:00 daily https://www.pharmasources.com/industryinsights/mithra-and-libbs-partner-to-commercialis-297777.html 0.6 2026-06-20T23:59:38+08:00 daily https://www.pharmasources.com/industryinsights/cfda-approves-gileads-sovaldi-for-chroni-297778.html 0.6 2026-06-21T02:12:50+08:00 daily https://www.pharmasources.com/industryinsights/allergan-receives-fdas-rtf-letter-for-vr-297779.html 0.6 2026-07-23T11:47:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-the-max-foundation-to-provi-297780.html 0.6 2026-02-24T02:29:30+08:00 daily https://www.pharmasources.com/industryinsights/medicago-announces-phase-3-study-of-vlp--297781.html 0.6 2026-06-22T10:51:01+08:00 daily https://www.pharmasources.com/industryinsights/lannett-receives-approval-for-dexmethylp-297782.html 0.6 2026-06-20T15:37:07+08:00 daily https://www.pharmasources.com/industryinsights/face-lift-surgery-the-anti-aging-and-lif-297783.html 0.6 2026-06-20T20:19:51+08:00 daily https://www.pharmasources.com/industryinsights/rutgers-scientists-use-genetic-engineeri-297784.html 0.6 2026-06-21T03:01:45+08:00 daily https://www.pharmasources.com/industryinsights/synthace-raises-73m-series-a-round-to-br-297785.html 0.6 2026-06-21T19:11:17+08:00 daily https://www.pharmasources.com/industryinsights/roche-receives-eu-approval-of-tecentriq-297786.html 0.6 2026-08-05T11:56:19+08:00 daily https://www.pharmasources.com/industryinsights/gsk-receives-japanese-nod-for-benylsta-297787.html 0.6 2026-06-21T05:56:47+08:00 daily https://www.pharmasources.com/industryinsights/simcere-amgen-to-bring-in-4-biosimilars--297788.html 0.6 2026-06-30T14:13:17+08:00 daily https://www.pharmasources.com/industryinsights/sri-lankan-medtech-start-up-raises-funds-297789.html 0.6 2026-06-22T04:05:47+08:00 daily https://www.pharmasources.com/industryinsights/korean-scientists-use-bilirubin-nanopart-297790.html 0.6 2026-07-18T23:10:11+08:00 daily https://www.pharmasources.com/industryinsights/pall-life-sciences-introduces-continuous-297791.html 0.6 2026-04-12T05:11:48+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-demonstrates-significant-efficac-297792.html 0.6 2026-07-30T14:13:46+08:00 daily https://www.pharmasources.com/industryinsights/genetic-fault-reduces-the-effectiveness--297793.html 0.6 2026-06-20T15:00:04+08:00 daily https://www.pharmasources.com/industryinsights/wickham-laboratories-announces-successfu-297794.html 0.6 2026-06-20T14:46:10+08:00 daily https://www.pharmasources.com/industryinsights/cyc065-eribulin-combination-for-triple-n-297795.html 0.6 2026-03-20T04:53:47+08:00 daily https://www.pharmasources.com/industryinsights/adc-bio-to-bioconjugation-facility-recei-297796.html 0.6 2026-06-22T00:02:49+08:00 daily https://www.pharmasources.com/industryinsights/up-to-20000-available-to-the-digital-hea-297797.html 0.6 2026-06-21T03:55:36+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-simcere-announce-strategic-col-297798.html 0.6 2026-06-27T15:34:41+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-scores-approvals-in-met-297799.html 0.6 2026-04-04T14:40:07+08:00 daily https://www.pharmasources.com/industryinsights/improved-heart-attack-test-could-save-mi-297800.html 0.6 2026-06-22T02:07:42+08:00 daily https://www.pharmasources.com/industryinsights/ema-relocation-will-cause-drug-approval--297801.html 0.6 2026-08-03T05:47:52+08:00 daily https://www.pharmasources.com/industryinsights/ahsn-develops-kidney-toolkit-for-gps-297802.html 0.6 2026-08-10T01:26:07+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-janssens-sy-297803.html 0.6 2026-06-22T08:04:51+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-and-geisinger-to-develop-risk-297804.html 0.6 2026-07-18T19:50:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-support-plans-for-puerto-r-297805.html 0.6 2026-06-23T13:50:54+08:00 daily https://www.pharmasources.com/industryinsights/lexicon-initiates-patient-dosing-in-lx92-297806.html 0.6 2026-06-14T20:34:53+08:00 daily https://www.pharmasources.com/industryinsights/lannett-receives-fda-approval-for-oxycod-297807.html 0.6 2026-08-07T16:19:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-supplemental-nda-for-lenvati-297808.html 0.6 2026-06-22T01:52:33+08:00 daily https://www.pharmasources.com/industryinsights/bruker-announces-acquisition-of-merlin-297809.html 0.6 2026-03-17T19:00:33+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-expands-plasmid-dna-purifi-297810.html 0.6 2026-06-21T16:17:34+08:00 daily https://www.pharmasources.com/industryinsights/amgen-simcere-to-co-develop-and-commerci-297811.html 0.6 2026-06-21T06:03:54+08:00 daily https://www.pharmasources.com/industryinsights/analytics-4-life-nets-25m-for-ai-based-c-297812.html 0.6 2026-06-21T10:53:10+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-promises-its-sticking-with-ceos-p-297813.html 0.6 2026-08-08T02:22:16+08:00 daily https://www.pharmasources.com/industryinsights/qiagen-announces-first-installation-of-g-297814.html 0.6 2026-06-21T01:13:59+08:00 daily https://www.pharmasources.com/industryinsights/who-launches-new-ncds-progress-monitor-297815.html 0.6 2026-08-02T16:10:09+08:00 daily https://www.pharmasources.com/industryinsights/chinese-researchers-use-traditional-ink--297816.html 0.6 2026-07-01T22:44:13+08:00 daily https://www.pharmasources.com/industryinsights/rutgers-scientists-use-genetic-engineeri-297817.html 0.6 2026-06-21T01:11:51+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-marketing-authorisation-of-dup-297818.html 0.6 2026-06-22T10:43:31+08:00 daily https://www.pharmasources.com/industryinsights/ivermectin-found-to-suppresses-tumour-de-297819.html 0.6 2026-06-26T13:06:21+08:00 daily https://www.pharmasources.com/industryinsights/smart-capsules-make-water-soluble-drug-d-297820.html 0.6 2026-06-21T06:01:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-targets-potentially-dangerous-prescr-297821.html 0.6 2026-06-21T22:52:49+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-uc-berkeley-collaborate-to--297822.html 0.6 2026-08-03T05:42:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-improves-access-to-reports-of-advers-297823.html 0.6 2026-08-06T01:49:41+08:00 daily https://www.pharmasources.com/industryinsights/five-more-biosimilar-free-years-for-abbv-297824.html 0.6 2026-03-19T07:02:02+08:00 daily https://www.pharmasources.com/industryinsights/rates-of-hiv-rise-amongst-older-populati-297825.html 0.6 2026-06-27T05:18:37+08:00 daily https://www.pharmasources.com/industryinsights/roche-chalks-up-swiss-approval-for-multi-297826.html 0.6 2026-07-03T08:49:51+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regenerons-projected-blockbus-297827.html 0.6 2026-07-06T04:53:30+08:00 daily https://www.pharmasources.com/industryinsights/nice-knocks-back-janssens-imbruvica-in-m-297828.html 0.6 2026-06-20T17:10:26+08:00 daily https://www.pharmasources.com/industryinsights/brexit-move-creates-ema-risk-report-297829.html 0.6 2026-06-22T02:00:53+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dupixent-gets-europe-eczema-nod-297830.html 0.6 2026-06-22T21:03:00+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-srikakulam-unit-clears-us-fda--297831.html 0.6 2026-06-22T04:37:23+08:00 daily https://www.pharmasources.com/industryinsights/digital-can-help-bridge-the-growth-gap-f-297832.html 0.6 2026-07-18T17:09:29+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-simcere-partner-to-develop-and-297833.html 0.6 2026-06-21T05:01:45+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-agrees-to-review-eisais-applicati-297834.html 0.6 2026-08-07T02:07:51+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-maviret-receives-japanese-mhlw-a-297835.html 0.6 2026-06-21T00:37:22+08:00 daily https://www.pharmasources.com/industryinsights/pivotal-moments-for-this-years-fierce-15-297836.html 0.6 2026-06-21T01:00:46+08:00 daily https://www.pharmasources.com/industryinsights/novartis-uc-berkeley-join-forces-for-und-297837.html 0.6 2026-07-01T18:04:57+08:00 daily https://www.pharmasources.com/industryinsights/zynerba-soars-on-fragile-x-data-297838.html 0.6 2026-08-04T19:24:43+08:00 daily https://www.pharmasources.com/industryinsights/rna-biotech-arcturus-backs-onto-nasdaq-i-297839.html 0.6 2026-07-27T21:16:48+08:00 daily https://www.pharmasources.com/industryinsights/the-thinking-process-behind-biopharma-co-297840.html 0.6 2026-06-22T06:58:51+08:00 daily https://www.pharmasources.com/industryinsights/cancer-gene-therapy-biotechs-raise-303m--297841.html 0.6 2026-06-22T17:28:42+08:00 daily https://www.pharmasources.com/industryinsights/thanks-to-amgen-biosim-settlement-abbvie-297842.html 0.6 2026-08-08T14:38:09+08:00 daily https://www.pharmasources.com/industryinsights/lilly-steps-up-to-rival-pfizer-novartis--297843.html 0.6 2026-06-21T08:19:12+08:00 daily https://www.pharmasources.com/industryinsights/bring-it-on-pharma-finger-pointing-at-in-297844.html 0.6 2026-06-28T19:35:30+08:00 daily https://www.pharmasources.com/industryinsights/iconic-landmarks-turn-red-for-world-hear-297845.html 0.6 2026-06-20T13:17:45+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-disease-drug-carbidopa-shows--297846.html 0.6 2026-08-07T13:45:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-verzenio-for-metastatic-bre-297847.html 0.6 2026-08-05T16:31:31+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-new-drug-application-to--297848.html 0.6 2026-08-09T01:17:30+08:00 daily https://www.pharmasources.com/industryinsights/us25-million-share-repurchase-programme--297849.html 0.6 2026-08-06T23:08:09+08:00 daily https://www.pharmasources.com/industryinsights/idf-and-novo-nordisk-launch-first-ever-g-297850.html 0.6 2026-06-21T05:07:49+08:00 daily https://www.pharmasources.com/industryinsights/gileads-coo-retires-shares-take-a-dive-297851.html 0.6 2026-06-21T00:55:45+08:00 daily https://www.pharmasources.com/industryinsights/makers-of-immediate-release-opioids-must-297852.html 0.6 2026-06-20T20:05:37+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--297853.html 0.6 2026-06-21T11:54:06+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-natsimbio-in-agreement-for-pro-297854.html 0.6 2026-06-23T02:54:05+08:00 daily https://www.pharmasources.com/industryinsights/hilleman-laboratories-receives-indo-swed-297855.html 0.6 2026-06-09T19:57:41+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-mithra-hainan-haiyao-the-297856.html 0.6 2026-06-20T21:01:40+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-zhejiang-hisoar-pharmaceut-297857.html 0.6 2026-07-04T03:42:59+08:00 daily https://www.pharmasources.com/industryinsights/gsks-benlysta-receives-japanese-mhlw-app-297858.html 0.6 2026-08-06T00:42:37+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-marketing-authorisation-for-sa-297859.html 0.6 2026-06-22T12:59:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-certain-a-297860.html 0.6 2026-06-21T00:53:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-improves-access-to-reports-of-advers-297861.html 0.6 2026-06-21T09:50:00+08:00 daily https://www.pharmasources.com/industryinsights/valeant-pharmaceuticals-completes-sale-o-297862.html 0.6 2026-06-21T03:56:44+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-resolves-humira-patent-disputes-w-297863.html 0.6 2026-08-09T09:36:27+08:00 daily https://www.pharmasources.com/industryinsights/merck-discontinues-mk-3682b-and-mk-3682c-297864.html 0.6 2026-06-15T00:33:55+08:00 daily https://www.pharmasources.com/industryinsights/amag-pharmaceuticals-appoints-chief-comp-297865.html 0.6 2026-07-07T15:40:37+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-bags-expanded-fda-ok-for-heart-297866.html 0.6 2026-06-21T11:46:57+08:00 daily https://www.pharmasources.com/industryinsights/after-roller-coaster-year-abbott-moves-t-297867.html 0.6 2026-06-21T07:02:00+08:00 daily https://www.pharmasources.com/industryinsights/skovronsky-to-take-over-lilly-research-l-297868.html 0.6 2026-08-07T00:37:29+08:00 daily https://www.pharmasources.com/industryinsights/chutes-laddersallergans-finance-overseer-297869.html 0.6 2026-06-20T14:51:07+08:00 daily https://www.pharmasources.com/industryinsights/prothena-scratches-mcam-psoriasis-antibo-297870.html 0.6 2026-07-02T21:13:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-pans-ptcs-post-hoc-pitch-shred-297871.html 0.6 2026-06-22T07:58:51+08:00 daily https://www.pharmasources.com/industryinsights/looking-for-insulin-rebound-novo-nordisk-297872.html 0.6 2026-06-21T04:50:44+08:00 daily https://www.pharmasources.com/industryinsights/as-merck-cans-another-hepatitis-c-projec-297873.html 0.6 2026-06-21T02:07:48+08:00 daily https://www.pharmasources.com/industryinsights/amgens-china-biosim-deal-sovaldis-chines-297874.html 0.6 2026-07-23T00:57:55+08:00 daily https://www.pharmasources.com/industryinsights/institut-pasteur-signs-mou-with-qatars-h-297875.html 0.6 2026-06-22T11:43:26+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-current-situation-of-erythro-297876.html 0.6 2026-08-05T08:04:46+08:00 daily https://www.pharmasources.com/industryinsights/scientists-in-korea-develop-sensor-for-d-297877.html 0.6 2026-08-05T23:31:13+08:00 daily https://www.pharmasources.com/industryinsights/chop-and-uae-health-ministry-sign-mou-297878.html 0.6 2026-06-22T11:55:56+08:00 daily https://www.pharmasources.com/industryinsights/indonesia-to-cooperate-with-japan-for-he-297879.html 0.6 2026-06-21T20:53:44+08:00 daily https://www.pharmasources.com/industryinsights/histoindex-receives-frost-sullivan-2017--297880.html 0.6 2026-06-21T23:13:13+08:00 daily https://www.pharmasources.com/industryinsights/unique-tumour-dna-found-in-blood-to-help-297881.html 0.6 2026-08-08T01:36:32+08:00 daily https://www.pharmasources.com/industryinsights/verge-genomics-joins-special-departments-297882.html 0.6 2026-05-31T05:55:00+08:00 daily https://www.pharmasources.com/industryinsights/abs-plans-to-undertake-human-clinical-tr-297883.html 0.6 2026-06-21T09:02:00+08:00 daily https://www.pharmasources.com/industryinsights/asco-and-friends-of-cancer-research-say--297884.html 0.6 2026-07-31T10:07:53+08:00 daily https://www.pharmasources.com/industryinsights/baylor-genetics-announces-partnership-wi-297885.html 0.6 2026-06-21T21:24:53+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-newly-approved-cancer-drugs--297886.html 0.6 2026-06-21T08:05:59+08:00 daily https://www.pharmasources.com/industryinsights/microcapsules-are-more-efficient-in-geno-297887.html 0.6 2026-06-21T21:44:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-access-to-venclyxto-for--297888.html 0.6 2026-06-21T02:05:42+08:00 daily https://www.pharmasources.com/industryinsights/smart-bandage-could-promote-better-faste-297889.html 0.6 2026-06-21T05:20:16+08:00 daily https://www.pharmasources.com/industryinsights/engineering-approach-combines-drugs-to-c-297890.html 0.6 2026-06-21T05:52:51+08:00 daily https://www.pharmasources.com/industryinsights/alcohol-aversion-drug-disulfiram-may-com-297891.html 0.6 2026-07-18T17:44:52+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-disease-drug-carbidopa-shows--297892.html 0.6 2026-06-21T05:07:46+08:00 daily https://www.pharmasources.com/industryinsights/cancer-id-consortium-finds-first-asian-p-297893.html 0.6 2026-06-20T15:54:01+08:00 daily https://www.pharmasources.com/industryinsights/new-abbvie-biologics-facility-in-singapo-297894.html 0.6 2026-06-21T04:15:54+08:00 daily https://www.pharmasources.com/industryinsights/new-ge-healthcare-3d-printing-lab-aims-t-297895.html 0.6 2026-06-21T04:49:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-insulin-fiasp-by-novo-n-297896.html 0.6 2026-07-02T12:28:46+08:00 daily https://www.pharmasources.com/industryinsights/sparcs-baclofen-grs-fails-to-meet-primar-297897.html 0.6 2026-06-20T18:16:44+08:00 daily https://www.pharmasources.com/industryinsights/iit-roorkee-scientists-identify-drug-to--297898.html 0.6 2026-08-08T23:40:52+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-eir-from-usfda-for-o-297899.html 0.6 2026-08-07T06:14:33+08:00 daily https://www.pharmasources.com/industryinsights/novartis-divests-anti-infectives-brands--297900.html 0.6 2026-06-22T04:57:36+08:00 daily https://www.pharmasources.com/industryinsights/fosun-pharma-acquires-74-per-cent-stake--297901.html 0.6 2026-06-22T11:00:51+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-valeant-pharmaceuticals--297902.html 0.6 2026-06-22T05:12:50+08:00 daily https://www.pharmasources.com/industryinsights/synthons-generic-version-of-copaxone-at--297903.html 0.6 2026-06-20T18:09:25+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-stallergenes-greer-medicur-297904.html 0.6 2026-06-20T20:59:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-kd-297905.html 0.6 2026-06-21T00:09:48+08:00 daily https://www.pharmasources.com/industryinsights/hoping-to-advance-cheaper-pneumonia-vacc-297906.html 0.6 2026-06-20T21:06:54+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-pharma-strikes-a-chord-with-overs-297907.html 0.6 2026-06-20T20:44:23+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-receives-2017-global-integra-297908.html 0.6 2026-02-28T11:23:50+08:00 daily https://www.pharmasources.com/industryinsights/china-accelerates-new-drug-approvals-297909.html 0.6 2026-06-21T03:54:56+08:00 daily https://www.pharmasources.com/industryinsights/a-zika-vaccine-shows-signs-of-success-in-297910.html 0.6 2026-04-05T04:57:56+08:00 daily https://www.pharmasources.com/industryinsights/dsm-sinochem-pharma-files-lawsuit-for-pa-297911.html 0.6 2026-06-21T22:50:41+08:00 daily https://www.pharmasources.com/industryinsights/alcon-receives-ce-mark-for-its-autonome--297912.html 0.6 2026-06-23T15:51:28+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-to-close-insulin-pump-bu-297913.html 0.6 2026-08-09T22:05:46+08:00 daily https://www.pharmasources.com/industryinsights/horiba-scientific-introduces-new-clue-se-297914.html 0.6 2026-08-07T16:17:41+08:00 daily https://www.pharmasources.com/industryinsights/clot-busting-drugs-found-to-be-safe-for--297915.html 0.6 2026-06-30T10:13:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-297916.html 0.6 2026-07-08T23:59:58+08:00 daily https://www.pharmasources.com/industryinsights/inc-5000-list-of-fastest-growing-private-297917.html 0.6 2026-02-10T13:31:56+08:00 daily https://www.pharmasources.com/industryinsights/roche-launches-navify-tumor-board-soluti-297918.html 0.6 2026-07-27T07:48:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-tagrisso-secures-breakthrou-297919.html 0.6 2026-08-07T10:33:16+08:00 daily https://www.pharmasources.com/industryinsights/trump-repealed-birth-control-coverage-in-297920.html 0.6 2026-06-28T15:44:39+08:00 daily https://www.pharmasources.com/industryinsights/china-to-accelerate-new-drug-approvals-b-297921.html 0.6 2026-06-21T20:08:48+08:00 daily https://www.pharmasources.com/industryinsights/janssens-hiv-combo-pill-hits-safety-effi-297922.html 0.6 2026-08-06T18:28:15+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-venclyxto-now-available-through--297923.html 0.6 2026-06-20T18:52:30+08:00 daily https://www.pharmasources.com/industryinsights/depression-affects-nearly-half-of-older--297924.html 0.6 2026-07-19T11:58:02+08:00 daily https://www.pharmasources.com/industryinsights/oncoarendi-therapeutics-to-begin-the-pha-297925.html 0.6 2026-06-20T23:57:42+08:00 daily https://www.pharmasources.com/industryinsights/piramal-invests-55m-to-expand-api-mfg-ca-297926.html 0.6 2026-08-07T05:15:00+08:00 daily https://www.pharmasources.com/industryinsights/amyris-adds-coo-role-297927.html 0.6 2026-08-08T23:29:05+08:00 daily https://www.pharmasources.com/industryinsights/vice-president-to-inaugurate-third-inter-297928.html 0.6 2026-04-13T02:39:15+08:00 daily https://www.pharmasources.com/industryinsights/marksans-pharma-gets-eir-from-us-fda-for-297929.html 0.6 2026-06-21T04:19:04+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--297930.html 0.6 2026-07-30T05:11:41+08:00 daily https://www.pharmasources.com/industryinsights/intas-pharma-brings-down-cancer-treatmen-297931.html 0.6 2026-06-22T05:59:33+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-grants-orphan-drug-s-297932.html 0.6 2026-06-20T20:17:02+08:00 daily https://www.pharmasources.com/industryinsights/avara-pharmaceutical-buys-astrazenecas-r-297933.html 0.6 2026-06-20T14:08:52+08:00 daily https://www.pharmasources.com/industryinsights/researchers-to-use-supercomputing-techno-297934.html 0.6 2026-06-22T01:51:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-15-grants-for-clinical-trials-297935.html 0.6 2026-06-22T02:01:47+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-appoints-senior-vic-297936.html 0.6 2026-06-29T16:17:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-livanovas-device-combo-to-t-297937.html 0.6 2026-06-21T18:12:40+08:00 daily https://www.pharmasources.com/industryinsights/novo-petitions-fda-to-require-victoza-co-297938.html 0.6 2026-06-21T04:59:42+08:00 daily https://www.pharmasources.com/industryinsights/dr-sotheara-chhim-wins-2017-dr-guislain--297939.html 0.6 2026-06-21T08:07:08+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--297940.html 0.6 2026-06-20T16:59:14+08:00 daily https://www.pharmasources.com/industryinsights/roches-zika-screening-test-secured-appro-297941.html 0.6 2026-08-08T01:06:49+08:00 daily https://www.pharmasources.com/industryinsights/biomarkers-can-play-a-key-role-in-improv-297942.html 0.6 2026-06-29T07:08:43+08:00 daily https://www.pharmasources.com/industryinsights/adult-patients-with-schizophrenia-in-sin-297943.html 0.6 2026-01-13T12:47:34+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-community-join-to-fight-fragi-297944.html 0.6 2026-06-21T03:57:46+08:00 daily https://www.pharmasources.com/industryinsights/ibuprofen-better-choice-over-oral-morphi-297945.html 0.6 2026-06-20T15:12:19+08:00 daily https://www.pharmasources.com/industryinsights/topical-treatment-strategy-for-fighting--297946.html 0.6 2026-06-21T08:59:12+08:00 daily https://www.pharmasources.com/industryinsights/common-acid-reflux-medications-promote-c-297947.html 0.6 2026-06-20T23:16:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-multiple-sclerosis-drugs-fr-297948.html 0.6 2025-12-04T11:33:59+08:00 daily https://www.pharmasources.com/industryinsights/elligo-is-awarded-evaluation-of-fda-led--297949.html 0.6 2026-07-07T15:29:07+08:00 daily https://www.pharmasources.com/industryinsights/more-to-be-done-by-indian-government-to--297950.html 0.6 2026-06-23T08:27:26+08:00 daily https://www.pharmasources.com/industryinsights/safe-to-treat-dementia-patients-with-clo-297951.html 0.6 2026-07-09T21:01:26+08:00 daily https://www.pharmasources.com/industryinsights/use-of-antacids-found-to-promote-liver-d-297952.html 0.6 2026-08-04T12:43:30+08:00 daily https://www.pharmasources.com/industryinsights/scottish-government-reveals-extra-fundin-297953.html 0.6 2026-06-30T12:37:05+08:00 daily https://www.pharmasources.com/industryinsights/california-signs-into-law-transparency-o-297954.html 0.6 2026-04-28T19:56:28+08:00 daily https://www.pharmasources.com/industryinsights/gsk-ranked-at-bottom-of-good-governance--297955.html 0.6 2026-06-21T05:14:56+08:00 daily https://www.pharmasources.com/industryinsights/future-quality-of-nhs-and-social-care-is-297956.html 0.6 2026-06-20T15:59:21+08:00 daily https://www.pharmasources.com/industryinsights/akceas-rare-lipid-disorder-drug-wins-pim-297957.html 0.6 2026-06-27T06:14:41+08:00 daily https://www.pharmasources.com/industryinsights/az-lung-cancer-drug-tagrisso-bags-breakt-297958.html 0.6 2026-06-21T04:50:44+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-epclusa-will-be-funded-on-nhs-s-297959.html 0.6 2026-06-21T05:57:49+08:00 daily https://www.pharmasources.com/industryinsights/regenerative-medicine-to-radically-chang-297960.html 0.6 2026-04-20T20:32:03+08:00 daily https://www.pharmasources.com/industryinsights/suven-gets-product-patent-for-neurologic-297961.html 0.6 2026-06-21T14:36:34+08:00 daily https://www.pharmasources.com/industryinsights/clariant-launches-packaging-solutions-fo-297962.html 0.6 2026-06-21T10:03:08+08:00 daily https://www.pharmasources.com/industryinsights/pharma-exports-declined-by-4-per-cent-up-297963.html 0.6 2026-06-20T15:42:23+08:00 daily https://www.pharmasources.com/industryinsights/pps-to-expand-api-manufacturing-capabili-297964.html 0.6 2026-07-02T19:17:58+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-flexions-zilretta-to-tre-297965.html 0.6 2026-06-20T14:58:04+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-marketing-application-for-im-297966.html 0.6 2026-07-17T14:08:21+08:00 daily https://www.pharmasources.com/industryinsights/piramal-to-expand-in-api-manufacturing-c-297967.html 0.6 2026-06-20T17:04:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-sbla-for-prolia-in-glucocort-297968.html 0.6 2026-06-21T08:07:02+08:00 daily https://www.pharmasources.com/industryinsights/twitter-is-rife-with-antivaccine-sentime-297969.html 0.6 2026-06-21T12:12:24+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-bags-option-on-turnstone-oncolyti-297970.html 0.6 2026-06-08T07:41:29+08:00 daily https://www.pharmasources.com/industryinsights/new-data-shows-astigmatism-tends-to-wors-297971.html 0.6 2026-08-05T19:42:42+08:00 daily https://www.pharmasources.com/industryinsights/vertex-ventures-launches-life-sciences-a-297972.html 0.6 2026-06-21T14:43:18+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-reviewing-strategic-alternatives--297973.html 0.6 2026-08-09T03:02:48+08:00 daily https://www.pharmasources.com/industryinsights/merck-pays-760m-to-buy-into-kalvista-dru-297974.html 0.6 2026-06-23T02:55:18+08:00 daily https://www.pharmasources.com/industryinsights/synaptive-medical-introduces-new-surgica-297975.html 0.6 2026-06-21T08:10:02+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-launches-its-first-hepatitis-st-297976.html 0.6 2026-06-22T02:59:41+08:00 daily https://www.pharmasources.com/industryinsights/neratinib-prevents-ras-genes-from-causin-297977.html 0.6 2026-06-21T01:56:19+08:00 daily https://www.pharmasources.com/industryinsights/new-targets-found-in-approved-cancer-dru-297978.html 0.6 2026-06-21T16:07:30+08:00 daily https://www.pharmasources.com/industryinsights/ansm-grants-authorisation-for-phase-iii--297979.html 0.6 2026-07-27T16:03:59+08:00 daily https://www.pharmasources.com/industryinsights/marken-acquires-life-science-logistics-c-297980.html 0.6 2026-06-20T18:56:37+08:00 daily https://www.pharmasources.com/industryinsights/kossan-rubber-receives-frost-sullivan-20-297981.html 0.6 2026-06-17T20:15:22+08:00 daily https://www.pharmasources.com/industryinsights/allergy-drug-improves-function-in-patien-297982.html 0.6 2026-06-21T12:20:44+08:00 daily https://www.pharmasources.com/industryinsights/tagrisso-granted-breakthrough-therapy-de-297983.html 0.6 2026-06-20T14:52:03+08:00 daily https://www.pharmasources.com/industryinsights/childhood-obesity-increased-10-fold-over-297984.html 0.6 2026-06-22T15:16:33+08:00 daily https://www.pharmasources.com/industryinsights/lupin-scoops-up-womens-health-specialist-297985.html 0.6 2026-06-20T17:48:17+08:00 daily https://www.pharmasources.com/industryinsights/moffitt-scientists-discover-new-applicat-297986.html 0.6 2026-06-21T01:02:45+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-biocon-neulasta-biosimilar-kno-297987.html 0.6 2026-06-21T10:18:30+08:00 daily https://www.pharmasources.com/industryinsights/myeloma-uk-trial-to-test-novel-myeloma-t-297988.html 0.6 2026-06-22T10:12:50+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-seeking-options-for-the-future-of-297989.html 0.6 2026-08-07T00:33:38+08:00 daily https://www.pharmasources.com/industryinsights/merck-buys-into-kalvista-and-its-dme-can-297990.html 0.6 2026-08-07T00:01:21+08:00 daily https://www.pharmasources.com/industryinsights/lillys-verzenio-misses-key-survival-goal-297991.html 0.6 2026-08-06T23:56:44+08:00 daily https://www.pharmasources.com/industryinsights/preeti-sudan-is-new-health-secretary-moh-297992.html 0.6 2026-08-06T23:46:20+08:00 daily https://www.pharmasources.com/industryinsights/biocon-receives-crl-from-us-fda-over-can-297993.html 0.6 2026-08-07T19:53:02+08:00 daily https://www.pharmasources.com/industryinsights/pharma-city-to-attract-investment-worth--297994.html 0.6 2026-08-09T19:06:29+08:00 daily https://www.pharmasources.com/industryinsights/lupin-to-acquire-symbiomix-therapeutics-297995.html 0.6 2026-08-09T22:07:39+08:00 daily https://www.pharmasources.com/industryinsights/smc-approves-daratumumab-for-myeloma-pat-297996.html 0.6 2026-08-07T15:41:17+08:00 daily https://www.pharmasources.com/industryinsights/pistoia-alliance-to-develop-elsevier-uni-297997.html 0.6 2026-06-27T10:27:13+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-accepts-marketing-applicat-297998.html 0.6 2026-08-05T23:19:54+08:00 daily https://www.pharmasources.com/industryinsights/ansun-biopharma-announces-breakthrough-d-297999.html 0.6 2026-06-22T07:56:43+08:00 daily https://www.pharmasources.com/industryinsights/avita-to-raise-13m-for-regenerative-burn-298000.html 0.6 2026-06-24T07:10:38+08:00 daily https://www.pharmasources.com/industryinsights/world-bosai-foruminternational-disaster--298001.html 0.6 2026-06-27T02:04:40+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-receives-the-1st-fda-a-298002.html 0.6 2026-06-21T23:46:45+08:00 daily https://www.pharmasources.com/industryinsights/koreas-boryung-pharmaceuticals-to-launch-298003.html 0.6 2026-06-22T09:46:53+08:00 daily https://www.pharmasources.com/industryinsights/tb-alliance-declares-potential-of-two-no-298004.html 0.6 2026-06-20T15:00:07+08:00 daily https://www.pharmasources.com/industryinsights/korean-scientists-invent-hydrogel-to-com-298005.html 0.6 2026-06-25T10:12:25+08:00 daily https://www.pharmasources.com/industryinsights/novel-bi-specific-antibody-shows-strong--298006.html 0.6 2026-08-07T01:27:50+08:00 daily https://www.pharmasources.com/industryinsights/ncd-poses-major-challenge-for-asia-pacif-298007.html 0.6 2026-08-07T01:18:49+08:00 daily https://www.pharmasources.com/industryinsights/pi3k-inhibitors-carries-hope-for-rare-bo-298008.html 0.6 2026-08-07T01:13:57+08:00 daily https://www.pharmasources.com/industryinsights/polyphor-launches-the-development-of-an--298009.html 0.6 2026-08-08T00:55:20+08:00 daily https://www.pharmasources.com/industryinsights/rapamycin-treatment-prevents-crippling-h-298010.html 0.6 2026-08-07T01:06:41+08:00 daily https://www.pharmasources.com/industryinsights/strong-ibs-and-constipation-phase-3-data-298011.html 0.6 2026-08-07T01:19:28+08:00 daily https://www.pharmasources.com/industryinsights/aeries-glaucoma-drug-gets-strong-prelimi-298012.html 0.6 2026-08-07T01:28:54+08:00 daily https://www.pharmasources.com/industryinsights/nice-gives-final-draft-guidance-on-two-k-298013.html 0.6 2026-08-07T13:16:43+08:00 daily https://www.pharmasources.com/industryinsights/msd-gives-up-on-cholesterol-drug-despite-298014.html 0.6 2026-08-08T03:08:08+08:00 daily https://www.pharmasources.com/industryinsights/shortage-of-radiologists-risking-early-c-298015.html 0.6 2026-08-07T20:14:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-backing-for-bayers-stivarga-in-gist-298016.html 0.6 2026-08-09T10:31:06+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-nda-of-fda-in-q3-nearly-half-298017.html 0.6 2026-08-07T04:18:37+08:00 daily https://www.pharmasources.com/industryinsights/health-and-care-leaders-fear-winter-will-298018.html 0.6 2026-08-07T00:39:39+08:00 daily https://www.pharmasources.com/industryinsights/msd-pulls-plug-on-cholesterol-drug-anace-298019.html 0.6 2026-08-07T00:02:58+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-hope-for-rare-bone-cancer-patie-298020.html 0.6 2026-08-06T23:48:03+08:00 daily https://www.pharmasources.com/industryinsights/mc2-therapeutics-as-announces-first-pati-298021.html 0.6 2026-08-06T23:46:13+08:00 daily https://www.pharmasources.com/industryinsights/which-are-to-dominate-the-chinese-hcv-dr-298022.html 0.6 2026-08-06T23:55:25+08:00 daily https://www.pharmasources.com/industryinsights/icmr-published-its-strategic-plan-and-vi-298023.html 0.6 2026-08-06T23:36:18+08:00 daily https://www.pharmasources.com/industryinsights/hilleman-labs-completes-phase-iii-clinic-298024.html 0.6 2026-08-06T23:55:38+08:00 daily https://www.pharmasources.com/industryinsights/oneup-trek-challenge-held-for-diabetes-p-298025.html 0.6 2026-08-07T00:01:50+08:00 daily https://www.pharmasources.com/industryinsights/pharmexcils-13th-annual-meet-held-in-hyd-298026.html 0.6 2026-08-07T00:41:31+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-obtains-licence-for-turnstone-bio-298027.html 0.6 2026-08-07T13:17:42+08:00 daily https://www.pharmasources.com/industryinsights/janssen-biotech-submits-nda-to-fda-for-a-298028.html 0.6 2026-08-08T03:25:14+08:00 daily https://www.pharmasources.com/industryinsights/rsv-vaccine-player-codagenix-snags-3m-in-298029.html 0.6 2026-08-08T04:36:30+08:00 daily https://www.pharmasources.com/industryinsights/sierra-leone-first-lady-and-beingmate-la-298030.html 0.6 2026-08-08T07:47:36+08:00 daily https://www.pharmasources.com/industryinsights/key-technologies-gathering-real-time-dat-298031.html 0.6 2026-08-09T02:10:58+08:00 daily https://www.pharmasources.com/industryinsights/averting-toxic-side-effects-from-car-t-c-298032.html 0.6 2026-08-09T04:34:43+08:00 daily https://www.pharmasources.com/industryinsights/merck-writes-off-big-bet-on-cetp-drug-an-298033.html 0.6 2026-06-21T07:56:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-expands-bayers-stivarga-prospects-w-298034.html 0.6 2026-06-21T08:10:05+08:00 daily https://www.pharmasources.com/industryinsights/japanese-scientists-grow-drugs-in-chicke-298035.html 0.6 2026-06-21T11:58:07+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-plans-acquisition-of-tian-298036.html 0.6 2026-07-30T16:30:52+08:00 daily https://www.pharmasources.com/industryinsights/with-the-new-blood-testing-technology-th-298037.html 0.6 2026-06-21T07:33:25+08:00 daily https://www.pharmasources.com/industryinsights/ebola-vaccines-in-a-trial-elicit-immune--298038.html 0.6 2026-06-21T21:04:40+08:00 daily https://www.pharmasources.com/industryinsights/new-way-found-to-deliver-nano-chemo-drug-298039.html 0.6 2026-07-20T00:34:44+08:00 daily https://www.pharmasources.com/industryinsights/nih-launches-215m-partnership-for-cancer-298040.html 0.6 2026-06-21T23:39:08+08:00 daily https://www.pharmasources.com/industryinsights/low-rates-of-stroke-and-major-bleeding-w-298041.html 0.6 2026-06-21T10:06:08+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-drugs-market-to-boost-in-both-298042.html 0.6 2026-06-21T10:54:06+08:00 daily https://www.pharmasources.com/industryinsights/chemistry-provides-a-new-supply-of-a-pro-298043.html 0.6 2026-07-20T11:47:00+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-study-could-revolutionise-m-298044.html 0.6 2026-07-08T19:05:56+08:00 daily https://www.pharmasources.com/industryinsights/bms-agrees-deal-on-opdivo-availability-t-298045.html 0.6 2026-06-20T19:16:56+08:00 daily https://www.pharmasources.com/industryinsights/roches-skin-cancer-drug-erivedge-pulled--298046.html 0.6 2026-06-21T11:12:19+08:00 daily https://www.pharmasources.com/industryinsights/abpi-blf-launch-lung-disease-taskforce-298047.html 0.6 2026-06-22T01:57:32+08:00 daily https://www.pharmasources.com/industryinsights/genomics-england-links-with-inivata-ther-298048.html 0.6 2026-06-21T01:37:23+08:00 daily https://www.pharmasources.com/industryinsights/amri-offers-stand-alone-impurity-service-298049.html 0.6 2026-08-08T03:27:14+08:00 daily https://www.pharmasources.com/industryinsights/tulex-completes-nj-development-and-manuf-298050.html 0.6 2026-06-21T14:54:21+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-invests-170m-in-new-vaccine-facil-298051.html 0.6 2026-06-21T14:48:46+08:00 daily https://www.pharmasources.com/industryinsights/ipc-conducts-4th-regional-workshop-on-pv-298052.html 0.6 2026-07-08T07:57:15+08:00 daily https://www.pharmasources.com/industryinsights/icmr-releases-guidelines-on-biomedical-a-298053.html 0.6 2026-06-21T20:17:58+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-anti-de-298054.html 0.6 2026-07-03T11:18:37+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-to-increase-stake-in-ranbaxy--298055.html 0.6 2026-06-21T06:58:56+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-first-coin-capital-china-g-298057.html 0.6 2026-06-21T10:36:54+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-catalent-pharma-solution-298058.html 0.6 2026-06-20T14:54:03+08:00 daily https://www.pharmasources.com/industryinsights/your-article-volume-can-counts-on-us-298059.html 0.6 2026-07-03T14:25:32+08:00 daily https://www.pharmasources.com/industryinsights/ebola-vaccines-from-gsk-merck-elicit-yea-298060.html 0.6 2026-06-21T08:54:25+08:00 daily https://www.pharmasources.com/industryinsights/genomics-england-taps-inivata-for-liquid-298061.html 0.6 2026-07-02T18:07:44+08:00 daily https://www.pharmasources.com/industryinsights/inflarx-snags-55m-for-inflammatory-autoi-298062.html 0.6 2026-06-21T06:57:58+08:00 daily https://www.pharmasources.com/industryinsights/nuvasives-limb-lengthening-tech-earns-ex-298063.html 0.6 2026-06-20T14:43:29+08:00 daily https://www.pharmasources.com/industryinsights/spark-therapeutics-luxturna-advisory-com-298064.html 0.6 2025-11-29T01:25:45+08:00 daily https://www.pharmasources.com/industryinsights/nih-public-private-pact-aims-to-fire-the-298065.html 0.6 2026-06-20T18:05:22+08:00 daily https://www.pharmasources.com/industryinsights/carrier-celebrates-the-115th-anniversary-298066.html 0.6 2026-07-05T01:02:54+08:00 daily https://www.pharmasources.com/industryinsights/protom-international-to-install-three-ro-298067.html 0.6 2026-08-09T08:24:02+08:00 daily https://www.pharmasources.com/industryinsights/who-antibiotics-in-an-emergency-a-review-298068.html 0.6 2026-06-29T21:00:20+08:00 daily https://www.pharmasources.com/industryinsights/who-antibiotics-in-an-emergency-a-review-298069.html 0.6 2026-08-07T03:07:05+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20171016-298070.html 0.6 2026-08-06T23:46:16+08:00 daily https://www.pharmasources.com/industryinsights/intercept-icpt-extends-strategic-partner-298071.html 0.6 2026-08-06T23:57:27+08:00 daily https://www.pharmasources.com/industryinsights/philips-receives-us-fda-clearance-to-its-298072.html 0.6 2026-08-07T00:02:07+08:00 daily https://www.pharmasources.com/industryinsights/genepoc-introduces-new-molecular-diagnos-298073.html 0.6 2026-08-09T10:31:01+08:00 daily https://www.pharmasources.com/industryinsights/otago-university-teams-up-with-chinese-i-298074.html 0.6 2026-06-21T09:06:08+08:00 daily https://www.pharmasources.com/industryinsights/researchers-in-canada-create-a-smart-ban-298075.html 0.6 2026-07-03T20:42:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-under-legal-fire-over-split-from-a-298076.html 0.6 2026-06-22T21:52:45+08:00 daily https://www.pharmasources.com/industryinsights/macrophages-play-critical-role-in-sustai-298077.html 0.6 2026-07-07T14:51:48+08:00 daily https://www.pharmasources.com/industryinsights/janssen-announces-fda-approval-of-stelar-298078.html 0.6 2026-06-20T18:55:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-that-tagrisso-gran-298079.html 0.6 2026-06-17T16:59:09+08:00 daily https://www.pharmasources.com/industryinsights/bayer-navigate-esus-study-stopped-early--298080.html 0.6 2026-07-04T12:10:15+08:00 daily https://www.pharmasources.com/industryinsights/magic-mushrooms-may-reset-the-brains-of--298081.html 0.6 2026-06-21T07:00:59+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-turnstone-biologics-announce--298082.html 0.6 2026-08-01T11:35:43+08:00 daily https://www.pharmasources.com/industryinsights/trials-reveal-two-strong-vaccine-candida-298083.html 0.6 2026-06-21T08:10:04+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-admits-cancer-data-for-acqui-298084.html 0.6 2026-06-22T08:21:48+08:00 daily https://www.pharmasources.com/industryinsights/chmp-backs-one-generic-and-six-label-ext-298085.html 0.6 2026-06-21T12:25:17+08:00 daily https://www.pharmasources.com/industryinsights/ai-has-the-potential-to-bring-630bn-to-u-298086.html 0.6 2026-07-13T12:09:28+08:00 daily https://www.pharmasources.com/industryinsights/roche-links-with-warp-drive-bio-in-antib-298087.html 0.6 2026-08-03T23:34:30+08:00 daily https://www.pharmasources.com/industryinsights/antabio-raises-73m-series-a-financing-to-298088.html 0.6 2026-07-04T11:42:49+08:00 daily https://www.pharmasources.com/industryinsights/aeglea-biotherapeutics-merck-enter-clini-298089.html 0.6 2026-08-09T12:11:57+08:00 daily https://www.pharmasources.com/industryinsights/ayurvedic-products-to-witness-threefold--298090.html 0.6 2026-08-05T19:30:12+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-india-celebrates-daanutsav-298091.html 0.6 2026-07-09T13:08:10+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-us-fda-nod-for-aprepitant--298092.html 0.6 2026-06-21T06:20:14+08:00 daily https://www.pharmasources.com/industryinsights/msf-approaches-delhi-hc-to-challenge-unm-298093.html 0.6 2026-06-20T14:36:10+08:00 daily https://www.pharmasources.com/industryinsights/hilleman-labs-successfully-completes-pha-298094.html 0.6 2026-06-21T00:57:52+08:00 daily https://www.pharmasources.com/industryinsights/us-nih-launches-215m-partnership-for-acc-298095.html 0.6 2026-07-30T19:34:10+08:00 daily https://www.pharmasources.com/industryinsights/shires-lyophilised-oncaspar-receives-pos-298096.html 0.6 2026-07-29T01:21:02+08:00 daily https://www.pharmasources.com/industryinsights/gsks-shingrix-receives-approval-in-canad-298097.html 0.6 2026-06-21T13:04:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-stelara-for-adolescents-wit-298098.html 0.6 2026-08-06T20:23:09+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-picks-up-afib-player-a-298099.html 0.6 2026-08-09T09:38:50+08:00 daily https://www.pharmasources.com/industryinsights/reckitt-benckisers-still-wantx-to-buy-pf-298100.html 0.6 2026-08-01T11:25:32+08:00 daily https://www.pharmasources.com/industryinsights/avnet-and-mediotek-to-transform-healthca-298101.html 0.6 2026-07-31T20:09:41+08:00 daily https://www.pharmasources.com/industryinsights/paxter-announces-launch-of-kickstarter-c-298102.html 0.6 2026-08-06T15:54:40+08:00 daily https://www.pharmasources.com/industryinsights/aimmune-therapeutics-to-collaborate-with-298103.html 0.6 2026-08-07T16:38:21+08:00 daily https://www.pharmasources.com/industryinsights/gsk-collaborates-with-plasticell-for-ste-298104.html 0.6 2026-08-07T03:09:44+08:00 daily https://www.pharmasources.com/industryinsights/marken-continued-its-expansion-in-asia-p-298105.html 0.6 2026-08-09T03:23:33+08:00 daily https://www.pharmasources.com/industryinsights/singhealth-duke-nus-and-gsk-join-forces--298106.html 0.6 2026-06-20T21:38:22+08:00 daily https://www.pharmasources.com/industryinsights/new-applications-laboratory-opens-in-sou-298107.html 0.6 2026-07-16T11:15:55+08:00 daily https://www.pharmasources.com/industryinsights/defining-standards-measures-for-amr-is-t-298108.html 0.6 2026-06-08T18:07:22+08:00 daily https://www.pharmasources.com/industryinsights/who-supports-the-immunization-of-people--298109.html 0.6 2026-07-23T09:54:04+08:00 daily https://www.pharmasources.com/industryinsights/opportunity-or-challenge-favorable-polic-298110.html 0.6 2026-07-31T00:41:42+08:00 daily https://www.pharmasources.com/industryinsights/oral-semaglutide-shows-promise-for-type--298111.html 0.6 2026-06-21T04:12:56+08:00 daily https://www.pharmasources.com/industryinsights/doacs-used-as-a-alternative-to-warfarin--298112.html 0.6 2026-08-07T22:18:16+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-that-flu-vaccines-not-effect-298113.html 0.6 2026-06-22T10:56:47+08:00 daily https://www.pharmasources.com/industryinsights/opportunity-or-challenge-favorable-polic-298114.html 0.6 2026-08-03T08:33:08+08:00 daily https://www.pharmasources.com/industryinsights/new-trial-ordered-all-previous-judgement-298115.html 0.6 2026-08-04T12:33:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bristol-myers-squibbs-applic-298116.html 0.6 2026-08-04T09:00:36+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-lung-cancer-drug-proves-able-298117.html 0.6 2026-06-22T10:32:06+08:00 daily https://www.pharmasources.com/industryinsights/peanut-allergies-theres-a-clinical-trial-298118.html 0.6 2026-06-20T20:53:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-plans-summit-to-tackle-diabetes-i-298119.html 0.6 2026-06-21T23:02:56+08:00 daily https://www.pharmasources.com/industryinsights/no-deal-brexit-could-cost-nhs-500m-a-yea-298120.html 0.6 2026-06-22T09:07:47+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-lorlatinib-impresses-in-phase-ii-298121.html 0.6 2026-06-21T07:48:50+08:00 daily https://www.pharmasources.com/industryinsights/the-netherlands-cancer-institute-awarded-298122.html 0.6 2026-06-22T15:50:42+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-2017anticipated-cdmo-mark-298123.html 0.6 2026-07-06T23:08:53+08:00 daily https://www.pharmasources.com/industryinsights/kerala-to-manufacture-anti-rabies-vaccin-298124.html 0.6 2026-06-21T08:20:14+08:00 daily https://www.pharmasources.com/industryinsights/pm-dedicates-all-india-institute-of-ayur-298125.html 0.6 2026-08-06T05:40:39+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-gets-us-fda-nod-for-hea-298126.html 0.6 2026-08-08T21:02:58+08:00 daily https://www.pharmasources.com/industryinsights/warren-wang-appointed-senior-vp-and-pres-298127.html 0.6 2026-06-21T22:48:45+08:00 daily https://www.pharmasources.com/industryinsights/glenmarks-saldanha-takes-over-as-preside-298128.html 0.6 2026-06-22T12:50:17+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-faslodex-receives-chmp-opin-298129.html 0.6 2026-06-17T11:00:32+08:00 daily https://www.pharmasources.com/industryinsights/genomics-and-biogen-partner-to-discover--298130.html 0.6 2026-07-01T00:07:52+08:00 daily https://www.pharmasources.com/industryinsights/warp-drive-and-roche-collaborate-to-deve-298131.html 0.6 2026-06-22T01:48:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ind-of-amniofix-298132.html 0.6 2026-06-29T14:38:54+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-wins-first-ever-nod-for--298133.html 0.6 2026-06-21T03:20:01+08:00 daily https://www.pharmasources.com/industryinsights/with-kite-in-the-bag-gilead-boosts-oncol-298134.html 0.6 2026-07-05T03:02:06+08:00 daily https://www.pharmasources.com/industryinsights/anpac-bio-surpasses-50000-case-study-mil-298135.html 0.6 2026-07-16T12:47:59+08:00 daily https://www.pharmasources.com/industryinsights/beyond-ventures-and-alibaba-lead-us40-mi-298136.html 0.6 2026-06-22T05:53:32+08:00 daily https://www.pharmasources.com/industryinsights/india-and-china-have-potential-growth-op-298137.html 0.6 2026-06-21T09:05:05+08:00 daily https://www.pharmasources.com/industryinsights/mcgill-teams-up-with-japans-nips-for-neu-298138.html 0.6 2026-07-03T12:43:39+08:00 daily https://www.pharmasources.com/industryinsights/singapore-conducts-research-on-asthma-an-298139.html 0.6 2026-06-21T14:45:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-regulatory-submission-for-ly-298140.html 0.6 2026-06-23T08:35:37+08:00 daily https://www.pharmasources.com/industryinsights/revolade-shows-long-term-disease-control-298141.html 0.6 2026-08-03T15:49:18+08:00 daily https://www.pharmasources.com/industryinsights/arsenic-identified-as-a-potential-treatm-298142.html 0.6 2026-06-21T13:17:43+08:00 daily https://www.pharmasources.com/industryinsights/three-of-the-most-deadly-cancers-get-cri-298143.html 0.6 2026-06-25T00:32:16+08:00 daily https://www.pharmasources.com/industryinsights/first-ever-study-in-the-personalised-tre-298144.html 0.6 2026-06-21T10:10:16+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-ai-able-to-identify-97-of-b-298145.html 0.6 2026-06-24T05:22:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-shut-down-its-us-generics-pl-298146.html 0.6 2026-03-07T07:55:47+08:00 daily https://www.pharmasources.com/industryinsights/new-studies-point-to-cracks-forming-in-n-298147.html 0.6 2026-06-20T15:48:31+08:00 daily https://www.pharmasources.com/industryinsights/gsk-plasticell-sign-deal-to-produce-haem-298148.html 0.6 2026-07-01T14:54:57+08:00 daily https://www.pharmasources.com/industryinsights/gp-referrals-to-weight-watchers-cut-diab-298149.html 0.6 2026-06-20T16:00:29+08:00 daily https://www.pharmasources.com/industryinsights/new-analysis-backs-use-of-takedas-entyvi-298150.html 0.6 2026-06-29T06:33:36+08:00 daily https://www.pharmasources.com/industryinsights/prime-status-for-ignytas-entrectinib-298151.html 0.6 2026-06-21T12:55:23+08:00 daily https://www.pharmasources.com/industryinsights/the-next-frontier-for-cmos-298152.html 0.6 2026-06-21T17:53:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-pharma-gets-dcgi-nod-to-mark-298153.html 0.6 2026-06-21T05:18:32+08:00 daily https://www.pharmasources.com/industryinsights/optel-launches-verification-and-decommis-298154.html 0.6 2026-06-22T05:00:39+08:00 daily https://www.pharmasources.com/industryinsights/plasticell-in-collaboration-with-gsk-298155.html 0.6 2026-06-20T22:57:40+08:00 daily https://www.pharmasources.com/industryinsights/amneal-pharmaceuticals-in-agreement-with-298156.html 0.6 2026-06-20T19:06:43+08:00 daily https://www.pharmasources.com/industryinsights/mutabilis-joins-european-enable-project--298157.html 0.6 2026-06-20T15:47:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-exelixis--298158.html 0.6 2025-11-16T16:06:30+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-boston-childrens-hospital-to-i-298159.html 0.6 2026-07-09T09:40:42+08:00 daily https://www.pharmasources.com/industryinsights/flugen-awarded-144-million-by-the-dod-to-298160.html 0.6 2026-06-22T09:09:50+08:00 daily https://www.pharmasources.com/industryinsights/spyryx-biosciences-announces-first-patie-298161.html 0.6 2026-06-20T23:11:56+08:00 daily https://www.pharmasources.com/industryinsights/lilly-curevac-pen-18b-mrna-cancer-vaccin-298162.html 0.6 2026-06-21T20:00:35+08:00 daily https://www.pharmasources.com/industryinsights/forty-seven-raises-another-75m-to-expand-298163.html 0.6 2026-06-21T15:43:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-optiscans-automated-bedside-g-298164.html 0.6 2026-06-21T12:59:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lynparza-ups-the-ante-at-th-298165.html 0.6 2026-06-20T18:05:24+08:00 daily https://www.pharmasources.com/industryinsights/merck-brings-customers-closer-to-gene-th-298166.html 0.6 2026-06-20T19:01:39+08:00 daily https://www.pharmasources.com/industryinsights/alcami-establishes-international-sales-o-298167.html 0.6 2026-06-21T11:12:21+08:00 daily https://www.pharmasources.com/industryinsights/in-depth-report-on-antihypertensive-drug-298168.html 0.6 2026-07-06T09:12:13+08:00 daily https://www.pharmasources.com/industryinsights/in-depth-report-on-antihypertensive-drug-298169.html 0.6 2026-08-05T19:26:29+08:00 daily https://www.pharmasources.com/industryinsights/in-depth-report-on-antihypertensive-drug-298170.html 0.6 2026-06-27T14:55:49+08:00 daily https://www.pharmasources.com/industryinsights/piramal-enterprise-plans-rs-7000-crore-f-298171.html 0.6 2026-06-20T23:17:55+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-unveils-new-signature-298172.html 0.6 2026-06-20T16:58:19+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-plasticell-to-manufacture-haemat-298173.html 0.6 2026-06-20T16:04:27+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-hemoshear-partner-to-discover-298174.html 0.6 2026-06-24T11:39:28+08:00 daily https://www.pharmasources.com/industryinsights/uniqure-chasing-spark-level-fix-activity-298175.html 0.6 2026-06-22T04:47:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-second-car-t-cell-therapy-a-298176.html 0.6 2026-06-23T01:19:26+08:00 daily https://www.pharmasources.com/industryinsights/japan-provides-funds-to-pakistan-for-era-298177.html 0.6 2026-06-23T15:05:30+08:00 daily https://www.pharmasources.com/industryinsights/integrated-lab-on-a-chip-uses-smartphone-298178.html 0.6 2026-06-21T15:39:29+08:00 daily https://www.pharmasources.com/industryinsights/cphi-annual-report-reveals-slow-and-disc-298179.html 0.6 2026-06-26T16:06:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-yescarta-to-treat-adults-wi-298180.html 0.6 2026-06-21T11:55:30+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-invests-us55-mi-298181.html 0.6 2026-07-20T00:09:10+08:00 daily https://www.pharmasources.com/industryinsights/chinas-amino-acids-market-expansion-to-t-298182.html 0.6 2026-07-23T21:19:05+08:00 daily https://www.pharmasources.com/industryinsights/merck-brings-customers-closer-to-gene-th-298183.html 0.6 2026-06-30T13:47:31+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-where-hiv-hides-to-evade-298184.html 0.6 2026-06-26T06:59:00+08:00 daily https://www.pharmasources.com/industryinsights/lilly-teams-up-with-curevac-in-18-billio-298185.html 0.6 2026-08-08T04:18:09+08:00 daily https://www.pharmasources.com/industryinsights/vir-biotech-blasts-out-of-the-blocks-wit-298186.html 0.6 2026-08-07T13:44:24+08:00 daily https://www.pharmasources.com/industryinsights/novos-diabetes-treatment-semaglutide-get-298187.html 0.6 2026-08-08T19:28:28+08:00 daily https://www.pharmasources.com/industryinsights/worrying-number-of-organ-donations-block-298188.html 0.6 2026-06-29T04:24:36+08:00 daily https://www.pharmasources.com/industryinsights/allergy-therapeutics-kicks-off-dosing-in-298189.html 0.6 2026-06-21T17:42:09+08:00 daily https://www.pharmasources.com/industryinsights/researchers-uncover-new-approach-for-tar-298190.html 0.6 2026-06-21T18:52:59+08:00 daily https://www.pharmasources.com/industryinsights/speedy-review-for-az-lynparza-in-breast--298191.html 0.6 2025-12-07T03:25:07+08:00 daily https://www.pharmasources.com/industryinsights/the-first-recombinant-ebola-virus-vaccin-298192.html 0.6 2026-08-07T16:42:19+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-acquires-us-clinical-researc-298193.html 0.6 2026-07-19T15:55:11+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-pharma-bids-for-cardinal-health-298194.html 0.6 2026-07-07T17:40:10+08:00 daily https://www.pharmasources.com/industryinsights/singapore-grants-patent-to-suven-for-neu-298195.html 0.6 2026-07-19T16:15:05+08:00 daily https://www.pharmasources.com/industryinsights/new-vaccine-offers-hope-for-pneumonia-298196.html 0.6 2026-06-21T11:05:16+08:00 daily https://www.pharmasources.com/industryinsights/functionalizing-liposomes-could-pave-the-298197.html 0.6 2026-07-08T16:44:17+08:00 daily https://www.pharmasources.com/industryinsights/growth-of-german-pharma-market-will-be-h-298198.html 0.6 2026-07-07T03:03:07+08:00 daily https://www.pharmasources.com/industryinsights/part-i-of-cphi-annual-report-highlights--298199.html 0.6 2026-06-21T03:05:44+08:00 daily https://www.pharmasources.com/industryinsights/a-great-place-to-do-great-things-develop-298200.html 0.6 2026-08-09T21:31:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-car-t-cell-therapy-to-treat-298201.html 0.6 2026-08-07T19:41:31+08:00 daily https://www.pharmasources.com/industryinsights/report-reveals-impact-of-pollution-with--298202.html 0.6 2026-08-09T20:29:56+08:00 daily https://www.pharmasources.com/industryinsights/small-number-of-mutations-driving-most-c-298203.html 0.6 2026-06-20T14:45:08+08:00 daily https://www.pharmasources.com/industryinsights/teva-under-investigation-over-illegal-re-298204.html 0.6 2026-06-21T04:53:14+08:00 daily https://www.pharmasources.com/industryinsights/medicines-discovery-catapult-antruk-star-298205.html 0.6 2026-08-09T08:14:37+08:00 daily https://www.pharmasources.com/industryinsights/nice-says-no-for-opdivo-in-urothelial-ca-298206.html 0.6 2026-08-02T02:16:25+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20171023-298207.html 0.6 2026-06-21T09:07:05+08:00 daily https://www.pharmasources.com/industryinsights/30-million-newborns-could-die-by-2030-un-298208.html 0.6 2026-07-07T02:23:27+08:00 daily https://www.pharmasources.com/industryinsights/who-supports-containment-of-rare-virus-o-298209.html 0.6 2026-06-21T02:05:51+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-bydureon-bcise-by-astraz-298210.html 0.6 2026-07-24T12:21:48+08:00 daily https://www.pharmasources.com/industryinsights/china-shortage-of-doctors-and-medicine-f-298211.html 0.6 2026-06-27T09:43:04+08:00 daily https://www.pharmasources.com/industryinsights/pivot-pharma-executes-letter-of-intent-t-298212.html 0.6 2026-06-21T12:55:43+08:00 daily https://www.pharmasources.com/industryinsights/ketamine-may-help-treat-migraine-pain-un-298213.html 0.6 2026-08-08T19:00:06+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-granted-fda-approval-f-298214.html 0.6 2026-08-07T04:19:59+08:00 daily https://www.pharmasources.com/industryinsights/sta-pharmaceutical-to-launch-transition--298215.html 0.6 2026-08-09T02:07:58+08:00 daily https://www.pharmasources.com/industryinsights/the-union-for-international-cancer-contr-298216.html 0.6 2026-06-21T06:21:19+08:00 daily https://www.pharmasources.com/industryinsights/public-health-england-sounds-warning-aga-298217.html 0.6 2026-07-05T00:12:47+08:00 daily https://www.pharmasources.com/industryinsights/gsks-shingles-vaccine-scores-us-approval-298218.html 0.6 2026-07-30T17:36:14+08:00 daily https://www.pharmasources.com/industryinsights/msd-cuts-1800-jobs-in-us-operations-rest-298219.html 0.6 2026-06-26T19:53:47+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-gsks-bubble-baby-syndrome-g-298220.html 0.6 2026-07-01T21:14:30+08:00 daily https://www.pharmasources.com/industryinsights/nice-bars-nhs-access-to-lenvima-nexavar--298221.html 0.6 2026-07-12T12:03:30+08:00 daily https://www.pharmasources.com/industryinsights/two-new-approvals-for-janssens-simponi-a-298222.html 0.6 2026-07-02T12:57:45+08:00 daily https://www.pharmasources.com/industryinsights/which-is-to-dominate-the-future-heart-fa-298223.html 0.6 2026-06-21T07:03:56+08:00 daily https://www.pharmasources.com/industryinsights/which-is-to-dominate-the-future-heart-fa-298224.html 0.6 2026-06-21T10:19:03+08:00 daily https://www.pharmasources.com/industryinsights/over-30000-published-articles-have-mista-298225.html 0.6 2026-07-18T08:00:57+08:00 daily https://www.pharmasources.com/industryinsights/electronic-batch-records-are-your-system-298226.html 0.6 2026-08-06T04:50:38+08:00 daily https://www.pharmasources.com/industryinsights/biogen-takes-up-option-to-co-develop-eis-298227.html 0.6 2026-06-26T20:01:35+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-badge-for-novartis-skin-can-298228.html 0.6 2026-07-01T21:01:41+08:00 daily https://www.pharmasources.com/industryinsights/cancer-vanguard-amgen-develop-commission-298229.html 0.6 2026-07-15T22:41:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-q3-jimenez-talks-up-alcon-gleev-298230.html 0.6 2026-06-22T10:51:00+08:00 daily https://www.pharmasources.com/industryinsights/az-tops-annual-rd-spend-in-uk-roche-is-g-298231.html 0.6 2026-06-20T14:44:59+08:00 daily https://www.pharmasources.com/industryinsights/eisai-banks-on-potential-of-biogens-alzh-298232.html 0.6 2026-06-23T07:44:36+08:00 daily https://www.pharmasources.com/industryinsights/adc-therapeutics-brings-in-200-million-o-298233.html 0.6 2026-03-17T22:41:26+08:00 daily https://www.pharmasources.com/industryinsights/new-collaborative-rd-report-released-by--298234.html 0.6 2026-06-21T13:53:24+08:00 daily https://www.pharmasources.com/industryinsights/proton-therapy-may-be-better-option-for--298235.html 0.6 2026-06-20T17:06:41+08:00 daily https://www.pharmasources.com/industryinsights/blood-based-epigenetic-may-hold-clues-to-298236.html 0.6 2026-06-20T16:00:21+08:00 daily https://www.pharmasources.com/industryinsights/albendazole-antibiotic-combination-short-298237.html 0.6 2026-04-06T22:19:14+08:00 daily https://www.pharmasources.com/industryinsights/sterling-expands-api-capabilities-298238.html 0.6 2026-08-08T07:45:16+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-makes-4-million-investment-in-n-298239.html 0.6 2026-08-06T20:07:00+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-releases-part-iii-of-its--298240.html 0.6 2026-08-08T02:45:06+08:00 daily https://www.pharmasources.com/industryinsights/par-panel-reports-have-persuasive-value--298241.html 0.6 2026-08-06T22:00:11+08:00 daily https://www.pharmasources.com/industryinsights/biocon-bags-recognition-at-science-caree-298242.html 0.6 2026-08-06T22:12:35+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-oral-drug-for-psoriasi-298243.html 0.6 2026-07-20T13:07:05+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-plows-205m-upfront-into-alectors--298244.html 0.6 2026-06-22T19:47:37+08:00 daily https://www.pharmasources.com/industryinsights/neuropace-closes-74-million-equity-fundi-298245.html 0.6 2026-06-22T04:55:39+08:00 daily https://www.pharmasources.com/industryinsights/odelga-invests-to-improve-sri-lankas-hea-298246.html 0.6 2026-06-20T16:02:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-clearance-for-advanced-cardiac-mappi-298247.html 0.6 2026-08-08T17:20:44+08:00 daily https://www.pharmasources.com/industryinsights/new-report-reveals-singapore-productivit-298248.html 0.6 2026-06-22T06:52:55+08:00 daily https://www.pharmasources.com/industryinsights/tarloxitinib-puts-tumour-seeking-tail-on-298249.html 0.6 2026-06-22T18:59:01+08:00 daily https://www.pharmasources.com/industryinsights/anticoagulant-drugs-appear-to-reduce-the-298250.html 0.6 2026-06-21T08:20:19+08:00 daily https://www.pharmasources.com/industryinsights/plasticell-and-gsk-collaborate-to-produc-298251.html 0.6 2026-06-21T04:42:28+08:00 daily https://www.pharmasources.com/industryinsights/shinva-how-to-walk-out-a-road-of-intelli-298252.html 0.6 2026-06-20T15:09:18+08:00 daily https://www.pharmasources.com/industryinsights/biocad-enters-the-european-market-298253.html 0.6 2026-06-22T01:42:42+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-launches-patent-infringement-laws-298254.html 0.6 2026-06-21T00:01:38+08:00 daily https://www.pharmasources.com/industryinsights/lilly-considering-spinning-out-or-entire-298255.html 0.6 2026-06-21T03:10:49+08:00 daily https://www.pharmasources.com/industryinsights/gsks-bubble-boy-gene-therapy-secures-nic-298256.html 0.6 2026-06-23T15:19:36+08:00 daily https://www.pharmasources.com/industryinsights/research-finds-blood-thinners-protect-ag-298257.html 0.6 2026-06-20T20:56:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-start-up-echo-raises-7m-to-grow-apps--298258.html 0.6 2026-06-21T04:01:45+08:00 daily https://www.pharmasources.com/industryinsights/gvk-bio-launches-ecule-298259.html 0.6 2026-06-20T20:46:41+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-testoster-298260.html 0.6 2026-08-08T20:50:48+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-pharma-q2-net-up-32-per--298261.html 0.6 2026-06-21T04:56:43+08:00 daily https://www.pharmasources.com/industryinsights/chinas-fosun-pharma-takeover-of-an-india-298262.html 0.6 2026-08-05T11:58:54+08:00 daily https://www.pharmasources.com/industryinsights/alopexx-completes-first-in-man-trial-of--298263.html 0.6 2026-07-01T09:45:57+08:00 daily https://www.pharmasources.com/industryinsights/new-double-decker-antibody-technology-fi-298264.html 0.6 2026-06-22T17:52:53+08:00 daily https://www.pharmasources.com/industryinsights/incyte-and-macrogenics-collaborates-for--298265.html 0.6 2026-06-18T00:35:51+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-domestic-ebola-vaccine-298266.html 0.6 2026-08-07T11:39:25+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-ineffectiveness-of--298267.html 0.6 2026-06-21T01:11:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-collaboration-uses-organs-on-chips-t-298268.html 0.6 2026-06-22T00:54:45+08:00 daily https://www.pharmasources.com/industryinsights/transplanted-hematopoietic-stem-cells-re-298269.html 0.6 2026-06-23T03:57:02+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-psoriasis-drug-smashes-all-endpo-298270.html 0.6 2026-06-22T13:04:05+08:00 daily https://www.pharmasources.com/industryinsights/gsk-eyes-healthcare-expansion-hits-targe-298271.html 0.6 2026-06-21T12:21:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-begin-auction-of-consumer-heal-298272.html 0.6 2026-06-13T06:37:20+08:00 daily https://www.pharmasources.com/industryinsights/nhs-patients-could-be-offered-airbnb-lik-298273.html 0.6 2026-06-20T19:07:38+08:00 daily https://www.pharmasources.com/industryinsights/shires-haemophilia-a-gene-therapy-wins-o-298274.html 0.6 2026-06-20T22:42:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-ptcs-dmd-drug-translarna-298275.html 0.6 2026-06-21T08:21:17+08:00 daily https://www.pharmasources.com/industryinsights/tim-freemans-powder-flow-feature-underst-298276.html 0.6 2026-08-07T00:19:35+08:00 daily https://www.pharmasources.com/industryinsights/tim-freemans-powder-flow-feature-what-ma-298277.html 0.6 2026-08-07T00:15:30+08:00 daily https://www.pharmasources.com/industryinsights/ciplas-us-subsidiary-receives-us-fda-for-298278.html 0.6 2026-06-21T12:10:17+08:00 daily https://www.pharmasources.com/industryinsights/unichem-recalls-96876-bottles-of-bisopro-298279.html 0.6 2026-06-21T18:59:35+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-launch-consumer-health-sale-in-298280.html 0.6 2026-07-01T16:00:14+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-researchers-find-out-that-skin-298281.html 0.6 2026-06-18T03:15:57+08:00 daily https://www.pharmasources.com/industryinsights/clean-sterilized-silk-from-a-breed-of-mo-298282.html 0.6 2026-08-08T23:45:59+08:00 daily https://www.pharmasources.com/industryinsights/ucla-neuroscientists-use-weak-electrical-298283.html 0.6 2026-08-07T05:50:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-procainamide-hcl-injection--298284.html 0.6 2026-08-09T01:25:19+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--298285.html 0.6 2026-06-21T11:15:19+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-recipients-of-1-million--298286.html 0.6 2026-07-20T05:18:33+08:00 daily https://www.pharmasources.com/industryinsights/new-treatments-help-those-with-mild-mode-298287.html 0.6 2026-06-20T16:05:29+08:00 daily https://www.pharmasources.com/industryinsights/new-initiative-to-accelerate-development-298288.html 0.6 2026-06-20T19:02:36+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-proposed-biosimilar-pegfilgrastim-298289.html 0.6 2026-06-21T12:19:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-warns-against-blanket-use-of-antibi-298290.html 0.6 2026-06-20T22:59:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-considers-avastin-as-first-line-ovar-298291.html 0.6 2026-06-21T10:16:27+08:00 daily https://www.pharmasources.com/industryinsights/nhs-was-crippled-by-unsophisticated-cybe-298292.html 0.6 2026-07-03T22:19:55+08:00 daily https://www.pharmasources.com/industryinsights/celgene-hikes-price-of-revlimid-to-mask--298293.html 0.6 2026-06-21T02:55:59+08:00 daily https://www.pharmasources.com/industryinsights/insys-pharma-founder-charged-over-nation-298294.html 0.6 2026-06-20T21:58:39+08:00 daily https://www.pharmasources.com/industryinsights/dont-be-surprised-that-gold-is-used-to-t-298295.html 0.6 2026-08-05T12:56:07+08:00 daily https://www.pharmasources.com/industryinsights/fun-of-the-colors-of-china-and-us-rlds-298296.html 0.6 2026-07-26T00:08:41+08:00 daily https://www.pharmasources.com/industryinsights/a-legend-from-africa--prunus-africana-298297.html 0.6 2026-08-07T05:31:27+08:00 daily https://www.pharmasources.com/industryinsights/smart-artificial-beta-cells-could-lead-t-298298.html 0.6 2026-06-20T14:14:47+08:00 daily https://www.pharmasources.com/industryinsights/new-dosing-for-janssens-xarelto-approved-298299.html 0.6 2026-06-20T21:11:47+08:00 daily https://www.pharmasources.com/industryinsights/new-injectable-bydureon-bcise-for-type-2-298300.html 0.6 2026-07-18T02:10:46+08:00 daily https://www.pharmasources.com/industryinsights/vetter-announces-major-expansion-of-seco-298301.html 0.6 2026-06-20T22:43:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-the-planned-acquisiti-298302.html 0.6 2026-07-17T11:28:48+08:00 daily https://www.pharmasources.com/industryinsights/msd-withdraws-eu-application-of-keytruda-298303.html 0.6 2026-06-21T02:03:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-licenses-genetic-disease-dru-298304.html 0.6 2026-06-21T03:06:49+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-reinforces-biologic-ma-298305.html 0.6 2026-07-04T04:52:16+08:00 daily https://www.pharmasources.com/industryinsights/complaints-to-uk-pharma-regulator-jumped-298306.html 0.6 2026-07-07T07:40:05+08:00 daily https://www.pharmasources.com/industryinsights/uk-pharma-contributes-190m-to-nhs-meds-b-298307.html 0.6 2026-06-21T14:57:22+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-to-review-sandoz-neulasta--298308.html 0.6 2026-06-21T01:16:02+08:00 daily https://www.pharmasources.com/industryinsights/cmp-pharmas-carospir-now-available-298309.html 0.6 2026-06-20T16:46:03+08:00 daily https://www.pharmasources.com/industryinsights/mustang-bio-establishes-car-t-cell-thera-298310.html 0.6 2026-06-20T17:58:18+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-2018-invitation-298311.html 0.6 2026-06-21T00:44:39+08:00 daily https://www.pharmasources.com/industryinsights/successful-closing-of-cphi-p-mec-china-2-298312.html 0.6 2026-06-24T11:56:04+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-2018-298313.html 0.6 2026-06-20T19:57:41+08:00 daily https://www.pharmasources.com/industryinsights/chinas-taiwan-china-biotech-firms-urged--298314.html 0.6 2026-06-29T15:43:58+08:00 daily https://www.pharmasources.com/industryinsights/blackrock-launches-ishares-us-biotech-et-298315.html 0.6 2026-06-24T16:09:12+08:00 daily https://www.pharmasources.com/industryinsights/lupin-net-profit-falls-31-in-q2-to-rs-45-298316.html 0.6 2026-06-21T22:43:54+08:00 daily https://www.pharmasources.com/industryinsights/urgent-need-for-greater-political-commit-298317.html 0.6 2025-12-12T13:26:39+08:00 daily https://www.pharmasources.com/industryinsights/cfda-accepts-eisais-nda-for-cancer-drug-298318.html 0.6 2026-06-20T14:27:54+08:00 daily https://www.pharmasources.com/industryinsights/lonzanews-long-term-use-of-ppis-linked-t-298319.html 0.6 2026-06-21T10:58:04+08:00 daily https://www.pharmasources.com/industryinsights/focused-ultrasound-shows-promise-for-tre-298320.html 0.6 2026-06-23T23:55:24+08:00 daily https://www.pharmasources.com/industryinsights/omniactive-health-technologies-wins-fros-298321.html 0.6 2026-07-07T10:56:07+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-announces-an-investment-of-us7-298322.html 0.6 2026-06-08T06:47:36+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-disease-might-be-a-whole-body-298323.html 0.6 2026-06-22T00:57:46+08:00 daily https://www.pharmasources.com/industryinsights/shire-to-streamline-operations-with-100--298324.html 0.6 2026-07-20T11:52:24+08:00 daily https://www.pharmasources.com/industryinsights/novartis-submits-second-fda-application--298325.html 0.6 2026-06-21T16:59:41+08:00 daily https://www.pharmasources.com/industryinsights/kirin-holdings-to-withdraw-from-30-year--298326.html 0.6 2026-06-21T10:11:17+08:00 daily https://www.pharmasources.com/industryinsights/bayer-files-long-acting-haemophilia-ther-298327.html 0.6 2026-04-15T21:40:19+08:00 daily https://www.pharmasources.com/industryinsights/who-collaborating-centre-for-pharmacovig-298328.html 0.6 2026-07-22T09:09:09+08:00 daily https://www.pharmasources.com/industryinsights/netmeds-raises-14-m-from-tanncam-sistema-298329.html 0.6 2026-06-21T08:19:14+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-walks-away-from-voyagers-phase-23-298330.html 0.6 2026-06-21T12:59:32+08:00 daily https://www.pharmasources.com/industryinsights/new-study-indicates-bone-marrow-protein--298331.html 0.6 2026-08-06T23:09:17+08:00 daily https://www.pharmasources.com/industryinsights/avella-selected-by-astrazeneca-to-distri-298332.html 0.6 2026-06-27T08:57:12+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-acquire-radio-pharma-for-39b-298333.html 0.6 2026-06-20T20:05:36+08:00 daily https://www.pharmasources.com/industryinsights/combating-viruses-code-breakers-turn-cod-298334.html 0.6 2026-06-21T10:14:18+08:00 daily https://www.pharmasources.com/industryinsights/poxel-sumitomo-dianippon-pharma-ink-300--298335.html 0.6 2026-08-05T18:45:35+08:00 daily https://www.pharmasources.com/industryinsights/new-nanoparticles-technology-to-improve--298336.html 0.6 2026-06-21T06:15:20+08:00 daily https://www.pharmasources.com/industryinsights/anabasum-shows-promise-for-patients-with-298337.html 0.6 2026-06-20T16:57:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-calquence-for-adults-with-m-298338.html 0.6 2026-07-01T16:36:40+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-predicts-intense-innovato-298339.html 0.6 2026-06-20T15:13:21+08:00 daily https://www.pharmasources.com/industryinsights/new-us-study-reveals-key-reasons-why-mil-298340.html 0.6 2026-06-22T09:57:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-companies-marketing-unproven-p-298341.html 0.6 2025-12-11T20:44:44+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-approved-for-funding-in-298342.html 0.6 2026-07-17T14:04:59+08:00 daily https://www.pharmasources.com/industryinsights/indiviors-opioid-addiction-treatment-rec-298343.html 0.6 2026-06-21T12:05:11+08:00 daily https://www.pharmasources.com/industryinsights/nice-back-roches-tecentriq-for-cdf-298344.html 0.6 2026-06-20T19:10:42+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-biologic-shines-again--298345.html 0.6 2026-04-12T22:29:01+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmaceuticals-acquires-orit-la-298346.html 0.6 2026-04-08T17:10:35+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-partners-with-m-298347.html 0.6 2026-08-07T05:31:25+08:00 daily https://www.pharmasources.com/industryinsights/ispe-announces-2017-facility-of-the-year-298348.html 0.6 2026-08-06T20:08:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-scientist-wounded-in-nyc-terror-298349.html 0.6 2026-08-06T23:38:05+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-reports-unaudited-financi-298350.html 0.6 2026-08-06T21:58:27+08:00 daily https://www.pharmasources.com/industryinsights/western-european-ivd-market-boosted-by-f-298351.html 0.6 2026-08-08T03:09:03+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-enters-into-partnership-with-cu-298352.html 0.6 2026-08-07T05:31:24+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-signs-agreement-with-bluep-298353.html 0.6 2026-06-21T05:14:58+08:00 daily https://www.pharmasources.com/industryinsights/ulcerative-colitis-patients-see-long-ter-298354.html 0.6 2026-07-01T07:36:12+08:00 daily https://www.pharmasources.com/industryinsights/nusinersen-enables-infants-with-sma-to-r-298355.html 0.6 2026-06-20T20:59:38+08:00 daily https://www.pharmasources.com/industryinsights/topical-valsartan-found-to-be-effective--298356.html 0.6 2026-06-21T12:52:18+08:00 daily https://www.pharmasources.com/industryinsights/elligo-health-research-announces-technol-298357.html 0.6 2026-06-21T00:15:52+08:00 daily https://www.pharmasources.com/industryinsights/cancer-cells-destroyed-with-dinosaur-ext-298358.html 0.6 2026-07-02T20:16:20+08:00 daily https://www.pharmasources.com/industryinsights/new-tissue-engineered-blood-vessel-repla-298359.html 0.6 2026-06-22T02:56:41+08:00 daily https://www.pharmasources.com/industryinsights/tevas-woes-continue-as-shares-sink-to-17-298360.html 0.6 2026-06-20T22:06:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-warnings-in-crackdown-on-base-298361.html 0.6 2026-06-21T15:14:14+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-maintains-its-guidance-for-2017--298362.html 0.6 2026-06-20T23:02:42+08:00 daily https://www.pharmasources.com/industryinsights/az-experimental-asthma-drug-fails-in-pha-298363.html 0.6 2026-08-05T15:25:59+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-nod-for-sanofis-kevzara-298364.html 0.6 2026-06-20T21:57:35+08:00 daily https://www.pharmasources.com/industryinsights/gsks-anoro-ellipta-beats-bis-spiolto-res-298365.html 0.6 2026-07-26T12:54:23+08:00 daily https://www.pharmasources.com/industryinsights/eu-oks-low-dose-xarelto-to-prevent-recur-298366.html 0.6 2026-06-21T23:14:00+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-acticlate-tablets-298367.html 0.6 2026-06-21T11:11:16+08:00 daily https://www.pharmasources.com/industryinsights/symic-bio-announces-results-from-sb-030--298368.html 0.6 2026-06-21T13:01:29+08:00 daily https://www.pharmasources.com/industryinsights/compugen-mount-sinai-collaborate-on-nove-298369.html 0.6 2026-06-20T23:08:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-companies-marketing-unproven-p-298370.html 0.6 2026-06-21T19:15:58+08:00 daily https://www.pharmasources.com/industryinsights/astellas-announces-leadership-changes-in-298371.html 0.6 2026-06-20T19:23:07+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-to-acquire-ocera-therapeuti-298372.html 0.6 2026-06-22T10:53:58+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-biolabs-announce-fo-298373.html 0.6 2026-07-02T07:11:07+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-ditches-il-4il-13-antibody-drug-i-298374.html 0.6 2026-06-20T23:00:40+08:00 daily https://www.pharmasources.com/industryinsights/novartis-amgen-and-banner-aim-for-alzhei-298375.html 0.6 2026-06-21T05:05:44+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-dicerna-pen-201m-pact-to-hit--298376.html 0.6 2026-06-21T02:53:32+08:00 daily https://www.pharmasources.com/industryinsights/where-could-allergans-cost-cuts-fall-dtc-298377.html 0.6 2026-04-15T08:53:48+08:00 daily https://www.pharmasources.com/industryinsights/opening-ceremony-of-cstone-pharmaceutica-298378.html 0.6 2026-07-08T01:02:24+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-pall-corporation-esta-298379.html 0.6 2026-06-23T22:55:00+08:00 daily https://www.pharmasources.com/industryinsights/celonic-buys-out-glycotopes-bio-manufact-298380.html 0.6 2026-07-17T11:12:42+08:00 daily https://www.pharmasources.com/industryinsights/new-gene-identified-responsible-for-scol-298381.html 0.6 2026-03-27T16:41:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vyzulta-for-open-angle-glau-298382.html 0.6 2026-06-20T15:13:19+08:00 daily https://www.pharmasources.com/industryinsights/4-in-1-vaccine-may-provide-lifelong-prot-298383.html 0.6 2026-06-20T02:09:09+08:00 daily https://www.pharmasources.com/industryinsights/basf-to-enter-medical-foods-market-in-th-298384.html 0.6 2026-06-20T14:46:02+08:00 daily https://www.pharmasources.com/industryinsights/combined-therapies-increase-side-effects-298385.html 0.6 2026-06-21T07:58:08+08:00 daily https://www.pharmasources.com/industryinsights/factory-cro-announces-acquisition-of-mil-298386.html 0.6 2026-06-20T15:08:15+08:00 daily https://www.pharmasources.com/industryinsights/novartis-amgen-bai-start-new-alzheimers--298387.html 0.6 2026-07-02T03:42:13+08:00 daily https://www.pharmasources.com/industryinsights/gsks-rd-head-to-move-on-after-shift-in-f-298388.html 0.6 2026-07-01T23:55:49+08:00 daily https://www.pharmasources.com/industryinsights/witty-to-lead-way-in-fast-tracking-medic-298389.html 0.6 2026-06-21T05:12:51+08:00 daily https://www.pharmasources.com/industryinsights/gsks-experimental-multiple-myeloma-score-298390.html 0.6 2026-06-20T21:05:40+08:00 daily https://www.pharmasources.com/industryinsights/an-overview-of-the-user-fee-systems-conc-298391.html 0.6 2026-07-28T01:30:05+08:00 daily https://www.pharmasources.com/industryinsights/bi-dicerna-to-develop-rnai-therapeutics--298392.html 0.6 2026-06-21T18:16:39+08:00 daily https://www.pharmasources.com/industryinsights/uk-children-experiencing-chronic-delays--298393.html 0.6 2026-08-03T05:13:38+08:00 daily https://www.pharmasources.com/industryinsights/torrent-pharma-in-agreement-with-unichem-298394.html 0.6 2026-06-21T03:50:31+08:00 daily https://www.pharmasources.com/industryinsights/itrc-convenes-second-isag-meeting-298395.html 0.6 2026-08-09T07:56:55+08:00 daily https://www.pharmasources.com/industryinsights/msf-secures-generic-hepatitis-c-treatmen-298396.html 0.6 2026-08-08T22:36:29+08:00 daily https://www.pharmasources.com/industryinsights/drl-launches-generic-azacitidine-for-inj-298397.html 0.6 2026-08-07T13:18:48+08:00 daily https://www.pharmasources.com/industryinsights/clariant-healthcare-packaging-site-in-cu-298398.html 0.6 2026-06-21T07:57:09+08:00 daily https://www.pharmasources.com/industryinsights/lung-cancer-research-foundation-awards-1-298399.html 0.6 2026-08-07T04:07:17+08:00 daily https://www.pharmasources.com/industryinsights/biogen-appoints-executive-vice-president-298400.html 0.6 2026-08-07T03:55:08+08:00 daily https://www.pharmasources.com/industryinsights/geckos-talent-for-regrowing-its-tail-cou-298401.html 0.6 2026-08-07T03:34:17+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-rd-chief-vallance-to-lea-298402.html 0.6 2026-08-07T03:02:32+08:00 daily https://www.pharmasources.com/industryinsights/amerisourcebergen-sees-end-in-sight-for--298403.html 0.6 2026-08-07T02:55:24+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-biotech-announces-receipt-of-del-298404.html 0.6 2026-08-07T02:45:46+08:00 daily https://www.pharmasources.com/industryinsights/wat-med-will-display-emeterm-and-headate-298405.html 0.6 2026-08-07T02:40:38+08:00 daily https://www.pharmasources.com/industryinsights/researchers-design-a-vaccine-for-strepto-298406.html 0.6 2026-08-07T01:21:59+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-a-new-way-to-acquire-via-298407.html 0.6 2026-08-07T01:27:46+08:00 daily https://www.pharmasources.com/industryinsights/four-genes-linked-to-pancreatic-cancer-i-298408.html 0.6 2026-08-07T01:36:36+08:00 daily https://www.pharmasources.com/industryinsights/tucson-startup-revolutionary-medical-dev-298409.html 0.6 2026-08-07T02:30:55+08:00 daily https://www.pharmasources.com/industryinsights/frazier-healthcare-partners-raises-419m--298410.html 0.6 2026-08-07T02:33:35+08:00 daily https://www.pharmasources.com/industryinsights/researchers-claim-that-an-acid-reflex-dr-298411.html 0.6 2026-08-07T02:40:19+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-biolabs-announce-fo-298412.html 0.6 2026-08-07T02:52:35+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-revenue-up-52-driven-by-biophar-298413.html 0.6 2026-08-07T03:02:30+08:00 daily https://www.pharmasources.com/industryinsights/bariatric-surgery-after-age-60-is-safe-a-298414.html 0.6 2026-08-09T20:19:38+08:00 daily https://www.pharmasources.com/industryinsights/interview-cse-group-298415.html 0.6 2026-08-07T02:43:01+08:00 daily https://www.pharmasources.com/industryinsights/teva-to-set-up-jv-with-guangzhou-pharma-298416.html 0.6 2026-06-23T04:01:53+08:00 daily https://www.pharmasources.com/industryinsights/mass-spectrometry-technique-could-lead-t-298417.html 0.6 2026-06-21T06:58:52+08:00 daily https://www.pharmasources.com/industryinsights/research-of-in-vitro-dissolution-of-rani-298418.html 0.6 2026-08-07T03:33:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vimpat-for-partial-onset-se-298419.html 0.6 2026-01-30T21:20:53+08:00 daily https://www.pharmasources.com/industryinsights/anabolic-androgenic-steroids-associated--298420.html 0.6 2026-08-09T07:56:36+08:00 daily https://www.pharmasources.com/industryinsights/anhui-chem-brightdescription-of-featured-298421.html 0.6 2026-06-25T18:27:44+08:00 daily https://www.pharmasources.com/industryinsights/interview-ruian-jianghua-machinery-co-lt-298422.html 0.6 2026-08-07T01:14:28+08:00 daily https://www.pharmasources.com/industryinsights/can-cannabinoids-be-used-to-treat-cancer-298423.html 0.6 2026-08-08T10:13:47+08:00 daily https://www.pharmasources.com/industryinsights/valeant-begins-long-comeback-trail-with--298424.html 0.6 2026-08-08T07:57:36+08:00 daily https://www.pharmasources.com/industryinsights/development-trends-of-capsules-in-china--298425.html 0.6 2026-08-09T05:33:43+08:00 daily https://www.pharmasources.com/industryinsights/quintilesims-is-now-iqvia-298426.html 0.6 2026-08-07T13:55:35+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-invests-rs-75-cr-in-pace-ho-298427.html 0.6 2026-08-08T23:08:41+08:00 daily https://www.pharmasources.com/industryinsights/basf-in-agreement-with-diem-labs-298428.html 0.6 2026-08-09T12:47:19+08:00 daily https://www.pharmasources.com/industryinsights/artemis-therapeutics-receives-orphan-dru-298429.html 0.6 2026-06-21T00:07:08+08:00 daily https://www.pharmasources.com/industryinsights/stelara-shows-positive-results-in-treatm-298430.html 0.6 2026-07-29T13:29:56+08:00 daily https://www.pharmasources.com/industryinsights/vimpat-approved-by-fda-to-treat-partial--298431.html 0.6 2026-06-30T15:59:04+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-doses-first-subject-in-bioequiv-298432.html 0.6 2026-06-23T12:57:48+08:00 daily https://www.pharmasources.com/industryinsights/ann-barbier-says-adios-to-agios-as-she-t-298433.html 0.6 2026-06-21T12:07:18+08:00 daily https://www.pharmasources.com/industryinsights/after-a-strong-few-years-aimmune-ceo-dil-298434.html 0.6 2026-06-20T17:00:27+08:00 daily https://www.pharmasources.com/industryinsights/teva-looks-to-sell-generics-in-china-thr-298435.html 0.6 2026-07-30T20:52:27+08:00 daily https://www.pharmasources.com/industryinsights/cedrus-investments-executive-director-ol-298436.html 0.6 2026-06-25T01:01:04+08:00 daily https://www.pharmasources.com/industryinsights/best-performing-clinical-applications-in-298437.html 0.6 2026-04-24T04:38:12+08:00 daily https://www.pharmasources.com/industryinsights/pd-1-and-its-clinical-application-a-20-y-298438.html 0.6 2026-08-07T05:28:30+08:00 daily https://www.pharmasources.com/industryinsights/tim-freemans-powder-flow-feature-explori-298439.html 0.6 2026-08-07T00:02:44+08:00 daily https://www.pharmasources.com/industryinsights/77-of-healthcare-leaders-believe-they-ne-298440.html 0.6 2026-08-07T05:05:27+08:00 daily https://www.pharmasources.com/industryinsights/bioclinica-acquires-mddx-research-inform-298441.html 0.6 2026-08-07T01:52:02+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-an-app-for-rheumatoi-298442.html 0.6 2026-08-07T01:43:06+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-startup-in-pakistan-raises-1m-298443.html 0.6 2026-08-07T01:27:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zelboraf-for-certain-patien-298444.html 0.6 2026-08-07T01:20:08+08:00 daily https://www.pharmasources.com/industryinsights/electric-bandages-can-help-fight-biofilm-298445.html 0.6 2026-08-07T01:19:57+08:00 daily https://www.pharmasources.com/industryinsights/carbon-nanotubes-may-pose-cancer-risk-si-298446.html 0.6 2026-08-07T01:27:35+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-science-centre-singapore-launc-298447.html 0.6 2026-08-07T01:36:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-certain-298448.html 0.6 2026-08-07T01:39:36+08:00 daily https://www.pharmasources.com/industryinsights/breathalyser-for-malaria-shows-promise-i-298449.html 0.6 2026-08-07T01:43:11+08:00 daily https://www.pharmasources.com/industryinsights/takedas-dengue-vaccine-surpasses-sanofis-298450.html 0.6 2026-08-07T01:51:58+08:00 daily https://www.pharmasources.com/industryinsights/bayer-files-low-dose-xareltoaspirin-comb-298451.html 0.6 2026-08-07T02:04:53+08:00 daily https://www.pharmasources.com/industryinsights/roche-granted-us-approval-for-wider-use--298452.html 0.6 2026-06-20T14:44:21+08:00 daily https://www.pharmasources.com/industryinsights/new-test-could-detect-oesophageal-cancer-298453.html 0.6 2026-06-20T23:18:04+08:00 daily https://www.pharmasources.com/industryinsights/gsk-consumer-q2-profit-up-marginally-at--298454.html 0.6 2026-07-04T03:44:31+08:00 daily https://www.pharmasources.com/industryinsights/cipla-posts-rs-435-cr-profit-at-q2-298455.html 0.6 2026-06-21T06:21:23+08:00 daily https://www.pharmasources.com/industryinsights/mylan-seeks-ema-approval-for-two-biosimi-298456.html 0.6 2026-06-21T22:55:37+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-us-fda-warning-letters-298457.html 0.6 2026-08-07T21:08:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-erdheim-298458.html 0.6 2026-06-20T19:02:32+08:00 daily https://www.pharmasources.com/industryinsights/new-data-shows-tremfya-improved-psoriati-298459.html 0.6 2026-07-04T01:50:46+08:00 daily https://www.pharmasources.com/industryinsights/amgen-targets-west-coast-rd-jobs-in-late-298460.html 0.6 2026-03-25T19:37:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-lifts-hold-on-cellectis-car-t-trial--298461.html 0.6 2026-07-27T13:53:28+08:00 daily https://www.pharmasources.com/industryinsights/did-allergan-lose-its-21b-kythera-bet-or-298462.html 0.6 2026-07-17T22:52:34+08:00 daily https://www.pharmasources.com/industryinsights/with-new-fda-nod-roches-alecensa-set-to--298463.html 0.6 2026-07-23T08:47:52+08:00 daily https://www.pharmasources.com/industryinsights/equashield-signs-exclusive-distribution--298464.html 0.6 2026-06-21T10:56:10+08:00 daily https://www.pharmasources.com/industryinsights/darling-ingredients-inc-reports-third-qu-298465.html 0.6 2026-04-07T23:34:44+08:00 daily https://www.pharmasources.com/industryinsights/roche-gives-free-access-to-cancer-drug-a-298466.html 0.6 2026-08-07T03:30:39+08:00 daily https://www.pharmasources.com/industryinsights/portland-biotech-firm-immucell-completes-298467.html 0.6 2026-08-07T03:18:53+08:00 daily https://www.pharmasources.com/industryinsights/singapores-national-cancer-centre-partne-298468.html 0.6 2026-08-07T03:08:20+08:00 daily https://www.pharmasources.com/industryinsights/neuroscientists-identify-source-of-early-298469.html 0.6 2026-08-07T02:55:25+08:00 daily https://www.pharmasources.com/industryinsights/researcher-develop-new-treatment-of-chro-298470.html 0.6 2026-08-07T02:52:01+08:00 daily https://www.pharmasources.com/industryinsights/frutarom-acquires-ab-fortis-product-from-298471.html 0.6 2026-08-07T02:40:34+08:00 daily https://www.pharmasources.com/industryinsights/researchers-collaborate-to-study-neuro-d-298472.html 0.6 2026-08-07T02:51:53+08:00 daily https://www.pharmasources.com/industryinsights/banner-alzheimers-institute-novartis-and-298473.html 0.6 2026-08-07T03:06:33+08:00 daily https://www.pharmasources.com/industryinsights/gene-breakthrough-on-lithium-treatment-f-298474.html 0.6 2026-08-07T13:15:25+08:00 daily https://www.pharmasources.com/industryinsights/tolvaptan-identified-as-a-treatment-for--298475.html 0.6 2026-08-08T08:03:36+08:00 daily https://www.pharmasources.com/industryinsights/colon-cancer-breakthrough-could-lead-to--298476.html 0.6 2026-08-08T10:05:21+08:00 daily https://www.pharmasources.com/industryinsights/spark-therapeutics-and-pfizer-amend-lice-298477.html 0.6 2026-08-08T12:18:41+08:00 daily https://www.pharmasources.com/industryinsights/cellectis-reopens-the-off-the-shelf-car--298478.html 0.6 2026-08-08T18:13:18+08:00 daily https://www.pharmasources.com/industryinsights/bayers-stivarga-rejected-by-nice-for-liv-298479.html 0.6 2026-06-21T08:08:03+08:00 daily https://www.pharmasources.com/industryinsights/congress-weighs-repeal-of-tax-credit-for-298480.html 0.6 2026-06-20T17:58:50+08:00 daily https://www.pharmasources.com/industryinsights/abbott-pioneered-in-india-market-by-laun-298481.html 0.6 2026-06-21T14:09:33+08:00 daily https://www.pharmasources.com/industryinsights/cathay-pacific-bags-iata-ceiv-pharma-cer-298482.html 0.6 2026-07-27T02:20:58+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-q2-net-rises-to-rs-121-cr-298483.html 0.6 2026-06-21T00:18:55+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-wins-industry-p-298484.html 0.6 2026-06-21T06:07:58+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-announces-positive-data-from-tri-298485.html 0.6 2026-08-08T04:28:44+08:00 daily https://www.pharmasources.com/industryinsights/biopharmx-receives-concurrence-from-fda--298486.html 0.6 2026-08-08T03:31:01+08:00 daily https://www.pharmasources.com/industryinsights/long-term-use-of-taltz-shows-efficacy-im-298487.html 0.6 2026-08-07T14:15:18+08:00 daily https://www.pharmasources.com/industryinsights/roche-calico-vet-hal-barron-takes-gsk-rd-298488.html 0.6 2026-08-07T13:57:42+08:00 daily https://www.pharmasources.com/industryinsights/zebra-medical-to-bring-ai-based-image-an-298489.html 0.6 2026-08-07T13:19:29+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-renews-know-pneumonia-campaign-wi-298490.html 0.6 2026-08-07T05:51:48+08:00 daily https://www.pharmasources.com/industryinsights/nice-shoots-down-bayers-stivarga-in-live-298491.html 0.6 2026-08-07T05:39:34+08:00 daily https://www.pharmasources.com/industryinsights/united-states-food-and-drug-administrati-298492.html 0.6 2026-08-07T05:37:05+08:00 daily https://www.pharmasources.com/industryinsights/singapores-restalyst-develops-new-method-298493.html 0.6 2026-08-07T05:01:24+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20171110-298494.html 0.6 2026-08-07T04:33:43+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-poaches-new-cso-from-goo-298495.html 0.6 2026-08-07T02:41:08+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-updated-status-for-its-3500-jo-298496.html 0.6 2026-08-09T06:17:39+08:00 daily https://www.pharmasources.com/industryinsights/sage-soars-as-postpartum-depression-phas-298497.html 0.6 2026-08-08T14:47:40+08:00 daily https://www.pharmasources.com/industryinsights/otonomys-renaissance-starts-as-mnires-di-298498.html 0.6 2026-08-08T17:53:11+08:00 daily https://www.pharmasources.com/industryinsights/trump-poised-to-nominate-ex-lilly-execut-298499.html 0.6 2026-08-08T23:20:15+08:00 daily https://www.pharmasources.com/industryinsights/after-hep-c-hit-mercks-antiviral-busines-298500.html 0.6 2026-06-21T12:24:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-seattle-genetics-adcetris-t-298501.html 0.6 2026-06-21T04:20:12+08:00 daily https://www.pharmasources.com/industryinsights/bay-areas-principia-biopharma-scores-765-298502.html 0.6 2026-06-20T23:03:43+08:00 daily https://www.pharmasources.com/industryinsights/singapores-restalyst-develops-new-method-298503.html 0.6 2026-06-20T22:16:10+08:00 daily https://www.pharmasources.com/industryinsights/novartis-breast-cancer-medication-kisqal-298504.html 0.6 2026-06-21T04:58:48+08:00 daily https://www.pharmasources.com/industryinsights/tim-freemans-powder-flow-feature-explori-298505.html 0.6 2026-08-06T23:56:05+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-announces-40m-uk-fill-and-finish-298506.html 0.6 2026-06-21T00:15:52+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-helps-child-regrow-80-of-sk-298507.html 0.6 2026-06-21T11:19:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ties-with-royal-marsden-to-boos-298508.html 0.6 2026-06-20T17:04:15+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-mina-therapeuti-298509.html 0.6 2026-02-28T13:35:03+08:00 daily https://www.pharmasources.com/industryinsights/nanoshells-could-deliver-more-chemo-with-298510.html 0.6 2026-06-21T08:51:07+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-posts-q2-net-profit-at-rs-298511.html 0.6 2026-06-21T19:14:52+08:00 daily https://www.pharmasources.com/industryinsights/morepen-labs-ties-up-with-vesale-pharma-298512.html 0.6 2026-06-18T05:32:53+08:00 daily https://www.pharmasources.com/industryinsights/wisdomsmith-advisors-releases-report-on--298513.html 0.6 2026-06-20T19:43:37+08:00 daily https://www.pharmasources.com/industryinsights/hester-biosciences-net-profit-up-in-q2fy-298514.html 0.6 2026-06-20T21:12:46+08:00 daily https://www.pharmasources.com/industryinsights/neurimmune-ono-pharmaceutical-collaborat-298515.html 0.6 2026-06-24T01:34:22+08:00 daily https://www.pharmasources.com/industryinsights/protagonist-therapeutics-initiates-ptg-2-298516.html 0.6 2026-06-20T23:02:48+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-principia-agree-to-develop-multip-298517.html 0.6 2026-06-21T02:12:47+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-pays-40m-commits-765m-more-for-pr-298518.html 0.6 2026-06-29T08:08:08+08:00 daily https://www.pharmasources.com/industryinsights/otonomys-renaissance-starts-as-mnires-di-298519.html 0.6 2026-06-20T15:01:06+08:00 daily https://www.pharmasources.com/industryinsights/after-hep-c-hit-mercks-antiviral-busines-298520.html 0.6 2026-06-24T03:09:49+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-health-management-smart-bel-298521.html 0.6 2026-06-21T03:56:40+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-limited-announces-third-quart-298522.html 0.6 2026-08-10T01:26:35+08:00 daily https://www.pharmasources.com/industryinsights/quality-management-of-hubei-xinji-pharma-298523.html 0.6 2026-08-05T23:36:20+08:00 daily https://www.pharmasources.com/industryinsights/hebei-huaheng-biological-technology-well-298524.html 0.6 2026-08-06T11:48:25+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-collaborates-with-principia-bioph-298525.html 0.6 2026-06-20T15:53:23+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-based-biotech-firm-raises-32m-298526.html 0.6 2026-07-20T19:57:03+08:00 daily https://www.pharmasources.com/industryinsights/us-scientists-use-gold-nanoshells-for-dr-298527.html 0.6 2026-06-21T04:51:38+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-marketing-authorisation-for-p-298528.html 0.6 2026-08-06T01:03:31+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccine-found-to-prevent-childhood-r-298529.html 0.6 2026-03-19T23:38:10+08:00 daily https://www.pharmasources.com/industryinsights/animal-free-media-formulation-service-by-298530.html 0.6 2026-06-22T08:56:40+08:00 daily https://www.pharmasources.com/industryinsights/bms-pfizer-alliance-to-unveil-real-world-298531.html 0.6 2026-08-08T03:28:40+08:00 daily https://www.pharmasources.com/industryinsights/hep-b-vaccine-four-year-battle-for-fda-a-298532.html 0.6 2026-06-20T14:49:08+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-mercks-mavenclad-for-ms-298533.html 0.6 2026-06-22T04:00:38+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-buys-rights-to-principias-btk-inh-298534.html 0.6 2026-06-21T03:07:48+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-reducing-185-jobs-while-add-298535.html 0.6 2026-07-03T02:42:05+08:00 daily https://www.pharmasources.com/industryinsights/roches-ocrevus-ocrelizumab-gains-positiv-298536.html 0.6 2026-06-20T21:09:46+08:00 daily https://www.pharmasources.com/industryinsights/adalimumab-biosimilar-exhibits-same-effi-298537.html 0.6 2026-06-20T17:58:16+08:00 daily https://www.pharmasources.com/industryinsights/palliative-medicinal-cannabis-can-reduce-298538.html 0.6 2026-02-15T13:35:33+08:00 daily https://www.pharmasources.com/industryinsights/towards-a-smarter-insulin-298539.html 0.6 2026-06-21T09:04:00+08:00 daily https://www.pharmasources.com/industryinsights/tim-freemans-powder-flow-feature-explori-298540.html 0.6 2026-08-06T23:33:05+08:00 daily https://www.pharmasources.com/industryinsights/tim-freemans-powder-flow-feature-embraci-298541.html 0.6 2026-08-06T23:36:50+08:00 daily https://www.pharmasources.com/industryinsights/insights-and-learnings-galore-at-pharma--298542.html 0.6 2026-07-17T17:04:50+08:00 daily https://www.pharmasources.com/industryinsights/export-excellence-awarded-at-pharma-cxo--298543.html 0.6 2026-07-24T18:58:48+08:00 daily https://www.pharmasources.com/industryinsights/ofev-study-results-released-of-fibrotic--298544.html 0.6 2026-06-21T07:14:09+08:00 daily https://www.pharmasources.com/industryinsights/amgen-allergan-receive-positive-chmp-for-298545.html 0.6 2026-06-20T17:53:23+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-announces-new-data-f-298546.html 0.6 2025-12-06T21:42:29+08:00 daily https://www.pharmasources.com/industryinsights/vertex-receives-chmp-positive-opinion-fo-298547.html 0.6 2026-06-21T11:00:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-sprycel-298548.html 0.6 2026-06-21T11:15:19+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-announces-fda-acceptance-for-nd-298549.html 0.6 2026-06-21T03:03:42+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-posts-early-checkpoint-com-298550.html 0.6 2026-08-09T05:56:40+08:00 daily https://www.pharmasources.com/industryinsights/chutes-laddersglaxosmithkline-cso-vallan-298551.html 0.6 2026-03-20T03:18:44+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaas-mavenclad-roches-perjeta-win-298552.html 0.6 2026-03-21T12:55:23+08:00 daily https://www.pharmasources.com/industryinsights/heron-takes-on-mercks-emend-with-fda-win-298553.html 0.6 2026-07-18T04:43:22+08:00 daily https://www.pharmasources.com/industryinsights/statement-by-resmed-on-united-kingdom-ca-298554.html 0.6 2026-06-22T11:52:15+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-names-aquasana-inc-north--298555.html 0.6 2026-06-21T03:07:50+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20171113-298556.html 0.6 2026-06-20T18:14:42+08:00 daily https://www.pharmasources.com/industryinsights/review-summary-and-analysis-of-the-novel-298557.html 0.6 2026-06-22T06:04:39+08:00 daily https://www.pharmasources.com/industryinsights/stachyosethe-chinese-strength-contribute-298558.html 0.6 2026-08-08T00:29:25+08:00 daily https://www.pharmasources.com/industryinsights/stachyosethe-chinese-strength-contribute-298559.html 0.6 2026-08-07T12:00:24+08:00 daily https://www.pharmasources.com/industryinsights/stachyosethe-chinese-strength-contribute-298560.html 0.6 2026-07-02T18:30:19+08:00 daily https://www.pharmasources.com/industryinsights/un-steps-up-vaccination-of-rohingyas-as--298561.html 0.6 2026-06-20T15:14:21+08:00 daily https://www.pharmasources.com/industryinsights/stryker-receives-us-fda-hde-approval-for-298562.html 0.6 2026-07-04T13:32:09+08:00 daily https://www.pharmasources.com/industryinsights/fosun-pharma-to-buy-stake-in-shenzhen-ho-298563.html 0.6 2026-08-07T18:58:19+08:00 daily https://www.pharmasources.com/industryinsights/singapore-researchers-develop-self-illum-298564.html 0.6 2026-06-20T19:01:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vraylar-in-the-maintenance--298565.html 0.6 2026-07-27T20:58:24+08:00 daily https://www.pharmasources.com/industryinsights/new-novartis-entresto-real-world-evidenc-298566.html 0.6 2026-06-20T14:39:23+08:00 daily https://www.pharmasources.com/industryinsights/mushrooms-are-full-of-antioxidants-that--298567.html 0.6 2026-07-05T08:18:07+08:00 daily https://www.pharmasources.com/industryinsights/mylan-to-withdraw-from-tel-aviv-stock-ex-298568.html 0.6 2026-08-03T04:57:29+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-approval-of-roches-ocrevu-298569.html 0.6 2026-08-09T21:45:43+08:00 daily https://www.pharmasources.com/industryinsights/uk-rates-of-obesity-increased-by-92-over-298570.html 0.6 2026-07-03T04:24:38+08:00 daily https://www.pharmasources.com/industryinsights/gates-streams-50m-into-britains-dementia-298571.html 0.6 2026-07-07T05:56:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-first-new-hep-b-vaccine-in-25-298572.html 0.6 2026-06-21T13:10:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pill-with-sensor-that-digit-298573.html 0.6 2026-06-21T23:01:44+08:00 daily https://www.pharmasources.com/industryinsights/trump-nominates-ex-drug-company-executiv-298574.html 0.6 2026-06-18T00:35:29+08:00 daily https://www.pharmasources.com/industryinsights/life-science-giant-ppd-cuts-an-undisclos-298575.html 0.6 2026-06-21T21:55:38+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-q2-net-dips-to-rs-111-cr-298576.html 0.6 2026-06-21T03:58:46+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-net-profit-at-rs-488-crore-i-298577.html 0.6 2026-08-07T03:56:31+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-fda-approval-for-gonal-f--298578.html 0.6 2026-06-22T12:14:05+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-positive-chmp-opinion-for-298579.html 0.6 2026-06-23T17:14:38+08:00 daily https://www.pharmasources.com/industryinsights/theravance-biopharma-mylan-submit-nda-fo-298580.html 0.6 2026-06-21T01:02:48+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-announces-activation-of-first--298581.html 0.6 2026-06-26T19:05:50+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-alnylam-accelerated-assessmen-298582.html 0.6 2026-07-25T13:57:42+08:00 daily https://www.pharmasources.com/industryinsights/allergan-receives-fda-approval-for-use-o-298583.html 0.6 2026-08-07T13:52:29+08:00 daily https://www.pharmasources.com/industryinsights/novartis-already-up-on-crispr-car-t-look-298584.html 0.6 2026-08-07T15:55:16+08:00 daily https://www.pharmasources.com/industryinsights/takeda-lundbeck-plan-us-test-for-depress-298585.html 0.6 2026-08-09T15:53:37+08:00 daily https://www.pharmasources.com/industryinsights/cedrus-investments-hosted-life-sciences--298586.html 0.6 2026-06-22T14:31:34+08:00 daily https://www.pharmasources.com/industryinsights/standigm-an-ai-based-drug-discovery-comp-298587.html 0.6 2026-06-21T01:01:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pill-with-sensor-298588.html 0.6 2026-06-21T01:28:21+08:00 daily https://www.pharmasources.com/industryinsights/koreas-dongsung-pharmaceuticals-opens-a--298589.html 0.6 2026-06-20T18:57:50+08:00 daily https://www.pharmasources.com/industryinsights/pma-announces-free-eye-surgeries-by-chin-298590.html 0.6 2026-07-03T19:36:22+08:00 daily https://www.pharmasources.com/industryinsights/helperby-therapeutics-develops-sustainab-298591.html 0.6 2026-06-22T12:51:40+08:00 daily https://www.pharmasources.com/industryinsights/meet-the-4-biotechs-that-are-disrupting--298592.html 0.6 2026-06-21T07:22:16+08:00 daily https://www.pharmasources.com/industryinsights/with-only-2-warnings-in-2017-pharmas-ad--298593.html 0.6 2026-06-20T19:43:16+08:00 daily https://www.pharmasources.com/industryinsights/with-new-digital-abilify-big-brother-isn-298594.html 0.6 2026-06-25T02:23:25+08:00 daily https://www.pharmasources.com/industryinsights/bayer-loxo-partner-up-for-15b-cancer-dru-298595.html 0.6 2026-07-17T06:30:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-about-illegal-use-of-injectabl-298596.html 0.6 2026-06-29T16:02:24+08:00 daily https://www.pharmasources.com/industryinsights/scotland-approves-three-new-meds-for-nhs-298597.html 0.6 2026-06-21T06:12:58+08:00 daily https://www.pharmasources.com/industryinsights/louis-roy-president-optel-group-bags-que-298598.html 0.6 2026-06-20T22:04:40+08:00 daily https://www.pharmasources.com/industryinsights/drl-launches-clofarabine-injection-in-us-298599.html 0.6 2026-06-20T21:00:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pill-that-tracks-if-patient-298600.html 0.6 2026-06-21T22:01:40+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-gets-eir-from-us-fda-for-ap--298601.html 0.6 2026-06-20T15:10:25+08:00 daily https://www.pharmasources.com/industryinsights/roche-appoints-lara-bezerra-as-md-roche--298602.html 0.6 2026-06-21T23:56:42+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-celebrates-eu-approval-of-hum-298603.html 0.6 2026-07-17T10:26:15+08:00 daily https://www.pharmasources.com/industryinsights/novartis-targets-specific-patient-popula-298604.html 0.6 2026-06-21T09:54:19+08:00 daily https://www.pharmasources.com/industryinsights/bayer-loxo-oncology-to-develop-commercia-298605.html 0.6 2026-07-07T16:35:46+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-orphan-drug-designation-to-de-298606.html 0.6 2026-07-15T18:35:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pill-with-sensor-that-digit-298607.html 0.6 2026-06-21T23:58:41+08:00 daily https://www.pharmasources.com/industryinsights/locus-raises-19m-to-take-crispr-based-an-298608.html 0.6 2026-06-24T12:32:24+08:00 daily https://www.pharmasources.com/industryinsights/bayer-pays-400m-upfront-to-buy-into-loxo-298609.html 0.6 2026-07-05T00:34:01+08:00 daily https://www.pharmasources.com/industryinsights/jj-abandons-remicade-patent-fight-agains-298610.html 0.6 2026-07-01T10:38:13+08:00 daily https://www.pharmasources.com/industryinsights/flagship-cancer-startup-torque-gets-25m--298611.html 0.6 2026-06-21T00:55:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-glaxosmithkline-face-hepatitis-a-v-298612.html 0.6 2026-06-21T06:02:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-looks-past-psoriasis-for-even-b-298613.html 0.6 2026-06-22T06:00:38+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-who-why-a-marriage-between-298614.html 0.6 2026-06-20T14:01:20+08:00 daily https://www.pharmasources.com/industryinsights/alpinion-medical-systems-launches-e-cube-298615.html 0.6 2026-06-21T08:51:08+08:00 daily https://www.pharmasources.com/industryinsights/thailand-emerges-as-southeast-asias-prim-298616.html 0.6 2026-08-03T09:59:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-marketing-authorization-of-th-298617.html 0.6 2026-07-06T21:34:46+08:00 daily https://www.pharmasources.com/industryinsights/harnessing-immunotherapy-to-reverse-type-298618.html 0.6 2026-06-24T13:02:11+08:00 daily https://www.pharmasources.com/industryinsights/genentech-dumps-another-650m-in-new-have-298619.html 0.6 2026-06-20T18:16:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-rare-genetic--298620.html 0.6 2026-06-21T19:00:11+08:00 daily https://www.pharmasources.com/industryinsights/amgens-repatha-reduces-cardiovascular-ev-298621.html 0.6 2026-06-20T14:26:28+08:00 daily https://www.pharmasources.com/industryinsights/nuhcs-singapore-aims-to-raise-s50000-for-298622.html 0.6 2026-06-20T19:19:01+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-therapy-shows-promise-for-macu-298623.html 0.6 2026-06-20T23:00:40+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-marketing-authorisation-for-s-298624.html 0.6 2026-06-23T14:10:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-ar-298625.html 0.6 2026-06-20T20:03:37+08:00 daily https://www.pharmasources.com/industryinsights/ipsos-mori-gsk-vaccinate-for-life-survey-298626.html 0.6 2026-06-22T09:02:46+08:00 daily https://www.pharmasources.com/industryinsights/nhs-backs-innovative-means-of-cutting-di-298627.html 0.6 2026-06-21T12:09:20+08:00 daily https://www.pharmasources.com/industryinsights/promising-new-car-t-therapy-able-to-targ-298628.html 0.6 2026-02-10T16:17:18+08:00 daily https://www.pharmasources.com/industryinsights/psoriasis-patients-at-greater-risk-of-ty-298629.html 0.6 2026-08-04T13:05:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-signals-crackdown-on-controversial-p-298630.html 0.6 2026-03-28T13:34:20+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-in-agreement-with-technol-298631.html 0.6 2026-06-22T10:02:48+08:00 daily https://www.pharmasources.com/industryinsights/first-made-in-india-digital-pill-to-unde-298632.html 0.6 2026-08-02T21:23:09+08:00 daily https://www.pharmasources.com/industryinsights/health-bodies-test-digital-interventions-298633.html 0.6 2026-07-21T01:01:28+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-posts-net-profit-of-rs-912-cr-298634.html 0.6 2026-06-21T20:48:54+08:00 daily https://www.pharmasources.com/industryinsights/cubex-with-nicholas-hall-company-to-orga-298635.html 0.6 2026-07-04T02:43:23+08:00 daily https://www.pharmasources.com/industryinsights/az-fasenra-gets-us-nod-for-eosinophilic--298636.html 0.6 2026-06-20T22:59:41+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-announces-treatment-of-first-pat-298637.html 0.6 2026-06-21T02:51:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-fasenra-for-severe-eosinoph-298638.html 0.6 2026-08-05T13:26:11+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-novo-back-rare-disease-startup-in-298639.html 0.6 2026-02-10T17:30:46+08:00 daily https://www.pharmasources.com/industryinsights/amgen-merck-roche-get-in-on-syapses-30m--298640.html 0.6 2026-08-06T12:01:48+08:00 daily https://www.pharmasources.com/industryinsights/bayer-its-consumer-health-ambitions-snag-298641.html 0.6 2026-06-22T00:00:43+08:00 daily https://www.pharmasources.com/industryinsights/takeda-leverages-lung-cancer-awareness-m-298642.html 0.6 2026-06-20T23:58:41+08:00 daily https://www.pharmasources.com/industryinsights/clearbridge-biomedics-and-leica-biosyste-298643.html 0.6 2026-06-26T23:51:28+08:00 daily https://www.pharmasources.com/industryinsights/shareholder-alert-pomerantz-law-firm-inv-298644.html 0.6 2026-06-20T15:01:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-genentechs-hemlibra-the-fir-298645.html 0.6 2026-05-05T18:58:33+08:00 daily https://www.pharmasources.com/industryinsights/lilly-used-nursing-services-as-kickbacks-298646.html 0.6 2026-07-04T13:24:46+08:00 daily https://www.pharmasources.com/industryinsights/newly-discovered-molecular-guardian-keep-298647.html 0.6 2026-07-03T00:13:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-berates-lupin-for-repeatedly-making--298648.html 0.6 2026-06-20T17:18:35+08:00 daily https://www.pharmasources.com/industryinsights/5-deaths-force-acorda-to-stop-enrollment-298649.html 0.6 2026-06-22T03:01:45+08:00 daily https://www.pharmasources.com/industryinsights/with-merck-footing-the-200m-bill-moderna-298650.html 0.6 2026-07-18T04:17:49+08:00 daily https://www.pharmasources.com/industryinsights/inozyme-pharma-secures-49m-funding-for-r-298651.html 0.6 2026-07-29T21:45:23+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-gets-ok-for-huge-expansion-in--298652.html 0.6 2026-06-21T20:00:44+08:00 daily https://www.pharmasources.com/industryinsights/cardinal-health-sells-off-china-business-298653.html 0.6 2026-06-21T08:56:59+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-therapy-fails-to-improve-sympt-298654.html 0.6 2026-06-21T15:51:40+08:00 daily https://www.pharmasources.com/industryinsights/gsk-gets-eu-go-ahead-for-triple-therapy--298655.html 0.6 2026-06-21T00:46:36+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-novartis-and-pfizers-rival-298656.html 0.6 2026-06-29T13:32:28+08:00 daily https://www.pharmasources.com/industryinsights/tapeworm-drug-fights-prostate-cancer-298657.html 0.6 2026-06-22T07:44:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-fasenra-for-severe-eosinoph-298658.html 0.6 2026-07-04T14:51:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-kisqali-as-a-cost-effect-298659.html 0.6 2026-08-09T09:47:08+08:00 daily https://www.pharmasources.com/industryinsights/mitraclip-by-abbott-receives-approval-in-298660.html 0.6 2026-06-20T21:12:42+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-durart-r-450-298661.html 0.6 2026-07-04T00:42:28+08:00 daily https://www.pharmasources.com/industryinsights/suven-gets-patents-from-hk-india-us-on-n-298662.html 0.6 2026-06-21T16:56:28+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-kwitz-298663.html 0.6 2026-07-18T16:27:12+08:00 daily https://www.pharmasources.com/industryinsights/optel-group-bags-loan-worth-cad-68-m-fro-298664.html 0.6 2026-06-21T10:55:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-rare-genetic--298665.html 0.6 2026-06-09T19:36:30+08:00 daily https://www.pharmasources.com/industryinsights/evelo-biosciences-mayo-clinic-announce-c-298666.html 0.6 2026-03-22T10:13:59+08:00 daily https://www.pharmasources.com/industryinsights/insulia-receives-fda-clearance-ce-mark-t-298667.html 0.6 2026-03-27T15:20:26+08:00 daily https://www.pharmasources.com/industryinsights/cue-biopharma-in-374m-plus-merck-immunot-298668.html 0.6 2026-07-06T21:05:42+08:00 daily https://www.pharmasources.com/industryinsights/newly-discovered-molecular-guardian-keep-298669.html 0.6 2026-08-07T05:05:58+08:00 daily https://www.pharmasources.com/industryinsights/roche-nabs-blockbuster-fda-approval-for--298670.html 0.6 2026-08-07T02:22:09+08:00 daily https://www.pharmasources.com/industryinsights/lilly-used-nursing-services-as-kickbacks-298671.html 0.6 2026-08-07T02:04:50+08:00 daily https://www.pharmasources.com/industryinsights/chinas-yingkou-favored-by-investors-eyei-298672.html 0.6 2026-08-07T01:51:55+08:00 daily https://www.pharmasources.com/industryinsights/caligor-holdco-llc-leader-in-strategic-c-298673.html 0.6 2026-08-07T01:42:50+08:00 daily https://www.pharmasources.com/industryinsights/mitsubhishi-tanabe-pharmas-als-drug-trea-298674.html 0.6 2026-08-07T06:06:51+08:00 daily https://www.pharmasources.com/industryinsights/ionis-pharmaceuticals-licenses-second-an-298675.html 0.6 2026-08-07T10:52:54+08:00 daily https://www.pharmasources.com/industryinsights/cue-biopharma-announces-research-collabo-298676.html 0.6 2026-08-07T11:23:01+08:00 daily https://www.pharmasources.com/industryinsights/engineers-at-nus-develop-a-microfibre-se-298677.html 0.6 2026-07-07T15:59:06+08:00 daily https://www.pharmasources.com/industryinsights/drugmaker-acorda-suffers-after-deaths-in-298678.html 0.6 2026-08-07T03:25:02+08:00 daily https://www.pharmasources.com/industryinsights/the-future-of-cell-culture-a-new-continu-298679.html 0.6 2026-08-07T03:08:28+08:00 daily https://www.pharmasources.com/industryinsights/anti-malaria-drug-may-also-be-effective--298680.html 0.6 2026-08-07T03:02:37+08:00 daily https://www.pharmasources.com/industryinsights/subcontract-awarded-to-velesco-pharma-fo-298681.html 0.6 2026-08-07T02:52:25+08:00 daily https://www.pharmasources.com/industryinsights/schizophrenia-drugs-market-will-be-worth-298682.html 0.6 2026-08-07T02:41:01+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ascp-and-acs-join-forces-to-fig-298683.html 0.6 2026-08-07T02:30:46+08:00 daily https://www.pharmasources.com/industryinsights/bayer-and-loxo-oncology-to-develop-and-c-298684.html 0.6 2026-08-07T02:37:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-use-of-pfizers-sutent-in-kid-298685.html 0.6 2026-08-07T02:52:30+08:00 daily https://www.pharmasources.com/industryinsights/roches-hep-a-treatment-gets-nod-but-with-298686.html 0.6 2026-08-07T03:02:52+08:00 daily https://www.pharmasources.com/industryinsights/copd-survey-reveals-gaps-in-care-298687.html 0.6 2026-08-07T05:05:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-telehealth-option-to--298688.html 0.6 2026-04-24T22:41:35+08:00 daily https://www.pharmasources.com/industryinsights/statement-by-fda-commissioner-scott-gott-298689.html 0.6 2025-11-14T07:32:04+08:00 daily https://www.pharmasources.com/industryinsights/eris-lifesciences-q2-net-up-35-per-cent--298690.html 0.6 2025-11-24T08:05:22+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-divests-india-brand-busin-298691.html 0.6 2026-07-01T11:08:58+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-drug-us-298692.html 0.6 2025-11-28T20:24:34+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-us-fda-approval-for-gener-298693.html 0.6 2026-07-20T04:21:31+08:00 daily https://www.pharmasources.com/industryinsights/egalet-announces-positive-top-line-resul-298694.html 0.6 2026-01-21T13:43:53+08:00 daily https://www.pharmasources.com/industryinsights/optune-analysis-finds-predicted-increase-298695.html 0.6 2026-08-09T15:36:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-sutent-298696.html 0.6 2026-06-12T11:47:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-behind-the-ear-device-for-opioid-298697.html 0.6 2026-07-27T15:07:25+08:00 daily https://www.pharmasources.com/industryinsights/pentagon-will-not-decide-on-battlefield--298698.html 0.6 2025-11-08T23:05:44+08:00 daily https://www.pharmasources.com/industryinsights/ionis-licenses-another-antisense-gi-drug-298699.html 0.6 2026-06-26T01:57:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-asks-that-baxter-saline-plants-in-pu-298700.html 0.6 2026-01-14T10:35:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-sutent-kidney-cancer-win-should--298701.html 0.6 2026-07-18T23:10:37+08:00 daily https://www.pharmasources.com/industryinsights/novogen-becomes-kazia-therapeutics-298702.html 0.6 2025-11-20T10:18:41+08:00 daily https://www.pharmasources.com/industryinsights/resmed-elects-karen-drexler-to-its-board-298703.html 0.6 2026-01-11T23:09:43+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2017112-298704.html 0.6 2026-06-08T15:25:06+08:00 daily https://www.pharmasources.com/industryinsights/hydroponics-to-partner-with-israels-bol--298705.html 0.6 2026-04-04T15:22:05+08:00 daily https://www.pharmasources.com/industryinsights/health-official-receives-recognition-in--298706.html 0.6 2026-06-23T07:40:26+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-change-relocation-to-amsterdam-in-298707.html 0.6 2025-10-31T08:53:41+08:00 daily https://www.pharmasources.com/industryinsights/cell-weighing-method-may-predict-how-dru-298708.html 0.6 2026-02-06T17:22:58+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-dengue-vaccine-dengvaxia-in-298709.html 0.6 2026-01-26T11:12:01+08:00 daily https://www.pharmasources.com/industryinsights/pre-diabetes-discovery-marks-step-toward-298710.html 0.6 2026-03-01T02:06:03+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-acquire-viewics-inc-to-provide--298711.html 0.6 2026-08-07T12:09:06+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-public-has-low-awareness-of--298712.html 0.6 2026-08-06T23:00:34+08:00 daily https://www.pharmasources.com/industryinsights/bayers-stivarga-wins-nice-approval-for-g-298713.html 0.6 2026-07-04T09:00:51+08:00 daily https://www.pharmasources.com/industryinsights/roches-hemlibra-reduces-bleeds-in-haemop-298714.html 0.6 2026-01-14T17:10:32+08:00 daily https://www.pharmasources.com/industryinsights/a-glimpse-of-existing-pattern-of-the-qua-298715.html 0.6 2026-01-10T03:08:06+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-first-herceptin-biosimilar-298716.html 0.6 2026-08-06T22:06:40+08:00 daily https://www.pharmasources.com/industryinsights/acorda-takes-a-363m-hit-as-deaths-lead-t-298717.html 0.6 2026-05-20T12:29:26+08:00 daily https://www.pharmasources.com/industryinsights/3-top-drugmakers-leading-lung-cancer-rd--298718.html 0.6 2026-08-07T15:53:27+08:00 daily https://www.pharmasources.com/industryinsights/allergan-could-sell-womens-health-for-6b-298719.html 0.6 2025-11-16T00:16:21+08:00 daily https://www.pharmasources.com/industryinsights/antihistamine-shows-potential-to-repair--298720.html 0.6 2026-02-28T13:43:55+08:00 daily https://www.pharmasources.com/industryinsights/acasti-catapults-on-133m-deal-with-unnam-298721.html 0.6 2026-01-30T16:34:43+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-beauty-challenge-crowdso-298722.html 0.6 2026-07-04T23:00:29+08:00 daily https://www.pharmasources.com/industryinsights/canadian-researchers-discover-medication-298723.html 0.6 2026-08-09T23:53:57+08:00 daily https://www.pharmasources.com/industryinsights/laurus-infosystems-to-launch-padisys-bio-298724.html 0.6 2026-08-07T00:01:22+08:00 daily https://www.pharmasources.com/industryinsights/gsk-health-names-navneet-saluja-as-india-298725.html 0.6 2026-08-09T13:05:34+08:00 daily https://www.pharmasources.com/industryinsights/icmr-signs-mou-with-ficci-298726.html 0.6 2026-07-08T20:49:11+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-us-fda-approval-for-ha-298727.html 0.6 2026-07-18T15:19:36+08:00 daily https://www.pharmasources.com/industryinsights/promentis-begins-study-for-sxc-2023-targ-298728.html 0.6 2026-06-26T11:37:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-auvi-q-01-mg-auto-injector-298729.html 0.6 2026-06-20T12:47:34+08:00 daily https://www.pharmasources.com/industryinsights/after-penning-loxo-deal-bayer-signs-anot-298730.html 0.6 2026-06-17T11:31:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-in-fight-with-states-over-their-i-298731.html 0.6 2026-08-07T05:58:22+08:00 daily https://www.pharmasources.com/industryinsights/allergan-could-sell-womens-health-for-6b-298732.html 0.6 2026-06-08T15:14:42+08:00 daily https://www.pharmasources.com/industryinsights/mnx-global-logistics-acquires-specialty--298733.html 0.6 2026-02-09T14:56:48+08:00 daily https://www.pharmasources.com/industryinsights/microsoft-and-indegene-announce-the-laun-298734.html 0.6 2026-05-04T17:08:58+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-pharma-buys-drug-distribution-u-298735.html 0.6 2026-07-19T00:09:29+08:00 daily https://www.pharmasources.com/industryinsights/cuba-to-develop-joint-projects-with-sout-298736.html 0.6 2026-06-08T17:58:54+08:00 daily https://www.pharmasources.com/industryinsights/merck-subsidiary-acquires-teqqa-an-infec-298737.html 0.6 2026-04-20T00:48:49+08:00 daily https://www.pharmasources.com/industryinsights/researchers-in-japan-develop-a-color-dev-298738.html 0.6 2026-04-17T12:03:36+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-makes-its-best-mole-298739.html 0.6 2026-04-02T03:20:24+08:00 daily https://www.pharmasources.com/industryinsights/fgf-inhibitors-may-provide-a-new-way-to--298740.html 0.6 2026-06-24T10:43:39+08:00 daily https://www.pharmasources.com/industryinsights/third-esmo-asia-congress-is-completed-su-298741.html 0.6 2026-04-18T21:41:35+08:00 daily https://www.pharmasources.com/industryinsights/maintaining-sufficient-vitamin-d-levels--298742.html 0.6 2026-06-08T20:01:32+08:00 daily https://www.pharmasources.com/industryinsights/obesity-leads-to-larger-harder-to-detect-298743.html 0.6 2026-06-12T14:27:16+08:00 daily https://www.pharmasources.com/industryinsights/nhs-faced-with-5700-increase-in-drug-pri-298744.html 0.6 2026-06-09T19:08:31+08:00 daily https://www.pharmasources.com/industryinsights/acorda-drops-experimental-parkinsons-dru-298745.html 0.6 2026-06-23T11:10:13+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-marketing-authorisation-for-z-298746.html 0.6 2026-06-29T07:36:02+08:00 daily https://www.pharmasources.com/industryinsights/janssens-zytiga-approved-for-earlier-use-298747.html 0.6 2026-07-03T11:48:43+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-consults-on-simplifying-rese-298748.html 0.6 2026-04-26T13:10:01+08:00 daily https://www.pharmasources.com/industryinsights/tiny-corbus-aims-to-have-four-drugs-in-m-298749.html 0.6 2026-01-19T17:47:19+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-secures-api-divestiture-for-110m-298750.html 0.6 2026-08-10T01:58:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-two-drug-regimen-for--298751.html 0.6 2026-04-13T01:21:13+08:00 daily https://www.pharmasources.com/industryinsights/ajanta-pharma-receives-us-fda-approval-f-298752.html 0.6 2026-06-12T16:54:29+08:00 daily https://www.pharmasources.com/industryinsights/ai-enabled-pharmacy-platform-redbook-rai-298753.html 0.6 2026-07-02T11:31:48+08:00 daily https://www.pharmasources.com/industryinsights/biocon-receives-eir-from-us-fda-298754.html 0.6 2026-06-19T05:49:07+08:00 daily https://www.pharmasources.com/industryinsights/leukemia-lymphoma-society-funds-46-milli-298755.html 0.6 2026-03-20T19:32:55+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-relocate-to-amsterdam-the-netherl-298756.html 0.6 2026-07-18T10:18:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-regulatory-submission-and-gr-298757.html 0.6 2026-06-24T08:04:03+08:00 daily https://www.pharmasources.com/industryinsights/lkk-health-products-group-consecutively--298758.html 0.6 2026-07-23T04:57:56+08:00 daily https://www.pharmasources.com/industryinsights/shineco-inc-enters-into-rmb-112-billion--298759.html 0.6 2026-03-29T09:03:53+08:00 daily https://www.pharmasources.com/industryinsights/amsterdam-beats-out-milan-to-host-ema-298760.html 0.6 2025-11-20T00:48:56+08:00 daily https://www.pharmasources.com/industryinsights/cytokinetics-cans-lead-drug-after-phase--298761.html 0.6 2026-05-03T09:47:22+08:00 daily https://www.pharmasources.com/industryinsights/merck-will-delay-filing-ebola-vaccine-fo-298762.html 0.6 2026-06-28T15:47:38+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-preps-big-obesity-push-unde-298763.html 0.6 2026-07-07T00:00:38+08:00 daily https://www.pharmasources.com/industryinsights/novel-in-vitro-model-investigates-drug-c-298764.html 0.6 2026-03-20T00:02:30+08:00 daily https://www.pharmasources.com/industryinsights/lls-funds-46-million-in-new-research-to--298765.html 0.6 2026-08-05T20:53:37+08:00 daily https://www.pharmasources.com/industryinsights/chinese-researchers-develop-electronic-s-298766.html 0.6 2026-06-08T19:37:11+08:00 daily https://www.pharmasources.com/industryinsights/21st-century-oncology-chooses-elekta-for-298767.html 0.6 2026-03-19T06:50:41+08:00 daily https://www.pharmasources.com/industryinsights/grants4apps-singapore-inventors-digital--298768.html 0.6 2026-06-14T06:58:33+08:00 daily https://www.pharmasources.com/industryinsights/esmo-celebrates-successful-completion-of-298769.html 0.6 2026-08-05T19:44:41+08:00 daily https://www.pharmasources.com/industryinsights/jj-lilly-and-az-diabetes-medications-get-298770.html 0.6 2026-01-10T03:06:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-two-drug-regimen-juluca-for-298771.html 0.6 2026-04-03T05:42:34+08:00 daily https://www.pharmasources.com/industryinsights/takeda-spins-off-cancer-assets-to-incuba-298772.html 0.6 2026-07-04T14:35:08+08:00 daily https://www.pharmasources.com/industryinsights/advantages-and-market-trends-of-monk-fru-298773.html 0.6 2026-08-07T04:22:17+08:00 daily https://www.pharmasources.com/industryinsights/advantages-and-development-of-thunder-go-298774.html 0.6 2026-08-07T05:05:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-implanted-lens-that-c-298775.html 0.6 2026-04-13T03:49:29+08:00 daily https://www.pharmasources.com/industryinsights/canadas-concordia-accused-of-6000-price--298776.html 0.6 2026-08-09T07:56:42+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-suspend-filing-ebola-vaccine-fo-298777.html 0.6 2026-08-08T08:25:01+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-genentech-duke-it-out-in-cour-298778.html 0.6 2026-08-07T13:15:43+08:00 daily https://www.pharmasources.com/industryinsights/sclerosis-medicine-can-fight-multi-resis-298779.html 0.6 2026-08-07T04:07:42+08:00 daily https://www.pharmasources.com/industryinsights/unexpected-safety-issue-forces-bay-areas-298780.html 0.6 2026-08-07T03:55:04+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-post-chemo-option-for-patien-298781.html 0.6 2026-08-07T03:24:52+08:00 daily https://www.pharmasources.com/industryinsights/ayush-ministry-holds-meeting-to-examine--298782.html 0.6 2026-08-07T03:03:03+08:00 daily https://www.pharmasources.com/industryinsights/strand-life-sciences-receives-cap-re-acc-298783.html 0.6 2026-08-07T02:51:49+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-introduces-patent-submission-date-298784.html 0.6 2026-08-07T02:37:10+08:00 daily https://www.pharmasources.com/industryinsights/rakez-receives-overwhelming-response-fro-298785.html 0.6 2026-08-07T02:37:28+08:00 daily https://www.pharmasources.com/industryinsights/vanrx-pharmasystems-to-exhibit-microcell-298786.html 0.6 2026-03-11T16:50:40+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-application-to-fda-to-ex-298787.html 0.6 2026-08-07T02:52:19+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-slows-in-q2-but-expects-growth-298788.html 0.6 2026-08-07T03:03:10+08:00 daily https://www.pharmasources.com/industryinsights/takeda-spins-off-cancer-assets-to-incuba-298789.html 0.6 2026-08-07T03:18:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-lifts-second-trial-hold-for-prescien-298790.html 0.6 2026-08-07T03:33:48+08:00 daily https://www.pharmasources.com/industryinsights/amerisourcebergen-says-civil-penalty-to--298791.html 0.6 2026-08-07T03:55:04+08:00 daily https://www.pharmasources.com/industryinsights/healthwatch-technologies-won-the-most-pr-298792.html 0.6 2026-08-07T04:06:59+08:00 daily https://www.pharmasources.com/industryinsights/step-pharma-completes-145-million-series-298793.html 0.6 2026-08-07T04:33:59+08:00 daily https://www.pharmasources.com/industryinsights/the-34-million-project-for-assessing-liv-298794.html 0.6 2026-08-07T15:28:12+08:00 daily https://www.pharmasources.com/industryinsights/roches-erivedge-no-longer-be-financed-on-298795.html 0.6 2026-04-30T19:26:15+08:00 daily https://www.pharmasources.com/industryinsights/healthindustry-groups-react-to-autumn-bu-298796.html 0.6 2026-05-03T19:24:41+08:00 daily https://www.pharmasources.com/industryinsights/molecules-in-spit-may-be-able-to-diagnos-298797.html 0.6 2025-12-02T08:40:50+08:00 daily https://www.pharmasources.com/industryinsights/glatiramer-acetate-found-to-fight-multi--298798.html 0.6 2026-02-28T13:17:44+08:00 daily https://www.pharmasources.com/industryinsights/nigel-brooksby-appointed-as-new-pertinax-298799.html 0.6 2026-03-29T12:52:17+08:00 daily https://www.pharmasources.com/industryinsights/tesaro-secures-eu-approval-in-specific-o-298800.html 0.6 2026-02-09T18:28:21+08:00 daily https://www.pharmasources.com/industryinsights/amerisourcebergen-coughs-up-625m-to-reso-298801.html 0.6 2026-08-04T03:37:59+08:00 daily https://www.pharmasources.com/industryinsights/the-love-and-hatred-between-antibiotics--298802.html 0.6 2026-08-08T08:49:21+08:00 daily https://www.pharmasources.com/industryinsights/embracing-medtronic-after-hurricane-mari-298803.html 0.6 2026-08-03T23:26:39+08:00 daily https://www.pharmasources.com/industryinsights/exploring-the-drug-innovations-in-top-10-298804.html 0.6 2026-06-27T23:57:33+08:00 daily https://www.pharmasources.com/industryinsights/research-finds-gastric-acid-suppressant--298805.html 0.6 2026-05-09T03:26:32+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-key-to-regenerating-bloo-298806.html 0.6 2026-06-17T08:50:31+08:00 daily https://www.pharmasources.com/industryinsights/cytokinetics-als-treatment-tirasemtiv-fa-298807.html 0.6 2026-06-20T11:49:28+08:00 daily https://www.pharmasources.com/industryinsights/uk-regulator-accuses-concordia-of-overch-298808.html 0.6 2026-07-17T03:23:31+08:00 daily https://www.pharmasources.com/industryinsights/teva-looks-set-to-axe-thousands-of-posit-298809.html 0.6 2025-12-29T09:28:31+08:00 daily https://www.pharmasources.com/industryinsights/lead-pharma-achieves-third-milestone-in--298810.html 0.6 2026-06-04T16:36:40+08:00 daily https://www.pharmasources.com/industryinsights/pharmatechnologyindexcom-signs-mou-with--298811.html 0.6 2025-12-02T08:27:12+08:00 daily https://www.pharmasources.com/industryinsights/merck-germany-launches-merck-foundation-298812.html 0.6 2025-12-02T08:26:06+08:00 daily https://www.pharmasources.com/industryinsights/this-is-what-amazon-can-do-to-start-sell-298813.html 0.6 2025-12-02T08:24:57+08:00 daily https://www.pharmasources.com/industryinsights/hong-kong-sar-china-researchers-design-t-298814.html 0.6 2026-07-26T20:48:15+08:00 daily https://www.pharmasources.com/industryinsights/uzbek-moh-collaborates-with-s-korean-cli-298815.html 0.6 2026-08-09T22:48:38+08:00 daily https://www.pharmasources.com/industryinsights/gsk-submits-landmark-impact-data-to-us-r-298816.html 0.6 2026-08-07T16:51:03+08:00 daily https://www.pharmasources.com/industryinsights/online-gp-appointments-found-to-be-large-298817.html 0.6 2026-08-10T00:03:31+08:00 daily https://www.pharmasources.com/industryinsights/stem-education-in-asia-pacific-research--298818.html 0.6 2026-03-17T22:14:42+08:00 daily https://www.pharmasources.com/industryinsights/microsoft-heungkong-group-and-china-nans-298819.html 0.6 2026-08-08T00:32:25+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2017112-298820.html 0.6 2026-06-08T15:25:07+08:00 daily https://www.pharmasources.com/industryinsights/eu-invests-63m-into-cancer-project-led-b-298821.html 0.6 2026-04-22T15:12:00+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-based-chemopharm-acquired-by-ev-298822.html 0.6 2026-03-27T21:31:04+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-announces-fda-approval-and-us--298823.html 0.6 2026-08-03T10:55:30+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-reports-second-quarter-financi-298824.html 0.6 2026-06-19T01:18:39+08:00 daily https://www.pharmasources.com/industryinsights/puma-biotech-and-specialised-therapeutic-298825.html 0.6 2026-04-20T01:18:47+08:00 daily https://www.pharmasources.com/industryinsights/pembrolizumab-shows-hope-for-cancerous-g-298826.html 0.6 2026-03-12T00:15:48+08:00 daily https://www.pharmasources.com/industryinsights/virus-like-particle-vaccine-protects-aga-298827.html 0.6 2026-06-29T05:08:10+08:00 daily https://www.pharmasources.com/industryinsights/galen-growth-asia-summits-attract-12-bil-298828.html 0.6 2025-12-02T08:05:31+08:00 daily https://www.pharmasources.com/industryinsights/different-gene-mutations-in-multiple-mye-298829.html 0.6 2026-06-22T19:42:32+08:00 daily https://www.pharmasources.com/industryinsights/ex-pharmacy-compliance-director-pleads-g-298830.html 0.6 2026-07-09T15:31:12+08:00 daily https://www.pharmasources.com/industryinsights/az-partners-with-combinations-alliance-t-298831.html 0.6 2026-03-21T11:25:49+08:00 daily https://www.pharmasources.com/industryinsights/lirilumabopdivo-combo-shows-no-clear-evi-298832.html 0.6 2026-06-15T04:00:29+08:00 daily https://www.pharmasources.com/industryinsights/uk-launch-for-janssens-novel-psoriasis-b-298833.html 0.6 2026-06-23T11:59:32+08:00 daily https://www.pharmasources.com/industryinsights/gst-makes-orphan-drugs-prices-soar-298834.html 0.6 2026-03-10T08:34:31+08:00 daily https://www.pharmasources.com/industryinsights/more-life-saving-medicines-to-become-che-298835.html 0.6 2026-02-15T13:31:18+08:00 daily https://www.pharmasources.com/industryinsights/what-trump-should-do-if-he-actually-want-298836.html 0.6 2026-03-01T03:06:54+08:00 daily https://www.pharmasources.com/industryinsights/think-youre-too-old-to-be-vaccinated-you-298837.html 0.6 2025-12-02T07:55:13+08:00 daily https://www.pharmasources.com/industryinsights/medlife-collaborates-with-aiocd-awacs-298838.html 0.6 2026-01-04T19:51:26+08:00 daily https://www.pharmasources.com/industryinsights/nppa-caps-prices-of-51-essential-medicin-298839.html 0.6 2025-12-02T07:52:53+08:00 daily https://www.pharmasources.com/industryinsights/idma-marketing-and-sales-conference-2017-298840.html 0.6 2026-07-27T05:45:13+08:00 daily https://www.pharmasources.com/industryinsights/korean-plastic-surgery-info---tl-clinic--298841.html 0.6 2026-03-26T22:50:02+08:00 daily https://www.pharmasources.com/industryinsights/second-phase-3-study-results-for-lmtx-pu-298842.html 0.6 2025-12-02T07:49:29+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-eris-lifesciences-sichua-298843.html 0.6 2025-12-31T07:22:10+08:00 daily https://www.pharmasources.com/industryinsights/janssen-launches-tremfya-in-uk-to-treat--298844.html 0.6 2026-08-06T23:50:14+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-boehringer-ingelheim-enter-dn-298845.html 0.6 2026-01-31T21:24:04+08:00 daily https://www.pharmasources.com/industryinsights/light-therapy-might-help-in-the-treatmen-298846.html 0.6 2026-02-09T04:32:41+08:00 daily https://www.pharmasources.com/industryinsights/36-million-horizon-2020-phase-ii-grant-s-298847.html 0.6 2025-12-02T07:42:34+08:00 daily https://www.pharmasources.com/industryinsights/lung-function-of-copd-patients-improved--298848.html 0.6 2026-07-18T23:28:40+08:00 daily https://www.pharmasources.com/industryinsights/the-uk-government-announces-major-life-s-298849.html 0.6 2026-06-16T13:06:07+08:00 daily https://www.pharmasources.com/industryinsights/extension-of-orchards-collaboration-with-298850.html 0.6 2025-12-21T12:24:17+08:00 daily https://www.pharmasources.com/industryinsights/achievement-of-biotech-company-treat-bur-298851.html 0.6 2026-08-01T03:06:46+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-chinese-future-industry--298852.html 0.6 2026-07-31T05:34:40+08:00 daily https://www.pharmasources.com/industryinsights/bayers-175-million-pneumonia-drug-fails--298853.html 0.6 2026-05-06T09:02:15+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-forced-to-drop-eylea-combo-adv-298854.html 0.6 2025-12-02T07:34:29+08:00 daily https://www.pharmasources.com/industryinsights/teva-expected-to-fire-up-to-1700-workers-298855.html 0.6 2026-05-25T01:16:13+08:00 daily https://www.pharmasources.com/industryinsights/acerus-grants-apsen-rights-to-market-nat-298856.html 0.6 2026-04-06T13:27:12+08:00 daily https://www.pharmasources.com/industryinsights/specialised-therapeutics-to-commercialis-298857.html 0.6 2026-04-04T18:01:37+08:00 daily https://www.pharmasources.com/industryinsights/biogen-forges-278m-ms-tie-up-with-alkerm-298858.html 0.6 2026-04-01T04:42:39+08:00 daily https://www.pharmasources.com/industryinsights/competing-drugs-to-treat-opioid-addictio-298859.html 0.6 2026-04-03T23:58:51+08:00 daily https://www.pharmasources.com/industryinsights/pharming-submits-supplemental-bla-to-fda-298860.html 0.6 2026-04-15T14:09:04+08:00 daily https://www.pharmasources.com/industryinsights/acadia-launches-parkinsons-campaign-to-s-298861.html 0.6 2026-04-08T16:36:52+08:00 daily https://www.pharmasources.com/industryinsights/microbial-contamination-forces-sun-pharm-298862.html 0.6 2026-06-23T04:02:52+08:00 daily https://www.pharmasources.com/industryinsights/merck-places-1b-bet-on-rd-in-post-brexit-298863.html 0.6 2026-07-16T14:53:01+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-abuse-deterrent-opioids-for--298864.html 0.6 2025-12-11T06:49:34+08:00 daily https://www.pharmasources.com/industryinsights/the-delta4-discover-a-4d-in-vivo-dosimet-298865.html 0.6 2026-04-15T05:07:34+08:00 daily https://www.pharmasources.com/industryinsights/nippon-chemiphar-announces-progress-on-i-298866.html 0.6 2026-08-09T17:58:35+08:00 daily https://www.pharmasources.com/industryinsights/symcel-secures-36-million-horizon-2020-p-298867.html 0.6 2026-02-10T13:47:34+08:00 daily https://www.pharmasources.com/industryinsights/global-response-to-malaria-at-crossroads-298868.html 0.6 2026-03-24T03:33:27+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-chinese-fiif-establish-joint-298869.html 0.6 2026-03-26T17:02:51+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-natural-mimetics-of-anti-298870.html 0.6 2026-05-20T02:42:40+08:00 daily https://www.pharmasources.com/industryinsights/cristal-therapeutics-awarded-25-million--298871.html 0.6 2026-04-05T21:28:25+08:00 daily https://www.pharmasources.com/industryinsights/melinta-buys-infectious-disease-unit-fro-298872.html 0.6 2026-08-05T20:44:26+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-fast-track-status-to-steal-298873.html 0.6 2026-04-08T01:29:30+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-submit-cdf-proposal-for-cancer--298874.html 0.6 2026-01-31T09:35:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-new-approach-to-advance-me-298875.html 0.6 2026-01-29T09:18:00+08:00 daily https://www.pharmasources.com/industryinsights/amphivena-receives-orphan-drug-designati-298876.html 0.6 2026-02-28T13:21:27+08:00 daily https://www.pharmasources.com/industryinsights/gilead-lowers-the-price-to-launche-hep-c-298877.html 0.6 2026-05-12T00:20:35+08:00 daily https://www.pharmasources.com/industryinsights/human-heart-patch-could-repair-dead-tiss-298878.html 0.6 2026-02-28T21:27:56+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-licences-experimental-ms-therap-298879.html 0.6 2026-06-08T17:38:58+08:00 daily https://www.pharmasources.com/industryinsights/frazier-backed-mavupharma-scores-20m-to--298880.html 0.6 2026-07-18T00:47:22+08:00 daily https://www.pharmasources.com/industryinsights/pph-series-extrusion-wound-equipment-for-298881.html 0.6 2026-07-30T07:36:51+08:00 daily https://www.pharmasources.com/industryinsights/current-development-situation-of-valeria-298882.html 0.6 2026-07-20T18:40:37+08:00 daily https://www.pharmasources.com/industryinsights/codiak-biosciences-closes-765-million-se-298883.html 0.6 2026-06-12T10:59:28+08:00 daily https://www.pharmasources.com/industryinsights/janssen-supports-first-of-its-kind-asia--298884.html 0.6 2026-02-15T13:36:14+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-may-help-predict-disease-acti-298885.html 0.6 2026-06-07T18:19:53+08:00 daily https://www.pharmasources.com/industryinsights/roche-launches-fully-integrated-and-stre-298886.html 0.6 2026-07-08T09:46:41+08:00 daily https://www.pharmasources.com/industryinsights/genmab-achieves-20m-janssen-milestone-298887.html 0.6 2026-01-13T22:37:51+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-regulatory-submission-accep-298888.html 0.6 2026-06-08T03:40:53+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-takes-a-120m-hit-as-potential-den-298889.html 0.6 2025-12-26T11:38:50+08:00 daily https://www.pharmasources.com/industryinsights/ecg-kardia-band-becomes-first-ever-fda-a-298890.html 0.6 2026-06-19T03:01:57+08:00 daily https://www.pharmasources.com/industryinsights/us-federal-government-withdraws-approval-298891.html 0.6 2026-08-05T19:45:33+08:00 daily https://www.pharmasources.com/industryinsights/viiv-trials-drug-for-hiv-prevention-in-w-298892.html 0.6 2026-08-08T22:52:11+08:00 daily https://www.pharmasources.com/industryinsights/stellar-results-for-novartis-teva-anti-c-298893.html 0.6 2026-05-28T14:55:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-approval-cms-proposes-cove-298894.html 0.6 2026-06-26T20:46:34+08:00 daily https://www.pharmasources.com/industryinsights/mind-blowing-amgens-aimovig-halves-lengt-298895.html 0.6 2026-01-05T07:45:42+08:00 daily https://www.pharmasources.com/industryinsights/morphosys-sells-china-rights-to-darzalex-298896.html 0.6 2026-04-16T23:35:39+08:00 daily https://www.pharmasources.com/industryinsights/massachusetts-fractyl-bags-44m-to-advanc-298897.html 0.6 2026-04-12T21:01:28+08:00 daily https://www.pharmasources.com/industryinsights/ifpbm-invited-to-present-at-the-internat-298898.html 0.6 2026-03-23T02:49:31+08:00 daily https://www.pharmasources.com/industryinsights/sciex-and-nus-faculty-of-science-announc-298899.html 0.6 2026-08-05T21:39:33+08:00 daily https://www.pharmasources.com/industryinsights/zhongbao-chemicals----a-professional-and-298900.html 0.6 2026-02-18T19:30:04+08:00 daily https://www.pharmasources.com/industryinsights/jn-medsys-introduces-new-generation-digi-298901.html 0.6 2026-07-04T23:20:02+08:00 daily https://www.pharmasources.com/industryinsights/first-and-only-medicine-of-its-kind-for--298902.html 0.6 2026-06-28T04:38:45+08:00 daily https://www.pharmasources.com/industryinsights/mr-jeong-woo-choo-has-been-appointed-as--298903.html 0.6 2026-02-04T17:10:41+08:00 daily https://www.pharmasources.com/industryinsights/genomicare-biotechnology-announces-the-c-298904.html 0.6 2026-07-04T19:42:41+08:00 daily https://www.pharmasources.com/industryinsights/nice-issues-new-recommendations-for-asth-298905.html 0.6 2026-03-10T05:27:26+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-marketing-authorization-appl-298906.html 0.6 2025-12-02T06:33:02+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-bacterial-link-with--298907.html 0.6 2026-03-22T13:19:08+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-enters-into-agreement-to-develop--298908.html 0.6 2026-08-04T02:51:11+08:00 daily https://www.pharmasources.com/industryinsights/polyganics-awarded-12-million-to-complet-298909.html 0.6 2026-08-05T16:09:14+08:00 daily https://www.pharmasources.com/industryinsights/new-data-at-the-san-antonio-breast-cance-298910.html 0.6 2026-08-07T23:32:45+08:00 daily https://www.pharmasources.com/industryinsights/zydus-pharmaceuticals-usa-receives-us-fd-298911.html 0.6 2026-01-21T15:00:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-status-to-shires--298912.html 0.6 2025-12-02T06:26:03+08:00 daily https://www.pharmasources.com/industryinsights/gottlieb-looking-to-approve-cancer-treat-298913.html 0.6 2026-03-26T21:52:08+08:00 daily https://www.pharmasources.com/industryinsights/men-twice-as-likely-to-develop-oral-canc-298914.html 0.6 2026-06-18T16:36:49+08:00 daily https://www.pharmasources.com/industryinsights/astellas-buys-dmd-drug-in-450m-mitochond-298915.html 0.6 2026-06-08T04:53:29+08:00 daily https://www.pharmasources.com/industryinsights/teva-pharmaceutical-industries-teva-give-298916.html 0.6 2026-07-23T09:03:22+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-lung-cancer-opdivo-trial-s-298917.html 0.6 2026-05-23T23:01:20+08:00 daily https://www.pharmasources.com/industryinsights/fit-biotech-granted-us-patent-for-treati-298918.html 0.6 2026-01-05T10:12:57+08:00 daily https://www.pharmasources.com/industryinsights/beechwoods-softwares-herve-jourdain-elec-298919.html 0.6 2026-01-10T03:05:13+08:00 daily https://www.pharmasources.com/industryinsights/appasamy-named-as-recipient-of-excellenc-298920.html 0.6 2026-06-28T06:13:39+08:00 daily https://www.pharmasources.com/industryinsights/nicotinamide-mononucleotide-nmn-the-very-298921.html 0.6 2026-08-03T06:51:05+08:00 daily https://www.pharmasources.com/industryinsights/destiny-pharma-collaborates-with-chinese-298922.html 0.6 2026-03-27T20:07:01+08:00 daily https://www.pharmasources.com/industryinsights/ogivri-approved-as-the-first-biosimilar--298923.html 0.6 2026-04-06T21:00:48+08:00 daily https://www.pharmasources.com/industryinsights/neoantigen-based-immunotherapy-targets-m-298924.html 0.6 2025-12-12T01:29:04+08:00 daily https://www.pharmasources.com/industryinsights/3-d-printing-could-help-improve-surgical-298925.html 0.6 2025-12-07T17:02:17+08:00 daily https://www.pharmasources.com/industryinsights/cvs-health-to-take-over-aetna-for-69bn-298926.html 0.6 2026-08-06T19:27:10+08:00 daily https://www.pharmasources.com/industryinsights/akilis-video-game-digital-treatment-show-298927.html 0.6 2026-04-12T14:30:09+08:00 daily https://www.pharmasources.com/industryinsights/gilead-commits-100m-to-tackle-the-hivaid-298928.html 0.6 2025-12-22T09:33:35+08:00 daily https://www.pharmasources.com/industryinsights/jj-snaps-up-idorsias-resistant-hypertens-298929.html 0.6 2026-02-15T02:21:50+08:00 daily https://www.pharmasources.com/industryinsights/a-novel-immuno-oncology-approach-to-trea-298930.html 0.6 2026-06-08T13:09:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-foundation-medicines-founda-298931.html 0.6 2026-02-15T00:10:17+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-heparin-shows-potential-in-lung--298932.html 0.6 2026-04-04T21:36:42+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-bad-end-of-the-year-continues-wi-298933.html 0.6 2025-12-02T06:02:43+08:00 daily https://www.pharmasources.com/industryinsights/the-philippines-suspends-sanofis-dengue--298934.html 0.6 2026-01-05T10:00:58+08:00 daily https://www.pharmasources.com/industryinsights/sca-pharmaceuticals-expands-operations-298935.html 0.6 2026-08-09T07:36:57+08:00 daily https://www.pharmasources.com/industryinsights/nhs-ae-performance-target-remains-well-u-298936.html 0.6 2026-07-13T11:24:33+08:00 daily https://www.pharmasources.com/industryinsights/hainan-nicepal-develop-fruit-powder-busi-298937.html 0.6 2026-08-06T23:33:13+08:00 daily https://www.pharmasources.com/industryinsights/gempex-gmp-consulting-execution-for-the--298938.html 0.6 2026-08-06T23:48:09+08:00 daily https://www.pharmasources.com/industryinsights/infinitus-certified-as-a-top-employer-in-298939.html 0.6 2026-08-06T21:58:46+08:00 daily https://www.pharmasources.com/industryinsights/biostar-regains-compliance-with-nasdaq-c-298940.html 0.6 2026-08-06T23:54:33+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-signs-120-m-deal-with-morphosys-298941.html 0.6 2026-07-12T09:33:48+08:00 daily https://www.pharmasources.com/industryinsights/women-achievers-spl-ms-siew-hwa-ong-impr-298942.html 0.6 2026-07-08T12:27:02+08:00 daily https://www.pharmasources.com/industryinsights/what-is-andrographis-extract-298943.html 0.6 2026-08-06T20:01:35+08:00 daily https://www.pharmasources.com/industryinsights/synthetic-biological-hybrid-nanocapsule--298944.html 0.6 2026-06-21T00:50:54+08:00 daily https://www.pharmasources.com/industryinsights/envisagenics-receives-dynamk-capital-inv-298945.html 0.6 2026-01-16T15:41:53+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-pfizer-alliance-urge-people-to-t-298946.html 0.6 2026-06-29T12:30:57+08:00 daily https://www.pharmasources.com/industryinsights/agendia-collaborates-with-prestigious-ca-298947.html 0.6 2026-08-07T00:12:02+08:00 daily https://www.pharmasources.com/industryinsights/current-situation-of-biosimilars-in-chin-298948.html 0.6 2026-08-04T06:59:26+08:00 daily https://www.pharmasources.com/industryinsights/us-astho-seeks-1bn-funding-for-opioid-ep-298949.html 0.6 2025-12-02T05:48:25+08:00 daily https://www.pharmasources.com/industryinsights/taltz-receives-fda-approval-for-active-p-298950.html 0.6 2026-04-19T05:20:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-repatha-to-prevent-heart-at-298951.html 0.6 2026-01-10T04:08:39+08:00 daily https://www.pharmasources.com/industryinsights/monosol-rx-changes-name-to-aquestive-the-298952.html 0.6 2026-02-28T17:30:53+08:00 daily https://www.pharmasources.com/industryinsights/levofloxacin-still-got-it-298953.html 0.6 2026-07-28T13:38:19+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-unveils-hard-hitting-data-f-298954.html 0.6 2026-03-17T23:44:43+08:00 daily https://www.pharmasources.com/industryinsights/vanilla-compound-found-to-prevent-psoria-298955.html 0.6 2026-01-10T03:02:46+08:00 daily https://www.pharmasources.com/industryinsights/nhs-talking-therapies-for-mental-health--298956.html 0.6 2025-12-02T05:41:43+08:00 daily https://www.pharmasources.com/industryinsights/az-tudorza-hits-study-goals-in-copd-pati-298957.html 0.6 2026-04-07T18:53:45+08:00 daily https://www.pharmasources.com/industryinsights/msd-wayra-uk-launch-third-velocity-healt-298958.html 0.6 2026-01-30T08:17:29+08:00 daily https://www.pharmasources.com/industryinsights/why-pfizer-could-and-should-scoop-up-cel-298959.html 0.6 2026-06-16T03:26:38+08:00 daily https://www.pharmasources.com/industryinsights/lexicon-pharma-secures-up-to-200m-non-di-298960.html 0.6 2025-12-02T05:37:17+08:00 daily https://www.pharmasources.com/industryinsights/79-employees-affected-as-novartis-plans--298961.html 0.6 2026-03-23T06:37:27+08:00 daily https://www.pharmasources.com/industryinsights/xencor-earns-10m-amgen-milestone-298962.html 0.6 2026-07-29T05:36:19+08:00 daily https://www.pharmasources.com/industryinsights/adc-bio-signs-agreement-with-sector-spec-298963.html 0.6 2026-03-24T18:37:35+08:00 daily https://www.pharmasources.com/industryinsights/foster-criticizes-trump-administration-o-298964.html 0.6 2026-01-10T03:02:48+08:00 daily https://www.pharmasources.com/industryinsights/taiwan-china-based-health-startup-raises-298965.html 0.6 2026-05-15T10:14:42+08:00 daily https://www.pharmasources.com/industryinsights/inventor-of-the-first-fda-approved-defib-298966.html 0.6 2026-04-08T13:45:32+08:00 daily https://www.pharmasources.com/industryinsights/discover-the-disruptive-technology-trend-298967.html 0.6 2026-07-02T16:58:56+08:00 daily https://www.pharmasources.com/industryinsights/new-research-into-old-antibiotic-unearth-298968.html 0.6 2026-06-08T07:55:56+08:00 daily https://www.pharmasources.com/industryinsights/gsk-submits-bold-us-application-for-tafe-298969.html 0.6 2026-05-02T10:38:53+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-alkermes-announce-collaborati-298970.html 0.6 2026-07-17T06:00:19+08:00 daily https://www.pharmasources.com/industryinsights/gene-based-zika-vaccine-is-safe-and-indu-298971.html 0.6 2026-01-22T09:51:34+08:00 daily https://www.pharmasources.com/industryinsights/indiabulls-pharmaceuticals-receives-rs-1-298972.html 0.6 2026-06-27T03:06:59+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-posts-third-quarter-results-298973.html 0.6 2026-08-08T04:33:51+08:00 daily https://www.pharmasources.com/industryinsights/dnatrix-announces-first-pediatric-patien-298974.html 0.6 2026-04-06T00:55:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ozempic-injection-for-type--298975.html 0.6 2026-04-08T15:33:34+08:00 daily https://www.pharmasources.com/industryinsights/galectin-therapeutics-share-value-plumme-298976.html 0.6 2026-06-16T01:00:45+08:00 daily https://www.pharmasources.com/industryinsights/two-big-pharma-companies-accused-of-fals-298977.html 0.6 2026-03-17T23:22:11+08:00 daily https://www.pharmasources.com/industryinsights/gsk-commits-to-multi-million-investment--298978.html 0.6 2026-08-06T10:38:58+08:00 daily https://www.pharmasources.com/industryinsights/roche-links-with-uk-gov-on-digital-patho-298979.html 0.6 2026-02-28T13:42:37+08:00 daily https://www.pharmasources.com/industryinsights/novo-bags-first-approval-for-once-weekly-298980.html 0.6 2026-06-13T19:10:41+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-biotech-obsidian-launches-with-298981.html 0.6 2026-08-06T23:33:16+08:00 daily https://www.pharmasources.com/industryinsights/in-a-crowded-market-abbvie-may-still-hav-298982.html 0.6 2026-08-06T22:00:26+08:00 daily https://www.pharmasources.com/industryinsights/amgen-carmot-ink-backloaded-240m-parkins-298983.html 0.6 2026-08-06T21:52:22+08:00 daily https://www.pharmasources.com/industryinsights/shire-rani-to-develop-oral-factor-viii-t-298984.html 0.6 2026-08-06T21:47:08+08:00 daily https://www.pharmasources.com/industryinsights/hawthorn-leaf-extract-and-nervonic-acid--298985.html 0.6 2026-08-06T19:59:26+08:00 daily https://www.pharmasources.com/industryinsights/metacrine-announces-completion-of-series-298986.html 0.6 2026-01-04T13:19:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-amgens-repatha-evolocumab-298987.html 0.6 2025-12-02T05:48:23+08:00 daily https://www.pharmasources.com/industryinsights/females-are-at-higher-risk-of-suffering--298988.html 0.6 2025-12-02T05:49:29+08:00 daily https://www.pharmasources.com/industryinsights/micurx-announces-closing-of-100-million--298989.html 0.6 2026-01-10T03:10:56+08:00 daily https://www.pharmasources.com/industryinsights/the-lancet-publishes-twelve-month-result-298990.html 0.6 2026-06-15T00:35:45+08:00 daily https://www.pharmasources.com/industryinsights/a-risk-factor-for-drug-induced-skin-dise-298991.html 0.6 2026-01-10T03:06:57+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-decibel-therapeutics-collabora-298992.html 0.6 2026-04-10T15:26:45+08:00 daily https://www.pharmasources.com/industryinsights/biolife-solutions-announces-signing-of-c-298993.html 0.6 2026-08-08T13:01:43+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-genentechs-avastin-for-g-298994.html 0.6 2026-07-18T06:33:45+08:00 daily https://www.pharmasources.com/industryinsights/everest-to-offer-two-arena-pharma-drugs--298995.html 0.6 2025-12-02T05:57:14+08:00 daily https://www.pharmasources.com/industryinsights/curadev-announces-partnership-with-unive-298996.html 0.6 2026-01-31T10:09:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-access-programmes-shaved-up-to-a-yea-298997.html 0.6 2026-01-12T04:26:57+08:00 daily https://www.pharmasources.com/industryinsights/roches-haemophilia-a-drug-shows-meaningf-298998.html 0.6 2026-08-09T02:59:40+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-available-via-cdf-298999.html 0.6 2026-08-07T04:39:22+08:00 daily https://www.pharmasources.com/industryinsights/cambridges-neon-therapeutics-completes-1-299000.html 0.6 2026-08-08T19:25:12+08:00 daily https://www.pharmasources.com/industryinsights/sage-therapeutics-erupts-as-depression-d-299001.html 0.6 2026-06-17T07:30:22+08:00 daily https://www.pharmasources.com/industryinsights/san-diegos-halozyme-lands-potential-680m-299002.html 0.6 2026-08-06T18:14:54+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-tecentriq-avastin-chemo-combo-299003.html 0.6 2026-05-03T17:15:25+08:00 daily https://www.pharmasources.com/industryinsights/bay-areas-xoma-snags-240m-deal-with-newl-299004.html 0.6 2026-07-02T14:43:53+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-to-launch-4-vaccines-ent-299005.html 0.6 2026-08-07T05:01:15+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-invest-40m-in-uks-life-sciences-s-299006.html 0.6 2026-08-07T04:37:01+08:00 daily https://www.pharmasources.com/industryinsights/avastin-wins-full-green-light-for-gliobl-299007.html 0.6 2026-08-07T04:24:57+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-impower150-study-showed-tecent-299008.html 0.6 2026-08-07T03:03:42+08:00 daily https://www.pharmasources.com/industryinsights/featured-products-of-hangzhou-johncan-mu-299009.html 0.6 2026-08-07T02:52:14+08:00 daily https://www.pharmasources.com/industryinsights/interview-shijiazhuang-shimu-animal-phar-299010.html 0.6 2026-08-07T02:59:33+08:00 daily https://www.pharmasources.com/industryinsights/story-of-baicao-pharmaceutical-and-its-t-299011.html 0.6 2026-07-24T16:06:46+08:00 daily https://www.pharmasources.com/industryinsights/clal-biotech-portfolio-co-neon-raises-10-299012.html 0.6 2026-06-20T20:47:34+08:00 daily https://www.pharmasources.com/industryinsights/adecco-group-acquires-life-sciences-firm-299013.html 0.6 2026-06-08T17:34:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pan-tumour-genomic-profilin-299014.html 0.6 2026-04-01T00:50:38+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-commits-210m-to-grow-life--299015.html 0.6 2026-08-07T23:10:01+08:00 daily https://www.pharmasources.com/industryinsights/mekong-countries-call-for-accelerated-ac-299016.html 0.6 2026-04-26T09:36:37+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-a-small-molecule-tha-299017.html 0.6 2026-05-04T00:18:13+08:00 daily https://www.pharmasources.com/industryinsights/melinta-therapeutics-acquisition-of-the--299018.html 0.6 2026-03-27T16:52:42+08:00 daily https://www.pharmasources.com/industryinsights/icr-scientists-find-new-target-protein-f-299019.html 0.6 2026-07-02T14:52:57+08:00 daily https://www.pharmasources.com/industryinsights/novartis-begins-study-evaluating-higher--299020.html 0.6 2026-08-03T08:16:50+08:00 daily https://www.pharmasources.com/industryinsights/stp705-granted-orphan-designation-for-tr-299021.html 0.6 2026-06-08T16:35:59+08:00 daily https://www.pharmasources.com/industryinsights/roche-tecentriq-combo-effective-but-is-i-299022.html 0.6 2026-06-13T14:30:33+08:00 daily https://www.pharmasources.com/industryinsights/gilead-makes-567m-strategic-acquisition--299023.html 0.6 2026-07-15T18:28:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-nods-for-abbvie-in-hep-c-and-novart-299024.html 0.6 2026-03-13T13:43:56+08:00 daily https://www.pharmasources.com/industryinsights/over-2000-immune-oncology-drugs-now-in-d-299025.html 0.6 2026-05-03T10:14:30+08:00 daily https://www.pharmasources.com/industryinsights/mygenomebox-presents-new-standard-of-bea-299026.html 0.6 2026-03-28T20:01:55+08:00 daily https://www.pharmasources.com/industryinsights/smart-hospitals-to-invest-over-11-billio-299027.html 0.6 2026-07-19T02:10:19+08:00 daily https://www.pharmasources.com/industryinsights/new-report-shows-cryotherapy-market-worl-299028.html 0.6 2026-03-08T05:37:28+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20171211-299029.html 0.6 2026-07-07T22:08:01+08:00 daily https://www.pharmasources.com/industryinsights/ex-genentech-employees-denali-breaks-201-299030.html 0.6 2026-06-22T16:10:03+08:00 daily https://www.pharmasources.com/industryinsights/talazoparib-significantly-extends-progre-299031.html 0.6 2026-03-11T13:49:34+08:00 daily https://www.pharmasources.com/industryinsights/denali-pulls-off-2017s-biggest-biotech-i-299032.html 0.6 2026-03-28T00:58:02+08:00 daily https://www.pharmasources.com/industryinsights/roches-hemlibra-continued-to-substantial-299033.html 0.6 2026-03-19T22:29:40+08:00 daily https://www.pharmasources.com/industryinsights/novartis-seeks-to-revive-neulasta-biosim-299034.html 0.6 2026-07-30T17:01:07+08:00 daily https://www.pharmasources.com/industryinsights/gphc-hits-the-go-button-on-revalidation-299035.html 0.6 2025-12-24T01:50:24+08:00 daily https://www.pharmasources.com/industryinsights/taking-quality-as-life-organic-high-qual-299036.html 0.6 2026-08-07T02:29:56+08:00 daily https://www.pharmasources.com/industryinsights/interview-jiangsu-gusu-purifying-technol-299037.html 0.6 2026-08-09T02:36:59+08:00 daily https://www.pharmasources.com/industryinsights/juno-therapeutics-signs-three-license-ag-299038.html 0.6 2026-04-05T17:17:28+08:00 daily https://www.pharmasources.com/industryinsights/roche-announces-phase-iii-study-results--299039.html 0.6 2026-07-20T07:41:35+08:00 daily https://www.pharmasources.com/industryinsights/fullerton-health-acquires-stake-in-intel-299040.html 0.6 2026-04-13T12:25:03+08:00 daily https://www.pharmasources.com/industryinsights/abatacept-improves-survival-in-patients--299041.html 0.6 2026-04-05T21:28:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-public-education-campaign-t-299042.html 0.6 2026-07-03T00:35:13+08:00 daily https://www.pharmasources.com/industryinsights/torrent-novo-nordisk-india-expand-insuli-299043.html 0.6 2026-07-03T12:34:47+08:00 daily https://www.pharmasources.com/industryinsights/curadev-in-research-partnership-with-ut--299044.html 0.6 2026-07-04T10:14:33+08:00 daily https://www.pharmasources.com/industryinsights/bill-gates-acknowledges-hester-for-devel-299045.html 0.6 2025-12-02T06:55:21+08:00 daily https://www.pharmasources.com/industryinsights/us-scientists-find-potential-therapy-for-299046.html 0.6 2025-12-02T06:56:32+08:00 daily https://www.pharmasources.com/industryinsights/meiragtx-obtains-rare-disease-designatio-299047.html 0.6 2026-06-08T04:53:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bla-to-review-galcanezumab-f-299048.html 0.6 2026-08-09T13:09:56+08:00 daily https://www.pharmasources.com/industryinsights/phrma-challenges-unconstitutional-provis-299049.html 0.6 2026-06-18T18:32:49+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-completes-acquisition-of-oc-299050.html 0.6 2026-01-27T18:48:23+08:00 daily https://www.pharmasources.com/industryinsights/rumours-have-it-that-teva-job-cut-could--299051.html 0.6 2026-07-02T16:12:27+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kymriah-shows-durable-response--299052.html 0.6 2026-07-15T17:23:05+08:00 daily https://www.pharmasources.com/industryinsights/twenty-percent-of-millennium-generation--299053.html 0.6 2026-03-21T10:44:12+08:00 daily https://www.pharmasources.com/industryinsights/tw-group---process-chemistry-expert-299054.html 0.6 2026-08-07T02:52:28+08:00 daily https://www.pharmasources.com/industryinsights/pharmaessentia-announces-favorable-two-y-299055.html 0.6 2026-04-09T15:55:30+08:00 daily https://www.pharmasources.com/industryinsights/xultophyr-significantly-reduces-blood-su-299056.html 0.6 2026-08-04T06:58:06+08:00 daily https://www.pharmasources.com/industryinsights/market-prospect-of-hesperidin-299057.html 0.6 2026-05-24T13:44:04+08:00 daily https://www.pharmasources.com/industryinsights/gilead-backs-60m-hookipa-round-to-fund-i-299058.html 0.6 2026-08-05T19:43:41+08:00 daily https://www.pharmasources.com/industryinsights/lillys-cyramza-fails-to-improve-overall--299059.html 0.6 2026-08-06T02:35:51+08:00 daily https://www.pharmasources.com/industryinsights/oriental-tongxiang-international-contrib-299060.html 0.6 2026-06-24T18:27:53+08:00 daily https://www.pharmasources.com/industryinsights/hookipa-biotech-raises-60-million-in-rou-299061.html 0.6 2025-12-02T07:13:47+08:00 daily https://www.pharmasources.com/industryinsights/nky-pharmaceuticals-to-buy-biovision-299062.html 0.6 2025-12-14T04:03:33+08:00 daily https://www.pharmasources.com/industryinsights/jw-pharma-releases-cancer-treatment-tria-299063.html 0.6 2026-06-30T06:38:51+08:00 daily https://www.pharmasources.com/industryinsights/advent-access-raises-s26-million-pre-ser-299064.html 0.6 2026-04-08T13:42:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vercise-deep-brain-stimulat-299065.html 0.6 2026-04-05T19:39:48+08:00 daily https://www.pharmasources.com/industryinsights/using-light-emitting-nanoparticles-may-l-299066.html 0.6 2026-01-26T20:31:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-admelog-the-first-follow-on-299067.html 0.6 2026-04-08T17:51:14+08:00 daily https://www.pharmasources.com/industryinsights/phrma-report-shows-how-supply-chain-shap-299068.html 0.6 2026-04-02T17:16:30+08:00 daily https://www.pharmasources.com/industryinsights/northsea-therapeutics-secures-25-million-299069.html 0.6 2026-06-30T15:35:20+08:00 daily https://www.pharmasources.com/industryinsights/psioxus-achieves-15m-bms-milestone-299070.html 0.6 2026-07-17T22:40:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-scapho-shows-pioneering-4-year--299071.html 0.6 2026-04-05T12:25:17+08:00 daily https://www.pharmasources.com/industryinsights/synlogic-and-ginkgo-bioworks-enter-drug--299072.html 0.6 2026-06-08T21:37:19+08:00 daily https://www.pharmasources.com/industryinsights/megglethe-world-leading-lactose-producer-299073.html 0.6 2026-07-05T02:44:00+08:00 daily https://www.pharmasources.com/industryinsights/phrma-announces-commitment-to-address-th-299074.html 0.6 2026-03-02T16:34:10+08:00 daily https://www.pharmasources.com/industryinsights/latest-us-company-accused-of-price-gougi-299075.html 0.6 2026-04-07T19:33:03+08:00 daily https://www.pharmasources.com/industryinsights/single-high-dose-vaccine-could-provide-b-299076.html 0.6 2026-07-07T06:16:00+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-issues-us-wide-recall-for-arthrit-299077.html 0.6 2026-04-19T04:15:03+08:00 daily https://www.pharmasources.com/industryinsights/medherant-raises-38-million-for-transder-299078.html 0.6 2026-07-18T08:46:13+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-recognizes-caradigm-as-a--299079.html 0.6 2026-01-30T18:17:37+08:00 daily https://www.pharmasources.com/industryinsights/cmc-biologics-announces-development-and--299080.html 0.6 2026-03-18T08:12:38+08:00 daily https://www.pharmasources.com/industryinsights/scotland-approves-nhs-funding-for-ibranc-299081.html 0.6 2026-07-31T05:17:31+08:00 daily https://www.pharmasources.com/industryinsights/lamotrigine-taken-during-pregnancy-not-l-299082.html 0.6 2026-07-01T15:15:53+08:00 daily https://www.pharmasources.com/industryinsights/ardelyx-signs-license-agreement-with-fos-299083.html 0.6 2025-12-02T07:39:04+08:00 daily https://www.pharmasources.com/industryinsights/hit-zhongao-biological-engineering----an-299084.html 0.6 2026-06-19T21:30:31+08:00 daily https://www.pharmasources.com/industryinsights/differences-between-vegetarian-and-gelat-299085.html 0.6 2026-08-07T00:41:33+08:00 daily https://www.pharmasources.com/industryinsights/singapore-medtech-company-advent-access--299086.html 0.6 2026-02-10T18:22:25+08:00 daily https://www.pharmasources.com/industryinsights/thailand-to-work-with-pakistan-for-promo-299087.html 0.6 2026-03-14T02:49:22+08:00 daily https://www.pharmasources.com/industryinsights/scientists-in-china-develop-novel-photo--299088.html 0.6 2026-08-07T00:02:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sanofis-admelog-299089.html 0.6 2026-02-28T04:49:52+08:00 daily https://www.pharmasources.com/industryinsights/new-study-reveals-barrier-in-quality-end-299090.html 0.6 2025-12-02T07:47:13+08:00 daily https://www.pharmasources.com/industryinsights/mid-infrared-spectroscopy-used-to-diagno-299091.html 0.6 2026-07-20T16:37:48+08:00 daily https://www.pharmasources.com/industryinsights/niclosamide-could-lead-to-new-treatment--299092.html 0.6 2026-08-06T00:09:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-new-tool-for-sharing-inform-299093.html 0.6 2026-07-20T00:22:28+08:00 daily https://www.pharmasources.com/industryinsights/northsea-therapeutics-secures-funding-to-299094.html 0.6 2026-08-07T13:59:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-for-eosinophilic-299095.html 0.6 2026-06-09T01:55:57+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-sees-pipeline-fruition-in-2018-299096.html 0.6 2026-08-07T05:13:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-cracks-down-on-snortable-chocolate-p-299097.html 0.6 2026-08-07T05:05:59+08:00 daily https://www.pharmasources.com/industryinsights/jjs-darzalex-cuts-risk-of-disease-progre-299098.html 0.6 2026-08-07T01:06:35+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-fall-foul-of-abpis-code-299099.html 0.6 2026-08-07T00:59:23+08:00 daily https://www.pharmasources.com/industryinsights/vernalis-daiichi-sankyo-work-together-on-299100.html 0.6 2026-08-07T00:40:05+08:00 daily https://www.pharmasources.com/industryinsights/interview-jinan-pengbo-biotechnology-co--299101.html 0.6 2026-04-05T05:15:08+08:00 daily https://www.pharmasources.com/industryinsights/uk-hospital-combines-gaming-and-ar-for-p-299102.html 0.6 2026-08-07T00:36:42+08:00 daily https://www.pharmasources.com/industryinsights/hitlab-and-unitus-seed-fund-invite-healt-299103.html 0.6 2026-08-08T20:19:07+08:00 daily https://www.pharmasources.com/industryinsights/cmc-biologics-announces-development-and--299104.html 0.6 2026-08-07T02:40:10+08:00 daily https://www.pharmasources.com/industryinsights/pionyr-immunotherapeutics-gains-meaty-62-299105.html 0.6 2026-08-07T01:27:45+08:00 daily https://www.pharmasources.com/industryinsights/sanofiregenerons-breakthrough-pd-1-hits--299106.html 0.6 2026-08-07T01:19:18+08:00 daily https://www.pharmasources.com/industryinsights/yacooprofessional-people-provide-you-wit-299107.html 0.6 2026-08-09T12:15:43+08:00 daily https://www.pharmasources.com/industryinsights/victar----the-manufacturer-of-superior-h-299108.html 0.6 2026-08-07T01:14:28+08:00 daily https://www.pharmasources.com/industryinsights/snortable-chocolate-arrives-in-us-stores-299109.html 0.6 2026-08-07T00:43:31+08:00 daily https://www.pharmasources.com/industryinsights/israeli-firm-to-invest-in-japanese-start-299110.html 0.6 2026-08-07T00:41:40+08:00 daily https://www.pharmasources.com/industryinsights/half-the-world-lacks-access-to-essential-299111.html 0.6 2026-08-07T00:01:15+08:00 daily https://www.pharmasources.com/industryinsights/bangladesh-moves-to-protect-rohingya-chi-299112.html 0.6 2026-08-07T05:30:52+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-russian-researchers-join-forces-a-299113.html 0.6 2026-04-05T20:15:48+08:00 daily https://www.pharmasources.com/industryinsights/plasmonic-biosensors-lead-to-new-easy-to-299114.html 0.6 2026-08-02T22:46:08+08:00 daily https://www.pharmasources.com/industryinsights/yesherb-organic-fruit-vegetable-powder-b-299115.html 0.6 2026-08-06T23:55:40+08:00 daily https://www.pharmasources.com/industryinsights/lactic-acid-bacteria-can-protect-against-299116.html 0.6 2026-07-30T13:59:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-zy-299117.html 0.6 2026-08-03T07:28:31+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-and-puma-biotech-to-asses-299118.html 0.6 2026-08-01T05:31:22+08:00 daily https://www.pharmasources.com/industryinsights/st-johns-wort-extract-299119.html 0.6 2026-07-30T22:50:54+08:00 daily https://www.pharmasources.com/industryinsights/foodchem--rooted-in-china-serves-the-wor-299120.html 0.6 2026-06-08T00:07:16+08:00 daily https://www.pharmasources.com/industryinsights/epfl-researchers-use-electrochemical-ima-299121.html 0.6 2026-01-10T03:02:13+08:00 daily https://www.pharmasources.com/industryinsights/a-drug-lowers-huntingtons-disease-protei-299122.html 0.6 2026-08-08T23:10:13+08:00 daily https://www.pharmasources.com/industryinsights/who-advises-dengvaxia-to-be-used-only-in-299123.html 0.6 2026-08-08T21:34:24+08:00 daily https://www.pharmasources.com/industryinsights/professionalism-out-of-devotion----overv-299124.html 0.6 2026-08-09T02:54:40+08:00 daily https://www.pharmasources.com/industryinsights/scientists-of-osaka-university-find-that-299125.html 0.6 2026-08-08T20:04:47+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-distribute-all-avanti-polar-lip-299126.html 0.6 2026-08-08T17:01:00+08:00 daily https://www.pharmasources.com/industryinsights/admelog-the-first-short-acting-follow-on-299127.html 0.6 2026-08-07T13:15:56+08:00 daily https://www.pharmasources.com/industryinsights/nanoparticles-as-a-solution-against-anti-299128.html 0.6 2026-08-07T00:41:23+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-and-gnthon-announce-299129.html 0.6 2026-08-07T00:01:14+08:00 daily https://www.pharmasources.com/industryinsights/rimidi-eli-lilly-enter-partnership-for-d-299130.html 0.6 2026-08-10T00:04:13+08:00 daily https://www.pharmasources.com/industryinsights/cosmetic-peptide-299131.html 0.6 2026-08-09T20:49:20+08:00 daily https://www.pharmasources.com/industryinsights/germanys-evotec-and-crtd-to-find-new-the-299132.html 0.6 2026-08-08T21:33:50+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-restructuring-plan-cuts-2-299133.html 0.6 2026-08-08T13:15:38+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-agrees-largest-drug-d-299134.html 0.6 2026-08-07T01:11:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-president-of-oncology-announces-299135.html 0.6 2026-08-09T12:17:02+08:00 daily https://www.pharmasources.com/industryinsights/shire-and-partners-launch-irish-haemophi-299136.html 0.6 2026-08-08T20:37:24+08:00 daily https://www.pharmasources.com/industryinsights/us-regulators-approve-pfizers-remicade-b-299137.html 0.6 2026-08-08T22:35:16+08:00 daily https://www.pharmasources.com/industryinsights/expert-in-ginseng-specialty-in-quality---299138.html 0.6 2026-08-07T13:15:42+08:00 daily https://www.pharmasources.com/industryinsights/gilead-could-make-a-move-for-galapagos-w-299139.html 0.6 2026-08-09T01:21:04+08:00 daily https://www.pharmasources.com/industryinsights/these-2-startups-are-amgens-2017-golden--299140.html 0.6 2026-08-04T15:56:19+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-pfizer-jump-in-on-newly-launched--299141.html 0.6 2026-08-08T00:14:53+08:00 daily https://www.pharmasources.com/industryinsights/biotechs-drool-as-vc-firm-andreessen-hor-299142.html 0.6 2026-08-06T20:01:06+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-receives-operating-permit-299143.html 0.6 2026-08-08T16:08:46+08:00 daily https://www.pharmasources.com/industryinsights/top-minds-at-sunway-university-for-the-c-299144.html 0.6 2026-07-30T03:47:01+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20171218-299145.html 0.6 2026-07-08T05:53:16+08:00 daily https://www.pharmasources.com/industryinsights/committed-for-better-and-dedicated-for-c-299146.html 0.6 2026-08-07T02:52:36+08:00 daily https://www.pharmasources.com/industryinsights/mellow-hope-from-hepatitis-a-vaccine-to--299147.html 0.6 2026-06-08T15:25:21+08:00 daily https://www.pharmasources.com/industryinsights/tianhe-life-sciences-leads-95m-series-a--299148.html 0.6 2026-03-21T18:07:25+08:00 daily https://www.pharmasources.com/industryinsights/gileads-patent-for-hepatitis-c-be-challe-299149.html 0.6 2026-08-02T14:44:37+08:00 daily https://www.pharmasources.com/industryinsights/viimed-teams-up-with-jhhc-to-enhance-dig-299150.html 0.6 2025-11-07T07:22:25+08:00 daily https://www.pharmasources.com/industryinsights/heroin-vaccine-could-be-a-treatment-for--299151.html 0.6 2026-08-01T13:27:57+08:00 daily https://www.pharmasources.com/industryinsights/xultophy-shows-significant-results-for-t-299152.html 0.6 2026-08-01T21:48:15+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-regulatory-submission-for-299153.html 0.6 2026-08-05T02:52:07+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-qingdao-tai-tong-pharmaceuti-299154.html 0.6 2026-07-15T01:45:53+08:00 daily https://www.pharmasources.com/industryinsights/lonza-integrates-new-serialization-secur-299155.html 0.6 2026-08-05T15:43:20+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-receives-operating-permit-299156.html 0.6 2026-01-12T02:03:42+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-isa-enter-immuno-oncology--299157.html 0.6 2026-08-08T17:00:34+08:00 daily https://www.pharmasources.com/industryinsights/indian-firm-bags-nod-to-conduct-phase-i--299158.html 0.6 2026-01-24T18:24:06+08:00 daily https://www.pharmasources.com/industryinsights/allergan-richter-announce-positive-resul-299159.html 0.6 2026-08-02T12:09:37+08:00 daily https://www.pharmasources.com/industryinsights/novartis-snaps-up-priority-review-vouche-299160.html 0.6 2026-06-12T19:45:25+08:00 daily https://www.pharmasources.com/industryinsights/us-priority-review-for-az-tagrisso-299161.html 0.6 2026-05-03T09:56:20+08:00 daily https://www.pharmasources.com/industryinsights/new-cns-partnership-between-boehringer-a-299162.html 0.6 2026-06-22T11:42:07+08:00 daily https://www.pharmasources.com/industryinsights/horizon-expands-agreement-with-roche-dia-299163.html 0.6 2026-06-28T18:00:49+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-xeljanz-wins-us-nod-for-psoriati-299164.html 0.6 2026-07-29T23:03:39+08:00 daily https://www.pharmasources.com/industryinsights/seven-therapies-backed-for-eu-approval-299165.html 0.6 2026-07-29T09:53:49+08:00 daily https://www.pharmasources.com/industryinsights/worlds-top-5-best-selling-drugs-in-2017-299166.html 0.6 2026-05-05T18:21:37+08:00 daily https://www.pharmasources.com/industryinsights/8-possible-biopharma-takeover-targets-fo-299167.html 0.6 2026-06-14T19:44:11+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-inks-6275m-deal-with-glaxosmi-299168.html 0.6 2025-12-31T08:53:45+08:00 daily https://www.pharmasources.com/industryinsights/service-as-product-solutions-to-become-t-299169.html 0.6 2026-08-03T20:18:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-buys-rare-drug-voucher-for-130m-299170.html 0.6 2026-08-06T01:47:22+08:00 daily https://www.pharmasources.com/industryinsights/aptinyx-bags-70m-financing-to-fuel-expan-299171.html 0.6 2026-08-08T00:42:28+08:00 daily https://www.pharmasources.com/industryinsights/shires-hunter-syndrome-treatment-failed--299172.html 0.6 2026-08-02T16:12:01+08:00 daily https://www.pharmasources.com/industryinsights/with-a-collaboration-deal-in-place-with--299173.html 0.6 2026-08-04T18:02:09+08:00 daily https://www.pharmasources.com/industryinsights/bay-area-biotech-company-inked-multi-yea-299174.html 0.6 2026-08-10T00:17:06+08:00 daily https://www.pharmasources.com/industryinsights/spark-gets-fda-greenlight-for-luxturna-t-299175.html 0.6 2026-08-09T02:18:52+08:00 daily https://www.pharmasources.com/industryinsights/pfenex-earns-185m-in-milestones-and-upda-299176.html 0.6 2026-08-09T00:37:51+08:00 daily https://www.pharmasources.com/industryinsights/xbrane-biopharma-signs-agreement-with-bl-299177.html 0.6 2026-08-08T22:44:56+08:00 daily https://www.pharmasources.com/industryinsights/argenx-announces-closing-of-us-public-of-299178.html 0.6 2026-08-08T20:54:17+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-to-announce-results-299179.html 0.6 2026-08-07T14:15:22+08:00 daily https://www.pharmasources.com/industryinsights/sensorion-and-cochlear-announce-collabor-299180.html 0.6 2026-08-07T13:54:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-gene-therapy-to-treat-299181.html 0.6 2026-08-07T13:17:19+08:00 daily https://www.pharmasources.com/industryinsights/abbott-launches-insertable-cardiac-monit-299182.html 0.6 2026-08-07T11:55:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-two-draft-guidances-on-dev-299183.html 0.6 2026-03-25T19:01:56+08:00 daily https://www.pharmasources.com/industryinsights/cpnps-cellprotect-receives-orphan-drug-d-299184.html 0.6 2026-08-06T22:08:16+08:00 daily https://www.pharmasources.com/industryinsights/clearpath-launches-partnership-with-aste-299185.html 0.6 2026-08-07T10:53:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-pledges-to-crack-down-on-homeopathy--299186.html 0.6 2026-08-04T00:23:42+08:00 daily https://www.pharmasources.com/industryinsights/100000-vacancies-contribute-to-nhs-crisi-299187.html 0.6 2026-08-07T12:00:05+08:00 daily https://www.pharmasources.com/industryinsights/tevas-anti-cgrp-drug-under-review-for-mi-299188.html 0.6 2026-08-07T13:17:45+08:00 daily https://www.pharmasources.com/industryinsights/tl-plastic-surgerys-dr-choi-sewoo---sele-299189.html 0.6 2026-08-08T07:59:13+08:00 daily https://www.pharmasources.com/industryinsights/wearable-data-analytics-bring-humans-int-299190.html 0.6 2026-08-07T13:17:45+08:00 daily https://www.pharmasources.com/industryinsights/create-a-special-christmas-card-and-shar-299191.html 0.6 2026-08-07T01:18:56+08:00 daily https://www.pharmasources.com/industryinsights/meggle-experts-in-excipients-the-whole-w-299192.html 0.6 2026-08-07T01:14:13+08:00 daily https://www.pharmasources.com/industryinsights/sunkeen-yeast-product-introduction-299193.html 0.6 2026-08-07T01:52:10+08:00 daily https://www.pharmasources.com/industryinsights/xian-sanjiang-bio-engineering-coltd-comp-299194.html 0.6 2026-08-07T01:19:37+08:00 daily https://www.pharmasources.com/industryinsights/sundia-meditech-co-ltd-company-overview-299195.html 0.6 2026-08-07T00:42:45+08:00 daily https://www.pharmasources.com/industryinsights/why-this-little-known-biotech-is-pharmas-299196.html 0.6 2026-08-07T02:05:25+08:00 daily https://www.pharmasources.com/industryinsights/3-hottest-areas-of-drug-development-to-k-299197.html 0.6 2026-07-04T10:27:14+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-scores-key-trial-win-for-ra-drug--299198.html 0.6 2026-07-11T00:12:58+08:00 daily https://www.pharmasources.com/industryinsights/jsr-life-sciences-snaps-up-cro-in-400m-d-299199.html 0.6 2026-07-29T14:47:19+08:00 daily https://www.pharmasources.com/industryinsights/loxo-oncology-initiates-rolling-submissi-299200.html 0.6 2026-03-17T22:50:47+08:00 daily https://www.pharmasources.com/industryinsights/amneal-brings-generic-for-renvela-to-mar-299201.html 0.6 2026-08-02T06:57:12+08:00 daily https://www.pharmasources.com/industryinsights/galectin-therapeutics-announces-10-milli-299202.html 0.6 2026-08-03T07:35:57+08:00 daily https://www.pharmasources.com/industryinsights/nuritas-raises-16-million-in-series-a-fu-299203.html 0.6 2026-08-01T19:11:33+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drugs-market-will-be-worth-us58-299204.html 0.6 2026-03-27T19:13:20+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-to-run-ophthalmology-portfol-299205.html 0.6 2026-08-08T06:03:19+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-110m-seri-299206.html 0.6 2026-01-31T02:51:58+08:00 daily https://www.pharmasources.com/industryinsights/avista-pharma-completes-facility-upgrade-299207.html 0.6 2026-08-05T02:04:41+08:00 daily https://www.pharmasources.com/industryinsights/jj-struck-by-25m-fine-over-fentanyl-pain-299208.html 0.6 2026-07-04T00:56:34+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-novartis-extavia-for-ms--299209.html 0.6 2026-01-10T03:06:08+08:00 daily https://www.pharmasources.com/industryinsights/gsk-forced-to-pay-back-15m-to-scottish-g-299210.html 0.6 2025-12-22T02:20:16+08:00 daily https://www.pharmasources.com/industryinsights/shire-hunter-syndrome-therapy-fails-to-h-299211.html 0.6 2026-04-19T03:58:54+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-alnylam-file-hattr-amyloidosis-th-299212.html 0.6 2026-04-16T01:43:24+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-rare-skin-disease-implan-299213.html 0.6 2026-03-19T07:34:54+08:00 daily https://www.pharmasources.com/industryinsights/mydx-cancels-reverse-stock-split-299214.html 0.6 2026-07-12T11:49:48+08:00 daily https://www.pharmasources.com/industryinsights/jhl-biotech-submits-clinical-trial-appli-299215.html 0.6 2026-08-07T01:52:08+08:00 daily https://www.pharmasources.com/industryinsights/bone-biologics-release-new-preclinical-d-299216.html 0.6 2026-08-07T01:21:35+08:00 daily https://www.pharmasources.com/industryinsights/enzymeking-biotechnology-company-limited-299217.html 0.6 2026-08-07T01:14:31+08:00 daily https://www.pharmasources.com/industryinsights/cigna-jiangsu-province-foreign-trade-pha-299218.html 0.6 2026-08-08T05:24:23+08:00 daily https://www.pharmasources.com/industryinsights/accela-chembio-co-ldt-company-overview-299219.html 0.6 2026-08-08T23:09:45+08:00 daily https://www.pharmasources.com/industryinsights/surprise-fda-clears-launch-for-portolas--299220.html 0.6 2026-08-09T06:59:45+08:00 daily https://www.pharmasources.com/industryinsights/google-backed-flx-bio-scores-60m-financi-299221.html 0.6 2026-07-05T14:28:56+08:00 daily https://www.pharmasources.com/industryinsights/what-are-the-top-5-biotech-stocks-to-buy-299222.html 0.6 2026-08-05T11:51:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-type-2-diabetes-drug-fr-299223.html 0.6 2026-04-23T10:08:18+08:00 daily https://www.pharmasources.com/industryinsights/fosun-pharma-unit-to-raise-190-million-f-299224.html 0.6 2026-06-08T21:07:21+08:00 daily https://www.pharmasources.com/industryinsights/tracon-pharma-ambrx-ink-deal-up-to-1435m-299225.html 0.6 2026-06-12T13:52:31+08:00 daily https://www.pharmasources.com/industryinsights/basilea-reports-that-ceftobiprole-receiv-299226.html 0.6 2026-08-07T09:24:07+08:00 daily https://www.pharmasources.com/industryinsights/mei-pharma-announces-study-of-clinical-s-299227.html 0.6 2025-10-28T15:53:12+08:00 daily https://www.pharmasources.com/industryinsights/eu-follows-us-and-approves-chugais-alk-i-299228.html 0.6 2026-06-22T00:25:03+08:00 daily https://www.pharmasources.com/industryinsights/jacobson-pharma-enters-agreements-with-h-299229.html 0.6 2026-06-20T06:47:55+08:00 daily https://www.pharmasources.com/industryinsights/taris-biomedical-announces-25m-series-b--299230.html 0.6 2026-06-18T14:06:44+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-report-fourth-quarter-and-year-299231.html 0.6 2026-08-04T00:36:20+08:00 daily https://www.pharmasources.com/industryinsights/prominent-israeli-philanthropist-morris--299232.html 0.6 2026-06-18T14:06:45+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-uses-thinfilms-nfc-solution--299233.html 0.6 2026-06-18T14:15:44+08:00 daily https://www.pharmasources.com/industryinsights/nih-study-finds-clues-about-why-common-c-299234.html 0.6 2025-10-30T11:09:45+08:00 daily https://www.pharmasources.com/industryinsights/higher-mutational-burdens-in-tumours-lin-299235.html 0.6 2026-06-18T12:48:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breast-cancer-approval-to-roc-299236.html 0.6 2025-11-09T18:10:33+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-bosulif-scores-us-green-light-in-299237.html 0.6 2025-12-05T23:05:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-spark-therapeutics-luxturna-299238.html 0.6 2026-06-12T19:28:12+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-grants-orphan-drug-d-299239.html 0.6 2026-06-12T09:04:11+08:00 daily https://www.pharmasources.com/industryinsights/zuellig-pharma-signs-mou-with-vietnamese-299240.html 0.6 2026-03-22T13:44:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-routine-access-to-beta-i-299241.html 0.6 2026-08-09T03:10:50+08:00 daily https://www.pharmasources.com/industryinsights/natural-ingredients-healthy-life-299242.html 0.6 2026-08-07T03:24:32+08:00 daily https://www.pharmasources.com/industryinsights/what-are-the-main-product-lines-of-tianj-299243.html 0.6 2026-08-07T03:08:25+08:00 daily https://www.pharmasources.com/industryinsights/buying-excipients-and-apis-could-be-done-299244.html 0.6 2026-02-15T01:06:24+08:00 daily https://www.pharmasources.com/industryinsights/roche-does-last-minute-christmas-shoppin-299245.html 0.6 2026-08-07T03:24:45+08:00 daily https://www.pharmasources.com/industryinsights/9-reasons-to-buy-pfizer-in-2018-and-1-bi-299246.html 0.6 2026-08-07T03:54:55+08:00 daily https://www.pharmasources.com/industryinsights/teva-sees-approval-at-finish-line-for-an-299247.html 0.6 2026-08-07T04:07:03+08:00 daily https://www.pharmasources.com/industryinsights/3-immuno-oncology-therapeutics-expected--299248.html 0.6 2026-08-07T13:31:06+08:00 daily https://www.pharmasources.com/industryinsights/novabay-pharmaceuticals-receives-stockho-299249.html 0.6 2026-06-30T16:32:25+08:00 daily https://www.pharmasources.com/industryinsights/centinel-spine-completes-acquisition-of--299250.html 0.6 2026-06-28T23:00:56+08:00 daily https://www.pharmasources.com/industryinsights/first-successful-clinical-implantation-o-299251.html 0.6 2026-06-11T06:36:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-the-label-of-tasigna-to-refl-299252.html 0.6 2026-06-09T16:04:57+08:00 daily https://www.pharmasources.com/industryinsights/merck-agrees-to-manufacture-viral-vector-299253.html 0.6 2025-11-08T22:06:33+08:00 daily https://www.pharmasources.com/industryinsights/la-jolla-pharmaceutical-scores-fda-appro-299254.html 0.6 2026-06-15T07:44:16+08:00 daily https://www.pharmasources.com/industryinsights/novartis-hit-by-court-loss-could-spur-nu-299255.html 0.6 2026-06-17T02:11:05+08:00 daily https://www.pharmasources.com/industryinsights/roche-boosts-oncology-portfolio-with-17b-299256.html 0.6 2026-07-22T10:10:25+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-status-for-pfizermercks-ave-299257.html 0.6 2026-06-22T00:33:49+08:00 daily https://www.pharmasources.com/industryinsights/az-and-icl-link-to-research-respiratory--299258.html 0.6 2026-06-24T03:25:51+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-roches-tecentriq-for-pre-tr-299259.html 0.6 2026-01-05T10:30:14+08:00 daily https://www.pharmasources.com/industryinsights/celgene-crashed-after-follicular-lymphom-299260.html 0.6 2026-05-04T13:41:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-agiles-contraceptive-patch-t-299261.html 0.6 2026-03-25T17:44:21+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-medicine-terminates-phase-iii-o-299262.html 0.6 2026-07-12T04:31:24+08:00 daily https://www.pharmasources.com/industryinsights/janssen-forges-global-pact-with-legend-b-299263.html 0.6 2026-08-03T04:46:04+08:00 daily https://www.pharmasources.com/industryinsights/north-carolina-sues-insys-accused-of-bri-299264.html 0.6 2026-02-06T22:58:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-orthos-hiv-diagnostic-test-299265.html 0.6 2026-08-08T10:13:50+08:00 daily https://www.pharmasources.com/industryinsights/impax-to-sell-taiwan-china-manufacturing-299266.html 0.6 2026-08-08T07:37:12+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-110m-seri-299267.html 0.6 2026-08-08T04:31:07+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20171225-299268.html 0.6 2026-08-07T04:16:00+08:00 daily https://www.pharmasources.com/industryinsights/5-milestones-of-2017-in-the-war-on-cance-299269.html 0.6 2026-08-07T17:15:24+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-signs-licensing-agreemen-299270.html 0.6 2026-08-08T08:00:35+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-ignyta-signs-merger-agreement-299271.html 0.6 2026-08-08T10:11:03+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-announces-initiation-stem-cell-299272.html 0.6 2026-08-08T12:18:40+08:00 daily https://www.pharmasources.com/industryinsights/auromedics-issues-voluntary-nationwide-r-299273.html 0.6 2026-08-08T13:46:41+08:00 daily https://www.pharmasources.com/industryinsights/india-fast-emerging-as-inventors-hub-for-299274.html 0.6 2026-08-09T07:36:23+08:00 daily https://www.pharmasources.com/industryinsights/folic-acid-in-pregnancy-can-up-risk-of-a-299275.html 0.6 2026-03-21T16:01:52+08:00 daily https://www.pharmasources.com/industryinsights/west-virginia-leads-nation-in-drug-overd-299276.html 0.6 2026-06-22T05:57:49+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-bmy-downgraded-by-v-299277.html 0.6 2025-11-12T21:11:15+08:00 daily https://www.pharmasources.com/industryinsights/array-biopharma-arry-price-target-increa-299278.html 0.6 2026-02-28T22:50:31+08:00 daily https://www.pharmasources.com/industryinsights/amarin-amrn-cut-to-sell-at-zacks-investm-299279.html 0.6 2026-04-16T06:49:11+08:00 daily https://www.pharmasources.com/industryinsights/mizuho-analysts-give-biogen-biib-a-40000-299280.html 0.6 2026-02-28T23:27:07+08:00 daily https://www.pharmasources.com/industryinsights/adaptive-phase-ii-study-of-ban2401-in-ea-299281.html 0.6 2026-03-17T20:42:24+08:00 daily https://www.pharmasources.com/industryinsights/novartis-combination-therapy-tafinlar-me-299282.html 0.6 2026-07-03T04:05:34+08:00 daily https://www.pharmasources.com/industryinsights/transgene-announces-financial-calendar-f-299283.html 0.6 2026-06-08T17:16:46+08:00 daily https://www.pharmasources.com/industryinsights/metavivor-announces-2017-grant-awards-fo-299284.html 0.6 2026-01-30T19:06:29+08:00 daily https://www.pharmasources.com/industryinsights/primary-endpoint-met-in-corvia-medicals--299285.html 0.6 2026-03-17T20:30:59+08:00 daily https://www.pharmasources.com/industryinsights/quidel-receives-fda-clearance-and-clia-w-299286.html 0.6 2026-05-21T11:13:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-proposes-easing-of-medical-device-ma-299287.html 0.6 2026-06-22T08:46:41+08:00 daily https://www.pharmasources.com/industryinsights/the-2017-biotech-ipo-winners-and-losers-299288.html 0.6 2026-06-21T04:49:27+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-based-aura-biosciences-scoops--299289.html 0.6 2026-03-17T22:50:31+08:00 daily https://www.pharmasources.com/industryinsights/astellas-pharma-exec-shares-his-best-lif-299290.html 0.6 2026-07-18T12:29:13+08:00 daily https://www.pharmasources.com/industryinsights/histogenics-medinet-ink-pact-for-develop-299291.html 0.6 2026-04-08T13:34:44+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-priority-review-to-janssen-299292.html 0.6 2026-07-08T07:19:58+08:00 daily https://www.pharmasources.com/industryinsights/3-fda-topics-to-watch-in-2018-299293.html 0.6 2026-02-28T14:29:26+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-trends-to-watch-in-2018-299294.html 0.6 2026-08-08T07:33:28+08:00 daily https://www.pharmasources.com/industryinsights/zomedica-pharmaceuticals-enters-into-lic-299295.html 0.6 2026-02-26T19:33:15+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-collaborates-with-x-chem-for-new--299296.html 0.6 2026-02-15T13:33:16+08:00 daily https://www.pharmasources.com/industryinsights/niaid-scientists-zika-remains-public-hea-299297.html 0.6 2026-06-13T14:56:05+08:00 daily https://www.pharmasources.com/industryinsights/japanese-scientists-create-a-database-of-299298.html 0.6 2026-08-08T16:54:21+08:00 daily https://www.pharmasources.com/industryinsights/current-situation-of-biosimilars-in-chin-299299.html 0.6 2026-08-06T12:10:00+08:00 daily https://www.pharmasources.com/industryinsights/west-china-hospital-sichuan-university-r-299300.html 0.6 2026-07-28T17:12:20+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-merck-to-launch-biotech-incubator-299301.html 0.6 2026-03-17T22:33:01+08:00 daily https://www.pharmasources.com/industryinsights/sta-pharmaceutical-sees-rapid-growth-in--299302.html 0.6 2026-01-05T06:28:23+08:00 daily https://www.pharmasources.com/industryinsights/drl-launches-melphalan-hydrochloride-for-299303.html 0.6 2026-03-28T15:51:41+08:00 daily https://www.pharmasources.com/industryinsights/current-situation-of-biosimilars-in-chin-299304.html 0.6 2026-07-09T10:40:24+08:00 daily https://www.pharmasources.com/industryinsights/rhizen-receives-us-fda-orphan-drug-desig-299305.html 0.6 2026-08-06T19:08:47+08:00 daily https://www.pharmasources.com/industryinsights/lonza-shimadzu-fda-approves-drug-to-trea-299306.html 0.6 2026-08-07T04:53:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-299307.html 0.6 2026-08-07T04:36:38+08:00 daily https://www.pharmasources.com/industryinsights/end-of-the-era-of-api-approval-numbers-d-299308.html 0.6 2026-08-07T04:27:50+08:00 daily https://www.pharmasources.com/industryinsights/blow-fill-seal-machine-299309.html 0.6 2026-08-07T04:22:20+08:00 daily https://www.pharmasources.com/industryinsights/chinasun-s-pre-syringe-automatic-product-299310.html 0.6 2026-08-07T13:17:36+08:00 daily https://www.pharmasources.com/industryinsights/model-adjg120-ampoule-automatic-inspecti-299311.html 0.6 2026-06-08T15:25:26+08:00 daily https://www.pharmasources.com/industryinsights/qsgb-high-speed-ampoule-filling-monobloc-299312.html 0.6 2026-08-06T21:54:43+08:00 daily https://www.pharmasources.com/industryinsights/fooya-founder-in-patent-war-over-digital-299313.html 0.6 2026-08-06T22:09:26+08:00 daily https://www.pharmasources.com/industryinsights/zacks-analysts-anticipate-cardiome-pharm-299314.html 0.6 2026-08-09T22:08:09+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-takes-out-sucampo-in-surpri-299315.html 0.6 2026-07-02T09:51:23+08:00 daily https://www.pharmasources.com/industryinsights/array-biopharma-spun-off-heart-drug-rd-i-299316.html 0.6 2026-06-14T06:32:48+08:00 daily https://www.pharmasources.com/industryinsights/shire-plans-to-hire-for-its-new-manufact-299317.html 0.6 2026-06-19T07:45:59+08:00 daily https://www.pharmasources.com/industryinsights/marylands-precision-medicine-group-lands-299318.html 0.6 2026-08-08T23:58:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-review-date-of-portolas-ande-299319.html 0.6 2026-06-24T21:46:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-tasigna-wins-fda-nod-for-first--299320.html 0.6 2026-07-02T22:48:45+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-shows-off-long-term-pulmonary-fu-299321.html 0.6 2026-07-17T22:03:30+08:00 daily https://www.pharmasources.com/industryinsights/innovation-pharmaceuticals-obtains-direc-299322.html 0.6 2026-06-28T14:17:03+08:00 daily https://www.pharmasources.com/industryinsights/agios-submits-new-drug-application-to-th-299323.html 0.6 2026-04-08T11:58:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-insys-therapeutics-fast-track-299324.html 0.6 2026-07-05T11:11:53+08:00 daily https://www.pharmasources.com/industryinsights/tearlab-to-cut-more-jobs-299325.html 0.6 2026-08-07T00:18:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-green-lights-anikas-injectable-ha-ba-299326.html 0.6 2026-05-11T20:43:29+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-melphalan-hydrochlori-299327.html 0.6 2026-02-09T04:31:52+08:00 daily https://www.pharmasources.com/industryinsights/canbridge-submits-investigational-new-dr-299328.html 0.6 2026-04-21T03:22:34+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-to-pay-12b-for-sucampo-phar-299329.html 0.6 2026-07-09T00:44:45+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-x-chem-partner-for-drug-discovery-299330.html 0.6 2026-04-14T03:15:55+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-acquire-ignyta-in-17b-deal-299331.html 0.6 2026-01-22T21:51:52+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-diagnostics-receives-fda-299332.html 0.6 2026-07-20T23:26:38+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-exclusive-launch-of-gener-299333.html 0.6 2026-07-18T06:01:29+08:00 daily https://www.pharmasources.com/industryinsights/fully-automatical-non-pvc-film-soft-bag--299334.html 0.6 2026-06-15T05:35:52+08:00 daily https://www.pharmasources.com/industryinsights/gzl-series-vacuum-freezing-dryer-machine-299335.html 0.6 2026-07-04T22:10:58+08:00 daily https://www.pharmasources.com/industryinsights/plastic-bottle-iv-production-line-299336.html 0.6 2026-06-08T15:25:30+08:00 daily https://www.pharmasources.com/industryinsights/vial-linkage-line-automatic-feeding-and--299337.html 0.6 2026-06-08T15:25:31+08:00 daily https://www.pharmasources.com/industryinsights/cochlear-implant-successfully-performed--299338.html 0.6 2026-07-25T02:17:27+08:00 daily https://www.pharmasources.com/industryinsights/zimmer-biomet-announces-publication-of-p-299339.html 0.6 2026-06-17T14:01:41+08:00 daily https://www.pharmasources.com/industryinsights/new-study-reveals-correlation-between-pr-299340.html 0.6 2025-10-20T01:29:45+08:00 daily https://www.pharmasources.com/industryinsights/researchers-in-japan-develop-new-strateg-299341.html 0.6 2026-04-04T23:44:04+08:00 daily https://www.pharmasources.com/industryinsights/obesity-has-pernicious-effect-on-bone-ma-299342.html 0.6 2026-08-07T03:55:10+08:00 daily https://www.pharmasources.com/industryinsights/antibacterial-drugs-market-to-be-worth-u-299343.html 0.6 2026-08-07T03:34:32+08:00 daily https://www.pharmasources.com/industryinsights/germanys-vetter-begins-construction-on-3-299344.html 0.6 2026-08-07T03:06:36+08:00 daily https://www.pharmasources.com/industryinsights/5-biotechs-awaiting-fda-decisions-in-jan-299345.html 0.6 2026-08-06T22:14:13+08:00 daily https://www.pharmasources.com/industryinsights/natural-hepatoprotective-drug---vine-tea-299346.html 0.6 2026-08-06T22:08:22+08:00 daily https://www.pharmasources.com/industryinsights/four-best-performing-sp-500-biotech-stoc-299347.html 0.6 2026-08-06T23:32:22+08:00 daily https://www.pharmasources.com/industryinsights/todd-campbell-notesfour-biopharma-stocks-299348.html 0.6 2026-08-07T13:17:32+08:00 daily https://www.pharmasources.com/industryinsights/doctors-accuse-nextsource-biotech-for-hi-299349.html 0.6 2026-08-08T01:01:25+08:00 daily https://www.pharmasources.com/industryinsights/amneal-pharmaceuticals-welcomes-new-pres-299350.html 0.6 2026-08-09T12:55:04+08:00 daily https://www.pharmasources.com/industryinsights/indian-immunologicals-launches-intranasa-299351.html 0.6 2026-07-23T15:58:02+08:00 daily https://www.pharmasources.com/industryinsights/fervent-pharmaceuticals-to-begin-menopau-299352.html 0.6 2026-07-21T03:43:30+08:00 daily https://www.pharmasources.com/industryinsights/medical-solution-company-specializing-in-299353.html 0.6 2026-02-15T13:58:07+08:00 daily https://www.pharmasources.com/industryinsights/cstone-files-cs1003-an-anti-pd-1-antibod-299354.html 0.6 2026-08-05T17:53:58+08:00 daily https://www.pharmasources.com/industryinsights/4-biotechs-ready-to-kill-the-market-in-2-299355.html 0.6 2026-06-08T17:40:32+08:00 daily https://www.pharmasources.com/industryinsights/celgene-takes-a-411m-hit-from-discontinu-299356.html 0.6 2026-07-30T15:32:57+08:00 daily https://www.pharmasources.com/industryinsights/the-numbers-are-in-bay-areas-depomed-rev-299357.html 0.6 2026-06-23T20:55:18+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-potential-depression-bl-299358.html 0.6 2025-12-20T15:11:02+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-quest-face-a-more-difficult-2018-299359.html 0.6 2026-04-07T18:15:18+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-unloads-four-ndas-to-ani-pha-299360.html 0.6 2026-08-06T21:05:11+08:00 daily https://www.pharmasources.com/industryinsights/shanghais-sari-pays-359m-for-italian-can-299361.html 0.6 2026-02-15T00:04:13+08:00 daily https://www.pharmasources.com/industryinsights/avadel-pharmaceuticals-issues-2018-corpo-299362.html 0.6 2026-03-21T17:21:40+08:00 daily https://www.pharmasources.com/industryinsights/mylan-adds-to-us-womens-healthcare-portf-299363.html 0.6 2026-03-17T20:43:20+08:00 daily https://www.pharmasources.com/industryinsights/biocon-and-mylans-biosimilar-trastuzumab-299364.html 0.6 2026-06-08T23:29:52+08:00 daily https://www.pharmasources.com/industryinsights/global-foundation-for-human-aging-resear-299365.html 0.6 2026-07-10T11:59:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-marketing-of-sanuwaves-shoc-299366.html 0.6 2026-07-05T14:29:02+08:00 daily https://www.pharmasources.com/industryinsights/germanys-vetter-begins-construction-on-3-299367.html 0.6 2026-07-01T15:51:59+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-acquires-phenom-world-299368.html 0.6 2026-06-25T11:53:24+08:00 daily https://www.pharmasources.com/industryinsights/kpbma-seeks-expanded-govt-support-and-fu-299369.html 0.6 2026-07-19T23:32:17+08:00 daily https://www.pharmasources.com/industryinsights/german-researchers-conduct-a-new-study-o-299370.html 0.6 2026-04-19T18:27:07+08:00 daily https://www.pharmasources.com/industryinsights/china-launches-the-largest-human-genome--299371.html 0.6 2026-06-22T09:14:07+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biocons-breast-cancer-biosimilar-g-299372.html 0.6 2026-04-05T20:12:21+08:00 daily https://www.pharmasources.com/industryinsights/vivimed-labs-receives-75-million-fund-fr-299373.html 0.6 2026-04-02T02:55:46+08:00 daily https://www.pharmasources.com/industryinsights/some-of-fdas-major-policy-goals-for-2018-299374.html 0.6 2026-04-07T18:12:01+08:00 daily https://www.pharmasources.com/industryinsights/cstones-anti-ctla-4-antibody-cs1002-file-299375.html 0.6 2026-06-14T07:45:34+08:00 daily https://www.pharmasources.com/industryinsights/lunit-leads-the-expansion-of-ai-in-the-h-299376.html 0.6 2026-05-05T20:43:48+08:00 daily https://www.pharmasources.com/industryinsights/boston-startup-centrexion-by-pfizers-ex--299377.html 0.6 2026-05-04T20:18:45+08:00 daily https://www.pharmasources.com/industryinsights/top-20-life-science-startups-to-watch-in-299378.html 0.6 2026-04-24T11:26:15+08:00 daily https://www.pharmasources.com/industryinsights/5-massachusetts-biotechs-that-tanked-mor-299379.html 0.6 2026-06-21T12:29:49+08:00 daily https://www.pharmasources.com/industryinsights/2-underappreciated-biotech-stocks-to-buy-299380.html 0.6 2026-04-30T21:42:04+08:00 daily https://www.pharmasources.com/industryinsights/3-biotechs-seeking-271m-ipo-in-the-new-y-299381.html 0.6 2026-08-05T18:11:14+08:00 daily https://www.pharmasources.com/industryinsights/pear-therapeutics-scores-50m-in-series-b-299382.html 0.6 2026-08-09T21:07:28+08:00 daily https://www.pharmasources.com/industryinsights/celgene-co-founder-bags-23m-for-johns-ho-299383.html 0.6 2026-06-14T11:29:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-seattle-genetics-bla-and-gra-299384.html 0.6 2026-04-01T13:54:10+08:00 daily https://www.pharmasources.com/industryinsights/beigene-initiates-global-phase-iii-trial-299385.html 0.6 2026-08-07T19:34:38+08:00 daily https://www.pharmasources.com/industryinsights/india-globalization-capital-reports-prom-299386.html 0.6 2026-06-21T17:05:25+08:00 daily https://www.pharmasources.com/industryinsights/exercise-may-improve-thinking-ability-an-299387.html 0.6 2025-10-20T18:12:24+08:00 daily https://www.pharmasources.com/industryinsights/ccmd-offers-inexpensive-treatment-for-he-299388.html 0.6 2026-04-15T22:47:03+08:00 daily https://www.pharmasources.com/industryinsights/nppa-fixes-retail-prices-of-14-formulati-299389.html 0.6 2026-07-09T17:26:37+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-mylans-copy-of-allergans-299390.html 0.6 2026-03-19T22:43:33+08:00 daily https://www.pharmasources.com/industryinsights/nice-to-take-another-look-at-pfizers-leu-299391.html 0.6 2025-12-13T10:16:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-shock-wave-wound-healing-de-299392.html 0.6 2026-08-05T18:36:42+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-buy-ignyta-for-17-billion-299393.html 0.6 2025-11-21T21:19:54+08:00 daily https://www.pharmasources.com/industryinsights/nice-to-reassess-pfizers-leukaemia-drug--299394.html 0.6 2026-02-28T16:24:43+08:00 daily https://www.pharmasources.com/industryinsights/us-green-light-for-pfizermerck-diabetes--299395.html 0.6 2026-06-08T15:17:36+08:00 daily https://www.pharmasources.com/industryinsights/jhl-biotech-welcomes-new-chief-medical-o-299396.html 0.6 2026-07-19T09:11:13+08:00 daily https://www.pharmasources.com/industryinsights/elyptol-launches-with-australias-largest-299397.html 0.6 2026-03-19T10:24:37+08:00 daily https://www.pharmasources.com/industryinsights/46-new-drugs-the-number-of-new-drugs-mar-299398.html 0.6 2026-08-05T21:42:15+08:00 daily https://www.pharmasources.com/industryinsights/diagrammatizing-of-the-chinese-produced--299399.html 0.6 2026-08-09T00:10:07+08:00 daily https://www.pharmasources.com/industryinsights/new-socal-biotech-launches-with-553m-bac-299400.html 0.6 2026-07-19T19:26:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-hails-novartis-kisqali-a-breakthroug-299401.html 0.6 2026-05-03T00:08:52+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-pfizer-deepen-relationship-with--299402.html 0.6 2026-01-30T20:06:59+08:00 daily https://www.pharmasources.com/industryinsights/biotech-startup-elstar-therapeutics-clos-299403.html 0.6 2026-06-14T21:04:55+08:00 daily https://www.pharmasources.com/industryinsights/addex-indivior-forge-335m-addiction-diso-299404.html 0.6 2026-02-22T13:34:35+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-ups-venture-fund-to-299405.html 0.6 2026-04-09T13:59:46+08:00 daily https://www.pharmasources.com/industryinsights/palatin-technologies-announces-fda-clear-299406.html 0.6 2026-04-13T15:43:41+08:00 daily https://www.pharmasources.com/industryinsights/cytokinetics-announces-progress-against--299407.html 0.6 2026-07-21T10:44:24+08:00 daily https://www.pharmasources.com/industryinsights/zosano-pharma-announces-notice-of-allowa-299408.html 0.6 2026-03-24T18:26:38+08:00 daily https://www.pharmasources.com/industryinsights/diagnosing-treating-sleep-apnea-in-hospi-299409.html 0.6 2026-03-20T19:05:41+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-limited-releases-letter-to-sh-299410.html 0.6 2026-08-09T06:51:26+08:00 daily https://www.pharmasources.com/industryinsights/seegene-develops-worlds-first-multiplex--299411.html 0.6 2026-08-09T02:37:04+08:00 daily https://www.pharmasources.com/industryinsights/hetero-launches-humiratm-biosimilar-in-i-299412.html 0.6 2026-08-08T22:04:02+08:00 daily https://www.pharmasources.com/industryinsights/alexion-bags-japanese-approval-for-solir-299413.html 0.6 2026-08-08T07:47:45+08:00 daily https://www.pharmasources.com/industryinsights/5-fu-cream-found-to-reduce-the-risk-of-s-299414.html 0.6 2026-08-08T05:07:10+08:00 daily https://www.pharmasources.com/industryinsights/removable-implant-may-control-type-1-dia-299415.html 0.6 2026-08-07T13:15:52+08:00 daily https://www.pharmasources.com/industryinsights/kisqali-receives-fda-breakthrough-therap-299416.html 0.6 2026-08-07T02:05:02+08:00 daily https://www.pharmasources.com/industryinsights/biolive-forecasts-major-changes-to-bio-s-299417.html 0.6 2026-08-07T01:19:31+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-work-with-bluebird-bio-on-viral-299418.html 0.6 2026-08-07T01:10:45+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-cut-1000-jobs-299419.html 0.6 2026-08-07T01:15:28+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-arvinas-forge-830m-protein-degrad-299420.html 0.6 2026-06-27T10:08:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-2018s-second-fda-brea-299421.html 0.6 2026-07-29T12:54:15+08:00 daily https://www.pharmasources.com/industryinsights/macrogenics-nabs-380m-pact-with-drug-gia-299422.html 0.6 2026-07-02T18:07:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-bestows-breakthrough-tag-on-shires-m-299423.html 0.6 2026-08-03T22:24:19+08:00 daily https://www.pharmasources.com/industryinsights/the-fda-fast-tracks-60-degrees-pharmas-m-299424.html 0.6 2026-06-20T17:32:05+08:00 daily https://www.pharmasources.com/industryinsights/cascadian-therapeutics-announces-2018-ou-299425.html 0.6 2026-06-25T07:16:59+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-biosciences-initiates-phase-iii-299426.html 0.6 2026-07-06T20:05:51+08:00 daily https://www.pharmasources.com/industryinsights/momenta-and-mylan-announce-development-s-299427.html 0.6 2026-07-01T08:20:46+08:00 daily https://www.pharmasources.com/industryinsights/review-progress-of-acceptance-work-of-ge-299428.html 0.6 2026-07-25T10:21:48+08:00 daily https://www.pharmasources.com/industryinsights/drug-for-diabetes-type-2-shows-potential-299429.html 0.6 2026-06-08T21:56:33+08:00 daily https://www.pharmasources.com/industryinsights/china-based-haplox-biotechnology-closes--299430.html 0.6 2026-08-09T07:49:12+08:00 daily https://www.pharmasources.com/industryinsights/nuvo-pharmaceuticals-acquires-global-pro-299431.html 0.6 2026-06-30T13:30:43+08:00 daily https://www.pharmasources.com/industryinsights/pharmamar-signs-commercialisation-and-di-299432.html 0.6 2026-04-05T22:07:50+08:00 daily https://www.pharmasources.com/industryinsights/precision-editing-of-gut-bacteria-potent-299433.html 0.6 2026-06-27T03:28:38+08:00 daily https://www.pharmasources.com/industryinsights/cfda-approves-new-once-weekly-bydureonr--299434.html 0.6 2026-07-19T20:02:34+08:00 daily https://www.pharmasources.com/industryinsights/glucagon-receptor-structure-offers-new-o-299435.html 0.6 2026-01-24T17:32:23+08:00 daily https://www.pharmasources.com/industryinsights/hycor-biomedical-applies-ce-mark-to-ivd--299436.html 0.6 2026-03-07T11:23:58+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-makes-830m-drug-discovery-pact-wi-299437.html 0.6 2026-03-22T13:51:34+08:00 daily https://www.pharmasources.com/industryinsights/celgene-scoops-up-san-diego-biotech-in-7-299438.html 0.6 2026-08-05T10:51:30+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-dives-into-2018-with-15--299439.html 0.6 2026-03-28T21:23:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-cut-300-jobs-as-it-ends-alzhei-299440.html 0.6 2026-02-14T16:40:58+08:00 daily https://www.pharmasources.com/industryinsights/struggling-acorda-considering-a-sale-lea-299441.html 0.6 2025-12-09T23:27:20+08:00 daily https://www.pharmasources.com/industryinsights/rejected-again-ablynx-turns-down-novo-no-299442.html 0.6 2026-03-12T08:59:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gains-rights-to-hemophilia-drug-i-299443.html 0.6 2026-07-05T03:31:53+08:00 daily https://www.pharmasources.com/industryinsights/teva-alder-biopharma-forge-200m-anti-cgr-299444.html 0.6 2025-12-09T23:30:27+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-redistribute-research-funding-299445.html 0.6 2026-06-09T02:40:24+08:00 daily https://www.pharmasources.com/industryinsights/summary-of-mas-in-2017-299446.html 0.6 2026-03-26T15:53:14+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-marketing-authorization-appl-299447.html 0.6 2026-08-07T23:45:04+08:00 daily https://www.pharmasources.com/industryinsights/vsasl-imaging-can-detect-placental-perfu-299448.html 0.6 2026-06-16T22:01:33+08:00 daily https://www.pharmasources.com/industryinsights/orchid-pharma-gets-eir-from-us-fda-299449.html 0.6 2026-05-14T14:52:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-mal-299450.html 0.6 2025-12-09T23:36:44+08:00 daily https://www.pharmasources.com/industryinsights/inotersen-nda-accepted-for-priority-revi-299451.html 0.6 2026-03-27T06:39:47+08:00 daily https://www.pharmasources.com/industryinsights/mei-announces-fda-clearance-of-ind-appli-299452.html 0.6 2026-03-30T14:02:58+08:00 daily https://www.pharmasources.com/industryinsights/axovants-drug-bested-by-placebo-shares-r-299453.html 0.6 2025-10-30T12:22:16+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-alynylam-rejig-sees-global-ri-299454.html 0.6 2026-02-09T07:54:00+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-in-america-299455.html 0.6 2026-07-25T10:10:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-amgens-bone-drug-for-multiple-299456.html 0.6 2026-03-21T18:45:47+08:00 daily https://www.pharmasources.com/industryinsights/women-at-risk-from-sub-standard-heart-at-299457.html 0.6 2026-03-01T03:38:12+08:00 daily https://www.pharmasources.com/industryinsights/neuclone-discloses-details-of-its-fifth--299458.html 0.6 2026-06-27T00:52:07+08:00 daily https://www.pharmasources.com/industryinsights/agc-bioscience-biomeva-and-cmc-biologics-299459.html 0.6 2026-07-05T06:58:15+08:00 daily https://www.pharmasources.com/industryinsights/novotech-wins-2017-asia-pacific-biotech--299460.html 0.6 2026-06-28T23:37:10+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-in-eu-299461.html 0.6 2026-06-08T18:26:43+08:00 daily https://www.pharmasources.com/industryinsights/shire-to-break-up-business-into-two-comp-299462.html 0.6 2026-04-20T21:51:19+08:00 daily https://www.pharmasources.com/industryinsights/top-5-biotech-stocks-appear-vulnerable-i-299463.html 0.6 2026-06-29T02:53:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-slaps-breakthrough-tag-on-eisai-merc-299464.html 0.6 2026-06-25T15:37:35+08:00 daily https://www.pharmasources.com/industryinsights/why-pfizer-could-and-should-make-another-299465.html 0.6 2026-06-08T19:51:13+08:00 daily https://www.pharmasources.com/industryinsights/jobs-lost-as-cellectar-biosciences-shutt-299466.html 0.6 2026-04-10T21:35:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-calls-bay-area-global-blood-therapeu-299467.html 0.6 2026-03-20T16:43:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-advances-head-to-head-superiori-299468.html 0.6 2026-03-27T20:35:46+08:00 daily https://www.pharmasources.com/industryinsights/wacker-obtains-fda-approval-to-manufactu-299469.html 0.6 2026-07-08T17:16:19+08:00 daily https://www.pharmasources.com/industryinsights/uspto-grants-glytec-patent-allowance-for-299470.html 0.6 2026-06-30T13:52:59+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-announces-positive-results-from-299471.html 0.6 2026-05-06T19:14:16+08:00 daily https://www.pharmasources.com/industryinsights/histogenics-corporation-announces-receip-299472.html 0.6 2026-05-03T23:19:30+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-has-proposed-to-acquire-abl-299473.html 0.6 2026-07-06T05:05:08+08:00 daily https://www.pharmasources.com/industryinsights/xcision-receives-fda-clearance-for-the-g-299474.html 0.6 2026-04-27T09:58:59+08:00 daily https://www.pharmasources.com/industryinsights/drug-capsule-may-allow-weekly-hiv-treatm-299475.html 0.6 2026-04-20T17:36:04+08:00 daily https://www.pharmasources.com/industryinsights/upadacitinib-receives-breakthrough-thera-299476.html 0.6 2026-05-07T08:26:29+08:00 daily https://www.pharmasources.com/industryinsights/propranolol-delays-tumour-growth-and-inc-299477.html 0.6 2026-04-08T15:00:55+08:00 daily https://www.pharmasources.com/industryinsights/celixirs-cell-therapy-gets-green-light-f-299478.html 0.6 2025-12-11T15:15:05+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regeneron-beef-up-investment-in-i-299479.html 0.6 2026-03-18T01:53:29+08:00 daily https://www.pharmasources.com/industryinsights/ucb-amgens-evenity-under-review-in-europ-299480.html 0.6 2026-04-06T22:33:09+08:00 daily https://www.pharmasources.com/industryinsights/axovant-shares-plummet-on-dementia-drug--299481.html 0.6 2026-04-09T19:12:36+08:00 daily https://www.pharmasources.com/industryinsights/bioposture-names-savio-chan-chairman-of--299482.html 0.6 2025-12-11T15:10:56+08:00 daily https://www.pharmasources.com/industryinsights/emotional-brains-fsiad-products-lybrido--299483.html 0.6 2026-04-16T20:31:23+08:00 daily https://www.pharmasources.com/industryinsights/heidrick-struggles-names-new-leader-for--299484.html 0.6 2026-04-21T05:12:04+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-ceo-replaced-50-top-mana-299485.html 0.6 2026-07-09T17:35:30+08:00 daily https://www.pharmasources.com/industryinsights/2018-gilead-is-not-done-shopping-299486.html 0.6 2026-08-07T21:58:17+08:00 daily https://www.pharmasources.com/industryinsights/adaptimmunes-cmo-moves-forward-with-spea-299487.html 0.6 2025-12-28T10:38:36+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-is-eyeing-pfizers-15b-co-299488.html 0.6 2026-06-16T18:51:44+08:00 daily https://www.pharmasources.com/industryinsights/ambitious-bluebird-seeks-three-drug-appr-299489.html 0.6 2026-04-17T23:37:49+08:00 daily https://www.pharmasources.com/industryinsights/nestle-emerges-as-the-frontrunner-for-me-299490.html 0.6 2025-12-11T15:02:44+08:00 daily https://www.pharmasources.com/industryinsights/forensic-exam-shows-pattern-in-4-deaths--299491.html 0.6 2026-08-06T02:24:29+08:00 daily https://www.pharmasources.com/industryinsights/can-2018-possibly-rival-2017s-biotechs-r-299492.html 0.6 2026-04-10T01:00:38+08:00 daily https://www.pharmasources.com/industryinsights/avadel-pharmaceuticals-receives-orphan-d-299493.html 0.6 2026-01-31T11:05:00+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-bydureon-bcise-injectable-m-299494.html 0.6 2026-04-17T21:57:52+08:00 daily https://www.pharmasources.com/industryinsights/drug-discovery-it-solutions-to-hit-53-bi-299495.html 0.6 2026-02-10T15:28:46+08:00 daily https://www.pharmasources.com/industryinsights/heroic-dentistry-nine-cavities-filled-in-299496.html 0.6 2026-04-27T03:00:56+08:00 daily https://www.pharmasources.com/industryinsights/world-of-children-2018-call-for-nominati-299497.html 0.6 2026-04-29T19:33:11+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-wider-use-of-msds-simponi-299498.html 0.6 2026-05-02T04:59:10+08:00 daily https://www.pharmasources.com/industryinsights/vertex-cf-therapy-orkambi-cleared-for-yo-299499.html 0.6 2026-06-20T11:24:38+08:00 daily https://www.pharmasources.com/industryinsights/msd-launches-clostridium-difficile-antit-299500.html 0.6 2026-04-24T16:11:50+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-partners-with-vanderbilt-univer-299501.html 0.6 2026-04-21T05:43:15+08:00 daily https://www.pharmasources.com/industryinsights/new-project-examining-fda-approved-drugs-299502.html 0.6 2026-08-07T23:59:19+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-forms-consortium-to-advance-hu-299503.html 0.6 2026-06-22T01:04:29+08:00 daily https://www.pharmasources.com/industryinsights/teva-and-alder-sign-global-licence-agree-299504.html 0.6 2026-07-20T11:37:12+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-fda-approval-299505.html 0.6 2026-03-27T23:08:28+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-expects-80-per-cent-sales-by-20-299506.html 0.6 2026-07-29T21:14:16+08:00 daily https://www.pharmasources.com/industryinsights/abbott-collaborates-with-yrgcare-299507.html 0.6 2026-06-27T13:37:19+08:00 daily https://www.pharmasources.com/industryinsights/disappointing-pharmaceutical-enterprises-299508.html 0.6 2026-07-24T11:11:03+08:00 daily https://www.pharmasources.com/industryinsights/winter-is-coming-events-of-the-chinese-a-299509.html 0.6 2026-07-19T23:58:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-steals-new-oncology-head-from-p-299510.html 0.6 2026-04-19T05:44:21+08:00 daily https://www.pharmasources.com/industryinsights/4-major-biopharmas-what-went-down-at-jpm-299511.html 0.6 2026-03-24T12:36:10+08:00 daily https://www.pharmasources.com/industryinsights/2-under-the-radar-pharma-ma-targets-for--299512.html 0.6 2026-01-22T08:14:21+08:00 daily https://www.pharmasources.com/industryinsights/teva-board-members-face-50-pay-cut-299513.html 0.6 2025-12-11T14:39:01+08:00 daily https://www.pharmasources.com/industryinsights/new-jerseys-braeburn-pharma-lands-110m-299514.html 0.6 2026-08-07T01:11:31+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-faces-data-breach-overse-299515.html 0.6 2026-04-21T03:30:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-rejects-lipocines-testosterone-299516.html 0.6 2026-08-09T11:57:39+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-fosun-forms-50m-us-jv---with-it-299517.html 0.6 2026-04-23T13:11:20+08:00 daily https://www.pharmasources.com/industryinsights/the-7-best-life-science-companies-to-wor-299518.html 0.6 2026-07-24T21:07:59+08:00 daily https://www.pharmasources.com/industryinsights/can-fite-12-months-activities-milestones-299519.html 0.6 2026-06-08T21:52:41+08:00 daily https://www.pharmasources.com/industryinsights/nanobiotix-partners-with-the-providence--299520.html 0.6 2026-05-04T16:23:00+08:00 daily https://www.pharmasources.com/industryinsights/exact-therapy-for-rare-genetic-disorders-299521.html 0.6 2026-05-07T08:04:31+08:00 daily https://www.pharmasources.com/industryinsights/adapsyn-bioscience-announces-research-co-299522.html 0.6 2026-01-16T04:08:18+08:00 daily https://www.pharmasources.com/industryinsights/dietary-xenoestrogens-may-reduce-effecti-299523.html 0.6 2026-07-09T12:46:21+08:00 daily https://www.pharmasources.com/industryinsights/interactive-app-provides-disease-managem-299524.html 0.6 2026-01-31T10:17:10+08:00 daily https://www.pharmasources.com/industryinsights/novartis-appoints-elizabeth-barrett-as-o-299525.html 0.6 2026-08-09T14:46:04+08:00 daily https://www.pharmasources.com/industryinsights/azs-fasenra-approved-in-europe-as-an-add-299526.html 0.6 2026-08-09T02:38:49+08:00 daily https://www.pharmasources.com/industryinsights/aids-charity-lambasts-ethically-challeng-299527.html 0.6 2026-08-08T07:53:20+08:00 daily https://www.pharmasources.com/industryinsights/nestle-reportedly-pulls-out-in-front-to--299528.html 0.6 2026-08-07T13:19:22+08:00 daily https://www.pharmasources.com/industryinsights/nhs-confed-orders-reports-into-nhs-fundi-299529.html 0.6 2026-08-07T04:22:03+08:00 daily https://www.pharmasources.com/industryinsights/eurocine-vaccines-obtains-authorization--299530.html 0.6 2026-08-07T03:55:28+08:00 daily https://www.pharmasources.com/industryinsights/mydx-appoints-dr-jessica-peatross-as-chi-299531.html 0.6 2026-08-07T03:25:19+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-on-the-hunt-for-cancer-deals-t-299532.html 0.6 2026-08-07T03:31:39+08:00 daily https://www.pharmasources.com/industryinsights/biotechs-froth-as-famed-startup-incubato-299533.html 0.6 2026-08-09T05:46:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-green-lights-astrazeneca-mercks-lynp-299534.html 0.6 2026-08-08T01:44:28+08:00 daily https://www.pharmasources.com/industryinsights/sage-therapeutics-looks-to-file-nda-for--299535.html 0.6 2026-08-07T13:15:39+08:00 daily https://www.pharmasources.com/industryinsights/6-blood-testing-startups-hoping-to-be-th-299536.html 0.6 2026-08-08T15:12:09+08:00 daily https://www.pharmasources.com/industryinsights/why-bluebird-bio-got-more-attention-than-299537.html 0.6 2026-08-09T06:59:46+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-gets-expanded-fda-win-fo-299538.html 0.6 2026-02-28T13:19:30+08:00 daily https://www.pharmasources.com/industryinsights/roches-star-ms-drug-snags-eu-approval-299539.html 0.6 2026-02-28T21:30:04+08:00 daily https://www.pharmasources.com/industryinsights/ortho-dermatologics-announces-us-fda-fil-299540.html 0.6 2026-06-09T04:01:00+08:00 daily https://www.pharmasources.com/industryinsights/immunity-to-crispr-gene-editing-poses-a--299541.html 0.6 2026-08-01T10:03:18+08:00 daily https://www.pharmasources.com/industryinsights/ping-ans-lung-nodule-smart-reading-techn-299542.html 0.6 2026-06-23T20:56:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-protects-children-from-opioids-by-re-299543.html 0.6 2026-02-28T13:17:36+08:00 daily https://www.pharmasources.com/industryinsights/iodine-deficiency-may-reduce-pregnancy-c-299544.html 0.6 2026-03-17T23:21:43+08:00 daily https://www.pharmasources.com/industryinsights/celgene-to-buy-impact-biomedicines-for-u-299545.html 0.6 2026-06-02T16:51:45+08:00 daily https://www.pharmasources.com/industryinsights/easy-to-swallow-rapid-growth-in-smart-pi-299546.html 0.6 2026-06-25T21:28:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-steps-in-to-prohibit-codeine-cough-s-299547.html 0.6 2026-06-08T14:14:19+08:00 daily https://www.pharmasources.com/industryinsights/brca-gene-mutation-found-not-to-impact-s-299548.html 0.6 2026-07-21T11:36:34+08:00 daily https://www.pharmasources.com/industryinsights/nhs-chooses-next-batch-of-entrepreneurs--299549.html 0.6 2026-03-13T19:14:08+08:00 daily https://www.pharmasources.com/industryinsights/systech-europetm-announces-rapid-expansi-299550.html 0.6 2026-03-20T13:51:08+08:00 daily https://www.pharmasources.com/industryinsights/current-situation-of-biosimilars-in-chin-299551.html 0.6 2026-06-26T01:40:44+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofcphicn20180115-299552.html 0.6 2026-06-08T15:25:33+08:00 daily https://www.pharmasources.com/industryinsights/current-situation-of-biosimilars-in-chin-299553.html 0.6 2026-07-20T10:52:58+08:00 daily https://www.pharmasources.com/industryinsights/5-worthwhile-ma-targets-for-2018-299554.html 0.6 2026-01-03T23:11:26+08:00 daily https://www.pharmasources.com/industryinsights/rigel-pharma-awaits-fda-approval-for-tav-299555.html 0.6 2026-08-05T18:11:16+08:00 daily https://www.pharmasources.com/industryinsights/3-biopharmas-worth-watching-in-2018-299556.html 0.6 2026-08-03T04:36:23+08:00 daily https://www.pharmasources.com/industryinsights/google-backs-vaccitechs-27m-series-a-fun-299557.html 0.6 2026-02-10T15:36:00+08:00 daily https://www.pharmasources.com/industryinsights/teva-wins-fda-nod-for-trisenox-arsenic-t-299558.html 0.6 2026-04-06T06:12:06+08:00 daily https://www.pharmasources.com/industryinsights/shire-granted-eu-marketing-authorization-299559.html 0.6 2026-07-06T23:19:27+08:00 daily https://www.pharmasources.com/industryinsights/creative-peptides-added-new-glp-1-peptid-299560.html 0.6 2026-06-22T01:03:38+08:00 daily https://www.pharmasources.com/industryinsights/ausindustry-awards-recce-support-for-au5-299561.html 0.6 2026-02-28T14:38:10+08:00 daily https://www.pharmasources.com/industryinsights/hua-medicine-of-shanghai-to-raise-200m-t-299562.html 0.6 2026-06-29T03:04:44+08:00 daily https://www.pharmasources.com/industryinsights/cannimed-therapeutics-inc-launches-725-m-299563.html 0.6 2026-08-06T04:10:37+08:00 daily https://www.pharmasources.com/industryinsights/cphi-release-japanese-pharma---no-longer-299564.html 0.6 2026-03-26T14:08:20+08:00 daily https://www.pharmasources.com/industryinsights/mindray-launches-benevision-n1-for-unint-299565.html 0.6 2026-07-20T23:30:13+08:00 daily https://www.pharmasources.com/industryinsights/united-family-hospitals-new-community-cl-299566.html 0.6 2026-04-09T18:43:05+08:00 daily https://www.pharmasources.com/industryinsights/grunenthal-and-mundipharma-enter-commerc-299567.html 0.6 2026-06-26T18:25:20+08:00 daily https://www.pharmasources.com/industryinsights/upstream-medical-sources-global-funding--299568.html 0.6 2026-02-15T08:49:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-breast--299569.html 0.6 2025-12-11T13:41:41+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-azmsds-lynparza-for-breast-c-299570.html 0.6 2025-12-11T13:40:39+08:00 daily https://www.pharmasources.com/industryinsights/uk-startup-developing-flu-jab-attracts-2-299571.html 0.6 2026-07-18T18:27:47+08:00 daily https://www.pharmasources.com/industryinsights/asthma-carves-82-billion-out-of-us-econo-299572.html 0.6 2026-06-23T14:50:04+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-a-remote-controlled--299573.html 0.6 2026-08-09T17:50:02+08:00 daily https://www.pharmasources.com/industryinsights/computer-aided-facial-analysis-aids-rare-299574.html 0.6 2026-04-16T00:42:15+08:00 daily https://www.pharmasources.com/industryinsights/mercks-ace-keytruda-impresses-again-stun-299575.html 0.6 2026-07-17T16:26:05+08:00 daily https://www.pharmasources.com/industryinsights/a-new-biotech-hub-is-emerging-in-the-bay-299576.html 0.6 2026-01-10T02:41:19+08:00 daily https://www.pharmasources.com/industryinsights/why-this-mostly-unheard-of-colorado-biot-299577.html 0.6 2026-04-02T00:09:29+08:00 daily https://www.pharmasources.com/industryinsights/what-you-need-to-know-about-tango-therap-299578.html 0.6 2026-03-25T00:58:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-beats-johnson-johnsons-299579.html 0.6 2026-07-15T15:38:36+08:00 daily https://www.pharmasources.com/industryinsights/shangpharma-and-icahn-school-of-medicine-299580.html 0.6 2026-07-20T09:03:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-indication-for-boehring-299581.html 0.6 2026-06-03T07:13:35+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-applauds-stanley-healthca-299582.html 0.6 2026-05-02T17:42:57+08:00 daily https://www.pharmasources.com/industryinsights/marken-opens-new-kit-building-facility-i-299583.html 0.6 2026-07-31T14:44:47+08:00 daily https://www.pharmasources.com/industryinsights/aprinoia-therapeutics-closes-us11-millio-299584.html 0.6 2026-02-28T11:58:49+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-may-be-the-first-marketed-in-chin-299585.html 0.6 2026-08-09T07:40:01+08:00 daily https://www.pharmasources.com/industryinsights/varians-halcyon-got-nod-from-taiwan-chin-299586.html 0.6 2026-04-23T04:20:57+08:00 daily https://www.pharmasources.com/industryinsights/dietary-fat-changes-in-fat-metabolism-ma-299587.html 0.6 2025-12-23T12:30:29+08:00 daily https://www.pharmasources.com/industryinsights/electrical-circuits-used-to-map-out-cell-299588.html 0.6 2026-02-15T13:47:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-report-reaffirms-safety-profile-and--299589.html 0.6 2026-07-19T13:40:18+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-regulatory-submission-for-propose-299590.html 0.6 2026-04-02T02:27:07+08:00 daily https://www.pharmasources.com/industryinsights/avacta-glythera-link-to-develop-drug-con-299591.html 0.6 2026-04-05T09:05:34+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-beats-jjs-stelara-in-p-299592.html 0.6 2026-08-07T05:07:15+08:00 daily https://www.pharmasources.com/industryinsights/msds-interim-keytruda-combo-data-spooks--299593.html 0.6 2026-08-07T09:06:23+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-signs-chinese-licensing-and--299594.html 0.6 2026-08-07T04:52:48+08:00 daily https://www.pharmasources.com/industryinsights/helsinn-obtains-orphan-designation-for-p-299595.html 0.6 2026-08-07T04:36:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lynparza-to-treat-inherited-299596.html 0.6 2026-08-07T04:27:44+08:00 daily https://www.pharmasources.com/industryinsights/heres-the-chance-a-core-patent-of-novart-299597.html 0.6 2026-08-07T00:40:59+08:00 daily https://www.pharmasources.com/industryinsights/juno-explodes-on-celgene-takeover-rumors-299598.html 0.6 2026-08-07T00:42:49+08:00 daily https://www.pharmasources.com/industryinsights/the-biggest-winners-and-losers-of-jpm-20-299599.html 0.6 2025-12-11T13:31:26+08:00 daily https://www.pharmasources.com/industryinsights/how-this-little-biopharma-could-beat-amg-299600.html 0.6 2026-06-23T13:38:41+08:00 daily https://www.pharmasources.com/industryinsights/why-investors-should-avoid-israeli-biote-299601.html 0.6 2026-03-03T06:23:58+08:00 daily https://www.pharmasources.com/industryinsights/4-up-and-coming-new-york-biotech-startup-299602.html 0.6 2026-03-28T23:11:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-slaps-warning-on-san-diegos-imprimis-299603.html 0.6 2026-05-21T17:47:41+08:00 daily https://www.pharmasources.com/industryinsights/genocea-biosciences-announces-pricing-of-299604.html 0.6 2026-08-09T12:07:43+08:00 daily https://www.pharmasources.com/industryinsights/mimedx-announces-the-enrollment-of-the-f-299605.html 0.6 2026-08-07T11:10:10+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-announces-partial-monotherapy--299606.html 0.6 2026-01-30T21:24:06+08:00 daily https://www.pharmasources.com/industryinsights/first-chronic-hepatitis-b-patient-dosed--299607.html 0.6 2026-07-26T17:13:04+08:00 daily https://www.pharmasources.com/industryinsights/technology-advancements-to-conquer-the-p-299608.html 0.6 2026-08-08T02:37:07+08:00 daily https://www.pharmasources.com/industryinsights/a-comprehensive-industry-event-platform--299609.html 0.6 2026-07-17T16:06:20+08:00 daily https://www.pharmasources.com/industryinsights/more-space-for-visual-workflows---wacom--299610.html 0.6 2026-03-11T10:19:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-therapy-kymriah-scores-ac-299611.html 0.6 2026-08-09T16:04:36+08:00 daily https://www.pharmasources.com/industryinsights/fully-biodegradable-sensor-offers-safer--299612.html 0.6 2026-03-28T20:47:36+08:00 daily https://www.pharmasources.com/industryinsights/digital-solutions-from-veevas-european-c-299613.html 0.6 2026-01-31T01:52:53+08:00 daily https://www.pharmasources.com/industryinsights/blood-cancer-care-needs-improving-finds--299614.html 0.6 2026-06-09T20:37:34+08:00 daily https://www.pharmasources.com/industryinsights/little-orphan-drugs-can-lead-to-big-mark-299615.html 0.6 2026-06-27T08:34:11+08:00 daily https://www.pharmasources.com/industryinsights/new-player-joining-what-will-be-its-odds-299616.html 0.6 2026-07-24T01:19:00+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-philadelphia-area-layoffs-299617.html 0.6 2026-08-07T06:54:00+08:00 daily https://www.pharmasources.com/industryinsights/group-health-cooperative-eau-claire-part-299618.html 0.6 2026-02-15T13:49:21+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-commissioner-on-new-p-299619.html 0.6 2026-05-24T17:42:37+08:00 daily https://www.pharmasources.com/industryinsights/celgene-confirms-9b-juno-buyout-sees-3b--299620.html 0.6 2026-07-21T13:52:45+08:00 daily https://www.pharmasources.com/industryinsights/novartis-feeling-the-heat-from-head-to-h-299621.html 0.6 2026-04-09T16:03:58+08:00 daily https://www.pharmasources.com/industryinsights/7-key-cancer-trends-for-2018-299622.html 0.6 2026-04-06T20:36:57+08:00 daily https://www.pharmasources.com/industryinsights/biotech-ma-in-2018-a-tsunami-or-a-ripple-299623.html 0.6 2026-08-08T07:49:31+08:00 daily https://www.pharmasources.com/industryinsights/feds-may-sue-generic-drugmakers-to-recov-299624.html 0.6 2026-08-07T15:07:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-reports-erenumab-met-all-primar-299625.html 0.6 2026-08-07T13:17:57+08:00 daily https://www.pharmasources.com/industryinsights/plant-virus-resistant-cytosinpeptidemyci-299626.html 0.6 2026-08-07T12:18:27+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-ifez-ink-mou-for-expanding-inv-299627.html 0.6 2026-08-07T12:00:01+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-inc-selected-as-201-299628.html 0.6 2026-08-07T11:33:47+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-adopts-trinetx-platform-to-speed--299629.html 0.6 2026-02-23T12:25:18+08:00 daily https://www.pharmasources.com/industryinsights/german-researchers-propose-new-medicatio-299630.html 0.6 2026-08-07T06:06:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-confirmed-the-deal-to-buy-biovera-299631.html 0.6 2026-08-07T00:15:34+08:00 daily https://www.pharmasources.com/industryinsights/combination-chemotherapy-may-significant-299632.html 0.6 2026-08-07T00:40:53+08:00 daily https://www.pharmasources.com/industryinsights/engineers-design-artificial-synapse-for--299633.html 0.6 2026-08-07T00:42:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-ind-for-the-treatment-of-muc-299634.html 0.6 2026-08-08T00:42:38+08:00 daily https://www.pharmasources.com/industryinsights/cells-of-3-advanced-cancers-die-with-dru-299635.html 0.6 2026-08-07T16:22:03+08:00 daily https://www.pharmasources.com/industryinsights/top-3-takeover-targets-for-pfizer-299636.html 0.6 2026-08-08T00:54:03+08:00 daily https://www.pharmasources.com/industryinsights/3-biotechs-that-have-doubled-investors-m-299637.html 0.6 2026-08-09T07:56:51+08:00 daily https://www.pharmasources.com/industryinsights/amgen-jumps-as-migraine-drug-wows-in-lat-299638.html 0.6 2026-04-01T23:53:29+08:00 daily https://www.pharmasources.com/industryinsights/shire-continues-to-uphold-high-standards-299639.html 0.6 2026-03-31T23:55:00+08:00 daily https://www.pharmasources.com/industryinsights/vitricell-raises-over-12m-in-series-a-fu-299640.html 0.6 2026-06-05T12:37:17+08:00 daily https://www.pharmasources.com/industryinsights/biocancell-announces-terms-of-25m-fundin-299641.html 0.6 2026-01-05T15:54:25+08:00 daily https://www.pharmasources.com/industryinsights/tevas-subcutaneous-asthma-drug-fails-in--299642.html 0.6 2026-04-19T05:42:59+08:00 daily https://www.pharmasources.com/industryinsights/jj-withdraws-controversial-vaginal-mesh--299643.html 0.6 2026-01-20T06:58:55+08:00 daily https://www.pharmasources.com/industryinsights/gsk-wins-case-against-reckitt-benckiser--299644.html 0.6 2026-06-27T00:45:15+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-yervoy-scores-eu-a-299645.html 0.6 2025-12-14T14:40:06+08:00 daily https://www.pharmasources.com/industryinsights/sobi-receives-ind-acceptance-from-fda-299646.html 0.6 2026-01-11T13:40:31+08:00 daily https://www.pharmasources.com/industryinsights/promis-neurosciences-candidate-for-alzhe-299647.html 0.6 2025-12-11T14:20:26+08:00 daily https://www.pharmasources.com/industryinsights/bio-rad-wins-additional-fda-clearances-f-299648.html 0.6 2026-01-05T05:51:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-topcons-ocular-diagnostic-instru-299649.html 0.6 2026-07-17T23:54:58+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-superiority-of-pharmajet-nee-299650.html 0.6 2026-04-07T14:54:06+08:00 daily https://www.pharmasources.com/industryinsights/puma-sinks-after-the-chmp-throws-a-roadb-299651.html 0.6 2026-01-31T11:09:46+08:00 daily https://www.pharmasources.com/industryinsights/5-biotechs-drawing-buyout-buzz-in-2018-299652.html 0.6 2026-04-06T20:40:23+08:00 daily https://www.pharmasources.com/industryinsights/why-this-connecticut-biotech-could-be-a--299653.html 0.6 2026-07-03T16:33:02+08:00 daily https://www.pharmasources.com/industryinsights/top-trends-impacting-biopharma-innovatio-299654.html 0.6 2026-06-28T00:19:51+08:00 daily https://www.pharmasources.com/industryinsights/ai-biotech-startup-xtalpi-scores-15m-fro-299655.html 0.6 2026-07-09T09:30:35+08:00 daily https://www.pharmasources.com/industryinsights/flushed-with-cash-shanghai-pharma-hunts--299656.html 0.6 2026-07-20T12:02:37+08:00 daily https://www.pharmasources.com/industryinsights/nih-gets-into-crisprcas9-launches-190m-g-299657.html 0.6 2026-07-06T20:32:16+08:00 daily https://www.pharmasources.com/industryinsights/chinese-tycoon-eyes-500m-ipo-of-luye-lif-299658.html 0.6 2026-03-23T08:34:40+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-spend-more-on-rd-with-tax-reform-m-299659.html 0.6 2025-11-12T02:53:14+08:00 daily https://www.pharmasources.com/industryinsights/why-this-heart-drug-could-be-a-5b-blockb-299660.html 0.6 2025-11-08T21:24:32+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-biosimilar-of-biogen-roches-ritu-299661.html 0.6 2026-07-31T14:37:53+08:00 daily https://www.pharmasources.com/industryinsights/top-6-generic-drug-companies-to-work-for-299662.html 0.6 2026-06-26T20:46:54+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-announces-final-fda-approval-and-299663.html 0.6 2026-07-05T02:42:11+08:00 daily https://www.pharmasources.com/industryinsights/cerus-reports-positive-top-line-results--299664.html 0.6 2026-04-15T21:31:18+08:00 daily https://www.pharmasources.com/industryinsights/apexian-pharmaceuticals-opens-phase-i-cl-299665.html 0.6 2026-06-28T09:00:49+08:00 daily https://www.pharmasources.com/industryinsights/equashield-reports-surging-growth-in-bot-299666.html 0.6 2026-02-28T15:32:15+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-announces-formation-of-sc-299667.html 0.6 2026-07-23T18:26:32+08:00 daily https://www.pharmasources.com/industryinsights/young-innovations-announces-acquisition--299668.html 0.6 2025-11-16T23:35:20+08:00 daily https://www.pharmasources.com/industryinsights/new-vaccine-provides-universal-protectio-299669.html 0.6 2026-06-26T13:15:52+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-taltz-get-eu-approval-in-psor-299670.html 0.6 2026-03-22T10:20:53+08:00 daily https://www.pharmasources.com/industryinsights/cobra-awarded-26m-from-innovate-uk-for-e-299671.html 0.6 2026-06-23T10:58:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-ftc-warn-companies-for-selling-illeg-299672.html 0.6 2026-06-21T01:48:34+08:00 daily https://www.pharmasources.com/industryinsights/nih-begins-large-hiv-treatment-study-in--299673.html 0.6 2026-06-30T07:36:49+08:00 daily https://www.pharmasources.com/industryinsights/human-skin-pigmentation-recreated-with-a-299674.html 0.6 2026-03-05T06:33:58+08:00 daily https://www.pharmasources.com/industryinsights/nanoparticle-vaccine-offers-universal-pr-299675.html 0.6 2025-11-14T12:32:59+08:00 daily https://www.pharmasources.com/industryinsights/which-will-be-the-final-winner-on-the-ma-299676.html 0.6 2026-06-24T07:09:19+08:00 daily https://www.pharmasources.com/industryinsights/which-will-be-the-final-winner-on-the-ma-299677.html 0.6 2026-07-24T11:09:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-shire-manufacturing-move-299678.html 0.6 2026-08-03T06:48:04+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-drops-out-of-the-race-fo-299679.html 0.6 2025-11-30T07:10:12+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-biogens-ms-drug-tecfidera-co-299680.html 0.6 2026-06-24T12:05:21+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-pharma-seeking-deals-to-drive-o-299681.html 0.6 2026-03-17T21:50:38+08:00 daily https://www.pharmasources.com/industryinsights/china-ai-biotech-xtalpi-lands-15m-from-s-299682.html 0.6 2026-08-07T23:03:33+08:00 daily https://www.pharmasources.com/industryinsights/microsoft-partners-with-adaptive-biotech-299683.html 0.6 2026-03-31T20:56:42+08:00 daily https://www.pharmasources.com/industryinsights/scientists-synthesize-nanoparticle-antio-299684.html 0.6 2026-04-09T18:06:13+08:00 daily https://www.pharmasources.com/industryinsights/solid-biosciences-discloses-dmd-trial-se-299685.html 0.6 2026-07-02T15:47:34+08:00 daily https://www.pharmasources.com/industryinsights/why-bay-areas-xoma-surged-700-in-2017-by-299686.html 0.6 2026-02-15T07:27:07+08:00 daily https://www.pharmasources.com/industryinsights/jj-bows-out-of-race-for-pfizers-20b-cons-299687.html 0.6 2026-04-14T02:22:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-three-in-one-copd-inhaler-s-299688.html 0.6 2026-07-18T23:26:00+08:00 daily https://www.pharmasources.com/industryinsights/spectris-snaps-up-concept-life-sciences--299689.html 0.6 2026-07-07T04:16:05+08:00 daily https://www.pharmasources.com/industryinsights/ballsy-celgene-continues-to-tread-carefu-299690.html 0.6 2026-07-06T19:57:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-bet-pays-off-as-advanced-accele-299691.html 0.6 2026-06-24T06:46:08+08:00 daily https://www.pharmasources.com/industryinsights/hardin-scientific-to-open-new-plant-crea-299692.html 0.6 2026-07-16T09:17:00+08:00 daily https://www.pharmasources.com/industryinsights/independent-study-reaffirms-penumbra-asp-299693.html 0.6 2026-06-13T00:23:34+08:00 daily https://www.pharmasources.com/industryinsights/mothers-antibodies-may-worsen-dengue-inf-299694.html 0.6 2025-12-13T01:07:44+08:00 daily https://www.pharmasources.com/industryinsights/ptt-to-establish-production-plant-for-ca-299695.html 0.6 2026-08-08T00:36:32+08:00 daily https://www.pharmasources.com/industryinsights/let-data-talk-is-nature-or-humans-to-bla-299696.html 0.6 2026-06-13T06:05:03+08:00 daily https://www.pharmasources.com/industryinsights/let-data-talk-is-nature-or-humans-to-bla-299697.html 0.6 2026-06-13T02:50:30+08:00 daily https://www.pharmasources.com/industryinsights/sofosbuvir-can-be-a-potential-treatment--299698.html 0.6 2026-03-19T23:40:50+08:00 daily https://www.pharmasources.com/industryinsights/miniaturised-neural-system-developed-for-299699.html 0.6 2025-11-07T16:34:50+08:00 daily https://www.pharmasources.com/industryinsights/drug-trial-protocol-redactions-by-indust-299700.html 0.6 2026-06-21T03:37:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-certain-d-299701.html 0.6 2026-07-01T10:34:07+08:00 daily https://www.pharmasources.com/industryinsights/spark-therapeutics-acquires-licence-to-s-299702.html 0.6 2026-04-20T19:05:43+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-reports-full-year-and-fourth-quar-299703.html 0.6 2026-05-03T20:49:55+08:00 daily https://www.pharmasources.com/industryinsights/nice-urges-curbing-the-use-of-antibiotic-299704.html 0.6 2026-06-13T22:06:04+08:00 daily https://www.pharmasources.com/industryinsights/azs-triple-therapy-inhaler-hits-8-out-of-299705.html 0.6 2026-04-27T11:49:51+08:00 daily https://www.pharmasources.com/industryinsights/iqos-heat-not-burn-electronic-tobacco-pr-299706.html 0.6 2026-06-08T04:43:33+08:00 daily https://www.pharmasources.com/industryinsights/scotlands-synpromics-expands-gene-therap-299707.html 0.6 2026-01-31T09:23:38+08:00 daily https://www.pharmasources.com/industryinsights/takedazinfadel-ends-late-stage-alzheimer-299708.html 0.6 2026-04-27T16:33:19+08:00 daily https://www.pharmasources.com/industryinsights/rexgenero-treats-first-patients-in-cli-t-299709.html 0.6 2026-08-08T13:55:39+08:00 daily https://www.pharmasources.com/industryinsights/water-saving-device-of-first-stage-ro-wa-299710.html 0.6 2026-07-14T15:27:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-calls-roches-autism-drug-a-breakthro-299711.html 0.6 2026-07-31T13:40:28+08:00 daily https://www.pharmasources.com/industryinsights/no-deal-for-novo-as-sanofi-swoops-in-wit-299712.html 0.6 2026-06-08T16:39:06+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-to-award-shareholders-increase-em-299713.html 0.6 2026-07-08T02:51:40+08:00 daily https://www.pharmasources.com/industryinsights/6-promising-biopharmas-with-major-cataly-299714.html 0.6 2026-04-05T13:49:30+08:00 daily https://www.pharmasources.com/industryinsights/filing-reveals-kendall-squares-invivo-th-299715.html 0.6 2026-03-01T02:01:45+08:00 daily https://www.pharmasources.com/industryinsights/3-small-biotechs-big-drugmakers-are-maki-299716.html 0.6 2026-07-19T13:52:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-formally-rejects-aradigms-linhaliq-r-299717.html 0.6 2026-06-10T20:37:36+08:00 daily https://www.pharmasources.com/industryinsights/sun-biopharma-announces-initiation-of-fi-299718.html 0.6 2026-04-02T06:09:37+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-expands-santen-ophthalmic-pa-299719.html 0.6 2026-04-12T04:19:28+08:00 daily https://www.pharmasources.com/industryinsights/syntheticmr-ab---segmentation-and-quanti-299720.html 0.6 2026-06-28T18:56:06+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-reports-breakthrough-in-mitoch-299721.html 0.6 2026-06-21T18:30:54+08:00 daily https://www.pharmasources.com/industryinsights/exagen-collaborates-with-gsk-for-lupus-t-299722.html 0.6 2026-03-31T15:16:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-agreed-to-buy-ablynx-for-48-b-299723.html 0.6 2026-08-08T01:26:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lutathera-for-somatostatin--299724.html 0.6 2026-03-31T15:25:27+08:00 daily https://www.pharmasources.com/industryinsights/tecan-to-launch-fluent-gx-automation-wor-299725.html 0.6 2026-04-29T17:55:21+08:00 daily https://www.pharmasources.com/industryinsights/enzyme-replacement-therapy-to-treat-alph-299726.html 0.6 2026-06-12T03:31:39+08:00 daily https://www.pharmasources.com/industryinsights/takedas-zika-vaccine-candidate-receives--299727.html 0.6 2026-08-07T12:20:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-revises-methods-after-public-outrage-299728.html 0.6 2026-06-12T04:27:08+08:00 daily https://www.pharmasources.com/industryinsights/santheras-raxone-rejected-in-europe-for--299729.html 0.6 2026-06-15T14:28:35+08:00 daily https://www.pharmasources.com/industryinsights/ema-committee-recommends-seven-therapies-299730.html 0.6 2026-06-08T07:54:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-india-appoints-jawed-zia-as-vc--299731.html 0.6 2026-03-25T15:49:32+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biocon-receive-chmp-opinion-for-se-299732.html 0.6 2026-06-13T05:10:00+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-receives-us-fda-approval-299733.html 0.6 2026-03-24T02:04:34+08:00 daily https://www.pharmasources.com/industryinsights/brexit-alliance-calls-for-brexit-deal-on-299734.html 0.6 2026-05-04T01:19:54+08:00 daily https://www.pharmasources.com/industryinsights/seven-medicines-leap-closer-to-eu-approv-299735.html 0.6 2026-06-09T13:34:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-confirms-neuroscience-cuts-shelve-299736.html 0.6 2026-06-12T12:13:19+08:00 daily https://www.pharmasources.com/industryinsights/one-year-old-dracen-pharma-raises-405m-h-299737.html 0.6 2026-01-04T14:16:36+08:00 daily https://www.pharmasources.com/industryinsights/bridgebio-launches-qed-therapeutics-with-299738.html 0.6 2026-07-28T14:13:42+08:00 daily https://www.pharmasources.com/industryinsights/shire-snaps-up-rights-to-a-preclinical-a-299739.html 0.6 2026-06-08T17:32:26+08:00 daily https://www.pharmasources.com/industryinsights/socals-artelo-biosciences-inks-202m-rd-d-299740.html 0.6 2026-03-08T05:39:24+08:00 daily https://www.pharmasources.com/industryinsights/sunovions-parkinsons-drug-succeeds-in-la-299741.html 0.6 2026-08-08T22:05:47+08:00 daily https://www.pharmasources.com/industryinsights/upsher-smith-receives-fda-approval-for-b-299742.html 0.6 2026-08-07T07:32:59+08:00 daily https://www.pharmasources.com/industryinsights/first-wave-bio-to-begin-clinical-trials--299743.html 0.6 2026-08-08T20:07:14+08:00 daily https://www.pharmasources.com/industryinsights/aldeyra-therapeutics-announces-first-pat-299744.html 0.6 2026-03-28T02:37:26+08:00 daily https://www.pharmasources.com/industryinsights/update-on-priority-review-by-cde-accepta-299745.html 0.6 2026-08-04T00:55:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-da-299746.html 0.6 2026-08-06T02:08:24+08:00 daily https://www.pharmasources.com/industryinsights/ifpbm-invited-to-present-at-the-2nd-annu-299747.html 0.6 2026-06-30T17:44:03+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-aravive-biologics-to--299748.html 0.6 2026-07-18T13:18:38+08:00 daily https://www.pharmasources.com/industryinsights/update-on-priority-review-by-cde-biggest-299749.html 0.6 2026-07-04T12:53:29+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-wireless-light-switc-299750.html 0.6 2026-07-17T22:19:57+08:00 daily https://www.pharmasources.com/industryinsights/zika-vaccine-candidate-granted-fda-fast--299751.html 0.6 2026-03-31T23:41:40+08:00 daily https://www.pharmasources.com/industryinsights/pyridostigmine-reverses-paediatric-compl-299752.html 0.6 2026-08-05T10:24:32+08:00 daily https://www.pharmasources.com/industryinsights/brexit-may-disrupt-medicines-supply-warn-299753.html 0.6 2026-03-18T00:27:25+08:00 daily https://www.pharmasources.com/industryinsights/roches-balovaptan-obtains-fda-breakthrou-299754.html 0.6 2026-07-27T09:06:09+08:00 daily https://www.pharmasources.com/industryinsights/ablynx-enters-39bn-acquisition-deal-with-299755.html 0.6 2026-01-10T13:05:46+08:00 daily https://www.pharmasources.com/industryinsights/philippines-department-of-health-demands-299756.html 0.6 2026-06-28T15:17:19+08:00 daily https://www.pharmasources.com/industryinsights/apotex-president-resigns-amidst-founders-299757.html 0.6 2026-04-23T06:37:49+08:00 daily https://www.pharmasources.com/industryinsights/az-triple-combo-copd-inhaler-hits-phiii--299758.html 0.6 2026-07-28T11:44:43+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-uni-launches-42m-nhs-care-rese-299759.html 0.6 2025-11-27T15:55:38+08:00 daily https://www.pharmasources.com/industryinsights/eu-clears-msds-prevymis-for-cmv-preventi-299760.html 0.6 2026-02-28T12:03:28+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-awarded-34m-by-innovate--299761.html 0.6 2026-05-14T14:51:47+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-tech-299762.html 0.6 2026-08-06T23:45:55+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-tech-299763.html 0.6 2026-08-07T05:28:41+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-snaps-up-cascadian-in-6-299764.html 0.6 2026-04-26T10:27:47+08:00 daily https://www.pharmasources.com/industryinsights/socals-vical-terminates-54-of-workforce--299765.html 0.6 2026-04-03T20:17:33+08:00 daily https://www.pharmasources.com/industryinsights/3-cases-of-brain-damage-force-the-fda-to-299766.html 0.6 2025-11-27T15:49:19+08:00 daily https://www.pharmasources.com/industryinsights/new-report-johnson-johnson-tops-employme-299767.html 0.6 2026-08-06T20:59:03+08:00 daily https://www.pharmasources.com/industryinsights/3-big-drugmakers-with-huge-catalysts-on--299768.html 0.6 2026-07-06T19:20:23+08:00 daily https://www.pharmasources.com/industryinsights/meet-the-unnoticed-alzheimers-biotech-fa-299769.html 0.6 2026-08-07T13:23:16+08:00 daily https://www.pharmasources.com/industryinsights/engine-biosciences-raises-10m-in-seed-fi-299770.html 0.6 2026-08-09T00:13:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-a-phase-ii-clinical-trial-in--299771.html 0.6 2026-06-09T14:30:57+08:00 daily https://www.pharmasources.com/industryinsights/thomas-jefferson-university-release-micr-299772.html 0.6 2026-04-08T23:34:48+08:00 daily https://www.pharmasources.com/industryinsights/aquestive-therapeutics-receives-us-fda-o-299773.html 0.6 2026-03-24T04:17:57+08:00 daily https://www.pharmasources.com/industryinsights/astellas-reports-financial-results-for-t-299774.html 0.6 2026-07-19T04:59:51+08:00 daily https://www.pharmasources.com/industryinsights/lilly-reports-strong-fourth-quarter-and--299775.html 0.6 2026-06-28T15:05:31+08:00 daily https://www.pharmasources.com/industryinsights/nanjing-ying-peng-becomes-major-sharehol-299776.html 0.6 2026-04-24T02:30:41+08:00 daily https://www.pharmasources.com/industryinsights/dental-scanner-professionals-dof-inc-lau-299777.html 0.6 2026-04-28T00:18:51+08:00 daily https://www.pharmasources.com/industryinsights/smart-footwear-to-provide-unique-data-op-299778.html 0.6 2026-04-07T08:18:36+08:00 daily https://www.pharmasources.com/industryinsights/biomx-in-licenses-novel-bacterial-target-299779.html 0.6 2026-06-08T17:39:08+08:00 daily https://www.pharmasources.com/industryinsights/russian-researchers-develop-a-rapid-diag-299780.html 0.6 2026-06-22T07:27:30+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-huge-improvement-for-sever-299781.html 0.6 2026-04-02T10:42:07+08:00 daily https://www.pharmasources.com/industryinsights/new-approach-identifies-existing-leukaem-299782.html 0.6 2026-03-18T00:33:43+08:00 daily https://www.pharmasources.com/industryinsights/icmr-pfizer-to-work-on-antimicrobial-res-299783.html 0.6 2026-07-01T10:18:05+08:00 daily https://www.pharmasources.com/industryinsights/seattle-in-614m-move-for-cascadian-thera-299784.html 0.6 2026-04-02T03:27:45+08:00 daily https://www.pharmasources.com/industryinsights/uk-charity-breast-cancer-care-receives-6-299785.html 0.6 2026-08-07T22:32:29+08:00 daily https://www.pharmasources.com/industryinsights/nhs-digital-lambasted-for-collusion-with-299786.html 0.6 2026-03-22T02:58:02+08:00 daily https://www.pharmasources.com/industryinsights/nhs-plans-to-be-first-to-eliminate-hepat-299787.html 0.6 2026-07-06T21:38:19+08:00 daily https://www.pharmasources.com/industryinsights/roche-throws-in-the-towel-on-a-host-of-e-299788.html 0.6 2026-03-24T05:04:36+08:00 daily https://www.pharmasources.com/industryinsights/3-fda-decisions-to-look-out-for-in-febru-299789.html 0.6 2026-03-23T05:22:39+08:00 daily https://www.pharmasources.com/industryinsights/newcomer-partner-therapeutics-nabs-60m-a-299790.html 0.6 2026-06-17T17:44:10+08:00 daily https://www.pharmasources.com/industryinsights/booming-celltrion-falls-after-fda-warnin-299791.html 0.6 2026-06-04T07:30:16+08:00 daily https://www.pharmasources.com/industryinsights/investors-elated-as-vertex-picks-two-top-299792.html 0.6 2026-03-11T04:28:33+08:00 daily https://www.pharmasources.com/industryinsights/teva-wraps-up-703m-sale-of-global-womens-299793.html 0.6 2026-04-04T19:04:47+08:00 daily https://www.pharmasources.com/industryinsights/lilly-exploring-strategic-alternatives-f-299794.html 0.6 2025-12-18T02:56:09+08:00 daily https://www.pharmasources.com/industryinsights/ferrings-zomacton-somatropin-for-injecti-299795.html 0.6 2026-04-12T00:29:00+08:00 daily https://www.pharmasources.com/industryinsights/amneal-introduces-isotretinoin-capsules--299796.html 0.6 2026-04-17T11:43:33+08:00 daily https://www.pharmasources.com/industryinsights/childrens-hospital-of-philadelphia-relea-299797.html 0.6 2026-06-26T14:23:50+08:00 daily https://www.pharmasources.com/industryinsights/jhl-biotech-shareholders-vote-to-volunta-299798.html 0.6 2026-01-30T19:21:18+08:00 daily https://www.pharmasources.com/industryinsights/semaglutide-demonstrated-significant-red-299799.html 0.6 2026-08-06T02:52:43+08:00 daily https://www.pharmasources.com/industryinsights/envirotainer-receives-award-as-best-acti-299800.html 0.6 2026-08-08T08:19:15+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-budget-2018--a-gigantic-task-299801.html 0.6 2026-06-27T13:01:31+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-and-eskayef-unite-to-manufa-299802.html 0.6 2025-12-27T18:31:14+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-technology-for-studyi-299803.html 0.6 2026-06-29T00:01:58+08:00 daily https://www.pharmasources.com/industryinsights/cancer-vaccine-eliminates-tumours-299804.html 0.6 2026-04-07T19:42:33+08:00 daily https://www.pharmasources.com/industryinsights/nih-partnership-to-improve-clinical-tria-299805.html 0.6 2026-04-10T08:06:04+08:00 daily https://www.pharmasources.com/industryinsights/incidence-of-strokes-in-younger-people-r-299806.html 0.6 2026-07-05T15:18:56+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-perjeta-for-routine-use-on-299807.html 0.6 2026-03-24T16:15:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-halts-bellicum-trial-over-brain-dise-299808.html 0.6 2026-08-07T09:18:01+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-dndi-seek-ema-review-for-sleeping-299809.html 0.6 2026-08-08T19:05:44+08:00 daily https://www.pharmasources.com/industryinsights/syndax-announces-immuno-oncology-clinica-299810.html 0.6 2026-08-07T01:20:03+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018020-299811.html 0.6 2026-08-07T05:07:22+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-allies-with-alibaba-and-tenc-299812.html 0.6 2026-06-22T03:08:49+08:00 daily https://www.pharmasources.com/industryinsights/in-wine-theres-health-low-levels-of-alco-299813.html 0.6 2026-01-31T11:29:04+08:00 daily https://www.pharmasources.com/industryinsights/amgen-sinks-after-q4-earnings-miss-despi-299814.html 0.6 2025-12-15T03:13:55+08:00 daily https://www.pharmasources.com/industryinsights/merck-expects-a-flat-tax-rate-in-2018-as-299815.html 0.6 2026-06-14T06:30:33+08:00 daily https://www.pharmasources.com/industryinsights/preliminary-report-outlines-causal-assoc-299816.html 0.6 2026-03-31T20:43:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-api-maker-daito-kasei-kogyo-ba-299817.html 0.6 2026-04-08T23:53:06+08:00 daily https://www.pharmasources.com/industryinsights/china-commits-us13b-in-venture-funds-for-299818.html 0.6 2026-07-01T17:46:32+08:00 daily https://www.pharmasources.com/industryinsights/list-of-top-500-enterprises-market-value-299819.html 0.6 2026-06-25T22:31:07+08:00 daily https://www.pharmasources.com/industryinsights/europes-biggest-private-biotech-company--299820.html 0.6 2026-08-03T05:19:10+08:00 daily https://www.pharmasources.com/industryinsights/edible-qr-code-could-be-the-medicine-of--299821.html 0.6 2026-06-28T08:42:49+08:00 daily https://www.pharmasources.com/industryinsights/roche-reports-good-results-in-2017-299822.html 0.6 2026-08-06T11:15:32+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-detects-early-stages-of-alzhe-299823.html 0.6 2026-06-03T16:46:18+08:00 daily https://www.pharmasources.com/industryinsights/merck-celebrates-its-350th-anniversary-299824.html 0.6 2025-12-27T16:41:18+08:00 daily https://www.pharmasources.com/industryinsights/us-states-penalise-japanese-drug-firm-ov-299825.html 0.6 2025-12-27T07:22:39+08:00 daily https://www.pharmasources.com/industryinsights/antibiotics-sold-in-india-pose-global-su-299826.html 0.6 2026-06-22T07:03:20+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-beats-street-revenu-299827.html 0.6 2026-06-19T11:38:39+08:00 daily https://www.pharmasources.com/industryinsights/hot-atmosphere-on-the-site-of-the-7th-cp-299828.html 0.6 2026-06-16T10:04:01+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-class-1-oncology-drugs-a-299829.html 0.6 2026-08-02T23:42:56+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-to-offer-hpv-vaccine-to-me-299830.html 0.6 2026-03-05T10:52:58+08:00 daily https://www.pharmasources.com/industryinsights/gardasils-growth-led-mercks-vaccine-sale-299831.html 0.6 2026-06-09T20:13:44+08:00 daily https://www.pharmasources.com/industryinsights/new-research-suggests-your-immune-system-299832.html 0.6 2026-03-20T11:09:04+08:00 daily https://www.pharmasources.com/industryinsights/cfda-approves-luxury-skincare-products-o-299833.html 0.6 2026-07-08T13:51:02+08:00 daily https://www.pharmasources.com/industryinsights/crizotinib-radiation-therapy-combination-299834.html 0.6 2026-03-23T02:35:04+08:00 daily https://www.pharmasources.com/industryinsights/lupin-q3-net-profit-dips-65-pc-to-rs-222-299835.html 0.6 2026-04-17T08:59:08+08:00 daily https://www.pharmasources.com/industryinsights/price-rise-of-the-wild-medicinal-materia-299836.html 0.6 2026-06-14T15:38:29+08:00 daily https://www.pharmasources.com/industryinsights/ema-discusses-future-amsterdam-premises-299837.html 0.6 2026-03-18T00:22:21+08:00 daily https://www.pharmasources.com/industryinsights/old-antibiotic-compounds-could-become-to-299838.html 0.6 2026-02-15T09:05:14+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-teva-sign-license-agreemen-299839.html 0.6 2026-08-07T04:58:22+08:00 daily https://www.pharmasources.com/industryinsights/report-shows-less-asthma-attacks-in-us-c-299840.html 0.6 2026-08-09T01:21:29+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-investors-are-betting-on-299841.html 0.6 2026-08-07T12:55:15+08:00 daily https://www.pharmasources.com/industryinsights/diet-may-influence-the-spread-of-a-deadl-299842.html 0.6 2026-06-17T03:48:54+08:00 daily https://www.pharmasources.com/industryinsights/crushing-defeatstop-ten-rd-pipelines-tha-299843.html 0.6 2026-03-17T20:15:06+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-the-global-oncology-and-supp-299844.html 0.6 2026-07-03T10:18:41+08:00 daily https://www.pharmasources.com/industryinsights/gsk-reported-3-percent-hike-in-2017-sale-299845.html 0.6 2026-05-02T07:33:57+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-hit-by-yet-another-recall-of-8-299846.html 0.6 2026-08-07T10:36:28+08:00 daily https://www.pharmasources.com/industryinsights/gileads-biktarvy-wins-megablockbuster-hi-299847.html 0.6 2026-07-20T02:20:22+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-notifies-sec-doj-of-new--299848.html 0.6 2026-03-02T10:32:49+08:00 daily https://www.pharmasources.com/industryinsights/gsk-bayer-top-global-ranking-for-online--299849.html 0.6 2026-04-21T06:56:41+08:00 daily https://www.pharmasources.com/industryinsights/dogged-by-abbvies-new-share-stealing-mav-299850.html 0.6 2026-07-06T01:47:19+08:00 daily https://www.pharmasources.com/industryinsights/chinas-dl-medicine-forms-research-allian-299851.html 0.6 2026-07-04T19:21:07+08:00 daily https://www.pharmasources.com/industryinsights/2017-a-year-of-innovation-and-advances-299852.html 0.6 2026-07-02T13:31:49+08:00 daily https://www.pharmasources.com/industryinsights/other-novel-drug-approvals-advances-in-p-299853.html 0.6 2026-02-06T06:14:36+08:00 daily https://www.pharmasources.com/industryinsights/cders-drug-therapy-approvals-of-2017-299854.html 0.6 2026-08-09T08:40:21+08:00 daily https://www.pharmasources.com/industryinsights/rexahn-haichang-collaborate-for-developi-299855.html 0.6 2026-08-06T23:30:33+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-acquire-australian-biotech-s-299856.html 0.6 2026-08-08T19:19:06+08:00 daily https://www.pharmasources.com/industryinsights/cold-chain-pie-to-nearly-double-in-five--299857.html 0.6 2026-06-27T08:58:47+08:00 daily https://www.pharmasources.com/industryinsights/viiv-files-hiv-drug-patent-infringement--299858.html 0.6 2026-02-15T13:43:47+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-kapvay-tabs-in-th-299859.html 0.6 2026-05-14T04:04:52+08:00 daily https://www.pharmasources.com/industryinsights/shaanxi-aoxing-pharmaceutical-renews-gmp-299860.html 0.6 2026-06-30T07:49:29+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca2018-sale-directions-from-201-299861.html 0.6 2026-06-20T03:42:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-drugs-with-potential-in-201-299862.html 0.6 2026-07-27T14:06:36+08:00 daily https://www.pharmasources.com/industryinsights/delays-in-drug-approval-cause-more-probl-299863.html 0.6 2026-02-28T16:06:07+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-refocuses-pde9-inhi-299864.html 0.6 2026-04-21T06:54:08+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-corticosteroids-may-increase-bon-299865.html 0.6 2025-11-27T05:21:25+08:00 daily https://www.pharmasources.com/industryinsights/going-glocal-is-it-the-way-forward-299866.html 0.6 2026-06-27T14:57:16+08:00 daily https://www.pharmasources.com/industryinsights/novartis-could-cut-its-kymriah-price-to--299867.html 0.6 2025-11-17T11:35:19+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-pasteur-posts-83-growth-despite-2-299868.html 0.6 2026-08-07T03:33:56+08:00 daily https://www.pharmasources.com/industryinsights/acg-appoints-steven-facer-as-vice-presid-299869.html 0.6 2026-08-07T03:27:50+08:00 daily https://www.pharmasources.com/industryinsights/using-injectable-self-assembled-nanomate-299870.html 0.6 2026-08-07T03:24:32+08:00 daily https://www.pharmasources.com/industryinsights/chinese-researchers-report-first-lung-st-299871.html 0.6 2026-08-07T03:03:40+08:00 daily https://www.pharmasources.com/industryinsights/singapore-biotech-startup-raises-10m-to--299872.html 0.6 2026-08-07T02:52:28+08:00 daily https://www.pharmasources.com/industryinsights/who-can-expect-the-biggest-hit-under-the-299873.html 0.6 2025-11-27T05:26:42+08:00 daily https://www.pharmasources.com/industryinsights/pci-to-acquire-pharmaceutical-packaging--299874.html 0.6 2026-08-07T02:30:48+08:00 daily https://www.pharmasources.com/industryinsights/review-of-drugs-for-alzheimers-diseaselu-299875.html 0.6 2026-08-07T01:39:39+08:00 daily https://www.pharmasources.com/industryinsights/the-7th-enterprise-applying-for-car-t-in-299876.html 0.6 2026-07-27T07:18:32+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-and-regulus-announce-microrna-d-299877.html 0.6 2026-07-05T07:03:59+08:00 daily https://www.pharmasources.com/industryinsights/basf-launches-first-dedicated-product-to-299878.html 0.6 2026-02-08T17:39:42+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-establish-cell--and-gene-therap-299879.html 0.6 2026-07-19T07:44:59+08:00 daily https://www.pharmasources.com/industryinsights/cha-biotech-receives-patent-for-stem-cel-299880.html 0.6 2026-01-31T04:05:39+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-tatweer-medical-team-up-fo-299881.html 0.6 2026-03-19T17:16:07+08:00 daily https://www.pharmasources.com/industryinsights/scientists-in-korea-develop-biosensing-l-299882.html 0.6 2026-03-04T15:11:36+08:00 daily https://www.pharmasources.com/industryinsights/singapore-researchers-work-on-developing-299883.html 0.6 2026-01-04T22:27:06+08:00 daily https://www.pharmasources.com/industryinsights/china-ethopia-sign-mou-for-biotechnology-299884.html 0.6 2026-06-28T22:42:47+08:00 daily https://www.pharmasources.com/industryinsights/atomo-rps-diagnostics-collaborate-to-add-299885.html 0.6 2025-11-27T05:38:17+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-seeks-approval-for-diagno-299886.html 0.6 2026-02-28T16:09:29+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-scd-pharma-sign-pact-for-market-299887.html 0.6 2026-03-26T22:07:08+08:00 daily https://www.pharmasources.com/industryinsights/tetraphase-enters-into-agreement-with-bi-299888.html 0.6 2026-06-09T11:00:35+08:00 daily https://www.pharmasources.com/industryinsights/merck-invests-additional-40-m-to-enhance-299889.html 0.6 2026-08-05T23:27:28+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-namenda-xr-capsul-299890.html 0.6 2026-04-10T00:25:38+08:00 daily https://www.pharmasources.com/industryinsights/pharmajet-unites-with-genexine-to-develo-299891.html 0.6 2025-11-27T05:44:37+08:00 daily https://www.pharmasources.com/industryinsights/npl-launches-metrology-for-medical-physi-299892.html 0.6 2026-06-16T20:42:02+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-antidepressants-to-be-more-e-299893.html 0.6 2026-04-20T02:02:36+08:00 daily https://www.pharmasources.com/industryinsights/autoimmune-disease-research-community-ge-299894.html 0.6 2026-06-21T02:13:49+08:00 daily https://www.pharmasources.com/industryinsights/pausing-evolution-makes-bioproduction-of-299895.html 0.6 2026-06-04T09:02:44+08:00 daily https://www.pharmasources.com/industryinsights/top-10-pharmaceutical-enterprises-making-299896.html 0.6 2026-08-06T05:21:16+08:00 daily https://www.pharmasources.com/industryinsights/review-of-drug-use-on-hospital-market-in-299897.html 0.6 2026-07-23T12:47:51+08:00 daily https://www.pharmasources.com/industryinsights/race-for-7-organised-in-bengaluru-and-mu-299898.html 0.6 2026-03-18T00:27:57+08:00 daily https://www.pharmasources.com/industryinsights/nus-team-develops-aerogels-to-control-ex-299899.html 0.6 2026-03-17T22:18:01+08:00 daily https://www.pharmasources.com/industryinsights/shionogis-thrombocytopenia-drug-granted--299900.html 0.6 2026-04-16T06:12:05+08:00 daily https://www.pharmasources.com/industryinsights/twi-biotechnology-gets-tfda-nod-to-treat-299901.html 0.6 2026-07-18T21:21:36+08:00 daily https://www.pharmasources.com/industryinsights/alma-lasers-gets-fda-clearance-for-its-a-299902.html 0.6 2026-06-08T18:33:15+08:00 daily https://www.pharmasources.com/industryinsights/genesis-healthcare-raises-165-b-yen-299903.html 0.6 2026-06-29T05:01:40+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-diabetes-pill-presents-the-299904.html 0.6 2026-04-09T15:47:05+08:00 daily https://www.pharmasources.com/industryinsights/malaysian-health-ministry-bans-three-cos-299905.html 0.6 2026-07-19T20:57:48+08:00 daily https://www.pharmasources.com/industryinsights/canada-announces-79-m-investment-for-hea-299906.html 0.6 2026-07-18T14:00:33+08:00 daily https://www.pharmasources.com/industryinsights/sumitomo-dainippon-appoints-nomura-as-pr-299907.html 0.6 2026-02-15T00:41:18+08:00 daily https://www.pharmasources.com/industryinsights/new-ftc-rules-hurt-ma-prospects-for-hard-299908.html 0.6 2026-07-16T19:57:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-could-face-502m-bill-if-it-comes--299909.html 0.6 2026-07-08T18:53:00+08:00 daily https://www.pharmasources.com/industryinsights/new-link-between-gut-bacteria-and-obesit-299910.html 0.6 2025-12-03T20:04:07+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-authorisation-to-amglidia-299911.html 0.6 2026-06-29T23:48:58+08:00 daily https://www.pharmasources.com/industryinsights/siemens-and-perceptive-engineering-combi-299912.html 0.6 2026-08-04T07:59:58+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-medication-brings-improveme-299913.html 0.6 2026-06-09T23:15:01+08:00 daily https://www.pharmasources.com/industryinsights/cancer-drugs-could-transform-the-lives-o-299914.html 0.6 2026-03-01T02:04:47+08:00 daily https://www.pharmasources.com/industryinsights/hormone-therapy-helps-reduce-hyperkyphos-299915.html 0.6 2026-04-21T10:04:10+08:00 daily https://www.pharmasources.com/industryinsights/acg-signs-mou-with-applied-dna-sciences-299916.html 0.6 2025-11-27T06:10:33+08:00 daily https://www.pharmasources.com/industryinsights/who-approves-cholera-vaccine-for-use-at--299917.html 0.6 2025-11-27T06:11:37+08:00 daily https://www.pharmasources.com/industryinsights/lilly-receives-additional-fda-approval-f-299918.html 0.6 2026-03-31T08:35:23+08:00 daily https://www.pharmasources.com/industryinsights/elsevier-and-beijing-university-to-expan-299919.html 0.6 2026-03-28T07:14:25+08:00 daily https://www.pharmasources.com/industryinsights/3k3a-apc-demonstrates-safety-in-clinical-299920.html 0.6 2026-03-12T03:13:57+08:00 daily https://www.pharmasources.com/industryinsights/algorithm-proves-its-worth-in-preventing-299921.html 0.6 2026-02-15T13:56:40+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-accurately-diagn-299922.html 0.6 2026-06-29T04:59:07+08:00 daily https://www.pharmasources.com/industryinsights/mk-8353-shows-promise-for-melanoma-with--299923.html 0.6 2025-12-08T15:41:08+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-gel-shows-promise-against-ca-299924.html 0.6 2026-02-15T09:12:26+08:00 daily https://www.pharmasources.com/industryinsights/new-research-looks-to-reduce-side-effect-299925.html 0.6 2026-06-20T19:35:46+08:00 daily https://www.pharmasources.com/industryinsights/bayer-announces-publication-of-larotrect-299926.html 0.6 2026-04-23T15:01:46+08:00 daily https://www.pharmasources.com/industryinsights/treatment-with-novartis-ultibro-breezhal-299927.html 0.6 2026-02-15T13:30:15+08:00 daily https://www.pharmasources.com/industryinsights/fertility-study-finds-hormone-that-could-299928.html 0.6 2026-04-05T19:20:31+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-acquire-flatiron-health-to-acce-299929.html 0.6 2026-08-07T01:39:40+08:00 daily https://www.pharmasources.com/industryinsights/study-weighs-risks-and-benefits-of-phase-299930.html 0.6 2026-08-07T01:36:58+08:00 daily https://www.pharmasources.com/industryinsights/2017-otc-drug-rankings-released-what-blo-299931.html 0.6 2026-08-07T01:42:48+08:00 daily https://www.pharmasources.com/industryinsights/mabspace-granted-fda-approval-for-msb231-299932.html 0.6 2026-08-07T01:52:09+08:00 daily https://www.pharmasources.com/industryinsights/bgn-tech-biosensorix-to-create-poc-diagn-299933.html 0.6 2026-08-07T02:05:24+08:00 daily https://www.pharmasources.com/industryinsights/hkstp-to-focus-on-biotech-ai-to-drive-in-299934.html 0.6 2026-08-07T02:15:45+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cancer-chief-joins-biotech-star-299935.html 0.6 2026-08-07T02:21:56+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-lowers-risk-of-death-for-patient-299936.html 0.6 2026-08-07T02:31:02+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-use-during-pregnancy-linke-299937.html 0.6 2026-08-07T02:40:01+08:00 daily https://www.pharmasources.com/industryinsights/online-tool-provides-3-d-view-of-human-m-299938.html 0.6 2026-08-07T02:43:00+08:00 daily https://www.pharmasources.com/industryinsights/unique-pancreatic-stem-cells-have-potent-299939.html 0.6 2026-08-07T03:06:22+08:00 daily https://www.pharmasources.com/industryinsights/inspirational-patient-stories-reveal-the-299940.html 0.6 2026-08-07T13:16:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-three-partners-start-explorebi-299941.html 0.6 2026-08-08T00:54:20+08:00 daily https://www.pharmasources.com/industryinsights/calcium-may-play-a-role-in-the-developme-299942.html 0.6 2026-08-08T07:51:42+08:00 daily https://www.pharmasources.com/industryinsights/cipla-ties-up-with-roche-to-sell-2-key-d-299943.html 0.6 2026-08-08T23:20:02+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-sedativ-299944.html 0.6 2026-08-09T04:18:28+08:00 daily https://www.pharmasources.com/industryinsights/ai-and-facial-diagnosis-company-fdna-set-299945.html 0.6 2026-08-09T06:51:49+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-subpoenaed-again-over-sales-299946.html 0.6 2025-12-22T15:03:01+08:00 daily https://www.pharmasources.com/industryinsights/bayer-healthcares-faltering-even-before--299947.html 0.6 2026-02-15T12:13:46+08:00 daily https://www.pharmasources.com/industryinsights/selvita-announces-successful-completion--299948.html 0.6 2026-06-15T22:55:20+08:00 daily https://www.pharmasources.com/industryinsights/serious-about-serialisation-dcc-vital-se-299949.html 0.6 2026-08-06T00:26:29+08:00 daily https://www.pharmasources.com/industryinsights/biopharmaspec-launches-new-host-cell-pro-299950.html 0.6 2025-11-27T06:41:08+08:00 daily https://www.pharmasources.com/industryinsights/project-pharmaceutics-expands-facilities-299951.html 0.6 2026-01-18T21:19:07+08:00 daily https://www.pharmasources.com/industryinsights/the-future-pattern-of-biosimilars-in-chi-299952.html 0.6 2026-08-04T08:55:21+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-add-70-jobs-with-25m-dublin-in-299953.html 0.6 2026-02-14T13:13:27+08:00 daily https://www.pharmasources.com/industryinsights/mylan-partners-with-revance-therapeutics-299954.html 0.6 2026-03-31T20:02:41+08:00 daily https://www.pharmasources.com/industryinsights/nice-positive-recommendation-supports-us-299955.html 0.6 2026-04-24T17:15:50+08:00 daily https://www.pharmasources.com/industryinsights/finch-therapeutics-group-raises-36-milli-299956.html 0.6 2025-11-17T04:16:57+08:00 daily https://www.pharmasources.com/industryinsights/torrent-shareholders-clear-hike-in-borro-299957.html 0.6 2026-06-30T02:05:22+08:00 daily https://www.pharmasources.com/industryinsights/troikaa-bags-recognition-from-govt-of-in-299958.html 0.6 2026-06-24T07:11:04+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-include-ceratin-brands-for-con-299959.html 0.6 2026-08-08T21:53:47+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-seeks-us-fda-approval-for-h-299960.html 0.6 2026-08-08T12:18:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-label-update-of-cosentyx-to-299961.html 0.6 2026-08-08T18:12:32+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-seek-fda-approval-o-299962.html 0.6 2026-08-08T20:37:30+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-abbvie-voluntarily-pull-multi-299963.html 0.6 2026-08-08T22:01:48+08:00 daily https://www.pharmasources.com/industryinsights/ionis-and-roche-tout-positive-data-in-ea-299964.html 0.6 2026-08-09T05:33:45+08:00 daily https://www.pharmasources.com/industryinsights/meiragtx-earns-ema-prime-designation-for-299965.html 0.6 2026-07-28T23:14:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-new-draft-guidance-for-alzhei-299966.html 0.6 2026-06-19T16:03:47+08:00 daily https://www.pharmasources.com/industryinsights/opko-healths-annual-report-a-mixed-bag-299967.html 0.6 2026-07-09T00:05:39+08:00 daily https://www.pharmasources.com/industryinsights/mylan-to-introduce-two-new-cost-saving-h-299968.html 0.6 2026-06-04T04:42:47+08:00 daily https://www.pharmasources.com/industryinsights/eating-fish-may-be-tied-to-a-reduced-ris-299969.html 0.6 2026-04-17T21:12:36+08:00 daily https://www.pharmasources.com/industryinsights/revolutionary-robotic-treatment-for-pati-299970.html 0.6 2026-04-16T02:51:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-fraudulent-and-unapproved-f-299971.html 0.6 2026-01-30T18:06:19+08:00 daily https://www.pharmasources.com/industryinsights/commitment-to-curing-cancer-high-school--299972.html 0.6 2025-12-28T03:41:40+08:00 daily https://www.pharmasources.com/industryinsights/legal-cannabis-and-cbd-sales-are-on-the--299973.html 0.6 2026-04-01T12:22:58+08:00 daily https://www.pharmasources.com/industryinsights/michigan-governor-snyder-signs-bill-faci-299974.html 0.6 2026-06-08T09:28:36+08:00 daily https://www.pharmasources.com/industryinsights/philips-hologic-to-provide-integrated-he-299975.html 0.6 2025-11-10T10:42:47+08:00 daily https://www.pharmasources.com/industryinsights/drug-free-nonsurgical-pain-relief-comes--299976.html 0.6 2025-12-24T08:05:58+08:00 daily https://www.pharmasources.com/industryinsights/vera-whole-health-receives-seattle-busin-299977.html 0.6 2025-11-09T19:23:01+08:00 daily https://www.pharmasources.com/industryinsights/regenerx-secures-1-million-in-funding-299978.html 0.6 2026-06-28T19:46:06+08:00 daily https://www.pharmasources.com/industryinsights/roche-achieves-two-major-milestones-in-t-299979.html 0.6 2026-07-08T17:07:37+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-announces-fda-accep-299980.html 0.6 2026-06-12T15:00:49+08:00 daily https://www.pharmasources.com/industryinsights/tricida-announces-100-million-venture-de-299981.html 0.6 2026-08-08T21:39:34+08:00 daily https://www.pharmasources.com/industryinsights/aytu-bioscience-announces-pricing-of-120-299982.html 0.6 2026-08-07T07:11:30+08:00 daily https://www.pharmasources.com/industryinsights/china-based-carsgen-gets-60m-equity-inve-299983.html 0.6 2026-01-31T09:59:35+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-completed-60-million-pre-c-finan-299984.html 0.6 2026-03-12T01:13:23+08:00 daily https://www.pharmasources.com/industryinsights/dha-approves-clinical-trial-application--299985.html 0.6 2026-08-09T10:11:18+08:00 daily https://www.pharmasources.com/industryinsights/alibaba-group-opens-first-research-insti-299986.html 0.6 2026-07-21T18:50:00+08:00 daily https://www.pharmasources.com/industryinsights/philips-and-hologic-announce-global-part-299987.html 0.6 2026-04-07T21:12:40+08:00 daily https://www.pharmasources.com/industryinsights/new-global-commission-to-accelerate-diag-299988.html 0.6 2026-07-03T02:10:38+08:00 daily https://www.pharmasources.com/industryinsights/msd-ferring-complete-clinical-trial-for--299989.html 0.6 2026-08-07T16:28:08+08:00 daily https://www.pharmasources.com/industryinsights/bd-announces-results-of-offer-to-repurch-299990.html 0.6 2026-06-12T04:34:54+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-takeda-use-organs-on-chip-tech-299991.html 0.6 2026-04-24T04:36:37+08:00 daily https://www.pharmasources.com/industryinsights/endo-granted-injunction-to-block-blood-p-299992.html 0.6 2026-08-07T22:55:28+08:00 daily https://www.pharmasources.com/industryinsights/study-identifies-five-kinds-of-diabetes--299993.html 0.6 2026-03-13T09:22:49+08:00 daily https://www.pharmasources.com/industryinsights/artificial-cell-technologies-cfo-accused-299994.html 0.6 2026-01-21T09:58:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-forms-a-pear-to-develop-mobile--299995.html 0.6 2026-07-04T05:10:38+08:00 daily https://www.pharmasources.com/industryinsights/veronas-rpl554-improves-lung-function-in-299996.html 0.6 2026-03-23T03:37:52+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-files-dupixent-for-severe-asthma-299997.html 0.6 2026-06-15T06:07:47+08:00 daily https://www.pharmasources.com/industryinsights/wize-pharma-raises-114-million-299998.html 0.6 2026-03-01T04:33:56+08:00 daily https://www.pharmasources.com/industryinsights/west-cfo-announces-plans-to-retire-299999.html 0.6 2026-01-30T19:23:53+08:00 daily https://www.pharmasources.com/industryinsights/valeant-teams-up-with-kaken-for-psoriasi-300000.html 0.6 2026-03-17T18:33:55+08:00 daily https://www.pharmasources.com/industryinsights/iqgen-raises-25m-for-healthcare-investme-300001.html 0.6 2026-03-02T19:13:37+08:00 daily https://www.pharmasources.com/industryinsights/eloxx-pharma-brings-jasbir-seehra-on-boa-300002.html 0.6 2026-06-23T18:21:17+08:00 daily https://www.pharmasources.com/industryinsights/chr-hansen-gets-patent-for-its-probiotic-300003.html 0.6 2026-07-22T08:36:23+08:00 daily https://www.pharmasources.com/industryinsights/9-characteristics-of-chinas-pharmaceutic-300004.html 0.6 2026-07-30T03:31:38+08:00 daily https://www.pharmasources.com/industryinsights/cccmhpie-data-of-chinas-pharmaceutical-f-300005.html 0.6 2026-07-16T05:27:48+08:00 daily https://www.pharmasources.com/industryinsights/gileads-preclinical-combo-trial-might-er-300006.html 0.6 2026-06-18T11:16:31+08:00 daily https://www.pharmasources.com/industryinsights/vividion-therapeutics-snags-101m-from-ce-300007.html 0.6 2026-06-18T11:15:27+08:00 daily https://www.pharmasources.com/industryinsights/prometic-snags-rare-pediatric-disease-de-300008.html 0.6 2025-12-21T04:28:27+08:00 daily https://www.pharmasources.com/industryinsights/dermiras-acne-medication-olumacostat-gla-300009.html 0.6 2026-08-09T00:36:25+08:00 daily https://www.pharmasources.com/industryinsights/vanda-pharmaceuticals-hetlioz-shows-prom-300010.html 0.6 2026-06-13T17:25:37+08:00 daily https://www.pharmasources.com/industryinsights/unum-therapeutics-looks-to-file-ipo-reve-300011.html 0.6 2026-06-12T17:46:56+08:00 daily https://www.pharmasources.com/industryinsights/g1-therapeutics-unveils-positive-mid-sta-300012.html 0.6 2026-08-04T14:22:02+08:00 daily https://www.pharmasources.com/industryinsights/top-50-drugs-by-global-sales-in-2017-hum-300013.html 0.6 2026-07-17T19:48:10+08:00 daily https://www.pharmasources.com/industryinsights/gtx-announced-new-data-demonstrating-eno-300014.html 0.6 2025-11-27T13:42:34+08:00 daily https://www.pharmasources.com/industryinsights/nihon-kohden-launches-nk-hiq-wireless-pa-300015.html 0.6 2025-12-29T02:42:18+08:00 daily https://www.pharmasources.com/industryinsights/celgene-announces-expiration-of-cash-ten-300016.html 0.6 2026-04-06T11:43:58+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-pharmaceuticals-to-participate-at-300017.html 0.6 2026-08-06T22:23:56+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-to-take-part-in-cow-300018.html 0.6 2026-03-25T13:42:21+08:00 daily https://www.pharmasources.com/industryinsights/arqule-reports-fourth-quarter-and-full-y-300019.html 0.6 2026-03-17T21:02:52+08:00 daily https://www.pharmasources.com/industryinsights/ibm-watson-health-announces-100-top-hosp-300020.html 0.6 2026-08-05T20:31:30+08:00 daily https://www.pharmasources.com/industryinsights/owlstone-medical-raises-15-million-usd-1-300021.html 0.6 2026-06-17T00:06:58+08:00 daily https://www.pharmasources.com/industryinsights/chinas-pharmaceutical-market-flourishing-300022.html 0.6 2026-06-23T07:17:08+08:00 daily https://www.pharmasources.com/industryinsights/green-pharma-clean-pharma-300023.html 0.6 2026-05-03T16:55:38+08:00 daily https://www.pharmasources.com/industryinsights/corindus-receives-fda-clearance-for-firs-300024.html 0.6 2026-02-09T07:03:49+08:00 daily https://www.pharmasources.com/industryinsights/new-opportunities-for-the-pharmaceutical-300025.html 0.6 2026-07-20T06:02:21+08:00 daily https://www.pharmasources.com/industryinsights/innopack-china-2018-to-take-place-soon-300026.html 0.6 2026-02-26T04:18:10+08:00 daily https://www.pharmasources.com/industryinsights/ms-awareness-week-2018-celebrates-people-300027.html 0.6 2026-07-03T07:39:03+08:00 daily https://www.pharmasources.com/industryinsights/optimizing-and-upgrading-zones-and-gathe-300028.html 0.6 2026-06-09T02:21:32+08:00 daily https://www.pharmasources.com/industryinsights/people-oriented-thinking-and-then-acting-300029.html 0.6 2026-07-10T12:02:30+08:00 daily https://www.pharmasources.com/industryinsights/wascop-launches-2018-campaign-to-promote-300030.html 0.6 2026-04-06T01:40:24+08:00 daily https://www.pharmasources.com/industryinsights/focusing-on-lab-science-and-technology-i-300031.html 0.6 2026-07-22T14:37:31+08:00 daily https://www.pharmasources.com/industryinsights/nex-2018-to-start-a-new-journey-as-the-i-300032.html 0.6 2026-07-18T10:43:48+08:00 daily https://www.pharmasources.com/industryinsights/celgene-to-tackle-undruggable-targets-wi-300033.html 0.6 2026-02-28T20:20:20+08:00 daily https://www.pharmasources.com/industryinsights/facilitating-normalized-and-intelligent--300034.html 0.6 2026-07-22T05:54:01+08:00 daily https://www.pharmasources.com/industryinsights/china-intelligent-pharmaceuticals-2025-i-300035.html 0.6 2026-06-24T12:06:50+08:00 daily https://www.pharmasources.com/industryinsights/china-intelligent-pharmaceuticals-2025-i-300036.html 0.6 2026-02-21T11:18:14+08:00 daily https://www.pharmasources.com/industryinsights/breath-biopsy-company-adds-new-investor--300037.html 0.6 2026-03-17T23:02:49+08:00 daily https://www.pharmasources.com/industryinsights/china-intelligent-pharmaceuticals-2025-i-300038.html 0.6 2026-07-28T12:08:30+08:00 daily https://www.pharmasources.com/industryinsights/focusing-on-intelligent-plants-to-help-c-300039.html 0.6 2026-06-27T08:14:37+08:00 daily https://www.pharmasources.com/industryinsights/from-stressing-threshold-to-stressing-su-300040.html 0.6 2026-07-28T18:05:03+08:00 daily https://www.pharmasources.com/industryinsights/nhs-drug-deal-could-fund-vital-cystic-fi-300041.html 0.6 2026-07-06T14:13:20+08:00 daily https://www.pharmasources.com/industryinsights/a-nice-yes-for-latest-immunotherapy-bave-300042.html 0.6 2026-02-15T07:11:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-sanofis-dupixent-in-asthma-300043.html 0.6 2026-06-24T00:54:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-develop-digital-therapies-wi-300044.html 0.6 2026-06-10T08:38:35+08:00 daily https://www.pharmasources.com/industryinsights/gilead-investigational-data-gives-hope-f-300045.html 0.6 2026-04-07T04:13:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-finds-major-manufacturing-issues-at--300046.html 0.6 2026-02-14T15:47:23+08:00 daily https://www.pharmasources.com/industryinsights/celgene-strikes-101m-partnership-in-onco-300047.html 0.6 2026-03-01T05:25:37+08:00 daily https://www.pharmasources.com/industryinsights/nhs-trials-world-leading-initiative-to-c-300048.html 0.6 2026-07-08T06:44:36+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-build-new-facility-in-dublin-c-300049.html 0.6 2026-03-20T22:41:24+08:00 daily https://www.pharmasources.com/industryinsights/discover-anesthetic-sevoflurane-market-300050.html 0.6 2026-04-11T12:56:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-sunovions-latuda-expanded-app-300051.html 0.6 2026-04-08T02:14:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-23andmes-direct-to-consumer-300052.html 0.6 2026-04-06T13:30:00+08:00 daily https://www.pharmasources.com/industryinsights/vcs-are-pouring-billions-into-biotech-in-300053.html 0.6 2025-10-28T08:39:45+08:00 daily https://www.pharmasources.com/industryinsights/physician-group-releases-less-stringent--300054.html 0.6 2026-06-08T19:52:05+08:00 daily https://www.pharmasources.com/industryinsights/magenta-therapeutics-collaborates-with-h-300055.html 0.6 2026-06-23T17:13:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-bristol-myers-squibbs-opdivo-300056.html 0.6 2026-07-30T14:16:49+08:00 daily https://www.pharmasources.com/industryinsights/martin-shkreli-ordered-to-forfeit-736-mi-300057.html 0.6 2025-12-27T11:50:32+08:00 daily https://www.pharmasources.com/industryinsights/bioverativ-announces-first-patient-dosed-300058.html 0.6 2026-08-09T04:01:29+08:00 daily https://www.pharmasources.com/industryinsights/chi-med-initiates-a-phase-ibii-proof-of--300059.html 0.6 2026-06-29T11:41:01+08:00 daily https://www.pharmasources.com/industryinsights/fifty-two-week-safety-study-on-symproic--300060.html 0.6 2026-06-12T13:54:42+08:00 daily https://www.pharmasources.com/industryinsights/dna-study-redefines-link-between-the-fto-300061.html 0.6 2026-04-18T04:45:51+08:00 daily https://www.pharmasources.com/industryinsights/unitedhealthcare-launches-expansion-of-d-300062.html 0.6 2026-04-23T10:07:36+08:00 daily https://www.pharmasources.com/industryinsights/orthoxel-announces-worlds-first-patient--300063.html 0.6 2026-04-26T10:09:49+08:00 daily https://www.pharmasources.com/industryinsights/dentists-find-that-children-and-teens-be-300064.html 0.6 2026-06-17T17:39:47+08:00 daily https://www.pharmasources.com/industryinsights/novartis-xolair-backed-in-global-urticar-300065.html 0.6 2026-04-13T01:18:44+08:00 daily https://www.pharmasources.com/industryinsights/santheras-raxone-fails-in-ms-trial-300066.html 0.6 2026-04-08T05:07:06+08:00 daily https://www.pharmasources.com/industryinsights/regulation-of-pharmaceutical-production--300067.html 0.6 2026-06-24T20:02:56+08:00 daily https://www.pharmasources.com/industryinsights/gsks-nucala-improves-control-of-severe-a-300068.html 0.6 2026-07-06T22:44:23+08:00 daily https://www.pharmasources.com/industryinsights/truking-smart-robots-project-investigati-300069.html 0.6 2026-07-19T19:02:12+08:00 daily https://www.pharmasources.com/industryinsights/shires-constipation-drug-under-us-review-300070.html 0.6 2026-07-06T20:19:25+08:00 daily https://www.pharmasources.com/industryinsights/green-and-intelligent-pharmaceutical-pac-300071.html 0.6 2026-08-05T04:13:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-hiv-treatment-for-patie-300072.html 0.6 2026-02-15T02:44:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-replacement-hear-300073.html 0.6 2026-08-10T00:32:12+08:00 daily https://www.pharmasources.com/industryinsights/aytu-bioscience-announces-closing-of-120-300074.html 0.6 2025-11-27T15:57:31+08:00 daily https://www.pharmasources.com/industryinsights/energy-saving-clean-workshops-for-pharma-300075.html 0.6 2026-01-31T01:02:16+08:00 daily https://www.pharmasources.com/industryinsights/aranz-medical-announces-issuance-of-new--300076.html 0.6 2026-04-08T18:34:28+08:00 daily https://www.pharmasources.com/industryinsights/fume-hood-a-safety-link-that-shall-not-b-300077.html 0.6 2026-07-14T22:45:54+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-logistics-developing-into-300078.html 0.6 2026-03-17T20:49:42+08:00 daily https://www.pharmasources.com/industryinsights/focuses-of-validation-of-pharmaceutical--300079.html 0.6 2026-08-04T12:45:45+08:00 daily https://www.pharmasources.com/industryinsights/amgen-announces-preliminary-results-of-t-300080.html 0.6 2025-10-18T23:47:25+08:00 daily https://www.pharmasources.com/industryinsights/cultivating-the-technology-for-aseptic-p-300081.html 0.6 2026-06-23T22:04:14+08:00 daily https://www.pharmasources.com/industryinsights/requirements-for-pharmaceutical-equipmen-300082.html 0.6 2026-08-02T09:57:50+08:00 daily https://www.pharmasources.com/industryinsights/small-enterprises-will-be-knocked-out-wi-300083.html 0.6 2026-07-09T20:22:03+08:00 daily https://www.pharmasources.com/industryinsights/celgene-completes-acquisition-of-juno-th-300084.html 0.6 2026-07-23T11:40:37+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-centers-on-the-rise-claim-high-300085.html 0.6 2025-10-28T04:52:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-with-special-controls-dir-300086.html 0.6 2025-11-11T08:58:11+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-expands-capacity-at-berkel-300087.html 0.6 2026-03-19T11:50:46+08:00 daily https://www.pharmasources.com/industryinsights/global-analytical-instrument-market-dyna-300088.html 0.6 2026-07-24T07:12:21+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-amends-shareholder-rights-plan-300089.html 0.6 2026-07-12T05:46:28+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-could-predict-treatment-effec-300090.html 0.6 2026-08-08T20:38:11+08:00 daily https://www.pharmasources.com/industryinsights/switching-to-gileads-biktarvy-proves-non-300091.html 0.6 2026-08-09T23:58:07+08:00 daily https://www.pharmasources.com/industryinsights/cdc-report-indicates-opioid-crisis-in-am-300092.html 0.6 2026-05-23T10:22:06+08:00 daily https://www.pharmasources.com/industryinsights/esperions-cholesterol-drug-positive-in-p-300093.html 0.6 2026-07-09T02:05:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-greenlights-new-treatment-for-multi--300094.html 0.6 2025-11-08T14:30:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-23andmes-direct-to-consumer-300095.html 0.6 2026-07-09T01:59:59+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-commences-dosing-in-ear-300096.html 0.6 2026-06-14T12:00:12+08:00 daily https://www.pharmasources.com/industryinsights/roivant-licenses-diabetes-drug-from-liga-300097.html 0.6 2025-10-21T01:23:37+08:00 daily https://www.pharmasources.com/industryinsights/at-kearneys-health250-report-identifies--300098.html 0.6 2026-08-05T22:41:09+08:00 daily https://www.pharmasources.com/industryinsights/immuno-oncology-sector-deals-dominate-20-300099.html 0.6 2026-03-13T18:37:12+08:00 daily https://www.pharmasources.com/industryinsights/visterra-to-present-new-preclinical-data-300100.html 0.6 2026-04-04T21:04:16+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-darmstadt-germany-announces-p-300101.html 0.6 2026-06-20T15:16:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-invites-public-to-view-and-listen-300102.html 0.6 2026-07-01T22:47:16+08:00 daily https://www.pharmasources.com/industryinsights/compugen-has-licensed-selexis-cell-line--300103.html 0.6 2026-03-12T18:23:32+08:00 daily https://www.pharmasources.com/industryinsights/tocagen-receives-european-medicines-agen-300104.html 0.6 2026-03-11T11:35:11+08:00 daily https://www.pharmasources.com/industryinsights/burstiq-announces-partnership-with-flowm-300105.html 0.6 2026-04-08T01:13:42+08:00 daily https://www.pharmasources.com/industryinsights/biolase-secures-6-million-revolving-line-300106.html 0.6 2026-06-13T01:58:10+08:00 daily https://www.pharmasources.com/industryinsights/eip-pharma-publishes-positive-alzheimers-300107.html 0.6 2026-02-28T13:52:46+08:00 daily https://www.pharmasources.com/industryinsights/orthofix-secures-fda-and-ce-mark-approva-300108.html 0.6 2026-04-08T17:50:38+08:00 daily https://www.pharmasources.com/industryinsights/combination-therapy-suppresses-hiv-like--300109.html 0.6 2026-04-03T17:45:21+08:00 daily https://www.pharmasources.com/industryinsights/biotime-announces-dsmb-approval-to-proce-300110.html 0.6 2026-04-13T03:52:18+08:00 daily https://www.pharmasources.com/industryinsights/alliance-pt-completes-acquisition-of-agi-300111.html 0.6 2026-08-05T01:21:03+08:00 daily https://www.pharmasources.com/industryinsights/danaher-provides-update-on-first-quarter-300112.html 0.6 2026-04-20T03:00:00+08:00 daily https://www.pharmasources.com/industryinsights/magnetic-nanoparticles-prevent-internal--300113.html 0.6 2026-07-03T02:28:04+08:00 daily https://www.pharmasources.com/industryinsights/new-prevencio-study-using-ai-demonstrate-300114.html 0.6 2026-07-05T06:51:32+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-appoints-harvard-professor-dr-300115.html 0.6 2026-04-06T23:44:27+08:00 daily https://www.pharmasources.com/industryinsights/panther-orthopedics-inc-receives-fda-510-300116.html 0.6 2026-08-05T20:57:13+08:00 daily https://www.pharmasources.com/industryinsights/study-of-childhood-asthma-cautions-again-300117.html 0.6 2026-07-05T01:24:06+08:00 daily https://www.pharmasources.com/industryinsights/antibiotics-may-impact-cancer-treatment--300118.html 0.6 2026-04-06T11:06:06+08:00 daily https://www.pharmasources.com/industryinsights/bloomberg-philanthropies-launches-stoppi-300119.html 0.6 2026-07-04T22:40:03+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-congratulates-taimed-on-f-300120.html 0.6 2026-07-20T19:57:18+08:00 daily https://www.pharmasources.com/industryinsights/4c-medicals-transcatheter-mitral-valve-t-300121.html 0.6 2026-08-09T07:59:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-greenlights-alternative-therapy-for--300122.html 0.6 2026-08-08T04:35:43+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-concerning-low-standards-o-300123.html 0.6 2026-08-07T13:15:19+08:00 daily https://www.pharmasources.com/industryinsights/japan-saves-record-122bn-in-2017-through-300124.html 0.6 2026-08-07T02:09:49+08:00 daily https://www.pharmasources.com/industryinsights/cepi-grants-themis-375m-for-lassa-and-me-300125.html 0.6 2026-08-07T02:05:18+08:00 daily https://www.pharmasources.com/industryinsights/many-clinical-trial-status-discrepancies-300126.html 0.6 2026-08-07T01:14:48+08:00 daily https://www.pharmasources.com/industryinsights/price-of-blockbuster-cancer-drug-opidivo-300127.html 0.6 2026-08-07T01:06:40+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-to-acquire-advanced-300128.html 0.6 2026-08-07T00:59:18+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-gets-recognition-at-bioph-300129.html 0.6 2026-08-07T00:52:58+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-ma-outlook-bright-for-2018-an-300130.html 0.6 2026-08-07T00:42:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-eisai-ink-576b-cancer-deal-300131.html 0.6 2026-08-07T00:59:19+08:00 daily https://www.pharmasources.com/industryinsights/prevail-therapeutics-grabs-75-million-to-300132.html 0.6 2026-08-07T01:11:20+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-sanofi-collaborate-on-infecti-300133.html 0.6 2026-08-07T13:19:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-terminates-pdc-agreement-with-cyt-300134.html 0.6 2026-08-07T15:01:42+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-tech-300135.html 0.6 2026-08-06T21:47:06+08:00 daily https://www.pharmasources.com/industryinsights/health-insurer-cigna-paying-67-billion-t-300136.html 0.6 2026-08-08T22:01:24+08:00 daily https://www.pharmasources.com/industryinsights/roches-john-reed-is-stepping-down-300137.html 0.6 2026-08-09T07:36:47+08:00 daily https://www.pharmasources.com/industryinsights/juno-therapeutics-spinout-raises-90m-300138.html 0.6 2026-08-04T21:00:18+08:00 daily https://www.pharmasources.com/industryinsights/next-generation-biologics-janssens-tremf-300139.html 0.6 2026-03-03T03:52:41+08:00 daily https://www.pharmasources.com/industryinsights/juniper-pharmaceuticals-reports-full-yea-300140.html 0.6 2026-03-05T19:41:40+08:00 daily https://www.pharmasources.com/industryinsights/opioids-are-no-more-effective-than-commo-300141.html 0.6 2026-01-10T09:37:32+08:00 daily https://www.pharmasources.com/industryinsights/ontruzant-launches-to-become-first-herce-300142.html 0.6 2026-06-08T01:36:25+08:00 daily https://www.pharmasources.com/industryinsights/evotec-to-command-vast-sanofi-resources--300143.html 0.6 2025-11-28T10:31:56+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-msd-team-up-to-combine-lenvima-300144.html 0.6 2026-07-01T00:26:24+08:00 daily https://www.pharmasources.com/industryinsights/invivo-therapeutics-receives-fda-approva-300145.html 0.6 2026-02-15T12:12:39+08:00 daily https://www.pharmasources.com/industryinsights/prokaryotics-receives-25-million-sbir-gr-300146.html 0.6 2026-08-05T23:13:40+08:00 daily https://www.pharmasources.com/industryinsights/efsd-jdrf-and-lilly-extend-collaboration-300147.html 0.6 2026-04-24T06:39:09+08:00 daily https://www.pharmasources.com/industryinsights/johns-hopkins-study-reveals-artificial-i-300148.html 0.6 2026-03-17T22:16:50+08:00 daily https://www.pharmasources.com/industryinsights/microsoft-partnered-with-apollo-to-creat-300149.html 0.6 2026-03-20T09:38:44+08:00 daily https://www.pharmasources.com/industryinsights/cdi-labs-collaborates-on-discovery-of-ne-300150.html 0.6 2026-06-14T03:27:49+08:00 daily https://www.pharmasources.com/industryinsights/at-acc-siemens-healthineers-introduces-a-300151.html 0.6 2026-08-06T23:56:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-device-designati-300152.html 0.6 2026-08-07T02:52:45+08:00 daily https://www.pharmasources.com/industryinsights/oxford-vacmedix-raises-125-m-from-chines-300153.html 0.6 2026-08-07T00:02:48+08:00 daily https://www.pharmasources.com/industryinsights/varex-imaging-names-managing-director-fo-300154.html 0.6 2026-08-09T08:01:44+08:00 daily https://www.pharmasources.com/industryinsights/jw-therapeutics-closes-90-million-series-300155.html 0.6 2026-07-19T13:16:51+08:00 daily https://www.pharmasources.com/industryinsights/ms-kimberly-nearing-head-of-life-science-300156.html 0.6 2026-03-31T17:28:30+08:00 daily https://www.pharmasources.com/industryinsights/limacorporate-awarded-with-two-new-odep--300157.html 0.6 2026-03-28T05:57:08+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approves-taiwan-chinas-hiv-drug-300158.html 0.6 2026-05-15T12:36:49+08:00 daily https://www.pharmasources.com/industryinsights/pao-to-head-drugs-research-at-roche-300159.html 0.6 2026-07-11T05:49:49+08:00 daily https://www.pharmasources.com/industryinsights/method-to-predict-drug-stability-could-l-300160.html 0.6 2026-06-15T18:46:36+08:00 daily https://www.pharmasources.com/industryinsights/cbd-may-help-curb-frequency-of-epileptic-300161.html 0.6 2026-08-07T16:40:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-fraudulent-and-unapproved-f-300162.html 0.6 2026-03-19T03:09:03+08:00 daily https://www.pharmasources.com/industryinsights/ucbs-vimpat-gets-nhs-green-light-in-wale-300163.html 0.6 2025-11-28T10:11:28+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-on-treatment-for-giant-cell--300164.html 0.6 2025-11-28T10:10:21+08:00 daily https://www.pharmasources.com/industryinsights/uk-launch-for-europes-first-herceptin-bi-300165.html 0.6 2026-04-13T09:11:01+08:00 daily https://www.pharmasources.com/industryinsights/us-green-lights-novel-hiv-treatment-300166.html 0.6 2026-02-15T13:30:56+08:00 daily https://www.pharmasources.com/industryinsights/surprise-finding-could-lead-to-new-ms-tr-300167.html 0.6 2026-07-03T03:47:02+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-surface-oncology-sign-seco-300168.html 0.6 2026-04-15T19:55:37+08:00 daily https://www.pharmasources.com/industryinsights/xeris-raises-55m-for-glucagon-rescue-pen-300169.html 0.6 2025-11-28T10:04:42+08:00 daily https://www.pharmasources.com/industryinsights/myokardia-sees-positive-results-in-mid-s-300170.html 0.6 2026-04-13T22:35:21+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-pharma-plans-to-resubmit-new-drug-300171.html 0.6 2026-08-07T01:50:15+08:00 daily https://www.pharmasources.com/industryinsights/abiomed-will-pay-31-million-to-settle-ki-300172.html 0.6 2026-04-05T20:10:17+08:00 daily https://www.pharmasources.com/industryinsights/voyager-therapeutics-parkinsons-trial-sh-300173.html 0.6 2026-06-05T14:28:39+08:00 daily https://www.pharmasources.com/industryinsights/ampliphi-biosciences-announces-presentat-300174.html 0.6 2026-06-26T14:15:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pivotal-clinical-trial-for--300175.html 0.6 2025-11-28T09:56:47+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-announces-publication-of-p-300176.html 0.6 2026-04-02T03:07:20+08:00 daily https://www.pharmasources.com/industryinsights/jingxin-enters-with-a-product-of-two-spe-300177.html 0.6 2026-08-04T10:58:55+08:00 daily https://www.pharmasources.com/industryinsights/new-campaign-tackles-falls-prevention-yo-300178.html 0.6 2026-03-27T01:40:10+08:00 daily https://www.pharmasources.com/industryinsights/danaher-to-acquire-integrated-dna-techno-300179.html 0.6 2026-04-07T09:52:31+08:00 daily https://www.pharmasources.com/industryinsights/mina-therapeutics-announces-publication--300180.html 0.6 2026-08-07T15:20:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-duodenoscope-manufacturers-abo-300181.html 0.6 2026-04-18T04:51:55+08:00 daily https://www.pharmasources.com/industryinsights/the-silverstein-foundation-for-parkinson-300182.html 0.6 2026-07-01T00:55:42+08:00 daily https://www.pharmasources.com/industryinsights/covance-forms-immunology-immunotoxicolog-300183.html 0.6 2026-03-02T18:55:35+08:00 daily https://www.pharmasources.com/industryinsights/maple-raises-4-million-in-funding-to-adv-300184.html 0.6 2026-04-04T01:56:29+08:00 daily https://www.pharmasources.com/industryinsights/am-pharma-announces-phase-ii-study-resul-300185.html 0.6 2026-06-03T23:49:01+08:00 daily https://www.pharmasources.com/industryinsights/major-trends-for-pharma-packaging-in-201-300186.html 0.6 2026-01-31T13:31:07+08:00 daily https://www.pharmasources.com/industryinsights/hovione-divestment-marks-its-commitment--300187.html 0.6 2026-02-28T17:52:47+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-completes-acquisition-o-300188.html 0.6 2026-06-08T03:36:22+08:00 daily https://www.pharmasources.com/industryinsights/epivax-and-gaia-vaccine-foundation-celeb-300189.html 0.6 2026-08-05T21:26:51+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-announces-proposed-underwritt-300190.html 0.6 2026-03-23T20:54:46+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-adagene-announce-stra-300191.html 0.6 2026-08-03T17:48:31+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-announces-pricing-of-84-milli-300192.html 0.6 2026-03-01T13:04:53+08:00 daily https://www.pharmasources.com/industryinsights/hua-medicine-picks-hong-kong-sar-china-f-300193.html 0.6 2026-03-13T00:37:25+08:00 daily https://www.pharmasources.com/industryinsights/cancer-is-an-increasingly-important-heal-300194.html 0.6 2026-03-17T21:10:04+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-a-new-tool-for-imprin-300195.html 0.6 2026-03-28T06:30:12+08:00 daily https://www.pharmasources.com/industryinsights/bmsnivolumab-now-the-first-and-only-fda--300196.html 0.6 2026-02-21T20:17:10+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expands-alliance-with-science-3-300197.html 0.6 2026-05-27T20:00:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-eyes-gastro-use-for-xeljanz-after-300198.html 0.6 2025-11-28T09:31:53+08:00 daily https://www.pharmasources.com/industryinsights/australian-scientists-to-develop-blood-t-300199.html 0.6 2025-12-11T12:17:37+08:00 daily https://www.pharmasources.com/industryinsights/merck-shows-canny-cancer-strategy-in-576-300200.html 0.6 2026-07-23T14:54:01+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-in-talks-with-evotec-to-out-licen-300201.html 0.6 2026-01-15T07:56:38+08:00 daily https://www.pharmasources.com/industryinsights/antiviral-drug-not-beneficial-for-reduci-300202.html 0.6 2026-06-24T11:39:26+08:00 daily https://www.pharmasources.com/industryinsights/trogarzo-approved-for-hiv-patients-with--300203.html 0.6 2026-02-15T13:36:37+08:00 daily https://www.pharmasources.com/industryinsights/eu-expands-scope-of-gskinnovivas-asthma--300204.html 0.6 2026-04-26T00:38:01+08:00 daily https://www.pharmasources.com/industryinsights/thalidomide-could-suppress-nerve-cell-de-300205.html 0.6 2026-04-16T15:38:50+08:00 daily https://www.pharmasources.com/industryinsights/us-panel-backs-pfizers-xeljanz-for-ulcer-300206.html 0.6 2026-02-12T19:09:51+08:00 daily https://www.pharmasources.com/industryinsights/cytox-gets-80000-from-innovate-uk-300207.html 0.6 2026-08-09T02:58:07+08:00 daily https://www.pharmasources.com/industryinsights/gsk-loses-37m-appeal-over-pay-to-delay-t-300208.html 0.6 2026-08-07T11:28:18+08:00 daily https://www.pharmasources.com/industryinsights/convert-secures-136m-grant-to-develop-ta-300209.html 0.6 2026-08-09T00:22:50+08:00 daily https://www.pharmasources.com/industryinsights/in-two-months-biotech-startups-raised-mo-300210.html 0.6 2026-08-07T03:33:35+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-slash-cost-of-new-c-300211.html 0.6 2026-08-07T03:55:07+08:00 daily https://www.pharmasources.com/industryinsights/biogen-buys-pfizers-phii-ready-schizophr-300212.html 0.6 2026-08-07T04:22:18+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-to-seek-fda-approval-for-second--300213.html 0.6 2026-08-07T04:49:01+08:00 daily https://www.pharmasources.com/industryinsights/realm-therapeutics-flunks-phii-trial-for-300214.html 0.6 2026-08-07T05:01:23+08:00 daily https://www.pharmasources.com/industryinsights/immutep-strikes-deal-with-merck-to-pair--300215.html 0.6 2026-01-31T00:41:04+08:00 daily https://www.pharmasources.com/industryinsights/merrimack-pharmaceuticals-expands-phase--300216.html 0.6 2025-11-28T09:10:24+08:00 daily https://www.pharmasources.com/industryinsights/anti-obesity-drugmaker-orexigen-therapeu-300217.html 0.6 2026-02-08T18:53:39+08:00 daily https://www.pharmasources.com/industryinsights/hikmas-advair-generic-gets-further-delay-300218.html 0.6 2026-06-03T15:35:33+08:00 daily https://www.pharmasources.com/industryinsights/keeping-pace-with-the-global-topical-and-300219.html 0.6 2026-08-07T03:58:59+08:00 daily https://www.pharmasources.com/industryinsights/tae-life-sciences-to-develop-groundbreak-300220.html 0.6 2026-06-09T10:38:31+08:00 daily https://www.pharmasources.com/industryinsights/gs-5734-inhibits-a-range-of-emerging-cor-300221.html 0.6 2026-02-19T11:36:33+08:00 daily https://www.pharmasources.com/industryinsights/enrollment-completed-in-phase-3-registra-300222.html 0.6 2026-08-07T00:29:59+08:00 daily https://www.pharmasources.com/industryinsights/bioventrix-announces-first-patient-at-ca-300223.html 0.6 2026-08-09T00:11:13+08:00 daily https://www.pharmasources.com/industryinsights/improving-malaria-diagnosis-using-artifi-300224.html 0.6 2026-07-19T13:53:05+08:00 daily https://www.pharmasources.com/industryinsights/slow-release-hydrogel-aids-immunotherapy-300225.html 0.6 2026-03-28T00:59:32+08:00 daily https://www.pharmasources.com/industryinsights/hikmavecturas-generic-advair-delayed-in--300226.html 0.6 2026-07-04T13:23:06+08:00 daily https://www.pharmasources.com/industryinsights/az-announces-results-delay-for-key-lung--300227.html 0.6 2026-07-01T03:10:52+08:00 daily https://www.pharmasources.com/industryinsights/nice-minded-to-reject-keytruda-for-class-300228.html 0.6 2025-11-28T08:56:46+08:00 daily https://www.pharmasources.com/industryinsights/impax-agrees-to-35-million-settlement-ov-300229.html 0.6 2026-04-12T02:26:55+08:00 daily https://www.pharmasources.com/industryinsights/fiber-fermenting-bacteria-improve-health-300230.html 0.6 2026-04-07T16:42:30+08:00 daily https://www.pharmasources.com/industryinsights/citoxlab-acquires-solvo-biotechnology-300231.html 0.6 2026-07-13T09:54:36+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-bms-restructure-migraine-allian-300232.html 0.6 2026-08-08T07:12:10+08:00 daily https://www.pharmasources.com/industryinsights/io-biotech-merck-to-evaluate-keytruda-co-300233.html 0.6 2026-06-13T15:10:27+08:00 daily https://www.pharmasources.com/industryinsights/drug-producing-bacteria-possible-with-sy-300234.html 0.6 2026-01-05T09:09:42+08:00 daily https://www.pharmasources.com/industryinsights/potential-new-approach-to-the-treatment--300235.html 0.6 2026-01-21T18:09:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-dupixent-dupilumab-as-pote-300236.html 0.6 2026-07-28T15:16:23+08:00 daily https://www.pharmasources.com/industryinsights/inspirational-patient-stories-reveal-the-300237.html 0.6 2026-07-16T20:48:32+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-roche-enter-immunology-research-300238.html 0.6 2026-04-15T11:47:11+08:00 daily https://www.pharmasources.com/industryinsights/treatment-with-novartis-ultibro-breezhal-300239.html 0.6 2026-08-02T16:19:53+08:00 daily https://www.pharmasources.com/industryinsights/immutep-merck-co-enter-partnership-300240.html 0.6 2026-01-30T17:29:33+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-nextcode-announces-executive-leader-300241.html 0.6 2026-03-18T00:22:19+08:00 daily https://www.pharmasources.com/industryinsights/smartphone-based-retinal-imaging-togethe-300242.html 0.6 2025-11-28T08:41:55+08:00 daily https://www.pharmasources.com/industryinsights/xw-labs-initiates-first-in-human-phase-i-300243.html 0.6 2026-01-30T13:41:38+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-finds-philips-instant-wav-300244.html 0.6 2026-02-15T03:23:47+08:00 daily https://www.pharmasources.com/industryinsights/eiger-biopharmaceuticals-reports-fourth--300245.html 0.6 2026-01-30T11:42:04+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-acquire-from-pfizer-first-in-c-300246.html 0.6 2026-08-09T15:02:23+08:00 daily https://www.pharmasources.com/industryinsights/myr-pharma-completes-clinical-trial-of-m-300247.html 0.6 2026-01-31T09:59:25+08:00 daily https://www.pharmasources.com/industryinsights/cleveland-clinic-study-affirms-accurate--300248.html 0.6 2025-11-28T08:35:06+08:00 daily https://www.pharmasources.com/industryinsights/laborie-medical-technologies-to-acquire--300249.html 0.6 2026-08-08T00:57:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-halts-advaxis-study-following-patien-300250.html 0.6 2026-06-22T16:45:45+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-elagolix-dazzles-in-phase-iii-tr-300251.html 0.6 2026-01-05T06:35:05+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-therapeutics-snags-breakthr-300252.html 0.6 2026-02-05T08:01:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-mercks-keytruda-priority-revi-300253.html 0.6 2026-08-06T20:10:11+08:00 daily https://www.pharmasources.com/industryinsights/protalix-biotherapeutics-treatment-for-u-300254.html 0.6 2026-03-12T14:13:08+08:00 daily https://www.pharmasources.com/industryinsights/aeglea-biotherapeutics-updates-phase-iii-300255.html 0.6 2026-06-05T16:18:32+08:00 daily https://www.pharmasources.com/industryinsights/biostage-preclinical-study-results-publi-300256.html 0.6 2025-11-28T08:26:58+08:00 daily https://www.pharmasources.com/industryinsights/ampliphi-to-collaborate-with-the-us-depa-300257.html 0.6 2026-07-20T03:02:15+08:00 daily https://www.pharmasources.com/industryinsights/gryt-health-and-bristol-myers-squibb-ann-300258.html 0.6 2026-01-31T09:21:06+08:00 daily https://www.pharmasources.com/industryinsights/cerus-announces-the-fourth-biologics-lic-300259.html 0.6 2025-11-28T08:22:21+08:00 daily https://www.pharmasources.com/industryinsights/certara-launches-industry-first-quantita-300260.html 0.6 2026-07-04T15:50:38+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-positive-topline-result-300261.html 0.6 2026-01-23T11:08:59+08:00 daily https://www.pharmasources.com/industryinsights/ideaya-biosciences-and-cancer-research-u-300262.html 0.6 2026-07-29T07:54:03+08:00 daily https://www.pharmasources.com/industryinsights/precision-biologic-presents-new-approach-300263.html 0.6 2026-03-07T08:12:02+08:00 daily https://www.pharmasources.com/industryinsights/exegi-pharma-launches-high-potency-veter-300264.html 0.6 2026-03-20T20:52:26+08:00 daily https://www.pharmasources.com/industryinsights/forbion-leads-19-million-series-b-financ-300265.html 0.6 2026-08-07T04:16:35+08:00 daily https://www.pharmasources.com/industryinsights/aralez-announces-fourth-quarter-and-full-300266.html 0.6 2026-08-08T03:15:30+08:00 daily https://www.pharmasources.com/industryinsights/life-sciences-pcr-market-strength-seen-i-300267.html 0.6 2026-08-06T18:35:29+08:00 daily https://www.pharmasources.com/industryinsights/parexel-and-cha-medical-group-partner-to-300268.html 0.6 2026-01-04T21:33:27+08:00 daily https://www.pharmasources.com/industryinsights/temple-therapeutics-announces-unpreceden-300269.html 0.6 2026-03-17T22:25:15+08:00 daily https://www.pharmasources.com/industryinsights/sosei-regains-worldwide-rights-from-teva-300270.html 0.6 2026-07-04T23:10:26+08:00 daily https://www.pharmasources.com/industryinsights/market-pattern-of-the-targeted-cancer-dr-300271.html 0.6 2026-08-07T20:33:53+08:00 daily https://www.pharmasources.com/industryinsights/researchers-discover-new-line-of-attack--300272.html 0.6 2026-01-26T08:56:03+08:00 daily https://www.pharmasources.com/industryinsights/cancer-drug-study-placed-on-hold-after-p-300273.html 0.6 2025-11-28T08:06:15+08:00 daily https://www.pharmasources.com/industryinsights/smc-nod-for-novartis-kisqali-msds-keytru-300274.html 0.6 2026-06-02T20:20:56+08:00 daily https://www.pharmasources.com/industryinsights/sglt-2-inhibitors-cut-risk-of-death-in-d-300275.html 0.6 2026-02-25T14:25:42+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-appoints-two-new-sr-vice-p-300276.html 0.6 2026-06-16T10:46:21+08:00 daily https://www.pharmasources.com/industryinsights/hebron-technology-co-ltd-acquires-equity-300277.html 0.6 2026-03-08T00:13:46+08:00 daily https://www.pharmasources.com/industryinsights/menarini-hires-their-17000th-employee-300278.html 0.6 2026-06-07T05:51:14+08:00 daily https://www.pharmasources.com/industryinsights/nsf-international-appoints-frank-pan-man-300279.html 0.6 2026-06-08T22:31:28+08:00 daily https://www.pharmasources.com/industryinsights/uk-seeks-investment-from-health-and-life-300280.html 0.6 2026-01-09T23:02:58+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-tizanid-300281.html 0.6 2026-03-12T19:20:23+08:00 daily https://www.pharmasources.com/industryinsights/agilent-won-two-2018-scientists-choice-a-300282.html 0.6 2025-11-28T07:56:56+08:00 daily https://www.pharmasources.com/industryinsights/kerry-corning-initiates-phase-1-trial-fo-300283.html 0.6 2026-03-01T00:04:51+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-acquire-first-in-class-phase-i-300284.html 0.6 2026-01-30T20:28:32+08:00 daily https://www.pharmasources.com/industryinsights/hope-on-the-horizon-for-hair-loss-suffer-300285.html 0.6 2026-06-30T02:12:26+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-grows-market-position-in-dach--300286.html 0.6 2026-03-17T22:23:18+08:00 daily https://www.pharmasources.com/industryinsights/antigen-study-provides-a-new-approach-to-300287.html 0.6 2026-04-09T10:55:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tests-to-screen-for-tickbor-300288.html 0.6 2026-07-05T17:37:32+08:00 daily https://www.pharmasources.com/industryinsights/calcium-petct-testing-in-coronary-arteri-300289.html 0.6 2026-06-09T00:35:56+08:00 daily https://www.pharmasources.com/industryinsights/theranos-elizabeth-holmes-charged-with-f-300290.html 0.6 2026-06-07T00:34:58+08:00 daily https://www.pharmasources.com/industryinsights/8-biotech-companies-with-upcoming-cataly-300291.html 0.6 2026-06-10T20:34:08+08:00 daily https://www.pharmasources.com/industryinsights/foghorn-therapeutics-launches-with-50-mi-300292.html 0.6 2026-08-06T18:33:26+08:00 daily https://www.pharmasources.com/industryinsights/crinetics-pharmaceuticals-snags-635-mill-300293.html 0.6 2026-08-07T09:39:58+08:00 daily https://www.pharmasources.com/industryinsights/auris-medical-fails-again-in-phase-iii-t-300294.html 0.6 2026-08-06T14:02:41+08:00 daily https://www.pharmasources.com/industryinsights/pharmajet-releases-positive-phase-i-resu-300295.html 0.6 2026-02-14T19:40:29+08:00 daily https://www.pharmasources.com/industryinsights/mardil-medical-announces-first-human-imp-300296.html 0.6 2026-08-01T04:33:56+08:00 daily https://www.pharmasources.com/industryinsights/nanotechnology-delivers-a-two-punch-comb-300297.html 0.6 2026-01-10T03:01:57+08:00 daily https://www.pharmasources.com/industryinsights/cerapedics-receives-fda-ide-approval-to--300298.html 0.6 2026-06-30T13:32:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-for-filing-supplemental-biol-300299.html 0.6 2026-06-30T08:31:33+08:00 daily https://www.pharmasources.com/industryinsights/bright-minds-work-together-to-develop-ne-300300.html 0.6 2026-04-04T23:26:56+08:00 daily https://www.pharmasources.com/industryinsights/progress-prospects-for-regulations-in-ch-300301.html 0.6 2026-08-05T21:20:49+08:00 daily https://www.pharmasources.com/industryinsights/preventing-type-2-diabetes-with-proven-p-300302.html 0.6 2026-04-15T09:38:56+08:00 daily https://www.pharmasources.com/industryinsights/promis-neurosciences-announces-fiscal-ye-300303.html 0.6 2025-12-18T10:18:47+08:00 daily https://www.pharmasources.com/industryinsights/bridge-medicines-accepts-novel-small-mol-300304.html 0.6 2026-07-20T05:18:50+08:00 daily https://www.pharmasources.com/industryinsights/arsanis-granted-key-patents-for-asn100-c-300305.html 0.6 2026-07-09T16:00:22+08:00 daily https://www.pharmasources.com/industryinsights/bio-techne-launches-mimex-gi-an-accessib-300306.html 0.6 2026-01-29T20:03:28+08:00 daily https://www.pharmasources.com/industryinsights/flagship-pioneering-launches-foghorn-the-300307.html 0.6 2026-06-08T15:53:21+08:00 daily https://www.pharmasources.com/industryinsights/saneca-wins-significant-tablet-developme-300308.html 0.6 2026-02-22T13:40:51+08:00 daily https://www.pharmasources.com/industryinsights/riata-capital-groups-eyecare-platform-ac-300309.html 0.6 2026-06-20T21:18:06+08:00 daily https://www.pharmasources.com/industryinsights/johnson-matthey-to-offer-gusev-ester-hyd-300310.html 0.6 2026-06-22T15:09:39+08:00 daily https://www.pharmasources.com/industryinsights/arena-pharmaceuticals-provides-corporate-300311.html 0.6 2026-07-01T15:36:58+08:00 daily https://www.pharmasources.com/industryinsights/novel-drug-delivery-technologies-for-val-300312.html 0.6 2026-04-13T22:22:34+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-newly-elected-board-of-directors-300313.html 0.6 2026-06-30T01:40:04+08:00 daily https://www.pharmasources.com/industryinsights/international-investor-influx-in-south-e-300314.html 0.6 2026-08-02T23:43:52+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-publishes-update-coverage-300315.html 0.6 2026-04-17T15:29:07+08:00 daily https://www.pharmasources.com/industryinsights/tracelinks-network-approach-gets-pioneer-300316.html 0.6 2026-05-29T13:29:44+08:00 daily https://www.pharmasources.com/industryinsights/united-biopharma-plans-expansion-in-chin-300317.html 0.6 2026-01-19T13:32:30+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-invest-39-m-in-singapore-rd-300318.html 0.6 2026-07-03T07:45:42+08:00 daily https://www.pharmasources.com/industryinsights/gc-pharma-announces-approval-for-lantus--300319.html 0.6 2026-06-08T12:31:08+08:00 daily https://www.pharmasources.com/industryinsights/parexel-cha-to-enhance-early-phase-clini-300320.html 0.6 2026-02-22T13:39:07+08:00 daily https://www.pharmasources.com/industryinsights/golden-meditechs-largest-shareholder-acq-300321.html 0.6 2026-08-03T06:55:19+08:00 daily https://www.pharmasources.com/industryinsights/pilatus-clinical-services---german-subsi-300322.html 0.6 2026-06-07T22:48:04+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-sign-up-new-sr-vice-presid-300323.html 0.6 2026-03-01T01:23:58+08:00 daily https://www.pharmasources.com/industryinsights/edico-genome-introduces-bio-it-global-di-300324.html 0.6 2026-01-30T12:36:22+08:00 daily https://www.pharmasources.com/industryinsights/chancellor-criticised-for-lack-of-action-300325.html 0.6 2026-05-24T05:47:39+08:00 daily https://www.pharmasources.com/industryinsights/pilatus-clinical-services-receives-wdl-g-300326.html 0.6 2026-01-01T07:25:15+08:00 daily https://www.pharmasources.com/industryinsights/cancer-researck-uk-links-with-ideaya-on--300327.html 0.6 2026-03-28T21:47:32+08:00 daily https://www.pharmasources.com/industryinsights/speedy-us-review-for-msds-keytruda-in-ce-300328.html 0.6 2026-06-24T07:26:59+08:00 daily https://www.pharmasources.com/industryinsights/teva-denies-wrongdoing-in-cephalon-pay-t-300329.html 0.6 2026-01-27T02:38:12+08:00 daily https://www.pharmasources.com/industryinsights/hammond-suggests-nhs-may-receive-cash-bo-300330.html 0.6 2026-06-18T17:33:02+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-synthetic-non-biologic-vacc-300331.html 0.6 2026-03-31T17:51:10+08:00 daily https://www.pharmasources.com/industryinsights/sks-skyzoster-grabs-korean-market-share--300332.html 0.6 2026-06-15T18:27:52+08:00 daily https://www.pharmasources.com/industryinsights/researchers-use-novel-methods-to-determi-300333.html 0.6 2026-02-15T00:11:57+08:00 daily https://www.pharmasources.com/industryinsights/generic-antiplatelet-drugs-are-as-effect-300334.html 0.6 2026-01-17T18:55:31+08:00 daily https://www.pharmasources.com/industryinsights/mrc-secures-40million-for-uk-dementia-re-300335.html 0.6 2026-02-28T12:13:43+08:00 daily https://www.pharmasources.com/industryinsights/alexions-prospects-rise-with-positive-ph-300336.html 0.6 2026-07-06T04:56:22+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-gets-another-shot-at-fda-appro-300337.html 0.6 2026-07-03T19:57:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-slaps-clinical-hold-on-solid-bioscie-300338.html 0.6 2026-03-17T23:23:59+08:00 daily https://www.pharmasources.com/industryinsights/is-celgene-considering-going-private-300339.html 0.6 2025-11-28T06:50:04+08:00 daily https://www.pharmasources.com/industryinsights/ideaya-biosciences-nabs-94-million-300340.html 0.6 2025-11-28T06:48:54+08:00 daily https://www.pharmasources.com/industryinsights/ionis-pharmaceuticals-partners-with-akce-300341.html 0.6 2026-06-11T15:05:31+08:00 daily https://www.pharmasources.com/industryinsights/amo-pharma-announces-results-of-phase-2--300342.html 0.6 2026-01-30T20:07:26+08:00 daily https://www.pharmasources.com/industryinsights/tobacco-free-kids-fda-plan-to-reduce-nic-300343.html 0.6 2026-03-31T23:56:19+08:00 daily https://www.pharmasources.com/industryinsights/tapimmune-announces-publication-of-clini-300344.html 0.6 2025-11-28T06:42:55+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-2018-floor-plan-and-updates-o-300345.html 0.6 2026-03-12T10:09:22+08:00 daily https://www.pharmasources.com/industryinsights/macrolide-pharmaceuticals-presents-new-d-300346.html 0.6 2026-06-10T20:06:55+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-submits-us-supplemental-new-dru-300347.html 0.6 2026-04-19T08:58:47+08:00 daily https://www.pharmasources.com/industryinsights/registration-for-cphi-china-2018-hotly-i-300348.html 0.6 2026-03-23T02:01:52+08:00 daily https://www.pharmasources.com/industryinsights/fdb-releases-opioid-risk-management-drug-300349.html 0.6 2025-11-28T06:38:11+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-2018-visitor-registration-upg-300350.html 0.6 2026-08-03T03:49:12+08:00 daily https://www.pharmasources.com/industryinsights/food-and-drug-administration-grants-clea-300351.html 0.6 2026-08-08T19:41:57+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-present-at-the-2018-advances-i-300352.html 0.6 2026-08-07T13:00:02+08:00 daily https://www.pharmasources.com/industryinsights/spherix-announces-pricing-of-3-million-p-300353.html 0.6 2026-07-03T19:30:18+08:00 daily https://www.pharmasources.com/industryinsights/transgene-to-present-data-on-a-novel-vir-300354.html 0.6 2026-03-30T11:34:22+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-2018-to-be-grandly-held-at-sh-300355.html 0.6 2026-08-09T01:18:37+08:00 daily https://www.pharmasources.com/industryinsights/worldwide-clinical-trials-acquires-conti-300356.html 0.6 2026-06-30T02:58:01+08:00 daily https://www.pharmasources.com/industryinsights/biorem-announces-orders-totalling-53-mil-300357.html 0.6 2026-06-30T18:44:59+08:00 daily https://www.pharmasources.com/industryinsights/helixbind-awarded-grant-from-carb-x-to-a-300358.html 0.6 2026-07-06T21:18:48+08:00 daily https://www.pharmasources.com/industryinsights/ideaya-biosciences-raises-94-million-cro-300359.html 0.6 2025-11-28T06:26:26+08:00 daily https://www.pharmasources.com/industryinsights/shearwater-health-earns-urac-accreditati-300360.html 0.6 2026-07-01T10:57:25+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-sets-the-record-straight-regardi-300361.html 0.6 2026-06-06T12:57:18+08:00 daily https://www.pharmasources.com/industryinsights/dr-kent-crossley-joins-ondine-biomedical-300362.html 0.6 2026-05-19T06:00:35+08:00 daily https://www.pharmasources.com/industryinsights/cphi-p-mec-china-2018-to-focus-on-the-st-300363.html 0.6 2026-04-20T01:02:21+08:00 daily https://www.pharmasources.com/industryinsights/which-exhibitors-will-join-cphi-china-20-300364.html 0.6 2026-06-29T05:09:20+08:00 daily https://www.pharmasources.com/industryinsights/new-guidelines-recommend-hysteroscopy-te-300365.html 0.6 2026-03-30T10:58:22+08:00 daily https://www.pharmasources.com/industryinsights/patients-on-diabetes-scheme-shed-weight--300366.html 0.6 2025-11-28T06:18:24+08:00 daily https://www.pharmasources.com/industryinsights/charities-link-with-benevolentai-to-disc-300367.html 0.6 2026-06-15T06:57:39+08:00 daily https://www.pharmasources.com/industryinsights/fat-fighting-pharma-business-files-for-b-300368.html 0.6 2026-04-19T07:31:11+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-expo-2018-to-help-pharmaceuti-300369.html 0.6 2026-07-20T05:19:37+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-launches-automated-bioreactor--300370.html 0.6 2026-07-07T15:55:57+08:00 daily https://www.pharmasources.com/industryinsights/hemispherx-unmc-partner-for-pancreatic-c-300371.html 0.6 2026-06-23T15:37:01+08:00 daily https://www.pharmasources.com/industryinsights/ardena-acquires-chemconnection-300372.html 0.6 2026-06-10T05:42:00+08:00 daily https://www.pharmasources.com/industryinsights/significant-role-of-cphi-china-2018-to-t-300373.html 0.6 2026-07-21T17:48:06+08:00 daily https://www.pharmasources.com/industryinsights/foxconn-to-promote-health-management-in--300374.html 0.6 2026-02-07T15:43:00+08:00 daily https://www.pharmasources.com/industryinsights/japan-provides-aid-to-sri-lankan-health--300375.html 0.6 2026-03-28T09:43:23+08:00 daily https://www.pharmasources.com/industryinsights/biogen-acquires-schizophrenia-investigat-300376.html 0.6 2026-08-08T05:09:02+08:00 daily https://www.pharmasources.com/industryinsights/pieriandx-unites-with-cancer-genetics-to-300377.html 0.6 2026-08-07T22:34:51+08:00 daily https://www.pharmasources.com/industryinsights/propanc-biopharma-completes-reproduction-300378.html 0.6 2026-08-07T13:16:00+08:00 daily https://www.pharmasources.com/industryinsights/china-with-space-technology-develops-art-300379.html 0.6 2026-08-07T02:39:50+08:00 daily https://www.pharmasources.com/industryinsights/ai-singapore-signs-mou-with-intel-300380.html 0.6 2026-08-07T02:37:22+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-medical-care-gets-recognition--300381.html 0.6 2026-08-07T02:33:34+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-acquires-prexton-therapeutics-300382.html 0.6 2026-08-07T02:40:52+08:00 daily https://www.pharmasources.com/industryinsights/arbor-biotechnologies-comes-out-of-steal-300383.html 0.6 2026-08-07T11:47:10+08:00 daily https://www.pharmasources.com/industryinsights/theranos-serves-as-a-cautionary-tale-for-300384.html 0.6 2026-08-07T12:12:03+08:00 daily https://www.pharmasources.com/industryinsights/amo-pharma-sees-positive-results-in-phas-300385.html 0.6 2026-08-07T13:18:20+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-selling-lifescan-unit-fo-300386.html 0.6 2026-08-09T07:36:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-gives-go-ahead-for-tetras-phase-ii-t-300387.html 0.6 2025-11-28T05:54:53+08:00 daily https://www.pharmasources.com/industryinsights/adaptimmune-sees-positive-early-results--300388.html 0.6 2026-03-27T01:45:06+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-announces-the-lau-300389.html 0.6 2026-03-22T07:35:59+08:00 daily https://www.pharmasources.com/industryinsights/parachute-health-raises-55-million-seed--300390.html 0.6 2025-11-28T05:50:24+08:00 daily https://www.pharmasources.com/industryinsights/a-comparison-of-update-cycle-and-charact-300391.html 0.6 2026-07-27T17:09:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-hizentra-immune-globulin-su-300392.html 0.6 2026-04-01T04:10:49+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-inc-announces-fda-filing-for-ap-300393.html 0.6 2026-07-17T11:06:47+08:00 daily https://www.pharmasources.com/industryinsights/forbions-portfolio-company-prexton-thera-300394.html 0.6 2026-08-07T12:18:18+08:00 daily https://www.pharmasources.com/industryinsights/a-comparison-of-update-cycle-and-charact-300395.html 0.6 2026-08-08T01:35:49+08:00 daily https://www.pharmasources.com/industryinsights/china-cord-blood-corporation-announces-r-300396.html 0.6 2026-01-04T11:48:04+08:00 daily https://www.pharmasources.com/industryinsights/infinitus-wins-quality-innovation-award--300397.html 0.6 2025-11-28T05:44:45+08:00 daily https://www.pharmasources.com/industryinsights/how-can-intelligent-technology-benefit-m-300398.html 0.6 2026-06-29T07:56:46+08:00 daily https://www.pharmasources.com/industryinsights/biotherm-hosts-the-first-biotherm-healin-300399.html 0.6 2025-11-28T05:43:40+08:00 daily https://www.pharmasources.com/industryinsights/alexion-gears-up-to-file-new-blood-disor-300400.html 0.6 2026-07-18T06:13:51+08:00 daily https://www.pharmasources.com/industryinsights/nice-endorses-keytruda-for-bladder-cance-300401.html 0.6 2026-03-01T21:35:08+08:00 daily https://www.pharmasources.com/industryinsights/rising-levels-of-opioid-prescriptions-pu-300402.html 0.6 2025-11-28T05:38:01+08:00 daily https://www.pharmasources.com/industryinsights/allergan-navigating-choppy-waters-as-sha-300403.html 0.6 2026-04-11T02:02:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-hizentra-300404.html 0.6 2025-11-28T05:36:53+08:00 daily https://www.pharmasources.com/industryinsights/abeona-receives-fda-rare-pediatric-disea-300405.html 0.6 2026-01-03T17:32:01+08:00 daily https://www.pharmasources.com/industryinsights/nih-funded-trials-for-h7n9-influenza-vac-300406.html 0.6 2026-08-07T09:06:11+08:00 daily https://www.pharmasources.com/industryinsights/janssens-urothelial-cancer-drug-gets-bre-300407.html 0.6 2026-07-26T09:06:37+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-to-acquire-prexton-therapeutics-300408.html 0.6 2026-06-08T19:59:33+08:00 daily https://www.pharmasources.com/industryinsights/loncar-introduces-china-biopharma-index-300409.html 0.6 2026-01-18T11:59:21+08:00 daily https://www.pharmasources.com/industryinsights/nearly-200-oncology-experts-gather-to-di-300410.html 0.6 2026-02-15T07:56:37+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-announces-plans-300411.html 0.6 2026-05-01T04:22:27+08:00 daily https://www.pharmasources.com/industryinsights/accelerating-new-clinical-trials-and-tre-300412.html 0.6 2026-05-16T15:12:35+08:00 daily https://www.pharmasources.com/industryinsights/corindus-announces-25-million-private-pl-300413.html 0.6 2025-11-28T05:26:49+08:00 daily https://www.pharmasources.com/industryinsights/gsk-expects-brexit-admin-to-cost-70m-300414.html 0.6 2026-06-06T02:44:40+08:00 daily https://www.pharmasources.com/industryinsights/nanologica-and-sterling-partnership-furt-300415.html 0.6 2026-01-23T09:20:17+08:00 daily https://www.pharmasources.com/industryinsights/mayne-pharma-launches-generic-version-of-300416.html 0.6 2026-02-28T08:28:28+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-therapeutics-receives-fda-a-300417.html 0.6 2025-12-06T20:54:11+08:00 daily https://www.pharmasources.com/industryinsights/partnership-struck-to-increase-productio-300418.html 0.6 2026-06-09T06:33:02+08:00 daily https://www.pharmasources.com/industryinsights/placental-extract-products-from-japan-300419.html 0.6 2026-08-09T16:17:01+08:00 daily https://www.pharmasources.com/industryinsights/agilent-creates-new-colour-to-detect-can-300420.html 0.6 2026-06-08T07:24:24+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-eylea-shows-promising-data-fo-300421.html 0.6 2026-07-25T00:04:23+08:00 daily https://www.pharmasources.com/industryinsights/alzheon-launches-ipo-to-fund-alzheimers--300422.html 0.6 2026-03-01T05:26:01+08:00 daily https://www.pharmasources.com/industryinsights/heron-therapeutics-soars-on-positive-pha-300423.html 0.6 2026-06-24T15:38:44+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-huge-potential-for-mrna-dr-300424.html 0.6 2025-11-28T05:14:32+08:00 daily https://www.pharmasources.com/industryinsights/new-study-indicates-dna-plays-role-in-ge-300425.html 0.6 2026-08-06T20:35:14+08:00 daily https://www.pharmasources.com/industryinsights/cidara-touts-positive-phase-ii-antifunga-300426.html 0.6 2026-06-24T07:19:22+08:00 daily https://www.pharmasources.com/industryinsights/denali-therapeutics-adds-155-million-fro-300427.html 0.6 2026-06-18T11:48:23+08:00 daily https://www.pharmasources.com/industryinsights/6-biotech-companies-with-upside-potentia-300428.html 0.6 2026-07-06T20:59:19+08:00 daily https://www.pharmasources.com/industryinsights/unity-biotechnology-inc-completes-55-mil-300429.html 0.6 2026-02-15T09:47:29+08:00 daily https://www.pharmasources.com/industryinsights/dariohealth-reports-fourth-quarter-and-y-300430.html 0.6 2026-07-17T12:26:00+08:00 daily https://www.pharmasources.com/industryinsights/semaglutide-injection-phase-2-data-prese-300431.html 0.6 2026-08-09T03:24:34+08:00 daily https://www.pharmasources.com/industryinsights/invivo-therapeutics-announces-contempora-300432.html 0.6 2026-06-11T14:00:30+08:00 daily https://www.pharmasources.com/industryinsights/crh-medical-corporation-announces-the-pu-300433.html 0.6 2025-11-20T19:49:26+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-mitraclip-therapy-receives-natio-300434.html 0.6 2026-04-13T19:18:38+08:00 daily https://www.pharmasources.com/industryinsights/amplyx-pharmaceuticals-receives-fourth-q-300435.html 0.6 2026-04-19T04:33:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-nin-300436.html 0.6 2026-04-29T20:20:01+08:00 daily https://www.pharmasources.com/industryinsights/benaroya-research-institute-scientists-u-300437.html 0.6 2026-04-24T22:05:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-presents-new-data-evaluating-300438.html 0.6 2026-08-06T01:52:25+08:00 daily https://www.pharmasources.com/industryinsights/funds-advised-by-apax-partners-to-acquir-300439.html 0.6 2026-06-20T20:29:39+08:00 daily https://www.pharmasources.com/industryinsights/invicro-launches-amyloidiq-to-advance-cl-300440.html 0.6 2026-06-27T19:24:45+08:00 daily https://www.pharmasources.com/industryinsights/123rd-canton-fair-to-open-on-april-15-hi-300441.html 0.6 2025-12-10T22:40:07+08:00 daily https://www.pharmasources.com/industryinsights/immuno-oncology-therapeutics-market-to-r-300442.html 0.6 2026-02-08T21:46:34+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-reports-remarkable-2017-a-300443.html 0.6 2026-07-21T18:52:32+08:00 daily https://www.pharmasources.com/industryinsights/cspc-pharmaceutical-announces-2017-annua-300444.html 0.6 2026-06-09T01:54:29+08:00 daily https://www.pharmasources.com/industryinsights/game-changer-stem-cell-transplant-shows--300445.html 0.6 2026-04-03T01:42:07+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-takes-risk-on-parkinsons-treatm-300446.html 0.6 2026-01-31T10:35:24+08:00 daily https://www.pharmasources.com/industryinsights/indias-narcotics-control-bureau-seizes-5-300447.html 0.6 2026-07-03T06:06:31+08:00 daily https://www.pharmasources.com/industryinsights/medicinal-cannabis-is-safe-and-effective-300448.html 0.6 2025-11-27T04:36:31+08:00 daily https://www.pharmasources.com/industryinsights/h7n9-influenza-vaccine-clinical-trials-b-300449.html 0.6 2026-06-09T07:25:39+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-rapid-test-that-deter-300450.html 0.6 2026-01-31T10:43:45+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-tecentriq-shows-promise-for-f-300451.html 0.6 2026-03-18T02:28:25+08:00 daily https://www.pharmasources.com/industryinsights/can-gilead-develop-a-cure-for-hiv-300452.html 0.6 2026-05-28T11:43:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-prostate--300453.html 0.6 2026-08-07T18:23:06+08:00 daily https://www.pharmasources.com/industryinsights/arena-pharmaceuticals-shares-explode-on--300454.html 0.6 2026-04-15T15:09:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-shows-off-new-farxiga-data-f-300455.html 0.6 2026-04-07T07:30:51+08:00 daily https://www.pharmasources.com/industryinsights/mylan-adds-to-growing-oncology-portfolio-300456.html 0.6 2026-08-03T16:53:16+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-enrolled-in-cavion-multi-c-300457.html 0.6 2026-08-06T11:43:39+08:00 daily https://www.pharmasources.com/industryinsights/exactechs-vitamin-e-acetabular-polyethyl-300458.html 0.6 2026-06-29T13:25:01+08:00 daily https://www.pharmasources.com/industryinsights/biotechnology-company-epigentek-backs-ne-300459.html 0.6 2026-06-29T00:02:55+08:00 daily https://www.pharmasources.com/industryinsights/sold-out-broadway-belts-for-pff-raises-r-300460.html 0.6 2026-07-17T22:50:39+08:00 daily https://www.pharmasources.com/industryinsights/micell-technologies-announces-expanded-p-300461.html 0.6 2026-05-07T19:46:06+08:00 daily https://www.pharmasources.com/industryinsights/akonni-biosystems-announces-strategic-pa-300462.html 0.6 2026-08-08T02:48:32+08:00 daily https://www.pharmasources.com/industryinsights/docdoc-raises-us545-million-to-boost-pat-300463.html 0.6 2026-07-01T18:12:18+08:00 daily https://www.pharmasources.com/industryinsights/fdi-global-survey-shows-children-are-not-300464.html 0.6 2026-03-17T20:43:11+08:00 daily https://www.pharmasources.com/industryinsights/quanterix-corporation-and-destina-genomi-300465.html 0.6 2026-02-28T13:33:20+08:00 daily https://www.pharmasources.com/industryinsights/biocodex-microbiota-foundation-awards-gr-300466.html 0.6 2026-06-09T22:44:56+08:00 daily https://www.pharmasources.com/industryinsights/us-patent-and-trademark-office-awards-bi-300467.html 0.6 2026-06-13T03:06:22+08:00 daily https://www.pharmasources.com/industryinsights/monsanto-and-pairwise-announce-rd-collab-300468.html 0.6 2025-11-27T04:58:59+08:00 daily https://www.pharmasources.com/industryinsights/national-research-council-contribution-p-300469.html 0.6 2026-06-19T19:10:50+08:00 daily https://www.pharmasources.com/industryinsights/dova-pharma-inks-distribution-pact-with--300470.html 0.6 2026-02-28T21:31:39+08:00 daily https://www.pharmasources.com/industryinsights/evolva-provides-2017-financial-results-a-300471.html 0.6 2025-11-27T05:01:05+08:00 daily https://www.pharmasources.com/industryinsights/new-alzheimers-association-report-reveal-300472.html 0.6 2025-12-28T13:59:43+08:00 daily https://www.pharmasources.com/industryinsights/harvard-bioengineers-biomaterial-based-c-300473.html 0.6 2026-03-21T22:28:32+08:00 daily https://www.pharmasources.com/industryinsights/oxford-nanopore-announces-100-million-14-300474.html 0.6 2026-07-06T23:57:33+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-halts-disease-in-squamo-300475.html 0.6 2026-04-06T10:11:46+08:00 daily https://www.pharmasources.com/industryinsights/gsk-welcomes-brexit-transition-deal-but--300476.html 0.6 2026-03-26T20:50:43+08:00 daily https://www.pharmasources.com/industryinsights/japan-donates-15-m-for-healthcare-servic-300477.html 0.6 2025-11-27T05:02:07+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-rare-eye-disease-drug-300478.html 0.6 2026-08-08T00:11:01+08:00 daily https://www.pharmasources.com/industryinsights/real-world-data-back-sanofis-toujeo-for--300479.html 0.6 2026-07-18T13:55:30+08:00 daily https://www.pharmasources.com/industryinsights/heron-soars-after-its-painkiller-agent-r-300480.html 0.6 2026-06-12T14:25:37+08:00 daily https://www.pharmasources.com/industryinsights/novartis-steps-into-the-medical-marijuan-300481.html 0.6 2026-07-31T15:19:09+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-eylea-smashes-phase-3-trial-g-300482.html 0.6 2026-04-22T14:51:01+08:00 daily https://www.pharmasources.com/industryinsights/research-connects-stem-cell-therapy-with-300483.html 0.6 2026-08-05T19:44:08+08:00 daily https://www.pharmasources.com/industryinsights/ntu-launches-nationwide-research-for-lun-300484.html 0.6 2026-06-08T01:53:01+08:00 daily https://www.pharmasources.com/industryinsights/proteomics-launches-diagnostic-test-lead-300485.html 0.6 2026-07-07T19:29:39+08:00 daily https://www.pharmasources.com/industryinsights/docdoc-raises-545-m-for-product-scaling-300486.html 0.6 2026-03-17T23:17:16+08:00 daily https://www.pharmasources.com/industryinsights/usfda-grants-priority-to-xtandis-snda-300487.html 0.6 2026-07-15T17:07:41+08:00 daily https://www.pharmasources.com/industryinsights/tissuegene-changes-name-to-kolon-tissueg-300488.html 0.6 2026-03-01T06:41:06+08:00 daily https://www.pharmasources.com/industryinsights/single-steroid-bronchodilator-treatment--300489.html 0.6 2026-08-08T12:50:29+08:00 daily https://www.pharmasources.com/industryinsights/mle490-reduces-the-number-and-severity-o-300490.html 0.6 2026-06-13T07:07:17+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-helping-people-do-more-f-300491.html 0.6 2026-06-16T19:08:44+08:00 daily https://www.pharmasources.com/industryinsights/celgene-partners-with-prothena-therapeut-300492.html 0.6 2025-11-27T05:21:20+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-gains-another-fda-appro-300493.html 0.6 2025-11-27T05:22:35+08:00 daily https://www.pharmasources.com/industryinsights/tcr2-therapeutics-snags-125-million-to-e-300494.html 0.6 2026-06-24T16:04:32+08:00 daily https://www.pharmasources.com/industryinsights/is-there-a-biotech-bubble-brewing-in-bos-300495.html 0.6 2026-06-23T22:17:17+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-is-taking-a-tough-approa-300496.html 0.6 2026-05-03T05:25:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-genentechs-lucentis-ranibiz-300497.html 0.6 2026-07-04T20:27:03+08:00 daily https://www.pharmasources.com/industryinsights/long-term-ppi-use-does-not-increase-hip--300498.html 0.6 2026-02-28T15:31:13+08:00 daily https://www.pharmasources.com/industryinsights/independent-study-demonstrates-significa-300499.html 0.6 2026-03-01T02:03:07+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-announces-agreement-to-300500.html 0.6 2026-08-07T11:28:45+08:00 daily https://www.pharmasources.com/industryinsights/saladax-receives-approval-to-sell-a-new--300501.html 0.6 2026-03-30T15:54:51+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-the-international-myeloma-fou-300502.html 0.6 2026-03-24T01:48:19+08:00 daily https://www.pharmasources.com/industryinsights/amisulpride-reduces-post-operative-nause-300503.html 0.6 2026-04-28T16:59:38+08:00 daily https://www.pharmasources.com/industryinsights/childrens-hospital-los-angeles-treats-fi-300504.html 0.6 2026-03-20T06:13:56+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-us-fda-approval-of--300505.html 0.6 2026-08-04T10:37:41+08:00 daily https://www.pharmasources.com/industryinsights/semaglutide-may-help-people-with-obesity-300506.html 0.6 2026-04-12T19:48:29+08:00 daily https://www.pharmasources.com/industryinsights/global-cardiovascular-drugs-markets-to-2-300507.html 0.6 2026-06-15T01:58:12+08:00 daily https://www.pharmasources.com/industryinsights/tamoxifen-and-raloxifene-slow-down-the-p-300508.html 0.6 2026-03-09T06:27:35+08:00 daily https://www.pharmasources.com/industryinsights/global-rheumatoid-arthritis-drugs-market-300509.html 0.6 2026-05-03T20:37:09+08:00 daily https://www.pharmasources.com/industryinsights/global-cervical-cancer-diagnostics-pap-t-300510.html 0.6 2026-01-11T01:26:05+08:00 daily https://www.pharmasources.com/industryinsights/eleven-biotherapeutics-announces-pricing-300511.html 0.6 2026-06-15T07:12:54+08:00 daily https://www.pharmasources.com/industryinsights/tcr2-therapeutics-raises-125-million-in--300512.html 0.6 2026-04-23T15:35:31+08:00 daily https://www.pharmasources.com/industryinsights/acoustic-cluster-therapy-drives-drug-the-300513.html 0.6 2025-11-27T05:35:09+08:00 daily https://www.pharmasources.com/industryinsights/longhorn-vaccines-and-diagnostics-llc-re-300514.html 0.6 2026-04-28T09:12:40+08:00 daily https://www.pharmasources.com/industryinsights/cantel-medical-acquires-aexis-medical-300515.html 0.6 2026-05-02T16:19:11+08:00 daily https://www.pharmasources.com/industryinsights/aahrpp-accredits-research-organizations--300516.html 0.6 2026-05-01T11:16:26+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-install-industrys-larg-300517.html 0.6 2026-08-02T18:34:37+08:00 daily https://www.pharmasources.com/industryinsights/celgene-pursues-neuro-breakthrough-with--300518.html 0.6 2026-07-02T14:35:18+08:00 daily https://www.pharmasources.com/industryinsights/nhs-and-digital-health-firms-must-improv-300519.html 0.6 2026-06-14T23:29:39+08:00 daily https://www.pharmasources.com/industryinsights/metformin-lowers-risk-of-late-miscarriag-300520.html 0.6 2026-04-18T04:00:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-links-with-nhs-cancer-vanguard--300521.html 0.6 2026-07-10T05:08:09+08:00 daily https://www.pharmasources.com/industryinsights/charity-forms-alzheimers-disease-taskfor-300522.html 0.6 2026-04-19T23:57:27+08:00 daily https://www.pharmasources.com/industryinsights/taiwan-china-promotes-biomedical-industr-300523.html 0.6 2026-04-06T23:07:28+08:00 daily https://www.pharmasources.com/industryinsights/skin-conditions-cost-nhs-723m-a-year-300524.html 0.6 2026-08-06T02:08:22+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-rare-eye-disease-drug-300525.html 0.6 2026-04-13T17:52:33+08:00 daily https://www.pharmasources.com/industryinsights/novavax-details-pre-commercialization-ac-300526.html 0.6 2026-03-18T20:27:46+08:00 daily https://www.pharmasources.com/industryinsights/agendia-announces-ce-mark-for-ngs-based--300527.html 0.6 2026-06-08T21:43:48+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-cfo-dominic-caruso-to-re-300528.html 0.6 2026-05-30T00:19:07+08:00 daily https://www.pharmasources.com/industryinsights/remarkable-achievements-promising-future-300529.html 0.6 2026-06-26T13:22:02+08:00 daily https://www.pharmasources.com/industryinsights/multinational-enterprises-occupy-the-mar-300530.html 0.6 2026-06-27T01:22:05+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-install-largest-csr-di-300531.html 0.6 2026-07-19T20:04:51+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-alnylam-team-up-to-tackle--300532.html 0.6 2026-08-04T10:55:23+08:00 daily https://www.pharmasources.com/industryinsights/poor-mid-stage-results-sink-abbvies-plan-300533.html 0.6 2026-02-09T05:10:32+08:00 daily https://www.pharmasources.com/industryinsights/array-biopharma-touts-phase-iii-results--300534.html 0.6 2026-07-18T21:12:20+08:00 daily https://www.pharmasources.com/industryinsights/gsk-is-now-favorite-to-acquire-pfizers-c-300535.html 0.6 2026-01-30T19:20:48+08:00 daily https://www.pharmasources.com/industryinsights/rheos-medicines-launches-with-60-million-300536.html 0.6 2026-03-29T03:49:35+08:00 daily https://www.pharmasources.com/industryinsights/arena-pharma-raising-352-million-followi-300537.html 0.6 2026-04-17T08:16:59+08:00 daily https://www.pharmasources.com/industryinsights/oxford-nanopore-raises-140-m-led-by-asia-300538.html 0.6 2026-07-04T05:59:07+08:00 daily https://www.pharmasources.com/industryinsights/orthofix-receives-fda-510k-clearance-of--300539.html 0.6 2026-02-28T19:33:47+08:00 daily https://www.pharmasources.com/industryinsights/singapore-a-strong-growing-healthcare-in-300540.html 0.6 2026-08-03T12:58:03+08:00 daily https://www.pharmasources.com/industryinsights/takeda-announces-publication-of-final-da-300541.html 0.6 2026-06-05T20:12:39+08:00 daily https://www.pharmasources.com/industryinsights/respiratory-motion-inc-is-excited-to-ann-300542.html 0.6 2026-07-06T22:40:58+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-receives-orphan-drug-designati-300543.html 0.6 2026-06-08T03:00:37+08:00 daily https://www.pharmasources.com/industryinsights/allergan-launches-ozurdex-in-china-300544.html 0.6 2026-07-19T02:57:21+08:00 daily https://www.pharmasources.com/industryinsights/midwest-healthcare-companies-raise-a-rec-300545.html 0.6 2026-04-15T21:46:27+08:00 daily https://www.pharmasources.com/industryinsights/teva-canada-announces-the-launch-of-c-ac-300546.html 0.6 2026-07-02T16:04:02+08:00 daily https://www.pharmasources.com/industryinsights/human-xtensions-receives-fda-clearance-f-300547.html 0.6 2026-04-26T20:27:59+08:00 daily https://www.pharmasources.com/industryinsights/cronos-group-inc-announces-100-million-b-300548.html 0.6 2026-06-24T02:03:12+08:00 daily https://www.pharmasources.com/industryinsights/us-scientists-uncover-new-strategy-for-s-300549.html 0.6 2026-05-08T14:21:04+08:00 daily https://www.pharmasources.com/industryinsights/neogen-reports-third-quarter-results-300550.html 0.6 2026-04-18T07:14:56+08:00 daily https://www.pharmasources.com/industryinsights/ozurdexr-dexamethasone-07mg-now-availabl-300551.html 0.6 2026-07-14T19:35:28+08:00 daily https://www.pharmasources.com/industryinsights/pace-of-pharmaceutical-innovation-accele-300552.html 0.6 2026-06-24T17:37:45+08:00 daily https://www.pharmasources.com/industryinsights/leading-us-artificial-intelligence-compa-300553.html 0.6 2026-07-26T07:14:19+08:00 daily https://www.pharmasources.com/industryinsights/cphi-to-hold-fiscal-year-2017-earnings-c-300554.html 0.6 2026-06-24T14:36:37+08:00 daily https://www.pharmasources.com/industryinsights/nejm-publishes-venetoclaxrituximab-data-300555.html 0.6 2026-08-07T05:32:45+08:00 daily https://www.pharmasources.com/industryinsights/psoriasis-patients-get-nhs-access-to-leo-300556.html 0.6 2026-08-09T03:56:16+08:00 daily https://www.pharmasources.com/industryinsights/us-green-lights-new-biologic-for-psorias-300557.html 0.6 2026-04-06T17:07:40+08:00 daily https://www.pharmasources.com/industryinsights/gsk-trials-benlystarituximab-combo-for-l-300558.html 0.6 2026-08-09T21:40:49+08:00 daily https://www.pharmasources.com/industryinsights/promising-drug-for-hormone-therapy-resis-300559.html 0.6 2026-08-07T03:58:59+08:00 daily https://www.pharmasources.com/industryinsights/bayer-monsanto-deal-one-step-closer-afte-300560.html 0.6 2026-08-07T03:48:45+08:00 daily https://www.pharmasources.com/industryinsights/brain-trauma-in-children-linked-to-incre-300561.html 0.6 2026-08-08T22:10:25+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-imf-collaborate-to-manage-multipl-300562.html 0.6 2026-08-07T04:07:30+08:00 daily https://www.pharmasources.com/industryinsights/nihr-launches-new-national-standards-for-300563.html 0.6 2026-08-07T03:24:31+08:00 daily https://www.pharmasources.com/industryinsights/iran-mauritania-sign-mou-for-healthcare-300564.html 0.6 2026-08-07T02:52:04+08:00 daily https://www.pharmasources.com/industryinsights/flight-simulator-for-brain-thrills-neuro-300565.html 0.6 2026-08-07T02:42:56+08:00 daily https://www.pharmasources.com/industryinsights/professional-pharmaceutical-conferences--300566.html 0.6 2026-08-07T02:33:46+08:00 daily https://www.pharmasources.com/industryinsights/lippo-group-to-focus-on-healthcare-in-in-300567.html 0.6 2026-08-07T02:31:02+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-shares-fall-nearly-12-percent-af-300568.html 0.6 2026-08-07T01:14:04+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-hits-mark-in-squamous-n-300569.html 0.6 2025-12-08T03:49:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sun-pharmas-ilumya-for-trea-300570.html 0.6 2026-08-07T01:27:41+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-seen-as-favourite-to-buy-300571.html 0.6 2026-08-07T01:39:29+08:00 daily https://www.pharmasources.com/industryinsights/us-house-passes-bill-giving-patients-rig-300572.html 0.6 2026-08-07T11:47:29+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-rituxan-subcutane-300573.html 0.6 2026-08-07T12:11:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-drug-tasigna-approved-by-fda-to-300574.html 0.6 2026-08-07T13:18:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-published-multiple-sclerosis-tr-300575.html 0.6 2026-06-04T15:16:59+08:00 daily https://www.pharmasources.com/industryinsights/gsk-walks-away-from-acquiring-pfizer-con-300576.html 0.6 2026-08-07T00:33:14+08:00 daily https://www.pharmasources.com/industryinsights/akebia-announces-85m-public-offering-300577.html 0.6 2026-08-09T02:33:05+08:00 daily https://www.pharmasources.com/industryinsights/german-biotech-morphosys-seeks-nasdaq-li-300578.html 0.6 2025-11-30T11:10:45+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-commissioner-scott-go-300579.html 0.6 2026-06-16T02:58:58+08:00 daily https://www.pharmasources.com/industryinsights/csl-behring-announces-first-patient-enro-300580.html 0.6 2026-07-05T23:00:52+08:00 daily https://www.pharmasources.com/industryinsights/canon-medical-systems-premium-ultrasound-300581.html 0.6 2026-07-04T14:08:12+08:00 daily https://www.pharmasources.com/industryinsights/cbt-pharmaceuticals-to-grow-immuno-oncol-300582.html 0.6 2026-08-07T20:34:03+08:00 daily https://www.pharmasources.com/industryinsights/anticancer-agent-lenvima-approved-for-ad-300583.html 0.6 2026-08-07T23:01:10+08:00 daily https://www.pharmasources.com/industryinsights/auris-health-unveils-the-fda-cleared-mon-300584.html 0.6 2026-06-01T02:21:09+08:00 daily https://www.pharmasources.com/industryinsights/caris-life-sciences-announces-published--300585.html 0.6 2026-03-20T17:20:54+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-reports-top-line-results-from-a-s-300586.html 0.6 2026-07-13T11:58:54+08:00 daily https://www.pharmasources.com/industryinsights/philips-provides-university-of-ottawa-he-300587.html 0.6 2026-07-07T13:33:53+08:00 daily https://www.pharmasources.com/industryinsights/global-influenza-therapeutics-market-rep-300588.html 0.6 2026-08-08T00:42:14+08:00 daily https://www.pharmasources.com/industryinsights/global-respiratory-tract-infection-treat-300589.html 0.6 2026-06-26T19:55:59+08:00 daily https://www.pharmasources.com/industryinsights/2017-2025-global-bio-mems-market-size-ma-300590.html 0.6 2026-06-21T17:07:31+08:00 daily https://www.pharmasources.com/industryinsights/lamea-smart-insulin-pens-market-2017-202-300591.html 0.6 2026-06-15T12:29:38+08:00 daily https://www.pharmasources.com/industryinsights/north-america-vascular-graft-market-anal-300592.html 0.6 2026-06-21T07:28:42+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-the-launch-of-a-generic-v-300593.html 0.6 2026-07-07T02:45:03+08:00 daily https://www.pharmasources.com/industryinsights/global-transcatheter-heart-valves-market-300594.html 0.6 2026-04-07T08:54:51+08:00 daily https://www.pharmasources.com/industryinsights/big-events-on-pharmaceuticals-during-npc-300595.html 0.6 2026-06-24T00:58:44+08:00 daily https://www.pharmasources.com/industryinsights/2017-2025-global-cell-free-protein-expre-300596.html 0.6 2025-12-29T09:02:24+08:00 daily https://www.pharmasources.com/industryinsights/nuvo-pharmaceuticals-announces-2017-four-300597.html 0.6 2026-03-30T19:42:19+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-technology-again-wins-world-clas-300598.html 0.6 2026-08-04T02:56:15+08:00 daily https://www.pharmasources.com/industryinsights/world-tb-day-2018-us-food-and-drug-admin-300599.html 0.6 2026-05-02T23:43:57+08:00 daily https://www.pharmasources.com/industryinsights/quorum-technologies-inc-acquires-volocit-300600.html 0.6 2026-05-07T23:00:59+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-azs-potential-blockbuster-hy-300601.html 0.6 2026-05-01T12:26:27+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-shares-tank-after-cancer-hopeful-300602.html 0.6 2026-04-10T10:31:32+08:00 daily https://www.pharmasources.com/industryinsights/amazon-hires-former-fda-data-guru-to-sec-300603.html 0.6 2026-03-17T19:30:33+08:00 daily https://www.pharmasources.com/industryinsights/tata-chemicals-launches-medikarb-300604.html 0.6 2026-04-28T11:33:52+08:00 daily https://www.pharmasources.com/industryinsights/cytoreason-uses-artificial-intelligence--300605.html 0.6 2026-03-28T11:19:42+08:00 daily https://www.pharmasources.com/industryinsights/legend-dies-hawkings-gone-but-als-drug-d-300606.html 0.6 2026-08-07T01:18:51+08:00 daily https://www.pharmasources.com/industryinsights/li-ka-shing-announced-his-retirement-but-300607.html 0.6 2026-07-28T03:20:01+08:00 daily https://www.pharmasources.com/industryinsights/new-als-gene-discovered-kif5a-300608.html 0.6 2026-08-06T18:09:22+08:00 daily https://www.pharmasources.com/industryinsights/oncology-drug-market-a-spotlight-on-the--300609.html 0.6 2026-04-27T11:14:06+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-discovery-for-accurate-diag-300610.html 0.6 2026-06-18T10:11:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-harvard-team-up-for-cancer-immu-300611.html 0.6 2026-02-27T08:10:48+08:00 daily https://www.pharmasources.com/industryinsights/two-taiwan-china-researchers-win-asian-r-300612.html 0.6 2026-01-11T20:09:19+08:00 daily https://www.pharmasources.com/industryinsights/programming-dna-to-deliver-cancer-drugs-300613.html 0.6 2026-08-05T07:34:11+08:00 daily https://www.pharmasources.com/industryinsights/integrated-imaging-method-offers-unique--300614.html 0.6 2026-08-07T11:12:13+08:00 daily https://www.pharmasources.com/industryinsights/semathera-announces-licensing-deal-for-c-300615.html 0.6 2025-11-30T10:31:16+08:00 daily https://www.pharmasources.com/industryinsights/insilico-medicine-starts-asias-first-ai--300616.html 0.6 2026-07-20T02:58:44+08:00 daily https://www.pharmasources.com/industryinsights/quorum-tech-acquires-volocity-imaging-pl-300617.html 0.6 2026-08-04T00:52:48+08:00 daily https://www.pharmasources.com/industryinsights/dpp-4-inhibitors-may-be-linked-to-inflam-300618.html 0.6 2026-08-03T22:51:57+08:00 daily https://www.pharmasources.com/industryinsights/acg-group-worlds-only-market-ready-track-300619.html 0.6 2026-08-07T01:19:40+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-late-stage-trial-data-shows-c-300620.html 0.6 2026-08-07T02:21:51+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-tech-300621.html 0.6 2026-08-06T20:05:57+08:00 daily https://www.pharmasources.com/industryinsights/immunogen-stock-climbs-on-positive-ovari-300622.html 0.6 2026-08-07T02:30:58+08:00 daily https://www.pharmasources.com/industryinsights/ablynx-drug-fails-again-in-mid-stage-tri-300623.html 0.6 2026-08-07T02:36:35+08:00 daily https://www.pharmasources.com/industryinsights/allecra-therapeutics-new-antibiotic-show-300624.html 0.6 2026-03-17T22:30:51+08:00 daily https://www.pharmasources.com/industryinsights/forma-therapeutics-collaborates-with-arp-300625.html 0.6 2026-08-02T10:47:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-510k-clears-ortho-connect-middleware-300626.html 0.6 2026-08-08T15:14:23+08:00 daily https://www.pharmasources.com/industryinsights/gt-biopharma-inc-announces-additional-po-300627.html 0.6 2026-06-08T18:03:46+08:00 daily https://www.pharmasources.com/industryinsights/palatin-technologies-announces-submissio-300628.html 0.6 2026-08-06T17:55:46+08:00 daily https://www.pharmasources.com/industryinsights/bioness-receives-fda-clearance-for-mybio-300629.html 0.6 2026-08-02T16:28:03+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-laboratories-announces-ref-300630.html 0.6 2026-08-08T14:21:25+08:00 daily https://www.pharmasources.com/industryinsights/newly-published-data-demonstrates-85-era-300631.html 0.6 2026-07-30T01:54:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-inclusion-of-data-from-safe-300632.html 0.6 2026-08-07T01:13:53+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-and-hitachi-to-use-ai-to-hast-300633.html 0.6 2026-08-05T17:44:50+08:00 daily https://www.pharmasources.com/industryinsights/does-genome-sequencing-increase-downstre-300634.html 0.6 2026-07-30T05:27:49+08:00 daily https://www.pharmasources.com/industryinsights/gsk-passes-up-pfizer-consumer-buy-shares-300635.html 0.6 2026-08-10T01:52:01+08:00 daily https://www.pharmasources.com/industryinsights/jeremy-hunt-calls-for-10-year-nhs-budget-300636.html 0.6 2026-08-07T20:36:54+08:00 daily https://www.pharmasources.com/industryinsights/injectable-mdp-hydrogel-may-help-heal-di-300637.html 0.6 2025-11-30T10:43:34+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-and-hitachi-to-use-ai-to-hast-300638.html 0.6 2026-02-15T13:39:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-adcetris-for-sta-300639.html 0.6 2026-07-09T02:03:51+08:00 daily https://www.pharmasources.com/industryinsights/industry-welcomes-progress-on-brexit-300640.html 0.6 2026-03-22T00:13:28+08:00 daily https://www.pharmasources.com/industryinsights/shire-links-with-nanomedsyn-to-work-on-n-300641.html 0.6 2026-03-24T18:17:58+08:00 daily https://www.pharmasources.com/industryinsights/eu-clears-first-allogeneic-stem-cell-the-300642.html 0.6 2026-03-19T07:12:30+08:00 daily https://www.pharmasources.com/industryinsights/six-new-therapies-backed-for-eu-approval-300643.html 0.6 2026-07-06T01:44:31+08:00 daily https://www.pharmasources.com/industryinsights/edelfosine-prevents-breast-cancer-cells--300644.html 0.6 2026-04-02T06:23:42+08:00 daily https://www.pharmasources.com/industryinsights/novel-methodology-increases-resolution-i-300645.html 0.6 2026-07-08T05:40:43+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-gain-breakthrough-thera-300646.html 0.6 2026-04-26T10:45:48+08:00 daily https://www.pharmasources.com/industryinsights/t-vec-treatment-shows-promise-for-treati-300647.html 0.6 2026-03-18T01:41:09+08:00 daily https://www.pharmasources.com/industryinsights/ablynxs-vobarilizumab-trial-fails-and-se-300648.html 0.6 2026-03-23T21:09:26+08:00 daily https://www.pharmasources.com/industryinsights/roche-says-tecentriq-avastin-chemotherap-300649.html 0.6 2025-12-07T14:59:51+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-publishes-update-coverage-300650.html 0.6 2026-06-08T19:31:33+08:00 daily https://www.pharmasources.com/industryinsights/global-biologics-market-to-surpass-300-b-300651.html 0.6 2026-01-30T19:13:36+08:00 daily https://www.pharmasources.com/industryinsights/3sbio-unveils-2017-annual-results-revenu-300652.html 0.6 2026-07-23T16:37:02+08:00 daily https://www.pharmasources.com/industryinsights/philips-enhances-point-of-care-ultrasoun-300653.html 0.6 2026-03-31T18:01:39+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-lodosyn-tabs-in-t-300654.html 0.6 2026-08-07T20:06:16+08:00 daily https://www.pharmasources.com/industryinsights/cipla-launches-authorised-generic-of-alo-300655.html 0.6 2025-12-19T23:28:31+08:00 daily https://www.pharmasources.com/industryinsights/after-spurning-pfizer-glaxosmithkline-cu-300656.html 0.6 2026-08-07T07:41:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bristol-myers-combo-applicat-300657.html 0.6 2026-08-09T00:14:19+08:00 daily https://www.pharmasources.com/industryinsights/imprimis-jumps-secures-patent-for-non-op-300658.html 0.6 2026-08-05T21:23:40+08:00 daily https://www.pharmasources.com/industryinsights/clot-busting-stroke-medicine-mired-in-co-300659.html 0.6 2026-03-28T12:09:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kicks-alcon-spinoff-decision-do-300660.html 0.6 2026-07-23T10:44:22+08:00 daily https://www.pharmasources.com/industryinsights/anaptysbios-mid-stage-peanut-allergy-dat-300661.html 0.6 2026-03-24T21:23:45+08:00 daily https://www.pharmasources.com/industryinsights/pdl-biopharma-buy-or-sell-300662.html 0.6 2026-01-22T15:33:40+08:00 daily https://www.pharmasources.com/industryinsights/after-rova-t-failure-a-look-at-abbvies-p-300663.html 0.6 2026-03-17T22:22:21+08:00 daily https://www.pharmasources.com/industryinsights/arrowhead-begins-dosing-in-phase-12-stud-300664.html 0.6 2026-04-05T15:07:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-toujeo-max-solostar-300665.html 0.6 2026-01-10T14:54:31+08:00 daily https://www.pharmasources.com/industryinsights/intact-vascular-welcomes-toba-btk-trial--300666.html 0.6 2026-01-20T10:36:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-innovations-on-hologics-300667.html 0.6 2026-03-20T04:51:50+08:00 daily https://www.pharmasources.com/industryinsights/inflammation-testing-prompts-care-change-300668.html 0.6 2026-06-04T22:07:22+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-fast-track-designation-fo-300669.html 0.6 2026-03-17T20:54:27+08:00 daily https://www.pharmasources.com/industryinsights/global-dendritic-cell-cancer-vaccine-mar-300670.html 0.6 2026-08-05T20:36:35+08:00 daily https://www.pharmasources.com/industryinsights/singlera-genomics-raises-60-million-in-s-300671.html 0.6 2026-01-31T09:38:37+08:00 daily https://www.pharmasources.com/industryinsights/survey-finds-reducing-stigma-attributed--300672.html 0.6 2026-08-06T11:31:56+08:00 daily https://www.pharmasources.com/industryinsights/adagene-raises-50-million-in-series-c-fu-300673.html 0.6 2026-04-19T01:58:22+08:00 daily https://www.pharmasources.com/industryinsights/breckenridge-pharmaceutical-inc-announce-300674.html 0.6 2026-03-13T16:07:16+08:00 daily https://www.pharmasources.com/industryinsights/new-survey-reveals-many-misconceptions-e-300675.html 0.6 2026-03-25T16:24:15+08:00 daily https://www.pharmasources.com/industryinsights/hanmi-pharmaceutical-completes-innovatio-300676.html 0.6 2026-02-11T21:32:35+08:00 daily https://www.pharmasources.com/industryinsights/leaf-healthcare-earns-frost-sullivans-te-300677.html 0.6 2026-04-05T15:59:33+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-enters-into-amendment-to-amalgam-300678.html 0.6 2026-04-09T07:31:45+08:00 daily https://www.pharmasources.com/industryinsights/ubc-thanks-to-a-generous-gift-of-15-bill-300679.html 0.6 2026-03-24T21:05:30+08:00 daily https://www.pharmasources.com/industryinsights/adagene-raises-50-million-in-series-c-fu-300680.html 0.6 2026-03-24T22:50:26+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-pay-13bn-for-novartis-stake-in-ot-300681.html 0.6 2026-08-03T11:47:10+08:00 daily https://www.pharmasources.com/industryinsights/nhs-financial-state-remains-perilous-con-300682.html 0.6 2026-03-23T19:33:26+08:00 daily https://www.pharmasources.com/industryinsights/ablynx-vobarilizumab-fails-in-lupus-tria-300683.html 0.6 2026-04-02T00:45:59+08:00 daily https://www.pharmasources.com/industryinsights/new-organ-discovery-has-implications-for-300684.html 0.6 2026-04-05T21:59:56+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-pays-out-over-3m-after-its-testos-300685.html 0.6 2026-07-19T02:25:41+08:00 daily https://www.pharmasources.com/industryinsights/the-big-tease-takeda-considers-buying-sh-300686.html 0.6 2026-08-08T05:55:51+08:00 daily https://www.pharmasources.com/industryinsights/five-deaths-in-genentechs-hemlibra-patie-300687.html 0.6 2026-05-01T02:04:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-gives-mylans-new-hiv-drug-a-thumbs-u-300688.html 0.6 2026-07-26T17:04:38+08:00 daily https://www.pharmasources.com/industryinsights/tempest-therapeutics-leaps-into-ido-deve-300689.html 0.6 2026-08-09T08:49:25+08:00 daily https://www.pharmasources.com/industryinsights/homology-medicines-snags-144-million-ipo-300690.html 0.6 2026-08-09T23:08:48+08:00 daily https://www.pharmasources.com/industryinsights/celgene-and-bluebird-bio-team-up-in-new--300691.html 0.6 2026-03-17T21:21:51+08:00 daily https://www.pharmasources.com/industryinsights/with-cash-in-hand-novartis-could-seek-de-300692.html 0.6 2026-08-08T12:02:26+08:00 daily https://www.pharmasources.com/industryinsights/mimedx-enrolls-first-patient-in-its-phas-300693.html 0.6 2026-06-21T14:57:09+08:00 daily https://www.pharmasources.com/industryinsights/european-bone-densitometers-market-repor-300694.html 0.6 2026-01-04T09:26:01+08:00 daily https://www.pharmasources.com/industryinsights/latest-trends-in-orphan-drug-pricing-and-300695.html 0.6 2026-03-23T16:46:38+08:00 daily https://www.pharmasources.com/industryinsights/apac-vascular-graft-market-report-2017-2-300696.html 0.6 2026-06-29T00:00:07+08:00 daily https://www.pharmasources.com/industryinsights/2018-global-electrocardiograph-ecg-marke-300697.html 0.6 2026-03-20T02:39:47+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-tops-the-pharmaceutical-inno-300698.html 0.6 2026-04-20T22:12:59+08:00 daily https://www.pharmasources.com/industryinsights/cignas-partnership-with-physicians-succe-300699.html 0.6 2026-03-19T22:53:44+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-announces-ema-validation-of-filing-300700.html 0.6 2026-07-20T14:28:59+08:00 daily https://www.pharmasources.com/industryinsights/abionic-successfully-raises-chf20-millio-300701.html 0.6 2026-04-18T04:38:01+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-biocon-receive-approvals-from--300702.html 0.6 2026-02-28T13:18:51+08:00 daily https://www.pharmasources.com/industryinsights/letsgetchecked-raises-12m-to-bring-perso-300703.html 0.6 2026-03-24T12:08:37+08:00 daily https://www.pharmasources.com/industryinsights/aranz-medical-launches-two-new-silhouett-300704.html 0.6 2026-01-31T11:14:27+08:00 daily https://www.pharmasources.com/industryinsights/sunquest-earns-frost-sullivans-company-o-300705.html 0.6 2026-04-29T16:21:19+08:00 daily https://www.pharmasources.com/industryinsights/lkk-health-products-group-infinitus-cons-300706.html 0.6 2026-08-06T02:14:36+08:00 daily https://www.pharmasources.com/industryinsights/novo-cleared-to-add-key-data-to-tresiba--300707.html 0.6 2026-07-06T16:56:45+08:00 daily https://www.pharmasources.com/industryinsights/mays-funding-pledge-could-be-a-radical-b-300708.html 0.6 2026-04-26T00:46:52+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-nhs-improvement-reveal-plans-300709.html 0.6 2026-07-05T04:45:06+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-green-light-for-ipsens-cometr-300710.html 0.6 2026-07-20T11:40:37+08:00 daily https://www.pharmasources.com/industryinsights/high-doses-of-favipiravir-may-be-effecti-300711.html 0.6 2026-07-02T08:21:34+08:00 daily https://www.pharmasources.com/industryinsights/nus-scientists-crack-mystery-of-flu-tran-300712.html 0.6 2026-07-05T03:42:36+08:00 daily https://www.pharmasources.com/industryinsights/singlera-genomics-raises-funds-worth-60m-300713.html 0.6 2025-11-30T12:09:45+08:00 daily https://www.pharmasources.com/industryinsights/biocon-gets-european-nod-for-its-insulin-300714.html 0.6 2026-06-21T14:43:03+08:00 daily https://www.pharmasources.com/industryinsights/merck-as-the-best-bioprocessing-supplier-300715.html 0.6 2026-08-07T05:05:49+08:00 daily https://www.pharmasources.com/industryinsights/analysts-question-takeda-shire-deal-spec-300716.html 0.6 2026-06-20T15:17:43+08:00 daily https://www.pharmasources.com/industryinsights/lawsuits-allege-safety-concern-over-nova-300717.html 0.6 2026-03-19T10:41:23+08:00 daily https://www.pharmasources.com/industryinsights/medicinovas-drug-flunks-phase-ii-trial-300718.html 0.6 2026-07-07T02:55:39+08:00 daily https://www.pharmasources.com/industryinsights/redx-pharma-cancer-trial-paused-serious--300719.html 0.6 2026-07-03T16:07:58+08:00 daily https://www.pharmasources.com/industryinsights/prometic-reports-positive-clinical-data--300720.html 0.6 2026-06-21T12:31:12+08:00 daily https://www.pharmasources.com/industryinsights/scholar-rock-granted-orphan-drug-designa-300721.html 0.6 2025-11-30T12:20:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-blincyto-for-tre-300722.html 0.6 2026-08-07T14:17:13+08:00 daily https://www.pharmasources.com/industryinsights/resmed-to-announce-third-quarter-fiscal--300723.html 0.6 2026-05-02T07:03:06+08:00 daily https://www.pharmasources.com/industryinsights/bioconsortia-continues-growth-and-succes-300724.html 0.6 2026-04-22T18:20:31+08:00 daily https://www.pharmasources.com/industryinsights/martin-pharmaceuticals-receives-fda-orph-300725.html 0.6 2026-03-17T22:14:56+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-positive-topline-result-300726.html 0.6 2026-04-08T13:21:13+08:00 daily https://www.pharmasources.com/industryinsights/spiriva-tiotropium-boehringer-ingelheim--300727.html 0.6 2026-07-20T00:44:37+08:00 daily https://www.pharmasources.com/industryinsights/natrecor-nesiritide-johnson-johnson-drug-300728.html 0.6 2026-03-27T23:10:22+08:00 daily https://www.pharmasources.com/industryinsights/breo-ellipta-glaxosmithklineinnoviva-dru-300729.html 0.6 2026-04-04T23:18:53+08:00 daily https://www.pharmasources.com/industryinsights/pulmatrix-announces-pricing-of-152-milli-300730.html 0.6 2026-06-08T19:51:26+08:00 daily https://www.pharmasources.com/industryinsights/global-metastatic-cancer-drug-market-dos-300731.html 0.6 2026-03-17T21:22:43+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-increases-footprint-in-bot-300732.html 0.6 2026-04-23T05:00:56+08:00 daily https://www.pharmasources.com/industryinsights/turkeyana-clinic-side-by-side-with-forbe-300733.html 0.6 2025-12-21T14:04:26+08:00 daily https://www.pharmasources.com/industryinsights/eternity-healthcare-inc-completes-tongre-300734.html 0.6 2026-08-03T12:50:36+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharma-a-healthy-thirty-percent-ann-300735.html 0.6 2026-07-19T19:06:03+08:00 daily https://www.pharmasources.com/industryinsights/new-data-boosts-roche-lung-cancer-combo-300736.html 0.6 2025-11-30T12:37:53+08:00 daily https://www.pharmasources.com/industryinsights/eu-ready-to-review-shires-lanadelumab-fo-300737.html 0.6 2025-12-02T22:44:19+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-review-sanofis-type-i-diabetes-th-300738.html 0.6 2026-02-15T13:36:56+08:00 daily https://www.pharmasources.com/industryinsights/hua-medicine-raises-1174-m-funding-300739.html 0.6 2025-12-29T01:55:25+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-backs-own-car-t-prospect-takes--300740.html 0.6 2026-07-21T10:45:45+08:00 daily https://www.pharmasources.com/industryinsights/teva-spared-payout-to-gsk-over-patent-in-300741.html 0.6 2026-03-31T02:49:20+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-bolsters-healthcare-with-two-bi-300742.html 0.6 2026-04-05T22:38:57+08:00 daily https://www.pharmasources.com/industryinsights/shires-investigational-hae-treatment-lan-300743.html 0.6 2026-06-27T00:31:47+08:00 daily https://www.pharmasources.com/industryinsights/ema-agrees-to-review-sanofis-filing-for--300744.html 0.6 2025-12-12T01:57:14+08:00 daily https://www.pharmasources.com/industryinsights/actinium-astellas-form-research-partners-300745.html 0.6 2026-08-08T17:20:43+08:00 daily https://www.pharmasources.com/industryinsights/eisai-nichi-iko-pharma-enters-strategic--300746.html 0.6 2026-08-06T19:18:32+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-roivant-collaborate-for-china-ri-300747.html 0.6 2026-06-30T09:06:58+08:00 daily https://www.pharmasources.com/industryinsights/a-simple-method-developed-for-3d-bio-fab-300748.html 0.6 2026-06-10T10:13:39+08:00 daily https://www.pharmasources.com/industryinsights/dongkoo-bio-signs-deal-to-sell-otc-prost-300749.html 0.6 2026-06-08T21:36:20+08:00 daily https://www.pharmasources.com/industryinsights/opioid-analgesics-reduce-the-use-of-anti-300750.html 0.6 2026-02-28T23:20:42+08:00 daily https://www.pharmasources.com/industryinsights/high-doses-of-favipiravir-may-be-effecti-300751.html 0.6 2026-07-16T10:51:01+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lokelma-receives-eu-approva-300752.html 0.6 2026-02-23T10:52:33+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-to-acquire-2-biotech-units-for--300753.html 0.6 2025-12-23T15:07:17+08:00 daily https://www.pharmasources.com/industryinsights/nus-researchers-develop-chip-for-faster--300754.html 0.6 2026-01-31T10:30:07+08:00 daily https://www.pharmasources.com/industryinsights/eagle-pharma-receives-new-patent-for-bio-300755.html 0.6 2026-07-18T00:16:06+08:00 daily https://www.pharmasources.com/industryinsights/ghit-grants-funds-for-malaria-vaccine-re-300756.html 0.6 2026-03-29T03:04:01+08:00 daily https://www.pharmasources.com/industryinsights/study-uncovers-new-findings-on-antimicro-300757.html 0.6 2026-02-25T13:49:14+08:00 daily https://www.pharmasources.com/industryinsights/test-for-antibiotic-associated-kidney-da-300758.html 0.6 2026-07-23T16:01:29+08:00 daily https://www.pharmasources.com/industryinsights/to-solve-the-urgent-need-import-of-anti--300759.html 0.6 2026-08-05T05:06:19+08:00 daily https://www.pharmasources.com/industryinsights/serious-disease-insurance-and-vat-reduct-300760.html 0.6 2026-08-07T19:01:00+08:00 daily https://www.pharmasources.com/industryinsights/nicotinamide-riboside-shows-promise-for--300761.html 0.6 2025-12-17T10:17:27+08:00 daily https://www.pharmasources.com/industryinsights/sorafenib-improves-progression-free-surv-300762.html 0.6 2026-03-28T22:29:44+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasuns-generic-ibuprofen-receiv-300763.html 0.6 2026-04-20T13:09:30+08:00 daily https://www.pharmasources.com/industryinsights/cmab-biopharma-raises-funds-worth-34-m-300764.html 0.6 2026-04-16T23:45:46+08:00 daily https://www.pharmasources.com/industryinsights/breckenridge-announces-approval-of-hep-b-300765.html 0.6 2026-08-07T00:42:32+08:00 daily https://www.pharmasources.com/industryinsights/esco-max-planck-cooperate-on-research-of-300766.html 0.6 2026-08-07T00:41:06+08:00 daily https://www.pharmasources.com/industryinsights/chrys-capital-to-buy-10-in-mankind-for-3-300767.html 0.6 2026-08-07T00:02:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-committee-votes-to-approve-lofexidin-300768.html 0.6 2026-08-06T23:55:42+08:00 daily https://www.pharmasources.com/industryinsights/europes-biggest-private-biotech-company--300769.html 0.6 2026-08-07T23:08:22+08:00 daily https://www.pharmasources.com/industryinsights/itri-teams-up-with-merck-for-drug-manufa-300770.html 0.6 2026-08-06T20:06:53+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-pharma-in-licenses-pws-candidate--300771.html 0.6 2026-08-06T22:53:23+08:00 daily https://www.pharmasources.com/industryinsights/agilent-tech-to-acquire-lasergen-for-105-300772.html 0.6 2026-03-21T22:14:27+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-alofisel-for-complex-periana-300773.html 0.6 2026-08-07T01:27:30+08:00 daily https://www.pharmasources.com/industryinsights/oestrogen-levels-do-not-rise-for-transge-300774.html 0.6 2026-08-07T01:19:43+08:00 daily https://www.pharmasources.com/industryinsights/taking-a-standard-prostate-cancer-drug-w-300775.html 0.6 2026-08-07T00:42:41+08:00 daily https://www.pharmasources.com/industryinsights/unity-biotechnology-looking-to-infuse-ne-300776.html 0.6 2026-08-07T01:19:36+08:00 daily https://www.pharmasources.com/industryinsights/takeda-ceo-discusses-potential-shire-dea-300777.html 0.6 2026-08-07T01:27:58+08:00 daily https://www.pharmasources.com/industryinsights/how-blockchain-might-be-used-by-biopharm-300778.html 0.6 2026-01-30T22:59:10+08:00 daily https://www.pharmasources.com/industryinsights/incyte-nosedives-drug-combo-fails-melano-300779.html 0.6 2026-07-23T11:40:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-clrs-for-two-celltrion-and-te-300780.html 0.6 2026-07-09T11:46:27+08:00 daily https://www.pharmasources.com/industryinsights/evaluating-risk-gilead-sciences-biogen-a-300781.html 0.6 2026-08-08T17:45:05+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-ties-up-sickle-cell-disease-300782.html 0.6 2025-12-19T09:24:27+08:00 daily https://www.pharmasources.com/industryinsights/incyte-and-merck-provide-update-on-phase-300783.html 0.6 2026-08-05T10:55:45+08:00 daily https://www.pharmasources.com/industryinsights/cipher-pharmaceuticals-acquires-exclusiv-300784.html 0.6 2026-03-17T23:02:32+08:00 daily https://www.pharmasources.com/industryinsights/alopexx-pharmaceuticals-f598-monoclonal--300785.html 0.6 2026-07-03T00:33:11+08:00 daily https://www.pharmasources.com/industryinsights/immunoprecise-acquires-modiquest-researc-300786.html 0.6 2026-08-05T20:35:10+08:00 daily https://www.pharmasources.com/industryinsights/mylan-strengthens-its-capital-structure--300787.html 0.6 2026-02-15T00:34:10+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-strikes-deal-blockbuster-humira-i-300788.html 0.6 2026-06-28T18:18:45+08:00 daily https://www.pharmasources.com/industryinsights/ferring-buys-rebiotix-acquires-phase-iii-300789.html 0.6 2026-07-14T03:25:16+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-ose-immunothera-300790.html 0.6 2026-04-21T03:59:03+08:00 daily https://www.pharmasources.com/industryinsights/cardiva-medical-announces-fda-approval-o-300791.html 0.6 2026-04-16T21:19:21+08:00 daily https://www.pharmasources.com/industryinsights/usfda-accepts-bla-for-moxetumomab-pasudo-300792.html 0.6 2026-04-12T18:23:36+08:00 daily https://www.pharmasources.com/industryinsights/ubiquigent-forma-therapeutics-collaborat-300793.html 0.6 2026-07-17T09:40:36+08:00 daily https://www.pharmasources.com/industryinsights/biogen-bioepis-resolve-dispute-over-humi-300794.html 0.6 2026-07-01T01:19:19+08:00 daily https://www.pharmasources.com/industryinsights/aleafia-steps-up-battle-against-opioid-c-300795.html 0.6 2026-04-07T20:05:34+08:00 daily https://www.pharmasources.com/industryinsights/feinstein-nih-launch-groundbreaking-clin-300796.html 0.6 2025-12-26T13:06:22+08:00 daily https://www.pharmasources.com/industryinsights/japans-healthcare-paradox---high-culture-300797.html 0.6 2026-07-04T07:15:59+08:00 daily https://www.pharmasources.com/industryinsights/cyient-to-collaborate-with-the-india2022-300798.html 0.6 2026-08-06T10:12:19+08:00 daily https://www.pharmasources.com/industryinsights/specialised-therapeutics-asia-initiates--300799.html 0.6 2026-06-22T08:28:57+08:00 daily https://www.pharmasources.com/industryinsights/roche-suffers-ocrevus-knockback-by-nice-300800.html 0.6 2026-07-10T22:05:35+08:00 daily https://www.pharmasources.com/industryinsights/jj-pays-out-37m-in-damages-over-claims-i-300801.html 0.6 2026-06-08T15:05:10+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-found-to-predict-onset-of-tb--300802.html 0.6 2026-01-31T01:55:15+08:00 daily https://www.pharmasources.com/industryinsights/two-drug-combination-proves-effective-fo-300803.html 0.6 2026-04-02T13:01:22+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-warning-letters-issued-by-fd-300804.html 0.6 2026-07-05T12:53:46+08:00 daily https://www.pharmasources.com/industryinsights/summary-of-warning-letters-issued-by-fda-300805.html 0.6 2026-07-06T11:45:37+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-eir-from-usfda-for-pitham-300806.html 0.6 2026-07-10T14:34:40+08:00 daily https://www.pharmasources.com/industryinsights/ferring-acquires-rebiotix-inc-300807.html 0.6 2026-03-12T15:17:45+08:00 daily https://www.pharmasources.com/industryinsights/feinstein-nih-launch-groundbreaking-clin-300808.html 0.6 2026-05-02T09:28:41+08:00 daily https://www.pharmasources.com/industryinsights/transformational-investment-boosts-human-300809.html 0.6 2026-02-28T19:33:12+08:00 daily https://www.pharmasources.com/industryinsights/aleafia-steps-up-battle-against-opioid-c-300810.html 0.6 2026-03-18T02:05:16+08:00 daily https://www.pharmasources.com/industryinsights/biogen-bioepis-resolve-dispute-over-humi-300811.html 0.6 2026-04-19T12:07:46+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-moms-brains-hard-wired-to-ga-300812.html 0.6 2026-04-07T09:51:23+08:00 daily https://www.pharmasources.com/industryinsights/livanova-completes-tandemlife-acquisitio-300813.html 0.6 2026-04-04T09:38:06+08:00 daily https://www.pharmasources.com/industryinsights/ubiquigent-forma-therapeutics-collaborat-300814.html 0.6 2026-07-19T08:43:52+08:00 daily https://www.pharmasources.com/industryinsights/australian-university-research-gives-hop-300815.html 0.6 2026-04-17T09:16:33+08:00 daily https://www.pharmasources.com/industryinsights/usfda-accepts-bla-for-moxetumomab-pasudo-300816.html 0.6 2026-05-11T07:23:37+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-oncology-drugs-receive-regu-300817.html 0.6 2026-08-08T13:22:07+08:00 daily https://www.pharmasources.com/industryinsights/trumps-latest-pick-for-a-top-healthcare--300818.html 0.6 2026-08-09T19:33:33+08:00 daily https://www.pharmasources.com/industryinsights/endreon-chairwoman-figures-provenge-grow-300819.html 0.6 2026-03-01T02:05:05+08:00 daily https://www.pharmasources.com/industryinsights/eating-pecans-may-cut-risk-of-cardiovasc-300820.html 0.6 2026-08-01T23:02:14+08:00 daily https://www.pharmasources.com/industryinsights/incyte-merck-provide-update-study-of-epa-300821.html 0.6 2026-04-06T22:54:30+08:00 daily https://www.pharmasources.com/industryinsights/forma-meets-objective-with-celgene-to-ad-300822.html 0.6 2026-04-28T02:54:56+08:00 daily https://www.pharmasources.com/industryinsights/ucb-acquires-element-genomics-300823.html 0.6 2026-04-13T09:50:06+08:00 daily https://www.pharmasources.com/industryinsights/lilly-sigilon-therapeutics-announce-coll-300824.html 0.6 2026-06-19T06:09:16+08:00 daily https://www.pharmasources.com/industryinsights/ferring-acquires-rebiotix-300825.html 0.6 2026-07-07T13:54:47+08:00 daily https://www.pharmasources.com/industryinsights/quralis-launches-with-seed-funding-from--300826.html 0.6 2025-11-06T20:40:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-european-medicines-agency-accept-reg-300827.html 0.6 2026-08-08T22:25:45+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-ose-immunotherapeut-300828.html 0.6 2026-08-07T15:11:24+08:00 daily https://www.pharmasources.com/industryinsights/terns-acquires-rights-to-develop-commerc-300829.html 0.6 2026-08-09T01:28:17+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-allogene-therapeutics-enter-into--300830.html 0.6 2026-08-09T20:11:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-b-300831.html 0.6 2026-05-02T22:02:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-ta-300832.html 0.6 2026-04-28T13:19:56+08:00 daily https://www.pharmasources.com/industryinsights/swift-biosciences-launches-unique-dual-i-300833.html 0.6 2026-04-19T22:36:38+08:00 daily https://www.pharmasources.com/industryinsights/if-you-purchased-solodyn-andor-its-gener-300834.html 0.6 2026-04-20T21:58:06+08:00 daily https://www.pharmasources.com/industryinsights/japans-healthcare-paradox---high-culture-300835.html 0.6 2026-02-03T10:24:52+08:00 daily https://www.pharmasources.com/industryinsights/amgens-blincyto-gets-us-approval-for-acu-300836.html 0.6 2026-08-04T07:02:50+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-trial-success-for-rare--300837.html 0.6 2026-06-27T15:11:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-astrazenecas-licensing-appli-300838.html 0.6 2026-06-22T11:15:01+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-review-sanofis-dupixent-drug-for--300839.html 0.6 2026-06-23T16:22:13+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-buyout-consumer-healthcare-busine-300840.html 0.6 2026-06-21T13:21:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-sigilon-to-collaborate-on-cell-300841.html 0.6 2026-03-26T01:10:05+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-allogene-therapeutics-enter-i-300842.html 0.6 2026-04-17T13:58:26+08:00 daily https://www.pharmasources.com/industryinsights/combining-tradition-with-modernity-bayer-300843.html 0.6 2026-04-26T00:09:00+08:00 daily https://www.pharmasources.com/industryinsights/researchers-propose-key-elements-of-anti-300844.html 0.6 2026-06-29T18:13:41+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-found-to-predict-onset-of-tb--300845.html 0.6 2026-03-21T07:12:48+08:00 daily https://www.pharmasources.com/industryinsights/frontage-laboratories-acquires-concord-b-300846.html 0.6 2026-01-05T09:08:41+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-recalls-over-1-lakh-bottles-of--300847.html 0.6 2026-07-18T15:38:17+08:00 daily https://www.pharmasources.com/industryinsights/researchers-to-investigate-screening-for-300848.html 0.6 2026-07-06T14:41:08+08:00 daily https://www.pharmasources.com/industryinsights/genome-sequencing-of-first-50000-uk-biob-300849.html 0.6 2026-07-24T14:21:37+08:00 daily https://www.pharmasources.com/industryinsights/larotrectinib-shows-promise-in-paediatri-300850.html 0.6 2025-12-24T12:22:29+08:00 daily https://www.pharmasources.com/industryinsights/are-high-risk-anticholinergic-medicines--300851.html 0.6 2026-06-17T00:16:22+08:00 daily https://www.pharmasources.com/industryinsights/flare-responsive-hydrogel-developed-to-t-300852.html 0.6 2026-03-20T18:37:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-blincyto-for-tre-300853.html 0.6 2026-03-19T23:39:24+08:00 daily https://www.pharmasources.com/industryinsights/in-second-gene-therapy-buy-of-the-year-n-300854.html 0.6 2026-04-26T03:27:00+08:00 daily https://www.pharmasources.com/industryinsights/acadia-pharmaceuticals-plunges-following-300855.html 0.6 2026-02-15T03:36:02+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-grabs-another-late-stage-300856.html 0.6 2026-06-24T02:21:25+08:00 daily https://www.pharmasources.com/industryinsights/doctor-calls-for-alzheimers-boot-camps-t-300857.html 0.6 2026-04-22T05:21:27+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-arthritis-drug-dazzles-in-phase--300858.html 0.6 2025-11-08T13:40:28+08:00 daily https://www.pharmasources.com/industryinsights/failed-clinical-trial-menlos-stock-tanks-300859.html 0.6 2026-07-08T22:40:22+08:00 daily https://www.pharmasources.com/industryinsights/constellation-raises-100m-to-advance-sev-300860.html 0.6 2026-06-24T08:28:56+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-tech-300861.html 0.6 2026-08-06T19:24:53+08:00 daily https://www.pharmasources.com/industryinsights/magenta-therapeutics-snags-52-million-to-300862.html 0.6 2026-03-25T07:10:27+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-backs-new-innovations-for-nh-300863.html 0.6 2026-08-05T13:57:37+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-sees-roches-tecentriq-backed-300864.html 0.6 2025-10-25T23:29:41+08:00 daily https://www.pharmasources.com/industryinsights/new-us-approval-for-clovis-rubraca-300865.html 0.6 2026-04-01T11:17:42+08:00 daily https://www.pharmasources.com/industryinsights/equashield-and-transmedic-pte-ltd-partne-300866.html 0.6 2026-03-25T17:11:57+08:00 daily https://www.pharmasources.com/industryinsights/max-capital-management-holding-ltd-and-n-300867.html 0.6 2026-04-05T08:02:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-buy-avexis-for-87b-300868.html 0.6 daily https://www.pharmasources.com/industryinsights/beigene-appoints-j-samuel-su-to-its-boar-300869.html 0.6 2026-07-22T23:55:57+08:00 daily https://www.pharmasources.com/industryinsights/incytemsds-immunotherapy-combo-fails-in--300870.html 0.6 2026-07-27T14:01:03+08:00 daily https://www.pharmasources.com/industryinsights/amarantus-reacquires-three-diagnostic-te-300871.html 0.6 2026-06-21T03:26:35+08:00 daily https://www.pharmasources.com/industryinsights/equashield-transmedic-unite-to-increase--300872.html 0.6 2026-03-25T17:26:05+08:00 daily https://www.pharmasources.com/industryinsights/encapsulation-enters-the-pharma-industry-300873.html 0.6 2026-04-04T16:05:48+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-us-fda-nod-for-acycl-300874.html 0.6 2026-06-13T16:49:12+08:00 daily https://www.pharmasources.com/industryinsights/new-nightmare-bacteria-cannot-withstand--300875.html 0.6 2026-08-07T11:15:18+08:00 daily https://www.pharmasources.com/industryinsights/ionis-licenses-nash-drug-to-astrazeneca-300876.html 0.6 2026-08-08T07:31:01+08:00 daily https://www.pharmasources.com/industryinsights/fischer-medical-receives-us-fda-510k-cle-300877.html 0.6 2026-01-20T14:09:53+08:00 daily https://www.pharmasources.com/industryinsights/protalex-initiates-fourth-cohort-dosing--300878.html 0.6 2026-01-13T08:36:26+08:00 daily https://www.pharmasources.com/industryinsights/inspire-files-for-8625m-ipo-300879.html 0.6 2026-01-04T04:49:40+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-collaborates-with-ortho-cl-300880.html 0.6 2026-06-24T11:45:27+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-cardiamp-heart-failure-trial-f-300881.html 0.6 2026-03-01T01:31:06+08:00 daily https://www.pharmasources.com/industryinsights/korean-researchers-develop-new-personali-300882.html 0.6 2026-02-09T05:02:03+08:00 daily https://www.pharmasources.com/industryinsights/therapix-biosciences-announces-topline-r-300883.html 0.6 2025-11-15T16:47:08+08:00 daily https://www.pharmasources.com/industryinsights/roche-completes-flatiron-health-acquisit-300884.html 0.6 2025-11-14T12:57:29+08:00 daily https://www.pharmasources.com/industryinsights/regenerx-announces-outcome-of-fda-discus-300885.html 0.6 2026-01-30T19:00:20+08:00 daily https://www.pharmasources.com/industryinsights/immunoprecise-acquires-modiquest-for-7m-300886.html 0.6 2026-01-04T20:24:49+08:00 daily https://www.pharmasources.com/industryinsights/align-technology-expands-product-portfol-300887.html 0.6 2026-06-22T02:47:27+08:00 daily https://www.pharmasources.com/industryinsights/upadacitinib-meets-all-primary-and-ranke-300888.html 0.6 2026-08-09T19:03:26+08:00 daily https://www.pharmasources.com/industryinsights/gtx-announces-early-completion-of-patien-300889.html 0.6 2026-02-11T15:01:55+08:00 daily https://www.pharmasources.com/industryinsights/zucara-therapeutics-secures-us39m-from-t-300890.html 0.6 2026-07-10T02:20:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-restricts-sale-and-distribution-of-e-300891.html 0.6 2026-02-28T15:29:47+08:00 daily https://www.pharmasources.com/industryinsights/stealth-biotherapeutics-granted-orphan-d-300892.html 0.6 2026-03-25T20:02:41+08:00 daily https://www.pharmasources.com/industryinsights/global-urology-devices-market---forecast-300893.html 0.6 2026-07-05T00:16:57+08:00 daily https://www.pharmasources.com/industryinsights/italy-biotechnology-market-trends-analys-300894.html 0.6 2026-04-30T18:24:19+08:00 daily https://www.pharmasources.com/industryinsights/does-novartiss-acquisition-of-avexis-spe-300895.html 0.6 2026-07-30T23:38:23+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharma-and-orchard-biggest-uk-biotech-300896.html 0.6 2026-06-05T16:57:33+08:00 daily https://www.pharmasources.com/industryinsights/vtvs-azeliragon-is-latest-alzheimers-dru-300897.html 0.6 2026-06-21T19:57:17+08:00 daily https://www.pharmasources.com/industryinsights/epigenetics-focused-biotech-constellatio-300898.html 0.6 2026-06-24T00:56:13+08:00 daily https://www.pharmasources.com/industryinsights/az-buys-ionis-nash-candidate-300899.html 0.6 2026-06-21T00:19:19+08:00 daily https://www.pharmasources.com/industryinsights/theresa-may-unveils-75m-prostate-cancer--300900.html 0.6 2026-03-26T02:55:01+08:00 daily https://www.pharmasources.com/industryinsights/smc-endorses-five-new-therapies-for-nhs--300901.html 0.6 2026-01-13T10:52:02+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-bags-another-trial-success-300902.html 0.6 2026-06-20T15:21:27+08:00 daily https://www.pharmasources.com/industryinsights/media-reports-over-parkinsons-drug-risk--300903.html 0.6 2026-01-14T10:50:24+08:00 daily https://www.pharmasources.com/industryinsights/antiepileptic-drug-use-linked-to-increas-300904.html 0.6 2026-02-28T15:30:03+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-inlyta-fails-to-prolong-disease--300905.html 0.6 2026-06-21T01:48:12+08:00 daily https://www.pharmasources.com/industryinsights/cromsource-offers-clients-one-trial-one--300906.html 0.6 2026-04-27T04:07:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-ka-300907.html 0.6 2026-07-07T16:17:41+08:00 daily https://www.pharmasources.com/industryinsights/oliver-healthcare-packaging-expands-glob-300908.html 0.6 2026-08-04T14:58:28+08:00 daily https://www.pharmasources.com/industryinsights/reviva-pharmaceuticals-receives-fda-orph-300909.html 0.6 2026-01-31T10:06:14+08:00 daily https://www.pharmasources.com/industryinsights/wave-life-sciences-and-deep-genomics-for-300910.html 0.6 2026-06-08T19:12:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-roche-ms-drug-ocrevus-300911.html 0.6 2026-08-07T23:14:48+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-find-40-genes-associated--300912.html 0.6 2026-04-09T14:56:16+08:00 daily https://www.pharmasources.com/industryinsights/roche-closes-19bn-flatiron-health-acquis-300913.html 0.6 2026-06-29T05:44:52+08:00 daily https://www.pharmasources.com/industryinsights/antibiotics-may-treat-drug-resistant-bac-300914.html 0.6 2026-04-20T20:53:46+08:00 daily https://www.pharmasources.com/industryinsights/drl-gets-eir-from-us-fda-300915.html 0.6 2025-12-08T16:43:21+08:00 daily https://www.pharmasources.com/industryinsights/rmb-5741-billion-to-raise-the-second-uni-300916.html 0.6 2026-07-20T01:57:56+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-monotherapy-trial-meets--300917.html 0.6 2025-12-06T03:32:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-joins-the-trinetx-global-research-300918.html 0.6 2026-08-09T11:41:45+08:00 daily https://www.pharmasources.com/industryinsights/cphi-south-east-asia-to-expand-to-thaila-300919.html 0.6 2026-03-05T04:33:41+08:00 daily https://www.pharmasources.com/industryinsights/new-immunotherapy-for-lung-cancer-shows--300920.html 0.6 2025-12-06T03:29:24+08:00 daily https://www.pharmasources.com/industryinsights/global-peripheral-vascular-disease-marke-300921.html 0.6 2025-12-06T03:27:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-first-contact-lens-with-light-300922.html 0.6 2026-08-09T01:35:15+08:00 daily https://www.pharmasources.com/industryinsights/worlds-largest-dedicated-cell-and-gene-t-300923.html 0.6 2025-12-06T03:28:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-provides-update-on-phase-3-trial--300924.html 0.6 2026-04-07T12:59:33+08:00 daily https://www.pharmasources.com/industryinsights/amgen-to-build-first-of-its-kind-biomanu-300925.html 0.6 2026-08-08T22:32:03+08:00 daily https://www.pharmasources.com/industryinsights/reshape-lifesciences-pioneers-new-bio-el-300926.html 0.6 2026-05-30T01:55:33+08:00 daily https://www.pharmasources.com/industryinsights/cphi-south-east-asia-strengthens-asean-i-300927.html 0.6 2026-08-07T11:49:29+08:00 daily https://www.pharmasources.com/industryinsights/new-report-from-the-national-center-on-a-300928.html 0.6 2026-03-21T03:21:29+08:00 daily https://www.pharmasources.com/industryinsights/morphotek-inks-license-deal-with-blissbi-300929.html 0.6 2026-08-08T11:42:55+08:00 daily https://www.pharmasources.com/industryinsights/7-steps-to-avoid-falling-foul-of-fmd-300930.html 0.6 2026-06-24T17:59:52+08:00 daily https://www.pharmasources.com/industryinsights/immunomedics-appoints-new-cmo-300931.html 0.6 2026-01-30T20:15:53+08:00 daily https://www.pharmasources.com/industryinsights/astar-team-creates-nanocoating-to-preven-300932.html 0.6 2026-07-09T06:37:53+08:00 daily https://www.pharmasources.com/industryinsights/luye-strengthens-presence-in-singapore-w-300933.html 0.6 2026-08-07T17:23:54+08:00 daily https://www.pharmasources.com/industryinsights/therapix-biosciences-announces-topline-r-300934.html 0.6 2026-07-01T22:33:57+08:00 daily https://www.pharmasources.com/industryinsights/yuhan-corporation-collaborates-with-synt-300935.html 0.6 2026-05-09T19:52:06+08:00 daily https://www.pharmasources.com/industryinsights/alexion-purchases-wilson-therapeutics-fo-300936.html 0.6 2026-07-03T21:22:06+08:00 daily https://www.pharmasources.com/industryinsights/roche-halts-colorectal-cancer-trial-recr-300937.html 0.6 2025-12-29T02:35:18+08:00 daily https://www.pharmasources.com/industryinsights/cellectis-snags-164-million-in-ipo-to-ad-300938.html 0.6 2026-07-06T19:38:52+08:00 daily https://www.pharmasources.com/industryinsights/pipeline-concerns-four-biotechs-to-keep--300939.html 0.6 2026-07-02T23:36:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-pushes-back-pdufa-date-for-abbvies-e-300940.html 0.6 2025-12-06T03:09:22+08:00 daily https://www.pharmasources.com/industryinsights/cvs-unveils-tool-will-the-pharma-industr-300941.html 0.6 2026-07-07T02:39:26+08:00 daily https://www.pharmasources.com/industryinsights/after-trial-failure-pfizers-inlyta-unlik-300942.html 0.6 2026-07-12T15:53:39+08:00 daily https://www.pharmasources.com/industryinsights/survey-says-these-five-biotech-companies-300943.html 0.6 2026-06-26T07:04:30+08:00 daily https://www.pharmasources.com/industryinsights/arkay-therapeutics-submits-investigation-300944.html 0.6 2026-04-29T20:15:25+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-vision-announces-revolut-300945.html 0.6 2026-06-21T14:45:13+08:00 daily https://www.pharmasources.com/industryinsights/lensar-laser-system-receives-fda-clearan-300946.html 0.6 2026-02-28T15:22:51+08:00 daily https://www.pharmasources.com/industryinsights/biondvax-begins-nih-sponsored-phase-2-cl-300947.html 0.6 2026-08-08T22:23:28+08:00 daily https://www.pharmasources.com/industryinsights/multiple-studies-show-freespira-eliminat-300948.html 0.6 2026-04-07T07:02:52+08:00 daily https://www.pharmasources.com/industryinsights/kidneys-initially-deemed-unfit-for-trans-300949.html 0.6 2026-04-10T05:44:12+08:00 daily https://www.pharmasources.com/industryinsights/titan-spine-announces-review-of-research-300950.html 0.6 2026-04-14T01:10:45+08:00 daily https://www.pharmasources.com/industryinsights/mylan-partners-with-fujifilm-kyowa-kirin-300951.html 0.6 2026-04-07T09:05:55+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-launches-rebinyn-a-new-long-300952.html 0.6 2026-01-14T22:15:26+08:00 daily https://www.pharmasources.com/industryinsights/nektar-announces-dosing-of-first-patient-300953.html 0.6 2026-04-07T17:48:09+08:00 daily https://www.pharmasources.com/industryinsights/abbott-initiates-groundbreaking-study-to-300954.html 0.6 2026-08-07T15:52:58+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-unveils-eu-fmd-express-a-purpo-300955.html 0.6 2026-08-04T00:57:24+08:00 daily https://www.pharmasources.com/industryinsights/herbalife-healthy-breakfast-survey-revea-300956.html 0.6 2026-06-24T00:32:38+08:00 daily https://www.pharmasources.com/industryinsights/echosens-is-introducing-fibroscan-630-ex-300957.html 0.6 2026-02-10T20:06:41+08:00 daily https://www.pharmasources.com/industryinsights/exocad-releases-partialcad-for-partial-f-300958.html 0.6 2026-06-12T06:48:05+08:00 daily https://www.pharmasources.com/industryinsights/clovis-parp-drug-gets-new-us-ovarian-can-300959.html 0.6 2026-04-17T12:13:45+08:00 daily https://www.pharmasources.com/industryinsights/alexion-bids-855m-for-rare-disease-biote-300960.html 0.6 2026-04-11T12:39:40+08:00 daily https://www.pharmasources.com/industryinsights/novartis-afinitor-disperz-wins-new-tsc-r-300961.html 0.6 2026-01-02T12:35:45+08:00 daily https://www.pharmasources.com/industryinsights/acadia-shares-hit-by-media-doubts-over-p-300962.html 0.6 2026-04-06T22:59:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-no-for-roches-alecensa-300963.html 0.6 2025-12-06T02:45:20+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-expand-reach-of-sobis-kine-300964.html 0.6 2026-04-04T20:00:03+08:00 daily https://www.pharmasources.com/industryinsights/ionis-pharma-astrazeneca-to-advance-new--300965.html 0.6 2025-12-06T02:42:12+08:00 daily https://www.pharmasources.com/industryinsights/eloxx-pharmaceuticals-promising-treatmen-300966.html 0.6 2026-01-14T00:42:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-criminal-investigation-into-300967.html 0.6 2026-06-15T17:04:23+08:00 daily https://www.pharmasources.com/industryinsights/gsk-divests-rare-disease-gene-therapy-bu-300968.html 0.6 2026-03-30T00:42:45+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-strikes-a-series-of-300969.html 0.6 2026-06-23T14:54:16+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-harvard-stem-ce-300970.html 0.6 2026-06-04T04:44:07+08:00 daily https://www.pharmasources.com/industryinsights/new-biotech-incubator-will-have-new-busi-300971.html 0.6 2026-06-23T22:05:05+08:00 daily https://www.pharmasources.com/industryinsights/symcel-partners-with-karolinska-institut-300972.html 0.6 2026-03-23T02:53:53+08:00 daily https://www.pharmasources.com/industryinsights/translate-bio-announces-fda-clearance-to-300973.html 0.6 2026-06-29T15:14:24+08:00 daily https://www.pharmasources.com/industryinsights/invokana-canagliflozin-demonstrated-sign-300974.html 0.6 2026-04-18T19:55:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-permits-marketing-of-idx-dr-for-auto-300975.html 0.6 2026-08-08T03:18:01+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-doses-first-patient-using-investi-300976.html 0.6 2026-03-08T10:21:45+08:00 daily https://www.pharmasources.com/industryinsights/aruna-biomedical-announces-publication-o-300977.html 0.6 2026-04-13T05:02:12+08:00 daily https://www.pharmasources.com/industryinsights/cirius-therapeutics-preclinical-data-dem-300978.html 0.6 2026-02-28T16:07:53+08:00 daily https://www.pharmasources.com/industryinsights/transmedics-inc-receives-fda-pre-market--300979.html 0.6 2026-07-20T22:06:31+08:00 daily https://www.pharmasources.com/industryinsights/canbridge-receives-approval-to-commence--300980.html 0.6 2026-07-16T19:34:51+08:00 daily https://www.pharmasources.com/industryinsights/the-most-comprehensive-summary-ever-abou-300981.html 0.6 2026-07-03T18:20:11+08:00 daily https://www.pharmasources.com/industryinsights/spinalcyte-applies-with-fda-to-expand-hu-300982.html 0.6 2026-06-15T06:02:53+08:00 daily https://www.pharmasources.com/industryinsights/crisprcas9-gene-editing-market-2018-and--300983.html 0.6 2026-08-07T03:03:24+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-appoints-new-site-headgene-300984.html 0.6 2026-08-07T02:51:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-helps-accelerate-global-access-to--300985.html 0.6 2026-08-07T02:40:54+08:00 daily https://www.pharmasources.com/industryinsights/alland-robert-survey-researches-the-nutr-300986.html 0.6 2026-08-07T02:36:41+08:00 daily https://www.pharmasources.com/industryinsights/gsk-sells-rare-disease-drugs-including-g-300987.html 0.6 2026-08-07T02:34:22+08:00 daily https://www.pharmasources.com/industryinsights/takeda-looks-for-loans-to-fund-40bn-shir-300988.html 0.6 2026-08-07T02:31:11+08:00 daily https://www.pharmasources.com/industryinsights/owlstone-adds-astrazeneca-to-roster-of-b-300989.html 0.6 2026-08-07T02:22:04+08:00 daily https://www.pharmasources.com/industryinsights/uks-enterprise-therapeutics-raises-29m-300990.html 0.6 2026-08-07T02:05:30+08:00 daily https://www.pharmasources.com/industryinsights/world-leading-pharmaceutical-conferences-300991.html 0.6 2026-08-07T02:22:13+08:00 daily https://www.pharmasources.com/industryinsights/us-delay-for-abbvieneurocrines-uterine-p-300992.html 0.6 2026-08-08T01:20:51+08:00 daily https://www.pharmasources.com/industryinsights/final-guidance-from-nice-on-merck-pfizer-300993.html 0.6 2026-08-04T00:14:33+08:00 daily https://www.pharmasources.com/industryinsights/new-hepatitis-c-combo-boasts-97-cure-rat-300994.html 0.6 2026-04-20T01:25:25+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-protein-treatment-that-works--300995.html 0.6 2026-04-03T02:27:32+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-invest-350m-in-new-canadian-va-300996.html 0.6 2026-03-27T08:20:01+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-arm-gets-us-fda-nod-for-a-300997.html 0.6 2026-03-23T16:45:49+08:00 daily https://www.pharmasources.com/industryinsights/simultaneous-chemo-and-immunotherapy-is--300998.html 0.6 2026-03-27T23:50:43+08:00 daily https://www.pharmasources.com/industryinsights/injectable-sensor-could-provide-unobtrus-300999.html 0.6 2026-07-19T19:07:08+08:00 daily https://www.pharmasources.com/industryinsights/first-in-human-trial-of-cannabis-based-t-301000.html 0.6 2026-04-06T23:32:51+08:00 daily https://www.pharmasources.com/industryinsights/novel-drug-shows-promise-against-acute-m-301001.html 0.6 2026-04-09T15:46:11+08:00 daily https://www.pharmasources.com/industryinsights/robotics-takes-mass-spec-to-the-third-di-301002.html 0.6 2026-04-13T01:53:35+08:00 daily https://www.pharmasources.com/industryinsights/hrt-trial-demonstrates-improved-memory-f-301003.html 0.6 2026-02-04T17:07:30+08:00 daily https://www.pharmasources.com/industryinsights/adhesive-patch-offers-bloodless-diabetes-301004.html 0.6 2026-01-05T02:46:51+08:00 daily https://www.pharmasources.com/industryinsights/boston-therapeutics-poised-to-acquire-mt-301005.html 0.6 2025-12-06T02:00:32+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-boss-ian-read-claims-they-wont-bu-301006.html 0.6 2026-02-09T15:36:00+08:00 daily https://www.pharmasources.com/industryinsights/us-court-ruled-that-coffee-contains-a-ca-301007.html 0.6 2026-07-29T06:41:02+08:00 daily https://www.pharmasources.com/industryinsights/mylan-rumored-to-be-in-discussions-to-bu-301008.html 0.6 2025-12-06T01:57:30+08:00 daily https://www.pharmasources.com/industryinsights/suit-alleges-drug-impurity-price-fixing--301009.html 0.6 2025-12-06T01:56:27+08:00 daily https://www.pharmasources.com/industryinsights/rigel-website-shows-erroneous-informatio-301010.html 0.6 2026-03-17T22:53:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-new-guidance-for-next-gener-301011.html 0.6 2026-02-28T14:35:11+08:00 daily https://www.pharmasources.com/industryinsights/in-first-trial-of-new-gene-therapy-progr-301012.html 0.6 2026-01-31T08:43:28+08:00 daily https://www.pharmasources.com/industryinsights/genoox-collaborates-with-bionano-to-enha-301013.html 0.6 2026-01-11T19:48:05+08:00 daily https://www.pharmasources.com/industryinsights/saint-gobain-acquires-micro-hydraulics-p-301014.html 0.6 2026-08-09T03:20:10+08:00 daily https://www.pharmasources.com/industryinsights/bms-begins-harvard-fibrosis-stem-cell-re-301015.html 0.6 2026-07-16T13:11:32+08:00 daily https://www.pharmasources.com/industryinsights/pacira-ceo-hopes-for-further-expansion-t-301016.html 0.6 2026-01-31T10:59:49+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-ai-market-worth-10bn-plus-by--301017.html 0.6 2026-07-31T09:36:06+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-suppresses-peanut-allergies-in-m-301018.html 0.6 2026-01-15T10:27:58+08:00 daily https://www.pharmasources.com/industryinsights/trumps-trade-war-with-china-could-drive--301019.html 0.6 2026-04-07T09:05:39+08:00 daily https://www.pharmasources.com/industryinsights/uk-study-to-investigate-kidney-disease-p-301020.html 0.6 2026-05-10T23:32:41+08:00 daily https://www.pharmasources.com/industryinsights/public-backs-tax-rise-for-nhs-301021.html 0.6 2025-12-06T01:43:09+08:00 daily https://www.pharmasources.com/industryinsights/sensitive-new-assay-detects-hepatitis-b--301022.html 0.6 2026-01-30T21:53:56+08:00 daily https://www.pharmasources.com/industryinsights/nhs-in-never-ending-winter-301023.html 0.6 2025-12-06T01:42:08+08:00 daily https://www.pharmasources.com/industryinsights/hanmi-terminates-lung-cancer-drug-after--301024.html 0.6 2026-06-30T15:22:14+08:00 daily https://www.pharmasources.com/industryinsights/evolutionary-path-of-kidney-cancer-track-301025.html 0.6 2025-12-06T01:40:05+08:00 daily https://www.pharmasources.com/industryinsights/eisai-forms-partnership-to-find-new-tube-301026.html 0.6 2026-03-18T02:29:18+08:00 daily https://www.pharmasources.com/industryinsights/inovio-nets-56m-cepi-grant-for-lassa-fev-301027.html 0.6 2025-12-06T01:38:03+08:00 daily https://www.pharmasources.com/industryinsights/uk-team-develops-novel-skin-patch-for-di-301028.html 0.6 2026-07-19T19:01:26+08:00 daily https://www.pharmasources.com/industryinsights/taiwan-china-launches-flu-prediction-ser-301029.html 0.6 2026-06-08T17:59:55+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biocon-to-launch-adalimumab-biosim-301030.html 0.6 2026-03-28T06:27:34+08:00 daily https://www.pharmasources.com/industryinsights/philips-launches-tele-radiology-services-301031.html 0.6 2026-07-30T13:59:18+08:00 daily https://www.pharmasources.com/industryinsights/ak-medical-buys-jri-orthopedics-for-24m-301032.html 0.6 2026-01-10T10:53:02+08:00 daily https://www.pharmasources.com/industryinsights/new-study-brings-relief-for-travellers-f-301033.html 0.6 2025-12-08T06:51:17+08:00 daily https://www.pharmasources.com/industryinsights/uk-team-develops-novel-skin-patch-for-di-301034.html 0.6 2026-01-11T21:10:54+08:00 daily https://www.pharmasources.com/industryinsights/abbott-initiates-groundbreaking-study-to-301035.html 0.6 2026-08-05T19:09:56+08:00 daily https://www.pharmasources.com/industryinsights/personalized-tumor-vaccine-shows-promise-301036.html 0.6 2026-05-03T20:50:52+08:00 daily https://www.pharmasources.com/industryinsights/nature-cell-and-biostar-stem-cell-resear-301037.html 0.6 2026-06-08T01:50:43+08:00 daily https://www.pharmasources.com/industryinsights/merck-co-details-positive-late-stage-dat-301038.html 0.6 2026-04-27T15:14:50+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-ret-inhibitor-blu-66-301039.html 0.6 2026-08-07T20:45:08+08:00 daily https://www.pharmasources.com/industryinsights/hanmi-scraps-development-of-lung-cancer--301040.html 0.6 2026-07-28T09:50:31+08:00 daily https://www.pharmasources.com/industryinsights/abpro-therapeutics-on-deck-for-ipo-301041.html 0.6 2026-08-07T03:05:49+08:00 daily https://www.pharmasources.com/industryinsights/capital-raise-for-vermillion-301042.html 0.6 2025-12-10T05:24:07+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-invest-in-canadian-vaccine-fac-301043.html 0.6 2025-12-06T01:21:23+08:00 daily https://www.pharmasources.com/industryinsights/australian-researchers-invent-tiny-fibre-301044.html 0.6 2026-04-03T07:17:05+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-shares-drop-on-posi-301045.html 0.6 2026-03-16T14:12:32+08:00 daily https://www.pharmasources.com/industryinsights/roche-diagnostics-assay-receives-fda-cle-301046.html 0.6 2026-02-28T15:24:59+08:00 daily https://www.pharmasources.com/industryinsights/crispr-therapeutics-plans-to-treat-first-301047.html 0.6 2025-12-06T01:17:12+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-gains-nda-acceptance-for-mdd-tr-301048.html 0.6 2026-06-08T20:17:12+08:00 daily https://www.pharmasources.com/industryinsights/shire-sells-oncology-business-to-frances-301049.html 0.6 2025-12-06T01:15:07+08:00 daily https://www.pharmasources.com/industryinsights/merck-may-have-too-many-eggs-in-its-keyt-301050.html 0.6 2026-08-08T14:48:56+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-unveils-next-ge-301051.html 0.6 2026-07-27T00:34:22+08:00 daily https://www.pharmasources.com/industryinsights/predicine-closes-series-a-financing-tota-301052.html 0.6 2026-07-04T09:02:20+08:00 daily https://www.pharmasources.com/industryinsights/newly-published-phase-2-study-found-eske-301053.html 0.6 2026-06-03T19:34:26+08:00 daily https://www.pharmasources.com/industryinsights/roche-receives-fda-clearance-for-cobas-c-301054.html 0.6 2026-06-08T16:55:57+08:00 daily https://www.pharmasources.com/industryinsights/syros-announces-new-preclinical-data-on--301055.html 0.6 2025-12-06T01:08:46+08:00 daily https://www.pharmasources.com/industryinsights/eagle-pharmaceuticals-vasopressin-anda-a-301056.html 0.6 2025-12-06T01:07:46+08:00 daily https://www.pharmasources.com/industryinsights/x4-pharmaceuticals-presents-clinical-dat-301057.html 0.6 2025-12-06T01:06:42+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-announces-acquisition--301058.html 0.6 2026-08-06T21:16:36+08:00 daily https://www.pharmasources.com/industryinsights/medimergent-and-fda-launch-new-stakehold-301059.html 0.6 2026-07-08T06:24:39+08:00 daily https://www.pharmasources.com/industryinsights/kineta-to-collaborate-on-the-development-301060.html 0.6 2026-05-08T17:58:26+08:00 daily https://www.pharmasources.com/industryinsights/tela-bio-announces-series-b-investment-b-301061.html 0.6 2026-08-08T14:15:20+08:00 daily https://www.pharmasources.com/industryinsights/shires-24bn-oncology-sell-off-seen-as-ta-301062.html 0.6 2026-07-04T16:25:28+08:00 daily https://www.pharmasources.com/industryinsights/public-backs-sharing-patient-details-wit-301063.html 0.6 2026-08-08T00:39:51+08:00 daily https://www.pharmasources.com/industryinsights/alphabetama-challenge-startups-to-improv-301064.html 0.6 2026-06-27T15:04:39+08:00 daily https://www.pharmasources.com/industryinsights/azs-tagrisso-brings-unprecedented-benefi-301065.html 0.6 2026-02-28T15:34:38+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-hopes-for-2018-filing-for-rnai-l-301066.html 0.6 2025-12-06T00:57:20+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-prolongs-recurrence-free-surviv-301067.html 0.6 2025-12-06T00:56:16+08:00 daily https://www.pharmasources.com/industryinsights/novartis-entresto-helps-preserve-kidney--301068.html 0.6 2026-07-09T04:51:54+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-looks-to-trim-down-with-divestmen-301069.html 0.6 2026-01-31T10:14:11+08:00 daily https://www.pharmasources.com/industryinsights/jjs-ketamine-nasal-spray-for-depression--301070.html 0.6 2026-07-17T15:50:38+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-johnson-johnson-ink-301071.html 0.6 2026-02-15T14:29:06+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-opdivo-yervoy-comb-301072.html 0.6 2025-12-15T01:07:37+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-new-analysis-demonstr-301073.html 0.6 2026-07-25T22:58:43+08:00 daily https://www.pharmasources.com/industryinsights/herantis-pharma-announces-positive-inter-301074.html 0.6 2026-06-15T23:14:10+08:00 daily https://www.pharmasources.com/industryinsights/rd-of-universal-flu-vaccine-in-the-darkn-301075.html 0.6 2026-06-15T21:15:05+08:00 daily https://www.pharmasources.com/industryinsights/a-glimpse-of-the-latest-developments-of--301076.html 0.6 2026-07-25T22:06:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-permits-marketing-of-ai-based-device-301077.html 0.6 2026-01-16T14:36:00+08:00 daily https://www.pharmasources.com/industryinsights/nivolumab-reduces-size-of-some-lung-canc-301078.html 0.6 2026-04-09T04:59:11+08:00 daily https://www.pharmasources.com/industryinsights/certain-iron-supplements-may-influence-t-301079.html 0.6 2026-07-04T07:52:42+08:00 daily https://www.pharmasources.com/industryinsights/shire-offloads-its-oncology-business-for-301080.html 0.6 2026-04-10T10:50:15+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-korea-to-foster-biotech-301081.html 0.6 2025-12-06T00:41:33+08:00 daily https://www.pharmasources.com/industryinsights/israeli-unions-warn-teva-pharmaceutical-301082.html 0.6 2026-06-14T04:51:12+08:00 daily https://www.pharmasources.com/industryinsights/maternal-metabolic-factors-and-early-ons-301083.html 0.6 2026-07-07T11:47:16+08:00 daily https://www.pharmasources.com/industryinsights/major-italian-sector-federations-showcas-301084.html 0.6 2026-04-20T19:04:10+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sales-drive-jjs-first-quarter-301085.html 0.6 2026-07-09T17:40:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-sell-its-generic-division-to-a-301086.html 0.6 2026-04-18T23:11:47+08:00 daily https://www.pharmasources.com/industryinsights/general-electric-creates-ready-made-vira-301087.html 0.6 2026-04-15T16:52:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-genentechs-hemophilia-drug-br-301088.html 0.6 2026-07-10T04:02:22+08:00 daily https://www.pharmasources.com/industryinsights/janssen-bristol-myers-squibb-team-up-to--301089.html 0.6 2025-12-06T00:32:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-spend-100m-on-malaria-initia-301090.html 0.6 2026-04-06T08:25:30+08:00 daily https://www.pharmasources.com/industryinsights/kineta-chronic-pain-inks-license-deal-wi-301091.html 0.6 2026-04-03T12:16:33+08:00 daily https://www.pharmasources.com/industryinsights/bellicum-pharmaceuticals-announces-propo-301092.html 0.6 2025-12-06T00:29:46+08:00 daily https://www.pharmasources.com/industryinsights/pharmacyte-biotech-successfully-complete-301093.html 0.6 2026-05-20T20:01:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-full-approval-to-praxbind-s-301094.html 0.6 2026-06-24T18:04:27+08:00 daily https://www.pharmasources.com/industryinsights/livongo-health-acquires-retrofit-301095.html 0.6 2026-08-09T10:49:31+08:00 daily https://www.pharmasources.com/industryinsights/sobi-receives-approval-from-health-canad-301096.html 0.6 2026-08-09T10:10:13+08:00 daily https://www.pharmasources.com/industryinsights/pharmamar-discovers-new-data-on-the-mech-301097.html 0.6 2025-12-06T00:24:17+08:00 daily https://www.pharmasources.com/industryinsights/bioverativ-highlights-the-impact-of-huma-301098.html 0.6 2026-03-04T04:16:58+08:00 daily https://www.pharmasources.com/industryinsights/arrevus-announces-receipt-of-nih-fast-tr-301099.html 0.6 2026-07-06T18:49:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-the-first-use-of-tracer-qc-at-301100.html 0.6 2026-07-09T13:43:28+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-first-phase-three-studie-301101.html 0.6 2026-06-07T11:09:58+08:00 daily https://www.pharmasources.com/industryinsights/obsidian-therapeutics-presents-preclinic-301102.html 0.6 2026-08-09T07:56:36+08:00 daily https://www.pharmasources.com/industryinsights/vicarious-surgical-closes-1675-million-i-301103.html 0.6 2026-08-08T10:49:40+08:00 daily https://www.pharmasources.com/industryinsights/h3-biomedicine-reports-discovery-of-recu-301104.html 0.6 2026-08-08T03:25:28+08:00 daily https://www.pharmasources.com/industryinsights/national-ms-society-commits-142-million--301105.html 0.6 2026-08-08T01:01:42+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-is-king-in-lung-cancer-putting--301106.html 0.6 2026-08-07T13:19:13+08:00 daily https://www.pharmasources.com/industryinsights/azs-tagrisso-brings-unprecedented-benefi-301107.html 0.6 2026-08-07T03:55:16+08:00 daily https://www.pharmasources.com/industryinsights/roche-haemophilia-drug-gets-fast-fda-rev-301108.html 0.6 2026-08-07T03:27:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-flip-flops-on-alkermes-drug-applicat-301109.html 0.6 2026-08-07T03:24:47+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-ups-the-ante-in-vaccines-with-new-301110.html 0.6 2026-08-07T03:12:47+08:00 daily https://www.pharmasources.com/industryinsights/jhl-biotech-submits-application-for-beva-301111.html 0.6 2026-08-09T05:52:03+08:00 daily https://www.pharmasources.com/industryinsights/shire-offloads-its-oncology-business-for-301112.html 0.6 2026-08-07T02:51:48+08:00 daily https://www.pharmasources.com/industryinsights/painkillers-in-pregnancy-may-affect-baby-301113.html 0.6 2026-08-07T02:40:30+08:00 daily https://www.pharmasources.com/industryinsights/naloxone-promotes-stroke-recovery-in-rat-301114.html 0.6 2026-08-07T00:21:30+08:00 daily https://www.pharmasources.com/industryinsights/gsk-recruiting-score-genentechs-kevin-si-301115.html 0.6 2026-08-07T00:40:21+08:00 daily https://www.pharmasources.com/industryinsights/recent-hack-of-sangamo-therapeutics-exec-301116.html 0.6 2026-08-07T13:19:15+08:00 daily https://www.pharmasources.com/industryinsights/amgens-migraine-drug-heads-toward-possib-301117.html 0.6 2026-08-09T22:00:37+08:00 daily https://www.pharmasources.com/industryinsights/1q2018-earnings-call-highlights-abbotts--301118.html 0.6 2026-08-07T04:34:05+08:00 daily https://www.pharmasources.com/industryinsights/pharmacannis-takes-biopharma-approach-to-301119.html 0.6 2026-08-08T21:33:36+08:00 daily https://www.pharmasources.com/industryinsights/the-growing-legal-battles-against-opioid-301120.html 0.6 2026-08-07T04:24:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-newlinks-ebola-vaccine-leads-t-301121.html 0.6 2026-06-22T17:03:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-commissioner-goes-to-bat-for-the-bio-301122.html 0.6 2026-08-07T09:21:13+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-shows-off-more-verzenio-data-a-301123.html 0.6 2026-06-20T15:55:23+08:00 daily https://www.pharmasources.com/industryinsights/janssen-bristol-myers-squibb-team-up-to--301124.html 0.6 2026-08-02T08:26:18+08:00 daily https://www.pharmasources.com/industryinsights/ani-pharmaceuticals-announces-approval-o-301125.html 0.6 2026-07-02T11:52:08+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-bayer-advance-third-endometri-301126.html 0.6 2026-04-12T18:34:07+08:00 daily https://www.pharmasources.com/industryinsights/neurovives-kl1333-receives-fda-orphan-dr-301127.html 0.6 2026-01-31T10:17:49+08:00 daily https://www.pharmasources.com/industryinsights/synlogic-doses-first-subject-in-phase-12-301128.html 0.6 2026-03-17T21:12:19+08:00 daily https://www.pharmasources.com/industryinsights/global-neuropathic-back-pain-epidemiolog-301129.html 0.6 2025-12-25T18:39:49+08:00 daily https://www.pharmasources.com/industryinsights/sempre-health-and-novo-nordisk-partner-t-301130.html 0.6 2026-06-26T22:19:26+08:00 daily https://www.pharmasources.com/industryinsights/blood-disorders-pipeline-database-2018-n-301131.html 0.6 2026-03-17T21:09:03+08:00 daily https://www.pharmasources.com/industryinsights/cannabics-pharmaceuticals-announces-new--301132.html 0.6 2026-03-28T22:15:42+08:00 daily https://www.pharmasources.com/industryinsights/tetherex-pharmaceuticals-inc-completes-5-301133.html 0.6 2026-07-08T02:19:54+08:00 daily https://www.pharmasources.com/industryinsights/institute-of-human-virology-ihv-will-und-301134.html 0.6 2026-02-28T22:57:38+08:00 daily https://www.pharmasources.com/industryinsights/abbott-reports-first-quarter-2018-result-301135.html 0.6 2026-07-07T06:05:38+08:00 daily https://www.pharmasources.com/industryinsights/shire-drives-awareness-on-hemophilia-in--301136.html 0.6 2026-02-09T08:15:30+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-may-not-reduce-risk-of-dea-301137.html 0.6 2025-12-05T23:44:51+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-pasteurs-vaccine-facility-to-be-s-301138.html 0.6 2026-08-06T05:13:35+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-strengthens-innovation-partn-301139.html 0.6 2026-06-30T10:11:33+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-nod-to-market-testoste-301140.html 0.6 2026-07-10T21:56:58+08:00 daily https://www.pharmasources.com/industryinsights/us-gives-nod-to-glenmark-for-skin-ointme-301141.html 0.6 2026-08-07T18:41:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-therapy-for-rare-inhe-301142.html 0.6 2026-07-17T04:13:56+08:00 daily https://www.pharmasources.com/industryinsights/vaccibody-moving-forward-with-cancer-neo-301143.html 0.6 2026-08-08T00:02:54+08:00 daily https://www.pharmasources.com/industryinsights/highmark-signs-outcomes-based-agreement--301144.html 0.6 2026-01-05T22:48:34+08:00 daily https://www.pharmasources.com/industryinsights/obi-pharma-gets-fda-clearance-for-new-dr-301145.html 0.6 2025-12-28T23:01:26+08:00 daily https://www.pharmasources.com/industryinsights/shire-rejects-takedas-60-billion-acquisi-301146.html 0.6 2025-12-05T23:32:31+08:00 daily https://www.pharmasources.com/industryinsights/fdas-chowdhury-leaves-to-take-exec-posit-301147.html 0.6 2025-12-05T23:31:31+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-and-incyte-shares-drop-as-fda--301148.html 0.6 2025-12-05T23:30:28+08:00 daily https://www.pharmasources.com/industryinsights/benevolentai-grabs-115-million-to-advanc-301149.html 0.6 2025-12-12T11:35:42+08:00 daily https://www.pharmasources.com/industryinsights/amgen-exec-john-tsai-to-head-novartis-gl-301150.html 0.6 2026-03-19T05:39:20+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sees-sharp-decline-in-generic-d-301151.html 0.6 2026-02-06T19:40:02+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-tagrisso-nabs-another-lung--301152.html 0.6 2026-06-26T20:38:22+08:00 daily https://www.pharmasources.com/industryinsights/pg-acquires-merck-kgaas-consumer-health--301153.html 0.6 2026-07-28T22:29:54+08:00 daily https://www.pharmasources.com/industryinsights/teva-and-the-procter-gamble-company-have-301154.html 0.6 2026-01-04T11:44:59+08:00 daily https://www.pharmasources.com/industryinsights/neuropeptide-y-y1-receptor-structures-of-301155.html 0.6 2026-08-09T10:51:43+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-healthprize-exp-301156.html 0.6 2026-06-01T05:46:40+08:00 daily https://www.pharmasources.com/industryinsights/iqvia-institute-for-human-data-science-s-301157.html 0.6 2026-08-06T16:36:30+08:00 daily https://www.pharmasources.com/industryinsights/novadigm-therapeutics-announces-initiati-301158.html 0.6 2026-07-07T16:08:11+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-announces-preliminary-results-of-301159.html 0.6 2026-08-06T18:58:36+08:00 daily https://www.pharmasources.com/industryinsights/biogo-introduces-bioproduction-agility-t-301160.html 0.6 2026-06-01T05:43:44+08:00 daily https://www.pharmasources.com/industryinsights/world-automated-microbiology-market-repo-301161.html 0.6 2026-06-01T05:22:20+08:00 daily https://www.pharmasources.com/industryinsights/world-tumor-markers-testing-market-2018--301162.html 0.6 2026-08-07T21:25:14+08:00 daily https://www.pharmasources.com/industryinsights/acute-pain---2018-pipeline-highlights-301163.html 0.6 2026-06-01T05:16:38+08:00 daily https://www.pharmasources.com/industryinsights/merck-foundation-mahe-to-train-embryolog-301164.html 0.6 2026-06-01T05:19:33+08:00 daily https://www.pharmasources.com/industryinsights/sterling-pharma-invests-6m-to-expand-off-301165.html 0.6 2026-06-01T05:16:39+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-knee-os-301166.html 0.6 2026-06-01T05:19:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-first-therapy-for-inherited-r-301167.html 0.6 2026-06-01T05:22:22+08:00 daily https://www.pharmasources.com/industryinsights/amazon-shelves-plans-to-sell-drugs-to-ho-301168.html 0.6 2026-06-01T05:25:28+08:00 daily https://www.pharmasources.com/industryinsights/final-nhs-nod-for-roches-roactemra-301169.html 0.6 2026-06-01T05:40:46+08:00 daily https://www.pharmasources.com/industryinsights/spectacular-results-for-bluebirds-gene-t-301170.html 0.6 2026-07-05T08:30:18+08:00 daily https://www.pharmasources.com/industryinsights/gws-epidiolex-takes-a-leap-toward-us-app-301171.html 0.6 2026-08-07T15:48:06+08:00 daily https://www.pharmasources.com/industryinsights/gsk-picks-kevin-sim-to-lead-business-dev-301172.html 0.6 2026-03-29T02:29:29+08:00 daily https://www.pharmasources.com/industryinsights/novartis-snatches-amgen-and-bms-veteran--301173.html 0.6 2026-02-28T15:31:49+08:00 daily https://www.pharmasources.com/industryinsights/editorial-questions-study-design-support-301174.html 0.6 2026-07-28T11:44:55+08:00 daily https://www.pharmasources.com/industryinsights/takeda-comes-back-to-the-table-shire-acq-301175.html 0.6 2026-08-06T23:45:45+08:00 daily https://www.pharmasources.com/industryinsights/exponential-pharma-growth-expected-in-ch-301176.html 0.6 2026-08-06T23:37:15+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-ionis-tie-up-in-1-billion-dea-301177.html 0.6 2026-08-07T03:33:47+08:00 daily https://www.pharmasources.com/industryinsights/companies-advance-antimicrobial-treatmen-301178.html 0.6 2026-08-07T13:19:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-recommends-gw-pharmas-cannabis-301179.html 0.6 2026-02-15T00:15:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-provides-additional-phase-iii-d-301180.html 0.6 2026-08-08T21:48:36+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-one-step-closer-to-its-firs-301181.html 0.6 2026-08-09T05:33:55+08:00 daily https://www.pharmasources.com/industryinsights/vaxart-announces-5-million-inavir-revenu-301182.html 0.6 2026-04-05T21:33:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-veloxiss-supplemental-new-dr-301183.html 0.6 2026-08-07T15:05:08+08:00 daily https://www.pharmasources.com/industryinsights/a-glimpse-of-influences-of-tariff-slappi-301184.html 0.6 2026-08-07T02:39:47+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-pharmaceuticals-announces-enrol-301185.html 0.6 2026-03-24T10:43:00+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-fast-track-designation-for-301186.html 0.6 2026-04-17T02:36:34+08:00 daily https://www.pharmasources.com/industryinsights/epigenomics-ag-blood-test-shows-promise--301187.html 0.6 2026-01-31T05:21:52+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-to-expand-drug-development-t-301188.html 0.6 2026-07-19T10:46:38+08:00 daily https://www.pharmasources.com/industryinsights/iterum-therapeutics-presents-data-on-pre-301189.html 0.6 2026-06-09T22:26:08+08:00 daily https://www.pharmasources.com/industryinsights/allergan-says-not-interested-in-buying-s-301190.html 0.6 2026-04-15T18:55:10+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-unicorn-benevolentai-raises-c-301191.html 0.6 2026-06-27T06:24:10+08:00 daily https://www.pharmasources.com/industryinsights/novartis-appoints-john-tsai-as-head-gdd--301192.html 0.6 2026-04-13T21:07:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-pharma-calls-for-cooperation-as-ema-c-301193.html 0.6 2026-07-24T22:34:22+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-incytes-resubmission-of-arthri-301194.html 0.6 2026-04-29T21:23:04+08:00 daily https://www.pharmasources.com/industryinsights/prototype-skin-implant-signals-cancer-by-301195.html 0.6 2026-06-09T01:51:06+08:00 daily https://www.pharmasources.com/industryinsights/us-widens-use-of-az-tagrisso-in-lung-can-301196.html 0.6 2026-04-13T22:03:39+08:00 daily https://www.pharmasources.com/industryinsights/ucb-to-acquire-proximagens-midazolam-nas-301197.html 0.6 2026-08-06T20:12:41+08:00 daily https://www.pharmasources.com/industryinsights/ucb-to-expand-epilepsy-portfolio-with-ac-301198.html 0.6 2026-06-27T21:57:44+08:00 daily https://www.pharmasources.com/industryinsights/myairvo-significantly-benefits-copd-pati-301199.html 0.6 2026-08-07T22:53:33+08:00 daily https://www.pharmasources.com/industryinsights/tocagen-inks-commercialisation-deal-with-301200.html 0.6 2026-04-03T03:00:55+08:00 daily https://www.pharmasources.com/industryinsights/who-south-east-asia-emphasizes-on-life-s-301201.html 0.6 2026-04-05T05:02:24+08:00 daily https://www.pharmasources.com/industryinsights/astellas-sells-certain-us-research-facil-301202.html 0.6 2026-08-05T20:02:54+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-ceo-maintains-position-in-th-301203.html 0.6 2026-04-07T11:58:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-snda-for-the-de-novo-indicat-301204.html 0.6 2026-03-24T18:55:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-steps-to-advance-development-o-301205.html 0.6 2026-01-30T20:20:31+08:00 daily https://www.pharmasources.com/industryinsights/using-ai-to-detect-heart-disease-301206.html 0.6 2026-06-08T20:34:25+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-terminates-43-billion-mer-301207.html 0.6 2026-03-24T04:58:11+08:00 daily https://www.pharmasources.com/industryinsights/knight-therapeutics-announces-canadian-r-301208.html 0.6 2025-12-29T03:35:16+08:00 daily https://www.pharmasources.com/industryinsights/heritage-pharma-makes-leadership-changes-301209.html 0.6 2026-06-28T11:01:24+08:00 daily https://www.pharmasources.com/industryinsights/sterling-pharma-invests-6m-to-expand-off-301210.html 0.6 2026-03-24T21:10:23+08:00 daily https://www.pharmasources.com/industryinsights/who-recommends-testing-before-use-of-san-301211.html 0.6 2026-03-20T16:41:59+08:00 daily https://www.pharmasources.com/industryinsights/bliss-gvs-pharma-buys-stake-in-eco-rich--301212.html 0.6 2026-03-11T21:09:47+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018042-301213.html 0.6 2026-06-08T15:25:35+08:00 daily https://www.pharmasources.com/industryinsights/book-your-accommodation-via-cphi-china-s-301214.html 0.6 2026-06-12T05:24:35+08:00 daily https://www.pharmasources.com/industryinsights/first-quarter-acquisition-activity-lifts-301215.html 0.6 2026-08-07T01:10:44+08:00 daily https://www.pharmasources.com/industryinsights/safety-concerns-force-loss-of-breakthrou-301216.html 0.6 2026-02-16T20:23:42+08:00 daily https://www.pharmasources.com/industryinsights/car-t-trailblazer-carl-june-who-collabor-301217.html 0.6 2026-04-04T00:17:20+08:00 daily https://www.pharmasources.com/industryinsights/the-fda-giveth-and-taketh-away-grants-pf-301218.html 0.6 2026-08-06T11:29:55+08:00 daily https://www.pharmasources.com/industryinsights/sage-therapeutics-postpartum-depression--301219.html 0.6 2026-02-15T13:49:30+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-subsidiaries-ramp-up-treatment-301220.html 0.6 2026-08-07T22:21:07+08:00 daily https://www.pharmasources.com/industryinsights/surmodics-announces-fda-clearance-of-a-n-301221.html 0.6 2026-03-23T04:38:42+08:00 daily https://www.pharmasources.com/industryinsights/aobiome-therapeutics-expands-clinical-st-301222.html 0.6 2026-07-02T23:31:55+08:00 daily https://www.pharmasources.com/industryinsights/amerigen-and-dipharma-announce-us-fda-ap-301223.html 0.6 2026-06-25T10:11:05+08:00 daily https://www.pharmasources.com/industryinsights/decisiondx-melanoma-test-independently-i-301224.html 0.6 2026-06-26T05:03:21+08:00 daily https://www.pharmasources.com/industryinsights/pmdalliance-and-acadia-pharmaceuticals-s-301225.html 0.6 2026-03-01T03:04:05+08:00 daily https://www.pharmasources.com/industryinsights/relapsing-ms-patients-who-switched-to-au-301226.html 0.6 2025-12-10T21:55:14+08:00 daily https://www.pharmasources.com/industryinsights/cbt-pharmaceuticals-and-crystalgenomics--301227.html 0.6 2026-08-06T18:15:07+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-announces-50-mi-301228.html 0.6 2026-01-05T06:23:13+08:00 daily https://www.pharmasources.com/industryinsights/takeda-woos-shire-shareholders-with-incr-301229.html 0.6 2026-05-05T17:22:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-pear-to-develop-substance-u-301230.html 0.6 2026-05-02T20:05:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-unicorn-benevolentai-raises-c-301231.html 0.6 2026-08-09T04:32:47+08:00 daily https://www.pharmasources.com/industryinsights/vertex-and-nhs-close-in-on-cystic-fibros-301232.html 0.6 2026-08-07T13:16:06+08:00 daily https://www.pharmasources.com/industryinsights/nhs-gene-sequencing-project-may-fail-to--301233.html 0.6 2026-08-06T23:32:50+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-pulls-out-of-43bn-akorn-merger-301234.html 0.6 2026-08-06T23:46:57+08:00 daily https://www.pharmasources.com/industryinsights/chmp-rejects-ab-sciences-als-drug-301235.html 0.6 2026-08-06T23:55:55+08:00 daily https://www.pharmasources.com/industryinsights/oramed-initiates-90-day-clinical-study-f-301236.html 0.6 2026-08-07T00:02:19+08:00 daily https://www.pharmasources.com/industryinsights/sage-therapeutics-submits-nda-for-intrav-301237.html 0.6 2026-08-07T00:39:40+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-receives-positive-opinion-for-or-301238.html 0.6 2026-08-07T01:19:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-invests-100-mn-to-eliminate-mal-301239.html 0.6 2026-08-07T05:37:12+08:00 daily https://www.pharmasources.com/industryinsights/cystic-fibrosis-company-urged-to-lower-c-301240.html 0.6 2026-08-07T05:45:56+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-invests-50m-to-grow-biolog-301241.html 0.6 2026-06-09T20:16:43+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-may-reveal-cause-effect-301242.html 0.6 2026-08-07T05:39:42+08:00 daily https://www.pharmasources.com/industryinsights/new-vaccine-could-help-people-overcome-c-301243.html 0.6 2026-08-09T04:22:46+08:00 daily https://www.pharmasources.com/industryinsights/development-of-a-quantitative-pharmacody-301244.html 0.6 2026-01-30T18:29:45+08:00 daily https://www.pharmasources.com/industryinsights/improved-method-of-delivering-anti-cance-301245.html 0.6 2025-12-10T22:15:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-therapy-for-rare-inhe-301246.html 0.6 2026-06-18T11:13:38+08:00 daily https://www.pharmasources.com/industryinsights/kl1333-receives-fda-odd-for-mitochondria-301247.html 0.6 2026-06-21T09:12:21+08:00 daily https://www.pharmasources.com/industryinsights/could-statins-ease-deadly-heart-conditio-301248.html 0.6 2026-03-19T22:42:26+08:00 daily https://www.pharmasources.com/industryinsights/painkillers-in-pregnancy-may-affect-baby-301249.html 0.6 2026-03-26T22:03:50+08:00 daily https://www.pharmasources.com/industryinsights/takeda-pharma-and-shire-come-back-to-the-301250.html 0.6 2026-02-15T12:35:49+08:00 daily https://www.pharmasources.com/industryinsights/biogens-first-quarter-driven-by-ms-drugs-301251.html 0.6 2026-07-31T15:15:31+08:00 daily https://www.pharmasources.com/industryinsights/new-sanofi-rd-boss-marks-yet-another-hig-301252.html 0.6 2026-02-11T22:15:32+08:00 daily https://www.pharmasources.com/industryinsights/urovant-strengthens-management-team-and--301253.html 0.6 2026-01-15T08:03:04+08:00 daily https://www.pharmasources.com/industryinsights/revolution-medicines-raises-another-56-m-301254.html 0.6 2026-07-06T05:41:00+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-arthritis-drug-gets-mixed-rec-301255.html 0.6 2026-03-17T18:25:47+08:00 daily https://www.pharmasources.com/industryinsights/cedilla-therapeutics-launches-with-562-m-301256.html 0.6 2026-04-06T00:21:25+08:00 daily https://www.pharmasources.com/industryinsights/new-analyses-from-pivotal-phase-iii-tria-301257.html 0.6 2026-06-08T19:36:24+08:00 daily https://www.pharmasources.com/industryinsights/aldeyra-therapeutics-announces-first-pat-301258.html 0.6 2026-06-23T07:32:23+08:00 daily https://www.pharmasources.com/industryinsights/tarveda-therapeutics-announces-dosing-of-301259.html 0.6 2026-07-05T06:09:09+08:00 daily https://www.pharmasources.com/industryinsights/freenome-and-biognosys-announce-collabor-301260.html 0.6 2026-07-05T00:45:20+08:00 daily https://www.pharmasources.com/industryinsights/third-rock-ventures-launches-cedilla-the-301261.html 0.6 2026-06-04T13:37:56+08:00 daily https://www.pharmasources.com/industryinsights/cytosorbents-enrolls-first-patient-into--301262.html 0.6 2026-07-07T05:17:08+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-announces-positive-lat-301263.html 0.6 2026-04-28T20:07:36+08:00 daily https://www.pharmasources.com/industryinsights/takeda-eyes-shire-will-it-be-2018s-bigge-301264.html 0.6 2026-04-21T02:38:17+08:00 daily https://www.pharmasources.com/industryinsights/somagenics-announces-upcoming-data-prese-301265.html 0.6 2026-02-15T03:19:17+08:00 daily https://www.pharmasources.com/industryinsights/quotient-limited-announces-fda-approval--301266.html 0.6 2026-06-16T13:14:57+08:00 daily https://www.pharmasources.com/industryinsights/science-37-and-visualdx-partner-to-provi-301267.html 0.6 2025-12-10T22:38:22+08:00 daily https://www.pharmasources.com/industryinsights/oral-biologics-delivery-could-be-the-key-301268.html 0.6 2026-02-09T06:36:45+08:00 daily https://www.pharmasources.com/industryinsights/groundbreaking-micromedicine-with-picosu-301269.html 0.6 2026-08-10T00:41:05+08:00 daily https://www.pharmasources.com/industryinsights/abeona-announces-fda-grants-rmat-designa-301270.html 0.6 2026-03-19T22:32:32+08:00 daily https://www.pharmasources.com/industryinsights/x-biotix-therapeutics-inc-secures-7-mill-301271.html 0.6 2026-02-28T15:32:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-pfizer-herceptin-biosimilar--301272.html 0.6 2026-06-08T21:55:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisors-back-lillyincytes-rheumatoi-301273.html 0.6 2026-06-20T12:02:25+08:00 daily https://www.pharmasources.com/industryinsights/mhra-bans-valproate-without-pregnancy-pr-301274.html 0.6 2026-04-01T12:45:11+08:00 daily https://www.pharmasources.com/industryinsights/tandem-announces-australia-new-zealand-d-301275.html 0.6 2026-06-10T10:30:44+08:00 daily https://www.pharmasources.com/industryinsights/zymeworks-celgene-expand-bispecific-anti-301276.html 0.6 2026-07-07T21:06:48+08:00 daily https://www.pharmasources.com/industryinsights/orexigen-to-be-sold-to-nalpropion-pharma-301277.html 0.6 2026-07-04T00:05:34+08:00 daily https://www.pharmasources.com/industryinsights/new-leadership-at-advaxis-301278.html 0.6 2026-03-31T08:50:53+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-receives-eir-from-usfda-for-uk-301279.html 0.6 2026-01-17T12:45:04+08:00 daily https://www.pharmasources.com/industryinsights/searo-makes-progress-in-malaria-eliminat-301280.html 0.6 2026-03-21T20:08:11+08:00 daily https://www.pharmasources.com/industryinsights/eu-reviewing-msds-keytrudachemo-combo-301281.html 0.6 2026-03-24T09:01:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-pfizers-herceptin-biosimilar-301282.html 0.6 2026-03-21T18:53:58+08:00 daily https://www.pharmasources.com/industryinsights/az-lung-cancer-combo-fails-to-hit-target-301283.html 0.6 2026-02-13T09:00:38+08:00 daily https://www.pharmasources.com/industryinsights/combination-of-astrazenecas-imfinzi-trem-301284.html 0.6 2026-04-16T03:55:52+08:00 daily https://www.pharmasources.com/industryinsights/takeda-reaches-preliminary-agreement-to--301285.html 0.6 2025-12-10T22:56:41+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-lifts-annual-guidance-as-first-301286.html 0.6 2026-05-03T00:56:59+08:00 daily https://www.pharmasources.com/industryinsights/catalent-bolsters-drug-development-capab-301287.html 0.6 2026-07-08T14:02:01+08:00 daily https://www.pharmasources.com/industryinsights/rapid-detection-of-pathogen-and-antibiot-301288.html 0.6 2026-08-07T18:31:58+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-introduces-mini-301289.html 0.6 2026-08-07T13:18:39+08:00 daily https://www.pharmasources.com/industryinsights/gsks-shingles-vaccine-is-bright-spot-in--301290.html 0.6 2026-08-07T00:40:38+08:00 daily https://www.pharmasources.com/industryinsights/overseas-partnerships-eli-lilly-forges-c-301291.html 0.6 2026-08-06T22:24:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-joins-innovative-solution-trend-301292.html 0.6 2026-07-09T01:04:08+08:00 daily https://www.pharmasources.com/industryinsights/stock-dives-as-celldex-cuts-20-of-staff--301293.html 0.6 2026-06-19T12:06:04+08:00 daily https://www.pharmasources.com/industryinsights/amgens-new-products-deliver-double-digit-301294.html 0.6 2026-05-23T02:52:26+08:00 daily https://www.pharmasources.com/industryinsights/former-alexion-execs-launch-rare-disease-301295.html 0.6 2025-12-10T23:06:50+08:00 daily https://www.pharmasources.com/industryinsights/corvidia-raises-60-million-series-b-to-p-301296.html 0.6 2026-07-27T06:51:37+08:00 daily https://www.pharmasources.com/industryinsights/results-from-positive-phase-2-study-of-n-301297.html 0.6 2026-07-02T16:39:42+08:00 daily https://www.pharmasources.com/industryinsights/paxvax-announces-the-initiation-of-phase-301298.html 0.6 2026-07-05T00:57:22+08:00 daily https://www.pharmasources.com/industryinsights/mylan-adds-to-growing-womens-healthcare--301299.html 0.6 2026-04-05T19:17:38+08:00 daily https://www.pharmasources.com/industryinsights/adc-bio-secures-114m-investment-from-dow-301300.html 0.6 2026-04-01T02:39:39+08:00 daily https://www.pharmasources.com/industryinsights/corvidia-therapeutics-secures-60-million-301301.html 0.6 2026-03-19T13:24:45+08:00 daily https://www.pharmasources.com/industryinsights/kamedis-conducts-1st-us-clinical-study-o-301302.html 0.6 2026-03-20T00:36:58+08:00 daily https://www.pharmasources.com/industryinsights/rallybio-established-by-industry-leaders-301303.html 0.6 2026-02-21T21:45:19+08:00 daily https://www.pharmasources.com/industryinsights/women-with-breast-cancer-risk-opting-out-301304.html 0.6 2026-07-05T02:44:38+08:00 daily https://www.pharmasources.com/industryinsights/shire-recommends-takedas-46bn-bid-301305.html 0.6 2026-04-17T02:17:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-mylotarg-wins-eu-approval-for-am-301306.html 0.6 2026-08-02T01:55:25+08:00 daily https://www.pharmasources.com/industryinsights/lillys-arthritis-drug-found-to-prevent-p-301307.html 0.6 2026-03-07T23:05:21+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-makes-ex-roche-scientist-new-rd-c-301308.html 0.6 2025-12-10T23:21:19+08:00 daily https://www.pharmasources.com/industryinsights/azs-immunotherapy-combo-fails-again-in-l-301309.html 0.6 2026-02-28T13:08:12+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-vaccine-receives-fdas-breakthroug-301310.html 0.6 2026-08-06T11:30:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-use-for-gsks-copd--301311.html 0.6 2026-07-25T07:30:46+08:00 daily https://www.pharmasources.com/industryinsights/otsukas-jynarque-garners-fda-approval-fo-301312.html 0.6 2026-08-06T14:31:09+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-posts-5-percent-sal-301313.html 0.6 2026-04-29T23:34:42+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-alder-showcase-latest-migraine-301314.html 0.6 2026-03-29T17:49:17+08:00 daily https://www.pharmasources.com/industryinsights/first-quarter-sales-of-glaxosmithklines--301315.html 0.6 2026-07-07T12:06:11+08:00 daily https://www.pharmasources.com/industryinsights/new-migraine-study-reveals-alder-drugs-t-301316.html 0.6 2026-04-17T01:13:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-actions-to-restrict-kids-acces-301317.html 0.6 2026-02-15T13:49:16+08:00 daily https://www.pharmasources.com/industryinsights/dubai-australia-tie-up-for-cancer-resear-301318.html 0.6 2026-01-04T12:44:57+08:00 daily https://www.pharmasources.com/industryinsights/collplant-opens-a-new-production-facilit-301319.html 0.6 2026-07-05T01:37:56+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-seeks-us-approval-of-risankizumab-301320.html 0.6 2026-07-15T06:03:44+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-a-derivative-selectively-kills-l-301321.html 0.6 2025-12-10T23:34:52+08:00 daily https://www.pharmasources.com/industryinsights/rapid-detection-of-pathogen-and-antibiot-301322.html 0.6 2026-07-17T17:49:56+08:00 daily https://www.pharmasources.com/industryinsights/institute-for-clinical-and-economic-revi-301323.html 0.6 2026-04-02T00:24:05+08:00 daily https://www.pharmasources.com/industryinsights/india-has-highest-prevalence-of-anemia-a-301324.html 0.6 2026-02-09T08:09:10+08:00 daily https://www.pharmasources.com/industryinsights/physician-views-what-opportunity-for-eyl-301325.html 0.6 2026-06-27T22:15:13+08:00 daily https://www.pharmasources.com/industryinsights/tarnea-launches-new-product-for-pharmacy-301326.html 0.6 2026-06-09T08:46:44+08:00 daily https://www.pharmasources.com/industryinsights/cone-beam-ct-offers-detailed-imaging-for-301327.html 0.6 2026-08-07T14:26:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorises-new-use-of-test-to-identi-301328.html 0.6 2026-06-23T02:06:07+08:00 daily https://www.pharmasources.com/industryinsights/combining-drugs-that-target-braf-and-hsp-301329.html 0.6 2026-08-05T22:00:16+08:00 daily https://www.pharmasources.com/industryinsights/acg-exhibits-a-wide-range-of-capsules-so-301330.html 0.6 2026-04-13T22:40:55+08:00 daily https://www.pharmasources.com/industryinsights/strong-sales-of-humira-imbruvica-and-hcv-301331.html 0.6 2026-04-09T18:33:24+08:00 daily https://www.pharmasources.com/industryinsights/are-pharma-companies-ready-for-gdrp-to-g-301332.html 0.6 2026-08-08T17:08:25+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-is-the-buzz-in-c-301333.html 0.6 2026-08-05T16:48:03+08:00 daily https://www.pharmasources.com/industryinsights/is-the-push-for-lower-drug-prices-surgin-301334.html 0.6 2025-12-11T20:04:37+08:00 daily https://www.pharmasources.com/industryinsights/mammoth-biosciences-comes-out-of-stealth-301335.html 0.6 2026-03-19T22:28:30+08:00 daily https://www.pharmasources.com/industryinsights/acadia-pharma-stock-plummets-after-fda-h-301336.html 0.6 2026-03-17T23:30:03+08:00 daily https://www.pharmasources.com/industryinsights/saniona-cleared-to-continue-phase-ii-pra-301337.html 0.6 2026-03-17T23:14:20+08:00 daily https://www.pharmasources.com/industryinsights/french-insulin-maker-spurned-by-eli-lill-301338.html 0.6 2026-07-20T05:59:41+08:00 daily https://www.pharmasources.com/industryinsights/tso3-details-results-of-prion-inactivati-301339.html 0.6 2026-08-06T02:25:23+08:00 daily https://www.pharmasources.com/industryinsights/foundation-medicines-new-liquid-biopsy-a-301340.html 0.6 2026-04-19T04:21:45+08:00 daily https://www.pharmasources.com/industryinsights/neuraltus-pharmaceuticals-reports-result-301341.html 0.6 2026-04-27T14:08:35+08:00 daily https://www.pharmasources.com/industryinsights/lupus-research-alliance-and-lupus-therap-301342.html 0.6 2026-02-15T13:31:45+08:00 daily https://www.pharmasources.com/industryinsights/promedica-health-system-to-acquire-hcr-m-301343.html 0.6 2025-12-10T23:57:23+08:00 daily https://www.pharmasources.com/industryinsights/new-migraine-registry-offers-hope-for-pa-301344.html 0.6 2026-08-06T12:54:33+08:00 daily https://www.pharmasources.com/industryinsights/imaging-may-allow-safe-tpa-treatment-of--301345.html 0.6 2026-04-30T20:12:40+08:00 daily https://www.pharmasources.com/industryinsights/lc-tem-provides-a-window-into-the-nanosc-301346.html 0.6 2026-06-25T11:16:17+08:00 daily https://www.pharmasources.com/industryinsights/bd-launches-bd-facsymphony-s6-high-param-301347.html 0.6 2026-06-07T21:40:11+08:00 daily https://www.pharmasources.com/industryinsights/innovus-pharma-announces-the-launch-of-i-301348.html 0.6 2025-12-11T00:01:25+08:00 daily https://www.pharmasources.com/industryinsights/cardiac-dimensions-announces-39-million--301349.html 0.6 2026-02-23T12:21:02+08:00 daily https://www.pharmasources.com/industryinsights/new-data-supports-dalazatide-from-kv13-t-301350.html 0.6 2026-02-05T02:38:38+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-completed-us150-milli-301351.html 0.6 2026-06-09T06:28:52+08:00 daily https://www.pharmasources.com/industryinsights/anticholinergic-medications-linked-to-de-301352.html 0.6 2026-06-24T10:07:00+08:00 daily https://www.pharmasources.com/industryinsights/mixed-results-from-roches-key-new-drugs--301353.html 0.6 2025-12-11T00:06:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-app-allows-ophthalmology-patien-301354.html 0.6 2026-07-19T23:40:42+08:00 daily https://www.pharmasources.com/industryinsights/astellas-files-experimental-aml-therapy-301355.html 0.6 2026-08-07T02:23:10+08:00 daily https://www.pharmasources.com/industryinsights/us-court-upholds-verdict-voiding-msds-cl-301356.html 0.6 2026-04-12T05:07:36+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-in-licenses-entasiss-broad-spect-301357.html 0.6 2026-07-06T20:48:49+08:00 daily https://www.pharmasources.com/industryinsights/uk-media-coverage-vastly-underrepresents-301358.html 0.6 2026-04-17T03:46:53+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-some-anticholinergic-drug-301359.html 0.6 2026-06-27T07:14:28+08:00 daily https://www.pharmasources.com/industryinsights/cabinet-approves-mou-with-brics-nations-301360.html 0.6 2026-04-30T18:44:33+08:00 daily https://www.pharmasources.com/industryinsights/eppendorf-continues-to-generate-above-av-301361.html 0.6 2026-05-20T17:23:08+08:00 daily https://www.pharmasources.com/industryinsights/fabian-buller-joins-as-chief-business-of-301362.html 0.6 2025-12-11T00:18:02+08:00 daily https://www.pharmasources.com/industryinsights/new-business-chief-at-immunogen-301363.html 0.6 2026-01-31T10:25:45+08:00 daily https://www.pharmasources.com/industryinsights/discgenics-announces-first-patient-treat-301364.html 0.6 2025-12-11T00:15:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-serious-immune-system-react-301365.html 0.6 2026-07-20T01:01:12+08:00 daily https://www.pharmasources.com/industryinsights/paxvax-announces-the-initiation-of-phase-301366.html 0.6 2026-05-03T03:32:24+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-first-quarter-sales-top-estimate-301367.html 0.6 2026-04-27T07:11:33+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-to-become-the-first-anti-pd-l-301368.html 0.6 2026-04-27T17:39:55+08:00 daily https://www.pharmasources.com/industryinsights/car-t-20-a-split-universal-and-programma-301369.html 0.6 2026-06-08T13:34:38+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-quarterly-sales-sluggish-with-foc-301370.html 0.6 2026-03-09T05:37:28+08:00 daily https://www.pharmasources.com/industryinsights/alexion-pharmaceuticals-to-file-for-fda--301371.html 0.6 2026-03-06T01:32:19+08:00 daily https://www.pharmasources.com/industryinsights/mereo-biopharmas-rationale-for-halting-i-301372.html 0.6 2026-08-05T01:09:21+08:00 daily https://www.pharmasources.com/industryinsights/strong-sales-of-humira-imbruvica-and-hcv-301373.html 0.6 2026-06-23T09:04:17+08:00 daily https://www.pharmasources.com/industryinsights/foundation-fighting-blindness-and-vitris-301374.html 0.6 2026-04-25T19:57:16+08:00 daily https://www.pharmasources.com/industryinsights/lyndra-inc-and-global-drug-commercializa-301375.html 0.6 2026-08-06T22:46:31+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-first-quarter-2018-business-eps-u-301376.html 0.6 2026-05-04T11:26:46+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-announces-8-million-cirm-grant-f-301377.html 0.6 2025-12-11T00:32:54+08:00 daily https://www.pharmasources.com/industryinsights/centogene-publishes-study-identifying-th-301378.html 0.6 2026-08-09T01:23:30+08:00 daily https://www.pharmasources.com/industryinsights/amgen-receives-positive-chmp-opinion-to--301379.html 0.6 2026-08-07T12:03:01+08:00 daily https://www.pharmasources.com/industryinsights/sqi-diagnostics-to-announce-second-quart-301380.html 0.6 2026-08-08T20:57:59+08:00 daily https://www.pharmasources.com/industryinsights/bolder-biotechnology-announces-positive--301381.html 0.6 2026-06-09T03:31:19+08:00 daily https://www.pharmasources.com/industryinsights/takedas-hard-won-shire-deal-and-nektar-i-301382.html 0.6 2026-06-17T11:53:33+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-rolls-out-copd-digi-301383.html 0.6 2026-07-07T05:04:16+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-tech-301384.html 0.6 2026-07-20T12:59:45+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-pins-hopes-on-novel-psoriasis-301385.html 0.6 2026-06-28T09:33:43+08:00 daily https://www.pharmasources.com/industryinsights/exasperated-allergan-investors-recruitin-301386.html 0.6 2026-06-25T12:06:28+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-next-generation-hiv-bat-301387.html 0.6 2026-06-30T17:02:15+08:00 daily https://www.pharmasources.com/industryinsights/gsk-strengthens-core-prescription-busine-301388.html 0.6 2026-07-05T14:53:58+08:00 daily https://www.pharmasources.com/industryinsights/takeda-bids-on-shire-for-64-billion-301389.html 0.6 2026-07-13T11:59:30+08:00 daily https://www.pharmasources.com/industryinsights/milkshake-study-reveals-how-gene-variant-301390.html 0.6 2026-08-05T05:08:36+08:00 daily https://www.pharmasources.com/industryinsights/fm-roche-dian-collaborate-for-personaliz-301391.html 0.6 2026-02-28T20:19:12+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-boost-stake-in-biosims-joint-v-301392.html 0.6 2025-12-11T00:47:32+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-to-build-new-rd-centre-in-shang-301393.html 0.6 2026-08-07T15:57:43+08:00 daily https://www.pharmasources.com/industryinsights/new-uses-for-existing-antiviral-drugs-301394.html 0.6 2026-08-10T01:48:21+08:00 daily https://www.pharmasources.com/industryinsights/researchers-3-d-print-electronics-and-ce-301395.html 0.6 2026-05-04T07:52:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-demand-puts-compugens-solid-tumor-ch-301396.html 0.6 2026-08-06T00:32:17+08:00 daily https://www.pharmasources.com/industryinsights/gi-toxicity-hits-midstage-sanofi-glp-1-d-301397.html 0.6 2026-01-30T20:04:11+08:00 daily https://www.pharmasources.com/industryinsights/takeda-announce-new-uk-md-ahead-of-possi-301398.html 0.6 2026-06-23T15:34:22+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-partners-with-chinese-institut-301399.html 0.6 2026-05-05T19:40:05+08:00 daily https://www.pharmasources.com/industryinsights/experimental-arthritis-drug-prevents-ste-301400.html 0.6 2026-05-06T22:25:22+08:00 daily https://www.pharmasources.com/industryinsights/jennifer-doudnas-new-crispr-company-will-301401.html 0.6 2026-06-15T01:49:12+08:00 daily https://www.pharmasources.com/industryinsights/werfen-sales-increases-over-13-per-cent-301402.html 0.6 2026-04-29T11:24:35+08:00 daily https://www.pharmasources.com/industryinsights/two-fda-drug-review-directors-to-leave-t-301403.html 0.6 2026-03-12T17:06:31+08:00 daily https://www.pharmasources.com/industryinsights/aska-neopharma-arm-team-up-for-rs350-cr--301404.html 0.6 2026-01-12T13:28:02+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-widespread-belief-in-mythica-301405.html 0.6 2026-04-20T23:15:54+08:00 daily https://www.pharmasources.com/industryinsights/vertex-to-test-cf-triple-combo-therapy-i-301406.html 0.6 2026-04-17T16:47:53+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-files-risankizumab-in-the-us-301407.html 0.6 2026-02-28T15:35:52+08:00 daily https://www.pharmasources.com/industryinsights/car-t-therapy-could-be-available-to-nhs--301408.html 0.6 2026-06-07T10:05:30+08:00 daily https://www.pharmasources.com/industryinsights/novel-cancer-immunotherapy-research-land-301409.html 0.6 2026-04-06T21:53:37+08:00 daily https://www.pharmasources.com/industryinsights/starpharma-completes-us-new-drug-applica-301410.html 0.6 2026-04-16T00:12:18+08:00 daily https://www.pharmasources.com/industryinsights/zeotis-to-expand-vaccine-research-facili-301411.html 0.6 2026-01-31T11:12:21+08:00 daily https://www.pharmasources.com/industryinsights/manufacturing-hiccup-in-china-trips-up-s-301412.html 0.6 2026-04-03T14:33:37+08:00 daily https://www.pharmasources.com/industryinsights/innovent-secures-funding-worth-150m-301413.html 0.6 2026-08-06T10:13:54+08:00 daily https://www.pharmasources.com/industryinsights/thinking-of-developing-a-universal-flu-j-301414.html 0.6 2025-12-11T01:10:25+08:00 daily https://www.pharmasources.com/industryinsights/nus-researchers-address-cancer-related-f-301415.html 0.6 2026-01-04T12:47:57+08:00 daily https://www.pharmasources.com/industryinsights/9-days-for-gardasil-9-china-hands-out-la-301416.html 0.6 2026-03-24T03:11:38+08:00 daily https://www.pharmasources.com/industryinsights/gsks-shingrix-blows-past-sales-projectio-301417.html 0.6 2026-04-14T02:23:46+08:00 daily https://www.pharmasources.com/industryinsights/singapore-with-strict-drug-laws-to-devel-301418.html 0.6 2026-02-28T15:30:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-hits-mexican-drugmaker-degasa-with-w-301419.html 0.6 2026-03-21T20:34:44+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-introduces-sem-for-3d-prin-301420.html 0.6 2026-08-09T17:26:50+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-drops-phase-3-trial-301421.html 0.6 2026-04-27T09:12:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-el-301422.html 0.6 2026-08-08T01:13:21+08:00 daily https://www.pharmasources.com/industryinsights/allergan-rd-head-still-sees-value-in-ror-301424.html 0.6 2026-03-19T17:03:00+08:00 daily https://www.pharmasources.com/industryinsights/3-d-printing-is-transforming-care-for-co-301425.html 0.6 2026-06-15T16:15:30+08:00 daily https://www.pharmasources.com/industryinsights/roche-reports-a-strong-start-in-2018-301426.html 0.6 2026-03-21T23:02:51+08:00 daily https://www.pharmasources.com/industryinsights/getting-to-true-agile-irt-5-questions-to-301427.html 0.6 2026-04-09T20:23:04+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-drops-phase-3-trial-301428.html 0.6 2026-06-30T23:03:40+08:00 daily https://www.pharmasources.com/industryinsights/a-potential-new-weapon-in-the-addiction--301429.html 0.6 2026-06-08T21:49:02+08:00 daily https://www.pharmasources.com/industryinsights/iterum-files-for-92m-ipo-to-bankroll-pha-301430.html 0.6 2026-04-29T02:40:06+08:00 daily https://www.pharmasources.com/industryinsights/cancer-drug-helps-treat-tuberculosis-by--301431.html 0.6 2025-12-11T01:26:58+08:00 daily https://www.pharmasources.com/industryinsights/calcium-based-mri-sensor-enables-more-se-301432.html 0.6 2026-08-05T23:19:22+08:00 daily https://www.pharmasources.com/industryinsights/denosumab-reduces-glucocorticoid-induced-301433.html 0.6 2026-07-30T04:36:27+08:00 daily https://www.pharmasources.com/industryinsights/gilead-verily-ally-to-analyze-immune-cel-301434.html 0.6 2026-08-06T00:38:32+08:00 daily https://www.pharmasources.com/industryinsights/ms-drug-could-reduce-painful-side-effect-301435.html 0.6 2026-03-21T13:13:04+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-to-slim-down-split-into-2-disti-301436.html 0.6 2026-04-06T23:04:04+08:00 daily https://www.pharmasources.com/industryinsights/incyte-wipes-out-late-phase-epacadostat--301437.html 0.6 2026-03-24T17:58:50+08:00 daily https://www.pharmasources.com/industryinsights/anti-pd-1pd-l1-monoclonal-antibodies-not-301438.html 0.6 2026-03-21T01:57:12+08:00 daily https://www.pharmasources.com/industryinsights/feng-zhang-quietly-starting-new-crispr-b-301439.html 0.6 2026-03-29T00:56:38+08:00 daily https://www.pharmasources.com/industryinsights/jazz-grabs-sparks-priority-review-vouche-301440.html 0.6 2026-04-15T17:04:04+08:00 daily https://www.pharmasources.com/industryinsights/sanofiregeneron-forced-to-slash-price-in-301441.html 0.6 2026-01-31T10:48:46+08:00 daily https://www.pharmasources.com/industryinsights/anti-pd-1pd-l1-monoclonal-antibodies-not-301442.html 0.6 2026-06-23T21:32:41+08:00 daily https://www.pharmasources.com/industryinsights/first-its-offices-then-its-websiteswhat--301443.html 0.6 2026-08-06T07:58:43+08:00 daily https://www.pharmasources.com/industryinsights/synthorx-reels-in-63m-to-push-synthetic--301444.html 0.6 2026-08-03T10:13:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-culls-5-experimental-cancer-trial-301445.html 0.6 2026-06-04T13:01:22+08:00 daily https://www.pharmasources.com/industryinsights/porton-biopharma-opens-new-leukaemia-dru-301446.html 0.6 2026-03-23T01:16:51+08:00 daily https://www.pharmasources.com/industryinsights/ovarian-cancer-rates-set-to-rise-by-55-301447.html 0.6 2026-03-17T22:21:02+08:00 daily https://www.pharmasources.com/industryinsights/karyopharm-slumps-then-leaps-on-selinexo-301448.html 0.6 2026-03-07T08:34:41+08:00 daily https://www.pharmasources.com/industryinsights/kiniksa-and-scholar-rock-gun-for-175m-ip-301449.html 0.6 2026-06-02T07:57:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-keytruda-priority-review-301450.html 0.6 2026-03-31T08:19:03+08:00 daily https://www.pharmasources.com/industryinsights/mrc-awards-bristol-researcher-12m-to-inv-301451.html 0.6 2026-05-29T17:05:37+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018050-301452.html 0.6 2026-06-08T18:02:47+08:00 daily https://www.pharmasources.com/industryinsights/attacking-treatment-resistant-prostate-c-301453.html 0.6 2026-08-07T06:58:35+08:00 daily https://www.pharmasources.com/industryinsights/esperions-phase-3-ldl-study-raises-flags-301454.html 0.6 2025-12-11T01:51:30+08:00 daily https://www.pharmasources.com/industryinsights/refuge-biotech-scores-25m-from-chinese-b-301455.html 0.6 2026-02-15T13:57:15+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-pens-140m-deal-for-precl-301456.html 0.6 2026-04-07T03:52:01+08:00 daily https://www.pharmasources.com/industryinsights/deshpande-leaves-achillion-after-oversee-301457.html 0.6 2026-07-04T15:07:29+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-results-show-glp-1s-are-job-301458.html 0.6 2026-04-06T00:36:19+08:00 daily https://www.pharmasources.com/industryinsights/watch-out-gileadnovartis-got-the-fda-nod-301459.html 0.6 2026-08-10T01:03:14+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-sanofi-strike-exclusive-pcsk9--301460.html 0.6 2026-06-30T00:46:57+08:00 daily https://www.pharmasources.com/industryinsights/gearing-up-for-junes-big-confab-lions-he-301461.html 0.6 2026-03-20T19:46:26+08:00 daily https://www.pharmasources.com/industryinsights/chinese-investors-back-drug-stocks-to-we-301462.html 0.6 2026-08-06T08:59:57+08:00 daily https://www.pharmasources.com/industryinsights/flexion-ceo-says-its-zilretta-representa-301463.html 0.6 2026-03-27T07:55:43+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-receives-usfda-approval-f-301464.html 0.6 2026-04-18T13:10:52+08:00 daily https://www.pharmasources.com/industryinsights/warner-chilcotts-marketing-probe-snared--301465.html 0.6 2026-04-08T16:01:46+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-stock-slides-after-reg-301466.html 0.6 2026-04-06T11:11:10+08:00 daily https://www.pharmasources.com/industryinsights/ono-pharma-submits-marketing-approval-of-301467.html 0.6 2026-07-05T18:23:04+08:00 daily https://www.pharmasources.com/industryinsights/indias-drug-regulatory-force-conducts-th-301468.html 0.6 2026-07-05T17:47:06+08:00 daily https://www.pharmasources.com/industryinsights/singapore-to-boost-liver-cancer-treatmen-301469.html 0.6 2026-01-29T07:34:50+08:00 daily https://www.pharmasources.com/industryinsights/daphne-koller-a-list-backers-unite-to-cr-301470.html 0.6 2025-12-11T02:07:45+08:00 daily https://www.pharmasources.com/industryinsights/with-hepatitis-c-in-freefall-gileads-bot-301471.html 0.6 2026-07-17T21:58:59+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-build-biomanufacturing-301472.html 0.6 2026-08-06T00:10:48+08:00 daily https://www.pharmasources.com/industryinsights/450000-missed-breast-cancer-screenings-2-301473.html 0.6 2026-08-09T07:56:25+08:00 daily https://www.pharmasources.com/industryinsights/bms-pulls-the-plug-on-phase-3-trials-of--301474.html 0.6 2026-08-09T02:18:47+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-shares-down-6bn-after--301475.html 0.6 2026-08-09T00:10:22+08:00 daily https://www.pharmasources.com/industryinsights/startup-ceo-who-injected-untested-herpes-301476.html 0.6 2026-08-07T19:34:57+08:00 daily https://www.pharmasources.com/industryinsights/mercks-ms-treatment-shows-promise-in-new-301477.html 0.6 2026-08-07T18:15:30+08:00 daily https://www.pharmasources.com/industryinsights/cruk-launches-18m-fund-for-brain-tumour--301478.html 0.6 2026-08-07T13:17:37+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-therapy-gets-second-fda-a-301479.html 0.6 2026-08-07T01:52:02+08:00 daily https://www.pharmasources.com/industryinsights/pill-for-breast-cancer-diagnosis-may-out-301480.html 0.6 2026-08-07T01:42:43+08:00 daily https://www.pharmasources.com/industryinsights/clinical-researcher-of-the-year-the-amer-301481.html 0.6 2026-08-07T01:22:36+08:00 daily https://www.pharmasources.com/industryinsights/us-priority-review-for-sanofi-regenerons-301482.html 0.6 2026-08-07T03:06:27+08:00 daily https://www.pharmasources.com/industryinsights/three-medicines-step-closer-to-eu-approv-301483.html 0.6 2026-08-07T03:33:35+08:00 daily https://www.pharmasources.com/industryinsights/analysis-links-us-government-global-heal-301484.html 0.6 2026-08-07T03:25:24+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-participates-in-new-researc-301485.html 0.6 2026-08-07T04:04:03+08:00 daily https://www.pharmasources.com/industryinsights/not-enough-women-included-in-some-heart--301486.html 0.6 2026-08-07T04:21:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-therapy-kymriah-receives--301487.html 0.6 2026-08-07T04:27:49+08:00 daily https://www.pharmasources.com/industryinsights/lapatinib-can-accelerate-cancer-cell-gro-301488.html 0.6 2026-08-07T04:36:41+08:00 daily https://www.pharmasources.com/industryinsights/cancer-vaccine-strategy-blocks-death-of--301489.html 0.6 2026-08-07T04:49:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tafinlarmekinist-for-braf-v-301490.html 0.6 2026-02-28T11:59:03+08:00 daily https://www.pharmasources.com/industryinsights/cellmid-inks-deal-with-chinas-fukangren--301491.html 0.6 2026-08-02T08:57:02+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-inks-deals-with-daiichi-an-301492.html 0.6 2026-08-09T06:30:57+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-pharma-to-split-into-two-entiti-301493.html 0.6 2026-04-09T04:22:54+08:00 daily https://www.pharmasources.com/industryinsights/medical-ai-startup-synyi-raises-157-m-301494.html 0.6 2026-08-02T19:53:14+08:00 daily https://www.pharmasources.com/industryinsights/korea-to-invest-334m-in-medical-ai-syste-301495.html 0.6 2026-06-08T20:24:02+08:00 daily https://www.pharmasources.com/industryinsights/singapore-researchers-discover-novel-the-301496.html 0.6 2026-04-20T06:36:51+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-licenses-starpharmas-vivagel-301497.html 0.6 2026-03-19T07:44:26+08:00 daily https://www.pharmasources.com/industryinsights/certain-iron-supplements-may-influence-t-301498.html 0.6 2026-08-07T03:55:22+08:00 daily https://www.pharmasources.com/industryinsights/uaes-neopharma-and-aska-of-japan-to-buil-301499.html 0.6 2026-04-06T00:17:03+08:00 daily https://www.pharmasources.com/industryinsights/drug-contamination-test-maker-rapid-micr-301500.html 0.6 2026-02-28T15:28:02+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-needs-revved-up-newcomers-to-b-301501.html 0.6 2025-12-28T23:04:37+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-halts-high-doses-of-phase-3-os-301502.html 0.6 2026-08-07T15:36:33+08:00 daily https://www.pharmasources.com/industryinsights/what-biosimilar-threat-roche-wins-anothe-301503.html 0.6 2026-07-24T09:41:11+08:00 daily https://www.pharmasources.com/industryinsights/review-of-policies-data-and-events-of-th-301504.html 0.6 2026-08-01T07:04:40+08:00 daily https://www.pharmasources.com/industryinsights/horizon-discovery-rejects-abcams-highly--301505.html 0.6 2026-03-01T03:38:09+08:00 daily https://www.pharmasources.com/industryinsights/chinas-pharmaceutical-innovation-to-ente-301506.html 0.6 2026-08-01T09:58:10+08:00 daily https://www.pharmasources.com/industryinsights/foresite-capital-closes-oversubscribed-6-301507.html 0.6 2026-01-14T08:35:31+08:00 daily https://www.pharmasources.com/industryinsights/eurobiotech-more-articles-of-note-301508.html 0.6 2026-07-08T06:33:51+08:00 daily https://www.pharmasources.com/industryinsights/crescendos-70m-round-horizon-rebuffs-abc-301509.html 0.6 2026-07-18T17:00:13+08:00 daily https://www.pharmasources.com/industryinsights/the-path-for-the-chinese-api-industry-to-301510.html 0.6 2026-07-20T03:02:14+08:00 daily https://www.pharmasources.com/industryinsights/c4-therapeutics-promotes-chief-science-o-301511.html 0.6 2026-08-06T23:48:12+08:00 daily https://www.pharmasources.com/industryinsights/with-the-arrival-of-the-deadline-small-a-301512.html 0.6 2026-08-06T20:07:19+08:00 daily https://www.pharmasources.com/industryinsights/christoph-westphal-back-on-the-horse-wit-301513.html 0.6 2026-08-06T22:08:04+08:00 daily https://www.pharmasources.com/industryinsights/casma-launches-with-585m-for-treatments--301514.html 0.6 2026-08-06T23:46:54+08:00 daily https://www.pharmasources.com/industryinsights/innovative-rd-atmosphere-gradually-becom-301515.html 0.6 2026-08-06T22:54:11+08:00 daily https://www.pharmasources.com/industryinsights/why-chinese-cros-low-key-all-the-time-fi-301516.html 0.6 2026-08-07T00:02:30+08:00 daily https://www.pharmasources.com/industryinsights/bayers-growth-driving-quintet-better-mak-301517.html 0.6 2026-08-06T23:57:21+08:00 daily https://www.pharmasources.com/industryinsights/cutting-costs-and-copaxone-prices-pays-o-301518.html 0.6 2026-08-07T00:40:55+08:00 daily https://www.pharmasources.com/industryinsights/chinas-wuxi-biologics-to-build-biologics-301519.html 0.6 2026-08-07T01:19:28+08:00 daily https://www.pharmasources.com/industryinsights/bms-looks-to-leverage-real-world-data-wi-301520.html 0.6 2026-08-07T02:22:14+08:00 daily https://www.pharmasources.com/industryinsights/new-study-argues-the-importance-of-exist-301521.html 0.6 2026-08-07T02:30:41+08:00 daily https://www.pharmasources.com/industryinsights/recreational-drug-mdma-proves-efficacy-i-301522.html 0.6 2026-08-07T02:33:37+08:00 daily https://www.pharmasources.com/industryinsights/speakers-announced-for-veeva-rd-summit-e-301523.html 0.6 2026-08-07T04:34:02+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-us-woes-continue-with-biosimilar--301524.html 0.6 2026-08-07T05:02:15+08:00 daily https://www.pharmasources.com/industryinsights/janssen-acquires-benevir-biopharm-to-adv-301525.html 0.6 2026-04-05T20:33:50+08:00 daily https://www.pharmasources.com/industryinsights/demands-for-plant-extracts-to-constantly-301526.html 0.6 2026-08-07T01:10:57+08:00 daily https://www.pharmasources.com/industryinsights/bayer-cuts-profit-guidance-301527.html 0.6 2026-01-12T16:58:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-biosimilar-rituximab-delayed-in-301528.html 0.6 2026-04-16T23:40:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-becomes-first-to-gain-second-ca-301529.html 0.6 2026-03-02T19:39:20+08:00 daily https://www.pharmasources.com/industryinsights/development-trend-of-going-green-and-env-301530.html 0.6 2026-07-20T23:00:18+08:00 daily https://www.pharmasources.com/industryinsights/botox-rivals-are-looming-thats-why-its-n-301531.html 0.6 2026-01-25T13:21:09+08:00 daily https://www.pharmasources.com/industryinsights/size-of-the-global-pharmaceutical-packag-301532.html 0.6 2026-02-15T13:31:01+08:00 daily https://www.pharmasources.com/industryinsights/the-latest-rules-for-the-accreditation-o-301533.html 0.6 2026-08-07T10:29:34+08:00 daily https://www.pharmasources.com/industryinsights/world-courier-supports-its-global-depot--301534.html 0.6 2026-02-09T12:55:10+08:00 daily https://www.pharmasources.com/industryinsights/a-reflection-of-the-pharmaceutical-equip-301535.html 0.6 2026-08-07T05:07:18+08:00 daily https://www.pharmasources.com/industryinsights/hand-in-hand-on-the-belt-and-road-pharme-301536.html 0.6 2026-08-07T05:01:38+08:00 daily https://www.pharmasources.com/industryinsights/new-leads-on-treating-dementia-and-alzhe-301537.html 0.6 2026-08-07T04:34:19+08:00 daily https://www.pharmasources.com/industryinsights/industrys-largest-survey-on-serializatio-301538.html 0.6 2026-08-07T04:22:16+08:00 daily https://www.pharmasources.com/industryinsights/china-eliminates-import-duties-on-28-ind-301539.html 0.6 2026-08-07T03:33:33+08:00 daily https://www.pharmasources.com/industryinsights/refuge-biotechnologies-secures-25m-fundi-301540.html 0.6 2026-08-07T00:40:21+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-astar-co-develop-innovativ-301541.html 0.6 2026-08-07T01:19:24+08:00 daily https://www.pharmasources.com/industryinsights/new-study-gives-hope-to-fight-minimal-tu-301542.html 0.6 2025-12-23T16:28:52+08:00 daily https://www.pharmasources.com/industryinsights/inspire-medical-systems-upsizes-ipo-301543.html 0.6 2026-08-09T14:24:15+08:00 daily https://www.pharmasources.com/industryinsights/daily-aspirin-linked-to-higher-risk-in-m-301544.html 0.6 2025-11-07T09:45:01+08:00 daily https://www.pharmasources.com/industryinsights/use-of-nsaids-reduces-progression-free-s-301545.html 0.6 2026-08-06T19:59:44+08:00 daily https://www.pharmasources.com/industryinsights/zoledronic-acid-could-be-used-to-treat-b-301546.html 0.6 2026-08-06T23:32:51+08:00 daily https://www.pharmasources.com/industryinsights/chmp-takes-negative-view-on-sareptas-dmd-301547.html 0.6 2026-08-06T23:36:31+08:00 daily https://www.pharmasources.com/industryinsights/merck-invests-in-moderna-301548.html 0.6 2026-08-06T23:38:18+08:00 daily https://www.pharmasources.com/industryinsights/herceptin-biosimilar-herzuma-launched-in-301549.html 0.6 2026-08-06T23:46:14+08:00 daily https://www.pharmasources.com/industryinsights/mat-blood-test-safely-and-accurately-dia-301550.html 0.6 2026-08-06T23:54:35+08:00 daily https://www.pharmasources.com/industryinsights/long-term-benefit-of-qarziba-uncertain-s-301551.html 0.6 2026-08-07T00:02:37+08:00 daily https://www.pharmasources.com/industryinsights/organ-chips-model-and-predict-thrombotic-301552.html 0.6 2026-08-07T00:39:52+08:00 daily https://www.pharmasources.com/industryinsights/top-ten-most-popular-articles-this-week-301553.html 0.6 2026-08-08T18:05:37+08:00 daily https://www.pharmasources.com/industryinsights/los-angeles-becomes-latest-us-city-to-su-301554.html 0.6 2026-08-07T05:28:44+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-gets-two-thumbs-down-from-f-301555.html 0.6 2026-06-19T23:06:40+08:00 daily https://www.pharmasources.com/industryinsights/free-webinar-rational-eu-risk-management-301556.html 0.6 2026-03-25T19:02:16+08:00 daily https://www.pharmasources.com/industryinsights/hazards-of-growth-by-ma-debt-laden-conco-301557.html 0.6 2026-02-19T02:14:07+08:00 daily https://www.pharmasources.com/industryinsights/patent-fights-jump-in-2017-as-eli-lilly--301558.html 0.6 2026-07-19T05:22:13+08:00 daily https://www.pharmasources.com/industryinsights/sham-or-public-interest-icer-suggests-70-301559.html 0.6 2026-03-17T10:55:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-chief-gottlieb-to-pharma-those-rebat-301561.html 0.6 2026-05-01T22:01:44+08:00 daily https://www.pharmasources.com/industryinsights/chinas-historic-drug-nod-biogens-stepped-301562.html 0.6 2025-12-11T03:40:05+08:00 daily https://www.pharmasources.com/industryinsights/teva-expects-fda-preapproval-inspection--301563.html 0.6 2025-12-21T20:44:47+08:00 daily https://www.pharmasources.com/industryinsights/the-minor-effects-of-multiple-genetic-va-301564.html 0.6 2026-04-29T19:52:32+08:00 daily https://www.pharmasources.com/industryinsights/after-fda-rebuff-celgene-on-track-to-ref-301565.html 0.6 2026-08-03T19:41:45+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-adds-muscular-dystrophy-gene-the-301566.html 0.6 2026-02-28T15:35:50+08:00 daily https://www.pharmasources.com/industryinsights/fox-foundation-and-charles-river-renew-p-301567.html 0.6 2026-08-06T08:42:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-delays-decision-on-inotersen-handing-301568.html 0.6 2025-12-11T03:46:08+08:00 daily https://www.pharmasources.com/industryinsights/adverum-loses-ceo-cmo-in-quick-fire-depa-301569.html 0.6 2026-07-24T00:16:37+08:00 daily https://www.pharmasources.com/industryinsights/moderna-grabs-125m-in-expanded-merck-can-301570.html 0.6 2026-08-02T02:31:43+08:00 daily https://www.pharmasources.com/industryinsights/medical-device-woes-torpedo-cardinal-hea-301572.html 0.6 2026-03-19T08:10:12+08:00 daily https://www.pharmasources.com/industryinsights/hologic-makes-732m-write-down-as-recent--301573.html 0.6 2026-04-21T06:52:32+08:00 daily https://www.pharmasources.com/industryinsights/ucb-and-science-37-partner-up-for-virtua-301574.html 0.6 2026-07-10T01:51:16+08:00 daily https://www.pharmasources.com/industryinsights/sirtex-medical-gets-unsolicited-141b-cou-301575.html 0.6 2026-04-12T12:38:46+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-changzhou-site-passes-first-us--301576.html 0.6 2026-08-07T22:14:54+08:00 daily https://www.pharmasources.com/industryinsights/michele-marin-appointed-as-new-member-of-301577.html 0.6 2026-04-20T02:45:52+08:00 daily https://www.pharmasources.com/industryinsights/werfen-increases-sales-by-over-13-and-re-301578.html 0.6 2026-04-04T18:10:19+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-invest-325-million-to--301579.html 0.6 2026-03-18T04:43:26+08:00 daily https://www.pharmasources.com/industryinsights/to-treat-pain-you-need-to-treat-the-pati-301580.html 0.6 2026-02-20T19:55:29+08:00 daily https://www.pharmasources.com/industryinsights/abcam-and-shuwen-biotech-sign-strategic--301581.html 0.6 2026-04-20T13:40:12+08:00 daily https://www.pharmasources.com/industryinsights/haselmeier-and-common-sensing-enter-conn-301582.html 0.6 2026-08-05T06:50:03+08:00 daily https://www.pharmasources.com/industryinsights/the-swiss-biotech-association-honors-maj-301583.html 0.6 2025-10-27T05:30:45+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-participates-in-new-researc-301584.html 0.6 2026-07-02T12:54:04+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-otl-200-receives-ra-301585.html 0.6 2026-07-31T16:55:27+08:00 daily https://www.pharmasources.com/industryinsights/smi-presents-the-9th-conference-on-biosi-301586.html 0.6 2025-11-08T05:27:10+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-neurimmune-announce-option-ex-301587.html 0.6 2026-06-24T12:09:04+08:00 daily https://www.pharmasources.com/industryinsights/atara-hires-ex-genentech-svp-to-lead-glo-301588.html 0.6 2026-01-25T12:11:02+08:00 daily https://www.pharmasources.com/industryinsights/turning-crispr-from-a-gene-editing-hatch-301589.html 0.6 2026-03-18T23:44:06+08:00 daily https://www.pharmasources.com/industryinsights/belldegruns-allogene-looks-to-poach-vete-301590.html 0.6 2026-01-31T00:35:12+08:00 daily https://www.pharmasources.com/industryinsights/promore-sells-rights-to-pxl01-in-spinal--301591.html 0.6 2026-01-30T13:25:52+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-preps-for-esketamine-fil-301592.html 0.6 2026-07-31T13:41:52+08:00 daily https://www.pharmasources.com/industryinsights/optimize-human-gene-transfer-trials-crea-301593.html 0.6 2025-11-07T04:11:28+08:00 daily https://www.pharmasources.com/industryinsights/why-choose-a-site-network-for-your-clini-301594.html 0.6 2026-08-08T00:56:23+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018050-301595.html 0.6 2026-08-07T22:54:10+08:00 daily https://www.pharmasources.com/industryinsights/genetic-test-maker-color-teams-with-heal-301596.html 0.6 2026-04-05T20:40:53+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-taps-invitae-to-identify-partici-301597.html 0.6 2026-03-27T02:23:51+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-cocktail-hops-into-the--301598.html 0.6 2026-08-05T10:43:52+08:00 daily https://www.pharmasources.com/industryinsights/where-is-pfizer-putting-its-rd-hopes-vac-301599.html 0.6 2026-07-08T08:26:40+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-bids-16b-for-novartis-us-derma-301600.html 0.6 2026-06-23T09:32:16+08:00 daily https://www.pharmasources.com/industryinsights/why-did-merck-issue-an-unusual-press-rel-301601.html 0.6 2026-06-19T08:42:26+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-alleges-blatant-fraud-at-the-v-301602.html 0.6 2026-06-12T15:10:06+08:00 daily https://www.pharmasources.com/industryinsights/portolas-andexxa-bleeding-antidote-wins--301603.html 0.6 2026-02-09T07:33:28+08:00 daily https://www.pharmasources.com/industryinsights/precisioneffect-boosts-digital-chops-glo-301604.html 0.6 2026-01-05T00:10:51+08:00 daily https://www.pharmasources.com/industryinsights/aslan-prices-ipo-of-its-american-deposit-301605.html 0.6 2026-03-26T17:45:48+08:00 daily https://www.pharmasources.com/industryinsights/pharma-has-a-real-world-problem-and-its--301606.html 0.6 2026-03-17T19:44:34+08:00 daily https://www.pharmasources.com/industryinsights/ironwoods-no-angel-campaign-taps-into-st-301607.html 0.6 2026-08-04T17:58:49+08:00 daily https://www.pharmasources.com/industryinsights/hype-or-hope-new-e-book-tackles-artifici-301608.html 0.6 2026-06-08T14:04:06+08:00 daily https://www.pharmasources.com/industryinsights/rxcelerate-acquires-bioanalysis-cro-tota-301609.html 0.6 2026-03-28T05:48:58+08:00 daily https://www.pharmasources.com/industryinsights/news-of-notea-drug-to-reduce-age-related-301610.html 0.6 2026-06-13T02:48:29+08:00 daily https://www.pharmasources.com/industryinsights/to-treat-corneal-blindness-atelerix-ltd--301611.html 0.6 2026-07-03T10:23:20+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-launches-16-billion-bid-to-buy-301612.html 0.6 2026-03-12T15:32:27+08:00 daily https://www.pharmasources.com/industryinsights/kindred-biosciences-receives-fda-approva-301613.html 0.6 2025-12-27T17:46:18+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-receives-pai-from-the-us-fda-301614.html 0.6 2026-07-31T05:48:38+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develops-a-glue-to-fix-broke-301615.html 0.6 2025-12-24T12:55:07+08:00 daily https://www.pharmasources.com/industryinsights/microbeads-to-combat-infection-show-prom-301616.html 0.6 2026-01-21T21:28:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-places-paxvaxs-phase-2-chikungunya-s-301617.html 0.6 2026-02-28T13:15:08+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-plant-gets-fda-nod-for-2-apis-p-301618.html 0.6 2026-07-16T09:48:35+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-vault-into-big-pharma-with-62b-301619.html 0.6 2026-08-06T00:59:08+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-continues-yard-sale-strategy-301620.html 0.6 2026-04-01T01:34:37+08:00 daily https://www.pharmasources.com/industryinsights/south-africas-aspen-opens-80m-high-poten-301621.html 0.6 2026-07-01T02:29:18+08:00 daily https://www.pharmasources.com/industryinsights/ts-another-dust-up-over-astrazenecas-ceo-301622.html 0.6 2026-08-06T19:57:39+08:00 daily https://www.pharmasources.com/industryinsights/meet-the-new-valeant-drugmaker-drops-tai-301623.html 0.6 2026-04-01T12:33:10+08:00 daily https://www.pharmasources.com/industryinsights/boosted-by-china-launch-mercks-gardasil--301624.html 0.6 2026-02-15T14:24:18+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-darzalex-snags-landmark-301625.html 0.6 2026-06-29T02:19:13+08:00 daily https://www.pharmasources.com/industryinsights/improved-glass-slide-turns-microscopes-i-301626.html 0.6 2026-01-12T18:04:23+08:00 daily https://www.pharmasources.com/industryinsights/antipsychotics-during-pregnancy-may-rais-301627.html 0.6 2026-06-06T18:58:49+08:00 daily https://www.pharmasources.com/industryinsights/bacteria-therapy-shows-promise-for-eczem-301628.html 0.6 2026-01-30T20:27:03+08:00 daily https://www.pharmasources.com/industryinsights/celecoxib-shows-potential-benefit-for-du-301629.html 0.6 2026-03-23T10:47:41+08:00 daily https://www.pharmasources.com/industryinsights/ai-algorithm-detects-retinopathy-of-prem-301630.html 0.6 2026-04-29T18:42:25+08:00 daily https://www.pharmasources.com/industryinsights/artificial-retina-may-restore-sight-301631.html 0.6 2026-05-05T04:30:50+08:00 daily https://www.pharmasources.com/industryinsights/takeda-clinches-62b-deal-to-drugmaker-sh-301632.html 0.6 2026-05-05T16:40:33+08:00 daily https://www.pharmasources.com/industryinsights/who-asks-se-asia-to-promote-hand-hygiene-301633.html 0.6 2026-05-02T20:53:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-selects-two-targets-under-partner-301634.html 0.6 2026-06-20T16:47:45+08:00 daily https://www.pharmasources.com/industryinsights/new-chief-at-biodelivery-sciences-301635.html 0.6 2026-04-19T04:24:15+08:00 daily https://www.pharmasources.com/industryinsights/who-starts-its-first-cholera-vaccine-cam-301636.html 0.6 2026-03-24T00:10:32+08:00 daily https://www.pharmasources.com/industryinsights/dar-to-merge-with-pear-tree-pharma-301637.html 0.6 2026-03-21T20:12:18+08:00 daily https://www.pharmasources.com/industryinsights/pharma-tech-company-wuxi-apptec-announce-301638.html 0.6 2026-07-19T22:58:56+08:00 daily https://www.pharmasources.com/industryinsights/delcath-launches-pivotal-study-to-treat--301639.html 0.6 2026-08-09T06:20:10+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-enterprises-to-be-listed--301640.html 0.6 2026-07-29T23:36:30+08:00 daily https://www.pharmasources.com/industryinsights/mahdeep-system-reform-to-promote-pharmac-301641.html 0.6 2026-07-21T12:52:12+08:00 daily https://www.pharmasources.com/industryinsights/lupin-submits-new-drug-application-for-e-301642.html 0.6 2026-04-15T11:25:14+08:00 daily https://www.pharmasources.com/industryinsights/lupin-submits-new-drug-application-for-e-301643.html 0.6 2026-06-22T09:36:57+08:00 daily https://www.pharmasources.com/industryinsights/mri-glove-provides-clear-images-of-hand--301644.html 0.6 2026-04-30T19:32:58+08:00 daily https://www.pharmasources.com/industryinsights/to-treat-corneal-blindness-atelerix-ltd--301645.html 0.6 2026-04-06T09:42:34+08:00 daily https://www.pharmasources.com/industryinsights/mri-glove-provides-clear-images-of-hand--301646.html 0.6 2026-06-08T23:44:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-rights-for-seroquel-to-301647.html 0.6 2026-07-08T03:31:30+08:00 daily https://www.pharmasources.com/industryinsights/ardena-acquisition-strengthens-api-offer-301648.html 0.6 2026-01-25T13:22:02+08:00 daily https://www.pharmasources.com/industryinsights/business-combination-creates-5th-largest-301649.html 0.6 2025-12-07T23:09:57+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-changzhou-site-passes-first-fda-301650.html 0.6 2026-08-08T23:50:29+08:00 daily https://www.pharmasources.com/industryinsights/rssl-appoints-new-head-of-training-301651.html 0.6 2026-03-05T17:24:29+08:00 daily https://www.pharmasources.com/industryinsights/essential-malaria-parasite-genes-reveale-301652.html 0.6 2026-03-23T15:44:22+08:00 daily https://www.pharmasources.com/industryinsights/value-added-formulations-for-generic-and-301653.html 0.6 2026-03-28T17:27:24+08:00 daily https://www.pharmasources.com/industryinsights/catalent-announces-organizational-restru-301654.html 0.6 2026-04-19T08:50:33+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-to-build-new-rd-center-in-shang-301655.html 0.6 2026-07-21T09:06:36+08:00 daily https://www.pharmasources.com/industryinsights/glycoscores-technique-accelerates-protei-301656.html 0.6 2026-03-31T02:48:36+08:00 daily https://www.pharmasources.com/industryinsights/rssl-appoints-new-head-of-training-301657.html 0.6 2026-01-21T13:46:16+08:00 daily https://www.pharmasources.com/industryinsights/sponsored-trial-of-a-universal-influenza-301658.html 0.6 2025-11-02T10:57:51+08:00 daily https://www.pharmasources.com/industryinsights/triboluminescence-instrument-rapidly-tes-301659.html 0.6 2026-06-27T04:27:14+08:00 daily https://www.pharmasources.com/industryinsights/abcam-ends-pursuit-of-270m-horizon-disco-301660.html 0.6 2026-06-24T06:07:41+08:00 daily https://www.pharmasources.com/industryinsights/gsks-cfo-chooses-to-exit-company-301661.html 0.6 2026-08-09T21:45:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-roches-can-301662.html 0.6 2026-07-17T16:27:11+08:00 daily https://www.pharmasources.com/industryinsights/hypertensive-patients-may-benefit-from-f-301663.html 0.6 2026-06-21T11:56:15+08:00 daily https://www.pharmasources.com/industryinsights/chemical-octopus-catches-sneaky-cancer-c-301664.html 0.6 2026-02-15T13:31:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-luye-pharma-group-enter--301665.html 0.6 2026-07-10T11:25:34+08:00 daily https://www.pharmasources.com/industryinsights/new-leads-on-treating-dementia-and-alzhe-301666.html 0.6 2026-08-06T17:59:02+08:00 daily https://www.pharmasources.com/industryinsights/smi-presents-the-9th-conference-on-biosi-301667.html 0.6 2026-04-13T23:30:39+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-participates-in-new-researc-301668.html 0.6 2026-06-20T17:26:52+08:00 daily https://www.pharmasources.com/industryinsights/strides-apotex-merge-their-australian-bu-301669.html 0.6 2026-08-09T17:59:35+08:00 daily https://www.pharmasources.com/industryinsights/google-rebrands-its-google-research-divi-301670.html 0.6 2026-07-04T06:49:51+08:00 daily https://www.pharmasources.com/industryinsights/facebook-opens-new-ai-research-labs-in-s-301671.html 0.6 2026-04-29T21:46:16+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-corcal-bone-and-beauty-su-301672.html 0.6 2026-08-08T01:08:15+08:00 daily https://www.pharmasources.com/industryinsights/epygen-plans-to-raise-rs-300-cr-to-prope-301673.html 0.6 2026-07-01T05:05:36+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-to-present-updated-info--301674.html 0.6 2026-04-09T16:39:09+08:00 daily https://www.pharmasources.com/industryinsights/annual-opex-in-pharma-summit-to-be-held--301675.html 0.6 2026-08-06T04:52:49+08:00 daily https://www.pharmasources.com/industryinsights/cipla-partners-with-mannkind-for-afrezza-301676.html 0.6 2026-06-23T16:14:16+08:00 daily https://www.pharmasources.com/industryinsights/ai-can-guess-chances-of-getting-a-heart--301677.html 0.6 2026-06-21T03:18:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-says-there-is-shortage-of-mylans-epi-301678.html 0.6 2026-06-13T18:02:39+08:00 daily https://www.pharmasources.com/industryinsights/osteoporosis-drug-could-treat-human-hair-301679.html 0.6 2026-03-25T00:27:26+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-cause-of-resistance--301680.html 0.6 2026-04-02T07:32:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tafinlar-mekinist-combinati-301681.html 0.6 2026-06-14T15:51:05+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-agreement-to-acquire-arm-301682.html 0.6 2026-07-26T16:40:26+08:00 daily https://www.pharmasources.com/industryinsights/aquinox-and-astellas-announce-exclusive--301683.html 0.6 2026-07-07T00:16:03+08:00 daily https://www.pharmasources.com/industryinsights/lodo-therapeutics-corporation-forms-mult-301684.html 0.6 2026-06-13T14:13:38+08:00 daily https://www.pharmasources.com/industryinsights/merck-highlights-anemias-higher-risk-for-301685.html 0.6 2026-07-07T13:31:32+08:00 daily https://www.pharmasources.com/industryinsights/aravive-biologics-achieves-proof-of-mech-301686.html 0.6 2026-08-01T11:42:53+08:00 daily https://www.pharmasources.com/industryinsights/risk-management-planning-signal-manageme-301687.html 0.6 2026-07-05T20:06:42+08:00 daily https://www.pharmasources.com/industryinsights/3ms-patient-warming-device-goes-on-trial-301688.html 0.6 2026-06-19T11:00:05+08:00 daily https://www.pharmasources.com/industryinsights/reject-trumps-threat-to-affordable-medic-301689.html 0.6 2025-11-23T07:59:46+08:00 daily https://www.pharmasources.com/industryinsights/nafdac-reopens-emzor-pharmaceutical-firm-301690.html 0.6 2026-01-31T10:55:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-eyes-ai-powered-drug-discovery-an-301691.html 0.6 2026-01-04T13:45:08+08:00 daily https://www.pharmasources.com/industryinsights/3-companies-linked-to-bank-fraud-bad-deb-301692.html 0.6 2026-04-27T16:12:59+08:00 daily https://www.pharmasources.com/industryinsights/unsettled-issues-at-the-minnesota-legisl-301693.html 0.6 2026-06-23T14:01:53+08:00 daily https://www.pharmasources.com/industryinsights/early-thoughts-on-autolus-ipo-301694.html 0.6 2026-01-31T03:34:52+08:00 daily https://www.pharmasources.com/industryinsights/experimental-vaccine-to-be-used-against--301695.html 0.6 2026-01-17T13:34:43+08:00 daily https://www.pharmasources.com/industryinsights/keep-showing-up-a-q-and-a-with-this-is-h-301696.html 0.6 2026-02-08T17:43:38+08:00 daily https://www.pharmasources.com/industryinsights/watchman-thrombi-not-infrequent-may-caus-301697.html 0.6 2026-03-29T00:36:48+08:00 daily https://www.pharmasources.com/industryinsights/csrc-approves-spin-off-of-carbon-biotech-301698.html 0.6 2026-06-12T07:29:57+08:00 daily https://www.pharmasources.com/industryinsights/changing-of-the-guard-at-european-chemic-301700.html 0.6 2026-06-09T10:44:26+08:00 daily https://www.pharmasources.com/industryinsights/german-premier-angela-merkel-marks-merck-301701.html 0.6 2026-06-12T01:00:35+08:00 daily https://www.pharmasources.com/industryinsights/chinese-chemical-firms-forced-to-stop-pr-301702.html 0.6 2026-07-02T18:08:17+08:00 daily https://www.pharmasources.com/industryinsights/making-acs-meetings-welcoming-portals-to-301703.html 0.6 2026-07-07T19:24:02+08:00 daily https://www.pharmasources.com/industryinsights/communications-team-of-the-year-new-chal-301704.html 0.6 2026-01-05T06:12:47+08:00 daily https://www.pharmasources.com/industryinsights/unisound-raises-100m-from-cec-data-fund-301705.html 0.6 2026-06-28T13:01:07+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-lens-to-reduce-myopi-301706.html 0.6 2026-02-28T13:35:42+08:00 daily https://www.pharmasources.com/industryinsights/researchers-create-3-d-printed-mouth-gua-301707.html 0.6 2026-07-04T00:31:09+08:00 daily https://www.pharmasources.com/industryinsights/vyriad-signs-a-contract-with-ibm-to-buil-301708.html 0.6 2026-06-24T09:45:50+08:00 daily https://www.pharmasources.com/industryinsights/us-biotech-firm-stealth-may-apply-for-ho-301709.html 0.6 2026-07-17T16:07:17+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-buy-armo-biosciences-for-us-301710.html 0.6 2026-08-08T17:00:57+08:00 daily https://www.pharmasources.com/industryinsights/biotech-firm-ascletis-first-to-apply-for-301711.html 0.6 2026-08-08T15:11:50+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-opens-headquarters-in-si-301712.html 0.6 2026-08-07T21:32:10+08:00 daily https://www.pharmasources.com/industryinsights/neuclone-announces-preclinical-results-f-301713.html 0.6 2026-08-07T03:03:01+08:00 daily https://www.pharmasources.com/industryinsights/review-of-new-policies-of-chinese-medica-301714.html 0.6 2026-08-07T02:51:53+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018051-301715.html 0.6 2026-08-07T02:46:00+08:00 daily https://www.pharmasources.com/industryinsights/coeliac-uk-innovate-uk-launch-research-c-301716.html 0.6 2025-12-15T13:38:21+08:00 daily https://www.pharmasources.com/industryinsights/emergex-wins-innovate-uk-grant-to-advanc-301717.html 0.6 2026-08-07T03:03:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novartis-gilenya-for-paedia-301718.html 0.6 2025-11-09T16:03:59+08:00 daily https://www.pharmasources.com/industryinsights/price-cuts-secure-nhs-place-for-ms-drugs-301719.html 0.6 2026-08-09T14:32:53+08:00 daily https://www.pharmasources.com/industryinsights/only-one-week-to-go---book-now-301720.html 0.6 2026-06-23T00:23:46+08:00 daily https://www.pharmasources.com/industryinsights/janssens-tremfya-backed-for-nhs-use-301721.html 0.6 2026-06-18T06:39:12+08:00 daily https://www.pharmasources.com/industryinsights/lilly-buys-armo-biosciences-for-16-billi-301722.html 0.6 2026-07-27T05:47:45+08:00 daily https://www.pharmasources.com/industryinsights/medigene-and-bluebird-bio-expand-immunot-301723.html 0.6 2026-06-18T05:29:08+08:00 daily https://www.pharmasources.com/industryinsights/takeda-financials-show-why-the-shire-dea-301724.html 0.6 2026-07-29T08:54:15+08:00 daily https://www.pharmasources.com/industryinsights/new-cancer-immunotherapy-drugs-rapidly-r-301725.html 0.6 2026-08-07T02:51:44+08:00 daily https://www.pharmasources.com/industryinsights/pharma-unfazed-by-trump-price-reduction--301726.html 0.6 2026-04-04T19:38:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-first-paediatric-ms-approval--301727.html 0.6 2026-06-22T06:09:51+08:00 daily https://www.pharmasources.com/industryinsights/free-webinar-eu-risk-management-for-onco-301728.html 0.6 2026-04-23T04:36:14+08:00 daily https://www.pharmasources.com/industryinsights/janssens-tremfya-gets-go-ahead-from-nice-301729.html 0.6 2026-01-13T17:27:10+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriqcotellic-combo-therapy-f-301730.html 0.6 2026-04-12T20:53:27+08:00 daily https://www.pharmasources.com/industryinsights/engineers-make-drug-microparticles-a-tho-301731.html 0.6 2026-04-13T01:08:10+08:00 daily https://www.pharmasources.com/industryinsights/azs-fasenra-stumbles-in-p3-for-copd-301732.html 0.6 2026-06-21T19:22:07+08:00 daily https://www.pharmasources.com/industryinsights/dia-cmc-workshop-301733.html 0.6 2026-06-21T11:31:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-moves-quickly-to-secure-16bn-buyou-301734.html 0.6 2026-07-29T11:54:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-lawsuits-against-stem-cell--301735.html 0.6 2026-06-10T12:55:58+08:00 daily https://www.pharmasources.com/industryinsights/emergex-vaccines-receives-grant-for-univ-301736.html 0.6 2026-06-13T13:02:04+08:00 daily https://www.pharmasources.com/industryinsights/lodo-and-roche-go-digging-for-drug-candi-301737.html 0.6 2026-05-14T08:38:37+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-healthcare-boost-digital-ad-s-301738.html 0.6 2026-07-08T08:26:58+08:00 daily https://www.pharmasources.com/industryinsights/senator-launching-probe-into-novartis-de-301739.html 0.6 2026-07-14T18:27:39+08:00 daily https://www.pharmasources.com/industryinsights/discngine-receives-600000-funding-from-b-301740.html 0.6 2026-06-22T00:21:35+08:00 daily https://www.pharmasources.com/industryinsights/amplexor-webinar-transformation-in-life--301741.html 0.6 2026-03-17T10:15:48+08:00 daily https://www.pharmasources.com/industryinsights/uae-conducts-an-innovative-medical-study-301742.html 0.6 2026-07-16T18:06:14+08:00 daily https://www.pharmasources.com/industryinsights/from-old-behemoth-lipitor-to-new-king-hu-301743.html 0.6 2026-01-12T20:35:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-perrigo-knockoff-of-tevas-pr-301744.html 0.6 2025-11-12T01:55:32+08:00 daily https://www.pharmasources.com/industryinsights/semma-therapeutics-appoints-new-presiden-301745.html 0.6 2026-02-23T12:40:54+08:00 daily https://www.pharmasources.com/industryinsights/treatment-for-mrsa-no-longer-more-costly-301746.html 0.6 2026-03-01T21:34:22+08:00 daily https://www.pharmasources.com/industryinsights/noninvasive-therapy-may-reverse-atherosc-301747.html 0.6 2026-07-01T10:55:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-a--301748.html 0.6 2026-06-08T18:32:37+08:00 daily https://www.pharmasources.com/industryinsights/isim-tirf-microscope-offers-unprecedente-301749.html 0.6 2026-06-21T18:28:32+08:00 daily https://www.pharmasources.com/industryinsights/oral-antibiotics-may-raise-risk-of-kidne-301750.html 0.6 2025-12-29T07:23:18+08:00 daily https://www.pharmasources.com/industryinsights/market-layout-and-development-prospects--301751.html 0.6 2026-07-16T04:40:43+08:00 daily https://www.pharmasources.com/industryinsights/latest-release-of-cfda-the-upgraded-and--301752.html 0.6 2026-07-30T23:38:26+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-vet-travis-wager-takes-rd-reins-a-301753.html 0.6 2026-07-17T21:22:12+08:00 daily https://www.pharmasources.com/industryinsights/roche-pens-death-notice-for-newlink-idot-301754.html 0.6 2026-06-21T22:15:18+08:00 daily https://www.pharmasources.com/industryinsights/celsius-bags-65m-to-develop-precision-dr-301755.html 0.6 2026-06-16T16:12:40+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-startup-meiragtx-files-for--301756.html 0.6 2026-06-08T23:36:58+08:00 daily https://www.pharmasources.com/industryinsights/zymeworks-could-get-up-to-485m-in-expand-301757.html 0.6 2026-06-13T00:46:21+08:00 daily https://www.pharmasources.com/industryinsights/attacking-the-common-cold-by-unshielding-301758.html 0.6 2026-06-22T04:18:33+08:00 daily https://www.pharmasources.com/industryinsights/box-and-usdm-work-together-to-keep-your--301759.html 0.6 2026-07-03T13:06:50+08:00 daily https://www.pharmasources.com/industryinsights/stephen-eck-leaves-aravive-ceo-job-to-jo-301760.html 0.6 2026-07-02T14:58:32+08:00 daily https://www.pharmasources.com/industryinsights/atyr-slashes-headcount-cuts-costs-after--301761.html 0.6 2026-07-19T23:26:53+08:00 daily https://www.pharmasources.com/industryinsights/bispecific-antibody-builder-abpro-postpo-301762.html 0.6 2026-08-07T17:39:26+08:00 daily https://www.pharmasources.com/industryinsights/celldex-plans-life-after-glembatumumab-c-301763.html 0.6 2026-03-19T00:24:30+08:00 daily https://www.pharmasources.com/industryinsights/faron-fingers-low-bioactivity-as-possibl-301764.html 0.6 2026-02-28T15:21:57+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-adds-targets-500m-in-milestones-301765.html 0.6 2026-01-19T16:02:16+08:00 daily https://www.pharmasources.com/industryinsights/in-split-vote-fda-advisory-committee-bac-301766.html 0.6 2026-02-28T08:33:00+08:00 daily https://www.pharmasources.com/industryinsights/australia-allocates-393-m-to-nanotechnol-301767.html 0.6 2026-04-12T23:37:19+08:00 daily https://www.pharmasources.com/industryinsights/semma-names-former-novartis-magenta-exec-301768.html 0.6 2026-04-05T07:15:47+08:00 daily https://www.pharmasources.com/industryinsights/computer-modeling-improves-life-span-of--301769.html 0.6 2026-02-15T00:40:42+08:00 daily https://www.pharmasources.com/industryinsights/lilly-boosts-immuno-oncology-pipeline-wi-301770.html 0.6 2026-05-25T14:03:33+08:00 daily https://www.pharmasources.com/industryinsights/feng-zhang-and-david-lius-base-editing-c-301771.html 0.6 2026-08-06T20:19:34+08:00 daily https://www.pharmasources.com/industryinsights/astellas-to-pay-aquinox-25m-upfront-for--301772.html 0.6 2026-04-07T12:32:11+08:00 daily https://www.pharmasources.com/industryinsights/longer-term-results-back-rhythms-ultrara-301773.html 0.6 2026-02-15T13:30:08+08:00 daily https://www.pharmasources.com/industryinsights/kitov-pharma-inks-deal-with-chinas-chang-301774.html 0.6 2026-07-18T19:59:47+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-tees-up-for-50m-ipo-301775.html 0.6 2026-07-06T17:35:10+08:00 daily https://www.pharmasources.com/industryinsights/amgen-opens-its-next-generation-workplac-301776.html 0.6 2026-07-03T23:57:56+08:00 daily https://www.pharmasources.com/industryinsights/using-machine-learning-to-see-inside-liv-301777.html 0.6 2026-08-07T02:51:23+08:00 daily https://www.pharmasources.com/industryinsights/new-online-customer-portal-for-custom-re-301778.html 0.6 2026-06-09T15:44:44+08:00 daily https://www.pharmasources.com/industryinsights/novartis-durect-renegotiate-293m-painkil-301779.html 0.6 2026-07-08T23:01:12+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-acquire-aurka-pharma-301780.html 0.6 2026-06-21T01:39:41+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-in-pursuit-of-novartis-ry-301781.html 0.6 2026-02-28T18:21:28+08:00 daily https://www.pharmasources.com/industryinsights/osteoporosis-drug-may-benefit-heart-heal-301782.html 0.6 2025-12-14T23:15:28+08:00 daily https://www.pharmasources.com/industryinsights/china-invests-85-m-in-ansun-biopharma-301783.html 0.6 2026-06-14T18:34:38+08:00 daily https://www.pharmasources.com/industryinsights/agilent-completes-acquisition-of-genohm-301784.html 0.6 2026-06-22T08:19:41+08:00 daily https://www.pharmasources.com/industryinsights/plano-partners-with-hpb-to-address-child-301785.html 0.6 2026-06-20T17:46:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-briviact-for-partial-onset--301786.html 0.6 2026-06-09T13:46:21+08:00 daily https://www.pharmasources.com/industryinsights/vbi-vaccines-touts-positive-phase-1-data-301787.html 0.6 2026-03-07T06:02:27+08:00 daily https://www.pharmasources.com/industryinsights/mercks-experimental-ebola-shot-gets-set--301788.html 0.6 2026-04-10T00:11:47+08:00 daily https://www.pharmasources.com/industryinsights/chinas-sinovac-biotech-halts-hepatitis-a-301789.html 0.6 2026-04-04T23:39:45+08:00 daily https://www.pharmasources.com/industryinsights/amplexor-webinar-transformation-in-life--301790.html 0.6 2026-04-01T07:59:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-places-paxvaxs-phase-2-chikungunya-s-301791.html 0.6 2026-07-17T14:16:36+08:00 daily https://www.pharmasources.com/industryinsights/where-is-pfizer-putting-its-rd-hopes-vac-301792.html 0.6 2026-08-07T13:04:34+08:00 daily https://www.pharmasources.com/industryinsights/manufacturing-hiccup-in-china-trips-up-s-301793.html 0.6 2025-12-14T22:57:59+08:00 daily https://www.pharmasources.com/industryinsights/thinking-of-developing-a-universal-flu-j-301794.html 0.6 2026-04-05T20:23:47+08:00 daily https://www.pharmasources.com/industryinsights/new-rabies-test-could-radically-change-t-301795.html 0.6 2026-08-05T05:05:42+08:00 daily https://www.pharmasources.com/industryinsights/better-diet-quality-associated-with-larg-301796.html 0.6 2026-04-13T03:42:19+08:00 daily https://www.pharmasources.com/industryinsights/addition-of-cannabidiol-may-cut-drop-sei-301797.html 0.6 2026-02-15T08:31:30+08:00 daily https://www.pharmasources.com/industryinsights/more-cases-in-lettuce-linked-e-coli-outb-301798.html 0.6 2026-01-21T09:42:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lucemyra-301799.html 0.6 2026-04-30T04:58:51+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-301800.html 0.6 2025-12-16T03:54:49+08:00 daily https://www.pharmasources.com/industryinsights/biolamina-and-novo-nordisk-partner-to-ad-301801.html 0.6 2026-04-27T11:52:01+08:00 daily https://www.pharmasources.com/industryinsights/nonprofit-manufacturer-could-keep-generi-301802.html 0.6 2026-08-08T23:44:26+08:00 daily https://www.pharmasources.com/industryinsights/low-dose-of-cbd-oil-eases-epilepsy-seizu-301803.html 0.6 2026-04-19T02:44:16+08:00 daily https://www.pharmasources.com/industryinsights/organs-from-opioid-od-victims-are-saving-301804.html 0.6 2026-01-12T03:17:48+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-patients-may-shorten-herce-301805.html 0.6 2026-04-13T07:18:26+08:00 daily https://www.pharmasources.com/industryinsights/hepatitis-c-exposed-infants-not-adequate-301806.html 0.6 2026-04-07T14:29:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-retacrit-301807.html 0.6 2026-03-12T08:38:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-indication-for-tru-301808.html 0.6 2026-02-07T11:50:41+08:00 daily https://www.pharmasources.com/industryinsights/aerie-pharmaceuticals-submits-nda-to-fda-301809.html 0.6 2026-02-08T11:24:09+08:00 daily https://www.pharmasources.com/industryinsights/ucb-announces-briviact-brivaracetam-now--301810.html 0.6 2026-04-03T03:23:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-subcutaneous-formulation-of-301811.html 0.6 2026-08-03T00:54:50+08:00 daily https://www.pharmasources.com/industryinsights/japan-approves-stem-cell-based-trials-fo-301812.html 0.6 2026-06-22T08:11:15+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-increases-commitment-to-cel-301813.html 0.6 2026-07-03T09:19:01+08:00 daily https://www.pharmasources.com/industryinsights/us-china-to-sign-mou-for-biotechnology-i-301814.html 0.6 2026-07-07T12:32:01+08:00 daily https://www.pharmasources.com/industryinsights/qventus-receives-30m-investment-to-bring-301815.html 0.6 2026-08-07T22:51:51+08:00 daily https://www.pharmasources.com/industryinsights/jeil-pharma-unveils-new-research-centre-301816.html 0.6 2026-06-25T00:21:26+08:00 daily https://www.pharmasources.com/industryinsights/asymchem-cofounds-innovative-drug-fund-301817.html 0.6 2026-08-09T08:23:00+08:00 daily https://www.pharmasources.com/industryinsights/new-molecule-to-improve-pharmaceuticals--301818.html 0.6 2026-01-03T15:20:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-non-opioid-treatment--301819.html 0.6 2026-04-13T20:22:11+08:00 daily https://www.pharmasources.com/industryinsights/mabvax-receives-patent-for-fully-human-a-301820.html 0.6 2026-04-23T01:58:43+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-reports-results-of-phase-2-stu-301821.html 0.6 2026-04-05T12:23:33+08:00 daily https://www.pharmasources.com/industryinsights/crysvita-study-met-primary-endpoint-301822.html 0.6 2026-06-28T09:20:32+08:00 daily https://www.pharmasources.com/industryinsights/amneal-announces-fda-approval-launch-of--301823.html 0.6 2026-01-03T00:33:11+08:00 daily https://www.pharmasources.com/industryinsights/amgen-receives-ec-approval-for-repatha-301824.html 0.6 2026-08-04T12:33:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-epoetin-alfa-biosimil-301825.html 0.6 2026-07-01T06:54:14+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-use-genome-editing-in-study-of--301826.html 0.6 2026-05-05T13:37:52+08:00 daily https://www.pharmasources.com/industryinsights/auromedics-pharma-issues-voluntary-natio-301827.html 0.6 2026-03-01T15:10:57+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-announces-first-patient-dosed-i-301828.html 0.6 2026-02-15T13:35:56+08:00 daily https://www.pharmasources.com/industryinsights/amneal-introduces-first-generic-for-meph-301829.html 0.6 2026-08-08T18:04:58+08:00 daily https://www.pharmasources.com/industryinsights/lillys-galcanezumab-meets-primary-endpoi-301830.html 0.6 2026-06-29T17:14:16+08:00 daily https://www.pharmasources.com/industryinsights/alkahest-announces-start-of-two-phase-2--301831.html 0.6 2025-11-27T20:45:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-gilenya-301832.html 0.6 2026-02-28T15:32:45+08:00 daily https://www.pharmasources.com/industryinsights/ucb-announces-briviact-approved-by-fda-301833.html 0.6 2026-07-06T19:05:20+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-confirms-first-to-file-patent-ch-301834.html 0.6 2026-06-09T13:31:16+08:00 daily https://www.pharmasources.com/industryinsights/fasenra-does-not-meet-primary-endpoint-i-301835.html 0.6 2026-08-02T17:40:29+08:00 daily https://www.pharmasources.com/industryinsights/auromedics-pharma-issues-voluntary-natio-301836.html 0.6 2026-06-11T18:47:12+08:00 daily https://www.pharmasources.com/industryinsights/amneal-to-close-hayward-california-based-301837.html 0.6 2026-03-28T22:20:53+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-terminates-43-billion-merger-w-301838.html 0.6 2026-07-30T08:36:54+08:00 daily https://www.pharmasources.com/industryinsights/rxi-receives-patent-from-uspto-301839.html 0.6 2026-06-14T19:31:36+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-agreement-to-acquire-arm-301840.html 0.6 2026-06-30T11:01:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-seeks-permanent-injunctions-against--301841.html 0.6 2026-08-02T13:08:48+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-getting-to-grips-with-qualit-301842.html 0.6 2026-08-06T23:45:57+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-resubmits-new-drug-application-fo-301843.html 0.6 2026-06-08T17:48:33+08:00 daily https://www.pharmasources.com/industryinsights/tecentriq-cotellic-did-not-meet-primary--301844.html 0.6 2026-03-17T22:25:46+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-build-new-cdmo-plant-301845.html 0.6 2026-06-25T23:30:17+08:00 daily https://www.pharmasources.com/industryinsights/ligand-pharma-readies-650m-convertible-d-301846.html 0.6 2026-03-01T20:14:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-non-opioid-treatment--301847.html 0.6 2026-06-18T09:45:21+08:00 daily https://www.pharmasources.com/industryinsights/cerus-receives-15m-government-contract-301848.html 0.6 2026-07-04T02:06:38+08:00 daily https://www.pharmasources.com/industryinsights/indoco-facilities-bag-us-fda-nod-301849.html 0.6 2026-03-17T21:24:25+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-posts-q4-fy18-and-fy18-re-301850.html 0.6 2026-07-10T12:17:00+08:00 daily https://www.pharmasources.com/industryinsights/stempeutics-partners-with-cipla-301851.html 0.6 2026-05-20T07:22:41+08:00 daily https://www.pharmasources.com/industryinsights/biocon-sells-188-pc-stake-in-syngene-for-301852.html 0.6 2026-01-12T17:21:10+08:00 daily https://www.pharmasources.com/industryinsights/veeda-clinical-research-bags-assocham-aw-301853.html 0.6 2026-02-10T11:59:08+08:00 daily https://www.pharmasources.com/industryinsights/iscrs-theme-for-international-clinical-t-301854.html 0.6 2026-06-08T19:46:19+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-launches-authorised-generic-f-301855.html 0.6 2025-12-28T05:25:33+08:00 daily https://www.pharmasources.com/industryinsights/divis-labs-choutuppal-unit-1-gets-us-fda-301856.html 0.6 2026-07-04T21:40:49+08:00 daily https://www.pharmasources.com/industryinsights/suven-gets-product-patents-by-australia--301857.html 0.6 2026-03-29T00:45:07+08:00 daily https://www.pharmasources.com/industryinsights/morepen-laboratories-posts-25-rise-in-it-301858.html 0.6 2026-04-07T10:16:41+08:00 daily https://www.pharmasources.com/industryinsights/granules-gets-us-fda-nod-for-postpartum--301859.html 0.6 2026-08-09T13:57:47+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-posts-net-profit-of-rs-93-301860.html 0.6 2026-06-24T11:33:14+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-to-host-scientific--301861.html 0.6 2026-02-06T18:18:17+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-launches-seretide-accuha-301862.html 0.6 2026-08-07T05:01:12+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-eir-for-telangana-fa-301863.html 0.6 2026-04-10T07:50:06+08:00 daily https://www.pharmasources.com/industryinsights/veeda-cro-launches-new-website-301864.html 0.6 2026-01-31T00:33:06+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-achieves-milestone-in-stem--301865.html 0.6 2026-07-30T13:12:53+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-gets-us-fda-nod-for-heart--301866.html 0.6 2025-11-12T22:11:36+08:00 daily https://www.pharmasources.com/industryinsights/pig-virus-may-pose-threat-to-humans-stud-301867.html 0.6 2026-07-28T14:34:04+08:00 daily https://www.pharmasources.com/industryinsights/netmeds-appoints-ms-dhoni-as-brand-ambas-301868.html 0.6 2026-03-09T03:17:47+08:00 daily https://www.pharmasources.com/industryinsights/goran-pharmas-gujarat-facility-receives--301869.html 0.6 2026-08-04T12:05:36+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-buy-aurka-pharma-301870.html 0.6 2026-06-22T22:31:49+08:00 daily https://www.pharmasources.com/industryinsights/jb-chemicals-and-pharmaceuticals-gets-us-301871.html 0.6 2026-02-15T00:39:42+08:00 daily https://www.pharmasources.com/industryinsights/ipga-felicitates-dilip-sanghvi-md-sun-ph-301872.html 0.6 2026-04-16T17:34:47+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-completes-inspection-of-lupins-na-301873.html 0.6 2026-01-04T13:50:49+08:00 daily https://www.pharmasources.com/industryinsights/9-valent-hpv-vaccine-will-go-through-cus-301874.html 0.6 2026-08-06T04:55:23+08:00 daily https://www.pharmasources.com/industryinsights/universal-antibodies-disarm-various-path-301875.html 0.6 2026-06-28T03:19:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-epilepsy-medication-lyrica-gives-301876.html 0.6 2026-07-04T02:28:44+08:00 daily https://www.pharmasources.com/industryinsights/efforts-to-form-asias-leading-ivf-medica-301877.html 0.6 2026-01-12T00:58:54+08:00 daily https://www.pharmasources.com/industryinsights/cuba-and-china-expand-cooperation-in-the-301878.html 0.6 2026-04-19T14:39:37+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-sanofis-drug-shows-positive-ef-301879.html 0.6 2026-08-08T01:39:53+08:00 daily https://www.pharmasources.com/industryinsights/unaids-calls-for-an-increase-in-vaccine--301880.html 0.6 2026-07-04T07:46:55+08:00 daily https://www.pharmasources.com/industryinsights/insmed-appoints-leo-lee-to-its-board-of--301881.html 0.6 2026-08-07T02:55:24+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018052-301882.html 0.6 2026-08-07T02:52:01+08:00 daily https://www.pharmasources.com/industryinsights/gc-pharma-idri-mibr-launch-curevo-301883.html 0.6 2026-08-07T03:03:08+08:00 daily https://www.pharmasources.com/industryinsights/roche-announces-haven-3-haven-4-study-re-301884.html 0.6 2026-08-07T03:12:34+08:00 daily https://www.pharmasources.com/industryinsights/avenue-announces-positive-phase-3-trial--301885.html 0.6 2026-08-07T03:25:03+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-announces-positive-trial-results-301886.html 0.6 2026-08-07T03:33:49+08:00 daily https://www.pharmasources.com/industryinsights/pdl-biopharma-appoints-bd-vp-301887.html 0.6 2026-08-07T03:55:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-harmony-breakthrough-therapy--301888.html 0.6 2026-08-07T04:22:24+08:00 daily https://www.pharmasources.com/industryinsights/astex-to-install-thermo-fishers-glacios--301889.html 0.6 2026-08-07T04:26:02+08:00 daily https://www.pharmasources.com/industryinsights/genvion-adds-spray-drying-capabilities-301890.html 0.6 2026-08-07T05:06:54+08:00 daily https://www.pharmasources.com/industryinsights/galecto-biotech-appoints-cmo-301891.html 0.6 2026-01-05T05:03:42+08:00 daily https://www.pharmasources.com/industryinsights/gc-pharma-establishes-vax-subsidiary-301892.html 0.6 2026-04-03T15:37:42+08:00 daily https://www.pharmasources.com/industryinsights/arthritis-drugs-potentially-safe-for-exp-301893.html 0.6 2026-08-07T04:19:58+08:00 daily https://www.pharmasources.com/industryinsights/xenogesis-to-move-into-biocity-discovery-301894.html 0.6 2026-06-21T21:24:21+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-bioasis-in-strategic-devm-301895.html 0.6 2026-07-09T16:31:50+08:00 daily https://www.pharmasources.com/industryinsights/vectalys-flashcell-merge-to-form-new-gen-301896.html 0.6 2026-04-06T09:22:58+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-expands-operations-301897.html 0.6 2026-03-26T21:10:23+08:00 daily https://www.pharmasources.com/industryinsights/ge-increases-cell-culture-media-producti-301898.html 0.6 2026-03-18T18:41:17+08:00 daily https://www.pharmasources.com/industryinsights/catalent-completes-55m-clinical-storage--301899.html 0.6 2026-04-17T10:09:01+08:00 daily https://www.pharmasources.com/industryinsights/oncolytics-merck-northwestern-conduct-ph-301900.html 0.6 2026-07-05T22:12:00+08:00 daily https://www.pharmasources.com/industryinsights/tedor-pharma-makes-organizational-change-301901.html 0.6 2026-04-02T01:46:14+08:00 daily https://www.pharmasources.com/industryinsights/biothera-appoints-cfo-301902.html 0.6 2026-04-09T07:27:38+08:00 daily https://www.pharmasources.com/industryinsights/txa-may-benefit-stroke-patients-301903.html 0.6 2026-08-06T02:47:54+08:00 daily https://www.pharmasources.com/industryinsights/west-introduces-new-analytical-services-301904.html 0.6 2026-08-08T22:04:28+08:00 daily https://www.pharmasources.com/industryinsights/algenuity-appoints-new-chief-scientific--301905.html 0.6 2026-08-07T09:11:01+08:00 daily https://www.pharmasources.com/industryinsights/anticancer-drug-nintedanib-found-to-be-e-301906.html 0.6 2025-11-03T17:33:21+08:00 daily https://www.pharmasources.com/industryinsights/takeda-divests-techpool-to-joint-venture-301907.html 0.6 2026-01-31T08:35:06+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approves-astrazenecas-lokelma-301908.html 0.6 2025-10-20T07:51:51+08:00 daily https://www.pharmasources.com/industryinsights/congo-begins-ebola-vaccination-301909.html 0.6 2026-07-30T14:07:57+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drugs-show-promise-to-treat-sym-301910.html 0.6 2026-06-17T08:57:37+08:00 daily https://www.pharmasources.com/industryinsights/nih-funds-three-national-cryo-em-service-301911.html 0.6 2026-02-28T13:34:58+08:00 daily https://www.pharmasources.com/industryinsights/salubris-announces-investment-deal-with--301912.html 0.6 2026-06-30T10:58:40+08:00 daily https://www.pharmasources.com/industryinsights/web-tool-predicts-phenotypes-from-a-dna--301913.html 0.6 2026-06-21T00:51:48+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-improves-stroke--301914.html 0.6 2025-12-06T04:48:09+08:00 daily https://www.pharmasources.com/industryinsights/cbd-significantly-reduces-seizures-in-pa-301915.html 0.6 2026-02-28T18:51:36+08:00 daily https://www.pharmasources.com/industryinsights/china-creates-innovative-medical-instrum-301916.html 0.6 2026-03-07T10:09:35+08:00 daily https://www.pharmasources.com/industryinsights/accent-therapeutics-to-provide-precision-301917.html 0.6 2026-06-14T01:15:45+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-new-possibilities-with-cardi-301918.html 0.6 2026-07-04T01:02:21+08:00 daily https://www.pharmasources.com/industryinsights/nipah-virus-causes-panic-attack-in-keral-301919.html 0.6 2025-11-08T18:03:55+08:00 daily https://www.pharmasources.com/industryinsights/singapore-researchers-offer-new-hope-for-301920.html 0.6 2026-05-06T18:47:58+08:00 daily https://www.pharmasources.com/industryinsights/axogen-appoints-karen-as-chairman-of-the-301921.html 0.6 2026-07-16T16:45:05+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-and-mitsubishi-tanabe-initiate--301922.html 0.6 2026-04-30T18:51:46+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-debuts-its-codar-arms-pcr-liquid--301923.html 0.6 2026-04-27T09:15:22+08:00 daily https://www.pharmasources.com/industryinsights/new-insights-into-hookipas-therat-replic-301924.html 0.6 2025-11-10T10:40:24+08:00 daily https://www.pharmasources.com/industryinsights/agendias-mammaprint-and-blueprint-breast-301925.html 0.6 2026-04-07T17:17:24+08:00 daily https://www.pharmasources.com/industryinsights/successful-first-series-c-round-closing--301926.html 0.6 2026-01-21T21:59:46+08:00 daily https://www.pharmasources.com/industryinsights/emergex-awarded-innovate-uk-grant-to-pro-301927.html 0.6 2026-03-21T00:37:22+08:00 daily https://www.pharmasources.com/industryinsights/new-uv-monitor-kit-for-large-scale-purif-301928.html 0.6 2026-05-03T14:11:54+08:00 daily https://www.pharmasources.com/industryinsights/celonic-ag-appoints-soenke-brunswieck-as-301929.html 0.6 2026-06-07T22:01:51+08:00 daily https://www.pharmasources.com/industryinsights/abcam-and-shuwen-biotech-sign-strategic--301930.html 0.6 2026-08-08T16:19:33+08:00 daily https://www.pharmasources.com/industryinsights/the-swiss-biotech-association-honors-maj-301931.html 0.6 2026-05-22T11:47:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-data-at-asco-and-eha-reinforce--301932.html 0.6 2026-04-27T09:08:59+08:00 daily https://www.pharmasources.com/industryinsights/ovarian-cancer-drug-shows-promise-in-pan-301933.html 0.6 2026-04-20T22:41:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-preventive-treatment--301934.html 0.6 2026-04-13T22:55:34+08:00 daily https://www.pharmasources.com/industryinsights/doctors-in-us-and-canada-launch-sweeping-301935.html 0.6 2026-04-09T20:18:04+08:00 daily https://www.pharmasources.com/industryinsights/smi-presents-the-launch-of-cell-gene-the-301936.html 0.6 2026-08-08T01:00:09+08:00 daily https://www.pharmasources.com/industryinsights/stroke-prevention-drug-combo-shows-promi-301937.html 0.6 2026-04-26T23:48:11+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-increases-commitment-to-ste-301938.html 0.6 2026-03-24T05:34:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-epoetin-alfa-biosimil-301939.html 0.6 2026-02-09T09:18:16+08:00 daily https://www.pharmasources.com/industryinsights/first-clues-to-the-causes-of-multiple-sc-301940.html 0.6 2026-03-22T08:24:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-ablynx-announce-the-successfu-301941.html 0.6 2026-01-18T21:13:31+08:00 daily https://www.pharmasources.com/industryinsights/guidance-on-the-usage-of-cphi-pre-show-m-301942.html 0.6 2026-07-20T02:43:22+08:00 daily https://www.pharmasources.com/industryinsights/even-reported-by-cctv-the-tcm-industry-m-301943.html 0.6 2026-06-25T17:30:23+08:00 daily https://www.pharmasources.com/industryinsights/research-claims-childhood-leukemia-likel-301944.html 0.6 2026-04-24T21:57:23+08:00 daily https://www.pharmasources.com/industryinsights/a-single-injection-vaccine-for-the-polio-301945.html 0.6 2025-11-28T03:28:22+08:00 daily https://www.pharmasources.com/industryinsights/innovative-light-delivery-technique-impr-301946.html 0.6 2026-08-07T03:45:42+08:00 daily https://www.pharmasources.com/industryinsights/ebselen-provides-promising-new-avenue-fo-301947.html 0.6 2026-02-25T15:01:17+08:00 daily https://www.pharmasources.com/industryinsights/will-amgens-migraine-win-and-5th-thumbs--301948.html 0.6 2026-07-25T18:55:40+08:00 daily https://www.pharmasources.com/industryinsights/up-and-coming-pfizer-abbvie-drugs-set-to-301949.html 0.6 2026-08-08T04:25:53+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-roches-tecentriq-may-lag-301950.html 0.6 2026-06-18T18:12:05+08:00 daily https://www.pharmasources.com/industryinsights/pharma-talkwe-prodcuce-food-grade-bcaa-i-301951.html 0.6 2026-06-13T16:27:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-amgens-prolia-for-glucocortic-301952.html 0.6 2026-07-09T18:01:22+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-mitsubishi-link-for-early-acces-301953.html 0.6 2026-07-19T16:57:00+08:00 daily https://www.pharmasources.com/industryinsights/uk-streams-30m-into-global-fight-against-301954.html 0.6 2026-04-21T10:24:12+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-repatha-for-reduction-of-cv--301955.html 0.6 2026-06-08T19:50:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-begins-testing-rsv-vaccine-in-hea-301956.html 0.6 2026-06-11T15:27:57+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-paediatric-use-of-gsks-arnuity-301957.html 0.6 2026-04-27T06:56:23+08:00 daily https://www.pharmasources.com/industryinsights/community-services-are-being-neglected-w-301958.html 0.6 2026-04-21T05:20:23+08:00 daily https://www.pharmasources.com/industryinsights/novos-refixia-beats-rival-in-head-to-hea-301959.html 0.6 2026-01-15T05:01:45+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-viivjanssens-two-drug-hiv-reg-301960.html 0.6 2026-04-16T18:54:54+08:00 daily https://www.pharmasources.com/industryinsights/trial-findings-back-wider-use-of-roches--301961.html 0.6 2026-04-13T05:10:38+08:00 daily https://www.pharmasources.com/industryinsights/us-green-light-for-az-lokelma-301962.html 0.6 2026-04-08T15:49:43+08:00 daily https://www.pharmasources.com/industryinsights/ai-should-be-used-to-detect-chronic-dise-301963.html 0.6 2026-08-06T19:46:35+08:00 daily https://www.pharmasources.com/industryinsights/ema-confirms-risks-of-ms-drug-zinbryta-301964.html 0.6 2026-08-07T20:07:07+08:00 daily https://www.pharmasources.com/industryinsights/data-show-enduring-benefits-of-gsks-nuca-301965.html 0.6 2026-03-25T09:24:03+08:00 daily https://www.pharmasources.com/industryinsights/us-oks-first-in-class-drug-aimovig-for-m-301966.html 0.6 2026-04-05T11:51:24+08:00 daily https://www.pharmasources.com/industryinsights/international-clinical-researcher-of-the-301967.html 0.6 2026-08-05T18:12:25+08:00 daily https://www.pharmasources.com/industryinsights/janssen-pulls-plug-on-alzheimers-candida-301968.html 0.6 2026-08-06T19:15:09+08:00 daily https://www.pharmasources.com/industryinsights/trials-show-benefit-of-on-demand-use-of--301969.html 0.6 2026-07-03T23:53:29+08:00 daily https://www.pharmasources.com/industryinsights/generic-competition-hits-az-first-quarte-301970.html 0.6 2026-06-15T15:49:23+08:00 daily https://www.pharmasources.com/industryinsights/nejm-publishes-second-successful-epidiol-301971.html 0.6 2026-03-27T09:11:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-cracks-down-on-benzocaine-teething-p-301972.html 0.6 2026-02-05T01:24:34+08:00 daily https://www.pharmasources.com/industryinsights/astellas-begins-major-restructure-as-600-301973.html 0.6 2026-08-08T00:39:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sandoz-scores-eu-approval-for-r-301974.html 0.6 2026-04-14T03:47:36+08:00 daily https://www.pharmasources.com/industryinsights/report-calls-for-tax-rises-to-fund-ailin-301975.html 0.6 2026-06-19T08:48:56+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-scores-impressive-first-li-301976.html 0.6 2026-04-04T19:01:48+08:00 daily https://www.pharmasources.com/industryinsights/vifor-fresenius-snap-up-rights-to-caras--301977.html 0.6 2025-11-06T10:15:30+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-drug-combo-scoresfda-approval-301978.html 0.6 2026-07-08T09:41:41+08:00 daily https://www.pharmasources.com/industryinsights/world-heading-towards-25-of-total-popula-301979.html 0.6 2026-07-03T06:01:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-reprimands-suppliers-of-opioid-subst-301980.html 0.6 2026-06-30T12:38:08+08:00 daily https://www.pharmasources.com/industryinsights/takeda-begins-to-shore-up-finances-with--301981.html 0.6 2026-06-28T11:09:28+08:00 daily https://www.pharmasources.com/industryinsights/india-sweden-and-the-netherlands-form-hi-301982.html 0.6 2026-07-03T00:28:50+08:00 daily https://www.pharmasources.com/industryinsights/nhs-trust-harnesses-ai-to-speed-up-treat-301983.html 0.6 2026-07-05T11:33:00+08:00 daily https://www.pharmasources.com/industryinsights/the-cause-of-the-most-common-form-of-chi-301984.html 0.6 2026-07-06T08:49:51+08:00 daily https://www.pharmasources.com/industryinsights/viivs-two-drug-regimen-gets-eu-approval--301985.html 0.6 2026-07-08T19:58:09+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-closes-in-on-bringing-new-class--301986.html 0.6 2026-04-08T12:46:15+08:00 daily https://www.pharmasources.com/industryinsights/gilead-expands-operations-in-cork-irelan-301987.html 0.6 2026-04-15T10:56:03+08:00 daily https://www.pharmasources.com/industryinsights/ema-review-confirms-risks-of-abbvie-and--301988.html 0.6 2026-04-17T17:05:46+08:00 daily https://www.pharmasources.com/industryinsights/roches-hemlibra-stakes-claim-to-be-haemo-301989.html 0.6 2026-07-04T08:17:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-azs-lokelma-for-hyperkalaem-301990.html 0.6 2026-08-06T02:11:32+08:00 daily https://www.pharmasources.com/industryinsights/investigation-of-kickbacks-in-greece-spu-301991.html 0.6 2026-04-15T11:19:30+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-scores-long-sought-fda-nod-for--301992.html 0.6 2026-06-26T19:08:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-stalls-eisaiand-its-new-partner-merc-301993.html 0.6 2026-06-20T08:44:24+08:00 daily https://www.pharmasources.com/industryinsights/fiercepharmaasiaastellas-job-cuts-gsk-ve-301994.html 0.6 2026-03-29T02:04:06+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-survival-win-shores-301995.html 0.6 2026-07-09T02:47:06+08:00 daily https://www.pharmasources.com/industryinsights/danone-nestle-kkr-and-more-suit-up-for-g-301996.html 0.6 2026-06-18T12:02:41+08:00 daily https://www.pharmasources.com/industryinsights/in-a-win-for-merckand-just-maybe-for-pha-301997.html 0.6 2026-07-23T10:03:37+08:00 daily https://www.pharmasources.com/industryinsights/lillys-cancer-business-loses-its-chief-j-301998.html 0.6 2025-11-10T04:18:28+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-eyes-imbruvica-expansion-in-cll-a-301999.html 0.6 2026-06-21T00:37:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-inks-238m-deal-to-settle-justice--302000.html 0.6 2026-07-30T05:10:27+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-suffers-another-cancer-s-302001.html 0.6 2026-06-20T13:19:58+08:00 daily https://www.pharmasources.com/industryinsights/dea-gives-some-of-pfizers-injected-narco-302002.html 0.6 2026-03-04T04:20:07+08:00 daily https://www.pharmasources.com/industryinsights/hello-200b-super-pricey-new-cancer-drugs-302003.html 0.6 2026-06-09T20:47:50+08:00 daily https://www.pharmasources.com/industryinsights/look-out-jj-sun-pharmas-yonsa-nod-in-pro-302004.html 0.6 2026-08-07T16:13:19+08:00 daily https://www.pharmasources.com/industryinsights/astellas-cuts-600-positions-in-japan-as--302005.html 0.6 2026-04-06T19:23:19+08:00 daily https://www.pharmasources.com/industryinsights/merck-rains-on-roches-parade-with-double-302006.html 0.6 2026-02-28T19:34:35+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-makes-good-on-charity-promise-wit-302007.html 0.6 2026-06-19T21:13:48+08:00 daily https://www.pharmasources.com/industryinsights/novartis-brand-new-gene-therapy-player-a-302008.html 0.6 2026-06-07T22:50:50+08:00 daily https://www.pharmasources.com/industryinsights/plan-plan-and-plan-some-more-alimeras-re-302009.html 0.6 2026-05-03T14:25:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-demonizes-pharma-over-generics-but-m-302010.html 0.6 2025-10-20T17:10:33+08:00 daily https://www.pharmasources.com/industryinsights/expanding-jj-visions-new-corporate-site--302011.html 0.6 2026-07-07T16:15:34+08:00 daily https://www.pharmasources.com/industryinsights/a-description-of-the-market-data-of-the--302012.html 0.6 2026-08-05T21:31:19+08:00 daily https://www.pharmasources.com/industryinsights/koreas-gc-pharma-establishes-vaccine-dev-302013.html 0.6 2026-08-07T08:15:46+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-build-new-facility-in--302014.html 0.6 2026-08-08T19:47:42+08:00 daily https://www.pharmasources.com/industryinsights/brii-bio-raises-260m-to-bring-drugs-to-c-302015.html 0.6 2026-06-24T22:36:25+08:00 daily https://www.pharmasources.com/industryinsights/promoting-blood-vessel-growth-in-bone-co-302016.html 0.6 2026-06-20T13:33:17+08:00 daily https://www.pharmasources.com/industryinsights/pivotal-bioventure-partners-debuts-150m--302017.html 0.6 2026-06-23T18:53:23+08:00 daily https://www.pharmasources.com/industryinsights/magenta-eyes-100m-ipo-to-help-lead-a-new-302018.html 0.6 2026-06-23T18:54:27+08:00 daily https://www.pharmasources.com/industryinsights/promoting-blood-vessel-growth-in-bone-co-302019.html 0.6 2025-11-29T04:52:14+08:00 daily https://www.pharmasources.com/industryinsights/new-study-shows-that-old-bones-can-heal--302020.html 0.6 2025-12-12T07:50:26+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-biotech-bliss-pharma-unite-for-co-302021.html 0.6 2026-07-06T21:46:56+08:00 daily https://www.pharmasources.com/industryinsights/gut-liver-connection-uncovers-new-avenue-302022.html 0.6 2025-10-21T18:13:33+08:00 daily https://www.pharmasources.com/industryinsights/pivotal-bioventure-partners-debuts-150m--302023.html 0.6 2026-04-20T18:54:40+08:00 daily https://www.pharmasources.com/industryinsights/celgenes-rd-report-card-somewhat-disappo-302024.html 0.6 2026-06-03T10:31:37+08:00 daily https://www.pharmasources.com/industryinsights/magenta-eyes-100m-ipo-to-help-lead-a-new-302025.html 0.6 2026-04-02T12:25:31+08:00 daily https://www.pharmasources.com/industryinsights/after-al-amyloidosis-flop-prothena-slash-302026.html 0.6 2025-10-22T01:50:00+08:00 daily https://www.pharmasources.com/industryinsights/insights-into-gene-network-could-expose--302027.html 0.6 2026-08-06T20:18:45+08:00 daily https://www.pharmasources.com/industryinsights/growing-requirements-for-medicines-for-c-302028.html 0.6 2026-05-03T14:16:00+08:00 daily https://www.pharmasources.com/industryinsights/bloom-bags-cash-ucla-tech-to-treat-epile-302029.html 0.6 2026-08-05T08:33:30+08:00 daily https://www.pharmasources.com/industryinsights/aptinyx-seeks-80m-ipo-to-push-nmda-drug--302030.html 0.6 2025-10-19T19:48:00+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-licenses-kidney-disease-dru-302031.html 0.6 2026-06-21T22:38:10+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-veteran-zhi-hong-launche-302032.html 0.6 2026-01-30T23:07:04+08:00 daily https://www.pharmasources.com/industryinsights/keryxs-auryxia-shows-potential-in-delayi-302033.html 0.6 2026-04-16T18:25:45+08:00 daily https://www.pharmasources.com/industryinsights/esperions-ldl-drug-aces-a-third-pivotal--302034.html 0.6 2026-07-12T09:41:56+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-opens-south-san-francisco-fa-302035.html 0.6 2026-04-08T15:00:53+08:00 daily https://www.pharmasources.com/industryinsights/verrica-seeks-86m-ipo-to-take-on-compoun-302036.html 0.6 2026-03-23T02:01:44+08:00 daily https://www.pharmasources.com/industryinsights/lava-bags-cash-from-gilde-and-versant-an-302037.html 0.6 2026-03-26T02:12:04+08:00 daily https://www.pharmasources.com/industryinsights/russia-returns-to-ebola-smallpox-virus-m-302038.html 0.6 2025-11-08T18:16:33+08:00 daily https://www.pharmasources.com/industryinsights/house-passes-right-to-try-bill-sending-i-302039.html 0.6 2025-10-30T02:28:10+08:00 daily https://www.pharmasources.com/industryinsights/takeda-divests-chinese-jv-for-280m-after-302040.html 0.6 2026-06-26T01:20:07+08:00 daily https://www.pharmasources.com/industryinsights/a-protein-linking-parkinsons-and-tubercu-302041.html 0.6 2026-01-31T08:25:24+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharma-acquires-astrazenecas-signat-302042.html 0.6 2026-06-07T14:52:08+08:00 daily https://www.pharmasources.com/industryinsights/allergan-acquires-nmda-depression-drug-f-302043.html 0.6 2026-07-04T12:29:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-palynziq-for-pku-a-rare-and-302044.html 0.6 2026-06-23T04:43:54+08:00 daily https://www.pharmasources.com/industryinsights/antidepressant-use-may-be-linked-to-incr-302045.html 0.6 2025-11-16T13:20:32+08:00 daily https://www.pharmasources.com/industryinsights/experimental-drug-eases-effects-of-glute-302046.html 0.6 2026-08-04T09:02:28+08:00 daily https://www.pharmasources.com/industryinsights/with-global-supplies-running-short-stepp-302047.html 0.6 2026-08-06T23:40:34+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-survival-win-shores-302048.html 0.6 2026-05-03T13:02:47+08:00 daily https://www.pharmasources.com/industryinsights/lillys-cancer-business-loses-its-chief-j-302049.html 0.6 2026-06-21T02:00:43+08:00 daily https://www.pharmasources.com/industryinsights/diagrammatizing-of-the-varieties-with-sa-302050.html 0.6 2026-08-01T03:07:20+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018052-302051.html 0.6 2026-06-08T15:25:40+08:00 daily https://www.pharmasources.com/industryinsights/alibaba-health-it-buys-ali-jk-medical-pr-302052.html 0.6 2026-08-03T08:53:12+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharma-joins-us-firm-to-develop-imm-302053.html 0.6 2026-01-02T01:07:57+08:00 daily https://www.pharmasources.com/industryinsights/tobacco-is-responsible-for-more-than-one-302054.html 0.6 2026-03-01T02:55:50+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivering-nanoparticles-could-help-302055.html 0.6 2026-07-06T07:41:55+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-oral-glp-1-analogue-ozempi-302056.html 0.6 2026-07-27T20:33:56+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-outperforms-derm-302057.html 0.6 2026-08-07T06:00:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-bayer-lox-302058.html 0.6 2026-04-13T09:39:32+08:00 daily https://www.pharmasources.com/industryinsights/nih-begins-testing-ebola-treatment-in-ea-302059.html 0.6 2026-06-25T14:57:38+08:00 daily https://www.pharmasources.com/industryinsights/roche-says-first-line-tecentriq-combinat-302060.html 0.6 2026-01-14T05:26:08+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-priority-review-to-astella-302061.html 0.6 2026-08-03T02:26:44+08:00 daily https://www.pharmasources.com/industryinsights/portland-immunotherapy-startup-tops-10m--302062.html 0.6 2025-11-15T01:36:26+08:00 daily https://www.pharmasources.com/industryinsights/clovis-oncology-announces-european-commi-302063.html 0.6 2025-11-15T01:39:35+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-celgene-expand-ipsc-collabora-302064.html 0.6 2026-06-22T19:25:23+08:00 daily https://www.pharmasources.com/industryinsights/cerenis-therapeutics-and-university-of-n-302065.html 0.6 2026-07-08T17:06:58+08:00 daily https://www.pharmasources.com/industryinsights/where-do-big-cap-biopharmas-stand-on-the-302066.html 0.6 2026-02-28T15:25:16+08:00 daily https://www.pharmasources.com/industryinsights/profectus-emergent-biosolutions-and-path-302067.html 0.6 2026-08-06T02:25:23+08:00 daily https://www.pharmasources.com/industryinsights/up-and-coming-pfizer-abbvie-drugs-set-to-302068.html 0.6 2026-06-01T02:56:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-demonizes-pharma-over-generics-but-m-302069.html 0.6 2026-06-16T16:22:01+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-group-has-presented-data-at-two-i-302070.html 0.6 2026-06-05T16:34:09+08:00 daily https://www.pharmasources.com/industryinsights/centogene-announces-agreement-with-aldey-302071.html 0.6 2026-03-28T11:19:47+08:00 daily https://www.pharmasources.com/industryinsights/arcturus-therapeutics-appoints-four-new--302072.html 0.6 2026-08-06T23:31:30+08:00 daily https://www.pharmasources.com/industryinsights/fibrocell-announces-60-million-registere-302073.html 0.6 2026-07-07T06:55:45+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-and-md-anderson-announce-bench-to--302074.html 0.6 2026-07-04T00:12:55+08:00 daily https://www.pharmasources.com/industryinsights/olix-pharmaceuticals-receives-clinical-t-302075.html 0.6 2026-06-27T05:24:23+08:00 daily https://www.pharmasources.com/industryinsights/is-the-chinese-cro-industry-still-the-lo-302076.html 0.6 2026-07-30T22:02:43+08:00 daily https://www.pharmasources.com/industryinsights/author-biography-tim-freeman-302077.html 0.6 2026-06-21T02:40:50+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-may-30-2018-302078.html 0.6 2026-06-24T11:26:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-imvexxy-302079.html 0.6 2026-06-27T07:25:09+08:00 daily https://www.pharmasources.com/industryinsights/birth-control-pills-taytulla-physician-s-302080.html 0.6 2026-06-06T04:29:34+08:00 daily https://www.pharmasources.com/industryinsights/acs-updates-colorectal-cancer-screening--302081.html 0.6 2025-11-21T09:18:12+08:00 daily https://www.pharmasources.com/industryinsights/theres-no-healthy-obesity-for-women-stud-302082.html 0.6 2026-05-05T08:58:34+08:00 daily https://www.pharmasources.com/industryinsights/annual-health-care-expenditure-higher-fo-302083.html 0.6 2026-07-17T20:59:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-ulcerativ-302084.html 0.6 2026-06-18T03:38:00+08:00 daily https://www.pharmasources.com/industryinsights/older-adults-often-reluctant-to-set-up-s-302085.html 0.6 2026-02-08T11:02:26+08:00 daily https://www.pharmasources.com/industryinsights/first-artificial-iris-is-approved-302086.html 0.6 2026-03-28T00:40:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-1st-artificial-iris-302087.html 0.6 2026-04-01T01:39:19+08:00 daily https://www.pharmasources.com/industryinsights/braeburn-resubmits-new-drug-application--302088.html 0.6 2026-06-22T06:07:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-palynziq-302089.html 0.6 2026-03-30T19:54:51+08:00 daily https://www.pharmasources.com/industryinsights/gsk-receives-fda-approval-of-arnuity-ell-302090.html 0.6 2026-06-25T08:41:22+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-announces-fda-acceptance-of-nda-f-302091.html 0.6 2026-06-23T15:37:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-yonsa-302092.html 0.6 2026-03-22T19:19:34+08:00 daily https://www.pharmasources.com/industryinsights/biostage-brings-dr-wei-zhang-on-board-302093.html 0.6 2026-06-23T16:42:54+08:00 daily https://www.pharmasources.com/industryinsights/lillys-taltz-ixekizumab-receives-the-fir-302094.html 0.6 2026-06-12T22:04:18+08:00 daily https://www.pharmasources.com/industryinsights/insys-therapeutics-confirms-outcome-of-f-302095.html 0.6 2026-06-29T11:50:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-zynquista-sotagliflozin-as-302096.html 0.6 2026-02-28T10:29:28+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-tsinghua-announce-strategic-partner-302097.html 0.6 2026-07-19T19:53:33+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-announces-the-c-302098.html 0.6 2026-08-08T15:42:54+08:00 daily https://www.pharmasources.com/industryinsights/jhl-biotech-raises-106m-in-pre-ipo-fundi-302099.html 0.6 2026-03-31T01:57:59+08:00 daily https://www.pharmasources.com/industryinsights/pharma-are-sunnier-than-they-used-to-be--302100.html 0.6 2026-03-01T02:21:49+08:00 daily https://www.pharmasources.com/industryinsights/out-of-the-fda-doghouse-celltrion-again--302101.html 0.6 2026-03-20T00:20:57+08:00 daily https://www.pharmasources.com/industryinsights/lung-on-a-chip-simulates-pulmonary-fibro-302102.html 0.6 2026-06-21T11:29:25+08:00 daily https://www.pharmasources.com/industryinsights/aibp-injection-alleviates-chemotherapy-p-302103.html 0.6 2026-04-08T07:03:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-new-drug-application-for-nov-302104.html 0.6 2026-04-19T04:04:34+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-to-develop-new-inflammato-302105.html 0.6 2026-03-16T11:37:19+08:00 daily https://www.pharmasources.com/industryinsights/aptar-and-propeller-health-partner-on-di-302106.html 0.6 2026-06-21T03:30:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-astellas-n-302107.html 0.6 2026-06-22T13:20:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-biomarins-enzyme-substituti-302108.html 0.6 2026-03-17T08:51:51+08:00 daily https://www.pharmasources.com/industryinsights/allergan-recalls-out-of-order-contracept-302109.html 0.6 2026-02-18T15:00:39+08:00 daily https://www.pharmasources.com/industryinsights/ec-proposes-adjustment-to-pharma-intelle-302110.html 0.6 2026-08-07T22:29:21+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-extends-master-services-agreement-302111.html 0.6 2026-06-08T07:50:24+08:00 daily https://www.pharmasources.com/industryinsights/alibaba-to-sell-medical-assets-to-hong-k-302112.html 0.6 2026-07-19T18:00:34+08:00 daily https://www.pharmasources.com/industryinsights/avara-pharmaceutical-to-buy-novartiss-pr-302113.html 0.6 2026-07-01T21:44:34+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-and-intravacc-t-302114.html 0.6 2026-06-11T21:30:36+08:00 daily https://www.pharmasources.com/industryinsights/jawed-zia-joins-abbott-as-vp-established-302115.html 0.6 2026-07-07T17:06:14+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-genzyme-partners-with-mssi-to-sup-302116.html 0.6 2026-03-24T21:34:26+08:00 daily https://www.pharmasources.com/industryinsights/lupin-appoints-nicholas-hart-as-presiden-302117.html 0.6 2026-06-08T10:43:16+08:00 daily https://www.pharmasources.com/industryinsights/granules-pharmaceuticals-hikma-launch-ge-302118.html 0.6 2026-02-11T21:05:23+08:00 daily https://www.pharmasources.com/industryinsights/who-joins-hands-with-whf-for-world-no-to-302119.html 0.6 2026-03-12T17:40:47+08:00 daily https://www.pharmasources.com/industryinsights/greening-the-pill-302120.html 0.6 2026-07-12T00:07:33+08:00 daily https://www.pharmasources.com/industryinsights/syngene-international-partners-with-zumu-302121.html 0.6 2026-05-05T20:20:59+08:00 daily https://www.pharmasources.com/industryinsights/lupin-recalls-43922-cartons-of-contracep-302122.html 0.6 2026-05-03T17:21:10+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-oral-diabetes-drug-beats-j-302123.html 0.6 2026-05-05T14:35:25+08:00 daily https://www.pharmasources.com/industryinsights/acg-develops-modular-customizable-soluti-302124.html 0.6 2026-07-02T08:09:50+08:00 daily https://www.pharmasources.com/industryinsights/cda-approves-gileads-chronic-hepatitis-c-302125.html 0.6 2026-03-17T22:55:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-xalkori-receives-fda-breakthroug-302126.html 0.6 2026-08-01T12:02:32+08:00 daily https://www.pharmasources.com/industryinsights/mongolian-government-sets-pace-to-curb-h-302127.html 0.6 2026-04-19T09:04:21+08:00 daily https://www.pharmasources.com/industryinsights/agilent-to-acquire-assets-of-ultra-scien-302128.html 0.6 2026-06-08T15:40:23+08:00 daily https://www.pharmasources.com/industryinsights/korean-team-develops-algorithm-for-disea-302129.html 0.6 2026-08-08T20:11:55+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-and-propeller-health-partne-302130.html 0.6 2026-08-07T12:51:31+08:00 daily https://www.pharmasources.com/industryinsights/ibrutinib-may-benefit-glioblastoma-patie-302131.html 0.6 2026-06-13T09:18:25+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-and-crescendo-biologics-enter-ex-302132.html 0.6 2026-07-08T07:17:26+08:00 daily https://www.pharmasources.com/industryinsights/thrombolytic-science-to-participate-in-2-302133.html 0.6 2026-03-17T09:02:57+08:00 daily https://www.pharmasources.com/industryinsights/ppd-and-neogenomics-forming-global-strat-302134.html 0.6 2026-02-27T07:54:21+08:00 daily https://www.pharmasources.com/industryinsights/biotheranostics-announces-presentation-o-302135.html 0.6 2026-07-29T16:11:01+08:00 daily https://www.pharmasources.com/industryinsights/phase-ii-clinical-trials-of-dcvac-show-s-302136.html 0.6 2026-06-11T14:56:45+08:00 daily https://www.pharmasources.com/industryinsights/lunaphore-and-vitro-sign-collaboration-a-302137.html 0.6 2026-06-30T06:19:41+08:00 daily https://www.pharmasources.com/industryinsights/sotio-starts-phase-iii-trial-of-dcvac-in-302138.html 0.6 2026-06-09T02:13:47+08:00 daily https://www.pharmasources.com/industryinsights/thrombolytic-science-to-present-at-the-1-302139.html 0.6 2026-04-08T10:34:19+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-announces-further-development--302140.html 0.6 2026-08-06T18:34:35+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-biotech-and-bliss-biopharmaceutic-302141.html 0.6 2026-04-23T19:07:21+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-debuts-its-codar-arms-pcr-liquid--302142.html 0.6 2026-05-03T13:03:37+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-and-mitsubishi-tanabe-initiate--302143.html 0.6 2026-06-08T09:10:18+08:00 daily https://www.pharmasources.com/industryinsights/peptide-display-company-orbit-discovery--302144.html 0.6 2026-04-30T04:54:38+08:00 daily https://www.pharmasources.com/industryinsights/chinese-ai-startup-raises-12-billion-in--302145.html 0.6 2025-11-27T12:26:39+08:00 daily https://www.pharmasources.com/industryinsights/rfxcel-covers-the-cost-of-emvo-onboardin-302146.html 0.6 2026-07-19T23:12:13+08:00 daily https://www.pharmasources.com/industryinsights/agendia-and-angsana-to-provide-breast-ca-302147.html 0.6 2025-11-08T09:14:11+08:00 daily https://www.pharmasources.com/industryinsights/new-uv-monitor-kit-for-large-scale-purif-302148.html 0.6 2026-08-06T20:06:02+08:00 daily https://www.pharmasources.com/industryinsights/emergex-awarded-innovate-uk-grant-to-pro-302149.html 0.6 2025-11-25T13:41:57+08:00 daily https://www.pharmasources.com/industryinsights/successful-first-series-c-round-closing--302150.html 0.6 2026-04-13T06:05:18+08:00 daily https://www.pharmasources.com/industryinsights/agendias-mammaprint-and-blueprint-breast-302151.html 0.6 2026-06-26T07:13:09+08:00 daily https://www.pharmasources.com/industryinsights/merck-premier-to-codevelop-new-intervent-302152.html 0.6 daily https://www.pharmasources.com/industryinsights/new-insights-into-hookipas-therat-replic-302153.html 0.6 daily https://www.pharmasources.com/industryinsights/scientists-use-rfid-chips-to-track-biolo-302154.html 0.6 2026-04-16T06:32:45+08:00 daily https://www.pharmasources.com/industryinsights/prasm-expands-blockchain-ecosystem-by-si-302155.html 0.6 2026-03-17T19:33:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-halts-crispr-and-vertexs-upcoming-ge-302156.html 0.6 2026-05-10T15:19:05+08:00 daily https://www.pharmasources.com/industryinsights/koreas-oci-inks-strategic-deal-with-bukw-302157.html 0.6 2026-02-15T12:51:41+08:00 daily https://www.pharmasources.com/industryinsights/xynomic-pharma-completes-series-b-financ-302158.html 0.6 2026-08-09T06:33:22+08:00 daily https://www.pharmasources.com/industryinsights/immunosuppressant-drugs-may-protect-agai-302159.html 0.6 2026-07-05T05:25:09+08:00 daily https://www.pharmasources.com/industryinsights/asco-novartis-makes-a-case-for-earlier-k-302160.html 0.6 2026-08-09T16:52:57+08:00 daily https://www.pharmasources.com/industryinsights/tiny-particles-could-help-fight-brain-ca-302161.html 0.6 2026-02-05T04:16:40+08:00 daily https://www.pharmasources.com/industryinsights/patient-reported-outcomes-tool-revealed--302162.html 0.6 2026-01-13T18:20:33+08:00 daily https://www.pharmasources.com/industryinsights/most-popular-vitamin-and-mineral-supplem-302163.html 0.6 2026-04-25T07:22:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-new-steps-to-advance-digital-h-302164.html 0.6 2026-08-06T03:41:26+08:00 daily https://www.pharmasources.com/industryinsights/new-drugs-could-also-be-deployed-against-302165.html 0.6 2026-07-19T13:01:36+08:00 daily https://www.pharmasources.com/industryinsights/amgen-foundation-and-harvard-team-up-to--302166.html 0.6 2026-04-06T01:19:23+08:00 daily https://www.pharmasources.com/industryinsights/soy-lecithin-nsaid-combo-drug-protects-a-302167.html 0.6 2026-06-24T08:01:53+08:00 daily https://www.pharmasources.com/industryinsights/the-pfizer-foundation-announces-5-millio-302168.html 0.6 2026-07-20T04:48:14+08:00 daily https://www.pharmasources.com/industryinsights/new-findings-link-estrogen-and-t-cell-im-302169.html 0.6 2026-06-13T00:23:08+08:00 daily https://www.pharmasources.com/industryinsights/ophthalmic-drugs-conference-2018-302170.html 0.6 2026-08-06T21:19:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-preventive-treatment--302171.html 0.6 2026-04-05T06:40:13+08:00 daily https://www.pharmasources.com/industryinsights/ovarian-cancer-drug-shows-promise-in-pan-302172.html 0.6 2026-03-07T14:39:57+08:00 daily https://www.pharmasources.com/industryinsights/novartis-data-at-asco-and-eha-reinforce--302173.html 0.6 2026-06-11T15:22:24+08:00 daily https://www.pharmasources.com/industryinsights/eczema-drug-effective-against-severe-ast-302174.html 0.6 2026-07-10T16:40:56+08:00 daily https://www.pharmasources.com/industryinsights/study-demonstrates-new-treatment-for-sev-302175.html 0.6 2026-07-04T21:10:35+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-begins-a-phase-12-study-to-evalua-302176.html 0.6 2026-07-01T00:03:21+08:00 daily https://www.pharmasources.com/industryinsights/antidepressant-use-may-contribute-to-lon-302177.html 0.6 2026-06-23T10:57:26+08:00 daily https://www.pharmasources.com/industryinsights/spiolto-respimat-enables-greater-physica-302178.html 0.6 2026-06-18T18:12:14+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-antioxidant-enriched-vitamin-302179.html 0.6 2026-06-13T11:27:02+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-heads-to-2018-asco-annual-me-302180.html 0.6 2026-06-13T01:31:00+08:00 daily https://www.pharmasources.com/industryinsights/want-to-score-on-social-pharma-follow-sa-302181.html 0.6 2026-03-24T19:11:22+08:00 daily https://www.pharmasources.com/industryinsights/womens-hormone-drug-prices-have-climbed--302182.html 0.6 2026-08-06T06:17:38+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-racks-up-opdivo-combo-data-302183.html 0.6 2026-05-23T22:56:22+08:00 daily https://www.pharmasources.com/industryinsights/new-drugs-new-money-surge-in-cancer-dtc--302184.html 0.6 2026-08-07T19:32:45+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approves-mylan-and-biocons-fulphil-302185.html 0.6 2026-04-17T03:33:14+08:00 daily https://www.pharmasources.com/industryinsights/acasti-pharma-appoints-brian-groch-as-cc-302186.html 0.6 2026-04-04T22:09:46+08:00 daily https://www.pharmasources.com/industryinsights/versartis-aravive-enter-into-merger-agre-302187.html 0.6 2026-04-02T00:20:32+08:00 daily https://www.pharmasources.com/industryinsights/scientists-use-nanoparticles-to-study-wo-302188.html 0.6 2026-06-25T13:00:49+08:00 daily https://www.pharmasources.com/industryinsights/which-of-the-blockbuster-drugs-on-the-au-302189.html 0.6 2026-05-01T14:16:20+08:00 daily https://www.pharmasources.com/industryinsights/which-of-the-blockbuster-drugs-on-the-au-302190.html 0.6 2026-08-06T13:16:35+08:00 daily https://www.pharmasources.com/industryinsights/which-of-the-blockbuster-drugs-on-the-au-302191.html 0.6 2026-08-10T01:22:14+08:00 daily https://www.pharmasources.com/industryinsights/which-of-the-blockbuster-drugs-on-the-au-302192.html 0.6 2026-08-07T01:52:28+08:00 daily https://www.pharmasources.com/industryinsights/which-of-the-blockbuster-drugs-on-the-au-302193.html 0.6 2026-08-07T01:22:13+08:00 daily https://www.pharmasources.com/industryinsights/novartis-aimovig-leads-chmp-recommendati-302194.html 0.6 2026-08-07T22:47:32+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-lillyincytes-olumiant-302195.html 0.6 2026-06-15T23:35:24+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-takes-lead-in-squamous-nsc-302196.html 0.6 2026-05-03T07:04:02+08:00 daily https://www.pharmasources.com/industryinsights/trial-first-to-show-immunotherapy-benefi-302197.html 0.6 2026-04-08T06:54:36+08:00 daily https://www.pharmasources.com/industryinsights/us-oks-first-biosimilar-of-amgens-neulas-302198.html 0.6 2026-03-01T03:10:29+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-cuts-risk-of-melanoma-recurre-302199.html 0.6 2026-04-02T08:08:13+08:00 daily https://www.pharmasources.com/industryinsights/eu-filing-for-clovis-rubraca-in-ovarian--302200.html 0.6 2026-03-20T18:11:51+08:00 daily https://www.pharmasources.com/industryinsights/roche-scrambles-to-boost-herceptin-suppl-302201.html 0.6 2026-07-23T13:47:54+08:00 daily https://www.pharmasources.com/industryinsights/nice-rules-against-first-line-use-of-ips-302202.html 0.6 2026-08-05T08:30:29+08:00 daily https://www.pharmasources.com/industryinsights/az-msds-lynparzaabiraterone-combo-hits-p-302203.html 0.6 2026-04-20T20:47:58+08:00 daily https://www.pharmasources.com/industryinsights/marketer-of-the-year-302204.html 0.6 2026-05-03T14:27:28+08:00 daily https://www.pharmasources.com/industryinsights/ab-sciences-decides-against-re-examinati-302205.html 0.6 2026-06-14T23:26:51+08:00 daily https://www.pharmasources.com/industryinsights/amgens-39b-neulasta-to-face-us-biosim-in-302206.html 0.6 2026-02-28T15:40:38+08:00 daily https://www.pharmasources.com/industryinsights/janssen-terminates-darzalextecentriq-com-302207.html 0.6 2026-06-08T06:19:03+08:00 daily https://www.pharmasources.com/industryinsights/health-and-pharma-link-to-tackle-dementi-302208.html 0.6 2026-07-07T15:29:12+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-ucbs-cimzia-for-psoriasis-302209.html 0.6 2026-03-23T11:46:48+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-unveils-10m-fund-to-retain-g-302210.html 0.6 2026-05-04T06:15:25+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-test-cancer-combo-in-both-adult-302211.html 0.6 2026-07-07T12:32:00+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-boosted-shingrix-educati-302212.html 0.6 2026-04-19T11:26:03+08:00 daily https://www.pharmasources.com/industryinsights/bayerloxos-larotrectinib-gets-speedy-rev-302213.html 0.6 2026-07-03T22:06:56+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-for-astellas-aml-drug-302214.html 0.6 2026-07-22T20:10:19+08:00 daily https://www.pharmasources.com/industryinsights/novos-oral-semaglutide-beats-lillyboehri-302215.html 0.6 2026-06-27T18:08:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-xeljanz-for-ulcerat-302216.html 0.6 2026-06-18T18:29:18+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-grabs-top-astrazeneca-cancer-exe-302217.html 0.6 2026-08-07T23:15:34+08:00 daily https://www.pharmasources.com/industryinsights/cash-rich-but-growth-stymied-gilead-prom-302218.html 0.6 2026-06-08T12:01:30+08:00 daily https://www.pharmasources.com/industryinsights/cphi-report-predicts-new-finished-produc-302219.html 0.6 2026-04-27T09:35:53+08:00 daily https://www.pharmasources.com/industryinsights/eisai-partners-with-chong-kun-dang-for-d-302220.html 0.6 2026-02-09T05:03:17+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-president-of-oncology-to-reti-302221.html 0.6 2026-05-03T16:03:17+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-msds-keytruda-for-advanc-302222.html 0.6 2026-07-03T06:53:10+08:00 daily https://www.pharmasources.com/industryinsights/az-and-msd-impress-at-asco-with-lynparza-302223.html 0.6 2026-07-29T13:35:39+08:00 daily https://www.pharmasources.com/industryinsights/mylan-lands-biosimilar-sucker-punch-to-a-302224.html 0.6 2026-08-07T12:01:12+08:00 daily https://www.pharmasources.com/industryinsights/allergan-mauled-by-investors-in-public-l-302225.html 0.6 2026-07-05T06:17:32+08:00 daily https://www.pharmasources.com/industryinsights/axovant-snatches-teva-and-allergan-execs-302226.html 0.6 2026-04-27T21:29:57+08:00 daily https://www.pharmasources.com/industryinsights/how-different-are-i-o-stars-from-merck-r-302227.html 0.6 2026-05-06T11:50:16+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-biocons-fulphila-becomes-first-302228.html 0.6 2026-07-31T16:42:38+08:00 daily https://www.pharmasources.com/industryinsights/underwhelming-drug-data-devastates-nekta-302229.html 0.6 2026-05-07T00:06:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-links-intragastric-balloons-to-5-mor-302230.html 0.6 2026-08-07T13:19:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-greenlights-lillys-olumiant-in-rheum-302231.html 0.6 2026-08-02T01:10:16+08:00 daily https://www.pharmasources.com/industryinsights/staff-shortfall-leads-to-massive-deficit-302232.html 0.6 2026-05-03T01:34:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-us-oncology-head-makes-leap-to--302233.html 0.6 2026-05-05T19:05:12+08:00 daily https://www.pharmasources.com/industryinsights/roche-resigns-itself-to-failure-on-sma-d-302234.html 0.6 2026-05-02T18:20:00+08:00 daily https://www.pharmasources.com/industryinsights/bayer-eyes-rd-cuts-as-monsanto-deal-rais-302235.html 0.6 2026-01-30T19:23:51+08:00 daily https://www.pharmasources.com/industryinsights/kitovs-combo-gets-fda-approval-in-osteoa-302236.html 0.6 2026-01-10T02:16:41+08:00 daily https://www.pharmasources.com/industryinsights/roches-multiple-sclerosis-drug-ocrevus-l-302237.html 0.6 2026-07-31T05:33:58+08:00 daily https://www.pharmasources.com/industryinsights/celgene-bring-in-new-cfo-to-steady-the-s-302238.html 0.6 2026-04-18T03:13:56+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-offers-significant-hope-in-subs-302239.html 0.6 2026-07-06T03:51:43+08:00 daily https://www.pharmasources.com/industryinsights/amgennovartis-migraine-med-gets-chmp-nod-302240.html 0.6 2026-04-05T18:19:48+08:00 daily https://www.pharmasources.com/industryinsights/roches-breast-lung-cancer-offerings-fail-302241.html 0.6 2026-04-08T06:05:02+08:00 daily https://www.pharmasources.com/industryinsights/janssen-debuts-promising-new-cancer-data-302242.html 0.6 2026-08-03T04:18:20+08:00 daily https://www.pharmasources.com/industryinsights/merck-co-prepares-for-brexit-drug-supply-302243.html 0.6 2026-01-31T17:16:40+08:00 daily https://www.pharmasources.com/industryinsights/with-its-case-count-climbing-johnson-joh-302244.html 0.6 2026-06-17T09:04:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-expand-venture-with-600-m-inve-302245.html 0.6 2026-03-28T08:48:01+08:00 daily https://www.pharmasources.com/industryinsights/tesaro-roche-to-evaluate-triplet-therapy-302246.html 0.6 2026-02-09T08:09:59+08:00 daily https://www.pharmasources.com/industryinsights/new-study-shows-increased-risk-for-diabe-302247.html 0.6 2026-07-08T01:30:01+08:00 daily https://www.pharmasources.com/industryinsights/made-in-chinaalbuvirtide-the-worlds-firs-302248.html 0.6 2026-07-25T17:08:42+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-humira-mercks-keytruda-and-more--302249.html 0.6 2026-07-04T07:26:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-wants-social-media-giants-to-help-cr-302250.html 0.6 2026-03-01T01:34:34+08:00 daily https://www.pharmasources.com/industryinsights/market-leader-novo-nordisk-still-has-lot-302251.html 0.6 2026-06-16T08:04:34+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-marketing-authorisation-t-302252.html 0.6 2025-11-14T14:49:02+08:00 daily https://www.pharmasources.com/industryinsights/dna-test-may-detect-liver-cancer-302253.html 0.6 2026-06-24T23:42:40+08:00 daily https://www.pharmasources.com/industryinsights/sri-lanka-to-register-two-foreign-cancer-302254.html 0.6 2026-07-01T03:40:26+08:00 daily https://www.pharmasources.com/industryinsights/metformin-found-to-be-safe-for-most-diab-302255.html 0.6 2026-06-28T02:24:01+08:00 daily https://www.pharmasources.com/industryinsights/ex-takeda-executive-takes-up-cmo-post-at-302256.html 0.6 2026-08-07T13:19:47+08:00 daily https://www.pharmasources.com/industryinsights/bio-lightning-round-with-john-maraganore-302257.html 0.6 2026-08-07T13:57:30+08:00 daily https://www.pharmasources.com/industryinsights/it-might-be-a-bumpy-ride-why-life-scienc-302258.html 0.6 2026-08-08T15:03:22+08:00 daily https://www.pharmasources.com/industryinsights/servier-opens-kendall-square-site-plans--302259.html 0.6 2026-08-09T03:34:15+08:00 daily https://www.pharmasources.com/industryinsights/fiercebiotech-bio-breakfastcar-t-20-biom-302260.html 0.6 2026-02-28T15:35:38+08:00 daily https://www.pharmasources.com/industryinsights/new-genetic-atlas-of-plasma-proteins-cou-302261.html 0.6 2026-07-02T21:19:26+08:00 daily https://www.pharmasources.com/industryinsights/gates-foundations-100m-a-year-nonprofit--302262.html 0.6 2026-03-11T23:17:02+08:00 daily https://www.pharmasources.com/industryinsights/advaxis-cuts-staff-as-it-seeks-partner-f-302263.html 0.6 2026-01-31T01:47:45+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-moves-us-headquarters-to-kendall-s-302264.html 0.6 2026-07-02T16:28:23+08:00 daily https://www.pharmasources.com/industryinsights/hydrogel-could-enable-pancreatic-islet-t-302265.html 0.6 2025-11-17T13:45:03+08:00 daily https://www.pharmasources.com/industryinsights/tricida-files-for-150m-ipo-to-fund-kidne-302266.html 0.6 2026-02-15T13:58:34+08:00 daily https://www.pharmasources.com/industryinsights/curt-herberts-to-head-up-business-develo-302267.html 0.6 2026-07-03T20:54:58+08:00 daily https://www.pharmasources.com/industryinsights/asco-pfizers-dacomitinib-bests-iressa-in-302268.html 0.6 2026-08-03T08:53:24+08:00 daily https://www.pharmasources.com/industryinsights/secret-amazon-research-unit-developing-h-302269.html 0.6 2026-01-09T19:23:34+08:00 daily https://www.pharmasources.com/industryinsights/axovant-pivots-with-new-gene-therapy-spa-302270.html 0.6 2026-03-31T22:58:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-puts-neuroscience-at-heart-of-new-302271.html 0.6 2026-06-25T00:26:54+08:00 daily https://www.pharmasources.com/industryinsights/eisai-purdue-reveal-eye-opening-data-for-302272.html 0.6 2026-08-08T20:15:37+08:00 daily https://www.pharmasources.com/industryinsights/gilead-hookipa-pen-hepatitis-b-hiv-resea-302273.html 0.6 2026-08-07T05:05:23+08:00 daily https://www.pharmasources.com/industryinsights/could-an-old-amgen-developed-ra-drug-mak-302274.html 0.6 2026-08-07T02:40:41+08:00 daily https://www.pharmasources.com/industryinsights/trial-suggests-kandys-menopause-drug-cou-302275.html 0.6 2026-08-07T02:05:16+08:00 daily https://www.pharmasources.com/industryinsights/future-growth-of-lupin-with-complex-gene-302276.html 0.6 2026-08-07T01:22:27+08:00 daily https://www.pharmasources.com/industryinsights/xiangxue-pharma-to-build-cell-therapy-fa-302277.html 0.6 2026-08-07T01:27:35+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-invest-60-million-for--302278.html 0.6 2026-08-07T01:32:19+08:00 daily https://www.pharmasources.com/industryinsights/merck-impresses-nice-with-keytruda-dataa-302279.html 0.6 2026-08-07T01:52:01+08:00 daily https://www.pharmasources.com/industryinsights/weekly-injections-shows-hiv-1-viral-supp-302280.html 0.6 2026-04-05T18:25:11+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-may-block-bowel-tumour-formation-302281.html 0.6 2026-04-04T09:24:57+08:00 daily https://www.pharmasources.com/industryinsights/salmonella-outbreaks-in-36-states-linked-302282.html 0.6 2026-02-28T15:36:23+08:00 daily https://www.pharmasources.com/industryinsights/kitchen-towels-laden-with-bacteria-302283.html 0.6 2026-07-20T22:36:33+08:00 daily https://www.pharmasources.com/industryinsights/certification-status-tied-to-physician-p-302284.html 0.6 2026-03-06T11:17:56+08:00 daily https://www.pharmasources.com/industryinsights/lengthy-viral-suppression-may-cut-cancer-302285.html 0.6 2025-12-09T10:19:33+08:00 daily https://www.pharmasources.com/industryinsights/kitchen-towels-are-source-of-possibly-pa-302286.html 0.6 2026-04-08T17:11:55+08:00 daily https://www.pharmasources.com/industryinsights/cdc-invasive-mrsa-more-likely-among-inje-302287.html 0.6 2026-04-09T18:58:16+08:00 daily https://www.pharmasources.com/industryinsights/poor-social-network-adds-health-risks-ac-302288.html 0.6 2026-02-28T15:32:53+08:00 daily https://www.pharmasources.com/industryinsights/antiviral-treatments-reduce-cancer-risk--302289.html 0.6 2026-04-05T03:57:30+08:00 daily https://www.pharmasources.com/industryinsights/strict-handgun-laws-lower-gun-murder-rat-302290.html 0.6 2026-07-09T17:26:24+08:00 daily https://www.pharmasources.com/industryinsights/impotent-maybe-you-should-see-a-heart-do-302291.html 0.6 2026-04-09T17:52:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-genentechs-rituxan-rituxima-302292.html 0.6 2026-08-05T16:19:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mircera-for-anemia-associat-302293.html 0.6 2026-02-09T03:57:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-fulphila-302294.html 0.6 2026-01-18T17:51:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-olumiant-302295.html 0.6 2026-08-08T22:04:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-consensi-302296.html 0.6 2026-08-07T02:21:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-zynquista-sotagliflozin-as-302297.html 0.6 2026-03-23T01:34:42+08:00 daily https://www.pharmasources.com/industryinsights/insys-therapeutics-confirms-outcome-of-f-302298.html 0.6 2026-03-18T14:24:30+08:00 daily https://www.pharmasources.com/industryinsights/teva-confirms-september-pdufa-date-for-f-302299.html 0.6 2026-03-25T03:08:28+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-announces-fda-acceptance-of-nda-f-302300.html 0.6 2026-07-08T15:21:43+08:00 daily https://www.pharmasources.com/industryinsights/braeburn-resubmits-new-drug-application--302301.html 0.6 2026-07-05T11:43:04+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-receives-european-clearance--302302.html 0.6 2026-07-07T09:25:21+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-pasteur-and-translate-bio-to-deve-302303.html 0.6 2026-07-06T13:21:41+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-wins-appeal-against-cma-fine-over-302304.html 0.6 2026-07-08T20:21:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-beefs-up-generics-use-push-with-radi-302305.html 0.6 2026-06-26T17:06:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-and-ema-accept-marketing-application-302306.html 0.6 2026-01-04T14:32:41+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-chinese-scientists-partner-on-new-302307.html 0.6 2026-08-07T16:15:43+08:00 daily https://www.pharmasources.com/industryinsights/ge-provides-flexfactory-platform-to-xian-302308.html 0.6 2026-08-07T13:27:21+08:00 daily https://www.pharmasources.com/industryinsights/old-ceo-new-chairman-some-allergan-inves-302309.html 0.6 2026-06-30T12:36:27+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-slammed-by-fda-for-improper-handl-302310.html 0.6 2026-04-07T08:37:35+08:00 daily https://www.pharmasources.com/industryinsights/aduro-starts-phase-1b-trial-of-its-immun-302311.html 0.6 2026-07-10T02:26:15+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-optinose-kitov-pharma-cl-302312.html 0.6 2026-03-01T02:53:09+08:00 daily https://www.pharmasources.com/industryinsights/jj-partners-with-boston-university-to-ta-302313.html 0.6 2026-03-07T04:13:38+08:00 daily https://www.pharmasources.com/industryinsights/genentech-and-microbiotica-to-develop-ne-302314.html 0.6 2025-12-14T04:34:41+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-intermediate-capital-group-302315.html 0.6 2026-01-22T04:46:31+08:00 daily https://www.pharmasources.com/industryinsights/biogen-acquires-licence-for-japanese-com-302316.html 0.6 2026-08-07T05:25:53+08:00 daily https://www.pharmasources.com/industryinsights/fully-automated-facility-for-drug-discov-302317.html 0.6 2026-07-18T11:45:23+08:00 daily https://www.pharmasources.com/industryinsights/axovant-buys-rights-for-oxford-biomedica-302318.html 0.6 2026-08-06T02:19:39+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-to-pass-10b-in-2024-vacc-302319.html 0.6 2026-08-08T03:11:34+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-appoints-astrazenecas-william-li-302320.html 0.6 2026-07-12T07:15:23+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-insilico-unite-to-integrate--302321.html 0.6 2026-07-23T09:07:03+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-receives-eu-nod-for-lung-can-302322.html 0.6 2026-06-25T20:16:23+08:00 daily https://www.pharmasources.com/industryinsights/regenerative-bandage-accelerates-healing-302323.html 0.6 2026-08-07T01:14:53+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-tobramycin-inhala-302324.html 0.6 2026-08-07T01:14:35+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-acquire-stake-in-monsanto-india-302325.html 0.6 2026-08-09T18:43:29+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-acquire-stake-in-monsanto-india-302326.html 0.6 2026-07-01T23:15:23+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-progress-towar-302327.html 0.6 2026-06-26T00:11:06+08:00 daily https://www.pharmasources.com/industryinsights/schreiner-medipharm-and-schreiner-protec-302328.html 0.6 2026-07-01T16:59:30+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-kinetic-to-acquire-elliquence-f-302329.html 0.6 2026-08-07T01:07:03+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-receives-eir-for-halol-facili-302330.html 0.6 2026-07-03T02:14:25+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-eli-lilly-scrap-alzheimers-t-302331.html 0.6 2026-03-13T08:34:11+08:00 daily https://www.pharmasources.com/industryinsights/ftc-investigates-dna-testing-firms-over--302332.html 0.6 2026-08-06T19:01:28+08:00 daily https://www.pharmasources.com/industryinsights/galectin-announces-new-ceo-302333.html 0.6 2026-04-03T20:38:16+08:00 daily https://www.pharmasources.com/industryinsights/jci-appoints-john-yoon-as-md-of-asia-pac-302334.html 0.6 2026-05-03T14:08:12+08:00 daily https://www.pharmasources.com/industryinsights/jj-agrees-to-sell-lifescan-unit-for-21b-302335.html 0.6 2026-07-07T05:55:50+08:00 daily https://www.pharmasources.com/industryinsights/pharma-suffers-biggest-loss-ever-of-cons-302336.html 0.6 2026-06-29T16:49:22+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-to-buy-sanofi-inhalation-contr-302337.html 0.6 2026-01-04T22:04:34+08:00 daily https://www.pharmasources.com/industryinsights/drug-companies-are-indeed-looking-at-sub-302338.html 0.6 2025-12-08T17:51:13+08:00 daily https://www.pharmasources.com/industryinsights/want-to-help-patients-get-rid-of-drug-re-302339.html 0.6 2026-05-03T14:08:13+08:00 daily https://www.pharmasources.com/industryinsights/suven-life-sciences-gets-product-patents-302340.html 0.6 2026-08-09T15:11:42+08:00 daily https://www.pharmasources.com/industryinsights/suven-life-sciences-gets-product-patents-302341.html 0.6 2026-03-29T04:04:23+08:00 daily https://www.pharmasources.com/industryinsights/new-hope-for-a-syphilis-vaccine-302342.html 0.6 2026-06-01T08:06:43+08:00 daily https://www.pharmasources.com/industryinsights/pains-of-tcm-injections-and-imminent-ree-302343.html 0.6 2026-07-23T21:25:48+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-new-drug-rd-strategies-advan-302344.html 0.6 2026-08-06T02:59:07+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-evaluating-the-powder-testin-302345.html 0.6 2026-08-06T23:32:10+08:00 daily https://www.pharmasources.com/industryinsights/artelo-syngene-enter-partnership-302346.html 0.6 2026-06-08T12:39:41+08:00 daily https://www.pharmasources.com/industryinsights/marken-moves-chicago-ops-to-new-full-ser-302347.html 0.6 2026-03-21T17:24:18+08:00 daily https://www.pharmasources.com/industryinsights/bridgebio-launches-coa-therapeutics-302348.html 0.6 2026-03-26T23:12:08+08:00 daily https://www.pharmasources.com/industryinsights/acm-global-labs-acquires-abs-labs-302349.html 0.6 2026-08-07T22:10:07+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-serb-enter-agreement-302350.html 0.6 2025-11-22T19:41:45+08:00 daily https://www.pharmasources.com/industryinsights/aclaris-therapeutics-announces-key-hires-302351.html 0.6 2026-06-19T18:23:46+08:00 daily https://www.pharmasources.com/industryinsights/adents-microsoft-launch-adents-novatrack-302352.html 0.6 2026-04-07T19:03:38+08:00 daily https://www.pharmasources.com/industryinsights/oncobiologics-enters-first-cdmo-contract-302353.html 0.6 2026-08-08T23:27:52+08:00 daily https://www.pharmasources.com/industryinsights/sharp-selects-werum-it-solutions-as-part-302354.html 0.6 2026-06-29T05:31:43+08:00 daily https://www.pharmasources.com/industryinsights/ge-introduces-biacore-8k-302355.html 0.6 2026-08-09T05:43:10+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-opens-us-precision-medicin-302356.html 0.6 2026-02-28T20:54:42+08:00 daily https://www.pharmasources.com/industryinsights/alcami-extends-workbench-laboratory-serv-302357.html 0.6 2026-01-10T01:27:09+08:00 daily https://www.pharmasources.com/industryinsights/sinclair-research-announces-executive-ap-302358.html 0.6 2026-02-28T13:16:48+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-acquires-sanofis-uk-cmo-biz-302359.html 0.6 2026-08-08T07:03:24+08:00 daily https://www.pharmasources.com/industryinsights/catalent-appoints-clinical-supply-servic-302360.html 0.6 2026-08-09T23:51:26+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-enables-ascletis-to-receive-nda-302361.html 0.6 2026-07-27T20:57:28+08:00 daily https://www.pharmasources.com/industryinsights/brammer-bio-sarepta-enter-long-term-mfg--302362.html 0.6 2026-08-07T20:23:46+08:00 daily https://www.pharmasources.com/industryinsights/pci-names-vp-of-global-operations-strate-302363.html 0.6 2026-05-20T13:18:18+08:00 daily https://www.pharmasources.com/industryinsights/eisai-launches-dementia-discovery-center-302364.html 0.6 2026-04-11T11:20:09+08:00 daily https://www.pharmasources.com/industryinsights/lakepharma-harbour-antibodies-form-disco-302365.html 0.6 2026-02-28T23:30:15+08:00 daily https://www.pharmasources.com/industryinsights/ppd-and-neogenomics-forming-global-strat-302366.html 0.6 2025-10-25T00:04:52+08:00 daily https://www.pharmasources.com/industryinsights/phase-ii-clinical-trials-of-dcvac-show-s-302368.html 0.6 2026-06-22T07:00:48+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-appointme-302369.html 0.6 2026-06-08T08:26:09+08:00 daily https://www.pharmasources.com/industryinsights/vetter-strikes-out-on-new-pathways-to-fu-302370.html 0.6 2026-06-21T01:14:01+08:00 daily https://www.pharmasources.com/industryinsights/rsp-systems-secures-series-b-funding-to--302371.html 0.6 2026-04-19T19:34:20+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-and-siemens-sig-302372.html 0.6 2026-08-08T19:03:40+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-signs-exclusive-supply-distribu-302373.html 0.6 2026-08-07T19:27:09+08:00 daily https://www.pharmasources.com/industryinsights/triple-digit-growth-in-emea-as-pharma-co-302374.html 0.6 2026-08-07T13:15:34+08:00 daily https://www.pharmasources.com/industryinsights/update-on-phase-iii-clinical-trials-of-l-302375.html 0.6 2026-08-07T13:56:02+08:00 daily https://www.pharmasources.com/industryinsights/david-vs-goliath-how-a-small-molecule-ca-302376.html 0.6 2026-07-05T12:58:27+08:00 daily https://www.pharmasources.com/industryinsights/university-of-tokyos-rcast-fujitsu-and-k-302377.html 0.6 2026-06-22T13:00:55+08:00 daily https://www.pharmasources.com/industryinsights/big-data-identifies-lipids-as-signatures-302378.html 0.6 2026-06-21T00:06:39+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-extension-of-zithromax--302379.html 0.6 2026-08-04T16:56:38+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-link-between-allergen-i-302380.html 0.6 2026-06-21T08:06:06+08:00 daily https://www.pharmasources.com/industryinsights/new-long-term-data-confirm-roches-gazyva-302381.html 0.6 2026-06-08T05:24:53+08:00 daily https://www.pharmasources.com/industryinsights/online-information-on-vaccines-and-autis-302382.html 0.6 2026-06-21T04:14:55+08:00 daily https://www.pharmasources.com/industryinsights/alcon-acrysof-iq-panoptix-trifocal-intra-302383.html 0.6 2026-07-25T16:14:19+08:00 daily https://www.pharmasources.com/industryinsights/research-shows-how-a-moderate-dose-of-al-302384.html 0.6 2026-06-21T17:05:31+08:00 daily https://www.pharmasources.com/industryinsights/tax-rises-on-the-horizon-for-nhs-budget--302385.html 0.6 2026-06-20T23:15:14+08:00 daily https://www.pharmasources.com/industryinsights/scotland-to-house-world-first-manufactur-302386.html 0.6 2026-06-20T18:19:54+08:00 daily https://www.pharmasources.com/industryinsights/us-regulators-reject-valeants-duobrii-302387.html 0.6 2026-06-20T16:20:35+08:00 daily https://www.pharmasources.com/industryinsights/roche-snaps-up-rest-of-foundation-medici-302388.html 0.6 2026-06-20T22:56:36+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-success-for-janssens-esketamin-302389.html 0.6 2026-06-20T00:58:56+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-joint-damage-data-for-cosent-302390.html 0.6 2026-06-22T08:51:45+08:00 daily https://www.pharmasources.com/industryinsights/amgens-blincyto-gets-full-eu-approval-fo-302391.html 0.6 2026-06-20T19:56:31+08:00 daily https://www.pharmasources.com/industryinsights/novo-kallyope-link-to-develop-obesity-di-302392.html 0.6 2026-06-22T05:51:38+08:00 daily https://www.pharmasources.com/industryinsights/pancreatic-cancer-survival-much-lower-th-302393.html 0.6 2026-06-21T17:04:25+08:00 daily https://www.pharmasources.com/industryinsights/uk-announces-review-of-medicinal-cannabi-302394.html 0.6 2026-06-21T01:54:34+08:00 daily https://www.pharmasources.com/industryinsights/prime-minister-reveals-20bn-a-year-boost-302395.html 0.6 2026-06-21T12:08:29+08:00 daily https://www.pharmasources.com/industryinsights/teva-pulls-fremanezumab-cluster-headache-302396.html 0.6 2026-06-23T15:08:19+08:00 daily https://www.pharmasources.com/industryinsights/ddf-immuneering-form-13m-alzheimers-rese-302397.html 0.6 2026-06-22T01:05:58+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-unveils-high-undetectable-disease-302398.html 0.6 2026-07-03T20:35:09+08:00 daily https://www.pharmasources.com/industryinsights/tax-rises-on-the-horizon-for-nhs-budget--302399.html 0.6 2026-06-22T21:38:35+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-spend-must-double-to-raise-302400.html 0.6 2026-06-21T06:09:52+08:00 daily https://www.pharmasources.com/industryinsights/wales-backs-nhs-use-of-actelions-uptravi-302401.html 0.6 2026-03-21T08:50:04+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-adjuvant-use-of-perjeta-pos-302402.html 0.6 2026-07-06T17:49:57+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-approved-for-second-blood-cance-302403.html 0.6 2026-07-08T11:06:39+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-therapy-crysvita-to-be-barr-302404.html 0.6 2026-07-04T00:03:45+08:00 daily https://www.pharmasources.com/industryinsights/powder-flowmicromeritics-instrument-corp-302405.html 0.6 2026-08-06T23:32:47+08:00 daily https://www.pharmasources.com/industryinsights/facebook-unveils-new-feature-to-battle-o-302406.html 0.6 2026-06-27T03:11:27+08:00 daily https://www.pharmasources.com/industryinsights/extremely-promising-blood-test-for-autis-302407.html 0.6 2026-06-22T17:06:07+08:00 daily https://www.pharmasources.com/industryinsights/kallyope-and-novo-nordisk-announce-obesi-302408.html 0.6 2026-06-22T00:45:55+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-shares-surge-after-gene-therapy--302409.html 0.6 2026-04-29T08:37:07+08:00 daily https://www.pharmasources.com/industryinsights/nhs-could-save-7-billion-via-new-diagnos-302410.html 0.6 2026-06-21T07:15:19+08:00 daily https://www.pharmasources.com/industryinsights/aquinnah-pharmaceuticals-receives-34-mil-302411.html 0.6 2026-06-20T17:55:21+08:00 daily https://www.pharmasources.com/industryinsights/novos-oral-semaglutide-beats-victoza-and-302412.html 0.6 2026-06-19T13:22:04+08:00 daily https://www.pharmasources.com/industryinsights/anikas-osteoarthritis-pain-drug-falls-sh-302413.html 0.6 2026-06-21T05:51:42+08:00 daily https://www.pharmasources.com/industryinsights/purdue-culls-350-positions-eradicates-sa-302414.html 0.6 2026-06-21T07:03:56+08:00 daily https://www.pharmasources.com/industryinsights/elderly-cancer-cases-to-increase-80-by-2-302415.html 0.6 2026-07-04T17:42:30+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-becomes-first-immuno-oncology-302416.html 0.6 2026-07-28T02:34:26+08:00 daily https://www.pharmasources.com/industryinsights/20bn-promised-to-nhs-but-questions-over--302417.html 0.6 2026-06-21T00:01:38+08:00 daily https://www.pharmasources.com/industryinsights/teva-axes-phase-3-trial-into-chronic-clu-302418.html 0.6 2026-06-20T22:16:17+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccine-slashes-rate-of-infection-by-302419.html 0.6 2026-08-07T13:26:45+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-just-approved-opioid-dependenc-302420.html 0.6 2026-07-03T01:00:52+08:00 daily https://www.pharmasources.com/industryinsights/theranos-founder-charged-with-fraud-302421.html 0.6 2026-06-14T01:47:23+08:00 daily https://www.pharmasources.com/industryinsights/roche-buys-out-rest-of-foundation-medici-302422.html 0.6 2026-06-20T22:12:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-valeant-plaque-psoriasis-lot-302423.html 0.6 2026-06-22T01:38:58+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-results-in-sma-has-biog-302424.html 0.6 2026-06-21T21:53:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-places-hold-on-ziopharm-car-t-trial-302425.html 0.6 2026-06-20T19:21:08+08:00 daily https://www.pharmasources.com/industryinsights/anikas-combo-arthritis-drug-cingal-flunk-302426.html 0.6 2026-06-20T21:21:22+08:00 daily https://www.pharmasources.com/industryinsights/eidos-therapeutics-raises-106m-ipo-to-ad-302427.html 0.6 2026-08-07T23:46:54+08:00 daily https://www.pharmasources.com/industryinsights/brainstorm-mulls-making-modest-profits-f-302428.html 0.6 2026-06-21T01:05:51+08:00 daily https://www.pharmasources.com/industryinsights/molecular-partners-names-regeneron-cance-302429.html 0.6 2026-06-21T00:07:43+08:00 daily https://www.pharmasources.com/industryinsights/aptinyx-magenta-lead-biotech-ipo-flurry--302430.html 0.6 2026-06-21T02:05:44+08:00 daily https://www.pharmasources.com/industryinsights/new-insight-into-how-an-old-tb-vaccine-l-302431.html 0.6 2026-06-21T08:05:01+08:00 daily https://www.pharmasources.com/industryinsights/big-data-analysis-links-herpes-virus-to--302432.html 0.6 2026-07-17T02:50:41+08:00 daily https://www.pharmasources.com/industryinsights/targeting-cancer-cells-escape-vehicles-t-302433.html 0.6 2026-06-21T14:58:22+08:00 daily https://www.pharmasources.com/industryinsights/nanobiotix-soars-as-late-phase-cancer-tr-302434.html 0.6 2026-06-21T09:01:03+08:00 daily https://www.pharmasources.com/industryinsights/ipo-bonanza-continues-with-150m-listing--302435.html 0.6 2026-06-20T23:57:39+08:00 daily https://www.pharmasources.com/industryinsights/can-fite-says-liver-cancer-trial-is-dela-302436.html 0.6 2026-06-23T03:27:03+08:00 daily https://www.pharmasources.com/industryinsights/vertex-doubles-size-of-cystic-fibrosis-d-302437.html 0.6 2026-06-20T17:18:30+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-leaps-50-on-early-data-for-duche-302438.html 0.6 2026-06-21T00:46:05+08:00 daily https://www.pharmasources.com/industryinsights/novimmune-tg-ally-to-take-cd47-cd19-bisp-302439.html 0.6 2026-08-03T23:47:12+08:00 daily https://www.pharmasources.com/industryinsights/iteos-raises-75m-to-trial-immuno-oncolog-302440.html 0.6 2026-08-07T22:38:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-hits-ziopharm-car-t-trial-with-clini-302441.html 0.6 2026-06-22T10:56:45+08:00 daily https://www.pharmasources.com/industryinsights/using-crispr-to-predict-heart-disease-ri-302442.html 0.6 2026-08-02T07:20:12+08:00 daily https://www.pharmasources.com/industryinsights/medivir-delays-pivotal-hdac-trial-as-fda-302443.html 0.6 2026-06-21T12:05:12+08:00 daily https://www.pharmasources.com/industryinsights/veteran-analyst-eric-schmidt-moves-over--302444.html 0.6 2026-06-20T02:32:45+08:00 daily https://www.pharmasources.com/industryinsights/syncona-powers-gene-therapy-startup-free-302445.html 0.6 2026-06-21T20:13:55+08:00 daily https://www.pharmasources.com/industryinsights/tot-biopharm-opens-new-biologics-facilit-302446.html 0.6 2026-08-08T01:29:58+08:00 daily https://www.pharmasources.com/industryinsights/is-india-jumping-the-gun-on-e-cigarettes-302447.html 0.6 2025-11-28T12:18:26+08:00 daily https://www.pharmasources.com/industryinsights/viruses-may-play-a-role-in-alzheimers-di-302448.html 0.6 2026-06-19T17:02:29+08:00 daily https://www.pharmasources.com/industryinsights/alibaba-sells-medical-assets-for-hk-106--302449.html 0.6 2026-06-21T17:07:26+08:00 daily https://www.pharmasources.com/industryinsights/korean-company-launches-anti-malaria-dru-302450.html 0.6 2026-06-22T07:34:31+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-oral-semaglutide-impresses-302451.html 0.6 2026-07-01T19:03:48+08:00 daily https://www.pharmasources.com/industryinsights/drug-shortages-again-on-the-rise-after-5-302452.html 0.6 2026-06-21T11:55:13+08:00 daily https://www.pharmasources.com/industryinsights/after-making-1m-on-illegal-trades-former-302453.html 0.6 2026-06-08T18:11:43+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-investing-50m-addi-302454.html 0.6 2026-06-20T17:50:14+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-to-pass-10b-in-2024-vacc-302455.html 0.6 2026-07-02T17:09:11+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-bids-adieu-to-vaccines-p-302456.html 0.6 2026-06-21T19:57:47+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-translate-bio-ink-mrna-vaccine-rd-302457.html 0.6 2026-06-20T15:12:19+08:00 daily https://www.pharmasources.com/industryinsights/eyeing-the-most-lucrative-vaccine-market-302458.html 0.6 2026-08-06T08:16:09+08:00 daily https://www.pharmasources.com/industryinsights/10-years-after-a-rejection-merck-returns-302459.html 0.6 2026-06-20T23:01:39+08:00 daily https://www.pharmasources.com/industryinsights/universal-flu-vaccine-biotech-seeks-big--302460.html 0.6 2026-08-06T23:32:37+08:00 daily https://www.pharmasources.com/industryinsights/doctors-worry-shingrix-side-effects-will-302461.html 0.6 2026-06-19T19:54:51+08:00 daily https://www.pharmasources.com/industryinsights/roches-multiple-sclerosis-drug-ocrevus-l-302462.html 0.6 2026-06-21T11:19:41+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-limits-shingrix-orders-d-302463.html 0.6 2026-07-13T10:13:52+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-boosted-shingrix-educati-302464.html 0.6 2026-08-08T01:21:12+08:00 daily https://www.pharmasources.com/industryinsights/citing-substantial-benefit-for-patients--302465.html 0.6 2026-06-21T06:50:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-epidiolex-302466.html 0.6 2026-06-21T10:57:07+08:00 daily https://www.pharmasources.com/industryinsights/ama-docs-declare-drug-shortages-public-h-302467.html 0.6 2026-06-21T18:56:35+08:00 daily https://www.pharmasources.com/industryinsights/efavirenz-doesnt-up-depression-suicidal--302468.html 0.6 2026-06-21T09:03:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-greenlights-gws-epidiolex-the-first--302469.html 0.6 2026-07-19T00:08:02+08:00 daily https://www.pharmasources.com/industryinsights/percentage-of-teens-trying-to-lose-weigh-302470.html 0.6 2026-06-20T17:00:17+08:00 daily https://www.pharmasources.com/industryinsights/direct-acting-antivirals-effective-for-h-302471.html 0.6 2026-06-21T04:07:54+08:00 daily https://www.pharmasources.com/industryinsights/parents-urged-to-ask-playdates-if-there--302472.html 0.6 2026-06-21T13:05:27+08:00 daily https://www.pharmasources.com/industryinsights/families-need-summertime-sleep-schedules-302473.html 0.6 2026-06-04T11:16:56+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-june-25-2018-302474.html 0.6 2026-06-21T12:41:23+08:00 daily https://www.pharmasources.com/industryinsights/forget-tagrissos-3b-sales-target-itll-be-302475.html 0.6 2026-07-07T21:35:13+08:00 daily https://www.pharmasources.com/industryinsights/with-latest-data-has-roches-tecentriq-fo-302476.html 0.6 2026-01-04T11:45:30+08:00 daily https://www.pharmasources.com/industryinsights/can-cannes-push-the-pharma-ad-envelope-r-302477.html 0.6 2026-08-04T08:40:34+08:00 daily https://www.pharmasources.com/industryinsights/in-rare-slip-pfizer-steamroller-ibrance--302478.html 0.6 2026-06-22T10:54:45+08:00 daily https://www.pharmasources.com/industryinsights/roche-appoints-james-sabry-as-global-par-302479.html 0.6 2026-08-06T16:48:57+08:00 daily https://www.pharmasources.com/industryinsights/casi-yiling-wanzhou-team-up-to-manufactu-302480.html 0.6 2026-08-10T01:21:19+08:00 daily https://www.pharmasources.com/industryinsights/sda-issued-the-2017-drug-inspection-repo-302481.html 0.6 2026-07-29T21:30:57+08:00 daily https://www.pharmasources.com/industryinsights/gaining-the-initiative-sda-becoming-an-i-302482.html 0.6 2026-07-30T22:41:27+08:00 daily https://www.pharmasources.com/industryinsights/a-glimpse-of-the-situation-of-sglt-2-inh-302483.html 0.6 2026-05-05T08:13:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-comprised-of-mar-302484.html 0.6 2026-06-21T08:17:25+08:00 daily https://www.pharmasources.com/industryinsights/enteris-biopharma-announces-positive-res-302485.html 0.6 2026-07-21T16:36:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-baloxavir--302486.html 0.6 2026-03-19T10:54:20+08:00 daily https://www.pharmasources.com/industryinsights/navitor-pharmaceuticals-initiates-a-clin-302487.html 0.6 2026-06-21T14:52:20+08:00 daily https://www.pharmasources.com/industryinsights/delmar-announces-accelerated-patient-enr-302488.html 0.6 2026-07-01T01:04:22+08:00 daily https://www.pharmasources.com/industryinsights/imbruvica-rituxan-combination-snda-accep-302489.html 0.6 2026-08-03T03:29:12+08:00 daily https://www.pharmasources.com/industryinsights/mm-141-trial-does-not-meet-primary-secon-302490.html 0.6 2026-07-18T04:30:42+08:00 daily https://www.pharmasources.com/industryinsights/pulmatrix-announces-positive-top-line-re-302491.html 0.6 2026-06-22T03:02:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-sbla-for-mercks-keytruda-as--302492.html 0.6 2026-07-31T11:00:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-automated-insulin-delivery--302493.html 0.6 2026-06-23T06:12:17+08:00 daily https://www.pharmasources.com/industryinsights/revance-doses-first-patient-in-aspen-pha-302494.html 0.6 2026-08-04T18:17:04+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-pharmaceuticals-initiates-pivot-302495.html 0.6 2026-08-09T17:31:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-continuous-glucose-mo-302496.html 0.6 2026-06-21T04:35:18+08:00 daily https://www.pharmasources.com/industryinsights/us-food-and-drug-administration-fda-acce-302497.html 0.6 2026-06-22T05:01:38+08:00 daily https://www.pharmasources.com/industryinsights/processa-pharmaceuticals-receives-orphan-302498.html 0.6 2026-06-20T03:02:04+08:00 daily https://www.pharmasources.com/industryinsights/distek-inc-releases-bione-1250-bioproces-302499.html 0.6 2026-08-06T17:54:31+08:00 daily https://www.pharmasources.com/industryinsights/clinical-data-management-leaders-reveal--302500.html 0.6 2026-06-20T08:15:50+08:00 daily https://www.pharmasources.com/industryinsights/bionj-launches-inaugural-entrepreneurshi-302501.html 0.6 2026-06-20T14:46:06+08:00 daily https://www.pharmasources.com/industryinsights/caris-life-sciences-presents-data-demons-302502.html 0.6 2026-07-06T20:55:38+08:00 daily https://www.pharmasources.com/industryinsights/htx-011-for-postoperative-pain-managemen-302503.html 0.6 2026-06-21T07:53:51+08:00 daily https://www.pharmasources.com/industryinsights/price-of-pfizers-smoking-cessation-drug--302504.html 0.6 2026-06-21T03:12:56+08:00 daily https://www.pharmasources.com/industryinsights/the-first-single-dose-flu-drug-nod-could-302505.html 0.6 2026-06-21T08:46:54+08:00 daily https://www.pharmasources.com/industryinsights/delivering-insulin-in-a-pill-302506.html 0.6 2026-08-04T08:01:49+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-combined-therapy-for--302507.html 0.6 2026-07-06T12:30:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-automated-insulin-delivery--302508.html 0.6 2026-06-20T18:58:40+08:00 daily https://www.pharmasources.com/industryinsights/beta-cell-function-of-diabetic-patients--302509.html 0.6 2026-06-19T13:55:44+08:00 daily https://www.pharmasources.com/industryinsights/prothena-announces-new-coo-302510.html 0.6 2026-06-21T00:02:42+08:00 daily https://www.pharmasources.com/industryinsights/plasticell-leads-gene-therapy-manufactur-302511.html 0.6 2026-07-18T11:12:42+08:00 daily https://www.pharmasources.com/industryinsights/bcg-vaccine-leads-to-long-term-blood-sug-302512.html 0.6 2026-06-21T03:18:59+08:00 daily https://www.pharmasources.com/industryinsights/bio-techne-to-acquire-exosome-diagnostic-302513.html 0.6 2026-06-22T01:06:01+08:00 daily https://www.pharmasources.com/industryinsights/deerfield-buys-alivamab-mouse-technology-302514.html 0.6 2026-06-20T19:16:57+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-closes-16bn-armo-biosciences-a-302515.html 0.6 2026-06-21T22:47:37+08:00 daily https://www.pharmasources.com/industryinsights/embl-researchers-develop-new-device-to-t-302516.html 0.6 2026-06-21T13:06:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-cannabis-based-drug-t-302517.html 0.6 2026-06-23T02:45:14+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-to-invest-230m-in-biologics-r-302518.html 0.6 2026-06-22T12:12:23+08:00 daily https://www.pharmasources.com/industryinsights/kaleido-ends-oversubscribed-funding-roun-302519.html 0.6 2026-06-20T21:19:14+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-to-become-independent-comp-302520.html 0.6 2026-06-20T23:17:52+08:00 daily https://www.pharmasources.com/industryinsights/new-approach-may-eliminate-daily-injecti-302521.html 0.6 2026-06-22T09:06:50+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-calibr-partner-to-develop-t-c-302522.html 0.6 2026-07-17T21:23:38+08:00 daily https://www.pharmasources.com/industryinsights/celgene-and-skyhawk-initiate-five-year-c-302523.html 0.6 2026-06-21T02:58:44+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-almost-half-of-uk-women-expe-302524.html 0.6 2026-06-21T07:00:55+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-buy-remaining-stake-in-foundati-302525.html 0.6 2026-06-21T10:10:14+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-drug-reduces-hearing-loss-in-302526.html 0.6 2026-06-20T22:50:34+08:00 daily https://www.pharmasources.com/industryinsights/natera-and-institut-jules-bordet-partner-302527.html 0.6 2026-04-12T15:45:33+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-brain-metals-that-m-302528.html 0.6 2026-06-21T08:53:54+08:00 daily https://www.pharmasources.com/industryinsights/sugar-can-delay-neurodegeneration-caused-302529.html 0.6 2026-06-21T08:00:08+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-distribute-histocyte-laboratori-302530.html 0.6 2026-04-20T17:40:54+08:00 daily https://www.pharmasources.com/industryinsights/deals-and-mas-this-week-alliance-pharma--302531.html 0.6 2026-07-05T15:28:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bmss-application-for-non-sma-302532.html 0.6 2026-06-22T12:56:33+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-becomes-first-canadian-pharmaceut-302533.html 0.6 2026-06-20T18:18:54+08:00 daily https://www.pharmasources.com/industryinsights/philips-showcases-commitment-towards-nuc-302534.html 0.6 2026-08-06T20:11:13+08:00 daily https://www.pharmasources.com/industryinsights/emirates-hospital-partners-with-regen-me-302535.html 0.6 2026-04-01T19:44:38+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-acquires-rights-to-nov-302536.html 0.6 2026-07-03T00:45:02+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-merck-eye-1-billion-boost-fr-302537.html 0.6 2026-06-20T17:57:37+08:00 daily https://www.pharmasources.com/industryinsights/lupin-partners-with-mylan-to-commerciali-302538.html 0.6 2026-06-23T13:00:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-breast-cancer-drug-combo-falls-s-302539.html 0.6 2026-06-21T16:50:16+08:00 daily https://www.pharmasources.com/industryinsights/apcer-life-sciences-arisglobal-launch-in-302540.html 0.6 2026-06-22T05:59:40+08:00 daily https://www.pharmasources.com/industryinsights/piramal-subsidiary-sells-stake-in-pisa-t-302541.html 0.6 2026-06-20T19:40:31+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-evaluating-the-powder-testin-302542.html 0.6 2026-08-06T22:37:08+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharmas-generic-ertapenem-inje-302543.html 0.6 2026-06-21T06:10:53+08:00 daily https://www.pharmasources.com/industryinsights/ideal-cures-launches-new-film-coating-pr-302544.html 0.6 2026-08-09T06:59:30+08:00 daily https://www.pharmasources.com/industryinsights/lupin-aims-to-launch-around-30-generic-p-302545.html 0.6 2026-08-08T08:39:00+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharmas-multidose-dispenser-approv-302546.html 0.6 2026-08-08T07:37:09+08:00 daily https://www.pharmasources.com/industryinsights/acg-films-foils-launches-lamination-faci-302547.html 0.6 2026-08-08T04:31:04+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-receives-dcgi-nod-for-durval-302548.html 0.6 2026-08-07T13:18:24+08:00 daily https://www.pharmasources.com/industryinsights/dil-approves-scheme-of-amalgamation-with-302549.html 0.6 2026-08-06T20:08:15+08:00 daily https://www.pharmasources.com/industryinsights/sebi-to-act-against-pharma-cos-in-case-o-302550.html 0.6 2026-08-06T23:49:08+08:00 daily https://www.pharmasources.com/industryinsights/strides-shasun-gets-who-pre-qualificatio-302551.html 0.6 2026-08-06T23:56:58+08:00 daily https://www.pharmasources.com/industryinsights/india-for-formal-recognition-of-traditio-302552.html 0.6 2026-08-07T02:04:45+08:00 daily https://www.pharmasources.com/industryinsights/gsk-takes-billion-dollar-drug-fight-with-302553.html 0.6 2026-08-07T00:59:17+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-final-approval-for-testos-302554.html 0.6 2026-08-07T00:53:01+08:00 daily https://www.pharmasources.com/industryinsights/roche-buys-foundation-medicine-for-24-bi-302555.html 0.6 2026-08-07T00:41:11+08:00 daily https://www.pharmasources.com/industryinsights/cipla-gets-us-fda-approval-for-generic-s-302556.html 0.6 2026-06-22T03:44:30+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-erectil-302557.html 0.6 2026-08-06T23:56:40+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-specialist-spectrum-eyes-po-302558.html 0.6 2026-08-06T23:46:37+08:00 daily https://www.pharmasources.com/industryinsights/the-top-5-highest-paid-women-biopharma-e-302559.html 0.6 2026-08-06T23:56:54+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-taltz-pads-case-for-a-shot-at-302560.html 0.6 2026-08-07T00:41:12+08:00 daily https://www.pharmasources.com/industryinsights/ready-to-challenge-novartis-and-roche-ar-302561.html 0.6 2026-08-07T00:42:37+08:00 daily https://www.pharmasources.com/industryinsights/controversial-us-cost-watchdog-plans-to--302562.html 0.6 2026-08-07T00:52:57+08:00 daily https://www.pharmasources.com/industryinsights/amazon-gets-a-drug-distribution-beachhea-302563.html 0.6 2026-08-07T00:57:40+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-trumpets-more-januvia-toppi-302564.html 0.6 2026-08-07T13:16:11+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-advent-finally-shake-hands-on-22b-302565.html 0.6 2026-08-08T00:54:05+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-novartis-gender-bias-suits-dra-302566.html 0.6 2026-08-08T10:11:55+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-spend-700m-to-build-its-stake--302567.html 0.6 2026-08-08T12:18:41+08:00 daily https://www.pharmasources.com/industryinsights/car-t-race-heads-to-europe-as-gilead-nov-302568.html 0.6 2026-08-08T14:03:25+08:00 daily https://www.pharmasources.com/industryinsights/agilent-opens-new-logistics-hub-in-china-302569.html 0.6 2026-06-24T17:11:06+08:00 daily https://www.pharmasources.com/industryinsights/yourui-pharma-completes-series-b-financi-302570.html 0.6 2026-07-23T09:38:05+08:00 daily https://www.pharmasources.com/industryinsights/us-scientists-to-develop-rapid-diagnosti-302571.html 0.6 2026-06-21T04:56:42+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018070-302572.html 0.6 2026-06-21T13:16:15+08:00 daily https://www.pharmasources.com/industryinsights/abcam-merck-launch-anti-pd-l1-antibody-c-302573.html 0.6 2026-06-22T10:59:52+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-launches-standalone-serializat-302574.html 0.6 2026-06-21T03:05:47+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-launches-global-rd-ops-in-china-302575.html 0.6 2026-06-22T05:13:50+08:00 daily https://www.pharmasources.com/industryinsights/prestige-biopharma-alvogen-enter-agreeme-302576.html 0.6 2026-06-22T12:48:35+08:00 daily https://www.pharmasources.com/industryinsights/basi-seventh-wave-labs-merge-302577.html 0.6 2026-06-23T20:16:24+08:00 daily https://www.pharmasources.com/industryinsights/agilent-technologies-acquires-prozyme-302579.html 0.6 2026-06-21T09:04:12+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-bolsters-biologics--302580.html 0.6 2026-08-09T14:24:13+08:00 daily https://www.pharmasources.com/industryinsights/adents-launches-verification-router-serv-302581.html 0.6 2026-08-08T02:12:46+08:00 daily https://www.pharmasources.com/industryinsights/advent-to-acquire-sanofis-generics-biz-i-302582.html 0.6 2026-06-21T10:05:11+08:00 daily https://www.pharmasources.com/industryinsights/kymab-roche-partner-to-evaluate-ky1044-302583.html 0.6 2026-02-28T21:28:43+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-launches-oncomine-tcr-beta-302584.html 0.6 2026-06-20T18:21:06+08:00 daily https://www.pharmasources.com/industryinsights/pharmamar-chugai-execute-early-terminati-302585.html 0.6 2026-06-20T22:41:32+08:00 daily https://www.pharmasources.com/industryinsights/ligand-wuxi-biologics-amend-agreement-302586.html 0.6 2026-06-23T21:58:03+08:00 daily https://www.pharmasources.com/industryinsights/ibi-lorenzini-selects-tracelink-as-compl-302587.html 0.6 2026-08-06T23:38:06+08:00 daily https://www.pharmasources.com/industryinsights/wcg-and-informeddna-enter-strategic-part-302588.html 0.6 2026-04-12T19:18:55+08:00 daily https://www.pharmasources.com/industryinsights/catalent-appoints-madison-wi-facility-gm-302589.html 0.6 2026-06-21T11:54:13+08:00 daily https://www.pharmasources.com/industryinsights/skyhawk-celgene-in-strategic-discovery-a-302590.html 0.6 2026-06-21T13:02:28+08:00 daily https://www.pharmasources.com/industryinsights/car-t-therapies-leap-towards-eu-approval-302591.html 0.6 2026-08-09T19:18:06+08:00 daily https://www.pharmasources.com/industryinsights/roche-gearing-up-to-file-tecentriq-for-b-302592.html 0.6 2026-08-09T01:58:56+08:00 daily https://www.pharmasources.com/industryinsights/nice-no-for-roches-ocrevus-in-primary-pr-302593.html 0.6 2026-08-07T00:59:09+08:00 daily https://www.pharmasources.com/industryinsights/would-you-be-optimistic-about-the-chines-302594.html 0.6 2026-08-07T00:42:53+08:00 daily https://www.pharmasources.com/industryinsights/new-paradigms-for-toxicological-testing-302595.html 0.6 2026-08-07T00:53:06+08:00 daily https://www.pharmasources.com/industryinsights/esco-group-to-set-up-innovation-centre-i-302596.html 0.6 2026-08-07T00:59:52+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-raises-prices-on-100-drugs-its-se-302597.html 0.6 2026-08-07T01:10:32+08:00 daily https://www.pharmasources.com/industryinsights/cvc-capital-revs-up-rare-disease-ambitio-302598.html 0.6 2026-06-21T10:05:19+08:00 daily https://www.pharmasources.com/industryinsights/metformin-reverses-established-lung-fibr-302599.html 0.6 2026-06-22T01:56:39+08:00 daily https://www.pharmasources.com/industryinsights/higher-rifampin-doses-for-tb-appear-more-302600.html 0.6 2026-07-27T23:53:10+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-predicts-treatment-response-f-302601.html 0.6 2026-06-21T09:58:22+08:00 daily https://www.pharmasources.com/industryinsights/inthera-bioscience-ag-expands-management-302602.html 0.6 2026-06-20T15:44:37+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-nouscom-sign-license-agree-302603.html 0.6 2026-06-22T03:59:42+08:00 daily https://www.pharmasources.com/industryinsights/reapplix-positive-outcome-data-of-large--302604.html 0.6 2026-06-22T07:43:58+08:00 daily https://www.pharmasources.com/industryinsights/mdxhealths-selectmdx-test-successfully-s-302605.html 0.6 2026-06-21T11:14:22+08:00 daily https://www.pharmasources.com/industryinsights/nbe-therapeutics-closes-a-chf-20-million-302606.html 0.6 2026-06-21T06:56:47+08:00 daily https://www.pharmasources.com/industryinsights/prestige-biopharma-and-alvogen-announce--302607.html 0.6 2026-07-17T01:56:27+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-appoints-jim-geragh-302608.html 0.6 2026-06-20T15:10:21+08:00 daily https://www.pharmasources.com/industryinsights/aptamer-group-uk-biotech-business-raises-302609.html 0.6 2026-07-05T04:31:24+08:00 daily https://www.pharmasources.com/industryinsights/abcam-merck-collaboration-produces-new-p-302610.html 0.6 2026-08-09T06:59:30+08:00 daily https://www.pharmasources.com/industryinsights/varmx-raises-125-million-to-develop-modi-302611.html 0.6 2026-08-08T18:12:35+08:00 daily https://www.pharmasources.com/industryinsights/cellgenix-completed-first-step-of-facili-302612.html 0.6 2026-08-07T13:17:45+08:00 daily https://www.pharmasources.com/industryinsights/tfs-international-appoints-dr-suzanne-pa-302613.html 0.6 2026-08-06T20:06:22+08:00 daily https://www.pharmasources.com/industryinsights/neural-analytics-inc-receives-ce-mark-fo-302614.html 0.6 2026-08-06T21:54:31+08:00 daily https://www.pharmasources.com/industryinsights/triple-digit-growth-in-emea-as-pharma-co-302615.html 0.6 2026-08-07T02:31:11+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-signs-exclusive-supply-distribu-302616.html 0.6 2026-08-07T02:37:04+08:00 daily https://www.pharmasources.com/industryinsights/uk-space-agency-links-with-nhs-england-t-302617.html 0.6 2026-06-21T07:06:00+08:00 daily https://www.pharmasources.com/industryinsights/aslan-submits-authorisation-application--302618.html 0.6 2026-08-06T23:33:01+08:00 daily https://www.pharmasources.com/industryinsights/nhs-has-lost-more-than-6000-beds-in-four-302619.html 0.6 2026-06-21T07:18:11+08:00 daily https://www.pharmasources.com/industryinsights/azmsd-pursue-wider-indication-for-lynpar-302620.html 0.6 2026-06-20T17:17:37+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-calico-extend-age-related-disease-302621.html 0.6 2026-08-07T12:55:33+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-names-winners-of-healthcare-hub-c-302622.html 0.6 2026-06-22T14:24:36+08:00 daily https://www.pharmasources.com/industryinsights/can-aspirin-treat-alzheimers-302623.html 0.6 2026-06-20T17:01:17+08:00 daily https://www.pharmasources.com/industryinsights/athenex-announces-joint-venture-with-xia-302624.html 0.6 2026-06-22T12:02:53+08:00 daily https://www.pharmasources.com/industryinsights/no-massachusetts-you-cant-run-a-pbm-styl-302625.html 0.6 2026-07-06T22:25:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-for-excessive-drooling-302626.html 0.6 2026-01-30T18:22:22+08:00 daily https://www.pharmasources.com/industryinsights/rcgp-urges-parents-to-vaccinate-children-302627.html 0.6 2026-01-03T07:36:01+08:00 daily https://www.pharmasources.com/industryinsights/amgen-novartis-overwhelmed-by-early-inte-302628.html 0.6 2026-06-20T23:57:34+08:00 daily https://www.pharmasources.com/industryinsights/gdpr-behind-drop-in-pharma-payment-discl-302629.html 0.6 2026-06-20T15:13:21+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-scores-third-appeals-win-302630.html 0.6 2026-08-08T00:35:45+08:00 daily https://www.pharmasources.com/industryinsights/eu-green-light-for-cimzia-to-treat-psori-302631.html 0.6 2026-06-21T04:43:31+08:00 daily https://www.pharmasources.com/industryinsights/celgene-pledges-to-limit-price-hikesor-d-302632.html 0.6 2026-08-05T19:01:33+08:00 daily https://www.pharmasources.com/industryinsights/nice-says-tookad-too-expensive-for-prost-302633.html 0.6 2026-06-21T01:44:30+08:00 daily https://www.pharmasources.com/industryinsights/car-t-therapies-leap-towards-eu-approval-302634.html 0.6 2026-06-22T12:52:38+08:00 daily https://www.pharmasources.com/industryinsights/antiviral-drug-market-hiv-drugs-to-becom-302635.html 0.6 2026-08-05T20:50:23+08:00 daily https://www.pharmasources.com/industryinsights/celgene-acceleron-to-file-mds-therapy-in-302636.html 0.6 2026-08-07T20:50:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-clear-about-psoriasis-survey-da-302637.html 0.6 2026-06-21T10:48:11+08:00 daily https://www.pharmasources.com/industryinsights/poliovirus-therapy-for-recurrent-gliobla-302638.html 0.6 2026-06-08T19:38:37+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-novartis-present-new-data-demo-302639.html 0.6 2026-07-16T16:48:53+08:00 daily https://www.pharmasources.com/industryinsights/global-study-by-novartis-and-european-mi-302640.html 0.6 2026-07-03T21:45:42+08:00 daily https://www.pharmasources.com/industryinsights/some-existing-anti-cancer-drugs-may-act--302641.html 0.6 2026-06-20T17:58:22+08:00 daily https://www.pharmasources.com/industryinsights/roche-commences-tender-offer-for-all-sha-302642.html 0.6 2026-07-06T23:04:56+08:00 daily https://www.pharmasources.com/industryinsights/can-aspirin-treat-alzheimers-302643.html 0.6 2026-04-18T05:38:19+08:00 daily https://www.pharmasources.com/industryinsights/how-targeting-metabolism-can-defeat-canc-302644.html 0.6 2026-08-07T23:07:33+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-foundation-medicine-reach-defi-302645.html 0.6 2026-06-21T16:43:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-comprised-of-an--302646.html 0.6 2026-06-21T00:02:37+08:00 daily https://www.pharmasources.com/industryinsights/kallyope-and-novo-nordisk-announce-colla-302647.html 0.6 2026-06-23T07:54:24+08:00 daily https://www.pharmasources.com/industryinsights/kiss-of-death-cancer-302648.html 0.6 2026-07-04T02:19:23+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-is-one-of-the-most-common--302649.html 0.6 2025-11-07T12:29:29+08:00 daily https://www.pharmasources.com/industryinsights/in-mice-stem-cells-seem-to-work-in-fight-302650.html 0.6 2026-06-22T09:47:40+08:00 daily https://www.pharmasources.com/industryinsights/probiotics-can-protect-the-skeletons-of--302651.html 0.6 2026-06-21T04:02:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-steps-to-foster-greater-effici-302652.html 0.6 2026-06-22T10:57:45+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-breakthrough-brain-metals-tha-302653.html 0.6 2026-06-20T23:56:39+08:00 daily https://www.pharmasources.com/industryinsights/axm-pharma-appoints-new-302654.html 0.6 2026-06-21T09:12:14+08:00 daily https://www.pharmasources.com/industryinsights/msds-antiviral-prevymis-fails-to-win-nic-302655.html 0.6 2026-06-14T08:04:28+08:00 daily https://www.pharmasources.com/industryinsights/uks-genome-sequencing-project-will-hit-1-302656.html 0.6 2026-06-20T21:02:38+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-no-for-bms-opdivo-in-urotheli-302657.html 0.6 2026-06-22T00:56:47+08:00 daily https://www.pharmasources.com/industryinsights/iran-syria-sign-mou-for-academic-coopera-302658.html 0.6 2026-06-20T14:42:04+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-opens-77-m-rd-facility-in-chengdu-302659.html 0.6 2026-06-30T22:37:18+08:00 daily https://www.pharmasources.com/industryinsights/roche-announces-positive-results-of-lung-302660.html 0.6 2026-07-17T12:41:04+08:00 daily https://www.pharmasources.com/industryinsights/unsw-students-pioneering-artificial-inte-302661.html 0.6 2026-06-21T12:23:46+08:00 daily https://www.pharmasources.com/industryinsights/flow-chemistry-helps-enhance-biocatalysi-302662.html 0.6 2026-06-20T15:40:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-aristada-inito-for-the-init-302663.html 0.6 2026-06-20T04:46:14+08:00 daily https://www.pharmasources.com/industryinsights/researcher-uses-hpv-vaccine-to-treat-pat-302664.html 0.6 2026-07-09T04:52:02+08:00 daily https://www.pharmasources.com/industryinsights/global-top-10-best-selling-drugs-302665.html 0.6 2026-07-21T23:52:12+08:00 daily https://www.pharmasources.com/industryinsights/data-show-imnovid-based-triple-therapy-p-302666.html 0.6 2026-04-06T22:56:41+08:00 daily https://www.pharmasources.com/industryinsights/survey-shows-public-support-for-nhs-tax--302667.html 0.6 2026-06-23T01:49:56+08:00 daily https://www.pharmasources.com/industryinsights/govt-announces-215m-investment-in-nhs-he-302668.html 0.6 2026-05-16T08:23:04+08:00 daily https://www.pharmasources.com/industryinsights/novos-oral-semaglutide-bests-msds-januvi-302669.html 0.6 2026-06-21T01:03:53+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-pfizers-xeljanz-for-psoriati-302670.html 0.6 2026-06-19T23:01:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pierre-fabrearray-biotech-m-302671.html 0.6 2026-08-02T13:55:13+08:00 daily https://www.pharmasources.com/industryinsights/survey-shows-public-support-for-nhs-tax--302672.html 0.6 2026-06-21T02:12:49+08:00 daily https://www.pharmasources.com/industryinsights/data-show-imnovid-based-triple-therapy-p-302673.html 0.6 2026-06-21T03:07:44+08:00 daily https://www.pharmasources.com/industryinsights/review-signals-step-towards-legalisation-302674.html 0.6 2026-06-22T07:55:49+08:00 daily https://www.pharmasources.com/industryinsights/abivax-drug-lowers-hiv-dna-in-blood-and--302675.html 0.6 2026-02-28T15:29:17+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-bms-blockbuster-opdivo-f-302676.html 0.6 2026-07-15T22:55:50+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-sell-osaka-site-to-soften-shir-302677.html 0.6 2026-06-21T07:05:57+08:00 daily https://www.pharmasources.com/industryinsights/global-animal-health-market-set-to-be-wo-302678.html 0.6 2026-06-23T16:48:31+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-novartis-car-t-therapy-k-302679.html 0.6 2026-06-20T22:00:38+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-reveals-positive-phase-2-data-of-c-302680.html 0.6 2026-08-09T22:12:40+08:00 daily https://www.pharmasources.com/industryinsights/illegally-manufactured-fentanyl-drives-d-302681.html 0.6 2026-04-13T13:58:10+08:00 daily https://www.pharmasources.com/industryinsights/the-julyaugust-issue-of-pharmafocus-is-n-302682.html 0.6 2026-06-21T15:34:43+08:00 daily https://www.pharmasources.com/industryinsights/gsk-director-indicted-in-massachusetts-o-302683.html 0.6 2026-06-21T21:41:34+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-combo-gives-strong-phas-302684.html 0.6 2026-06-22T00:05:48+08:00 daily https://www.pharmasources.com/industryinsights/ema-approves-cimzia-for-use-in-treating--302685.html 0.6 2026-06-21T05:02:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-invests-66m-in-chinese-rd-hub-302686.html 0.6 2026-06-23T23:53:56+08:00 daily https://www.pharmasources.com/industryinsights/unfazed-by-trump-pfizer-hikes-prices-for-302687.html 0.6 2026-06-22T01:52:29+08:00 daily https://www.pharmasources.com/industryinsights/novartis-secures-us-rights-to-adamis-epi-302688.html 0.6 2026-06-22T05:09:52+08:00 daily https://www.pharmasources.com/industryinsights/cadila-scores-fda-approval-for-bms-and-a-302689.html 0.6 2026-07-26T08:06:56+08:00 daily https://www.pharmasources.com/industryinsights/bayer-expands-broad-institute-partnershi-302690.html 0.6 2026-08-07T22:00:21+08:00 daily https://www.pharmasources.com/industryinsights/promising-new-drug-slows-parkinsons-prog-302691.html 0.6 2026-06-23T02:28:48+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-presents-positive-results-of-long-302692.html 0.6 2026-06-22T03:54:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-xeljanz-scores-eu-approval-for-a-302693.html 0.6 2026-06-20T14:57:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-spins-off-alcon-as-ceo-focuses--302694.html 0.6 2026-06-21T07:22:43+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-ordered-to-pay-448m-over-generic--302695.html 0.6 2026-07-22T01:22:04+08:00 daily https://www.pharmasources.com/industryinsights/takedas-entyvio-secures-japanese-approva-302696.html 0.6 2026-06-21T18:06:44+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-chalks-up-double-japanese-ap-302697.html 0.6 2026-08-08T02:55:51+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-to-determine-best-timing-to-a-302698.html 0.6 2026-06-20T21:52:55+08:00 daily https://www.pharmasources.com/industryinsights/researchers-in-japan-devise-method-to-pr-302699.html 0.6 2026-06-21T08:57:54+08:00 daily https://www.pharmasources.com/industryinsights/trumps-uk-visit-sparks-plans-for-mass-pr-302700.html 0.6 2026-06-21T04:11:53+08:00 daily https://www.pharmasources.com/industryinsights/takedas-osaka-headquarters-up-for-sale-a-302701.html 0.6 2026-07-31T04:37:00+08:00 daily https://www.pharmasources.com/industryinsights/new-anti-clotting-drugs-linked-to-lower--302702.html 0.6 2026-06-22T01:10:58+08:00 daily https://www.pharmasources.com/industryinsights/plerixafor-may-protect-against-smoke-rel-302703.html 0.6 2026-06-21T18:00:23+08:00 daily https://www.pharmasources.com/industryinsights/viivs-two-drug-hiv-regimen-hits-phiii-ta-302704.html 0.6 2026-06-20T19:06:43+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-supply-chains-on-brink-of-col-302705.html 0.6 2026-06-22T05:58:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-xalkori-makes-it-onto-cancer-dru-302706.html 0.6 2026-07-03T05:12:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-xeljanz-for-ulcerat-302707.html 0.6 2026-04-08T16:47:14+08:00 daily https://www.pharmasources.com/industryinsights/vertex-presents-real-world-data-highligh-302708.html 0.6 2026-06-20T17:15:25+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-janssens-zytiga-for-early-a-302709.html 0.6 2026-06-20T03:52:21+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-unveils-600m-investment-in-ventur-302710.html 0.6 2026-06-21T08:57:58+08:00 daily https://www.pharmasources.com/industryinsights/nice-deems-msds-keytruda-cost-effective--302711.html 0.6 2026-06-20T14:55:04+08:00 daily https://www.pharmasources.com/industryinsights/uk-health-spends-lags-behind-eu-peers-302712.html 0.6 2026-06-28T05:54:32+08:00 daily https://www.pharmasources.com/industryinsights/high-court-rejects-homeopathy-plea-302713.html 0.6 2026-06-28T03:39:02+08:00 daily https://www.pharmasources.com/industryinsights/boehringers-spiriva-gets-uk-license-for--302714.html 0.6 2026-07-07T17:46:39+08:00 daily https://www.pharmasources.com/industryinsights/are-you-an-agency-that-has-strong-experi-302715.html 0.6 2026-06-22T12:10:10+08:00 daily https://www.pharmasources.com/industryinsights/cgt-catapult-unveils-major-uk-investment-302716.html 0.6 2026-06-22T06:59:47+08:00 daily https://www.pharmasources.com/industryinsights/microbiome-startup-nextbiotix-raises-7m--302717.html 0.6 2026-06-21T19:04:24+08:00 daily https://www.pharmasources.com/industryinsights/jefferies-says-gilead-is-poised-for-turn-302718.html 0.6 2026-06-22T08:57:40+08:00 daily https://www.pharmasources.com/industryinsights/amplexor-life-sciences-what-life-science-302719.html 0.6 2026-06-20T20:59:39+08:00 daily https://www.pharmasources.com/industryinsights/cellect-denovomatrix-start-stem-cell-res-302720.html 0.6 2026-06-22T16:47:21+08:00 daily https://www.pharmasources.com/industryinsights/arming-antibiotics-with-a-vaccination-li-302721.html 0.6 2026-06-21T11:15:22+08:00 daily https://www.pharmasources.com/industryinsights/ionis-backed-dynacure-bags-47m-to-start--302722.html 0.6 2026-07-24T11:19:23+08:00 daily https://www.pharmasources.com/industryinsights/one-step-closer-to-personalized-treatmen-302723.html 0.6 2026-06-20T18:17:53+08:00 daily https://www.pharmasources.com/industryinsights/orion-takes-repurposed-heart-failure-dru-302724.html 0.6 2026-06-20T23:58:36+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-eisais-previously-bleak-alzhe-302725.html 0.6 2026-07-17T02:10:34+08:00 daily https://www.pharmasources.com/industryinsights/after-breathing-new-life-into-old-mice-s-302726.html 0.6 2026-06-21T12:56:47+08:00 daily https://www.pharmasources.com/industryinsights/sen-patty-murray-calls-out-bio-phrma-on--302727.html 0.6 2026-06-22T01:47:39+08:00 daily https://www.pharmasources.com/industryinsights/cash-strapped-titan-delays-parkinsons-im-302728.html 0.6 2026-07-08T14:29:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-dumps-aveo-drug-as-relationship-302729.html 0.6 2026-07-19T02:58:08+08:00 daily https://www.pharmasources.com/industryinsights/antibe-builds-case-for-gi-safety-of-napr-302730.html 0.6 2026-06-28T11:48:00+08:00 daily https://www.pharmasources.com/industryinsights/shkreli-in-the-stocks-is-still-sharing-b-302731.html 0.6 2026-07-04T14:54:20+08:00 daily https://www.pharmasources.com/industryinsights/controlling-crispr-and-gene-therapy-with-302732.html 0.6 2026-06-20T21:08:58+08:00 daily https://www.pharmasources.com/industryinsights/predictimmune-names-paul-kinnon-as-ceo-302733.html 0.6 2026-06-21T02:59:43+08:00 daily https://www.pharmasources.com/industryinsights/liquidia-files-for-ipo-to-challenge-unit-302734.html 0.6 2026-08-09T13:04:59+08:00 daily https://www.pharmasources.com/industryinsights/the-old-diabetes-drug-metformin-may-find-302735.html 0.6 2026-06-20T19:47:55+08:00 daily https://www.pharmasources.com/industryinsights/athenex-rakes-in-100m-sets-up-chinese-tc-302736.html 0.6 2026-06-20T13:20:52+08:00 daily https://www.pharmasources.com/industryinsights/voyager-therapeutics-poaches-genzyme-san-302737.html 0.6 2026-07-08T13:53:39+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-dumps-galapagos-cystic-fibrosis-c-302738.html 0.6 2026-07-08T13:51:58+08:00 daily https://www.pharmasources.com/industryinsights/after-nearly-3-years-fda-lifts-hold-on-a-302739.html 0.6 2026-06-21T01:59:41+08:00 daily https://www.pharmasources.com/industryinsights/gemphire-sparkles-on-third-trial-win-for-302740.html 0.6 2026-06-22T11:07:56+08:00 daily https://www.pharmasources.com/industryinsights/mouse-study-reveals-potential-new-treatm-302741.html 0.6 2026-08-06T06:09:02+08:00 daily https://www.pharmasources.com/industryinsights/takeda-bags-japans-approval-for-ulcerati-302742.html 0.6 2026-06-21T08:56:58+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-intention-to-spin-off-302743.html 0.6 2026-06-21T11:58:11+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-to-commercialise-ryaltris-in-au-302744.html 0.6 2026-07-07T14:51:43+08:00 daily https://www.pharmasources.com/industryinsights/new-medical-chief-at-acceleron-302745.html 0.6 2026-08-08T05:20:25+08:00 daily https://www.pharmasources.com/industryinsights/biogens-alzheimers-drug-succeeds-in-tria-302746.html 0.6 2026-07-19T09:42:49+08:00 daily https://www.pharmasources.com/industryinsights/indivumed-imcb-to-build-multiomics-cance-302747.html 0.6 2026-06-22T06:04:38+08:00 daily https://www.pharmasources.com/industryinsights/neovii-mundipharma-enter-strategic-colla-302748.html 0.6 2026-06-22T03:08:01+08:00 daily https://www.pharmasources.com/industryinsights/adva-calls-for-collaboration-efforts-to--302749.html 0.6 2026-06-20T14:27:44+08:00 daily https://www.pharmasources.com/industryinsights/nanofiber-based-wound-dressings-induce-p-302750.html 0.6 2026-06-19T15:56:52+08:00 daily https://www.pharmasources.com/industryinsights/judge-strikes-140m-androgel-verdict-afte-302751.html 0.6 2026-08-07T00:21:10+08:00 daily https://www.pharmasources.com/industryinsights/pharma-shells-out-100b-on-ma-in-2018-so--302752.html 0.6 2026-07-06T23:31:41+08:00 daily https://www.pharmasources.com/industryinsights/teva-lured-by-40m-tax-break-packs-its-ba-302753.html 0.6 2026-07-07T02:53:20+08:00 daily https://www.pharmasources.com/industryinsights/europe-recalling-some-valsartan-meds-on--302754.html 0.6 2026-06-22T19:25:34+08:00 daily https://www.pharmasources.com/industryinsights/chinese-firms-eyeing-up-sinclair-pharma-302755.html 0.6 2026-06-22T21:18:01+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-looks-to-sell-frenc-302756.html 0.6 2026-06-21T15:11:46+08:00 daily https://www.pharmasources.com/industryinsights/eisai-biogens-alzheimers-candidate-shows-302757.html 0.6 2026-06-21T02:57:41+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-uk-md-takes-the-helm-at-the-abpi-302758.html 0.6 2026-06-21T22:13:06+08:00 daily https://www.pharmasources.com/industryinsights/gsks-chief-financial-officer-to-retire-302759.html 0.6 2026-06-21T04:19:06+08:00 daily https://www.pharmasources.com/industryinsights/govt-suspends-controversial-nhs-data-sha-302760.html 0.6 2026-06-21T00:19:05+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-buy-shire-for-46-billion-302761.html 0.6 2026-07-19T18:29:51+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-widen-lynparzas-reach-302762.html 0.6 2026-06-18T02:49:21+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-moves-to-fast-track-clinical-302763.html 0.6 2026-06-21T01:52:43+08:00 daily https://www.pharmasources.com/industryinsights/uk-synthetic-antibody-firm-raises-15m-302764.html 0.6 2026-06-21T20:14:04+08:00 daily https://www.pharmasources.com/industryinsights/faron-stock-falls-on-traumakine-failure-302765.html 0.6 2026-07-04T01:25:06+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sheds-seroquel-rights-302766.html 0.6 2026-07-04T09:36:36+08:00 daily https://www.pharmasources.com/industryinsights/five-therapies-endorsed-for-use-on-nhs-s-302767.html 0.6 2026-06-20T02:33:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-oks-three-new-therapies-for-blood-c-302768.html 0.6 2026-06-20T22:49:38+08:00 daily https://www.pharmasources.com/industryinsights/first-line-use-of-roches-tecentriq-given-302769.html 0.6 2026-08-09T07:36:32+08:00 daily https://www.pharmasources.com/industryinsights/big-biopharma-not-the-best-investment-so-302770.html 0.6 2026-06-21T03:07:49+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-combo-wins-nod-for-newly-diagno-302771.html 0.6 2026-08-07T13:19:11+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriqcotellic-study-fails-in--302772.html 0.6 2026-08-09T18:56:25+08:00 daily https://www.pharmasources.com/industryinsights/opportunities-with-pharmaceutical-confer-302773.html 0.6 2026-08-07T02:31:18+08:00 daily https://www.pharmasources.com/industryinsights/testosterone-replacement-drug-rejected-b-302774.html 0.6 2026-08-07T11:55:06+08:00 daily https://www.pharmasources.com/industryinsights/gp-continuity-of-care-is-slipping-finds--302775.html 0.6 2026-08-09T09:06:01+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018070-302776.html 0.6 2026-08-07T06:06:54+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-clears-specialised-treatment-302777.html 0.6 2026-08-07T22:59:57+08:00 daily https://www.pharmasources.com/industryinsights/anti-cancer-drugs-prices-not-reduced-as--302778.html 0.6 2026-08-07T00:40:08+08:00 daily https://www.pharmasources.com/industryinsights/vertex-nhs-england-no-closer-to-orkambi--302779.html 0.6 2026-08-07T01:21:40+08:00 daily https://www.pharmasources.com/industryinsights/after-thousands-of-vaccinations-who-repo-302780.html 0.6 2026-08-07T01:15:06+08:00 daily https://www.pharmasources.com/industryinsights/cell-based-flu-vaccines-only-slightly-be-302781.html 0.6 2026-08-08T03:09:09+08:00 daily https://www.pharmasources.com/industryinsights/first-clinical-mers-vaccine-by-inovio-an-302782.html 0.6 2026-08-08T07:57:59+08:00 daily https://www.pharmasources.com/industryinsights/senators-demand-more-from-glaxosmithklin-302783.html 0.6 2026-08-08T08:59:20+08:00 daily https://www.pharmasources.com/industryinsights/pah-patients-in-england-denied-access-to-302784.html 0.6 2026-08-07T13:15:25+08:00 daily https://www.pharmasources.com/industryinsights/endocyte-and-itm-announce-long-term-supp-302785.html 0.6 2026-08-08T10:05:16+08:00 daily https://www.pharmasources.com/industryinsights/pluristem-signs-collaboration-agreement--302786.html 0.6 2026-08-08T15:51:49+08:00 daily https://www.pharmasources.com/industryinsights/txcell-exercises-in-license-option-to-th-302787.html 0.6 2026-06-21T00:38:47+08:00 daily https://www.pharmasources.com/industryinsights/clovis-parp-inhibitor-rubraca-under-eu-r-302788.html 0.6 2026-07-04T04:05:40+08:00 daily https://www.pharmasources.com/industryinsights/codexis-doses-first-subjects-in-phase-1a-302789.html 0.6 2026-06-21T22:40:47+08:00 daily https://www.pharmasources.com/industryinsights/helix-biopharma-corp-closes-private-plac-302790.html 0.6 2026-06-22T10:51:48+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-regains-full-rights-to-symproic-302791.html 0.6 2026-06-24T10:50:37+08:00 daily https://www.pharmasources.com/industryinsights/motivating-generic-drugs-from-multiple-p-302792.html 0.6 2026-08-08T11:08:37+08:00 daily https://www.pharmasources.com/industryinsights/trio-awarded-natalee-study-largest-singl-302793.html 0.6 2026-06-28T15:59:22+08:00 daily https://www.pharmasources.com/industryinsights/celgene-and-acceleron-announce-luspaterc-302794.html 0.6 2026-06-21T08:00:04+08:00 daily https://www.pharmasources.com/industryinsights/china-to-reduce-tariffs-increase-imports-302795.html 0.6 2026-06-11T12:14:31+08:00 daily https://www.pharmasources.com/industryinsights/cellectars-clr-131-receives-fda-orphan-d-302796.html 0.6 2026-06-21T20:10:22+08:00 daily https://www.pharmasources.com/industryinsights/nhs-should-employ-robots-to-save-time-an-302797.html 0.6 2026-06-21T12:56:24+08:00 daily https://www.pharmasources.com/industryinsights/athenex-names-timothy-cook-as-senior-vic-302798.html 0.6 2026-06-21T01:10:54+08:00 daily https://www.pharmasources.com/industryinsights/brexit-health-alliance-calls-for-co-oper-302799.html 0.6 2026-06-21T13:50:20+08:00 daily https://www.pharmasources.com/industryinsights/spero-therapeutics-announces-proposed-of-302800.html 0.6 2026-07-05T13:32:55+08:00 daily https://www.pharmasources.com/industryinsights/g1-therapeutics-expands-executive-leader-302801.html 0.6 2026-06-30T18:31:17+08:00 daily https://www.pharmasources.com/industryinsights/list-of-blockbuster-drugs-becoming-off-p-302802.html 0.6 2026-06-21T10:20:22+08:00 daily https://www.pharmasources.com/industryinsights/end-of-life-care-depends-on-doctor-302803.html 0.6 2026-06-20T17:01:21+08:00 daily https://www.pharmasources.com/industryinsights/public-backs-nhs-spending-increases-302804.html 0.6 2026-07-04T15:53:16+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-diagnosis-silver-lining-other-f-302805.html 0.6 2026-06-21T07:01:00+08:00 daily https://www.pharmasources.com/industryinsights/new-funding-to-digitise-info-between-hea-302806.html 0.6 2026-06-20T16:07:33+08:00 daily https://www.pharmasources.com/industryinsights/hepatitis-infected-kidneys-may-be-safe-n-302807.html 0.6 2026-06-20T22:59:36+08:00 daily https://www.pharmasources.com/industryinsights/parents-urged-to-look-before-you-lock-ca-302808.html 0.6 2026-06-19T21:56:52+08:00 daily https://www.pharmasources.com/industryinsights/cdc-wildfire-smoke-poses-health-risks-302809.html 0.6 2026-06-20T20:10:43+08:00 daily https://www.pharmasources.com/industryinsights/gruenenthal-launches-phiii-trials-of-ner-302810.html 0.6 2026-06-20T14:48:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-drops-zika-testing-for-blood-donors-302811.html 0.6 2026-06-22T01:43:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-msds-keytruda-for-advanced-cervi-302812.html 0.6 2026-07-03T12:49:58+08:00 daily https://www.pharmasources.com/industryinsights/red-cross-issues-nationwide-call-for-blo-302813.html 0.6 2026-06-28T12:31:20+08:00 daily https://www.pharmasources.com/industryinsights/az-lilly-pull-plug-on-alzheimers-disease-302814.html 0.6 2026-07-18T02:10:51+08:00 daily https://www.pharmasources.com/industryinsights/high-rates-of-salmonella-contamination-i-302815.html 0.6 2026-06-21T11:21:28+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-tests-asterias-novel-lung-cancer-i-302816.html 0.6 2026-07-31T10:51:19+08:00 daily https://www.pharmasources.com/industryinsights/smc-approves-funding-for-six-new-therapi-302817.html 0.6 2026-02-28T17:07:37+08:00 daily https://www.pharmasources.com/industryinsights/allergans-experimental-migraine-drug-hit-302818.html 0.6 2026-06-20T16:57:24+08:00 daily https://www.pharmasources.com/industryinsights/researchers-to-trial-prostate-cancer-sal-302819.html 0.6 2026-06-21T08:49:48+08:00 daily https://www.pharmasources.com/industryinsights/huddersfield-uni-launches-pharma-policy--302820.html 0.6 2026-06-21T20:59:40+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-first-line-use-of-az-tagriss-302821.html 0.6 2026-06-21T15:58:19+08:00 daily https://www.pharmasources.com/industryinsights/us-nod-for-venclextarituxan-combo-302822.html 0.6 2026-04-14T02:54:40+08:00 daily https://www.pharmasources.com/industryinsights/us-widens-scope-of-rituxan-to-include-li-302823.html 0.6 2026-06-20T14:51:07+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-files-parp-inhibitor-for-breast-c-302824.html 0.6 2025-11-14T03:09:17+08:00 daily https://www.pharmasources.com/industryinsights/takeda-gets-us-nod-for-shire-buy-302825.html 0.6 2026-06-22T08:48:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-advises-restricted-use-of-antibioti-302826.html 0.6 2026-06-21T02:11:53+08:00 daily https://www.pharmasources.com/industryinsights/cti-serviers-pixuvri-fails-in-post-marke-302827.html 0.6 2026-06-22T09:59:39+08:00 daily https://www.pharmasources.com/industryinsights/three-cancer-treatments-approved-for-use-302828.html 0.6 2026-06-22T16:07:36+08:00 daily https://www.pharmasources.com/industryinsights/may-names-hancock-as-new-health-and-soci-302829.html 0.6 2026-06-21T04:08:05+08:00 daily https://www.pharmasources.com/industryinsights/teva-launches-generic-version-of-uceris--302830.html 0.6 2026-04-17T07:40:36+08:00 daily https://www.pharmasources.com/industryinsights/recursion-receives-fda-clearance-for-rec-302831.html 0.6 2026-06-20T20:00:36+08:00 daily https://www.pharmasources.com/industryinsights/arena-pharmaceuticals-announces-board-of-302832.html 0.6 2026-02-14T18:12:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-sees-20-percent-hike-in-cases-of-syph-302833.html 0.6 2026-06-21T00:59:41+08:00 daily https://www.pharmasources.com/industryinsights/highmark-announces-outcomes-based-agreem-302834.html 0.6 2025-12-28T23:12:48+08:00 daily https://www.pharmasources.com/industryinsights/bioarctic-receives-approval-in-finland-f-302835.html 0.6 2026-06-21T05:01:42+08:00 daily https://www.pharmasources.com/industryinsights/numedii-announces-research-collaboration-302836.html 0.6 2026-06-23T08:19:23+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-xalkori-makes-it-onto-cancer-dru-302837.html 0.6 2026-06-21T13:16:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ind-for-adg-106-study-302838.html 0.6 2026-06-21T13:05:33+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-generic-exelon-patch-302839.html 0.6 2026-07-17T20:02:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-recall-of-zofran-and--302840.html 0.6 2026-08-05T10:15:45+08:00 daily https://www.pharmasources.com/industryinsights/statement-by-fda-commissioner-on-balanci-302841.html 0.6 2026-06-20T20:18:57+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-announces-licensing-agreement-w-302842.html 0.6 2026-06-21T04:19:10+08:00 daily https://www.pharmasources.com/industryinsights/pharmascience-launches-prpms-trandolapri-302843.html 0.6 2026-08-08T04:57:17+08:00 daily https://www.pharmasources.com/industryinsights/teva-to-move-us-headquarters-to-new-jers-302844.html 0.6 2026-06-20T19:56:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-xeljanz-for-ulcerat-302845.html 0.6 2026-06-21T13:02:53+08:00 daily https://www.pharmasources.com/industryinsights/aradigm-appoints-dr-theresa-matkovits-to-302846.html 0.6 2026-05-03T14:18:14+08:00 daily https://www.pharmasources.com/industryinsights/acceleron-appoints-chief-medical-officer-302847.html 0.6 2026-08-09T07:10:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-encourage-more-informative-drug-l-302848.html 0.6 2026-06-20T05:02:16+08:00 daily https://www.pharmasources.com/industryinsights/forendo-pharma-initiates-endometriosis-s-302849.html 0.6 2026-06-22T20:13:12+08:00 daily https://www.pharmasources.com/industryinsights/first-volunteers-dosed-in-phase-i-clinic-302850.html 0.6 2026-06-22T07:05:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xeomin-302851.html 0.6 2026-04-13T08:57:26+08:00 daily https://www.pharmasources.com/industryinsights/dermira-receives-fda-approval-for-qbrexz-302852.html 0.6 2026-06-19T15:13:16+08:00 daily https://www.pharmasources.com/industryinsights/elite-pharmaceuticals-receives-fda-appro-302853.html 0.6 2026-07-16T12:06:39+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-approved-in-japan-for-brca-muta-302854.html 0.6 2026-04-18T04:35:54+08:00 daily https://www.pharmasources.com/industryinsights/mabvax-grants-sublicense-to-y-mabs-for-n-302855.html 0.6 2026-06-21T02:14:53+08:00 daily https://www.pharmasources.com/industryinsights/juniper-signs-definitive-agreement-to-be-302856.html 0.6 2026-06-20T21:47:00+08:00 daily https://www.pharmasources.com/industryinsights/genmabnovatis-arzerra-fails-to-hit-nhl-t-302857.html 0.6 2026-06-13T20:22:04+08:00 daily https://www.pharmasources.com/industryinsights/eagle-pharmaceuticals-announces-new-pate-302858.html 0.6 2026-07-03T21:30:17+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-first-enzyme-therapy-for-pku-302859.html 0.6 2026-06-21T02:45:36+08:00 daily https://www.pharmasources.com/industryinsights/imbruvicagazyva-combo-improves-pfs-in-cl-302860.html 0.6 2026-06-21T01:55:40+08:00 daily https://www.pharmasources.com/industryinsights/nice-issues-decision-on-mylotarg-bespons-302861.html 0.6 2026-08-07T01:51:56+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-sandoz-remicade-biosimilar-ze-302862.html 0.6 2026-08-07T01:49:02+08:00 daily https://www.pharmasources.com/industryinsights/cqc-finds-half-of-ae-services-sub-standa-302863.html 0.6 2026-08-07T20:30:29+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-chiesis-lamzede-302864.html 0.6 2026-08-07T01:42:42+08:00 daily https://www.pharmasources.com/industryinsights/tax-rises-needed-to-boost-health-and-soc-302865.html 0.6 2026-08-07T01:27:49+08:00 daily https://www.pharmasources.com/industryinsights/lilly-takes-back-cancer-drug-with-aurka--302866.html 0.6 2026-08-07T01:19:28+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-dye-for-brain-tumour-r-302867.html 0.6 2026-08-07T13:16:23+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-appoints-national-clinical-a-302868.html 0.6 2026-08-07T20:55:50+08:00 daily https://www.pharmasources.com/industryinsights/glasgow-university-uncovers-molecular-st-302869.html 0.6 2026-08-07T23:40:08+08:00 daily https://www.pharmasources.com/industryinsights/blood-pressure-drug-verapamil-may-help-t-302870.html 0.6 2026-08-08T03:25:46+08:00 daily https://www.pharmasources.com/industryinsights/axovant-and-benitec-estbalish-gene-thera-302871.html 0.6 2026-08-08T10:39:41+08:00 daily https://www.pharmasources.com/industryinsights/janssen-launches-phiiiii-programme-testi-302872.html 0.6 2026-08-07T22:09:27+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-develop-new-technique-for-302873.html 0.6 2026-08-08T12:07:31+08:00 daily https://www.pharmasources.com/industryinsights/combining-antibiotics-with-immune-respon-302874.html 0.6 2026-06-20T17:01:18+08:00 daily https://www.pharmasources.com/industryinsights/govt-launches-10-antimicrobial-research--302875.html 0.6 2026-08-07T23:40:01+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-xalkori-makes-it-onto-cancer-dru-302876.html 0.6 2026-06-20T22:56:37+08:00 daily https://www.pharmasources.com/industryinsights/valley-northern-launches-improved-denatu-302877.html 0.6 2026-06-20T14:59:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-xeljanz-for-ulcerat-302878.html 0.6 2026-06-23T13:00:59+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-generic-version-of-novart-302879.html 0.6 2026-06-20T15:12:19+08:00 daily https://www.pharmasources.com/industryinsights/biocryst-terminates-merger-agreement-wit-302880.html 0.6 2026-07-17T08:35:49+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-acquires-mabvaxs-pr-302881.html 0.6 2026-06-20T14:49:06+08:00 daily https://www.pharmasources.com/industryinsights/roche-ends-development-of-olesoxime-afte-302882.html 0.6 2026-06-20T20:45:17+08:00 daily https://www.pharmasources.com/industryinsights/eusa-pharmas-tivozanib-drug-approved-for-302883.html 0.6 2026-07-09T16:01:02+08:00 daily https://www.pharmasources.com/industryinsights/ema-facing-higher-than-expected-staff-lo-302884.html 0.6 2026-06-21T05:13:53+08:00 daily https://www.pharmasources.com/industryinsights/tesaros-ovarian-cancer-drug-zejula-added-302885.html 0.6 2026-07-01T11:45:01+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-expands-drug-manufacturing-ca-302886.html 0.6 2026-07-26T06:55:37+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-sanofi-ebos-menarini-asi-302887.html 0.6 2026-06-21T12:05:16+08:00 daily https://www.pharmasources.com/industryinsights/chinese-consortium-to-acquire-german-pha-302888.html 0.6 2026-07-16T02:54:37+08:00 daily https://www.pharmasources.com/industryinsights/us-oks-first-biosimilar-of-amgens-neulas-302889.html 0.6 2026-06-21T13:15:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-merzs-xeomin-for-sialorrhea-302890.html 0.6 2026-07-01T19:22:53+08:00 daily https://www.pharmasources.com/industryinsights/cqc-finds-half-of-ae-services-sub-standa-302891.html 0.6 2026-06-20T20:02:39+08:00 daily https://www.pharmasources.com/industryinsights/vertex-and-nhs-england-reach-impasse-ove-302892.html 0.6 2026-06-20T22:00:08+08:00 daily https://www.pharmasources.com/industryinsights/bms-sprycel-secures-european-nod-to-trea-302893.html 0.6 2026-06-21T14:58:23+08:00 daily https://www.pharmasources.com/industryinsights/herantis-pharma-to-develop-non-invasive--302894.html 0.6 2026-06-21T09:54:28+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-sandoz-withdraw-medicines-f-302895.html 0.6 2026-06-22T01:08:00+08:00 daily https://www.pharmasources.com/industryinsights/uk-ivf-regulator-issues-new-guidelines-o-302896.html 0.6 2026-08-10T00:39:49+08:00 daily https://www.pharmasources.com/industryinsights/glasgow-university-uncovers-molecular-st-302897.html 0.6 2026-06-20T14:41:17+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-viivjanssens-two-drug-hiv-reg-302898.html 0.6 2026-06-21T00:21:14+08:00 daily https://www.pharmasources.com/industryinsights/eu-oks-first-line-use-of-ipsens-cabomety-302899.html 0.6 2026-05-03T09:44:18+08:00 daily https://www.pharmasources.com/industryinsights/dupixent-trial-hits-targets-in-adolescen-302900.html 0.6 2026-06-22T09:07:51+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-roches-tecentriq-for-pre-trea-302901.html 0.6 2026-06-21T09:53:18+08:00 daily https://www.pharmasources.com/industryinsights/nejm-publishes-second-successful-epidiol-302902.html 0.6 2026-06-20T18:17:48+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-buy-speciality-healthcare-fi-302903.html 0.6 2026-08-06T02:08:31+08:00 daily https://www.pharmasources.com/industryinsights/apro-collaborates-with-pivotal-on-three--302904.html 0.6 2026-06-22T06:07:45+08:00 daily https://www.pharmasources.com/industryinsights/anticoagulants-study-shows-lower-risk-of-302905.html 0.6 2026-07-19T05:09:51+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-catalent-cvc-bain-capital--302906.html 0.6 2026-06-21T17:10:32+08:00 daily https://www.pharmasources.com/industryinsights/mercks-ms-treatment-shows-promise-in-new-302907.html 0.6 2026-06-21T02:02:45+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-irish-regulators-recall-valsartan-302908.html 0.6 2026-06-20T09:15:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approval-for-novartis-melanoma-combo-302909.html 0.6 2026-08-05T19:53:54+08:00 daily https://www.pharmasources.com/industryinsights/az-lung-cancer-drug-tagrisso-backed-for--302910.html 0.6 2026-06-20T11:31:38+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-nod-for-keytruda-in-bladder-c-302911.html 0.6 2026-06-21T17:04:33+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-darzalex-combo-for-pre-t-302912.html 0.6 2026-06-19T18:18:38+08:00 daily https://www.pharmasources.com/industryinsights/gsk-sells-psoriasisdermatitis-therapy-to-302913.html 0.6 2026-06-20T14:56:11+08:00 daily https://www.pharmasources.com/industryinsights/zogenix-drug-cuts-seizures-in-dravet-syn-302914.html 0.6 2026-07-05T04:31:02+08:00 daily https://www.pharmasources.com/industryinsights/nhs-under-intolerable-strain-302915.html 0.6 2026-03-27T17:53:41+08:00 daily https://www.pharmasources.com/industryinsights/roches-venclexta-filed-in-the-us-for-acu-302916.html 0.6 2026-07-18T17:36:14+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-qarziba-for-children-with-hig-302917.html 0.6 2026-07-09T21:39:25+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-jjs-imbruvica-fails-to-target-in--302918.html 0.6 2026-06-21T09:15:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-re-organises-into-three-business--302919.html 0.6 2026-06-22T08:14:57+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-viivjanssens-two-drug-hiv-reg-302920.html 0.6 2026-06-18T03:15:54+08:00 daily https://www.pharmasources.com/industryinsights/mixed-trial-results-for-lillys-headache--302921.html 0.6 2026-06-21T19:51:39+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-pfizers-biosimilar-or-epogen-p-302922.html 0.6 2026-06-21T09:02:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-top-lawyer-resigns-in-wake-of-t-302923.html 0.6 2026-06-30T23:41:04+08:00 daily https://www.pharmasources.com/industryinsights/elsevierbayer-study-findings-could-cut-a-302924.html 0.6 2026-06-20T21:56:35+08:00 daily https://www.pharmasources.com/industryinsights/groups-hails-potential-of-organ-on-a-chi-302925.html 0.6 2026-06-21T10:01:04+08:00 daily https://www.pharmasources.com/industryinsights/new-mental-health-approach-cuts-hospital-302926.html 0.6 2026-06-20T19:41:11+08:00 daily https://www.pharmasources.com/industryinsights/nhs-confederation-launches-petition-on-n-302927.html 0.6 2026-07-08T18:15:52+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-procedure-for-benign-prostate-302928.html 0.6 2026-07-05T06:16:42+08:00 daily https://www.pharmasources.com/industryinsights/gsk-reports-q1-sales-decline-302929.html 0.6 2026-02-15T14:47:00+08:00 daily https://www.pharmasources.com/industryinsights/gskinnovivas-trelegy-ellipta-wins-expand-302930.html 0.6 2026-06-22T08:01:51+08:00 daily https://www.pharmasources.com/industryinsights/ministers-write-letter-to-vertex-over-or-302931.html 0.6 2026-06-20T21:57:35+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-jjs-imbruvica-fails-to-target-in--302932.html 0.6 2026-06-21T09:06:03+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-qarziba-for-children-with-hig-302933.html 0.6 2026-06-20T01:59:19+08:00 daily https://www.pharmasources.com/industryinsights/roches-venclexta-filed-in-the-us-for-acu-302934.html 0.6 2026-06-21T06:12:58+08:00 daily https://www.pharmasources.com/industryinsights/nhs-under-intolerable-strain-302935.html 0.6 2026-06-21T08:02:02+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-pulls-out-of-43bn-akorn-merger-302936.html 0.6 2026-02-28T13:36:15+08:00 daily https://www.pharmasources.com/industryinsights/zogenix-drug-cuts-seizures-in-dravet-syn-302937.html 0.6 2026-07-02T13:41:48+08:00 daily https://www.pharmasources.com/industryinsights/gsk-sells-psoriasisdermatitis-therapy-to-302938.html 0.6 2026-06-25T10:03:40+08:00 daily https://www.pharmasources.com/industryinsights/takeda-ups-its-offer-for-shire-302939.html 0.6 2026-06-21T21:13:52+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-darzalex-combo-for-pre-t-302940.html 0.6 2026-06-26T06:19:14+08:00 daily https://www.pharmasources.com/industryinsights/brexit-ambition-is-fine-but-execution-is-302941.html 0.6 2026-07-05T15:14:36+08:00 daily https://www.pharmasources.com/industryinsights/communications-team-of-the-year-join-our-302942.html 0.6 2026-05-05T11:21:29+08:00 daily https://www.pharmasources.com/industryinsights/recognising-the-outstanding-achievements-302943.html 0.6 2026-06-22T06:33:20+08:00 daily https://www.pharmasources.com/industryinsights/shire-turns-down-takedas-advances-302944.html 0.6 2026-06-22T07:56:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisors-back-approval-of-gws-epidio-302945.html 0.6 2026-06-22T10:41:30+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-appoints-national-clinical-a-302946.html 0.6 2026-06-20T16:06:18+08:00 daily https://www.pharmasources.com/industryinsights/merck-sells-consumer-healthcare-unit-to--302947.html 0.6 2026-06-21T06:58:57+08:00 daily https://www.pharmasources.com/industryinsights/govt-launches-10-antimicrobial-research--302948.html 0.6 2026-08-07T02:13:11+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-dye-for-brain-tumour-r-302949.html 0.6 2026-06-21T05:57:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-re-organises-into-three-business--302950.html 0.6 2026-06-20T20:59:36+08:00 daily https://www.pharmasources.com/industryinsights/final-nhs-nod-for-roches-roactemra-302951.html 0.6 2026-06-21T02:09:45+08:00 daily https://www.pharmasources.com/industryinsights/may-names-hancock-as-new-health-and-soci-302952.html 0.6 2026-06-21T08:08:03+08:00 daily https://www.pharmasources.com/industryinsights/three-cancer-treatments-approved-for-use-302953.html 0.6 2026-06-20T19:18:00+08:00 daily https://www.pharmasources.com/industryinsights/cti-serviers-pixuvri-fails-in-post-marke-302954.html 0.6 2026-06-21T01:46:28+08:00 daily https://www.pharmasources.com/industryinsights/nice-advises-restricted-use-of-antibioti-302955.html 0.6 2026-06-20T21:20:22+08:00 daily https://www.pharmasources.com/industryinsights/mps-slate-rate-of-progress-on-nhs-cyber--302956.html 0.6 2026-06-21T09:00:04+08:00 daily https://www.pharmasources.com/industryinsights/takeda-gets-us-nod-for-shire-buy-302957.html 0.6 2026-06-21T10:40:52+08:00 daily https://www.pharmasources.com/industryinsights/gsk-picks-kevin-sim-to-lead-business-dev-302958.html 0.6 2026-06-20T18:13:44+08:00 daily https://www.pharmasources.com/industryinsights/europe-recalling-some-valsartan-meds-on--302959.html 0.6 2026-06-22T23:39:36+08:00 daily https://www.pharmasources.com/industryinsights/factors-to-consider-for-a-cleaning-and-d-302960.html 0.6 2026-07-22T06:52:52+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-aacr-form-international-cancer-all-302961.html 0.6 2026-06-20T02:16:24+08:00 daily https://www.pharmasources.com/industryinsights/clovis-parp-inhibitor-rubraca-under-eu-r-302962.html 0.6 2026-06-20T15:56:27+08:00 daily https://www.pharmasources.com/industryinsights/rigel-bags-first-fda-approval-302963.html 0.6 2026-06-20T18:02:20+08:00 daily https://www.pharmasources.com/industryinsights/pah-patients-in-england-denied-access-to-302964.html 0.6 2026-06-22T10:50:01+08:00 daily https://www.pharmasources.com/industryinsights/us-expands-use-of-shires-vonvendi-302965.html 0.6 2026-06-22T04:49:33+08:00 daily https://www.pharmasources.com/industryinsights/vertex-nhs-england-no-closer-to-orkambi--302966.html 0.6 2026-06-21T11:10:15+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-clears-specialised-treatment-302967.html 0.6 2026-07-05T10:03:08+08:00 daily https://www.pharmasources.com/industryinsights/amgen-novartis-migraine-therapy-impresse-302968.html 0.6 2026-06-21T11:44:11+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivoyervoy-combo-cleared-for-kidne-302969.html 0.6 2026-07-16T02:54:40+08:00 daily https://www.pharmasources.com/industryinsights/keytrudachemo-combo-cut-risk-of-death-in-302970.html 0.6 2026-06-21T03:10:04+08:00 daily https://www.pharmasources.com/industryinsights/oxford-uni-boehringer-lilly-link-to-test-302971.html 0.6 2026-06-20T22:09:46+08:00 daily https://www.pharmasources.com/industryinsights/bms-ties-with-janssen-on-factor-xia-inhi-302972.html 0.6 2026-06-21T03:16:56+08:00 daily https://www.pharmasources.com/industryinsights/x4-pharma-appoints-michael-wyzga-as-chai-302973.html 0.6 2026-08-09T07:56:33+08:00 daily https://www.pharmasources.com/industryinsights/merck-inks-deal-with-chinas-xian-janssen-302974.html 0.6 2026-08-09T00:16:58+08:00 daily https://www.pharmasources.com/industryinsights/immatics-genmab-to-develop-bispecific-ca-302975.html 0.6 2026-08-08T22:04:00+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-acquires-visterra-for-430-m-302976.html 0.6 2026-08-07T18:15:23+08:00 daily https://www.pharmasources.com/industryinsights/cipla-to-acquire-south-african-drug-firm-302977.html 0.6 2026-08-07T05:06:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-us-post-brexit-trade-deal-risks-incre-302978.html 0.6 2026-08-06T22:37:09+08:00 daily https://www.pharmasources.com/industryinsights/biotechnologypharmaceutical-services-out-302979.html 0.6 2026-08-06T22:32:20+08:00 daily https://www.pharmasources.com/industryinsights/watson-system-increases-clinical-trial-e-302980.html 0.6 2026-08-06T22:20:54+08:00 daily https://www.pharmasources.com/industryinsights/outsourcing-aids-microbiology-testing-ma-302981.html 0.6 2026-08-06T22:09:28+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-reviewing-the-traditional-po-302982.html 0.6 2026-08-06T23:47:38+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018071-302983.html 0.6 2026-08-06T21:54:25+08:00 daily https://www.pharmasources.com/industryinsights/takedas-ninlaro-clears-phase-3-endpoint--302984.html 0.6 2026-08-07T04:30:55+08:00 daily https://www.pharmasources.com/industryinsights/with-just-6-weeks-to-go-spaces-are-filli-302985.html 0.6 2026-08-06T22:21:24+08:00 daily https://www.pharmasources.com/industryinsights/alvogen-court-case-causes-nevada-judge-t-302986.html 0.6 2026-08-07T04:52:59+08:00 daily https://www.pharmasources.com/industryinsights/jj-ordered-to-pay-468-billion-to-talc-po-302987.html 0.6 2026-08-07T05:07:20+08:00 daily https://www.pharmasources.com/industryinsights/gsk-confirms-250m-deal-to-sell-experimen-302988.html 0.6 2026-07-15T11:56:37+08:00 daily https://www.pharmasources.com/industryinsights/indivior-shares-soar-as-us-judge-rules-a-302989.html 0.6 2026-06-20T20:11:47+08:00 daily https://www.pharmasources.com/industryinsights/sobi-launches-kineret-for-aosd-sjia-302990.html 0.6 2026-08-07T04:57:06+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-az-asthma-biologic-fasenra-302991.html 0.6 2026-06-21T21:07:46+08:00 daily https://www.pharmasources.com/industryinsights/european-cannabis-market-set-to-be-worth-302992.html 0.6 2026-06-20T18:09:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-smallpox-therapy-302993.html 0.6 2026-06-25T02:38:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-smallpox-therapy-to-d-302994.html 0.6 2026-06-21T18:00:31+08:00 daily https://www.pharmasources.com/industryinsights/ucb-amgen-refile-osteoporosis-drug-eveni-302995.html 0.6 2026-06-21T14:55:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-pfizer-and-astellas-xtandi-i-302996.html 0.6 2026-06-22T07:53:44+08:00 daily https://www.pharmasources.com/industryinsights/senate-claims-novartis-misled-public-on--302997.html 0.6 2026-06-20T19:10:41+08:00 daily https://www.pharmasources.com/industryinsights/gsk-picks-kevin-sim-to-lead-business-dev-302998.html 0.6 2026-06-21T21:07:45+08:00 daily https://www.pharmasources.com/industryinsights/az-tagrisso-offers-sustained-benefit-in--302999.html 0.6 2026-06-20T20:14:07+08:00 daily https://www.pharmasources.com/industryinsights/shire-sells-oncology-unit-to-servier-for-303000.html 0.6 2026-06-20T15:15:29+08:00 daily https://www.pharmasources.com/industryinsights/trump-forces-pfizer-to-back-down-and-del-303001.html 0.6 2026-06-21T07:51:44+08:00 daily https://www.pharmasources.com/industryinsights/wellcome-trust-announces-250m-fund-for-h-303002.html 0.6 2026-06-21T10:47:56+08:00 daily https://www.pharmasources.com/industryinsights/ema-survey-identifies-gaps-in-pharma-ind-303003.html 0.6 2026-06-21T17:59:40+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-announces-10m-antimicrobia-303004.html 0.6 2026-06-25T18:29:12+08:00 daily https://www.pharmasources.com/industryinsights/mps-criticise-nhs-digitalhome-office-dat-303005.html 0.6 2026-08-05T23:30:43+08:00 daily https://www.pharmasources.com/industryinsights/celgene-and-accelerons-blood-disorder-dr-303006.html 0.6 2026-08-06T02:11:40+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-sell-generics-unit-for-19-bill-303007.html 0.6 2026-06-20T23:19:00+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-treatment-for-rare-and-dea-303008.html 0.6 2026-03-19T22:29:12+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pulls-out-of-antibiotics-cuts-1-303009.html 0.6 2026-07-20T00:27:01+08:00 daily https://www.pharmasources.com/industryinsights/ucb-and-pharmamar-breach-abpi-code-of-pr-303010.html 0.6 2026-06-22T09:05:49+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-restructures-in-preparation-for-p-303011.html 0.6 2026-08-07T06:49:48+08:00 daily https://www.pharmasources.com/industryinsights/gsk-hands-rare-disease-gene-therapies-ov-303012.html 0.6 2026-08-08T01:00:19+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-janssen-announce-failure-of-c-303013.html 0.6 2026-06-20T16:58:17+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-snaps-up-visterra-in-430-million--303014.html 0.6 2026-08-08T11:01:19+08:00 daily https://www.pharmasources.com/industryinsights/purdue-defends-against-opioid-lawsuits-b-303015.html 0.6 2026-08-06T22:08:11+08:00 daily https://www.pharmasources.com/industryinsights/msds-ulcerative-colitis-drug-scores-expa-303016.html 0.6 2026-06-20T15:14:22+08:00 daily https://www.pharmasources.com/industryinsights/trump-slams-pfizer-over-price-hikes-pfiz-303017.html 0.6 2026-06-21T01:43:28+08:00 daily https://www.pharmasources.com/industryinsights/nice-calls-to-limit-antibiotic-use-in-co-303018.html 0.6 2026-06-22T06:36:31+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-shut-down-french-plant-over-astro-303019.html 0.6 2026-06-20T00:18:26+08:00 daily https://www.pharmasources.com/industryinsights/ema-issues-global-recall-of-heart-drugs--303020.html 0.6 2026-06-21T13:00:05+08:00 daily https://www.pharmasources.com/industryinsights/china-opens-market-to-indian-drugs-with--303021.html 0.6 2026-07-08T01:29:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-pulls-plug-on-inlyta-trial-303022.html 0.6 2026-06-21T20:42:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-joins-eu-in-seeking-recall-of-certai-303023.html 0.6 2026-06-27T06:24:47+08:00 daily https://www.pharmasources.com/industryinsights/alexion-to-buy-wilson-for-855m-303024.html 0.6 2026-06-21T14:55:22+08:00 daily https://www.pharmasources.com/industryinsights/vtv-reports-alzheimers-candidate-failure-303025.html 0.6 2026-06-21T16:56:28+08:00 daily https://www.pharmasources.com/industryinsights/incytemsds-immunotherapy-combo-fails-in--303026.html 0.6 2026-08-05T18:11:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-snaps-up-avexis-in-87bn-deal-303027.html 0.6 2026-03-19T22:44:55+08:00 daily https://www.pharmasources.com/industryinsights/will-mylans-big-copaxone-price-break-for-303028.html 0.6 2026-06-28T01:29:51+08:00 daily https://www.pharmasources.com/industryinsights/with-fda-nod-pfizer-and-astellas-xtandi--303029.html 0.6 2026-06-21T09:55:03+08:00 daily https://www.pharmasources.com/industryinsights/hansoh-being-the-first-in-passing-the-co-303030.html 0.6 2026-07-15T13:30:28+08:00 daily https://www.pharmasources.com/industryinsights/a-fantastic-ld-opportunity-for-sales-man-303031.html 0.6 2026-08-07T23:35:11+08:00 daily https://www.pharmasources.com/industryinsights/hcps-asked-to-name-their-sales-represent-303032.html 0.6 2026-08-06T08:26:27+08:00 daily https://www.pharmasources.com/industryinsights/sales-manager-of-the-year-opens-for-entr-303033.html 0.6 2026-06-22T02:02:42+08:00 daily https://www.pharmasources.com/industryinsights/biogen-samsung-bioepis-and-abbvie-settle-303034.html 0.6 2026-06-20T19:47:24+08:00 daily https://www.pharmasources.com/industryinsights/us-delay-for-celltrions-rituxan-hercepti-303035.html 0.6 2026-02-28T19:42:57+08:00 daily https://www.pharmasources.com/industryinsights/nice-no-for-roches-ocrevus-303036.html 0.6 2026-06-20T22:51:48+08:00 daily https://www.pharmasources.com/industryinsights/novo-buys-into-epidestinys-experimental--303037.html 0.6 2026-06-20T16:08:34+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-files-lung-cancer-drug-in-the-eu--303038.html 0.6 2026-04-29T22:08:45+08:00 daily https://www.pharmasources.com/industryinsights/eu-green-light-for-chiesis-lamzede-303039.html 0.6 2026-06-21T10:03:08+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-kymera-team-up-for-protein-degra-303040.html 0.6 2026-06-21T09:03:13+08:00 daily https://www.pharmasources.com/industryinsights/hengrui-topped-the-ranking-list-of-class-303041.html 0.6 2026-08-09T02:52:42+08:00 daily https://www.pharmasources.com/industryinsights/bi-snaps-up-oses-novel-checkpoint-inhibi-303042.html 0.6 2026-06-21T03:49:10+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-sigilon-partner-to-develop-dia-303043.html 0.6 2026-07-16T19:21:27+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-allogene-link-to-develop-cancer-t-303044.html 0.6 2026-06-19T14:39:10+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-for-az-hairy-cell-leukae-303045.html 0.6 2026-07-08T14:20:21+08:00 daily https://www.pharmasources.com/industryinsights/eu-expands-scope-of-amgens-xgeva-303046.html 0.6 2026-08-06T22:53:34+08:00 daily https://www.pharmasources.com/industryinsights/eu-reviews-first-parp-inhibitor-for-brea-303047.html 0.6 2026-08-06T21:54:14+08:00 daily https://www.pharmasources.com/industryinsights/nhs-pilots-one-stop-shops-for-cancer-dia-303048.html 0.6 2026-08-06T20:07:48+08:00 daily https://www.pharmasources.com/industryinsights/thumbnail-image-for-nhs-england-publishe-303049.html 0.6 2026-08-06T19:23:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-halts-production-at-india-injecta-303050.html 0.6 2026-08-06T20:07:41+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-to-lay-off-149-as-w-303051.html 0.6 2026-08-06T21:47:19+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-predicts-4-to-6-net-pric-303052.html 0.6 2026-08-06T23:57:05+08:00 daily https://www.pharmasources.com/industryinsights/winning-trumps-praise-was-easy-for-pfize-303053.html 0.6 2026-08-07T00:02:10+08:00 daily https://www.pharmasources.com/industryinsights/ieon-nanodrugs-announces-collaboration-w-303054.html 0.6 2026-08-07T00:40:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-calcitriols-new-contract-ma-303055.html 0.6 2026-08-07T01:10:55+08:00 daily https://www.pharmasources.com/industryinsights/strengthen-efforts-to-immunize-5-million-303056.html 0.6 2026-08-07T00:53:10+08:00 daily https://www.pharmasources.com/industryinsights/nice-calls-for-quicker-treatment-of-kidn-303057.html 0.6 2026-08-07T01:14:53+08:00 daily https://www.pharmasources.com/industryinsights/record-numbers-taking-part-in-life-scien-303058.html 0.6 2026-08-07T01:19:22+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-janssens-hiv-pill-symtuza-303059.html 0.6 2026-08-07T02:36:38+08:00 daily https://www.pharmasources.com/industryinsights/mps-vote-for-uk-to-remain-part-of-ema-303060.html 0.6 2026-08-07T02:48:54+08:00 daily https://www.pharmasources.com/industryinsights/vertex-mulls-over-nhs-englands-offer-for-303061.html 0.6 2026-08-07T03:03:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-diabetes-drug-trulicity-leapfrogs--303062.html 0.6 2026-08-07T02:31:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-cancer-drug-through-n-303063.html 0.6 2026-08-07T03:12:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-revolution-medicines-launch-g-303064.html 0.6 2026-08-07T13:19:00+08:00 daily https://www.pharmasources.com/industryinsights/ceo-weber-sees-china-as-takedas-second-l-303065.html 0.6 2026-08-08T13:11:48+08:00 daily https://www.pharmasources.com/industryinsights/lyophilization-usa-conference-2018-303066.html 0.6 2026-08-09T07:56:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-runs-into-kymriah-production-gl-303067.html 0.6 2026-08-08T07:50:21+08:00 daily https://www.pharmasources.com/industryinsights/new-findings-suggest-allergic-responses--303068.html 0.6 2026-06-21T03:02:55+08:00 daily https://www.pharmasources.com/industryinsights/under-scrutiny-for-cohen-deal-novartis-c-303069.html 0.6 2026-07-25T01:36:21+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-initiates-pivotal-phase-3-program-303070.html 0.6 2026-07-04T14:01:32+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-extends-its-hot-streak--303071.html 0.6 2026-07-07T08:08:43+08:00 daily https://www.pharmasources.com/industryinsights/the-immune-system-t-cells-are-built-for--303072.html 0.6 2026-08-09T18:12:46+08:00 daily https://www.pharmasources.com/industryinsights/az-signs-up-for-access-to-compugens-pipe-303073.html 0.6 2026-06-20T20:54:07+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-fund-balloon-pulmonary-angioplast-303074.html 0.6 2026-06-21T09:59:12+08:00 daily https://www.pharmasources.com/industryinsights/eu-reviews-for-sanofis-dupixent-cemiplim-303075.html 0.6 2026-07-23T10:54:07+08:00 daily https://www.pharmasources.com/industryinsights/atopic-dermatitis-patients-to-be-denied--303076.html 0.6 2026-06-20T20:24:01+08:00 daily https://www.pharmasources.com/industryinsights/metabocin-shows-promise-as-a-potent-anti-303077.html 0.6 2026-06-21T05:02:41+08:00 daily https://www.pharmasources.com/industryinsights/communications-team-of-the-year-opens-fo-303078.html 0.6 2026-06-20T16:20:57+08:00 daily https://www.pharmasources.com/industryinsights/research-backs-halving-chemo-after-bowel-303079.html 0.6 2026-06-21T12:57:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-the-first-drug-with-an-indi-303080.html 0.6 2026-06-21T20:58:35+08:00 daily https://www.pharmasources.com/industryinsights/takeda-eyes-up-shire-303081.html 0.6 2026-06-21T01:00:48+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-may-predict-side-303082.html 0.6 2026-01-03T14:28:11+08:00 daily https://www.pharmasources.com/industryinsights/marinomed-effectively-tests-new-combinat-303083.html 0.6 2026-06-20T22:14:26+08:00 daily https://www.pharmasources.com/industryinsights/japans-otsuka-pharma-to-acquire-visterra-303084.html 0.6 2026-07-07T00:06:19+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-humira-patent-license-w-303085.html 0.6 2026-06-21T00:11:48+08:00 daily https://www.pharmasources.com/industryinsights/discovery-of-kidney-cancer-driver-could--303086.html 0.6 2026-01-10T06:33:22+08:00 daily https://www.pharmasources.com/industryinsights/be-recognised-for-the-part-you-play-in-t-303087.html 0.6 2026-06-20T18:02:20+08:00 daily https://www.pharmasources.com/industryinsights/industry-shows-support-for-new-medical-s-303088.html 0.6 2026-06-30T09:23:27+08:00 daily https://www.pharmasources.com/industryinsights/sub-cutaneous-form-of-entyvio-hits-phiii-303089.html 0.6 2026-07-01T01:16:52+08:00 daily https://www.pharmasources.com/industryinsights/kisqali-wins-speedy-us-breast-cancer-nod-303090.html 0.6 2026-06-20T21:04:54+08:00 daily https://www.pharmasources.com/industryinsights/four-pharmas-named-for-breaching-abpi-co-303091.html 0.6 2026-06-20T16:56:15+08:00 daily https://www.pharmasources.com/industryinsights/novartis-bags-rights-to-galapagosmorphos-303092.html 0.6 2026-06-22T11:51:48+08:00 daily https://www.pharmasources.com/industryinsights/dementia-accounts-for-13-percent-of-tota-303093.html 0.6 2026-06-19T14:46:05+08:00 daily https://www.pharmasources.com/industryinsights/lords-call-for-clarity-on-eu-healthcare--303094.html 0.6 2026-06-20T12:57:23+08:00 daily https://www.pharmasources.com/industryinsights/may-backs-new-funding-plan-for-nhs-303095.html 0.6 2026-06-20T18:05:24+08:00 daily https://www.pharmasources.com/industryinsights/hospitals-failing-to-test-for-lynch-synd-303096.html 0.6 2026-06-20T21:56:52+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-buy-out-novartis-stake-in-consume-303097.html 0.6 2026-06-21T01:13:55+08:00 daily https://www.pharmasources.com/industryinsights/gsk-no-longer-vying-for-pfizers-consumer-303098.html 0.6 2026-07-04T11:00:47+08:00 daily https://www.pharmasources.com/industryinsights/tasigna-cleared-for-use-in-children-with-303099.html 0.6 2026-08-07T20:13:59+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-az-potassium-binder-for-hype-303100.html 0.6 2026-06-20T13:17:33+08:00 daily https://www.pharmasources.com/industryinsights/us-eu-filings-imminent-for-novartis-ms-t-303101.html 0.6 2026-07-20T08:09:54+08:00 daily https://www.pharmasources.com/industryinsights/uk-patients-get-early-access-to-akceas-v-303102.html 0.6 2026-08-07T11:39:47+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pays-95m-to-bag-dermatitis-drug-303103.html 0.6 2026-06-20T14:43:04+08:00 daily https://www.pharmasources.com/industryinsights/gritstone-bristol-myers-squibb-to-trial--303104.html 0.6 2026-08-08T04:22:28+08:00 daily https://www.pharmasources.com/industryinsights/could-a-chili-pepper-derivative-used-for-303105.html 0.6 2026-06-20T20:56:44+08:00 daily https://www.pharmasources.com/industryinsights/stripped-down-vical-considering-options--303106.html 0.6 2026-06-22T03:32:48+08:00 daily https://www.pharmasources.com/industryinsights/puretech-lifted-by-news-of-roche-deal-303107.html 0.6 2026-06-22T20:58:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-drug-advisors-recommend-rescheduling--303108.html 0.6 2026-07-24T15:50:34+08:00 daily https://www.pharmasources.com/industryinsights/cell-based-flu-vaccines-only-slightly-be-303109.html 0.6 2026-07-08T06:14:36+08:00 daily https://www.pharmasources.com/industryinsights/first-clinical-mers-vaccine-by-inovio-an-303110.html 0.6 2026-06-20T23:03:57+08:00 daily https://www.pharmasources.com/industryinsights/allergan-molecular-partners-amd-drug-non-303111.html 0.6 2026-06-20T14:58:08+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-radionuclide-therapy-for-some-303112.html 0.6 2026-06-21T01:07:50+08:00 daily https://www.pharmasources.com/industryinsights/senators-demand-more-from-glaxosmithklin-303113.html 0.6 2026-07-04T22:13:24+08:00 daily https://www.pharmasources.com/industryinsights/accusing-orbimed-as-co-conspirator-in-fa-303114.html 0.6 2026-06-20T22:22:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-targeted-treatment-fo-303115.html 0.6 2026-06-22T13:16:02+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-joins-universal-flu-vaccine-part-303116.html 0.6 2026-06-22T16:09:29+08:00 daily https://www.pharmasources.com/industryinsights/moderna-opens-110m-manufacturing-site-fo-303117.html 0.6 2026-06-20T18:02:20+08:00 daily https://www.pharmasources.com/industryinsights/spooked-abbvie-investors-are-selling-off-303118.html 0.6 2026-08-08T02:32:16+08:00 daily https://www.pharmasources.com/industryinsights/top-chinese-rabies-vaccine-maker-ordered-303119.html 0.6 2026-07-20T05:03:31+08:00 daily https://www.pharmasources.com/industryinsights/chemists-characterize-the-fatal-fungus-a-303120.html 0.6 2026-08-06T19:17:18+08:00 daily https://www.pharmasources.com/industryinsights/mercks-price-cuts-are-flashy-but-no-more-303121.html 0.6 2026-08-05T00:15:14+08:00 daily https://www.pharmasources.com/industryinsights/univercells-raises-188m-to-commercialize-303122.html 0.6 2026-06-21T01:01:46+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-to-pass-10b-in-2024-vacc-303123.html 0.6 2026-06-23T01:48:38+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-bids-adieu-to-vaccines-p-303124.html 0.6 2026-06-22T11:47:33+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-translate-bio-ink-mrna-vaccine-rd-303125.html 0.6 2026-06-22T09:00:42+08:00 daily https://www.pharmasources.com/industryinsights/gsk-trials-benlystarituximab-combo-for-l-303126.html 0.6 2026-06-20T22:17:50+08:00 daily https://www.pharmasources.com/industryinsights/10-years-after-a-rejection-merck-returns-303127.html 0.6 2026-06-21T01:13:57+08:00 daily https://www.pharmasources.com/industryinsights/universal-flu-vaccine-biotech-seeks-big--303128.html 0.6 2026-06-21T23:14:04+08:00 daily https://www.pharmasources.com/industryinsights/doctors-worry-shingrix-side-effects-will-303129.html 0.6 2026-07-17T03:43:46+08:00 daily https://www.pharmasources.com/industryinsights/us-expands-scope-of-seattle-genetics-adc-303130.html 0.6 2026-06-21T10:20:25+08:00 daily https://www.pharmasources.com/industryinsights/after-thousands-of-vaccinations-who-repo-303131.html 0.6 2026-06-20T16:56:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-chief-gottlieb-blames-drugmakers-for-303132.html 0.6 2026-06-20T16:04:22+08:00 daily https://www.pharmasources.com/industryinsights/nihr-launches-new-standards-for-public-i-303133.html 0.6 2026-06-29T18:44:47+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-limits-shingrix-orders-d-303134.html 0.6 2026-06-20T21:58:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-krintafel-303135.html 0.6 2026-06-21T10:44:55+08:00 daily https://www.pharmasources.com/industryinsights/napp-secures-distribution-rights-to-cell-303136.html 0.6 2026-06-21T21:04:55+08:00 daily https://www.pharmasources.com/industryinsights/how-common-is-dementia-among-lgbt-senior-303137.html 0.6 2026-06-22T11:08:07+08:00 daily https://www.pharmasources.com/industryinsights/mps-call-on-government-to-help-with-orka-303138.html 0.6 2026-03-17T21:54:28+08:00 daily https://www.pharmasources.com/industryinsights/for-breast-feeding-working-moms-co-worke-303139.html 0.6 2026-06-21T10:56:08+08:00 daily https://www.pharmasources.com/industryinsights/life-is-short-after-dementia-diagnosis-n-303140.html 0.6 2026-06-21T00:59:47+08:00 daily https://www.pharmasources.com/industryinsights/performance-on-ae-target-slips-further-303141.html 0.6 2026-06-21T11:51:08+08:00 daily https://www.pharmasources.com/industryinsights/coeliac-uk-launches-new-research-fund-an-303142.html 0.6 2026-08-09T13:17:58+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-snaps-up-parkinsons-candidate-v-303143.html 0.6 2026-06-20T15:44:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-targets-price-gouging-drugmakers-wit-303144.html 0.6 2026-04-04T08:15:07+08:00 daily https://www.pharmasources.com/industryinsights/us-nod-for-csl-behrings-hizentra-303145.html 0.6 2026-06-20T16:55:12+08:00 daily https://www.pharmasources.com/industryinsights/janssen-wins-fda-nod-for-symtuza-but-the-303146.html 0.6 2026-05-15T12:48:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pays-95m-to-bag-dermatitis-drug-303147.html 0.6 2026-06-08T16:56:24+08:00 daily https://www.pharmasources.com/industryinsights/number-of-prescriptions-rises-as-net-ing-303148.html 0.6 2026-06-24T07:20:32+08:00 daily https://www.pharmasources.com/industryinsights/gileads-kite-bags-option-to-buy-gamma-de-303149.html 0.6 2026-06-20T15:58:31+08:00 daily https://www.pharmasources.com/industryinsights/amryt-in-licenses-novel-gene-therapy-pla-303150.html 0.6 2026-07-04T15:12:33+08:00 daily https://www.pharmasources.com/industryinsights/uk-votes-to-fully-participate-in-ema-aft-303151.html 0.6 2026-07-08T03:26:32+08:00 daily https://www.pharmasources.com/industryinsights/researchers-call-for-investigation-into--303152.html 0.6 2026-07-19T00:38:58+08:00 daily https://www.pharmasources.com/industryinsights/p-mec-china-2020-invitation-303153.html 0.6 2026-06-21T00:58:40+08:00 daily https://www.pharmasources.com/industryinsights/gsk-considers-splitting-up-303154.html 0.6 2026-06-23T21:39:09+08:00 daily https://www.pharmasources.com/industryinsights/workforce-technology-and-prevention-nhs--303155.html 0.6 2026-06-23T08:26:17+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-first-in-class-targeted-aml--303156.html 0.6 2026-07-10T01:34:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-symtuza-303157.html 0.6 2026-06-22T17:28:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-bags-approval-for-neupogen-biosim-303158.html 0.6 2026-06-20T14:49:12+08:00 daily https://www.pharmasources.com/industryinsights/novartis-enters-into-license-agreement-w-303159.html 0.6 2026-06-24T18:53:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-indications-for-zomacto-303160.html 0.6 2026-07-11T19:02:31+08:00 daily https://www.pharmasources.com/industryinsights/chance-for-global-vaccine-makers-chinas--303161.html 0.6 2026-06-23T03:55:16+08:00 daily https://www.pharmasources.com/industryinsights/puretech-health-announces-collaboration--303162.html 0.6 2026-06-20T16:02:30+08:00 daily https://www.pharmasources.com/industryinsights/west-opens-of-new-manufacturing-facility-303163.html 0.6 2026-06-21T12:12:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-biosimilar-nivestym-303164.html 0.6 2026-06-26T19:50:59+08:00 daily https://www.pharmasources.com/industryinsights/aerie-announces-early-notification-of-fd-303165.html 0.6 2026-07-02T18:14:30+08:00 daily https://www.pharmasources.com/industryinsights/confirmatory-clinical-study-to-support-t-303166.html 0.6 2026-07-13T12:15:05+08:00 daily https://www.pharmasources.com/industryinsights/anima-biotech-announces-collaboration-wi-303167.html 0.6 2026-07-06T21:54:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tibsovo-303168.html 0.6 2026-07-19T13:21:30+08:00 daily https://www.pharmasources.com/industryinsights/azafaros-bv-secures-seed-funding-to-deve-303169.html 0.6 2026-02-28T14:15:00+08:00 daily https://www.pharmasources.com/industryinsights/vyriad-announces-collaboration-with-merc-303170.html 0.6 2026-06-20T07:09:37+08:00 daily https://www.pharmasources.com/industryinsights/kite-and-gadeta-announce-strategic-colla-303171.html 0.6 2026-08-06T19:58:17+08:00 daily https://www.pharmasources.com/industryinsights/who-recognizes-new-antifungal-class-by-g-303172.html 0.6 2026-08-08T18:44:48+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-biotechs-clinical-lab-successfull-303173.html 0.6 2026-07-20T01:01:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-cancer-drug-through-n-303174.html 0.6 2026-06-22T07:51:43+08:00 daily https://www.pharmasources.com/industryinsights/polares-medical-closes-a-25m-financing-t-303175.html 0.6 2026-04-25T01:49:10+08:00 daily https://www.pharmasources.com/industryinsights/new-phase-3-data-shows-vedolizumab-met-p-303176.html 0.6 2026-06-22T02:36:23+08:00 daily https://www.pharmasources.com/industryinsights/statement-by-fda-commissioner-on-formati-303177.html 0.6 2026-08-06T23:54:32+08:00 daily https://www.pharmasources.com/industryinsights/roche-halts-price-hikes-for-2018but-only-303178.html 0.6 2026-07-07T15:55:07+08:00 daily https://www.pharmasources.com/industryinsights/leon-nanodrugs-supports-takeda-in-a-feas-303179.html 0.6 2026-08-07T00:42:59+08:00 daily https://www.pharmasources.com/industryinsights/antabio-completes-125m-series-a-303180.html 0.6 2026-08-07T00:01:40+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-gritstone-oncology--303181.html 0.6 2026-06-21T19:20:27+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-announces-fda-accepta-303182.html 0.6 2026-06-21T12:54:18+08:00 daily https://www.pharmasources.com/industryinsights/immatics-enters-into-a-strategic-partner-303183.html 0.6 2026-08-07T00:45:45+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-commercial-chief-go-303184.html 0.6 2026-08-07T00:39:43+08:00 daily https://www.pharmasources.com/industryinsights/aevi-genomic-medicine-announces-novel-co-303185.html 0.6 2026-08-07T00:42:50+08:00 daily https://www.pharmasources.com/industryinsights/carmelina-cardiovascular-outcome-trial-m-303186.html 0.6 2026-08-07T13:15:35+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-commissioner-to-impro-303187.html 0.6 2026-08-09T15:05:49+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-pionyr-immunotherapeutics--303188.html 0.6 2026-06-21T02:15:52+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-appoints-joanne-bec-303189.html 0.6 2026-08-08T21:34:16+08:00 daily https://www.pharmasources.com/industryinsights/agios-wins-fda-nod-for-targeted-aml-drug-303190.html 0.6 2026-08-09T00:10:08+08:00 daily https://www.pharmasources.com/industryinsights/varmx-raises-125-million-to-develop-modi-303191.html 0.6 2026-08-08T20:04:43+08:00 daily https://www.pharmasources.com/industryinsights/abcam-merck-collaboration-produces-new-p-303192.html 0.6 2026-08-09T00:51:51+08:00 daily https://www.pharmasources.com/industryinsights/aptamer-group-uk-biotech-business-raises-303193.html 0.6 2026-08-09T05:33:55+08:00 daily https://www.pharmasources.com/industryinsights/is-now-the-time-for-the-glaxosmithkline--303194.html 0.6 2026-08-08T19:48:34+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-neurocrines-fibroid-drug-hits-phi-303195.html 0.6 2026-02-15T09:25:03+08:00 daily https://www.pharmasources.com/industryinsights/changchun-changsheng-life-sciences-to-st-303196.html 0.6 2026-08-01T14:48:05+08:00 daily https://www.pharmasources.com/industryinsights/biogen-buys-pfizers-schizophrenia-drug-303197.html 0.6 2026-06-20T19:09:44+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharma-receives-china-approval-for--303198.html 0.6 2026-07-18T03:00:00+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regeneron-to-cut-price-of-praluen-303199.html 0.6 2026-08-04T14:50:40+08:00 daily https://www.pharmasources.com/industryinsights/rcem-calls-for-public-action-on-ae-crisi-303200.html 0.6 2026-06-21T05:05:47+08:00 daily https://www.pharmasources.com/industryinsights/hk-researchers-design-neurosurgical-robo-303201.html 0.6 2026-06-22T03:53:41+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-stop-essure-sales-at-year-end-303202.html 0.6 2026-07-29T08:33:00+08:00 daily https://www.pharmasources.com/industryinsights/an-overview-of-the-mental-disorder-field-303203.html 0.6 2026-07-19T02:47:56+08:00 daily https://www.pharmasources.com/industryinsights/rise-chinese-produced-drug-fruquintinib--303204.html 0.6 2026-06-20T19:18:20+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-reproducible-powder-testing-303205.html 0.6 2026-08-09T06:55:07+08:00 daily https://www.pharmasources.com/industryinsights/jcvi-backs-hpv-jab-for-boys-303206.html 0.6 2026-06-20T15:12:16+08:00 daily https://www.pharmasources.com/industryinsights/lilly-links-with-anima-303207.html 0.6 2026-03-27T00:07:18+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-atacand-rights-to-chep-303208.html 0.6 2026-06-21T05:14:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-staff-question-efficacy-of-gsks-nuca-303209.html 0.6 2026-06-22T10:19:57+08:00 daily https://www.pharmasources.com/industryinsights/atacand-to-be-divested-to-cheplapharm-in-303210.html 0.6 2026-06-22T03:49:50+08:00 daily https://www.pharmasources.com/industryinsights/novartis-renews-drug-donation-of-egaten--303211.html 0.6 2026-06-21T19:03:36+08:00 daily https://www.pharmasources.com/industryinsights/alkem-labs-gets-eir-from-usfda-for-its-d-303212.html 0.6 2026-06-21T07:08:01+08:00 daily https://www.pharmasources.com/industryinsights/ceiling-of-drug-prices-helped-save-inr-1-303213.html 0.6 2026-06-21T11:24:44+08:00 daily https://www.pharmasources.com/industryinsights/hyderabad-to-witness-latest-innovations--303214.html 0.6 2026-08-05T22:05:10+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-offer-mercks-gardasil-to-boys-afte-303215.html 0.6 2026-06-20T20:18:02+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-biogen-to-move-forward-with-al-303216.html 0.6 2026-06-20T14:40:21+08:00 daily https://www.pharmasources.com/industryinsights/dr-partap-chauhan-honoured-with-lifetime-303217.html 0.6 2026-06-23T19:34:29+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddy-launches-esomeprazole-magnesium-303218.html 0.6 2026-06-19T19:13:53+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-tentative-fda-approval-for-ta-303219.html 0.6 2026-08-04T00:05:11+08:00 daily https://www.pharmasources.com/industryinsights/zydus-to-market-piroxicam-capsules-303220.html 0.6 2026-06-19T17:53:20+08:00 daily https://www.pharmasources.com/industryinsights/biogens-spinraza-zooms-through-blockbust-303221.html 0.6 2026-06-19T15:01:04+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-july-24-2018-303222.html 0.6 2026-07-05T07:01:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-european-rights-for-he-303223.html 0.6 2026-07-31T23:12:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-orilissa-303224.html 0.6 2026-06-21T14:45:15+08:00 daily https://www.pharmasources.com/industryinsights/parents-childhood-affects-their-children-303225.html 0.6 2026-06-20T15:02:33+08:00 daily https://www.pharmasources.com/industryinsights/zecotek-reforms-to-align-technology-ip-a-303226.html 0.6 2026-06-21T12:01:10+08:00 daily https://www.pharmasources.com/industryinsights/reduced-cognitive-function-for-students--303227.html 0.6 2026-06-24T05:37:54+08:00 daily https://www.pharmasources.com/industryinsights/cstone-pharmaceuticals-appoints-richard--303228.html 0.6 2026-07-29T17:46:32+08:00 daily https://www.pharmasources.com/industryinsights/new-hope-in-saving-kids-from-blood-infec-303229.html 0.6 2026-07-04T15:05:52+08:00 daily https://www.pharmasources.com/industryinsights/blood-sugar-spikes-seen-in-seemingly-hea-303230.html 0.6 2026-06-22T05:15:00+08:00 daily https://www.pharmasources.com/industryinsights/oramed-gets-japanese-patent-for-glp-1-an-303231.html 0.6 2026-08-07T23:28:36+08:00 daily https://www.pharmasources.com/industryinsights/can-celgenes-latest-revlimid-win-reverse-303232.html 0.6 2026-06-21T02:51:34+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-launches-full-on-assault-303233.html 0.6 2026-06-21T04:58:49+08:00 daily https://www.pharmasources.com/industryinsights/immune-responses-from-johnson-johnsons-m-303234.html 0.6 2026-06-21T10:01:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-303235.html 0.6 2026-07-03T22:09:46+08:00 daily https://www.pharmasources.com/industryinsights/pharmacovigilance-of-new-drugs-should-be-303236.html 0.6 2026-07-08T09:56:56+08:00 daily https://www.pharmasources.com/industryinsights/nano-submarines-to-help-target-headaches-303237.html 0.6 2026-06-23T03:23:07+08:00 daily https://www.pharmasources.com/industryinsights/slayback-pharma-appoints-dr-girish-jain--303238.html 0.6 2026-01-04T17:52:10+08:00 daily https://www.pharmasources.com/industryinsights/heart-health-calculator-predicts-cvd-ris-303239.html 0.6 2026-06-22T11:59:45+08:00 daily https://www.pharmasources.com/industryinsights/bms-collaborates-with-tsinghua-universit-303240.html 0.6 2026-06-21T03:59:46+08:00 daily https://www.pharmasources.com/industryinsights/rws-life-sciences-welcomes-new-vp-of-qua-303241.html 0.6 2026-06-21T22:48:47+08:00 daily https://www.pharmasources.com/industryinsights/iti-214-parkinsons-drug-may-be-useful-fo-303242.html 0.6 2026-07-04T15:46:58+08:00 daily https://www.pharmasources.com/industryinsights/anti-pd-1-therapy-linked-to-delayed-onse-303243.html 0.6 2026-06-21T11:39:46+08:00 daily https://www.pharmasources.com/industryinsights/eu-and-japan-extend-partnership-on-inspe-303244.html 0.6 2026-06-21T08:58:57+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-pionyr-initiate-2nd-immuno-303245.html 0.6 2026-06-22T09:35:27+08:00 daily https://www.pharmasources.com/industryinsights/new-screening-company-exploits-the-lates-303246.html 0.6 2026-06-20T05:00:07+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-and-antengene-sign-development--303247.html 0.6 2026-08-02T02:02:25+08:00 daily https://www.pharmasources.com/industryinsights/south-koreas-finished-drug-market-growth-303248.html 0.6 2026-08-09T11:59:12+08:00 daily https://www.pharmasources.com/industryinsights/gileads-truvada-for-prep-can-reduce-hiv--303249.html 0.6 2026-02-28T19:28:18+08:00 daily https://www.pharmasources.com/industryinsights/gileads-top-executives-milligan-and-mart-303250.html 0.6 2026-06-21T04:08:01+08:00 daily https://www.pharmasources.com/industryinsights/gsk-ups-guidance-and-unveils-major-restr-303251.html 0.6 2026-06-21T07:14:11+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-shores-up-head-and-neck--303252.html 0.6 2026-06-20T20:58:38+08:00 daily https://www.pharmasources.com/industryinsights/boosting-the-safety-of-bulk-drug-substan-303253.html 0.6 2026-08-05T19:58:15+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-extends-survival-in-first-line--303254.html 0.6 2026-06-23T10:54:35+08:00 daily https://www.pharmasources.com/industryinsights/takedas-also-ran-alk-drug-alunbrig-aims--303255.html 0.6 2026-06-21T12:45:19+08:00 daily https://www.pharmasources.com/industryinsights/nih-health-care-systems-research-collabo-303256.html 0.6 2026-04-29T15:29:47+08:00 daily https://www.pharmasources.com/industryinsights/opioid-analgesics-z-drugs-linked-to-harm-303257.html 0.6 2026-06-24T00:17:48+08:00 daily https://www.pharmasources.com/industryinsights/viiv-unveils-positive-data-for-two-drug--303258.html 0.6 2026-06-21T02:11:57+08:00 daily https://www.pharmasources.com/industryinsights/former-major-leaguers-take-the-field-for-303259.html 0.6 2026-06-22T07:01:48+08:00 daily https://www.pharmasources.com/industryinsights/procellicssup-in-line-and-real-time-biop-303260.html 0.6 2026-06-21T02:53:01+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-abbvieneurocrines-uterine-pa-303261.html 0.6 2026-07-05T17:07:32+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-receives-the-first-fda-303262.html 0.6 2026-06-17T09:50:02+08:00 daily https://www.pharmasources.com/industryinsights/pharmajet-mundipharma-unite-to-expand-ne-303263.html 0.6 2026-08-09T12:37:55+08:00 daily https://www.pharmasources.com/industryinsights/hpv-jab-will-be-given-to-boys-in-england-303264.html 0.6 2026-06-22T10:14:13+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-enters-growing-finished-dosage-f-303265.html 0.6 2026-06-20T22:53:02+08:00 daily https://www.pharmasources.com/industryinsights/who-congo-ebola-outbreak-over-303266.html 0.6 2026-06-22T02:04:42+08:00 daily https://www.pharmasources.com/industryinsights/biogen-pays-275m-upfront-for-2-alivegen--303267.html 0.6 2026-06-19T19:43:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-magnetic-system-for-guiding-303268.html 0.6 2026-08-07T00:57:53+08:00 daily https://www.pharmasources.com/industryinsights/pharmacovigilance-post-brexit---simpler--303269.html 0.6 2026-06-20T18:55:56+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-tsinghua-university-303270.html 0.6 2026-08-09T00:41:25+08:00 daily https://www.pharmasources.com/industryinsights/forget-a-consumer-spinoff-glaxosmithklin-303271.html 0.6 2026-06-21T23:42:26+08:00 daily https://www.pharmasources.com/industryinsights/qa-with-cardinal-health-regulatory-scien-303272.html 0.6 2026-08-08T03:47:03+08:00 daily https://www.pharmasources.com/industryinsights/regulations-restrict-providers-ability-t-303273.html 0.6 2026-06-30T00:24:34+08:00 daily https://www.pharmasources.com/industryinsights/repurposing-a-glp-1-diabetes-drug-to-slo-303274.html 0.6 2026-06-22T04:14:55+08:00 daily https://www.pharmasources.com/industryinsights/one-third-of-hep-c-rx-receive-absolute-d-303275.html 0.6 2026-06-21T18:42:20+08:00 daily https://www.pharmasources.com/industryinsights/experimental-breast-cancer-drug-could-he-303276.html 0.6 2026-06-21T01:38:16+08:00 daily https://www.pharmasources.com/industryinsights/first-ivf-baby-louise-brown-turns-40-303277.html 0.6 2026-07-01T09:33:11+08:00 daily https://www.pharmasources.com/industryinsights/why-are-doctors-removing-too-many-thyroi-303278.html 0.6 2026-07-03T10:33:05+08:00 daily https://www.pharmasources.com/industryinsights/epizyme-nabs-sqz-biotech-tesaro-biotech--303279.html 0.6 2026-06-27T11:59:44+08:00 daily https://www.pharmasources.com/industryinsights/giving-plasma-during-air-transport-may-s-303280.html 0.6 2026-06-29T19:02:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-vc-arm-backs-17m-round-for-digita-303281.html 0.6 2026-06-21T06:50:48+08:00 daily https://www.pharmasources.com/industryinsights/get-dizzy-upon-standing-it-could-be-sign-303282.html 0.6 2026-06-19T23:52:28+08:00 daily https://www.pharmasources.com/industryinsights/intensive-blood-pressure-control-may-hel-303283.html 0.6 2026-07-20T12:57:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-abbvies-orilissa-for-endome-303284.html 0.6 2026-06-20T16:57:12+08:00 daily https://www.pharmasources.com/industryinsights/alzheon-says-data-back-plans-for-phase-3-303285.html 0.6 2026-06-21T20:01:36+08:00 daily https://www.pharmasources.com/industryinsights/anima-eli-lilly-pen-1b-plus-biobucks-res-303286.html 0.6 2026-06-21T23:58:42+08:00 daily https://www.pharmasources.com/industryinsights/human-longevity-accuses-j-craig-venter-o-303287.html 0.6 2026-06-22T07:01:47+08:00 daily https://www.pharmasources.com/industryinsights/dutch-viagra-trial-on-pregnant-women-sto-303288.html 0.6 2026-06-23T01:18:51+08:00 daily https://www.pharmasources.com/industryinsights/ptc-inks-200m-agilis-takeover-to-snag-la-303289.html 0.6 2026-08-05T20:40:10+08:00 daily https://www.pharmasources.com/industryinsights/lilly-forms-up-to-1bn-drug-discovery-all-303290.html 0.6 2026-07-15T15:29:38+08:00 daily https://www.pharmasources.com/industryinsights/gossamer-bio-secures-230m-to-support-gro-303291.html 0.6 2026-06-08T01:51:56+08:00 daily https://www.pharmasources.com/industryinsights/patient-death-prompts-fda-hold-on-mersan-303292.html 0.6 2026-06-24T21:28:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-build-465m-injectable-medicine-303293.html 0.6 2026-06-24T20:36:22+08:00 daily https://www.pharmasources.com/industryinsights/roche-puretech-team-up-to-develop-oral-a-303294.html 0.6 2026-06-21T05:00:44+08:00 daily https://www.pharmasources.com/industryinsights/an-eye-drop-for-macular-degeneration-sho-303295.html 0.6 2026-06-22T12:40:09+08:00 daily https://www.pharmasources.com/industryinsights/ifm-therapeutics-inflammation-focused-su-303296.html 0.6 2026-07-06T19:08:08+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-strikes-txcell-takeover-to-gain--303297.html 0.6 2026-06-17T22:53:03+08:00 daily https://www.pharmasources.com/industryinsights/ema-stops-imports-of-sterile-drugs-from--303298.html 0.6 2026-06-19T16:59:05+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-tools-for-powder-characteriz-303299.html 0.6 2026-08-06T23:56:58+08:00 daily https://www.pharmasources.com/industryinsights/yet-another-successful-edition-of-cphi-c-303300.html 0.6 2026-07-23T10:42:39+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-buys-global-rights-to-horizons--303301.html 0.6 2026-06-21T21:43:32+08:00 daily https://www.pharmasources.com/industryinsights/new-selective-biosensor-made-using-synth-303302.html 0.6 2026-06-23T13:46:49+08:00 daily https://www.pharmasources.com/industryinsights/takedas-alunbrig-beats-pfizers-xalkori-o-303303.html 0.6 2026-06-20T20:12:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-backing-for-keytruda-in-classical-h-303304.html 0.6 2026-06-22T03:07:53+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-building-465m-sterile-injectables-303305.html 0.6 2026-06-21T07:05:00+08:00 daily https://www.pharmasources.com/industryinsights/improving-outcomes-how-does-90-patient-a-303306.html 0.6 2026-08-08T01:18:40+08:00 daily https://www.pharmasources.com/industryinsights/use-of-2017-accaha-guidelines-would-incr-303307.html 0.6 2026-08-06T23:32:13+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-cambrex-snatches-halo-pharma-gettin-303308.html 0.6 2026-08-06T23:37:31+08:00 daily https://www.pharmasources.com/industryinsights/cdc-salmonella-tainted-melon-outbreak-ap-303309.html 0.6 2026-08-06T23:38:26+08:00 daily https://www.pharmasources.com/industryinsights/canada-updates-guidelines-for-hepatitis--303310.html 0.6 2026-08-06T23:37:26+08:00 daily https://www.pharmasources.com/industryinsights/focused-ultrasound-may-briefly-open-bloo-303311.html 0.6 2026-08-06T23:46:53+08:00 daily https://www.pharmasources.com/industryinsights/judge-rules-aceto-can-supply-drugs-to-va-303312.html 0.6 2026-08-06T23:36:39+08:00 daily https://www.pharmasources.com/industryinsights/assessing-improving-patient-satisfaction-303313.html 0.6 2026-08-07T02:40:59+08:00 daily https://www.pharmasources.com/industryinsights/hikma-to-ease-us-hydromorphone-shortage--303314.html 0.6 2026-08-07T02:31:44+08:00 daily https://www.pharmasources.com/industryinsights/whey-powder-blamed-for-salmonella-tied-t-303315.html 0.6 2026-08-07T03:02:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-nails-baxter-with-warning-letter-for-303316.html 0.6 2026-08-07T02:52:14+08:00 daily https://www.pharmasources.com/industryinsights/scuba-diving-may-be-risky-for-older-hear-303317.html 0.6 2026-07-09T06:25:12+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-brexit-prep-to-cost-40m-as-i-303318.html 0.6 2026-08-07T03:34:12+08:00 daily https://www.pharmasources.com/industryinsights/aha-personal-trainer-is-half-the-woman-s-303319.html 0.6 2026-06-21T01:44:34+08:00 daily https://www.pharmasources.com/industryinsights/south-korean-company-buys-cdmo-ampac-303320.html 0.6 2026-06-22T01:20:37+08:00 daily https://www.pharmasources.com/industryinsights/illicit-use-of-adhd-meds-wont-boost-grad-303321.html 0.6 2026-07-01T15:12:00+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-focuses-on-data-computer-lapse-303322.html 0.6 2026-06-21T02:07:41+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-reaches-milestone-with-303323.html 0.6 2026-06-29T03:19:06+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-nucala-hopes-take-a-hit-303324.html 0.6 2026-06-21T12:56:29+08:00 daily https://www.pharmasources.com/industryinsights/gileads-top-executives-milligan-and-mart-303325.html 0.6 2026-06-22T09:09:51+08:00 daily https://www.pharmasources.com/industryinsights/takedas-also-ran-alk-drug-alunbrig-aims--303326.html 0.6 2026-06-20T16:13:39+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-shores-up-head-and-neck--303327.html 0.6 2026-06-22T09:04:44+08:00 daily https://www.pharmasources.com/industryinsights/gileads-truvada-for-prep-can-reduce-hiv--303328.html 0.6 2026-07-08T16:48:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-study-validates-need-for-better-303329.html 0.6 2026-08-08T14:00:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-nabs-much-needed-new-nod-for-sl-303330.html 0.6 2026-06-22T22:16:19+08:00 daily https://www.pharmasources.com/industryinsights/is-roches-latest-tecentriq-win-really-a--303331.html 0.6 2026-06-21T22:33:31+08:00 daily https://www.pharmasources.com/industryinsights/eisai-obesity-drug-belviq-may-have-an-ed-303332.html 0.6 2026-06-22T12:06:58+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-h1-results-new-drugs-and-eme-303333.html 0.6 2026-06-30T15:40:23+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-divests-atacands-european-ri-303334.html 0.6 2026-06-21T08:15:17+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-tsinghua-university-enter-clinic-303335.html 0.6 2026-06-30T14:31:41+08:00 daily https://www.pharmasources.com/industryinsights/us-regulators-on-track-for-another-stron-303336.html 0.6 2026-06-21T09:53:03+08:00 daily https://www.pharmasources.com/industryinsights/gsk-invests-300m-in-23andme-under-drug-d-303337.html 0.6 2026-07-02T07:02:50+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-announces-study-supporting-bios-303338.html 0.6 2026-06-22T02:52:37+08:00 daily https://www.pharmasources.com/industryinsights/opportunity-for-biotech-firms-to-pursue--303339.html 0.6 2026-04-14T02:05:45+08:00 daily https://www.pharmasources.com/industryinsights/kilitch-drugs-announces-appointment-of-n-303340.html 0.6 2026-06-22T01:06:59+08:00 daily https://www.pharmasources.com/industryinsights/lifcare-raises-11m-series-b-from-saif-pa-303341.html 0.6 2026-07-04T03:58:27+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-enters-dna-encoded-library-drug-d-303342.html 0.6 2026-06-21T06:59:59+08:00 daily https://www.pharmasources.com/industryinsights/q2-results-roundup---27-july-303343.html 0.6 2026-08-06T23:57:39+08:00 daily https://www.pharmasources.com/industryinsights/fiercepharmaasiabiogen-eisai-alzheimers--303344.html 0.6 2025-11-08T12:51:20+08:00 daily https://www.pharmasources.com/industryinsights/quality-blip-halts-sarepta-muscular-dyst-303345.html 0.6 2026-06-21T00:50:51+08:00 daily https://www.pharmasources.com/industryinsights/dim-the-lights-to-help-your-child-fall-a-303346.html 0.6 2026-07-03T11:25:43+08:00 daily https://www.pharmasources.com/industryinsights/as-humira-competition-nears-abbvies-imbr-303347.html 0.6 2026-06-19T15:54:29+08:00 daily https://www.pharmasources.com/industryinsights/biogen-eisais-anti-amyloid-drug-slows-al-303348.html 0.6 2026-06-20T20:52:32+08:00 daily https://www.pharmasources.com/industryinsights/amgen-rd-head-harper-to-leave-for-new-pa-303349.html 0.6 2026-06-21T06:03:47+08:00 daily https://www.pharmasources.com/industryinsights/shield-yourself-from-the-summer-sun-303350.html 0.6 2026-06-22T11:04:43+08:00 daily https://www.pharmasources.com/industryinsights/sutro-biopharma-nets-854m-to-drive-antib-303351.html 0.6 2026-06-28T15:09:22+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-shingrix-beats-expectat-303352.html 0.6 2026-06-08T18:32:33+08:00 daily https://www.pharmasources.com/industryinsights/cross-continuum-communication-beneficial-303353.html 0.6 2026-06-20T15:52:27+08:00 daily https://www.pharmasources.com/industryinsights/muscle-discovery-could-open-new-treatmen-303354.html 0.6 2026-06-08T08:01:22+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-surprise-threatened-i-o-dr-303355.html 0.6 2026-06-30T23:41:29+08:00 daily https://www.pharmasources.com/industryinsights/two-athenex-phase-3-trials-show-100-skin-303356.html 0.6 2026-07-04T00:47:56+08:00 daily https://www.pharmasources.com/industryinsights/aldehydes-dominant-carcinogen-in-tobacco-303357.html 0.6 2026-07-01T17:13:49+08:00 daily https://www.pharmasources.com/industryinsights/siemens-gets-fda-clearance-for-high-sens-303358.html 0.6 2026-07-08T04:03:23+08:00 daily https://www.pharmasources.com/industryinsights/cdc-homicides-by-firearm-on-the-rise-in--303359.html 0.6 2026-07-06T19:09:02+08:00 daily https://www.pharmasources.com/industryinsights/the-day-has-come-mercks-keytruda-surpass-303360.html 0.6 2026-06-25T01:51:37+08:00 daily https://www.pharmasources.com/industryinsights/illumina-scientists-startup-aims-to-rapi-303361.html 0.6 2026-07-01T16:54:37+08:00 daily https://www.pharmasources.com/industryinsights/nfid-initiative-working-to-up-hepatitis--303362.html 0.6 2026-07-09T08:52:39+08:00 daily https://www.pharmasources.com/industryinsights/fatal-child-drownings-in-open-water-area-303363.html 0.6 2026-06-27T13:22:17+08:00 daily https://www.pharmasources.com/industryinsights/gyms-with-tanning-beds-send-mixed-messag-303364.html 0.6 2026-06-20T14:52:01+08:00 daily https://www.pharmasources.com/industryinsights/women-and-older-people-under-represented-303365.html 0.6 2026-07-19T10:24:53+08:00 daily https://www.pharmasources.com/industryinsights/summers-less-smoggy-now-but-winter-air-h-303366.html 0.6 2026-06-21T02:09:47+08:00 daily https://www.pharmasources.com/industryinsights/tevas-picked-an-address-in-parsippany-ne-303367.html 0.6 2026-06-21T16:17:53+08:00 daily https://www.pharmasources.com/industryinsights/raman-used-to-detect-post-traumatic-stre-303368.html 0.6 2026-06-21T11:56:22+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-q2-results-demand-for-new-prod-303369.html 0.6 2026-08-07T20:04:37+08:00 daily https://www.pharmasources.com/industryinsights/quality-assessment-of-biologics-higher-o-303370.html 0.6 2026-08-09T19:59:29+08:00 daily https://www.pharmasources.com/industryinsights/chugai-pharmaceutical-to-expand-singapor-303371.html 0.6 2026-06-21T16:02:21+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-ptc-therapeutics-cambrex-303372.html 0.6 2026-06-22T12:58:08+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-shingrix-beats-expectat-303373.html 0.6 2026-06-21T22:15:54+08:00 daily https://www.pharmasources.com/industryinsights/uk-prepares-to-stockpile-medical-supplie-303374.html 0.6 2026-06-22T23:58:51+08:00 daily https://www.pharmasources.com/industryinsights/brains-lymphatic-system-just-recently-di-303375.html 0.6 2026-04-09T19:48:30+08:00 daily https://www.pharmasources.com/industryinsights/alector-raises-133m-to-advance-alzheimer-303376.html 0.6 2026-06-20T19:36:07+08:00 daily https://www.pharmasources.com/industryinsights/will-payers-support-amgens-bolus-of-eage-303377.html 0.6 2026-06-21T12:10:20+08:00 daily https://www.pharmasources.com/industryinsights/achaogen-wields-ax-on-rd-c-suite-as-anti-303378.html 0.6 2026-06-20T15:10:26+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-astrazeneca-biogen-midat-303379.html 0.6 2026-07-18T12:02:56+08:00 daily https://www.pharmasources.com/industryinsights/gsk-adjusts-fy2018-guidance-after-encour-303380.html 0.6 2026-06-21T04:06:51+08:00 daily https://www.pharmasources.com/industryinsights/eurobiotech-reportastrazeneca-cancer-tri-303381.html 0.6 2026-06-20T14:51:11+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-h1-results-new-drugs-and-eme-303382.html 0.6 2026-08-06T00:53:11+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-selumetinib-flops-in-thyroi-303383.html 0.6 2026-06-20T16:02:28+08:00 daily https://www.pharmasources.com/industryinsights/new-startup-convelo-links-old-and-new-co-303384.html 0.6 2026-06-21T11:55:26+08:00 daily https://www.pharmasources.com/industryinsights/mesa-biotech-provides-corporate-update-303385.html 0.6 2026-06-20T17:51:34+08:00 daily https://www.pharmasources.com/industryinsights/using-zika-virus-to-treat-neuroblastoma--303386.html 0.6 2026-06-20T22:21:00+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-divests-atacands-european-ri-303387.html 0.6 2026-07-04T09:28:22+08:00 daily https://www.pharmasources.com/industryinsights/canadas-inversago-raises-7m-to-target-ca-303388.html 0.6 2026-06-22T11:56:48+08:00 daily https://www.pharmasources.com/industryinsights/solasia-pharma-announces-approval-of-san-303389.html 0.6 2026-08-07T19:41:00+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-abl-bio-collaborate-for--303390.html 0.6 2026-06-21T17:52:11+08:00 daily https://www.pharmasources.com/industryinsights/those-at-risk-of-hiv-to-be-offered-prep--303391.html 0.6 2026-08-07T06:07:07+08:00 daily https://www.pharmasources.com/industryinsights/mercks-formulation-steps-further-for-app-303392.html 0.6 2026-06-20T17:16:39+08:00 daily https://www.pharmasources.com/industryinsights/a-world-reference-and-international-lead-303393.html 0.6 2026-08-06T23:38:02+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018073-303394.html 0.6 2026-08-06T23:36:19+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-extends-and-expands-research-coll-303395.html 0.6 2026-08-06T23:45:14+08:00 daily https://www.pharmasources.com/industryinsights/protein-kinase-c-alpha-inhibitor-reverse-303396.html 0.6 2026-06-20T16:01:25+08:00 daily https://www.pharmasources.com/industryinsights/after-its-recent-funding-round-hifibio-p-303397.html 0.6 2026-06-21T12:51:13+08:00 daily https://www.pharmasources.com/industryinsights/freshly-funded-ifm-therapeutics-defines--303398.html 0.6 2026-06-21T06:14:57+08:00 daily https://www.pharmasources.com/industryinsights/redhill-sees-positive-results-for-anti-m-303399.html 0.6 2026-06-21T20:45:16+08:00 daily https://www.pharmasources.com/industryinsights/sienna-slumps-as-acne-asset-flunks-phase-303400.html 0.6 2026-06-20T22:44:57+08:00 daily https://www.pharmasources.com/industryinsights/lilly-firms-up-cancer-collaboration-with-303401.html 0.6 2026-06-21T00:00:39+08:00 daily https://www.pharmasources.com/industryinsights/takeda-signs-antibody-therapy-deal-with--303402.html 0.6 2026-06-21T10:17:21+08:00 daily https://www.pharmasources.com/industryinsights/redhills-rhb-104-hits-primary-endpoint-i-303403.html 0.6 2026-06-21T03:12:50+08:00 daily https://www.pharmasources.com/industryinsights/healx-reels-in-10m-in-series-a-funding-f-303404.html 0.6 2026-06-20T16:52:26+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-chemotherapy-combination-gets-c-303405.html 0.6 2026-06-21T04:00:48+08:00 daily https://www.pharmasources.com/industryinsights/novartis-links-with-medidatas-shyft-to-s-303406.html 0.6 2026-07-06T20:23:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-azedra-iobenguane-i-131-for-303407.html 0.6 2026-06-20T21:41:25+08:00 daily https://www.pharmasources.com/industryinsights/isogenica-inks-licensing-deal-with-aro-b-303408.html 0.6 2026-07-06T18:14:36+08:00 daily https://www.pharmasources.com/industryinsights/reva-moves-into-peripheral-artery-diseas-303409.html 0.6 2026-06-22T19:00:05+08:00 daily https://www.pharmasources.com/industryinsights/medical-boards-may-contribute-to-mental--303410.html 0.6 2026-06-20T16:59:22+08:00 daily https://www.pharmasources.com/industryinsights/clinical-innovations-expands-into-china--303411.html 0.6 2026-08-04T23:03:13+08:00 daily https://www.pharmasources.com/industryinsights/startup-aims-to-use-ai-to-spot-connectio-303412.html 0.6 2026-04-20T21:27:58+08:00 daily https://www.pharmasources.com/industryinsights/better-care-quality-needed-for-universal-303413.html 0.6 2026-06-19T19:11:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-finalizes-guidance-on-integrating-eh-303414.html 0.6 2026-07-31T10:05:46+08:00 daily https://www.pharmasources.com/industryinsights/ama-opposes-proposed-cuts-gag-orders-for-303415.html 0.6 2026-06-21T07:12:03+08:00 daily https://www.pharmasources.com/industryinsights/bayer-dismisses-essure-concerns-as-safet-303416.html 0.6 2026-04-06T20:11:27+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-innocore-team-up-on-exten-303417.html 0.6 2026-06-21T05:15:00+08:00 daily https://www.pharmasources.com/industryinsights/teen-boy-suffers-serious-burns-after-hot-303418.html 0.6 2026-07-16T23:21:33+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-first-implantable-drug-delive-303419.html 0.6 2026-06-21T23:10:31+08:00 daily https://www.pharmasources.com/industryinsights/european-backing-for-mercks-keytruda-rub-303420.html 0.6 2026-06-20T23:49:31+08:00 daily https://www.pharmasources.com/industryinsights/if-youre-tempted-to-eat-raw-centipedes-d-303421.html 0.6 2026-07-17T21:37:18+08:00 daily https://www.pharmasources.com/industryinsights/systematic-data-fabrication-chinese-poli-303422.html 0.6 2026-07-02T11:28:47+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-builds-40m-plant-in-dubai-to-p-303423.html 0.6 2026-06-22T04:06:53+08:00 daily https://www.pharmasources.com/industryinsights/hiv-doubles-heart-disease-risk-303424.html 0.6 2026-06-21T06:09:47+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-closes-bangladesh-manufa-303425.html 0.6 2026-06-20T23:06:45+08:00 daily https://www.pharmasources.com/industryinsights/dont-believe-the-hype-on-vaginal-rejuven-303426.html 0.6 2026-08-09T22:49:00+08:00 daily https://www.pharmasources.com/industryinsights/indiviors-new-antipsychotic-wins-fda-nod-303427.html 0.6 2026-06-21T00:59:43+08:00 daily https://www.pharmasources.com/industryinsights/heres-what-happened-when-1-unvaccinated--303428.html 0.6 2026-06-20T18:02:24+08:00 daily https://www.pharmasources.com/industryinsights/bms-pfizers-fast-growing-eliquis-is-abou-303429.html 0.6 2026-06-22T10:02:44+08:00 daily https://www.pharmasources.com/industryinsights/gsk-announces-closure-of-bangladesh-faci-303430.html 0.6 2026-06-22T00:49:57+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-launches-40m-manufacturing-pla-303431.html 0.6 2026-06-22T08:04:49+08:00 daily https://www.pharmasources.com/industryinsights/eu-commission-grants-market-authorisatio-303432.html 0.6 2026-08-06T18:35:20+08:00 daily https://www.pharmasources.com/industryinsights/tonix-plunges-68-after-ptsd-drug-failure-303433.html 0.6 2026-08-08T10:54:12+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommend-white-blood-cell-growth-s-303434.html 0.6 2026-06-21T12:06:11+08:00 daily https://www.pharmasources.com/industryinsights/army-to-ferry-medicines-in-case-of-no-de-303435.html 0.6 2026-07-09T10:11:58+08:00 daily https://www.pharmasources.com/industryinsights/world-hepatitis-day-2018-89-of-people-wi-303436.html 0.6 2026-06-20T11:02:57+08:00 daily https://www.pharmasources.com/industryinsights/merck-gets-chinese-approval-for-keytruda-303437.html 0.6 2026-06-21T22:10:54+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-builds-40m-plant-in-dubai-to-p-303438.html 0.6 2026-06-20T22:00:45+08:00 daily https://www.pharmasources.com/industryinsights/ex-biogen-manager-claims-she-was-fired-a-303439.html 0.6 2025-12-08T00:27:15+08:00 daily https://www.pharmasources.com/industryinsights/nebraska-lawmaker-urges-pfizer-to-sue-ov-303440.html 0.6 2026-07-10T16:30:10+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-announced-successful-comp-303441.html 0.6 2026-07-28T18:05:38+08:00 daily https://www.pharmasources.com/industryinsights/china-investors-lead-financing-round-for-303442.html 0.6 2026-06-29T13:51:48+08:00 daily https://www.pharmasources.com/industryinsights/ups-and-downs-pain-medication-tanezumab--303443.html 0.6 2026-07-23T11:00:13+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-phase-iii-clinical-study-of-303444.html 0.6 2026-06-25T09:40:07+08:00 daily https://www.pharmasources.com/industryinsights/big-secret-uncovering-hengruis-shr-1603--303445.html 0.6 2026-07-27T15:02:16+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-pfizers-herceptin-biosimilar-303446.html 0.6 2026-08-08T02:55:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-profits-and-sales-fall-in-q2-303447.html 0.6 2026-06-30T16:59:38+08:00 daily https://www.pharmasources.com/industryinsights/novartis-migraine-drug-gets-ema-approval-303448.html 0.6 2026-07-09T15:25:25+08:00 daily https://www.pharmasources.com/industryinsights/shires-fast-track-nash-drug-abruptly-sto-303449.html 0.6 2026-07-30T15:07:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mulpleta-lusutrombopag-for--303450.html 0.6 2026-06-20T17:18:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-drops-diabetes-and-cancer-drugs-f-303451.html 0.6 2026-07-04T03:43:09+08:00 daily https://www.pharmasources.com/industryinsights/united-therapeutics-announces-fda-approv-303452.html 0.6 2026-06-22T04:14:20+08:00 daily https://www.pharmasources.com/industryinsights/inpatient-volume-greater-driver-of-ambul-303453.html 0.6 2026-08-09T00:10:32+08:00 daily https://www.pharmasources.com/industryinsights/after-its-recent-funding-round-hifibio-p-303454.html 0.6 2026-08-09T06:59:52+08:00 daily https://www.pharmasources.com/industryinsights/flu-vaccine-cuts-mortality-in-rheumatoid-303455.html 0.6 2026-08-08T20:53:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-azedra-for-rare-adrenal-tum-303456.html 0.6 2026-08-08T07:45:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-the-dangers-of-vaginal-reju-303457.html 0.6 2026-08-07T14:28:58+08:00 daily https://www.pharmasources.com/industryinsights/otsukas-guadecitabine-fails-phase-3-aml--303458.html 0.6 2026-08-08T08:39:06+08:00 daily https://www.pharmasources.com/industryinsights/learning-to-change-important-for-improvi-303459.html 0.6 2026-08-06T20:05:19+08:00 daily https://www.pharmasources.com/industryinsights/active-bio-and-tevas-laquinimod-fails-on-303460.html 0.6 2026-08-07T13:16:02+08:00 daily https://www.pharmasources.com/industryinsights/to-boost-colon-cancer-screening-use-the--303461.html 0.6 2026-06-21T18:01:28+08:00 daily https://www.pharmasources.com/industryinsights/lyme-disease-striking-more-americans-in--303462.html 0.6 2026-04-08T16:57:02+08:00 daily https://www.pharmasources.com/industryinsights/sublimity-hires-new-cmo-as-it-advances-u-303463.html 0.6 2026-08-10T00:35:08+08:00 daily https://www.pharmasources.com/industryinsights/brains-plasticity-amazes-as-boy-recovers-303464.html 0.6 2026-06-21T22:45:02+08:00 daily https://www.pharmasources.com/industryinsights/the-growing-need-for-data-management-sol-303465.html 0.6 2026-06-29T08:10:49+08:00 daily https://www.pharmasources.com/industryinsights/alan-alda-reveals-parkinsons-diagnosis-303466.html 0.6 2026-03-18T12:59:54+08:00 daily https://www.pharmasources.com/industryinsights/wirb-copernicus-group-snaps-up-a-pair-of-303467.html 0.6 2026-06-20T22:47:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-finds-drugmaker-using-filthy-kitchen-303468.html 0.6 2026-06-22T12:59:29+08:00 daily https://www.pharmasources.com/industryinsights/illuminas-stock-rides-wave-of-high-deman-303469.html 0.6 2026-06-27T23:28:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-insys-opioid-spray-buvaya-303470.html 0.6 2026-06-23T04:30:24+08:00 daily https://www.pharmasources.com/industryinsights/gv-backed-verana-raises-30m-to-mine-pati-303471.html 0.6 2026-06-22T17:56:02+08:00 daily https://www.pharmasources.com/industryinsights/mannkind-signs-distribution-deal-with-ta-303472.html 0.6 2026-07-09T22:23:48+08:00 daily https://www.pharmasources.com/industryinsights/indivior-secures-fda-approval-for-perser-303473.html 0.6 2026-08-07T04:04:33+08:00 daily https://www.pharmasources.com/industryinsights/despite-high-flying-gardasil-sales-merck-303474.html 0.6 2026-06-22T01:08:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-ships-first-of-70m-doses-of-flu-s-303475.html 0.6 2026-06-22T22:08:24+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-expands-cancer-research-allian-303476.html 0.6 2026-06-21T12:42:24+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-says-shortage-of-adult-dose-epipe-303477.html 0.6 2026-06-20T16:05:18+08:00 daily https://www.pharmasources.com/industryinsights/cstones-mek-inhibitor-approved-for-trial-303478.html 0.6 2026-07-09T00:33:06+08:00 daily https://www.pharmasources.com/industryinsights/progenics-snags-fda-nod-for-300k-ultra-o-303479.html 0.6 2026-06-20T17:26:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-insys-therapeutics-sublingua-303480.html 0.6 2026-06-12T13:00:46+08:00 daily https://www.pharmasources.com/industryinsights/indiviors-new-antipsychotic-wins-fda-nod-303481.html 0.6 2026-08-06T17:46:27+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-teams-with-geisinger-on-ehr--303482.html 0.6 2026-06-09T06:36:44+08:00 daily https://www.pharmasources.com/industryinsights/bms-pfizers-fast-growing-eliquis-is-abou-303483.html 0.6 2026-07-01T20:55:50+08:00 daily https://www.pharmasources.com/industryinsights/amarins-vascepa-goes-on-tv-to-lay-ground-303484.html 0.6 2026-06-20T20:18:49+08:00 daily https://www.pharmasources.com/industryinsights/got-lolo-allergan-hypes-ultralow-estroge-303485.html 0.6 2026-06-21T05:51:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-rejig-made-for-growth-but-its-al-303486.html 0.6 2026-06-22T06:08:45+08:00 daily https://www.pharmasources.com/industryinsights/thanks-to-genzymeand-no-thanks-to-vaccin-303487.html 0.6 2026-06-23T22:10:30+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-sell-prescription-dermatology-u-303488.html 0.6 2026-06-21T23:09:55+08:00 daily https://www.pharmasources.com/industryinsights/justice-department-probes-claims-that-as-303489.html 0.6 2026-07-05T13:28:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-rejig-made-for-growth-but-its-al-303490.html 0.6 2026-06-21T09:01:00+08:00 daily https://www.pharmasources.com/industryinsights/eisai-to-market-anti-obesity-agent-in-ch-303491.html 0.6 2026-08-05T19:45:35+08:00 daily https://www.pharmasources.com/industryinsights/tcels-giving-a-boost-to-start-ups-in-the-303492.html 0.6 2026-06-19T16:04:14+08:00 daily https://www.pharmasources.com/industryinsights/gilead-investors-see-celgene-veteran-jac-303493.html 0.6 2026-06-21T03:14:54+08:00 daily https://www.pharmasources.com/industryinsights/lung-cell-discovery-opens-new-route-for--303494.html 0.6 2026-07-08T11:07:07+08:00 daily https://www.pharmasources.com/industryinsights/newlink-wields-ax-clearing-the-way-for-l-303495.html 0.6 2026-08-05T15:18:49+08:00 daily https://www.pharmasources.com/industryinsights/car-t-player-cell-medica-names-kites-eur-303496.html 0.6 2026-06-20T20:58:36+08:00 daily https://www.pharmasources.com/industryinsights/a-slowing-marketnot-new-rivalsis-hurting-303497.html 0.6 2026-04-16T21:29:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-licenses-out-unwanted-glaxosmit-303498.html 0.6 2026-08-03T04:36:19+08:00 daily https://www.pharmasources.com/industryinsights/oncorus-poaches-moderna-cancer-executive-303499.html 0.6 2026-06-21T14:55:23+08:00 daily https://www.pharmasources.com/industryinsights/reviral-raises-55m-to-run-midphase-rsv-c-303500.html 0.6 2026-06-21T09:04:03+08:00 daily https://www.pharmasources.com/industryinsights/early-trial-shows-application-of-rxis-sk-303501.html 0.6 2026-07-05T06:00:28+08:00 daily https://www.pharmasources.com/industryinsights/novartis-partners-with-albumedix-to-expl-303502.html 0.6 2026-07-07T20:39:56+08:00 daily https://www.pharmasources.com/industryinsights/ema-prepares-to-scale-back-more-activiti-303503.html 0.6 2026-06-08T21:54:48+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-united-receive-approval-for-fu-303504.html 0.6 2026-06-19T21:56:01+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-other-drugmakers-stockpile-dr-303505.html 0.6 2026-06-21T10:02:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-widens-approval-of-roche-cobas-hpv-t-303506.html 0.6 2026-04-30T04:42:02+08:00 daily https://www.pharmasources.com/industryinsights/first-treatment-for-lipodystrophy-approv-303507.html 0.6 2026-06-22T17:54:53+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-xeljanz-cleared-for-ulcerative-c-303508.html 0.6 2026-08-07T21:46:29+08:00 daily https://www.pharmasources.com/industryinsights/the-top-5-vaccine-companies-by-2017-reve-303509.html 0.6 2026-08-09T03:21:49+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-sales-rise-as-jardiance-and-o-303510.html 0.6 2026-06-14T02:49:51+08:00 daily https://www.pharmasources.com/industryinsights/biosimilars-and-key-brands-drive-pfizer--303511.html 0.6 2026-07-17T16:13:46+08:00 daily https://www.pharmasources.com/industryinsights/amgen-breaks-ground-on-200m-next-gen-bio-303512.html 0.6 2026-06-22T23:17:34+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-pfizers-herceptin-biosimilar-303513.html 0.6 2026-06-23T08:28:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-hits-japanese-api-maker-with-warning-303514.html 0.6 2026-06-21T01:58:38+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-other-drugmakers-stockpile-dr-303515.html 0.6 2026-06-25T09:55:04+08:00 daily https://www.pharmasources.com/industryinsights/sticker-prices-in-drug-ads-just-got-clos-303516.html 0.6 2026-06-21T10:02:12+08:00 daily https://www.pharmasources.com/industryinsights/as-opioid-epidemic-rages-painkiller-pres-303517.html 0.6 2026-06-21T04:55:38+08:00 daily https://www.pharmasources.com/industryinsights/alcohol-exposure-via-breastmilk-may-affe-303518.html 0.6 2026-06-21T21:04:41+08:00 daily https://www.pharmasources.com/industryinsights/hop-on-the-bus-abbvie-takes-hepatitis-c--303519.html 0.6 2026-06-21T05:58:47+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receives-eu-nod-for-ulcerative-co-303520.html 0.6 2026-07-19T23:26:18+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-channels-70s-magic-in-first-303521.html 0.6 2026-04-23T16:00:45+08:00 daily https://www.pharmasources.com/industryinsights/want-to-save-28b-plus-medicare-drug-pric-303522.html 0.6 2026-06-21T07:19:24+08:00 daily https://www.pharmasources.com/industryinsights/dogs-saliva-caused-bacterial-infection-l-303523.html 0.6 2026-06-21T15:57:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-ceo-psychs-up-investors-for-a-reb-303524.html 0.6 2026-06-21T09:17:16+08:00 daily https://www.pharmasources.com/industryinsights/update-on-salmonella-outbreak-tied-to-hy-303525.html 0.6 2026-06-22T06:56:46+08:00 daily https://www.pharmasources.com/industryinsights/national-guideline-clearinghouse-offline-303526.html 0.6 2025-11-12T23:43:26+08:00 daily https://www.pharmasources.com/industryinsights/summer-sounds-can-cause-hearing-damage-303527.html 0.6 2026-07-04T15:52:36+08:00 daily https://www.pharmasources.com/industryinsights/folic-acid-supplements-in-pregnancy-help-303528.html 0.6 2026-07-20T07:58:12+08:00 daily https://www.pharmasources.com/industryinsights/obesity-could-set-stage-for-heart-issues-303529.html 0.6 2026-06-22T10:58:44+08:00 daily https://www.pharmasources.com/industryinsights/lack-of-blockbuster-candidates-at-takeda-303530.html 0.6 2026-06-22T10:59:48+08:00 daily https://www.pharmasources.com/industryinsights/germs-gaining-resistance-to-hand-gels-in-303531.html 0.6 2026-06-21T21:53:44+08:00 daily https://www.pharmasources.com/industryinsights/australian-stem-cell-researchers-receive-303532.html 0.6 2026-06-20T17:46:11+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-scores-eu-schizophrenia-approval--303533.html 0.6 2026-06-20T14:41:22+08:00 daily https://www.pharmasources.com/industryinsights/parents-demonstrate-in-response-to-chine-303534.html 0.6 2026-06-20T23:47:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-303535.html 0.6 2026-06-19T16:02:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-notches-two-eu-approvals-includin-303536.html 0.6 2026-06-22T05:03:40+08:00 daily https://www.pharmasources.com/industryinsights/progenics-azedra-becomes-first-fda-appro-303537.html 0.6 2026-06-20T20:59:35+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-doctors-political-views-as-303538.html 0.6 2026-08-09T10:46:28+08:00 daily https://www.pharmasources.com/industryinsights/orig3n-and-zhongan-partner-to-bring-heal-303539.html 0.6 2026-07-16T08:03:19+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-nda-for-its-all-oral-hcv-treatm-303540.html 0.6 2026-06-21T00:02:36+08:00 daily https://www.pharmasources.com/industryinsights/teva-raises-earnings-estimates-despite-c-303541.html 0.6 2026-06-22T22:10:40+08:00 daily https://www.pharmasources.com/industryinsights/poll-reveals-mps-attitudes-on-pharma-in--303542.html 0.6 2026-06-24T01:48:23+08:00 daily https://www.pharmasources.com/industryinsights/nih-releases-large-scale-dataset-of-ct-i-303543.html 0.6 2026-06-22T15:12:23+08:00 daily https://www.pharmasources.com/industryinsights/cdc-salmonella-outbreaks-in-44-states-li-303544.html 0.6 2026-06-21T03:13:52+08:00 daily https://www.pharmasources.com/industryinsights/a-better-enzyme-for-crispr-gene-editing-303545.html 0.6 2026-08-08T23:05:34+08:00 daily https://www.pharmasources.com/industryinsights/health-affairs-announces-launch-of-new-t-303546.html 0.6 2026-08-08T23:20:11+08:00 daily https://www.pharmasources.com/industryinsights/three-financial-metrics-can-improve-prac-303547.html 0.6 2026-06-30T14:36:03+08:00 daily https://www.pharmasources.com/industryinsights/new-ebola-outbreak-in-congo-303548.html 0.6 2026-06-20T14:51:14+08:00 daily https://www.pharmasources.com/industryinsights/brexit-forces-ema-to-suspend-tasks-as-jo-303549.html 0.6 2026-08-07T05:14:21+08:00 daily https://www.pharmasources.com/industryinsights/opioid-addicts-turning-to-unapproved-ant-303550.html 0.6 2026-08-07T00:46:21+08:00 daily https://www.pharmasources.com/industryinsights/karuna-raises-42m-to-resurrect-abandoned-303551.html 0.6 2026-06-21T03:01:42+08:00 daily https://www.pharmasources.com/industryinsights/aha-heart-problem-forced-her-baby-to-be--303552.html 0.6 2026-06-27T06:34:09+08:00 daily https://www.pharmasources.com/industryinsights/how-to-get-your-kids-to-eat-better-303553.html 0.6 2026-06-27T18:21:43+08:00 daily https://www.pharmasources.com/industryinsights/clovis-loses-servier-pact-agrees-to-sett-303554.html 0.6 2026-06-20T19:11:54+08:00 daily https://www.pharmasources.com/industryinsights/scans-help-spot-heart-trouble-early-in-p-303555.html 0.6 2026-06-22T07:08:02+08:00 daily https://www.pharmasources.com/industryinsights/fortress-bios-in-house-stockbrokers-rais-303556.html 0.6 2026-06-20T17:16:33+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-diabetes-executive-makes-the-jump-303557.html 0.6 2026-06-20T23:49:48+08:00 daily https://www.pharmasources.com/industryinsights/roche-johnson-johnson-pulled-into-justic-303558.html 0.6 2026-01-15T06:15:47+08:00 daily https://www.pharmasources.com/industryinsights/celtaxsys-cystic-fibrosis-drug-reduces-l-303559.html 0.6 2026-06-21T12:57:39+08:00 daily https://www.pharmasources.com/industryinsights/endomag-nets-approval-for-liquid-magneti-303560.html 0.6 2026-07-01T02:09:34+08:00 daily https://www.pharmasources.com/industryinsights/hologics-stock-dips-despite-strong-quart-303561.html 0.6 2026-06-20T18:43:17+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-unveils-its-first-oncology-biosim-303562.html 0.6 2026-07-01T10:47:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-halts-sales-of-injectable-opioids-303563.html 0.6 2026-07-11T23:11:20+08:00 daily https://www.pharmasources.com/industryinsights/takeda-closes-tigenix-acquisition-for-ab-303564.html 0.6 2026-08-08T10:32:32+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-plots-dtc-advertising-and-disc-303565.html 0.6 2026-06-20T23:11:51+08:00 daily https://www.pharmasources.com/industryinsights/tevas-copaxone-holds-its-own-in-wake-of--303566.html 0.6 2026-07-20T12:29:18+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-to-acquire-bayers-prescriptio-303567.html 0.6 2026-08-09T18:56:17+08:00 daily https://www.pharmasources.com/industryinsights/roche-johnson-johnson-pulled-into-justic-303568.html 0.6 2026-03-26T23:15:06+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-launching-initiative-to-discover--303569.html 0.6 2026-08-06T07:28:26+08:00 daily https://www.pharmasources.com/industryinsights/avelas-biosciences-initiates-period-2-of-303570.html 0.6 2026-06-21T21:14:57+08:00 daily https://www.pharmasources.com/industryinsights/janssen-receives-positive-chmp-opinion-t-303571.html 0.6 2026-04-04T23:51:33+08:00 daily https://www.pharmasources.com/industryinsights/armagen-receives-orphan-drug-designation-303572.html 0.6 2026-07-17T06:48:34+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-initiates-nitric-oxide-gas--303573.html 0.6 2026-06-20T23:08:45+08:00 daily https://www.pharmasources.com/industryinsights/unc-develops-artificial-intelligence-sys-303574.html 0.6 2026-06-21T19:14:44+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-commissioner-on-overs-303575.html 0.6 2026-06-21T07:06:58+08:00 daily https://www.pharmasources.com/industryinsights/lawsuit-alleges-pharma-giants-funded-ter-303576.html 0.6 2026-06-22T02:07:45+08:00 daily https://www.pharmasources.com/industryinsights/stroke-imaging-technology-could-reduce-p-303577.html 0.6 2026-07-07T12:42:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-hands-over-global-rights-for-tw-303578.html 0.6 2026-08-07T21:50:24+08:00 daily https://www.pharmasources.com/industryinsights/want-to-save-28b-plus-medicare-drug-pric-303579.html 0.6 2026-06-21T01:55:44+08:00 daily https://www.pharmasources.com/industryinsights/perfect-polymer-pill-proves-it-can-deliv-303580.html 0.6 2026-06-27T01:35:18+08:00 daily https://www.pharmasources.com/industryinsights/two-injured-in-chemical-incident-at-sano-303581.html 0.6 2026-02-28T08:16:26+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-cut-activities-as-it-forecasts-lo-303582.html 0.6 2026-05-29T23:25:21+08:00 daily https://www.pharmasources.com/industryinsights/biosimilars-and-generics-saved-nhs-324m--303583.html 0.6 2026-08-07T06:32:31+08:00 daily https://www.pharmasources.com/industryinsights/legend-capital-co-invests-293m-in-chines-303584.html 0.6 2026-08-10T00:20:04+08:00 daily https://www.pharmasources.com/industryinsights/applied-dna-reaches-new-milestones-303585.html 0.6 2026-06-20T20:00:40+08:00 daily https://www.pharmasources.com/industryinsights/congo-declares-new-ebola-outbreak-303586.html 0.6 2026-06-20T17:15:29+08:00 daily https://www.pharmasources.com/industryinsights/medpacto-inks-deal-with-astrazeneca-303587.html 0.6 2026-06-21T11:03:21+08:00 daily https://www.pharmasources.com/industryinsights/research-study-aims-to-identify-new-ways-303588.html 0.6 2026-06-21T05:56:42+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-approved-for-marketing-in--303589.html 0.6 2026-07-20T03:02:03+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-vaccines-marketed-in-chi-303590.html 0.6 2026-08-03T12:50:39+08:00 daily https://www.pharmasources.com/industryinsights/sda-to-speed-up-the-new-drug-rd-clinical-303591.html 0.6 2026-08-08T12:11:53+08:00 daily https://www.pharmasources.com/industryinsights/janssen-bayer-to-close-south-korean-plan-303592.html 0.6 2026-06-27T12:42:18+08:00 daily https://www.pharmasources.com/industryinsights/allergan-sues-pfizer-saying-it-needs-to--303593.html 0.6 2026-06-18T19:15:19+08:00 daily https://www.pharmasources.com/industryinsights/allergan-preludes-major-selloffs-with-65-303594.html 0.6 2026-03-06T03:58:26+08:00 daily https://www.pharmasources.com/industryinsights/eisais-lenvima-posts-big-growth-numbers--303595.html 0.6 2026-07-05T08:39:27+08:00 daily https://www.pharmasources.com/industryinsights/with-ipo-filing-lilly-pulls-back-the-cur-303596.html 0.6 2026-07-05T02:42:07+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-announces-united-kingdoms-mhra-g-303597.html 0.6 2026-06-21T13:30:42+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-prime-status-for-roche-huntin-303598.html 0.6 2026-07-19T03:21:34+08:00 daily https://www.pharmasources.com/industryinsights/salix-expands-research-discovery-collabo-303599.html 0.6 2026-06-21T00:00:37+08:00 daily https://www.pharmasources.com/industryinsights/titan-announces-amendment-to-agreement-w-303600.html 0.6 2026-06-21T13:01:28+08:00 daily https://www.pharmasources.com/industryinsights/az-and-msd-get-orphan-designation-for-ne-303601.html 0.6 2026-06-20T02:48:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-ec-approval-of-its-onco-303602.html 0.6 2026-08-08T01:54:58+08:00 daily https://www.pharmasources.com/industryinsights/almirall-buys-allergans-us-dermatology-p-303603.html 0.6 2026-06-21T08:07:01+08:00 daily https://www.pharmasources.com/industryinsights/selumetinib-granted-orphan-designation-i-303604.html 0.6 2026-06-20T15:40:13+08:00 daily https://www.pharmasources.com/industryinsights/ionis-htt-rx-granted-prime-designation-b-303605.html 0.6 2026-04-08T15:42:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-lu-303606.html 0.6 2026-06-21T03:08:44+08:00 daily https://www.pharmasources.com/industryinsights/what-makes-a-better-baseball-batter-303607.html 0.6 2026-06-20T22:52:36+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-appoints-jon-ellis--303608.html 0.6 2026-06-22T11:57:00+08:00 daily https://www.pharmasources.com/industryinsights/how-to-keep-foodborne-illness-at-bay-303609.html 0.6 2026-06-21T02:06:43+08:00 daily https://www.pharmasources.com/industryinsights/turkish-pharmaceutical-industry-leader-a-303610.html 0.6 2026-06-21T12:12:24+08:00 daily https://www.pharmasources.com/industryinsights/mushrooms-of-the-far-east-hold-promise-f-303611.html 0.6 2026-06-21T13:03:58+08:00 daily https://www.pharmasources.com/industryinsights/cdc-e-cigarette-sales-in-the-united-stat-303612.html 0.6 2026-06-21T12:52:18+08:00 daily https://www.pharmasources.com/industryinsights/amgen-breaks-ground-on-next-generation-b-303613.html 0.6 2026-07-26T23:12:22+08:00 daily https://www.pharmasources.com/industryinsights/some-bacteria-now-more-tolerant-of-alcoh-303614.html 0.6 2026-03-27T00:34:08+08:00 daily https://www.pharmasources.com/industryinsights/innovative-technique-converts-white-fat--303615.html 0.6 2026-07-01T13:13:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-rare-adre-303616.html 0.6 2026-04-07T19:16:48+08:00 daily https://www.pharmasources.com/industryinsights/robert-wicke-appointed-as-new-ceo-of-hal-303617.html 0.6 2026-06-22T03:48:40+08:00 daily https://www.pharmasources.com/industryinsights/parent-child-interactive-intervention-cu-303618.html 0.6 2026-06-21T13:47:39+08:00 daily https://www.pharmasources.com/industryinsights/variation-in-specialty-drug-coverage-acr-303619.html 0.6 2026-07-06T21:17:42+08:00 daily https://www.pharmasources.com/industryinsights/pushing-doctors-to-prescribe-cholesterol-303620.html 0.6 2026-02-28T13:18:13+08:00 daily https://www.pharmasources.com/industryinsights/boosting-cancer-immunotherapy-by-switchi-303621.html 0.6 2026-06-22T23:16:30+08:00 daily https://www.pharmasources.com/industryinsights/skin-appears-to-be-key-pathway-for-absor-303622.html 0.6 2026-08-07T02:52:23+08:00 daily https://www.pharmasources.com/industryinsights/car-t-player-cellectis-poaches-stefan-sc-303623.html 0.6 2026-08-09T18:43:16+08:00 daily https://www.pharmasources.com/industryinsights/why-choo-choo-is-better-for-babys-langua-303624.html 0.6 2026-08-07T02:40:45+08:00 daily https://www.pharmasources.com/industryinsights/thomas-hughes-leaves-zafgen-to-take-ceo--303625.html 0.6 2026-08-07T02:49:03+08:00 daily https://www.pharmasources.com/industryinsights/why-seniors-can-struggle-with-swallowing-303626.html 0.6 2026-08-07T03:03:14+08:00 daily https://www.pharmasources.com/industryinsights/castle-study-shows-decisiondx-gene-test--303627.html 0.6 2026-08-07T03:12:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-xeljanz-secures-marketing-author-303628.html 0.6 2026-08-08T02:48:23+08:00 daily https://www.pharmasources.com/industryinsights/australian-researchers-find-drug-to-put--303629.html 0.6 2026-07-17T09:19:35+08:00 daily https://www.pharmasources.com/industryinsights/cherwell-publishes-guide-on-environmenta-303630.html 0.6 2026-08-07T02:48:50+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-to-commercialise-akceas-303631.html 0.6 2026-06-20T21:59:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-shionogis-mulpleta-for-cld--303632.html 0.6 2026-08-07T19:29:48+08:00 daily https://www.pharmasources.com/industryinsights/almirall-picks-up-allergans-dermatology--303633.html 0.6 2026-06-17T11:33:36+08:00 daily https://www.pharmasources.com/industryinsights/epizyme-shuts-down-failing-lymphoma-tria-303634.html 0.6 2026-06-21T09:02:59+08:00 daily https://www.pharmasources.com/industryinsights/ttp-completes-expansion-of-life-sciences-303635.html 0.6 2026-06-22T12:51:19+08:00 daily https://www.pharmasources.com/industryinsights/allergan-sues-pfizer-over-opioid-crisis--303636.html 0.6 2026-06-20T21:55:35+08:00 daily https://www.pharmasources.com/industryinsights/computer-simulations-predict-spread-of-h-303637.html 0.6 2026-07-04T22:02:39+08:00 daily https://www.pharmasources.com/industryinsights/solving-costly-tablet-manufacturing-issu-303638.html 0.6 2026-02-15T09:19:19+08:00 daily https://www.pharmasources.com/industryinsights/partnership-struck-to-aid-bio-manufactur-303639.html 0.6 2026-06-23T12:41:07+08:00 daily https://www.pharmasources.com/industryinsights/mhra-clarifies-post-brexit-clinical-tria-303640.html 0.6 2026-07-01T10:51:08+08:00 daily https://www.pharmasources.com/industryinsights/pain-therapeutics-hit-with-yet-another-c-303641.html 0.6 2026-06-21T10:42:07+08:00 daily https://www.pharmasources.com/industryinsights/janssen-and-immune-bioscience-team-up-fo-303642.html 0.6 2026-06-23T10:12:55+08:00 daily https://www.pharmasources.com/industryinsights/ovid-posts-results-from-midstage-rare-di-303643.html 0.6 2026-06-20T17:59:17+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-bluebird-bio-collaborate-o-303644.html 0.6 2026-06-20T17:02:13+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-lands-option-on-cys-303645.html 0.6 2026-06-22T06:01:38+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-joins-consortium-to-develop-n-303646.html 0.6 2026-06-21T05:02:46+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-bluebird-ink-anti-cancer-cell--303647.html 0.6 2026-07-27T13:31:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-chief-scott-gottlieb-churns-out-stat-303648.html 0.6 2026-06-21T01:05:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-new-steps-to-encourage-the-dev-303649.html 0.6 2026-06-20T16:57:20+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-abandons-deal-with-astrazeneca--303650.html 0.6 2026-06-21T22:56:41+08:00 daily https://www.pharmasources.com/industryinsights/female-internists-consistently-earn-less-303651.html 0.6 2026-06-20T17:56:20+08:00 daily https://www.pharmasources.com/industryinsights/premier-research-acquires-regulatory-fir-303652.html 0.6 2026-06-21T03:04:43+08:00 daily https://www.pharmasources.com/industryinsights/combined-digital-screening-best-for-dete-303653.html 0.6 2026-08-07T02:03:28+08:00 daily https://www.pharmasources.com/industryinsights/certara-modeling-aided-95-drug-approvals-303654.html 0.6 2026-06-20T14:57:10+08:00 daily https://www.pharmasources.com/industryinsights/thirteen-confirmed-ebola-cases-in-latest-303655.html 0.6 2026-06-20T18:54:35+08:00 daily https://www.pharmasources.com/industryinsights/one-more-dose-sanofi-pushes-importance-o-303656.html 0.6 2026-06-21T13:04:38+08:00 daily https://www.pharmasources.com/industryinsights/merck-hitgen-expand-dna-library-screenin-303657.html 0.6 2026-06-21T02:04:07+08:00 daily https://www.pharmasources.com/industryinsights/signs-your-child-might-have-hearing-loss-303658.html 0.6 2026-06-16T09:25:08+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-contracts-with-antares-to-build-a-303659.html 0.6 2026-06-20T15:56:29+08:00 daily https://www.pharmasources.com/industryinsights/evidation-raises-30m-alongside-launch-of-303660.html 0.6 2026-06-21T03:59:42+08:00 daily https://www.pharmasources.com/industryinsights/mercks-ebola-vaccine-to-be-used-in-lates-303661.html 0.6 2026-06-21T04:06:54+08:00 daily https://www.pharmasources.com/industryinsights/bionano-files-30m-ipo-to-fund-its-long-b-303662.html 0.6 2026-06-21T04:15:04+08:00 daily https://www.pharmasources.com/industryinsights/many-youths-believe-gun-control-would-de-303663.html 0.6 2026-06-19T19:00:39+08:00 daily https://www.pharmasources.com/industryinsights/moms-who-smoked-as-teens-more-likely-to--303664.html 0.6 2026-08-07T14:53:24+08:00 daily https://www.pharmasources.com/industryinsights/access-to-diabetes-drugs-improved-under--303665.html 0.6 2026-02-28T14:01:43+08:00 daily https://www.pharmasources.com/industryinsights/pliant-receives-fda-orphan-drug-designat-303666.html 0.6 2026-08-06T02:44:05+08:00 daily https://www.pharmasources.com/industryinsights/barriers-to-doctor-nurse-communications--303667.html 0.6 2026-06-21T04:52:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-about-increased-risk-of-cancer-303668.html 0.6 2026-06-20T17:08:21+08:00 daily https://www.pharmasources.com/industryinsights/croda-invests-in-sisafs-novel-bio-courie-303669.html 0.6 2026-06-22T07:47:34+08:00 daily https://www.pharmasources.com/industryinsights/allergan-divests-five-dermatology-medici-303670.html 0.6 2026-06-21T15:13:36+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-updated-indication-vial-p-303671.html 0.6 2026-06-20T19:57:41+08:00 daily https://www.pharmasources.com/industryinsights/pharma-reps-get-more-respect-from-doctor-303672.html 0.6 2026-08-08T19:46:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-encourages-development-of-treatments-303673.html 0.6 2026-08-03T03:59:59+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-merck-obtain-ema-orphan--303674.html 0.6 2026-07-20T22:57:13+08:00 daily https://www.pharmasources.com/industryinsights/studies-find-shorter-tuberculosis-therap-303675.html 0.6 2026-06-21T14:50:19+08:00 daily https://www.pharmasources.com/industryinsights/bayer-cares-foundation-promotes-sustaina-303676.html 0.6 2026-06-20T17:49:05+08:00 daily https://www.pharmasources.com/industryinsights/un-agency-calls-for-development-of-afric-303677.html 0.6 2026-08-07T22:23:33+08:00 daily https://www.pharmasources.com/industryinsights/impurity-in-valsartan-leads-to-voluntary-303678.html 0.6 2026-06-22T12:22:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-stockpile-medicines-in-prepera-303679.html 0.6 2026-06-21T15:17:14+08:00 daily https://www.pharmasources.com/industryinsights/senescent-cells-targeted-with-new-nanoca-303680.html 0.6 2026-08-08T02:47:33+08:00 daily https://www.pharmasources.com/industryinsights/epigenetic-qpcr-tool-detects-disease-in--303681.html 0.6 2026-06-20T22:49:40+08:00 daily https://www.pharmasources.com/industryinsights/irish-trade-lobby-warns-eu-amendments-co-303682.html 0.6 2026-03-17T19:31:27+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-join-astrazeneca-and-msd-in-stock-303683.html 0.6 2026-06-21T17:56:50+08:00 daily https://www.pharmasources.com/industryinsights/tan-tock-seng-hospital-zuellig-pharma-un-303684.html 0.6 2026-07-06T08:43:49+08:00 daily https://www.pharmasources.com/industryinsights/ema-issues-positive-opinion-to-janssens--303685.html 0.6 2026-06-21T10:46:07+08:00 daily https://www.pharmasources.com/industryinsights/a-new-era-for-migraine-patients-303686.html 0.6 2026-08-06T17:46:22+08:00 daily https://www.pharmasources.com/industryinsights/spark-slides-on-hemophilia-a-data-aims-f-303687.html 0.6 2026-06-20T19:15:51+08:00 daily https://www.pharmasources.com/industryinsights/government-looks-to-include-biosimilars--303688.html 0.6 2026-06-20T18:44:19+08:00 daily https://www.pharmasources.com/industryinsights/gsk-appoints-hsbcs-iain-mackay-as-cfo-303689.html 0.6 2026-06-21T06:57:59+08:00 daily https://www.pharmasources.com/industryinsights/uk-commits-to-adopt-eu-trial-regulation--303690.html 0.6 2026-08-08T12:53:32+08:00 daily https://www.pharmasources.com/industryinsights/mayo-clinic-pinpoints-genes-that-raise-t-303691.html 0.6 2026-06-19T18:58:32+08:00 daily https://www.pharmasources.com/industryinsights/akouos-raises-50m-to-take-hearing-loss-g-303692.html 0.6 2026-06-21T05:59:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-notes-paratek-antibiotics-noninferio-303693.html 0.6 2026-07-19T17:38:59+08:00 daily https://www.pharmasources.com/industryinsights/syneos-health-to-make-secondary-stock-of-303694.html 0.6 2026-03-26T12:35:00+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-signs-licence-deal-with-harbour-303695.html 0.6 2026-07-30T14:22:27+08:00 daily https://www.pharmasources.com/industryinsights/school-prep-includes-planning-allergy-as-303696.html 0.6 2026-06-21T08:10:07+08:00 daily https://www.pharmasources.com/industryinsights/could-a-dose-of-blockchain-prevent-china-303697.html 0.6 2026-08-07T15:26:47+08:00 daily https://www.pharmasources.com/industryinsights/new-tick-species-spreading-in-the-united-303698.html 0.6 2026-06-21T01:00:42+08:00 daily https://www.pharmasources.com/industryinsights/overtreatment-of-thyroid-cancers-seems-c-303699.html 0.6 2026-06-21T04:59:51+08:00 daily https://www.pharmasources.com/industryinsights/tainted-valsartan-has-been-on-the-market-303700.html 0.6 2026-06-25T21:33:46+08:00 daily https://www.pharmasources.com/industryinsights/hiv-syphilis-screening-low-with-ed-diagn-303701.html 0.6 2026-07-19T23:43:44+08:00 daily https://www.pharmasources.com/industryinsights/express-scripts-bars-48-drugs-for-2019-h-303703.html 0.6 2026-07-02T22:15:52+08:00 daily https://www.pharmasources.com/industryinsights/with-patisiran-launch-in-its-sights-alny-303704.html 0.6 2026-06-21T01:09:51+08:00 daily https://www.pharmasources.com/industryinsights/pharma-reps-get-more-respect-from-doctor-303705.html 0.6 2026-06-21T06:57:52+08:00 daily https://www.pharmasources.com/industryinsights/look-whos-talking-fda-chief-scott-gottli-303706.html 0.6 2026-06-21T12:02:11+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-blockbuster-hopeful-orilissa-sho-303707.html 0.6 2026-01-13T15:28:34+08:00 daily https://www.pharmasources.com/industryinsights/ama-proposes-policy-opposing-medicaid-lo-303708.html 0.6 2026-04-12T06:52:30+08:00 daily https://www.pharmasources.com/industryinsights/pcp-statin-prescribing-up-with-automated-303709.html 0.6 2026-06-19T16:03:14+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-chief-recruits-new-cfo-i-303710.html 0.6 2026-07-24T21:52:12+08:00 daily https://www.pharmasources.com/industryinsights/have-glaucoma-and-need-to-switch-eye-doc-303711.html 0.6 2026-06-21T02:46:35+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-dumps-astrazeneca-gout-drug-zur-303712.html 0.6 2026-06-21T13:11:36+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-roche-and-pfizer-the-worst-patent-303713.html 0.6 2026-08-03T23:53:38+08:00 daily https://www.pharmasources.com/industryinsights/study-urges-genetic-testing-of-relatives-303714.html 0.6 2026-06-08T07:16:06+08:00 daily https://www.pharmasources.com/industryinsights/curegenetics-secures-17-m-in-series-a-fi-303715.html 0.6 2026-04-02T03:04:31+08:00 daily https://www.pharmasources.com/industryinsights/health-woes-hit-1-in-7-babies-exposed-to-303716.html 0.6 2026-06-21T04:54:46+08:00 daily https://www.pharmasources.com/industryinsights/rsp-systems-is-awarded-the-iso-134852016-303717.html 0.6 2026-06-21T12:11:17+08:00 daily https://www.pharmasources.com/industryinsights/italys-senate-ends-parental-obligation-t-303718.html 0.6 2026-06-20T14:29:31+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-the-uk-cystic-fibro-303719.html 0.6 2026-06-20T22:55:46+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-partners-harbour-biomed-to-deve-303720.html 0.6 2026-07-30T14:22:27+08:00 daily https://www.pharmasources.com/industryinsights/varian-acquires-humediq-global-gmbh-303721.html 0.6 2026-07-26T14:52:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-support-development-of-nicotine-r-303722.html 0.6 2026-06-29T23:03:40+08:00 daily https://www.pharmasources.com/industryinsights/allergan-editas-medicine-to-jointly-deve-303723.html 0.6 2026-06-20T14:50:03+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-forms-new-alliance-to-develop-303724.html 0.6 2026-06-21T11:15:19+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-returns-us-zurampic-rights-to-a-303725.html 0.6 2026-06-20T13:17:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-new-guidelines-for-opioid-use-303726.html 0.6 2026-06-20T20:04:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-policy-shift-to-encourage--303727.html 0.6 2026-06-22T06:24:57+08:00 daily https://www.pharmasources.com/industryinsights/pain-therapeutics-refocuses-on-alzheimer-303728.html 0.6 2026-08-05T18:23:04+08:00 daily https://www.pharmasources.com/industryinsights/mhra-sets-out-brexit-implementation-peri-303729.html 0.6 2026-08-07T22:05:10+08:00 daily https://www.pharmasources.com/industryinsights/fmi-test-helps-predict-response-to-roche-303730.html 0.6 2026-06-10T18:41:42+08:00 daily https://www.pharmasources.com/industryinsights/mundipharmas-painfocus-set-to-transform--303731.html 0.6 2026-06-20T18:59:33+08:00 daily https://www.pharmasources.com/industryinsights/dotbio-successfully-raises-23-m-in-seed--303732.html 0.6 2026-06-20T14:31:51+08:00 daily https://www.pharmasources.com/industryinsights/iglucose-validic-unite-to-simplify-diabe-303733.html 0.6 2026-06-21T04:17:17+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-device-receives-fda-approv-303734.html 0.6 2026-06-21T09:04:07+08:00 daily https://www.pharmasources.com/industryinsights/extended-distribution-agreement-enables--303735.html 0.6 2026-06-22T08:01:48+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-pharma-and-bluebird-bio-announ-303736.html 0.6 2026-06-21T14:45:16+08:00 daily https://www.pharmasources.com/industryinsights/a-carcinogen-lurking-around-is-the-thing-303737.html 0.6 2026-08-06T19:42:51+08:00 daily https://www.pharmasources.com/industryinsights/confirmed-reishi-has-anticancer-actions-303738.html 0.6 2026-06-21T11:20:26+08:00 daily https://www.pharmasources.com/industryinsights/china-pharmaceutical-industry-rankings-r-303739.html 0.6 2026-07-21T13:00:12+08:00 daily https://www.pharmasources.com/industryinsights/takeda-partners-with-new-biotech-ambys-i-303740.html 0.6 2026-07-27T08:04:29+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-settles-us-seroquelcrestor-l-303741.html 0.6 2026-06-20T23:06:47+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-sees-revenues-drop-in-q2-303742.html 0.6 2026-06-23T01:13:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-poteligeo-mogamulizumab-kpk-303743.html 0.6 2026-06-21T05:11:54+08:00 daily https://www.pharmasources.com/industryinsights/boxers-vs-briefs-and-your-chances-of-bec-303744.html 0.6 2026-06-19T18:08:29+08:00 daily https://www.pharmasources.com/industryinsights/how-virus-clusters-cause-norovirus-and-o-303745.html 0.6 2025-12-05T22:16:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-poteligeo-for-rare-types-of-303746.html 0.6 2026-07-03T08:36:14+08:00 daily https://www.pharmasources.com/industryinsights/regenxbios-wet-amd-gene-therapy-shows-pr-303747.html 0.6 2026-08-07T20:22:56+08:00 daily https://www.pharmasources.com/industryinsights/measles-case-reported-in-minnesota-303748.html 0.6 2026-07-09T13:50:22+08:00 daily https://www.pharmasources.com/industryinsights/quick-fire-fundraisings-give-apexigen-73-303749.html 0.6 2026-06-21T12:03:11+08:00 daily https://www.pharmasources.com/industryinsights/sqz-raises-72m-as-cell-therapies-close-i-303750.html 0.6 2026-06-22T01:55:33+08:00 daily https://www.pharmasources.com/industryinsights/liver-focused-ambys-launches-with-140m-t-303751.html 0.6 2026-06-22T16:19:16+08:00 daily https://www.pharmasources.com/industryinsights/most-antipsychotics-prescribed-in-nursin-303752.html 0.6 2026-06-21T01:02:46+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-q2-revenues-up-25-buoyed-b-303753.html 0.6 2026-07-08T19:26:17+08:00 daily https://www.pharmasources.com/industryinsights/agilents-keytruda-pd-l1-assay-expanded-i-303754.html 0.6 2026-06-21T06:46:50+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-acquires-remainder-of--303755.html 0.6 2026-06-22T00:40:18+08:00 daily https://www.pharmasources.com/industryinsights/credence-medsystems-draws-128m-to-fund-s-303756.html 0.6 2026-06-19T17:18:47+08:00 daily https://www.pharmasources.com/industryinsights/cyber-insurance-recommended-for-all-phys-303757.html 0.6 2026-06-21T03:09:55+08:00 daily https://www.pharmasources.com/industryinsights/ai-data-miner-sensyne-health-looks-to-go-303758.html 0.6 2026-07-20T01:21:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-finds-spiders-and-insects-around-pac-303759.html 0.6 2026-06-30T06:22:33+08:00 daily https://www.pharmasources.com/industryinsights/inducing-labor-at-term-appears-to-reduce-303760.html 0.6 2026-06-20T10:11:48+08:00 daily https://www.pharmasources.com/industryinsights/samsung-commits-billions-of-dollars-to-b-303761.html 0.6 2026-06-21T23:01:44+08:00 daily https://www.pharmasources.com/industryinsights/teva-confident-in-september-approval-for-303762.html 0.6 2026-06-20T05:56:16+08:00 daily https://www.pharmasources.com/industryinsights/elective-labor-induction-may-cut-c-secti-303763.html 0.6 2026-06-21T14:52:18+08:00 daily https://www.pharmasources.com/industryinsights/texas-spanks-astrazeneca-as-a-repeat-off-303764.html 0.6 2026-07-01T10:07:06+08:00 daily https://www.pharmasources.com/industryinsights/severe-diarrhea-can-send-ibs-patients-ov-303765.html 0.6 2026-08-07T01:42:55+08:00 daily https://www.pharmasources.com/industryinsights/cimzia-maker-ucb-signs-myhealthteams-to--303766.html 0.6 2026-08-07T01:45:44+08:00 daily https://www.pharmasources.com/industryinsights/far-fetched-fictional-pharma-study-ancho-303767.html 0.6 2026-08-07T01:32:18+08:00 daily https://www.pharmasources.com/industryinsights/new-treatment-for-non-hodgkin-lymphoma-a-303768.html 0.6 2026-08-07T01:21:56+08:00 daily https://www.pharmasources.com/industryinsights/novo-ceo-expect-us-diabetes-drug-prices--303769.html 0.6 2026-08-07T01:27:51+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-ceo-alex-gorsky-dines-wi-303770.html 0.6 2026-08-07T01:13:59+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-pay-110m-to-settle-allega-303771.html 0.6 2026-08-07T00:52:48+08:00 daily https://www.pharmasources.com/industryinsights/insys-to-cough-up-150m-to-settle-justice-303772.html 0.6 2026-08-07T00:41:38+08:00 daily https://www.pharmasources.com/industryinsights/stem-cells-could-reset-immune-system-in--303773.html 0.6 2026-08-07T01:10:51+08:00 daily https://www.pharmasources.com/industryinsights/msds-experimental-vaccine-to-be-used-in--303774.html 0.6 2026-06-20T14:53:06+08:00 daily https://www.pharmasources.com/industryinsights/mylan-releases-statement-on-future-of-us-303775.html 0.6 2026-08-09T22:52:43+08:00 daily https://www.pharmasources.com/industryinsights/strong-efficacy-but-serious-side-effects-303776.html 0.6 2026-06-21T14:55:22+08:00 daily https://www.pharmasources.com/industryinsights/drugs-should-be-preferred-first-choice-t-303777.html 0.6 2026-06-28T08:15:59+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-returns-us-zurampic-rights-to-a-303778.html 0.6 2026-07-04T09:47:33+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-methylphenidate-is-most-effe-303779.html 0.6 2026-06-21T11:14:41+08:00 daily https://www.pharmasources.com/industryinsights/parp-inhibitors-show-promise-for-treatin-303780.html 0.6 2026-07-02T20:41:22+08:00 daily https://www.pharmasources.com/industryinsights/ampio-pharma-craters-on-fda-setback-but--303781.html 0.6 2026-06-28T01:30:41+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-builds-in-gene-therapy-with-30m--303782.html 0.6 2026-03-01T01:36:07+08:00 daily https://www.pharmasources.com/industryinsights/novo-powers-rare-disease-startup-therach-303783.html 0.6 2026-06-20T16:05:24+08:00 daily https://www.pharmasources.com/industryinsights/congressman-charged-in-biotech-insider-t-303784.html 0.6 2026-06-22T12:09:24+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-plans-to-separate-prescription-d-303785.html 0.6 2026-06-20T18:57:37+08:00 daily https://www.pharmasources.com/industryinsights/parateks-omadacycline-sails-through-adco-303786.html 0.6 2026-06-15T04:19:30+08:00 daily https://www.pharmasources.com/industryinsights/millendo-plans-to-go-public-through-ovas-303787.html 0.6 2026-06-21T10:56:17+08:00 daily https://www.pharmasources.com/industryinsights/ligand-to-buy-uk-biotech-vernaliss-for-4-303788.html 0.6 2026-01-17T12:32:10+08:00 daily https://www.pharmasources.com/industryinsights/senseonics-debuts-its-90-day-eversense-c-303789.html 0.6 2026-06-21T19:07:39+08:00 daily https://www.pharmasources.com/industryinsights/nice-changes-its-mind-on-pfizers-bespons-303790.html 0.6 2026-06-21T13:11:01+08:00 daily https://www.pharmasources.com/industryinsights/akili-raises-extra-13m-ahead-of-fda-deci-303791.html 0.6 2026-08-05T12:24:15+08:00 daily https://www.pharmasources.com/industryinsights/nuvasive-siemens-healthineers-pair-up-on-303792.html 0.6 2026-06-19T15:48:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-arakoda-tafenoquine-for-the-303793.html 0.6 2026-08-07T01:58:01+08:00 daily https://www.pharmasources.com/industryinsights/ligand-makes-offer-to-acquire-vernalis-303794.html 0.6 2026-06-21T04:30:35+08:00 daily https://www.pharmasources.com/industryinsights/aha-a-diverse-diet-may-not-promote-a-hea-303795.html 0.6 2026-06-21T12:11:17+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-expands-otc-growth-strategy-with-303796.html 0.6 2026-06-21T13:00:37+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-announces-positive-preliminary-d-303797.html 0.6 2026-06-21T22:59:47+08:00 daily https://www.pharmasources.com/industryinsights/feeling-young-may-be-reflected-in-brain--303798.html 0.6 2026-06-21T12:03:10+08:00 daily https://www.pharmasources.com/industryinsights/australia-gives-its-nod-to-trastuzumab-b-303799.html 0.6 2026-06-20T22:15:52+08:00 daily https://www.pharmasources.com/industryinsights/biopharmx-announces-patent-award-303800.html 0.6 2026-06-20T23:13:05+08:00 daily https://www.pharmasources.com/industryinsights/parental-belief-in-religion-lowers-child-303801.html 0.6 2026-06-22T04:53:42+08:00 daily https://www.pharmasources.com/industryinsights/milestone-pharmaceuticals-announces-firs-303802.html 0.6 2026-02-14T19:50:28+08:00 daily https://www.pharmasources.com/industryinsights/scientists-use-nanoparticles-to-detect-d-303803.html 0.6 2026-06-21T03:12:53+08:00 daily https://www.pharmasources.com/industryinsights/mylan-says-plant-remediation-dictated-in-303804.html 0.6 2026-04-04T14:11:42+08:00 daily https://www.pharmasources.com/industryinsights/ama-adopts-policy-to-advance-gender-equi-303805.html 0.6 2026-07-06T20:34:49+08:00 daily https://www.pharmasources.com/industryinsights/pharma-watchers-on-twitter-chat-up-johns-303806.html 0.6 2026-06-22T11:08:54+08:00 daily https://www.pharmasources.com/industryinsights/can-a-strategic-review-solve-mylans-prob-303807.html 0.6 2026-06-21T02:51:58+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-works-towards-better-healthcare-303808.html 0.6 2026-07-06T07:43:36+08:00 daily https://www.pharmasources.com/industryinsights/vaccinations-begin-in-congo-ebola-outbre-303809.html 0.6 2026-06-20T14:58:05+08:00 daily https://www.pharmasources.com/industryinsights/china-targets-cosentyx-shingrix-and-luxt-303810.html 0.6 2026-08-03T17:47:11+08:00 daily https://www.pharmasources.com/industryinsights/doctors-write-fewer-opioid-scripts-after-303811.html 0.6 2026-06-21T06:03:49+08:00 daily https://www.pharmasources.com/industryinsights/who-hcv-guidelines-recommends-ascletis-r-303812.html 0.6 2026-06-21T11:09:13+08:00 daily https://www.pharmasources.com/industryinsights/citing-appeals-court-anarchy-amgen-asks--303813.html 0.6 2026-06-21T00:42:35+08:00 daily https://www.pharmasources.com/industryinsights/childhood-brain-tumor-treatment-may-hamp-303814.html 0.6 2026-06-21T22:58:40+08:00 daily https://www.pharmasources.com/industryinsights/eisai-inks-deal-with-taiwan-chinas-cy-bi-303815.html 0.6 2026-06-20T19:07:40+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-morphosys-declares-china-303816.html 0.6 2026-08-02T10:32:00+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-innovative-drug-ibrance-gets-chi-303817.html 0.6 2026-06-21T16:50:24+08:00 daily https://www.pharmasources.com/industryinsights/new-dads-can-get-the-baby-blues-too-303818.html 0.6 2026-05-01T22:06:12+08:00 daily https://www.pharmasources.com/industryinsights/number-of-opioid-addicted-women-giving-b-303819.html 0.6 2026-02-28T16:09:20+08:00 daily https://www.pharmasources.com/industryinsights/us-congressman-arrested-over-insider-tra-303820.html 0.6 2026-07-08T10:28:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-list-of-valsartan-recalls-303821.html 0.6 2026-08-06T00:27:25+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-eli-lillys-psoriatic-art-303822.html 0.6 2026-08-08T02:33:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-pfizers-besponsa-in-rare-303823.html 0.6 2025-12-01T18:46:55+08:00 daily https://www.pharmasources.com/industryinsights/insys-therapeutics-reaches-150m-agreemen-303824.html 0.6 2026-06-22T02:49:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vertexs-cystic-fibrosis-the-303825.html 0.6 2025-12-01T18:49:12+08:00 daily https://www.pharmasources.com/industryinsights/array-biopharmas-mcrc-therapy-gets-break-303826.html 0.6 2026-06-20T18:51:35+08:00 daily https://www.pharmasources.com/industryinsights/gemphire-pulls-the-plug-on-gemcabene-fat-303827.html 0.6 2026-02-28T20:44:17+08:00 daily https://www.pharmasources.com/industryinsights/astellas-absorbs-uk-ocular-gene-therapy--303828.html 0.6 2026-08-07T23:05:01+08:00 daily https://www.pharmasources.com/industryinsights/could-a-glaucoma-drug-also-fight-obesity-303829.html 0.6 2026-06-21T12:23:08+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-inks-pact-with-true-north-for-p-303830.html 0.6 2026-08-06T17:07:07+08:00 daily https://www.pharmasources.com/industryinsights/artios-bags-84m-to-trial-next-generation-303831.html 0.6 2026-06-21T10:57:07+08:00 daily https://www.pharmasources.com/industryinsights/pharma-lacks-engagement-with-mental-heal-303832.html 0.6 2026-04-01T05:13:12+08:00 daily https://www.pharmasources.com/industryinsights/vernalis-weakened-by-fda-rejections-acce-303833.html 0.6 2026-06-20T03:12:11+08:00 daily https://www.pharmasources.com/industryinsights/vicinium-granted-fast-track-designation--303834.html 0.6 2026-06-20T20:08:40+08:00 daily https://www.pharmasources.com/industryinsights/artios-pharma-raises-65m-to-develop-ddr--303835.html 0.6 2026-06-22T06:04:10+08:00 daily https://www.pharmasources.com/industryinsights/merck-profits-decline-but-new-drugs-main-303836.html 0.6 2026-06-21T10:11:16+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-to-separate-prescription-pharmac-303837.html 0.6 2026-06-20T14:57:08+08:00 daily https://www.pharmasources.com/industryinsights/synergy-pharmaceuticals-inks-deal-with-l-303838.html 0.6 2026-06-20T17:56:29+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-begins-bevacizumab-biosimilar--303839.html 0.6 2026-06-20T22:59:36+08:00 daily https://www.pharmasources.com/industryinsights/eye-disease-link-to-alzheimers-seen-303840.html 0.6 2026-06-21T06:08:00+08:00 daily https://www.pharmasources.com/industryinsights/gsk-ships-seasonal-influenza-vaccines-fo-303841.html 0.6 2026-07-04T18:37:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-galafold-migalastat-for-the-303842.html 0.6 2026-06-23T01:51:11+08:00 daily https://www.pharmasources.com/industryinsights/astellas-acquires-quethera-for-up-to-85m-303843.html 0.6 2026-06-21T06:20:21+08:00 daily https://www.pharmasources.com/industryinsights/ai-based-ct-imaging-company-maxq-formerl-303844.html 0.6 2026-06-21T10:57:08+08:00 daily https://www.pharmasources.com/industryinsights/bundling-doesnt-cut-medicare-payments-fo-303845.html 0.6 2026-06-21T06:04:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-found-big-problems-a-year-ago-at-chi-303846.html 0.6 2026-06-21T08:08:07+08:00 daily https://www.pharmasources.com/industryinsights/cdc-rates-of-opioid-use-disorder-seen-at-303847.html 0.6 2026-06-21T11:56:07+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-aims-top-seller-xifaxan-at-303848.html 0.6 2026-06-21T00:04:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-of-its-kind-targeted--303849.html 0.6 2026-06-21T01:16:15+08:00 daily https://www.pharmasources.com/industryinsights/dermatologist-intervention-tied-to-bette-303850.html 0.6 2026-06-21T12:47:49+08:00 daily https://www.pharmasources.com/industryinsights/star-combo-pharma-acquires-ausway-group--303851.html 0.6 2026-06-21T21:02:40+08:00 daily https://www.pharmasources.com/industryinsights/court-rules-that-us-must-halt-sales-of-p-303852.html 0.6 2026-08-09T00:00:38+08:00 daily https://www.pharmasources.com/industryinsights/new-research-suggests-glaucoma-may-be-an-303853.html 0.6 2026-06-21T02:55:37+08:00 daily https://www.pharmasources.com/industryinsights/dining-out-with-smartphones-isnt-appetiz-303854.html 0.6 2026-06-21T03:42:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-jornay-pm-methylphenidate-e-303855.html 0.6 2026-07-22T19:52:32+08:00 daily https://www.pharmasources.com/industryinsights/states-say-alvogen-lawsuit-is-part-of-a--303856.html 0.6 2026-06-21T05:02:42+08:00 daily https://www.pharmasources.com/industryinsights/oncocyte-appoints-albert-p-parker-as-coo-303857.html 0.6 2026-06-21T01:55:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-drug-under-ne-303858.html 0.6 2026-08-05T07:10:49+08:00 daily https://www.pharmasources.com/industryinsights/amid-pricing-spat-with-uk-government-ver-303859.html 0.6 2026-06-22T09:11:53+08:00 daily https://www.pharmasources.com/industryinsights/express-scripts-new-formulary-ejects-som-303860.html 0.6 2026-08-08T01:04:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-besponsa-lillys-taltz-rack-up-re-303861.html 0.6 2026-06-20T19:12:02+08:00 daily https://www.pharmasources.com/industryinsights/takeda-unite-ambys-to-treat-serious-live-303862.html 0.6 2026-06-21T11:01:09+08:00 daily https://www.pharmasources.com/industryinsights/step-therapy-changes-at-medicare-part-b--303863.html 0.6 2026-06-21T22:57:47+08:00 daily https://www.pharmasources.com/industryinsights/cancer-cells-release-biological-drones-t-303864.html 0.6 2026-07-06T22:57:23+08:00 daily https://www.pharmasources.com/industryinsights/uc-berkeley-backs-oral-gene-therapy-comp-303865.html 0.6 2026-06-29T23:21:53+08:00 daily https://www.pharmasources.com/industryinsights/ambys-medicines-and-takeda-to-develop-ne-303866.html 0.6 2026-04-20T02:34:43+08:00 daily https://www.pharmasources.com/industryinsights/jhl-biotech-gets-positive-chmp-scientifi-303867.html 0.6 2026-07-16T20:45:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kyowa-kirins-poteligeo-to-t-303868.html 0.6 2026-08-07T23:43:11+08:00 daily https://www.pharmasources.com/industryinsights/yun-yen-md-phd-and-winson-sze-chun-ho-md-303869.html 0.6 2026-06-21T03:54:51+08:00 daily https://www.pharmasources.com/industryinsights/nhs-scraps-restriction-on-availability-o-303870.html 0.6 2026-06-29T01:11:22+08:00 daily https://www.pharmasources.com/industryinsights/letters-to-doctors-reduce-opioid-prescri-303871.html 0.6 2026-06-21T04:58:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approved-more-generics-in-july-than--303872.html 0.6 2026-06-20T20:18:30+08:00 daily https://www.pharmasources.com/industryinsights/abpi-chief-warns-of-brexit-impact-on-eu-303873.html 0.6 2026-06-20T20:59:48+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-surprised-investors-with-its-hepa-303874.html 0.6 2026-06-21T05:01:43+08:00 daily https://www.pharmasources.com/industryinsights/predicting-the-risk-of-heart-disease-dia-303876.html 0.6 2026-06-22T03:14:59+08:00 daily https://www.pharmasources.com/industryinsights/izana-starts-proof-of-concept-trial-for--303877.html 0.6 2026-06-21T00:15:49+08:00 daily https://www.pharmasources.com/industryinsights/fresh-from-gsk-deal-orchard-raises-150m--303878.html 0.6 2026-06-20T22:56:00+08:00 daily https://www.pharmasources.com/industryinsights/mustang-bio-picks-up-st-judes-bubble-boy-303879.html 0.6 2026-06-26T18:09:43+08:00 daily https://www.pharmasources.com/industryinsights/md-anderson-accelerator-bake-up-magnolia-303880.html 0.6 2026-06-20T16:59:12+08:00 daily https://www.pharmasources.com/industryinsights/modulus-discovery-rakes-in-72m-in-series-303881.html 0.6 2026-06-21T16:01:24+08:00 daily https://www.pharmasources.com/industryinsights/bowel-cancer-screening-to-start-10-years-303882.html 0.6 2026-06-22T11:02:51+08:00 daily https://www.pharmasources.com/industryinsights/eiger-biopharmaceuticals-completes-enrol-303883.html 0.6 2026-08-09T21:57:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-rare-gene-303884.html 0.6 2026-06-24T22:32:54+08:00 daily https://www.pharmasources.com/industryinsights/amicus-galafold-wins-us-approval-303885.html 0.6 2026-06-21T09:05:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-303886.html 0.6 2026-08-07T21:59:20+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-raises-150-m-to-imp-303887.html 0.6 2026-06-21T07:55:04+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-to-initiate-phase-1-clin-303888.html 0.6 2026-06-20T23:55:37+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-diabetes-patient-engagement-pr-303889.html 0.6 2026-06-20T04:15:17+08:00 daily https://www.pharmasources.com/industryinsights/gn-announces-new-premium-plus-addition-t-303890.html 0.6 2026-06-21T07:00:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-amicus-galafold-for-fabry-d-303891.html 0.6 2026-06-21T01:07:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-flexible-reusable-contracep-303892.html 0.6 2026-06-22T09:04:46+08:00 daily https://www.pharmasources.com/industryinsights/adherium-launches-over-the-counter-digit-303893.html 0.6 2026-06-20T14:41:22+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-to-acquire-paxvax--303894.html 0.6 2026-03-13T13:51:53+08:00 daily https://www.pharmasources.com/industryinsights/aging-population-prompts-si-group-to-aga-303895.html 0.6 2026-07-05T10:23:55+08:00 daily https://www.pharmasources.com/industryinsights/roches-xolair-challenged-in-asthma-wins--303896.html 0.6 2026-06-22T12:11:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-stiff-arms-regenerons-bid-for-more-c-303897.html 0.6 2026-07-24T09:08:54+08:00 daily https://www.pharmasources.com/industryinsights/outcomes-image-rehab-rolls-on-with-niels-303898.html 0.6 2026-07-19T20:09:43+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-ai-technique-to-trea-303899.html 0.6 2026-08-05T23:31:15+08:00 daily https://www.pharmasources.com/industryinsights/novo-has-a-big-pricing-decision-to-make--303900.html 0.6 2026-06-20T21:43:20+08:00 daily https://www.pharmasources.com/industryinsights/artios-pharma-announces-84-m-series-b-fi-303901.html 0.6 2026-06-21T18:58:35+08:00 daily https://www.pharmasources.com/industryinsights/neuron-biohub-envisions-setting-global-s-303902.html 0.6 2026-02-28T13:19:50+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-hakko-kirin-announces-results-of-p-303903.html 0.6 2026-06-22T04:01:42+08:00 daily https://www.pharmasources.com/industryinsights/oxford-genetics-signs-major-supply-and-l-303904.html 0.6 2026-06-21T03:06:45+08:00 daily https://www.pharmasources.com/industryinsights/compact-serialization-ready-manual-works-303905.html 0.6 2026-06-21T07:06:01+08:00 daily https://www.pharmasources.com/industryinsights/alnylams-novel-rna-therapy-onpattro-wins-303906.html 0.6 2026-06-21T05:16:55+08:00 daily https://www.pharmasources.com/industryinsights/cdc-more-than-400-sickened-by-mcdonalds--303907.html 0.6 2026-06-24T02:50:27+08:00 daily https://www.pharmasources.com/industryinsights/four-pros-to-integrating-ehr-practice-ma-303908.html 0.6 2026-06-20T16:05:25+08:00 daily https://www.pharmasources.com/industryinsights/aap-provides-safety-precautions-to-preve-303909.html 0.6 2026-07-28T09:49:30+08:00 daily https://www.pharmasources.com/industryinsights/jury-awards-36289-million-in-case-linkin-303910.html 0.6 2026-01-25T10:53:05+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-tdap-vaccination-not-linked-to--303911.html 0.6 2025-11-10T15:24:27+08:00 daily https://www.pharmasources.com/industryinsights/jury-awards-289-million-in-case-linking--303912.html 0.6 2026-06-21T06:09:51+08:00 daily https://www.pharmasources.com/industryinsights/new-guidelines-for-urinary-incontinence--303913.html 0.6 2026-06-20T14:47:58+08:00 daily https://www.pharmasources.com/industryinsights/young-adults-favor-family-over-friends-i-303914.html 0.6 2026-06-21T19:00:37+08:00 daily https://www.pharmasources.com/industryinsights/aha-after-mini-stroke-at-41-shes-on-a-mi-303915.html 0.6 2026-06-22T23:04:04+08:00 daily https://www.pharmasources.com/industryinsights/nice-suspends-review-of-vertexs-symkevi--303916.html 0.6 2026-06-22T23:51:34+08:00 daily https://www.pharmasources.com/industryinsights/aralez-pharmaceuticals-divests-core-busi-303917.html 0.6 2026-08-07T22:57:13+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-plans-separation-of-rx-business-303918.html 0.6 2026-06-18T01:49:49+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-to-acquire-paxvax--303919.html 0.6 2026-06-22T05:59:35+08:00 daily https://www.pharmasources.com/industryinsights/indicted-gop-congressman-chris-collins-t-303920.html 0.6 2026-06-20T19:58:34+08:00 daily https://www.pharmasources.com/industryinsights/astellas-acquires-gene-therapy-group-que-303921.html 0.6 2026-06-21T08:46:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rna-therapy-for-rare-geneti-303922.html 0.6 2026-06-21T10:10:23+08:00 daily https://www.pharmasources.com/industryinsights/chicago-judge-overturns-140-million-abbv-303923.html 0.6 2026-06-22T08:37:38+08:00 daily https://www.pharmasources.com/industryinsights/four-new-medicines-cleared-for-use-on-nh-303924.html 0.6 2026-06-21T00:57:45+08:00 daily https://www.pharmasources.com/industryinsights/xolair-deemed-breakthrough-therapy-for-f-303925.html 0.6 2026-06-22T06:43:41+08:00 daily https://www.pharmasources.com/industryinsights/draft-guidelines-reject-nhs-funding-for--303926.html 0.6 2026-03-19T07:46:35+08:00 daily https://www.pharmasources.com/industryinsights/insilico-juvenescence-and-the-buck-insti-303927.html 0.6 2026-06-20T15:58:21+08:00 daily https://www.pharmasources.com/industryinsights/how-elephants-resist-cancer-by-reviving--303928.html 0.6 2026-06-21T08:10:10+08:00 daily https://www.pharmasources.com/industryinsights/motif-bios-antibiotic-granted-us-priorit-303929.html 0.6 2026-06-22T03:09:46+08:00 daily https://www.pharmasources.com/industryinsights/orchard-raises-150m-to-advance-gene-ther-303930.html 0.6 2026-06-21T09:01:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-biosig-system-for-high-fideli-303931.html 0.6 2026-07-03T15:13:54+08:00 daily https://www.pharmasources.com/industryinsights/batycky-exits-acorda-to-head-up-new-biot-303932.html 0.6 2026-06-20T20:59:37+08:00 daily https://www.pharmasources.com/industryinsights/most-postmenopausal-bleeding-not-associa-303933.html 0.6 2025-10-21T21:35:06+08:00 daily https://www.pharmasources.com/industryinsights/realm-tanks-again-as-second-drug-fails-p-303934.html 0.6 2026-04-21T04:31:55+08:00 daily https://www.pharmasources.com/industryinsights/tbi-linked-to-increased-suicide-risk-303935.html 0.6 2026-04-23T06:11:52+08:00 daily https://www.pharmasources.com/industryinsights/triple-combo-blood-pressure-pill-can-imp-303936.html 0.6 2026-07-20T12:02:38+08:00 daily https://www.pharmasources.com/industryinsights/bioverativ-executive-rogerio-vivaldi-to--303937.html 0.6 2026-08-07T10:34:38+08:00 daily https://www.pharmasources.com/industryinsights/bayer-haplogen-ink-rd-deal-for-pulmonary-303938.html 0.6 2026-03-27T17:14:08+08:00 daily https://www.pharmasources.com/industryinsights/ama-adopts-new-policy-on-housing-for-hom-303939.html 0.6 2026-06-21T04:21:47+08:00 daily https://www.pharmasources.com/industryinsights/fundamentalvr-launches-virtual-surgery-t-303940.html 0.6 2026-06-20T17:18:33+08:00 daily https://www.pharmasources.com/industryinsights/profusa-nets-45m-to-sell-implanted-tissu-303941.html 0.6 2026-08-06T11:08:15+08:00 daily https://www.pharmasources.com/industryinsights/zika-west-nile-cases-reported-in-alabama-303942.html 0.6 2026-06-21T00:16:54+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-seqirus-launch-first-rou-303943.html 0.6 2026-06-25T18:23:06+08:00 daily https://www.pharmasources.com/industryinsights/cellphone-use-puts-pedestrians-off-balan-303944.html 0.6 2026-06-21T09:14:10+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-secures-30m-loan-as-it-e-303945.html 0.6 2026-06-22T06:53:45+08:00 daily https://www.pharmasources.com/industryinsights/mylan-brings-first-generic-for-adcirca-t-303946.html 0.6 2026-06-30T13:37:12+08:00 daily https://www.pharmasources.com/industryinsights/roches-genentech-has-become-serial-tax-a-303947.html 0.6 2026-07-02T21:07:22+08:00 daily https://www.pharmasources.com/industryinsights/dialysis-linked-to-dementia-in-seniors-303948.html 0.6 2026-06-21T12:18:34+08:00 daily https://www.pharmasources.com/industryinsights/reeling-from-cohen-scandal-novartis-recr-303949.html 0.6 2026-06-29T05:20:19+08:00 daily https://www.pharmasources.com/industryinsights/aids-health-group-brings-gilead-patent-s-303950.html 0.6 2026-06-21T00:53:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-joins-doj-probe-into-claims-pharm-303951.html 0.6 2026-06-21T01:52:40+08:00 daily https://www.pharmasources.com/industryinsights/aha-home-delivered-meals-keep-heart-fail-303952.html 0.6 2026-06-18T06:08:34+08:00 daily https://www.pharmasources.com/industryinsights/allergan-taps-pfizer-oncology-veteran-as-303953.html 0.6 2026-06-30T14:21:08+08:00 daily https://www.pharmasources.com/industryinsights/kaneka-officially-starts-continuous-manu-303954.html 0.6 2026-06-21T05:15:59+08:00 daily https://www.pharmasources.com/industryinsights/key-california-lawmaker-calls-eli-lillys-303955.html 0.6 2026-07-03T00:24:21+08:00 daily https://www.pharmasources.com/industryinsights/nice-cost-watchdogs-spurn-biogens-pricey-303956.html 0.6 2026-06-21T09:00:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sodium-nitroprusside-inject-303957.html 0.6 2026-06-21T14:59:31+08:00 daily https://www.pharmasources.com/industryinsights/entasis-announces-positive-topline-resul-303958.html 0.6 2026-06-21T12:16:46+08:00 daily https://www.pharmasources.com/industryinsights/india-loses-its-vaccine-export-sheen-303959.html 0.6 2026-08-06T16:13:56+08:00 daily https://www.pharmasources.com/industryinsights/gene-test-predicts-risk-of-5-common-dise-303960.html 0.6 2026-08-07T19:29:11+08:00 daily https://www.pharmasources.com/industryinsights/shire-submits-nda-in-japan-for-intuniv-t-303961.html 0.6 2026-06-20T14:49:05+08:00 daily https://www.pharmasources.com/industryinsights/nus-scientists-develop-new-technology-to-303962.html 0.6 2026-06-21T02:57:54+08:00 daily https://www.pharmasources.com/industryinsights/phrma-survey-shows-us-biopharma-exceeded-303963.html 0.6 2026-08-08T14:53:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-direct-to-consumer-co-303964.html 0.6 2026-07-11T04:18:36+08:00 daily https://www.pharmasources.com/industryinsights/ai-technology-to-help-design-personalise-303965.html 0.6 2026-06-20T16:00:25+08:00 daily https://www.pharmasources.com/industryinsights/haisco-to-make-10m-equity-investment-in--303966.html 0.6 2026-06-24T08:49:19+08:00 daily https://www.pharmasources.com/industryinsights/macrogen-receives-cap-accreditation-in-t-303967.html 0.6 2026-06-20T16:03:28+08:00 daily https://www.pharmasources.com/industryinsights/protecting-the-links-between-the-uk-and--303968.html 0.6 2026-06-22T02:44:02+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-announces-russia-compliance-so-303969.html 0.6 2026-06-21T00:15:54+08:00 daily https://www.pharmasources.com/industryinsights/exosome-isolation-manufacturing-and-char-303970.html 0.6 2026-06-20T19:51:39+08:00 daily https://www.pharmasources.com/industryinsights/astellas-pharma-acquires-quethera-for-10-303971.html 0.6 2026-06-21T15:17:48+08:00 daily https://www.pharmasources.com/industryinsights/onpattro-approved-by-fda-as-first-treatm-303972.html 0.6 2026-04-01T06:36:11+08:00 daily https://www.pharmasources.com/industryinsights/andrew-cheng-to-quit-gilead-6-months-aft-303973.html 0.6 2026-08-03T13:45:17+08:00 daily https://www.pharmasources.com/industryinsights/third-rock-names-ex-foundation-executive-303974.html 0.6 2026-06-21T00:59:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-geisinger-open-up-access-to-their--303975.html 0.6 2026-06-22T17:22:38+08:00 daily https://www.pharmasources.com/industryinsights/blueberry-therapeutics-bags-10m-to-push--303976.html 0.6 2026-06-21T09:07:06+08:00 daily https://www.pharmasources.com/industryinsights/activating-dormant-retinal-stem-cells-to-303977.html 0.6 2026-06-22T06:05:47+08:00 daily https://www.pharmasources.com/industryinsights/novocure-speeds-up-trial-of-drug-device--303978.html 0.6 2026-06-21T04:59:42+08:00 daily https://www.pharmasources.com/industryinsights/karuna-names-lilly-veteran-ex-voyager-ce-303979.html 0.6 2026-07-09T07:27:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-alumnus-geno-germano-heads-up-nan-303980.html 0.6 2026-06-21T07:53:56+08:00 daily https://www.pharmasources.com/industryinsights/sygnature-discovery-debuts-expansion-pla-303981.html 0.6 2026-06-22T02:07:40+08:00 daily https://www.pharmasources.com/industryinsights/cro-antibody-analytics-partners-with-onl-303982.html 0.6 2026-06-22T03:59:39+08:00 daily https://www.pharmasources.com/industryinsights/mayo-clinic-omnitier-speed-up-de-novo-ge-303983.html 0.6 2026-06-23T09:29:37+08:00 daily https://www.pharmasources.com/industryinsights/thyroid-drugs-made-with-ingredient-from--303984.html 0.6 2026-07-02T21:28:06+08:00 daily https://www.pharmasources.com/industryinsights/as-epipens-run-short-kalo-boasts-it-has--303985.html 0.6 2026-06-23T07:25:41+08:00 daily https://www.pharmasources.com/industryinsights/depomed-joins-ranks-of-scandal-plagued-p-303986.html 0.6 2026-07-03T14:36:38+08:00 daily https://www.pharmasources.com/industryinsights/ask-your-doctor-pitches-from-digital-ads-303987.html 0.6 2026-06-22T11:57:59+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-expands-heart-implant--303988.html 0.6 2026-06-21T01:11:01+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-receives-usan-approval-for-onv-303989.html 0.6 2026-06-20T23:08:48+08:00 daily https://www.pharmasources.com/industryinsights/aerie-reports-topline-result-from-rhopre-303990.html 0.6 2026-06-21T08:57:58+08:00 daily https://www.pharmasources.com/industryinsights/ortho-dermatologics-resubmits-nda-for-du-303991.html 0.6 2026-07-04T14:34:51+08:00 daily https://www.pharmasources.com/industryinsights/merck-awarded-australian-crispr-nickase--303992.html 0.6 2026-07-08T14:19:48+08:00 daily https://www.pharmasources.com/industryinsights/roundup-cancer-verdict-sends-bayer-share-303993.html 0.6 2026-06-20T17:59:16+08:00 daily https://www.pharmasources.com/industryinsights/lancet-publishes-phiii-data-on-kyowa-hak-303994.html 0.6 2026-06-20T02:50:52+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-could-detect-kidney-cancer-up-303995.html 0.6 2026-06-20T14:46:13+08:00 daily https://www.pharmasources.com/industryinsights/viiv-janssens-two-drug-hiv-regimen-hits--303996.html 0.6 2026-06-20T15:14:19+08:00 daily https://www.pharmasources.com/industryinsights/all-london-gp-practices-now-using-electr-303997.html 0.6 2026-06-21T15:55:21+08:00 daily https://www.pharmasources.com/industryinsights/emergency-hospital-visits-more-likely-fo-303998.html 0.6 2026-04-10T05:13:57+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-drug-promising-in-phase-3--303999.html 0.6 2026-06-20T11:02:50+08:00 daily https://www.pharmasources.com/industryinsights/reasons-for-undergoing-cosmetic-procedur-304000.html 0.6 2026-06-20T16:03:14+08:00 daily https://www.pharmasources.com/industryinsights/dnr-orders-linked-to-increased-mortality-304001.html 0.6 2026-02-10T09:46:13+08:00 daily https://www.pharmasources.com/industryinsights/health-professionals-have-role-in-warnin-304002.html 0.6 2026-06-21T17:08:36+08:00 daily https://www.pharmasources.com/industryinsights/talazoparib-beneficial-in-patients-with--304003.html 0.6 2026-06-22T09:12:59+08:00 daily https://www.pharmasources.com/industryinsights/ancient-gene-protects-elephants-from-can-304004.html 0.6 2026-07-17T07:25:15+08:00 daily https://www.pharmasources.com/industryinsights/why-you-should-watch-your-weight-after-y-304005.html 0.6 2026-06-27T06:15:19+08:00 daily https://www.pharmasources.com/industryinsights/one-reason-why-kidney-transplants-fail-304006.html 0.6 2026-06-20T14:50:04+08:00 daily https://www.pharmasources.com/industryinsights/stem-cells-restore-some-vision-in-blind--304007.html 0.6 2026-06-20T14:33:36+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-remifentanil-better-at-relie-304008.html 0.6 2026-06-27T02:05:13+08:00 daily https://www.pharmasources.com/industryinsights/mustang-bio-licenses-gene-therapy-for-bu-304009.html 0.6 2026-06-21T12:22:49+08:00 daily https://www.pharmasources.com/industryinsights/realm-therapeutics-shares-halved-after-f-304010.html 0.6 2026-06-22T00:01:47+08:00 daily https://www.pharmasources.com/industryinsights/janssen-and-viivs-monthly-injectable-hiv-304011.html 0.6 2026-08-09T23:29:59+08:00 daily https://www.pharmasources.com/industryinsights/rotavirus-vaccine-shown-to-reduce-risk-o-304012.html 0.6 2026-06-21T04:08:51+08:00 daily https://www.pharmasources.com/industryinsights/pharma-market-grows-by-127-per-cent-in-j-304013.html 0.6 2026-06-20T23:49:04+08:00 daily https://www.pharmasources.com/industryinsights/benzodiazepines-associated-with-increase-304014.html 0.6 2026-08-07T11:18:08+08:00 daily https://www.pharmasources.com/industryinsights/dr-r-ananthanarayanan-appointed-as-cipla-304015.html 0.6 2026-06-21T04:19:59+08:00 daily https://www.pharmasources.com/industryinsights/indoco-declares-q1fy19-results-304016.html 0.6 2026-06-21T11:19:32+08:00 daily https://www.pharmasources.com/industryinsights/epygen-biotech-first-company-in-india-to-304017.html 0.6 2026-06-21T07:17:10+08:00 daily https://www.pharmasources.com/industryinsights/morepen-labs-begins-fy-2018-19-with-soun-304018.html 0.6 2026-07-03T08:49:42+08:00 daily https://www.pharmasources.com/industryinsights/sda-to-accelerate-the-review-and-approva-304019.html 0.6 2026-08-07T19:48:29+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-announces-innovative-drug-discove-304020.html 0.6 2026-07-04T10:49:20+08:00 daily https://www.pharmasources.com/industryinsights/api-expensive-drugs-to-arrive-304021.html 0.6 2026-07-21T23:47:57+08:00 daily https://www.pharmasources.com/industryinsights/isoniazid-has-remarkable-effects-on-kill-304022.html 0.6 2026-08-03T14:46:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-epipen-autoin-304023.html 0.6 2026-06-20T18:44:28+08:00 daily https://www.pharmasources.com/industryinsights/what-can-a-soybean-worm-teach-us-about-n-304024.html 0.6 2026-07-10T04:52:26+08:00 daily https://www.pharmasources.com/industryinsights/too-scared-to-speak-in-public-biohaven-s-304025.html 0.6 2026-06-20T23:16:51+08:00 daily https://www.pharmasources.com/industryinsights/duke-antidepressant-startup-evecxia-brin-304026.html 0.6 2026-07-05T13:32:15+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-tevas-pain-drug-clears-phase-3-304027.html 0.6 2026-07-03T17:02:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-pays-biontech-120m-upfront-to-for-304028.html 0.6 2026-08-06T20:45:13+08:00 daily https://www.pharmasources.com/industryinsights/antoinette-gawin-to-replace-retiring-ter-304029.html 0.6 2026-06-20T17:43:16+08:00 daily https://www.pharmasources.com/industryinsights/phe-data-shows-link-between-cancer-diagn-304030.html 0.6 2026-07-08T12:23:50+08:00 daily https://www.pharmasources.com/industryinsights/former-china-fda-chief-to-resign-over-th-304031.html 0.6 2026-08-06T03:57:49+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-whacks-165-jobs-as-it-cl-304032.html 0.6 2026-06-22T18:11:02+08:00 daily https://www.pharmasources.com/industryinsights/uk-scientists-discover-potential-new-tre-304033.html 0.6 2026-07-05T03:13:14+08:00 daily https://www.pharmasources.com/industryinsights/apotex-plant-in-india-hit-with-third-war-304034.html 0.6 2026-06-22T05:39:33+08:00 daily https://www.pharmasources.com/industryinsights/ortho-resubmits-duobrii-in-the-us-304035.html 0.6 2026-06-21T00:02:38+08:00 daily https://www.pharmasources.com/industryinsights/louisiana-seeking-comments-on-netflix-mo-304036.html 0.6 2026-06-21T23:54:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-use-of-vertex-kalydeco-in-chi-304037.html 0.6 2026-07-18T12:16:26+08:00 daily https://www.pharmasources.com/industryinsights/analyst-chastises-mylannot-known-for-its-304038.html 0.6 2026-06-20T23:53:31+08:00 daily https://www.pharmasources.com/industryinsights/turnaround-believer-buffetts-big-teva-in-304039.html 0.6 2026-08-06T20:27:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-version-of-ep-304040.html 0.6 2026-07-01T10:28:49+08:00 daily https://www.pharmasources.com/industryinsights/teva-scoffs-at-whistleblowers-evidence-i-304041.html 0.6 2026-06-21T07:21:21+08:00 daily https://www.pharmasources.com/industryinsights/methylphenidate-good-first-choice-pediat-304042.html 0.6 2026-06-20T14:51:58+08:00 daily https://www.pharmasources.com/industryinsights/cdc-brucellosis-in-dogs-remains-a-public-304043.html 0.6 2026-08-08T02:24:37+08:00 daily https://www.pharmasources.com/industryinsights/westminster-pharmaceuticals-issues-recal-304044.html 0.6 2026-06-22T07:01:48+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-reports-positive-results-from-b-304045.html 0.6 2026-06-20T21:04:41+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-australian-crispr-nickase-304046.html 0.6 2026-06-22T00:07:53+08:00 daily https://www.pharmasources.com/industryinsights/practice-names-logos-should-be-carefully-304047.html 0.6 2026-06-30T17:30:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kalydeco-304048.html 0.6 2026-02-15T00:12:49+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-fda-approval-of-ceq-304049.html 0.6 2026-08-10T00:12:35+08:00 daily https://www.pharmasources.com/industryinsights/doctors-remove-contact-lens-embedded-in--304050.html 0.6 2026-06-21T18:58:34+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-teva-announce-positive-fasinum-304051.html 0.6 2026-08-07T02:40:11+08:00 daily https://www.pharmasources.com/industryinsights/new-blood-test-spots-parasitic-infection-304052.html 0.6 2026-08-07T00:52:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-1st-generic-epipen-304053.html 0.6 2026-08-07T00:02:23+08:00 daily https://www.pharmasources.com/industryinsights/sirnaomics-oncology-ind-receives-approva-304054.html 0.6 2026-08-07T00:40:38+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-in-early-pregnancy-may-predic-304055.html 0.6 2026-08-06T23:56:38+08:00 daily https://www.pharmasources.com/industryinsights/middle-east-africa-pharma-economy-to-rea-304056.html 0.6 2026-08-08T01:02:50+08:00 daily https://www.pharmasources.com/industryinsights/aha-are-eggs-good-for-you-or-not-304057.html 0.6 2026-08-07T00:01:43+08:00 daily https://www.pharmasources.com/industryinsights/janssen-and-viiv-report-positive-results-304058.html 0.6 2026-08-08T07:08:26+08:00 daily https://www.pharmasources.com/industryinsights/rxi-and-karolinska-institutet-target-sol-304059.html 0.6 2026-08-07T09:54:05+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-the-nda-for-motif-bios-ic-304060.html 0.6 2026-08-09T04:27:39+08:00 daily https://www.pharmasources.com/industryinsights/nih-funded-study-reverses-congenital-bli-304061.html 0.6 2026-06-29T23:59:55+08:00 daily https://www.pharmasources.com/industryinsights/nice-does-not-recommend-nhs-use-of-bioge-304062.html 0.6 2026-08-09T13:57:47+08:00 daily https://www.pharmasources.com/industryinsights/triple-pill-blood-pressure-combo-proves--304063.html 0.6 2026-06-21T01:47:36+08:00 daily https://www.pharmasources.com/industryinsights/ibalisumab-effective-in-in-treating-mult-304064.html 0.6 2026-03-25T16:26:48+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-reports-q1fy19-results-304065.html 0.6 2026-07-06T23:40:15+08:00 daily https://www.pharmasources.com/industryinsights/kilitch-drugs-india-registers-a-robust-g-304066.html 0.6 2026-06-21T03:48:32+08:00 daily https://www.pharmasources.com/industryinsights/avamed-responds-to-nppas-extension-of-pr-304067.html 0.6 2026-02-28T15:30:13+08:00 daily https://www.pharmasources.com/industryinsights/suven-life-sciences-announces-financial--304068.html 0.6 2026-06-22T03:15:53+08:00 daily https://www.pharmasources.com/industryinsights/dilemma-over-ai-and-drug-patenting-alrea-304069.html 0.6 2026-08-07T21:24:40+08:00 daily https://www.pharmasources.com/industryinsights/tandem-unveils-free-software-update-for--304070.html 0.6 2026-06-21T12:14:25+08:00 daily https://www.pharmasources.com/industryinsights/sirnaomics-cleared-to-start-first-trial--304071.html 0.6 2026-06-21T05:56:38+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-tolero-team-up-to-test-venclexta--304072.html 0.6 2026-06-22T12:45:14+08:00 daily https://www.pharmasources.com/industryinsights/novo-buys-ziylo-for-glucose-responsive-i-304073.html 0.6 2026-07-04T00:04:30+08:00 daily https://www.pharmasources.com/industryinsights/hubert-chen-resigns-as-pfenex-cmo-ahead--304074.html 0.6 2026-06-21T15:51:22+08:00 daily https://www.pharmasources.com/industryinsights/neotherma-picks-up-6m-to-test-adjunct-pa-304075.html 0.6 2026-06-21T14:53:23+08:00 daily https://www.pharmasources.com/industryinsights/teva-wins-fda-nod-for-its-generic-of-myl-304076.html 0.6 2026-06-21T02:02:49+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-opdivo-secures-a-l-304077.html 0.6 2026-07-06T10:11:02+08:00 daily https://www.pharmasources.com/industryinsights/fsd-pharma-scicann-launch-clinical-resea-304078.html 0.6 2026-08-09T20:52:36+08:00 daily https://www.pharmasources.com/industryinsights/eisai-merck-take-on-bayers-nexavar-with--304079.html 0.6 2026-06-12T06:07:51+08:00 daily https://www.pharmasources.com/industryinsights/eisai-merck-announce-fda-approval-of-len-304080.html 0.6 2026-06-22T14:39:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-eylea-injection-sbla-304081.html 0.6 2026-06-20T16:59:18+08:00 daily https://www.pharmasources.com/industryinsights/tolero-pharmaceuticals-abbvie-announces--304082.html 0.6 2026-06-22T16:27:46+08:00 daily https://www.pharmasources.com/industryinsights/regenacy-pharmaceuticals-announces-paten-304083.html 0.6 2026-06-20T16:59:20+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-acquires-ziylo-ltd-to-accel-304084.html 0.6 2026-06-21T08:59:10+08:00 daily https://www.pharmasources.com/industryinsights/new-approach-to-fight-tuberculosis-a-lea-304085.html 0.6 2026-06-22T21:09:06+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-150-milli-304086.html 0.6 2026-06-20T15:50:30+08:00 daily https://www.pharmasources.com/industryinsights/eisai-merck-get-fda-approval-for-lenvima-304087.html 0.6 2026-07-28T19:16:57+08:00 daily https://www.pharmasources.com/industryinsights/trump-urges-justice-department-to-target-304088.html 0.6 2026-06-22T07:17:23+08:00 daily https://www.pharmasources.com/industryinsights/days-after-fda-rejection-regeneron-wins--304089.html 0.6 2026-06-21T05:53:36+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-platform-to-kill-canc-304090.html 0.6 2026-06-20T18:05:27+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-chempartner-closes-deal-with-qu-304091.html 0.6 2026-07-13T11:25:47+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-introduces-inpact-admiral-dcb--304092.html 0.6 2026-03-09T09:19:38+08:00 daily https://www.pharmasources.com/industryinsights/blueberry-therapeutics-raises-10m-fundin-304093.html 0.6 2026-06-21T19:48:34+08:00 daily https://www.pharmasources.com/industryinsights/after-zavante-deal-nabriva-is-poised-to--304094.html 0.6 2026-08-09T14:35:47+08:00 daily https://www.pharmasources.com/industryinsights/revlimid-demonstrates-positive-phase-iii-304095.html 0.6 2026-08-07T00:02:50+08:00 daily https://www.pharmasources.com/industryinsights/bugworks-research-raises-9m-in-series-a--304096.html 0.6 2026-08-06T23:55:09+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018082-304097.html 0.6 2026-08-06T23:47:01+08:00 daily https://www.pharmasources.com/industryinsights/principia-biopharma-lines-up-for-86m-ipo-304098.html 0.6 2026-08-06T23:56:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-first-dual-lead-nerve-stimula-304099.html 0.6 2026-08-07T00:02:34+08:00 daily https://www.pharmasources.com/industryinsights/chinas-harbour-biomed-kelun-ink-a-pd-l1--304100.html 0.6 2026-08-07T00:40:59+08:00 daily https://www.pharmasources.com/industryinsights/after-seeing-poc-data-kyowa-advances-par-304101.html 0.6 2026-08-07T19:31:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-spinout-entasis-files-for-86-304102.html 0.6 2026-08-07T01:11:32+08:00 daily https://www.pharmasources.com/industryinsights/poised-for-phase-3-galeras-gc4419-wards--304103.html 0.6 2026-08-06T01:21:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-first-magnetic-noninvasive-de-304104.html 0.6 2026-06-20T23:15:57+08:00 daily https://www.pharmasources.com/industryinsights/profectus-emergent-biosolutions-nab-cepi-304105.html 0.6 2026-07-03T05:34:26+08:00 daily https://www.pharmasources.com/industryinsights/no-deal-brexit-airlift-sanofi-may-have-t-304106.html 0.6 2026-06-20T03:59:05+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-responds-to-fda-ema-and-canada-af-304107.html 0.6 2026-04-09T23:49:13+08:00 daily https://www.pharmasources.com/industryinsights/novo-data-buttress-its-oral-semaglutide--304108.html 0.6 2026-08-06T18:48:34+08:00 daily https://www.pharmasources.com/industryinsights/jazz-hiring-100-plus-sales-representativ-304109.html 0.6 2026-06-22T12:12:03+08:00 daily https://www.pharmasources.com/industryinsights/roving-poison-ivy-crawling-insects-and-a-304110.html 0.6 2026-07-29T03:35:42+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-reports-robust-2018-inter-304111.html 0.6 2026-06-26T09:26:20+08:00 daily https://www.pharmasources.com/industryinsights/evoke-gathers-all-its-agencies-under-one-304112.html 0.6 2026-06-20T16:54:17+08:00 daily https://www.pharmasources.com/industryinsights/nice-stands-firm-on-no-vote-for-roches-p-304113.html 0.6 2026-07-18T16:51:39+08:00 daily https://www.pharmasources.com/industryinsights/amgens-quick-aimovig-launch-boosts-block-304114.html 0.6 2026-08-04T13:29:28+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-its-new-hq-delayed-and-way-o-304115.html 0.6 2026-06-21T07:15:32+08:00 daily https://www.pharmasources.com/industryinsights/c-cit-sensors-single-use-cell-culture-in-304116.html 0.6 2026-06-21T05:13:55+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb---pfizer-alliance-a-304117.html 0.6 2026-08-09T17:43:40+08:00 daily https://www.pharmasources.com/industryinsights/viromed-secures-dna-production-facility--304118.html 0.6 2026-07-06T23:23:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-label-for-keytruda-304119.html 0.6 2026-06-21T12:18:33+08:00 daily https://www.pharmasources.com/industryinsights/torrent-pharmaceuticals-issues-recall-of-304120.html 0.6 2026-06-20T20:48:07+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-announces-fda-filing-for-stront-304121.html 0.6 2026-03-18T23:41:33+08:00 daily https://www.pharmasources.com/industryinsights/vertexs-orkambi-cf-drug-okayed-for-fundi-304122.html 0.6 2026-06-20T19:00:36+08:00 daily https://www.pharmasources.com/industryinsights/and-platinum-pharmaceuticals-and-columbo-304123.html 0.6 2026-06-22T01:55:31+08:00 daily https://www.pharmasources.com/industryinsights/tolero-pharmaceuticals-collaborates-with-304124.html 0.6 2026-07-04T00:30:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-status-to-aslans--304125.html 0.6 2026-06-21T08:05:00+08:00 daily https://www.pharmasources.com/industryinsights/nus-researchers-uncover-a-bidirectional--304126.html 0.6 2026-06-18T16:29:12+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-collaborates-with-myriad-gen-304127.html 0.6 2026-06-21T01:05:50+08:00 daily https://www.pharmasources.com/industryinsights/adlai-nortye-opens-boston-innovation-cen-304128.html 0.6 2026-06-21T18:11:31+08:00 daily https://www.pharmasources.com/industryinsights/cellect-receives-patent-for-stem-cell-se-304129.html 0.6 2026-06-21T20:56:39+08:00 daily https://www.pharmasources.com/industryinsights/biondvax-relocates-to-new-manufacturing--304130.html 0.6 2026-07-06T23:55:05+08:00 daily https://www.pharmasources.com/industryinsights/telix-nihon-collaborate-on-renal-cancer--304131.html 0.6 2026-06-20T21:11:45+08:00 daily https://www.pharmasources.com/industryinsights/amid-immunocores-c-suite-bloodletting-gl-304132.html 0.6 2026-06-22T18:58:14+08:00 daily https://www.pharmasources.com/industryinsights/novo-makes-another-early-stage-diabetes--304133.html 0.6 2026-02-28T18:45:18+08:00 daily https://www.pharmasources.com/industryinsights/esc-2018-preview-getting-to-the-heart-of-304134.html 0.6 2026-06-21T08:59:56+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-ology-bioservices-wins-84m-dod-awar-304135.html 0.6 2026-06-21T00:00:39+08:00 daily https://www.pharmasources.com/industryinsights/takara-bio-granted-mfg-license-from-swed-304136.html 0.6 2026-07-07T22:51:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-grifols-facility-for-produc-304137.html 0.6 2026-07-02T12:36:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-signs-425m-flu-vaccine-deal-with--304138.html 0.6 2026-08-09T04:32:02+08:00 daily https://www.pharmasources.com/industryinsights/amneal-jsp-enter-supply-agreement-304139.html 0.6 2026-08-08T14:47:18+08:00 daily https://www.pharmasources.com/industryinsights/syneos-health-enhances-end-to-end-capabi-304140.html 0.6 2026-08-08T13:17:53+08:00 daily https://www.pharmasources.com/industryinsights/agenus-receives-second-milestone-from-me-304141.html 0.6 2026-08-07T23:26:55+08:00 daily https://www.pharmasources.com/industryinsights/natera-fox-chase-cancer-center-partner-f-304142.html 0.6 2026-08-07T13:18:44+08:00 daily https://www.pharmasources.com/industryinsights/lakepharma-announces-304143.html 0.6 2026-08-07T00:59:26+08:00 daily https://www.pharmasources.com/industryinsights/kaneka-launches-continuous-mfg-capabilit-304144.html 0.6 2026-08-07T00:39:56+08:00 daily https://www.pharmasources.com/industryinsights/principia-biopharma-lines-up-for-86m-ipo-304145.html 0.6 2026-08-07T00:40:36+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-submits-nda-for-intuniv-304146.html 0.6 2026-07-23T08:04:25+08:00 daily https://www.pharmasources.com/industryinsights/sensei-brings-on-new-cmo-as-it-eyes-phas-304147.html 0.6 2026-07-11T17:45:11+08:00 daily https://www.pharmasources.com/industryinsights/in-defiance-of-trumps-budget-senate-pois-304148.html 0.6 2026-06-20T17:52:46+08:00 daily https://www.pharmasources.com/industryinsights/vectura-to-advance-asthma-inhaler-after--304149.html 0.6 2026-06-21T00:03:36+08:00 daily https://www.pharmasources.com/industryinsights/allegro-ophthalmics-prepping-for-phase-3-304150.html 0.6 2026-06-27T17:49:08+08:00 daily https://www.pharmasources.com/industryinsights/tonix-exhumes-positive-take-on-data-from-304151.html 0.6 2026-07-04T05:02:29+08:00 daily https://www.pharmasources.com/industryinsights/caprion-biosciences-acquires-primity-bio-304152.html 0.6 2026-08-07T06:35:59+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-expands-supply-chain-solutions-304153.html 0.6 2026-08-08T21:17:10+08:00 daily https://www.pharmasources.com/industryinsights/cepi-emergent-and-profectus-enter-vaccin-304154.html 0.6 2026-08-08T06:11:21+08:00 daily https://www.pharmasources.com/industryinsights/biondvax-moves-to-new-flu-vaccine-mfg-fa-304155.html 0.6 2026-06-22T07:57:47+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-kelun-biotech-enter-agree-304156.html 0.6 2026-06-20T23:12:05+08:00 daily https://www.pharmasources.com/industryinsights/viromed-secures-dna-production-facility--304157.html 0.6 2026-06-24T03:14:04+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-expansion-work-begins-304158.html 0.6 2026-06-21T13:02:40+08:00 daily https://www.pharmasources.com/industryinsights/marken-offers-hybrid-service-from-brazil-304159.html 0.6 2026-06-23T07:14:03+08:00 daily https://www.pharmasources.com/industryinsights/super-resolution-microscopy-to-identify--304160.html 0.6 2026-08-08T17:08:28+08:00 daily https://www.pharmasources.com/industryinsights/effect-of-radiation-exposure-in-brain-tu-304161.html 0.6 2026-06-21T06:51:46+08:00 daily https://www.pharmasources.com/industryinsights/ican-yom-chai-signs-mou-for-crohns-disea-304162.html 0.6 2026-07-07T00:21:30+08:00 daily https://www.pharmasources.com/industryinsights/awt-acquires-citation-clinical-labeling--304163.html 0.6 2026-08-06T04:13:16+08:00 daily https://www.pharmasources.com/industryinsights/consuming-milk-at-breakfast-lowers-blood-304164.html 0.6 2026-08-07T06:57:46+08:00 daily https://www.pharmasources.com/industryinsights/rexahn-merck-partner-for-cancer-304165.html 0.6 2026-06-21T05:12:59+08:00 daily https://www.pharmasources.com/industryinsights/imago-biosciences-completes-enrollment-i-304166.html 0.6 2026-04-13T07:09:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-rmat-designation-to-at132-304167.html 0.6 2026-06-21T09:13:12+08:00 daily https://www.pharmasources.com/industryinsights/linzess-approved-in-japan-for-additional-304168.html 0.6 2026-06-21T14:11:41+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-completes-enrollment-in-envision-304169.html 0.6 2026-06-21T11:20:28+08:00 daily https://www.pharmasources.com/industryinsights/adherium-launches-hailie-304170.html 0.6 2026-06-19T14:46:56+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--304171.html 0.6 2026-06-21T03:08:19+08:00 daily https://www.pharmasources.com/industryinsights/achillion-appoints-new-cmo-304172.html 0.6 2026-06-20T17:52:32+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-announces-partnership-wit-304173.html 0.6 2026-06-21T08:13:07+08:00 daily https://www.pharmasources.com/industryinsights/proposal-to-acquire-china-biologic-produ-304174.html 0.6 2026-07-23T14:37:50+08:00 daily https://www.pharmasources.com/industryinsights/cfdas-institute-of-executive-development-304175.html 0.6 2026-07-29T17:44:53+08:00 daily https://www.pharmasources.com/industryinsights/clalit-health-services-daytwo-announce-p-304176.html 0.6 2026-06-20T18:15:50+08:00 daily https://www.pharmasources.com/industryinsights/middle-east-and-africa-pharma-economy-to-304177.html 0.6 2026-06-20T22:00:38+08:00 daily https://www.pharmasources.com/industryinsights/tolero-pharmaceuticals-and-abbvie-partne-304178.html 0.6 2026-06-21T09:14:12+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-predictor-for-immuno-304179.html 0.6 2026-06-20T18:15:44+08:00 daily https://www.pharmasources.com/industryinsights/federal-appeals-court-calls-for-redo-of--304180.html 0.6 2026-06-27T15:17:33+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-opioids-lead-to-more-over-304181.html 0.6 2026-08-02T04:28:25+08:00 daily https://www.pharmasources.com/industryinsights/roches-alecensa-receives-priority-review-304182.html 0.6 2026-07-16T10:56:27+08:00 daily https://www.pharmasources.com/industryinsights/achillion-lures-zelenkofske-from-uniqure-304183.html 0.6 2026-07-10T00:49:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-tagrisso-gains-approval-in--304184.html 0.6 2026-08-06T09:32:13+08:00 daily https://www.pharmasources.com/industryinsights/tonix-exhumes-positive-take-on-data-from-304185.html 0.6 2026-02-28T15:23:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-allergans-esmya-to-treat-ble-304186.html 0.6 2026-08-08T03:18:52+08:00 daily https://www.pharmasources.com/industryinsights/cvs-and-rite-aid-riding-on-ftc-coattails-304187.html 0.6 2026-06-21T04:02:46+08:00 daily https://www.pharmasources.com/industryinsights/mc2-therapeutics-reports-positive-phase--304188.html 0.6 2026-06-21T21:43:26+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-seeking-bids-for-indian--304189.html 0.6 2026-06-21T07:52:47+08:00 daily https://www.pharmasources.com/industryinsights/scilabware-introduces-sterile-ready-to-u-304190.html 0.6 2026-07-18T07:34:49+08:00 daily https://www.pharmasources.com/industryinsights/amyris-announces-successful-closing-of-s-304191.html 0.6 2026-08-05T18:22:30+08:00 daily https://www.pharmasources.com/industryinsights/novos-semaglutide-hits-the-mark-in-phase-304192.html 0.6 2026-06-22T10:02:49+08:00 daily https://www.pharmasources.com/industryinsights/leaked-letter-warns-of-nhs-disruption-af-304193.html 0.6 2026-06-21T01:11:52+08:00 daily https://www.pharmasources.com/industryinsights/japan-approves-astrazenecas-tagrisso-in--304194.html 0.6 2026-07-02T20:28:59+08:00 daily https://www.pharmasources.com/industryinsights/chia-tai-tianqing-succeeded-in-patent-ch-304195.html 0.6 2026-07-05T06:03:39+08:00 daily https://www.pharmasources.com/industryinsights/drugs-approved-by-fda-expected-to-exceed-304196.html 0.6 2026-06-19T17:17:04+08:00 daily https://www.pharmasources.com/industryinsights/fdas-review-progress-of-noteworthy-pharm-304197.html 0.6 2026-04-28T09:08:51+08:00 daily https://www.pharmasources.com/industryinsights/bertilimumab-granted-orphan-drug-designa-304198.html 0.6 2026-06-21T10:45:08+08:00 daily https://www.pharmasources.com/industryinsights/enigma-biomedical-group-and-invicro-sign-304199.html 0.6 2026-06-22T08:55:45+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-further-approval-for-ta-304200.html 0.6 2026-07-17T06:37:12+08:00 daily https://www.pharmasources.com/industryinsights/nhs-lifted-imbruvica-restrictions-after--304201.html 0.6 2026-06-21T07:58:03+08:00 daily https://www.pharmasources.com/industryinsights/warning-over-nhs-drug-supply-as-no-deal--304202.html 0.6 2026-07-05T06:17:55+08:00 daily https://www.pharmasources.com/industryinsights/vectura-trial-for-children-using-vr647-i-304203.html 0.6 2026-06-21T01:05:57+08:00 daily https://www.pharmasources.com/industryinsights/with-just-3m-upfront-sierra-buys-an-unwa-304204.html 0.6 2026-07-08T08:37:15+08:00 daily https://www.pharmasources.com/industryinsights/2-proteins-show-promise-as-targets-for-t-304205.html 0.6 2026-06-20T18:02:23+08:00 daily https://www.pharmasources.com/industryinsights/china-national-drug-administration-grant-304206.html 0.6 2026-06-25T01:51:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-stroke-death-risks-linked-t-304207.html 0.6 2026-07-23T07:53:56+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-sales-representatives-to-co-promo-304208.html 0.6 2026-06-20T17:01:17+08:00 daily https://www.pharmasources.com/industryinsights/compass-pathways-receives-fda-approval-f-304209.html 0.6 2026-08-07T10:37:32+08:00 daily https://www.pharmasources.com/industryinsights/after-adcomm-rejection-mallinckrodts-sta-304210.html 0.6 2026-07-09T11:46:37+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-licenses-garp-checkpoint-inhibito-304211.html 0.6 2026-06-30T17:05:12+08:00 daily https://www.pharmasources.com/industryinsights/allergan-receives-response-letter-from-f-304212.html 0.6 2026-07-15T16:04:43+08:00 daily https://www.pharmasources.com/industryinsights/cel-sci-ceo-paints-promising-future-in-l-304213.html 0.6 2026-07-07T13:22:12+08:00 daily https://www.pharmasources.com/industryinsights/eagle-pharmaceuticals-announces-new-pate-304214.html 0.6 2026-06-21T03:16:59+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-and-cyclica-to-collaborate-o-304215.html 0.6 2026-06-21T22:11:56+08:00 daily https://www.pharmasources.com/industryinsights/agilent-companion-diagnostic-gains-expan-304216.html 0.6 2026-08-06T18:50:48+08:00 daily https://www.pharmasources.com/industryinsights/study-authors-receiving-payments-from-de-304217.html 0.6 2026-06-22T09:49:33+08:00 daily https://www.pharmasources.com/industryinsights/gic-receives-govt-funding-for-immuno-onc-304218.html 0.6 2026-06-23T23:13:57+08:00 daily https://www.pharmasources.com/industryinsights/evotec-novo-nordisk-enter-strategic-diab-304219.html 0.6 2026-08-07T07:09:53+08:00 daily https://www.pharmasources.com/industryinsights/investors-led-by-former-ceo-offer-39b-fo-304220.html 0.6 2026-08-07T02:22:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-fights-epipen-shortage-by-extending--304221.html 0.6 2026-08-07T02:09:50+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-indian-consumer-sale-he-304222.html 0.6 2026-08-07T02:04:55+08:00 daily https://www.pharmasources.com/industryinsights/almac-appoints-engineering-facilities-vp-304223.html 0.6 2026-08-07T23:27:33+08:00 daily https://www.pharmasources.com/industryinsights/epipen-partners-mylan-pfizer-have-to-fig-304224.html 0.6 2026-08-07T01:14:14+08:00 daily https://www.pharmasources.com/industryinsights/isoplexis-expands-in-apac-inks-deal-with-304225.html 0.6 2026-08-07T02:52:15+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-trump-tax-rate-cutbiggest-in-pha-304226.html 0.6 2026-08-07T00:41:25+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-tentative-fda-approval-fo-304227.html 0.6 2026-08-07T00:59:02+08:00 daily https://www.pharmasources.com/industryinsights/allergans-esmya-rejection-deals-a-blow-t-304228.html 0.6 2026-08-08T06:00:50+08:00 daily https://www.pharmasources.com/industryinsights/endo-building-on-dtc-success-ramps-up-aw-304229.html 0.6 2026-08-09T20:12:22+08:00 daily https://www.pharmasources.com/industryinsights/strides-receives-acceptance-from-usfda-f-304230.html 0.6 2026-06-22T10:08:01+08:00 daily https://www.pharmasources.com/industryinsights/hiv-viral-suppression-rates-nearly-tripl-304231.html 0.6 2026-06-20T16:40:56+08:00 daily https://www.pharmasources.com/industryinsights/lights-camera-action-as-fcb-health-spins-304232.html 0.6 2026-06-21T06:51:46+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-roches-lung-cancer-drug-a-304233.html 0.6 2026-06-21T07:11:04+08:00 daily https://www.pharmasources.com/industryinsights/genetron-3d-gets-launch-approval-to-ease-304234.html 0.6 2026-07-17T12:21:31+08:00 daily https://www.pharmasources.com/industryinsights/esmo-tumour-dna-scale-to-enable-personal-304235.html 0.6 2026-06-20T14:38:27+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-93-million-investment-to-accel-304236.html 0.6 2026-08-08T00:49:20+08:00 daily https://www.pharmasources.com/industryinsights/gym-class-memories-can-influence-adults--304237.html 0.6 2026-08-07T22:35:04+08:00 daily https://www.pharmasources.com/industryinsights/4-experimental-ebola-therapies-approved--304238.html 0.6 2026-08-07T13:17:11+08:00 daily https://www.pharmasources.com/industryinsights/leaf-expression-promises-rich-harvest-fo-304239.html 0.6 2026-06-21T07:56:01+08:00 daily https://www.pharmasources.com/industryinsights/middle-east-and-africa-pharma-economy-to-304240.html 0.6 2026-08-07T00:59:26+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-earns-silver-in-ecovadis-csr-r-304241.html 0.6 2026-08-07T01:19:22+08:00 daily https://www.pharmasources.com/industryinsights/small-practices-also-at-risk-for-data-br-304242.html 0.6 2026-08-07T00:39:59+08:00 daily https://www.pharmasources.com/industryinsights/prophylactic-tranexamic-acid-doesnt-cut--304243.html 0.6 2026-08-07T12:03:25+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-exercises-option-on-argenxs-exper-304244.html 0.6 2026-08-07T13:18:10+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-pushes-back-move-to-new-camb-304245.html 0.6 2026-08-07T20:13:23+08:00 daily https://www.pharmasources.com/industryinsights/gilead-offloads-experimental-myelofibros-304246.html 0.6 2026-06-14T19:47:58+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-inks-deal-with-evotec-to-de-304247.html 0.6 2026-08-07T02:35:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-mallinckrodts-filing-for-jau-304248.html 0.6 2026-08-08T20:18:02+08:00 daily https://www.pharmasources.com/industryinsights/new-postponement-packaging-service-launc-304249.html 0.6 2026-08-09T06:59:34+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-expands-capacity-at-denmar-304250.html 0.6 2026-06-21T20:49:45+08:00 daily https://www.pharmasources.com/industryinsights/newage-industriesadvantapure-completes-p-304251.html 0.6 2026-06-21T11:46:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-for-neurotrophic-304252.html 0.6 2026-06-20T23:53:55+08:00 daily https://www.pharmasources.com/industryinsights/orgenesis-enters-drug-devt-collaboration-304253.html 0.6 2026-06-21T09:14:17+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-gritstone-inks-deal-to-develop--304254.html 0.6 2026-06-22T12:51:26+08:00 daily https://www.pharmasources.com/industryinsights/china-national-drug-administration-grant-304255.html 0.6 2026-07-07T18:15:50+08:00 daily https://www.pharmasources.com/industryinsights/the-missing-piece-in-rare-disease-drug-d-304256.html 0.6 2026-06-21T12:16:39+08:00 daily https://www.pharmasources.com/industryinsights/dexcom-acquires-typezero-tech-304257.html 0.6 2026-01-16T14:15:48+08:00 daily https://www.pharmasources.com/industryinsights/lupin-recalls-over-11000-bottles-of-hype-304258.html 0.6 2026-06-21T17:06:23+08:00 daily https://www.pharmasources.com/industryinsights/solar-1-trial-of-novartis-investigationa-304259.html 0.6 2026-07-14T02:23:00+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astellas-amend-research-protocols-304260.html 0.6 2026-07-03T02:50:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pi3k-drug-hits-goal-in-phase-3--304261.html 0.6 2026-06-21T21:53:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-seizures--304262.html 0.6 2026-08-07T02:12:33+08:00 daily https://www.pharmasources.com/industryinsights/gritstone-oncology-files-for-80m-ipo-304263.html 0.6 2026-08-08T19:57:58+08:00 daily https://www.pharmasources.com/industryinsights/novartis-appoints-new-ceo-for-controvers-304264.html 0.6 2026-06-20T14:49:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-to-address-epipen-short-304265.html 0.6 2026-06-22T02:42:37+08:00 daily https://www.pharmasources.com/industryinsights/rakutens-ceo-raises-150m-to-fund-his-bio-304266.html 0.6 2026-06-22T01:47:36+08:00 daily https://www.pharmasources.com/industryinsights/state-of-louisiana-pharmacy-board-select-304267.html 0.6 2026-06-20T19:17:58+08:00 daily https://www.pharmasources.com/industryinsights/gbt-picks-up-roches-dropped-heart-drug-f-304268.html 0.6 2026-06-21T00:56:43+08:00 daily https://www.pharmasources.com/industryinsights/researchers-decode-the-structure-of-a-hu-304269.html 0.6 2026-06-22T03:57:38+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-receives-patent-for-improved-p-304270.html 0.6 2026-06-22T16:58:19+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-adds-to-diabetes-pipeline-w-304271.html 0.6 2026-06-21T11:19:45+08:00 daily https://www.pharmasources.com/industryinsights/eisai-gets-marketing-approval-from-ec-fo-304272.html 0.6 2026-06-21T10:18:28+08:00 daily https://www.pharmasources.com/industryinsights/accelerators-apogen-nets-new-biochem-lea-304273.html 0.6 2026-06-20T14:44:27+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-taps-gritstone-for-oncology-cel-304274.html 0.6 2026-06-21T23:49:34+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-snaps-up-preclinical-testin-304275.html 0.6 2026-06-20T20:19:47+08:00 daily https://www.pharmasources.com/industryinsights/congo-approves-4-more-experimental-ebola-304276.html 0.6 2026-07-07T06:19:46+08:00 daily https://www.pharmasources.com/industryinsights/strides-pharma-receives-usfda-nod-for-tw-304277.html 0.6 2026-06-21T19:57:38+08:00 daily https://www.pharmasources.com/industryinsights/vistusertib-and-paclitaxel-combination-s-304278.html 0.6 2026-06-23T04:07:03+08:00 daily https://www.pharmasources.com/industryinsights/ammonia-filtration-key-to-efficient-anti-304279.html 0.6 2026-06-20T21:18:58+08:00 daily https://www.pharmasources.com/industryinsights/simultaneous-automated-and-continuous-mo-304280.html 0.6 2026-06-30T15:36:16+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-bevespi-aerosphere-fails-to-304281.html 0.6 2026-08-07T14:01:16+08:00 daily https://www.pharmasources.com/industryinsights/late-stage-study-of-novartis-pi3k-inhibi-304282.html 0.6 2026-06-21T13:01:34+08:00 daily https://www.pharmasources.com/industryinsights/domps-oxervate-gains-fda-approval-as-fir-304283.html 0.6 2026-07-06T10:06:34+08:00 daily https://www.pharmasources.com/industryinsights/in-the-know-next-steps-for-prostate-canc-304284.html 0.6 2026-07-08T18:42:24+08:00 daily https://www.pharmasources.com/industryinsights/eisai-merck-co-bag-eu-approval-for-lenvi-304285.html 0.6 2026-05-07T03:09:49+08:00 daily https://www.pharmasources.com/industryinsights/for-first-time-in-40-years-cure-for-acut-304286.html 0.6 2026-06-21T04:59:44+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-npxe-announce-fda-fast-trac-304287.html 0.6 2026-06-20T15:01:33+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-receives-fda-approval-for-new-mf-304288.html 0.6 2026-06-22T17:43:04+08:00 daily https://www.pharmasources.com/industryinsights/astellas-appoints-latin-america-vp-304289.html 0.6 2026-06-20T21:57:40+08:00 daily https://www.pharmasources.com/industryinsights/lupin-enters-dermatology-segment-in-braz-304290.html 0.6 2026-06-22T07:55:49+08:00 daily https://www.pharmasources.com/industryinsights/domps-oxervate-gets-approval-to-treat-ne-304291.html 0.6 2026-06-21T03:21:35+08:00 daily https://www.pharmasources.com/industryinsights/deals-and-mas-this-week-tolero-pharmaceu-304292.html 0.6 2026-08-07T18:01:21+08:00 daily https://www.pharmasources.com/industryinsights/astellas-appoints-senior-vice-president--304293.html 0.6 2026-06-22T10:08:52+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-and-gritstone-oncology-part-304294.html 0.6 2026-07-03T03:24:33+08:00 daily https://www.pharmasources.com/industryinsights/facebook-nyu-to-initiate-fastmri-using-a-304295.html 0.6 2026-06-21T22:13:56+08:00 daily https://www.pharmasources.com/industryinsights/jury-still-out-on-aspirin-a-day-to-preve-304296.html 0.6 2026-06-20T23:01:43+08:00 daily https://www.pharmasources.com/industryinsights/bayer-johnson-johnsons-heart-drug-xarelt-304297.html 0.6 2026-06-20T18:02:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-adds-four-tropical-diseases-to-prior-304298.html 0.6 2026-06-22T23:03:08+08:00 daily https://www.pharmasources.com/industryinsights/ozempic-consistently-reduced-the-risk-of-304299.html 0.6 2026-06-29T04:25:42+08:00 daily https://www.pharmasources.com/industryinsights/blood-pressure-and-cholesterol-lowering--304300.html 0.6 2026-08-10T00:15:57+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-announces-first-patien-304301.html 0.6 2026-07-11T04:35:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-rare-here-304302.html 0.6 2026-07-09T08:39:49+08:00 daily https://www.pharmasources.com/industryinsights/domp-gives-the-fda-its-first-approved-ne-304303.html 0.6 2026-07-06T06:10:07+08:00 daily https://www.pharmasources.com/industryinsights/gl-capital-invests-125-m-in-oxford-biody-304304.html 0.6 2026-06-21T03:09:49+08:00 daily https://www.pharmasources.com/industryinsights/sec-charges-ex-sangamo-exec-with-insider-304305.html 0.6 2026-03-21T00:57:56+08:00 daily https://www.pharmasources.com/industryinsights/homeopathic-medicines-specialist-king-bi-304306.html 0.6 2026-06-22T10:23:59+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-cans-ex-glaxosmithkline-eczema-d-304307.html 0.6 2026-06-23T01:25:55+08:00 daily https://www.pharmasources.com/industryinsights/generics-could-save-us-medicare-1-billio-304308.html 0.6 2026-08-07T13:17:47+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-glucome-to-pilot-remote-digit-304309.html 0.6 2026-08-07T00:40:38+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018082-304310.html 0.6 2026-08-06T23:55:01+08:00 daily https://www.pharmasources.com/industryinsights/government-publishes-no-deal-brexit-guid-304311.html 0.6 2026-08-07T00:01:32+08:00 daily https://www.pharmasources.com/industryinsights/nus-team-develops-saliva-test-for-detect-304312.html 0.6 2026-06-23T18:55:32+08:00 daily https://www.pharmasources.com/industryinsights/uniqure-starts-dosing-in-pre-pivotal-hem-304313.html 0.6 2026-08-07T00:01:33+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-set-to-open-biotech-hub-in-304314.html 0.6 2026-08-07T00:40:34+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-shocked-as-inhaler-fails-to--304315.html 0.6 2026-08-07T01:10:29+08:00 daily https://www.pharmasources.com/industryinsights/3-million-gsk-verdict-thrown-out-of-cour-304316.html 0.6 2026-08-07T21:38:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-investigational-combo-impresses-304317.html 0.6 2025-11-14T13:53:55+08:00 daily https://www.pharmasources.com/industryinsights/the-top-5-cv-drugs-for-2017-to-2024-304318.html 0.6 2026-08-07T01:19:15+08:00 daily https://www.pharmasources.com/industryinsights/eisaimsds-lenvima-approved-in-europe-for-304319.html 0.6 2026-08-02T02:19:29+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-new-treatment-option-for-drave-304320.html 0.6 2026-07-04T20:48:43+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-abbvie-net-fda-breakthroug-304321.html 0.6 2026-08-07T23:33:37+08:00 daily https://www.pharmasources.com/industryinsights/shire-eyes-blockbuster-sales-with-best-i-304322.html 0.6 2026-06-21T01:00:45+08:00 daily https://www.pharmasources.com/industryinsights/drugmakers-large-and-small-score-fda-nod-304323.html 0.6 2026-08-08T22:26:41+08:00 daily https://www.pharmasources.com/industryinsights/trump-administration-senate-move-forward-304324.html 0.6 2026-08-08T00:16:06+08:00 daily https://www.pharmasources.com/industryinsights/additional-lots-added-to-the-torrent-nat-304325.html 0.6 2026-06-21T00:08:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-european-commission-ap-304326.html 0.6 2026-06-22T07:07:55+08:00 daily https://www.pharmasources.com/industryinsights/cantex-receives-fda-fast-track-designati-304327.html 0.6 2026-06-20T15:58:16+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-provides-cmc-services-for-can-304328.html 0.6 2026-06-19T16:59:15+08:00 daily https://www.pharmasources.com/industryinsights/evotec-centogene-enter-drug-discovery-co-304329.html 0.6 2026-06-20T15:09:27+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-therapy-kymriah-receives--304330.html 0.6 2026-07-08T22:56:14+08:00 daily https://www.pharmasources.com/industryinsights/cprit-awards-forbius-product-development-304331.html 0.6 2026-07-03T18:40:23+08:00 daily https://www.pharmasources.com/industryinsights/amgen-submits-supplemental-new-drug-appl-304332.html 0.6 2026-06-20T17:54:27+08:00 daily https://www.pharmasources.com/industryinsights/strategia-js-innopharm-partner-for-devel-304333.html 0.6 2026-07-08T13:51:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-imbruvica-plus-rituximab-304334.html 0.6 2026-07-30T21:25:03+08:00 daily https://www.pharmasources.com/industryinsights/novasep-announces-successful-fda-inspect-304335.html 0.6 2026-06-21T09:11:19+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-gritstone-enter-collaborati-304336.html 0.6 2026-06-20T23:16:54+08:00 daily https://www.pharmasources.com/industryinsights/jwp-leo-pharma-sign-licensing-agreement-304337.html 0.6 2026-06-22T10:55:03+08:00 daily https://www.pharmasources.com/industryinsights/chinese-biotech-harbour-lands-85m-to-run-304338.html 0.6 2026-06-21T04:52:38+08:00 daily https://www.pharmasources.com/industryinsights/3rd-loc-meeting-of-70th-ipc-was-held-at--304339.html 0.6 2026-06-21T00:53:33+08:00 daily https://www.pharmasources.com/industryinsights/y-mabs-preps-92m-ipo-to-push-lead-assets-304340.html 0.6 2026-06-21T08:00:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-roches-cobas-egfr-blood-tes-304341.html 0.6 2026-06-21T10:55:11+08:00 daily https://www.pharmasources.com/industryinsights/panacea-inks-pact-with-natco-breckenridg-304342.html 0.6 2026-06-20T18:50:25+08:00 daily https://www.pharmasources.com/industryinsights/substance-abuse-neurological-disease-and-304343.html 0.6 2026-06-21T19:57:36+08:00 daily https://www.pharmasources.com/industryinsights/bayer-jjs-heart-drug-xarelto-fails-trial-304344.html 0.6 2026-06-21T23:01:41+08:00 daily https://www.pharmasources.com/industryinsights/esperions-cholesterol-drug-cuts-ldl-c-in-304345.html 0.6 2026-06-20T20:11:48+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-contraceptive-drug-in-us-304346.html 0.6 2026-08-04T22:34:25+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-eyes-attr-cardiomyopathy-filing-f-304347.html 0.6 2026-06-21T04:20:27+08:00 daily https://www.pharmasources.com/industryinsights/us-deaths-from-suicide-drugs-surpass-dia-304348.html 0.6 2026-06-21T18:16:44+08:00 daily https://www.pharmasources.com/industryinsights/two-ebola-patients-who-received-experime-304349.html 0.6 2026-07-04T21:26:11+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-e-cigarette-use-45-percent-304350.html 0.6 2026-06-20T21:07:45+08:00 daily https://www.pharmasources.com/industryinsights/shire-receives-usfda-nod-for-takhzyro-304351.html 0.6 2026-06-21T13:50:15+08:00 daily https://www.pharmasources.com/industryinsights/bigger-drop-in-opioid-prescribing-after--304352.html 0.6 2026-06-21T09:44:11+08:00 daily https://www.pharmasources.com/industryinsights/high-ldl-in-young-healthy-adults-leaves--304353.html 0.6 2026-07-31T01:53:07+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-to-launch-cold-defence-in-tu-304354.html 0.6 2026-06-21T21:48:02+08:00 daily https://www.pharmasources.com/industryinsights/pediatricians-advise-against-use-of-mari-304355.html 0.6 2026-08-08T02:58:04+08:00 daily https://www.pharmasources.com/industryinsights/new-wrinkle-in-heart-health-furrowed-bro-304356.html 0.6 2026-04-07T00:22:18+08:00 daily https://www.pharmasources.com/industryinsights/could-too-much-good-hdl-cholesterol-be-b-304357.html 0.6 2026-07-16T09:51:56+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-new-blood-clot-preventi-304358.html 0.6 2026-06-20T18:01:25+08:00 daily https://www.pharmasources.com/industryinsights/rakuten-aspyrian-raises-150m-in-series-c-304359.html 0.6 2026-08-07T03:03:07+08:00 daily https://www.pharmasources.com/industryinsights/mabpharm-seeks-to-raise-capital-through--304360.html 0.6 2026-08-07T02:52:08+08:00 daily https://www.pharmasources.com/industryinsights/bhf-launches-30-m-funding-for-cardiovasc-304361.html 0.6 2026-08-07T02:45:41+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-announces-updates-on-unso-304362.html 0.6 2026-08-07T02:41:02+08:00 daily https://www.pharmasources.com/industryinsights/gt-biopharma-appoints-david-cardino-as-v-304363.html 0.6 2026-08-06T23:35:54+08:00 daily https://www.pharmasources.com/industryinsights/innovation-hindered-by-regulators-304364.html 0.6 2026-08-06T23:38:41+08:00 daily https://www.pharmasources.com/industryinsights/new-cancer-treatment-uses-enzymes-to-boo-304365.html 0.6 2026-08-07T13:18:30+08:00 daily https://www.pharmasources.com/industryinsights/taris-announces-positive-topline-data-fo-304366.html 0.6 2026-06-20T16:54:15+08:00 daily https://www.pharmasources.com/industryinsights/roche-diagnostics-ceo-to-resign-304367.html 0.6 2026-06-21T08:58:24+08:00 daily https://www.pharmasources.com/industryinsights/brf-awards-two-grants-to-reduce-opioid-r-304368.html 0.6 2026-07-07T06:26:29+08:00 daily https://www.pharmasources.com/industryinsights/apeiron-appoints-cmso-304369.html 0.6 2026-06-21T19:09:40+08:00 daily https://www.pharmasources.com/industryinsights/reflectionbio-receives-orphan-drug-desig-304370.html 0.6 2026-06-23T04:01:03+08:00 daily https://www.pharmasources.com/industryinsights/horizon-discovery-partners-for-target-id-304371.html 0.6 2026-07-03T21:51:20+08:00 daily https://www.pharmasources.com/industryinsights/accord-healthcare-issues-recall-of-hydro-304372.html 0.6 2026-06-21T04:59:53+08:00 daily https://www.pharmasources.com/industryinsights/sgs-expands-biopharma-testing-capabiliti-304373.html 0.6 2026-06-22T00:58:47+08:00 daily https://www.pharmasources.com/industryinsights/nvp015-program-accelerated-through-resea-304374.html 0.6 2026-06-21T14:16:47+08:00 daily https://www.pharmasources.com/industryinsights/arcturus-therapeutics-appoints-interim-c-304375.html 0.6 2025-11-14T15:05:55+08:00 daily https://www.pharmasources.com/industryinsights/spinalcyte-announces-new-us-patent-304376.html 0.6 2026-08-08T01:00:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tetraphases-xerava-304377.html 0.6 2026-06-21T09:10:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-wins-eu-approval-for-blood-canc-304378.html 0.6 2026-06-20T23:54:30+08:00 daily https://www.pharmasources.com/industryinsights/crispr-biotech-editas-to-lose-cmo-as-it--304379.html 0.6 2026-08-09T01:29:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-tafamidis-reduces-risk-of-death--304380.html 0.6 2026-08-07T13:50:01+08:00 daily https://www.pharmasources.com/industryinsights/affimed-lands-big-backloaded-immunothera-304381.html 0.6 2026-08-09T01:16:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-ec-approval-for-kymria-304382.html 0.6 2026-06-20T14:48:58+08:00 daily https://www.pharmasources.com/industryinsights/second-time-lucky-alzheon-tries-for-much-304383.html 0.6 2026-06-21T08:02:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-against-21-websites-mar-304384.html 0.6 2026-08-07T22:31:19+08:00 daily https://www.pharmasources.com/industryinsights/hey-pharma-marketers-print-is-still-rele-304385.html 0.6 2026-06-24T09:50:09+08:00 daily https://www.pharmasources.com/industryinsights/emotional-pain-tied-to-health-care-assoc-304386.html 0.6 2026-06-23T01:26:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-hundreds-of-human-pet-homeopathy-pro-304387.html 0.6 2026-06-21T05:26:53+08:00 daily https://www.pharmasources.com/industryinsights/medical-practices-should-address-negativ-304388.html 0.6 2026-06-21T02:06:39+08:00 daily https://www.pharmasources.com/industryinsights/alarming-rise-in-antibiotic-resistant-ut-304389.html 0.6 2026-06-20T20:18:53+08:00 daily https://www.pharmasources.com/industryinsights/aha-this-single-dad-kicked-30-year-tobac-304390.html 0.6 2026-06-20T14:31:18+08:00 daily https://www.pharmasources.com/industryinsights/gileads-car-t-cell-therapy-yescarta-gain-304391.html 0.6 2026-06-20T21:02:37+08:00 daily https://www.pharmasources.com/industryinsights/affimeds-shares-jump-on-cancer-drug-deve-304392.html 0.6 2026-06-24T03:03:31+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-eisais-obesity-drug-belviq-d-304393.html 0.6 2026-06-22T12:49:49+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-tabs-christopher-bo-304394.html 0.6 2026-06-27T03:41:01+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-to-acquire-adapt-p-304395.html 0.6 2026-06-21T09:55:02+08:00 daily https://www.pharmasources.com/industryinsights/astellas-announces-approval-of-linzess-t-304396.html 0.6 2026-08-07T22:50:10+08:00 daily https://www.pharmasources.com/industryinsights/chongqing-connectivity-initiatives-first-304397.html 0.6 2026-07-30T17:33:22+08:00 daily https://www.pharmasources.com/industryinsights/cell-research-corporation-announces-new--304398.html 0.6 2026-08-09T07:57:55+08:00 daily https://www.pharmasources.com/industryinsights/eisai-announces-long-term-cardiovascular-304399.html 0.6 2026-08-07T15:01:38+08:00 daily https://www.pharmasources.com/industryinsights/hebrew-university-researchers-develop-a--304400.html 0.6 2026-08-07T14:27:46+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-reasons-of-death-after-non-304401.html 0.6 2026-08-07T13:58:28+08:00 daily https://www.pharmasources.com/industryinsights/pharmax-initiates-operations-at-new-duba-304402.html 0.6 2026-08-07T13:17:45+08:00 daily https://www.pharmasources.com/industryinsights/new-biopharmaceutical-testing-laboratory-304403.html 0.6 2026-08-07T03:03:49+08:00 daily https://www.pharmasources.com/industryinsights/cannabis-extract-helps-reset-brain-funct-304404.html 0.6 2026-08-07T02:52:00+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-expands-leadership--304405.html 0.6 2026-04-08T09:34:09+08:00 daily https://www.pharmasources.com/industryinsights/kbi-biopharma-bvba-launches-belgium-lab--304406.html 0.6 2026-08-07T02:39:44+08:00 daily https://www.pharmasources.com/industryinsights/upm-appoints-analytical-development-dire-304407.html 0.6 2026-08-06T20:08:49+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-expanded-in-304408.html 0.6 2026-08-09T02:39:13+08:00 daily https://www.pharmasources.com/industryinsights/emergent-buys-adapt-pharma-for-735m-304409.html 0.6 2026-08-07T13:16:00+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-announces-plans-for-life-scien-304410.html 0.6 2026-06-21T08:15:13+08:00 daily https://www.pharmasources.com/industryinsights/statement-by-fda-commissioner-on-agencys-304411.html 0.6 2026-06-20T20:40:37+08:00 daily https://www.pharmasources.com/industryinsights/affimed-genentech-enter-cancer-collabora-304412.html 0.6 2026-03-28T03:38:02+08:00 daily https://www.pharmasources.com/industryinsights/first-subject-dosed-in-phase-1-trial-eva-304413.html 0.6 2026-06-22T16:59:54+08:00 daily https://www.pharmasources.com/industryinsights/tjoapack-veratrak-partner-for-blockchain-304414.html 0.6 2026-04-28T03:18:26+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-grants-orphan-drug-d-304415.html 0.6 2026-06-21T12:10:20+08:00 daily https://www.pharmasources.com/industryinsights/beigene-announces-acceptance-of-its-firs-304416.html 0.6 2026-06-26T22:50:11+08:00 daily https://www.pharmasources.com/industryinsights/sirona-biochem-receives-500000-milestone-304417.html 0.6 2026-07-01T16:47:51+08:00 daily https://www.pharmasources.com/industryinsights/illumina-receives-1st-approval-in-china--304418.html 0.6 2026-08-04T22:53:37+08:00 daily https://www.pharmasources.com/industryinsights/wasdell-group-to-open-new-facility-304419.html 0.6 2026-06-19T14:42:05+08:00 daily https://www.pharmasources.com/industryinsights/outset-medical-bags-another-132m-to-ramp-304420.html 0.6 2026-06-08T03:33:37+08:00 daily https://www.pharmasources.com/industryinsights/pci-expands-cold-chain-infrastructure-304421.html 0.6 2026-06-21T10:04:12+08:00 daily https://www.pharmasources.com/industryinsights/womens-health-firm-kandy-raises-32m-for--304422.html 0.6 2026-08-09T00:10:27+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-inks-tripartite-agreement-304423.html 0.6 2026-08-08T21:48:33+08:00 daily https://www.pharmasources.com/industryinsights/roches-ceo-of-the-diagnostic-division-to-304424.html 0.6 2026-06-21T17:53:11+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-nod-to-market-postherp-304425.html 0.6 2026-08-08T20:05:17+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-selected-into-the-hang-se-304426.html 0.6 2026-06-19T17:17:05+08:00 daily https://www.pharmasources.com/industryinsights/ascend-scoldedagainfor-estrogen-drug-pro-304427.html 0.6 2026-08-08T13:46:41+08:00 daily https://www.pharmasources.com/industryinsights/att-and-softbox-use-drones-to-transport--304428.html 0.6 2026-08-08T15:49:48+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-backed-studies-reveal-consta-304429.html 0.6 2026-08-08T12:18:34+08:00 daily https://www.pharmasources.com/industryinsights/tjoapack-and-veratrak-to-launch-blockcha-304430.html 0.6 2026-08-08T15:52:12+08:00 daily https://www.pharmasources.com/industryinsights/china-has-withheld-samples-of-deadly-avi-304431.html 0.6 2026-08-08T10:10:58+08:00 daily https://www.pharmasources.com/industryinsights/affimed-signs-up-to-5bn-cancer-therapeut-304432.html 0.6 2026-08-08T17:54:03+08:00 daily https://www.pharmasources.com/industryinsights/cadila-gets-five-observations-from-us-fd-304433.html 0.6 2026-07-16T20:08:57+08:00 daily https://www.pharmasources.com/industryinsights/suven-secures-product-patents-in-china-e-304434.html 0.6 2026-01-11T21:36:47+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-to-market-tiotropium-bromide-dr-304435.html 0.6 2026-06-08T06:37:10+08:00 daily https://www.pharmasources.com/industryinsights/emergent-snaps-up-adapt-and-its-opioid-o-304436.html 0.6 2026-07-27T15:48:48+08:00 daily https://www.pharmasources.com/industryinsights/nhs-guidance-suggests-mental-health-ther-304437.html 0.6 2026-06-20T17:13:34+08:00 daily https://www.pharmasources.com/industryinsights/almac-group-launches-gmp-high-throughput-304438.html 0.6 2026-08-09T02:39:04+08:00 daily https://www.pharmasources.com/industryinsights/sharp-begins-validation-phase-of-95-mill-304439.html 0.6 2026-06-21T13:00:23+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-for--304440.html 0.6 2026-08-06T23:55:41+08:00 daily https://www.pharmasources.com/industryinsights/blood-pressure-drug-slows-aortic-dilatat-304441.html 0.6 2026-03-22T15:44:08+08:00 daily https://www.pharmasources.com/industryinsights/seizures-could-be-stopped-and-prevented--304442.html 0.6 2026-06-23T19:04:54+08:00 daily https://www.pharmasources.com/industryinsights/oral-anticoagulants-and-antiplatelets-li-304443.html 0.6 2026-07-01T03:42:56+08:00 daily https://www.pharmasources.com/industryinsights/bayer-accelerates-six-new-startups-304444.html 0.6 2026-08-08T00:43:28+08:00 daily https://www.pharmasources.com/industryinsights/sotio-and-ppf-complete-acquisition-of-cy-304445.html 0.6 2026-08-07T17:55:32+08:00 daily https://www.pharmasources.com/industryinsights/supply-chain-wizard-ranks-on-inc-5000-304446.html 0.6 2026-06-21T10:40:10+08:00 daily https://www.pharmasources.com/industryinsights/sophiris-bio-releases-report-on-patient--304447.html 0.6 2026-08-09T04:40:31+08:00 daily https://www.pharmasources.com/industryinsights/crfs-trialmax-slate-chosen-for-phase-iii-304448.html 0.6 2026-08-09T03:45:06+08:00 daily https://www.pharmasources.com/industryinsights/regen-biopharma-reports-molecule-screeni-304449.html 0.6 2026-08-08T23:29:59+08:00 daily https://www.pharmasources.com/industryinsights/childrens-advil-suspension-bubble-gum-re-304450.html 0.6 2026-06-22T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-to-develop-new-product-304451.html 0.6 2026-08-08T21:33:30+08:00 daily https://www.pharmasources.com/industryinsights/bayer-receives-fda-approval-for-jivi-304452.html 0.6 2026-08-08T10:49:57+08:00 daily https://www.pharmasources.com/industryinsights/prince-sterilization-services-spins-off--304453.html 0.6 2026-08-07T20:14:59+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-acquires-maker-of--304454.html 0.6 2026-08-07T19:27:05+08:00 daily https://www.pharmasources.com/industryinsights/ultimovacs-acquires-immuneeds-immunother-304455.html 0.6 2026-08-07T13:19:59+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-bydureon-bc-304456.html 0.6 2026-08-06T22:53:59+08:00 daily https://www.pharmasources.com/industryinsights/grand-river-sungen-pharma-enter-injectab-304457.html 0.6 2026-08-06T21:58:54+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-announces-pipeline-expansion-w-304458.html 0.6 2026-08-08T02:42:17+08:00 daily https://www.pharmasources.com/industryinsights/endothelial-progenitor-cells-are-safe-fo-304460.html 0.6 2026-08-07T15:02:21+08:00 daily https://www.pharmasources.com/industryinsights/jiva-ayurveda-gargi-college-introduces-s-304461.html 0.6 2026-08-06T23:32:49+08:00 daily https://www.pharmasources.com/industryinsights/british-columbia-files-lawsuit-against-p-304462.html 0.6 2026-08-06T23:47:32+08:00 daily https://www.pharmasources.com/industryinsights/uks-nice-rejects-use-of-gileads-yescarta-304463.html 0.6 2026-08-06T23:56:16+08:00 daily https://www.pharmasources.com/industryinsights/brain-implant-puts-the-brakes-on-epilept-304464.html 0.6 2026-08-07T00:01:46+08:00 daily https://www.pharmasources.com/industryinsights/medicare-med-advantage-health-care-use-d-304465.html 0.6 2026-08-07T05:31:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-common-diabetes-meds-tied-to-serious-304466.html 0.6 2026-07-01T04:48:49+08:00 daily https://www.pharmasources.com/industryinsights/china-withholding-h7n9-bird-flu-virus-sa-304467.html 0.6 2026-06-21T20:58:39+08:00 daily https://www.pharmasources.com/industryinsights/drinking-water-turned-off-in-all-detroit-304468.html 0.6 2026-08-07T05:56:27+08:00 daily https://www.pharmasources.com/industryinsights/vascular-risk-factors-for-brain-calcific-304469.html 0.6 2026-08-08T23:54:52+08:00 daily https://www.pharmasources.com/industryinsights/strain-of-e-coli-spread-from-poultry-to--304470.html 0.6 2026-06-21T04:22:13+08:00 daily https://www.pharmasources.com/industryinsights/gene-editing-in-dog-study-shows-promise--304471.html 0.6 2026-06-21T21:11:44+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-hits-out-at-other-companies-over--304472.html 0.6 2026-06-21T10:16:33+08:00 daily https://www.pharmasources.com/industryinsights/new-program-increases-use-of-hiv-medicat-304473.html 0.6 2026-08-05T18:35:52+08:00 daily https://www.pharmasources.com/industryinsights/unnecessary-heart-procedures-avoided-tha-304474.html 0.6 2026-06-22T18:08:09+08:00 daily https://www.pharmasources.com/industryinsights/shire-completes-sale-of-oncology-franchi-304475.html 0.6 2026-06-19T17:05:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-complete-response-letter-for--304476.html 0.6 2026-06-20T15:50:14+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-terminates-domagrozumab-pf-062526-304477.html 0.6 2026-06-21T07:16:12+08:00 daily https://www.pharmasources.com/industryinsights/african-govtto-eliminate-cholera-by-2030-304478.html 0.6 2026-06-20T18:53:46+08:00 daily https://www.pharmasources.com/industryinsights/product-quest-manufacturing-recalls-all--304479.html 0.6 2026-06-21T11:08:31+08:00 daily https://www.pharmasources.com/industryinsights/regen-biopharma-reports-success-of-nr2f6-304480.html 0.6 2026-06-22T09:11:49+08:00 daily https://www.pharmasources.com/industryinsights/anifrolumab-trial-does-not-meet-primary--304481.html 0.6 2026-07-20T14:51:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-statement-on-valsartan-inve-304482.html 0.6 2026-06-21T23:51:56+08:00 daily https://www.pharmasources.com/industryinsights/israels-together-pharma-to-buy-50-percen-304483.html 0.6 2026-06-20T15:13:18+08:00 daily https://www.pharmasources.com/industryinsights/10x-genomics-acquires-epigenetic-startup-304484.html 0.6 2026-06-21T02:59:43+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-create-industry-ready-graduates-304485.html 0.6 2026-06-21T15:00:27+08:00 daily https://www.pharmasources.com/industryinsights/jacobio-pharma-raises-55-m-in-series-c-r-304486.html 0.6 2026-06-21T16:59:18+08:00 daily https://www.pharmasources.com/industryinsights/chugai-nippon-shinyaku-bring-gazyva-in-j-304487.html 0.6 2026-06-22T01:04:58+08:00 daily https://www.pharmasources.com/industryinsights/sotio-acquires-cytune-pharma-304488.html 0.6 2026-06-22T07:46:37+08:00 daily https://www.pharmasources.com/industryinsights/imaginab-cpdc-enter-into-an-agreement-304489.html 0.6 2026-07-02T09:30:45+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--304490.html 0.6 2026-06-21T11:54:26+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-nod-to-market-2--304491.html 0.6 2026-07-05T04:11:18+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lupus-drug-fails-to-meet-ma-304492.html 0.6 2026-08-07T03:20:12+08:00 daily https://www.pharmasources.com/industryinsights/hc-asks-guilty-pharma-co-to-give-150-cr--304493.html 0.6 2026-06-23T00:32:32+08:00 daily https://www.pharmasources.com/industryinsights/multiple-sclerosis-drug-slows-brain-shri-304494.html 0.6 2026-06-20T23:01:41+08:00 daily https://www.pharmasources.com/industryinsights/vertex-and-genomics-partner-to-use-human-304495.html 0.6 2026-07-03T01:22:14+08:00 daily https://www.pharmasources.com/industryinsights/bayers-new-haemophilia-a-drug-obtains-fd-304496.html 0.6 2026-06-30T13:47:51+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018090-304497.html 0.6 2026-07-02T15:31:01+08:00 daily https://www.pharmasources.com/industryinsights/multiple-sclerosis-drug-slows-brain-shri-304498.html 0.6 2026-06-29T22:17:57+08:00 daily https://www.pharmasources.com/industryinsights/tetrahertz-spectroscopy-could-be-used-to-304499.html 0.6 2026-06-21T05:15:10+08:00 daily https://www.pharmasources.com/industryinsights/new-tablet-production-facility-in-ingelh-304500.html 0.6 2026-06-21T23:53:45+08:00 daily https://www.pharmasources.com/industryinsights/camber-pharmaceuticals-issues-voluntary--304501.html 0.6 2026-07-23T14:24:33+08:00 daily https://www.pharmasources.com/industryinsights/brexit-woe-sends-investors-at-animal-med-304502.html 0.6 2026-06-21T06:56:52+08:00 daily https://www.pharmasources.com/industryinsights/integrating-treatment-at-the-intersectio-304503.html 0.6 2026-06-20T16:51:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-magnetic-brain-zapping-helm-304504.html 0.6 2026-07-05T04:49:51+08:00 daily https://www.pharmasources.com/industryinsights/mesoblasts-trial-data-in-agvhd-an-iomach-304505.html 0.6 2026-06-22T01:01:50+08:00 daily https://www.pharmasources.com/industryinsights/broker-tips-dechra-jd-wetherspoon-imperi-304506.html 0.6 2026-06-22T18:24:06+08:00 daily https://www.pharmasources.com/industryinsights/aquestive-therapeutics-announces-tentati-304507.html 0.6 2026-06-24T03:28:12+08:00 daily https://www.pharmasources.com/industryinsights/nus-scientists-harness-ai-platform-for-a-304508.html 0.6 2026-06-20T22:07:44+08:00 daily https://www.pharmasources.com/industryinsights/xingimaging-announces-alzheimers-disease-304509.html 0.6 2026-06-21T01:05:46+08:00 daily https://www.pharmasources.com/industryinsights/global-orphan-dermatology-products-marke-304510.html 0.6 2026-06-22T00:00:00+08:00 daily https://www.pharmasources.com/industryinsights/parp-inhibitors-arrive-in-china-via-new--304511.html 0.6 2026-07-14T13:56:43+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-invests-in-glucose-binding--304512.html 0.6 2026-07-23T20:30:55+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-inspects-lupins-tarapur-api-facil-304513.html 0.6 2026-06-22T18:46:10+08:00 daily https://www.pharmasources.com/industryinsights/amgens-blincyto-gets-eu-approval-for-rel-304514.html 0.6 2026-07-27T14:00:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-piloting-innovative-clinical-trial-d-304515.html 0.6 2026-07-21T16:12:05+08:00 daily https://www.pharmasources.com/industryinsights/europe-needs-uniform-policy-to-help-gene-304516.html 0.6 2026-06-20T23:23:53+08:00 daily https://www.pharmasources.com/industryinsights/improving-drug-safety-in-east-africa-is--304517.html 0.6 2026-07-30T14:20:13+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-receives-champalimaud-visio-304518.html 0.6 2026-07-10T22:09:44+08:00 daily https://www.pharmasources.com/industryinsights/antioxidant-reduces-risk-for-second-hear-304519.html 0.6 2026-06-21T03:08:48+08:00 daily https://www.pharmasources.com/industryinsights/check-cap-announces-c-scan-system-versio-304520.html 0.6 2026-06-20T21:56:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-voluntary-recall-of-montel-304521.html 0.6 2026-07-23T18:26:15+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-pharmaceutical-completes-acquisit-304522.html 0.6 2026-07-05T17:06:20+08:00 daily https://www.pharmasources.com/industryinsights/eiger-announces-positive-meeting-with-fd-304523.html 0.6 2026-06-20T22:07:47+08:00 daily https://www.pharmasources.com/industryinsights/pall-celltheon-form-partnership-for-biot-304524.html 0.6 2026-06-21T05:16:59+08:00 daily https://www.pharmasources.com/industryinsights/china-accepts-first-application-for-humi-304525.html 0.6 2026-07-01T18:05:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-tentatively-approves-sympazan-oral-f-304526.html 0.6 2026-06-20T21:15:03+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-releases-geneart-products--304527.html 0.6 2026-06-21T06:13:08+08:00 daily https://www.pharmasources.com/industryinsights/merck-bags-usfda-approval-for-2-new-hiv--304528.html 0.6 2026-06-21T06:53:58+08:00 daily https://www.pharmasources.com/industryinsights/shire-completes-sale-of-oncology-franchi-304529.html 0.6 2026-06-21T08:08:01+08:00 daily https://www.pharmasources.com/industryinsights/antioxidant-reduces-risk-for-second-hear-304530.html 0.6 2026-08-06T18:43:11+08:00 daily https://www.pharmasources.com/industryinsights/with-drugs-pipeline-in-focus-bayer-consi-304531.html 0.6 2026-06-21T01:11:10+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-wins-european-approval-for-rare-b-304532.html 0.6 2026-06-22T04:08:47+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-repligen-in-bioprocessing-pact-304533.html 0.6 2026-06-21T00:14:54+08:00 daily https://www.pharmasources.com/industryinsights/sotio-and-ppf-complete-acquisition-of-cy-304534.html 0.6 2026-06-19T16:48:14+08:00 daily https://www.pharmasources.com/industryinsights/mod-contracts-plasticell-for-pilot-progr-304535.html 0.6 2026-06-25T02:51:19+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-launches-next-gen-process-304536.html 0.6 2026-06-21T09:48:46+08:00 daily https://www.pharmasources.com/industryinsights/catalent-aucta-pharma-ink-commercial-mfg-304537.html 0.6 2026-06-22T11:49:42+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-lifeng-logistics-cphi-china-201-304538.html 0.6 2026-08-07T16:37:00+08:00 daily https://www.pharmasources.com/industryinsights/nhs-announces-groundbreaking-personalise-304539.html 0.6 2026-06-21T12:56:24+08:00 daily https://www.pharmasources.com/industryinsights/common-painkiller-linked-to-an-increased-304540.html 0.6 2026-06-22T04:51:33+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-terminates-domagrozumab-pf-062526-304541.html 0.6 2026-07-30T10:43:51+08:00 daily https://www.pharmasources.com/industryinsights/fibrocell-announces-fda-fast-track-desig-304542.html 0.6 2026-08-06T18:48:06+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-reports-fda-compliance-st-304543.html 0.6 2026-06-21T17:19:37+08:00 daily https://www.pharmasources.com/industryinsights/cgpa-issues-statement-on-the-resumption--304544.html 0.6 2026-06-20T16:55:14+08:00 daily https://www.pharmasources.com/industryinsights/loxo-announces-breakthrough-therapy-desi-304545.html 0.6 2026-06-21T01:40:18+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-reaches-civil-settlement-with-us--304546.html 0.6 2025-11-10T12:42:20+08:00 daily https://www.pharmasources.com/industryinsights/c-scan-system-receives-approval-from-the-304547.html 0.6 2026-07-07T14:53:16+08:00 daily https://www.pharmasources.com/industryinsights/how-tau-disrupts-brain-cell-connections--304548.html 0.6 2026-06-21T15:54:19+08:00 daily https://www.pharmasources.com/industryinsights/startup-gossamer-bio-poaches-bristol-mye-304549.html 0.6 2026-01-18T12:54:19+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-picks-up-astrazeneca-cns-drug-p-304550.html 0.6 2026-06-21T08:55:57+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-reaches-civil-settlement-with-us--304551.html 0.6 2026-08-07T22:41:34+08:00 daily https://www.pharmasources.com/industryinsights/ai-may-help-assess-brain-injury-patients-304552.html 0.6 2026-06-21T09:54:04+08:00 daily https://www.pharmasources.com/industryinsights/loxo-announces-breakthrough-therapy-desi-304553.html 0.6 2026-06-22T18:12:23+08:00 daily https://www.pharmasources.com/industryinsights/merck-launches-next-gen-tech-for-intensi-304554.html 0.6 2026-07-30T16:32:35+08:00 daily https://www.pharmasources.com/industryinsights/cgpa-issues-statement-on-the-resumption--304555.html 0.6 2026-06-21T10:57:15+08:00 daily https://www.pharmasources.com/industryinsights/dr-poonam-khetrapal-continues-as-regiona-304556.html 0.6 2026-06-21T00:00:37+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-reports-fda-compliance-st-304557.html 0.6 2026-06-20T22:03:40+08:00 daily https://www.pharmasources.com/industryinsights/bi-partners-with-tsinghua-for-immuno-the-304558.html 0.6 2026-06-23T08:11:59+08:00 daily https://www.pharmasources.com/industryinsights/strides-receives-usfda-approval-for-pota-304559.html 0.6 2026-07-05T08:05:33+08:00 daily https://www.pharmasources.com/industryinsights/with-promising-data-proqr-therapeutics-r-304560.html 0.6 2026-06-20T21:58:38+08:00 daily https://www.pharmasources.com/industryinsights/phasebio-nets-34m-to-advance-brilinta-re-304561.html 0.6 2026-06-20T16:44:10+08:00 daily https://www.pharmasources.com/industryinsights/otsukas-dose-tracking-digital-pill-chart-304562.html 0.6 2026-08-07T14:16:27+08:00 daily https://www.pharmasources.com/industryinsights/no-sweat-dermira-snags-reps-sets-price-a-304563.html 0.6 2026-08-09T03:17:09+08:00 daily https://www.pharmasources.com/industryinsights/thrombolytic-science-initiates-phase-2-c-304564.html 0.6 2026-06-21T16:43:09+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-and-repligen-co-304565.html 0.6 2026-06-21T09:13:13+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-agrees-on-monetary-settlement-for-304566.html 0.6 2026-06-20T16:21:11+08:00 daily https://www.pharmasources.com/industryinsights/mannkind-and-united-therapeutics-to-adva-304567.html 0.6 2026-06-21T03:03:41+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-find-8000-new-antibiotic--304568.html 0.6 2026-06-20T15:48:39+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-nod-for-herpes-v-304569.html 0.6 2026-06-09T20:06:51+08:00 daily https://www.pharmasources.com/industryinsights/proqr-drug-for-rare-childhood-blindness--304570.html 0.6 2026-06-23T07:57:15+08:00 daily https://www.pharmasources.com/industryinsights/malvinder-singh-asked-to-deposit-35-mn-s-304571.html 0.6 2026-02-09T07:30:54+08:00 daily https://www.pharmasources.com/industryinsights/cci-orders-investigation-into-pricing-pr-304572.html 0.6 2026-08-08T01:01:47+08:00 daily https://www.pharmasources.com/industryinsights/beijing-changliu-a-great-technological-b-304573.html 0.6 2026-07-28T08:15:50+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-for-skin-condition-granted-pr-304574.html 0.6 2026-03-17T20:40:17+08:00 daily https://www.pharmasources.com/industryinsights/peak-scientific-has-launched-its-first-h-304575.html 0.6 2025-11-09T00:31:12+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-divest-the-sandoz-us-dermato-304576.html 0.6 2026-07-25T15:27:35+08:00 daily https://www.pharmasources.com/industryinsights/neumentum-announces-phase-i-study-evalua-304577.html 0.6 2026-08-03T14:19:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tiglutik-oral-suspension-304578.html 0.6 2026-06-21T01:56:42+08:00 daily https://www.pharmasources.com/industryinsights/baxter-announces-fda-clearance-of-actifu-304579.html 0.6 2026-06-21T23:59:42+08:00 daily https://www.pharmasources.com/industryinsights/cross-industry-collaboration-announced-t-304580.html 0.6 2026-06-21T20:01:44+08:00 daily https://www.pharmasources.com/industryinsights/armgo-pharma-receives-fda-orphan-drug-de-304581.html 0.6 2026-06-24T23:37:52+08:00 daily https://www.pharmasources.com/industryinsights/who-to-strengthen-emergency-medical-team-304582.html 0.6 2026-06-22T02:50:37+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-divest-sandoz-us-dermatology-304583.html 0.6 2026-06-20T21:17:56+08:00 daily https://www.pharmasources.com/industryinsights/hu-manityco-launches-blockchain-app-to-h-304584.html 0.6 2026-08-07T01:14:40+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-first-made-in-china-cance-304585.html 0.6 2026-08-09T10:31:52+08:00 daily https://www.pharmasources.com/industryinsights/springworks-names-a-ceo-inks-a-combo-the-304586.html 0.6 2026-08-07T00:43:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receives-breakthrough-therapy-des-304587.html 0.6 2026-08-07T00:45:42+08:00 daily https://www.pharmasources.com/industryinsights/eisais-lenvima-gets-nod-in-china-for-liv-304588.html 0.6 2026-08-07T00:52:53+08:00 daily https://www.pharmasources.com/industryinsights/liver-disease-drug-could-help-restore-ce-304589.html 0.6 2026-08-07T00:59:10+08:00 daily https://www.pharmasources.com/industryinsights/drugmaker-gsk-to-eliminate-650-us-jobs-304590.html 0.6 2026-08-07T01:06:50+08:00 daily https://www.pharmasources.com/industryinsights/pall-corporation-celltheon-enter-into-pa-304591.html 0.6 2026-08-07T16:25:10+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-to-acquire-dermatology-and-ora-304592.html 0.6 2026-08-07T12:10:29+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-gets-global-rights-to-market-304593.html 0.6 2026-06-21T15:21:33+08:00 daily https://www.pharmasources.com/industryinsights/allogene-raises-another-120m-for-off-the-304594.html 0.6 2026-06-23T12:24:57+08:00 daily https://www.pharmasources.com/industryinsights/third-rocks-rheos-poaches-sanjay-keswani-304595.html 0.6 2026-07-08T15:57:09+08:00 daily https://www.pharmasources.com/industryinsights/moderna-picks-up-fda-vaccine-executive-w-304596.html 0.6 2026-06-19T20:56:55+08:00 daily https://www.pharmasources.com/industryinsights/finally-the-100-chinese-produced-targete-304597.html 0.6 2026-07-18T07:26:11+08:00 daily https://www.pharmasources.com/industryinsights/hospital-backed-civica-rx-nabs-amgen-vet-304598.html 0.6 2026-06-21T04:52:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-divest-sandoz-us-dermatology-304599.html 0.6 2026-06-22T04:54:34+08:00 daily https://www.pharmasources.com/industryinsights/armgo-pharma-receives-fda-orphan-drug-de-304600.html 0.6 2026-06-21T01:04:47+08:00 daily https://www.pharmasources.com/industryinsights/cross-industry-collaboration-announced-t-304601.html 0.6 2026-08-08T01:00:54+08:00 daily https://www.pharmasources.com/industryinsights/baxter-announces-fda-clearance-of-actifu-304602.html 0.6 2026-08-09T21:43:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tiglutik-oral-suspension-304603.html 0.6 2026-08-07T13:54:36+08:00 daily https://www.pharmasources.com/industryinsights/hospitals-using-two-strategies-to-up-qua-304604.html 0.6 2026-08-07T13:16:06+08:00 daily https://www.pharmasources.com/industryinsights/better-training-needed-to-boost-lgbtq-pa-304605.html 0.6 2026-08-07T00:02:39+08:00 daily https://www.pharmasources.com/industryinsights/hospital-groups-launch-own-generic-drug--304606.html 0.6 2026-08-07T00:41:59+08:00 daily https://www.pharmasources.com/industryinsights/goop-reaches-settlement-in-false-adverti-304607.html 0.6 2026-08-07T01:19:39+08:00 daily https://www.pharmasources.com/industryinsights/opioid-maker-to-pay-for-overdose-antidot-304608.html 0.6 2026-08-09T07:37:22+08:00 daily https://www.pharmasources.com/industryinsights/who-declares-sri-lanka-free-from-rubella-304609.html 0.6 2026-06-22T06:57:46+08:00 daily https://www.pharmasources.com/industryinsights/active-biotech-regains-rights-of-laquini-304610.html 0.6 2026-06-20T17:05:25+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-increases-manufacturing-ca-304611.html 0.6 2026-06-21T01:01:47+08:00 daily https://www.pharmasources.com/industryinsights/agios-celgene-terminate-partnership-for--304612.html 0.6 2026-06-20T16:08:20+08:00 daily https://www.pharmasources.com/industryinsights/jianke-raises-130-m-in-series-b-financin-304613.html 0.6 2026-07-09T02:36:12+08:00 daily https://www.pharmasources.com/industryinsights/tezepelumab-granted-breakthrough-therapy-304614.html 0.6 2026-08-04T13:56:03+08:00 daily https://www.pharmasources.com/industryinsights/lupin-to-train-over-1000-graduates-for-p-304615.html 0.6 2026-06-21T10:53:20+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-fda-breakthrough-therap-304616.html 0.6 2026-06-21T01:51:34+08:00 daily https://www.pharmasources.com/industryinsights/olaparib-durvalumab-for-i-spy-2-trial-an-304617.html 0.6 2026-06-21T08:57:07+08:00 daily https://www.pharmasources.com/industryinsights/incyte-announces-cfo-to-retire-at-end-of-304618.html 0.6 2026-06-22T03:04:45+08:00 daily https://www.pharmasources.com/industryinsights/health-ministry-invites-suggestions-for--304619.html 0.6 2026-06-21T09:06:05+08:00 daily https://www.pharmasources.com/industryinsights/regen-biopharma-files-new-composition-of-304620.html 0.6 2026-07-24T05:16:02+08:00 daily https://www.pharmasources.com/industryinsights/strides-pharmas-promoter-sells-stake-wor-304621.html 0.6 2026-03-13T16:14:33+08:00 daily https://www.pharmasources.com/industryinsights/compugen-announces-first-patient-dosed-w-304622.html 0.6 2026-08-07T11:42:29+08:00 daily https://www.pharmasources.com/industryinsights/using-machine-learning-to-interpret-mate-304623.html 0.6 2026-06-21T16:58:35+08:00 daily https://www.pharmasources.com/industryinsights/hd-vein-imaging-aids-intravenous-injecti-304624.html 0.6 2026-06-22T12:01:20+08:00 daily https://www.pharmasources.com/industryinsights/catalent-signs-commercial-supply-agreeme-304625.html 0.6 2026-05-03T00:38:58+08:00 daily https://www.pharmasources.com/industryinsights/akcea-lays-off-10-of-staff-following-vol-304626.html 0.6 2026-06-22T10:54:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-baxters-prepackaged-synthetic-304627.html 0.6 2026-07-28T14:12:46+08:00 daily https://www.pharmasources.com/industryinsights/using-genomics-and-machine-learning-to-p-304628.html 0.6 2026-06-21T03:01:43+08:00 daily https://www.pharmasources.com/industryinsights/blood-tester-guardant-health-files-for-n-304629.html 0.6 2026-06-20T15:46:46+08:00 daily https://www.pharmasources.com/industryinsights/fiercepharmaasiaaurobindos-1b-sandoz-buy-304630.html 0.6 2026-06-21T02:49:49+08:00 daily https://www.pharmasources.com/industryinsights/acing-intro-to-college-life-304631.html 0.6 2026-06-22T04:12:50+08:00 daily https://www.pharmasources.com/industryinsights/max-bupa-launches-wecare-initiative-to-a-304632.html 0.6 2026-06-21T07:13:07+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-presents-car-claudin182-t-data-a-304633.html 0.6 2026-08-05T01:32:24+08:00 daily https://www.pharmasources.com/industryinsights/tennis-skills-decline-equally-in-male-fe-304634.html 0.6 2026-06-22T00:42:42+08:00 daily https://www.pharmasources.com/industryinsights/beigene-and-springworks-therapeutics-ent-304635.html 0.6 2026-08-05T23:08:33+08:00 daily https://www.pharmasources.com/industryinsights/american-academy-of-pediatrics-updates-c-304636.html 0.6 2026-06-21T10:12:17+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-toxic-metals-may-up-cardiova-304637.html 0.6 2026-08-08T01:05:29+08:00 daily https://www.pharmasources.com/industryinsights/influenza-caused-emirates-flight-to-be-b-304638.html 0.6 2026-06-22T04:17:00+08:00 daily https://www.pharmasources.com/industryinsights/menarini-will-bring-lunaphores-ultra-rap-304639.html 0.6 2026-06-21T03:01:43+08:00 daily https://www.pharmasources.com/industryinsights/rsp-systems-adds-eur-385-million-in-a-se-304640.html 0.6 2026-06-24T10:05:32+08:00 daily https://www.pharmasources.com/industryinsights/oxford-regenerative-medicine-spinout-bri-304641.html 0.6 2026-06-28T09:17:15+08:00 daily https://www.pharmasources.com/industryinsights/amryt-gets-green-light-for-eb-treatment-304642.html 0.6 2026-06-23T23:13:48+08:00 daily https://www.pharmasources.com/industryinsights/your-daily-pharma-scoop-spectrum-positiv-304643.html 0.6 2026-06-20T14:54:13+08:00 daily https://www.pharmasources.com/industryinsights/raise-prices-or-risk-medicine-shortages--304644.html 0.6 2026-06-23T09:26:01+08:00 daily https://www.pharmasources.com/industryinsights/qatar-airways-cargo-charters-life-saving-304645.html 0.6 2026-07-31T17:21:34+08:00 daily https://www.pharmasources.com/industryinsights/xspray-pharma-announces-positive-clinica-304646.html 0.6 2026-06-22T02:24:18+08:00 daily https://www.pharmasources.com/industryinsights/study-links-widely-used-drug-azathioprin-304647.html 0.6 2026-06-21T07:50:43+08:00 daily https://www.pharmasources.com/industryinsights/halozyme-announces-new-board-of-director-304648.html 0.6 2026-06-20T15:22:33+08:00 daily https://www.pharmasources.com/industryinsights/human-brain-stimulated-by-artificial-syn-304649.html 0.6 2026-07-04T23:32:41+08:00 daily https://www.pharmasources.com/industryinsights/human-trials-begin-for-designmedix-anti--304650.html 0.6 2026-06-25T10:42:07+08:00 daily https://www.pharmasources.com/industryinsights/inmed-files-patent-application-for-its-c-304651.html 0.6 2026-06-21T23:48:57+08:00 daily https://www.pharmasources.com/industryinsights/russian-institute-for-drugs-and-good-pra-304652.html 0.6 2026-08-09T10:08:07+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-initiates-evaluation-of-alks-42-304653.html 0.6 2026-07-01T07:00:08+08:00 daily https://www.pharmasources.com/industryinsights/gsk-receives-crl-from-fda-for-mepolizuma-304654.html 0.6 2026-06-22T00:03:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-dosage-strength-of-cass-304655.html 0.6 2026-07-06T14:30:41+08:00 daily https://www.pharmasources.com/industryinsights/oxford-regenerative-medicine-spinout-bri-304656.html 0.6 2026-08-09T20:48:34+08:00 daily https://www.pharmasources.com/industryinsights/ul-absorbs-uk-based-medtech-human-factor-304657.html 0.6 2026-08-07T12:03:54+08:00 daily https://www.pharmasources.com/industryinsights/kodiak-sciences-preps-100m-ipo-to-advanc-304658.html 0.6 2026-08-07T01:52:14+08:00 daily https://www.pharmasources.com/industryinsights/medivir-names-linda-basse-as-cmo-adding--304659.html 0.6 2026-08-07T01:42:56+08:00 daily https://www.pharmasources.com/industryinsights/glythera-rebrands-as-iksuda-pledging-to--304660.html 0.6 2026-08-07T01:27:34+08:00 daily https://www.pharmasources.com/industryinsights/minnetronix-rebrands-from-contract-manuf-304661.html 0.6 2026-06-23T01:32:28+08:00 daily https://www.pharmasources.com/industryinsights/this-gene-mutation-is-key-to-glioblastom-304662.html 0.6 2026-06-26T13:03:09+08:00 daily https://www.pharmasources.com/industryinsights/error-cause-analysis-strategy-human-erro-304663.html 0.6 2026-08-07T12:26:11+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-hot-topics-in-p-304664.html 0.6 2026-08-07T03:55:09+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-inhibrx-enter-an-excl-304665.html 0.6 2026-07-01T18:42:32+08:00 daily https://www.pharmasources.com/industryinsights/darlly-filtration-concentration-and-inno-304666.html 0.6 2026-07-12T14:23:20+08:00 daily https://www.pharmasources.com/industryinsights/kunshan-qiangdi-we-focus-on-both-domesti-304667.html 0.6 2026-08-05T17:04:07+08:00 daily https://www.pharmasources.com/industryinsights/baoding-shenchen-our-overseas-business-i-304668.html 0.6 2026-06-25T00:44:40+08:00 daily https://www.pharmasources.com/industryinsights/guilin-seal-keeping-pace-with-the-times-304669.html 0.6 2026-06-24T07:10:27+08:00 daily https://www.pharmasources.com/industryinsights/guangzhou-hongke-customer-satisfaction-i-304670.html 0.6 2026-08-07T04:01:19+08:00 daily https://www.pharmasources.com/industryinsights/medopad-acquires-health-technology-firm--304671.html 0.6 2026-06-20T14:49:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-amgen-receive-breakthrou-304672.html 0.6 2026-08-03T02:03:52+08:00 daily https://www.pharmasources.com/industryinsights/walgreens-and-kalo-to-offer-auvi-q-shots-304673.html 0.6 2026-06-19T19:11:49+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-olon-spa-mannkind-shire-304674.html 0.6 2026-07-17T09:52:35+08:00 daily https://www.pharmasources.com/industryinsights/chi-meds-fruquintinib-gets-approval-for--304675.html 0.6 2026-06-20T23:59:36+08:00 daily https://www.pharmasources.com/industryinsights/regrowing-dental-tissue-with-stem-cells--304676.html 0.6 2026-06-20T23:59:40+08:00 daily https://www.pharmasources.com/industryinsights/statins-study-questions-their-widespread-304677.html 0.6 2026-06-29T21:46:42+08:00 daily https://www.pharmasources.com/industryinsights/wisely-machinery-we-have-developed-many--304678.html 0.6 2026-07-08T12:14:04+08:00 daily https://www.pharmasources.com/industryinsights/alcon-confirms-commitment-to-switzerland-304679.html 0.6 2026-06-21T19:47:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-304680.html 0.6 2026-06-20T16:55:35+08:00 daily https://www.pharmasources.com/industryinsights/quizartinib-receives-orphan-drug-designa-304681.html 0.6 2026-06-25T03:22:03+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-announces-date-of-fda-advisory-co-304682.html 0.6 2026-06-22T12:52:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-dosage-strength-of-bupr-304683.html 0.6 2026-08-08T02:44:00+08:00 daily https://www.pharmasources.com/industryinsights/zerbaxa-meets-primary-endpoints-304684.html 0.6 2026-04-06T08:19:51+08:00 daily https://www.pharmasources.com/industryinsights/pharm-d-solutions-issues-voluntary-recal-304685.html 0.6 2026-08-01T04:57:10+08:00 daily https://www.pharmasources.com/industryinsights/us-court-of-appeals-upholds-district-cou-304686.html 0.6 2026-06-20T20:08:46+08:00 daily https://www.pharmasources.com/industryinsights/medical-cannabis-effective-in-treating-w-304687.html 0.6 2026-06-22T05:59:37+08:00 daily https://www.pharmasources.com/industryinsights/medivir-appoints-new-cmo-304688.html 0.6 2026-06-21T06:52:54+08:00 daily https://www.pharmasources.com/industryinsights/immusant-to-develop-type-1-diabetes-vacc-304689.html 0.6 2026-06-20T21:01:08+08:00 daily https://www.pharmasources.com/industryinsights/whats-in-a-name-fcb-healths-powerhouse-s-304690.html 0.6 2026-06-22T05:48:27+08:00 daily https://www.pharmasources.com/industryinsights/endo-breaks-from-the-pack-with-opioid-li-304691.html 0.6 2026-06-21T01:00:46+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-strikes-tentative-deal-to-settle--304692.html 0.6 2026-07-08T06:19:18+08:00 daily https://www.pharmasources.com/industryinsights/new-us-legislation-aims-to-expedite-deve-304693.html 0.6 2026-08-05T06:16:41+08:00 daily https://www.pharmasources.com/industryinsights/chinas-self-developed-heart-stent-gets-r-304694.html 0.6 2026-07-23T16:31:01+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-novartis-to-distribute-pain--304695.html 0.6 2026-06-30T22:00:35+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-arm-to-acquire-shares-of-isra-304696.html 0.6 2026-06-22T03:51:37+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-tentative-nod-from-usf-304697.html 0.6 2026-06-20T17:57:28+08:00 daily https://www.pharmasources.com/industryinsights/exciting-skincare-to-protect-against-blu-304698.html 0.6 2026-06-22T10:56:49+08:00 daily https://www.pharmasources.com/industryinsights/bio-processing-and-manufacturing-league--304699.html 0.6 2026-06-20T21:21:23+08:00 daily https://www.pharmasources.com/industryinsights/conditional-approval-contributing-a-grea-304700.html 0.6 2026-06-27T15:42:51+08:00 daily https://www.pharmasources.com/industryinsights/new-drugs-that-have-received-conditional-304701.html 0.6 2026-08-08T00:11:14+08:00 daily https://www.pharmasources.com/industryinsights/sgs-invests-17m-to-expand-north-american-304702.html 0.6 2026-06-22T05:21:44+08:00 daily https://www.pharmasources.com/industryinsights/pci-pharma-services-to-acquire-sherpa-cl-304703.html 0.6 2026-06-22T18:24:08+08:00 daily https://www.pharmasources.com/industryinsights/pfenex-announces-new-coo-304704.html 0.6 2026-06-20T19:00:34+08:00 daily https://www.pharmasources.com/industryinsights/codiak-biosciences-appoints-evp-304705.html 0.6 2026-06-24T02:40:32+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-inhibrx-in-exclusive-mfg--304706.html 0.6 2026-06-21T08:20:33+08:00 daily https://www.pharmasources.com/industryinsights/dalton-invests-in-automated-sterile-liqu-304707.html 0.6 2026-06-22T04:51:36+08:00 daily https://www.pharmasources.com/industryinsights/wdbmd-acquires-dzs-clinical-services-304708.html 0.6 2026-07-05T22:10:40+08:00 daily https://www.pharmasources.com/industryinsights/pci-acquires-sherpa-clinical-packaging-304709.html 0.6 2026-03-17T22:47:52+08:00 daily https://www.pharmasources.com/industryinsights/changes-in-chinese-regulations-stimulate-304710.html 0.6 2026-08-09T17:29:49+08:00 daily https://www.pharmasources.com/industryinsights/driving-real-time-productivity-insights--304711.html 0.6 2026-08-07T05:22:34+08:00 daily https://www.pharmasources.com/industryinsights/drug-for-pancreatic-cancer-developed-by--304712.html 0.6 2026-08-09T22:06:31+08:00 daily https://www.pharmasources.com/industryinsights/alcon-confirms-commitment-to-switzerland-304713.html 0.6 2026-06-21T00:16:53+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-announces-submission-of-ind-for-304714.html 0.6 2026-06-21T04:03:46+08:00 daily https://www.pharmasources.com/industryinsights/amygdala-neurosciences-niaaa-to-conduct--304715.html 0.6 2026-06-20T20:50:27+08:00 daily https://www.pharmasources.com/industryinsights/oncternal-announces-first-patient-dosed--304716.html 0.6 2025-12-12T19:43:36+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-begins-phase-3-enro-304717.html 0.6 2026-06-21T07:01:56+08:00 daily https://www.pharmasources.com/industryinsights/takeda-set-to-move-from-deerfield-illino-304718.html 0.6 2026-08-03T01:29:33+08:00 daily https://www.pharmasources.com/industryinsights/hip-to-headaches-glaxosmithklines-cultur-304719.html 0.6 2026-06-21T15:11:44+08:00 daily https://www.pharmasources.com/industryinsights/gilead-galapagos-filgotinib-aces-first-p-304720.html 0.6 2026-06-20T14:43:17+08:00 daily https://www.pharmasources.com/industryinsights/atreca-bags-125m-as-solid-tumor-trial-co-304721.html 0.6 2026-06-21T07:12:07+08:00 daily https://www.pharmasources.com/industryinsights/merck-pfizer-intend-to-file-bavencio-inl-304722.html 0.6 2026-06-20T20:01:34+08:00 daily https://www.pharmasources.com/industryinsights/msd-to-file-antibiotic-zerbaxa-for-pneum-304723.html 0.6 2026-06-21T10:11:19+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-to-buy-minority-stake-in-isra-304724.html 0.6 2026-06-21T11:05:19+08:00 daily https://www.pharmasources.com/industryinsights/mhra-permits-cellgene-therapy-production-304725.html 0.6 2026-06-20T14:40:18+08:00 daily https://www.pharmasources.com/industryinsights/health-ministry-prohibits-manufacture-or-304726.html 0.6 2026-07-27T18:16:38+08:00 daily https://www.pharmasources.com/industryinsights/drl-launches-muscle-disease-drug-in-us-304727.html 0.6 2026-06-22T04:55:39+08:00 daily https://www.pharmasources.com/industryinsights/after-fda-about-face-amicus-galafold-nab-304728.html 0.6 2026-07-30T12:46:02+08:00 daily https://www.pharmasources.com/industryinsights/eyevance-pharmaceuticals-acquires-freshk-304729.html 0.6 2026-06-21T11:16:22+08:00 daily https://www.pharmasources.com/industryinsights/casma-therapeutics-announces-partnership-304730.html 0.6 2026-06-21T00:49:03+08:00 daily https://www.pharmasources.com/industryinsights/parexel-advances-patient-centric-drug-de-304731.html 0.6 2026-06-23T10:04:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-304732.html 0.6 2026-06-21T13:09:35+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharmas-mohali-plant-on-fda-radar-304733.html 0.6 2026-06-22T05:01:40+08:00 daily https://www.pharmasources.com/industryinsights/novartis-eyecare-unit-alcon-to-set-up-ne-304734.html 0.6 2026-06-21T05:15:52+08:00 daily https://www.pharmasources.com/industryinsights/opiant-pharmaceuticals-inc-and-consort-m-304735.html 0.6 2026-05-23T11:17:58+08:00 daily https://www.pharmasources.com/industryinsights/uk-health-improving-but-challenges-of-an-304736.html 0.6 2026-06-21T01:53:40+08:00 daily https://www.pharmasources.com/industryinsights/phrma-blames-hospitals-for-rising-drug-p-304737.html 0.6 2026-06-21T22:55:39+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-stockpiles-16-weeks-worth-o-304738.html 0.6 2026-06-21T03:02:52+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-fails-to-win-over-nice-as-adj-304739.html 0.6 2026-06-21T12:51:38+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-scores-ground-breaking-european-304740.html 0.6 2026-07-19T05:13:07+08:00 daily https://www.pharmasources.com/industryinsights/ec-green-lights-msds-keytruda-combo-for--304741.html 0.6 2026-06-13T06:34:25+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-opdivo-for-preventing-melan-304742.html 0.6 2026-06-21T19:44:35+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-amgens-tezepelumab-wins-brea-304743.html 0.6 2026-08-02T02:47:31+08:00 daily https://www.pharmasources.com/industryinsights/parents-technology-use-can-negatively-im-304744.html 0.6 2026-06-20T14:48:06+08:00 daily https://www.pharmasources.com/industryinsights/nhs-moves-to-clamp-down-on-incorrectfrau-304745.html 0.6 2026-06-20T14:46:06+08:00 daily https://www.pharmasources.com/industryinsights/fingolimod-cuts-multiple-sclerosis-relap-304746.html 0.6 2026-08-05T08:11:49+08:00 daily https://www.pharmasources.com/industryinsights/highest-opioid-related-mortality-seen-in-304747.html 0.6 2026-06-20T17:00:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-gets-tough-on-juul-other-electronic--304748.html 0.6 2026-06-21T04:59:43+08:00 daily https://www.pharmasources.com/industryinsights/us-regulators-reject-gsks-nucala-for-cop-304749.html 0.6 2026-06-21T06:58:56+08:00 daily https://www.pharmasources.com/industryinsights/at-least-15-men-near-ground-zero-have-br-304750.html 0.6 2026-06-22T09:12:06+08:00 daily https://www.pharmasources.com/industryinsights/btg-buys-irish-med-device-group-novate-304751.html 0.6 2026-08-08T02:25:29+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-completes-halo-acquisition-304752.html 0.6 2026-06-27T07:32:08+08:00 daily https://www.pharmasources.com/industryinsights/flodesign-cognate-announce-collaboration-304753.html 0.6 2026-06-22T00:12:56+08:00 daily https://www.pharmasources.com/industryinsights/bloom-science-biose-industrie-enter-mfg--304754.html 0.6 2026-06-23T04:18:26+08:00 daily https://www.pharmasources.com/industryinsights/trilink-biotechnologies-to-move-to-new-f-304755.html 0.6 2026-08-07T22:51:27+08:00 daily https://www.pharmasources.com/industryinsights/lilly-streams-5m-into-virtual-lab-pact-w-304756.html 0.6 2026-06-20T16:46:28+08:00 daily https://www.pharmasources.com/industryinsights/abzena-selects-sartorius-as-us-equipment-304757.html 0.6 2026-06-21T02:02:43+08:00 daily https://www.pharmasources.com/industryinsights/govt-sees-new-tech-as-key-to-nhs-success-304758.html 0.6 2026-06-21T12:58:44+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-sell-sandoz-assets-to-aurobi-304759.html 0.6 2026-06-21T03:58:48+08:00 daily https://www.pharmasources.com/industryinsights/can-sugar-pills-actually-relieve-chronic-304760.html 0.6 2026-06-20T22:11:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-kind-of-treatment-for-h-304761.html 0.6 2026-06-21T04:58:47+08:00 daily https://www.pharmasources.com/industryinsights/abbott-is-named-global-industry-leader-i-304762.html 0.6 2026-07-07T17:40:11+08:00 daily https://www.pharmasources.com/industryinsights/pall-aetos-biologics-announce-biosimilar-304763.html 0.6 2026-06-21T15:15:43+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-generic-brevibloc-injecti-304764.html 0.6 2026-07-19T21:35:16+08:00 daily https://www.pharmasources.com/industryinsights/showcase-your-agencys-abilitity-to-deal--304765.html 0.6 2026-06-20T18:09:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-crofab-product-improvements-304766.html 0.6 2026-07-22T19:32:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-eylea-injection-304767.html 0.6 2025-12-11T04:35:48+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-dsp-0509-trial-304768.html 0.6 2026-07-27T09:35:24+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-announces-organizational-change-304769.html 0.6 2026-06-22T21:31:06+08:00 daily https://www.pharmasources.com/industryinsights/invion-to-spinout-respiratory-assets-adv-304770.html 0.6 2026-06-20T19:17:03+08:00 daily https://www.pharmasources.com/industryinsights/gilead-taps-gene-editors-at-precision-bi-304771.html 0.6 2026-06-21T11:10:20+08:00 daily https://www.pharmasources.com/industryinsights/half-of-european-studies-fail-to-report--304772.html 0.6 2025-11-14T04:17:46+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-buys-oncolytic-virus-startup--304773.html 0.6 2026-06-22T05:05:23+08:00 daily https://www.pharmasources.com/industryinsights/is-moderna-prepping-for-biotechs-biggest-304774.html 0.6 2026-02-09T13:24:21+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-builds-case-for-potential-psorias-304775.html 0.6 2026-06-22T11:58:47+08:00 daily https://www.pharmasources.com/industryinsights/surfaces-biniszkiewicz-chappel-join-mpm--304776.html 0.6 2026-06-21T15:04:31+08:00 daily https://www.pharmasources.com/industryinsights/healthlynked-corp-announces-partnership--304777.html 0.6 2026-06-22T14:52:49+08:00 daily https://www.pharmasources.com/industryinsights/uk-first-eu-nation-to-launch-flutiform-k-304778.html 0.6 2026-06-23T11:54:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lumoxiti-304779.html 0.6 2026-06-20T17:54:21+08:00 daily https://www.pharmasources.com/industryinsights/cdc-about-one-in-five-us-adults-have-chr-304780.html 0.6 2026-05-01T18:01:57+08:00 daily https://www.pharmasources.com/industryinsights/takeda-may-sell-shire-assets-to-reduce-d-304781.html 0.6 2026-06-26T00:21:22+08:00 daily https://www.pharmasources.com/industryinsights/no-apparent-short-term-cancer-risk-from--304782.html 0.6 2026-06-20T19:56:49+08:00 daily https://www.pharmasources.com/industryinsights/ms-society-launches-petition-against-nic-304783.html 0.6 2026-06-22T11:52:51+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-exercises-option-to-304784.html 0.6 2026-06-21T02:57:07+08:00 daily https://www.pharmasources.com/industryinsights/experts-advise-against-universal-dna-seq-304785.html 0.6 2026-08-07T23:27:28+08:00 daily https://www.pharmasources.com/industryinsights/bayer-sanofi-in-executive-swap-as-french-304786.html 0.6 2026-06-22T14:49:00+08:00 daily https://www.pharmasources.com/industryinsights/pharmatimes-sales-awards-last-chance-to--304787.html 0.6 2026-06-21T08:47:02+08:00 daily https://www.pharmasources.com/industryinsights/including-calorie-count-on-menus-can-cut-304788.html 0.6 2026-06-21T11:19:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-review-of-filing-for-acordas-304789.html 0.6 2026-04-18T03:00:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-review-time-for-roches-tecen-304790.html 0.6 2026-06-23T02:48:45+08:00 daily https://www.pharmasources.com/industryinsights/new-chair-put-forward-for-nhs-england-304791.html 0.6 2026-06-21T06:20:15+08:00 daily https://www.pharmasources.com/industryinsights/teva-attracts-attention-from-pharma-priv-304792.html 0.6 2026-06-23T12:13:24+08:00 daily https://www.pharmasources.com/industryinsights/novartis-novo-glaxo-and-others-hunker-do-304793.html 0.6 2026-06-22T07:56:48+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-receives-emvo-approval-304794.html 0.6 2026-06-26T21:12:47+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-receives-emvo-approval-304795.html 0.6 2026-06-21T15:14:45+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-continues-new-york-expansion-w-304796.html 0.6 2026-06-20T16:51:26+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-calls-for-wider-use-of-biologi-304797.html 0.6 2025-12-12T18:03:58+08:00 daily https://www.pharmasources.com/industryinsights/pmi-biopharma-launches-research-and-mfg--304798.html 0.6 2026-05-03T14:21:01+08:00 daily https://www.pharmasources.com/industryinsights/teva-drops-development-of-laquinimod-304799.html 0.6 2026-06-20T14:35:48+08:00 daily https://www.pharmasources.com/industryinsights/particle-sciences-appoints-president-304800.html 0.6 2026-08-07T05:54:03+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-restructures-two-global-business--304801.html 0.6 2026-08-01T04:44:46+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-for-msds-keytruda-for-me-304802.html 0.6 2026-08-04T16:55:27+08:00 daily https://www.pharmasources.com/industryinsights/pall-aetos-partner-to-deliver-biosimilar-304803.html 0.6 2026-06-21T20:55:47+08:00 daily https://www.pharmasources.com/industryinsights/horizon-completes-enrollment-in-ted-tria-304804.html 0.6 2026-06-20T20:59:38+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-completes-halo-acquisition-304805.html 0.6 2026-08-01T23:01:12+08:00 daily https://www.pharmasources.com/industryinsights/study-discovers-immunotherapy-could-trea-304806.html 0.6 2026-08-07T15:45:41+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-strikes-deal-with-novartis-o-304807.html 0.6 2026-07-29T23:56:33+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-approves-funding-for-rare-di-304808.html 0.6 2026-06-21T14:58:23+08:00 daily https://www.pharmasources.com/industryinsights/80-at-risk-of-early-death-because-of-an--304809.html 0.6 2026-08-02T17:50:09+08:00 daily https://www.pharmasources.com/industryinsights/novo-oxford-uni-set-to-launch-diabetes-a-304810.html 0.6 2026-07-31T15:27:54+08:00 daily https://www.pharmasources.com/industryinsights/nhs-could-save-480m-a-year-by-cutting-ag-304811.html 0.6 2026-08-03T12:24:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-ends-two-duchenne-muscular-dystro-304812.html 0.6 2026-06-22T23:07:31+08:00 daily https://www.pharmasources.com/industryinsights/janssen-bags-new-eu-approval-for-darzale-304813.html 0.6 2026-08-02T04:29:04+08:00 daily https://www.pharmasources.com/industryinsights/az-lupus-therapy-fails-to-hit-the-mark-304814.html 0.6 2026-08-07T11:03:49+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-cablivi-cleared-for-rare-bleedin-304815.html 0.6 2026-06-22T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/evox-raises-35m-for-exosome-therapeutics-304816.html 0.6 2026-08-06T21:12:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-sunovions-adhd-drug-304817.html 0.6 2026-07-30T00:17:56+08:00 daily https://www.pharmasources.com/industryinsights/bayer-wins-us-nod-for-jivi-304818.html 0.6 2026-08-09T14:28:37+08:00 daily https://www.pharmasources.com/industryinsights/severe-asthma-patients-to-get-life-chang-304819.html 0.6 2026-08-08T08:59:00+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-msd-hiv-drugs-delstrigo-and--304820.html 0.6 2026-08-08T08:02:29+08:00 daily https://www.pharmasources.com/industryinsights/alnylams-rna-therapy-onpattro-bags-eu-no-304821.html 0.6 2026-08-07T13:54:56+08:00 daily https://www.pharmasources.com/industryinsights/shire-completes-sale-of-oncology-franchi-304822.html 0.6 2026-08-07T13:19:22+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-az-bydureon-bcise-device-304823.html 0.6 2026-08-07T01:11:41+08:00 daily https://www.pharmasources.com/industryinsights/janssens-first-of-its-kind-report-combat-304824.html 0.6 2026-08-07T00:40:06+08:00 daily https://www.pharmasources.com/industryinsights/rostec-to-build-unique-oncology-treatmen-304825.html 0.6 2026-08-07T00:40:15+08:00 daily https://www.pharmasources.com/industryinsights/biocad-sph-to-build-drug-substance-manuf-304826.html 0.6 2026-08-07T01:11:15+08:00 daily https://www.pharmasources.com/industryinsights/allergy-paid-search-pits-diverse-brands--304827.html 0.6 2026-08-07T01:21:44+08:00 daily https://www.pharmasources.com/industryinsights/with-eu-salivating-after-humira-biosims--304828.html 0.6 2026-08-08T20:48:01+08:00 daily https://www.pharmasources.com/industryinsights/kusum-group-of-companies-launches-90-cro-304829.html 0.6 2026-08-07T01:32:18+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-sparc-announce-fda-approval-o-304830.html 0.6 2026-06-23T12:26:24+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--304831.html 0.6 2026-08-07T00:59:33+08:00 daily https://www.pharmasources.com/industryinsights/lupins-nagpur-facility-inspection-conclu-304832.html 0.6 2026-08-07T00:43:00+08:00 daily https://www.pharmasources.com/industryinsights/merck-extends-io-lead-as-eu-oks-keytruda-304833.html 0.6 2026-08-07T00:57:27+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018091-304834.html 0.6 2026-08-07T02:52:25+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-to-invest-800m-in-rensselaer-304835.html 0.6 2026-08-07T03:03:03+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-acquire-bonti-for-195m-304836.html 0.6 2026-08-07T13:19:06+08:00 daily https://www.pharmasources.com/industryinsights/asymchem-passes-fda-inspection-at-api-mf-304837.html 0.6 2026-08-08T07:47:02+08:00 daily https://www.pharmasources.com/industryinsights/ips-to-provide-engineering-solutions-for-304838.html 0.6 2026-08-09T03:43:44+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-biotechs-pd-l1-detection-kit-vali-304839.html 0.6 2026-08-09T03:56:54+08:00 daily https://www.pharmasources.com/industryinsights/more-than-half-of-eu-clinical-trials-do--304840.html 0.6 2026-08-09T00:16:02+08:00 daily https://www.pharmasources.com/industryinsights/is-cancer-fundraising-fuelling-deceit-304841.html 0.6 2026-08-09T02:19:00+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-blood-pressure-drug-shows-promis-304842.html 0.6 2026-08-05T22:42:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-steps-up-action-to-ensure-quality-of-304843.html 0.6 2026-07-16T00:30:22+08:00 daily https://www.pharmasources.com/industryinsights/paracetamol-use-in-infancy-may-increase--304844.html 0.6 2026-08-03T13:10:38+08:00 daily https://www.pharmasources.com/industryinsights/computer-avatars-are-now-able-to-detect--304845.html 0.6 2026-07-19T00:12:13+08:00 daily https://www.pharmasources.com/industryinsights/dietary-fiber-reduces-brain-inflammation-304846.html 0.6 2026-08-04T10:49:53+08:00 daily https://www.pharmasources.com/industryinsights/allergan-snaps-up-bonti-304847.html 0.6 2026-06-21T07:00:58+08:00 daily https://www.pharmasources.com/industryinsights/the-lancet-respiratory-medicine-publishe-304848.html 0.6 2026-07-26T03:58:17+08:00 daily https://www.pharmasources.com/industryinsights/racing-ucb-and-roivant-argenx-clears-pha-304849.html 0.6 2026-06-21T06:20:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-lifts-clinical-hold-from-mersanas-br-304850.html 0.6 2026-06-20T22:06:38+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-chief-quality-officer-rec-304851.html 0.6 2026-07-20T05:01:15+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-novartis-targeted-skin-canc-304852.html 0.6 2025-11-13T06:21:16+08:00 daily https://www.pharmasources.com/industryinsights/tevas-anti-cgrp-drug-ajovy-cleared-for-m-304853.html 0.6 2026-06-20T17:02:14+08:00 daily https://www.pharmasources.com/industryinsights/its-an-industry-affair---new-medical-sci-304854.html 0.6 2026-08-09T19:44:53+08:00 daily https://www.pharmasources.com/industryinsights/viiv-submits-two-drug-regimen-for-hiv-in-304855.html 0.6 2026-01-14T09:01:09+08:00 daily https://www.pharmasources.com/industryinsights/az-to-file-triple-combination-therapy-fo-304856.html 0.6 2026-07-02T14:15:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-sebacia-microparticles-for-th-304857.html 0.6 2026-06-26T14:09:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-inbrija-nda-review-period-304858.html 0.6 2026-07-08T13:22:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ajovy-304859.html 0.6 2026-07-11T23:01:16+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-biotech-gets-pd-l1-detection-kit--304860.html 0.6 2026-07-19T22:02:32+08:00 daily https://www.pharmasources.com/industryinsights/roivant-launches-respivant-sciences-304861.html 0.6 2026-06-23T18:42:42+08:00 daily https://www.pharmasources.com/industryinsights/nih-to-accelerate-genetic-therapies-for--304862.html 0.6 2026-06-21T07:20:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-sbla-for-praluent-304863.html 0.6 2026-06-20T18:55:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-lin-bioscience-rare-pediatric-304864.html 0.6 2026-06-22T09:44:36+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-patient-reported-outcom-304865.html 0.6 2026-06-20T14:56:08+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-sparc-announce-fda-approval-o-304866.html 0.6 2026-07-15T14:21:44+08:00 daily https://www.pharmasources.com/industryinsights/epimab-announces-ind-filing-for-emb01-304867.html 0.6 2026-06-29T19:25:48+08:00 daily https://www.pharmasources.com/industryinsights/natera-signs-agreement-with-bristol-myer-304868.html 0.6 2026-06-20T11:10:48+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-acquire-bonti-304869.html 0.6 2026-06-21T05:09:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-kind-of-treatment-for-h-304870.html 0.6 2026-06-22T01:01:53+08:00 daily https://www.pharmasources.com/industryinsights/researchers-conduct-aspree-trial-to-stud-304871.html 0.6 2026-06-21T07:20:20+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-final-us-fda-nod-fo-304872.html 0.6 2026-06-29T11:45:05+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-us-fda-nod-for-diabe-304873.html 0.6 2026-08-09T07:19:47+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-does-not-reduce-heart-attack-str-304874.html 0.6 2026-07-27T19:00:08+08:00 daily https://www.pharmasources.com/industryinsights/nhs-summer-performance-hits-new-lows-304875.html 0.6 2026-06-21T10:20:20+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-buys-viratherapeutics-304876.html 0.6 2026-06-21T00:37:27+08:00 daily https://www.pharmasources.com/industryinsights/the-biggest-ever-trial-for-secondary-pro-304877.html 0.6 2026-06-20T22:15:51+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-az-hairy-cell-leukaemia-drug-304878.html 0.6 2026-06-21T05:14:57+08:00 daily https://www.pharmasources.com/industryinsights/ae-attendances-in-england-leap-22-in-a-d-304879.html 0.6 2026-06-20T18:37:10+08:00 daily https://www.pharmasources.com/industryinsights/gilead-precision-to-co-develop-hepatitis-304880.html 0.6 2026-06-21T08:06:12+08:00 daily https://www.pharmasources.com/industryinsights/realm-surrenders-after-back-to-back-clin-304881.html 0.6 2026-06-21T10:53:29+08:00 daily https://www.pharmasources.com/industryinsights/epic-sciences-gathers-52m-for-blood-test-304882.html 0.6 2026-06-22T11:00:50+08:00 daily https://www.pharmasources.com/industryinsights/xact-robotics-nets-ce-mark-5m-for-its-ro-304883.html 0.6 2026-06-20T19:02:37+08:00 daily https://www.pharmasources.com/industryinsights/tricking-muscles-into-burning-more-fat-304884.html 0.6 2026-06-22T01:01:55+08:00 daily https://www.pharmasources.com/industryinsights/allergan-defuses-botox-threat-with-195m--304885.html 0.6 2026-06-21T08:17:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-sets-back-review-date-of-acordas-lev-304886.html 0.6 2026-02-28T20:52:54+08:00 daily https://www.pharmasources.com/industryinsights/who-is-the-winner---meet-mr-right-buyers-304887.html 0.6 2026-06-21T03:04:42+08:00 daily https://www.pharmasources.com/industryinsights/5-months-after-launch-allogene-guns-for--304888.html 0.6 2026-06-13T11:43:06+08:00 daily https://www.pharmasources.com/industryinsights/supernus-adds-epilepsy-candidate-with-18-304889.html 0.6 2026-06-22T06:35:31+08:00 daily https://www.pharmasources.com/industryinsights/western-medicine-preparation-exportation-304890.html 0.6 2026-07-23T12:45:18+08:00 daily https://www.pharmasources.com/industryinsights/western-medicine-preparation-exportation-304891.html 0.6 2026-08-07T14:15:50+08:00 daily https://www.pharmasources.com/industryinsights/use-of-aspirin-in-healthy-elderly-questi-304892.html 0.6 2026-06-28T05:58:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-device-for-acute-coronary-a-304893.html 0.6 2026-06-28T01:48:12+08:00 daily https://www.pharmasources.com/industryinsights/factors-predictive-of-escalated-care-in--304894.html 0.6 2026-06-22T15:24:07+08:00 daily https://www.pharmasources.com/industryinsights/many-foster-kids-inappropriately-prescri-304895.html 0.6 2026-06-23T12:09:52+08:00 daily https://www.pharmasources.com/industryinsights/proportion-of-female-authors-rising-in-c-304896.html 0.6 2026-06-20T00:01:51+08:00 daily https://www.pharmasources.com/industryinsights/accenture-merck-amazon-partner-to-advanc-304897.html 0.6 2026-08-08T23:40:11+08:00 daily https://www.pharmasources.com/industryinsights/beigene-picks-ges-facility-to-boost-canc-304898.html 0.6 2026-08-07T14:01:26+08:00 daily https://www.pharmasources.com/industryinsights/china-fiji-ink-pact-for-health-and-welln-304899.html 0.6 2026-08-08T19:57:38+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-new-online-chatbot-availab-304900.html 0.6 2026-07-29T11:40:17+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-used-nurse-ambassadors-to-protect-304901.html 0.6 2026-06-19T22:54:02+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-gets-nod-from-south-afr-304902.html 0.6 2026-08-06T22:43:20+08:00 daily https://www.pharmasources.com/industryinsights/sc-allows-sale-of-saridon-three-other-dr-304903.html 0.6 2026-06-21T16:00:26+08:00 daily https://www.pharmasources.com/industryinsights/changes-of-the-global-hiv-drug-market-in-304904.html 0.6 2026-07-02T01:55:27+08:00 daily https://www.pharmasources.com/industryinsights/jobs-and-elon-musk-in-the-life-sciences--304905.html 0.6 2026-06-20T21:55:40+08:00 daily https://www.pharmasources.com/industryinsights/salidroside-among-the-three-legendary-tr-304906.html 0.6 2026-07-16T01:28:49+08:00 daily https://www.pharmasources.com/industryinsights/worlds-largest-alzheimers-survey-reveals-304907.html 0.6 2026-06-20T17:54:27+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-found-not-to-prolong-healthy-agi-304908.html 0.6 2026-04-10T05:23:48+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-announces-plans-to-transfor-304909.html 0.6 2026-06-21T01:06:46+08:00 daily https://www.pharmasources.com/industryinsights/braeburn-announces-positive-top-line-pha-304910.html 0.6 2026-06-21T11:19:30+08:00 daily https://www.pharmasources.com/industryinsights/relmada-provides-enrollment-update-in-re-304911.html 0.6 2026-06-21T06:01:46+08:00 daily https://www.pharmasources.com/industryinsights/oramed-receives-fda-clearance-for-ind-ap-304912.html 0.6 2026-07-29T08:09:00+08:00 daily https://www.pharmasources.com/industryinsights/fasenra-shows-consistent-safety-efficacy-304913.html 0.6 2026-06-21T05:01:42+08:00 daily https://www.pharmasources.com/industryinsights/viking-therapeutics-announces-positive-t-304914.html 0.6 2026-06-23T11:03:51+08:00 daily https://www.pharmasources.com/industryinsights/obi-pharma-granted-fda-orphan-drug-desig-304915.html 0.6 2026-06-22T20:56:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-encourage-appropriate-and-rationa-304916.html 0.6 2026-06-22T09:52:40+08:00 daily https://www.pharmasources.com/industryinsights/new-ai-tool-accurately-identifies-lung-c-304917.html 0.6 2026-06-21T22:03:45+08:00 daily https://www.pharmasources.com/industryinsights/ciscrp-releases-a-video-to-improve-diver-304918.html 0.6 2026-06-21T18:39:21+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-bags-receipt-of-european-comm-304919.html 0.6 2026-06-21T01:54:37+08:00 daily https://www.pharmasources.com/industryinsights/merck-follows-opdivos-suit-prices-keytru-304920.html 0.6 2026-08-08T01:23:43+08:00 daily https://www.pharmasources.com/industryinsights/sec-hands-clovis-20m-penalty-for-alleged-304921.html 0.6 2026-06-21T11:52:18+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-connects-to-european-hub-for-s-304922.html 0.6 2026-06-29T11:34:06+08:00 daily https://www.pharmasources.com/industryinsights/say-hello-to-sophia-novo-nordisks-new-on-304923.html 0.6 2026-06-22T10:35:33+08:00 daily https://www.pharmasources.com/industryinsights/novartis-moving-400-employees-to-amsterd-304924.html 0.6 2026-07-19T11:37:39+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biosimilar-to-stress-test-amgen-ne-304925.html 0.6 2026-08-06T08:40:05+08:00 daily https://www.pharmasources.com/industryinsights/nice-says-no-to-kymriah-for-adult-lympho-304926.html 0.6 2026-06-20T19:58:45+08:00 daily https://www.pharmasources.com/industryinsights/norgine-buys-rights-to-sell-shields-iron-304927.html 0.6 2026-02-28T21:29:25+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-novartis-car-t-kymriah-for--304928.html 0.6 2026-07-22T16:08:21+08:00 daily https://www.pharmasources.com/industryinsights/ai-drug-discovery-platform-gets-1m-innov-304929.html 0.6 2026-08-03T05:48:53+08:00 daily https://www.pharmasources.com/industryinsights/in-kickbacks-case-ca-insurance-chief-say-304930.html 0.6 2026-06-20T17:58:16+08:00 daily https://www.pharmasources.com/industryinsights/the-number-of-children-being-vaccinated--304931.html 0.6 2026-01-09T22:27:34+08:00 daily https://www.pharmasources.com/industryinsights/with-epipen-competitors-bearing-down-can-304932.html 0.6 2026-08-07T14:54:30+08:00 daily https://www.pharmasources.com/industryinsights/almirall-steps-into-psoriasis-market-wit-304933.html 0.6 2026-08-08T20:36:37+08:00 daily https://www.pharmasources.com/industryinsights/actelions-opsumit-shows-promise-in-porto-304934.html 0.6 2026-06-20T21:00:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-shut-out-of-copd-touts-long--304935.html 0.6 2026-06-21T13:20:53+08:00 daily https://www.pharmasources.com/industryinsights/allergan-sosei-suspend-clinical-developm-304936.html 0.6 2026-06-21T04:12:53+08:00 daily https://www.pharmasources.com/industryinsights/az-fasenra-shows-long-term-efficacy-in-e-304937.html 0.6 2026-07-02T20:26:41+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-invests-14m-in-london-cancer-bioth-304938.html 0.6 2026-06-21T06:43:35+08:00 daily https://www.pharmasources.com/industryinsights/new-study-to-explore-genetic-links-to-de-304939.html 0.6 2026-06-21T03:13:52+08:00 daily https://www.pharmasources.com/industryinsights/almiralls-ilumetri-scores-eu-approval-in-304940.html 0.6 2026-06-21T03:12:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-car-t-therapy-kymriah-for-d-304941.html 0.6 2026-08-09T16:04:35+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-relocate-arnhem-operations-t-304942.html 0.6 2026-06-21T18:11:31+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-increase-presence-in-chin-304943.html 0.6 2026-08-07T14:01:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-expand-rems-education-program-in-eff-304944.html 0.6 2026-06-21T09:15:13+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-announces-new-14m-res-304945.html 0.6 2026-06-21T12:58:16+08:00 daily https://www.pharmasources.com/industryinsights/rates-of-vaccination-decline-in-england--304946.html 0.6 2026-07-02T15:35:07+08:00 daily https://www.pharmasources.com/industryinsights/us-senate-pass-bipartisan-bill-to-tackle-304947.html 0.6 2026-06-21T04:45:42+08:00 daily https://www.pharmasources.com/industryinsights/us-house-of-representatives-blocks-drug--304948.html 0.6 2026-07-05T05:53:15+08:00 daily https://www.pharmasources.com/industryinsights/400-jobs-to-go-as-novo-nordisk-overhauls-304949.html 0.6 2026-06-20T19:07:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dupixent-improves-symptoms-for-a-304950.html 0.6 2026-06-21T03:52:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-astrazenecas-lumoxiti-for-h-304951.html 0.6 2026-07-06T04:34:55+08:00 daily https://www.pharmasources.com/industryinsights/allergan-acquires-neurotoxin-specialist--304952.html 0.6 2026-06-21T01:59:42+08:00 daily https://www.pharmasources.com/industryinsights/teva-shares-soar-after-migraine-treatmen-304953.html 0.6 2026-06-21T05:07:47+08:00 daily https://www.pharmasources.com/industryinsights/ucb-brings-promising-plaque-psoriasis-da-304954.html 0.6 2026-06-22T19:15:35+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-novartis-msd-novo-and-gsk-halt-op-304955.html 0.6 2026-06-21T01:58:49+08:00 daily https://www.pharmasources.com/industryinsights/scottish-government-invests-11m-into-gla-304956.html 0.6 2026-06-22T17:53:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-launch-plan-to-tackle-e-cig-epidemic-304957.html 0.6 2026-07-18T07:40:11+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-launches-new-research-304958.html 0.6 2026-06-21T15:55:16+08:00 daily https://www.pharmasources.com/industryinsights/niaid-and-childrens-national-boost-paedi-304959.html 0.6 2026-06-21T07:10:04+08:00 daily https://www.pharmasources.com/industryinsights/teva-secures-fda-approval-for-migraine-d-304960.html 0.6 2026-07-03T18:15:22+08:00 daily https://www.pharmasources.com/industryinsights/crispr-viacyte-team-up-to-develop-stem-c-304961.html 0.6 2026-06-21T19:15:39+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-daily-aspirin-does-not-reduc-304962.html 0.6 2026-06-22T11:47:43+08:00 daily https://www.pharmasources.com/industryinsights/the-merck-accelerator-program-2019-304963.html 0.6 2026-06-25T00:11:34+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-granted-fda-breakthrough-therapy--304964.html 0.6 2026-06-20T19:07:39+08:00 daily https://www.pharmasources.com/industryinsights/mylan-fujifilm-kyowa-kirin-biologics-rec-304965.html 0.6 2026-06-20T16:59:21+08:00 daily https://www.pharmasources.com/industryinsights/exicure-announces-positive-phase-1-resul-304966.html 0.6 2026-06-21T19:50:44+08:00 daily https://www.pharmasources.com/industryinsights/kymera-therapeutics-appoints-chief-medic-304967.html 0.6 2026-06-22T10:09:49+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-announces-research-collab-304968.html 0.6 2026-06-20T19:09:50+08:00 daily https://www.pharmasources.com/industryinsights/amgen-los-angeles-county-announce-collab-304969.html 0.6 2026-02-28T13:53:26+08:00 daily https://www.pharmasources.com/industryinsights/scientists-weigh-zika-vaccine-challenge--304970.html 0.6 2026-06-22T05:44:37+08:00 daily https://www.pharmasources.com/industryinsights/corbus-nets-over-600-endocannabinoid-rel-304971.html 0.6 2026-06-20T15:55:45+08:00 daily https://www.pharmasources.com/industryinsights/trial-takes-fibrogens-renal-anemia-drug--304972.html 0.6 2026-06-20T10:11:46+08:00 daily https://www.pharmasources.com/industryinsights/novartis-alcon-adds-online-training-port-304973.html 0.6 2026-06-21T03:19:58+08:00 daily https://www.pharmasources.com/industryinsights/uk-court-invalidates-gileads-truvada-pat-304974.html 0.6 2026-06-21T16:43:04+08:00 daily https://www.pharmasources.com/industryinsights/adverum-biotechnologies-receives-fast-tr-304975.html 0.6 2026-06-19T19:46:29+08:00 daily https://www.pharmasources.com/industryinsights/propanc-biopharma-enters-into-research-c-304976.html 0.6 2026-07-20T02:21:28+08:00 daily https://www.pharmasources.com/industryinsights/amsterdam-304977.html 0.6 2026-08-06T18:20:45+08:00 daily https://www.pharmasources.com/industryinsights/valeo-pharma-and-besins-healthcare-annou-304978.html 0.6 2026-06-21T04:08:58+08:00 daily https://www.pharmasources.com/industryinsights/5-benefits-of-bajaj-finserv-personal-loa-304979.html 0.6 2026-06-20T23:34:37+08:00 daily https://www.pharmasources.com/industryinsights/englands-cost-watchdogs-nix-novartis-kym-304980.html 0.6 2026-08-03T09:52:49+08:00 daily https://www.pharmasources.com/industryinsights/oceasoft-launches-cobalt-x2-its-new-gene-304981.html 0.6 2026-06-22T20:58:02+08:00 daily https://www.pharmasources.com/industryinsights/amgen-leaves-celeb-spokeswoman-blythe-da-304982.html 0.6 2026-07-04T12:56:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-encourages-appropriate-prescribing-o-304983.html 0.6 2026-06-21T11:13:32+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-fails-to-warn-of-pandemi-304984.html 0.6 2026-06-19T14:58:08+08:00 daily https://www.pharmasources.com/industryinsights/mylan-fujifilm-score-eu-thumbs-up-for-hu-304985.html 0.6 2026-08-04T19:37:47+08:00 daily https://www.pharmasources.com/industryinsights/allergan-eyeing-asia-for-growth-pours-14-304986.html 0.6 2026-08-06T01:59:30+08:00 daily https://www.pharmasources.com/industryinsights/gsk-grabs-new-drug-development-head-from-304987.html 0.6 2026-06-20T18:20:55+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-plots-china-robot-offensive--304988.html 0.6 2026-06-20T05:57:19+08:00 daily https://www.pharmasources.com/industryinsights/novel-computational-models-of-human-lung-304989.html 0.6 2026-07-29T12:09:57+08:00 daily https://www.pharmasources.com/industryinsights/who-calls-for-urgent-action-to-end-tb-304990.html 0.6 2026-06-22T09:09:50+08:00 daily https://www.pharmasources.com/industryinsights/abpi-enters-five-year-partnership-with-a-304991.html 0.6 2026-06-21T02:55:37+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-to-lay-off-400-employees-in-304992.html 0.6 2026-07-01T13:13:01+08:00 daily https://www.pharmasources.com/industryinsights/celgene-walks-away-from-oncomeds-navicix-304993.html 0.6 2026-06-21T08:48:54+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-to-test-cancer-drug-combo-304994.html 0.6 2026-06-21T09:54:17+08:00 daily https://www.pharmasources.com/industryinsights/new-compounds-may-prevent-spread-of-mala-304995.html 0.6 2026-06-21T11:13:25+08:00 daily https://www.pharmasources.com/industryinsights/eu-green-light-for-new-humira-biosimilar-304996.html 0.6 2026-06-22T01:47:32+08:00 daily https://www.pharmasources.com/industryinsights/zika-vaccine-shows-potential-for-brain-c-304997.html 0.6 2026-06-21T07:17:34+08:00 daily https://www.pharmasources.com/industryinsights/california-sues-abbvie-over-humira-kickb-304998.html 0.6 2026-06-21T10:12:17+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lumoxiti-secures-fda-nod-to-304999.html 0.6 2026-06-20T18:52:54+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-appoints-harvard-professo-305000.html 0.6 2026-07-26T12:23:11+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-announces-finalists-of-th-305001.html 0.6 2026-06-20T14:29:53+08:00 daily https://www.pharmasources.com/industryinsights/bayer-says-monsanto-india-integration-to-305002.html 0.6 2026-06-21T10:13:17+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-emory-sign-incubation-agreemen-305003.html 0.6 2026-06-20T22:51:32+08:00 daily https://www.pharmasources.com/industryinsights/changchun-high-new-technology-form-200-m-305004.html 0.6 2026-06-30T17:53:03+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-to-lay-off-400-employees-in-305005.html 0.6 2026-06-20T22:59:38+08:00 daily https://www.pharmasources.com/industryinsights/janssen-announces-mixed-results-of-esket-305006.html 0.6 2026-06-21T06:12:53+08:00 daily https://www.pharmasources.com/industryinsights/new-compounds-may-prevent-spread-of-mala-305007.html 0.6 2026-06-20T15:00:12+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-launch-authorised-generic-vers-305008.html 0.6 2026-07-30T15:48:57+08:00 daily https://www.pharmasources.com/industryinsights/alexion-eyes-500m-plus-in-new-soliris-sa-305010.html 0.6 2026-06-21T04:36:37+08:00 daily https://www.pharmasources.com/industryinsights/allergan-amps-aesthetics-advertising-in--305011.html 0.6 2026-02-28T15:37:08+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-backs-the-16-vaccine-campaign-to--305012.html 0.6 2026-06-20T22:17:13+08:00 daily https://www.pharmasources.com/industryinsights/english-court-backs-nhs-in-fight-with-ba-305013.html 0.6 2026-06-21T10:59:23+08:00 daily https://www.pharmasources.com/industryinsights/lillys-cgrp-emgality-and-sparks-luxturna-305014.html 0.6 2026-08-09T10:15:52+08:00 daily https://www.pharmasources.com/industryinsights/the-top-10-drugmakers-of-2024-305015.html 0.6 2026-08-01T12:04:27+08:00 daily https://www.pharmasources.com/industryinsights/biosimilars-market-to-increase-to-6147-b-305016.html 0.6 2026-06-23T12:06:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-axing-19-of-its-workforce-faces-305017.html 0.6 2026-06-30T13:33:21+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-astrazeneca-immunotherapy-dr-305018.html 0.6 2026-06-21T11:20:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-12-grants-to-fund-new-clinica-305019.html 0.6 2026-06-21T08:54:54+08:00 daily https://www.pharmasources.com/industryinsights/pre-clinical-success-for-a-universal-flu-305020.html 0.6 2026-07-06T02:38:40+08:00 daily https://www.pharmasources.com/industryinsights/dna-islands-effective-as-anti-bacterial--305021.html 0.6 2026-06-20T21:19:16+08:00 daily https://www.pharmasources.com/industryinsights/immutep-collaborates-with-merck-pfizer-f-305022.html 0.6 2026-06-22T05:49:49+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-file-entrectinib-for-ros-1-posi-305023.html 0.6 2026-06-21T11:45:34+08:00 daily https://www.pharmasources.com/industryinsights/az-imfinzi-reduces-risk-of-death-by-32-i-305024.html 0.6 2026-07-27T18:28:22+08:00 daily https://www.pharmasources.com/industryinsights/life-expectancy-growth-stalls-for-the-fi-305025.html 0.6 2026-06-20T14:50:07+08:00 daily https://www.pharmasources.com/industryinsights/takedas-alunbrig-shows-promise-as-first--305026.html 0.6 2026-07-03T13:57:49+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-shutter-grimsby-site-amid-ma-305027.html 0.6 2026-07-17T01:58:59+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-verastems-copiktra-for-blood-c-305028.html 0.6 2026-06-22T13:05:13+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-file-lucentis-for-rare-sight-305029.html 0.6 2026-06-20T14:48:58+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-new-option-for-metastatic-me-305030.html 0.6 2026-06-20T23:10:48+08:00 daily https://www.pharmasources.com/industryinsights/marking-a-bumper-month-for-committee-for-305031.html 0.6 2026-03-20T11:32:39+08:00 daily https://www.pharmasources.com/industryinsights/high-court-rejects-novartis-bayers-bid-t-305032.html 0.6 2026-06-21T07:04:57+08:00 daily https://www.pharmasources.com/industryinsights/congrats-ken-frazier-mercks-board-scraps-305033.html 0.6 2026-07-07T17:41:08+08:00 daily https://www.pharmasources.com/industryinsights/takedas-alunbrig-trounces-pfizer-drug-in-305034.html 0.6 2026-06-20T14:44:03+08:00 daily https://www.pharmasources.com/industryinsights/medical-scientific-excellence-awards---h-305035.html 0.6 2026-06-22T11:51:46+08:00 daily https://www.pharmasources.com/industryinsights/how-samsung-biologics-end-to-end-service-305036.html 0.6 2026-06-30T19:48:34+08:00 daily https://www.pharmasources.com/industryinsights/astellas-oncologys-crowdsourced-c3-prize-305037.html 0.6 2026-04-12T11:23:44+08:00 daily https://www.pharmasources.com/industryinsights/easy-as-1-2-3-gsks-triple-copd-drug-trel-305038.html 0.6 2026-08-06T17:15:51+08:00 daily https://www.pharmasources.com/industryinsights/arena-pharmaceuticals-reports-positive-r-305039.html 0.6 2026-06-21T09:55:04+08:00 daily https://www.pharmasources.com/industryinsights/blincyto-approved-in-japan-305040.html 0.6 2026-06-21T08:57:59+08:00 daily https://www.pharmasources.com/industryinsights/2018-pm-society-digital-awards-winners-a-305041.html 0.6 2026-06-22T08:03:48+08:00 daily https://www.pharmasources.com/industryinsights/abpi-enters-five-year-partnership-with-a-305042.html 0.6 2026-06-23T09:58:41+08:00 daily https://www.pharmasources.com/industryinsights/celgene-walks-away-from-oncomeds-navicix-305043.html 0.6 2026-06-21T10:08:09+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-to-test-cancer-drug-combo-305044.html 0.6 2026-06-20T21:06:50+08:00 daily https://www.pharmasources.com/industryinsights/catabasis-pharmaceuticals-initiates-phas-305045.html 0.6 2026-06-21T03:58:49+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-forms-30m-partnership-with-eu-canc-305046.html 0.6 2026-07-19T13:40:36+08:00 daily https://www.pharmasources.com/industryinsights/setback-for-pharmings-bid-to-expand-use--305047.html 0.6 2026-07-08T07:47:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-12-grants-to-fund-new-clinica-305048.html 0.6 2026-06-20T14:52:04+08:00 daily https://www.pharmasources.com/industryinsights/eu-green-light-for-new-humira-biosimilar-305049.html 0.6 2026-06-23T12:39:54+08:00 daily https://www.pharmasources.com/industryinsights/siteone-therapeutics-receives-nih-grant-305050.html 0.6 2026-07-06T20:19:59+08:00 daily https://www.pharmasources.com/industryinsights/astellas-kidney-disease-drug-shows-promi-305051.html 0.6 2026-07-22T04:49:45+08:00 daily https://www.pharmasources.com/industryinsights/nutriband-to-acquire-carmel-biosciences-305052.html 0.6 2026-06-22T07:05:54+08:00 daily https://www.pharmasources.com/industryinsights/georgia-bio-appoints-acting-president-an-305053.html 0.6 2026-02-28T19:21:15+08:00 daily https://www.pharmasources.com/industryinsights/addex-joins-uk-drug-and-brain-research-i-305054.html 0.6 2026-06-20T19:59:37+08:00 daily https://www.pharmasources.com/industryinsights/aldeyra-therapeutics-announces-positive--305055.html 0.6 2026-06-20T20:08:38+08:00 daily https://www.pharmasources.com/industryinsights/reatas-bardoxolone-hits-goals-in-phase-2-305056.html 0.6 2026-06-24T01:12:15+08:00 daily https://www.pharmasources.com/industryinsights/alexions-soliris-almost-entirely-elimina-305057.html 0.6 2026-06-21T23:49:55+08:00 daily https://www.pharmasources.com/industryinsights/emergency-eeg-maker-ceribell-raises-35m--305058.html 0.6 2026-06-22T03:01:39+08:00 daily https://www.pharmasources.com/industryinsights/takedas-lung-cancer-treatment-alunbrig-p-305059.html 0.6 2026-06-21T12:02:10+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriqchemo-combo-shows-first--305060.html 0.6 2026-06-24T01:31:14+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-expands-strategic-collab-305061.html 0.6 2026-07-08T00:31:09+08:00 daily https://www.pharmasources.com/industryinsights/tg-stock-sinks-after-setback-to-blood-ca-305062.html 0.6 2026-06-20T22:02:41+08:00 daily https://www.pharmasources.com/industryinsights/arena-3-for-3-as-crohns-drug-meets-proof-305063.html 0.6 2026-06-21T02:56:32+08:00 daily https://www.pharmasources.com/industryinsights/gemphire-cuts-33-of-staff-including-cfo--305064.html 0.6 2026-06-21T20:54:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-boston-scis-eluvia-drug-eluting--305065.html 0.6 2026-06-21T00:06:37+08:00 daily https://www.pharmasources.com/industryinsights/curis-moves-up-coo-as-ceo-fattaey-leaves-305066.html 0.6 2026-06-21T23:00:44+08:00 daily https://www.pharmasources.com/industryinsights/roche-backed-minoryx-raises-21m-to-expan-305067.html 0.6 2026-06-21T04:19:09+08:00 daily https://www.pharmasources.com/industryinsights/scientists-look-to-chinese-soup-ingredie-305068.html 0.6 2026-06-22T00:58:45+08:00 daily https://www.pharmasources.com/industryinsights/latest-lung-cancer-data-could-open-new-a-305069.html 0.6 2026-06-20T14:29:19+08:00 daily https://www.pharmasources.com/industryinsights/az-grabs-eu-approval-for-imfinzi-in-adva-305070.html 0.6 2026-06-21T14:32:24+08:00 daily https://www.pharmasources.com/industryinsights/patients-call-for-end-to-cf-drug-price-r-305071.html 0.6 2026-06-21T08:58:55+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-cut-2200-jobs-in-switzerland-305072.html 0.6 2026-06-21T03:12:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-12-grants-to-fund-new-clinica-305073.html 0.6 2026-06-21T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/gilead-launches-generics-of-own-hepatiti-305074.html 0.6 2026-07-09T03:44:36+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-trial-cancer-combinatio-305075.html 0.6 2026-06-08T06:30:44+08:00 daily https://www.pharmasources.com/industryinsights/roche-aims-to-improve-cancer-treatments--305076.html 0.6 2026-05-05T08:52:56+08:00 daily https://www.pharmasources.com/industryinsights/public-inquiry-investigates-thousands-of-305077.html 0.6 2026-06-22T09:11:54+08:00 daily https://www.pharmasources.com/industryinsights/alexion-to-acquire-syntimmune-305078.html 0.6 2026-06-21T23:11:49+08:00 daily https://www.pharmasources.com/industryinsights/inhaler-delivers-cannabinoids-faster-at--305079.html 0.6 2026-06-21T06:56:50+08:00 daily https://www.pharmasources.com/industryinsights/big-pharmas-antibody-drugs-for-asthma-sh-305080.html 0.6 2026-06-19T16:05:13+08:00 daily https://www.pharmasources.com/industryinsights/ema-feeling-better-about-drug-supply-int-305081.html 0.6 2026-06-20T20:19:49+08:00 daily https://www.pharmasources.com/industryinsights/pps-continuous-manufacturing-should-be-f-305082.html 0.6 2026-07-19T21:02:08+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-launch-generic-versions-of-hep-305083.html 0.6 2026-06-29T10:18:10+08:00 daily https://www.pharmasources.com/industryinsights/gsk-candidate-vaccine-helps-prevent-acti-305084.html 0.6 2026-06-20T20:55:47+08:00 daily https://www.pharmasources.com/industryinsights/alexion-snaps-up-another-biotech-paying--305085.html 0.6 2026-06-21T03:07:49+08:00 daily https://www.pharmasources.com/industryinsights/aldeyra-plans-reproxalap-phase-3-after-w-305086.html 0.6 2026-06-26T22:03:05+08:00 daily https://www.pharmasources.com/industryinsights/blueprints-tagrisso-combination-shows-ea-305087.html 0.6 2026-08-08T01:23:40+08:00 daily https://www.pharmasources.com/industryinsights/imdrf-to-launch-new-cybersecurity-harmon-305088.html 0.6 2026-07-30T09:49:45+08:00 daily https://www.pharmasources.com/industryinsights/antibody-combo-controls-hiv-for-months-305089.html 0.6 2026-06-21T01:42:46+08:00 daily https://www.pharmasources.com/industryinsights/butterfly-network-nets-250m-to-start-shi-305090.html 0.6 2026-07-15T16:06:20+08:00 daily https://www.pharmasources.com/industryinsights/f-prime-atlas-lead-cancer-startup-akrevi-305091.html 0.6 2026-06-20T15:42:39+08:00 daily https://www.pharmasources.com/industryinsights/spinal-stimulation-physical-therapy-comb-305092.html 0.6 2026-07-19T16:24:19+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-eyes-quickie-givosiran-filing-af-305093.html 0.6 2026-06-21T01:01:44+08:00 daily https://www.pharmasources.com/industryinsights/decibel-adds-first-clinical-candidate-wi-305094.html 0.6 2026-06-23T15:47:21+08:00 daily https://www.pharmasources.com/industryinsights/bayer-appoints-lead-for-pharmaceuticals--305095.html 0.6 2026-06-24T01:55:02+08:00 daily https://www.pharmasources.com/industryinsights/achieve-announces-study-results-demonstr-305096.html 0.6 2026-07-07T17:14:09+08:00 daily https://www.pharmasources.com/industryinsights/protagonist-therapeutics-announces-fast--305097.html 0.6 2026-06-22T13:23:29+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sharpens-imfinzis-lung-cance-305098.html 0.6 2026-08-07T04:57:10+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-completes-dosing-of-patients-t-305099.html 0.6 2026-08-07T04:49:03+08:00 daily https://www.pharmasources.com/industryinsights/big-pharmas-antibody-drugs-for-asthma-sh-305100.html 0.6 2026-08-07T04:36:46+08:00 daily https://www.pharmasources.com/industryinsights/ganovo-gets-enrolled-in-basic-medical-in-305101.html 0.6 2026-06-22T19:41:20+08:00 daily https://www.pharmasources.com/industryinsights/news-of-notebavarian-nordic-flugen-and-m-305102.html 0.6 2026-08-07T04:25:07+08:00 daily https://www.pharmasources.com/industryinsights/pall-and-g-con-manufacturing-announce-co-305103.html 0.6 2026-08-07T04:27:51+08:00 daily https://www.pharmasources.com/industryinsights/global-survey-reveals-that-physicians-ne-305104.html 0.6 2026-08-07T00:53:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-all-in-on-advancing-next-generati-305105.html 0.6 2026-08-07T00:39:47+08:00 daily https://www.pharmasources.com/industryinsights/outbreak-alliance-hands-johnson-johnson--305106.html 0.6 2026-08-07T01:21:39+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-research-by-scientists-on-c-305107.html 0.6 2026-08-07T00:59:18+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-sharpens-ax-for-650-job--305108.html 0.6 2026-08-07T01:14:16+08:00 daily https://www.pharmasources.com/industryinsights/selexis-sa-and-hoba-therapeutics-team-up-305109.html 0.6 2026-08-09T13:10:06+08:00 daily https://www.pharmasources.com/industryinsights/bayer-taps-veteran-sebastian-guth-to-lea-305110.html 0.6 2026-06-21T06:21:20+08:00 daily https://www.pharmasources.com/industryinsights/nutriband-inc-signs-acquisition-agreemen-305111.html 0.6 2026-07-07T05:04:21+08:00 daily https://www.pharmasources.com/industryinsights/biopharmas-to-disclose-payments-to-nurse-305112.html 0.6 2026-06-21T03:03:42+08:00 daily https://www.pharmasources.com/industryinsights/cdw-holding-to-sell-part-of-loss-making--305113.html 0.6 2026-06-20T19:55:32+08:00 daily https://www.pharmasources.com/industryinsights/global-survey-reveals-that-physicians-ne-305114.html 0.6 2026-06-21T06:12:58+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-portico-transcatheter-aortic-val-305115.html 0.6 2026-08-07T23:40:09+08:00 daily https://www.pharmasources.com/industryinsights/poor-diabetes-control-leads-to-increased-305116.html 0.6 2026-06-21T00:58:50+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-eu-and-us-pv-regulations-and-305117.html 0.6 2026-06-22T06:20:37+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-eu-and-us-pv-regulations-and-305118.html 0.6 2026-07-21T00:00:04+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-eu-and-us-pv-regulations-and-305119.html 0.6 2026-07-27T13:59:24+08:00 daily https://www.pharmasources.com/industryinsights/thunder-god-vine-poison-or-miracle-anti--305120.html 0.6 2026-06-21T05:16:57+08:00 daily https://www.pharmasources.com/industryinsights/global-cgrp-drug-market-expected-to-reac-305121.html 0.6 2026-08-09T01:48:01+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-for--305122.html 0.6 2026-08-07T00:41:04+08:00 daily https://www.pharmasources.com/industryinsights/emgality-receives-fda-approval-for-the-p-305123.html 0.6 2026-06-20T14:56:09+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-announces-fda-approval-of-pediatr-305124.html 0.6 2026-06-21T09:11:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dacomitinib-for-metastatic--305125.html 0.6 2026-04-21T17:47:37+08:00 daily https://www.pharmasources.com/industryinsights/hightide-therapeutics-receives-fast-trac-305126.html 0.6 2026-06-20T21:07:48+08:00 daily https://www.pharmasources.com/industryinsights/epidiolex-placed-in-schedule-v-of-contro-305127.html 0.6 2026-06-21T03:41:39+08:00 daily https://www.pharmasources.com/industryinsights/walgreens-boots-alliance-announces-agree-305128.html 0.6 2026-08-08T11:54:44+08:00 daily https://www.pharmasources.com/industryinsights/ksq-grabs-80m-to-move-t-cell-treatment-f-305129.html 0.6 2026-08-03T10:32:07+08:00 daily https://www.pharmasources.com/industryinsights/lillys-emgality-wins-first-nod-for-migra-305130.html 0.6 2026-06-21T04:01:44+08:00 daily https://www.pharmasources.com/industryinsights/roche-pays-70m-upfront-for-tusks-preclin-305131.html 0.6 2026-07-03T16:34:01+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharmas-epidiolex-nears-us-launch-305132.html 0.6 2026-06-21T21:50:45+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-pledges-10m-to-support-gp-se-305133.html 0.6 2026-08-06T19:22:08+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-car-t-partner-genscript--305134.html 0.6 2026-06-25T11:13:23+08:00 daily https://www.pharmasources.com/industryinsights/us-green-light-for-pfizers-lung-cancer-d-305135.html 0.6 2026-06-21T04:17:13+08:00 daily https://www.pharmasources.com/industryinsights/ema-mhra-and-glaxosmithkline-blast-bmjs--305136.html 0.6 2026-06-21T01:12:53+08:00 daily https://www.pharmasources.com/industryinsights/lillys-snaps-up-chugais-experimental-dia-305137.html 0.6 2026-07-23T11:37:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-once-failed-vizimpro-rebounds-wi-305138.html 0.6 2026-06-21T06:09:47+08:00 daily https://www.pharmasources.com/industryinsights/janssen-hands-back-rights-to-imetelstat-305139.html 0.6 2026-07-04T16:26:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-allergans-vraylar-for-review-305140.html 0.6 2026-03-27T01:37:35+08:00 daily https://www.pharmasources.com/industryinsights/draft-nice-decision-rejects-respreeza-fo-305141.html 0.6 2026-06-21T04:57:44+08:00 daily https://www.pharmasources.com/industryinsights/cellular-biomedicine-group-enters-into-s-305142.html 0.6 2026-08-03T11:04:34+08:00 daily https://www.pharmasources.com/industryinsights/emerald-health-pharmaceuticals-initiates-305143.html 0.6 2026-06-21T00:01:42+08:00 daily https://www.pharmasources.com/industryinsights/protagonist-therapeutics-announces-fast--305144.html 0.6 2026-06-20T14:39:39+08:00 daily https://www.pharmasources.com/industryinsights/dova-pharmaceuticals-and-salix-enter-int-305145.html 0.6 2026-06-19T19:59:46+08:00 daily https://www.pharmasources.com/industryinsights/daxor-corporation-appoints-robert-j-mich-305146.html 0.6 2026-07-03T08:22:33+08:00 daily https://www.pharmasources.com/industryinsights/novartis-strike-40m-deal-with-chinese-fi-305147.html 0.6 2026-06-22T10:57:44+08:00 daily https://www.pharmasources.com/industryinsights/novartis-collaborates-with-cellular-biom-305148.html 0.6 2026-07-20T23:26:23+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-release-generic-versions-of-he-305149.html 0.6 2026-06-20T14:52:02+08:00 daily https://www.pharmasources.com/industryinsights/selexis-hoba-therapeutics-in-development-305150.html 0.6 2026-06-21T02:13:49+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-accused-of-using-brexit-to-305151.html 0.6 2026-06-21T16:06:28+08:00 daily https://www.pharmasources.com/industryinsights/novartis-joins-forces-with-gardp-for-bet-305152.html 0.6 2026-06-21T10:04:21+08:00 daily https://www.pharmasources.com/industryinsights/researchers-eliminate-mosquito-populatio-305153.html 0.6 2026-06-20T23:58:36+08:00 daily https://www.pharmasources.com/industryinsights/ema-mhra-and-glaxosmithkline-blast-bmjs--305154.html 0.6 2026-06-09T16:30:45+08:00 daily https://www.pharmasources.com/industryinsights/lillys-emgality-nabs-third-to-market-mig-305155.html 0.6 2026-06-21T23:52:04+08:00 daily https://www.pharmasources.com/industryinsights/are-tiny-soft-robots-the-future-of-drug--305156.html 0.6 2026-03-24T02:22:58+08:00 daily https://www.pharmasources.com/industryinsights/us-china-trade-war-takedas-alunbrig-beat-305157.html 0.6 2026-08-07T01:21:33+08:00 daily https://www.pharmasources.com/industryinsights/bayer-taps-veteran-sebastian-guth-to-lea-305158.html 0.6 2026-06-21T06:07:58+08:00 daily https://www.pharmasources.com/industryinsights/not-just-doctors-biopharmas-to-disclose--305159.html 0.6 2026-06-21T01:05:47+08:00 daily https://www.pharmasources.com/industryinsights/diamedica-ahon-pharma-sign-license-agree-305160.html 0.6 2026-07-04T17:27:48+08:00 daily https://www.pharmasources.com/industryinsights/vetter-grants-award-for-novel-idea-at-in-305161.html 0.6 2026-06-22T00:51:46+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-to-slash-250-us-jobs-in-the-305162.html 0.6 2026-06-21T17:51:39+08:00 daily https://www.pharmasources.com/industryinsights/vivus-diving-into-the-cystic-fibrosis-sp-305163.html 0.6 2026-06-21T06:02:48+08:00 daily https://www.pharmasources.com/industryinsights/outbreak-alliance-hands-johnson-johnson--305164.html 0.6 2026-06-21T01:01:46+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-blast-chinas-zhejiang-huah-305165.html 0.6 2026-07-05T03:04:23+08:00 daily https://www.pharmasources.com/industryinsights/invion-spin-off-selects-leading-cro-for--305166.html 0.6 2026-06-21T09:45:48+08:00 daily https://www.pharmasources.com/industryinsights/senzers-inhaler-delivers-cannabinoids-fa-305167.html 0.6 2026-01-13T07:02:19+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-australian-tga-appr-305168.html 0.6 2026-06-20T14:59:09+08:00 daily https://www.pharmasources.com/industryinsights/takeda-gets-positive-chmp-opinion-for-al-305169.html 0.6 2026-07-24T12:55:19+08:00 daily https://www.pharmasources.com/industryinsights/changchun-high-new-technology-form-200-m-305170.html 0.6 2026-06-21T22:59:43+08:00 daily https://www.pharmasources.com/industryinsights/us-regulator-approves-tevas-migraine-dru-305171.html 0.6 2026-07-04T15:48:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-opens-s20-m-lab-in-singapore-305172.html 0.6 2026-06-21T11:40:49+08:00 daily https://www.pharmasources.com/industryinsights/obi-pharma-receives-fda-odd-for-obi-3424-305173.html 0.6 2026-06-22T05:54:40+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-gets-sa-health-authorit-305174.html 0.6 2025-12-29T03:05:49+08:00 daily https://www.pharmasources.com/industryinsights/neurimmune-achieves-milestone-with-ono-p-305175.html 0.6 2026-06-21T02:05:47+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-to-buy-minority-stake-in-isra-305176.html 0.6 2026-06-30T16:01:53+08:00 daily https://www.pharmasources.com/industryinsights/us-and-cuba-form-biotech-joint-venture-t-305177.html 0.6 2026-08-06T07:01:38+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-novartis-to-distribute-pain--305178.html 0.6 2026-07-30T17:34:54+08:00 daily https://www.pharmasources.com/industryinsights/korea-approves-opdivo-yervoy-for-renal-c-305179.html 0.6 2026-06-21T10:27:11+08:00 daily https://www.pharmasources.com/industryinsights/merck-bags-usfda-approval-for-2-new-hiv--305180.html 0.6 2026-06-21T08:14:12+08:00 daily https://www.pharmasources.com/industryinsights/vertex-announces-reimbursement-agreement-305181.html 0.6 2026-06-20T15:12:17+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-appoints-mr-joshua-zhongbao-lin-305182.html 0.6 2026-06-21T12:28:36+08:00 daily https://www.pharmasources.com/industryinsights/in-clinical-trials-new-antibody-therapy--305183.html 0.6 2026-06-21T06:03:50+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-announces-plans-to-transfor-305184.html 0.6 2026-06-21T06:56:49+08:00 daily https://www.pharmasources.com/industryinsights/worlds-largest-alzheimers-survey-reveals-305185.html 0.6 2026-06-20T22:56:43+08:00 daily https://www.pharmasources.com/industryinsights/clinical-gene-discovery-program-solves-3-305187.html 0.6 2026-06-22T06:00:44+08:00 daily https://www.pharmasources.com/industryinsights/hookipa-biotech-initiates-first-in-human-305188.html 0.6 2026-06-21T17:59:25+08:00 daily https://www.pharmasources.com/industryinsights/brazilian-court-strips-gilead-of-its-pat-305189.html 0.6 2026-08-07T19:39:13+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-for--305190.html 0.6 2026-08-07T15:25:55+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-for--305191.html 0.6 2026-08-07T00:02:04+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-characterization-for--305192.html 0.6 2026-08-07T00:42:40+08:00 daily https://www.pharmasources.com/industryinsights/believe-it-just-as-amarin-promised-vasce-305193.html 0.6 2026-08-07T18:16:09+08:00 daily https://www.pharmasources.com/industryinsights/say-hello-to-sophia-novo-nordisks-new-on-305194.html 0.6 2026-08-07T13:19:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-berates-chinese-drugmaker-tied-to-gl-305195.html 0.6 2026-08-07T05:52:04+08:00 daily https://www.pharmasources.com/industryinsights/allergan-adds-actor-scott-eastwood-to-al-305196.html 0.6 2026-08-07T05:45:49+08:00 daily https://www.pharmasources.com/industryinsights/englands-cost-watchdogs-nix-novartis-kym-305197.html 0.6 2026-08-07T05:39:44+08:00 daily https://www.pharmasources.com/industryinsights/sun-wins-approval-of-glaucoma-drug-and-i-305198.html 0.6 2026-08-07T05:37:07+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-glass-packaging-market-to-305199.html 0.6 2026-08-06T23:37:55+08:00 daily https://www.pharmasources.com/industryinsights/evidence-mounts-linking-aspirin-to-lower-305200.html 0.6 2026-08-06T20:00:29+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-names-new-ceo-305201.html 0.6 2026-08-06T23:32:50+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-hold-on-to-its-antibiotics-busine-305202.html 0.6 2026-08-06T23:36:34+08:00 daily https://www.pharmasources.com/industryinsights/pharma-manufacturers-that-dont-invest-in-305203.html 0.6 2026-08-06T23:55:48+08:00 daily https://www.pharmasources.com/industryinsights/patient-death-following-car-t-therapy-hi-305204.html 0.6 2026-08-07T13:17:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-licenses-three-novel-anti-infec-305205.html 0.6 2026-06-21T06:00:46+08:00 daily https://www.pharmasources.com/industryinsights/movement-on-the-market-reflected-at-cphi-305206.html 0.6 2026-06-21T14:58:52+08:00 daily https://www.pharmasources.com/industryinsights/new-horizontal-flow-wrapping-machine-for-305207.html 0.6 2026-06-07T21:49:00+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-changing-face-o-305208.html 0.6 2026-08-07T03:34:03+08:00 daily https://www.pharmasources.com/industryinsights/with-nod-in-older-adults-merck-drives-hp-305209.html 0.6 2026-07-17T21:56:57+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-hpapi-capacity-305210.html 0.6 2026-06-24T18:35:09+08:00 daily https://www.pharmasources.com/industryinsights/bioivt-acquires-ctls-305211.html 0.6 2026-06-25T05:39:04+08:00 daily https://www.pharmasources.com/industryinsights/could-treating-psoriasis-in-the-future-b-305212.html 0.6 2026-07-05T00:59:59+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-reaches-deal-with-gilead-on--305213.html 0.6 2026-08-08T01:18:25+08:00 daily https://www.pharmasources.com/industryinsights/roches-hemlibra-secures-extended-fda-app-305214.html 0.6 2026-07-16T08:40:16+08:00 daily https://www.pharmasources.com/industryinsights/strand-life-sciences-in-agreement-with-q-305215.html 0.6 2026-06-21T05:57:56+08:00 daily https://www.pharmasources.com/industryinsights/casi-pharmaceuticals-appoints-new-presid-305216.html 0.6 2026-08-06T15:43:11+08:00 daily https://www.pharmasources.com/industryinsights/adc-market-to-grow-to-4b-305217.html 0.6 2026-06-22T17:59:56+08:00 daily https://www.pharmasources.com/industryinsights/iavi-announces-clinical-trial-of-hiv-vac-305218.html 0.6 2026-06-21T20:54:36+08:00 daily https://www.pharmasources.com/industryinsights/litigation-teaches-chinese-valsartan-mak-305219.html 0.6 2026-08-03T14:07:01+08:00 daily https://www.pharmasources.com/industryinsights/the-first-fda-approved-digital-pill-what-305220.html 0.6 2026-07-17T23:57:17+08:00 daily https://www.pharmasources.com/industryinsights/seed-oils-are-best-for-ldl-cholesterol-305221.html 0.6 2026-06-20T16:50:16+08:00 daily https://www.pharmasources.com/industryinsights/weight-loss-drug-shows-positive-effects--305222.html 0.6 2026-07-03T21:37:28+08:00 daily https://www.pharmasources.com/industryinsights/celebrating-sales-and-marketing-excellen-305223.html 0.6 2026-08-05T21:28:18+08:00 daily https://www.pharmasources.com/industryinsights/xlh-patients-to-get-routine-access-to-fi-305224.html 0.6 2026-06-21T13:02:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-crizanlizumab-shows-promise-in--305225.html 0.6 2026-06-21T11:20:42+08:00 daily https://www.pharmasources.com/industryinsights/affimed-shares-plunge-on-trial-death-305226.html 0.6 2026-06-20T21:16:13+08:00 daily https://www.pharmasources.com/industryinsights/diurnal-shares-plummet-on-trial-failure-305227.html 0.6 2026-04-22T14:15:34+08:00 daily https://www.pharmasources.com/industryinsights/the-pharmatimes-medical-scientific-excel-305228.html 0.6 2026-06-20T14:54:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-files-ms-drug-siponimod-in-eu-a-305229.html 0.6 2026-06-20T14:39:40+08:00 daily https://www.pharmasources.com/industryinsights/new-uk-biopharma-sitryx-launches-with-30-305230.html 0.6 2026-06-20T14:53:02+08:00 daily https://www.pharmasources.com/industryinsights/mixed-data-for-xencors-sle-drug-305231.html 0.6 2026-06-23T20:39:14+08:00 daily https://www.pharmasources.com/industryinsights/four-new-therapies-to-be-funded-by-nhs-s-305232.html 0.6 2026-06-22T10:30:59+08:00 daily https://www.pharmasources.com/industryinsights/stelara-induces-remission-in-ulcerative--305233.html 0.6 2026-06-20T07:08:35+08:00 daily https://www.pharmasources.com/industryinsights/yisheng-receives-approval-for-rabies-vac-305234.html 0.6 2026-07-15T23:47:29+08:00 daily https://www.pharmasources.com/industryinsights/nice-expands-backing-for-pfizers-mylotar-305235.html 0.6 2026-06-23T17:47:00+08:00 daily https://www.pharmasources.com/industryinsights/us-nod-for-akceaionis-tegsedi-305236.html 0.6 2026-06-20T16:47:46+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-to-review-bluebirds-gene-t-305237.html 0.6 2026-06-22T04:58:40+08:00 daily https://www.pharmasources.com/industryinsights/gilead-strikes-deal-with-nhs-england-on--305238.html 0.6 2026-06-21T00:15:52+08:00 daily https://www.pharmasources.com/industryinsights/demonstrate-your-skills-and-expertise-305239.html 0.6 2026-06-20T22:07:44+08:00 daily https://www.pharmasources.com/industryinsights/mhra-consults-on-new-regulatory-framewor-305240.html 0.6 2026-06-20T04:15:38+08:00 daily https://www.pharmasources.com/industryinsights/use-of-roches-haemophilia-a-therapy-heml-305241.html 0.6 2026-07-10T04:24:06+08:00 daily https://www.pharmasources.com/industryinsights/eu-accepts-marketing-application-for-par-305242.html 0.6 2026-06-26T21:18:59+08:00 daily https://www.pharmasources.com/industryinsights/prime-status-for-orchards-gene-therapy-305243.html 0.6 2025-12-31T05:57:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-unanimously-backs-celltrions-r-305244.html 0.6 2026-07-19T13:45:30+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-widens-gp-recruitment-drive--305245.html 0.6 2026-06-20T03:00:59+08:00 daily https://www.pharmasources.com/industryinsights/roche-unveils-phiii-data-for-flu-drug-305246.html 0.6 2026-03-09T14:20:48+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-launches-second-digital-health-co-305247.html 0.6 2026-08-07T11:26:46+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pfizer-az-and-more-hand-china-5-305248.html 0.6 2026-08-09T02:26:55+08:00 daily https://www.pharmasources.com/industryinsights/govt-unveils-intent-to-improve-cancer-di-305249.html 0.6 2026-08-08T20:35:09+08:00 daily https://www.pharmasources.com/industryinsights/recardio-halts-uk-heart-trial-on-brexit--305250.html 0.6 2026-07-02T16:44:52+08:00 daily https://www.pharmasources.com/industryinsights/medherant-awarded-manufacturing-grant-fr-305251.html 0.6 2026-06-22T08:06:55+08:00 daily https://www.pharmasources.com/industryinsights/jinxin-fertility-announces-completion-of-305252.html 0.6 2026-08-02T08:52:28+08:00 daily https://www.pharmasources.com/industryinsights/preliminary-nice-no-for-takedas-alunbrig-305253.html 0.6 2026-06-21T06:53:11+08:00 daily https://www.pharmasources.com/industryinsights/green-light-for-acne-drug-seysara-in-the-305254.html 0.6 2026-08-09T19:18:50+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-lillys-new-breast-cancer-drug-305255.html 0.6 2026-06-21T04:00:43+08:00 daily https://www.pharmasources.com/industryinsights/gsk-updates-its-hcp-payment-policy-305256.html 0.6 2026-06-22T19:49:48+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-considers-buyback-of-sin-305257.html 0.6 2026-07-07T00:03:04+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-to-acquire-apotexs-biz-in-euro-305258.html 0.6 2026-06-20T15:14:25+08:00 daily https://www.pharmasources.com/industryinsights/gb-sciences-completes-tech-transfer-of-n-305259.html 0.6 2026-06-20T16:58:18+08:00 daily https://www.pharmasources.com/industryinsights/ema-brexit-preparedness-business-continu-305260.html 0.6 2026-06-22T18:46:07+08:00 daily https://www.pharmasources.com/industryinsights/admedus-launches-adapt-technology-in-ind-305261.html 0.6 2026-06-22T07:39:29+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-innovative-drug-ibrance-gets-chi-305262.html 0.6 2026-07-15T05:23:20+08:00 daily https://www.pharmasources.com/industryinsights/nektars-back-pain-opioid-gets-approval-f-305263.html 0.6 2026-07-12T06:14:39+08:00 daily https://www.pharmasources.com/industryinsights/agios-receives-nod-for-ivosidenib-305264.html 0.6 2026-07-07T03:23:04+08:00 daily https://www.pharmasources.com/industryinsights/govt-aims-to-raise-api-production-to-cut-305265.html 0.6 2026-06-22T12:51:24+08:00 daily https://www.pharmasources.com/industryinsights/allergan-works-toward-blockbuster-goal-w-305266.html 0.6 2026-06-21T05:57:43+08:00 daily https://www.pharmasources.com/industryinsights/latin-americas-medical-cannabis-market-t-305267.html 0.6 2026-06-21T13:06:34+08:00 daily https://www.pharmasources.com/industryinsights/hey-pharma-datas-more-than-a-defense-mec-305268.html 0.6 2026-06-23T11:34:40+08:00 daily https://www.pharmasources.com/industryinsights/celgene-notches-positive-otezla-data-in--305269.html 0.6 2026-06-21T13:03:30+08:00 daily https://www.pharmasources.com/industryinsights/stada-eyeing-otc-expansion-circles-brist-305270.html 0.6 2026-06-21T13:01:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-use-of-gardasil-9--305271.html 0.6 2026-06-20T15:14:14+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-executive-leadership-te-305272.html 0.6 2026-06-21T03:02:51+08:00 daily https://www.pharmasources.com/industryinsights/up-to-10-years-of-follow-up-data-reaffir-305273.html 0.6 2026-06-21T07:50:59+08:00 daily https://www.pharmasources.com/industryinsights/organs-on-chip-technology-reveals-new-dr-305274.html 0.6 2026-06-21T11:06:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-lifts-clinical-hold-on-gene-therapy--305275.html 0.6 2026-06-21T00:06:38+08:00 daily https://www.pharmasources.com/industryinsights/smi-group-announces-the-10th-annual-rna--305276.html 0.6 2026-06-22T11:11:13+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-compugen-announ-305277.html 0.6 2026-06-21T19:09:53+08:00 daily https://www.pharmasources.com/industryinsights/not-just-for-pharma-anymore-rfxcel-exten-305278.html 0.6 2026-06-21T10:23:32+08:00 daily https://www.pharmasources.com/industryinsights/ime-medical-electrospinning-enters-into--305279.html 0.6 2026-07-19T23:04:02+08:00 daily https://www.pharmasources.com/industryinsights/klckner-pentaplast-announces-25m-investm-305280.html 0.6 2026-08-05T20:54:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-corrects-previous-word-on-embattled--305281.html 0.6 2026-06-21T10:13:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tegsedi-305282.html 0.6 2026-06-21T07:55:53+08:00 daily https://www.pharmasources.com/industryinsights/breckenridge-announces-final-approval-of-305283.html 0.6 2026-07-09T01:04:58+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-therapeutics-introduces-new-305284.html 0.6 2025-11-24T19:08:17+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-fda-ema-filing-accept-305285.html 0.6 2026-06-22T06:51:41+08:00 daily https://www.pharmasources.com/industryinsights/cphis-15th-annual-pharma-awards-305286.html 0.6 2026-08-07T23:04:16+08:00 daily https://www.pharmasources.com/industryinsights/revolution-medicines-announces-first-pat-305287.html 0.6 2026-08-03T09:41:15+08:00 daily https://www.pharmasources.com/industryinsights/aerie-announces-drug-application-for-app-305288.html 0.6 2026-06-21T10:07:15+08:00 daily https://www.pharmasources.com/industryinsights/agenebio-announces-two-nih-grant-awards-305289.html 0.6 2026-06-20T20:18:56+08:00 daily https://www.pharmasources.com/industryinsights/new-data-released-on-stelara-for-ulcerat-305290.html 0.6 2026-07-19T09:15:29+08:00 daily https://www.pharmasources.com/industryinsights/iavi-announces-clinical-trial-of-hiv-vac-305291.html 0.6 2026-06-22T00:04:49+08:00 daily https://www.pharmasources.com/industryinsights/ligand-announces-the-close-of-its-acquis-305292.html 0.6 2026-06-20T23:00:41+08:00 daily https://www.pharmasources.com/industryinsights/nanoreactors-to-synthesise-organic-subst-305293.html 0.6 2026-06-21T08:56:56+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-receives-kl1333-clinical-trial-305294.html 0.6 2026-06-21T19:46:44+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-announces-board-of-directors-app-305295.html 0.6 2026-07-02T16:09:24+08:00 daily https://www.pharmasources.com/industryinsights/ionis-enters-collaboration-with-partner--305296.html 0.6 2026-07-06T14:47:37+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-maa-to-ema-for-esketamin-305297.html 0.6 2026-04-07T05:58:39+08:00 daily https://www.pharmasources.com/industryinsights/maxcyte-begins-dosing-in-first-clinical--305298.html 0.6 2026-06-20T18:55:39+08:00 daily https://www.pharmasources.com/industryinsights/organs-on-chip-technology-reveals-new-dr-305299.html 0.6 2026-06-21T04:22:11+08:00 daily https://www.pharmasources.com/industryinsights/promis-neurosciences-identifies-novel-an-305300.html 0.6 2026-06-22T07:09:56+08:00 daily https://www.pharmasources.com/industryinsights/mei-pharma-beigene-collaborate-on-me-401-305301.html 0.6 2026-07-04T23:07:46+08:00 daily https://www.pharmasources.com/industryinsights/pharmaxis-releases-positive-results-of-f-305302.html 0.6 2026-06-20T14:39:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-stiolto-respimat-snda-to-ad-305303.html 0.6 2026-06-20T15:41:32+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-compugen-announce-c-305304.html 0.6 2026-07-08T11:48:38+08:00 daily https://www.pharmasources.com/industryinsights/rigel-receives-ema-validation-for-fostam-305305.html 0.6 2026-06-20T21:03:38+08:00 daily https://www.pharmasources.com/industryinsights/carrick-bags-ex-onyx-cancer-drug-plans-p-305306.html 0.6 2026-06-21T09:35:50+08:00 daily https://www.pharmasources.com/industryinsights/up-to-10-years-of-follow-up-data-reaffir-305307.html 0.6 2026-07-23T17:32:58+08:00 daily https://www.pharmasources.com/industryinsights/carrick-licenses-targeted-ovarian-cancer-305308.html 0.6 2026-06-21T06:09:47+08:00 daily https://www.pharmasources.com/industryinsights/biocon-a-nesting-ground-for-biotech-spin-305309.html 0.6 2026-06-20T15:50:31+08:00 daily https://www.pharmasources.com/industryinsights/pharmatimes-international-clinical-resea-305310.html 0.6 2026-06-20T19:02:35+08:00 daily https://www.pharmasources.com/industryinsights/janssen-files-nasal-spray-for-depression-305311.html 0.6 2026-06-21T01:15:59+08:00 daily https://www.pharmasources.com/industryinsights/abpi-tells-mps-brexit-deal-on-medicines--305312.html 0.6 2026-08-07T03:02:42+08:00 daily https://www.pharmasources.com/industryinsights/first-generic-of-diabetes-drug-actos-app-305313.html 0.6 2026-08-08T15:11:11+08:00 daily https://www.pharmasources.com/industryinsights/interpol-seized-41-mn-fake-drugs-to-be-s-305314.html 0.6 2026-06-21T12:26:22+08:00 daily https://www.pharmasources.com/industryinsights/india-china-to-produce-generic-of-gilead-305315.html 0.6 2026-06-21T14:42:40+08:00 daily https://www.pharmasources.com/industryinsights/cipla-nurtures-global-vision-for-afforda-305316.html 0.6 2026-06-08T11:38:38+08:00 daily https://www.pharmasources.com/industryinsights/bayer-plea-for-stay-on-compulsory-licens-305317.html 0.6 2026-06-21T18:12:35+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-rejects-mylans-acquisition-bid-305318.html 0.6 2026-06-20T17:01:19+08:00 daily https://www.pharmasources.com/industryinsights/ranbaxy-lundbeck-face-eu-fury-for-blocki-305319.html 0.6 2026-07-27T16:57:19+08:00 daily https://www.pharmasources.com/industryinsights/cphi-recognizes-merck-for-innovative-pro-305320.html 0.6 2026-06-21T05:16:04+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-inks-yet-another-humira-biosim-de-305321.html 0.6 2026-06-20T21:05:45+08:00 daily https://www.pharmasources.com/industryinsights/mei-pharma-beigene-to-co-develop-cancer--305322.html 0.6 2026-06-20T20:54:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-update-on-valsartan-recalls-305323.html 0.6 2026-06-22T00:57:46+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-tentative-us-fda-nod-f-305324.html 0.6 2025-12-13T21:27:42+08:00 daily https://www.pharmasources.com/industryinsights/doctors-develop-new-technique-to-treat-c-305325.html 0.6 2026-08-04T00:50:22+08:00 daily https://www.pharmasources.com/industryinsights/uttar-pradesh-to-open-six-pharma-parks-305326.html 0.6 2026-08-07T19:38:30+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-announces-global-resolution-of-bi-305327.html 0.6 2026-08-05T22:40:48+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018101-305328.html 0.6 2026-07-04T23:24:27+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-rapid-test-for-infec-305329.html 0.6 2026-06-21T08:47:50+08:00 daily https://www.pharmasources.com/industryinsights/rmit-atmo-sign-licence-agreement-for-gut-305330.html 0.6 2026-06-23T23:17:12+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-signs-agreement-for-atheroscle-305331.html 0.6 2026-06-20T15:14:27+08:00 daily https://www.pharmasources.com/industryinsights/nus-team-invents-new-diagnostic-device-305332.html 0.6 2026-07-01T01:14:49+08:00 daily https://www.pharmasources.com/industryinsights/canadian-researchers-to-convert-any-bloo-305333.html 0.6 2026-06-21T06:09:52+08:00 daily https://www.pharmasources.com/industryinsights/manchester-team-develops-non-antibiotic--305334.html 0.6 2026-02-28T15:14:51+08:00 daily https://www.pharmasources.com/industryinsights/uk-regulator-declines-roche-ms-drug-305335.html 0.6 2026-06-20T22:05:43+08:00 daily https://www.pharmasources.com/industryinsights/medytox-files-bla-of-botulinum-toxin-305336.html 0.6 2026-07-05T10:13:43+08:00 daily https://www.pharmasources.com/industryinsights/australian-scientists-detect-cancer-with-305337.html 0.6 2026-08-07T05:05:15+08:00 daily https://www.pharmasources.com/industryinsights/viromed-acquires-us-based-dna-production-305338.html 0.6 2026-08-07T01:07:35+08:00 daily https://www.pharmasources.com/industryinsights/hku-researchers-design-sensor-to-measure-305339.html 0.6 2026-08-07T00:59:11+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-diagnostic-test-for--305340.html 0.6 2026-08-07T00:53:12+08:00 daily https://www.pharmasources.com/industryinsights/all-about-targeted-drugs-for-breast-canc-305341.html 0.6 2026-07-27T16:06:56+08:00 daily https://www.pharmasources.com/industryinsights/a-potential-nobel-prize-winner-the-miner-305342.html 0.6 2026-08-07T02:22:32+08:00 daily https://www.pharmasources.com/industryinsights/afdr-kadimastem-to-receive-bi-national-g-305343.html 0.6 2026-06-22T01:02:55+08:00 daily https://www.pharmasources.com/industryinsights/hkbu-researchers-invent-medical-device-u-305344.html 0.6 2026-06-21T03:02:55+08:00 daily https://www.pharmasources.com/industryinsights/platelet-biogenesis-licenses-induced-plu-305345.html 0.6 2026-06-21T16:59:30+08:00 daily https://www.pharmasources.com/industryinsights/amgen-novartis-first-to-launch-humira-bi-305346.html 0.6 2026-07-27T06:52:38+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-dupixent-hits-main-goa-305347.html 0.6 2026-04-13T18:32:29+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-lynparza-orphan-drug-desig-305348.html 0.6 2026-08-07T18:59:46+08:00 daily https://www.pharmasources.com/industryinsights/ken-cunningham-chairman-of-abzena-limite-305349.html 0.6 2026-06-20T17:58:16+08:00 daily https://www.pharmasources.com/industryinsights/uniqure-announces-presentations-at-the-u-305350.html 0.6 2026-06-21T08:00:57+08:00 daily https://www.pharmasources.com/industryinsights/human-colon-organoids-successfully-tissu-305351.html 0.6 2026-06-20T19:18:51+08:00 daily https://www.pharmasources.com/industryinsights/kol-views-how-does-opdivos-stumble-shift-305352.html 0.6 2026-06-21T12:56:37+08:00 daily https://www.pharmasources.com/industryinsights/lifecells-community-stem-cell-banking-re-305353.html 0.6 2026-06-20T20:10:09+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-lifts-annual-guidance-as-305354.html 0.6 2026-08-07T09:41:07+08:00 daily https://www.pharmasources.com/industryinsights/ait-therapeutics-to-present-high-dose-ni-305355.html 0.6 2026-06-21T09:11:18+08:00 daily https://www.pharmasources.com/industryinsights/can-pfizers-new-breast-cancer-drug-talze-305356.html 0.6 2026-06-22T21:56:00+08:00 daily https://www.pharmasources.com/industryinsights/officials-deny-shortage-of-seqirus-fluad-305357.html 0.6 2026-06-22T06:06:43+08:00 daily https://www.pharmasources.com/industryinsights/merck-joins-novartis-glaxosmithkline-in--305358.html 0.6 2026-06-21T06:18:08+08:00 daily https://www.pharmasources.com/industryinsights/cold-and-flu-beverage-to-go-gsk-launches-305359.html 0.6 2026-06-22T14:29:11+08:00 daily https://www.pharmasources.com/industryinsights/fcb-health-launches-next-generation-big--305360.html 0.6 2026-06-20T21:54:39+08:00 daily https://www.pharmasources.com/industryinsights/govt-to-introduce-tech-standards-for-the-305361.html 0.6 2026-06-20T19:05:39+08:00 daily https://www.pharmasources.com/industryinsights/nhs-green-light-for-novartis-skin-cancer-305362.html 0.6 2026-06-13T09:11:51+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-file-ubrogepant-for-migraine-305363.html 0.6 2026-06-25T09:40:57+08:00 daily https://www.pharmasources.com/industryinsights/novartis-buys-endocyte-for-21-billion-305364.html 0.6 2026-06-21T00:56:46+08:00 daily https://www.pharmasources.com/industryinsights/londons-health-and-care-system-hampering-305365.html 0.6 2026-06-21T10:03:07+08:00 daily https://www.pharmasources.com/industryinsights/azmsds-lynparza-assigned-orphan-status-i-305366.html 0.6 2026-06-21T15:01:30+08:00 daily https://www.pharmasources.com/industryinsights/another-humira-biosimilar-hits-eu-shores-305367.html 0.6 2026-06-22T05:05:42+08:00 daily https://www.pharmasources.com/industryinsights/uk-launch-for-first-eosinophilic-oesopha-305368.html 0.6 2026-06-20T23:06:43+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-talzenna-cleared-for-breast-canc-305369.html 0.6 2026-06-24T11:57:52+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-dupixent-shines-in-rhi-305370.html 0.6 2026-08-07T02:18:48+08:00 daily https://www.pharmasources.com/industryinsights/jhl-biotech-receives-china-approval-for--305371.html 0.6 2026-08-07T02:06:06+08:00 daily https://www.pharmasources.com/industryinsights/amgen-begins-rolling-out-humira-biosimil-305372.html 0.6 2026-08-07T02:09:48+08:00 daily https://www.pharmasources.com/industryinsights/nhs-trafford-ccg-placing-team-of-pharmac-305373.html 0.6 2026-08-07T02:23:00+08:00 daily https://www.pharmasources.com/industryinsights/puretech-affiliate-karuna-advances-schiz-305374.html 0.6 2026-08-07T03:06:09+08:00 daily https://www.pharmasources.com/industryinsights/pharma-firm-to-pay-13b-fine-for-vaccine--305375.html 0.6 2026-08-07T03:12:58+08:00 daily https://www.pharmasources.com/industryinsights/robot-addresses-british-mps-over-future--305376.html 0.6 2026-08-09T10:31:01+08:00 daily https://www.pharmasources.com/industryinsights/roches-kadcyla-shows-promise-in-early-br-305377.html 0.6 2026-06-20T15:15:39+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-axe-99-positions-at-memphis-site-305378.html 0.6 2026-07-02T16:35:00+08:00 daily https://www.pharmasources.com/industryinsights/england-falling-behind-peers-on-child-he-305379.html 0.6 2026-06-21T13:16:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-snaps-up-cancer-drug-developer--305380.html 0.6 2026-06-20T17:41:10+08:00 daily https://www.pharmasources.com/industryinsights/mhra-to-extend-epipen-expiry-dates-to-ta-305381.html 0.6 2026-06-21T21:35:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announce-cull-of-2-of-staff-305382.html 0.6 2026-06-20T11:09:47+08:00 daily https://www.pharmasources.com/industryinsights/idt-biologika-awarded-10-year-nih-contra-305383.html 0.6 2026-06-23T20:49:17+08:00 daily https://www.pharmasources.com/industryinsights/researchers-launch-phase-1-trial-of-hiv--305384.html 0.6 2026-06-20T19:09:44+08:00 daily https://www.pharmasources.com/industryinsights/merck-joins-novartis-glaxosmithkline-in--305385.html 0.6 2026-07-06T10:41:57+08:00 daily https://www.pharmasources.com/industryinsights/samsung-and-bioepis-launch-third-humira--305386.html 0.6 2026-06-21T23:07:50+08:00 daily https://www.pharmasources.com/industryinsights/roche-signs-1-billion-deal-with-cell-the-305387.html 0.6 2026-07-07T21:00:37+08:00 daily https://www.pharmasources.com/industryinsights/growth-of-medical-cannabis-market-after--305388.html 0.6 2026-06-21T18:07:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-steps-to-modernise-drug-de-305389.html 0.6 2026-06-20T20:00:38+08:00 daily https://www.pharmasources.com/industryinsights/targeted-drugs-for-advanced-cancer-move--305390.html 0.6 2026-06-21T06:56:04+08:00 daily https://www.pharmasources.com/industryinsights/fewer-patents-being-filed-for-novel-infe-305391.html 0.6 2026-06-20T21:41:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-talzenna-for-breast-305392.html 0.6 2026-08-08T02:48:38+08:00 daily https://www.pharmasources.com/industryinsights/prescription-painkillers-reclassified-am-305393.html 0.6 2026-06-30T22:58:29+08:00 daily https://www.pharmasources.com/industryinsights/roches-kadcyla-beats-herceptin-breast-ca-305394.html 0.6 2026-06-20T17:07:24+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-bayer-seek-to-oppose-high-c-305395.html 0.6 2026-04-08T16:48:15+08:00 daily https://www.pharmasources.com/industryinsights/santheras-cystic-fibrosis-drug-pol6014-i-305396.html 0.6 2026-07-30T14:23:25+08:00 daily https://www.pharmasources.com/industryinsights/amgen-launches-first-biosimilar-of-best--305397.html 0.6 2026-06-23T12:13:34+08:00 daily https://www.pharmasources.com/industryinsights/working-through-ceo-swap-pfizer-plots-jo-305398.html 0.6 2026-07-20T15:01:13+08:00 daily https://www.pharmasources.com/industryinsights/even-in-worst-case-scenario-roche-will-g-305399.html 0.6 2026-06-25T09:08:10+08:00 daily https://www.pharmasources.com/industryinsights/mannkinds-afrezza-facebook-page-gets-sla-305400.html 0.6 2026-06-27T11:22:50+08:00 daily https://www.pharmasources.com/industryinsights/amgen-lilly-migraine-drugs-nab-express-s-305401.html 0.6 2026-06-20T22:55:46+08:00 daily https://www.pharmasources.com/industryinsights/minnesota-ag-targets-sanofi-eli-lilly-an-305402.html 0.6 2026-08-07T05:05:48+08:00 daily https://www.pharmasources.com/industryinsights/chi-med-initiates-a-ph-i-trial-of-hmpl-5-305403.html 0.6 2026-08-07T01:11:04+08:00 daily https://www.pharmasources.com/industryinsights/eisai-discovers-new-compound-to-treat-pa-305404.html 0.6 2026-08-07T01:19:41+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-to-continue-mfg-ops-in-hgans-s-305405.html 0.6 2026-08-07T01:27:50+08:00 daily https://www.pharmasources.com/industryinsights/generic-drug-labelling-issues-could-fina-305406.html 0.6 2026-08-07T01:31:36+08:00 daily https://www.pharmasources.com/industryinsights/pace-of-cancer-drug-reimbursement-varies-305407.html 0.6 2026-06-21T08:02:00+08:00 daily https://www.pharmasources.com/industryinsights/eating-leafy-greens-could-help-prevent-m-305408.html 0.6 2026-06-20T22:01:47+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-acquire-us-cancer-drug-devel-305409.html 0.6 2026-06-20T19:57:37+08:00 daily https://www.pharmasources.com/industryinsights/few-biopharma-buyouts-in-quiet-third-qua-305410.html 0.6 2026-07-16T19:46:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-regeneron-sanofis-dupixent--305411.html 0.6 2026-08-07T10:14:32+08:00 daily https://www.pharmasources.com/industryinsights/anaeropharma-chugai-come-together-to-cre-305412.html 0.6 2026-03-18T01:45:39+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dupixent-set-for-25b-in-peak-ast-305413.html 0.6 2026-07-29T10:58:57+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-success-for-triple-negativ-305414.html 0.6 2026-08-08T10:10:39+08:00 daily https://www.pharmasources.com/industryinsights/cphi-report-says-global-pharma-set-for-s-305415.html 0.6 2026-08-08T08:58:58+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-reports-positive-results-f-305416.html 0.6 2026-08-08T07:34:51+08:00 daily https://www.pharmasources.com/industryinsights/roche-takes-on-loxo-bayer-in-gene-define-305417.html 0.6 2026-08-08T04:37:58+08:00 daily https://www.pharmasources.com/industryinsights/author-biography-sarah-harding-305418.html 0.6 2026-08-07T13:15:16+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-serialization-w-305419.html 0.6 2026-08-06T23:36:02+08:00 daily https://www.pharmasources.com/industryinsights/ground-breaking-approach-accelerates-dru-305420.html 0.6 2026-08-08T01:01:37+08:00 daily https://www.pharmasources.com/industryinsights/what-is-needed-for-a-successful-trial-su-305421.html 0.6 2026-08-08T07:51:47+08:00 daily https://www.pharmasources.com/industryinsights/covance-recieves-frost-and-sullivan-awar-305423.html 0.6 2026-08-08T10:01:39+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-pharmatech-board-member-steps-down-305424.html 0.6 2026-08-08T21:48:52+08:00 daily https://www.pharmasources.com/industryinsights/crystal-pharmatech-partner-sciences-join-305425.html 0.6 2026-08-08T22:51:15+08:00 daily https://www.pharmasources.com/industryinsights/eu-suspends-gvk-bio-medicine-for-non-com-305426.html 0.6 2026-08-09T01:19:22+08:00 daily https://www.pharmasources.com/industryinsights/generics-small-molecule-injectables-to-d-305427.html 0.6 2026-08-09T03:44:53+08:00 daily https://www.pharmasources.com/industryinsights/gvk-bio-eyes-top-spot-among-asian-cros-305428.html 0.6 2026-06-21T06:22:16+08:00 daily https://www.pharmasources.com/industryinsights/wuxis-api-manufacturing-passes-fda-inspe-305429.html 0.6 2026-07-29T13:37:46+08:00 daily https://www.pharmasources.com/industryinsights/quintiles-bags-frost-and-sullivans-apac--305430.html 0.6 2026-07-05T08:17:13+08:00 daily https://www.pharmasources.com/industryinsights/parexel-expands-regulatory-management-se-305431.html 0.6 2026-08-07T20:10:27+08:00 daily https://www.pharmasources.com/industryinsights/resmed-dominates-the-niche-sleep-disorde-305432.html 0.6 2026-07-21T09:24:21+08:00 daily https://www.pharmasources.com/industryinsights/sinopharm-demonstrates-king-size-growth--305433.html 0.6 2026-07-04T14:32:34+08:00 daily https://www.pharmasources.com/industryinsights/cipla-nurtures-global-vision-for-afforda-305434.html 0.6 2026-06-22T21:11:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-global-operation-to-crack-d-305435.html 0.6 2026-08-05T22:54:07+08:00 daily https://www.pharmasources.com/industryinsights/casi-pharmaceuticals-acquires-laurus-lab-305436.html 0.6 2026-06-21T15:12:34+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-buy-98-stake-in-frances-i-305437.html 0.6 2026-06-20T14:49:05+08:00 daily https://www.pharmasources.com/industryinsights/researchers-warn-of-impact-of-no-deal-br-305438.html 0.6 2026-04-06T23:27:39+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-expands-api-production-f-305439.html 0.6 2026-06-22T03:01:41+08:00 daily https://www.pharmasources.com/industryinsights/drug-discovery-outsourcing-market-foreca-305440.html 0.6 2026-06-20T22:11:59+08:00 daily https://www.pharmasources.com/industryinsights/dermira-completes-patient-enrollment-in--305441.html 0.6 2026-08-08T12:52:04+08:00 daily https://www.pharmasources.com/industryinsights/the-global-pain-index-an-insightful-surv-305442.html 0.6 2026-06-21T12:07:19+08:00 daily https://www.pharmasources.com/industryinsights/ranbaxy-retains-grip-on-generics-market-305443.html 0.6 2026-06-22T08:15:00+08:00 daily https://www.pharmasources.com/industryinsights/canbridge-pharmaceutical-and-wuxi-biolog-305444.html 0.6 2026-07-18T21:16:09+08:00 daily https://www.pharmasources.com/industryinsights/singapore-rides-high-on-biomedical-resea-305445.html 0.6 2026-06-20T22:05:40+08:00 daily https://www.pharmasources.com/industryinsights/csl-marks-a-billion-dollar-in-profits-305446.html 0.6 2026-08-07T01:10:19+08:00 daily https://www.pharmasources.com/industryinsights/cro-survey-2014-cro-landscape-across-apa-305447.html 0.6 2026-08-08T03:19:38+08:00 daily https://www.pharmasources.com/industryinsights/dong-a-pharma-diversifies-portfolio-to-i-305448.html 0.6 2026-07-31T15:12:06+08:00 daily https://www.pharmasources.com/industryinsights/mindray-medical-is-set-to-penetrate-the--305449.html 0.6 2026-07-31T16:17:31+08:00 daily https://www.pharmasources.com/industryinsights/included-in-the-medical-insurance-of-chi-305450.html 0.6 2026-08-03T10:25:34+08:00 daily https://www.pharmasources.com/industryinsights/biosimilars-of-the-drug-king-humira-bein-305451.html 0.6 2026-08-05T19:47:18+08:00 daily https://www.pharmasources.com/industryinsights/hepatitis-b-drug-market-to-reach-rmb-20--305452.html 0.6 2026-08-05T10:05:40+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-roches-rituxan-have-started-to--305453.html 0.6 2026-06-29T11:05:02+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-assumes-full-development-and-comm-305454.html 0.6 2026-08-08T15:38:18+08:00 daily https://www.pharmasources.com/industryinsights/forward-pharma-loses-tecfidera-patent-ap-305455.html 0.6 2026-08-05T21:29:26+08:00 daily https://www.pharmasources.com/industryinsights/bayer-orion-drug-shows-strong-results-in-305456.html 0.6 2026-08-05T00:45:27+08:00 daily https://www.pharmasources.com/industryinsights/medidata-teams-with-pharm-olam-305457.html 0.6 2026-08-03T02:37:43+08:00 daily https://www.pharmasources.com/industryinsights/revlimid-shows-significant-pfs-improveme-305458.html 0.6 2026-08-09T05:34:02+08:00 daily https://www.pharmasources.com/industryinsights/accelerated-access-collaborative-announc-305459.html 0.6 2026-07-30T22:36:24+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-announces-new-results-for-bif-305460.html 0.6 2026-08-09T08:12:54+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-eli-lilly-report-detailed-results-305461.html 0.6 2026-07-31T18:56:41+08:00 daily https://www.pharmasources.com/industryinsights/hansa-medical-receives-positive-opinion--305462.html 0.6 2026-08-08T02:16:45+08:00 daily https://www.pharmasources.com/industryinsights/strong-results-for-keytruda-in-head-and--305463.html 0.6 2026-06-21T12:56:35+08:00 daily https://www.pharmasources.com/industryinsights/az-and-msds-lynparza-shows-significant-r-305464.html 0.6 2026-06-21T12:09:18+08:00 daily https://www.pharmasources.com/industryinsights/ucb-and-biogens-lupus-drug-falls-short-a-305465.html 0.6 2026-08-03T05:19:06+08:00 daily https://www.pharmasources.com/industryinsights/bayer-inc-receives-approval-for-hemophil-305466.html 0.6 2026-08-02T15:07:09+08:00 daily https://www.pharmasources.com/industryinsights/new-2-million-programme-aims-at-increasi-305467.html 0.6 2026-07-03T18:01:11+08:00 daily https://www.pharmasources.com/industryinsights/orion-and-amgen-to-collaborate-on-the-co-305468.html 0.6 2026-07-07T12:29:22+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-lillys-non-opioid-drug-reduces-pa-305469.html 0.6 2026-07-28T19:50:11+08:00 daily https://www.pharmasources.com/industryinsights/industry-leaders-warn-public-may-have-to-305470.html 0.6 2026-07-30T16:16:58+08:00 daily https://www.pharmasources.com/industryinsights/balixafortide-combination-with-eribulin--305471.html 0.6 2026-07-28T21:22:33+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-therapeutics-prices-public--305472.html 0.6 2026-07-28T22:32:39+08:00 daily https://www.pharmasources.com/industryinsights/j-j-announces-offer-to-acquire-ciz-holdi-305473.html 0.6 2026-07-28T20:13:10+08:00 daily https://www.pharmasources.com/industryinsights/mesoblast-expands-partnership-with-jcr-p-305474.html 0.6 2026-06-22T06:58:50+08:00 daily https://www.pharmasources.com/industryinsights/xtalpi-announces-the-closing-of-46-milli-305475.html 0.6 2026-08-01T11:56:06+08:00 daily https://www.pharmasources.com/industryinsights/two-trial-wins-for-roches-immunotherapy--305476.html 0.6 2026-08-09T11:05:24+08:00 daily https://www.pharmasources.com/industryinsights/medicines-discovery-catapult-and-astraze-305477.html 0.6 2026-06-20T19:19:56+08:00 daily https://www.pharmasources.com/industryinsights/orexo-appoints-joseph-defeo-as-new-cfo-305478.html 0.6 2026-06-21T22:13:13+08:00 daily https://www.pharmasources.com/industryinsights/roches-alecensa-topples-pfizers-xalkori--305479.html 0.6 2026-06-21T12:30:46+08:00 daily https://www.pharmasources.com/industryinsights/first-line-keytruda-shows-better-overall-305480.html 0.6 2025-11-23T22:39:52+08:00 daily https://www.pharmasources.com/industryinsights/israel-to-build-first-biotechnology-plan-305481.html 0.6 2026-08-03T04:35:36+08:00 daily https://www.pharmasources.com/industryinsights/shares-in-mirati-plummet-after-disappoin-305482.html 0.6 2026-06-23T12:35:32+08:00 daily https://www.pharmasources.com/industryinsights/logicbio-announces-closing-of-initial-pu-305483.html 0.6 2026-06-20T22:17:09+08:00 daily https://www.pharmasources.com/industryinsights/tplus-signs-mou-with-yonsei-university-f-305484.html 0.6 2026-06-22T02:53:42+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-in-vivo-skin-imaging--305485.html 0.6 2026-08-08T03:04:05+08:00 daily https://www.pharmasources.com/industryinsights/holmusk-secures-975-m-in-pre-series-a-fi-305486.html 0.6 2026-07-10T11:48:35+08:00 daily https://www.pharmasources.com/industryinsights/uk-dementia-partnership-offering-100000--305487.html 0.6 2026-06-30T08:36:42+08:00 daily https://www.pharmasources.com/industryinsights/sigtuple-tech-receives-recognition-at-de-305488.html 0.6 2026-07-19T21:57:26+08:00 daily https://www.pharmasources.com/industryinsights/jj-announce-promising-phase-12a-results--305489.html 0.6 2026-06-20T17:58:16+08:00 daily https://www.pharmasources.com/industryinsights/keytrudainlyta-combo-shows-significant-s-305490.html 0.6 2026-06-20T23:58:33+08:00 daily https://www.pharmasources.com/industryinsights/huami-launches-health-band-1s-and-smart--305491.html 0.6 2026-08-03T04:24:49+08:00 daily https://www.pharmasources.com/industryinsights/cigna-launches-250-m-venture-fund-305492.html 0.6 2026-06-21T12:06:17+08:00 daily https://www.pharmasources.com/industryinsights/limacorporate-to-expand-digital-footprin-305493.html 0.6 2026-06-22T07:04:50+08:00 daily https://www.pharmasources.com/industryinsights/ai-may-help-assess-brain-injury-patients-305494.html 0.6 2026-06-22T05:15:12+08:00 daily https://www.pharmasources.com/industryinsights/rxhealth-raises-18m-seed-round-launches--305495.html 0.6 2026-07-05T03:17:08+08:00 daily https://www.pharmasources.com/industryinsights/us-team-develops-tool-to-identify-diseas-305496.html 0.6 2026-06-30T22:13:02+08:00 daily https://www.pharmasources.com/industryinsights/kare4u-introduces-block-chain-based-heal-305497.html 0.6 2026-06-20T22:08:43+08:00 daily https://www.pharmasources.com/industryinsights/verana-health-announces-30m-series-c-fin-305498.html 0.6 2026-06-20T20:51:39+08:00 daily https://www.pharmasources.com/industryinsights/jj-launches-robotics-digital-surgery-qui-305499.html 0.6 2026-08-07T22:11:48+08:00 daily https://www.pharmasources.com/industryinsights/pharmacovigilance-and-drug-safety-outsou-305500.html 0.6 2026-06-20T10:44:40+08:00 daily https://www.pharmasources.com/industryinsights/largest-census-of-cancer-genes-to-help-u-305501.html 0.6 2026-08-09T04:34:45+08:00 daily https://www.pharmasources.com/industryinsights/cphi-worldwide-records-44500-attendees-f-305502.html 0.6 2026-08-07T16:10:53+08:00 daily https://www.pharmasources.com/industryinsights/msf-warns-high-prices-of-tuberculosis-dr-305503.html 0.6 2026-08-07T13:17:07+08:00 daily https://www.pharmasources.com/industryinsights/biondvaxs-universal-flu-vaccine-clinical-305504.html 0.6 2026-08-07T02:51:58+08:00 daily https://www.pharmasources.com/industryinsights/eisai-announces-data-from-the-phase-ii-c-305505.html 0.6 2026-08-07T02:52:11+08:00 daily https://www.pharmasources.com/industryinsights/merck-q3-results-5-revenue-growth-primar-305506.html 0.6 2026-08-07T02:59:31+08:00 daily https://www.pharmasources.com/industryinsights/amgen-cuts-price-of-cholesterol-drug-rep-305507.html 0.6 2026-08-07T03:02:29+08:00 daily https://www.pharmasources.com/industryinsights/us-to-lower-medicare-drug-prices-based-o-305508.html 0.6 2026-08-07T04:30:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-new-influenza-treatme-305509.html 0.6 2026-08-09T14:33:53+08:00 daily https://www.pharmasources.com/industryinsights/marc-wolff-is-cfo-of-research-pharma-ser-305510.html 0.6 2026-06-21T12:10:42+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-concludes-2013-life-science-awards--305511.html 0.6 2026-06-21T07:19:11+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-boosts-its-glp-1-score-with-305512.html 0.6 2026-07-07T00:06:20+08:00 daily https://www.pharmasources.com/industryinsights/vietnam-quintiles-enter-deal-to-advance--305513.html 0.6 2026-06-22T07:02:49+08:00 daily https://www.pharmasources.com/industryinsights/radiationcisplatin-established-as-standa-305514.html 0.6 2026-06-20T14:38:14+08:00 daily https://www.pharmasources.com/industryinsights/aussie-firm-mayne-to-acquire-metrics-305515.html 0.6 2026-07-30T14:05:58+08:00 daily https://www.pharmasources.com/industryinsights/integrated-drug-discovery-fuels-healthy--305516.html 0.6 2026-06-30T14:02:50+08:00 daily https://www.pharmasources.com/industryinsights/alcohol-related-disorders-ethypharm-is-g-305517.html 0.6 2026-06-24T07:52:09+08:00 daily https://www.pharmasources.com/industryinsights/new-epigenetic-drug-strategy-to-treat-ca-305518.html 0.6 2026-06-20T14:35:20+08:00 daily https://www.pharmasources.com/industryinsights/synergy-pharmaceuticals-shares-plunge-as-305519.html 0.6 2026-08-05T10:57:41+08:00 daily https://www.pharmasources.com/industryinsights/dx-assay-announces-new-service-for-its-p-305520.html 0.6 2026-06-22T13:41:04+08:00 daily https://www.pharmasources.com/industryinsights/us-court-invalidates-patent-on-johnson-j-305521.html 0.6 2026-07-30T11:01:26+08:00 daily https://www.pharmasources.com/industryinsights/curadev-endo-pharma-oncology-program-rea-305523.html 0.6 2026-07-01T21:00:03+08:00 daily https://www.pharmasources.com/industryinsights/takeda-comments-on-ongoing-phase-1-revie-305524.html 0.6 2026-08-07T01:07:53+08:00 daily https://www.pharmasources.com/industryinsights/harlan-japan-appoints-hiroharu-okochi-as-305525.html 0.6 2026-06-22T09:04:46+08:00 daily https://www.pharmasources.com/industryinsights/two-year-amd-study-data-reaffirm-superio-305526.html 0.6 2026-07-26T13:53:17+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-pharmatech-partners-with-pharmacycl-305527.html 0.6 2026-06-21T09:05:10+08:00 daily https://www.pharmasources.com/industryinsights/us-administration-squares-off-with-pharm-305528.html 0.6 2026-06-20T23:58:43+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-boosts-drug-discovery-throug-305529.html 0.6 2026-07-02T11:46:13+08:00 daily https://www.pharmasources.com/industryinsights/widespread-side-effects-from-drugs-on-lu-305530.html 0.6 2026-07-03T18:43:14+08:00 daily https://www.pharmasources.com/industryinsights/jw-pharmaceutical-invests-in-british-ant-305531.html 0.6 2026-06-21T04:10:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-combination-hrt-to-treat-ho-305532.html 0.6 2026-02-27T11:23:24+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pfizer-join-forces-on-potential-305533.html 0.6 2026-06-08T23:33:28+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-appoints-chief-clinical-developm-305534.html 0.6 2026-06-21T11:09:12+08:00 daily https://www.pharmasources.com/industryinsights/tychan-completes-human-safety-studies-fo-305535.html 0.6 2026-06-23T18:11:26+08:00 daily https://www.pharmasources.com/industryinsights/elpis-biomed-human-cell-models-could-pot-305536.html 0.6 2026-07-14T22:44:04+08:00 daily https://www.pharmasources.com/industryinsights/new-method-for-characterising-liposome-f-305537.html 0.6 2026-07-05T07:24:51+08:00 daily https://www.pharmasources.com/industryinsights/actobio-doses-first-patient-in-study-of--305538.html 0.6 2026-08-07T17:14:01+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-clinical-collaboratio-305539.html 0.6 2026-08-03T06:54:17+08:00 daily https://www.pharmasources.com/industryinsights/nih-awards-grant-for-research-on-apexian-305540.html 0.6 2026-01-12T14:40:10+08:00 daily https://www.pharmasources.com/industryinsights/quadrant-biosciences-autism-speaks-to-st-305541.html 0.6 2026-07-05T11:33:50+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-approval-for-cosentyx--305542.html 0.6 2026-06-20T23:45:19+08:00 daily https://www.pharmasources.com/industryinsights/lonza-acquires-octane-biotech-305543.html 0.6 2026-06-17T08:41:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pfizer-partner-for-nash-305544.html 0.6 2026-06-21T10:51:23+08:00 daily https://www.pharmasources.com/industryinsights/lilly-dicerna-announce-global-licensing--305545.html 0.6 2026-06-22T00:57:47+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-symphogen-enter-collaborat-305546.html 0.6 2026-06-08T13:11:01+08:00 daily https://www.pharmasources.com/industryinsights/rigel-kissei-enter-agreement-305547.html 0.6 2026-06-30T20:27:32+08:00 daily https://www.pharmasources.com/industryinsights/lubrizol-to-invest-25m-in-facility-expan-305548.html 0.6 2026-06-21T08:05:01+08:00 daily https://www.pharmasources.com/industryinsights/aptargroup-appoints-chro-305549.html 0.6 2026-06-21T03:55:52+08:00 daily https://www.pharmasources.com/industryinsights/cromsource-appoints-regulatory-services--305550.html 0.6 2026-07-19T09:55:09+08:00 daily https://www.pharmasources.com/industryinsights/adesis-officially-opens-delaware-lab-305551.html 0.6 2026-06-21T07:55:19+08:00 daily https://www.pharmasources.com/industryinsights/aerie-pharmaceuticals-launches-gmp-facil-305552.html 0.6 2026-06-19T18:04:15+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-usfda-nod-for-generic-derm-305553.html 0.6 2026-06-20T22:49:06+08:00 daily https://www.pharmasources.com/industryinsights/agreement-with-grnenthal-for-rights-to-n-305554.html 0.6 2026-06-21T00:59:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-q3-results-growth-in-revenue-and--305555.html 0.6 2026-06-20T22:30:32+08:00 daily https://www.pharmasources.com/industryinsights/lilly-signs-licensing-and-research-deal--305556.html 0.6 2026-06-21T09:51:57+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-leads-pharma-pack-breaking--305557.html 0.6 2026-06-22T12:02:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dengue-shot-dengvaxia-wins-fda-p-305558.html 0.6 2026-06-20T17:06:19+08:00 daily https://www.pharmasources.com/industryinsights/continually-evolving-solid-dosage-forms-305559.html 0.6 2026-07-04T02:38:16+08:00 daily https://www.pharmasources.com/industryinsights/ciprofloxacin-has-dramatic-effects-on-mi-305560.html 0.6 2026-06-21T06:17:25+08:00 daily https://www.pharmasources.com/industryinsights/biomarkers-show-responsiveness-to-endome-305561.html 0.6 2026-06-20T14:49:10+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-agrees-to-divest-nexium-vimo-305562.html 0.6 2026-06-20T23:40:35+08:00 daily https://www.pharmasources.com/industryinsights/palbociclib-improves-patients-survival-i-305563.html 0.6 2026-06-20T18:00:21+08:00 daily https://www.pharmasources.com/industryinsights/mirati-therapeutics-announces-submission-305564.html 0.6 2026-08-05T18:24:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-305565.html 0.6 2026-07-06T20:11:39+08:00 daily https://www.pharmasources.com/industryinsights/encouraging-data-for-viivs-long-acting-t-305566.html 0.6 2026-03-25T19:42:45+08:00 daily https://www.pharmasources.com/industryinsights/half-of-kidney-cancer-patients-are-initi-305567.html 0.6 2026-06-22T03:51:52+08:00 daily https://www.pharmasources.com/industryinsights/hearing-loss-and-inner-ear-disorders-the-305568.html 0.6 2025-12-15T18:57:37+08:00 daily https://www.pharmasources.com/industryinsights/uk-mps-call-for-greater-action-on-clinic-305569.html 0.6 2026-06-21T06:12:52+08:00 daily https://www.pharmasources.com/industryinsights/gsk-announces-results-of-three-year-tria-305570.html 0.6 2026-07-08T04:47:02+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-receive-additional-205-billion-ea-305571.html 0.6 2026-06-20T17:16:30+08:00 daily https://www.pharmasources.com/industryinsights/effective-preventative-therapies-for-typ-305572.html 0.6 2026-07-20T08:28:30+08:00 daily https://www.pharmasources.com/industryinsights/us-court-overturns-jjs-zytiga-patent-in--305573.html 0.6 2026-07-18T08:37:08+08:00 daily https://www.pharmasources.com/industryinsights/roches-eye-drug-beats-lucentis-at-phase--305574.html 0.6 2026-06-20T14:29:31+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-coverage-falls-by-62-since-last--305575.html 0.6 2026-06-22T07:03:47+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-novartis-partner-up-to-develo-305576.html 0.6 2026-07-22T23:47:13+08:00 daily https://www.pharmasources.com/industryinsights/hhs-secretary-alex-azar-responds-to-phar-305577.html 0.6 2026-06-22T17:08:04+08:00 daily https://www.pharmasources.com/industryinsights/president-trump-unveils-new-plans-to-bri-305578.html 0.6 2026-06-21T22:52:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-issues-draft-guidance-rejecting-abb-305579.html 0.6 2026-02-28T18:31:03+08:00 daily https://www.pharmasources.com/industryinsights/gsk-opens-54m-api-plant-in-montrose-scot-305580.html 0.6 2026-07-04T10:16:45+08:00 daily https://www.pharmasources.com/industryinsights/amgen-slashes-price-of-cholesterol-drug--305581.html 0.6 2026-06-20T16:36:54+08:00 daily https://www.pharmasources.com/industryinsights/measles-outbreak-threatens-to-decimate-i-305582.html 0.6 2026-06-20T23:55:57+08:00 daily https://www.pharmasources.com/industryinsights/first-novel-single-dose-flu-drug-approve-305583.html 0.6 2026-06-20T14:45:13+08:00 daily https://www.pharmasources.com/industryinsights/economic-impact-of-excess-weight-now-exc-305584.html 0.6 2026-06-21T09:11:31+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-inaugurates-new-cen-305585.html 0.6 2026-04-23T08:27:42+08:00 daily https://www.pharmasources.com/industryinsights/depreciating-indian-rupee-to-offer-respi-305586.html 0.6 2026-08-07T23:54:33+08:00 daily https://www.pharmasources.com/industryinsights/metropolitan-police-charge-ith-pharma-ov-305587.html 0.6 2026-06-21T04:12:01+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-flogs-two-drug-licenses-in-9-305588.html 0.6 2026-06-20T17:18:32+08:00 daily https://www.pharmasources.com/industryinsights/madras-hc-stays-online-sale-of-medicines-305589.html 0.6 2026-05-03T02:59:56+08:00 daily https://www.pharmasources.com/industryinsights/common-diabetes-drug-can-protect-against-305590.html 0.6 2026-06-21T04:11:57+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-shingrix-zooms-toward-b-305591.html 0.6 2026-06-20T20:55:43+08:00 daily https://www.pharmasources.com/industryinsights/jjs-invokana-becomes-first-fda-approved--305592.html 0.6 2026-06-22T02:03:46+08:00 daily https://www.pharmasources.com/industryinsights/janssen-gets-fda-approval-for-invokana-t-305593.html 0.6 2026-06-21T06:22:32+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-sanofis-caprelsa-for-rar-305594.html 0.6 2026-06-22T06:48:52+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-commenced-construction-of-305595.html 0.6 2026-08-06T09:56:36+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-signs-922m-licensing-deal-wi-305596.html 0.6 2026-08-07T21:56:47+08:00 daily https://www.pharmasources.com/industryinsights/communications-team-of-the-year-finalist-305597.html 0.6 2026-06-22T09:49:09+08:00 daily https://www.pharmasources.com/industryinsights/mps-voice-concern-over-clinical-trials-t-305598.html 0.6 2026-06-21T19:57:45+08:00 daily https://www.pharmasources.com/industryinsights/guangdong-bans-transportation-of-pigs-du-305599.html 0.6 2026-06-22T05:54:36+08:00 daily https://www.pharmasources.com/industryinsights/roches-alecensa-topples-pfizers-xalkori--305600.html 0.6 2026-06-21T04:13:51+08:00 daily https://www.pharmasources.com/industryinsights/first-line-keytruda-shows-better-overall-305601.html 0.6 2026-06-21T13:06:33+08:00 daily https://www.pharmasources.com/industryinsights/shares-in-mirati-plummet-after-disappoin-305602.html 0.6 2026-06-21T06:55:03+08:00 daily https://www.pharmasources.com/industryinsights/gbg-yale-partner-for-drug-discovery-305603.html 0.6 2026-08-09T05:23:31+08:00 daily https://www.pharmasources.com/industryinsights/quanticate-expands-to-mumbai-appoints-sv-305604.html 0.6 2026-06-21T21:53:23+08:00 daily https://www.pharmasources.com/industryinsights/half-of-all-kidney-cancer-patients-initi-305605.html 0.6 2026-04-16T18:51:42+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-opens-first-us-mfg-site-305606.html 0.6 2026-06-21T02:43:51+08:00 daily https://www.pharmasources.com/industryinsights/q-labs-appoints-analytical-chemistry-man-305607.html 0.6 2026-06-20T23:51:58+08:00 daily https://www.pharmasources.com/industryinsights/avance-completes-successful-fda-inspecti-305608.html 0.6 2026-06-21T20:59:35+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-officially-opens-new-facil-305609.html 0.6 2026-06-20T22:15:58+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-build-new-biologics-ce-305610.html 0.6 2026-07-23T20:46:48+08:00 daily https://www.pharmasources.com/industryinsights/aaps-names-manuscript-award-winners-305611.html 0.6 2026-08-08T22:17:05+08:00 daily https://www.pharmasources.com/industryinsights/janssen-receives-fda-approval-for-invoka-305612.html 0.6 2026-08-02T16:18:08+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-305613.html 0.6 2026-08-07T07:25:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xofluza-a-first-in-class-fl-305614.html 0.6 2026-07-23T00:56:41+08:00 daily https://www.pharmasources.com/industryinsights/less-invasive-surgery-for-cervical-cance-305615.html 0.6 2026-06-21T14:46:14+08:00 daily https://www.pharmasources.com/industryinsights/barriers-to-prostate-cancer-research-in--305616.html 0.6 2026-06-21T09:13:12+08:00 daily https://www.pharmasources.com/industryinsights/opioid-use-often-persists-in-workers-com-305617.html 0.6 2026-06-21T12:16:58+08:00 daily https://www.pharmasources.com/industryinsights/some-weather-conditions-linked-to-myocar-305618.html 0.6 2026-06-21T08:02:58+08:00 daily https://www.pharmasources.com/industryinsights/as-shire-deal-inches-forward-takeda-tout-305619.html 0.6 2026-06-21T08:00:06+08:00 daily https://www.pharmasources.com/industryinsights/the-103rd-annual-american-college-of-sur-305620.html 0.6 2026-04-11T22:01:10+08:00 daily https://www.pharmasources.com/industryinsights/fentanyl-laced-crack-cocaine-a-deadly-ne-305621.html 0.6 2026-06-22T08:56:41+08:00 daily https://www.pharmasources.com/industryinsights/janssen-unveils-long-term-data-for-hiv-d-305622.html 0.6 2026-06-21T03:53:57+08:00 daily https://www.pharmasources.com/industryinsights/encouraging-data-for-viivs-long-acting-t-305623.html 0.6 2026-06-20T19:56:45+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-causing-500-premature-deaths-a--305624.html 0.6 2026-06-20T20:19:10+08:00 daily https://www.pharmasources.com/industryinsights/half-of-all-kidney-cancer-patients-initi-305625.html 0.6 2026-06-22T01:57:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-pfizer-link-to-develop-nash-305626.html 0.6 2026-08-07T00:54:11+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-venclyxto-hit-with-nice-rejectio-305627.html 0.6 2026-06-20T22:09:53+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-first-in-class-flu-drug-305628.html 0.6 2026-08-07T05:37:07+08:00 daily https://www.pharmasources.com/industryinsights/gilead-raises-outlook-despite-dip-in-rev-305629.html 0.6 2026-08-07T02:31:26+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-assumes-full-development-and-comm-305630.html 0.6 2026-08-07T00:39:43+08:00 daily https://www.pharmasources.com/industryinsights/forward-pharma-loses-tecfidera-patent-ap-305631.html 0.6 2026-08-07T00:53:15+08:00 daily https://www.pharmasources.com/industryinsights/az-and-msds-lynparza-shows-significant-r-305632.html 0.6 2026-08-07T02:31:16+08:00 daily https://www.pharmasources.com/industryinsights/medicines-discovery-catapult-and-astraze-305633.html 0.6 2026-08-07T02:40:04+08:00 daily https://www.pharmasources.com/industryinsights/us-filing-for-viivs-two-drug-single-pill-305634.html 0.6 2026-08-07T02:52:01+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-lillys-breast-cancer-drug-v-305635.html 0.6 2026-08-07T02:59:33+08:00 daily https://www.pharmasources.com/industryinsights/govt-to-introduce-tech-standards-for-the-305636.html 0.6 2026-08-09T07:59:08+08:00 daily https://www.pharmasources.com/industryinsights/nhs-green-light-for-novartis-skin-cancer-305637.html 0.6 2026-07-03T17:14:10+08:00 daily https://www.pharmasources.com/industryinsights/londons-health-and-care-system-hampering-305638.html 0.6 2026-06-21T08:03:00+08:00 daily https://www.pharmasources.com/industryinsights/azmsds-lynparza-assigned-orphan-status-i-305639.html 0.6 2026-06-21T17:49:30+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-dupixent-shines-in-rhi-305640.html 0.6 2026-06-20T20:40:16+08:00 daily https://www.pharmasources.com/industryinsights/nhs-trafford-ccg-placing-team-of-pharmac-305641.html 0.6 2026-06-21T03:56:43+08:00 daily https://www.pharmasources.com/industryinsights/intellias-clinical-head-moves-to-crispr--305642.html 0.6 2026-06-24T07:03:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-23andmes-dtc-drug-metabolism--305643.html 0.6 2026-07-09T03:49:40+08:00 daily https://www.pharmasources.com/industryinsights/calithera-compound-empowers-immuno-oncol-305644.html 0.6 2026-07-02T11:04:12+08:00 daily https://www.pharmasources.com/industryinsights/magenta-stem-cell-transplant-drug-seems--305645.html 0.6 2026-06-29T18:44:26+08:00 daily https://www.pharmasources.com/industryinsights/neuropointdx-looking-for-earlier-diagnos-305646.html 0.6 2026-06-20T19:00:40+08:00 daily https://www.pharmasources.com/industryinsights/forty-sevens-anti-cd47-combo-shows-promi-305647.html 0.6 2026-01-11T18:03:06+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-pays-denali-125m-to-buy-into-ripk-305648.html 0.6 2026-08-09T02:38:52+08:00 daily https://www.pharmasources.com/industryinsights/medtech-fierce-15-winner-axonics-gets-of-305649.html 0.6 2026-08-08T23:30:14+08:00 daily https://www.pharmasources.com/industryinsights/ferrings-chief-science-officer-to-take-o-305650.html 0.6 2026-08-08T22:01:48+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-war-chest-balloons--305651.html 0.6 2026-08-08T07:41:42+08:00 daily https://www.pharmasources.com/industryinsights/newly-discovered-link-between-the-append-305652.html 0.6 2026-08-08T04:28:05+08:00 daily https://www.pharmasources.com/industryinsights/ophthotech-adds-to-pipeline-again-as-cli-305653.html 0.6 2026-08-08T03:46:15+08:00 daily https://www.pharmasources.com/industryinsights/vayyar-launches-home-radar-sensor-for-re-305654.html 0.6 2026-08-08T03:08:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-staff-spotlight-bigbut-expectedissue-305655.html 0.6 2026-08-07T13:54:52+08:00 daily https://www.pharmasources.com/industryinsights/exact-sciences-ups-its-forecast-after-24-305656.html 0.6 2026-08-07T13:16:54+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-mulls-respiratory-exit-t-305657.html 0.6 2026-08-07T12:11:22+08:00 daily https://www.pharmasources.com/industryinsights/qiagen-unveils-3-next-generation-sequenc-305658.html 0.6 2026-08-07T13:17:46+08:00 daily https://www.pharmasources.com/industryinsights/gilead-pays-50m-to-team-up-with-syntheti-305659.html 0.6 2026-07-05T13:37:41+08:00 daily https://www.pharmasources.com/industryinsights/roche-taps-halozymes-drug-delivery-tech--305660.html 0.6 2026-07-18T07:33:44+08:00 daily https://www.pharmasources.com/industryinsights/schrdinger-wuxi-launch-virtual-drug-disc-305661.html 0.6 2026-06-21T07:56:06+08:00 daily https://www.pharmasources.com/industryinsights/genentech-staff-funneled-secrets-to-taiw-305662.html 0.6 2026-06-20T15:03:20+08:00 daily https://www.pharmasources.com/industryinsights/telehealth-firm-98point6-nets-50m-in-rou-305663.html 0.6 2026-06-21T13:03:28+08:00 daily https://www.pharmasources.com/industryinsights/nicox-pauses-nasdaq-ipo-plan-amid-market-305664.html 0.6 2026-06-20T14:50:03+08:00 daily https://www.pharmasources.com/industryinsights/orbimed-vivo-lead-80m-b-round-for-terns--305665.html 0.6 2026-08-09T09:53:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-cut-drug-research-projects-b-305666.html 0.6 2026-07-06T21:33:58+08:00 daily https://www.pharmasources.com/industryinsights/philips-launches-integrated-breast-ultra-305667.html 0.6 2026-08-05T22:38:43+08:00 daily https://www.pharmasources.com/industryinsights/2-studies-use-retinal-scans-to-potential-305668.html 0.6 2026-06-20T05:11:14+08:00 daily https://www.pharmasources.com/industryinsights/proqr-licenses-ionis-rna-drug-for-inheri-305669.html 0.6 2026-06-21T08:03:04+08:00 daily https://www.pharmasources.com/industryinsights/days-after-alexion-deal-dicerna-pens-100-305670.html 0.6 2026-07-18T00:31:05+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-to-open-jlabs-virtual-ne-305671.html 0.6 2026-06-20T02:51:02+08:00 daily https://www.pharmasources.com/industryinsights/discovery-of-cancer-kill-code-could-insp-305672.html 0.6 2026-06-21T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/big-pharma-rivals-pfizer-and-novartis-te-305673.html 0.6 2026-06-21T05:01:43+08:00 daily https://www.pharmasources.com/industryinsights/natural-protein-curbs-obesity-in-mice-305674.html 0.6 2026-06-20T18:00:20+08:00 daily https://www.pharmasources.com/industryinsights/ai-drug-miner-xtalpi-raises-another-46m--305675.html 0.6 2026-07-18T05:22:05+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-offers-up-80-humira-discount-in-e-305676.html 0.6 2026-06-21T03:07:47+08:00 daily https://www.pharmasources.com/industryinsights/tp-taps-almac-to-develop-repotrectinib-p-305677.html 0.6 2026-05-11T22:09:38+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-expands-job-cuts-to-1300-as-305678.html 0.6 2026-07-30T22:07:06+08:00 daily https://www.pharmasources.com/industryinsights/novel-antibacterial-drugs-developed-at-u-305679.html 0.6 2026-08-01T23:11:50+08:00 daily https://www.pharmasources.com/industryinsights/medical-cannabis-made-available-on-presc-305680.html 0.6 2026-06-21T07:01:56+08:00 daily https://www.pharmasources.com/industryinsights/booming-pharmaceutical-industry-in-scotl-305681.html 0.6 2026-08-08T22:17:02+08:00 daily https://www.pharmasources.com/industryinsights/gsk-announces-two-sets-of-positive-resul-305682.html 0.6 2026-07-20T09:54:20+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-receives-us-fda-approval-for-bios-305683.html 0.6 2026-07-30T14:55:08+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-96-tax-break-big-pharma-reaps-hu-305684.html 0.6 2026-06-20T22:01:43+08:00 daily https://www.pharmasources.com/industryinsights/celgene-lines-up-for-600m-revlimid-boost-305685.html 0.6 2026-06-20T21:11:16+08:00 daily https://www.pharmasources.com/industryinsights/numedii-announces-research-collaboration-305686.html 0.6 2026-06-21T18:01:28+08:00 daily https://www.pharmasources.com/industryinsights/insulin-supply-chain-transparency-needed-305687.html 0.6 2026-06-21T22:10:58+08:00 daily https://www.pharmasources.com/industryinsights/pantherx-specialty-pharmacy-and-rxcrossr-305688.html 0.6 2026-06-21T08:20:16+08:00 daily https://www.pharmasources.com/industryinsights/strategic-cooperation-between-genequantu-305689.html 0.6 2026-08-05T03:00:02+08:00 daily https://www.pharmasources.com/industryinsights/alarming-percentage-of-families-share-le-305690.html 0.6 2026-06-21T04:10:50+08:00 daily https://www.pharmasources.com/industryinsights/inflection-biosciences-announces-researc-305691.html 0.6 2026-06-30T21:22:15+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-and-tango-therapeutics-a-305692.html 0.6 2026-06-21T07:53:03+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-and-genexine-announce-china-ind-ap-305693.html 0.6 2026-07-22T01:26:25+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-vertexs-symkevi-for-cystic-f-305694.html 0.6 2026-06-08T08:09:13+08:00 daily https://www.pharmasources.com/industryinsights/link-between-early-antibiotic-exposure-a-305695.html 0.6 2026-06-20T15:59:21+08:00 daily https://www.pharmasources.com/industryinsights/protinex-joins-hands-with-inbody-to-esta-305696.html 0.6 2026-06-21T15:56:28+08:00 daily https://www.pharmasources.com/industryinsights/pascal-biosciences-and-the-university-of-305697.html 0.6 2026-08-07T19:00:48+08:00 daily https://www.pharmasources.com/industryinsights/distributed-bio-inc-announces-collaborat-305698.html 0.6 2026-07-17T01:09:16+08:00 daily https://www.pharmasources.com/industryinsights/rigel-pharmaceuticals-enters-collaborati-305699.html 0.6 2026-03-27T21:07:08+08:00 daily https://www.pharmasources.com/industryinsights/bioasis-announces-xb3-platform-technolog-305700.html 0.6 2026-06-21T00:58:47+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018110-305701.html 0.6 2026-06-21T05:11:50+08:00 daily https://www.pharmasources.com/industryinsights/plasticell-receives-eu-funding-to-advanc-305702.html 0.6 2026-07-03T08:29:28+08:00 daily https://www.pharmasources.com/industryinsights/lonza-acquires-controlling-stake-in-octa-305703.html 0.6 2026-08-01T15:26:16+08:00 daily https://www.pharmasources.com/industryinsights/us-expands-reach-of-keytruda-in-nsclc-305704.html 0.6 2026-06-20T18:20:54+08:00 daily https://www.pharmasources.com/industryinsights/bhf-urges-heart-patients-to-get-flu-jab-305705.html 0.6 2026-07-20T18:35:40+08:00 daily https://www.pharmasources.com/industryinsights/long-term-data-backs-safety-and-efficacy-305706.html 0.6 2026-08-01T11:56:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisors-turn-down-alkermes-alks-546-305707.html 0.6 2026-06-21T09:54:19+08:00 daily https://www.pharmasources.com/industryinsights/green-light-for-rocheabbvies-chemo-free--305708.html 0.6 2026-08-05T23:49:00+08:00 daily https://www.pharmasources.com/industryinsights/viivs-fostemsavir-shows-promise-in-heavi-305709.html 0.6 2026-06-22T03:10:46+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-vertex-cystic-fibrosis-combo-305710.html 0.6 2026-07-18T00:06:06+08:00 daily https://www.pharmasources.com/industryinsights/gsk-narrows-earnings-guidance-after-shin-305711.html 0.6 2026-07-17T11:05:32+08:00 daily https://www.pharmasources.com/industryinsights/mps-voice-concern-over-clinical-trials-t-305712.html 0.6 2026-07-04T00:14:30+08:00 daily https://www.pharmasources.com/industryinsights/az-sheds-nexium-vimovo-rights-to-gruenen-305713.html 0.6 2026-06-21T11:12:23+08:00 daily https://www.pharmasources.com/industryinsights/gsks-anti-seizure-drug-shows-promise-in--305714.html 0.6 2026-07-05T02:45:40+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-drops-oses-rheumatoid-ar-305715.html 0.6 2026-06-21T01:54:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-23andmes-dtc-drug-metabolism--305716.html 0.6 2026-06-21T11:11:24+08:00 daily https://www.pharmasources.com/industryinsights/klue-adds-insulin-reminders-to-behaviora-305717.html 0.6 2026-07-02T19:59:19+08:00 daily https://www.pharmasources.com/industryinsights/omeicos-raises-17m-to-run-phase-2-atrial-305718.html 0.6 2026-06-22T02:59:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-ups-the-ante-on-roche-blood-thinner--305719.html 0.6 2026-06-20T14:44:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-slams-alkermes-opioid-based-de-305720.html 0.6 2026-03-31T03:53:49+08:00 daily https://www.pharmasources.com/industryinsights/illumina-buys-pacbio-to-shore-up-dna-seq-305721.html 0.6 2026-04-17T07:19:57+08:00 daily https://www.pharmasources.com/industryinsights/new-edition-of-chinas-national-essential-305722.html 0.6 2026-08-05T20:54:44+08:00 daily https://www.pharmasources.com/industryinsights/research-shows-vulnerability-of-brain-ha-305723.html 0.6 2026-06-22T05:51:33+08:00 daily https://www.pharmasources.com/industryinsights/researchers-use-polygene-scores-to-treat-305724.html 0.6 2026-06-22T11:54:44+08:00 daily https://www.pharmasources.com/industryinsights/yuhan-licences-lung-cancer-asset-to-jans-305725.html 0.6 2026-07-02T15:36:22+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-signs-1bn-drug-development-deal-w-305726.html 0.6 2026-06-21T04:51:50+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-closing-o-305727.html 0.6 2026-06-22T09:35:29+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharmaceuticals-launches-cannabis-bas-305728.html 0.6 2026-08-06T22:19:21+08:00 daily https://www.pharmasources.com/industryinsights/researchers-have-found-that-glaxosmithkl-305729.html 0.6 2026-06-20T21:02:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-snags-ok-for-xalkori-follow-up-lo-305730.html 0.6 2026-06-21T02:13:49+08:00 daily https://www.pharmasources.com/industryinsights/2018s-fiercest-women-in-life-sciences-305731.html 0.6 2026-08-06T11:12:54+08:00 daily https://www.pharmasources.com/industryinsights/automation-could-help-chinas-pharmaceuti-305732.html 0.6 2026-06-21T22:58:41+08:00 daily https://www.pharmasources.com/industryinsights/fluorescent-marker-to-help-guide-surgeon-305733.html 0.6 2026-06-22T12:58:15+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-posts-over-two-fold-jump-in-305734.html 0.6 2026-06-20T16:06:16+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-recalls-hypertensive-drug-in-u-305735.html 0.6 2026-08-07T11:56:47+08:00 daily https://www.pharmasources.com/industryinsights/novartis-rd-update-highlights-industry-l-305736.html 0.6 2026-06-21T12:23:47+08:00 daily https://www.pharmasources.com/industryinsights/amazing-monthly-sales-performance-of-opd-305737.html 0.6 2026-07-26T15:57:18+08:00 daily https://www.pharmasources.com/industryinsights/29-monoclonal-antibody-drugs-marketed-in-305738.html 0.6 2026-07-19T06:01:09+08:00 daily https://www.pharmasources.com/industryinsights/monoclonal-antibody-drugs-in-development-305739.html 0.6 2026-08-05T21:00:13+08:00 daily https://www.pharmasources.com/industryinsights/oncology-analytics-raises-21m-series-b-f-305740.html 0.6 2026-06-22T10:01:48+08:00 daily https://www.pharmasources.com/industryinsights/yissum-announces-novel-tech-for-3d-print-305741.html 0.6 2025-12-16T04:30:43+08:00 daily https://www.pharmasources.com/industryinsights/maverick-medical-ai-raises-700k-305742.html 0.6 2026-08-08T17:24:45+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-rummage-sale-continues-with-305743.html 0.6 2026-06-20T20:07:42+08:00 daily https://www.pharmasources.com/industryinsights/lillys-trulicity-shows-superiority-in-re-305744.html 0.6 2026-07-02T18:32:28+08:00 daily https://www.pharmasources.com/industryinsights/scotland-seeks-answers-on-brexit-costs-t-305745.html 0.6 2026-06-22T12:00:45+08:00 daily https://www.pharmasources.com/industryinsights/ecdc-report-shows-drug-resistant-superbu-305746.html 0.6 2026-06-21T03:05:48+08:00 daily https://www.pharmasources.com/industryinsights/temperature-controlled-packaging-market--305747.html 0.6 2026-06-22T01:57:35+08:00 daily https://www.pharmasources.com/industryinsights/roche-imports-personalized-health-care-t-305748.html 0.6 2026-08-03T18:20:27+08:00 daily https://www.pharmasources.com/industryinsights/fosun-to-showcase-its-global-healthcare--305749.html 0.6 2026-07-18T01:00:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-lung-cancer-drug-305750.html 0.6 2026-06-30T00:24:38+08:00 daily https://www.pharmasources.com/industryinsights/cumberland-pharmaceuticals-to-acquire-vi-305751.html 0.6 2026-06-20T23:52:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lorlatinib-305752.html 0.6 2026-06-20T13:46:51+08:00 daily https://www.pharmasources.com/industryinsights/curevo-announces-fda-advancement-of-ind--305753.html 0.6 2026-06-21T13:01:29+08:00 daily https://www.pharmasources.com/industryinsights/janssen-issues-recall-for-ortho-novum-13-305754.html 0.6 2026-06-21T08:05:59+08:00 daily https://www.pharmasources.com/industryinsights/protagonist-therapeutics-announces-compl-305755.html 0.6 2026-08-07T04:59:04+08:00 daily https://www.pharmasources.com/industryinsights/dod-fda-collaborate-to-advance-medical-p-305756.html 0.6 2026-06-20T22:46:25+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-announces-fda-approval-of-dsuvia-305757.html 0.6 2026-06-22T11:49:55+08:00 daily https://www.pharmasources.com/industryinsights/acesion-pharma-announces-positive-result-305758.html 0.6 2026-08-07T21:38:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-alerts-some-epipen-auto-injectors-ma-305759.html 0.6 2026-06-21T00:56:46+08:00 daily https://www.pharmasources.com/industryinsights/thermo-scientific-launches-orbitrap-id-x-305760.html 0.6 2026-06-21T12:04:16+08:00 daily https://www.pharmasources.com/industryinsights/recro-gainesville-adds-new-facility-305761.html 0.6 2026-06-21T10:15:28+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-launches-biocontinuum-pla-305762.html 0.6 2026-04-07T06:38:27+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-global-patent-license-w-305763.html 0.6 2026-06-20T16:16:56+08:00 daily https://www.pharmasources.com/industryinsights/croda-opens-its-centre-of-innovation-for-305764.html 0.6 2026-06-22T08:52:54+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-pulls-the-plug-on-us-biosimilar-r-305765.html 0.6 2026-08-09T14:21:02+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-for-sanofi-regenerons-du-305766.html 0.6 2026-08-07T00:41:25+08:00 daily https://www.pharmasources.com/industryinsights/social-media-scheme-boosts-breast-cancer-305767.html 0.6 2026-08-06T23:57:49+08:00 daily https://www.pharmasources.com/industryinsights/health-secretary-throws-his-weight-behin-305768.html 0.6 2026-08-06T23:54:29+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-new-use-for-bms-empliciti-305769.html 0.6 2026-08-07T00:01:49+08:00 daily https://www.pharmasources.com/industryinsights/recro-pharma-expands-cdmo-business-in-ge-305770.html 0.6 2026-06-22T15:48:43+08:00 daily https://www.pharmasources.com/industryinsights/five-new-technology-centres-to-drive-ear-305771.html 0.6 2026-08-07T00:40:22+08:00 daily https://www.pharmasources.com/industryinsights/health-secretary-unveils-plans-for-great-305772.html 0.6 2026-08-07T00:59:27+08:00 daily https://www.pharmasources.com/industryinsights/some-factors-have-a-greater-impact-on-he-305773.html 0.6 2026-08-07T02:31:22+08:00 daily https://www.pharmasources.com/industryinsights/lilly-says-diabetes-drug-trulicity-reduc-305774.html 0.6 2026-08-07T13:15:59+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regenerons-dupixent-gets-more-305775.html 0.6 2026-08-06T23:37:13+08:00 daily https://www.pharmasources.com/industryinsights/spanish-authorities-restrict-prescriptio-305776.html 0.6 2026-08-06T23:33:04+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-chief-executive-officer-d-305777.html 0.6 2026-08-08T10:25:23+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodts-niemann-pick-type-c-drug-f-305778.html 0.6 2026-08-07T04:25:21+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-jazz-aml-chemo-305779.html 0.6 2026-08-07T04:53:12+08:00 daily https://www.pharmasources.com/industryinsights/az-books-sales-growth-for-the-third-quar-305780.html 0.6 2026-08-07T05:07:10+08:00 daily https://www.pharmasources.com/industryinsights/new-alliance-strives-to-advance-human-ba-305781.html 0.6 2026-06-20T15:56:43+08:00 daily https://www.pharmasources.com/industryinsights/az-sells-respiratory-trio-to-covis-305782.html 0.6 2026-06-20T17:07:23+08:00 daily https://www.pharmasources.com/industryinsights/themis-eyes-phase-3-study-for-chikunguny-305783.html 0.6 2026-06-22T04:54:46+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-controversial-dengvaxia-picks-up-305784.html 0.6 2025-10-26T14:46:05+08:00 daily https://www.pharmasources.com/industryinsights/invectys-raises-15m-series-a-to-fund-dna-305785.html 0.6 2026-07-04T08:21:38+08:00 daily https://www.pharmasources.com/industryinsights/unprecedented-demand-for-mercks-gardasil-305786.html 0.6 2026-06-21T06:49:49+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-steps-up-vaccines-rdand--305787.html 0.6 2026-06-21T07:07:01+08:00 daily https://www.pharmasources.com/industryinsights/jj-touts-latest-immune-response-data-for-305788.html 0.6 2026-06-21T02:57:44+08:00 daily https://www.pharmasources.com/industryinsights/china-slaps-13b-penalty-on-vaccine-scand-305789.html 0.6 2026-07-15T22:21:34+08:00 daily https://www.pharmasources.com/industryinsights/in-worrying-trend-vaccination-rates-in-u-305790.html 0.6 2026-06-22T05:43:26+08:00 daily https://www.pharmasources.com/industryinsights/cell-derived-flu-vaccine-strains-a-bette-305791.html 0.6 2026-07-08T08:18:11+08:00 daily https://www.pharmasources.com/industryinsights/flugens-broadly-protective-flu-vaccine-c-305792.html 0.6 2026-07-10T10:40:36+08:00 daily https://www.pharmasources.com/industryinsights/vaxart-touts-head-to-head-data-for-oral--305793.html 0.6 2026-02-28T15:33:22+08:00 daily https://www.pharmasources.com/industryinsights/first-us-cuba-biotech-jv-to-bring-cuban--305794.html 0.6 2026-06-20T20:01:34+08:00 daily https://www.pharmasources.com/industryinsights/outbreak-alliance-hands-johnson-johnson--305795.html 0.6 2026-02-16T14:58:47+08:00 daily https://www.pharmasources.com/industryinsights/racing-with-merck-pfizer-wins-fda-breakt-305796.html 0.6 2026-06-21T06:16:15+08:00 daily https://www.pharmasources.com/industryinsights/hikma-vectura-enter-deal-targeting-gener-305797.html 0.6 2026-07-16T09:21:54+08:00 daily https://www.pharmasources.com/industryinsights/merrimack-to-reduce-workforce-by-60-perc-305798.html 0.6 2026-06-21T21:00:45+08:00 daily https://www.pharmasources.com/industryinsights/immunomedics-expands-clinical-collaborat-305799.html 0.6 2026-06-21T07:19:19+08:00 daily https://www.pharmasources.com/industryinsights/cue-biopharma-announces-strategic-collab-305800.html 0.6 2026-03-08T07:17:43+08:00 daily https://www.pharmasources.com/industryinsights/takeda-announces-issuance-of-unsecured-e-305801.html 0.6 2026-08-06T18:32:29+08:00 daily https://www.pharmasources.com/industryinsights/hikma-acquires-medlac-an-injectable-manu-305802.html 0.6 2026-06-21T03:57:11+08:00 daily https://www.pharmasources.com/industryinsights/biotime-and-asterias-biotherapeutics-ent-305803.html 0.6 2026-04-13T19:22:22+08:00 daily https://www.pharmasources.com/industryinsights/incarda-therapeutics-provides-corporate--305804.html 0.6 2026-07-08T13:51:12+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-strengthens-global--305805.html 0.6 2026-07-05T12:10:51+08:00 daily https://www.pharmasources.com/industryinsights/elpis-biomed-human-cell-models-could-pot-305806.html 0.6 2026-08-06T14:02:27+08:00 daily https://www.pharmasources.com/industryinsights/cder-conversation-safely-using-the-newly-305807.html 0.6 2026-06-20T18:03:28+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-commissioner-scott-go-305808.html 0.6 2026-06-20T20:55:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-12-grants-to-fund-new-clinica-305809.html 0.6 2025-12-02T09:56:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-drug-to-treat-influenza-305810.html 0.6 2026-06-21T14:35:24+08:00 daily https://www.pharmasources.com/industryinsights/drug-establishments-current-registration-305811.html 0.6 2026-06-21T11:52:06+08:00 daily https://www.pharmasources.com/industryinsights/can-chocolate-tea-coffee-and-zinc-help-m-305812.html 0.6 2026-06-20T14:26:40+08:00 daily https://www.pharmasources.com/industryinsights/novartis-rd-update-highlights-industry-l-305813.html 0.6 2026-06-22T09:59:45+08:00 daily https://www.pharmasources.com/industryinsights/21st-annual-superbugs-superdrugs-confere-305814.html 0.6 2026-06-21T00:14:03+08:00 daily https://www.pharmasources.com/industryinsights/divestment-of-rights-to-alvesco-omnaris--305815.html 0.6 2026-08-06T02:17:34+08:00 daily https://www.pharmasources.com/industryinsights/tumour-immune-cells-could-aid-cancer-the-305816.html 0.6 2026-06-21T01:40:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-dupixent--305817.html 0.6 2026-07-21T21:51:17+08:00 daily https://www.pharmasources.com/industryinsights/gap-in-research-means-millions-living-wi-305818.html 0.6 2026-06-21T03:56:46+08:00 daily https://www.pharmasources.com/industryinsights/embark-and-novo-nordisk-enter-collaborat-305819.html 0.6 2025-12-04T18:58:58+08:00 daily https://www.pharmasources.com/industryinsights/blue-light-can-reduce-blood-pressure-305820.html 0.6 2026-06-21T03:50:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-highlights-record-breaking-number-of-305821.html 0.6 2026-06-21T06:56:58+08:00 daily https://www.pharmasources.com/industryinsights/icosabutate-latest-data-shows-direct-and-305822.html 0.6 2026-06-21T08:56:11+08:00 daily https://www.pharmasources.com/industryinsights/t3-pharmaceuticals-wins-prestigious-fall-305823.html 0.6 2026-06-21T09:13:08+08:00 daily https://www.pharmasources.com/industryinsights/selvita-to-present-new-data-from-sel120--305824.html 0.6 2026-06-21T12:26:11+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-announces-successful-bispecifi-305825.html 0.6 2026-06-21T01:05:53+08:00 daily https://www.pharmasources.com/industryinsights/selvita-to-present-new-data-from-its-onc-305826.html 0.6 2026-06-21T04:58:48+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-pricing-o-305827.html 0.6 2026-06-29T07:14:17+08:00 daily https://www.pharmasources.com/industryinsights/cristal-therapeutics-initiates-phase-2-c-305828.html 0.6 2026-08-09T06:59:13+08:00 daily https://www.pharmasources.com/industryinsights/vetter-further-expands-secondary-packagi-305829.html 0.6 2026-08-07T22:35:08+08:00 daily https://www.pharmasources.com/industryinsights/change-of-company-name-vtu-technology-is-305830.html 0.6 2026-08-07T20:13:33+08:00 daily https://www.pharmasources.com/industryinsights/polyganics-initiates-first-in-human-tria-305831.html 0.6 2026-08-07T13:18:07+08:00 daily https://www.pharmasources.com/industryinsights/apceth-biopharma-presents-positive-data--305832.html 0.6 2026-08-06T22:53:17+08:00 daily https://www.pharmasources.com/industryinsights/not-just-for-pharma-anymore-rfxcel-exten-305833.html 0.6 2026-06-21T11:13:19+08:00 daily https://www.pharmasources.com/industryinsights/tfs-collaboration-with-lobsor-pharmaceut-305834.html 0.6 2026-08-06T20:05:25+08:00 daily https://www.pharmasources.com/industryinsights/transplantation-medicine-c-cit-sensors-t-305835.html 0.6 2026-08-06T23:54:37+08:00 daily https://www.pharmasources.com/industryinsights/vetter-grants-award-for-novel-idea-at-th-305836.html 0.6 2026-08-06T23:57:56+08:00 daily https://www.pharmasources.com/industryinsights/new-flash-purification-system-and-column-305837.html 0.6 2026-08-07T00:03:32+08:00 daily https://www.pharmasources.com/industryinsights/metp-pharma-introduces-nascum-plus-again-305838.html 0.6 2026-08-07T12:03:14+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-receives-ema-prime--305839.html 0.6 2026-06-21T19:56:06+08:00 daily https://www.pharmasources.com/industryinsights/apceth-to-manufacture-first-potential-on-305840.html 0.6 2026-06-20T14:49:21+08:00 daily https://www.pharmasources.com/industryinsights/sikkims-tryst-with-pharma-sector-305841.html 0.6 2026-06-20T19:01:36+08:00 daily https://www.pharmasources.com/industryinsights/strides-subsidiary-inks-pact-with-suda-p-305842.html 0.6 2026-06-21T10:03:39+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-to-launch-trial-in-solid-tumour-305843.html 0.6 2026-07-30T16:27:27+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-theravances-copd-treatment-get-305844.html 0.6 2026-06-21T17:00:29+08:00 daily https://www.pharmasources.com/industryinsights/novartis-division-sandoz-recalls-one-lot-305845.html 0.6 2026-06-22T14:53:51+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-q2-net-loss-widens-to-23-crore-305846.html 0.6 2026-06-22T12:13:10+08:00 daily https://www.pharmasources.com/industryinsights/competition-watch-dog-raps-pharma-sector-305847.html 0.6 2026-06-21T11:01:14+08:00 daily https://www.pharmasources.com/industryinsights/express-pharma-hosts-sikkim-pharma-summi-305848.html 0.6 2026-06-21T01:03:47+08:00 daily https://www.pharmasources.com/industryinsights/flutiform-receives-positive-opinion-in-e-305849.html 0.6 2026-06-22T01:08:58+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-commissioner-on-updat-305850.html 0.6 2026-06-20T19:17:04+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-submits-maa-to-euro-305851.html 0.6 2026-06-21T04:42:33+08:00 daily https://www.pharmasources.com/industryinsights/nocdurna-sublingual-tablets-now-availabl-305852.html 0.6 2026-07-20T06:57:32+08:00 daily https://www.pharmasources.com/industryinsights/medday-announces-full-patient-enrollment-305853.html 0.6 2026-06-22T01:56:39+08:00 daily https://www.pharmasources.com/industryinsights/trelegy-ellipta-gains-expanded-copd-indi-305854.html 0.6 2026-06-20T13:19:25+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-issues-recall-of-losartan-potassi-305855.html 0.6 2025-10-19T20:00:13+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-rights-to-alvesco-omna-305856.html 0.6 2026-08-08T23:17:46+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-cd38xcd3-phase-1-trial-305857.html 0.6 2026-07-30T14:22:29+08:00 daily https://www.pharmasources.com/industryinsights/nektar-pfizer-announce-oncology-clinical-305858.html 0.6 2026-06-22T11:10:01+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-doses-first-patient-in-keynote-8-305859.html 0.6 2026-06-20T11:06:41+08:00 daily https://www.pharmasources.com/industryinsights/vivozons-non-opioid-pain-killer-granted--305860.html 0.6 2026-06-21T10:23:52+08:00 daily https://www.pharmasources.com/industryinsights/visterra-initiates-phase-1-clinical-stud-305861.html 0.6 2026-06-21T12:01:09+08:00 daily https://www.pharmasources.com/industryinsights/xencor-announces-board-of-directors-appo-305862.html 0.6 2026-06-21T05:30:07+08:00 daily https://www.pharmasources.com/industryinsights/kadesh-issues-voluntary-nationwide-recal-305863.html 0.6 2026-06-20T19:17:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-udenycaudenyca-is-coherus-f-305864.html 0.6 2026-06-29T01:20:29+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-astrazeneca-yuhan-bristo-305865.html 0.6 2026-06-21T08:05:05+08:00 daily https://www.pharmasources.com/industryinsights/vectura-and-hikma-to-jointly-develop-gen-305866.html 0.6 2026-06-21T17:54:35+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-alexion-pharmaceutical-ova-305867.html 0.6 2026-06-21T07:09:02+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-jazz-pharmaceuticals-vyx-305868.html 0.6 2026-06-22T05:55:35+08:00 daily https://www.pharmasources.com/industryinsights/foamix-publishes-top-line-phase-iii-resu-305869.html 0.6 2026-06-21T16:08:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-status-for-du-305870.html 0.6 2026-06-21T23:51:59+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-sell-drug-rights-to-covis-305871.html 0.6 2026-08-08T02:01:02+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-to-develop-amgens-celiac--305872.html 0.6 2026-06-21T06:00:56+08:00 daily https://www.pharmasources.com/industryinsights/as-novartis-other-cancer-launches-strugg-305873.html 0.6 2026-08-05T15:13:09+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-back-to-growth-but-can--305874.html 0.6 2026-06-21T11:10:19+08:00 daily https://www.pharmasources.com/industryinsights/gsk-execs-change-their-tune-as-az-sanofi-305875.html 0.6 2026-06-20T22:59:38+08:00 daily https://www.pharmasources.com/industryinsights/citing-brazen-trade-secrets-theft-genent-305876.html 0.6 2026-04-05T12:59:12+08:00 daily https://www.pharmasources.com/industryinsights/hikma-to-produce-injectables-in-vietnam--305877.html 0.6 2026-07-30T08:38:32+08:00 daily https://www.pharmasources.com/industryinsights/japan-conducts-worlds-first-ips-cell-tra-305878.html 0.6 2026-07-27T22:14:22+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-research-for-diabetic-kidne-305879.html 0.6 2026-07-01T15:06:00+08:00 daily https://www.pharmasources.com/industryinsights/hikma-acquires-medlac-pharma-305880.html 0.6 2026-07-04T12:23:05+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-back-to-growth-but-can--305881.html 0.6 2026-07-06T04:49:20+08:00 daily https://www.pharmasources.com/industryinsights/novartis-division-sandoz-recalls-one-lot-305882.html 0.6 2026-06-21T11:02:11+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-theravances-copd-treatment-get-305883.html 0.6 2026-07-16T10:00:51+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-jazz-pharmaceuticals-vyx-305884.html 0.6 2026-06-22T08:57:44+08:00 daily https://www.pharmasources.com/industryinsights/nuclear-medicine-imaging-targets-prostra-305885.html 0.6 2026-06-22T08:00:52+08:00 daily https://www.pharmasources.com/industryinsights/strides-enters-into-partnership-with-sud-305886.html 0.6 2026-06-20T17:34:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-vyxeos-for-specific-seco-305887.html 0.6 2026-07-28T08:05:57+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-issues-recall-of-losartan-potassi-305888.html 0.6 2026-06-22T08:56:54+08:00 daily https://www.pharmasources.com/industryinsights/abzena-invests-20m-to-expand-integrated--305889.html 0.6 2026-06-21T04:48:43+08:00 daily https://www.pharmasources.com/industryinsights/vgxi-opens-flex-scale-plant-for-gmp-rna--305890.html 0.6 2026-07-02T23:03:27+08:00 daily https://www.pharmasources.com/industryinsights/sharp-bsm-enter-agreement-305891.html 0.6 2026-06-21T10:52:01+08:00 daily https://www.pharmasources.com/industryinsights/pci-marks-80th-serialization-installatio-305892.html 0.6 2026-06-21T17:59:29+08:00 daily https://www.pharmasources.com/industryinsights/proprietary-nasal-delivery-formulation-o-305893.html 0.6 2026-06-24T23:13:34+08:00 daily https://www.pharmasources.com/industryinsights/gram-announces-successful-fda-inspection-305894.html 0.6 2026-07-17T23:58:18+08:00 daily https://www.pharmasources.com/industryinsights/schrdinger-wuxi-apptec-enter-drug-discov-305895.html 0.6 2026-06-21T22:10:55+08:00 daily https://www.pharmasources.com/industryinsights/pci-appoints-executive-director-of-opera-305896.html 0.6 2026-06-20T14:59:09+08:00 daily https://www.pharmasources.com/industryinsights/lsne-adds-to-leadership-team-305897.html 0.6 2026-06-24T22:04:34+08:00 daily https://www.pharmasources.com/industryinsights/tedor-appoints-formulation-development-h-305898.html 0.6 2026-06-21T09:53:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lillys-emgality-using-lonza-305899.html 0.6 2026-06-20T17:57:31+08:00 daily https://www.pharmasources.com/industryinsights/concept-life-sciences-expands-glp-capabi-305900.html 0.6 2026-06-29T08:18:57+08:00 daily https://www.pharmasources.com/industryinsights/nice-says-no-to-expanding-use-of-az-lynp-305901.html 0.6 2026-06-21T08:17:13+08:00 daily https://www.pharmasources.com/industryinsights/lenvima-backed-for-nhs-use-to-treat-live-305902.html 0.6 2026-07-16T09:54:58+08:00 daily https://www.pharmasources.com/industryinsights/liverpool-uni-leads-eu-kidney-research-p-305903.html 0.6 2026-06-21T08:17:16+08:00 daily https://www.pharmasources.com/industryinsights/hikma-vectura-to-develop-generic-rivals--305904.html 0.6 2026-02-09T12:06:42+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodts-niemann-pick-type-c-drug-f-305905.html 0.6 2026-06-20T23:15:19+08:00 daily https://www.pharmasources.com/industryinsights/nice-fail-to-recommend-astrazenecas-canc-305906.html 0.6 2026-07-04T14:35:22+08:00 daily https://www.pharmasources.com/industryinsights/nhs-diabetes-prescriptions-top-1-billion-305907.html 0.6 2026-04-13T19:44:01+08:00 daily https://www.pharmasources.com/industryinsights/merck-cos-keytruda-cleared-by-fda-for-ce-305908.html 0.6 2026-06-21T02:00:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-farxiga-staves-off-cardiac--305909.html 0.6 2026-06-21T10:07:14+08:00 daily https://www.pharmasources.com/industryinsights/nice-provisionally-knocks-back-astrazene-305910.html 0.6 2026-06-21T15:51:18+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018111-305911.html 0.6 2026-06-22T01:42:31+08:00 daily https://www.pharmasources.com/industryinsights/uk-parliamentary-enquiry-threatens-to-di-305912.html 0.6 2026-01-29T21:17:51+08:00 daily https://www.pharmasources.com/industryinsights/amarin-says-detailed-reduce-it-results-b-305913.html 0.6 2026-06-27T06:01:47+08:00 daily https://www.pharmasources.com/industryinsights/mylan-theravances-yupelri-approved-by-fd-305914.html 0.6 2026-06-21T10:49:05+08:00 daily https://www.pharmasources.com/industryinsights/harpoon-therapeutics-announces-closing-o-305915.html 0.6 2026-06-21T15:12:34+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-pharmaceuticals-announces-pricing-305916.html 0.6 2026-06-21T11:02:09+08:00 daily https://www.pharmasources.com/industryinsights/retipharma-secures-funding-to-develop-tr-305917.html 0.6 2026-06-21T02:02:43+08:00 daily https://www.pharmasources.com/industryinsights/t3-pharmaceuticals-wins-prestigious-fall-305918.html 0.6 2026-06-20T20:09:44+08:00 daily https://www.pharmasources.com/industryinsights/selvita-to-present-new-data-from-sel120--305919.html 0.6 2026-06-21T01:46:33+08:00 daily https://www.pharmasources.com/industryinsights/guided-therapeutics-announces-extension--305920.html 0.6 2026-06-21T19:18:52+08:00 daily https://www.pharmasources.com/industryinsights/brooklyn-immunotherapeutics-acquires-irx-305921.html 0.6 2026-07-31T11:56:23+08:00 daily https://www.pharmasources.com/industryinsights/vectura-group-announces-global-agreement-305922.html 0.6 2026-06-21T05:02:43+08:00 daily https://www.pharmasources.com/industryinsights/strides-enters-into-strategic-partnershi-305923.html 0.6 2026-07-17T21:54:50+08:00 daily https://www.pharmasources.com/industryinsights/amal-therapeutics-finalises-29-million-c-305924.html 0.6 2026-06-21T12:01:17+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-appoints-dr-lindi-tan-as-chief--305925.html 0.6 2026-06-22T06:43:52+08:00 daily https://www.pharmasources.com/industryinsights/eisai-launches-lenvima-in-china-305926.html 0.6 2026-05-23T11:57:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-yupelri-305927.html 0.6 2026-08-09T15:08:54+08:00 daily https://www.pharmasources.com/industryinsights/ngm-bio-announces-preliminary-results-fr-305928.html 0.6 2026-07-13T22:29:34+08:00 daily https://www.pharmasources.com/industryinsights/lannett-enters-into-agreement-with-amnea-305929.html 0.6 2026-08-09T07:49:13+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-trial-of-sitravat-305930.html 0.6 2026-06-21T01:14:57+08:00 daily https://www.pharmasources.com/industryinsights/shyft-analytics-parexel-enter-strategic--305931.html 0.6 2026-07-04T09:57:19+08:00 daily https://www.pharmasources.com/industryinsights/lonzas-launches-next-gen-robotic-solutio-305932.html 0.6 2026-07-01T23:22:58+08:00 daily https://www.pharmasources.com/industryinsights/bosch-introduces-sigpack-hml-machine-305933.html 0.6 2026-06-22T03:14:58+08:00 daily https://www.pharmasources.com/industryinsights/acquire-automation-introduces-countq-vis-305934.html 0.6 2026-07-30T16:55:04+08:00 daily https://www.pharmasources.com/industryinsights/keystone-folding-box-co-introduces-opioi-305935.html 0.6 2026-07-04T22:51:37+08:00 daily https://www.pharmasources.com/industryinsights/schreiner-medipharm-launches-nfc-label-f-305936.html 0.6 2026-06-21T11:02:10+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-introduces-sava-305937.html 0.6 2026-06-20T14:57:03+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-2020-invitation-305938.html 0.6 2026-06-19T14:46:58+08:00 daily https://www.pharmasources.com/industryinsights/pharma-tech-industries-hires-senior-qc-p-305939.html 0.6 2026-07-04T15:19:56+08:00 daily https://www.pharmasources.com/industryinsights/register-as-visitor-to-cphi-china-2019-305940.html 0.6 2026-06-22T04:02:40+08:00 daily https://www.pharmasources.com/industryinsights/bridgebio-pharma-enters-genetic-disease--305941.html 0.6 2026-06-22T04:52:37+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-pharma-appoints-cfo-305942.html 0.6 2026-06-20T14:59:05+08:00 daily https://www.pharmasources.com/industryinsights/who-uncovers-big-variations-in-antibioti-305943.html 0.6 2026-06-20T20:19:50+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-atovaquone-oral-s-305944.html 0.6 2026-06-21T14:50:19+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-mercks-lynparza-scores-speed-305945.html 0.6 2026-01-29T18:54:49+08:00 daily https://www.pharmasources.com/industryinsights/merck-quadruples-gardasil-supply-in-chin-305946.html 0.6 2026-07-19T19:02:13+08:00 daily https://www.pharmasources.com/industryinsights/mini-transfocator-for-microscopy-develop-305947.html 0.6 2026-06-22T06:52:50+08:00 daily https://www.pharmasources.com/industryinsights/crispr-and-maxcyte-sign-licensing-deal-f-305948.html 0.6 2026-07-04T23:23:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-says-entresto-outperforms-heart-305949.html 0.6 2026-08-07T06:43:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-astrazenec-305950.html 0.6 2026-06-21T02:57:43+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-us-rights-to-rsv-thera-305951.html 0.6 2026-06-30T04:11:43+08:00 daily https://www.pharmasources.com/industryinsights/bridgebio-pharma-llc-signs-joint-collabo-305952.html 0.6 2026-03-25T06:34:32+08:00 daily https://www.pharmasources.com/industryinsights/ziopharm-oncology-announces-immuno-oncol-305953.html 0.6 2026-05-25T21:12:14+08:00 daily https://www.pharmasources.com/industryinsights/virtual-manufacturing-system-training-se-305954.html 0.6 2026-06-20T14:31:31+08:00 daily https://www.pharmasources.com/industryinsights/ardena-cements-growth-and-expansion-with-305955.html 0.6 2026-06-20T23:57:35+08:00 daily https://www.pharmasources.com/industryinsights/smc-endorses-eusa-pharmas-qarziba-305956.html 0.6 2026-06-21T04:14:55+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biodynamics-signs-deal-to-develop-305957.html 0.6 2026-06-21T18:02:26+08:00 daily https://www.pharmasources.com/industryinsights/evox-bags-grant-from-duchenne-uk-to-engi-305958.html 0.6 2026-06-20T16:53:13+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-divests-us-rights-to-synagis-305959.html 0.6 2026-06-21T12:49:37+08:00 daily https://www.pharmasources.com/industryinsights/england-sees-steep-rise-in-measles-cases-305960.html 0.6 2026-08-05T19:54:28+08:00 daily https://www.pharmasources.com/industryinsights/eu-expands-label-of-gskinnovivas-copd-in-305961.html 0.6 2026-08-06T20:01:38+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-approved-for-liver-cancer-305962.html 0.6 2026-06-22T09:04:45+08:00 daily https://www.pharmasources.com/industryinsights/novartis-entresto-tops-enalapril-in-stab-305963.html 0.6 2026-08-06T20:10:26+08:00 daily https://www.pharmasources.com/industryinsights/cases-of-measles-nearly-quadruple-since--305964.html 0.6 2026-06-20T22:47:47+08:00 daily https://www.pharmasources.com/industryinsights/azacitidine-and-nivolumab-combo-proves-s-305965.html 0.6 2026-06-20T15:00:06+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-off-paediatric-lung-in-305966.html 0.6 2026-06-21T01:52:44+08:00 daily https://www.pharmasources.com/industryinsights/mercks-rolling-with-rotateq-in-china-whi-305967.html 0.6 2026-07-26T11:34:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-roches-fil-305968.html 0.6 2026-06-20T23:03:47+08:00 daily https://www.pharmasources.com/industryinsights/esco-medical-secures-cfda-approval-for-e-305969.html 0.6 2026-06-21T01:52:40+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-accepts-biosimilar-new-drug-applica-305970.html 0.6 2026-07-27T01:25:51+08:00 daily https://www.pharmasources.com/industryinsights/asclepix-therapeutics-raises-5m-in-new-f-305971.html 0.6 2026-06-28T07:41:32+08:00 daily https://www.pharmasources.com/industryinsights/nextcure-raises-93-million-in-series-b-f-305972.html 0.6 2026-07-08T02:25:17+08:00 daily https://www.pharmasources.com/industryinsights/takeda-sets-target-date-to-close-62b-shi-305973.html 0.6 2026-06-21T09:08:19+08:00 daily https://www.pharmasources.com/industryinsights/kymera-therapeutics-announces-65-million-305974.html 0.6 2026-06-20T18:08:30+08:00 daily https://www.pharmasources.com/industryinsights/radiomedix-and-orano-med-receive-fda-orp-305975.html 0.6 2026-04-11T21:07:19+08:00 daily https://www.pharmasources.com/industryinsights/akebia-therapeutics-sends-letter-to-shar-305976.html 0.6 2026-06-21T09:01:04+08:00 daily https://www.pharmasources.com/industryinsights/nw-bio-announces-5-million-bridge-fundin-305977.html 0.6 2026-06-21T00:03:39+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-inks-pact-with-advent-pharmace-305978.html 0.6 2026-04-21T12:52:04+08:00 daily https://www.pharmasources.com/industryinsights/ananth-kumar-parliamentary-affairs-and-c-305979.html 0.6 2026-06-21T23:01:43+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-end-to-end-service-to--305980.html 0.6 2026-07-23T00:15:22+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-inks-licensing-deal-to-boost-mavy-305981.html 0.6 2026-06-26T16:39:22+08:00 daily https://www.pharmasources.com/industryinsights/three-way-collaboration-to-advance-gene--305982.html 0.6 2026-06-20T18:14:52+08:00 daily https://www.pharmasources.com/industryinsights/new-formulation-modelling-successes-usin-305983.html 0.6 2026-08-08T02:30:33+08:00 daily https://www.pharmasources.com/industryinsights/genomic-study-directly-links-depression--305984.html 0.6 2026-07-21T12:57:17+08:00 daily https://www.pharmasources.com/industryinsights/particle-sciences-to-open-new-commercial-305985.html 0.6 2026-06-20T00:13:22+08:00 daily https://www.pharmasources.com/industryinsights/new-portable-and-ready-to-use-upper-resp-305986.html 0.6 2026-06-21T03:59:43+08:00 daily https://www.pharmasources.com/industryinsights/leukaemia-combination-therapy-effective--305987.html 0.6 2026-06-22T05:11:54+08:00 daily https://www.pharmasources.com/industryinsights/how-can-predictive-analytics-help-pharma-305988.html 0.6 2026-04-09T16:02:09+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-inks-pact-with-advent-pharmace-305989.html 0.6 2026-06-20T20:15:03+08:00 daily https://www.pharmasources.com/industryinsights/ascendis-pharma-announces-formation-of-v-305990.html 0.6 2026-06-20T17:49:39+08:00 daily https://www.pharmasources.com/industryinsights/compugen-announces-issuance-of-patent-fo-305991.html 0.6 2026-06-23T06:06:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-pembr-305992.html 0.6 2026-06-21T10:59:09+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-divest-us-synagis-rights--305993.html 0.6 2026-07-10T04:18:30+08:00 daily https://www.pharmasources.com/industryinsights/modis-announces-prime-designation-by-eur-305994.html 0.6 2026-06-20T15:48:35+08:00 daily https://www.pharmasources.com/industryinsights/gs1-us-launches-gs1-us-rx-epcis-conforma-305995.html 0.6 2026-06-21T03:03:42+08:00 daily https://www.pharmasources.com/industryinsights/enable-injections-partners-with-ucb-and--305996.html 0.6 2026-06-19T17:56:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-infant-drug-rights-for-305997.html 0.6 2026-06-21T00:56:46+08:00 daily https://www.pharmasources.com/industryinsights/pii-appoints-vp-business-development-305998.html 0.6 2026-06-20T20:15:03+08:00 daily https://www.pharmasources.com/industryinsights/bioivt-acquires-bsc-305999.html 0.6 2026-05-03T22:12:00+08:00 daily https://www.pharmasources.com/industryinsights/zenith-technologies-launches-mfg-trainin-306000.html 0.6 2026-06-21T03:02:45+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-open-second-clinical-supply--306001.html 0.6 2026-06-20T14:31:13+08:00 daily https://www.pharmasources.com/industryinsights/lgm-pharma-appoints-supply-chain-vp-306002.html 0.6 2026-04-04T21:31:11+08:00 daily https://www.pharmasources.com/industryinsights/two-factors-at-birth-can-boost-a-childs--306003.html 0.6 2026-08-06T23:42:21+08:00 daily https://www.pharmasources.com/industryinsights/aha-icosapent-ethyl-cuts-cv-risk-from-el-306004.html 0.6 2026-06-21T03:00:39+08:00 daily https://www.pharmasources.com/industryinsights/online-tool-helps-patients-with-advance--306005.html 0.6 2026-05-02T17:10:56+08:00 daily https://www.pharmasources.com/industryinsights/two-factors-at-birth-can-boost-a-childs--306006.html 0.6 2026-06-21T11:06:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-sends-warning-to-stemgenex-biologic--306007.html 0.6 2026-08-05T13:26:19+08:00 daily https://www.pharmasources.com/industryinsights/dnatrix-valo-therapeutics-announce-partn-306008.html 0.6 2026-06-20T22:40:26+08:00 daily https://www.pharmasources.com/industryinsights/invagen-to-acquire-avenue-therapeutics-f-306009.html 0.6 2026-06-21T03:00:38+08:00 daily https://www.pharmasources.com/industryinsights/genomic-profiling-offers-hope-for-rare-c-306010.html 0.6 2026-08-05T22:04:29+08:00 daily https://www.pharmasources.com/industryinsights/advancing-toward-the-goal-of-global-appr-306011.html 0.6 2026-06-21T23:00:43+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-commissioner-scott-go-306012.html 0.6 2026-06-21T07:14:03+08:00 daily https://www.pharmasources.com/industryinsights/record-year-for-pharma-packaging-and-dru-306013.html 0.6 2026-06-20T16:57:21+08:00 daily https://www.pharmasources.com/industryinsights/eu-fmd---time-is-running-out-306014.html 0.6 2026-08-09T22:38:18+08:00 daily https://www.pharmasources.com/industryinsights/dscsa-one-month-countdown-306015.html 0.6 2026-06-21T23:55:45+08:00 daily https://www.pharmasources.com/industryinsights/cure-pharmaceutical-names-veteran-execut-306016.html 0.6 2026-06-20T14:49:09+08:00 daily https://www.pharmasources.com/industryinsights/dow-silicones-investment-roadmap-into-si-306017.html 0.6 2026-07-04T07:10:59+08:00 daily https://www.pharmasources.com/industryinsights/three-way-collaboration-to-advance-gene--306018.html 0.6 2026-07-03T01:05:36+08:00 daily https://www.pharmasources.com/industryinsights/introducing-ima-in-the-pharmaceutical-wo-306019.html 0.6 2026-06-20T17:02:14+08:00 daily https://www.pharmasources.com/industryinsights/custom-scalable-turnkey-pods-for-flexibl-306020.html 0.6 2026-06-20T13:20:35+08:00 daily https://www.pharmasources.com/industryinsights/niche-cdmo-confirms-spray-drying-for-hig-306021.html 0.6 2026-06-19T13:18:57+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-picks-up-first-in-class--306022.html 0.6 2026-06-21T08:05:59+08:00 daily https://www.pharmasources.com/industryinsights/steriline-technologies-and-innovative-so-306024.html 0.6 2026-06-20T19:16:24+08:00 daily https://www.pharmasources.com/industryinsights/bioconjugation-expertise-and-increased-p-306025.html 0.6 2026-06-21T05:15:53+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-receives-manufacturing-licence--306026.html 0.6 2026-07-02T02:34:48+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-to-create-process-development-an-306027.html 0.6 2026-06-21T04:12:52+08:00 daily https://www.pharmasources.com/industryinsights/innovative-salts-for-biopharma-306028.html 0.6 2026-07-09T14:18:12+08:00 daily https://www.pharmasources.com/industryinsights/grunenthal-establishes-commercial-footpr-306029.html 0.6 2026-06-20T18:01:22+08:00 daily https://www.pharmasources.com/industryinsights/minakem-opens-new-high-containment-facil-306030.html 0.6 2026-08-07T12:59:29+08:00 daily https://www.pharmasources.com/industryinsights/lonza-endotoxin-expert-appointed-chair-o-306031.html 0.6 2026-08-08T19:10:07+08:00 daily https://www.pharmasources.com/industryinsights/croda-to-showcase-prosilic-drug-delivery-306032.html 0.6 2026-06-22T16:57:10+08:00 daily https://www.pharmasources.com/industryinsights/birla-ayurveda-launches-medicines-306033.html 0.6 2026-07-03T06:12:14+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-posts-net-profit-of-996-crore-306034.html 0.6 2026-06-24T02:54:12+08:00 daily https://www.pharmasources.com/industryinsights/south-korean-regulator-publishes-final-r-306035.html 0.6 2026-06-23T09:56:55+08:00 daily https://www.pharmasources.com/industryinsights/sobi-to-buy-us-rights-to-astrazenecas-sy-306036.html 0.6 2026-06-20T19:49:23+08:00 daily https://www.pharmasources.com/industryinsights/bedrocan-becomes-worlds-first-gmp-cannab-306037.html 0.6 2026-06-27T07:59:37+08:00 daily https://www.pharmasources.com/industryinsights/new-oral-treatment-for-metastatic-melano-306038.html 0.6 2026-06-22T06:00:38+08:00 daily https://www.pharmasources.com/industryinsights/complete-product-lifecycle-management-in-306039.html 0.6 2026-08-07T00:38:41+08:00 daily https://www.pharmasources.com/industryinsights/hovione-increases-oral-dosage-production-306040.html 0.6 2026-06-22T06:03:44+08:00 daily https://www.pharmasources.com/industryinsights/biomarkers-can-play-a-key-role-in-improv-306041.html 0.6 2026-06-13T06:20:00+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-picks-up-first-in-class--306042.html 0.6 2026-07-17T18:19:13+08:00 daily https://www.pharmasources.com/industryinsights/novartis-files-for-alcon-spinoff-citing--306043.html 0.6 2026-07-28T14:31:49+08:00 daily https://www.pharmasources.com/industryinsights/amarins-vascepa-cuts-heart-risks-in-key--306044.html 0.6 2026-06-25T14:09:16+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-for-pharma-marketers-th-306045.html 0.6 2026-06-20T22:03:46+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-backs-new-invokana-cv-no-306046.html 0.6 2026-06-21T17:04:22+08:00 daily https://www.pharmasources.com/industryinsights/planning-and-implementing-biomarker-test-306047.html 0.6 2026-04-05T11:53:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-falls-short-in-uk-patent-appeal-f-306048.html 0.6 2026-06-21T19:42:34+08:00 daily https://www.pharmasources.com/industryinsights/seniors-want-drug-prices-in-ads-young-pe-306049.html 0.6 2026-08-08T03:16:00+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-sponsored-hemophilia-musical-de-306050.html 0.6 2026-06-20T18:09:29+08:00 daily https://www.pharmasources.com/industryinsights/lured-by-high-demand-korean-wholesaler-s-306051.html 0.6 2026-08-01T03:22:50+08:00 daily https://www.pharmasources.com/industryinsights/the-top-10-cancer-drug-makers-of-2024-306052.html 0.6 2026-06-23T12:31:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-on-angiotensin-ii-receptor-b-306053.html 0.6 2026-08-08T07:48:55+08:00 daily https://www.pharmasources.com/industryinsights/patient-engagement-as-a-new-blockbuster--306054.html 0.6 2026-07-12T04:53:48+08:00 daily https://www.pharmasources.com/industryinsights/abbott-recommends-rejection-of-below-mar-306055.html 0.6 2026-07-08T22:09:47+08:00 daily https://www.pharmasources.com/industryinsights/obesity-both-feeds-tumors-and-helps-immu-306056.html 0.6 2026-06-22T21:15:14+08:00 daily https://www.pharmasources.com/industryinsights/preclinical-biotech-synthorx-wants-a-100-306057.html 0.6 2026-06-22T12:11:01+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-files-for-fda-approval-of-migr-306058.html 0.6 2026-06-20T16:59:15+08:00 daily https://www.pharmasources.com/industryinsights/svb-buys-leerink-for-280m-boosting-its-l-306059.html 0.6 2026-06-20T10:10:40+08:00 daily https://www.pharmasources.com/industryinsights/mineral-salts-made-in-germany-306060.html 0.6 2026-07-02T11:34:18+08:00 daily https://www.pharmasources.com/industryinsights/bosch-to-unveil-new-laboratory-device-fo-306061.html 0.6 2026-06-22T01:57:34+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-to-focus-on-more-lucrative-market-306062.html 0.6 2026-06-20T20:00:34+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-claims-have-gone-up-over-last-t-306063.html 0.6 2026-06-21T06:39:38+08:00 daily https://www.pharmasources.com/industryinsights/india-bans-pain-killer-36-years-after-th-306064.html 0.6 2026-02-28T07:58:55+08:00 daily https://www.pharmasources.com/industryinsights/merck-starts-rolling-fda-submission-for--306065.html 0.6 2026-06-21T06:10:20+08:00 daily https://www.pharmasources.com/industryinsights/beximco-pharma-enters-eu-market-306066.html 0.6 2026-07-03T13:31:19+08:00 daily https://www.pharmasources.com/industryinsights/record-year-for-pharma-packaging-and-dru-306067.html 0.6 2026-05-03T14:07:24+08:00 daily https://www.pharmasources.com/industryinsights/brickell-biotech-kaken-pharma-to-co-deve-306068.html 0.6 2026-08-04T06:03:03+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-us-fda-approval-306069.html 0.6 2026-06-20T22:58:52+08:00 daily https://www.pharmasources.com/industryinsights/lupin-scouts-for-acquisitions-across-the-306070.html 0.6 2026-06-21T21:59:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-loses-lyrica-patent-case-in-uk-su-306071.html 0.6 2026-06-21T06:48:47+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-orilissa-makes-its-uterine-fibro-306072.html 0.6 2026-06-21T10:04:11+08:00 daily https://www.pharmasources.com/industryinsights/teva-proposes-to-buy-mylan-for-401-billi-306073.html 0.6 2026-02-28T15:53:17+08:00 daily https://www.pharmasources.com/industryinsights/bacterial-pneumonia-more-dangerous-for-h-306074.html 0.6 2026-06-20T14:40:12+08:00 daily https://www.pharmasources.com/industryinsights/bruker-announces-us-fda-clearance-of-exp-306075.html 0.6 2026-06-21T04:09:51+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-positive-airway-pressure--306076.html 0.6 2026-06-20T23:49:28+08:00 daily https://www.pharmasources.com/industryinsights/japanese-regulators-grant-additional-app-306077.html 0.6 2026-07-05T02:30:38+08:00 daily https://www.pharmasources.com/industryinsights/generic-acticlate-tablets-launched-by-lu-306078.html 0.6 2026-08-09T07:56:23+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-fda-approval-for-generic--306079.html 0.6 2026-08-08T04:35:25+08:00 daily https://www.pharmasources.com/industryinsights/phamaceutical-trade-lobby-responds-to-br-306080.html 0.6 2026-08-07T13:19:20+08:00 daily https://www.pharmasources.com/industryinsights/msd-is-looking-for-a-digital-health-solu-306081.html 0.6 2026-08-07T04:33:54+08:00 daily https://www.pharmasources.com/industryinsights/scorpion-venom-to-shuttle-drugs-into-the-306082.html 0.6 2026-08-07T04:25:34+08:00 daily https://www.pharmasources.com/industryinsights/lilly-submits-new-drug-application-to-th-306083.html 0.6 2026-08-07T01:10:44+08:00 daily https://www.pharmasources.com/industryinsights/dr-anthony-tolcher-joins-the-scientific--306084.html 0.6 2026-08-07T00:40:45+08:00 daily https://www.pharmasources.com/industryinsights/elpis-biomed-wins-cambridge-start-up-of--306085.html 0.6 2026-08-07T00:01:34+08:00 daily https://www.pharmasources.com/industryinsights/top-oncologist-dr-samuel-fourie-joins-ad-306086.html 0.6 2026-08-06T23:56:44+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-to-strengthen-its-indian-product-306087.html 0.6 2026-08-07T00:02:54+08:00 daily https://www.pharmasources.com/industryinsights/impact-of-gst-has-largely-been-positive--306088.html 0.6 2026-08-07T13:19:13+08:00 daily https://www.pharmasources.com/industryinsights/shilpa-medicare-gets-tentative-us-fda-no-306089.html 0.6 2026-08-09T00:46:35+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-to-market-g-306090.html 0.6 2026-08-08T16:58:08+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-crisis-mercks-gardasil-306091.html 0.6 2026-08-09T02:39:18+08:00 daily https://www.pharmasources.com/industryinsights/quanticate-links-up-with-lancaster-unive-306092.html 0.6 2026-06-21T12:51:33+08:00 daily https://www.pharmasources.com/industryinsights/precision-maxcyte-enter-clinical-agreeme-306093.html 0.6 2026-07-17T03:50:01+08:00 daily https://www.pharmasources.com/industryinsights/f1-oncology-expands-operations-306094.html 0.6 2026-06-21T06:05:46+08:00 daily https://www.pharmasources.com/industryinsights/casi-to-build-gmp-mfg-site-in-wuxi-china-306095.html 0.6 2026-06-26T22:49:20+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-immunotherapy-combo-306096.html 0.6 2026-06-21T12:51:15+08:00 daily https://www.pharmasources.com/industryinsights/bha-abpi-welcome-uks-eu-withdrawal-agree-306097.html 0.6 2026-08-09T13:05:08+08:00 daily https://www.pharmasources.com/industryinsights/mission-links-with-abbvie-to-develop-alz-306098.html 0.6 2026-06-20T00:00:16+08:00 daily https://www.pharmasources.com/industryinsights/shires-lanadelumab-shown-to-significantl-306099.html 0.6 2026-06-21T11:08:15+08:00 daily https://www.pharmasources.com/industryinsights/nice-issues-final-draft-guidelines-for-n-306100.html 0.6 2026-07-07T08:11:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-ratcheting-up-pressure-on-flavored-t-306101.html 0.6 2026-06-20T21:50:27+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-shows-benefit-in-oesophage-306102.html 0.6 2026-06-19T13:44:43+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-green-light-for-pfizers-mylot-306103.html 0.6 2026-06-21T18:01:25+08:00 daily https://www.pharmasources.com/industryinsights/nihr-streams-5m-into-global-infectious-d-306104.html 0.6 2026-06-21T18:12:35+08:00 daily https://www.pharmasources.com/industryinsights/ipsens-cabometyx-wins-eu-nod-for-liver-c-306105.html 0.6 2026-06-21T22:59:42+08:00 daily https://www.pharmasources.com/industryinsights/lilly-files-lasmiditan-for-migraine-306106.html 0.6 2026-02-10T15:34:14+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-fund-continuous-blood-glucose-mon-306107.html 0.6 2026-06-21T00:09:50+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-opens-new-medical-device-tes-306108.html 0.6 2026-07-20T01:00:47+08:00 daily https://www.pharmasources.com/industryinsights/uk-launch-for-mylan-biocon-insulin-glarg-306109.html 0.6 2026-06-21T15:15:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-loses-landmark-second-medical-use-306110.html 0.6 2026-08-02T23:40:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-expanded-approval-for-novarti-306111.html 0.6 2026-06-20T20:49:22+08:00 daily https://www.pharmasources.com/industryinsights/after-historic-win-lilly-partner-chi-med-306112.html 0.6 2026-06-21T16:18:37+08:00 daily https://www.pharmasources.com/industryinsights/sonoma-pharmaceuticals-announces-pricing-306113.html 0.6 2026-06-21T03:02:55+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-laying-off-69-emplo-306114.html 0.6 2026-08-03T22:26:33+08:00 daily https://www.pharmasources.com/industryinsights/casi-to-build-gmp-mfg-site-in-wuxi-china-306115.html 0.6 2026-06-21T04:21:05+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-to-market-g-306116.html 0.6 2026-06-20T14:53:00+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-alone-and-in-combin-306117.html 0.6 2026-06-21T07:14:13+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-turns-to-drones-to-combat-aedes-306118.html 0.6 2026-06-21T05:53:18+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018111-306119.html 0.6 2026-06-20T22:49:33+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-swedish-orphan-biovitrum-306120.html 0.6 2026-06-20T21:01:39+08:00 daily https://www.pharmasources.com/industryinsights/world-diabetes-day-considering-cv-risk-w-306121.html 0.6 2026-06-21T12:30:39+08:00 daily https://www.pharmasources.com/industryinsights/world-polio-day-on-the-cusp-of-eradicati-306122.html 0.6 2026-07-23T14:22:56+08:00 daily https://www.pharmasources.com/industryinsights/severe-eczema-may-best-be-treated-by-all-306123.html 0.6 2026-06-21T00:57:47+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-biosimilar-to-humira-lau-306124.html 0.6 2026-06-21T19:42:18+08:00 daily https://www.pharmasources.com/industryinsights/icmr-to-conduct-trials-of-indigenously-d-306125.html 0.6 2026-07-17T10:29:18+08:00 daily https://www.pharmasources.com/industryinsights/nurocor-partners-with-intilaris-to-impro-306126.html 0.6 2026-07-03T01:00:51+08:00 daily https://www.pharmasources.com/industryinsights/majority-of-hiv-persistence-during-art-d-306127.html 0.6 2026-06-21T00:00:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sandozs-biosimilar-of-humir-306128.html 0.6 2026-07-29T08:11:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-boston-scientifics-spectra--306129.html 0.6 2026-06-22T07:40:27+08:00 daily https://www.pharmasources.com/industryinsights/genomics-reveals-key-macrophages-involve-306130.html 0.6 2026-07-04T17:50:23+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-and-pfizer-announce-collaboratio-306131.html 0.6 2026-06-21T18:19:54+08:00 daily https://www.pharmasources.com/industryinsights/implications-of-no-deal-brexit-on-access-306132.html 0.6 2026-06-20T13:19:26+08:00 daily https://www.pharmasources.com/industryinsights/array-biopharma-collaborates-with-pfizer-306133.html 0.6 2026-06-24T01:43:32+08:00 daily https://www.pharmasources.com/industryinsights/movember-reducing-the-adverse-effects-of-306134.html 0.6 2026-06-22T14:02:47+08:00 daily https://www.pharmasources.com/industryinsights/could-building-a-unique-brain-fingerprin-306135.html 0.6 2026-06-20T20:01:38+08:00 daily https://www.pharmasources.com/industryinsights/genetic-studies-a-powerful-tool-for-test-306136.html 0.6 2026-06-22T12:29:50+08:00 daily https://www.pharmasources.com/industryinsights/verge-genomics-employing-ai-to-improve-d-306137.html 0.6 2026-08-03T08:44:23+08:00 daily https://www.pharmasources.com/industryinsights/world-menopause-month-moving-from-hrt-to-306138.html 0.6 2026-06-23T09:47:36+08:00 daily https://www.pharmasources.com/industryinsights/vertexs-cystic-fibrosis-drugs-become-pub-306139.html 0.6 2026-06-20T16:58:15+08:00 daily https://www.pharmasources.com/industryinsights/nhs-genomic-medicine-service-the-uk-seek-306140.html 0.6 2026-08-02T16:18:55+08:00 daily https://www.pharmasources.com/industryinsights/concerns-over-brexit-cause-recardio-to-c-306141.html 0.6 2026-08-07T09:58:30+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-begins-succession-planning-f-306142.html 0.6 2026-08-03T13:31:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-drug-to-treat-travelers-306143.html 0.6 2026-06-21T06:52:51+08:00 daily https://www.pharmasources.com/industryinsights/first-all-oral-treatment-for-sleeping-si-306144.html 0.6 2026-06-20T16:15:16+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-to-focus-on-more-lucrative-market-306145.html 0.6 2026-06-20T22:58:42+08:00 daily https://www.pharmasources.com/industryinsights/grunenthal-establishes-commercial-footpr-306146.html 0.6 2026-07-04T21:16:54+08:00 daily https://www.pharmasources.com/industryinsights/angion-biomedica-sinovant-sciences-colla-306147.html 0.6 2026-06-21T03:55:45+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-immunotherapy-combo-306148.html 0.6 2026-06-21T08:02:04+08:00 daily https://www.pharmasources.com/industryinsights/ascendis-pharma-announces-formation-of-v-306149.html 0.6 2026-06-19T18:07:19+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-signs-300-million-deal-with-e-306150.html 0.6 2026-06-20T21:17:10+08:00 daily https://www.pharmasources.com/industryinsights/takeda-sets-target-date-to-close-62b-shi-306151.html 0.6 2025-12-25T22:10:26+08:00 daily https://www.pharmasources.com/industryinsights/united-therapeutics-buys-arenas-hyperten-306152.html 0.6 2026-06-22T08:54:40+08:00 daily https://www.pharmasources.com/industryinsights/ipsens-cabometyx-gains-european-approval-306153.html 0.6 2026-06-17T07:07:32+08:00 daily https://www.pharmasources.com/industryinsights/committee-advises-against-fda-approval-o-306154.html 0.6 2026-06-23T04:08:19+08:00 daily https://www.pharmasources.com/industryinsights/eisai-launches-lenvima-in-china-306155.html 0.6 2026-06-21T04:56:45+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharmas-epidiolex-becomes-first-canna-306156.html 0.6 2026-06-21T21:08:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-alert-for-risk-of-complicatio-306157.html 0.6 2026-06-20T18:57:31+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-teams-up-with-denali-in-1125bn-ne-306158.html 0.6 2026-06-22T09:08:51+08:00 daily https://www.pharmasources.com/industryinsights/two-senior-business-development-executiv-306159.html 0.6 2026-02-14T11:51:45+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-ipsens-cabo-306160.html 0.6 2026-06-21T07:11:00+08:00 daily https://www.pharmasources.com/industryinsights/bayers-regorafenib-is-the-first-drug-to--306161.html 0.6 2026-06-19T20:10:41+08:00 daily https://www.pharmasources.com/industryinsights/casi-to-build-gmp-mfg-site-in-wuxi-china-306162.html 0.6 2026-07-15T04:36:49+08:00 daily https://www.pharmasources.com/industryinsights/f1-oncology-expands-operations-306163.html 0.6 2026-07-19T11:41:52+08:00 daily https://www.pharmasources.com/industryinsights/precision-maxcyte-enter-clinical-agreeme-306164.html 0.6 2026-06-21T22:01:41+08:00 daily https://www.pharmasources.com/industryinsights/quanticate-links-up-with-lancaster-unive-306165.html 0.6 2026-06-21T01:11:50+08:00 daily https://www.pharmasources.com/industryinsights/goodwin-bio-radimmune-enter-oncology-pac-306166.html 0.6 2026-06-21T12:57:35+08:00 daily https://www.pharmasources.com/industryinsights/adc-bio-secures-25m-investment-306167.html 0.6 2026-06-20T16:54:16+08:00 daily https://www.pharmasources.com/industryinsights/restoring-sight-clinical-progress-toward-306168.html 0.6 2026-06-20T16:55:11+08:00 daily https://www.pharmasources.com/industryinsights/cliantha-research-organises-respiratory--306169.html 0.6 2026-06-21T03:06:47+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-to-launch-oncology-resp-306170.html 0.6 2026-07-27T08:45:11+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-acquires-rights-for-invossa--306171.html 0.6 2026-06-22T02:09:56+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-partners-with-epizyme-to-deve-306172.html 0.6 2026-07-18T19:57:36+08:00 daily https://www.pharmasources.com/industryinsights/chinas-nmpa-approves-gileads-vemlidy-for-306173.html 0.6 2026-06-19T22:58:48+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-to-bring-worlds-first-gene-t-306174.html 0.6 2026-06-21T06:11:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-scope-of-novartis-promacta-306175.html 0.6 2026-08-09T01:34:08+08:00 daily https://www.pharmasources.com/industryinsights/setback-for-az-imfinzi-lung-cancer-combi-306176.html 0.6 2026-06-22T07:01:49+08:00 daily https://www.pharmasources.com/industryinsights/roche-withdraws-tecentriq-combo-applicat-306177.html 0.6 2026-03-26T01:22:21+08:00 daily https://www.pharmasources.com/industryinsights/who-to-shift-focus-on-eliminating-chagas-306178.html 0.6 2026-07-02T14:02:00+08:00 daily https://www.pharmasources.com/industryinsights/eu-rules-may-be-stifling-britains-biotec-306179.html 0.6 2026-06-26T15:03:57+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-plotting-41-price-hikes-for-janua-306180.html 0.6 2026-08-05T22:55:01+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-to-treat-melanoma-in-engla-306181.html 0.6 2026-06-20T18:59:40+08:00 daily https://www.pharmasources.com/industryinsights/roche-withdraws-tecentriq-combo-applicat-306182.html 0.6 2026-06-20T20:52:30+08:00 daily https://www.pharmasources.com/industryinsights/novartis-promacta-cleared-by-fda-for-fir-306183.html 0.6 2026-08-06T20:14:54+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-to-treat-melanoma-in-engla-306184.html 0.6 2026-06-21T06:55:57+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-mission-partner-on-alzheimers-306185.html 0.6 2026-06-23T14:33:37+08:00 daily https://www.pharmasources.com/industryinsights/the-blockchain-revolution-and-what-it-me-306186.html 0.6 2026-06-27T11:35:34+08:00 daily https://www.pharmasources.com/industryinsights/rising-to-the-challenge-of-delivering-th-306187.html 0.6 2026-06-21T04:55:42+08:00 daily https://www.pharmasources.com/industryinsights/uk-health-service-may-face-shortage-of-3-306188.html 0.6 2026-06-20T16:17:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-peripheral-t--306189.html 0.6 2026-07-21T10:13:49+08:00 daily https://www.pharmasources.com/industryinsights/included-in-chinas-national-essential-dr-306190.html 0.6 2026-06-20T20:10:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-controversially-approves-potent-opio-306191.html 0.6 2026-06-21T02:03:39+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-initiate-recall-of-bloo-306192.html 0.6 2026-08-08T00:02:29+08:00 daily https://www.pharmasources.com/industryinsights/76-of-patients-no-longer-experience-ptsd-306193.html 0.6 2026-06-21T07:21:20+08:00 daily https://www.pharmasources.com/industryinsights/hiv-drug-reduces-viral-load-by-99-within-306194.html 0.6 2026-06-21T13:05:28+08:00 daily https://www.pharmasources.com/industryinsights/gsks-anti-seizure-drug-shows-promise-in--306195.html 0.6 2026-06-22T16:18:46+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-cuts-1300-jobs-in-the-midst-306196.html 0.6 2026-06-20T23:01:42+08:00 daily https://www.pharmasources.com/industryinsights/chanelle-pharma-announces-86m-investment-306197.html 0.6 2026-07-02T16:23:05+08:00 daily https://www.pharmasources.com/industryinsights/europes-biggest-private-biotech-company--306198.html 0.6 2026-06-21T00:55:48+08:00 daily https://www.pharmasources.com/industryinsights/mission-therapeutics-team-up-with-abbvie-306199.html 0.6 2026-07-09T22:45:13+08:00 daily https://www.pharmasources.com/industryinsights/usa-struggles-and-middle-income-countrie-306200.html 0.6 2026-05-03T14:12:21+08:00 daily https://www.pharmasources.com/industryinsights/vyera-to-initiate-phase-1-study-of-nce-f-306201.html 0.6 2026-06-20T21:02:46+08:00 daily https://www.pharmasources.com/industryinsights/roches-ocrevus-shows-earlier-better-outc-306202.html 0.6 2026-06-20T18:56:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-against-sanofi-306203.html 0.6 2026-06-21T06:10:53+08:00 daily https://www.pharmasources.com/industryinsights/new-us-trade-policy-may-limit-foreign-in-306204.html 0.6 2026-06-19T18:18:40+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-merck-kgaas-bavencio-flunks-ovari-306205.html 0.6 2026-07-18T08:23:58+08:00 daily https://www.pharmasources.com/industryinsights/sequiris-invest-40m-into-expansion-of-li-306206.html 0.6 2026-06-20T16:05:19+08:00 daily https://www.pharmasources.com/industryinsights/celltrions-rituxan-biosimilar-gets-unani-306207.html 0.6 2026-08-07T10:42:33+08:00 daily https://www.pharmasources.com/industryinsights/increased-funding-and-research-could-hel-306208.html 0.6 2026-03-19T13:33:39+08:00 daily https://www.pharmasources.com/industryinsights/menlo-therapeutics-cough-drug-fails-to-m-306209.html 0.6 2026-06-22T04:02:40+08:00 daily https://www.pharmasources.com/industryinsights/janssens-stelara-shows-promise-across-tw-306210.html 0.6 2026-06-21T08:55:13+08:00 daily https://www.pharmasources.com/industryinsights/new-hospital-led-organisation-aims-to-ta-306211.html 0.6 2026-07-09T11:41:02+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-hpv-vaccine-for-men-and--306212.html 0.6 2026-06-21T08:05:08+08:00 daily https://www.pharmasources.com/industryinsights/msd-signs-117m-deal-with-samsung-bioepis-306213.html 0.6 2026-06-20T20:02:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-indication-of-roches-hemlibr-306214.html 0.6 2026-01-19T18:24:48+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-appoves-gileads-car-t-therap-306215.html 0.6 2026-06-21T14:36:07+08:00 daily https://www.pharmasources.com/industryinsights/mhra-to-consult-on-potential-for-no-deal-306216.html 0.6 2026-06-21T10:52:03+08:00 daily https://www.pharmasources.com/industryinsights/new-group-blames-pbms-and-hospitals-for--306217.html 0.6 2026-06-14T16:47:29+08:00 daily https://www.pharmasources.com/industryinsights/baxter-partners-up-with-mayo-clinic-for--306218.html 0.6 2026-06-20T23:16:56+08:00 daily https://www.pharmasources.com/industryinsights/survey-reveals-56-gender-pay-gap-between-306219.html 0.6 2026-08-03T08:02:44+08:00 daily https://www.pharmasources.com/industryinsights/memorial-sloan-kettering-chief-resigns-f-306220.html 0.6 2026-06-21T04:19:59+08:00 daily https://www.pharmasources.com/industryinsights/20-year-old-man-died-after-leukaemia-cel-306221.html 0.6 2026-06-21T00:32:37+08:00 daily https://www.pharmasources.com/industryinsights/included-in-chinas-national-essential-dr-306222.html 0.6 2026-05-02T05:33:59+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-digital-pill----306223.html 0.6 2026-08-06T23:57:12+08:00 daily https://www.pharmasources.com/industryinsights/nobel-prize-awarded-to-immuno-oncology-i-306224.html 0.6 2026-06-22T05:59:34+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-ceo-ian-read-set-to-step-down-fro-306225.html 0.6 2026-06-22T07:52:01+08:00 daily https://www.pharmasources.com/industryinsights/top-10-research-fronts-in-medicine-in-20-306226.html 0.6 2026-06-21T06:21:19+08:00 daily https://www.pharmasources.com/industryinsights/top-20-companies-by-global-prescription--306227.html 0.6 2026-08-08T12:15:12+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-to-bring-worlds-first-gene-t-306228.html 0.6 2026-06-20T17:49:22+08:00 daily https://www.pharmasources.com/industryinsights/chinas-nmpa-approves-gileads-vemlidy-for-306229.html 0.6 2026-07-17T15:36:49+08:00 daily https://www.pharmasources.com/industryinsights/aquestive-receives-complete-response-let-306230.html 0.6 2026-06-22T09:59:48+08:00 daily https://www.pharmasources.com/industryinsights/perseris-now-available-in-the-us-for-the-306231.html 0.6 2026-03-27T18:27:08+08:00 daily https://www.pharmasources.com/industryinsights/armas-announces-launch-of-azacitidine-fo-306232.html 0.6 2026-06-21T00:45:42+08:00 daily https://www.pharmasources.com/industryinsights/siklos-now-available-in-1000-mg-triple-s-306233.html 0.6 2026-07-07T17:51:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-line-treatment-for-pe-306234.html 0.6 2026-07-23T23:44:43+08:00 daily https://www.pharmasources.com/industryinsights/roivant-sciences-intron-bio-sign-licensi-306235.html 0.6 2026-06-21T07:02:57+08:00 daily https://www.pharmasources.com/industryinsights/sollis-announces-the-first-patient-enrol-306236.html 0.6 2026-06-20T18:05:21+08:00 daily https://www.pharmasources.com/industryinsights/promentis-announces-successful-completio-306237.html 0.6 2026-08-06T18:10:47+08:00 daily https://www.pharmasources.com/industryinsights/aivita-announces-treatment-of-first-two--306238.html 0.6 2026-07-19T16:11:54+08:00 daily https://www.pharmasources.com/industryinsights/amgen-receives-chmp-positive-opinion-to--306239.html 0.6 2026-06-21T16:16:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-line-treatment-for-pe-306240.html 0.6 2026-07-05T03:39:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-provide-update-on-avelu-306241.html 0.6 2026-06-21T04:59:52+08:00 daily https://www.pharmasources.com/industryinsights/concomitant-usage-of-sleeping-pills-and--306242.html 0.6 2026-06-21T03:04:43+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-india-business-sweden-launch-306243.html 0.6 2026-06-21T12:14:40+08:00 daily https://www.pharmasources.com/industryinsights/vinod-p-shah-international-chairman-spds-306244.html 0.6 2026-06-21T09:55:00+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-us-fda-nod-for-generic-acn-306245.html 0.6 2026-07-07T07:07:35+08:00 daily https://www.pharmasources.com/industryinsights/gene-editing-shows-promise-in-treating-i-306246.html 0.6 2026-07-25T11:56:54+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-fuji-pharma-partner-for-biosimi-306247.html 0.6 2026-01-06T01:21:46+08:00 daily https://www.pharmasources.com/industryinsights/mylan-west-virginia-plant-tagged-with-wa-306248.html 0.6 2026-07-02T22:09:43+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-us-fda-nod-for-generic-acn-306249.html 0.6 2026-08-02T23:00:36+08:00 daily https://www.pharmasources.com/industryinsights/most-fda-required-post-marketing-drug-st-306250.html 0.6 2026-07-04T13:04:48+08:00 daily https://www.pharmasources.com/industryinsights/ribociclib-could-be-used-to-treat-gliobl-306251.html 0.6 2026-07-05T00:54:02+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-provide-update-on-avelu-306252.html 0.6 2026-06-21T10:11:27+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-and-omega-3-reduce-pre-cancerous-306253.html 0.6 2026-07-20T07:02:45+08:00 daily https://www.pharmasources.com/industryinsights/first-ever-all-oral-drug-for-sleeping-si-306254.html 0.6 2026-08-08T23:31:01+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-and-pfizers-bavencio-falls-sh-306255.html 0.6 2026-07-17T06:18:02+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-ipsens-cabometyx-in-second-l-306256.html 0.6 2026-06-21T16:09:38+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-resume-price-hiking-in-2019-41-306257.html 0.6 2026-08-05T21:58:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-chalk-up-another-fail-f-306258.html 0.6 2026-06-21T00:00:38+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-teams-with-fuji-pharma-for-bios-306259.html 0.6 2026-06-22T08:00:53+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-palantir-to-form-jv-to-advance-306260.html 0.6 2026-06-21T09:08:09+08:00 daily https://www.pharmasources.com/industryinsights/aimmune-publishes-phase-iii-data-for-pea-306261.html 0.6 2026-08-07T10:50:59+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-amicus-win-uk-prix-galien-awa-306262.html 0.6 2026-06-20T14:50:06+08:00 daily https://www.pharmasources.com/industryinsights/roivant-and-intron-sign-licensing-deal-f-306263.html 0.6 2026-06-21T04:19:04+08:00 daily https://www.pharmasources.com/industryinsights/focusing-on-the-advanced-productivity-in-306264.html 0.6 2026-07-23T21:07:58+08:00 daily https://www.pharmasources.com/industryinsights/proceeding-with-quality-sharing-opportun-306265.html 0.6 2026-06-22T10:52:39+08:00 daily https://www.pharmasources.com/industryinsights/gather-pharmaceutical-biochemical-and-an-306266.html 0.6 2026-06-20T20:54:34+08:00 daily https://www.pharmasources.com/industryinsights/gather-clean-pharmaceutical-technical-eq-306267.html 0.6 2026-06-24T08:08:32+08:00 daily https://www.pharmasources.com/industryinsights/gather-well-known-pharmaceutical-enterpr-306268.html 0.6 2026-07-23T05:15:59+08:00 daily https://www.pharmasources.com/industryinsights/intelligent-upgrading-of-pharmaceutical--306269.html 0.6 2026-07-18T13:16:55+08:00 daily https://www.pharmasources.com/industryinsights/with-eu-blessing-takeda-clears-final-reg-306270.html 0.6 2026-06-21T10:06:19+08:00 daily https://www.pharmasources.com/industryinsights/handful-pharma-companies-developing-bulk-306271.html 0.6 2026-06-22T11:47:39+08:00 daily https://www.pharmasources.com/industryinsights/pacific-biomarkers-merges-with-neomed-la-306272.html 0.6 2026-06-21T13:18:36+08:00 daily https://www.pharmasources.com/industryinsights/kaleo-under-fire-for-price-hikes-on-nalo-306273.html 0.6 2026-06-22T11:59:47+08:00 daily https://www.pharmasources.com/industryinsights/strong-spending-seen-in-us-medical-and-h-306274.html 0.6 2026-04-02T01:36:18+08:00 daily https://www.pharmasources.com/industryinsights/roche-pulls-eu-application-for-tecentriq-306275.html 0.6 2026-06-22T08:12:00+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivery-using-mirna-enriched-extra-306276.html 0.6 2026-06-22T08:56:40+08:00 daily https://www.pharmasources.com/industryinsights/most-pharma-firms-doing-little-rd-for-po-306277.html 0.6 2026-04-14T02:31:50+08:00 daily https://www.pharmasources.com/industryinsights/the-future-of-pfizers-5bn-lyrica-brand-i-306278.html 0.6 2026-07-16T22:57:14+08:00 daily https://www.pharmasources.com/industryinsights/gsk-retains-leading-position-on-access-t-306279.html 0.6 2026-06-22T06:57:54+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-unveils-cgmp-ki-306280.html 0.6 2026-06-21T14:46:13+08:00 daily https://www.pharmasources.com/industryinsights/takeda-must-sell-gastro-drug-to-merge-wi-306281.html 0.6 2026-08-07T07:57:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-ever-therapy-for-ultr-306282.html 0.6 2026-06-22T03:02:39+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-sues-nhs-over-hep-c-drug-procurem-306283.html 0.6 2026-08-05T20:13:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-ask-senator-cindy-hyde-smith-to-r-306284.html 0.6 2026-06-20T19:59:36+08:00 daily https://www.pharmasources.com/industryinsights/working-life-philippe-bastide-head-of-bi-306285.html 0.6 2026-06-22T04:08:48+08:00 daily https://www.pharmasources.com/industryinsights/living-with-fibular-hemimelia-306286.html 0.6 2026-08-08T00:58:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-pulls-support-for-senator-after-h-306287.html 0.6 2026-06-17T17:29:30+08:00 daily https://www.pharmasources.com/industryinsights/moments-matter-in-bms-and-pfizers-latest-306288.html 0.6 2026-07-31T18:10:28+08:00 daily https://www.pharmasources.com/industryinsights/cosmo-wins-fda-green-light-to-challenge--306289.html 0.6 2026-07-30T14:17:14+08:00 daily https://www.pharmasources.com/industryinsights/ligand-announces-omniab-partnership-with-306290.html 0.6 2026-06-21T04:09:07+08:00 daily https://www.pharmasources.com/industryinsights/roivant-sciences-and-intron-bio-sign-lic-306291.html 0.6 2026-03-21T17:15:08+08:00 daily https://www.pharmasources.com/industryinsights/sobi-snags-fda-nod-for-rare-disease-drug-306292.html 0.6 2026-06-21T13:12:25+08:00 daily https://www.pharmasources.com/industryinsights/roche-yanks-tecentriq-kidney-cancer-apps-306293.html 0.6 2026-06-21T23:35:33+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-and-pellepharm-announce-760-m-306294.html 0.6 2026-06-22T21:48:44+08:00 daily https://www.pharmasources.com/industryinsights/emergent-and-valnevas-zika-vaccine-clear-306295.html 0.6 2026-06-22T09:48:34+08:00 daily https://www.pharmasources.com/industryinsights/how-to-make-money-in-this-bear-market-306296.html 0.6 2026-06-21T17:48:09+08:00 daily https://www.pharmasources.com/industryinsights/gsk-retains-leading-position-on-access-t-306297.html 0.6 2026-06-21T05:01:40+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-commenced-construction-of-306298.html 0.6 2026-07-30T15:15:21+08:00 daily https://www.pharmasources.com/industryinsights/us-oks-first-treatment-for-haemophagocyt-306299.html 0.6 2026-01-25T19:23:34+08:00 daily https://www.pharmasources.com/industryinsights/takeda-gets-european-blessing-for-shire--306300.html 0.6 2026-03-17T21:14:15+08:00 daily https://www.pharmasources.com/industryinsights/psychological-therapy-recovery-rate-surp-306301.html 0.6 2026-06-22T09:58:40+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-lillys-emga-306302.html 0.6 2026-06-21T07:18:15+08:00 daily https://www.pharmasources.com/industryinsights/first-rare-disease-collaborative-network-306303.html 0.6 2026-06-21T17:57:45+08:00 daily https://www.pharmasources.com/industryinsights/mirati-joins-cr-uks-stratified-medicine--306304.html 0.6 2026-06-21T18:09:32+08:00 daily https://www.pharmasources.com/industryinsights/eisai-to-present-latest-data-on-perampan-306305.html 0.6 2026-06-21T11:51:05+08:00 daily https://www.pharmasources.com/industryinsights/thsti-ivi-holds-joint-symposium-in-korea-306306.html 0.6 2026-06-20T21:02:39+08:00 daily https://www.pharmasources.com/industryinsights/europes-biggest-private-biotech-company--306307.html 0.6 2026-06-21T08:53:52+08:00 daily https://www.pharmasources.com/industryinsights/elpis-human-cells-can-replace-animal-exp-306308.html 0.6 2026-06-26T18:03:54+08:00 daily https://www.pharmasources.com/industryinsights/novotech-cns-to-expand-cro-services-to-b-306309.html 0.6 2026-01-29T13:27:22+08:00 daily https://www.pharmasources.com/industryinsights/cellect-granted-key-european-patent-for--306310.html 0.6 2026-06-21T03:03:44+08:00 daily https://www.pharmasources.com/industryinsights/novoheart-appoints-biotech-industry-spec-306311.html 0.6 2026-06-21T03:09:48+08:00 daily https://www.pharmasources.com/industryinsights/china-gets-its-first-stem-cell-hospital--306312.html 0.6 2026-06-25T21:37:05+08:00 daily https://www.pharmasources.com/industryinsights/thousands-of-lung-cancer-patients-to-get-306313.html 0.6 2026-06-20T17:57:20+08:00 daily https://www.pharmasources.com/industryinsights/magi-partnering-with-pharmatimes-for-the-306314.html 0.6 2026-06-21T00:00:38+08:00 daily https://www.pharmasources.com/industryinsights/type-ii-diabetes-now-affects-7000-under--306315.html 0.6 2026-06-20T16:57:15+08:00 daily https://www.pharmasources.com/industryinsights/social-media-use-more-common-in-young-wi-306316.html 0.6 2026-06-21T04:46:39+08:00 daily https://www.pharmasources.com/industryinsights/the-pharmatimes-international-clinical-r-306317.html 0.6 2026-07-19T01:35:54+08:00 daily https://www.pharmasources.com/industryinsights/new-study-reveals-probiotics-do-not-help-306318.html 0.6 2026-06-20T19:11:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-patients--306319.html 0.6 2026-06-20T15:11:16+08:00 daily https://www.pharmasources.com/industryinsights/roche-abbvie-cancer-drug-gets-accelerate-306320.html 0.6 2026-07-02T16:23:52+08:00 daily https://www.pharmasources.com/industryinsights/strides-board-approves-15-m-investment-i-306321.html 0.6 2026-06-20T15:51:42+08:00 daily https://www.pharmasources.com/industryinsights/ables-bioeconomy-conclave-to-be-held-in--306322.html 0.6 2026-07-03T22:34:49+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-chatbot-anya-306323.html 0.6 2026-06-20T17:07:24+08:00 daily https://www.pharmasources.com/industryinsights/ceo-of-mhra-set-to-leave-agency-in-wake--306324.html 0.6 2026-07-03T19:36:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-commits-to-rapid-device-safety-respo-306325.html 0.6 2026-06-21T04:00:45+08:00 daily https://www.pharmasources.com/industryinsights/tough-to-overcome-obesity-the-gut-microb-306326.html 0.6 2026-06-06T18:26:30+08:00 daily https://www.pharmasources.com/industryinsights/eib-to-fund-f2g-biotechs-anti-fungal-dru-306327.html 0.6 2026-06-20T18:54:44+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-camuruss-buvidal-injections--306328.html 0.6 2026-06-22T17:54:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-daurismo-to-treat-a-306329.html 0.6 2026-07-04T06:58:19+08:00 daily https://www.pharmasources.com/industryinsights/deals-this-week-mundipharma-ligand-pharm-306330.html 0.6 2026-06-21T01:12:56+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-sinclair-pharma-direct-bio-306331.html 0.6 2026-06-21T03:12:51+08:00 daily https://www.pharmasources.com/industryinsights/alibaba-polyu-to-spearhead-ai-research-306332.html 0.6 2026-06-21T05:12:51+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-biogen-enter-a-dna-encoded-li-306333.html 0.6 2026-07-27T11:07:49+08:00 daily https://www.pharmasources.com/industryinsights/pliant-therapeutics-receives-fda-orphan--306334.html 0.6 2026-06-21T10:20:26+08:00 daily https://www.pharmasources.com/industryinsights/theravance-biopharma-announces-first-pat-306335.html 0.6 2026-06-21T17:17:37+08:00 daily https://www.pharmasources.com/industryinsights/innovus-pharmaceuticals-acquires-worldwi-306336.html 0.6 2026-02-28T13:11:05+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-and-roche-enter-exclusive-pegas-306337.html 0.6 2026-06-29T12:32:11+08:00 daily https://www.pharmasources.com/industryinsights/psioxus-therapeutics-to-collaborate-with-306338.html 0.6 2026-06-20T15:11:16+08:00 daily https://www.pharmasources.com/industryinsights/pm-pledges-35bn-annual-boost-for-nhs-com-306339.html 0.6 2026-06-21T23:56:41+08:00 daily https://www.pharmasources.com/industryinsights/grunenthal-acquires-averitas-pharmal-and-306340.html 0.6 2026-01-16T03:42:58+08:00 daily https://www.pharmasources.com/industryinsights/dragonfly-therapeutics-announces-the-exp-306341.html 0.6 2026-06-21T06:54:00+08:00 daily https://www.pharmasources.com/industryinsights/government-challenges-medical-devices-fi-306342.html 0.6 2026-06-21T22:56:42+08:00 daily https://www.pharmasources.com/industryinsights/rocket-pharmaceuticals-announces-clearan-306343.html 0.6 2026-06-20T20:06:42+08:00 daily https://www.pharmasources.com/industryinsights/fishawack-restructures-into-twin-med-com-306344.html 0.6 2026-08-06T02:32:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-tags-mylan-west-virginia-plant-with--306345.html 0.6 2026-08-08T00:35:55+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gene-therapy-luxturna-becomes-f-306346.html 0.6 2026-06-20T14:54:05+08:00 daily https://www.pharmasources.com/industryinsights/lawmakers-field-bill-tying-us-drug-price-306347.html 0.6 2026-06-21T05:10:49+08:00 daily https://www.pharmasources.com/industryinsights/cosmo-wins-fda-green-light-to-challenge--306348.html 0.6 2026-06-21T06:12:02+08:00 daily https://www.pharmasources.com/industryinsights/generation-z-expect-technology-revolutio-306349.html 0.6 2026-06-21T08:51:02+08:00 daily https://www.pharmasources.com/industryinsights/novartis-scores-new-fda-nod-breakthrough-306350.html 0.6 2026-06-22T23:56:53+08:00 daily https://www.pharmasources.com/industryinsights/emergent-and-valnevas-zika-vaccine-clear-306351.html 0.6 2026-06-20T14:49:00+08:00 daily https://www.pharmasources.com/industryinsights/cell-and-gene-therapy-catapult-addresses-306352.html 0.6 2026-06-21T19:02:38+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-plans-41-price-hikes-for-january-306353.html 0.6 2026-07-22T10:11:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-merck-kgaas-bavencio-flunks-ovari-306354.html 0.6 2026-06-20T20:56:52+08:00 daily https://www.pharmasources.com/industryinsights/rise-in-gp-numbers-must-be-sustained-and-306355.html 0.6 2026-06-21T00:47:49+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-adds-avista-pharma-to-the-fold-i-306356.html 0.6 2026-06-20T08:13:53+08:00 daily https://www.pharmasources.com/industryinsights/mayo-partnership-aims-to-teach-digital-s-306357.html 0.6 2026-08-10T01:08:26+08:00 daily https://www.pharmasources.com/industryinsights/indivior-hit-hard-as-generic-suboxone-de-306358.html 0.6 2026-08-07T15:32:48+08:00 daily https://www.pharmasources.com/industryinsights/eu-oks-novartis-gene-therapy-luxturna-fo-306359.html 0.6 2026-06-21T11:13:31+08:00 daily https://www.pharmasources.com/industryinsights/with-eu-blessing-takeda-clears-final-reg-306360.html 0.6 2026-08-09T20:07:35+08:00 daily https://www.pharmasources.com/industryinsights/pharma-agrees-to-2-cap-on-branded-meds-g-306361.html 0.6 2026-06-22T06:13:22+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-unveils-digital-initiat-306362.html 0.6 2026-08-05T05:01:20+08:00 daily https://www.pharmasources.com/industryinsights/novartis-focusing-on-cutting-car-t-costs-306363.html 0.6 2026-07-11T17:24:20+08:00 daily https://www.pharmasources.com/industryinsights/roche-pulls-extended-use-application-for-306364.html 0.6 2026-07-11T02:21:03+08:00 daily https://www.pharmasources.com/industryinsights/scorpion-venom-could-hold-the-key-to-bre-306365.html 0.6 2026-08-03T16:31:52+08:00 daily https://www.pharmasources.com/industryinsights/spinal-cord-stimulators-help-some-patien-306366.html 0.6 2026-05-28T05:46:58+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-appoints-former-gsk-exec-as--306367.html 0.6 2026-05-28T05:20:02+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-biogen-initiate-drug-discovery-co-306368.html 0.6 2026-08-05T06:55:43+08:00 daily https://www.pharmasources.com/industryinsights/zelda-therapeutics-partners-with-st-vinc-306369.html 0.6 2026-06-21T21:57:39+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-migraine-specific-preventio-306370.html 0.6 2026-06-20T21:50:40+08:00 daily https://www.pharmasources.com/industryinsights/obi-pharma-granted-fda-odd-for-obi-888-306371.html 0.6 2026-06-21T07:19:14+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-chatbot-anya-to-provide-m-306372.html 0.6 2026-06-21T19:17:00+08:00 daily https://www.pharmasources.com/industryinsights/exporting-pain-us-made-medical-devices-c-306373.html 0.6 2026-08-09T09:05:36+08:00 daily https://www.pharmasources.com/industryinsights/digital-tech-crucial-to-success-of-cance-306374.html 0.6 2026-07-10T02:08:50+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-enteric-coated-tablets-market-re-306375.html 0.6 2026-08-05T22:50:20+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-acquires-kinetic-discovery-to-306376.html 0.6 2026-07-28T17:46:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-on-voluntary-valsartan-recal-306377.html 0.6 2026-06-21T02:43:41+08:00 daily https://www.pharmasources.com/industryinsights/mirena-iud-by-bayer-is-no-2-on-adverse-e-306378.html 0.6 2026-08-04T01:12:45+08:00 daily https://www.pharmasources.com/industryinsights/thousands-to-benefit-as-nhs-funds-keytru-306379.html 0.6 2026-06-20T14:58:05+08:00 daily https://www.pharmasources.com/industryinsights/mei-pharma-khk-to-develop-and-commercial-306380.html 0.6 2026-06-21T01:02:47+08:00 daily https://www.pharmasources.com/industryinsights/obi-pharma-granted-fda-orphan-drug-desig-306381.html 0.6 2026-06-22T07:00:45+08:00 daily https://www.pharmasources.com/industryinsights/btg-chief-dame-louise-makin-in-line-for--306382.html 0.6 2026-06-21T08:55:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-jjs-invokana-for-heart-condition-306383.html 0.6 2026-08-08T00:56:38+08:00 daily https://www.pharmasources.com/industryinsights/selvita-announces-presentations-on-cdk8--306384.html 0.6 2026-08-06T01:09:47+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-announces-pipeline-expansion-w-306385.html 0.6 2026-08-08T03:11:31+08:00 daily https://www.pharmasources.com/industryinsights/halozyme-licenses-25m-drug-delivery-tech-306386.html 0.6 2026-06-21T10:20:21+08:00 daily https://www.pharmasources.com/industryinsights/patient-driven-gene-therapy-company-refl-306387.html 0.6 2026-06-23T11:24:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-eli-lillys-non-opioid-drug-helps--306388.html 0.6 2026-06-20T14:40:26+08:00 daily https://www.pharmasources.com/industryinsights/cycle-pharmaceuticals-receives-fda-appro-306389.html 0.6 2026-06-22T04:04:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-regeneron-sanofis-dupixent--306390.html 0.6 2026-06-20T15:51:38+08:00 daily https://www.pharmasources.com/industryinsights/pharmacists-still-under-used-as-unnecess-306391.html 0.6 2026-06-21T05:16:56+08:00 daily https://www.pharmasources.com/industryinsights/thousands-of-lung-cancer-patients-to-get-306392.html 0.6 2026-06-20T21:57:34+08:00 daily https://www.pharmasources.com/industryinsights/magi-partnering-with-pharmatimes-for-the-306393.html 0.6 2026-06-23T15:36:34+08:00 daily https://www.pharmasources.com/industryinsights/pennsylvania-uni-brings-penn-medicine-to-306394.html 0.6 2026-06-21T11:02:10+08:00 daily https://www.pharmasources.com/industryinsights/govt-announces-35bn-a-year-for-primary-c-306395.html 0.6 2026-06-20T14:49:11+08:00 daily https://www.pharmasources.com/industryinsights/a-powerful-catalyst-on-the-horizon-306396.html 0.6 2026-06-23T02:30:01+08:00 daily https://www.pharmasources.com/industryinsights/lords-ask-minister-for-clarity-on-access-306397.html 0.6 2026-06-21T10:12:15+08:00 daily https://www.pharmasources.com/industryinsights/one-in-three-copd-patients-believe-they--306398.html 0.6 2026-07-07T10:13:45+08:00 daily https://www.pharmasources.com/industryinsights/gsk-retains-leading-position-on-access-t-306399.html 0.6 2026-07-12T04:32:36+08:00 daily https://www.pharmasources.com/industryinsights/shires-veyvondi-approved-in-europe-for-b-306400.html 0.6 2026-07-06T23:06:27+08:00 daily https://www.pharmasources.com/industryinsights/vertex-invests-in-genomics-plc-as-the-fi-306401.html 0.6 2026-06-21T10:01:07+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018112-306402.html 0.6 2026-06-22T05:52:28+08:00 daily https://www.pharmasources.com/industryinsights/immune-regulation-announces-positive-res-306403.html 0.6 2026-06-19T23:59:51+08:00 daily https://www.pharmasources.com/industryinsights/sparc-announces-top-line-results-of-pivo-306404.html 0.6 2026-06-20T17:54:36+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-to-acquire-pola-pharma-in-jap-306405.html 0.6 2026-06-20T17:51:43+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-us-fda-nod-for-xyloc-306406.html 0.6 2026-06-23T12:19:03+08:00 daily https://www.pharmasources.com/industryinsights/fusion-antibodies-and-analytics-engines--306407.html 0.6 2026-04-01T07:19:19+08:00 daily https://www.pharmasources.com/industryinsights/new-uk-drug-pricing-deal-promises-faster-306408.html 0.6 2026-07-21T00:18:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-precision-medicine-drug-for-306409.html 0.6 2026-06-21T13:04:29+08:00 daily https://www.pharmasources.com/industryinsights/amags-label-expansion-of-lead-products-r-306410.html 0.6 2026-06-20T22:57:40+08:00 daily https://www.pharmasources.com/industryinsights/generation-z-happy-to-be-diagnosed-by-ch-306411.html 0.6 2026-06-21T14:51:19+08:00 daily https://www.pharmasources.com/industryinsights/breast-implants-reveal-problems-in-track-306412.html 0.6 2026-06-20T22:16:53+08:00 daily https://www.pharmasources.com/industryinsights/susie-hackett-and-effie-baoutis-join-hca-306413.html 0.6 2026-06-21T01:59:39+08:00 daily https://www.pharmasources.com/industryinsights/kbi-biopharma-bvba-opens-in-leuven-belgi-306414.html 0.6 2026-06-22T11:59:44+08:00 daily https://www.pharmasources.com/industryinsights/bellus-health-announces-positive-top-lin-306415.html 0.6 2026-06-20T14:55:12+08:00 daily https://www.pharmasources.com/industryinsights/novartissparks-sight-gene-therapy-approv-306416.html 0.6 2026-06-21T00:46:41+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-aims-to-cut-costs-with-digita-306417.html 0.6 2026-08-07T00:26:00+08:00 daily https://www.pharmasources.com/industryinsights/jj-shares-fall-after-court-refuses-to-bl-306418.html 0.6 2026-06-20T01:11:16+08:00 daily https://www.pharmasources.com/industryinsights/strategia-holdings-announces-strategic-p-306419.html 0.6 2026-06-26T14:21:52+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-firm-biomarin-stages-haemop-306420.html 0.6 2026-04-05T16:45:06+08:00 daily https://www.pharmasources.com/industryinsights/trump-administration-looks-to-give-priva-306421.html 0.6 2026-06-21T14:45:16+08:00 daily https://www.pharmasources.com/industryinsights/makara-health-promotes-helen-laurence-to-306422.html 0.6 2026-07-04T06:27:38+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-to-acquire-japans-pola-pharma-306423.html 0.6 2026-07-31T01:51:44+08:00 daily https://www.pharmasources.com/industryinsights/big-data-and-ai-provide-better-diagnosis-306424.html 0.6 2026-06-20T20:53:46+08:00 daily https://www.pharmasources.com/industryinsights/some-research-may-be-encouraging-ineffec-306425.html 0.6 2026-06-21T11:21:28+08:00 daily https://www.pharmasources.com/industryinsights/jw-pharmaceutical-signs-global-out-licen-306426.html 0.6 2026-07-09T15:15:30+08:00 daily https://www.pharmasources.com/industryinsights/ai-could-help-to-reduce-gadolinium-dose--306427.html 0.6 2026-06-22T08:03:46+08:00 daily https://www.pharmasources.com/industryinsights/contact-lens-patch-used-to-treat-eye-dis-306428.html 0.6 2026-06-21T12:59:27+08:00 daily https://www.pharmasources.com/industryinsights/revive-therapeutics-applies-to-fda-for-o-306429.html 0.6 2026-06-21T14:41:11+08:00 daily https://www.pharmasources.com/industryinsights/novartis-plots-innovative-payment-models-306430.html 0.6 2026-07-06T20:52:32+08:00 daily https://www.pharmasources.com/industryinsights/medical-devices-linked-to-deaths-and-inj-306431.html 0.6 2026-06-20T17:02:14+08:00 daily https://www.pharmasources.com/industryinsights/xeris-pharmaceuticals-and-ohsu-conductin-306432.html 0.6 2026-06-21T00:00:40+08:00 daily https://www.pharmasources.com/industryinsights/sun-gets-dermatology-portfolio-two-plant-306433.html 0.6 2026-06-21T01:47:32+08:00 daily https://www.pharmasources.com/industryinsights/most-pharma-firms-doing-little-rd-for-po-306434.html 0.6 2026-06-21T10:51:11+08:00 daily https://www.pharmasources.com/industryinsights/shattering-an-old-record-fda-quickly-oks-306435.html 0.6 2026-06-20T17:01:20+08:00 daily https://www.pharmasources.com/industryinsights/biontech-signs-collaboration-agreement-w-306436.html 0.6 2026-08-03T07:58:48+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-mundipharmas-pelmeg-to-treat-306437.html 0.6 2026-06-18T18:09:47+08:00 daily https://www.pharmasources.com/industryinsights/tolero-pharmaceuticals-announces-clinica-306438.html 0.6 2026-06-20T13:22:41+08:00 daily https://www.pharmasources.com/industryinsights/marmosets-viable-in-vivo-models-for-deve-306439.html 0.6 2026-06-21T12:03:17+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-hike-prices-of-41-drugs-despit-306440.html 0.6 2026-07-03T12:53:17+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-roche-take-venclexta-into-aml-are-306441.html 0.6 2026-06-19T23:05:53+08:00 daily https://www.pharmasources.com/industryinsights/cannabinoid-executive-switcheroo-fsd-pha-306442.html 0.6 2026-06-20T19:01:41+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-builds-ai-capability-with-kin-306443.html 0.6 2026-06-21T04:00:56+08:00 daily https://www.pharmasources.com/industryinsights/treatments-for-tomorrow-and-a-vision-for-306444.html 0.6 2026-06-08T20:02:03+08:00 daily https://www.pharmasources.com/industryinsights/hifibio-therapeutics-signs-multi-target--306445.html 0.6 2026-06-29T05:59:13+08:00 daily https://www.pharmasources.com/industryinsights/sun-closing-new-jersey-plant-laying-off--306446.html 0.6 2026-08-05T01:35:07+08:00 daily https://www.pharmasources.com/industryinsights/cosmos-diarrhoea-drug-approved-threateni-306447.html 0.6 2026-08-06T01:02:17+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-immunotherapy-fails-in-key--306448.html 0.6 2026-06-19T23:13:04+08:00 daily https://www.pharmasources.com/industryinsights/syneos-offers-predictions-for-2019-306449.html 0.6 2026-06-19T22:00:49+08:00 daily https://www.pharmasources.com/industryinsights/aarp-ads-tackle-big-pharma-lobbying-306450.html 0.6 2026-06-21T21:12:16+08:00 daily https://www.pharmasources.com/industryinsights/emergent-and-valnevas-zika-vaccine-clear-306451.html 0.6 2026-06-22T20:30:17+08:00 daily https://www.pharmasources.com/industryinsights/people-with-diabetes-want-real-families--306452.html 0.6 2026-06-20T09:13:04+08:00 daily https://www.pharmasources.com/industryinsights/in-swap-for-faster-uk-launches-pharma-ca-306453.html 0.6 2026-08-07T19:50:46+08:00 daily https://www.pharmasources.com/industryinsights/jj-loses-yet-another-fight-to-protect-zy-306454.html 0.6 2026-08-09T21:48:44+08:00 daily https://www.pharmasources.com/industryinsights/four-new-medicines-available-via-nhs-sco-306455.html 0.6 2026-03-21T01:37:25+08:00 daily https://www.pharmasources.com/industryinsights/ec-green-lights-msds-keytruda-combo-for--306456.html 0.6 2026-06-21T00:58:49+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-opdivo-for-preventing-melan-306457.html 0.6 2026-07-16T22:39:55+08:00 daily https://www.pharmasources.com/industryinsights/nhs-moves-to-clamp-down-on-incorrectfrau-306458.html 0.6 2026-02-28T08:12:53+08:00 daily https://www.pharmasources.com/industryinsights/uk-first-eu-nation-to-launch-flutiform-k-306459.html 0.6 2026-06-23T20:57:04+08:00 daily https://www.pharmasources.com/industryinsights/grant-winners-to-investigate-continuous--306460.html 0.6 2026-08-06T20:30:00+08:00 daily https://www.pharmasources.com/industryinsights/recipharms-proprietary-molecule-erdostei-306461.html 0.6 2026-07-27T16:23:23+08:00 daily https://www.pharmasources.com/industryinsights/manufacturing-of-life-enhancing-medicine-306462.html 0.6 2026-06-20T20:01:35+08:00 daily https://www.pharmasources.com/industryinsights/acquisition-boosts-cambrexs-early-stage--306463.html 0.6 2026-08-09T06:33:16+08:00 daily https://www.pharmasources.com/industryinsights/adc-bio-secures-additional-equity-round--306464.html 0.6 2026-06-21T16:02:23+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-set-to-save-300-million-poun-306465.html 0.6 2026-06-21T08:56:02+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-loxo-oncology-bayers-vitrakvi--306466.html 0.6 2026-06-21T06:21:16+08:00 daily https://www.pharmasources.com/industryinsights/dalton-excellthera-in-development-and-mf-306467.html 0.6 2026-06-21T03:04:44+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-opdivo-combination-306468.html 0.6 2026-08-04T09:00:38+08:00 daily https://www.pharmasources.com/industryinsights/cobra-pall-cell-and-gene-therapy-catapul-306469.html 0.6 2025-10-22T04:55:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-places-hold-on-study-of-zafgens-expe-306470.html 0.6 2026-06-20T13:20:36+08:00 daily https://www.pharmasources.com/industryinsights/anchiano-therapeutics-names-cmo-306471.html 0.6 2026-06-20T21:42:21+08:00 daily https://www.pharmasources.com/industryinsights/asit-biotech-adds-gmp-manufacturing-unit-306472.html 0.6 2026-06-20T21:10:48+08:00 daily https://www.pharmasources.com/industryinsights/telix-to-acquire-anmi-for-515m-306473.html 0.6 2026-06-20T21:15:16+08:00 daily https://www.pharmasources.com/industryinsights/akorn-receives-product-approval-ref-glob-306474.html 0.6 2026-06-22T15:16:05+08:00 daily https://www.pharmasources.com/industryinsights/oric-pharma-appoints-cbo-306475.html 0.6 2026-06-21T01:05:51+08:00 daily https://www.pharmasources.com/industryinsights/abeona-therapeutics-announces-ceo-transi-306476.html 0.6 2026-06-21T11:07:13+08:00 daily https://www.pharmasources.com/industryinsights/edge-therapeutics-pds-biotechnology-to-m-306477.html 0.6 2026-03-17T20:45:00+08:00 daily https://www.pharmasources.com/industryinsights/tasly-and-mesoblast-initiate-development-306478.html 0.6 2026-06-21T18:13:35+08:00 daily https://www.pharmasources.com/industryinsights/kol-views-what-to-make-of-oral-semagluti-306479.html 0.6 2026-06-21T19:02:38+08:00 daily https://www.pharmasources.com/industryinsights/cbt-bossan-enter-clinical-collaboration-306480.html 0.6 2026-07-21T19:50:45+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-begins-construction-of-ne-306481.html 0.6 2026-06-21T09:42:49+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-acquires-pola-pharma-in-japan-306482.html 0.6 2026-06-22T06:56:48+08:00 daily https://www.pharmasources.com/industryinsights/evotec-ag-immuneering-in-discovery-allia-306483.html 0.6 2026-06-20T14:55:11+08:00 daily https://www.pharmasources.com/industryinsights/pacific-biomarkers-merges-with-neomed-la-306484.html 0.6 2026-06-21T20:18:53+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-and-fuji-pharma-enter-biosimila-306485.html 0.6 2026-06-20T15:06:27+08:00 daily https://www.pharmasources.com/industryinsights/lonza-sartorius-modify-deal-for-supply-o-306486.html 0.6 2026-06-19T20:11:10+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-inaugurates-new-fill-and-fini-306487.html 0.6 2026-06-21T21:39:27+08:00 daily https://www.pharmasources.com/industryinsights/mettler-toledo-launches-safeline-x34-306488.html 0.6 2026-07-04T05:25:04+08:00 daily https://www.pharmasources.com/industryinsights/marken-rarechannels-announce-collaborati-306489.html 0.6 2026-06-23T01:19:39+08:00 daily https://www.pharmasources.com/industryinsights/paragon-named-to-deloittes-technology-fa-306490.html 0.6 2026-06-21T04:08:58+08:00 daily https://www.pharmasources.com/industryinsights/piramal-unveils-new-cgmp-kilo-lab-suite--306491.html 0.6 2026-08-09T17:36:06+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-buys-avista-for-252m-306492.html 0.6 2026-08-06T21:54:18+08:00 daily https://www.pharmasources.com/industryinsights/sea-vision-launches-harlenir-306493.html 0.6 2026-08-06T20:07:48+08:00 daily https://www.pharmasources.com/industryinsights/absorption-systems-acf-bioservices-certi-306494.html 0.6 2026-08-06T23:37:18+08:00 daily https://www.pharmasources.com/industryinsights/cobra-pall-cell-and-gene-therapy-catapul-306495.html 0.6 2026-08-06T23:46:30+08:00 daily https://www.pharmasources.com/industryinsights/edge-therapeutics-pds-biotechnology-to-m-306496.html 0.6 2026-06-20T19:06:42+08:00 daily https://www.pharmasources.com/industryinsights/royal-college-of-gps-backs-peoples-vote--306497.html 0.6 2026-06-22T03:54:35+08:00 daily https://www.pharmasources.com/industryinsights/poteligeo-approved-in-europe-for-mycosis-306498.html 0.6 2026-02-28T15:36:40+08:00 daily https://www.pharmasources.com/industryinsights/us-grants-az-fasenra-orphan-drug-status--306499.html 0.6 2026-08-02T07:07:45+08:00 daily https://www.pharmasources.com/industryinsights/nhs-lags-best-performers-in-cancer-care--306500.html 0.6 2026-06-22T03:06:43+08:00 daily https://www.pharmasources.com/industryinsights/vir-biotechnology-and-alnylam-pharmaceut-306501.html 0.6 2026-07-03T11:51:30+08:00 daily https://www.pharmasources.com/industryinsights/insulin-pumps-have-most-reported-problem-306502.html 0.6 2026-06-20T19:03:36+08:00 daily https://www.pharmasources.com/industryinsights/chi-med-announces-commercial-launch-of-e-306503.html 0.6 2026-06-24T09:11:11+08:00 daily https://www.pharmasources.com/industryinsights/vectura-takes-40-million-hit-as-asthma-d-306504.html 0.6 2026-08-04T19:13:14+08:00 daily https://www.pharmasources.com/industryinsights/cherry-acquired-by-communications-group--306505.html 0.6 2026-06-21T18:59:35+08:00 daily https://www.pharmasources.com/industryinsights/machavert-pharmaceuticals-unveils-a-new--306506.html 0.6 2026-08-05T23:19:33+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-diabetes-pill-clears-cardi-306507.html 0.6 2026-08-08T13:18:16+08:00 daily https://www.pharmasources.com/industryinsights/at-fda-a-new-goal-then-a-push-for-speedy-306508.html 0.6 2026-08-08T04:34:53+08:00 daily https://www.pharmasources.com/industryinsights/chinese-science-union-speaks-out-against-306509.html 0.6 2026-06-21T04:59:48+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-to-acquire-halo-pharma-adding-dr-306510.html 0.6 2026-08-07T12:03:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-consumers-against-using-rhino--306511.html 0.6 2026-08-07T13:16:45+08:00 daily https://www.pharmasources.com/industryinsights/adamis-pharmaceuticals-adds-sublingual-e-306512.html 0.6 2026-08-07T13:59:11+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-first-ever-trk-inhibitor-306513.html 0.6 2026-06-20T14:35:15+08:00 daily https://www.pharmasources.com/industryinsights/first-children-set-to-receive-novartis-k-306514.html 0.6 2026-06-20T15:01:06+08:00 daily https://www.pharmasources.com/industryinsights/compact-imaging-collaborates-with-global-306515.html 0.6 2026-06-22T09:53:47+08:00 daily https://www.pharmasources.com/industryinsights/eu-green-light-for-takedas-alunbrig-306516.html 0.6 2026-06-20T20:00:35+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-and-distributed-bio-enter--306517.html 0.6 2026-06-21T10:54:13+08:00 daily https://www.pharmasources.com/industryinsights/italy-free-to-reimburse-off-label-avasti-306518.html 0.6 2026-06-21T09:50:09+08:00 daily https://www.pharmasources.com/industryinsights/cms-finalizes-2019-medicare-clinical-lab-306519.html 0.6 2026-08-10T01:31:01+08:00 daily https://www.pharmasources.com/industryinsights/natera-and-neon-therapeutics-announce-cl-306520.html 0.6 2026-06-20T22:46:39+08:00 daily https://www.pharmasources.com/industryinsights/gmos-a-good-law-will-boost-agricultural--306521.html 0.6 2026-06-21T06:03:19+08:00 daily https://www.pharmasources.com/industryinsights/endocyte-enters-into-agreement-to-be-acq-306522.html 0.6 2026-07-03T16:58:25+08:00 daily https://www.pharmasources.com/industryinsights/aileron-pfizer-in-clinical-collaboration-306523.html 0.6 2026-08-08T07:54:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-investigator-for-violating-cli-306524.html 0.6 2026-06-21T04:19:03+08:00 daily https://www.pharmasources.com/industryinsights/novan-extends-technical-production-capac-306525.html 0.6 2026-07-08T21:14:55+08:00 daily https://www.pharmasources.com/industryinsights/why-amarins-latest-news-caused-shares-to-306526.html 0.6 2026-06-21T22:53:38+08:00 daily https://www.pharmasources.com/industryinsights/evelo-enters-into-clinical-trial-collabo-306527.html 0.6 2026-07-05T09:57:27+08:00 daily https://www.pharmasources.com/industryinsights/alcon-held-its-first-capital-markets-day-306528.html 0.6 2026-07-06T22:38:14+08:00 daily https://www.pharmasources.com/industryinsights/two-labs-acquires-pennside-partners-ltd-306529.html 0.6 2026-07-05T02:40:10+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-opdivo-yervoy-combo-fails--306530.html 0.6 2026-06-21T08:52:55+08:00 daily https://www.pharmasources.com/industryinsights/arsanis-and-x4-pharmaceuticals-announce--306531.html 0.6 2026-07-29T11:03:48+08:00 daily https://www.pharmasources.com/industryinsights/some-research-may-be-encouraging-ineffec-306532.html 0.6 2026-03-28T04:17:22+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-receives-eighth-ec-approval-for-b-306533.html 0.6 2026-06-20T19:11:45+08:00 daily https://www.pharmasources.com/industryinsights/using-graphene-as-a-tunable-ion-filter-306534.html 0.6 2026-08-07T05:58:48+08:00 daily https://www.pharmasources.com/industryinsights/protection-against-yellow-fever-provided-306535.html 0.6 2026-08-08T21:18:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-is-advancing-new-efforts-to-address--306536.html 0.6 2026-06-20T20:06:40+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-us-fda-approval-for--306537.html 0.6 2026-06-23T17:43:32+08:00 daily https://www.pharmasources.com/industryinsights/sygnature-discovery-establishes-us-ops-306538.html 0.6 2026-06-21T12:07:13+08:00 daily https://www.pharmasources.com/industryinsights/nkarta-appoints-svp-cmo-306539.html 0.6 2026-06-21T17:43:08+08:00 daily https://www.pharmasources.com/industryinsights/evelo-merck-enter-clinical-trial-collabo-306540.html 0.6 2026-06-21T07:58:06+08:00 daily https://www.pharmasources.com/industryinsights/catalent-expands-shanghai-clinical-packa-306541.html 0.6 2026-08-02T12:52:52+08:00 daily https://www.pharmasources.com/industryinsights/lonza-opens-innovation-center-in-israel-306542.html 0.6 2026-06-21T06:53:13+08:00 daily https://www.pharmasources.com/industryinsights/adial-pharma-selects-crown-cro-for-phase-306543.html 0.6 2026-06-22T08:15:49+08:00 daily https://www.pharmasources.com/industryinsights/immunocore-genentech-expand-anti-cancer--306544.html 0.6 2026-06-22T02:59:37+08:00 daily https://www.pharmasources.com/industryinsights/dnatrix-valo-therapeutics-enter-strategi-306545.html 0.6 2026-06-20T19:13:50+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-doubles-down-in-aml-with-daurismo-306546.html 0.6 2026-06-21T18:49:27+08:00 daily https://www.pharmasources.com/industryinsights/nhs-set-to-save-record-300-million-on-hi-306547.html 0.6 2026-06-21T09:06:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-scores-eu-nod-for-gene-therapy--306548.html 0.6 2026-06-20T22:15:12+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-shares-swoon-as-pharma-g-306549.html 0.6 2026-06-22T06:46:44+08:00 daily https://www.pharmasources.com/industryinsights/eu-oks-mundipharmas-neulasta-biosimilar-306550.html 0.6 2026-06-20T23:55:31+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-to-spend-140m-in-nc-flu-vaccine--306551.html 0.6 2026-06-19T16:45:04+08:00 daily https://www.pharmasources.com/industryinsights/vectura-pulls-the-plug-on-experimental-a-306552.html 0.6 2026-06-20T14:39:14+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-to-spend-140m-add-120-jobs-at-us-306553.html 0.6 2026-08-09T22:44:57+08:00 daily https://www.pharmasources.com/industryinsights/china-proposes-new-fines-for-vaccine-vio-306554.html 0.6 2026-08-03T20:52:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sobis-gamifant-for-rare-fat-306555.html 0.6 2026-06-21T10:18:44+08:00 daily https://www.pharmasources.com/industryinsights/after-scandals-china-proposes-new-fines--306556.html 0.6 2026-06-22T05:50:37+08:00 daily https://www.pharmasources.com/industryinsights/dupixent-and-vaccines-bring-sanofi-back--306557.html 0.6 2026-04-11T05:45:58+08:00 daily https://www.pharmasources.com/industryinsights/invectys-raises-15m-for-dna-cancer-vacci-306558.html 0.6 2026-07-12T19:31:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-an-oncology-drug-that-targe-306559.html 0.6 2026-07-07T17:41:59+08:00 daily https://www.pharmasources.com/industryinsights/pegfilgrastim-greenlight-marks-eighth-bi-306560.html 0.6 2026-07-08T07:20:24+08:00 daily https://www.pharmasources.com/industryinsights/phase-3-failure-of-asthma-therapy-sends--306561.html 0.6 2026-06-24T17:44:05+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-save-300-million-by-switching-to--306562.html 0.6 2026-06-27T00:43:27+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivoyervoy-combo-fails-in-small-ce-306563.html 0.6 2026-06-20T17:04:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-oral-trk-inhibitor-wi-306564.html 0.6 2026-08-05T21:04:30+08:00 daily https://www.pharmasources.com/industryinsights/how-chinese-and-overseas-enterprises-cat-306565.html 0.6 2026-08-08T17:44:49+08:00 daily https://www.pharmasources.com/industryinsights/received-approval-306566.html 0.6 2026-06-21T11:18:33+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharmas-new-jersey-manufacturing-ove-306567.html 0.6 2026-06-22T09:43:36+08:00 daily https://www.pharmasources.com/industryinsights/opioid-use-disorder-market-to-hit-48-bil-306568.html 0.6 2026-06-21T04:21:04+08:00 daily https://www.pharmasources.com/industryinsights/european-approval-for-takedas-alunbrig-i-306569.html 0.6 2026-06-21T00:55:45+08:00 daily https://www.pharmasources.com/industryinsights/roche-inks-deal-to-purchase-jecure-thera-306570.html 0.6 2026-07-04T11:06:29+08:00 daily https://www.pharmasources.com/industryinsights/teva-prices-generic-epipen-at-parity-wit-306571.html 0.6 2026-04-21T08:07:19+08:00 daily https://www.pharmasources.com/industryinsights/bayers-jivi-garners-eu-approval-for-trea-306572.html 0.6 2026-06-21T01:10:55+08:00 daily https://www.pharmasources.com/industryinsights/researcher-defends-use-of-gene-editing-t-306573.html 0.6 2026-06-21T14:53:20+08:00 daily https://www.pharmasources.com/industryinsights/trump-medicare-plan-targets-drugs-from-a-306574.html 0.6 2026-01-25T19:23:44+08:00 daily https://www.pharmasources.com/industryinsights/china-opens-door-to-foreign-drugs-for-a--306575.html 0.6 2026-07-20T23:48:37+08:00 daily https://www.pharmasources.com/industryinsights/biontech-mammatyper-validated-as-predict-306576.html 0.6 2026-06-20T19:17:57+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-sandozs-biosimilar-ziextenzo-306577.html 0.6 2026-06-20T21:00:41+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-acquires-metastron-from-ge-heal-306578.html 0.6 2026-06-21T23:58:40+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharmaceutical-agrees-to-acquire-jap-306579.html 0.6 2026-08-04T07:03:12+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-recall-306580.html 0.6 2026-06-21T18:08:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xospata-306581.html 0.6 2026-03-31T22:01:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-truxima-306582.html 0.6 2026-06-21T07:13:04+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-larotrectinib-the-first--306583.html 0.6 2026-06-21T11:43:14+08:00 daily https://www.pharmasources.com/industryinsights/c4x-discovery-launches-drug-discovery-pa-306584.html 0.6 2026-06-21T20:16:08+08:00 daily https://www.pharmasources.com/industryinsights/genentech-acquires-jecure-therapeutics-306585.html 0.6 2026-06-21T08:04:01+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-forms-new-polysynaptic-path-306586.html 0.6 2026-08-07T15:01:58+08:00 daily https://www.pharmasources.com/industryinsights/nuformix-expands-licensing-agreement-wit-306587.html 0.6 2026-06-20T21:22:30+08:00 daily https://www.pharmasources.com/industryinsights/new-technique-for-identifying-small-mole-306588.html 0.6 2026-04-29T19:33:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-biosimilar-for-non-ho-306589.html 0.6 2026-06-21T16:09:25+08:00 daily https://www.pharmasources.com/industryinsights/climate-change-ups-heat-deaths-especiall-306590.html 0.6 2026-06-20T16:02:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-odd-for-astrazenecas-fasenra--306591.html 0.6 2025-11-28T18:05:19+08:00 daily https://www.pharmasources.com/industryinsights/constant-pharmaceuticals-to-initiate-cli-306592.html 0.6 2026-06-22T05:42:39+08:00 daily https://www.pharmasources.com/industryinsights/lower-mortality-seen-for-cardiac-care-at-306593.html 0.6 2026-06-20T19:21:54+08:00 daily https://www.pharmasources.com/industryinsights/in-person-social-contact-tied-to-reduced-306594.html 0.6 2026-06-21T09:56:05+08:00 daily https://www.pharmasources.com/industryinsights/canada-clinical-trial-on-personalised-me-306595.html 0.6 2026-07-09T01:04:54+08:00 daily https://www.pharmasources.com/industryinsights/fluidic-analytics-gains-funding-for-lab--306596.html 0.6 2026-04-23T09:58:31+08:00 daily https://www.pharmasources.com/industryinsights/adhd-diagnosis-treatment-up-for-august-b-306597.html 0.6 2026-06-20T03:59:28+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-chatbot-anya-for-health-r-306598.html 0.6 2026-06-20T16:51:31+08:00 daily https://www.pharmasources.com/industryinsights/pulsed-radiofrequency-could-relieve-scia-306599.html 0.6 2026-06-22T06:08:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vitrakvi-for-solid-tumors-w-306600.html 0.6 2026-06-20T17:03:22+08:00 daily https://www.pharmasources.com/industryinsights/drl-launches-chlorthalidone-tablets-usp--306601.html 0.6 2026-08-08T02:35:25+08:00 daily https://www.pharmasources.com/industryinsights/zebrafish-help-unlock-mystery-of-motor-n-306602.html 0.6 2026-06-21T00:47:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-adult-patient-306603.html 0.6 2026-08-08T21:42:49+08:00 daily https://www.pharmasources.com/industryinsights/doctors-office-dementia-tests-are-often--306604.html 0.6 2026-06-22T00:11:00+08:00 daily https://www.pharmasources.com/industryinsights/aiping-pharmaceutical-strikes-ibuprofen--306605.html 0.6 2026-06-23T09:23:28+08:00 daily https://www.pharmasources.com/industryinsights/camurus-receives-eu-approval-for-weekly--306606.html 0.6 2026-07-20T18:48:15+08:00 daily https://www.pharmasources.com/industryinsights/eib-to-fund-f2g-biotechs-anti-fungal-dru-306607.html 0.6 2026-04-05T06:17:46+08:00 daily https://www.pharmasources.com/industryinsights/allergan-announces-fda-acceptance-of-snd-306608.html 0.6 2026-08-09T20:23:55+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-announces-new-d-306609.html 0.6 2026-06-21T06:11:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-daiichi-s-306610.html 0.6 2026-08-03T16:46:48+08:00 daily https://www.pharmasources.com/industryinsights/synthetic-biologics-announces-positive-f-306611.html 0.6 2026-07-19T04:01:47+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-odd-for-obi-pharmas-obi-88-306612.html 0.6 2026-06-20T04:14:22+08:00 daily https://www.pharmasources.com/industryinsights/glycomimetics-enrolls-first-patient-in-g-306613.html 0.6 2026-06-22T06:51:14+08:00 daily https://www.pharmasources.com/industryinsights/bayers-stivarga-wins-nice-backing-for-ad-306614.html 0.6 2026-06-21T06:01:54+08:00 daily https://www.pharmasources.com/industryinsights/eu-gives-bayers-jivi-the-green-light-306615.html 0.6 2026-06-20T20:45:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-move-uk-headquarters-to-lond-306616.html 0.6 2026-06-21T07:19:15+08:00 daily https://www.pharmasources.com/industryinsights/nhs-cracks-down-on-low-priority-prescrip-306617.html 0.6 2026-06-22T04:15:54+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-launches-type-ii-diabetes-a-306618.html 0.6 2026-06-20T15:53:33+08:00 daily https://www.pharmasources.com/industryinsights/cervical-cancer-screening-numbers-contin-306619.html 0.6 2026-06-21T02:06:44+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-to-open-uk-biotech-manufac-306620.html 0.6 2026-06-20T19:20:41+08:00 daily https://www.pharmasources.com/industryinsights/new-research-aims-to-help-prevent-sight--306621.html 0.6 2026-06-20T19:00:35+08:00 daily https://www.pharmasources.com/industryinsights/rcgp-calls-for-better-access-to-cancer-d-306622.html 0.6 2026-06-20T20:59:43+08:00 daily https://www.pharmasources.com/industryinsights/the-kings-fund-reports-life-expectancy-h-306623.html 0.6 2026-06-22T14:49:49+08:00 daily https://www.pharmasources.com/industryinsights/uk-cervical-cancer-screening-rates-fall--306624.html 0.6 2026-06-20T21:09:45+08:00 daily https://www.pharmasources.com/industryinsights/tevas-epipen-generic-retails-for-same-pr-306625.html 0.6 2026-06-22T12:01:09+08:00 daily https://www.pharmasources.com/industryinsights/bayers-jivi-approved-in-europe-for-previ-306626.html 0.6 2026-08-07T19:31:14+08:00 daily https://www.pharmasources.com/industryinsights/roches-genentech-to-acquire-inflammatory-306627.html 0.6 2026-06-22T11:02:54+08:00 daily https://www.pharmasources.com/industryinsights/european-approval-for-takedas-alunbrig-i-306628.html 0.6 2026-08-03T17:00:00+08:00 daily https://www.pharmasources.com/industryinsights/ono-files-for-approval-of-ono-7643-in-ja-306629.html 0.6 2026-06-20T22:01:39+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-launches-trastuzumab-bios-306630.html 0.6 2026-06-22T02:09:49+08:00 daily https://www.pharmasources.com/industryinsights/guangzhou-life-sciences-incubator-partne-306631.html 0.6 2026-07-02T22:45:55+08:00 daily https://www.pharmasources.com/industryinsights/biofourmis-brigham-and-womens-hospital-c-306632.html 0.6 2026-08-03T21:57:28+08:00 daily https://www.pharmasources.com/industryinsights/europes-biggest-private-biotech-company--306633.html 0.6 2026-06-23T09:07:44+08:00 daily https://www.pharmasources.com/industryinsights/coeptis-pharma-enters-into-agreement-to--306634.html 0.6 2026-06-20T14:41:09+08:00 daily https://www.pharmasources.com/industryinsights/buvidal-weekly-and-buvidal-monthly-cam20-306635.html 0.6 2026-06-21T08:48:45+08:00 daily https://www.pharmasources.com/industryinsights/generex-biotechnology-adds-world-class-l-306636.html 0.6 2026-06-21T10:01:07+08:00 daily https://www.pharmasources.com/industryinsights/government-of-quebec-offers-improved-acc-306637.html 0.6 2026-06-21T03:11:52+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-mercks-dels-306638.html 0.6 2026-06-21T18:00:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-on-opdivo-for-skin-cancer-re-306639.html 0.6 2026-06-19T20:01:50+08:00 daily https://www.pharmasources.com/industryinsights/c4xd-forms-discovery-partnership-with-ai-306640.html 0.6 2026-06-21T07:57:00+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-gilenya-for-paediatric-ms-306641.html 0.6 2026-06-22T14:38:42+08:00 daily https://www.pharmasources.com/industryinsights/cultural-shift-needed-to-keep-trust-in-h-306642.html 0.6 2026-08-07T06:17:27+08:00 daily https://www.pharmasources.com/industryinsights/kalydeco-approved-by-eu-for-cf-in-12-14--306643.html 0.6 2026-06-20T18:01:27+08:00 daily https://www.pharmasources.com/industryinsights/uk-is-among-the-first-to-meet-un-targets-306644.html 0.6 2026-06-22T01:55:32+08:00 daily https://www.pharmasources.com/industryinsights/astellas-xospata-becomes-us-approved-dru-306645.html 0.6 2026-08-05T21:24:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-rituxan-biosimilar-co-306646.html 0.6 2026-06-22T08:47:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gilenya-scores-paediatric-eu-ap-306647.html 0.6 2026-06-22T10:03:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-bayers-stivarga-for-adva-306648.html 0.6 2026-08-03T07:47:49+08:00 daily https://www.pharmasources.com/industryinsights/roches-genentech-to-acquire-inflammatory-306649.html 0.6 2026-08-09T06:24:38+08:00 daily https://www.pharmasources.com/industryinsights/pharma-tech-industries-appoints-plant-ma-306650.html 0.6 2026-06-21T12:46:21+08:00 daily https://www.pharmasources.com/industryinsights/new-brain-circuits-formed-for-motor-func-306651.html 0.6 2026-06-22T10:04:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-rare-au-306652.html 0.6 2026-06-21T15:17:48+08:00 daily https://www.pharmasources.com/industryinsights/tracon-i-mab-partner-for-immuno-oncology-306653.html 0.6 2026-06-21T04:17:24+08:00 daily https://www.pharmasources.com/industryinsights/oncolytics-biotech-appoints-cmo-306654.html 0.6 2026-08-03T04:21:46+08:00 daily https://www.pharmasources.com/industryinsights/lanadelumab-effective-in-reducing-heredi-306655.html 0.6 2026-06-22T12:12:03+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-appoints-president-ceo-306656.html 0.6 2026-07-16T15:05:23+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-nextcode-invests-400m-to-expand-pre-306657.html 0.6 2026-07-02T22:41:13+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-abl-bio-enter-development-306658.html 0.6 2026-08-04T16:54:02+08:00 daily https://www.pharmasources.com/industryinsights/aji-bio-pharma-introduces-new-adc-mfg-te-306659.html 0.6 2026-06-21T20:35:40+08:00 daily https://www.pharmasources.com/industryinsights/kansas-dept-of-commerce-helps-fssjcb-exp-306660.html 0.6 2026-06-15T04:44:24+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-builds-focus-on-rare-blood-disord-306661.html 0.6 2026-06-26T15:52:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gilteritinib-306662.html 0.6 2026-06-20T17:05:17+08:00 daily https://www.pharmasources.com/industryinsights/91-percent-response-rate-for-venetoclax--306663.html 0.6 2026-06-21T13:03:32+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-collaborates-with-autolus-on-a-306664.html 0.6 2026-06-23T00:17:56+08:00 daily https://www.pharmasources.com/industryinsights/merck-secures-ec-approval-for-delstrigo--306665.html 0.6 2026-06-26T16:16:35+08:00 daily https://www.pharmasources.com/industryinsights/dna-origami-full-of-potent-anticancer-ag-306666.html 0.6 2026-06-27T05:49:37+08:00 daily https://www.pharmasources.com/industryinsights/pari-devices-used-in-ship-study-of-hyper-306667.html 0.6 2026-06-20T16:00:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-filing-of-new-estrogen-free--306668.html 0.6 2026-06-20T21:43:21+08:00 daily https://www.pharmasources.com/industryinsights/x4-pharmaceuticals-signs-agreement-to-me-306669.html 0.6 2026-08-08T23:33:19+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-selected-as-forbes-asias--306670.html 0.6 2026-08-07T09:39:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-lambert-306671.html 0.6 2026-08-09T00:23:11+08:00 daily https://www.pharmasources.com/industryinsights/cvs-health-completes-acquisition-of-aetn-306672.html 0.6 2026-06-20T19:12:57+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-announces-formation-of-bioshin-306673.html 0.6 2026-06-23T02:14:20+08:00 daily https://www.pharmasources.com/industryinsights/roche-subsidiary-genentech-to-acquire-je-306674.html 0.6 2026-06-21T03:14:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-eu-approval-of-gileny-306675.html 0.6 2026-06-23T11:04:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-risks-with-multiple-sclerosis--306676.html 0.6 2026-08-02T20:34:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-firdapse-for-rare-autoimmun-306677.html 0.6 2026-06-22T18:29:20+08:00 daily https://www.pharmasources.com/industryinsights/meth-opioid-use-in-pregnancy-on-the-rise-306678.html 0.6 2026-06-21T13:10:34+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-bayers-liver-cancer-drug-306679.html 0.6 2026-06-20T20:57:40+08:00 daily https://www.pharmasources.com/industryinsights/blockchain-firm-witty-health-launches-di-306680.html 0.6 2026-06-08T02:25:07+08:00 daily https://www.pharmasources.com/industryinsights/genentech-buys-nash-biotech-jecure-306681.html 0.6 2026-07-04T06:01:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-plans-uk-headquarters-move-to-l-306682.html 0.6 2026-06-29T11:24:16+08:00 daily https://www.pharmasources.com/industryinsights/healios-begins-trials-of-mental-health-a-306683.html 0.6 2026-07-03T12:52:46+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-kyowa-kirins-drug-for-rare-l-306684.html 0.6 2026-07-07T06:46:37+08:00 daily https://www.pharmasources.com/industryinsights/gw-launches-cannabis-based-epilepsy-drug-306685.html 0.6 2026-06-21T05:14:54+08:00 daily https://www.pharmasources.com/industryinsights/bayerloxo-drug-approved-in-cancers-with--306686.html 0.6 2026-06-21T08:08:06+08:00 daily https://www.pharmasources.com/industryinsights/hikma-rises-on-cancer-generic-deal-with--306687.html 0.6 2026-06-28T01:21:39+08:00 daily https://www.pharmasources.com/industryinsights/nhs-saving-300m-with-humira-biosimilar-d-306688.html 0.6 2026-06-22T06:54:43+08:00 daily https://www.pharmasources.com/industryinsights/woman-scientist-is-frontrunner-to-be-fac-306689.html 0.6 2026-07-01T16:18:48+08:00 daily https://www.pharmasources.com/industryinsights/asian-longhorned-tick-is-invading-united-306690.html 0.6 2026-06-20T22:16:53+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-preps-filing-for-weight-friendl-306691.html 0.6 2026-06-21T09:00:00+08:00 daily https://www.pharmasources.com/industryinsights/firdapse-amifampridine-approved-for-rare-306692.html 0.6 2026-06-20T18:16:44+08:00 daily https://www.pharmasources.com/industryinsights/secondhand-pot-smoke-can-harm-an-asthmat-306693.html 0.6 2025-11-28T22:51:52+08:00 daily https://www.pharmasources.com/industryinsights/most-bills-enacted-into-law-limit-vaccin-306694.html 0.6 2026-06-20T21:16:59+08:00 daily https://www.pharmasources.com/industryinsights/genetic-analysis-shows-higher-bmi-may-up-306695.html 0.6 2026-06-20T20:46:21+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-bristol-myers-squibbs--306696.html 0.6 2026-08-04T09:00:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-clinical-testing-of-editas-me-306697.html 0.6 2026-08-06T23:34:27+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-the-francis-crick-ins-306698.html 0.6 2026-06-21T21:46:34+08:00 daily https://www.pharmasources.com/industryinsights/zambon-announces-approval-and-artg-listi-306699.html 0.6 2026-06-22T05:45:31+08:00 daily https://www.pharmasources.com/industryinsights/torii-has-agreed-with-jt-to-terminate-th-306700.html 0.6 2026-06-21T22:13:09+08:00 daily https://www.pharmasources.com/industryinsights/medicines-for-europe-welcomes-competitiv-306701.html 0.6 2026-07-06T21:35:14+08:00 daily https://www.pharmasources.com/industryinsights/richmond-based-e-claiborne-robins-co-inc-306702.html 0.6 2026-06-20T20:45:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-could-improve-designation-review-con-306703.html 0.6 2026-06-21T05:08:50+08:00 daily https://www.pharmasources.com/industryinsights/eureka-therapeutics-announces-data-prese-306704.html 0.6 2026-07-18T03:43:22+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-ucb-announce-fda-advisory-comm-306705.html 0.6 2026-06-23T04:55:56+08:00 daily https://www.pharmasources.com/industryinsights/biosimilar-pegfilgrastim-co-developed-by-306706.html 0.6 2026-07-14T05:31:51+08:00 daily https://www.pharmasources.com/industryinsights/tetra-bio-pharma-closes-financing-with-a-306707.html 0.6 2026-08-03T12:50:52+08:00 daily https://www.pharmasources.com/industryinsights/canadians-with-rare-lung-disease-are-rel-306708.html 0.6 2026-04-07T17:53:08+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-nystatin-and-tria-306709.html 0.6 2026-08-07T22:22:38+08:00 daily https://www.pharmasources.com/industryinsights/first-rxc006-data-suggests-it-has-great--306710.html 0.6 2026-06-30T11:56:37+08:00 daily https://www.pharmasources.com/industryinsights/what-innovative-technologies-are-shaping-306711.html 0.6 2026-06-21T17:59:32+08:00 daily https://www.pharmasources.com/industryinsights/pilot-scheme-trialing-electronic-gp-pres-306712.html 0.6 2026-08-07T13:02:52+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-trial-low-calorie-diets-to-combat-306713.html 0.6 2026-07-30T08:59:26+08:00 daily https://www.pharmasources.com/industryinsights/shire-receives-eu-approval-for-takhzyro-306714.html 0.6 2026-08-10T01:09:09+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-to-be-made-available-to-uk-melano-306715.html 0.6 2026-06-21T13:08:32+08:00 daily https://www.pharmasources.com/industryinsights/msd-chalks-up-two-hiv-drug-approvals-in--306716.html 0.6 2026-07-13T19:15:45+08:00 daily https://www.pharmasources.com/industryinsights/83-in-healthcare-say-uk-will-not-be-attr-306717.html 0.6 2026-06-20T21:55:40+08:00 daily https://www.pharmasources.com/industryinsights/bayer-announces-major-restructure-12000--306718.html 0.6 2026-07-23T07:52:46+08:00 daily https://www.pharmasources.com/industryinsights/bayer-group-restructures-306719.html 0.6 2026-08-03T10:57:14+08:00 daily https://www.pharmasources.com/industryinsights/bayer-group-restructures-306720.html 0.6 2026-08-08T23:42:51+08:00 daily https://www.pharmasources.com/industryinsights/innovent-hutchison-medipharma-in-drug-co-306721.html 0.6 2026-06-21T11:58:10+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-opens-shanghai-bioprocess--306722.html 0.6 2026-06-21T02:16:21+08:00 daily https://www.pharmasources.com/industryinsights/fette-compacting-coo-to-depart-306723.html 0.6 2026-04-08T13:42:46+08:00 daily https://www.pharmasources.com/industryinsights/concordia-international-becomes-advanz-p-306724.html 0.6 2026-06-21T08:16:22+08:00 daily https://www.pharmasources.com/industryinsights/huakang-biomed-holdings-announces-its-sh-306725.html 0.6 2026-06-21T22:52:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-lambert-306726.html 0.6 2026-08-06T04:55:06+08:00 daily https://www.pharmasources.com/industryinsights/viacyte-secures-80-million-financing-for-306727.html 0.6 2026-08-07T22:24:07+08:00 daily https://www.pharmasources.com/industryinsights/raman-singh-wins-global-executive-of-the-306728.html 0.6 2026-06-20T13:46:15+08:00 daily https://www.pharmasources.com/industryinsights/when-good-macrophages-go-bad-306729.html 0.6 2026-06-21T06:51:53+08:00 daily https://www.pharmasources.com/industryinsights/amgens-repatha-shows-durable-treatment-e-306730.html 0.6 2026-06-21T14:31:14+08:00 daily https://www.pharmasources.com/industryinsights/cardiac-cells-integrated-into-microneedl-306731.html 0.6 2026-08-09T22:08:04+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-takedas-alunbrig-for-alk-non-306732.html 0.6 2026-08-07T02:41:16+08:00 daily https://www.pharmasources.com/industryinsights/metrohm-usa-contributes-to-global-monogr-306733.html 0.6 2026-08-06T22:21:27+08:00 daily https://www.pharmasources.com/industryinsights/nanoscale-blood-test-could-discover-more-306734.html 0.6 2026-06-20T14:57:31+08:00 daily https://www.pharmasources.com/industryinsights/digital-manufacturing-is-a-top-priority--306735.html 0.6 2026-08-07T19:49:38+08:00 daily https://www.pharmasources.com/industryinsights/nih-to-evaluate-effectiveness-of-male-co-306736.html 0.6 2026-08-07T13:14:52+08:00 daily https://www.pharmasources.com/industryinsights/80-adolescents-a-day-will-still-die-of-a-306737.html 0.6 2026-08-07T08:02:32+08:00 daily https://www.pharmasources.com/industryinsights/catalent-expands-clinical-packaging-capa-306738.html 0.6 2026-08-07T05:01:20+08:00 daily https://www.pharmasources.com/industryinsights/us-scientists-reveal-new-gene-therapy-fo-306739.html 0.6 2026-08-07T04:27:48+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018120-306740.html 0.6 2026-08-07T04:07:02+08:00 daily https://www.pharmasources.com/industryinsights/aquestive-therapeutics-launches-sympazan-306741.html 0.6 2026-08-07T04:28:13+08:00 daily https://www.pharmasources.com/industryinsights/benefits-of-cbd-liquid-for-epilepsy-may--306742.html 0.6 2026-08-07T04:36:44+08:00 daily https://www.pharmasources.com/industryinsights/searchlight-pharma-q-biomed-quest-pharma-306743.html 0.6 2026-08-07T04:52:50+08:00 daily https://www.pharmasources.com/industryinsights/owc-reports-progress-in-clinical-trials--306744.html 0.6 2026-08-09T22:07:16+08:00 daily https://www.pharmasources.com/industryinsights/sudden-death-risk-in-epilepsy-can-wane-o-306745.html 0.6 2026-06-20T15:52:46+08:00 daily https://www.pharmasources.com/industryinsights/depression-is-a-risk-for-teens-adults-wi-306746.html 0.6 2026-06-21T09:59:13+08:00 daily https://www.pharmasources.com/industryinsights/nuvo-declared-winning-bidder-to-acquire--306747.html 0.6 2026-06-22T13:01:01+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-hutchison-to-test-sintilima-306748.html 0.6 2026-08-02T22:42:37+08:00 daily https://www.pharmasources.com/industryinsights/women-with-pregnancy-losses-are-at-risk--306749.html 0.6 2026-08-06T23:41:12+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-humira-global-patent-li-306750.html 0.6 2026-06-24T21:38:15+08:00 daily https://www.pharmasources.com/industryinsights/teva-recalls-two-blood-pressure-medicati-306751.html 0.6 2026-08-07T13:11:02+08:00 daily https://www.pharmasources.com/industryinsights/mirati-announces-clearance-of-ind-applic-306752.html 0.6 2026-06-20T15:55:15+08:00 daily https://www.pharmasources.com/industryinsights/mas-this-week-sun-pharma-genentech-cvs-h-306753.html 0.6 2026-06-20T22:01:44+08:00 daily https://www.pharmasources.com/industryinsights/limiting-social-media-may-improve-psycho-306754.html 0.6 2026-06-21T01:14:10+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-cut-12000-jobs-306755.html 0.6 2026-06-21T09:06:04+08:00 daily https://www.pharmasources.com/industryinsights/case-description-can-reliably-define-acu-306756.html 0.6 2026-06-21T03:10:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-filing-of-new-estrogen-free--306757.html 0.6 2026-04-12T17:49:46+08:00 daily https://www.pharmasources.com/industryinsights/autolus-therapeutics-announces-update-on-306758.html 0.6 2026-06-21T20:00:39+08:00 daily https://www.pharmasources.com/industryinsights/tracon-pharmaceuticals-and-i-mab-biophar-306759.html 0.6 2026-07-31T12:02:36+08:00 daily https://www.pharmasources.com/industryinsights/astellas-scores-first-us-blood-cancer-ap-306760.html 0.6 2026-06-21T04:51:05+08:00 daily https://www.pharmasources.com/industryinsights/athenex-announces-license-agreement-with-306761.html 0.6 2026-06-21T14:50:23+08:00 daily https://www.pharmasources.com/industryinsights/nhs-funds-bms-opdivo-to-prevent-skin-can-306762.html 0.6 2026-06-21T11:18:38+08:00 daily https://www.pharmasources.com/industryinsights/new-tech-allows-mobile-based-eye-tests-306763.html 0.6 2026-07-07T12:33:29+08:00 daily https://www.pharmasources.com/industryinsights/tris-pharma-expands-adhd-portfolio-with--306764.html 0.6 2026-06-29T23:54:36+08:00 daily https://www.pharmasources.com/industryinsights/knight-therapeutics-and-jaguar-health-an-306765.html 0.6 2026-06-22T03:07:50+08:00 daily https://www.pharmasources.com/industryinsights/emergex-enters-into-mou-with-brazils-fio-306766.html 0.6 2026-08-09T00:47:36+08:00 daily https://www.pharmasources.com/industryinsights/roivant-wins-200m-backing-to-expand-rd-o-306767.html 0.6 2026-08-07T05:37:56+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-and-morphosys-expand-strategi-306768.html 0.6 2026-06-21T07:19:39+08:00 daily https://www.pharmasources.com/industryinsights/defined-health-becomes-cello-health-bioc-306769.html 0.6 2026-06-21T21:59:47+08:00 daily https://www.pharmasources.com/industryinsights/gsk-begins-clinical-trials-of-pancreatic-306770.html 0.6 2026-04-02T19:04:23+08:00 daily https://www.pharmasources.com/industryinsights/x4-pharmaceuticals-presents-additional-p-306771.html 0.6 2026-06-21T12:13:20+08:00 daily https://www.pharmasources.com/industryinsights/athenex-announces-licensing-agreement-wi-306772.html 0.6 2026-08-08T12:43:18+08:00 daily https://www.pharmasources.com/industryinsights/als-organizations-collaborate-to-advance-306773.html 0.6 2026-06-04T15:15:38+08:00 daily https://www.pharmasources.com/industryinsights/qiagen-and-neogenomics-collaborate-to-of-306774.html 0.6 2026-07-02T20:51:23+08:00 daily https://www.pharmasources.com/industryinsights/direct-biologics-llc-has-acquired-paisle-306775.html 0.6 2026-06-21T12:59:31+08:00 daily https://www.pharmasources.com/industryinsights/canntrust-expands-global-reach-and-acces-306776.html 0.6 2026-06-24T21:17:07+08:00 daily https://www.pharmasources.com/industryinsights/owc-pharmaceutical-research-corp-complet-306777.html 0.6 2026-06-21T20:46:31+08:00 daily https://www.pharmasources.com/industryinsights/novaliqs-novatears-treatment-for-evapora-306778.html 0.6 2026-06-21T07:45:59+08:00 daily https://www.pharmasources.com/industryinsights/redhill-announces-us-co-promotion-agreem-306779.html 0.6 2026-06-21T17:07:30+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-lp-announces-successful-co-306780.html 0.6 2026-06-20T15:54:28+08:00 daily https://www.pharmasources.com/industryinsights/roche-expands-access-to-the-diabetes-man-306781.html 0.6 2026-06-21T14:40:23+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-to-buy-tesaro-for-51-bil-306782.html 0.6 2026-07-22T14:03:08+08:00 daily https://www.pharmasources.com/industryinsights/takeda-familys-last-push-to-kill-shire-t-306783.html 0.6 2026-07-08T07:44:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-clinical-testing-of-editas-me-306784.html 0.6 2026-06-22T00:57:01+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-pays-300-million-upfront-306785.html 0.6 2026-06-22T12:18:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-novartis-f-306786.html 0.6 2026-06-21T00:00:36+08:00 daily https://www.pharmasources.com/industryinsights/spark-therapeutics-announces-updated-dat-306787.html 0.6 2026-06-20T14:57:04+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-identifying-cqas-and-cpps-po-306788.html 0.6 2026-08-06T23:37:15+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-secures-humira-licence-agreements-306789.html 0.6 2026-07-25T13:38:38+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-new-crizanlizumab-dat-306790.html 0.6 2026-06-21T03:09:19+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-successfully-implanted-wit-306791.html 0.6 2026-06-22T00:57:46+08:00 daily https://www.pharmasources.com/industryinsights/pg-completes-mercks-consumer-health-unit-306792.html 0.6 2026-06-20T15:08:57+08:00 daily https://www.pharmasources.com/industryinsights/car-t-cell-update-therapy-improves-outco-306793.html 0.6 2026-07-03T10:26:05+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-delivers-positive-phase-3-resul-306794.html 0.6 2026-06-22T09:34:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dextenza-306795.html 0.6 2026-06-21T01:02:47+08:00 daily https://www.pharmasources.com/industryinsights/gileads-car-t-therapy-yescarta-shows-two-306796.html 0.6 2026-06-20T14:42:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-novartis-application-for-zol-306797.html 0.6 2026-06-20T18:07:51+08:00 daily https://www.pharmasources.com/industryinsights/schrdinger-and-sparc-announce-collaborat-306798.html 0.6 2026-06-21T00:15:50+08:00 daily https://www.pharmasources.com/industryinsights/gsk-adds-to-cancer-offering-with-51bn-te-306799.html 0.6 2026-06-21T03:18:02+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-announces-updated-results-from-306800.html 0.6 2026-06-20T15:43:13+08:00 daily https://www.pharmasources.com/industryinsights/cdc-acute-flaccid-myelitis-cases-appear--306801.html 0.6 2026-06-21T02:02:50+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kymriah-shows-strong-efficacy-d-306802.html 0.6 2026-06-09T20:09:39+08:00 daily https://www.pharmasources.com/industryinsights/amgen-ucb-announce-fda-to-review-evenity-306803.html 0.6 2026-06-20T22:08:45+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-extends-the-life-of-head-a-306804.html 0.6 2026-08-07T16:58:42+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-pursue-deals-and-acquisitions-desp-306805.html 0.6 2026-08-05T09:52:08+08:00 daily https://www.pharmasources.com/industryinsights/cost-related-insulin-underuse-may-affect-306806.html 0.6 2026-06-20T16:37:21+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-venclyxto-combo-beats-standard-o-306807.html 0.6 2026-06-21T04:46:42+08:00 daily https://www.pharmasources.com/industryinsights/entrepreneurship-model-for-biopharma-ind-306808.html 0.6 2026-06-21T16:53:32+08:00 daily https://www.pharmasources.com/industryinsights/vanda-announces-positive-phase-ii-study--306809.html 0.6 2026-03-21T05:38:25+08:00 daily https://www.pharmasources.com/industryinsights/elastic-contrast-protein-for-more-accura-306810.html 0.6 2026-03-26T21:36:44+08:00 daily https://www.pharmasources.com/industryinsights/global-2-year-trial-reports-on-car-t-the-306811.html 0.6 2026-06-22T03:11:52+08:00 daily https://www.pharmasources.com/industryinsights/shires-takhzyro-scores-eu-approval-in-ra-306812.html 0.6 2026-06-21T15:54:17+08:00 daily https://www.pharmasources.com/industryinsights/novartis-unveils-strong-longer-term-kymr-306813.html 0.6 2026-06-20T17:55:17+08:00 daily https://www.pharmasources.com/industryinsights/ash-ibrutinib-tops-bendamustine-rituxima-306814.html 0.6 2026-06-20T15:59:16+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-ever-diagnosed-asd-279-per-306815.html 0.6 2026-07-18T02:23:23+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-platelets-in-lab-306816.html 0.6 2026-08-09T23:01:46+08:00 daily https://www.pharmasources.com/industryinsights/rare-variants-associated-with-interval-b-306817.html 0.6 2026-06-21T12:21:45+08:00 daily https://www.pharmasources.com/industryinsights/nex-china-helping-enterprises-explore-ne-306818.html 0.6 2026-08-08T23:54:12+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-help-becoming-less-of-a-st-306819.html 0.6 2026-01-21T13:38:01+08:00 daily https://www.pharmasources.com/industryinsights/1-in-10-will-develop-eczema-in-their-lif-306820.html 0.6 2026-06-21T02:59:41+08:00 daily https://www.pharmasources.com/industryinsights/doctors-more-cautious-now-when-prescribi-306821.html 0.6 2026-05-02T01:59:05+08:00 daily https://www.pharmasources.com/industryinsights/another-tally-puts-autism-cases-at-1-in--306822.html 0.6 2026-06-21T09:02:03+08:00 daily https://www.pharmasources.com/industryinsights/scientistcom-partners-with-allele-biotec-306823.html 0.6 2026-06-20T22:00:40+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-and-immunochina-partner-to-adv-306824.html 0.6 2026-06-20T01:07:05+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-strikes-deal-with-chinese-online--306825.html 0.6 2026-08-09T05:30:07+08:00 daily https://www.pharmasources.com/industryinsights/celgene-scores-at-ash18-with-double-lusp-306826.html 0.6 2026-06-20T18:05:22+08:00 daily https://www.pharmasources.com/industryinsights/doj-tells-supreme-court-it-has-lost-inte-306827.html 0.6 2026-06-23T05:08:25+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-lp-enters-into-exclusive-o-306828.html 0.6 2026-06-21T03:53:40+08:00 daily https://www.pharmasources.com/industryinsights/lsk-biopharma-and-jiangsu-hengrui-medici-306829.html 0.6 2026-07-23T04:50:45+08:00 daily https://www.pharmasources.com/industryinsights/why-chinas-flu-vaccine-supply-is-sufferi-306830.html 0.6 2026-08-03T05:38:32+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-weighs-bexseros-promise--306831.html 0.6 2026-06-21T10:04:10+08:00 daily https://www.pharmasources.com/industryinsights/mergent-biosolutions-and-valnevas-zika-v-306832.html 0.6 2026-06-21T01:05:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-controversial-dengvaxia-picks-up-306833.html 0.6 2026-06-21T13:02:28+08:00 daily https://www.pharmasources.com/industryinsights/mercks-gardasil-turns-in-1b-in-monster-q-306834.html 0.6 2026-06-04T03:10:47+08:00 daily https://www.pharmasources.com/industryinsights/jj-opens-72m-vaccine-plant-for-stepped-u-306835.html 0.6 2026-06-21T13:23:56+08:00 daily https://www.pharmasources.com/industryinsights/jj-touts-new-immune-response-data-for-hi-306836.html 0.6 2026-06-21T11:56:35+08:00 daily https://www.pharmasources.com/industryinsights/nih-grants-idt-10-year-vaccine-manufactu-306837.html 0.6 2026-06-22T07:48:54+08:00 daily https://www.pharmasources.com/industryinsights/cell-derived-flu-strain-provides-a-bette-306838.html 0.6 2026-02-28T20:23:41+08:00 daily https://www.pharmasources.com/industryinsights/flugens-broadly-protective-flu-vaccine-c-306839.html 0.6 2026-07-08T09:52:06+08:00 daily https://www.pharmasources.com/industryinsights/zymeworks-and-leo-pharma-enter-into-bisp-306840.html 0.6 2026-06-20T21:03:43+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-pfizer-reach-licencing-agreement--306841.html 0.6 2026-08-04T09:54:35+08:00 daily https://www.pharmasources.com/industryinsights/entresto-tops-mainstay-ace-inhibitor-in--306842.html 0.6 2026-03-11T06:20:41+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drugs-cost-nhs-more-than-1bn-a--306843.html 0.6 2026-06-08T15:20:00+08:00 daily https://www.pharmasources.com/industryinsights/vertex-told-to-reveal-cf-drug-price-as-m-306844.html 0.6 2026-06-21T09:54:18+08:00 daily https://www.pharmasources.com/industryinsights/gsk-wraps-up-promised-horlicks-sell-off--306845.html 0.6 2026-06-20T23:11:47+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-cut-loose-animal-health-consume-306846.html 0.6 2026-06-21T17:57:35+08:00 daily https://www.pharmasources.com/industryinsights/bms-flips-negative-nice-ruling-on-opdivo-306847.html 0.6 2026-06-21T22:56:40+08:00 daily https://www.pharmasources.com/industryinsights/takeda-could-rack-up-10b-in-selloffs-aft-306848.html 0.6 2026-07-05T03:09:09+08:00 daily https://www.pharmasources.com/industryinsights/chinese-heparin-maker-banned-by-ema-over-306849.html 0.6 2026-06-21T02:54:55+08:00 daily https://www.pharmasources.com/industryinsights/rockwell-medical-inc-appoints-new-vice-p-306850.html 0.6 2026-06-21T09:55:18+08:00 daily https://www.pharmasources.com/industryinsights/scholar-rock-announces-positive-opinion--306851.html 0.6 2026-06-09T09:33:12+08:00 daily https://www.pharmasources.com/industryinsights/vybion-receives-orphan-drug-designation--306852.html 0.6 2026-06-22T09:11:51+08:00 daily https://www.pharmasources.com/industryinsights/aytu-bioscience-announces-appointment-of-306853.html 0.6 2026-06-20T22:04:39+08:00 daily https://www.pharmasources.com/industryinsights/allogene-therapeutics-presents-data-from-306854.html 0.6 2025-11-28T19:54:49+08:00 daily https://www.pharmasources.com/industryinsights/sinclair-pharma-announces-changes-in-us--306855.html 0.6 2026-06-21T03:03:40+08:00 daily https://www.pharmasources.com/industryinsights/casi-pharmaceuticals-announces-china-mar-306856.html 0.6 2026-08-06T23:48:24+08:00 daily https://www.pharmasources.com/industryinsights/enstilar-is-now-covered-by-the-alberta-d-306857.html 0.6 2026-06-20T19:48:40+08:00 daily https://www.pharmasources.com/industryinsights/adverum-biotechnologies-announces-public-306858.html 0.6 2026-06-22T11:00:47+08:00 daily https://www.pharmasources.com/industryinsights/solicitor-general-to-back-merck-at-supre-306859.html 0.6 2026-08-06T02:31:37+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-crosses-finish-line-w-306860.html 0.6 2026-06-22T12:51:17+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-ceo-goes-inside-its-lig-306861.html 0.6 2026-06-20T19:01:38+08:00 daily https://www.pharmasources.com/industryinsights/ash-with-gamifant-launch-rolling-sobi-un-306862.html 0.6 2026-06-21T08:38:50+08:00 daily https://www.pharmasources.com/industryinsights/ash-johnson-johnson-abbvies-imbruvica-st-306863.html 0.6 2026-06-21T20:02:38+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-ceo-goes-inside-its-lig-306864.html 0.6 2026-06-20T18:38:14+08:00 daily https://www.pharmasources.com/industryinsights/rivaroxaban-reduced-blood-clots-and-rela-306865.html 0.6 2026-06-20T20:08:44+08:00 daily https://www.pharmasources.com/industryinsights/ash-johnson-johnsons-fast-growing-darzal-306866.html 0.6 2026-06-23T01:37:33+08:00 daily https://www.pharmasources.com/industryinsights/ash-can-johnson-johnson-sell-regulators--306867.html 0.6 2026-06-20T18:02:21+08:00 daily https://www.pharmasources.com/industryinsights/janssen-merck-chip-in-for-100m-uk-vaccin-306868.html 0.6 2026-06-22T03:52:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-hits-sanofis-struggling-lemtrada-wit-306869.html 0.6 2026-06-21T15:49:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ceo-narasimhan-says-he-was-comp-306870.html 0.6 2026-06-21T20:12:52+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-inks-humira-patent-deal-no-7-dela-306871.html 0.6 2026-06-21T17:18:38+08:00 daily https://www.pharmasources.com/industryinsights/discovery-to-save-more-women-in-childbir-306872.html 0.6 2026-07-25T15:09:57+08:00 daily https://www.pharmasources.com/industryinsights/takeda-maintenance-data-set-up-ninlaro-f-306873.html 0.6 2026-06-20T16:53:29+08:00 daily https://www.pharmasources.com/industryinsights/gilead-novartis-tout-long-term-data-for--306874.html 0.6 2026-06-21T17:04:26+08:00 daily https://www.pharmasources.com/industryinsights/cphi-report-forecasts-india-to-have-stro-306875.html 0.6 2026-06-22T05:42:39+08:00 daily https://www.pharmasources.com/industryinsights/eisai-puts-water-focused-portraits-at-th-306876.html 0.6 2026-06-21T05:59:49+08:00 daily https://www.pharmasources.com/industryinsights/trumps-drug-prices-in-ads-idea-gets-two--306877.html 0.6 2026-06-21T12:58:44+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-silodosin-capsule-306878.html 0.6 2026-06-20T17:17:38+08:00 daily https://www.pharmasources.com/industryinsights/teva-hit-with-63m-retaliation-verdict-in-306879.html 0.6 2026-06-21T12:03:11+08:00 daily https://www.pharmasources.com/industryinsights/philadelphia-looks-to-crack-down-on-phar-306880.html 0.6 2026-06-23T12:58:11+08:00 daily https://www.pharmasources.com/industryinsights/catalysts-long-delayed-firdapse-snags-fd-306881.html 0.6 2026-07-04T14:24:08+08:00 daily https://www.pharmasources.com/industryinsights/dr-irina-buhimschi-joins-shuwen-biotech--306882.html 0.6 2026-08-04T00:57:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-agrees-accelerated-approval-pathway--306883.html 0.6 2026-06-30T08:33:40+08:00 daily https://www.pharmasources.com/industryinsights/roches-patent-cliff-just-got-steeper-as--306884.html 0.6 2026-08-09T01:21:33+08:00 daily https://www.pharmasources.com/industryinsights/icr-report-shows-lag-in-uk-patient-acces-306885.html 0.6 2026-08-05T20:07:11+08:00 daily https://www.pharmasources.com/industryinsights/panav-bio-tech-introduces-classical-swin-306886.html 0.6 2026-06-28T11:46:58+08:00 daily https://www.pharmasources.com/industryinsights/janssen-affiliate-cilag-and-argenx-sign--306887.html 0.6 2026-06-21T03:07:53+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-acquire-cancer-therapeutics-firm--306888.html 0.6 2026-08-09T02:19:53+08:00 daily https://www.pharmasources.com/industryinsights/imbruvica-plus-obinutuzumab-shown-to-inc-306889.html 0.6 2026-06-30T03:17:47+08:00 daily https://www.pharmasources.com/industryinsights/eiger-announces-fda-acceptance-of-ind-ap-306890.html 0.6 2025-11-28T19:14:00+08:00 daily https://www.pharmasources.com/industryinsights/jost-chemical-announces-construction-of--306891.html 0.6 2026-06-21T00:04:42+08:00 daily https://www.pharmasources.com/industryinsights/biocartis-astrazeneca-aim-faster-lung-ca-306892.html 0.6 2026-04-07T19:58:33+08:00 daily https://www.pharmasources.com/industryinsights/chemomab-appoints-chairman-of-the-board-306893.html 0.6 2026-06-20T21:18:31+08:00 daily https://www.pharmasources.com/industryinsights/medadvisor-forms-jv-with-healthcare-gian-306894.html 0.6 2026-07-04T13:02:14+08:00 daily https://www.pharmasources.com/industryinsights/alkahest-doses-first-subject-in-phase-2--306895.html 0.6 2026-06-21T03:59:56+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-immunochina-to-advance-immunot-306896.html 0.6 2026-07-20T13:57:22+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-generic-for-prevacid-solu-306897.html 0.6 2026-06-21T01:10:03+08:00 daily https://www.pharmasources.com/industryinsights/integral-molecular-awarded-14-million-by-306898.html 0.6 2026-06-20T07:49:19+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-baby-born-from-deceased-don-306899.html 0.6 2026-07-04T00:12:59+08:00 daily https://www.pharmasources.com/industryinsights/many-patients-withhold-information-from--306900.html 0.6 2026-06-21T23:52:42+08:00 daily https://www.pharmasources.com/industryinsights/hhs-issues-draft-strategy-for-reducing-h-306901.html 0.6 2026-08-04T06:06:50+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-phthalates-may-impact-timing-306902.html 0.6 2026-06-20T21:16:53+08:00 daily https://www.pharmasources.com/industryinsights/marathon-runners-show-markers-of-cardiac-306903.html 0.6 2026-06-21T08:54:37+08:00 daily https://www.pharmasources.com/industryinsights/obamacare-helped-more-women-access-care--306904.html 0.6 2026-01-25T19:23:26+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-for-sickle-cell-takes-anoth-306905.html 0.6 2026-06-20T16:04:26+08:00 daily https://www.pharmasources.com/industryinsights/gbt-heads-to-fda-with-sickle-cell-drug-v-306906.html 0.6 2026-06-20T22:17:52+08:00 daily https://www.pharmasources.com/industryinsights/gsk-enters-parp-space-with-tesaro-acquis-306907.html 0.6 2026-07-05T22:44:31+08:00 daily https://www.pharmasources.com/industryinsights/pluristem-therapeutics-enters-into-cell--306908.html 0.6 2026-08-07T22:29:14+08:00 daily https://www.pharmasources.com/industryinsights/evolus-receives-conditional-fda-acceptan-306909.html 0.6 2026-06-21T01:48:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-breakthrough-designation-for-bayer-a-306910.html 0.6 2026-06-21T08:09:03+08:00 daily https://www.pharmasources.com/industryinsights/beckley-canopy-therapeutics-raises-74m-f-306911.html 0.6 2026-06-22T03:07:50+08:00 daily https://www.pharmasources.com/industryinsights/open-health-merges-with-med-comms-servic-306912.html 0.6 2026-06-27T07:28:00+08:00 daily https://www.pharmasources.com/industryinsights/revance-announces-china-market-license-a-306913.html 0.6 2026-08-04T00:55:28+08:00 daily https://www.pharmasources.com/industryinsights/lilly-files-new-class-migraine-drug-with-306914.html 0.6 2026-06-29T06:45:28+08:00 daily https://www.pharmasources.com/industryinsights/chinas-beigene-delays-us-filing-for-riva-306915.html 0.6 2026-06-22T00:05:51+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-tool-aims-to-cut-stress-306916.html 0.6 2026-01-13T00:25:49+08:00 daily https://www.pharmasources.com/industryinsights/hca-opens-search-for-new-chairperson-306917.html 0.6 2026-06-21T23:48:49+08:00 daily https://www.pharmasources.com/industryinsights/gene-edited-babies-immune-to-hiv-a-discu-306918.html 0.6 2026-07-27T13:23:22+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-ceo-lifts-veil-on-light-306919.html 0.6 2026-06-21T22:59:45+08:00 daily https://www.pharmasources.com/industryinsights/nejm-article-ana-challenge-sticker-price-306920.html 0.6 2026-06-21T07:10:08+08:00 daily https://www.pharmasources.com/industryinsights/online-health-info-seekers-struggle-with-306921.html 0.6 2026-06-22T21:05:07+08:00 daily https://www.pharmasources.com/industryinsights/astellas-xospata-wins-aml-approval-with--306922.html 0.6 2026-07-20T20:01:10+08:00 daily https://www.pharmasources.com/industryinsights/catalysts-long-delayed-firdapse-snags-fd-306923.html 0.6 2026-07-01T12:56:24+08:00 daily https://www.pharmasources.com/industryinsights/philadelphia-looks-to-register-pharma-re-306924.html 0.6 2026-06-21T13:03:31+08:00 daily https://www.pharmasources.com/industryinsights/bms-sponsors-tv-host-robin-roberts-docus-306925.html 0.6 2026-08-04T00:03:52+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-semaglutide-is-headed-towa-306926.html 0.6 2026-06-22T22:04:55+08:00 daily https://www.pharmasources.com/industryinsights/ucbs-new-app-uses-voice-ai-to-help-parki-306927.html 0.6 2026-06-21T09:00:58+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-orilissa-scores-double-uterine-f-306928.html 0.6 2026-06-21T01:51:38+08:00 daily https://www.pharmasources.com/industryinsights/ucb-roche-lead-new-investments-in-uks-li-306929.html 0.6 2026-07-03T04:19:06+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-sema4-mount-sinai-collaborate-on--306930.html 0.6 2026-06-21T12:17:31+08:00 daily https://www.pharmasources.com/industryinsights/mayo-clinic-researchers-identify-new-str-306931.html 0.6 2026-08-07T19:42:16+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-presents-new-data-for-lenti-306932.html 0.6 2026-06-22T21:02:12+08:00 daily https://www.pharmasources.com/industryinsights/celyad-presents-update-on-cyad-01-hemato-306933.html 0.6 2026-06-21T15:42:03+08:00 daily https://www.pharmasources.com/industryinsights/roches-marketing-application-for-tecentr-306934.html 0.6 2026-08-04T10:53:16+08:00 daily https://www.pharmasources.com/industryinsights/analyst-answers-what-lies-ahead-for-mali-306935.html 0.6 2026-06-20T19:58:35+08:00 daily https://www.pharmasources.com/industryinsights/novo-keeps-adding-capacity-and-jobs-to-i-306936.html 0.6 2026-08-06T22:16:58+08:00 daily https://www.pharmasources.com/industryinsights/chinese-drugmaker-pours-145m-into-plant--306937.html 0.6 2026-06-21T04:15:11+08:00 daily https://www.pharmasources.com/industryinsights/mismanagement-allegations-send-sun-pharm-306938.html 0.6 2026-06-22T08:44:50+08:00 daily https://www.pharmasources.com/industryinsights/takeda-ceo-gets-his-shire-megamerger-tha-306939.html 0.6 2026-06-22T03:55:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-calquence-found-success-in--306940.html 0.6 2026-06-30T21:54:26+08:00 daily https://www.pharmasources.com/industryinsights/taking-aim-at-medicaid-misclassification-306941.html 0.6 2026-06-21T05:15:55+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-merges-biology-and-tech-with-rese-306942.html 0.6 2026-06-20T16:47:32+08:00 daily https://www.pharmasources.com/industryinsights/roche-aims-for-kadcyla-expansion-with-ne-306943.html 0.6 2026-06-21T08:00:12+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-hesitance-domestic-scandal-and-co-306944.html 0.6 2026-06-22T06:44:03+08:00 daily https://www.pharmasources.com/industryinsights/anti-vaccine-sentiment-causing-deaths-su-306945.html 0.6 2026-06-20T17:52:24+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-signs-on-as-sponsor-306946.html 0.6 2026-06-22T05:51:38+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-semaglutide-is-headed-towa-306947.html 0.6 2026-06-20T15:57:37+08:00 daily https://www.pharmasources.com/industryinsights/online-health-info-seekers-struggle-with-306948.html 0.6 2026-06-22T04:11:59+08:00 daily https://www.pharmasources.com/industryinsights/takeda-ex-chairman-speaks-out-against-sh-306949.html 0.6 2026-06-20T22:57:47+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-strikes-back-filing-la-306950.html 0.6 2026-06-20T21:06:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-device-designati-306951.html 0.6 2026-07-09T05:41:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-wins-blockbuster-lyrica-patent-ex-306952.html 0.6 2026-07-03T17:17:48+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-taps-unilever-as-lead-bi-306953.html 0.6 2026-06-21T09:51:34+08:00 daily https://www.pharmasources.com/industryinsights/valsartan-recall-expands-to-mylan-teva-p-306954.html 0.6 2026-06-21T16:16:31+08:00 daily https://www.pharmasources.com/industryinsights/takeda-receives-shareholders-approval-to-306955.html 0.6 2026-06-22T14:33:29+08:00 daily https://www.pharmasources.com/industryinsights/the-top-3-house-democrat-leaders-have-po-306956.html 0.6 2026-06-21T10:18:28+08:00 daily https://www.pharmasources.com/industryinsights/astellas-xospata-wins-fda-nod-in-aml-wit-306957.html 0.6 2026-06-21T08:52:19+08:00 daily https://www.pharmasources.com/industryinsights/ucb-to-invest-1bn-in-the-uk-life-science-306958.html 0.6 2026-06-22T04:49:37+08:00 daily https://www.pharmasources.com/industryinsights/new-parkinsons-disease-drug-target-revea-306959.html 0.6 2026-06-21T01:05:46+08:00 daily https://www.pharmasources.com/industryinsights/eusa-pharma-appoints-president-of-us-ope-306960.html 0.6 2026-06-23T12:46:09+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-phase-3-study-shows-efficacy-an-306961.html 0.6 2026-06-21T06:08:13+08:00 daily https://www.pharmasources.com/industryinsights/tris-pharma-issues-recall-of-infants-ibu-306962.html 0.6 2026-06-21T05:38:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-reaches-a-global-agreement-with-a-306963.html 0.6 2026-08-03T23:10:07+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-and-ipsen-initiate-phase-3-pivo-306964.html 0.6 2026-06-20T09:55:50+08:00 daily https://www.pharmasources.com/industryinsights/j-shaped-association-for-sleep-duration--306965.html 0.6 2026-06-21T01:03:44+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-linked-to-colorectal-can-306966.html 0.6 2026-06-21T22:57:43+08:00 daily https://www.pharmasources.com/industryinsights/cannabis-based-compound-may-reduce-seizu-306967.html 0.6 2026-06-21T14:47:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-rare-stroke-risk-with-multi-306968.html 0.6 2026-04-05T05:03:33+08:00 daily https://www.pharmasources.com/industryinsights/sabcs-delaying-chemo-lowers-survival-in--306969.html 0.6 2026-06-21T12:58:37+08:00 daily https://www.pharmasources.com/industryinsights/new-potential-breast-cancer-drug-identif-306970.html 0.6 2026-06-20T19:59:36+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-baby-born-via-womb-transpla-306971.html 0.6 2026-07-09T19:57:08+08:00 daily https://www.pharmasources.com/industryinsights/trastuzumab-taken-with-carvedilol-leads--306972.html 0.6 2026-06-21T04:55:16+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-katherine-trial-crossed-early--306973.html 0.6 2026-06-21T10:55:00+08:00 daily https://www.pharmasources.com/industryinsights/infections-linked-to-increased-later-ris-306974.html 0.6 2026-06-21T11:08:13+08:00 daily https://www.pharmasources.com/industryinsights/scans-ultrasound-spot-zika-brain-defects-306975.html 0.6 2026-06-21T14:55:20+08:00 daily https://www.pharmasources.com/industryinsights/too-much-time-in-the-sun-skin-patch-migh-306976.html 0.6 2026-06-23T05:16:06+08:00 daily https://www.pharmasources.com/industryinsights/botox-may-help-prevent-post-op-a-fib-306977.html 0.6 2026-08-07T13:32:57+08:00 daily https://www.pharmasources.com/industryinsights/novartis-takes-xolair-follow-up-into-pha-306978.html 0.6 2026-06-22T00:53:46+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-axes-biosimilars-de-306979.html 0.6 2026-06-21T04:53:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-okays-ucbs-cimzia-nixes-almiralls-i-306980.html 0.6 2026-08-05T15:14:21+08:00 daily https://www.pharmasources.com/industryinsights/digital-health-market-to-top-379bn-by-20-306981.html 0.6 2026-06-20T21:47:52+08:00 daily https://www.pharmasources.com/industryinsights/gilead-pushes-on-with-nash-drug-after-ph-306982.html 0.6 2026-06-20T13:20:35+08:00 daily https://www.pharmasources.com/industryinsights/new-vaccines-centre-a-major-commercial-o-306983.html 0.6 2026-08-07T12:22:37+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-pays-300m-to-develop-cus-306984.html 0.6 2026-06-20T21:19:20+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-offer-new-non-invasive-procedure--306985.html 0.6 2026-06-24T10:59:38+08:00 daily https://www.pharmasources.com/industryinsights/open-health-merges-with-peloton-advantag-306986.html 0.6 2026-07-04T00:18:14+08:00 daily https://www.pharmasources.com/industryinsights/roches-hemlibra-shows-sustained-bleed-co-306987.html 0.6 2026-06-21T23:52:04+08:00 daily https://www.pharmasources.com/industryinsights/janssen-unveils-new-data-backing-wider-u-306988.html 0.6 2026-06-21T07:59:01+08:00 daily https://www.pharmasources.com/industryinsights/shields-feraccru-accepted-for-review-in--306989.html 0.6 2026-02-26T18:23:52+08:00 daily https://www.pharmasources.com/industryinsights/new-cancer-drugs-taking-longer-to-reach--306990.html 0.6 2026-06-21T10:50:06+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sma-therapy-gets-us-priority-re-306991.html 0.6 2026-08-05T20:36:29+08:00 daily https://www.pharmasources.com/industryinsights/new-uk-health-data-research-alliance-to--306992.html 0.6 2026-06-21T01:01:53+08:00 daily https://www.pharmasources.com/industryinsights/uk-cancer-patients-waiting-months-for-ac-306993.html 0.6 2026-06-21T14:52:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-breakthrough-designation-for-bayer-a-306994.html 0.6 2026-06-20T22:57:44+08:00 daily https://www.pharmasources.com/industryinsights/as-amazon-takes-page-from-pharmas-ehr-pl-306995.html 0.6 2026-06-21T00:14:01+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-inks-research-deal-to-create-digi-306996.html 0.6 2026-06-20T15:55:34+08:00 daily https://www.pharmasources.com/industryinsights/roche-unveils-data-for-kadcyla-move-into-306997.html 0.6 2026-06-21T15:58:20+08:00 daily https://www.pharmasources.com/industryinsights/feds-to-back-merck-at-supreme-court-in-f-306998.html 0.6 2026-07-06T21:48:29+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-crosses-the-finish-li-306999.html 0.6 2026-06-20T23:59:38+08:00 daily https://www.pharmasources.com/industryinsights/jj-merck-chip-in-for-100m-uk-vaccine-cen-307000.html 0.6 2026-06-22T01:50:32+08:00 daily https://www.pharmasources.com/industryinsights/jj-makes-xarelto-case-for-clot-preventio-307001.html 0.6 2026-06-21T00:00:36+08:00 daily https://www.pharmasources.com/industryinsights/jjs-fast-growing-darzalex-lines-up-for-2-307002.html 0.6 2026-07-09T10:27:37+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-adcetris-posts-double-s-307003.html 0.6 2026-06-20T23:01:39+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-halts-late-stage-tahoe-study-of-r-307004.html 0.6 2026-06-20T15:56:23+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-closes-675-million-ser-307005.html 0.6 2026-06-21T13:05:28+08:00 daily https://www.pharmasources.com/industryinsights/axovant-announces-feedback-from-fda-meet-307006.html 0.6 2026-06-21T12:09:14+08:00 daily https://www.pharmasources.com/industryinsights/a-third-of-doctors-considering-leaving-c-307007.html 0.6 2026-06-21T10:20:47+08:00 daily https://www.pharmasources.com/industryinsights/shire-purchase-backed-by-takeda-sharehol-307008.html 0.6 2026-06-20T18:47:28+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-pays-300m-to-develop-cus-307009.html 0.6 2026-08-07T22:41:12+08:00 daily https://www.pharmasources.com/industryinsights/roches-kadcyla-cuts-risk-of-breast-cance-307010.html 0.6 2026-06-20T14:37:38+08:00 daily https://www.pharmasources.com/industryinsights/first-alzheimers-drug-from-eisaiucl-alli-307011.html 0.6 2026-06-21T10:03:06+08:00 daily https://www.pharmasources.com/industryinsights/norgine-launches-shields-feraccru-in-the-307012.html 0.6 2026-06-21T03:53:40+08:00 daily https://www.pharmasources.com/industryinsights/ucb-to-invest-1bn-into-uk-under-life-sci-307013.html 0.6 2026-06-22T11:56:48+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-wins-scrip-award-for-best-307014.html 0.6 2026-07-21T05:03:10+08:00 daily https://www.pharmasources.com/industryinsights/statins-overprescribed-for-primary-preve-307015.html 0.6 2026-06-20T17:00:15+08:00 daily https://www.pharmasources.com/industryinsights/gsk-reaches-agreement-to-acquire-tesaro--307016.html 0.6 2026-06-22T06:48:57+08:00 daily https://www.pharmasources.com/industryinsights/ucb-to-invest-1-billion-into-uk-rd-307017.html 0.6 2026-06-21T04:55:39+08:00 daily https://www.pharmasources.com/industryinsights/british-researchers-sequences-100000-who-307018.html 0.6 2026-08-07T08:41:42+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-cut-12000-jobs-by-2025-307019.html 0.6 2026-06-20T14:20:04+08:00 daily https://www.pharmasources.com/industryinsights/takeda-shareholders-approve-62bn-shire-a-307020.html 0.6 2026-07-17T12:56:04+08:00 daily https://www.pharmasources.com/industryinsights/five-more-countries-to-join-ema-fda-mutu-307021.html 0.6 2026-08-04T04:56:55+08:00 daily https://www.pharmasources.com/industryinsights/pet-tracer-able-to-image-tau-in-alzheime-307022.html 0.6 2026-06-21T20:03:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-announce-cull-of-670-french-jobs-307023.html 0.6 2026-06-21T05:13:58+08:00 daily https://www.pharmasources.com/industryinsights/amgen-unveils-double-whammy-of-data-for--307024.html 0.6 2026-06-22T12:59:19+08:00 daily https://www.pharmasources.com/industryinsights/new-diagnostic-test-can-detect-any-cance-307025.html 0.6 2026-06-22T18:17:16+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-announces-first-of-its-kin-307026.html 0.6 2026-06-20T23:04:45+08:00 daily https://www.pharmasources.com/industryinsights/roches-first-line-tecentriq-combo-scores-307027.html 0.6 2026-08-07T19:18:55+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-significantly-reduces-disease-p-307028.html 0.6 2026-08-10T00:59:27+08:00 daily https://www.pharmasources.com/industryinsights/hemlibra-shows-clinically-meaningful-ble-307029.html 0.6 2026-06-20T23:03:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-biosimilar-proves-non-inferior-t-307030.html 0.6 2026-06-27T19:05:28+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-cimzia-but-blocks-ilumetri-307031.html 0.6 2026-06-21T04:10:50+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-completes-inspection-of-lupins-ma-307032.html 0.6 2026-08-08T08:17:33+08:00 daily https://www.pharmasources.com/industryinsights/datwyler-starts-commercial-production-at-307033.html 0.6 2026-06-21T12:12:20+08:00 daily https://www.pharmasources.com/industryinsights/sun-gets-dermatology-portfolio-2-plants--307034.html 0.6 2026-07-02T19:33:23+08:00 daily https://www.pharmasources.com/industryinsights/pharma-caps-uks-branded-drug-spend-growt-307035.html 0.6 2026-07-31T01:11:09+08:00 daily https://www.pharmasources.com/industryinsights/step-off-our-doughnut-hole-deal-aarp-ads-307036.html 0.6 2026-07-20T22:10:19+08:00 daily https://www.pharmasources.com/industryinsights/halaven-maker-eisai-launches-metastatic--307037.html 0.6 2026-06-21T02:12:51+08:00 daily https://www.pharmasources.com/industryinsights/former-aveo-cfo-found-guilty-of-misleadi-307038.html 0.6 2026-06-20T17:15:33+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-like-me-survey-finds-older-peop-307039.html 0.6 2026-04-02T01:48:06+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-announced-exclusive-disco-307040.html 0.6 2026-06-20T15:13:17+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-shares-swoon-as-pharma-g-307041.html 0.6 2026-06-22T04:50:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-plots-innovative-payment-models-307042.html 0.6 2026-06-23T07:53:32+08:00 daily https://www.pharmasources.com/industryinsights/on-a-roll-with-fda-approvals-pfizer-doub-307043.html 0.6 2026-06-20T21:08:48+08:00 daily https://www.pharmasources.com/industryinsights/make-that-four-drug-approvals-for-pfizer-307044.html 0.6 2026-06-21T21:49:53+08:00 daily https://www.pharmasources.com/industryinsights/takeda-shire-votes-jj-legend-and-morefie-307045.html 0.6 2026-06-21T10:11:13+08:00 daily https://www.pharmasources.com/industryinsights/nice-give-go-ahead-to-gileads-yescarta-f-307046.html 0.6 2026-06-22T02:05:46+08:00 daily https://www.pharmasources.com/industryinsights/ucb-to-invest-1-billion-into-uk-rd-307047.html 0.6 2026-06-25T17:19:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-roches-tec-307048.html 0.6 2026-06-20T18:07:30+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-to-spin-off-its-speciality--307049.html 0.6 2026-08-07T03:33:54+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-head-and-neck-cancer-treatm-307050.html 0.6 2026-08-09T11:00:59+08:00 daily https://www.pharmasources.com/industryinsights/mas-glaxosmithkline-takeda-procter-gambl-307051.html 0.6 2026-08-07T03:12:38+08:00 daily https://www.pharmasources.com/industryinsights/suda-and-zelda-partner-to-develop-medica-307052.html 0.6 2026-08-07T03:03:47+08:00 daily https://www.pharmasources.com/industryinsights/mereo-biopharma-to-merge-with-oncomed-ph-307053.html 0.6 2026-06-21T06:14:56+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018121-307054.html 0.6 2026-08-07T02:52:15+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-halts-phase-iii-tahoe-trial-of-ro-307055.html 0.6 2026-06-20T14:58:06+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-gets-fda-priority-revie-307056.html 0.6 2026-08-09T02:39:49+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-ucl-deepen-drug-discovery-alli-307057.html 0.6 2026-06-21T12:39:24+08:00 daily https://www.pharmasources.com/industryinsights/mereo-biopharma-and-oncomed-propose-merg-307058.html 0.6 2026-06-21T12:09:22+08:00 daily https://www.pharmasources.com/industryinsights/mylan-recalls-all-lots-of-blood-pressure-307059.html 0.6 2026-06-20T16:17:48+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-to-split-business-307060.html 0.6 2026-06-21T21:11:51+08:00 daily https://www.pharmasources.com/industryinsights/az-imfinzi-fails-in-head-and-neck-cancer-307061.html 0.6 2026-08-07T12:35:31+08:00 daily https://www.pharmasources.com/industryinsights/mit-engineers-repurpose-wasp-venom-as-an-307062.html 0.6 2026-04-05T18:19:51+08:00 daily https://www.pharmasources.com/industryinsights/novartis-consistently-improved-pfs-in-pa-307063.html 0.6 2026-08-09T13:09:08+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-provides-update-on-the-phase-307064.html 0.6 2026-08-07T12:04:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-atezolizumab-with-chemother-307065.html 0.6 2026-08-06T22:08:00+08:00 daily https://www.pharmasources.com/industryinsights/mylan-expands-its-voluntary-nationwide-r-307066.html 0.6 2026-08-06T21:54:35+08:00 daily https://www.pharmasources.com/industryinsights/baxter-oasmia-ink-apealea-commercial-mfg-307067.html 0.6 2026-08-06T20:06:05+08:00 daily https://www.pharmasources.com/industryinsights/bio-thera-solutions-initiates-phase-i-cl-307068.html 0.6 2026-08-07T05:37:24+08:00 daily https://www.pharmasources.com/industryinsights/bluerock-mcewen-stem-cell-institute-expa-307069.html 0.6 2026-08-07T05:45:56+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-tanabe-pharma-america-announc-307070.html 0.6 2026-08-07T05:48:49+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-announces-fda-filing-for-orpha-307071.html 0.6 2026-08-07T05:52:43+08:00 daily https://www.pharmasources.com/industryinsights/ablexis-announces-licensing-agreement-wi-307072.html 0.6 2026-02-15T10:32:54+08:00 daily https://www.pharmasources.com/industryinsights/biogen-exercises-option-with-ionis-to-de-307073.html 0.6 2026-06-20T14:54:02+08:00 daily https://www.pharmasources.com/industryinsights/intellia-therapeutics-and-novartis-expan-307074.html 0.6 2026-07-04T22:39:44+08:00 daily https://www.pharmasources.com/industryinsights/break-a-sweat-over-the-holidays-but-do-i-307075.html 0.6 2026-06-22T05:05:44+08:00 daily https://www.pharmasources.com/industryinsights/azs-cancer-drug-fails-again-roches-rival-307076.html 0.6 2026-03-05T05:17:44+08:00 daily https://www.pharmasources.com/industryinsights/most-insured-patients-not-using-online-p-307077.html 0.6 2026-03-03T02:41:56+08:00 daily https://www.pharmasources.com/industryinsights/lower-rn-staffing-linked-to-increased-in-307078.html 0.6 2026-06-21T04:13:02+08:00 daily https://www.pharmasources.com/industryinsights/ultrarestrictive-opioid-rx-protocol-cuts-307079.html 0.6 2026-06-20T23:01:39+08:00 daily https://www.pharmasources.com/industryinsights/supernus-says-adhd-drug-trounces-rivals--307080.html 0.6 2026-06-21T20:13:06+08:00 daily https://www.pharmasources.com/industryinsights/awards-for-ai-based-drug-rd-continue-for-307081.html 0.6 2026-06-21T12:57:48+08:00 daily https://www.pharmasources.com/industryinsights/increasing-dose-of-statins-could-save-mo-307082.html 0.6 2026-08-06T21:54:20+08:00 daily https://www.pharmasources.com/industryinsights/nearly-300-gene-and-cell-therapies-in-de-307083.html 0.6 2026-07-06T22:30:20+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-suffers-fresh-setback-with-lung-c-307084.html 0.6 2026-06-21T23:06:00+08:00 daily https://www.pharmasources.com/industryinsights/new-ai-tech-could-outperform-humans-in-m-307085.html 0.6 2026-07-06T22:46:16+08:00 daily https://www.pharmasources.com/industryinsights/oxybutynin-improves-quality-of-life-for--307086.html 0.6 2026-06-20T18:54:33+08:00 daily https://www.pharmasources.com/industryinsights/after-delayed-ipo-mereo-gets-us-listing--307087.html 0.6 2026-06-22T06:59:50+08:00 daily https://www.pharmasources.com/industryinsights/big-pharmas-off-patent-drugs-lose-out-in-307088.html 0.6 2026-06-23T19:03:27+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-pharma-inks-distribution-pac-307089.html 0.6 2026-06-20T20:00:02+08:00 daily https://www.pharmasources.com/industryinsights/eisai-ucl-commence-phase-i-clinical-stud-307090.html 0.6 2026-08-05T23:18:37+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-wins-key-lung-cancer-ap-307091.html 0.6 2026-08-01T12:02:08+08:00 daily https://www.pharmasources.com/industryinsights/troubled-mallinckrodt-spins-off-specialt-307092.html 0.6 2026-07-05T03:13:45+08:00 daily https://www.pharmasources.com/industryinsights/actelion-inks-360m-deal-to-wrap-doj-kick-307093.html 0.6 2026-06-28T08:23:26+08:00 daily https://www.pharmasources.com/industryinsights/big-pharma-loses-out-in-chinas-latest-pr-307094.html 0.6 2026-07-20T20:00:44+08:00 daily https://www.pharmasources.com/industryinsights/akorn-fights-to-salvage-fresenius-deal-i-307095.html 0.6 2026-06-21T23:48:48+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-preps-early-2019-launch-for-epipe-307096.html 0.6 2026-06-21T17:43:35+08:00 daily https://www.pharmasources.com/industryinsights/novartis-aiming-to-keep-xolair-sales-pus-307097.html 0.6 2026-06-24T07:36:25+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-plots-670-layoffs-in-france-as-lo-307098.html 0.6 2026-06-20T21:10:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-priority-tag-sets-roches-tecentriq-u-307099.html 0.6 2026-07-23T23:28:09+08:00 daily https://www.pharmasources.com/industryinsights/us-court-affirms-decision-to-permit-fres-307100.html 0.6 2025-11-28T15:19:30+08:00 daily https://www.pharmasources.com/industryinsights/akorn-ceo-raj-rai-resigns-after-us-court-307101.html 0.6 2026-06-20T15:55:30+08:00 daily https://www.pharmasources.com/industryinsights/uk-warns-that-no-deal-brexit-could-lead--307102.html 0.6 2026-06-21T07:37:31+08:00 daily https://www.pharmasources.com/industryinsights/nhs-risks-losing-revenue-without-data-st-307103.html 0.6 2026-06-21T06:02:45+08:00 daily https://www.pharmasources.com/industryinsights/roches-daniel-oday-to-become-gileads-chi-307104.html 0.6 2026-07-22T11:20:29+08:00 daily https://www.pharmasources.com/industryinsights/ai-app-decreases-symptoms-of-copd-study--307105.html 0.6 2026-08-05T22:14:28+08:00 daily https://www.pharmasources.com/industryinsights/smc-accepts-four-medicines-for-nhs-use-307106.html 0.6 2026-07-04T03:24:55+08:00 daily https://www.pharmasources.com/industryinsights/health-secretary-orders-review-overpresc-307107.html 0.6 2026-06-20T14:33:07+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-uk-names-new-managing-director-307108.html 0.6 2026-08-08T09:54:21+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-and-astrazeneca-launch-g-307109.html 0.6 2026-08-08T17:10:59+08:00 daily https://www.pharmasources.com/industryinsights/pharma-calls-for-more-detail-on-plan-for-307110.html 0.6 2026-07-01T06:50:40+08:00 daily https://www.pharmasources.com/industryinsights/cepi-imperial-college-partner-for-emergi-307111.html 0.6 2026-08-07T15:21:00+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-opdivoyervoy-combo-for-k-307112.html 0.6 2026-08-09T17:56:10+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-partners-up-with-cruk-for-ne-307113.html 0.6 2026-06-21T04:19:59+08:00 daily https://www.pharmasources.com/industryinsights/children-being-treated-for-problems-with-307114.html 0.6 2026-06-22T04:47:50+08:00 daily https://www.pharmasources.com/industryinsights/trump-administration-block-nih-researche-307115.html 0.6 2026-06-21T19:00:40+08:00 daily https://www.pharmasources.com/industryinsights/activist-investor-elliotts-latest-target-307116.html 0.6 2026-06-20T14:50:08+08:00 daily https://www.pharmasources.com/industryinsights/akorns-ceo-bows-out-after-failing-last-d-307117.html 0.6 2026-06-21T04:05:48+08:00 daily https://www.pharmasources.com/industryinsights/lonza-building-biologics-facility-in-chi-307118.html 0.6 2026-06-21T06:57:53+08:00 daily https://www.pharmasources.com/industryinsights/global-coalition-backs-imperial-college--307119.html 0.6 2026-07-02T19:20:40+08:00 daily https://www.pharmasources.com/industryinsights/generics-cartel-probe-expands-to-a-whopp-307120.html 0.6 2026-07-23T17:41:31+08:00 daily https://www.pharmasources.com/industryinsights/gilead-looking-for-cancer-sales-swipes-r-307121.html 0.6 2026-06-21T01:54:36+08:00 daily https://www.pharmasources.com/industryinsights/x-marks-the-spot-merz-rolls-new-xeomin-b-307122.html 0.6 2026-06-21T04:42:49+08:00 daily https://www.pharmasources.com/industryinsights/gilead-appoints-current-roche-pharmaceut-307123.html 0.6 2026-08-03T10:56:57+08:00 daily https://www.pharmasources.com/industryinsights/roches-lung-cancer-combo-treatment-wins--307124.html 0.6 2026-06-22T12:10:10+08:00 daily https://www.pharmasources.com/industryinsights/cepi-and-imperial-college-london-collabo-307125.html 0.6 2026-06-20T18:12:33+08:00 daily https://www.pharmasources.com/industryinsights/delaware-supreme-court-allows-fresenius--307126.html 0.6 2026-06-21T15:10:50+08:00 daily https://www.pharmasources.com/industryinsights/merck-partners-with-cyclica-for-ai-based-307127.html 0.6 2026-06-25T18:23:26+08:00 daily https://www.pharmasources.com/industryinsights/vanda-announces-positive-study-results-f-307128.html 0.6 2026-02-24T02:59:06+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-cancer-research-uk-launch-fu-307129.html 0.6 2026-06-21T17:01:24+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-announces-positive-results-from-307130.html 0.6 2026-06-21T10:52:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-l-307131.html 0.6 2026-06-24T02:18:32+08:00 daily https://www.pharmasources.com/industryinsights/stealth-biotherapeutics-granted-fast-tra-307132.html 0.6 2026-06-22T05:15:56+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-establish-strategic-biomanufact-307133.html 0.6 2026-07-19T13:01:20+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-fails-to-meet-main--307134.html 0.6 2026-06-28T15:10:24+08:00 daily https://www.pharmasources.com/industryinsights/lupins-pithampur-unit-3-receives-eir-fro-307135.html 0.6 2026-06-29T00:22:25+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmaceuticals-gets-us-fda-nod--307136.html 0.6 2026-07-09T18:02:46+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biotherapeutics-expands-strategic-307137.html 0.6 2026-06-22T02:46:41+08:00 daily https://www.pharmasources.com/industryinsights/tap-water-in-neti-pot-linked-to-womans-d-307138.html 0.6 2026-06-21T03:05:50+08:00 daily https://www.pharmasources.com/industryinsights/hospital-discharge-at-christmastime-may--307139.html 0.6 2026-06-21T05:05:46+08:00 daily https://www.pharmasources.com/industryinsights/how-puzzles-games-might-help-your-aging--307140.html 0.6 2026-06-22T00:09:52+08:00 daily https://www.pharmasources.com/industryinsights/hit-related-stress-linked-to-burnout-amo-307141.html 0.6 2026-06-21T14:53:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-mobile-medical-app-to-help-th-307142.html 0.6 2026-07-03T20:50:59+08:00 daily https://www.pharmasources.com/industryinsights/higher-risk-for-breast-cancer-after-chil-307143.html 0.6 2026-06-21T21:02:41+08:00 daily https://www.pharmasources.com/industryinsights/veterans-health-administration-hospitals-307144.html 0.6 2026-06-22T08:59:45+08:00 daily https://www.pharmasources.com/industryinsights/fishawack-acquires-marketing-consultancy-307145.html 0.6 2026-06-21T21:58:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-frontotemporal-dementia-drug--307146.html 0.6 2026-06-22T07:56:49+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-links-with-ai-firm-to-iron-ou-307147.html 0.6 2026-02-28T15:00:56+08:00 daily https://www.pharmasources.com/industryinsights/risk-up-for-later-born-siblings-of-child-307148.html 0.6 2026-04-15T10:33:17+08:00 daily https://www.pharmasources.com/industryinsights/sporting-events-dangerous-for-spectators-307149.html 0.6 2026-06-24T10:38:16+08:00 daily https://www.pharmasources.com/industryinsights/aha-sleep-apnea-may-double-odds-for-high-307150.html 0.6 2026-06-21T08:17:13+08:00 daily https://www.pharmasources.com/industryinsights/az-and-cruk-team-up-to-go-all-in-on-cris-307151.html 0.6 2026-06-20T22:54:38+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-warned-over-no-deal-bre-307152.html 0.6 2026-06-22T02:56:45+08:00 daily https://www.pharmasources.com/industryinsights/moderna-shares-slide-after-record-604m-u-307153.html 0.6 2026-07-02T19:10:55+08:00 daily https://www.pharmasources.com/industryinsights/genecentric-therapeutics-enters-bladder--307154.html 0.6 2026-06-21T08:53:11+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-mitsubishi-tanabe-pharma-ente-307155.html 0.6 2026-06-21T01:10:55+08:00 daily https://www.pharmasources.com/industryinsights/roivant-wins-200m-backing-to-expand-rd-o-307156.html 0.6 2026-06-21T07:14:03+08:00 daily https://www.pharmasources.com/industryinsights/merck-co-begins-us-filing-of-ebola-vacci-307157.html 0.6 2026-06-21T05:00:47+08:00 daily https://www.pharmasources.com/industryinsights/nature-review-current-situation-of-the-g-307158.html 0.6 2026-06-20T13:52:01+08:00 daily https://www.pharmasources.com/industryinsights/eyeing-novartis-deal-akcea-trumpets-lipo-307159.html 0.6 2026-07-05T19:53:27+08:00 daily https://www.pharmasources.com/industryinsights/az-sells-rights-to-rsv-virus-drug-to-sob-307160.html 0.6 2026-07-04T08:07:44+08:00 daily https://www.pharmasources.com/industryinsights/jj-merck-chip-in-for-100m-uk-vaccine-cen-307161.html 0.6 2026-07-17T07:12:03+08:00 daily https://www.pharmasources.com/industryinsights/citing-low-vaccine-trust-experts-warn-of-307162.html 0.6 2026-07-30T20:49:35+08:00 daily https://www.pharmasources.com/industryinsights/anti-vaccine-sentiment-causing-first-dea-307163.html 0.6 2026-06-23T01:57:11+08:00 daily https://www.pharmasources.com/industryinsights/why-chinas-flu-vaccine-supply-is-sufferi-307164.html 0.6 2026-06-26T03:29:51+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-weighs-bexseros-promise--307165.html 0.6 2026-06-20T14:53:09+08:00 daily https://www.pharmasources.com/industryinsights/emergent-and-valnevas-zika-vaccine-clear-307166.html 0.6 2026-06-21T01:50:34+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-controversial-dengvaxia-picks-up-307167.html 0.6 2026-06-22T06:10:50+08:00 daily https://www.pharmasources.com/industryinsights/us-vaccination-rates-in-children-keep-dr-307168.html 0.6 2026-06-21T09:01:06+08:00 daily https://www.pharmasources.com/industryinsights/first-us-cuba-biotech-jv-to-bring-cuban--307169.html 0.6 2026-06-20T22:09:01+08:00 daily https://www.pharmasources.com/industryinsights/ema-gsk-blast-bmjs-flawed-pandemrix-safe-307170.html 0.6 2026-07-17T17:27:07+08:00 daily https://www.pharmasources.com/industryinsights/important-pipelines-in-development-of-th-307171.html 0.6 2026-06-22T21:47:48+08:00 daily https://www.pharmasources.com/industryinsights/nature-review-market-forecast-of-the-glo-307172.html 0.6 2026-07-20T03:48:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-sandoz-pear-therapeutics-pres-307173.html 0.6 2026-06-20T20:18:02+08:00 daily https://www.pharmasources.com/industryinsights/merck-co-says-global-human-health-presid-307174.html 0.6 2026-06-29T06:33:52+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-to-cut-10-percent-o-307175.html 0.6 2026-05-31T18:28:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-prescription-mobile-a-307176.html 0.6 2026-06-20T20:01:36+08:00 daily https://www.pharmasources.com/industryinsights/generics-firms-investigated-for-their-in-307177.html 0.6 2026-06-21T08:08:04+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-achieves-breakthrough-tit-307178.html 0.6 2026-06-21T09:46:17+08:00 daily https://www.pharmasources.com/industryinsights/who-confirm-tanzania-fda-as-africas-firs-307179.html 0.6 2026-05-31T18:46:36+08:00 daily https://www.pharmasources.com/industryinsights/boehringers-france-restructure-will-cull-307180.html 0.6 2026-06-20T14:52:01+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-palbociclib-most-commonly-used-b-307181.html 0.6 2026-03-22T03:39:44+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-chief-figures-amazon-cou-307182.html 0.6 2026-08-09T16:06:20+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-shingrix-shortage-expec-307183.html 0.6 2026-06-22T09:40:28+08:00 daily https://www.pharmasources.com/industryinsights/merck-promotes-oncology-vaccine-executiv-307184.html 0.6 2026-06-21T04:08:51+08:00 daily https://www.pharmasources.com/industryinsights/as-competition-heats-up-us-prices-for-re-307185.html 0.6 2026-06-20T21:00:06+08:00 daily https://www.pharmasources.com/industryinsights/delivering-a-baby-increases-then-lowers--307186.html 0.6 2026-06-30T17:41:38+08:00 daily https://www.pharmasources.com/industryinsights/chinas-zhejiang-huahai-lambasted-in-fda--307187.html 0.6 2026-06-21T00:57:48+08:00 daily https://www.pharmasources.com/industryinsights/new-zealand-moves-towards-legalising-med-307188.html 0.6 2026-06-20T18:01:19+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-and-vedanta-to-study-combi-307189.html 0.6 2026-06-22T03:53:45+08:00 daily https://www.pharmasources.com/industryinsights/these-20-women-are-2018s-fiercest-in-the-307190.html 0.6 2026-07-18T05:32:22+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-and-e-therapeutics-alliance-307191.html 0.6 2026-07-03T20:32:25+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-chops-295-jobs-in-f-307192.html 0.6 2026-06-23T03:28:21+08:00 daily https://www.pharmasources.com/industryinsights/astellas-launches-xospata-for-relapsedre-307193.html 0.6 2026-06-21T05:13:54+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-darmstadt-germany-announces-o-307194.html 0.6 2026-06-21T03:00:41+08:00 daily https://www.pharmasources.com/industryinsights/onconova-appoints-corporate-development--307195.html 0.6 2026-06-21T13:03:30+08:00 daily https://www.pharmasources.com/industryinsights/cadila-healthcare-arm-gets-usfda-nod-for-307196.html 0.6 2026-08-07T00:40:09+08:00 daily https://www.pharmasources.com/industryinsights/executive-moves-at-roche-307197.html 0.6 2026-06-20T23:51:40+08:00 daily https://www.pharmasources.com/industryinsights/avacta-lg-chem-announce-collaboration-307198.html 0.6 2026-04-06T09:12:48+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-establish-bio-mfg-base-in-china-307199.html 0.6 2026-08-07T00:39:38+08:00 daily https://www.pharmasources.com/industryinsights/rho-adds-regulatory-strategy-and-submiss-307200.html 0.6 2026-08-07T00:01:56+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-to-distribute-norspan-in-jap-307201.html 0.6 2026-08-07T01:14:10+08:00 daily https://www.pharmasources.com/industryinsights/nw-bio-announces-deal-worth-47m-307202.html 0.6 2026-08-06T23:57:45+08:00 daily https://www.pharmasources.com/industryinsights/inveniai-kyowa-hakko-kirin-partner-for-d-307203.html 0.6 2026-06-21T07:00:04+08:00 daily https://www.pharmasources.com/industryinsights/entera-amgen-sign-research-agreement-307204.html 0.6 2026-08-06T23:46:14+08:00 daily https://www.pharmasources.com/industryinsights/amgen-contributes-2-million-to-groundbre-307205.html 0.6 2026-08-06T23:36:00+08:00 daily https://www.pharmasources.com/industryinsights/federal-equipment-investor-group-purchas-307206.html 0.6 2026-08-06T20:05:44+08:00 daily https://www.pharmasources.com/industryinsights/entera-bio-amgen-announce-strategic-rese-307207.html 0.6 2026-08-06T22:14:08+08:00 daily https://www.pharmasources.com/industryinsights/drug-cocktail-turns-off-the-juice-to-can-307208.html 0.6 2026-08-06T22:08:40+08:00 daily https://www.pharmasources.com/industryinsights/avanir-terminates-license-agreement-with-307209.html 0.6 2026-08-06T22:54:24+08:00 daily https://www.pharmasources.com/industryinsights/vect-horus-announces-agreement-with-john-307210.html 0.6 2026-08-07T13:16:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-statement-on-new-efforts-to-assure-t-307211.html 0.6 2026-08-07T04:39:33+08:00 daily https://www.pharmasources.com/industryinsights/tailored-treatment-for-acute-myeloid-leu-307212.html 0.6 2026-08-09T07:36:37+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-announces-initiation-of-triple-307213.html 0.6 2026-07-02T10:17:54+08:00 daily https://www.pharmasources.com/industryinsights/prophylactic-mesh-implantation-reduces-h-307214.html 0.6 2026-04-09T08:40:16+08:00 daily https://www.pharmasources.com/industryinsights/us-medical-schools-see-increase-in-diver-307215.html 0.6 2026-06-21T00:45:39+08:00 daily https://www.pharmasources.com/industryinsights/animal-bug-bites-a-billion-dollar-burden-307216.html 0.6 2026-06-21T05:57:55+08:00 daily https://www.pharmasources.com/industryinsights/paid-childbearing-policies-lacking-for-r-307217.html 0.6 2026-03-19T22:57:45+08:00 daily https://www.pharmasources.com/industryinsights/case-numbers-of-us-children-with-polio-l-307218.html 0.6 2026-06-21T10:04:09+08:00 daily https://www.pharmasources.com/industryinsights/younger-breast-cancer-survivors-suffer-m-307219.html 0.6 2026-06-21T10:21:25+08:00 daily https://www.pharmasources.com/industryinsights/hospitalizations-rising-among-the-homele-307220.html 0.6 2026-06-22T12:01:53+08:00 daily https://www.pharmasources.com/industryinsights/hidden-dangers-in-dust-307221.html 0.6 2026-07-01T01:21:44+08:00 daily https://www.pharmasources.com/industryinsights/nice-reveals-new-standards-for-digital-t-307222.html 0.6 2026-06-21T12:01:14+08:00 daily https://www.pharmasources.com/industryinsights/generics-firms-the-biggest-cartel-in-us--307223.html 0.6 2026-06-22T08:58:45+08:00 daily https://www.pharmasources.com/industryinsights/akorn-searches-for-new-ceo-after-failed--307224.html 0.6 2026-06-22T07:45:36+08:00 daily https://www.pharmasources.com/industryinsights/certain-brain-tumours-could-respond-to-i-307225.html 0.6 2026-06-21T11:14:26+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-follows-sanofi-with-job-cuts--307226.html 0.6 2026-06-21T05:53:35+08:00 daily https://www.pharmasources.com/industryinsights/oxforb-biotherapeutics-expands-its-strat-307227.html 0.6 2026-06-21T05:05:47+08:00 daily https://www.pharmasources.com/industryinsights/secretive-moderna-could-finally-go-publi-307228.html 0.6 2026-06-21T00:01:37+08:00 daily https://www.pharmasources.com/industryinsights/google-hires-geisinger-ceo-as-new-health-307229.html 0.6 2026-06-21T03:50:40+08:00 daily https://www.pharmasources.com/industryinsights/australians-need-more-time-to-opt-out-of-307230.html 0.6 2026-06-22T07:03:54+08:00 daily https://www.pharmasources.com/industryinsights/merck-gets-fda-okay-for-keytruda-as-live-307231.html 0.6 2026-07-06T23:58:24+08:00 daily https://www.pharmasources.com/industryinsights/nhs-long-term-plan-focuses-on-preventive-307232.html 0.6 2026-03-25T13:45:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-green-lights-pfizers-lorbrena-for-ag-307233.html 0.6 2026-06-21T01:55:47+08:00 daily https://www.pharmasources.com/industryinsights/who-worries-mercks-ebola-vaccine-will-ru-307234.html 0.6 2026-07-31T08:40:02+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-weighs-men-b-shot-bexser-307235.html 0.6 2026-02-28T13:07:03+08:00 daily https://www.pharmasources.com/industryinsights/scientists-weigh-zika-challenge-study-re-307236.html 0.6 2026-06-20T23:00:40+08:00 daily https://www.pharmasources.com/industryinsights/needed-vaccines-unlikely-at-current-fund-307237.html 0.6 2026-06-21T06:02:52+08:00 daily https://www.pharmasources.com/industryinsights/with-advair-generics-looming-gsk-sharpen-307238.html 0.6 2026-07-30T17:40:46+08:00 daily https://www.pharmasources.com/industryinsights/moderna-picks-up-fda-vaccine-official-we-307239.html 0.6 2026-05-03T21:27:39+08:00 daily https://www.pharmasources.com/industryinsights/group-calls-for-flu-shots-over-astrazene-307240.html 0.6 2026-06-21T20:04:42+08:00 daily https://www.pharmasources.com/industryinsights/mercks-ebola-vaccine-widely-used-in-late-307241.html 0.6 2026-08-03T04:19:31+08:00 daily https://www.pharmasources.com/industryinsights/china-has-withheld-deadly-bird-flu-sampl-307242.html 0.6 2026-06-23T07:43:47+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-may-airlift-flu-shots-into-the-uk-307243.html 0.6 2026-08-10T01:06:35+08:00 daily https://www.pharmasources.com/industryinsights/launch-of-largest-ever-uk-lung-cancer-sc-307244.html 0.6 2026-06-21T09:50:14+08:00 daily https://www.pharmasources.com/industryinsights/new-nice-standards-to-improve-digital-he-307245.html 0.6 2026-08-05T19:16:27+08:00 daily https://www.pharmasources.com/industryinsights/circassia-takes-on-full-us-rights-to-az--307246.html 0.6 2026-06-23T09:11:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-mallinckrodts-abuse-deterren-307247.html 0.6 2026-06-21T19:00:45+08:00 daily https://www.pharmasources.com/industryinsights/rural-patients-less-likely-to-survive-ca-307248.html 0.6 2026-04-19T16:33:03+08:00 daily https://www.pharmasources.com/industryinsights/plaque-psoriasis-study-claims-tremfya-su-307249.html 0.6 2026-03-19T23:44:28+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-aveo-oncology-form-lung-canc-307250.html 0.6 2026-06-21T17:12:32+08:00 daily https://www.pharmasources.com/industryinsights/experts-call-for-national-lung-disease-p-307251.html 0.6 2026-06-21T23:58:44+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-nhs-funding-for-tegsedi-onp-307252.html 0.6 2026-06-22T11:13:00+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biotherapeutics-wuxi-biologics-te-307253.html 0.6 2026-06-24T12:39:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-mallinckrodts-abuse-deterren-307254.html 0.6 2026-01-30T13:51:16+08:00 daily https://www.pharmasources.com/industryinsights/scottish-medicines-consortium-approves-v-307255.html 0.6 2026-07-04T22:12:40+08:00 daily https://www.pharmasources.com/industryinsights/sprayable-gel-with-cd47-blockers-could-b-307256.html 0.6 2026-01-21T19:19:05+08:00 daily https://www.pharmasources.com/industryinsights/tech-platform-company-wuxi-biologics-ink-307257.html 0.6 2026-08-05T17:54:21+08:00 daily https://www.pharmasources.com/industryinsights/atopic-dermatitis-market-set-to-almost-t-307258.html 0.6 2026-06-21T07:16:26+08:00 daily https://www.pharmasources.com/industryinsights/licences-for-manufacturers-and-wholesale-307259.html 0.6 2026-08-05T13:18:58+08:00 daily https://www.pharmasources.com/industryinsights/amgen-donate-2m-towards-increasing-diver-307260.html 0.6 2026-06-30T00:52:36+08:00 daily https://www.pharmasources.com/industryinsights/strides-vivimed-jv-receives-approval-for-307261.html 0.6 2026-06-22T05:58:37+08:00 daily https://www.pharmasources.com/industryinsights/batavia-biosciences-partners-with-iavi-t-307262.html 0.6 2026-06-20T15:46:23+08:00 daily https://www.pharmasources.com/industryinsights/gardp-eisai-and-takeda-join-forces-to-id-307263.html 0.6 2026-08-07T11:26:10+08:00 daily https://www.pharmasources.com/industryinsights/vect-horus-and-janssen-partner-for-neuro-307264.html 0.6 2026-08-08T13:29:34+08:00 daily https://www.pharmasources.com/industryinsights/amgen-partners-with-magellan-on-patient--307265.html 0.6 2026-06-21T22:53:39+08:00 daily https://www.pharmasources.com/industryinsights/parle-global-technologies-india-in-jv-wi-307266.html 0.6 2026-08-08T00:54:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-api-manufacturer-involved-in-v-307267.html 0.6 2026-06-20T20:55:41+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-lilly-announce-license-and-col-307268.html 0.6 2026-07-06T20:42:57+08:00 daily https://www.pharmasources.com/industryinsights/the-future-of-injectable-drug-delivery---307269.html 0.6 2026-06-23T11:44:41+08:00 daily https://www.pharmasources.com/industryinsights/ar-501-enrolls-first-subject-in-trial-fo-307270.html 0.6 2026-08-07T05:31:00+08:00 daily https://www.pharmasources.com/industryinsights/helping-the-anti-parasitic-medicine-go-d-307271.html 0.6 2026-06-21T14:22:11+08:00 daily https://www.pharmasources.com/industryinsights/valbenazine-did-not-meet-primary-endpoin-307272.html 0.6 2026-08-07T05:33:42+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-announces-partnership-with-sri--307273.html 0.6 2026-07-21T07:35:47+08:00 daily https://www.pharmasources.com/industryinsights/scientists-pave-the-way-for-saliva-test--307274.html 0.6 2026-08-07T07:10:06+08:00 daily https://www.pharmasources.com/industryinsights/masco-group-acquires-high-purity-divisio-307275.html 0.6 2026-06-28T05:49:51+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-congratulates-tychan-on-f-307276.html 0.6 2026-07-18T12:58:20+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-expands-analytical-capabilities--307277.html 0.6 2026-06-20T23:07:45+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-expands-san-diego-site-307278.html 0.6 2026-06-22T00:35:47+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-lilly-partner-for-alzheimers-307279.html 0.6 2026-06-27T02:05:44+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-purchases-berkeley-lights-b-307280.html 0.6 2026-06-22T13:02:26+08:00 daily https://www.pharmasources.com/industryinsights/sleep-length-quality-linked-to-risk-for--307281.html 0.6 2026-06-20T23:58:32+08:00 daily https://www.pharmasources.com/industryinsights/antipsychotics-up-risk-for-unexpected-de-307282.html 0.6 2026-06-21T17:18:13+08:00 daily https://www.pharmasources.com/industryinsights/recalled-kotex-tampons-can-unravel-insid-307283.html 0.6 2026-06-23T10:39:30+08:00 daily https://www.pharmasources.com/industryinsights/enrollment-under-the-affordable-care-act-307284.html 0.6 2026-06-21T02:12:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-some-e-cigarette-liquids-contain-ere-307285.html 0.6 2026-06-20T14:39:19+08:00 daily https://www.pharmasources.com/industryinsights/extreme-dieting-in-teens-often-intensifi-307286.html 0.6 2026-06-21T09:04:09+08:00 daily https://www.pharmasources.com/industryinsights/surgery-may-benefit-some-with-early-pros-307287.html 0.6 2026-06-28T18:22:12+08:00 daily https://www.pharmasources.com/industryinsights/certain-female-vets-may-face-higher-deme-307288.html 0.6 2026-06-20T19:57:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-pearsandoz-app-for-opioid-use-307289.html 0.6 2026-06-21T08:58:04+08:00 daily https://www.pharmasources.com/industryinsights/clark-health-communications-forms-allian-307290.html 0.6 2026-06-25T02:23:47+08:00 daily https://www.pharmasources.com/industryinsights/novo-begins-rd-tie-up-with-ai-biotech-e--307291.html 0.6 2026-06-21T17:59:32+08:00 daily https://www.pharmasources.com/industryinsights/axovant-axes-neuroscience-drug-focuses-o-307292.html 0.6 2026-04-15T17:43:07+08:00 daily https://www.pharmasources.com/industryinsights/shinichi-tamura-re-takes-ceo-role-at-sos-307293.html 0.6 2026-07-07T16:34:33+08:00 daily https://www.pharmasources.com/industryinsights/almirall-and-x-chem-announce-dermatology-307294.html 0.6 2026-06-21T16:59:48+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-eyes-quick-filing-for-gist-dru-307295.html 0.6 2026-06-21T08:21:31+08:00 daily https://www.pharmasources.com/industryinsights/litmus-and-nih-study-use-of-wearables-in-307296.html 0.6 2026-06-21T04:41:32+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-backs-five-new-ai-health-p-307297.html 0.6 2026-08-03T06:19:56+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-claims-speedy-review-for--307298.html 0.6 2026-08-07T10:42:09+08:00 daily https://www.pharmasources.com/industryinsights/ai-pathology-project-awarded-101m-govern-307299.html 0.6 2026-06-22T10:12:05+08:00 daily https://www.pharmasources.com/industryinsights/biomx-enters-collaboration-with-johnson--307300.html 0.6 2026-08-06T00:01:32+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-ac-immune-announce-license-and-307301.html 0.6 2026-06-21T18:37:17+08:00 daily https://www.pharmasources.com/industryinsights/vect-horus-announces-agreement-with-john-307302.html 0.6 2026-06-22T01:43:31+08:00 daily https://www.pharmasources.com/industryinsights/rodin-therapeutics-announces-initiation--307303.html 0.6 2026-06-24T01:11:14+08:00 daily https://www.pharmasources.com/industryinsights/who-worries-mercks-ebola-vaccine-will-ru-307304.html 0.6 2026-06-22T07:36:33+08:00 daily https://www.pharmasources.com/industryinsights/ghit-fund-to-invest-46m-for-new-projects-307305.html 0.6 2026-07-20T03:25:07+08:00 daily https://www.pharmasources.com/industryinsights/ehealth-ventures-invests-in-disruptive-d-307306.html 0.6 2026-08-08T03:10:49+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-advances-cell-culture-pro-307307.html 0.6 2026-08-08T05:55:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-cancer-research-uk-open--307308.html 0.6 2026-03-02T09:06:50+08:00 daily https://www.pharmasources.com/industryinsights/innovate-uk-grant-for-predictimmunes-ibd-307309.html 0.6 2026-06-22T07:51:43+08:00 daily https://www.pharmasources.com/industryinsights/significant-scotland-health-gap-persists-307310.html 0.6 2026-06-21T19:07:41+08:00 daily https://www.pharmasources.com/industryinsights/uk-men-and-women-spending-less-of-their--307311.html 0.6 2026-06-23T02:16:37+08:00 daily https://www.pharmasources.com/industryinsights/sosei-doses-first-patient-with-experimen-307312.html 0.6 2026-06-21T13:00:35+08:00 daily https://www.pharmasources.com/industryinsights/nhs-performance-deeply-troubling-says-nh-307313.html 0.6 2026-06-20T15:51:41+08:00 daily https://www.pharmasources.com/industryinsights/shield-expecting-us-decision-on-feraccru-307314.html 0.6 2026-06-20T16:05:46+08:00 daily https://www.pharmasources.com/industryinsights/nice-reject-two-treatments-for-fatal-ult-307315.html 0.6 2026-06-21T06:47:50+08:00 daily https://www.pharmasources.com/industryinsights/government-choose-england-top-pharmacist-307316.html 0.6 2026-06-20T22:55:48+08:00 daily https://www.pharmasources.com/industryinsights/msd-announced-collaboration-with-brazili-307317.html 0.6 2026-07-03T19:00:49+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-buy-bankrupt-synergy-pharm-307318.html 0.6 2026-07-27T20:49:47+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-the-build-307319.html 0.6 2026-06-21T01:03:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-still-unable-to-get-on-top-of-pro-307320.html 0.6 2026-06-20T19:18:51+08:00 daily https://www.pharmasources.com/industryinsights/janssens-tremfya-shows-superiority-in-pl-307321.html 0.6 2026-07-28T10:15:43+08:00 daily https://www.pharmasources.com/industryinsights/lilly-teams-up-with-ac-immune-for-alzhei-307322.html 0.6 2026-03-20T17:51:48+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-self-administration-of-novar-307323.html 0.6 2026-06-22T07:13:56+08:00 daily https://www.pharmasources.com/industryinsights/nih-to-support-hiv-care-and-prevention-r-307324.html 0.6 2026-06-21T17:17:39+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-still-unable-to-get-on-top-of-pro-307325.html 0.6 2026-07-27T16:07:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-the-307326.html 0.6 2026-08-05T13:15:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-commissioner-scott-gottlieb-blasts-i-307327.html 0.6 2026-06-14T03:32:23+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-inks-200m-stalking-horse-d-307328.html 0.6 2026-06-20T19:03:39+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-tremfya-tops-novartis-b-307329.html 0.6 2026-07-17T00:28:33+08:00 daily https://www.pharmasources.com/industryinsights/uk-cost-watchdog-nice-issues-preliminary-307330.html 0.6 2026-06-21T05:49:23+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-commits-to-gene-the-307331.html 0.6 2026-06-21T09:11:12+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biocon-copy-inches-closer-to-chall-307332.html 0.6 2026-07-02T06:04:08+08:00 daily https://www.pharmasources.com/industryinsights/neurocrines-3rd-ingrezza-flop-in-tourett-307333.html 0.6 2026-08-07T23:37:35+08:00 daily https://www.pharmasources.com/industryinsights/ppd-adds-new-therapeutic-area-leaders-307334.html 0.6 2026-06-21T05:54:42+08:00 daily https://www.pharmasources.com/industryinsights/vast-therapeutics-announces-funding-from-307335.html 0.6 2026-06-21T00:09:50+08:00 daily https://www.pharmasources.com/industryinsights/adynxx-announces-notice-of-award-for-57m-307336.html 0.6 2026-08-08T00:27:30+08:00 daily https://www.pharmasources.com/industryinsights/us-patent-office-rules-sanofis-formulati-307337.html 0.6 2026-06-21T20:00:37+08:00 daily https://www.pharmasources.com/industryinsights/first-subject-dosed-in-phase-i-study-of--307338.html 0.6 2026-06-20T16:02:21+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-ec-approval-for-self-a-307339.html 0.6 2026-06-20T23:02:42+08:00 daily https://www.pharmasources.com/industryinsights/risk-factors-identified-for-late-recurre-307340.html 0.6 2026-07-09T00:23:49+08:00 daily https://www.pharmasources.com/industryinsights/cdc-more-cases-in-salmonella-outbreak-li-307341.html 0.6 2026-06-30T01:39:48+08:00 daily https://www.pharmasources.com/industryinsights/eligibility-criteria-limit-access-to-art-307342.html 0.6 2026-06-20T18:03:41+08:00 daily https://www.pharmasources.com/industryinsights/inhaling-hypertonic-saline-may-aid-infan-307343.html 0.6 2026-06-21T01:06:49+08:00 daily https://www.pharmasources.com/industryinsights/california-farm-implicated-in-outbreak-o-307344.html 0.6 2026-06-20T16:59:20+08:00 daily https://www.pharmasources.com/industryinsights/women-doctors-say-theyre-penalized-for-m-307345.html 0.6 2026-06-21T14:37:09+08:00 daily https://www.pharmasources.com/industryinsights/can-alzheimers-be-spread-mouse-study-hin-307346.html 0.6 2026-06-20T23:17:51+08:00 daily https://www.pharmasources.com/industryinsights/research-on-almost-2000-brains-brings-in-307347.html 0.6 2026-06-21T08:17:18+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-alnylam-and-akceas-amyloido-307348.html 0.6 2026-06-21T07:13:05+08:00 daily https://www.pharmasources.com/industryinsights/jjs-tremfya-outperforms-novartis-cosenty-307349.html 0.6 2026-06-20T14:44:24+08:00 daily https://www.pharmasources.com/industryinsights/az-begins-liver-cancer-immunotherapy-tie-307350.html 0.6 2026-06-21T04:09:50+08:00 daily https://www.pharmasources.com/industryinsights/garmin-to-develop-wearables-for-clinical-307351.html 0.6 2026-06-21T05:14:58+08:00 daily https://www.pharmasources.com/industryinsights/neurocrine-slumps-as-tourettes-drug-fail-307352.html 0.6 2026-07-17T09:30:15+08:00 daily https://www.pharmasources.com/industryinsights/interview-with-jimmy-from-shijiazhuang-s-307353.html 0.6 2026-06-21T11:48:01+08:00 daily https://www.pharmasources.com/industryinsights/amag-pharmaceuticals-enters-into-definit-307354.html 0.6 2026-06-22T11:56:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-says-4m-price-is-reasonable-for-307355.html 0.6 2026-06-22T15:10:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-european-commission-ap-307356.html 0.6 2026-06-20T15:10:24+08:00 daily https://www.pharmasources.com/industryinsights/bms-and-infinity-trial-immunotherapy-com-307357.html 0.6 2026-06-23T23:16:59+08:00 daily https://www.pharmasources.com/industryinsights/englands-public-health-body-hopes-app-wi-307358.html 0.6 2026-06-20T06:51:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-backs-sages-novel-antidepressa-307359.html 0.6 2026-08-05T18:11:56+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-axes-filing-of-us-rituxan-biosimi-307360.html 0.6 2026-06-20T23:43:31+08:00 daily https://www.pharmasources.com/industryinsights/data-integrity-and-compliance-with-drug--307361.html 0.6 2026-03-26T20:45:52+08:00 daily https://www.pharmasources.com/industryinsights/blood-tests-could-lead-to-personalised-c-307362.html 0.6 2026-06-19T18:16:39+08:00 daily https://www.pharmasources.com/industryinsights/mylan-says-sanofi-loses-lantus-insulin-p-307363.html 0.6 2026-06-24T02:01:34+08:00 daily https://www.pharmasources.com/industryinsights/rusan-pharma-launches-new-approved-drug--307364.html 0.6 2026-03-29T02:54:27+08:00 daily https://www.pharmasources.com/industryinsights/jj-says-its-psoriasis-drug-superior-to-n-307365.html 0.6 2026-08-07T21:17:14+08:00 daily https://www.pharmasources.com/industryinsights/innovent-declares-positive-result-of-ibi-307366.html 0.6 2026-06-22T04:01:40+08:00 daily https://www.pharmasources.com/industryinsights/avacta-lg-chem-life-sciences-to-develop--307367.html 0.6 2026-06-22T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-establish-new-base-in-china-usi-307368.html 0.6 2026-06-20T17:36:23+08:00 daily https://www.pharmasources.com/industryinsights/merck-collaborates-to-develop-vaccines-a-307369.html 0.6 2026-06-22T12:55:07+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-warning-health-products-by-307370.html 0.6 2026-06-21T04:12:59+08:00 daily https://www.pharmasources.com/industryinsights/amgen-direct-relief-partner-to-help-canc-307371.html 0.6 2026-06-21T15:52:32+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-heartwear-launches-first-ai-dr-307372.html 0.6 2026-07-27T09:08:09+08:00 daily https://www.pharmasources.com/industryinsights/generex-receives-ind-approval-from-fda-307373.html 0.6 2026-06-21T04:12:58+08:00 daily https://www.pharmasources.com/industryinsights/prestige-cipla-unite-to-sell-cancer-bios-307374.html 0.6 2026-06-20T19:10:44+08:00 daily https://www.pharmasources.com/industryinsights/prestige-biopharma-partners-with-cipla-l-307375.html 0.6 2026-03-13T09:55:44+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-and-sirion-biotech--307376.html 0.6 2026-06-21T10:03:05+08:00 daily https://www.pharmasources.com/industryinsights/russia-and-rusal-complete-ebola-vaccinat-307377.html 0.6 2026-06-20T15:14:21+08:00 daily https://www.pharmasources.com/industryinsights/mylan-announces-victory-over-sanofi-in-l-307378.html 0.6 2026-06-20T22:58:42+08:00 daily https://www.pharmasources.com/industryinsights/vect-horus-amgen-bristol-myers-squibb-307379.html 0.6 2026-06-20T14:59:08+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-makes-200m-bid-for-bankrup-307380.html 0.6 2026-06-20T15:00:07+08:00 daily https://www.pharmasources.com/industryinsights/astellas-acquires-potenza-therapeutics-307381.html 0.6 2026-06-22T08:51:48+08:00 daily https://www.pharmasources.com/industryinsights/chmp-grants-positive-opinion-for-new-ind-307382.html 0.6 2026-08-08T20:02:58+08:00 daily https://www.pharmasources.com/industryinsights/avacta-lg-chem-life-sciences-agree-multi-307383.html 0.6 2026-08-08T14:47:15+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-snda-for-xarelto-to-prev-307384.html 0.6 2026-08-08T13:11:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-initiates-for-20-valent-pneumococ-307385.html 0.6 2026-08-08T11:48:38+08:00 daily https://www.pharmasources.com/industryinsights/regentys-corporation-receives-european-p-307386.html 0.6 2026-08-08T10:11:46+08:00 daily https://www.pharmasources.com/industryinsights/orchard-sirion-enter-license-agreement-307387.html 0.6 2026-08-09T20:19:12+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-corp-restructures-307388.html 0.6 2026-08-08T04:30:42+08:00 daily https://www.pharmasources.com/industryinsights/amag-acquires-perosphere-307390.html 0.6 2026-08-07T13:18:04+08:00 daily https://www.pharmasources.com/industryinsights/save-your-skin-from-the-ravages-of-cold--307391.html 0.6 2026-08-06T23:36:40+08:00 daily https://www.pharmasources.com/industryinsights/early-pt-linked-to-less-opioid-use-in-mu-307392.html 0.6 2026-08-06T22:53:22+08:00 daily https://www.pharmasources.com/industryinsights/federal-equipment-investor-group-purchas-307393.html 0.6 2026-08-06T20:09:34+08:00 daily https://www.pharmasources.com/industryinsights/phone-based-intervention-aids-rheumatoid-307394.html 0.6 2026-08-07T02:39:36+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-lilly-partner-for-alzheimers-307395.html 0.6 2026-06-21T16:17:49+08:00 daily https://www.pharmasources.com/industryinsights/janssen-ohca-enter-lais-contract-307396.html 0.6 2026-06-20T19:21:10+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-sri-enter-asd-collaboration-307397.html 0.6 2026-08-07T03:03:03+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-appoints-innovation-307398.html 0.6 2026-02-14T23:41:21+08:00 daily https://www.pharmasources.com/industryinsights/celgene-licenses-two-dragonfly-immunothe-307399.html 0.6 2026-06-20T19:57:06+08:00 daily https://www.pharmasources.com/industryinsights/significant-health-outcomes-gap-still-ex-307400.html 0.6 2026-08-05T20:09:36+08:00 daily https://www.pharmasources.com/industryinsights/data-reveals-novembers-performance-was-w-307401.html 0.6 2026-06-22T03:57:38+08:00 daily https://www.pharmasources.com/industryinsights/apixaban-prevents-vte-in-cancer-patients-307402.html 0.6 2026-06-21T06:59:03+08:00 daily https://www.pharmasources.com/industryinsights/post-inflammatory-polyps-not-linked-to-c-307403.html 0.6 2026-06-22T09:23:17+08:00 daily https://www.pharmasources.com/industryinsights/emotional-stress-of-holidays-can-trigger-307404.html 0.6 2026-06-20T22:00:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-herzuma-trastuzumab-pkrb-a--307405.html 0.6 2026-08-09T02:03:48+08:00 daily https://www.pharmasources.com/industryinsights/beware-of-stressful-events-in-the-evenin-307406.html 0.6 2026-03-29T17:55:41+08:00 daily https://www.pharmasources.com/industryinsights/carthera-raises-9m-to-tackle-the-blood-b-307407.html 0.6 2026-08-08T16:22:49+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-warns-over-medicine-supplies-amid--307408.html 0.6 2026-06-20T21:46:06+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-eyes-acquisitions-after-1bn--307409.html 0.6 2026-06-24T11:03:02+08:00 daily https://www.pharmasources.com/industryinsights/biolive-china-2019-to-be-newly-upgraded--307410.html 0.6 2026-06-25T12:50:55+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-incyte-announce-strategic-c-307411.html 0.6 2026-08-07T22:13:42+08:00 daily https://www.pharmasources.com/industryinsights/most-pharma-firms-doing-little-rd-for-po-307412.html 0.6 2026-07-18T02:11:54+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-roche-eye-first-line-use-of-vencl-307413.html 0.6 2026-07-02T12:14:09+08:00 daily https://www.pharmasources.com/industryinsights/uk-opens-doors-to-cannabis-based-therapi-307414.html 0.6 2026-07-20T06:56:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-biosimilar-of-blockbuster-h-307415.html 0.6 2026-06-21T17:11:30+08:00 daily https://www.pharmasources.com/industryinsights/vertex-wins-european-approval-for-new-cy-307416.html 0.6 2026-06-21T10:50:27+08:00 daily https://www.pharmasources.com/industryinsights/chinese-api-market-growing-strongly-cphi-307417.html 0.6 2026-07-03T02:40:04+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receives-positive-chmp-opinion-fo-307418.html 0.6 2026-07-23T23:27:29+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-hydr-307419.html 0.6 2026-07-19T07:25:01+08:00 daily https://www.pharmasources.com/industryinsights/ensuring-supplier-and-compounded-drug-qu-307420.html 0.6 2026-08-07T21:48:56+08:00 daily https://www.pharmasources.com/industryinsights/predictions-of-early-responses-in-paedia-307421.html 0.6 2026-06-23T13:45:39+08:00 daily https://www.pharmasources.com/industryinsights/cx-partners-acquires-equity-stake-in-vee-307422.html 0.6 2026-06-20T20:59:39+08:00 daily https://www.pharmasources.com/industryinsights/rusan-pharma-launch-aposan-for-the-treat-307423.html 0.6 2026-06-22T16:21:01+08:00 daily https://www.pharmasources.com/industryinsights/can-chinas-rd-sector-shake-its-reputatio-307424.html 0.6 2026-06-20T16:49:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-amgens-nplate-for-certain-p-307425.html 0.6 2026-08-09T07:36:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-celltrion-tevas-biosimilar-ve-307426.html 0.6 2026-08-07T13:18:20+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pulls-eu-filing-for-canakinumab-307427.html 0.6 2026-08-07T12:03:18+08:00 daily https://www.pharmasources.com/industryinsights/verona-initiates-phase-ii-trial-for-copd-307428.html 0.6 2026-06-29T12:09:32+08:00 daily https://www.pharmasources.com/industryinsights/seven-medicines-leap-closer-to-eu-approv-307429.html 0.6 2026-07-27T08:34:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pulls-eu-filing-for-canakinumab-307430.html 0.6 2026-07-10T12:13:53+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-related-lower-limb-amputations--307431.html 0.6 2026-06-23T09:58:46+08:00 daily https://www.pharmasources.com/industryinsights/all-practices-in-england-now-offering-ex-307432.html 0.6 2026-06-22T00:53:48+08:00 daily https://www.pharmasources.com/industryinsights/china-and-us-tend-to-choose-win-win-coop-307433.html 0.6 2026-06-25T12:11:37+08:00 daily https://www.pharmasources.com/industryinsights/nhs-overcrowding-leads-to-ambulances-bei-307434.html 0.6 2026-08-09T05:34:22+08:00 daily https://www.pharmasources.com/industryinsights/no-deal-brexit-stockpiling-puts-pressure-307435.html 0.6 2026-08-08T21:48:33+08:00 daily https://www.pharmasources.com/industryinsights/chmp-approve-bristol-myers-squibbs-spryc-307436.html 0.6 2026-08-08T20:00:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-withdraw-marketing-application--307437.html 0.6 2026-06-20T18:07:27+08:00 daily https://www.pharmasources.com/industryinsights/kio-pfizer-enter-research-collaboration-307438.html 0.6 2026-08-07T23:39:48+08:00 daily https://www.pharmasources.com/industryinsights/astellas-pharma-acquires-potenza-therape-307439.html 0.6 2026-08-07T13:18:52+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-boston-medical--307440.html 0.6 2026-08-07T22:35:39+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-biogen-submit-nda-to-fda-307441.html 0.6 2026-08-06T20:07:37+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-genentech-sign-licensing-de-307442.html 0.6 2026-08-06T21:41:01+08:00 daily https://www.pharmasources.com/industryinsights/executive-moves-abbvie-307443.html 0.6 2026-08-06T20:07:01+08:00 daily https://www.pharmasources.com/industryinsights/neurotrope-announces-publication-of-phas-307444.html 0.6 2026-08-06T23:33:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-cut-price-version-of-avastin-win-307445.html 0.6 2026-08-06T22:08:20+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-buys-us-mfg-site-fr-307446.html 0.6 2026-08-06T23:36:07+08:00 daily https://www.pharmasources.com/industryinsights/lilly-acquires-hydra-biosciences-pain-as-307447.html 0.6 2026-08-07T13:15:18+08:00 daily https://www.pharmasources.com/industryinsights/amgens-nplate-approved-for-itp-307448.html 0.6 2026-08-07T13:55:50+08:00 daily https://www.pharmasources.com/industryinsights/biolive-china-2019-to-lead-bio-pharma-te-307449.html 0.6 2026-07-25T07:11:22+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-us-fda-approval-for-cloba-307450.html 0.6 2026-06-22T12:07:02+08:00 daily https://www.pharmasources.com/industryinsights/zymergen-announces-400m-in-series-c-fund-307451.html 0.6 2026-06-21T07:09:08+08:00 daily https://www.pharmasources.com/industryinsights/thorny-path-a-replay-of-how-tesaro-got-i-307452.html 0.6 2026-06-13T09:26:15+08:00 daily https://www.pharmasources.com/industryinsights/novartis-considers-reinsurance-model-to--307453.html 0.6 2026-06-21T02:08:42+08:00 daily https://www.pharmasources.com/industryinsights/finlands-mobidiag-forms-jv-with-autobio--307454.html 0.6 2026-07-19T16:59:30+08:00 daily https://www.pharmasources.com/industryinsights/innovent-buys-chinese-rights-to-incyte-d-307455.html 0.6 2026-06-28T15:33:11+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-licences-bioarctics-parkinsons-di-307456.html 0.6 2025-11-12T08:09:53+08:00 daily https://www.pharmasources.com/industryinsights/how-neurons-fend-off-alzheimers-with-a-c-307457.html 0.6 2026-06-21T13:00:35+08:00 daily https://www.pharmasources.com/industryinsights/astellas-buys-potenza-therapeutics-for-u-307458.html 0.6 2026-04-08T03:37:08+08:00 daily https://www.pharmasources.com/industryinsights/nicox-and-ocumension-partner-to-develop--307459.html 0.6 2026-06-21T12:16:28+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-biogen-submits-nda-for-diroxime-307460.html 0.6 2026-06-22T08:52:43+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-to-purchase-us-manu-307461.html 0.6 2026-06-20T19:01:04+08:00 daily https://www.pharmasources.com/industryinsights/kineta-enters-research-collaboration-and-307462.html 0.6 2026-06-21T12:52:45+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-therapeutics-announces-glob-307463.html 0.6 2026-07-04T11:12:13+08:00 daily https://www.pharmasources.com/industryinsights/decryption-of-the-feminization-drug-on-t-307464.html 0.6 2026-07-17T06:47:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-motegrity-prucalopride-for--307465.html 0.6 2026-07-25T05:24:14+08:00 daily https://www.pharmasources.com/industryinsights/buprenorphine-naloxone-cost-effective-fo-307466.html 0.6 2026-04-12T01:48:46+08:00 daily https://www.pharmasources.com/industryinsights/2010-to-2014-saw-increase-in-anemia-afte-307467.html 0.6 2026-06-21T11:47:02+08:00 daily https://www.pharmasources.com/industryinsights/follow-up-within-seven-days-of-heart-fai-307468.html 0.6 2026-06-20T23:07:47+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-risk-lower-in-women-with-307469.html 0.6 2026-06-20T22:18:59+08:00 daily https://www.pharmasources.com/industryinsights/more-us-teens-are-vaping-but-use-of-opio-307470.html 0.6 2026-06-20T15:54:25+08:00 daily https://www.pharmasources.com/industryinsights/runaway-immune-system-may-play-role-in-c-307471.html 0.6 2026-06-22T08:02:48+08:00 daily https://www.pharmasources.com/industryinsights/sleepless-night-could-make-morning-pastr-307472.html 0.6 2026-06-20T23:15:03+08:00 daily https://www.pharmasources.com/industryinsights/todays-more-potent-pot-means-higher-odds-307473.html 0.6 2025-12-17T00:17:54+08:00 daily https://www.pharmasources.com/industryinsights/celltriontevas-herceptin-biosimilar-appr-307474.html 0.6 2026-06-27T01:58:36+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-buy-animal-health-firm-antelliq-307475.html 0.6 2026-06-20T19:20:01+08:00 daily https://www.pharmasources.com/industryinsights/convatec-looks-to-support-uk-wound-care--307476.html 0.6 2026-08-09T04:18:28+08:00 daily https://www.pharmasources.com/industryinsights/brexit-affecting-supplies-of-generic-dru-307477.html 0.6 2026-08-09T01:20:47+08:00 daily https://www.pharmasources.com/industryinsights/jj-hits-back-over-asbestos-in-talc-claim-307478.html 0.6 2026-08-08T23:20:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-agrees-to-review-roches-tecentriq-co-307479.html 0.6 2026-08-07T13:15:14+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-approved-for-combination-lung-c-307480.html 0.6 2026-08-07T13:15:45+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-to-launch-blockchain-patien-307481.html 0.6 2026-08-07T01:42:35+08:00 daily https://www.pharmasources.com/industryinsights/amazon-sells-exclusive-diabetes-and-hype-307482.html 0.6 2026-08-07T01:21:32+08:00 daily https://www.pharmasources.com/industryinsights/90ten-appoints-abigail-last-as-an-associ-307483.html 0.6 2026-08-07T01:14:35+08:00 daily https://www.pharmasources.com/industryinsights/augmented-reality-pre-surgery-tech-appro-307484.html 0.6 2026-08-07T00:41:00+08:00 daily https://www.pharmasources.com/industryinsights/grnenthal-buys-certain-rights-to-azs-nex-307485.html 0.6 2026-08-07T00:59:20+08:00 daily https://www.pharmasources.com/industryinsights/dicerna-agrees-another-gene-silencing-de-307486.html 0.6 2026-08-07T01:06:57+08:00 daily https://www.pharmasources.com/industryinsights/delsitech-partners-with-innovare-to-crea-307487.html 0.6 2026-06-21T04:59:44+08:00 daily https://www.pharmasources.com/industryinsights/incyte-agrees-to-licence-three-products--307488.html 0.6 2026-08-04T19:22:33+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-signs-dyslipidaemia-drug-de-307489.html 0.6 2026-08-06T23:09:22+08:00 daily https://www.pharmasources.com/industryinsights/havas-lynx-group-recruitment-drive-creat-307490.html 0.6 2026-06-21T08:00:04+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-and-ares-genetics-partner-to-deve-307491.html 0.6 2026-08-06T15:17:03+08:00 daily https://www.pharmasources.com/industryinsights/75-projects-to-receive-1bn-in-nhs-servic-307492.html 0.6 2026-08-07T16:02:41+08:00 daily https://www.pharmasources.com/industryinsights/eiger-announces-breakthrough-therapy-des-307493.html 0.6 2026-06-21T13:07:42+08:00 daily https://www.pharmasources.com/industryinsights/private-firms-receive-26m-from-tight-nhs-307494.html 0.6 2026-06-20T05:21:55+08:00 daily https://www.pharmasources.com/industryinsights/astellas-sunovion-and-shield-breach-abpi-307495.html 0.6 2026-06-23T07:15:11+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-receives-anda-a-307496.html 0.6 2026-07-29T22:27:26+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-and-biogen-announce-new-ms-drug-307497.html 0.6 2026-06-20T17:53:13+08:00 daily https://www.pharmasources.com/industryinsights/german-cdmo-rentschler-expands-biologics-307498.html 0.6 2026-06-21T01:11:53+08:00 daily https://www.pharmasources.com/industryinsights/lillys-taltz-beats-out-abbvies-megadrug--307499.html 0.6 2026-07-20T09:24:16+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-spinoff-to-include-7-manufa-307500.html 0.6 2026-08-08T02:04:20+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-employees-go-door-to-door-del-307501.html 0.6 2026-06-22T08:20:57+08:00 daily https://www.pharmasources.com/industryinsights/bad-drug-lawsuit-ads-hurt-doc-patient-re-307502.html 0.6 2026-06-21T03:04:43+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-again-supplying-pain-drugs-to-vet-307503.html 0.6 2026-06-20T20:18:16+08:00 daily https://www.pharmasources.com/industryinsights/mylan-announces-launch-of-generic-lialda-307504.html 0.6 2026-07-22T09:51:58+08:00 daily https://www.pharmasources.com/industryinsights/shire-gears-up-to-battle-allergans-linze-307505.html 0.6 2026-06-20T21:09:02+08:00 daily https://www.pharmasources.com/industryinsights/what-to-do-when-an-expos-tanks-your-stoc-307506.html 0.6 2026-03-17T20:22:42+08:00 daily https://www.pharmasources.com/industryinsights/as-promised-novartis-eyes-new-method-for-307507.html 0.6 2026-06-29T23:26:53+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-nears-16b-sale-of-o-307508.html 0.6 2026-08-09T06:14:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-removal-of-not-for-home-use-307509.html 0.6 2026-07-15T05:47:30+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-streamlines-management-team-to-4--307510.html 0.6 2026-06-22T00:41:38+08:00 daily https://www.pharmasources.com/industryinsights/roquette-thermo-fisher-scientific-announ-307511.html 0.6 2026-06-21T03:44:26+08:00 daily https://www.pharmasources.com/industryinsights/thorny-path-a-replay-of-how-tesaro-got-i-307512.html 0.6 2026-08-07T01:40:56+08:00 daily https://www.pharmasources.com/industryinsights/amgen-golden-tickets-provide-startup-com-307513.html 0.6 2026-06-21T05:58:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-brainstorms-nurown-ind-appli-307514.html 0.6 2026-06-24T05:05:23+08:00 daily https://www.pharmasources.com/industryinsights/jj-stock-tumbles-after-reuters-report-on-307515.html 0.6 2026-06-22T15:07:06+08:00 daily https://www.pharmasources.com/industryinsights/croda-acquires-vaccine-adjuvant-speciali-307516.html 0.6 2026-06-25T04:37:21+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-xl-protein-forge-strategic-all-307517.html 0.6 2026-06-25T00:20:32+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-fuji-pharma-expand-biosimilars--307518.html 0.6 2026-04-17T23:27:31+08:00 daily https://www.pharmasources.com/industryinsights/sutimlimab-shows-promise-for-hard-to-tre-307519.html 0.6 2026-06-24T08:45:52+08:00 daily https://www.pharmasources.com/industryinsights/take-high-blood-pressure-meds-exercise-m-307520.html 0.6 2026-06-22T07:08:07+08:00 daily https://www.pharmasources.com/industryinsights/hospitalizations-up-for-homeless-from-20-307521.html 0.6 2026-08-09T03:42:31+08:00 daily https://www.pharmasources.com/industryinsights/delivery-mode-tied-to-pelvic-floor-disor-307522.html 0.6 2026-06-21T08:09:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-still-struggling-with-kymriah-m-307523.html 0.6 2026-06-20T17:56:22+08:00 daily https://www.pharmasources.com/industryinsights/opioids-offer-small-improvement-in-pain--307524.html 0.6 2026-06-20T18:58:36+08:00 daily https://www.pharmasources.com/industryinsights/exercise-linked-to-reduced-mortality-for-307525.html 0.6 2026-06-28T18:50:37+08:00 daily https://www.pharmasources.com/industryinsights/aggressive-steps-needed-to-stop-adolesce-307526.html 0.6 2026-06-21T11:57:15+08:00 daily https://www.pharmasources.com/industryinsights/3-in-4-americans-struggle-with-lonelines-307527.html 0.6 2026-06-20T16:02:25+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-signs-us40m-licen-307528.html 0.6 2026-07-06T20:11:08+08:00 daily https://www.pharmasources.com/industryinsights/merck-bags-adjuvant-okay-for-keytruda-in-307529.html 0.6 2026-06-21T15:59:20+08:00 daily https://www.pharmasources.com/industryinsights/alkermesbiogen-hope-for-less-tummy-troub-307530.html 0.6 2026-06-22T06:51:41+08:00 daily https://www.pharmasources.com/industryinsights/bms-looks-to-rna-splicing-to-boost-immun-307531.html 0.6 2026-07-02T21:53:20+08:00 daily https://www.pharmasources.com/industryinsights/lillys-taltz-beats-out-abbvies-megadrug--307532.html 0.6 2026-08-06T18:45:02+08:00 daily https://www.pharmasources.com/industryinsights/roches-sma-drug-gets-prime-regulatory-st-307533.html 0.6 2026-06-20T17:39:03+08:00 daily https://www.pharmasources.com/industryinsights/mobile-app-uses-pictograms-to-help-peopl-307534.html 0.6 2026-06-22T20:15:18+08:00 daily https://www.pharmasources.com/industryinsights/mercks-ebola-vaccine-has-major-impact-bu-307535.html 0.6 2026-06-24T07:05:48+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-shingrix-shortage-expec-307536.html 0.6 2026-07-10T03:32:26+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-teams-up-with-wearifi-for-der-307537.html 0.6 2026-06-22T10:52:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-novartis-collaborate-to-find--307538.html 0.6 2026-05-31T10:49:31+08:00 daily https://www.pharmasources.com/industryinsights/az-to-file-potential-blockbuster-potassi-307539.html 0.6 2026-06-20T14:13:20+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-cll-drug-venclyxto-too-expensive-307540.html 0.6 2026-06-21T00:59:40+08:00 daily https://www.pharmasources.com/industryinsights/magic-mushroom-drug-could-be-depression--307541.html 0.6 2026-06-21T06:00:44+08:00 daily https://www.pharmasources.com/industryinsights/stem-healthcare-appoints-jason-mckenna-a-307542.html 0.6 2026-06-21T08:53:56+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-craters-as-resistant-schizophre-307543.html 0.6 2026-08-04T10:31:40+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-ac-immune-to-establis-307544.html 0.6 2026-07-30T12:33:10+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-forays-into-branded-dermatology-307545.html 0.6 2026-08-09T10:41:40+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-okays-mylan-biocons--307546.html 0.6 2026-07-09T05:47:41+08:00 daily https://www.pharmasources.com/industryinsights/the-valsartan-carcinogen-mess-taught-pha-307547.html 0.6 2026-06-23T09:18:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-expands-its-recommendation-for-onco-307548.html 0.6 2026-07-03T17:41:58+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-molecular-partners-to-develop--307549.html 0.6 2026-08-09T01:29:10+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-prime-designation-for-sma-dru-307550.html 0.6 2026-06-20T16:15:06+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-pfizer-to-create-13bn-consumer-h-307551.html 0.6 2026-06-12T09:42:34+08:00 daily https://www.pharmasources.com/industryinsights/gilead-hands-scholar-rock-80m-in-fibroti-307552.html 0.6 2026-06-13T10:52:21+08:00 daily https://www.pharmasources.com/industryinsights/bruntwood-to-make-10m-life-science-inves-307553.html 0.6 2026-06-22T00:02:47+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-enters-into-commercialization-sup-307554.html 0.6 2026-06-20T18:59:59+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-approved-by-fda-for-first-line--307555.html 0.6 2026-06-20T22:56:36+08:00 daily https://www.pharmasources.com/industryinsights/dengvaxia-vaccine-approved-for-preventio-307556.html 0.6 2026-08-04T22:41:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-guidance-for-industry-on-cl-307557.html 0.6 2026-08-07T16:46:18+08:00 daily https://www.pharmasources.com/industryinsights/alcon-announces-acquisition-of-tear-film-307558.html 0.6 2026-07-03T14:04:09+08:00 daily https://www.pharmasources.com/industryinsights/lilly-aduro-biotech-announce-research-co-307559.html 0.6 2026-08-04T00:42:05+08:00 daily https://www.pharmasources.com/industryinsights/residential-greenness-linked-to-cardiova-307560.html 0.6 2026-06-21T06:44:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-panels-prescribe-naloxone-w-307561.html 0.6 2026-06-20T18:02:22+08:00 daily https://www.pharmasources.com/industryinsights/new-law-boosts-fight-against-sickle-cell-307562.html 0.6 2026-06-19T15:04:08+08:00 daily https://www.pharmasources.com/industryinsights/exercise-promotes-executive-functioning--307563.html 0.6 2026-08-09T06:59:20+08:00 daily https://www.pharmasources.com/industryinsights/more-us-kids-dying-from-guns-car-acciden-307564.html 0.6 2026-08-08T16:49:04+08:00 daily https://www.pharmasources.com/industryinsights/chugai-preps-filings-for-il-6-drug-in-ra-307565.html 0.6 2026-06-21T05:49:45+08:00 daily https://www.pharmasources.com/industryinsights/chemo-cocktail-embraced-as-pancreatic-ca-307566.html 0.6 2026-08-08T15:12:03+08:00 daily https://www.pharmasources.com/industryinsights/narcissists-not-fond-of-democracy-study-307567.html 0.6 2026-08-07T02:52:37+08:00 daily https://www.pharmasources.com/industryinsights/wearing-contacts-247-can-bring-infection-307568.html 0.6 2026-08-07T03:02:53+08:00 daily https://www.pharmasources.com/industryinsights/expect-more-transparency-around-pharmas--307569.html 0.6 2026-08-07T13:16:18+08:00 daily https://www.pharmasources.com/industryinsights/140-jobs-in-jeopardy-as-recipharm-weighs-307570.html 0.6 2026-08-07T03:19:08+08:00 daily https://www.pharmasources.com/industryinsights/nihrs-clinical-research-network-links-wi-307571.html 0.6 2026-06-26T14:19:47+08:00 daily https://www.pharmasources.com/industryinsights/eu-nice-authorise-msds-keytruda-for-stag-307572.html 0.6 2026-08-07T13:19:50+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-pfizer-to-create-consumer-health-307573.html 0.6 2026-06-21T15:44:14+08:00 daily https://www.pharmasources.com/industryinsights/nearly-half-of-ccgs-rated-requires-impro-307574.html 0.6 2026-06-22T15:19:23+08:00 daily https://www.pharmasources.com/industryinsights/tesaros-deal-struggles-theyre-actually-a-307575.html 0.6 2026-06-23T18:01:21+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-joins-medical-cannabis-drive-with-307576.html 0.6 2026-07-08T03:40:23+08:00 daily https://www.pharmasources.com/industryinsights/long-awaited-ma-boom-will-hit-biopharma--307577.html 0.6 2026-07-21T13:33:00+08:00 daily https://www.pharmasources.com/industryinsights/valnevas-lyme-vaccinethe-only-active-can-307578.html 0.6 2026-06-20T16:53:18+08:00 daily https://www.pharmasources.com/industryinsights/pharma-rd-productivity-hits-new-low-amid-307579.html 0.6 2026-08-03T16:32:48+08:00 daily https://www.pharmasources.com/industryinsights/chief-digital-officers-land-at-big-pharm-307580.html 0.6 2026-06-22T19:24:14+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-chatbot-to-launch-in-us-307581.html 0.6 2026-06-21T12:50:12+08:00 daily https://www.pharmasources.com/industryinsights/digital-therapeutics-from-apps-to-smart--307582.html 0.6 2026-06-21T07:14:04+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-hands-upsa-consumer-307583.html 0.6 2026-06-20T14:47:57+08:00 daily https://www.pharmasources.com/industryinsights/alexion-joins-with-dicerna-to-develop-rn-307584.html 0.6 2026-07-28T17:44:25+08:00 daily https://www.pharmasources.com/industryinsights/thank-politiciansand-maybe-your-doctoras-307585.html 0.6 2026-06-21T12:52:42+08:00 daily https://www.pharmasources.com/industryinsights/roche-claims-us-approval-for-novel-flu-t-307586.html 0.6 2026-06-20T16:21:37+08:00 daily https://www.pharmasources.com/industryinsights/no-peak-in-sight-cancer-marketing-spread-307587.html 0.6 2026-06-21T07:23:37+08:00 daily https://www.pharmasources.com/industryinsights/wpp-makes-us-changes-to-sudler-ogilvy-co-307588.html 0.6 2026-06-22T12:52:02+08:00 daily https://www.pharmasources.com/industryinsights/amgen-cuts-us-price-of-cholesterol-drug--307589.html 0.6 2026-06-21T08:44:12+08:00 daily https://www.pharmasources.com/industryinsights/trump-signs-legislation-to-tackle-opiate-307590.html 0.6 2025-11-11T09:19:53+08:00 daily https://www.pharmasources.com/industryinsights/politics-and-tech-cap-2018-in-pharma-mar-307591.html 0.6 2026-08-06T15:15:39+08:00 daily https://www.pharmasources.com/industryinsights/amazon-joins-nih-cloud-computing-initiat-307592.html 0.6 2026-06-21T04:09:55+08:00 daily https://www.pharmasources.com/industryinsights/innovation-challenges-multiply-will-phar-307593.html 0.6 2026-06-20T17:59:16+08:00 daily https://www.pharmasources.com/industryinsights/lucid-group-expands-its-presence-in-nort-307594.html 0.6 2026-02-15T03:39:11+08:00 daily https://www.pharmasources.com/industryinsights/nvidia-partners-with-scripps-to-develop--307595.html 0.6 2026-06-20T16:57:14+08:00 daily https://www.pharmasources.com/industryinsights/bayer-plans-filings-for-prostate-cancer--307596.html 0.6 2026-06-20T20:56:11+08:00 daily https://www.pharmasources.com/industryinsights/gsk-pfizer-go-for-radical-makeovers-with-307597.html 0.6 2026-01-18T07:15:29+08:00 daily https://www.pharmasources.com/industryinsights/talc-lawyer-says-jjs-multibillion-dollar-307598.html 0.6 2026-07-15T07:09:26+08:00 daily https://www.pharmasources.com/industryinsights/lilly-lays-out-sunny-2019-forecast-drive-307599.html 0.6 2026-08-07T22:32:21+08:00 daily https://www.pharmasources.com/industryinsights/feds-abandon-11-white-coat-kickback-prob-307600.html 0.6 2026-07-09T05:25:17+08:00 daily https://www.pharmasources.com/industryinsights/lilly-aduro-biotech-in-immunotherapy-all-307601.html 0.6 2026-08-07T19:48:37+08:00 daily https://www.pharmasources.com/industryinsights/pci-synthesis-to-become-seqens-307602.html 0.6 2026-07-31T06:29:03+08:00 daily https://www.pharmasources.com/industryinsights/expect-more-transparency-around-pharmas--307603.html 0.6 2026-07-07T17:38:07+08:00 daily https://www.pharmasources.com/industryinsights/politics-and-tech-cap-2018-in-pharma-mar-307604.html 0.6 2026-07-31T17:52:10+08:00 daily https://www.pharmasources.com/industryinsights/long-awaited-ma-boom-will-hit-biopharma--307605.html 0.6 2026-08-08T02:24:32+08:00 daily https://www.pharmasources.com/industryinsights/tesaros-deal-struggles-theyre-actually-a-307606.html 0.6 2026-06-21T22:16:31+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-fibrogen-give-china-bragging-307607.html 0.6 2026-08-07T22:26:26+08:00 daily https://www.pharmasources.com/industryinsights/new-pfizer-ceos-top-priorities-think-chi-307608.html 0.6 2026-06-21T21:13:59+08:00 daily https://www.pharmasources.com/industryinsights/clovis-should-put-itself-up-for-sale-act-307609.html 0.6 2026-08-09T12:49:34+08:00 daily https://www.pharmasources.com/industryinsights/vertex-to-submit-orkambi-symkevi-to-smc-307610.html 0.6 2026-07-30T04:44:36+08:00 daily https://www.pharmasources.com/industryinsights/new-cervical-cancer-test-100-effective-307611.html 0.6 2026-08-04T04:45:48+08:00 daily https://www.pharmasources.com/industryinsights/dengvaxia-approved-for-dengue-in-eu-307612.html 0.6 2026-08-07T00:01:19+08:00 daily https://www.pharmasources.com/industryinsights/28-cases-of-polio-like-afp-seen-in-2018-307613.html 0.6 2026-08-06T23:54:54+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-gets-fda-approval-for-ovarian-c-307614.html 0.6 2026-08-06T23:45:18+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-updated-guidance-with-exp-307615.html 0.6 2026-08-06T23:36:18+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-responds-to-immigration--307616.html 0.6 2026-08-06T23:33:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-mustang-bio-odd-307617.html 0.6 2026-08-06T22:53:26+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-appoints-mfg-vp-307618.html 0.6 2026-08-06T20:00:37+08:00 daily https://www.pharmasources.com/industryinsights/chi-med-and-lilly-amend-2013-agreement-307619.html 0.6 2026-08-04T10:15:26+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-intrexon-amend-car-t-alliance-307620.html 0.6 2026-08-06T12:31:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-positive-results-f-307621.html 0.6 2026-08-06T13:00:19+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-fibrogen-receive-approva-307622.html 0.6 2026-08-08T02:55:29+08:00 daily https://www.pharmasources.com/industryinsights/bayer-partners-with-imperial-college-lon-307623.html 0.6 2026-08-03T13:03:45+08:00 daily https://www.pharmasources.com/industryinsights/powder-testing-and-powder-flow-applicati-307624.html 0.6 2026-08-07T01:19:20+08:00 daily https://www.pharmasources.com/industryinsights/japans-taisho-offers-to-acquire-bristol--307625.html 0.6 2026-08-09T18:46:57+08:00 daily https://www.pharmasources.com/industryinsights/aldeyra-announces-last-patient-dosed-in--307626.html 0.6 2026-08-06T10:21:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-new-ceo-of-oncology-b-307627.html 0.6 2026-07-16T11:56:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pembrolizumab-for-merkel-ce-307628.html 0.6 2026-07-31T03:11:44+08:00 daily https://www.pharmasources.com/industryinsights/sirnaomics-receives-fda-clearance-to-ini-307629.html 0.6 2026-08-07T15:11:03+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-pfizer-to-form-new-consu-307630.html 0.6 2026-07-30T01:21:10+08:00 daily https://www.pharmasources.com/industryinsights/astellas-pfizer-announce-positive-top-li-307631.html 0.6 2026-07-17T22:45:24+08:00 daily https://www.pharmasources.com/industryinsights/bridge-bio-daewoong-pharma-to-develop-ne-307632.html 0.6 2026-08-08T01:11:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-gsk-form-consumer-healthcare-jv-307633.html 0.6 2026-07-29T23:02:23+08:00 daily https://www.pharmasources.com/industryinsights/amgen-molecular-partners-enter-immunothe-307634.html 0.6 2026-06-21T11:48:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-asparlas-calaspargase-pegol-307635.html 0.6 2026-07-31T17:13:06+08:00 daily https://www.pharmasources.com/industryinsights/racial-disparities-seen-in-use-of-oral-a-307636.html 0.6 2026-06-20T17:00:26+08:00 daily https://www.pharmasources.com/industryinsights/affordable-care-act-sign-ups-higher-than-307637.html 0.6 2026-06-01T06:25:31+08:00 daily https://www.pharmasources.com/industryinsights/growth-in-use-of-telemedicine-seen-from--307638.html 0.6 2026-07-31T21:22:05+08:00 daily https://www.pharmasources.com/industryinsights/cdc-65-percent-of-us-women-currently-usi-307639.html 0.6 2026-07-29T22:47:23+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-benzodiazepine-use-126-per-307640.html 0.6 2026-07-30T19:58:20+08:00 daily https://www.pharmasources.com/industryinsights/that-gift-of-exercise-might-go-to-waste-307641.html 0.6 2026-07-31T15:05:16+08:00 daily https://www.pharmasources.com/industryinsights/opioid-od-deaths-soaring-among-native-am-307642.html 0.6 2026-08-01T19:39:10+08:00 daily https://www.pharmasources.com/industryinsights/toy-guns-pose-big-threat-to-young-eyes-307643.html 0.6 2026-08-08T09:15:07+08:00 daily https://www.pharmasources.com/industryinsights/stress-keeps-1-in-3-americans-up-at-nigh-307644.html 0.6 2026-08-02T07:12:35+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-to-potentially-end-operations--307645.html 0.6 2026-08-07T19:43:26+08:00 daily https://www.pharmasources.com/industryinsights/pall-corp-establishes-biotech-coe-in-sha-307646.html 0.6 2026-08-09T06:07:34+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-xl-protein-forge-strategic-all-307647.html 0.6 2026-03-17T22:34:38+08:00 daily https://www.pharmasources.com/industryinsights/roquette-thermo-fisher-enter-distributio-307648.html 0.6 2026-07-29T23:26:16+08:00 daily https://www.pharmasources.com/industryinsights/selexis-teneobio-enter-second-services-a-307649.html 0.6 2026-07-31T06:10:08+08:00 daily https://www.pharmasources.com/industryinsights/gilead-agenus-enter-immuno-oncology-pact-307650.html 0.6 2026-08-08T00:52:08+08:00 daily https://www.pharmasources.com/industryinsights/marken-and-trakcel-collaborate-to-serve--307651.html 0.6 2026-07-29T18:37:04+08:00 daily https://www.pharmasources.com/industryinsights/scotlands-nhs-could-reimburse-vertex-cf--307652.html 0.6 2026-08-07T00:02:30+08:00 daily https://www.pharmasources.com/industryinsights/azmerck-co-get-new-us-use-for-ovarian-ca-307653.html 0.6 2026-06-20T18:01:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-oncology-ceo-quits-after-less-t-307654.html 0.6 2026-08-05T00:53:29+08:00 daily https://www.pharmasources.com/industryinsights/bms-confirms-taishos-16bn-offer-for-upsa-307655.html 0.6 2026-07-31T03:21:49+08:00 daily https://www.pharmasources.com/industryinsights/innate-pharma-gains-rights-to-azs-recent-307656.html 0.6 2026-07-31T18:19:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-cns-exit-takes-the-form-of-a-bio-307657.html 0.6 2026-08-05T00:06:15+08:00 daily https://www.pharmasources.com/industryinsights/alcon-to-build-digital-platform-to-impro-307658.html 0.6 2026-07-31T21:58:27+08:00 daily https://www.pharmasources.com/industryinsights/patients-may-have-to-build-drug-stockpil-307659.html 0.6 2026-07-09T19:20:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sanofiregenerons-dupixent-i-307660.html 0.6 2026-08-04T22:01:11+08:00 daily https://www.pharmasources.com/industryinsights/irish-authorities-demand-16bn-in-back-ta-307661.html 0.6 2026-08-09T21:56:59+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-agenus-sign-cancer-drug-devel-307662.html 0.6 2026-08-01T17:54:41+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-seeks-us-and-european-authorisati-307663.html 0.6 2026-07-17T11:08:16+08:00 daily https://www.pharmasources.com/industryinsights/astellas-pharma-taisho-pharmaceuticals-a-307664.html 0.6 2026-08-07T23:16:27+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-incyte-novo-nordisk-shar-307665.html 0.6 2026-08-06T02:44:09+08:00 daily https://www.pharmasources.com/industryinsights/novartis-makes-offer-to-acquire-french-c-307666.html 0.6 2026-08-02T22:01:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-rare-bl-307667.html 0.6 2026-06-20T02:14:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-medwatch-alert-for-fluoroq-307668.html 0.6 2026-08-05T18:52:32+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biotherapeutics-receives-ind-clea-307669.html 0.6 2026-08-08T16:48:42+08:00 daily https://www.pharmasources.com/industryinsights/therapix-biosciences-terminates-fsd-acqu-307670.html 0.6 2026-08-07T23:53:24+08:00 daily https://www.pharmasources.com/industryinsights/coaguchek-test-strips-recalled-307671.html 0.6 2026-07-09T13:27:28+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-initiates-study-of-two-in-307672.html 0.6 2026-08-03T22:58:47+08:00 daily https://www.pharmasources.com/industryinsights/gilead-agenus-form-18bn-partnership-307673.html 0.6 2026-06-21T02:59:45+08:00 daily https://www.pharmasources.com/industryinsights/new-clinical-trial-reduces-breast-cancer-307674.html 0.6 2026-06-21T12:07:13+08:00 daily https://www.pharmasources.com/industryinsights/molecule-discovery-shows-promise-for-pso-307675.html 0.6 2026-07-03T05:49:45+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-announces-offer-fro-307676.html 0.6 2026-08-04T23:31:46+08:00 daily https://www.pharmasources.com/industryinsights/aveo-oncology-announces-clinical-collabo-307677.html 0.6 2026-08-03T02:56:53+08:00 daily https://www.pharmasources.com/industryinsights/torrent-pharmaceuticals-issues-recall-of-307678.html 0.6 2026-07-29T21:27:04+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-application-to-fda-for-s-307679.html 0.6 2026-08-08T14:37:56+08:00 daily https://www.pharmasources.com/industryinsights/winters-many-challenges-to-eye-health-307680.html 0.6 2026-08-09T00:52:53+08:00 daily https://www.pharmasources.com/industryinsights/imperial-and-bayer-to-use-ai-for-heart-c-307681.html 0.6 2026-08-05T20:24:08+08:00 daily https://www.pharmasources.com/industryinsights/recro-pharma-amends-iv-meloxicam-license-307682.html 0.6 2026-08-02T02:29:23+08:00 daily https://www.pharmasources.com/industryinsights/windtree-therapeutics-and-cvie-therapeut-307683.html 0.6 2026-08-10T01:34:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-inbrija-levodopa-inhalation-307684.html 0.6 2026-06-22T05:50:35+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-receives-new-pdufa--307685.html 0.6 2026-08-04T00:52:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-companies-on-unsafe-unapproved-307686.html 0.6 2026-08-05T23:39:38+08:00 daily https://www.pharmasources.com/industryinsights/focusing-on-cro-cmo-industry-upgrading-h-307687.html 0.6 2026-08-09T17:48:27+08:00 daily https://www.pharmasources.com/industryinsights/incorrect-prescribing-alerts-common-for--307688.html 0.6 2026-08-05T03:49:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-offers-to-buy-kymriah-manufactu-307689.html 0.6 2026-06-21T12:18:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-review-of-merck-cos-keytruda-307690.html 0.6 2026-06-20T18:55:55+08:00 daily https://www.pharmasources.com/industryinsights/aimmune-therapeutics-submits-bla-to-fda--307691.html 0.6 2026-07-31T14:57:45+08:00 daily https://www.pharmasources.com/industryinsights/azs-new-copd-inhaler-bevespi-aerosphere--307692.html 0.6 2026-07-29T18:29:36+08:00 daily https://www.pharmasources.com/industryinsights/merck-takes-a-back-seat-on-car-t-handing-307693.html 0.6 2026-08-09T18:48:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-safety-monitoring-measures-307694.html 0.6 2026-06-22T13:05:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-elzonris-tagraxofusp-erzs-t-307695.html 0.6 2026-06-21T10:01:11+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-lenvima-for-advanced-liv-307696.html 0.6 2026-06-21T03:07:44+08:00 daily https://www.pharmasources.com/industryinsights/after-new-years-expect-more-drug-pricing-307697.html 0.6 2026-08-04T20:50:31+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-puts-heat-on-pfizer-merc-307698.html 0.6 2026-06-22T05:49:33+08:00 daily https://www.pharmasources.com/industryinsights/will-pharmas-exodus-from-consumer-health-307699.html 0.6 2026-06-23T11:04:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-mercks-lynparza-plows-ahead--307700.html 0.6 2026-07-06T02:19:38+08:00 daily https://www.pharmasources.com/industryinsights/fiercepharmas-annual-look-ahead-when-the-307701.html 0.6 2026-06-21T22:44:50+08:00 daily https://www.pharmasources.com/industryinsights/heres-a-top-10-quiz-what-kind-of-2018-ne-307702.html 0.6 2026-06-21T04:18:35+08:00 daily https://www.pharmasources.com/industryinsights/europes-biggest-private-biotech-company--307703.html 0.6 2026-07-06T00:59:02+08:00 daily https://www.pharmasources.com/industryinsights/dr-mohyuddin-mirza-to-join-phoenix-life--307704.html 0.6 2026-06-21T04:04:51+08:00 daily https://www.pharmasources.com/industryinsights/whiteswell-raises-30m-for-heart-failure--307705.html 0.6 2026-07-03T05:11:20+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-applies-for-marketing-remima-307706.html 0.6 2026-06-20T23:13:14+08:00 daily https://www.pharmasources.com/industryinsights/gilead-inks-18-bn-deal-with-immuno-oncol-307707.html 0.6 2026-06-20T16:56:13+08:00 daily https://www.pharmasources.com/industryinsights/kcl-researchers-find-link-between-overac-307708.html 0.6 2026-06-20T21:57:34+08:00 daily https://www.pharmasources.com/industryinsights/jjs-baby-powder-tested-in-india-and-bang-307709.html 0.6 2026-06-21T00:03:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-hands-over-car-t-therapy-busi-307710.html 0.6 2026-08-08T22:31:28+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018122-307711.html 0.6 2026-08-07T02:26:46+08:00 daily https://www.pharmasources.com/industryinsights/after-new-years-expect-more-drug-pricing-307712.html 0.6 2026-06-21T20:53:33+08:00 daily https://www.pharmasources.com/industryinsights/talc-lawyer-says-jjs-multibillion-dollar-307713.html 0.6 2026-06-20T15:10:20+08:00 daily https://www.pharmasources.com/industryinsights/as-immuno-oncology-heads-into-2019-one-t-307714.html 0.6 2026-06-24T10:36:16+08:00 daily https://www.pharmasources.com/industryinsights/expect-more-transparency-around-pharmas--307715.html 0.6 2026-08-07T12:09:09+08:00 daily https://www.pharmasources.com/industryinsights/vit-c-for-pregnant-smokers-may-improve-n-307716.html 0.6 2026-07-01T01:32:12+08:00 daily https://www.pharmasources.com/industryinsights/costs-expected-weight-loss-impact-bariat-307717.html 0.6 2026-07-01T05:26:16+08:00 daily https://www.pharmasources.com/industryinsights/ems-treatment-for-possible-heart-attack--307718.html 0.6 2026-06-22T07:53:39+08:00 daily https://www.pharmasources.com/industryinsights/holidays-pitfalls-for-those-with-food-al-307719.html 0.6 2026-06-21T12:13:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drugs-for-treatment-of-two--307720.html 0.6 2026-06-20T15:13:54+08:00 daily https://www.pharmasources.com/industryinsights/hpv-ups-cervical-cancer-risk-even-with-n-307721.html 0.6 2026-06-16T00:00:57+08:00 daily https://www.pharmasources.com/industryinsights/nhs-u-turns-on-afinitor-for-tsc-related--307722.html 0.6 2026-06-21T15:54:19+08:00 daily https://www.pharmasources.com/industryinsights/puretechs-vedanta-raises-27m-for-microbi-307723.html 0.6 2026-06-21T02:16:52+08:00 daily https://www.pharmasources.com/industryinsights/merckpfizers-bavencio-flunks-second-ovar-307724.html 0.6 2026-06-21T19:11:47+08:00 daily https://www.pharmasources.com/industryinsights/relay-therapeutics-bags-400m-to-ramp-up--307725.html 0.6 2026-06-21T02:06:18+08:00 daily https://www.pharmasources.com/industryinsights/can-chinas-rd-sector-shake-its-reputatio-307726.html 0.6 2026-06-21T04:56:44+08:00 daily https://www.pharmasources.com/industryinsights/six-practices-of-high-performing-clinica-307727.html 0.6 2026-06-21T07:58:02+08:00 daily https://www.pharmasources.com/industryinsights/2019s-medtech-industry-to-weigh-hype-and-307728.html 0.6 2026-07-06T06:53:42+08:00 daily https://www.pharmasources.com/industryinsights/g1-tanks-after-placebo-beats-drug-in-can-307729.html 0.6 2026-01-11T21:34:50+08:00 daily https://www.pharmasources.com/industryinsights/dbv-pulls-peanut-allergy-filing-after-fd-307730.html 0.6 2026-06-20T14:16:29+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-files-confidential-ipo-lis-307731.html 0.6 2026-06-21T09:15:12+08:00 daily https://www.pharmasources.com/industryinsights/amgen-pays-50m-for-molecular-partners-pr-307732.html 0.6 2026-06-23T10:16:22+08:00 daily https://www.pharmasources.com/industryinsights/roivant-strikes-broad-pipeline-pact-with-307733.html 0.6 2026-06-21T10:13:19+08:00 daily https://www.pharmasources.com/industryinsights/tetra-shionogi-ink-40m-pact-on-pde4-drug-307734.html 0.6 2026-04-17T22:18:55+08:00 daily https://www.pharmasources.com/industryinsights/geneva-health-partners-with-ochsner-in-r-307735.html 0.6 2026-06-21T19:57:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-taps-flatirons-abernethy-for-oversig-307736.html 0.6 2026-07-03T12:55:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-finalizes-breakthrough-device-guidan-307737.html 0.6 2026-06-24T01:09:32+08:00 daily https://www.pharmasources.com/industryinsights/sophiris-slides-on-prostate-cancer-data--307738.html 0.6 2026-05-06T17:14:57+08:00 daily https://www.pharmasources.com/industryinsights/erasca-picks-up-42m-to-target-biological-307739.html 0.6 2026-06-23T04:55:09+08:00 daily https://www.pharmasources.com/industryinsights/lexicon-pain-drug-advances-after-clearin-307740.html 0.6 2026-06-24T07:37:01+08:00 daily https://www.pharmasources.com/industryinsights/idorsias-selatogrel-hits-goals-in-phase--307741.html 0.6 2026-06-22T18:26:09+08:00 daily https://www.pharmasources.com/industryinsights/entrada-emerges-with-59m-to-fund-the-del-307742.html 0.6 2026-06-24T08:46:02+08:00 daily https://www.pharmasources.com/industryinsights/retia-medical-secures-510k-green-light-f-307743.html 0.6 2026-06-23T02:16:35+08:00 daily https://www.pharmasources.com/industryinsights/versant-closes-two-new-biotech-funds-tot-307744.html 0.6 2026-07-13T11:13:56+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-h3-biomedicine-explore-rna-307745.html 0.6 2026-06-22T12:29:02+08:00 daily https://www.pharmasources.com/industryinsights/politics-and-tech-cap-2018-in-pharma-mar-307746.html 0.6 2026-07-10T13:16:51+08:00 daily https://www.pharmasources.com/industryinsights/chief-digital-officers-land-at-big-pharm-307747.html 0.6 2026-06-23T09:25:54+08:00 daily https://www.pharmasources.com/industryinsights/digital-therapeutics-from-apps-to-smart--307748.html 0.6 2026-08-09T19:13:45+08:00 daily https://www.pharmasources.com/industryinsights/thank-politiciansand-maybe-your-doctoras-307749.html 0.6 2026-08-07T21:50:01+08:00 daily https://www.pharmasources.com/industryinsights/no-peak-in-sight-cancer-marketing-spread-307750.html 0.6 2026-08-09T20:57:01+08:00 daily https://www.pharmasources.com/industryinsights/talc-lawyer-says-jjs-multibillion-dollar-307751.html 0.6 2026-07-03T22:31:54+08:00 daily https://www.pharmasources.com/industryinsights/gsk-pfizer-go-for-radical-makeovers-with-307752.html 0.6 2026-06-21T02:00:02+08:00 daily https://www.pharmasources.com/industryinsights/lilly-lays-out-sunny-2019-forecast-drive-307753.html 0.6 2026-08-07T22:51:51+08:00 daily https://www.pharmasources.com/industryinsights/feds-abandon-11-white-coat-kickback-prob-307754.html 0.6 2026-06-20T22:17:02+08:00 daily https://www.pharmasources.com/industryinsights/summary-of-main-targeted-drugs-for-breas-307755.html 0.6 2026-06-22T22:17:33+08:00 daily https://www.pharmasources.com/industryinsights/treatments-of-breast-cancer-and-main-dru-307756.html 0.6 2026-07-28T04:43:57+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-clinical-trials-top-drugs--307757.html 0.6 2026-06-30T15:39:18+08:00 daily https://www.pharmasources.com/industryinsights/gathering-hotspots-of-the-preparation-in-307758.html 0.6 2026-07-24T05:11:29+08:00 daily https://www.pharmasources.com/industryinsights/gathering-quality-pharmaceutical-excipie-307759.html 0.6 2026-06-29T12:47:44+08:00 daily https://www.pharmasources.com/industryinsights/mergers-among-biotech-stocks-could-rise--307760.html 0.6 2026-06-21T11:59:22+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-delivery-delays-blamed-as-just-h-307761.html 0.6 2026-06-22T11:51:42+08:00 daily https://www.pharmasources.com/industryinsights/nature-publication-reports-first-in-huma-307762.html 0.6 2026-04-14T04:12:25+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharmas-shares-drop-on-acquisition--307763.html 0.6 2026-04-14T18:25:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-zydus-cadila-to-market-generi-307764.html 0.6 2026-06-20T19:49:00+08:00 daily https://www.pharmasources.com/industryinsights/loneliness-doesnt-take-a-holiday-307765.html 0.6 2026-06-21T04:01:48+08:00 daily https://www.pharmasources.com/industryinsights/how-to-handle-holiday-stressors-307766.html 0.6 2026-06-21T08:49:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ultomiris-ravulizumab-cwvz--307767.html 0.6 2026-07-28T14:32:57+08:00 daily https://www.pharmasources.com/industryinsights/pharmaxis-announces-resubmission-of-bron-307768.html 0.6 2026-06-21T18:04:38+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-and-biogen-announce-submission--307769.html 0.6 2026-06-20T22:59:45+08:00 daily https://www.pharmasources.com/industryinsights/imugene-encouraged-by-data-for-her2-vacc-307770.html 0.6 2026-07-28T07:37:56+08:00 daily https://www.pharmasources.com/industryinsights/novo-bags-430m-staten-buyout-option-to-b-307771.html 0.6 2026-08-07T22:00:53+08:00 daily https://www.pharmasources.com/industryinsights/proteome-blood-test-developer-seer-emerg-307772.html 0.6 2026-06-21T23:20:48+08:00 daily https://www.pharmasources.com/industryinsights/softbank-returns-to-back-synthetic-biolo-307773.html 0.6 2026-06-11T16:15:48+08:00 daily https://www.pharmasources.com/industryinsights/ideras-tlr9-yervoy-combo-sees-impressive-307774.html 0.6 2026-06-21T05:01:42+08:00 daily https://www.pharmasources.com/industryinsights/guardant-to-develop-cdx-and-tmb-liquid-b-307775.html 0.6 2026-06-13T01:19:00+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-and-evidation-expand-digital-b-307776.html 0.6 2026-06-21T12:04:15+08:00 daily https://www.pharmasources.com/industryinsights/bellicum-reports-first-data-on-controlla-307777.html 0.6 2026-08-07T01:42:51+08:00 daily https://www.pharmasources.com/industryinsights/sensorions-vertigo-drug-hits-tolerabilit-307778.html 0.6 2026-08-07T01:39:35+08:00 daily https://www.pharmasources.com/industryinsights/axovant-buys-more-gene-therapies-setting-307779.html 0.6 2026-08-07T01:27:32+08:00 daily https://www.pharmasources.com/industryinsights/owkin-launches-global-patient-data-shari-307780.html 0.6 2026-08-07T01:19:40+08:00 daily https://www.pharmasources.com/industryinsights/crispr-controls-obesity-in-mice-by-ampli-307781.html 0.6 2026-08-07T01:11:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-ar-safety-warning-system-for--307782.html 0.6 2026-08-07T00:40:44+08:00 daily https://www.pharmasources.com/industryinsights/mission-bio-reels-in-30m-for-single-cell-307783.html 0.6 2026-06-27T22:18:00+08:00 daily https://www.pharmasources.com/industryinsights/could-a-once-abandoned-obesity-drug-be-r-307784.html 0.6 2026-06-20T13:19:41+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-psychogenics-nondopamine-schizo-307785.html 0.6 2026-06-21T05:10:53+08:00 daily https://www.pharmasources.com/industryinsights/amag-merges-with-perosphere-adding-noac--307786.html 0.6 2026-07-03T22:07:03+08:00 daily https://www.pharmasources.com/industryinsights/biogen-bails-on-agtc-after-ocular-gene-t-307787.html 0.6 2026-06-21T11:00:14+08:00 daily https://www.pharmasources.com/industryinsights/biofrontera-cleared-of-wrongdoing-in-nas-307788.html 0.6 2026-06-20T16:51:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-hails-2018-as-bumper-year-for-drug-d-307789.html 0.6 2026-07-05T15:04:24+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-plans-pivotal-trial-after-seeing-307790.html 0.6 2026-06-22T08:05:18+08:00 daily https://www.pharmasources.com/industryinsights/cancer-killing-virus-plus-pd-1-and-mek-i-307791.html 0.6 2026-06-21T08:24:37+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-develop-new-dmmr-pan-cancer-tes-307792.html 0.6 2026-06-21T04:58:46+08:00 daily https://www.pharmasources.com/industryinsights/gensight-rebuilds-its-case-for-lhon-gene-307793.html 0.6 2026-06-23T18:47:41+08:00 daily https://www.pharmasources.com/industryinsights/nash-focused-akero-therapeutics-adds-ano-307794.html 0.6 2026-08-03T05:53:41+08:00 daily https://www.pharmasources.com/industryinsights/tailor-made-excipients-developed-the-kol-307795.html 0.6 2026-05-06T16:57:44+08:00 daily https://www.pharmasources.com/industryinsights/lupin-in-partnership-with-abbvie-307796.html 0.6 2026-06-21T10:56:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-still-struggling-with-kymriah-m-307797.html 0.6 2026-06-20T23:13:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-fibrogen-give-china-bragging-307798.html 0.6 2026-07-20T12:51:17+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-blueprints-hefty-new-boston-hq-wi-307799.html 0.6 2026-06-27T09:43:37+08:00 daily https://www.pharmasources.com/industryinsights/clovis-should-put-itself-up-for-sale-act-307800.html 0.6 2026-06-22T00:55:46+08:00 daily https://www.pharmasources.com/industryinsights/rd-returns-fall-to-lowest-level-in-nine--307801.html 0.6 2026-06-27T19:27:18+08:00 daily https://www.pharmasources.com/industryinsights/lupin-and-abbvie-announce-partnership-to-307802.html 0.6 2026-07-17T23:39:17+08:00 daily https://www.pharmasources.com/industryinsights/merck-pfizer-terminate-avelumab-trial-of-307803.html 0.6 2026-06-20T14:45:06+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-announces-fda-acceptance-307804.html 0.6 2026-06-20T22:00:38+08:00 daily https://www.pharmasources.com/industryinsights/orgenesis-collaborates-with-mangogen-pha-307805.html 0.6 2026-08-05T05:59:04+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-subsidiary-awarded-preliminar-307806.html 0.6 2026-06-22T08:57:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-makes-offer-for-french-cdmo-307807.html 0.6 2026-06-21T08:47:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-elzonris-for-bpdcn-307808.html 0.6 2026-06-21T06:02:46+08:00 daily https://www.pharmasources.com/industryinsights/agc-triples-us-biopharma-production-capa-307809.html 0.6 2026-06-21T07:24:17+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-appoints-director-of-business-d-307810.html 0.6 2026-07-17T10:44:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-paroxysma-307811.html 0.6 2026-04-17T04:03:58+08:00 daily https://www.pharmasources.com/industryinsights/ppd-expands-gmp-lab-testing-capabilities-307812.html 0.6 2026-05-11T08:43:49+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-begins-construction-of-fa-307813.html 0.6 2026-06-21T12:11:26+08:00 daily https://www.pharmasources.com/industryinsights/braeburn-announces-tentative-fda-approva-307814.html 0.6 2026-06-21T07:00:57+08:00 daily https://www.pharmasources.com/industryinsights/3p-biopharmaceuticals-completes-facility-307815.html 0.6 2026-06-21T11:10:18+08:00 daily https://www.pharmasources.com/industryinsights/elite-receives-fda-approval-for-hydrocod-307816.html 0.6 2026-06-21T17:06:30+08:00 daily https://www.pharmasources.com/industryinsights/entresto-awarded-prix-galien-canada-inno-307817.html 0.6 2026-06-21T17:41:29+08:00 daily https://www.pharmasources.com/industryinsights/theravance-biopharma-announces-first-pat-307818.html 0.6 2026-06-20T19:00:40+08:00 daily https://www.pharmasources.com/industryinsights/one-womans-case-gives-new-hope-against-d-307819.html 0.6 2026-06-20T20:33:09+08:00 daily https://www.pharmasources.com/industryinsights/if-youre-diabetic-foot-care-a-must-307820.html 0.6 2026-06-21T22:50:45+08:00 daily https://www.pharmasources.com/industryinsights/kicking-punching-whos-at-risk-for-a-viol-307821.html 0.6 2026-01-30T18:32:02+08:00 daily https://www.pharmasources.com/industryinsights/short-people-fare-worse-in-icus-study-307822.html 0.6 2026-06-21T17:00:29+08:00 daily https://www.pharmasources.com/industryinsights/home-oxygen-users-experience-problems-re-307823.html 0.6 2026-07-03T19:46:14+08:00 daily https://www.pharmasources.com/industryinsights/appalachia-western-states-have-highest-h-307824.html 0.6 2026-07-06T16:11:03+08:00 daily https://www.pharmasources.com/industryinsights/acog-interpregnancy-period-should-maximi-307825.html 0.6 2026-06-22T07:55:18+08:00 daily https://www.pharmasources.com/industryinsights/malnutrition-ups-risk-of-postop-issues-i-307826.html 0.6 2026-07-02T01:10:13+08:00 daily https://www.pharmasources.com/industryinsights/drug-use-associated-infective-endocardit-307827.html 0.6 2026-06-22T03:54:56+08:00 daily https://www.pharmasources.com/industryinsights/casma-names-third-rock-venture-partner-a-307828.html 0.6 2026-06-22T09:57:46+08:00 daily https://www.pharmasources.com/industryinsights/innovate-and-win-the-future-through-inte-307829.html 0.6 2026-07-31T05:40:42+08:00 daily https://www.pharmasources.com/industryinsights/lilly-pays-ac-immune-81m-upfront-for-pre-307830.html 0.6 2026-08-01T08:34:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-first-xenotransplantation-tri-307831.html 0.6 2026-06-20T22:03:40+08:00 daily https://www.pharmasources.com/industryinsights/ra-pharma-files-100m-round-as-soliris-ri-307832.html 0.6 2026-06-20T23:58:34+08:00 daily https://www.pharmasources.com/industryinsights/amgen-teams-with-entera-to-develop-oral--307833.html 0.6 2026-02-28T15:30:16+08:00 daily https://www.pharmasources.com/industryinsights/grasp-the-changing-trend-and-seek-indust-307834.html 0.6 2026-06-22T04:05:48+08:00 daily https://www.pharmasources.com/industryinsights/4-years-after-mega-ipo-circassia-set-for-307835.html 0.6 2026-06-20T13:20:45+08:00 daily https://www.pharmasources.com/industryinsights/janssen-alums-aro-biotherapeutics-takes--307836.html 0.6 2026-06-20T21:11:50+08:00 daily https://www.pharmasources.com/industryinsights/downsizing-storm-of-multinational-pharma-307837.html 0.6 2026-06-22T23:14:35+08:00 daily https://www.pharmasources.com/industryinsights/crispr-based-heart-test-pinpoints-geneti-307838.html 0.6 2026-07-04T08:39:56+08:00 daily https://www.pharmasources.com/industryinsights/genedit-reels-in-85m-to-tackle-delivery--307839.html 0.6 2026-06-26T21:30:34+08:00 daily https://www.pharmasources.com/industryinsights/olympus-medical-pleads-guilty-to-not-fil-307840.html 0.6 2026-06-21T21:12:50+08:00 daily https://www.pharmasources.com/industryinsights/black-diamond-debuts-with-20m-mission-to-307841.html 0.6 2026-06-21T02:58:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-pears-smartphone-app-therapy--307842.html 0.6 2026-06-21T02:40:20+08:00 daily https://www.pharmasources.com/industryinsights/post-monsanto-era-of-bayer-group-to-lay--307843.html 0.6 2026-08-08T18:53:29+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-fda-drug-review-in-2018-the--307844.html 0.6 2026-08-09T12:43:17+08:00 daily https://www.pharmasources.com/industryinsights/the-novel-drugs-marketed-in-2018-307845.html 0.6 2026-06-29T18:10:44+08:00 daily https://www.pharmasources.com/industryinsights/the-future-is-already-here-produce-the-l-307846.html 0.6 2026-08-07T03:25:23+08:00 daily https://www.pharmasources.com/industryinsights/delcath-announces-commercial-licensing-a-307847.html 0.6 2026-06-20T01:54:38+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-sales-rep-pleads-guilty-t-307848.html 0.6 2026-06-20T20:58:41+08:00 daily https://www.pharmasources.com/industryinsights/helsinn-grants-exclusive-licensing-right-307849.html 0.6 2026-06-20T00:15:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-daurismo-with-cytarabine-fo-307850.html 0.6 2026-07-21T19:54:13+08:00 daily https://www.pharmasources.com/industryinsights/cannabics-pharmaceuticals-announces-new--307851.html 0.6 2026-06-20T16:02:20+08:00 daily https://www.pharmasources.com/industryinsights/athenex-pharmaceutical-launches-levothyr-307852.html 0.6 2026-06-22T21:18:02+08:00 daily https://www.pharmasources.com/industryinsights/kidney-disease-risk-tied-to-sugar-sweete-307853.html 0.6 2026-06-24T09:56:04+08:00 daily https://www.pharmasources.com/industryinsights/ptsd-drug-may-do-more-harm-than-good-307854.html 0.6 2026-08-07T13:19:22+08:00 daily https://www.pharmasources.com/industryinsights/being-bullied-may-alter-the-teen-brain-307855.html 0.6 2026-06-22T16:15:51+08:00 daily https://www.pharmasources.com/industryinsights/oculomotor-response-to-head-impacts-stud-307856.html 0.6 2026-06-21T02:13:52+08:00 daily https://www.pharmasources.com/industryinsights/low-vitamin-d-tied-to-risk-for-renal-hyp-307857.html 0.6 2026-06-22T17:57:56+08:00 daily https://www.pharmasources.com/industryinsights/elevated-risk-for-lung-ca-in-lung-transp-307858.html 0.6 2026-06-28T15:28:32+08:00 daily https://www.pharmasources.com/industryinsights/universal-vaccination-for-menb-at-colleg-307859.html 0.6 2026-06-21T20:45:20+08:00 daily https://www.pharmasources.com/industryinsights/pediatric-asthma-risk-score-has-good-sen-307860.html 0.6 2026-06-20T19:08:42+08:00 daily https://www.pharmasources.com/industryinsights/is-your-state-a-hotspot-for-obesity-link-307861.html 0.6 2026-01-26T07:27:02+08:00 daily https://www.pharmasources.com/industryinsights/10x-genomics-steps-into-tissue-level-gen-307862.html 0.6 2026-06-21T01:05:51+08:00 daily https://www.pharmasources.com/industryinsights/gritstone-ramps-up-bispecifics-with-new--307863.html 0.6 2026-07-29T23:01:38+08:00 daily https://www.pharmasources.com/industryinsights/junshi-biosciences-aims-for-414m-hong-ko-307864.html 0.6 2026-06-21T12:59:28+08:00 daily https://www.pharmasources.com/industryinsights/novo-taps-e-therapeutics-for-diabetes-ta-307865.html 0.6 2026-06-20T20:20:19+08:00 daily https://www.pharmasources.com/industryinsights/macrogenics-halts-trials-of-cancer-drug--307866.html 0.6 2026-06-22T00:59:46+08:00 daily https://www.pharmasources.com/industryinsights/axovant-dumps-nelotanserin-in-retreat-fr-307867.html 0.6 2026-06-20T20:05:39+08:00 daily https://www.pharmasources.com/industryinsights/luma-begins-launch-of-ultraviolet-light--307868.html 0.6 2026-06-20T20:55:43+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-taps-cyclica-for-ai-based-scr-307869.html 0.6 2026-06-21T11:01:17+08:00 daily https://www.pharmasources.com/industryinsights/the-apple-watchs-ecg-features-are-live-307870.html 0.6 2026-06-20T15:57:43+08:00 daily https://www.pharmasources.com/industryinsights/eisai-ucl-extend-neuro-pact-gear-up-for--307871.html 0.6 2026-06-21T03:02:47+08:00 daily https://www.pharmasources.com/industryinsights/regenerating-insulin-producing-cells-wit-307872.html 0.6 2026-06-21T04:09:51+08:00 daily https://www.pharmasources.com/industryinsights/diamedica-pulls-off-ipo-to-fund-midphase-307873.html 0.6 2026-07-05T11:14:27+08:00 daily https://www.pharmasources.com/industryinsights/modernas-cash-juggernaut-rolls-on-with-r-307874.html 0.6 2026-06-20T23:17:01+08:00 daily https://www.pharmasources.com/industryinsights/myriad-study-shows-breast-cancer-recurre-307875.html 0.6 2026-06-21T08:10:04+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-tremelimumab-fails-another--307876.html 0.6 2026-06-21T07:55:57+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-a-new-model-for-307877.html 0.6 2026-08-07T05:08:19+08:00 daily https://www.pharmasources.com/industryinsights/all-powerful-drug-of-allergan-botox-push-307878.html 0.6 2026-08-07T03:30:50+08:00 daily https://www.pharmasources.com/industryinsights/the-strictest-law-for-vaccine-china-to-s-307879.html 0.6 2026-08-07T03:02:48+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-launch-of-sevelamer--307880.html 0.6 2026-07-26T05:12:54+08:00 daily https://www.pharmasources.com/industryinsights/independent-dmc-recommends-trial-discont-307881.html 0.6 2026-08-09T05:43:58+08:00 daily https://www.pharmasources.com/industryinsights/spectrum-submits-bla-for-rolontis-307882.html 0.6 2026-08-06T22:53:25+08:00 daily https://www.pharmasources.com/industryinsights/bio-thera-solutions-files-ind-for-phase--307883.html 0.6 2026-08-06T23:32:19+08:00 daily https://www.pharmasources.com/industryinsights/enclear-spins-out-of-quralis-307884.html 0.6 2026-08-07T23:49:56+08:00 daily https://www.pharmasources.com/industryinsights/horizon-pharma-announces-fda-approval-to-307885.html 0.6 2026-08-06T23:46:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vaxelis-307886.html 0.6 2026-07-04T23:14:06+08:00 daily https://www.pharmasources.com/industryinsights/merck-provides-update-on-keytruda-sbla-f-307887.html 0.6 2026-08-08T03:39:20+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-completes-enrollment-of-ph-307888.html 0.6 2026-06-21T08:08:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-new-drug-application-for-kpi-307889.html 0.6 2026-06-21T02:12:49+08:00 daily https://www.pharmasources.com/industryinsights/perlara-announces-partnership-with-ramba-307890.html 0.6 2026-06-20T15:51:30+08:00 daily https://www.pharmasources.com/industryinsights/bioxcels-agitation-drug-gets-fda-fast-tr-307891.html 0.6 2026-07-08T18:33:31+08:00 daily https://www.pharmasources.com/industryinsights/teva-and-neos-settle-over-cotempla-paten-307892.html 0.6 2026-06-21T11:01:12+08:00 daily https://www.pharmasources.com/industryinsights/hebrew-university-to-collaborate-with-ky-307893.html 0.6 2026-07-06T09:56:38+08:00 daily https://www.pharmasources.com/industryinsights/good-sleep-helps-kids-become-slimmer-hea-307894.html 0.6 2026-06-21T07:17:06+08:00 daily https://www.pharmasources.com/industryinsights/second-line-antidiabetic-meds-may-impact-307895.html 0.6 2026-06-21T18:01:22+08:00 daily https://www.pharmasources.com/industryinsights/effect-sizes-uncertain-for-meds-versus-p-307896.html 0.6 2026-06-21T03:15:52+08:00 daily https://www.pharmasources.com/industryinsights/high-sodium-intake-associated-with-new-a-307897.html 0.6 2026-08-07T05:30:41+08:00 daily https://www.pharmasources.com/industryinsights/new-guidelines-address-care-for-malignan-307898.html 0.6 2026-08-07T00:43:02+08:00 daily https://www.pharmasources.com/industryinsights/acog-updates-guidelines-for-gestational--307899.html 0.6 2026-08-07T00:41:24+08:00 daily https://www.pharmasources.com/industryinsights/people-with-movement-disorders-may-becom-307900.html 0.6 2026-08-07T00:02:32+08:00 daily https://www.pharmasources.com/industryinsights/opioid-overdose-deaths-triple-among-teen-307901.html 0.6 2026-08-06T23:55:16+08:00 daily https://www.pharmasources.com/industryinsights/navidea-brings-on-new-chief-medical-offi-307902.html 0.6 2026-08-07T00:02:05+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-to-pay-51m-to-settle-doj-claim-307903.html 0.6 2026-08-07T00:40:31+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-makes-a-flurry-of-deals-in-chi-307904.html 0.6 2026-08-08T23:17:05+08:00 daily https://www.pharmasources.com/industryinsights/supernus-stocks-down-once-more-despite-p-307905.html 0.6 2026-08-07T13:18:56+08:00 daily https://www.pharmasources.com/industryinsights/sofinnova-lsp-lead-17m-round-for-gene-th-307906.html 0.6 2026-08-08T03:08:51+08:00 daily https://www.pharmasources.com/industryinsights/impel-raises-675m-as-it-eyes-filing-for--307907.html 0.6 2026-08-08T07:57:13+08:00 daily https://www.pharmasources.com/industryinsights/genfits-elafibranor-hits-goal-in-phase-2-307908.html 0.6 2026-08-08T10:14:32+08:00 daily https://www.pharmasources.com/industryinsights/midphase-failure-of-novartis-nash-drug-c-307909.html 0.6 2026-08-08T12:07:14+08:00 daily https://www.pharmasources.com/industryinsights/mindfulness-can-help-tame-everyday-stres-307910.html 0.6 2026-08-08T21:57:50+08:00 daily https://www.pharmasources.com/industryinsights/staying-young-at-heart-307911.html 0.6 2026-08-09T05:33:31+08:00 daily https://www.pharmasources.com/industryinsights/catheter-ablation-tops-drug-therapy-for--307912.html 0.6 2026-06-20T22:58:42+08:00 daily https://www.pharmasources.com/industryinsights/nurse-led-program-in-primary-care-can-up-307913.html 0.6 2026-08-06T15:15:34+08:00 daily https://www.pharmasources.com/industryinsights/long-term-reduction-in-crc-risk-after-ne-307914.html 0.6 2026-06-22T04:59:41+08:00 daily https://www.pharmasources.com/industryinsights/incidence-of-end-stage-kidney-disease-up-307915.html 0.6 2026-06-20T22:00:36+08:00 daily https://www.pharmasources.com/industryinsights/three-novel-loci-associated-with-polycys-307916.html 0.6 2026-08-07T03:55:05+08:00 daily https://www.pharmasources.com/industryinsights/be-alert-for-concussions-in-young-athlet-307917.html 0.6 2026-08-07T03:24:37+08:00 daily https://www.pharmasources.com/industryinsights/adamis-pharmaceuticals-submits-new-drug--307918.html 0.6 2026-08-07T03:13:00+08:00 daily https://www.pharmasources.com/industryinsights/inventisbio-and-betta-pharma-to-co-devel-307919.html 0.6 2026-08-07T03:33:35+08:00 daily https://www.pharmasources.com/industryinsights/mycenaxs-actemra-biosimilar-edges-closer-307920.html 0.6 2026-08-07T04:34:02+08:00 daily https://www.pharmasources.com/industryinsights/brii-biosciences-ramps-up-with-vbi-vacci-307921.html 0.6 2026-08-07T04:52:43+08:00 daily https://www.pharmasources.com/industryinsights/billions-spent-but-abbvie-cant-catch-a-b-307922.html 0.6 2026-08-07T04:57:04+08:00 daily https://www.pharmasources.com/industryinsights/xenotransplantation-firm-egenesis-hires--307923.html 0.6 2026-07-10T01:21:26+08:00 daily https://www.pharmasources.com/industryinsights/neurimmunes-anti-sod1-antibody-shows-pro-307924.html 0.6 2026-06-21T23:58:42+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-sema4-launch-5-year-real-world-di-307925.html 0.6 2026-07-12T02:30:52+08:00 daily https://www.pharmasources.com/industryinsights/could-blocking-a-single-gene-cure-obesit-307926.html 0.6 2026-06-21T09:10:16+08:00 daily https://www.pharmasources.com/industryinsights/roche-taps-icagen-in-neuro-drug-discover-307927.html 0.6 2026-06-22T15:22:37+08:00 daily https://www.pharmasources.com/industryinsights/uk-sets-out-digital-data-driven-plan-to--307928.html 0.6 2026-06-21T01:06:46+08:00 daily https://www.pharmasources.com/industryinsights/ash18-bluebirds-anti-bcma-has-a-clear-le-307929.html 0.6 2026-06-21T06:17:13+08:00 daily https://www.pharmasources.com/industryinsights/using-water-and-gold-australian-research-307930.html 0.6 2026-06-21T07:01:06+08:00 daily https://www.pharmasources.com/industryinsights/ucb-to-spend-200m-to-create-uk-rd-hub-307931.html 0.6 2026-07-20T06:05:08+08:00 daily https://www.pharmasources.com/industryinsights/siemens-healthineers-cuts-ribbon-on-300m-307932.html 0.6 2026-07-02T12:56:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-device-designati-307933.html 0.6 2026-07-08T03:49:31+08:00 daily https://www.pharmasources.com/industryinsights/relay-adds-executives-to-its-chemistry-r-307934.html 0.6 2026-06-21T09:03:07+08:00 daily https://www.pharmasources.com/industryinsights/smartzyme-spins-off-protein-tech-company-307935.html 0.6 2026-07-27T00:50:18+08:00 daily https://www.pharmasources.com/industryinsights/with-gilead-and-rivals-deep-in-phase-3-f-307936.html 0.6 2026-06-20T21:57:36+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-inks-pact-with-domain-for-gpc-307937.html 0.6 2026-06-22T10:52:54+08:00 daily https://www.pharmasources.com/industryinsights/redhills-h-pylori-antibiotic-flies-throu-307938.html 0.6 2026-07-08T00:30:36+08:00 daily https://www.pharmasources.com/industryinsights/finding-of-dementia-genes-could-speed-dr-307939.html 0.6 2026-06-23T02:19:53+08:00 daily https://www.pharmasources.com/industryinsights/top-15-breaking-news-of-cphicn-in-2018-307940.html 0.6 2026-08-09T18:00:23+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019010-307941.html 0.6 2026-06-22T20:29:09+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-us-fda-approval--307942.html 0.6 2026-06-20T23:30:11+08:00 daily https://www.pharmasources.com/industryinsights/cipla-recalls-4800-bottles-of-anti-hiv-t-307943.html 0.6 2026-03-01T08:11:55+08:00 daily https://www.pharmasources.com/industryinsights/the-20-most-expensive-pharmacy-drugs-in--307944.html 0.6 2026-08-01T03:08:44+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-exercises-option-to-ac-307945.html 0.6 2026-06-21T18:17:43+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-announces-completion--307946.html 0.6 2026-06-22T06:57:45+08:00 daily https://www.pharmasources.com/industryinsights/innovus-pharma-announces-317-million-pri-307947.html 0.6 2026-08-09T22:48:38+08:00 daily https://www.pharmasources.com/industryinsights/children-should-be-given-flu-vaccine-to--307948.html 0.6 2026-06-20T14:41:14+08:00 daily https://www.pharmasources.com/industryinsights/jjs-baby-powder-tested-in-india-and-bang-307949.html 0.6 2026-06-21T01:05:49+08:00 daily https://www.pharmasources.com/industryinsights/bad-drug-lawsuit-ads-need-regulation-coa-307950.html 0.6 2026-06-21T07:15:22+08:00 daily https://www.pharmasources.com/industryinsights/jj-stock-tumbles-after-reuters-reports-i-307951.html 0.6 2026-01-25T19:24:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-lets-generics-makers-keep-their-lega-307952.html 0.6 2026-06-21T22:05:44+08:00 daily https://www.pharmasources.com/industryinsights/novartis-offers-to-acquire-cellforcure-307953.html 0.6 2026-07-22T10:06:22+08:00 daily https://www.pharmasources.com/industryinsights/bms-receives-offer-from-taisho-to-purcha-307954.html 0.6 2026-06-24T09:49:50+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-break-2018-price-freeze-307955.html 0.6 2026-07-09T03:43:10+08:00 daily https://www.pharmasources.com/industryinsights/aralez-completes-sale-of-drug-rights-to--307956.html 0.6 2026-07-11T14:19:26+08:00 daily https://www.pharmasources.com/industryinsights/french-inspectors-find-issues-at-indian--307957.html 0.6 2026-07-20T23:27:19+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-merck-win-fda-nod-for-6-in-1-pedi-307958.html 0.6 2026-06-19T14:27:17+08:00 daily https://www.pharmasources.com/industryinsights/mabspace-biosciences-merges-with-bioproc-307959.html 0.6 2026-06-21T21:59:48+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-nears-16b-sale-of-o-307960.html 0.6 2026-06-20T23:55:38+08:00 daily https://www.pharmasources.com/industryinsights/what-to-do-when-an-expos-tanks-your-stoc-307961.html 0.6 2026-06-21T22:53:58+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-to-fund-actelions-uptravi-307962.html 0.6 2026-06-20T13:20:38+08:00 daily https://www.pharmasources.com/industryinsights/chinas-antengene-raises-120m-to-boost-dr-307963.html 0.6 2026-06-22T14:14:47+08:00 daily https://www.pharmasources.com/industryinsights/new-breast-cancer-protein-discovered-307964.html 0.6 2026-08-07T19:48:17+08:00 daily https://www.pharmasources.com/industryinsights/early-access-to-tecentriq-combination-gr-307965.html 0.6 2026-07-12T09:24:12+08:00 daily https://www.pharmasources.com/industryinsights/aobiome-expands-receives-patent-for-use--307966.html 0.6 2026-06-20T21:02:39+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-fund-afinitor-for-tsc-related-epi-307967.html 0.6 2026-06-20T16:06:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-designation-f-307968.html 0.6 2026-08-05T19:49:17+08:00 daily https://www.pharmasources.com/industryinsights/merck-shells-out-24b-for-cutting-edge-an-307969.html 0.6 2026-08-04T18:58:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-lets-generics-makers-keep-their-lega-307970.html 0.6 2026-06-23T20:39:20+08:00 daily https://www.pharmasources.com/industryinsights/banner-receives-fda-tentative-approval-f-307971.html 0.6 2026-08-05T07:08:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-hydroxyprogesterone-caproat-307972.html 0.6 2026-06-20T14:53:38+08:00 daily https://www.pharmasources.com/industryinsights/luitpold-pharmaceuticals-renamed-america-307973.html 0.6 2026-06-22T01:07:09+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-medicine-licenses-exosome-tech-307974.html 0.6 2026-06-21T07:00:09+08:00 daily https://www.pharmasources.com/industryinsights/us-doctor-monitored-for-ebola-exposure-i-307975.html 0.6 2026-07-04T16:27:00+08:00 daily https://www.pharmasources.com/industryinsights/no-evidence-no-cal-sweeteners-will-help--307976.html 0.6 2026-07-15T03:33:09+08:00 daily https://www.pharmasources.com/industryinsights/partner-delivered-hiv-self-testing-can-u-307977.html 0.6 2026-06-20T16:19:46+08:00 daily https://www.pharmasources.com/industryinsights/comprehensive-care-for-joint-replacement-307978.html 0.6 2026-06-22T22:07:02+08:00 daily https://www.pharmasources.com/industryinsights/volumes-low-for-unprotected-left-main-pc-307979.html 0.6 2026-07-28T13:41:42+08:00 daily https://www.pharmasources.com/industryinsights/available-vial-sizes-can-cut-drug-waste--307980.html 0.6 2026-08-06T09:59:36+08:00 daily https://www.pharmasources.com/industryinsights/can-herbal-drug-kratom-kill-307981.html 0.6 2026-06-20T04:19:39+08:00 daily https://www.pharmasources.com/industryinsights/cant-taste-anything-you-might-want-to-ch-307982.html 0.6 2026-08-04T20:00:19+08:00 daily https://www.pharmasources.com/industryinsights/new-cholesterol-drug-alirocumabs-praluen-307983.html 0.6 2026-08-06T04:00:35+08:00 daily https://www.pharmasources.com/industryinsights/promethera-looks-to-asia-with-10m-invest-307984.html 0.6 2026-08-07T04:00:09+08:00 daily https://www.pharmasources.com/industryinsights/implandata-embeds-glaucoma-eye-pressure--307985.html 0.6 2026-08-08T03:09:35+08:00 daily https://www.pharmasources.com/industryinsights/resmed-to-acquire-connected-inhaler-deve-307986.html 0.6 2026-08-04T18:59:23+08:00 daily https://www.pharmasources.com/industryinsights/ash18-new-data-cant-lift-bluebird-bios-d-307987.html 0.6 2026-06-21T04:02:51+08:00 daily https://www.pharmasources.com/industryinsights/celgenes-luspatercept-aces-phase-3-beta--307988.html 0.6 2026-06-21T20:00:40+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-records-80-complete-response-r-307989.html 0.6 2026-06-21T13:03:33+08:00 daily https://www.pharmasources.com/industryinsights/the-top-10-medtech-companies-of-2024-307990.html 0.6 2026-07-01T12:39:20+08:00 daily https://www.pharmasources.com/industryinsights/ash18-jj-shells-out-500m-to-sew-up-argen-307991.html 0.6 2026-06-22T01:11:56+08:00 daily https://www.pharmasources.com/industryinsights/roche-launches-2-lab-management-apps-und-307992.html 0.6 2026-06-30T00:54:21+08:00 daily https://www.pharmasources.com/industryinsights/off-the-shelf-cell-therapy-for-cancer-fa-307993.html 0.6 2026-02-15T13:40:03+08:00 daily https://www.pharmasources.com/industryinsights/editas-bags-25m-from-allergan-as-fda-sig-307994.html 0.6 2026-06-29T01:02:10+08:00 daily https://www.pharmasources.com/industryinsights/auris-health-raises-another-220m-to-comm-307995.html 0.6 2026-03-28T12:01:12+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-break-2018-price-freeze-307996.html 0.6 2026-06-21T23:55:41+08:00 daily https://www.pharmasources.com/industryinsights/nash-market-forecast-to-be-worth-183bn-b-307997.html 0.6 2026-06-29T22:49:33+08:00 daily https://www.pharmasources.com/industryinsights/chinas-antengene-raises-120m-to-boost-dr-307998.html 0.6 2026-06-24T00:59:51+08:00 daily https://www.pharmasources.com/industryinsights/canagliflozin-may-not-be-associated-with-307999.html 0.6 2026-06-21T10:05:17+08:00 daily https://www.pharmasources.com/industryinsights/correcting-minority-underrepresentation--308000.html 0.6 2026-06-21T11:56:06+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-agenus-sign-cancer-drug-devel-308001.html 0.6 2026-06-20T14:59:05+08:00 daily https://www.pharmasources.com/industryinsights/federal-proposal-to-force-drug-prices-in-308002.html 0.6 2026-03-17T20:41:25+08:00 daily https://www.pharmasources.com/industryinsights/in-another-record-year-for-pharma-tv-ads-308003.html 0.6 2026-06-21T01:02:46+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-to-buy-celgene-for--308004.html 0.6 2026-06-22T00:53:52+08:00 daily https://www.pharmasources.com/industryinsights/bms-acquires-celgene-for-an-equity-value-308005.html 0.6 2026-06-21T11:52:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-imm-308006.html 0.6 2026-06-20T15:14:25+08:00 daily https://www.pharmasources.com/industryinsights/eqt-increases-offer-for-karo-pharma-to-6-308007.html 0.6 2026-06-21T22:06:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-bristol-myers-sprycel-to-tr-308008.html 0.6 2026-06-20T19:00:39+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-offloads-drug-programmes-to-myoka-308009.html 0.6 2026-08-08T01:23:22+08:00 daily https://www.pharmasources.com/industryinsights/propanc-biopharma-commences-drug-discove-308010.html 0.6 2026-06-20T18:12:24+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-and-allergan-announce-settlemen-308011.html 0.6 2026-08-09T10:59:03+08:00 daily https://www.pharmasources.com/industryinsights/flu-rides-the-subway-too-308012.html 0.6 2026-06-22T03:08:46+08:00 daily https://www.pharmasources.com/industryinsights/hepatitis-c-screening-can-help-prevent-l-308013.html 0.6 2026-08-07T15:07:51+08:00 daily https://www.pharmasources.com/industryinsights/after-opioid-od-most-patients-can-leave--308014.html 0.6 2026-06-22T01:01:50+08:00 daily https://www.pharmasources.com/industryinsights/the-skinny-on-schools-efforts-to-promote-308015.html 0.6 2026-06-22T21:45:50+08:00 daily https://www.pharmasources.com/industryinsights/sexual-minority-patients-prefer-nonverba-308016.html 0.6 2026-06-20T19:17:53+08:00 daily https://www.pharmasources.com/industryinsights/anemia-criteria-assist-decision-on-type--308017.html 0.6 2026-06-21T08:07:07+08:00 daily https://www.pharmasources.com/industryinsights/pediatric-mortality-rate-from-opioid-poi-308018.html 0.6 2026-06-21T20:03:43+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-high-rate-of-phlebitis-cau-308019.html 0.6 2026-06-22T12:16:19+08:00 daily https://www.pharmasources.com/industryinsights/moderate-drinking-not-harmful-for-senior-308020.html 0.6 2026-06-19T20:18:02+08:00 daily https://www.pharmasources.com/industryinsights/cruk-and-owlstone-launch-trial-for-cance-308021.html 0.6 2026-06-23T03:01:55+08:00 daily https://www.pharmasources.com/industryinsights/praluent-not-worth-the-price-finds-study-308022.html 0.6 2026-06-23T11:19:14+08:00 daily https://www.pharmasources.com/industryinsights/trumps-war-on-drug-pricing-looks-set-to--308023.html 0.6 2026-06-21T09:10:19+08:00 daily https://www.pharmasources.com/industryinsights/tiburio-launches-with-31m-and-clinical-s-308024.html 0.6 2026-06-22T00:26:00+08:00 daily https://www.pharmasources.com/industryinsights/ai-player-twoxar-teams-up-with-1st-bioth-308025.html 0.6 2026-06-20T14:43:18+08:00 daily https://www.pharmasources.com/industryinsights/bms-acquires-celgene-for-an-equity-value-308026.html 0.6 2026-06-20T22:51:48+08:00 daily https://www.pharmasources.com/industryinsights/ex-novartis-oncology-ceo-liz-barrett-joi-308027.html 0.6 2026-06-20T15:46:00+08:00 daily https://www.pharmasources.com/industryinsights/stealth-biotherapeutics-shoots-for-86m-i-308028.html 0.6 2026-06-20T19:59:34+08:00 daily https://www.pharmasources.com/industryinsights/special-report2-years-after-sluggish-201-308029.html 0.6 2026-06-21T03:13:53+08:00 daily https://www.pharmasources.com/industryinsights/deciphera-expands-cancer-trial-after-see-308030.html 0.6 2026-06-22T00:49:46+08:00 daily https://www.pharmasources.com/industryinsights/celgene-invests-in-chinese-biotech-anten-308031.html 0.6 2026-07-14T17:35:32+08:00 daily https://www.pharmasources.com/industryinsights/atlas-venture-raises-250m-for-later-stag-308032.html 0.6 2026-06-22T09:08:49+08:00 daily https://www.pharmasources.com/industryinsights/contextual-genomics-launches-new-liquid--308033.html 0.6 2026-06-22T12:11:05+08:00 daily https://www.pharmasources.com/industryinsights/at-the-end-of-a-bumper-year-for-approval-308034.html 0.6 2026-06-20T21:42:21+08:00 daily https://www.pharmasources.com/industryinsights/harpoon-files-86m-ipo-to-help-fund-its-t-308035.html 0.6 2026-06-22T14:18:02+08:00 daily https://www.pharmasources.com/industryinsights/deloitte-finds-pharma-returns-on-rd-reac-308036.html 0.6 2026-07-18T01:36:50+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-to-develop-breath-test-fo-308037.html 0.6 2026-06-21T00:09:57+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-us-fda-nod-for-parki-308038.html 0.6 2026-03-13T21:34:54+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-acquires-japans-pola-pharma-308039.html 0.6 2026-07-21T04:01:37+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-completes-sale-of-arlanxeo-to-sa-308040.html 0.6 2026-06-20T12:19:00+08:00 daily https://www.pharmasources.com/industryinsights/roche-diabetes-care-india-appoints-dr-ga-308041.html 0.6 2026-08-10T01:30:44+08:00 daily https://www.pharmasources.com/industryinsights/sprycel-combo-gets-fda-approval-308042.html 0.6 2026-08-07T21:18:12+08:00 daily https://www.pharmasources.com/industryinsights/dont-miss-out-on-the-chance-to-compete-a-308043.html 0.6 2026-08-10T00:49:09+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-myokardia-end-heart-disease-d-308044.html 0.6 2026-07-28T21:14:19+08:00 daily https://www.pharmasources.com/industryinsights/one-in-20-gp-appointments-missed-costing-308045.html 0.6 2026-06-22T12:01:50+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-merck-to-terminate-phase-iii-bave-308046.html 0.6 2026-07-09T08:01:14+08:00 daily https://www.pharmasources.com/industryinsights/takeda-announces-multiple-cell-therapy-c-308047.html 0.6 2026-06-23T01:37:04+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-and-allergan-settle-linzess-pat-308048.html 0.6 2026-07-17T06:17:37+08:00 daily https://www.pharmasources.com/industryinsights/takeda-forms-new-alliances-to-boosts-imm-308049.html 0.6 2026-06-22T20:19:12+08:00 daily https://www.pharmasources.com/industryinsights/janssen-signs-a-818m-crispr-products-dea-308050.html 0.6 2026-07-13T11:31:12+08:00 daily https://www.pharmasources.com/industryinsights/jazz-and-codiak-collaborate-on-creating--308051.html 0.6 2026-07-12T12:22:19+08:00 daily https://www.pharmasources.com/industryinsights/flex-salarius-merger-to-focus-on-epigene-308052.html 0.6 2026-07-01T18:29:12+08:00 daily https://www.pharmasources.com/industryinsights/physical-therapy-can-keep-sports-injurie-308053.html 0.6 2026-06-26T13:08:59+08:00 daily https://www.pharmasources.com/industryinsights/persistent-cough-may-mean-see-your-docto-308054.html 0.6 2026-06-22T11:57:50+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-and-click-therapeutics-collaborat-308055.html 0.6 2026-08-08T02:29:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-broadens-approval-for-astrazenecas--308056.html 0.6 2026-08-05T22:51:57+08:00 daily https://www.pharmasources.com/industryinsights/takeda-strikes-three-new-immuno-oncology-308057.html 0.6 2026-08-07T23:42:07+08:00 daily https://www.pharmasources.com/industryinsights/ribon-therapeutics-gains-novartis-jj-bac-308058.html 0.6 2026-08-05T23:00:18+08:00 daily https://www.pharmasources.com/industryinsights/md-anderson-cancer-centre-4d-pharma-coll-308059.html 0.6 2026-03-17T20:18:31+08:00 daily https://www.pharmasources.com/industryinsights/selecta-lays-off-staff-as-rd-cash-crunch-308060.html 0.6 2026-06-23T21:03:30+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-3sbio-partner-to-expand--308061.html 0.6 2026-06-21T15:13:34+08:00 daily https://www.pharmasources.com/industryinsights/swiss-biotech-oculis-raises-cash-nabs-no-308062.html 0.6 2026-06-21T06:32:34+08:00 daily https://www.pharmasources.com/industryinsights/nui-galway-opens-stem-cell-research-lab--308063.html 0.6 2026-06-20T09:42:49+08:00 daily https://www.pharmasources.com/industryinsights/solasia-initiates-phase-iii-programme-fo-308064.html 0.6 2026-06-13T17:19:16+08:00 daily https://www.pharmasources.com/industryinsights/verily-pockets-1b-with-eyes-on-partnersh-308065.html 0.6 2026-08-07T01:21:45+08:00 daily https://www.pharmasources.com/industryinsights/ablative-solutions-bags-77m-to-complete--308066.html 0.6 2026-07-30T14:19:08+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-click-therapeutics-to-create-ther-308067.html 0.6 2026-08-07T01:19:58+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-invests-80m-in-biontech-as-cancer-308068.html 0.6 2026-08-07T00:40:50+08:00 daily https://www.pharmasources.com/industryinsights/adagene-collaborates-with-nih-to-discove-308069.html 0.6 2026-08-07T00:24:26+08:00 daily https://www.pharmasources.com/industryinsights/dbv-cmo-leaves-as-peanut-allergy-player--308070.html 0.6 2026-08-07T00:02:09+08:00 daily https://www.pharmasources.com/industryinsights/blocking-brain-inflammation-in-multiple--308071.html 0.6 2026-08-07T00:59:02+08:00 daily https://www.pharmasources.com/industryinsights/nih-study-implicates-hyperactive-immune--308072.html 0.6 2026-08-07T00:40:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-cardivas-new-bioabsorbable--308073.html 0.6 2026-08-07T02:39:45+08:00 daily https://www.pharmasources.com/industryinsights/tizona-therapeutics-appoints-scott-clark-308074.html 0.6 2026-06-22T11:52:39+08:00 daily https://www.pharmasources.com/industryinsights/vedanta-nets-27m-to-move-microbiome-asse-308075.html 0.6 2026-06-20T14:39:26+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-inks-biosimilars-commercializatio-308076.html 0.6 2026-06-21T03:02:48+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-yuhan-to-treat-advanced--308077.html 0.6 2026-06-20T21:59:37+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019010-308078.html 0.6 2026-06-22T04:50:34+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-highlights-recent-a-308079.html 0.6 2026-06-22T05:50:35+08:00 daily https://www.pharmasources.com/industryinsights/velabs-therapeutics-to-cooperate-with-bi-308080.html 0.6 2026-07-05T00:07:09+08:00 daily https://www.pharmasources.com/industryinsights/biogen-signs-two-deals-to-address-neurol-308081.html 0.6 2026-06-21T11:21:27+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-revises-immuno-oncology-deal-with-308082.html 0.6 2026-06-21T01:00:43+08:00 daily https://www.pharmasources.com/industryinsights/merck-gains-nash-candidate-from-ngm-biop-308083.html 0.6 2026-08-06T17:50:11+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-organizational-cha-308084.html 0.6 2026-07-16T08:30:02+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-agreement-to-acquire-lox-308085.html 0.6 2026-06-21T08:08:08+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-announces-positive-pha-308086.html 0.6 2026-06-22T06:07:42+08:00 daily https://www.pharmasources.com/industryinsights/ampliphi-biosciences-and-c3j-therapeutic-308087.html 0.6 2026-08-09T02:56:01+08:00 daily https://www.pharmasources.com/industryinsights/adaptive-biotechnologies-to-enter-into-w-308088.html 0.6 2026-08-07T07:47:28+08:00 daily https://www.pharmasources.com/industryinsights/kempharm-announces-fda-approval-of-snda--308089.html 0.6 2026-03-17T20:21:42+08:00 daily https://www.pharmasources.com/industryinsights/radiation-doses-from-ct-scans-vary-widel-308090.html 0.6 2026-04-09T11:53:16+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-suicide-increased-in-year-after-308091.html 0.6 2026-06-27T01:07:09+08:00 daily https://www.pharmasources.com/industryinsights/gabapentin-improves-sexual-function-in-p-308092.html 0.6 2026-06-26T04:30:39+08:00 daily https://www.pharmasources.com/industryinsights/global-apis-market-predicted-to-reach-24-308093.html 0.6 2026-08-01T15:24:58+08:00 daily https://www.pharmasources.com/industryinsights/income-volatility-linked-to-cvd-all-caus-308094.html 0.6 2026-06-20T21:19:52+08:00 daily https://www.pharmasources.com/industryinsights/exercise-can-consistently-lower-blood-pr-308095.html 0.6 2026-07-05T06:21:23+08:00 daily https://www.pharmasources.com/industryinsights/withings-launches-ecg-watch-to-compete-w-308096.html 0.6 2025-11-17T19:28:13+08:00 daily https://www.pharmasources.com/industryinsights/takeda-unlikely-to-sell-otc-unit-to-pay--308097.html 0.6 2026-06-20T22:07:45+08:00 daily https://www.pharmasources.com/industryinsights/pair-of-deals-boosts-biogens-early-stage-308098.html 0.6 2026-06-21T11:50:11+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-grabs-spotlight-at-jp-morgan-w-308099.html 0.6 2026-07-22T22:51:30+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccines-continue-to-dominate-cancer-308100.html 0.6 2026-07-24T02:19:28+08:00 daily https://www.pharmasources.com/industryinsights/nhs-long-term-plan-focus-on-rd-and-digit-308101.html 0.6 2026-03-01T04:43:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-clarifies-activities-during-us-gover-308102.html 0.6 2026-07-01T02:19:06+08:00 daily https://www.pharmasources.com/industryinsights/pharma-still-puts-pricing-at-the-top-of--308103.html 0.6 2026-06-23T16:39:44+08:00 daily https://www.pharmasources.com/industryinsights/biogen-signs-two-deals-to-address-neurol-308104.html 0.6 2026-07-17T11:30:51+08:00 daily https://www.pharmasources.com/industryinsights/janssen-signs-a-818m-crispr-products-dea-308105.html 0.6 2026-06-22T16:58:53+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-nod-for-generic-schizo-308106.html 0.6 2026-08-09T08:17:05+08:00 daily https://www.pharmasources.com/industryinsights/janssen-files-stelara-in-europe-for-ulce-308107.html 0.6 2026-07-26T22:44:19+08:00 daily https://www.pharmasources.com/industryinsights/green-light-for-amryts-epidermolysis-bul-308108.html 0.6 2026-06-21T01:06:48+08:00 daily https://www.pharmasources.com/industryinsights/uk-surge-in-cell-and-gene-therapy-trials-308109.html 0.6 2026-06-20T20:21:59+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-to-develop-cancer-diagnos-308110.html 0.6 2026-06-22T04:44:27+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-to-buy-celgene-308111.html 0.6 2026-07-28T15:18:35+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-swipes-az-commercial-hotshot-ma-308112.html 0.6 2026-08-06T01:41:17+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sales-rep-regulations-proposal-st-308113.html 0.6 2026-08-09T12:33:48+08:00 daily https://www.pharmasources.com/industryinsights/mccann-health-taps-consumer-agency-veter-308114.html 0.6 2026-06-21T08:11:05+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-rejigs-commercial-ranks-arou-308115.html 0.6 2026-06-21T09:11:17+08:00 daily https://www.pharmasources.com/industryinsights/never-mind-last-weeks-hikes-pharma-still-308116.html 0.6 2025-11-11T00:47:24+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sales-rep-regulations-proposal-st-308117.html 0.6 2026-03-09T06:34:40+08:00 daily https://www.pharmasources.com/industryinsights/could-gilead-amgen-and-abbvie-follow-bri-308118.html 0.6 2026-06-21T04:56:43+08:00 daily https://www.pharmasources.com/industryinsights/celgene-executives-whipped-up-new-lucrat-308119.html 0.6 2026-08-07T11:43:13+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-fasenra-puts-more-pressure--308120.html 0.6 2026-08-07T11:14:38+08:00 daily https://www.pharmasources.com/industryinsights/the-bms-celgene-mergers-achilles-heel-an-308121.html 0.6 2026-08-07T10:52:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-partners-with-cytoreason-on-immun-308122.html 0.6 2026-08-07T06:09:42+08:00 daily https://www.pharmasources.com/industryinsights/crizanlizumab-receives-fda-breakthrough--308123.html 0.6 2026-08-07T03:54:45+08:00 daily https://www.pharmasources.com/industryinsights/biofrontera-receives-fda-approval-for-up-308124.html 0.6 2026-08-07T03:34:05+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharmaceutical-issues-voluntary-nati-308125.html 0.6 2026-08-07T03:27:33+08:00 daily https://www.pharmasources.com/industryinsights/stemedica-cell-technologies-reports-posi-308126.html 0.6 2026-08-07T03:18:59+08:00 daily https://www.pharmasources.com/industryinsights/mirati-announces-collaboration-with-bris-308127.html 0.6 2026-08-07T03:12:35+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-gynecologic-oncology-group-to-co-308128.html 0.6 2026-08-07T03:03:02+08:00 daily https://www.pharmasources.com/industryinsights/fedora-pharmaceuticals-and-meiji-seika-p-308129.html 0.6 2026-08-07T02:45:47+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-and-md-anderson-cancer--308130.html 0.6 2026-08-07T02:41:22+08:00 daily https://www.pharmasources.com/industryinsights/what-makes-for-a-good-nursing-home-308131.html 0.6 2026-08-07T00:01:48+08:00 daily https://www.pharmasources.com/industryinsights/aha-cardiac-arrest-survivor-reunites-wit-308132.html 0.6 2026-08-07T00:41:11+08:00 daily https://www.pharmasources.com/industryinsights/antibiotics-prescribed-for-children-more-308133.html 0.6 2026-08-07T05:05:54+08:00 daily https://www.pharmasources.com/industryinsights/women-with-cvd-have-worse-self-reported--308134.html 0.6 2026-08-07T05:37:14+08:00 daily https://www.pharmasources.com/industryinsights/cervical-cancer-screening-rates-unaccept-308135.html 0.6 2026-08-07T04:04:18+08:00 daily https://www.pharmasources.com/industryinsights/aca-coverage-gains-could-erode-without-i-308136.html 0.6 2026-08-07T20:22:06+08:00 daily https://www.pharmasources.com/industryinsights/cancer-death-rate-in-us-decreased-contin-308137.html 0.6 2026-08-07T04:25:03+08:00 daily https://www.pharmasources.com/industryinsights/2018-set-benchmark-for-digital-health-in-308138.html 0.6 2026-08-07T04:52:46+08:00 daily https://www.pharmasources.com/industryinsights/urogen-appoints-former-novartis-cancer-c-308139.html 0.6 2026-08-07T13:16:13+08:00 daily https://www.pharmasources.com/industryinsights/az-appoints-controversial-doctor-to-lead-308140.html 0.6 2026-08-08T10:38:56+08:00 daily https://www.pharmasources.com/industryinsights/space-travel-wont-turn-germs-into-superb-308141.html 0.6 2026-08-08T12:07:26+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-corridor-between-hksar-an-308142.html 0.6 2026-08-09T07:56:40+08:00 daily https://www.pharmasources.com/industryinsights/prescribed-opioids-raise-risk-of-pneumon-308143.html 0.6 2026-08-07T05:11:35+08:00 daily https://www.pharmasources.com/industryinsights/rising-drug-prices-linked-to-older-produ-308144.html 0.6 2026-06-21T07:54:00+08:00 daily https://www.pharmasources.com/industryinsights/ustekinumab-could-be-approved-to-treat-u-308145.html 0.6 2026-07-31T00:57:12+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-european-commission-nod-for-m-308146.html 0.6 2026-06-21T04:58:44+08:00 daily https://www.pharmasources.com/industryinsights/merck-loses-bid-to-revive-200-million-gi-308147.html 0.6 2026-08-08T22:47:25+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-pay-regeneron-462-million-in-r-308148.html 0.6 2026-08-01T16:41:50+08:00 daily https://www.pharmasources.com/industryinsights/what-are-the-most-important-acquisitions-308149.html 0.6 2026-08-09T08:17:01+08:00 daily https://www.pharmasources.com/industryinsights/tevas-escaped-the-generics-death-spiral--308150.html 0.6 2026-06-20T14:43:17+08:00 daily https://www.pharmasources.com/industryinsights/why-hasnt-merck-been-making-deals-its-no-308151.html 0.6 2026-06-22T05:57:46+08:00 daily https://www.pharmasources.com/industryinsights/years-into-troubled-launch-vaccine-head--308152.html 0.6 2026-08-07T00:31:48+08:00 daily https://www.pharmasources.com/industryinsights/novartis-building-out-cell-and-gene-ther-308153.html 0.6 2026-07-06T23:22:43+08:00 daily https://www.pharmasources.com/industryinsights/mercks-cancer-aims-gileads-new-ceo-pfize-308154.html 0.6 2026-06-20T17:18:29+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-keep-consumer-business-looks-o-308155.html 0.6 2026-06-21T06:14:04+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-celgene-ceos-trot-out-deta-308156.html 0.6 2026-06-21T02:52:58+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sales-rep-regulations-proposal-st-308157.html 0.6 2026-06-21T10:01:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-drafts-pathway-for-digital-health-in-308158.html 0.6 2026-06-22T00:14:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-status-f-308159.html 0.6 2026-06-22T16:55:57+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-application-to-european--308160.html 0.6 2026-06-21T10:19:22+08:00 daily https://www.pharmasources.com/industryinsights/karyopharm-announces-submission-of-marke-308161.html 0.6 2026-06-20T15:52:01+08:00 daily https://www.pharmasources.com/industryinsights/immunogen-announces-sale-of-residual-kad-308162.html 0.6 2026-08-06T17:01:53+08:00 daily https://www.pharmasources.com/industryinsights/drugmaker-wont-put-price-in-tv-ads-but-p-308163.html 0.6 2026-06-21T03:07:45+08:00 daily https://www.pharmasources.com/industryinsights/how-common-pain-relievers-may-promote-cl-308164.html 0.6 2026-08-07T21:20:19+08:00 daily https://www.pharmasources.com/industryinsights/evenity-romosozumab-receives-approval-in-308165.html 0.6 2026-07-10T14:07:00+08:00 daily https://www.pharmasources.com/industryinsights/new-california-governor-tackles-drug-pri-308166.html 0.6 2026-07-05T14:59:55+08:00 daily https://www.pharmasources.com/industryinsights/moberg-pharma-appoints-members-to-the-ma-308167.html 0.6 2026-07-02T00:29:21+08:00 daily https://www.pharmasources.com/industryinsights/astellas-announces-approval-in-japan-for-308168.html 0.6 2026-07-01T20:47:44+08:00 daily https://www.pharmasources.com/industryinsights/altering-the-supportive-structure-of-pan-308169.html 0.6 2026-08-08T21:03:31+08:00 daily https://www.pharmasources.com/industryinsights/compensating-for-loss-of-neurodegenerati-308170.html 0.6 2026-08-07T15:49:23+08:00 daily https://www.pharmasources.com/industryinsights/axim-biotechnologies-appoints-new-chief--308171.html 0.6 2026-06-23T22:23:32+08:00 daily https://www.pharmasources.com/industryinsights/abeona-therapeutics-strengthens-financia-308172.html 0.6 2026-07-04T07:38:22+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-receives-japanese-marketi-308173.html 0.6 2026-07-23T20:01:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-status-t-308174.html 0.6 2026-06-21T10:18:57+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-new-treatment-for-tb-308175.html 0.6 2026-06-21T06:55:04+08:00 daily https://www.pharmasources.com/industryinsights/generex-biotechnology-completes-acquisit-308176.html 0.6 2026-06-26T17:26:54+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-announces-new-license-w-308177.html 0.6 2026-07-20T17:08:16+08:00 daily https://www.pharmasources.com/industryinsights/lupin-pharmaceuticals-issues-voluntary-r-308178.html 0.6 2026-06-24T01:00:39+08:00 daily https://www.pharmasources.com/industryinsights/forbius-announces-the-first-patient-dose-308179.html 0.6 2026-06-21T08:01:04+08:00 daily https://www.pharmasources.com/industryinsights/sage-soars-on-postpartum-depression-data-308180.html 0.6 2026-06-21T17:56:28+08:00 daily https://www.pharmasources.com/industryinsights/takedas-shire-takeover-could-herald-new--308181.html 0.6 2026-06-23T08:00:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-novartis-migraine-preventio-308182.html 0.6 2026-06-20T21:08:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-further-plans-to-hasten-di-308183.html 0.6 2026-07-08T03:58:06+08:00 daily https://www.pharmasources.com/industryinsights/urogens-urothelial-cancer-drug-hits-targ-308184.html 0.6 2026-03-24T10:53:42+08:00 daily https://www.pharmasources.com/industryinsights/obesity-linked-to-lower-gray-matter-brai-308185.html 0.6 2026-06-21T04:08:57+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-buy-loxo-oncology-for-8-bil-308186.html 0.6 2026-07-20T08:31:39+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-recalls-about-14k-cartons-of--308187.html 0.6 2026-08-06T13:51:22+08:00 daily https://www.pharmasources.com/industryinsights/lupin-recalls-over-23000-bottles-of-anti-308188.html 0.6 2026-06-08T02:17:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-stop-manufacturing-operations--308189.html 0.6 2026-06-22T09:10:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-status-t-308190.html 0.6 2025-11-20T05:17:31+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-receives-japanese-marketi-308191.html 0.6 2026-06-20T23:55:31+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-new-treatment-for-tb-308192.html 0.6 2026-06-21T08:58:01+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-and-powder-testing-capsule-f-308193.html 0.6 2026-08-07T01:19:45+08:00 daily https://www.pharmasources.com/industryinsights/nice-draft-guidance-rejects-use-of-novar-308194.html 0.6 2026-06-22T06:06:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-shut-two-manufacturing-plants--308195.html 0.6 2026-06-20T19:34:48+08:00 daily https://www.pharmasources.com/industryinsights/trump-summons-advisers-to-white-house-ov-308196.html 0.6 2026-07-30T14:25:51+08:00 daily https://www.pharmasources.com/industryinsights/teva-to-produce-new-biosimilar-drugs-out-308197.html 0.6 2026-06-20T19:31:24+08:00 daily https://www.pharmasources.com/industryinsights/propeller-health-announces-my-pharmacy-e-308198.html 0.6 2026-06-30T00:28:42+08:00 daily https://www.pharmasources.com/industryinsights/aposense-has-signed-a-definitive-agreeme-308199.html 0.6 2026-06-21T05:10:52+08:00 daily https://www.pharmasources.com/industryinsights/intrabio-receives-niemann-pick-disease-e-308200.html 0.6 2026-06-20T18:04:24+08:00 daily https://www.pharmasources.com/industryinsights/celgene-invests-in-antengene-otsukas-new-308201.html 0.6 2026-08-06T17:45:16+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-plans-20m-us-facility-for-burge-308202.html 0.6 2026-08-07T00:31:18+08:00 daily https://www.pharmasources.com/industryinsights/supreme-court-rebuffs-appeals-from-merck-308203.html 0.6 2026-08-08T21:02:32+08:00 daily https://www.pharmasources.com/industryinsights/pharma-nears-landmark-win-as-supreme-cou-308204.html 0.6 2026-06-22T23:15:40+08:00 daily https://www.pharmasources.com/industryinsights/launch-woes-crossed-fingers-a-bulletproo-308205.html 0.6 2026-06-23T02:20:32+08:00 daily https://www.pharmasources.com/industryinsights/dont-fret-about-lillys-3rd-to-market-sta-308206.html 0.6 2026-06-28T23:06:15+08:00 daily https://www.pharmasources.com/industryinsights/with-pivot-to-less-rare-diseases-alexion-308207.html 0.6 2026-06-21T00:10:51+08:00 daily https://www.pharmasources.com/industryinsights/with-tesaro-in-the-bag-gsks-cancer-pipel-308208.html 0.6 2026-08-08T02:02:08+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-new-trulicity-tv-ad-counters--308209.html 0.6 2026-04-06T21:33:15+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-eylea-hits-double-digit-growt-308210.html 0.6 2026-07-25T00:04:54+08:00 daily https://www.pharmasources.com/industryinsights/toxys-appoints-four-new-board-members-to-308211.html 0.6 2026-06-20T13:26:45+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-extends-exclusive-european-clin-308212.html 0.6 2026-03-21T17:20:35+08:00 daily https://www.pharmasources.com/industryinsights/canbridge-pharmaceuticals-expands-partne-308213.html 0.6 2026-06-23T10:03:47+08:00 daily https://www.pharmasources.com/industryinsights/uc-berkeley-develops-drug-sponge-to-soak-308214.html 0.6 2026-03-26T04:37:03+08:00 daily https://www.pharmasources.com/industryinsights/acorda-therapeutics-announces-fda-approv-308215.html 0.6 2026-07-16T17:34:36+08:00 daily https://www.pharmasources.com/industryinsights/oncoimmune-announces-completion-of-phase-308216.html 0.6 2026-08-03T05:38:16+08:00 daily https://www.pharmasources.com/industryinsights/appeals-court-decision-affirms-patent-pr-308217.html 0.6 2026-08-09T18:56:40+08:00 daily https://www.pharmasources.com/industryinsights/chemomab-doses-first-patient-in-phase-1b-308218.html 0.6 2026-08-07T21:36:28+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-fda-approval-of-digital-i-308219.html 0.6 2026-06-21T05:56:45+08:00 daily https://www.pharmasources.com/industryinsights/sirion-biotech-and-denali-therapeutics-j-308220.html 0.6 2026-07-04T19:48:33+08:00 daily https://www.pharmasources.com/industryinsights/absci-establishes-new-collaboration-with-308221.html 0.6 2026-07-17T23:03:52+08:00 daily https://www.pharmasources.com/industryinsights/data-breaches-raise-new-concerns-about-a-308222.html 0.6 2026-08-09T22:07:28+08:00 daily https://www.pharmasources.com/industryinsights/hrt-tablets-linked-to-higher-blood-clot--308223.html 0.6 2026-06-20T23:17:54+08:00 daily https://www.pharmasources.com/industryinsights/amarantus-announces-commercialization-pa-308224.html 0.6 2026-06-21T19:46:54+08:00 daily https://www.pharmasources.com/industryinsights/puma-biotechnology-and-knight-therapeuti-308225.html 0.6 2026-06-27T01:15:56+08:00 daily https://www.pharmasources.com/industryinsights/new-opioid-alternative-raises-325-millio-308226.html 0.6 2026-07-01T13:14:34+08:00 daily https://www.pharmasources.com/industryinsights/icer-posts-draft-scoping-document-for-th-308227.html 0.6 2026-07-04T09:39:27+08:00 daily https://www.pharmasources.com/industryinsights/lilly-eyes-more-cancer-deals-but-wary-of-308228.html 0.6 2026-03-20T10:55:30+08:00 daily https://www.pharmasources.com/industryinsights/analysts-believe-ma-activity-in-the-phar-308229.html 0.6 2026-07-21T00:25:57+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-laboratories-and-atomwise--308230.html 0.6 2026-06-21T03:56:53+08:00 daily https://www.pharmasources.com/industryinsights/alk-appoints-new-head-of-product-supply-308231.html 0.6 2026-06-21T02:02:45+08:00 daily https://www.pharmasources.com/industryinsights/uncertainty-grows-for-biotech-as-governm-308232.html 0.6 2026-06-20T17:06:19+08:00 daily https://www.pharmasources.com/industryinsights/inmed-pharmaceuticals-announces-the-appo-308233.html 0.6 2026-06-21T21:13:51+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-set-to-enter-chinese-pharmaceu-308234.html 0.6 2026-06-30T15:18:08+08:00 daily https://www.pharmasources.com/industryinsights/kalytera-announces-private-placement-of--308235.html 0.6 2026-06-21T08:03:05+08:00 daily https://www.pharmasources.com/industryinsights/abpi-names-elliot-dunster-as-new-executi-308236.html 0.6 2026-06-23T02:18:46+08:00 daily https://www.pharmasources.com/industryinsights/novartis-aimovig-fails-to-win-nice-backi-308237.html 0.6 2026-07-17T23:52:44+08:00 daily https://www.pharmasources.com/industryinsights/medical-marketing-spend-is-inching-towar-308238.html 0.6 2026-06-22T13:28:38+08:00 daily https://www.pharmasources.com/industryinsights/2019-wraps-up-biopharmas-outlook-is-caut-308239.html 0.6 2026-06-20T17:47:24+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-plots-250-job-cuts-in-100m-rev-308240.html 0.6 2026-06-21T12:03:13+08:00 daily https://www.pharmasources.com/industryinsights/jpm-pricing-parley-false-choices-secret--308241.html 0.6 2026-07-04T09:17:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-puts-ai-on-the-job-to-help-reps-308242.html 0.6 2026-05-03T10:30:22+08:00 daily https://www.pharmasources.com/industryinsights/jj-still-sees-plenty-of-opportunity-in-c-308243.html 0.6 2026-06-22T06:29:31+08:00 daily https://www.pharmasources.com/industryinsights/amgens-repatha-hits-wall-at-scotus-but-p-308244.html 0.6 2026-06-21T22:23:46+08:00 daily https://www.pharmasources.com/industryinsights/lonza-collaborates-with-takeda-to-bring--308245.html 0.6 2026-06-20T17:42:03+08:00 daily https://www.pharmasources.com/industryinsights/actavis-infringes-orexos-long-term-zubso-308246.html 0.6 2026-08-10T00:36:01+08:00 daily https://www.pharmasources.com/industryinsights/epa-streamlines-hazardous-waste-pharmace-308247.html 0.6 2026-08-08T22:56:42+08:00 daily https://www.pharmasources.com/industryinsights/univercells-introduces-vaccine-manufactu-308248.html 0.6 2026-06-21T04:01:49+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-adds-to-nationwide-vals-308249.html 0.6 2026-06-21T01:55:53+08:00 daily https://www.pharmasources.com/industryinsights/nice-declines-to-endorse-novartis-pricey-308250.html 0.6 2026-06-22T07:39:25+08:00 daily https://www.pharmasources.com/industryinsights/common-medications-for-physical-health-m-308251.html 0.6 2026-06-20T16:07:43+08:00 daily https://www.pharmasources.com/industryinsights/sumitomo-dainippon-announces-good-result-308252.html 0.6 2026-06-21T02:09:46+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-hakko-kirin-signs-ai-drug-rd-deal--308253.html 0.6 2026-06-25T19:26:14+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-takes-option-on-diabetes--308254.html 0.6 2026-06-21T11:16:23+08:00 daily https://www.pharmasources.com/industryinsights/liquid-biopsy-based-system-could-prevent-308255.html 0.6 2026-06-20T17:19:48+08:00 daily https://www.pharmasources.com/industryinsights/exercise-caution-to-protect-your-skin-at-308256.html 0.6 2026-06-20T15:06:25+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019114-308257.html 0.6 2026-06-24T12:23:12+08:00 daily https://www.pharmasources.com/industryinsights/medical-marketing-has-skyrocketed-in-the-308258.html 0.6 2026-06-22T04:40:00+08:00 daily https://www.pharmasources.com/industryinsights/the-greener-alternative-for-drug-product-308259.html 0.6 2026-07-18T00:37:58+08:00 daily https://www.pharmasources.com/industryinsights/danish-malaria-vaccine-passes-test-in-hu-308260.html 0.6 2026-06-21T14:49:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-migraine-drug-not-cost-effectiv-308261.html 0.6 2025-11-07T00:10:27+08:00 daily https://www.pharmasources.com/industryinsights/hetero-launches-generic-lapatinib-under--308262.html 0.6 2026-06-22T11:10:01+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-initiates-a-collabo-308263.html 0.6 2026-06-21T20:41:22+08:00 daily https://www.pharmasources.com/industryinsights/knight-therapeutics-licences-cancer-drug-308264.html 0.6 2026-08-06T00:06:36+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-japan-partner-on-treatments-for-d-308265.html 0.6 2026-08-07T16:16:14+08:00 daily https://www.pharmasources.com/industryinsights/global-fund-seeks-14bn-to-fight-aids-tb--308266.html 0.6 2026-08-08T18:18:24+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-roche-renew-global-distri-308267.html 0.6 2026-08-08T21:53:43+08:00 daily https://www.pharmasources.com/industryinsights/leap-therapeutics-announces-an-investiga-308268.html 0.6 2026-08-09T00:10:14+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-initiates-pivotal-phase-3-308269.html 0.6 2026-06-23T19:42:59+08:00 daily https://www.pharmasources.com/industryinsights/prokidney-announces-62-million-acquisiti-308270.html 0.6 2026-08-09T04:34:48+08:00 daily https://www.pharmasources.com/industryinsights/amneal-announces-approval-of-rivastigmin-308271.html 0.6 2026-07-04T19:26:05+08:00 daily https://www.pharmasources.com/industryinsights/ifpmas-new-code-bans-all-gifts-no-except-308272.html 0.6 2026-06-27T06:56:43+08:00 daily https://www.pharmasources.com/industryinsights/gci-healths-rikki-jones-to-lead-the-agen-308273.html 0.6 2026-04-07T09:11:42+08:00 daily https://www.pharmasources.com/industryinsights/lillys-ceo-looks-to-ma-but-not-for-car-t-308274.html 0.6 2026-06-20T22:52:55+08:00 daily https://www.pharmasources.com/industryinsights/azs-chief-medical-officer-bohen-quits-af-308275.html 0.6 2026-06-20T14:43:19+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-services-falling-behind-re-308276.html 0.6 2026-06-20T19:55:33+08:00 daily https://www.pharmasources.com/industryinsights/gene-editing-tool-crispr-repurposed-to-d-308277.html 0.6 2026-08-08T20:00:40+08:00 daily https://www.pharmasources.com/industryinsights/red-cross-issues-emergency-call-for-bloo-308278.html 0.6 2026-06-22T13:01:02+08:00 daily https://www.pharmasources.com/industryinsights/short-sleep-duration-linked-to-higher-at-308279.html 0.6 2026-06-21T12:22:46+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-incidence-up-with-persiste-308280.html 0.6 2026-08-09T10:06:23+08:00 daily https://www.pharmasources.com/industryinsights/us-doctor-released-from-omaha-hospital-a-308281.html 0.6 2026-07-03T18:07:34+08:00 daily https://www.pharmasources.com/industryinsights/800-662-help-underappreciated-in-media-g-308282.html 0.6 2026-08-07T00:41:53+08:00 daily https://www.pharmasources.com/industryinsights/more-evidence-pot-may-damage-the-teen-br-308283.html 0.6 2026-08-06T23:56:47+08:00 daily https://www.pharmasources.com/industryinsights/large-meta-analysis-backs-probiotic-bene-308284.html 0.6 2026-06-21T08:02:02+08:00 daily https://www.pharmasources.com/industryinsights/social-support-key-to-good-mental-health-308285.html 0.6 2026-08-06T20:09:16+08:00 daily https://www.pharmasources.com/industryinsights/dil-announces-upgrade-in-credit-ratings--308286.html 0.6 2026-08-06T19:23:05+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-slashes-death-risk-by-31-308287.html 0.6 2026-08-06T20:08:23+08:00 daily https://www.pharmasources.com/industryinsights/further-scandal-for-chinas-pharmaceutica-308288.html 0.6 2026-08-07T05:05:52+08:00 daily https://www.pharmasources.com/industryinsights/global-fund-seeks-14bn-to-fight-aids-tb--308289.html 0.6 2026-06-20T14:52:12+08:00 daily https://www.pharmasources.com/industryinsights/us-lawmakers-to-introduce-new-bills-to-s-308290.html 0.6 2026-06-21T00:58:50+08:00 daily https://www.pharmasources.com/industryinsights/cellmax-life-blood-test-study-detects-pr-308291.html 0.6 2026-08-08T03:41:44+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-partners-with-vanderbilt-o-308292.html 0.6 2026-08-03T04:01:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-ossios-integrative-mineral-bo-308293.html 0.6 2026-06-21T04:03:54+08:00 daily https://www.pharmasources.com/industryinsights/the-first-and-only-oral-treatment-for-me-308294.html 0.6 2026-06-21T14:26:57+08:00 daily https://www.pharmasources.com/industryinsights/flutiform-pmdi-to-be-available-for-treat-308295.html 0.6 2026-06-20T21:17:53+08:00 daily https://www.pharmasources.com/industryinsights/bio-thera-solutions-ltd-partners-with-ci-308296.html 0.6 2026-06-21T03:59:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-use-of-adacel-tdap-308297.html 0.6 2026-06-25T19:36:23+08:00 daily https://www.pharmasources.com/industryinsights/scottish-medicines-consortium-tofacitini-308298.html 0.6 2026-07-04T07:18:29+08:00 daily https://www.pharmasources.com/industryinsights/hercules-capital-provides-us15m-from-exi-308299.html 0.6 2026-06-24T10:18:59+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-announces-us-fda-approval-of-ca-308300.html 0.6 2026-08-09T10:14:30+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-opdivo-in-combinat-308301.html 0.6 2026-06-21T11:16:36+08:00 daily https://www.pharmasources.com/industryinsights/us-house-oversight-committee-launches-in-308302.html 0.6 2026-06-24T00:47:56+08:00 daily https://www.pharmasources.com/industryinsights/biocure-signs-a-collaboration-agreement--308303.html 0.6 2026-07-09T13:47:04+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-pharmaceuticals-announces-propos-308304.html 0.6 2026-06-30T16:46:38+08:00 daily https://www.pharmasources.com/industryinsights/ferring-pharmaceuticals-adds-two-product-308305.html 0.6 2026-06-21T00:58:44+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-pharma-to-develop-alphamabs-vir-308306.html 0.6 2026-06-22T00:07:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-agrees-to-review-pfizers-ndas-for-ta-308307.html 0.6 2026-06-21T05:56:59+08:00 daily https://www.pharmasources.com/industryinsights/agc-to-acquire-malgrat-pharma-chemicals-308308.html 0.6 2026-05-06T16:42:46+08:00 daily https://www.pharmasources.com/industryinsights/nda-for-lemborexant-submitted-in-the-uni-308309.html 0.6 2026-06-20T22:46:43+08:00 daily https://www.pharmasources.com/industryinsights/beigene-receives-fda-breakthrough-therap-308310.html 0.6 2026-06-21T00:57:46+08:00 daily https://www.pharmasources.com/industryinsights/krystal-biotech-completes-construction-o-308311.html 0.6 2026-06-22T00:10:56+08:00 daily https://www.pharmasources.com/industryinsights/house-oversight-committee-launches-drug--308312.html 0.6 2026-06-20T17:01:16+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-308313.html 0.6 2026-08-03T08:56:43+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-cuts-risk-of-death-by-31-in-eso-308314.html 0.6 2026-06-22T11:52:47+08:00 daily https://www.pharmasources.com/industryinsights/pharma-stocks-fall-after-new-drug-price--308315.html 0.6 2026-08-06T19:53:24+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-cabometyx-approved-in-second-li-308316.html 0.6 2026-08-09T06:21:09+08:00 daily https://www.pharmasources.com/industryinsights/digital-health-innovators-get-boost-in-y-308317.html 0.6 2026-07-08T14:11:57+08:00 daily https://www.pharmasources.com/industryinsights/lucid-group-appoints-rob-apollo-to-its-s-308318.html 0.6 2026-07-03T11:14:32+08:00 daily https://www.pharmasources.com/industryinsights/new-birth-control-skin-patch-being-devel-308319.html 0.6 2026-06-29T11:52:28+08:00 daily https://www.pharmasources.com/industryinsights/simple-treatments-to-banish-winter-blues-308320.html 0.6 2026-06-26T07:40:34+08:00 daily https://www.pharmasources.com/industryinsights/race-may-matter-for-liver-transplant-suc-308321.html 0.6 2026-06-21T19:07:38+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-screening-can-prevent-cervical-c-308322.html 0.6 2026-06-20T11:36:08+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-supplementation-can-help-cut-c-308323.html 0.6 2026-06-21T16:53:32+08:00 daily https://www.pharmasources.com/industryinsights/american-college-of-physicians-releases--308324.html 0.6 2026-06-27T13:40:32+08:00 daily https://www.pharmasources.com/industryinsights/young-onset-type-2-diabetes-tied-to-incr-308325.html 0.6 2026-07-01T20:38:03+08:00 daily https://www.pharmasources.com/industryinsights/opioids-now-more-deadly-for-americans-th-308326.html 0.6 2026-07-05T13:43:41+08:00 daily https://www.pharmasources.com/industryinsights/recalling-positive-memories-may-cut-depr-308327.html 0.6 2026-07-10T14:22:18+08:00 daily https://www.pharmasources.com/industryinsights/breakdown-of-blood-brain-barrier-may-dri-308328.html 0.6 2026-06-20T18:03:25+08:00 daily https://www.pharmasources.com/industryinsights/oversight-committee-launches-sweeping-dr-308329.html 0.6 2026-06-22T10:59:53+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-dry-powder-formulation-of-trepro-308330.html 0.6 2026-07-18T06:18:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-amplatzer-piccolo-occluder--308331.html 0.6 2026-08-07T02:39:41+08:00 daily https://www.pharmasources.com/industryinsights/merck-roche-to-renew-global-distribution-308332.html 0.6 2026-08-07T06:31:46+08:00 daily https://www.pharmasources.com/industryinsights/congressmen-to-regulators-bms-celgene-me-308333.html 0.6 2026-03-17T22:56:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-halts-approval-process-due-to-govern-308334.html 0.6 2026-08-09T21:35:12+08:00 daily https://www.pharmasources.com/industryinsights/muscle-stem-cells-can-drive-cancer-that--308335.html 0.6 2026-06-20T22:16:57+08:00 daily https://www.pharmasources.com/industryinsights/preparing-samples-of-cannabis-plant-for--308336.html 0.6 2026-07-15T16:13:56+08:00 daily https://www.pharmasources.com/industryinsights/chinese-produced-new-drugs-to-be-markete-308337.html 0.6 2026-06-24T21:35:32+08:00 daily https://www.pharmasources.com/industryinsights/chinese-produced-new-drugs-approved-for--308338.html 0.6 2026-06-25T12:38:56+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-chinese-produced-new-dru-308339.html 0.6 2026-08-05T23:50:06+08:00 daily https://www.pharmasources.com/industryinsights/sln124-granted-orphan-drug-designation-b-308341.html 0.6 2026-06-21T11:07:17+08:00 daily https://www.pharmasources.com/industryinsights/cure-pharmaceutical-appoints-chairman-ad-308342.html 0.6 2026-07-09T06:36:28+08:00 daily https://www.pharmasources.com/industryinsights/biomunex-pharmaceuticals-signs-a-licensi-308343.html 0.6 2026-06-26T01:29:45+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-extends-tender-offer-for-308344.html 0.6 2026-05-11T19:43:41+08:00 daily https://www.pharmasources.com/industryinsights/beigene-gains-fda-breakthrough-therapy-s-308345.html 0.6 2026-08-07T03:51:53+08:00 daily https://www.pharmasources.com/industryinsights/immunocore-appoints-david-berman-as-rd-c-308346.html 0.6 2026-06-20T14:56:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-boost-staff-to-help-handle-antici-308347.html 0.6 2026-06-22T10:07:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-resumes-some-drug-inspections-halted-308348.html 0.6 2026-06-21T15:59:20+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-groups-weigh-in-on-uk-par-308349.html 0.6 2026-06-22T08:54:44+08:00 daily https://www.pharmasources.com/industryinsights/aha-says-penalties-as-well-as-incentives-308350.html 0.6 2026-06-21T18:02:23+08:00 daily https://www.pharmasources.com/industryinsights/sen-schumer-curiously-links-shingrix-sho-308351.html 0.6 2026-08-06T18:17:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-new-policies-for-cell-and--308352.html 0.6 2026-07-23T09:10:55+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-purdue-pharma-seek-us-approval-308353.html 0.6 2026-01-14T04:57:14+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-biomunex-partner-to-develop-a-308354.html 0.6 2026-07-16T09:13:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-cabozantinib-for-hepatocell-308355.html 0.6 2026-07-19T12:58:34+08:00 daily https://www.pharmasources.com/industryinsights/aivita-biomedical-receives-ind-clearance-308356.html 0.6 2026-08-01T17:09:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-version-of-sa-308357.html 0.6 2026-07-26T01:33:30+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-and-alphamab-announce-strategic-308358.html 0.6 2026-07-23T02:53:57+08:00 daily https://www.pharmasources.com/industryinsights/bioharmony-therapeutics-and-boehringer-i-308359.html 0.6 2026-06-21T01:52:42+08:00 daily https://www.pharmasources.com/industryinsights/bms-gets-new-ok-for-opdivoyervoy-in-kidn-308360.html 0.6 2026-06-21T22:02:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-delays-review-of-peanut-allergy-drug-308361.html 0.6 2026-06-20T14:50:04+08:00 daily https://www.pharmasources.com/industryinsights/pharma-calls-for-no-deal-preparation-aft-308362.html 0.6 2026-06-20T16:41:15+08:00 daily https://www.pharmasources.com/industryinsights/ex-roche-novartis-astrazeneca-leaders-ap-308363.html 0.6 2026-06-22T11:04:52+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-selects-finalists-in-digital-tech-308364.html 0.6 2026-08-07T22:31:28+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-call-for-action-followin-308365.html 0.6 2026-06-23T01:00:05+08:00 daily https://www.pharmasources.com/industryinsights/losartan-could-improve-ovarian-cancer-tr-308366.html 0.6 2026-07-07T15:39:27+08:00 daily https://www.pharmasources.com/industryinsights/sleeping-less-than-six-hours-a-night-may-308367.html 0.6 2026-06-21T16:05:23+08:00 daily https://www.pharmasources.com/industryinsights/abbott-to-acquire-cephea-valve-technolog-308368.html 0.6 2026-07-08T07:26:13+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-opdivo-nivo-308369.html 0.6 2026-07-28T10:49:43+08:00 daily https://www.pharmasources.com/industryinsights/gene-linked-iron-disorder-more-common-th-308370.html 0.6 2026-06-20T18:51:30+08:00 daily https://www.pharmasources.com/industryinsights/dermatologists-rx-for-antibiotics-droppe-308371.html 0.6 2026-06-21T06:23:37+08:00 daily https://www.pharmasources.com/industryinsights/adoption-of-advanced-health-it-capabilit-308372.html 0.6 2026-06-20T20:58:41+08:00 daily https://www.pharmasources.com/industryinsights/low-income-women-lack-menstrual-hygiene--308373.html 0.6 2026-06-21T12:57:41+08:00 daily https://www.pharmasources.com/industryinsights/high-levels-of-activity-motor-ability-li-308374.html 0.6 2026-06-09T09:25:21+08:00 daily https://www.pharmasources.com/industryinsights/climate-change-already-hurting-human-hea-308375.html 0.6 2026-06-21T07:38:00+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharma-strengthens-commitment-to-ca-308376.html 0.6 2026-06-20T23:05:44+08:00 daily https://www.pharmasources.com/industryinsights/how-getting-a-flu-shot-could-save-your-l-308377.html 0.6 2026-06-21T08:47:14+08:00 daily https://www.pharmasources.com/industryinsights/seres-elevates-cfo-eric-shaff-to-ceo-pos-308378.html 0.6 2026-06-21T05:07:46+08:00 daily https://www.pharmasources.com/industryinsights/anti-aging-startup-juvenescence-bags-46m-308379.html 0.6 2026-06-30T19:58:16+08:00 daily https://www.pharmasources.com/industryinsights/magnetic-therapy-developer-brainsway-fil-308380.html 0.6 2026-06-21T03:08:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-recalls-inspectors-as-shutdown-drags-308381.html 0.6 2026-07-02T04:51:55+08:00 daily https://www.pharmasources.com/industryinsights/zhongan-grab-unite-to-create-digital-ins-308382.html 0.6 2026-07-14T06:40:34+08:00 daily https://www.pharmasources.com/industryinsights/imported-drugs-approved-through-priority-308383.html 0.6 2026-07-23T04:52:28+08:00 daily https://www.pharmasources.com/industryinsights/looking-back-2018-review-and-analysis-of-308384.html 0.6 2026-06-21T08:21:20+08:00 daily https://www.pharmasources.com/industryinsights/will-other-pharmaceutical-enterprises-fo-308385.html 0.6 2026-06-27T13:39:10+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-39-new-biological-drugs-mark-308386.html 0.6 2026-06-21T01:05:51+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-staying-up-to-d-308387.html 0.6 2026-08-06T23:56:19+08:00 daily https://www.pharmasources.com/industryinsights/no-means-no-global-pharma-group-bans-any-308388.html 0.6 2026-07-19T22:00:10+08:00 daily https://www.pharmasources.com/industryinsights/acordas-sales-team-switches-gears-to-pus-308389.html 0.6 2026-07-01T18:22:07+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-enters-crowded-liver-cancer-fie-308390.html 0.6 2026-06-21T04:00:48+08:00 daily https://www.pharmasources.com/industryinsights/copay-coupons-help-a-little-with-cv-drug-308391.html 0.6 2026-06-20T14:39:14+08:00 daily https://www.pharmasources.com/industryinsights/merck-bumps-keytruda-credibility-with-re-308392.html 0.6 2026-07-02T22:40:34+08:00 daily https://www.pharmasources.com/industryinsights/sackler-family-directedand-covered-uppur-308393.html 0.6 2026-07-02T17:56:37+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-mohawk-tribe-ask-scotus-to--308394.html 0.6 2026-07-08T04:10:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-backs-amgen-ucbs-postmenopausa-308395.html 0.6 2026-06-22T06:51:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-cerecors-three-substrate-repl-308396.html 0.6 2026-06-21T09:51:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-version-of-sa-308397.html 0.6 2026-07-07T22:43:02+08:00 daily https://www.pharmasources.com/industryinsights/janssen-announces-european-commission-ap-308398.html 0.6 2026-06-21T00:56:53+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-drug-kymriah-should-be-publ-308399.html 0.6 2026-06-20T14:54:09+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-to-bring-worlds-first-gene-t-308400.html 0.6 2025-11-30T16:39:56+08:00 daily https://www.pharmasources.com/industryinsights/roche-phoenixmd-collaborate-on-diagnosti-308401.html 0.6 2026-08-05T09:54:52+08:00 daily https://www.pharmasources.com/industryinsights/five-prime-to-cut-workforce-by-20-percen-308402.html 0.6 2026-07-04T23:11:47+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-ucb-receive-positive-vote-from-308403.html 0.6 2026-07-23T00:58:18+08:00 daily https://www.pharmasources.com/industryinsights/smart-microrobots-that-can-adapt-to-thei-308404.html 0.6 2026-06-21T19:57:38+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019012-308405.html 0.6 2026-06-21T06:23:18+08:00 daily https://www.pharmasources.com/industryinsights/nanoparticle-breakthrough-in-the-fight-a-308406.html 0.6 2026-06-20T18:21:23+08:00 daily https://www.pharmasources.com/industryinsights/generic-version-of-seizure-drug-sabril-g-308407.html 0.6 2026-08-05T19:53:24+08:00 daily https://www.pharmasources.com/industryinsights/obsidian-therapeutics-announces-strategi-308408.html 0.6 2026-08-05T14:59:49+08:00 daily https://www.pharmasources.com/industryinsights/kyn-therapeutics-enters-into-global-stra-308409.html 0.6 2026-07-03T17:07:02+08:00 daily https://www.pharmasources.com/industryinsights/amag-pharmaceuticals-completes-acquisiti-308410.html 0.6 2026-08-07T05:31:00+08:00 daily https://www.pharmasources.com/industryinsights/thyas-obtains-exclusive-rights-to-manufa-308411.html 0.6 2026-08-07T04:34:09+08:00 daily https://www.pharmasources.com/industryinsights/survey-shows-efficacy-of-bont-a-treatmen-308412.html 0.6 2026-08-07T03:15:44+08:00 daily https://www.pharmasources.com/industryinsights/chinese-authorities-approve-sino-pharmas-308413.html 0.6 2026-08-07T03:06:37+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-lexicon-diabetes-drug-gets-split--308414.html 0.6 2026-08-06T23:32:44+08:00 daily https://www.pharmasources.com/industryinsights/acrotech-biopharma-to-buy-seven-drugs-fr-308415.html 0.6 2026-08-06T22:53:37+08:00 daily https://www.pharmasources.com/industryinsights/proteus-digital-health-introduces-digita-308416.html 0.6 2026-08-06T23:37:17+08:00 daily https://www.pharmasources.com/industryinsights/report-finds-nice-unaware-of-financial-i-308417.html 0.6 2026-08-06T23:44:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-licences-luye-pharma-cholest-308418.html 0.6 2026-08-06T23:54:25+08:00 daily https://www.pharmasources.com/industryinsights/terns-pharmaceuticals-announces-the-appo-308419.html 0.6 2026-06-20T15:50:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-modification-to-clozapine-r-308420.html 0.6 2026-07-23T21:26:17+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-launches-symjepi-in-the-us-308421.html 0.6 2026-06-23T10:52:05+08:00 daily https://www.pharmasources.com/industryinsights/aerpio-announces-completion-of-patient-d-308422.html 0.6 2026-06-21T05:07:47+08:00 daily https://www.pharmasources.com/industryinsights/phrma-welcomes-genentech-and-gilead-scie-308423.html 0.6 2026-07-04T19:42:59+08:00 daily https://www.pharmasources.com/industryinsights/omeros-finalizes-with-fda-clinical-plan--308424.html 0.6 2026-06-08T21:54:24+08:00 daily https://www.pharmasources.com/industryinsights/amgen-ucb-receive-positive-vote-from-fda-308425.html 0.6 2026-08-07T11:54:41+08:00 daily https://www.pharmasources.com/industryinsights/actelion-receives-complete-response-lett-308426.html 0.6 2026-06-20T14:13:54+08:00 daily https://www.pharmasources.com/industryinsights/aquinnah-pharmaceuticals-receives-grant--308427.html 0.6 2026-07-27T12:07:08+08:00 daily https://www.pharmasources.com/industryinsights/lillys-verzenios-approved-by-nice-308428.html 0.6 2026-06-20T17:05:46+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-oxford-university-begin-rd--308429.html 0.6 2026-06-22T04:12:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-decisions-could-slow-to-crawl-becaus-308430.html 0.6 2026-06-20T15:09:18+08:00 daily https://www.pharmasources.com/industryinsights/no-bidding-war-for-loxo-so-did-lilly-ove-308431.html 0.6 2026-06-21T03:05:43+08:00 daily https://www.pharmasources.com/industryinsights/troubled-immunomedics-now-hit-with-crl-f-308432.html 0.6 2026-07-01T14:10:39+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-drops-to-6-year-low-on-report-308433.html 0.6 2026-06-20T15:50:35+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-promotes-nerve-regeneration-308434.html 0.6 2026-06-22T08:46:24+08:00 daily https://www.pharmasources.com/industryinsights/engineered-immune-cells-target-broad-ran-308435.html 0.6 2026-07-06T20:18:04+08:00 daily https://www.pharmasources.com/industryinsights/jw-pharmaceutical-gains-korean-approval--308436.html 0.6 2026-06-21T06:18:10+08:00 daily https://www.pharmasources.com/industryinsights/bdi---novartis-partnership-is-announced-308437.html 0.6 2026-06-21T01:11:57+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-starts-search-for-new-ch-308438.html 0.6 2026-06-22T06:04:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ontruzant-trastuzumab-dttb--308439.html 0.6 2026-06-20T19:41:16+08:00 daily https://www.pharmasources.com/industryinsights/app-may-work-like-ritalin-on-brain-to-fo-308440.html 0.6 2026-06-22T01:53:29+08:00 daily https://www.pharmasources.com/industryinsights/why-glaxosmithkline-and-pfizer-are-spinn-308441.html 0.6 2026-08-09T04:12:50+08:00 daily https://www.pharmasources.com/industryinsights/celgene-continues-dealmaking-via-agreeme-308442.html 0.6 2026-08-07T15:43:03+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-introduces-bios-308443.html 0.6 2026-07-08T18:32:51+08:00 daily https://www.pharmasources.com/industryinsights/minervax-announces-award-of-44-million-e-308444.html 0.6 2026-07-14T19:13:16+08:00 daily https://www.pharmasources.com/industryinsights/novartis-chooses-kinaxis-technology-to-i-308445.html 0.6 2026-06-21T09:09:13+08:00 daily https://www.pharmasources.com/industryinsights/uk-royal-college-updates-guidance-on-com-308446.html 0.6 2026-06-30T14:19:30+08:00 daily https://www.pharmasources.com/industryinsights/nhs-plans-for-uk-medicines-supply-in-no--308447.html 0.6 2026-06-08T02:02:39+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-secures-fda-approval-for-308448.html 0.6 2026-06-22T04:55:38+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-university-of-oxford-partne-308449.html 0.6 2026-04-23T19:13:29+08:00 daily https://www.pharmasources.com/industryinsights/lilly-stops-promoting-cancer-drug-after--308450.html 0.6 2026-06-21T08:47:13+08:00 daily https://www.pharmasources.com/industryinsights/gsks-chairman-sir-philip-hampton-steps-d-308451.html 0.6 2026-06-21T01:12:53+08:00 daily https://www.pharmasources.com/industryinsights/nhs-faces-uphill-battle-in-prevention-su-308452.html 0.6 2026-06-22T12:05:25+08:00 daily https://www.pharmasources.com/industryinsights/court-backs-nhs-in-hepatitis-c-procureme-308453.html 0.6 2026-04-28T08:59:12+08:00 daily https://www.pharmasources.com/industryinsights/alphabets-smart-watch-ecg-gets-fda-backi-308454.html 0.6 2026-06-21T11:22:30+08:00 daily https://www.pharmasources.com/industryinsights/communiqu-awards-2019-opens-for-healthca-308455.html 0.6 2026-06-21T02:03:40+08:00 daily https://www.pharmasources.com/industryinsights/jj-partners-with-apple-for-ecg-monitorin-308456.html 0.6 2026-06-20T20:10:40+08:00 daily https://www.pharmasources.com/industryinsights/telehealth-firm-secures-more-cash-to-exp-308457.html 0.6 2026-06-21T04:56:41+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-investigate-alternatives--308458.html 0.6 2026-06-21T11:03:08+08:00 daily https://www.pharmasources.com/industryinsights/united-neuroscience-inches-closer-to-alz-308459.html 0.6 2026-07-29T11:32:32+08:00 daily https://www.pharmasources.com/industryinsights/mindfulness-stress-linked-to-menopausal--308460.html 0.6 2026-06-21T11:48:05+08:00 daily https://www.pharmasources.com/industryinsights/medication-treatment-for-substance-abuse-308461.html 0.6 2026-06-22T10:55:47+08:00 daily https://www.pharmasources.com/industryinsights/wait-times-have-improved-in-va-health-ca-308462.html 0.6 2026-06-21T06:20:18+08:00 daily https://www.pharmasources.com/industryinsights/assessing-symptoms-after-4-weeks-of-psyc-308463.html 0.6 2026-06-21T11:19:39+08:00 daily https://www.pharmasources.com/industryinsights/mandibular-contour-surgery-training-syst-308464.html 0.6 2026-06-21T15:15:53+08:00 daily https://www.pharmasources.com/industryinsights/many-parents-wrong-about-what-prevents-c-308465.html 0.6 2026-06-22T10:53:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-roches-supplemental-biologic-308466.html 0.6 2026-06-22T02:52:36+08:00 daily https://www.pharmasources.com/industryinsights/emerging-markets-drugs-worth-3b-could-be-308467.html 0.6 2026-06-22T04:07:51+08:00 daily https://www.pharmasources.com/industryinsights/lupin-glenmark-and-sun-pharma-recall-var-308468.html 0.6 2026-06-20T15:59:21+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-receives-us-fda-approval-for-l-308469.html 0.6 2026-06-20T22:58:43+08:00 daily https://www.pharmasources.com/industryinsights/lilly-reports-results-of-announce-308470.html 0.6 2026-06-22T21:56:50+08:00 daily https://www.pharmasources.com/industryinsights/study-connects-alzheimers-with-hearing-d-308471.html 0.6 2026-06-21T00:01:39+08:00 daily https://www.pharmasources.com/industryinsights/combination-therapy-for-coinfection-with-308472.html 0.6 2026-06-21T06:21:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-grant-to-help-increase-generic-drugs-308473.html 0.6 2026-07-24T10:29:59+08:00 daily https://www.pharmasources.com/industryinsights/nice-clears-pierre-fabres-targeted-melan-308474.html 0.6 2026-06-21T22:39:32+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-chairman-philip-hampton--308475.html 0.6 2026-06-22T12:40:49+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-abbvie-superstar-imbruvi-308476.html 0.6 2026-06-21T00:53:52+08:00 daily https://www.pharmasources.com/industryinsights/cost-watchdog-icer-lays-out-plans-to-scr-308477.html 0.6 2026-07-04T08:17:03+08:00 daily https://www.pharmasources.com/industryinsights/takeda-looking-to-divest-emerging-market-308478.html 0.6 2026-03-20T02:38:47+08:00 daily https://www.pharmasources.com/industryinsights/eu-label-for-vertexs-cystic-fibrosis-dru-308479.html 0.6 2026-06-22T09:59:53+08:00 daily https://www.pharmasources.com/industryinsights/companies-try-to-skirt-shutdowns-ipo-lim-308480.html 0.6 2026-06-22T03:53:41+08:00 daily https://www.pharmasources.com/industryinsights/scancell-appoints-head-of-research-and-h-308481.html 0.6 2026-04-04T11:58:18+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-fourth-quarter-drug-sal-308482.html 0.6 2026-06-22T10:09:49+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-canada-receives-health-canada-app-308483.html 0.6 2026-04-12T09:30:28+08:00 daily https://www.pharmasources.com/industryinsights/crispr-therapeutics-and-probiogen-sign-c-308484.html 0.6 2026-06-21T19:57:38+08:00 daily https://www.pharmasources.com/industryinsights/orchard-announces-publication-by-san-raf-308485.html 0.6 2026-08-06T00:51:59+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-new-mechanism-to-contro-308486.html 0.6 2026-06-20T14:43:15+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-partners-with-medison-to-offer-o-308487.html 0.6 2026-06-21T05:01:43+08:00 daily https://www.pharmasources.com/industryinsights/antiepileptics-linked-to-more-hospital-d-308488.html 0.6 2026-08-05T23:35:07+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-vertexs-orkambi-for-children-308489.html 0.6 2026-08-06T19:31:36+08:00 daily https://www.pharmasources.com/industryinsights/center-for-beta-cell-therapy-in-diabetes-308490.html 0.6 2026-07-03T22:23:06+08:00 daily https://www.pharmasources.com/industryinsights/prinston-issues-recall-of-irbesartan-irb-308491.html 0.6 2026-07-09T01:00:55+08:00 daily https://www.pharmasources.com/industryinsights/lilly-reports-lartruvo-study-did-not-mee-308492.html 0.6 2026-07-18T22:44:38+08:00 daily https://www.pharmasources.com/industryinsights/epilepsy-foundation-awards-300000-in-gra-308493.html 0.6 2026-06-21T01:02:46+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-receives-fda-ind-clearan-308494.html 0.6 2026-06-21T08:20:24+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-jjs-imbruvica-fails-pancreati-308495.html 0.6 2026-07-04T09:47:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-samsungmerck-cos-herceptin--308496.html 0.6 2026-06-23T03:20:03+08:00 daily https://www.pharmasources.com/industryinsights/novo-holdings-invests-in-three-more-amr--308497.html 0.6 2026-06-21T08:05:03+08:00 daily https://www.pharmasources.com/industryinsights/us-cancer-patients-trial-proteus-digital-308498.html 0.6 2026-06-22T07:04:54+08:00 daily https://www.pharmasources.com/industryinsights/takeda-mulling-sale-of-emerging-market-d-308499.html 0.6 2026-07-10T07:33:09+08:00 daily https://www.pharmasources.com/industryinsights/as-more-smoke-pot-are-their-jobs-at-risk-308500.html 0.6 2026-06-23T15:38:35+08:00 daily https://www.pharmasources.com/industryinsights/aha-too-much-of-this-in-the-blood-could--308501.html 0.6 2026-06-20T20:13:41+08:00 daily https://www.pharmasources.com/industryinsights/many-addiction-centers-lack-anti-opioid--308502.html 0.6 2026-08-07T23:15:23+08:00 daily https://www.pharmasources.com/industryinsights/poor-glycemic-control-in-type-1-diabetes-308503.html 0.6 2026-06-30T13:36:25+08:00 daily https://www.pharmasources.com/industryinsights/repeat-tubal-procedures-up-after-hystero-308504.html 0.6 2026-06-21T09:07:05+08:00 daily https://www.pharmasources.com/industryinsights/messages-for-increasing-parental-confide-308505.html 0.6 2026-06-21T10:21:19+08:00 daily https://www.pharmasources.com/industryinsights/many-new-cancer-patients-unaware-of-thei-308506.html 0.6 2026-06-21T03:41:22+08:00 daily https://www.pharmasources.com/industryinsights/exome-sequencing-beneficial-for-pediatri-308507.html 0.6 2026-07-03T22:39:07+08:00 daily https://www.pharmasources.com/industryinsights/frequent-use-of-aspirin-can-lead-to-incr-308508.html 0.6 2026-06-25T01:07:03+08:00 daily https://www.pharmasources.com/industryinsights/genetic-study-reveals-possible-new-route-308509.html 0.6 2026-07-23T18:34:12+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-to-bring-cold-fighting-produ-308510.html 0.6 2026-07-18T14:37:32+08:00 daily https://www.pharmasources.com/industryinsights/delhi-hc-asks-govt-to-inform-people-abou-308511.html 0.6 2026-07-04T07:20:18+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-us-fda-approval-for-levot-308512.html 0.6 2026-07-03T21:23:03+08:00 daily https://www.pharmasources.com/industryinsights/roche-says-no-thanks-to-megadeals-but-do-308513.html 0.6 2026-06-22T06:46:50+08:00 daily https://www.pharmasources.com/industryinsights/discounting-hit-jjs-xarelto-hard-can-a-n-308514.html 0.6 2026-06-24T09:02:03+08:00 daily https://www.pharmasources.com/industryinsights/or-can-they-abbvie-puts-endometriosis-op-308515.html 0.6 2026-06-22T19:12:18+08:00 daily https://www.pharmasources.com/industryinsights/unitedhealthcare-fueled-by-federal-probe-308516.html 0.6 2026-06-20T21:57:45+08:00 daily https://www.pharmasources.com/industryinsights/endo-turns-to-the-produce-aisle-for-g-ra-308517.html 0.6 2026-06-20T19:05:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-picks-hackathon-challengers-pre-308518.html 0.6 2026-07-01T10:33:04+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-completes-us-300m-financing-dea-308519.html 0.6 2026-06-25T20:32:59+08:00 daily https://www.pharmasources.com/industryinsights/editas-medicine-shares-fall-over-20-perc-308520.html 0.6 2026-06-03T23:07:38+08:00 daily https://www.pharmasources.com/industryinsights/familytech-wearables-company-joy-partner-308521.html 0.6 2026-07-08T06:53:02+08:00 daily https://www.pharmasources.com/industryinsights/rocket-pharmaceuticals-announces-clearan-308522.html 0.6 2026-07-06T15:59:22+08:00 daily https://www.pharmasources.com/industryinsights/bio-thera-solutions-announces-initiation-308523.html 0.6 2026-07-26T10:42:05+08:00 daily https://www.pharmasources.com/industryinsights/access-value-and-investment-making-the-r-308524.html 0.6 2026-06-26T05:51:35+08:00 daily https://www.pharmasources.com/industryinsights/trumps-drug-ad-price-transparency-contai-308525.html 0.6 2026-06-22T19:30:06+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-gets-usfda-ind-nod-for-a-308526.html 0.6 2026-07-15T14:51:10+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-offers-services-308527.html 0.6 2026-08-10T01:50:33+08:00 daily https://www.pharmasources.com/industryinsights/jj-reports-2018-fourth-quarter-results-308528.html 0.6 2026-08-07T16:28:58+08:00 daily https://www.pharmasources.com/industryinsights/peptidream-and-shionogi-sign-peptide-dru-308529.html 0.6 2026-06-21T21:00:42+08:00 daily https://www.pharmasources.com/industryinsights/gsk-closes-51bn-tesaro-acquisition-308530.html 0.6 2026-06-22T06:11:51+08:00 daily https://www.pharmasources.com/industryinsights/amgens-blincyto-gets-expanded-indication-308531.html 0.6 2026-06-21T09:55:09+08:00 daily https://www.pharmasources.com/industryinsights/regular-intake-of-aspirin-could-increase-308532.html 0.6 2026-06-23T17:11:07+08:00 daily https://www.pharmasources.com/industryinsights/tool-enables-imaging-of-neural-activity--308533.html 0.6 2026-01-17T07:40:49+08:00 daily https://www.pharmasources.com/industryinsights/cancer-drug-with-accelerated-approval-fa-308534.html 0.6 2026-08-02T22:57:31+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-announces-patent-for-combinati-308535.html 0.6 2026-06-21T01:02:53+08:00 daily https://www.pharmasources.com/industryinsights/second-genome-doses-first-patient-in-sgm-308536.html 0.6 2026-08-06T17:10:42+08:00 daily https://www.pharmasources.com/industryinsights/torrent-expands-its-voluntary-recall-of--308537.html 0.6 2026-06-20T16:58:18+08:00 daily https://www.pharmasources.com/industryinsights/gamida-cell-and-be-the-match-biotherapie-308538.html 0.6 2026-07-11T00:27:27+08:00 daily https://www.pharmasources.com/industryinsights/ferring-rebiotix-and-karolinska-institut-308539.html 0.6 2026-06-24T09:18:29+08:00 daily https://www.pharmasources.com/industryinsights/european-approval-for-paediatric-cystic--308540.html 0.6 2026-06-21T13:05:26+08:00 daily https://www.pharmasources.com/industryinsights/jj-ends-2018-on-a-high-but-coming-year-l-308541.html 0.6 2026-08-06T10:34:41+08:00 daily https://www.pharmasources.com/industryinsights/flourishing-wuxi-biologics-in-talks-to-m-308542.html 0.6 2026-07-26T01:10:32+08:00 daily https://www.pharmasources.com/industryinsights/vertexs-cf-drug-gets-label-extension-as--308543.html 0.6 2026-06-21T09:07:09+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-digital-cbt-for-youngsters-wi-308544.html 0.6 2026-06-21T11:20:33+08:00 daily https://www.pharmasources.com/industryinsights/crispr-gene-editing-stocks-fall-after-ed-308545.html 0.6 2026-08-08T01:59:00+08:00 daily https://www.pharmasources.com/industryinsights/documentaries-lift-lid-on-theranos-biote-308546.html 0.6 2026-08-07T13:17:41+08:00 daily https://www.pharmasources.com/industryinsights/a-healthy-2019-four-paws-for-more-relaxa-308547.html 0.6 2026-06-20T23:19:05+08:00 daily https://www.pharmasources.com/industryinsights/endometrial-scratching-does-not-increase-308548.html 0.6 2026-08-07T14:28:07+08:00 daily https://www.pharmasources.com/industryinsights/insulin-price-more-than-doubled-in-the-u-308549.html 0.6 2026-08-08T01:36:15+08:00 daily https://www.pharmasources.com/industryinsights/final-verdict-on-finasteride-safe-effect-308550.html 0.6 2026-08-08T01:01:10+08:00 daily https://www.pharmasources.com/industryinsights/objectively-assessed-exercise-protective-308551.html 0.6 2026-06-20T21:00:39+08:00 daily https://www.pharmasources.com/industryinsights/doctors-should-encourage-exercise-in-pat-308552.html 0.6 2026-06-21T08:00:18+08:00 daily https://www.pharmasources.com/industryinsights/ambient-air-pollution-exposure-linked-to-308553.html 0.6 2026-06-25T02:05:31+08:00 daily https://www.pharmasources.com/industryinsights/good-news-bad-news-on-levodopa-for-parki-308554.html 0.6 2026-06-21T03:54:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-committee-votes-on-zynquist-308555.html 0.6 2026-07-10T11:15:58+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-application-for-insomnia-disord-308556.html 0.6 2026-07-04T21:02:14+08:00 daily https://www.pharmasources.com/industryinsights/to-accelerate-linking-up-with-the-intern-308557.html 0.6 2026-08-06T01:26:25+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-global-biological-drugs-mark-308558.html 0.6 2026-08-07T03:24:35+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-global-biological-drugs-mark-308559.html 0.6 2026-08-07T03:03:02+08:00 daily https://www.pharmasources.com/industryinsights/new-combined-diagnostic-and-antimicrobia-308560.html 0.6 2026-07-17T23:51:01+08:00 daily https://www.pharmasources.com/industryinsights/bia-report-2018-was-a-record-year-for-uk-308561.html 0.6 2026-07-03T19:15:30+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-to-fund-three-interna-308562.html 0.6 2026-08-07T18:44:51+08:00 daily https://www.pharmasources.com/industryinsights/bridgebio-pharma-raises-299m-to-support--308563.html 0.6 2026-07-06T23:52:29+08:00 daily https://www.pharmasources.com/industryinsights/uk-unveils-plan-to-tackle-growing-antimi-308564.html 0.6 2026-06-22T10:07:54+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-receives-fda-may-proceed-letter-308565.html 0.6 2026-06-21T02:01:36+08:00 daily https://www.pharmasources.com/industryinsights/ferring-appoints-lead-to-new-us-oncology-308566.html 0.6 2026-06-20T20:53:00+08:00 daily https://www.pharmasources.com/industryinsights/inovios-synthetic-dna-vaccine-shows-prom-308567.html 0.6 2026-07-07T02:09:06+08:00 daily https://www.pharmasources.com/industryinsights/amgen-allergan-announce-positive-top-lin-308568.html 0.6 2026-06-21T08:14:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-use-of-fluzone-quadrivalent-308569.html 0.6 2026-06-20T15:48:22+08:00 daily https://www.pharmasources.com/industryinsights/b-mogen-biotechnologies-and-cytosen-ther-308570.html 0.6 2026-08-06T02:26:28+08:00 daily https://www.pharmasources.com/industryinsights/philogen-announces-drug-discovery-collab-308571.html 0.6 2026-04-09T10:10:15+08:00 daily https://www.pharmasources.com/industryinsights/nice-assessments-could-reform-in-new-sup-308572.html 0.6 2026-06-21T10:02:07+08:00 daily https://www.pharmasources.com/industryinsights/vertex-sacks-top-exec-citing-personal-be-308573.html 0.6 2026-01-25T10:11:28+08:00 daily https://www.pharmasources.com/industryinsights/ema-set-for-official-move-from-london-on-308574.html 0.6 2026-06-21T04:49:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-signs-china-digital-health-de-308575.html 0.6 2026-07-21T01:59:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-consumer-colorectal-cancer--308576.html 0.6 2026-06-24T11:48:59+08:00 daily https://www.pharmasources.com/industryinsights/flu-like-illness-tied-to-increased-relat-308577.html 0.6 2026-06-25T07:36:10+08:00 daily https://www.pharmasources.com/industryinsights/gun-injury-hospitalization-cost-over-911-308578.html 0.6 2026-06-25T12:44:14+08:00 daily https://www.pharmasources.com/industryinsights/measles-outbreak-prompts-public-emergenc-308579.html 0.6 2026-03-01T03:00:20+08:00 daily https://www.pharmasources.com/industryinsights/cdc-proportion-of-increased-risk-decease-308580.html 0.6 2026-07-17T17:13:45+08:00 daily https://www.pharmasources.com/industryinsights/teens-odds-for-suicide-may-triple-while--308581.html 0.6 2026-06-20T21:11:51+08:00 daily https://www.pharmasources.com/industryinsights/rock-a-bye-you-for-better-sleep-308582.html 0.6 2026-07-07T11:37:21+08:00 daily https://www.pharmasources.com/industryinsights/merck-enters-into-an-exclusive-licensing-308583.html 0.6 2026-07-08T16:56:18+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018128-308584.html 0.6 2026-06-27T11:47:42+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-brings-propofol-injectable-emu-308585.html 0.6 2026-06-28T15:41:18+08:00 daily https://www.pharmasources.com/industryinsights/philogen-signs-drug-discovery-contract-w-308586.html 0.6 2026-07-03T20:48:43+08:00 daily https://www.pharmasources.com/industryinsights/manufacturer-to-pay-penalty-for-entire-b-308587.html 0.6 2026-07-09T05:16:28+08:00 daily https://www.pharmasources.com/industryinsights/pharma-funding-for-neglected-disease-res-308588.html 0.6 2026-06-21T20:25:07+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-tencent-announce-collaboration-308589.html 0.6 2026-07-17T01:04:37+08:00 daily https://www.pharmasources.com/industryinsights/humira-biosimilars-catch-fire-in-europe--308590.html 0.6 2026-08-06T15:11:29+08:00 daily https://www.pharmasources.com/industryinsights/vertex-fires-coo-ian-smith-for-unspecifi-308591.html 0.6 2026-06-21T03:57:16+08:00 daily https://www.pharmasources.com/industryinsights/optum-slaps-former-executive-with-trade--308592.html 0.6 2026-06-21T13:02:28+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-workers-in-ireland-fight-to-keep--308593.html 0.6 2026-08-08T23:43:38+08:00 daily https://www.pharmasources.com/industryinsights/roche-dispatches-strategy-executive-alex-308594.html 0.6 2026-08-07T04:09:20+08:00 daily https://www.pharmasources.com/industryinsights/the-skeptics-were-right-bristol-myers-ha-308595.html 0.6 2026-06-22T16:24:50+08:00 daily https://www.pharmasources.com/industryinsights/bms-talks-up-celgene-merger-to-divert-op-308596.html 0.6 2026-06-21T01:01:46+08:00 daily https://www.pharmasources.com/industryinsights/lillys-tarnished-lartruvo-faces-uncertai-308597.html 0.6 2026-07-24T11:49:51+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-warns-of-bigger-hit-to-humira-sal-308598.html 0.6 2026-03-27T09:06:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expresses-concerns-over-no-deal-308599.html 0.6 2026-06-20T17:48:22+08:00 daily https://www.pharmasources.com/industryinsights/cvs-to-cover-migraine-drugs-from-teva-li-308600.html 0.6 2026-03-28T00:58:24+08:00 daily https://www.pharmasources.com/industryinsights/coherus-biosciences-announces-filing-of--308601.html 0.6 2026-06-21T06:11:51+08:00 daily https://www.pharmasources.com/industryinsights/bellerophon-announces-closing-of-7-milli-308602.html 0.6 2026-06-22T09:55:43+08:00 daily https://www.pharmasources.com/industryinsights/big-pharmas-drug-studies-are-getting-a-n-308603.html 0.6 2026-07-09T05:11:39+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-technology-partner-mannin-resea-308604.html 0.6 2026-06-21T03:43:37+08:00 daily https://www.pharmasources.com/industryinsights/government-of-ghana-partners-novartis-to-308605.html 0.6 2026-06-20T22:20:03+08:00 daily https://www.pharmasources.com/industryinsights/use-compulsory-license-and-put-ceiling-t-308606.html 0.6 2026-06-21T02:17:57+08:00 daily https://www.pharmasources.com/industryinsights/amgen-receives-nmpa-approval-for-repatha-308607.html 0.6 2026-06-22T04:58:36+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-roche-will-top-burgeoning--308608.html 0.6 2026-06-20T15:52:38+08:00 daily https://www.pharmasources.com/industryinsights/fdas-aggressive-move-on-tainted-sartan-l-308609.html 0.6 2026-06-20T22:51:01+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-aspirin-may-help-some-pat-308610.html 0.6 2026-06-22T08:02:46+08:00 daily https://www.pharmasources.com/industryinsights/study-may-explain-why-once-promising-can-308611.html 0.6 2026-06-21T06:16:12+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-approval-for-pfizers-depo-308612.html 0.6 2026-06-22T02:00:36+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-funding-increased-by-85-perce-308613.html 0.6 2026-06-22T07:59:51+08:00 daily https://www.pharmasources.com/industryinsights/genetically-modified-viral-injection-cou-308614.html 0.6 2026-06-22T05:12:53+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-gets-usfda-ind-approval-for-its-pr-308615.html 0.6 2026-04-29T05:27:15+08:00 daily https://www.pharmasources.com/industryinsights/takedas-dengue-shot-rival-to-sanofis-den-308616.html 0.6 2026-07-03T14:20:01+08:00 daily https://www.pharmasources.com/industryinsights/amgen-hunts-for-deals-of-all-sizes-to-co-308617.html 0.6 2026-06-21T10:50:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-finds-more-issues-at-lupin-plant-it--308618.html 0.6 2026-07-03T13:33:54+08:00 daily https://www.pharmasources.com/industryinsights/drug-compound-could-be-next-generation-t-308619.html 0.6 2026-07-10T08:44:08+08:00 daily https://www.pharmasources.com/industryinsights/growing-role-of-personalised-and-precisi-308620.html 0.6 2026-06-22T01:05:10+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-lilly-announce-top-line-resul-308621.html 0.6 2026-06-14T18:51:27+08:00 daily https://www.pharmasources.com/industryinsights/bio-st---a-new-platform-for-the-introduc-308622.html 0.6 2026-06-23T00:05:16+08:00 daily https://www.pharmasources.com/industryinsights/test-run-of-drug-prices-in-ads-exposes-a-308623.html 0.6 2026-08-01T01:10:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-moving-to-risk-based-inspections-eve-308624.html 0.6 2026-06-21T22:01:40+08:00 daily https://www.pharmasources.com/industryinsights/researchers-call-for-big-data-infrastruc-308625.html 0.6 2026-07-01T07:08:13+08:00 daily https://www.pharmasources.com/industryinsights/merck-granted-us-patent-for-novel-combin-308626.html 0.6 2026-06-21T04:58:53+08:00 daily https://www.pharmasources.com/industryinsights/new-study-analyzes-cost-effectiveness-of-308627.html 0.6 2026-06-29T14:25:03+08:00 daily https://www.pharmasources.com/industryinsights/proposed-medicare-reforms-spark-comments-308628.html 0.6 2026-04-16T23:43:35+08:00 daily https://www.pharmasources.com/industryinsights/strides-to-acquire-remaining-stake-in-vi-308629.html 0.6 2026-06-20T21:10:41+08:00 daily https://www.pharmasources.com/industryinsights/global-medicine-spending-to-exceeds-15-t-308630.html 0.6 2026-06-21T07:57:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-changes-nices-mind-on-kymriah-g-308631.html 0.6 2026-06-22T03:05:19+08:00 daily https://www.pharmasources.com/industryinsights/thanks-to-ocrevus-roche-outgrows-biosimi-308632.html 0.6 2026-06-21T08:03:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-advair-diskus-308633.html 0.6 2026-06-20T17:58:20+08:00 daily https://www.pharmasources.com/industryinsights/study-examines-long-term-opioid-use-in-p-308634.html 0.6 2026-07-03T04:44:57+08:00 daily https://www.pharmasources.com/industryinsights/dhl-launches-express-cold-chain-service--308635.html 0.6 2026-08-06T17:53:32+08:00 daily https://www.pharmasources.com/industryinsights/extended-recall-of-ibuprofen-oral-suspen-308636.html 0.6 2026-06-20T14:46:04+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-developing-a-design-space-fo-308637.html 0.6 2026-08-07T01:27:52+08:00 daily https://www.pharmasources.com/industryinsights/seven-trends-of-the-pharmaceutical-indus-308638.html 0.6 2026-07-03T23:24:03+08:00 daily https://www.pharmasources.com/industryinsights/seven-trends-of-the-pharmaceutical-indus-308639.html 0.6 2026-07-31T11:50:18+08:00 daily https://www.pharmasources.com/industryinsights/exciting-which-products-are-the-pharmapa-308640.html 0.6 2026-06-21T00:18:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-lillys-alimta-label-308641.html 0.6 2026-06-22T07:52:50+08:00 daily https://www.pharmasources.com/industryinsights/new-computational-method-reduces-risk-of-308642.html 0.6 2026-06-21T02:59:44+08:00 daily https://www.pharmasources.com/industryinsights/tevas-generic-epipen-launch-stalls-month-308643.html 0.6 2026-07-02T05:56:16+08:00 daily https://www.pharmasources.com/industryinsights/committee-demands-answers-on-rising-cost-308644.html 0.6 2026-05-01T15:38:39+08:00 daily https://www.pharmasources.com/industryinsights/public-consultation-on-key-principles-fo-308645.html 0.6 2026-01-20T14:06:06+08:00 daily https://www.pharmasources.com/industryinsights/takeda-hits-fda-snag-on-ninlaro-but-its--308646.html 0.6 2026-06-29T23:22:03+08:00 daily https://www.pharmasources.com/industryinsights/mylans-generic-version-of-advair-diskus--308647.html 0.6 2026-06-23T14:08:33+08:00 daily https://www.pharmasources.com/industryinsights/hitachi-to-acquire-apceth-biopharma-308648.html 0.6 2026-06-21T04:54:59+08:00 daily https://www.pharmasources.com/industryinsights/jp-morgan-no-expert-consensus-on-2019-ca-308649.html 0.6 2026-06-21T09:08:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-returns-to-work-post-shutdown-but-fe-308650.html 0.6 2026-06-21T09:03:00+08:00 daily https://www.pharmasources.com/industryinsights/global-humira-sales-near-20bn-but-expect-308651.html 0.6 2026-07-21T23:14:14+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-nhs-use-of-kymriah-for-s-308652.html 0.6 2026-06-21T02:43:24+08:00 daily https://www.pharmasources.com/industryinsights/lunar-new-year-focuses-on-traditional-ch-308653.html 0.6 2026-08-09T11:22:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-pilot-programme-to-track-an-308654.html 0.6 2026-06-23T18:48:44+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019021-308655.html 0.6 2026-06-21T09:25:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-therapy-for-the-treat-308656.html 0.6 2026-07-10T20:18:38+08:00 daily https://www.pharmasources.com/industryinsights/abbott-india-q3-net-profit-up-marginally-308657.html 0.6 2026-06-21T09:07:09+08:00 daily https://www.pharmasources.com/industryinsights/drug-costs-soaring-express-scripts-says--308658.html 0.6 2026-06-21T07:01:59+08:00 daily https://www.pharmasources.com/industryinsights/female-contraceptive-market-set-to-be-wo-308659.html 0.6 2026-07-20T04:02:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-against-17-companies-fo-308660.html 0.6 2026-06-23T03:08:06+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-seve-308661.html 0.6 2026-06-20T23:53:30+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-looks-to-zoom-past-opdiv-308662.html 0.6 2026-06-21T23:42:04+08:00 daily https://www.pharmasources.com/industryinsights/new-pill-can-deliver-insulin-308663.html 0.6 2026-07-02T04:05:12+08:00 daily https://www.pharmasources.com/industryinsights/new-insight-into-cell-receptors-opens-th-308664.html 0.6 2026-06-21T11:12:31+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-acquires-apotexs-operations-in-308665.html 0.6 2026-07-09T20:18:53+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-completes-inspection-of-lupins-pi-308666.html 0.6 2026-06-21T15:10:41+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-amicus-sign-exclusive-308667.html 0.6 2026-07-22T00:53:37+08:00 daily https://www.pharmasources.com/industryinsights/humira-topped-for-seven-times-in-sales-a-308668.html 0.6 2026-05-03T10:33:54+08:00 daily https://www.pharmasources.com/industryinsights/bio-macromolecular-drugs-in-the-autoimmu-308669.html 0.6 2026-07-26T19:18:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-clamps-down-on-illegal-dietary-suppl-308670.html 0.6 2026-06-21T07:06:00+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-teneobio-to-co-develop-new-dr-308671.html 0.6 2026-06-21T01:58:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-agrees-to-review-merck-and-pfizers-s-308672.html 0.6 2026-06-21T09:51:17+08:00 daily https://www.pharmasources.com/industryinsights/ucb-and-epilepsy-society-partner-to-brin-308673.html 0.6 2026-06-22T09:58:42+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-sanofi-cut-us-list-price-o-308674.html 0.6 2026-06-20T13:19:55+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-forms-new-alliance-to-ex-308675.html 0.6 2026-07-19T21:01:37+08:00 daily https://www.pharmasources.com/industryinsights/finch-therapeutics-c-difficile-drug-gets-308676.html 0.6 2026-06-20T14:51:07+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-recalls-valsartan-containing-bloo-308677.html 0.6 2026-06-21T05:38:13+08:00 daily https://www.pharmasources.com/industryinsights/icr-unveils-efficacious-cancer-drug-with-308678.html 0.6 2026-06-22T14:46:50+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-to-disclose-drug-prices--308679.html 0.6 2026-07-02T13:45:33+08:00 daily https://www.pharmasources.com/industryinsights/no-deal-brexit-could-put-uk-patients-at--308680.html 0.6 2026-06-20T14:51:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-darzalex-split-dosing-regim-308681.html 0.6 2026-06-20T21:17:57+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-appoints-chief-digital-officer-308682.html 0.6 2026-08-08T02:14:41+08:00 daily https://www.pharmasources.com/industryinsights/trial-shows-xtandi-significantly-improve-308683.html 0.6 2026-06-21T20:45:00+08:00 daily https://www.pharmasources.com/industryinsights/phase-3-stellar-4-study-of-selonsertib-d-308684.html 0.6 2026-07-31T12:40:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-am-308685.html 0.6 2026-06-22T09:03:45+08:00 daily https://www.pharmasources.com/industryinsights/neurotech-granted-fast-track-designation-308686.html 0.6 2026-06-20T23:42:41+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-sparks-price-row-in-us-with-300-308687.html 0.6 2026-07-18T00:45:24+08:00 daily https://www.pharmasources.com/industryinsights/nhs-should-invest-in-digital-ai-and-robo-308688.html 0.6 2025-11-13T18:49:27+08:00 daily https://www.pharmasources.com/industryinsights/gilead-nash-drug-fails-late-stage-trial-308689.html 0.6 2026-06-20T20:05:42+08:00 daily https://www.pharmasources.com/industryinsights/grey-wolf-raises-10m-for-tumour-illumina-308690.html 0.6 2026-06-20T22:02:40+08:00 daily https://www.pharmasources.com/industryinsights/verily-builds-us-drug-rehab-campus-amid--308691.html 0.6 2026-06-21T05:05:47+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-clear-the-rd-decks-in-q-308692.html 0.6 2026-06-21T09:01:05+08:00 daily https://www.pharmasources.com/industryinsights/usfda-accepts-merck-and-pfizers-sbla-for-308693.html 0.6 2026-06-21T08:05:02+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-potential-therapeuti-308694.html 0.6 2026-08-08T01:50:41+08:00 daily https://www.pharmasources.com/industryinsights/omadacycline-similar-to-commonly-used-an-308695.html 0.6 2026-06-25T21:33:23+08:00 daily https://www.pharmasources.com/industryinsights/combination-antiplatelet-therapy-reduces-308696.html 0.6 2026-06-21T16:48:24+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-canada-ltd-and-ibm--308697.html 0.6 2026-06-21T04:19:10+08:00 daily https://www.pharmasources.com/industryinsights/nano-drops-a-million-times-smaller-than--308698.html 0.6 2026-06-20T22:15:57+08:00 daily https://www.pharmasources.com/industryinsights/mhra-recalls-a-further-three-batches-of--308699.html 0.6 2026-03-03T02:59:48+08:00 daily https://www.pharmasources.com/industryinsights/dementia-consortium-welcomes-new-partner-308700.html 0.6 2026-08-07T00:06:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-supports-janssens-esketamine-n-308701.html 0.6 2026-07-30T13:32:38+08:00 daily https://www.pharmasources.com/industryinsights/ec-expands-takedas-adcetris-authorisatio-308702.html 0.6 2026-06-22T10:43:21+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-divest-proleukins-us-rights--308703.html 0.6 2026-06-21T12:10:18+08:00 daily https://www.pharmasources.com/industryinsights/moberg-pharma-and-bayer-sign-exclusive-l-308704.html 0.6 2026-07-05T12:27:49+08:00 daily https://www.pharmasources.com/industryinsights/regenerxs-us-joint-venture-initiates-key-308705.html 0.6 2026-06-22T20:58:02+08:00 daily https://www.pharmasources.com/industryinsights/ligand-announces-omniab-partnership-with-308706.html 0.6 2026-06-21T09:01:58+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-us-launch-of-a-generic-ve-308707.html 0.6 2026-06-22T01:46:41+08:00 daily https://www.pharmasources.com/industryinsights/pulmatrix-receives-ind-approval-for-pulm-308708.html 0.6 2026-06-22T04:53:34+08:00 daily https://www.pharmasources.com/industryinsights/merckpfizer-up-the-pressure-on-bms-in-fi-308709.html 0.6 2026-06-20T14:48:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-egaten-triclabendazole-for--308710.html 0.6 2026-07-25T01:11:08+08:00 daily https://www.pharmasources.com/industryinsights/autologous-stem-cell-transplant-may-aid--308711.html 0.6 2026-06-21T02:12:49+08:00 daily https://www.pharmasources.com/industryinsights/midlife-systemic-inflammation-linked-to--308712.html 0.6 2026-06-21T02:57:39+08:00 daily https://www.pharmasources.com/industryinsights/drug-company-payments-over-time-may-infl-308713.html 0.6 2026-08-07T03:25:21+08:00 daily https://www.pharmasources.com/industryinsights/alector-kicks-off-biotech-ipos-after-us--308714.html 0.6 2026-08-07T03:03:03+08:00 daily https://www.pharmasources.com/industryinsights/trojan-horse-cancer-drug-shows-promise-i-308715.html 0.6 2026-08-07T02:52:09+08:00 daily https://www.pharmasources.com/industryinsights/tasmanian-devils-likely-to-survive-cance-308716.html 0.6 2026-08-07T02:42:59+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-biotech-shares-sink-on-inco-308717.html 0.6 2026-08-07T02:36:40+08:00 daily https://www.pharmasources.com/industryinsights/nice-launches-scientific-advice-tie-up-w-308718.html 0.6 2026-08-07T02:33:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-premarket-guidance-on-comb-308719.html 0.6 2026-08-07T02:30:33+08:00 daily https://www.pharmasources.com/industryinsights/generic-advair-will-put-the-squeeze-on-g-308720.html 0.6 2026-08-07T02:21:58+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-gets-speedy-fda-review-for-rare--308721.html 0.6 2026-08-07T02:18:34+08:00 daily https://www.pharmasources.com/industryinsights/haselmeier-acquires-drug-manufacturing-l-308722.html 0.6 2026-08-07T06:09:44+08:00 daily https://www.pharmasources.com/industryinsights/sk-biopharmaceuticals-arvelle-partner-on-308723.html 0.6 2026-08-07T11:33:48+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-and-novartis-enter-into-multi--308724.html 0.6 2026-08-07T12:00:23+08:00 daily https://www.pharmasources.com/industryinsights/decoy-platelets-could-prevent-clots-and--308725.html 0.6 2026-08-07T13:16:32+08:00 daily https://www.pharmasources.com/industryinsights/eisai-seeks-ema-approval-for-fycompa-to--308726.html 0.6 2026-08-08T10:49:42+08:00 daily https://www.pharmasources.com/industryinsights/neurogene-raises-funds-to-support-gene-t-308727.html 0.6 2026-08-08T12:07:14+08:00 daily https://www.pharmasources.com/industryinsights/ibm-watson-health-invests-in-research-co-308728.html 0.6 2026-08-09T06:59:17+08:00 daily https://www.pharmasources.com/industryinsights/tanabe-research-labs-announce-fda-accept-308729.html 0.6 2026-06-21T11:12:40+08:00 daily https://www.pharmasources.com/industryinsights/mayne-pharma-launches-lexette-foam-005-i-308730.html 0.6 2026-07-03T08:56:23+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-to-acquire-auris-health-308731.html 0.6 2026-06-20T14:43:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-o-308732.html 0.6 2026-06-20T14:52:05+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-biosys-expands-collaboration-wi-308733.html 0.6 2026-06-21T06:03:52+08:00 daily https://www.pharmasources.com/industryinsights/chinese-patients-to-get-new-drugs-before-308734.html 0.6 2026-06-21T10:03:08+08:00 daily https://www.pharmasources.com/industryinsights/who-discusses-digital-health-roadmap-for-308735.html 0.6 2026-03-22T03:04:44+08:00 daily https://www.pharmasources.com/industryinsights/harpoon-and-gossamer-sneak-out-ipos-befo-308736.html 0.6 2026-08-08T02:47:04+08:00 daily https://www.pharmasources.com/industryinsights/azs-ceo-dismisses-fake-news-about-his-im-308737.html 0.6 2026-07-06T04:55:31+08:00 daily https://www.pharmasources.com/industryinsights/price-cut-unlocks-nice-nod-for-perjeta-i-308738.html 0.6 2026-06-24T10:26:02+08:00 daily https://www.pharmasources.com/industryinsights/cancer-death-risk-up-for-kidney-transpla-308739.html 0.6 2026-06-21T16:04:25+08:00 daily https://www.pharmasources.com/industryinsights/wisdom-linked-to-cognitive-performance-i-308740.html 0.6 2026-06-21T06:50:16+08:00 daily https://www.pharmasources.com/industryinsights/hip-preservation-appropriateness-guideli-308741.html 0.6 2026-08-06T18:18:26+08:00 daily https://www.pharmasources.com/industryinsights/science-puzzling-out-differences-in-gut--308742.html 0.6 2026-06-20T14:37:07+08:00 daily https://www.pharmasources.com/industryinsights/andrew-alliance-and-sartorius-collaborat-308743.html 0.6 2026-06-22T09:00:47+08:00 daily https://www.pharmasources.com/industryinsights/ashfield-creates-new-global-healthcare-c-308744.html 0.6 2026-06-21T05:12:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-sareptas-nda-for-precision-m-308745.html 0.6 2026-06-21T06:11:53+08:00 daily https://www.pharmasources.com/industryinsights/merck-initiates-three-phase-iii-trials-i-308746.html 0.6 2026-06-21T12:02:15+08:00 daily https://www.pharmasources.com/industryinsights/passage-bio-receives-115m-in-funding-to--308747.html 0.6 2026-08-07T05:55:53+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-to-establish-ne-308748.html 0.6 2026-06-21T07:58:58+08:00 daily https://www.pharmasources.com/industryinsights/canadian-researchers-develop-molecules-t-308749.html 0.6 2026-06-21T07:18:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-interoperable-insul-308750.html 0.6 2025-11-10T18:09:07+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-plus-yervoy-shows-response-in-pre-308751.html 0.6 2026-06-21T02:53:49+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-obtain-rights-to-vitrakvi-and-b-308752.html 0.6 2026-08-08T00:58:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-finalizes-bulk-drug-substances-rule-308753.html 0.6 2026-07-08T05:46:04+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-announces-board-of--308754.html 0.6 2026-06-20T15:58:27+08:00 daily https://www.pharmasources.com/industryinsights/amorsa-therapeutics-announces-us-patent--308755.html 0.6 2026-06-21T04:01:44+08:00 daily https://www.pharmasources.com/industryinsights/dicyclomine-hcl-injection-usp-now-availa-308756.html 0.6 2026-06-22T03:04:58+08:00 daily https://www.pharmasources.com/industryinsights/vivacelle-bio-receives-fda-clearance-to--308757.html 0.6 2026-08-08T01:06:08+08:00 daily https://www.pharmasources.com/industryinsights/statins-could-protect-against-motor-neur-308758.html 0.6 2026-07-04T05:52:29+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-takedas-alunbrig-in-second-li-308759.html 0.6 2026-06-20T21:07:43+08:00 daily https://www.pharmasources.com/industryinsights/protect-your-aging-eyes-from-macular-deg-308760.html 0.6 2026-06-21T23:54:23+08:00 daily https://www.pharmasources.com/industryinsights/hands-dont-spread-hpv-study-finds-308761.html 0.6 2026-07-07T12:25:30+08:00 daily https://www.pharmasources.com/industryinsights/sepsis-common-in-terminal-hospitalizatio-308762.html 0.6 2026-08-06T20:42:48+08:00 daily https://www.pharmasources.com/industryinsights/fewer-older-men-assessed-treated-for-ost-308763.html 0.6 2026-06-21T09:42:47+08:00 daily https://www.pharmasources.com/industryinsights/nurse-navigators-aid-outcomes-after-hear-308764.html 0.6 2026-06-22T11:52:43+08:00 daily https://www.pharmasources.com/industryinsights/atox-bio-announces-chief-commercial-offi-308765.html 0.6 2026-08-09T06:59:24+08:00 daily https://www.pharmasources.com/industryinsights/catabasis-announces-new-board-of-directo-308766.html 0.6 2026-08-08T05:08:40+08:00 daily https://www.pharmasources.com/industryinsights/decipher-biosciences-announces-research--308767.html 0.6 2026-08-07T13:18:25+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019021-308768.html 0.6 2026-08-07T03:33:48+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-acquires-chiron-behring-v-308769.html 0.6 2026-08-07T03:55:22+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-reversible-antiplate-308770.html 0.6 2026-08-07T04:04:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-new-steps-to-adopt-more-modern-308771.html 0.6 2026-08-07T04:21:58+08:00 daily https://www.pharmasources.com/industryinsights/bayer-exercised-option-to-obtain-full-li-308772.html 0.6 2026-08-07T04:49:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-asks-migraine-patients-to-use-thei-308773.html 0.6 2025-11-19T16:46:51+08:00 daily https://www.pharmasources.com/industryinsights/lilly-closes-8bn-loxo-oncology-acquisiti-308774.html 0.6 2026-07-20T03:02:29+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-divest-chiron-behring-vaccines-to-308775.html 0.6 2026-06-21T14:56:25+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-roches-breast-cancer-dru-308776.html 0.6 2026-06-20T23:58:40+08:00 daily https://www.pharmasources.com/industryinsights/ilc-dovers-jetmixer-an-efficient-method--308777.html 0.6 2026-07-03T14:43:48+08:00 daily https://www.pharmasources.com/industryinsights/merck-group-and-pfizer-announce-positive-308778.html 0.6 2026-06-21T10:49:18+08:00 daily https://www.pharmasources.com/industryinsights/aklrd-awarded-675000-grant-from-innovate-308779.html 0.6 2026-07-04T23:48:43+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-a-collaboration-with--308780.html 0.6 2026-06-21T09:10:28+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-combo-set-to-become-standard-of-308781.html 0.6 2026-06-20T16:59:18+08:00 daily https://www.pharmasources.com/industryinsights/medicare-coverage-for-car-t-drugs-on-the-308782.html 0.6 2026-06-20T17:01:14+08:00 daily https://www.pharmasources.com/industryinsights/open-health-rebrands-and-restructures-in-308783.html 0.6 2026-06-14T22:59:36+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-clob-308784.html 0.6 2026-06-20T22:05:41+08:00 daily https://www.pharmasources.com/industryinsights/circassia-prepares-for-potential-us-laun-308785.html 0.6 2026-07-27T00:39:23+08:00 daily https://www.pharmasources.com/industryinsights/transgender-hormone-therapy-could-pose-h-308786.html 0.6 2026-06-20T15:59:15+08:00 daily https://www.pharmasources.com/industryinsights/neurotrope-announces-agreement-for-bryos-308787.html 0.6 2026-06-22T12:58:16+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-top-line-phase-3-results-308788.html 0.6 2026-06-22T07:55:50+08:00 daily https://www.pharmasources.com/industryinsights/drug-combination-may-become-new-standard-308789.html 0.6 2026-04-12T06:58:06+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-launches-pelmeg-biosimilar-i-308790.html 0.6 2026-08-02T00:22:45+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-reaches-targeted-therapeutic-ex-308791.html 0.6 2026-06-21T04:18:06+08:00 daily https://www.pharmasources.com/industryinsights/vlp-therapeutics-to-initiate-first-clini-308792.html 0.6 2026-06-20T15:53:08+08:00 daily https://www.pharmasources.com/industryinsights/us-senate-invites-seven-pharma-majors-to-308793.html 0.6 2026-06-20T21:41:23+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-announces-myeloma-drug-meets-prim-308794.html 0.6 2026-06-20T21:49:38+08:00 daily https://www.pharmasources.com/industryinsights/argenx-to-leverage-halozymes-subcutaneou-308795.html 0.6 2026-08-08T03:46:19+08:00 daily https://www.pharmasources.com/industryinsights/us-and-european-regulatory-agencies-fast-308796.html 0.6 2026-08-08T20:59:36+08:00 daily https://www.pharmasources.com/industryinsights/gensights-lhon-drug-fails-to-meet-endpoi-308797.html 0.6 2026-08-08T01:44:00+08:00 daily https://www.pharmasources.com/industryinsights/policy-to-improve-access-and-foster-pric-308798.html 0.6 2026-08-09T06:59:30+08:00 daily https://www.pharmasources.com/industryinsights/researchers-discover-new-drug-target-to--308799.html 0.6 2026-08-08T01:01:27+08:00 daily https://www.pharmasources.com/industryinsights/no-association-between-antiepileptic-dru-308800.html 0.6 2026-08-07T17:16:11+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-fda-approval-for-egate-308801.html 0.6 2026-08-07T16:21:09+08:00 daily https://www.pharmasources.com/industryinsights/bharat-buys-gsks-indian-vaccine-unit-to--308802.html 0.6 2026-08-07T13:19:17+08:00 daily https://www.pharmasources.com/industryinsights/ema-completed-pre-approval-inspection-of-308803.html 0.6 2026-08-07T01:52:35+08:00 daily https://www.pharmasources.com/industryinsights/3d-microprint-use-the-ft4-powder-rheomet-308804.html 0.6 2026-08-07T01:51:53+08:00 daily https://www.pharmasources.com/industryinsights/rsp-systems-to-exhibit-its-cutting-edge--308805.html 0.6 2026-06-21T15:02:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-takedas-alunbrig-in-second-li-308806.html 0.6 2026-06-20T14:38:49+08:00 daily https://www.pharmasources.com/industryinsights/knight-therapeutics-invests-up-to-125m-i-308807.html 0.6 2026-08-06T00:29:27+08:00 daily https://www.pharmasources.com/industryinsights/genentech-gets-fda-priority-review-for-t-308808.html 0.6 2026-07-10T18:36:24+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-devise-new-radiotherapy-p-308809.html 0.6 2026-06-20T14:53:05+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-acquires-etons-m-100-inves-308810.html 0.6 2026-06-20T23:54:33+08:00 daily https://www.pharmasources.com/industryinsights/immune-pharmaceuticals-files-for-chapter-308811.html 0.6 2026-06-22T09:57:39+08:00 daily https://www.pharmasources.com/industryinsights/verdiperstat-receives-orphan-drug-design-308812.html 0.6 2026-06-20T22:59:34+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-lilly-announce-top-line-results-f-308813.html 0.6 2026-06-06T04:46:43+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-artificial-intelligence-marke-308814.html 0.6 2026-04-19T14:38:21+08:00 daily https://www.pharmasources.com/industryinsights/inhibrx-announces-dosing-of-first-patien-308815.html 0.6 2026-06-20T21:21:45+08:00 daily https://www.pharmasources.com/industryinsights/qiagen-partners-with-ares-genetics-to-ad-308816.html 0.6 2026-06-22T22:08:29+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-and-biolingus-sign-exclusive-te-308817.html 0.6 2026-06-27T03:14:37+08:00 daily https://www.pharmasources.com/industryinsights/cipla-taps-wellthy-for-digital-therapeut-308818.html 0.6 2026-08-02T21:23:04+08:00 daily https://www.pharmasources.com/industryinsights/two-new-cancer-priority-reviews-for-roch-308819.html 0.6 2026-06-20T14:40:19+08:00 daily https://www.pharmasources.com/industryinsights/mhra-investigates-opioid-regulation-as-a-308820.html 0.6 2026-07-04T23:11:42+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-says-screen-women-with-higher-ris-308821.html 0.6 2026-08-07T16:09:50+08:00 daily https://www.pharmasources.com/industryinsights/inappropriate-use-of-fentanyl-preps-seen-308822.html 0.6 2026-08-07T13:17:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-about-miracle-young-blood-infu-308823.html 0.6 2026-08-06T23:46:29+08:00 daily https://www.pharmasources.com/industryinsights/most-hip-knee-replacements-last-decades--308824.html 0.6 2026-08-06T23:32:51+08:00 daily https://www.pharmasources.com/industryinsights/acg-commits-to-further-investment-in-bra-308825.html 0.6 2026-08-06T23:36:40+08:00 daily https://www.pharmasources.com/industryinsights/heart-attacks-rising-among-younger-women-308826.html 0.6 2026-08-06T22:54:25+08:00 daily https://www.pharmasources.com/industryinsights/pain-therapeutics-announces-feedback-fro-308827.html 0.6 2026-06-21T11:14:35+08:00 daily https://www.pharmasources.com/industryinsights/taiho-pharmaceutical-licences-lung-cance-308828.html 0.6 2026-08-08T22:05:51+08:00 daily https://www.pharmasources.com/industryinsights/former-astrazeneca-uk-plant-back-up-for--308829.html 0.6 2026-08-06T23:32:31+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-galapagos-collaborate-for-new-308830.html 0.6 2026-08-07T02:22:08+08:00 daily https://www.pharmasources.com/industryinsights/between-merck-and-pfizer-the-race-is-on--308831.html 0.6 2026-08-09T11:20:19+08:00 daily https://www.pharmasources.com/industryinsights/new-machine-learning-technique-rapidly-a-308832.html 0.6 2026-08-07T02:04:50+08:00 daily https://www.pharmasources.com/industryinsights/inadequate-fda-oversight-concerning-fent-308833.html 0.6 2026-08-07T01:21:43+08:00 daily https://www.pharmasources.com/industryinsights/oral-antifungals-used-to-treat-yeast-inf-308834.html 0.6 2026-08-07T01:14:36+08:00 daily https://www.pharmasources.com/industryinsights/sapreme-technologies-in-a-68-m-eu-allian-308835.html 0.6 2026-08-07T00:53:13+08:00 daily https://www.pharmasources.com/industryinsights/calypso-biotech-bv-secures-20-million-eu-308836.html 0.6 2026-08-07T10:01:26+08:00 daily https://www.pharmasources.com/industryinsights/alzprotect-on-track-for-a-phase-2-entry--308837.html 0.6 2026-08-07T02:40:06+08:00 daily https://www.pharmasources.com/industryinsights/university-of-dundee-and-takeda-partner--308838.html 0.6 2026-06-21T21:51:35+08:00 daily https://www.pharmasources.com/industryinsights/uk-performs-badly-in-international-compa-308839.html 0.6 2026-06-21T12:23:47+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-new-partnership-focuses-on-digit-308840.html 0.6 2026-06-21T12:53:34+08:00 daily https://www.pharmasources.com/industryinsights/indivior-launches-generic-version-of-sub-308841.html 0.6 2026-06-22T09:11:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-agrees-to-review-abbvies-upadacitini-308842.html 0.6 2026-07-05T13:40:23+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-enrolls-first-patient-in-phase--308843.html 0.6 2026-06-21T20:07:47+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-announces-fda-acceptance-of-ind--308844.html 0.6 2026-06-20T14:52:09+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-cautioning-consumers--308845.html 0.6 2026-06-21T14:47:15+08:00 daily https://www.pharmasources.com/industryinsights/experimental-drug-helps-women-with-deadl-308846.html 0.6 2026-02-28T20:55:01+08:00 daily https://www.pharmasources.com/industryinsights/aucta-pharmaceuticals-and-oakrum-pharma--308847.html 0.6 2026-07-06T15:57:45+08:00 daily https://www.pharmasources.com/industryinsights/exicure-announces-license-and-developmen-308848.html 0.6 2026-06-22T10:59:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-head-says-feds-may-intervene-to-cut--308849.html 0.6 2026-06-25T00:51:38+08:00 daily https://www.pharmasources.com/industryinsights/morning-exercise-linked-to-bp-reduction--308850.html 0.6 2026-06-21T21:07:46+08:00 daily https://www.pharmasources.com/industryinsights/plazomicin-noninferior-to-meropenem-for--308851.html 0.6 2026-06-21T16:03:26+08:00 daily https://www.pharmasources.com/industryinsights/experimental-test-may-quickly-diagnose-s-308852.html 0.6 2026-06-20T22:03:46+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-generic-oncology-drugs-surge-308853.html 0.6 2026-06-20T20:01:36+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-gets-okay-from-fda-for-adjuvant-308854.html 0.6 2026-06-22T11:10:56+08:00 daily https://www.pharmasources.com/industryinsights/no-us-launch-until-2020-for-novos-new-ha-308855.html 0.6 2026-06-22T18:50:02+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-jak-inhibitor-upadacitinib-gets--308856.html 0.6 2026-06-21T08:07:03+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-gets-grant-for-further-trial--308857.html 0.6 2026-06-21T07:18:14+08:00 daily https://www.pharmasources.com/industryinsights/pregnant-women-should-delay-gallbladder--308858.html 0.6 2026-06-13T11:53:43+08:00 daily https://www.pharmasources.com/industryinsights/abbott-and-novo-nordisk-enter-partnershi-308859.html 0.6 2026-06-22T04:01:48+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-hits-the-skids-in-pivota-308860.html 0.6 2026-06-27T09:53:00+08:00 daily https://www.pharmasources.com/industryinsights/us-top-court-denies-indiviors-request-on-308861.html 0.6 2026-06-21T06:57:57+08:00 daily https://www.pharmasources.com/industryinsights/strides-pharma-science-arm-gets-usfda-no-308862.html 0.6 2026-06-20T21:51:43+08:00 daily https://www.pharmasources.com/industryinsights/structural-barriers-biggest-reason-for-l-308863.html 0.6 2026-07-10T05:48:34+08:00 daily https://www.pharmasources.com/industryinsights/salt-could-be-a-key-factor-in-allergic-i-308864.html 0.6 2026-06-21T15:10:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-fda-approval-for-egate-308865.html 0.6 2026-06-28T18:13:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-halts-xencors-study-of-xmab14045-fol-308866.html 0.6 2026-06-21T20:58:35+08:00 daily https://www.pharmasources.com/industryinsights/us-healthcare-spending-to-reach-6tn-by-2-308867.html 0.6 2026-07-10T00:14:21+08:00 daily https://www.pharmasources.com/industryinsights/biomx-raises-funds-to-advance-drug-candi-308868.html 0.6 2026-06-21T06:12:55+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-receives-fda-nod-for-haemop-308869.html 0.6 2026-06-22T12:55:15+08:00 daily https://www.pharmasources.com/industryinsights/indivior-announces-launch-of-suboxone-su-308870.html 0.6 2026-06-22T00:49:44+08:00 daily https://www.pharmasources.com/industryinsights/anixa-biosciences-extends-agreement-with-308871.html 0.6 2026-07-07T01:43:19+08:00 daily https://www.pharmasources.com/industryinsights/satsuma-provides-update-prepares-to-adva-308872.html 0.6 2026-06-22T02:12:06+08:00 daily https://www.pharmasources.com/industryinsights/nexus-receives-fda-approval-for-prochlor-308873.html 0.6 2026-06-23T15:36:31+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-announces-interim-analysis--308874.html 0.6 2026-06-21T18:13:32+08:00 daily https://www.pharmasources.com/industryinsights/vical-slashes-staff-after-culling-phase--308875.html 0.6 2026-06-21T11:55:09+08:00 daily https://www.pharmasources.com/industryinsights/more-positive-results-for-pfizerlillys-n-308876.html 0.6 2026-06-23T22:46:06+08:00 daily https://www.pharmasources.com/industryinsights/patients-switch-to-lower-dose-of-pfizers-308877.html 0.6 2026-07-09T01:35:32+08:00 daily https://www.pharmasources.com/industryinsights/brexit-could-disrupt-medicine-supplies-f-308878.html 0.6 2026-06-21T09:01:18+08:00 daily https://www.pharmasources.com/industryinsights/japan-second-fastest-pharma-growth-in-20-308879.html 0.6 2026-07-15T08:36:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-aims-to-strengthen-sunscreen-rules-308880.html 0.6 2026-06-24T22:54:27+08:00 daily https://www.pharmasources.com/industryinsights/us-agencies-probing-johnson-johnson-over-308881.html 0.6 2026-06-20T23:52:41+08:00 daily https://www.pharmasources.com/industryinsights/nanosphere-signs-definitive-licensing-ag-308882.html 0.6 2026-03-18T01:29:25+08:00 daily https://www.pharmasources.com/industryinsights/using-bristol-myers-popular-leukemia-dru-308883.html 0.6 2026-06-20T19:06:40+08:00 daily https://www.pharmasources.com/industryinsights/adial-pharmaceuticals-announces-partners-308884.html 0.6 2026-06-21T06:04:47+08:00 daily https://www.pharmasources.com/industryinsights/kratom-related-poisonings-are-soaring-st-308885.html 0.6 2026-08-07T19:22:09+08:00 daily https://www.pharmasources.com/industryinsights/eu-measures-in-support-of-generic-pharma-308886.html 0.6 2026-06-20T14:46:16+08:00 daily https://www.pharmasources.com/industryinsights/preventing-unnecessary-exposure-to-opioi-308887.html 0.6 2026-06-23T06:03:11+08:00 daily https://www.pharmasources.com/industryinsights/intuitive-surgical-receives-fda-clearanc-308888.html 0.6 2026-06-20T15:14:20+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-launches-brain-pacemaker-impla-308889.html 0.6 2026-06-20T14:29:12+08:00 daily https://www.pharmasources.com/industryinsights/smart-drug-shows-promise-for-metastatic--308890.html 0.6 2026-06-21T09:08:11+08:00 daily https://www.pharmasources.com/industryinsights/turbulent-times-for-xencor-as-fda-slaps--308891.html 0.6 2026-06-22T23:03:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-partners-with-nasscom-308892.html 0.6 2026-06-22T00:54:53+08:00 daily https://www.pharmasources.com/industryinsights/drl-recalls-2770-bags-of-epilepsy-inject-308893.html 0.6 2026-06-21T19:01:40+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-merck-jj-well-positioned-for-ma-a-308894.html 0.6 2026-06-22T07:01:48+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-for-duchenne-muscular-dystrophy-308895.html 0.6 2026-03-09T20:36:27+08:00 daily https://www.pharmasources.com/industryinsights/amgen-cytokinetics-and-servier-announce--308896.html 0.6 2026-06-21T19:11:08+08:00 daily https://www.pharmasources.com/industryinsights/approved-by-nmpa-dulaglutide-eli-lillys--308897.html 0.6 2026-08-07T02:33:59+08:00 daily https://www.pharmasources.com/industryinsights/global-hcv-drug-market-declined-to-below-308898.html 0.6 2026-06-25T03:13:50+08:00 daily https://www.pharmasources.com/industryinsights/icer-finds-novartis-gene-therapy-zolgens-308899.html 0.6 2026-06-17T16:04:06+08:00 daily https://www.pharmasources.com/industryinsights/alder-biopharmaceuticals-files-for-fda-a-308900.html 0.6 2026-06-21T11:15:27+08:00 daily https://www.pharmasources.com/industryinsights/icer-to-publish-upcoming-assessment-on-a-308901.html 0.6 2026-07-16T18:14:10+08:00 daily https://www.pharmasources.com/industryinsights/following-deal-focused-on-alzheimers-dis-308902.html 0.6 2026-06-21T08:57:56+08:00 daily https://www.pharmasources.com/industryinsights/study-links-celebrex-heart-valve-calcifi-308903.html 0.6 2026-06-24T19:30:28+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-otsuka-and-lundbe-308904.html 0.6 2026-06-20T21:55:34+08:00 daily https://www.pharmasources.com/industryinsights/intellipharmaceutics-announces-fiscal-ye-308905.html 0.6 2026-06-26T02:29:44+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-announces-filing-of-308906.html 0.6 2026-07-15T15:30:53+08:00 daily https://www.pharmasources.com/industryinsights/10-million-for-adhd-medicine-on-the-pbs-308907.html 0.6 2026-08-06T13:01:14+08:00 daily https://www.pharmasources.com/industryinsights/rapid-relief-of-pain-in-oral-mucositis-n-308908.html 0.6 2026-06-29T22:37:20+08:00 daily https://www.pharmasources.com/industryinsights/delhi-hc-sets-aside-govt-ban-on-lupins-a-308909.html 0.6 2026-06-21T01:50:34+08:00 daily https://www.pharmasources.com/industryinsights/drug-for-children-with-spinal-muscular-a-308910.html 0.6 2026-06-18T10:16:05+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-presents-two-year-f-308911.html 0.6 2026-06-22T04:43:30+08:00 daily https://www.pharmasources.com/industryinsights/nice-says-drug-to-treat-batten-disease-c-308912.html 0.6 2026-07-18T21:32:31+08:00 daily https://www.pharmasources.com/industryinsights/brainstorm-announces-first-contracted-us-308913.html 0.6 2026-06-20T21:56:39+08:00 daily https://www.pharmasources.com/industryinsights/tg-therapeutics-inc-announces-data-prese-308914.html 0.6 2026-08-07T11:51:48+08:00 daily https://www.pharmasources.com/industryinsights/paladin-labs-inc-announces-approval-of-e-308915.html 0.6 2026-06-22T03:55:42+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-prices-375-million-su-308916.html 0.6 2026-06-22T10:03:41+08:00 daily https://www.pharmasources.com/industryinsights/dbv-technologies-announces-publication-o-308917.html 0.6 2026-06-21T09:02:59+08:00 daily https://www.pharmasources.com/industryinsights/can-this-biotech-stock-redeem-its-sales--308918.html 0.6 2026-06-20T22:01:40+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-determines-trigger-event-occurre-308919.html 0.6 2026-06-20T18:06:23+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-commences-cash-tender-offe-308920.html 0.6 2026-08-08T02:57:08+08:00 daily https://www.pharmasources.com/industryinsights/statement-on-the-fdas-efforts-to-maintai-308921.html 0.6 2026-08-05T23:34:58+08:00 daily https://www.pharmasources.com/industryinsights/childrens-vaccine-87-effective-against-c-308922.html 0.6 2026-06-21T04:00:55+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-receives-marketing-authorisatio-308923.html 0.6 2026-07-05T04:50:37+08:00 daily https://www.pharmasources.com/industryinsights/phoenix-tissue-repair-doses-first-patien-308924.html 0.6 2026-08-07T14:55:09+08:00 daily https://www.pharmasources.com/industryinsights/bexion-pharmaceuticals-announces-the-ope-308925.html 0.6 2026-06-20T21:15:51+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-announces-launch-of-privat-308926.html 0.6 2026-07-04T17:50:09+08:00 daily https://www.pharmasources.com/industryinsights/logicbio-therapeutics-appoints-kenneth-h-308927.html 0.6 2026-06-22T02:50:32+08:00 daily https://www.pharmasources.com/industryinsights/ppd-and-hlt-to-create-data-science-drive-308928.html 0.6 2026-08-07T23:13:28+08:00 daily https://www.pharmasources.com/industryinsights/innovate-biopharmaceuticals-announces-a--308929.html 0.6 2026-06-20T19:20:11+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-shifts-several-top-leader-308930.html 0.6 2026-06-21T02:12:50+08:00 daily https://www.pharmasources.com/industryinsights/progenity-announces-expansion-of-board-o-308931.html 0.6 2026-06-23T02:46:57+08:00 daily https://www.pharmasources.com/industryinsights/chamber-launches-ad-blitz-against-trump--308932.html 0.6 2026-06-24T13:31:50+08:00 daily https://www.pharmasources.com/industryinsights/purdue-exec-agreed-to-hide-oxycontin-str-308933.html 0.6 2026-06-22T00:08:56+08:00 daily https://www.pharmasources.com/industryinsights/momenta-pharmaceuticals-reports-fourth-q-308934.html 0.6 2026-06-21T22:55:40+08:00 daily https://www.pharmasources.com/industryinsights/insmed-reports-fourth-quarter-and-full-y-308935.html 0.6 2026-08-07T10:50:23+08:00 daily https://www.pharmasources.com/industryinsights/odonate-therapeutics-announces-financial-308936.html 0.6 2026-06-21T10:17:35+08:00 daily https://www.pharmasources.com/industryinsights/karolinska-developments-portfolio-compan-308937.html 0.6 2026-06-22T19:22:50+08:00 daily https://www.pharmasources.com/industryinsights/bayer-pairs-its-products-in-first-ever-p-308938.html 0.6 2026-06-21T12:52:32+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-racks-up-more-repeat-violation-308939.html 0.6 2026-06-21T08:15:16+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-oncology-drug-plant-escapes-cl-308940.html 0.6 2026-06-20T17:58:25+08:00 daily https://www.pharmasources.com/industryinsights/philippine-officials-pull-dengvaxias-mar-308941.html 0.6 2026-07-10T13:13:50+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-cdmo-sta-pharma-inks-exclusi-308942.html 0.6 2026-07-29T09:07:58+08:00 daily https://www.pharmasources.com/industryinsights/congressman-aims-to-break-pharmas-insuli-308943.html 0.6 2026-06-27T01:25:51+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-nabs-fda-nod-for-hemophilia-308944.html 0.6 2026-06-21T05:59:48+08:00 daily https://www.pharmasources.com/industryinsights/justice-department-sec-subpoenas-put-jjs-308945.html 0.6 2026-06-21T13:14:37+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-confirms-activist-starboar-308946.html 0.6 2026-06-21T08:09:03+08:00 daily https://www.pharmasources.com/industryinsights/its-not-a-brexit-problem-sanofi-says-of--308947.html 0.6 2026-06-20T16:07:40+08:00 daily https://www.pharmasources.com/industryinsights/not-ready-to-quit-smoking-cold-turkey-pf-308948.html 0.6 2026-06-21T06:03:54+08:00 daily https://www.pharmasources.com/industryinsights/doctors-advice-for-pharma-in-2019-lay-of-308949.html 0.6 2026-04-05T22:47:56+08:00 daily https://www.pharmasources.com/industryinsights/allogene-therapeutics-to-build-out-facil-308950.html 0.6 2026-07-08T09:44:22+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-switches-ra-patients-to-lower-dos-308951.html 0.6 2026-02-16T09:21:11+08:00 daily https://www.pharmasources.com/industryinsights/organic-growth-and-pivoting-at-bausch-he-308952.html 0.6 2026-06-21T04:02:47+08:00 daily https://www.pharmasources.com/industryinsights/teva-ftc-enter-expanded-settlement-barri-308953.html 0.6 2026-07-26T17:01:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-merck-jj-well-positioned-for-ma-a-308954.html 0.6 2026-06-20T22:50:00+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-hits-the-skids-in-pivota-308955.html 0.6 2026-06-22T07:12:00+08:00 daily https://www.pharmasources.com/industryinsights/activist-starboard-wants-to-know-if-bris-308956.html 0.6 2026-07-13T08:11:22+08:00 daily https://www.pharmasources.com/industryinsights/under-pressure-allergan-backs-a-ceo-chai-308957.html 0.6 2026-08-07T01:06:57+08:00 daily https://www.pharmasources.com/industryinsights/insulin-pricing-lawsuit-against-sanofi-n-308958.html 0.6 2026-07-02T23:13:06+08:00 daily https://www.pharmasources.com/industryinsights/novartis-avexis-doubles-down-with-115m-m-308959.html 0.6 2026-06-21T14:38:18+08:00 daily https://www.pharmasources.com/industryinsights/pipeline-hungry-bayer-antes-up-on-vitrak-308960.html 0.6 2026-06-21T08:15:12+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-dethrones-abbvie-as-xeljanz-soars-308961.html 0.6 2026-06-20T15:58:34+08:00 daily https://www.pharmasources.com/industryinsights/marketing-with-safety-data-bayer-could-c-308962.html 0.6 2026-06-21T07:11:04+08:00 daily https://www.pharmasources.com/industryinsights/egalets-70-price-increase-shows-the-buy--308963.html 0.6 2026-06-22T12:00:47+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-rides-high-on-sales-rebound--308964.html 0.6 2026-06-20T16:59:40+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-japan-drawn-into-valsartan-recall-308965.html 0.6 2026-07-29T23:35:24+08:00 daily https://www.pharmasources.com/industryinsights/chinas-latest-bid-to-spur-new-drugs-a-ta-308966.html 0.6 2026-08-06T23:45:44+08:00 daily https://www.pharmasources.com/industryinsights/will-mutant-strains-hurt-prospects-for-r-308967.html 0.6 2026-08-06T23:35:51+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-expects-to-shell-out-120m-to-sett-308968.html 0.6 2026-08-07T11:20:44+08:00 daily https://www.pharmasources.com/industryinsights/indias-glenmark-spins-out-nmes-into-us-c-308969.html 0.6 2026-08-06T23:46:10+08:00 daily https://www.pharmasources.com/industryinsights/astellas-and-affinivaxs-novel-pneumococc-308970.html 0.6 2026-08-06T23:56:53+08:00 daily https://www.pharmasources.com/industryinsights/korean-biotechs-snatch-us-stem-cell-manu-308971.html 0.6 2026-08-07T00:03:30+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-racks-up-more-repeat-violation-308972.html 0.6 2026-08-07T00:40:33+08:00 daily https://www.pharmasources.com/industryinsights/swayed-by-discounts-nice-finally-backs-r-308973.html 0.6 2026-08-07T01:14:04+08:00 daily https://www.pharmasources.com/industryinsights/insys-opioid-reps-rapped-about-boosting--308974.html 0.6 2026-08-07T01:18:49+08:00 daily https://www.pharmasources.com/industryinsights/with-split-up-nearing-ironwood-adds-35-m-308975.html 0.6 2026-08-07T01:27:50+08:00 daily https://www.pharmasources.com/industryinsights/teva-forecasts-worse-than-expected-troug-308976.html 0.6 2026-08-09T20:34:42+08:00 daily https://www.pharmasources.com/industryinsights/mckesson-called-out-by-fdas-gottlieb-ove-308977.html 0.6 2026-08-07T16:40:21+08:00 daily https://www.pharmasources.com/industryinsights/mylans-aggressive-generic-advair-discoun-308978.html 0.6 2026-08-09T07:56:22+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-new-chief-digital-officer-joins--308979.html 0.6 2026-06-21T12:22:46+08:00 daily https://www.pharmasources.com/industryinsights/bayer-geisinger-add-digital-touch-to-off-308980.html 0.6 2026-07-03T01:07:36+08:00 daily https://www.pharmasources.com/industryinsights/big-keytruda-survival-win-sets-merck-up--308981.html 0.6 2026-06-21T14:31:13+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-holds-firm-on-300000-plus-net-f-308982.html 0.6 2026-06-21T10:55:12+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-holds-firm-on-300000-plus-net-f-308983.html 0.6 2026-06-20T04:13:25+08:00 daily https://www.pharmasources.com/industryinsights/bms-can-breathe-easier-now-celgenes-revl-308984.html 0.6 2026-08-03T19:44:53+08:00 daily https://www.pharmasources.com/industryinsights/americans-cross-border-into-mexico-to-bu-308985.html 0.6 2026-06-20T21:56:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-chiefs-2018-take-home-pay-suffe-308986.html 0.6 2026-07-04T01:51:07+08:00 daily https://www.pharmasources.com/industryinsights/progenics-buys-a-manufacturing-facility--308987.html 0.6 2026-06-22T01:43:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astellas-chase-new-xtandi-nod-wit-308988.html 0.6 2026-06-21T22:49:42+08:00 daily https://www.pharmasources.com/industryinsights/unitedhealthcare-demands-drug-rebates-ev-308989.html 0.6 2026-06-22T09:08:51+08:00 daily https://www.pharmasources.com/industryinsights/pcsk9-price-cut-matchup-is-on-as-regener-308990.html 0.6 2026-06-21T14:51:19+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-bachupally-plant-experiences-a-308991.html 0.6 2026-08-09T03:17:27+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-loses-bid-to-hoard-documents-in-h-308992.html 0.6 2026-08-07T02:06:43+08:00 daily https://www.pharmasources.com/industryinsights/tipping-point-digital-communications-fro-308993.html 0.6 2026-08-08T21:49:53+08:00 daily https://www.pharmasources.com/industryinsights/philly-council-nixes-pharma-gift-ban-sal-308994.html 0.6 2026-06-27T05:54:14+08:00 daily https://www.pharmasources.com/industryinsights/rebounding-teva-is-too-cheap-to-ignore-u-308995.html 0.6 2026-08-07T06:29:59+08:00 daily https://www.pharmasources.com/industryinsights/doctor-payments-drove-scripts-for-cancer-308996.html 0.6 2026-07-13T21:11:30+08:00 daily https://www.pharmasources.com/industryinsights/takeda-hits-fda-snag-on-ninlaro-but-its--308997.html 0.6 2026-06-23T17:37:10+08:00 daily https://www.pharmasources.com/industryinsights/takeda-ordered-to-pay-bayer-155m-for-hem-308998.html 0.6 2026-06-20T18:59:36+08:00 daily https://www.pharmasources.com/industryinsights/hibercell-launches-with-60m-to-combat-ca-308999.html 0.6 2026-06-21T09:01:07+08:00 daily https://www.pharmasources.com/industryinsights/china-smacks-48-officials-including-ex-f-309000.html 0.6 2026-06-27T14:00:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-finds-big-issue-with-chinese-otc-dru-309001.html 0.6 2026-07-03T06:14:24+08:00 daily https://www.pharmasources.com/industryinsights/how-to-trump-the-trump-administration-fo-309002.html 0.6 2026-06-21T11:53:21+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-buoyed-by-dupixent-and-rare-disea-309003.html 0.6 2026-06-21T12:11:24+08:00 daily https://www.pharmasources.com/industryinsights/pharma-ceos-enthuse-about-trumps-plan-to-309004.html 0.6 2026-05-30T08:22:34+08:00 daily https://www.pharmasources.com/industryinsights/novum-best-known-for-astronomical-price--309005.html 0.6 2026-06-21T11:22:31+08:00 daily https://www.pharmasources.com/industryinsights/biogen-faces-multibillion-dollar-tecfide-309006.html 0.6 2026-06-22T14:36:37+08:00 daily https://www.pharmasources.com/industryinsights/meredith-signs-up-to-craft-custom-conten-309007.html 0.6 2026-06-20T23:49:35+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-libtayo-is-chugging-along-in--309008.html 0.6 2026-07-20T20:05:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-braces-for-work-stoppage-after-an-309009.html 0.6 2026-07-05T05:37:54+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-scores-fda-nod-for-270k-nanobody--309010.html 0.6 2026-06-23T10:55:32+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-rumored-activists-havent-m-309011.html 0.6 2026-06-21T12:03:13+08:00 daily https://www.pharmasources.com/industryinsights/as-advair-generic-hits-gsk-looks-to-onco-309012.html 0.6 2026-06-21T09:03:30+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-surprise-lartruvo-failure-lox-309013.html 0.6 2026-06-20T20:42:19+08:00 daily https://www.pharmasources.com/industryinsights/on-second-thought-big-pharma-ceos-decide-309014.html 0.6 2026-06-22T06:58:53+08:00 daily https://www.pharmasources.com/industryinsights/trumps-hiv-pledge-comes-as-gilead-pumps--309015.html 0.6 2026-06-20T20:59:40+08:00 daily https://www.pharmasources.com/industryinsights/revamped-pharma-rep-and-gift-ban-bill-ba-309016.html 0.6 2026-06-22T05:58:39+08:00 daily https://www.pharmasources.com/industryinsights/as-rebates-face-the-ax-pbms-cast-themsel-309017.html 0.6 2026-06-20T22:10:55+08:00 daily https://www.pharmasources.com/industryinsights/tris-pharma-expands-retrieval-of-potenti-309018.html 0.6 2026-06-20T16:53:19+08:00 daily https://www.pharmasources.com/industryinsights/hedge-funder-renews-call-for-allergan-ce-309019.html 0.6 2026-06-30T14:32:38+08:00 daily https://www.pharmasources.com/industryinsights/alexion-runs-toward-big-ultomiris-goals--309020.html 0.6 2026-06-23T00:46:33+08:00 daily https://www.pharmasources.com/industryinsights/another-hospital-group-targets-drug-shor-309021.html 0.6 2026-06-23T03:56:57+08:00 daily https://www.pharmasources.com/industryinsights/roche-nabs-coveted-fda-real-time-review--309022.html 0.6 2026-08-08T03:26:14+08:00 daily https://www.pharmasources.com/industryinsights/cimzia-maker-ucb-takes-next-step-in-preg-309023.html 0.6 2026-08-08T01:44:10+08:00 daily https://www.pharmasources.com/industryinsights/indivior-faces-huge-sales-loss-as-suboxo-309024.html 0.6 2026-08-07T13:18:12+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019022-309025.html 0.6 2026-08-07T02:51:41+08:00 daily https://www.pharmasources.com/industryinsights/focusing-on-advanced-laboratory-instrume-309026.html 0.6 2026-08-07T03:02:58+08:00 daily https://www.pharmasources.com/industryinsights/novartis-exercises-rights-to-ionis-cv-dr-309027.html 0.6 2026-08-07T03:24:43+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-its-brilinta-reduc-309028.html 0.6 2026-08-07T03:31:19+08:00 daily https://www.pharmasources.com/industryinsights/nice-refuses-to-endorse-biomarins-batten-309029.html 0.6 2026-06-20T23:14:55+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-acquire-gene-therapy-specialist-309030.html 0.6 2026-06-20T20:53:37+08:00 daily https://www.pharmasources.com/industryinsights/ucsf-discover-potential-new-treatment-ap-309031.html 0.6 2026-06-20T20:00:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-agrees-to-acquire-immune-design-fo-309032.html 0.6 2026-06-21T10:01:12+08:00 daily https://www.pharmasources.com/industryinsights/morphic-and-janssen-collaboratively-deve-309033.html 0.6 2026-06-20T21:48:25+08:00 daily https://www.pharmasources.com/industryinsights/outcome-based-payment-system-could-exped-309034.html 0.6 2026-08-08T02:24:36+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-generic-suboxone-sublingu-309035.html 0.6 2026-06-20T18:15:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-e-309036.html 0.6 2026-08-05T08:06:10+08:00 daily https://www.pharmasources.com/industryinsights/aivita-completes-treatment-of-first-pati-309037.html 0.6 2026-08-03T22:32:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-adds-boxed-warning-for-uloric-309038.html 0.6 2026-07-31T14:52:45+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-to-buy-rare-disease-firm-clementia-309039.html 0.6 2026-06-23T04:26:44+08:00 daily https://www.pharmasources.com/industryinsights/cell-therapy-produces-encouraging-first--309040.html 0.6 2026-07-22T22:10:20+08:00 daily https://www.pharmasources.com/industryinsights/mendelian-gets-500000-for-rare-disease-s-309041.html 0.6 2026-06-21T08:02:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-thermography-no-substitute-for-mammo-309042.html 0.6 2026-06-21T10:57:20+08:00 daily https://www.pharmasources.com/industryinsights/single-application-fit-moderately-sensit-309043.html 0.6 2026-06-21T09:10:10+08:00 daily https://www.pharmasources.com/industryinsights/aaaai-exclusive-breastfeeding-not-linked-309044.html 0.6 2026-04-10T07:39:53+08:00 daily https://www.pharmasources.com/industryinsights/prognostic-bleeding-risk-models-develope-309045.html 0.6 2026-06-21T18:01:22+08:00 daily https://www.pharmasources.com/industryinsights/blood-donation-by-teen-girls-may-raise-a-309046.html 0.6 2026-06-22T03:05:56+08:00 daily https://www.pharmasources.com/industryinsights/samsungs-new-smart-watch-has-blood-press-309047.html 0.6 2026-06-21T05:55:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-drafts-leapfrog-guidance-on-brain-co-309048.html 0.6 2026-08-10T00:17:32+08:00 daily https://www.pharmasources.com/industryinsights/autolus-taps-vineti-to-help-deliver-pers-309049.html 0.6 2026-08-07T00:59:14+08:00 daily https://www.pharmasources.com/industryinsights/uk-department-of-health-updates-its-no-d-309050.html 0.6 2026-08-07T00:53:10+08:00 daily https://www.pharmasources.com/industryinsights/ge-to-divest-its-biopharma-business-to-d-309051.html 0.6 2026-08-07T02:40:09+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regeneron-lose-patent-dispute-wit-309052.html 0.6 2026-06-21T17:00:35+08:00 daily https://www.pharmasources.com/industryinsights/bausch-lomb-announces-fda-approval-of-lo-309053.html 0.6 2026-06-21T11:21:45+08:00 daily https://www.pharmasources.com/industryinsights/pcma-releases-statement-on-senate-financ-309054.html 0.6 2026-06-20T14:31:11+08:00 daily https://www.pharmasources.com/industryinsights/lonza-announces-new-executive-committee--309055.html 0.6 2026-06-22T00:57:54+08:00 daily https://www.pharmasources.com/industryinsights/romeg-therapeutics-receives-fda-approval-309056.html 0.6 2026-06-21T12:23:56+08:00 daily https://www.pharmasources.com/industryinsights/nanoviricides-reaches-agreement-on-terms-309057.html 0.6 2026-06-21T12:58:47+08:00 daily https://www.pharmasources.com/industryinsights/safety-trial-finds-risk-of-blood-clots-i-309058.html 0.6 2026-03-11T06:12:45+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-biogen-announce-fda-acceptance--309059.html 0.6 2026-06-21T03:02:45+08:00 daily https://www.pharmasources.com/industryinsights/titan-pharmaceuticals-partners-with-alli-309060.html 0.6 2026-06-20T22:55:36+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-announces-collaboration-agr-309061.html 0.6 2026-06-21T21:59:48+08:00 daily https://www.pharmasources.com/industryinsights/azmerck-cos-lynparza-delays-spread-of-pa-309062.html 0.6 2026-06-20T16:53:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofiregenerons-dupixent-shows-more-pro-309063.html 0.6 2026-08-06T06:55:07+08:00 daily https://www.pharmasources.com/industryinsights/verilygoogle-use-algorithm-to-detect-dia-309064.html 0.6 2026-08-08T00:02:46+08:00 daily https://www.pharmasources.com/industryinsights/alexion-aims-for-fourth-rare-disease-use-309065.html 0.6 2026-06-23T09:09:52+08:00 daily https://www.pharmasources.com/industryinsights/converting-naloxone-to-otc-expected-to-i-309066.html 0.6 2026-07-28T11:52:09+08:00 daily https://www.pharmasources.com/industryinsights/contributors-to-delay-of-multiple-sclero-309067.html 0.6 2026-06-21T04:57:44+08:00 daily https://www.pharmasources.com/industryinsights/glaucoma-burden-increasing-globally-but--309068.html 0.6 2026-06-23T14:37:29+08:00 daily https://www.pharmasources.com/industryinsights/immatics-roche-ally-to-trial-tecentriq-w-309069.html 0.6 2026-06-21T10:03:14+08:00 daily https://www.pharmasources.com/industryinsights/notable-labs-brings-on-2-development-exe-309070.html 0.6 2026-06-21T08:58:56+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-taps-tetragenetics-for-ion-309071.html 0.6 2026-08-01T20:54:52+08:00 daily https://www.pharmasources.com/industryinsights/flatiron-health-expands-real-world-cance-309072.html 0.6 2026-06-21T08:58:00+08:00 daily https://www.pharmasources.com/industryinsights/cac-and-rfxcel-announce-a-partnership-ag-309073.html 0.6 2026-06-21T09:12:16+08:00 daily https://www.pharmasources.com/industryinsights/uk-prioritises-rare-diseases-in-genomic--309074.html 0.6 2026-06-21T21:58:40+08:00 daily https://www.pharmasources.com/industryinsights/oyster-point-raises-93m-in-financing-rou-309075.html 0.6 2026-06-21T23:58:45+08:00 daily https://www.pharmasources.com/industryinsights/experts-warn-all-forms-of-brexit-would-h-309076.html 0.6 2026-06-22T10:06:58+08:00 daily https://www.pharmasources.com/industryinsights/direct-infusion-of-gdnf-into-brain-offer-309077.html 0.6 2026-06-22T05:39:21+08:00 daily https://www.pharmasources.com/industryinsights/tirosint-sol-now-available-to-treat-hypo-309078.html 0.6 2026-06-24T12:52:46+08:00 daily https://www.pharmasources.com/industryinsights/heron-announces-fda-approval-of-snda-to--309079.html 0.6 2026-06-21T18:03:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-tremfya-one-press-pat-309080.html 0.6 2026-06-20T18:21:36+08:00 daily https://www.pharmasources.com/industryinsights/kadimastem-announces-the-completion-of-c-309081.html 0.6 2026-06-20T20:55:41+08:00 daily https://www.pharmasources.com/industryinsights/selexis-sa-and-turgut-pharmaceuticals-ex-309082.html 0.6 2026-06-21T06:44:38+08:00 daily https://www.pharmasources.com/industryinsights/imbrium-therapeutics-and-tetragenetics-a-309083.html 0.6 2026-06-21T11:02:16+08:00 daily https://www.pharmasources.com/industryinsights/aaaai-egg-oral-immunotherapy-shows-susta-309084.html 0.6 2026-06-21T10:59:12+08:00 daily https://www.pharmasources.com/industryinsights/celgene-gets-fast-fda-review-of-revlimid-309085.html 0.6 2026-06-21T13:44:32+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-vitamin-intake-in-early-pregnan-309086.html 0.6 2026-06-22T15:51:43+08:00 daily https://www.pharmasources.com/industryinsights/mylan-reports-lower-than-expected-earnin-309087.html 0.6 2026-06-23T12:08:39+08:00 daily https://www.pharmasources.com/industryinsights/advisers-urge-fda-to-delay-decision-on-k-309088.html 0.6 2026-06-22T11:56:55+08:00 daily https://www.pharmasources.com/industryinsights/pharma-ceos-grilled-by-us-senators-over--309089.html 0.6 2026-06-22T05:13:56+08:00 daily https://www.pharmasources.com/industryinsights/eu-steps-closer-to-generics-and-biosimil-309090.html 0.6 2026-06-22T02:52:36+08:00 daily https://www.pharmasources.com/industryinsights/lymphadenectomy-does-not-up-survival-in--309091.html 0.6 2026-06-20T18:19:56+08:00 daily https://www.pharmasources.com/industryinsights/3d-printing-firm-clinches-rd-deal-with-a-309092.html 0.6 2025-11-04T18:16:21+08:00 daily https://www.pharmasources.com/industryinsights/servier-terminates-cti-cancer-pact-follo-309093.html 0.6 2026-06-21T22:57:43+08:00 daily https://www.pharmasources.com/industryinsights/cytomx-slumps-as-bms-bails-on-3-partnere-309094.html 0.6 2026-07-09T12:04:59+08:00 daily https://www.pharmasources.com/industryinsights/blackstone-novartis-found-cardiovascular-309095.html 0.6 2026-07-01T14:17:59+08:00 daily https://www.pharmasources.com/industryinsights/abl-bio-expands-strategic-collaboration--309096.html 0.6 2026-06-21T01:00:45+08:00 daily https://www.pharmasources.com/industryinsights/confo-therapeutics-forms-scientific-advi-309097.html 0.6 2026-06-21T02:51:30+08:00 daily https://www.pharmasources.com/industryinsights/nex-china-takes-the-express-for-healthy--309098.html 0.6 2026-06-26T05:21:43+08:00 daily https://www.pharmasources.com/industryinsights/seize-the-strategic-market-of-the-livest-309099.html 0.6 2026-07-20T04:01:10+08:00 daily https://www.pharmasources.com/industryinsights/cac-and-rfxcel-announce-a-partnership-ag-309100.html 0.6 2026-05-06T19:45:02+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-congratulates-amicus-on-r-309101.html 0.6 2026-07-28T09:29:34+08:00 daily https://www.pharmasources.com/industryinsights/sapreme-technologies-in-a-68-m-eu-allian-309102.html 0.6 2026-06-20T21:02:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-indication-for-soliqua-10033-309103.html 0.6 2026-06-26T20:47:21+08:00 daily https://www.pharmasources.com/industryinsights/pharma-stocks-fell-in-2018-but-innovatio-309104.html 0.6 2026-07-15T22:48:10+08:00 daily https://www.pharmasources.com/industryinsights/calypso-biotech-bv-secures-20-million-eu-309105.html 0.6 2026-08-08T00:19:15+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-chronic-angina-treatment--309106.html 0.6 2026-06-22T13:10:49+08:00 daily https://www.pharmasources.com/industryinsights/could-medical-marijuana-help-grandma-and-309107.html 0.6 2026-07-13T00:35:04+08:00 daily https://www.pharmasources.com/industryinsights/jury-upholds-amgens-patents-on-repatha-e-309108.html 0.6 2026-08-04T12:34:39+08:00 daily https://www.pharmasources.com/industryinsights/haselmeier-acquires-drug-manufacturing-l-309109.html 0.6 2026-06-22T07:51:41+08:00 daily https://www.pharmasources.com/industryinsights/expansion-of-the-global-antibiotics-mark-309110.html 0.6 2026-06-21T11:00:11+08:00 daily https://www.pharmasources.com/industryinsights/pharma-in-south-east-asia-booming-as-cph-309111.html 0.6 2026-07-08T19:54:14+08:00 daily https://www.pharmasources.com/industryinsights/china-national-medical-products-associat-309112.html 0.6 2026-07-23T16:31:07+08:00 daily https://www.pharmasources.com/industryinsights/india-signs-mou-with-chinese-medical-zon-309113.html 0.6 2026-07-08T17:27:06+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-europe-esperion-announce--309114.html 0.6 2026-07-23T11:58:50+08:00 daily https://www.pharmasources.com/industryinsights/first-human-study-of-robotic-ranipill-ca-309115.html 0.6 2026-08-09T10:16:20+08:00 daily https://www.pharmasources.com/industryinsights/adorx-therapeutics-announces-collaborati-309116.html 0.6 2026-06-20T14:50:06+08:00 daily https://www.pharmasources.com/industryinsights/immunogens-antibody-drug-conjugate-mirve-309117.html 0.6 2026-06-20T16:22:12+08:00 daily https://www.pharmasources.com/industryinsights/ema-panel-backs-approval-of-astrazeneca--309118.html 0.6 2026-06-21T05:16:04+08:00 daily https://www.pharmasources.com/industryinsights/spectrum-pharmaceuticals-announces-the-c-309119.html 0.6 2026-06-21T05:51:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-executives-face-criminal-charges--309120.html 0.6 2026-06-20T21:17:58+08:00 daily https://www.pharmasources.com/industryinsights/akorn-comments-on-favorable-court-order-309121.html 0.6 2026-06-21T02:00:37+08:00 daily https://www.pharmasources.com/industryinsights/acadia-neurocrine-could-be-next-takeover-309122.html 0.6 2026-05-06T16:54:26+08:00 daily https://www.pharmasources.com/industryinsights/drug-companies-interested-in-louisiana-h-309123.html 0.6 2026-06-20T22:53:33+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-keeps-the-heat-on-tremfy-309124.html 0.6 2026-06-20T21:45:32+08:00 daily https://www.pharmasources.com/industryinsights/bispecifics-player-abpro-teams-up-with-c-309125.html 0.6 2026-06-20T14:18:54+08:00 daily https://www.pharmasources.com/industryinsights/takeda-microsoft-rare-disease-partnershi-309126.html 0.6 2026-06-21T05:58:44+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-solid-dose-plant-pinched-by-fd-309127.html 0.6 2026-02-15T13:39:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-finds-aurobindo-sterile-drug-plant-c-309128.html 0.6 2026-07-07T02:16:25+08:00 daily https://www.pharmasources.com/industryinsights/ppd-inks-deal-with-chinas-hlt-to-create--309129.html 0.6 2026-06-21T04:21:06+08:00 daily https://www.pharmasources.com/industryinsights/third-akorn-sterile-drug-plant-hit-by-fd-309130.html 0.6 2026-07-30T15:06:26+08:00 daily https://www.pharmasources.com/industryinsights/boston-agency-projects-photos-of-patient-309131.html 0.6 2026-06-21T10:09:12+08:00 daily https://www.pharmasources.com/industryinsights/endo-terminates-190m-deal-for-sterile-in-309132.html 0.6 2026-07-01T03:04:34+08:00 daily https://www.pharmasources.com/industryinsights/novartis-shift-to-superpricey-cell-and-g-309133.html 0.6 2026-08-07T03:25:00+08:00 daily https://www.pharmasources.com/industryinsights/sanders-escalates-fight-with-catalyst-as-309134.html 0.6 2026-08-07T03:06:34+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019030-309135.html 0.6 2026-08-07T00:59:03+08:00 daily https://www.pharmasources.com/industryinsights/ema-panel-backs-approval-of-astrazeneca--309136.html 0.6 2026-08-07T01:14:28+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-is-target-of-federal-civil-probe--309137.html 0.6 2026-08-07T01:21:37+08:00 daily https://www.pharmasources.com/industryinsights/top-10-drugs-losing-exclusivity-in-2019-309138.html 0.6 2026-08-07T01:28:00+08:00 daily https://www.pharmasources.com/industryinsights/ema-follows-fda-in-putting-pfizers-xelja-309139.html 0.6 2026-06-20T16:57:18+08:00 daily https://www.pharmasources.com/industryinsights/pharma-can-bms-rebels-scuttle-its-celgen-309140.html 0.6 2026-08-07T13:17:58+08:00 daily https://www.pharmasources.com/industryinsights/divis-gland-fidelity-enter-race-to-buy-o-309141.html 0.6 2026-06-21T08:54:26+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-launch-authorised-humalog-g-309142.html 0.6 2026-08-08T20:42:15+08:00 daily https://www.pharmasources.com/industryinsights/agc-completes-acquisition-of-malgrat-pha-309143.html 0.6 2026-08-07T05:25:34+08:00 daily https://www.pharmasources.com/industryinsights/3sbio-tlc-to-commercialize-two-nanox-pro-309144.html 0.6 2026-08-09T03:31:16+08:00 daily https://www.pharmasources.com/industryinsights/adagene-to-evaluate-dynamic-precision-li-309145.html 0.6 2026-06-20T22:16:15+08:00 daily https://www.pharmasources.com/industryinsights/smartfuture-introduces-teleconsultation--309146.html 0.6 2026-07-04T00:32:16+08:00 daily https://www.pharmasources.com/industryinsights/abpro-njcttq-to-develop-multiple-novel-b-309147.html 0.6 2026-06-21T21:20:55+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-appoints-new-general-manager-chin-309148.html 0.6 2026-07-28T15:53:55+08:00 daily https://www.pharmasources.com/industryinsights/rakuten-aspyrian-changes-name-to-rakuten-309149.html 0.6 2026-06-21T04:04:45+08:00 daily https://www.pharmasources.com/industryinsights/kadimastem-completes-cell-transplantatio-309150.html 0.6 2026-06-21T02:05:49+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-brings-former-msd-global-vp-on--309151.html 0.6 2026-06-27T20:02:58+08:00 daily https://www.pharmasources.com/industryinsights/novago-therapeutics-raises-chf-10-millio-309152.html 0.6 2025-11-17T21:13:39+08:00 daily https://www.pharmasources.com/industryinsights/neurimmune-appoints-john-dellapa-as-gene-309153.html 0.6 2026-06-22T04:51:39+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-sell-cheaper-version-of-ins-309154.html 0.6 2026-06-20T19:05:38+08:00 daily https://www.pharmasources.com/industryinsights/low-dose-aspirin-does-not-cut-death-from-309155.html 0.6 2026-03-27T19:29:19+08:00 daily https://www.pharmasources.com/industryinsights/american-regent-announces-the-re-introdu-309156.html 0.6 2026-06-22T07:33:20+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-diagnosis-delays-seen-with-309157.html 0.6 2026-06-21T07:56:09+08:00 daily https://www.pharmasources.com/industryinsights/mmr-not-linked-to-autism-in-danish-cohor-309158.html 0.6 2026-06-22T11:02:52+08:00 daily https://www.pharmasources.com/industryinsights/actor-luke-perry-dies-of-stroke-at-age-5-309159.html 0.6 2026-08-09T16:51:04+08:00 daily https://www.pharmasources.com/industryinsights/high-deductibles-may-threaten-breast-can-309160.html 0.6 2026-06-22T00:36:35+08:00 daily https://www.pharmasources.com/industryinsights/the-deadliest-plastic-for-seabirds-ballo-309161.html 0.6 2026-06-20T21:07:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-another-carcinogenic-impur-309162.html 0.6 2026-07-09T19:39:57+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-buy-gene-therapy-firm-nightsta-309163.html 0.6 2026-07-09T07:39:37+08:00 daily https://www.pharmasources.com/industryinsights/emas-chmp-meeting-recommends-eight-medic-309164.html 0.6 2026-07-24T20:13:26+08:00 daily https://www.pharmasources.com/industryinsights/eu-committee-recommends-astrazenecas-lyn-309165.html 0.6 2026-07-08T15:17:00+08:00 daily https://www.pharmasources.com/industryinsights/auden-and-waymade-accused-of-illegal-hyd-309166.html 0.6 2026-06-20T22:07:43+08:00 daily https://www.pharmasources.com/industryinsights/philippines-pharma-all-set-for-continuou-309167.html 0.6 2026-07-03T16:10:35+08:00 daily https://www.pharmasources.com/industryinsights/sagent-pharma-acquires-raleigh-manufactu-309168.html 0.6 2026-06-21T06:06:51+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-healthcare-forum-2019-starts-in-sha-309169.html 0.6 2026-06-21T02:04:38+08:00 daily https://www.pharmasources.com/industryinsights/apac-healthcare-start-up-halodoc-raises--309170.html 0.6 2026-06-22T06:58:50+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-canadian-crispr-nickase-p-309171.html 0.6 2026-06-20T20:11:43+08:00 daily https://www.pharmasources.com/industryinsights/duke-nus-team-reveals-unknown-mechanisms-309172.html 0.6 2026-08-07T23:54:00+08:00 daily https://www.pharmasources.com/industryinsights/only-37-of-women-receive-critical-cancer-309173.html 0.6 2026-06-21T08:19:13+08:00 daily https://www.pharmasources.com/industryinsights/data-sharing-uncovers-five-new-risk-gene-309174.html 0.6 2026-06-21T20:55:45+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-announces-presentation-of-new-s-309175.html 0.6 2026-06-21T04:58:46+08:00 daily https://www.pharmasources.com/industryinsights/vertex-ceo-cco-head-for-uk-hearing-on-or-309176.html 0.6 2026-06-21T06:56:22+08:00 daily https://www.pharmasources.com/industryinsights/a-third-cancer-causing-impurity-detected-309177.html 0.6 2026-06-20T22:55:45+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-help-hiv-patients-age-positive-309178.html 0.6 2026-02-11T23:20:25+08:00 daily https://www.pharmasources.com/industryinsights/big-pharma-gave-money-to-patient-advocac-309179.html 0.6 2026-03-20T03:58:04+08:00 daily https://www.pharmasources.com/industryinsights/hill-holliday-health-launches-inside-its-309180.html 0.6 2026-06-20T22:57:40+08:00 daily https://www.pharmasources.com/industryinsights/salixs-giant-inflatable-captain-colon-em-309181.html 0.6 2026-06-22T12:59:43+08:00 daily https://www.pharmasources.com/industryinsights/lilly-introduces-cheaper-generic-insulin-309182.html 0.6 2026-06-21T04:42:30+08:00 daily https://www.pharmasources.com/industryinsights/pharma-drug-delivery-market-worth-16947--309183.html 0.6 2026-06-21T10:54:08+08:00 daily https://www.pharmasources.com/industryinsights/breaking-news-fda-chief-scott-gottlieb-s-309184.html 0.6 2026-06-20T18:19:18+08:00 daily https://www.pharmasources.com/industryinsights/top-10-drugs-losing-exclusivity-in-2019-309185.html 0.6 2026-07-28T17:40:09+08:00 daily https://www.pharmasources.com/industryinsights/ozempic-superior-in-lowering-blood-sugar-309186.html 0.6 2026-06-22T12:14:05+08:00 daily https://www.pharmasources.com/industryinsights/novel-treatments-offer-new-hope-for-pati-309187.html 0.6 2026-06-24T07:35:58+08:00 daily https://www.pharmasources.com/industryinsights/how-celastrol-sensitizes-brains-to-lepti-309188.html 0.6 2026-06-22T21:01:59+08:00 daily https://www.pharmasources.com/industryinsights/protein-content-as-a-marker-for-response-309189.html 0.6 2026-06-20T20:19:55+08:00 daily https://www.pharmasources.com/industryinsights/new-treatment-offers-potentially-promisi-309190.html 0.6 2026-06-23T06:00:52+08:00 daily https://www.pharmasources.com/industryinsights/artificial-lung-cancer-tissue-could-help-309191.html 0.6 2026-06-22T12:42:14+08:00 daily https://www.pharmasources.com/industryinsights/groundbreaking-memory-research-shows-ama-309192.html 0.6 2026-07-03T10:36:28+08:00 daily https://www.pharmasources.com/industryinsights/new-microscope-offers-options-for-drug-d-309193.html 0.6 2026-06-20T18:09:36+08:00 daily https://www.pharmasources.com/industryinsights/china-has-entered-the-era-of-tumor-immun-309194.html 0.6 2026-07-08T01:39:03+08:00 daily https://www.pharmasources.com/industryinsights/cipla-to-launch-cinacalcet-hydrochloride-309195.html 0.6 2026-07-06T06:28:15+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-and-novasep-to--309196.html 0.6 2026-06-20T14:37:07+08:00 daily https://www.pharmasources.com/industryinsights/7-anti-pd-l1-antibodies-in-phase-iii-cli-309197.html 0.6 2026-07-28T00:07:22+08:00 daily https://www.pharmasources.com/industryinsights/adult-stem-cell-derived-kidney-on-a-chip-309198.html 0.6 2026-06-21T08:57:10+08:00 daily https://www.pharmasources.com/industryinsights/ozempic-superior-in-lowering-blood-sugar-309199.html 0.6 2026-06-21T15:48:15+08:00 daily https://www.pharmasources.com/industryinsights/how-celastrol-sensitizes-brains-to-lepti-309200.html 0.6 2026-07-05T13:46:16+08:00 daily https://www.pharmasources.com/industryinsights/largest-study-to-date-finds-no-link-betw-309201.html 0.6 2026-06-24T09:05:17+08:00 daily https://www.pharmasources.com/industryinsights/orion-and-bayer-seek-marketing-clearance-309202.html 0.6 2026-06-20T20:59:35+08:00 daily https://www.pharmasources.com/industryinsights/nantkwest-and-promab-partner-to-develop--309203.html 0.6 2026-06-21T08:56:57+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-introduce-lower-priced-insulin-309204.html 0.6 2026-06-22T15:49:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-update-on-arb-drug-product--309205.html 0.6 2026-06-25T16:34:30+08:00 daily https://www.pharmasources.com/industryinsights/pacira-to-acquire-myoscience-309206.html 0.6 2026-08-08T12:21:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-rolling-review-for-cytodyns-p-309207.html 0.6 2026-02-28T13:19:27+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-acquire-nightstar-therapeutics-309208.html 0.6 2026-06-20T17:02:18+08:00 daily https://www.pharmasources.com/industryinsights/apotex-issues-voluntary-nationwide-recal-309209.html 0.6 2026-07-06T23:41:45+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-spravato-garners-fda-ap-309210.html 0.6 2026-06-20T23:04:41+08:00 daily https://www.pharmasources.com/industryinsights/corbus-pharmaceuticals-announces-appoint-309211.html 0.6 2026-07-08T18:25:31+08:00 daily https://www.pharmasources.com/industryinsights/abivax-chosen-to-deliver-abx464-oral-pre-309212.html 0.6 2026-06-21T19:51:06+08:00 daily https://www.pharmasources.com/industryinsights/aap-social-media-companies-must-curb-spr-309213.html 0.6 2026-06-21T01:00:42+08:00 daily https://www.pharmasources.com/industryinsights/studies-look-at-ways-to-reduce-depressiv-309214.html 0.6 2025-11-10T10:32:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-spravato-esketamine-nasal-s-309215.html 0.6 2026-06-21T16:07:30+08:00 daily https://www.pharmasources.com/industryinsights/staph-infections-drop-but-levels-still-w-309216.html 0.6 2026-06-20T20:07:37+08:00 daily https://www.pharmasources.com/industryinsights/could-too-much-soda-worsen-ms-309217.html 0.6 2026-06-21T04:13:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-chief-dr-scott-gottlieb-resigns-309218.html 0.6 2026-06-22T11:30:20+08:00 daily https://www.pharmasources.com/industryinsights/second-man-hiv-free-after-stem-cell-tran-309219.html 0.6 2026-06-22T04:59:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-pfizer-added-to-bioxcels-panc-309220.html 0.6 2026-07-16T08:20:16+08:00 daily https://www.pharmasources.com/industryinsights/philips-launches-new-image-guided-proced-309221.html 0.6 2026-06-20T16:54:09+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-ark-biosciences-sign-cmc-develo-309222.html 0.6 2026-07-23T22:25:40+08:00 daily https://www.pharmasources.com/industryinsights/accenture-to-acquire-enterprise-system-p-309223.html 0.6 2026-06-20T23:14:59+08:00 daily https://www.pharmasources.com/industryinsights/eppendorf-introduced-manual-pipetting-of-309224.html 0.6 2026-07-16T16:29:03+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-health2sync-collaborate-for-309225.html 0.6 2026-06-22T05:49:44+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-novasep-to-develop-nove-309226.html 0.6 2026-06-21T05:55:44+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-appoints-alessandro-riva-as-ceo-309227.html 0.6 2026-06-21T04:58:45+08:00 daily https://www.pharmasources.com/industryinsights/singaporeans-thais-suffer-from-symptoms--309228.html 0.6 2026-07-08T20:31:03+08:00 daily https://www.pharmasources.com/industryinsights/medical-korea-2019-to-explore-global-hea-309229.html 0.6 2026-06-21T01:49:28+08:00 daily https://www.pharmasources.com/industryinsights/avita-medical-to-commercialize-wounds-tr-309230.html 0.6 2026-06-21T01:51:00+08:00 daily https://www.pharmasources.com/industryinsights/pressure-biosciences-collaborates-with-t-309231.html 0.6 2026-06-23T21:43:27+08:00 daily https://www.pharmasources.com/industryinsights/after-november-rollout-gw-pharma-says-ep-309232.html 0.6 2026-06-21T10:21:31+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-coverage-is-improving-but-could-309233.html 0.6 2026-08-08T23:04:22+08:00 daily https://www.pharmasources.com/industryinsights/celgene-slipped-up-repeatedly-last-year--309234.html 0.6 2026-08-07T11:30:40+08:00 daily https://www.pharmasources.com/industryinsights/novartis-chairman-says-drugmaker-has-no--309235.html 0.6 2026-08-09T01:34:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-commissioner-scott-gottlieb-to-step--309236.html 0.6 2026-06-20T15:58:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-filing-for-309237.html 0.6 2026-08-03T09:28:07+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-spravato-garners-fda-ap-309238.html 0.6 2026-06-21T01:54:51+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-gets-nod-for-sale-of-bio-309239.html 0.6 2026-06-20T14:50:02+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-pharma-ltd-partners-with-he-309240.html 0.6 2026-06-24T10:43:47+08:00 daily https://www.pharmasources.com/industryinsights/biogen-acquisition-boosts-its-ophthalmol-309241.html 0.6 2026-06-20T16:46:15+08:00 daily https://www.pharmasources.com/industryinsights/japan-solid-dose-market-predicted-to-blo-309242.html 0.6 2026-06-20T21:36:16+08:00 daily https://www.pharmasources.com/industryinsights/hiv-is-reported-cured-in-a-second-patien-309243.html 0.6 2026-06-22T04:12:51+08:00 daily https://www.pharmasources.com/industryinsights/lilly-answers-insulin-price-hike-critics-309244.html 0.6 2026-06-22T10:23:36+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-boosted-by-partnerships-lays-out--309245.html 0.6 2026-06-30T04:25:32+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-help-hiv-patients-age-positive-309246.html 0.6 2026-06-22T12:49:01+08:00 daily https://www.pharmasources.com/industryinsights/statins-might-be-linked-to-increased-ris-309247.html 0.6 2026-06-21T09:07:23+08:00 daily https://www.pharmasources.com/industryinsights/adjusted-fees-for-ema-applicants-from-ap-309248.html 0.6 2026-06-20T19:12:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-nasal-spray-medication--309249.html 0.6 2026-06-21T02:57:53+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-appoints-alessandro-riva-as-ceo-309250.html 0.6 2026-07-07T10:38:12+08:00 daily https://www.pharmasources.com/industryinsights/inovio-initiates-reveal-2-global-phase-3-309251.html 0.6 2026-06-20T21:04:44+08:00 daily https://www.pharmasources.com/industryinsights/agc-completes-acquisition-of-spanish-syn-309252.html 0.6 2026-08-09T23:20:42+08:00 daily https://www.pharmasources.com/industryinsights/fluorouracil-cream-best-choice-for-tx-of-309253.html 0.6 2026-06-22T11:08:36+08:00 daily https://www.pharmasources.com/industryinsights/flexible-schedules-for-residents-do-not--309254.html 0.6 2026-03-17T19:38:47+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-can-social-connection-aid-heart-309255.html 0.6 2026-06-28T13:45:43+08:00 daily https://www.pharmasources.com/industryinsights/ambrx-and-beigene-announce-global-resear-309256.html 0.6 2026-06-22T02:55:12+08:00 daily https://www.pharmasources.com/industryinsights/pacira-to-acquire-myoscience-adding-fda--309257.html 0.6 2026-06-21T03:45:35+08:00 daily https://www.pharmasources.com/industryinsights/antolrx-announces-pfizer-exercises-optio-309258.html 0.6 2026-06-21T18:17:50+08:00 daily https://www.pharmasources.com/industryinsights/concert-pharmaceuticals-announces-initia-309259.html 0.6 2026-06-26T12:22:54+08:00 daily https://www.pharmasources.com/industryinsights/iksuda-therapeutics-and-femtogenix-sign--309260.html 0.6 2026-06-23T09:09:04+08:00 daily https://www.pharmasources.com/industryinsights/cyrus-biotechnology-announces-release-of-309261.html 0.6 2026-06-20T16:54:25+08:00 daily https://www.pharmasources.com/industryinsights/lilly-claims-fast-fda-review-for-emgalit-309262.html 0.6 2026-06-21T10:01:21+08:00 daily https://www.pharmasources.com/industryinsights/uk-politicians-to-grill-vertex-ceo-over--309263.html 0.6 2026-06-20T15:56:23+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-could-get-patient-friendly-6-we-309264.html 0.6 2026-04-23T03:20:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-janssens-ketamine-based-nas-309265.html 0.6 2026-08-08T01:43:59+08:00 daily https://www.pharmasources.com/industryinsights/bayer-files-prostate-cancer-drug-darolut-309266.html 0.6 2026-08-08T00:54:06+08:00 daily https://www.pharmasources.com/industryinsights/gilead-expands-car-t-deal-with-maxcyte-p-309267.html 0.6 2026-08-08T00:49:14+08:00 daily https://www.pharmasources.com/industryinsights/telehealth-could-save-nhs-england-75bn-309268.html 0.6 2026-08-07T22:18:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-sell-generic-humalog-insulin-at-309269.html 0.6 2026-08-07T13:16:19+08:00 daily https://www.pharmasources.com/industryinsights/zebras-ai-systems-eu-certified-for-pneum-309270.html 0.6 2026-08-07T02:31:19+08:00 daily https://www.pharmasources.com/industryinsights/mundipharmas-neulasta-biosimilar-approve-309271.html 0.6 2026-08-07T00:41:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-nasal-spray-medication--309272.html 0.6 2026-08-06T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-ark-biosciences-sign-cmc-devt-m-309273.html 0.6 2026-08-08T01:36:55+08:00 daily https://www.pharmasources.com/industryinsights/nitech-solutions-forms-partnership-in-us-309274.html 0.6 2026-08-06T23:45:52+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-appoints-new-innovation-company-309275.html 0.6 2026-08-06T20:06:08+08:00 daily https://www.pharmasources.com/industryinsights/numab-intarcia-enter-license-agreement-309276.html 0.6 2026-08-06T23:56:51+08:00 daily https://www.pharmasources.com/industryinsights/almac-group-launches-almac-one-309277.html 0.6 2026-08-07T05:37:18+08:00 daily https://www.pharmasources.com/industryinsights/reform-biologics-astellas-form-collabora-309278.html 0.6 2026-08-07T05:52:45+08:00 daily https://www.pharmasources.com/industryinsights/ourcrowd-launches-50m-medtech-fund-309279.html 0.6 2026-08-07T05:57:58+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-pfizer-return-to-the-top-of-p-309280.html 0.6 2026-08-09T19:43:23+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-pfizer-return-to-the-top-of-p-309281.html 0.6 2026-06-24T03:28:14+08:00 daily https://www.pharmasources.com/industryinsights/rml-to-appliy-abbotts-latest-diagnostics-309282.html 0.6 2026-06-20T22:59:38+08:00 daily https://www.pharmasources.com/industryinsights/pacira-to-buy-myoscience-309283.html 0.6 2026-06-20T22:49:47+08:00 daily https://www.pharmasources.com/industryinsights/kezar-life-sciences-to-test-a-new-drug-f-309284.html 0.6 2026-06-22T14:56:04+08:00 daily https://www.pharmasources.com/industryinsights/dr-albers-receives-the-distinguished-cli-309285.html 0.6 2026-06-20T18:22:55+08:00 daily https://www.pharmasources.com/industryinsights/eisai-submits-marketing-authorization-ap-309286.html 0.6 2026-06-22T12:13:03+08:00 daily https://www.pharmasources.com/industryinsights/who-se-asia-urges-health-authorities-to--309287.html 0.6 2026-06-22T00:02:46+08:00 daily https://www.pharmasources.com/industryinsights/singaporeans-thais-suffer-from-mgd-sympt-309288.html 0.6 2026-06-21T16:19:52+08:00 daily https://www.pharmasources.com/industryinsights/inflammation-in-the-brain-enhances-the-s-309289.html 0.6 2026-06-21T09:10:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-genentechs-xofluza-for-the-t-309290.html 0.6 2026-06-20T21:56:46+08:00 daily https://www.pharmasources.com/industryinsights/allergans-rapastinel-fails-to-meet-prima-309291.html 0.6 2026-07-27T00:27:15+08:00 daily https://www.pharmasources.com/industryinsights/vertexs-vx-445-triple-combination-regime-309292.html 0.6 2026-06-20T21:40:25+08:00 daily https://www.pharmasources.com/industryinsights/dan-furrer-appointed-as-head-of-corporat-309293.html 0.6 2026-08-06T18:29:42+08:00 daily https://www.pharmasources.com/industryinsights/clementia-pharmaceuticals-inc-obtains-in-309294.html 0.6 2026-06-20T15:42:31+08:00 daily https://www.pharmasources.com/industryinsights/indian-government-plans-to-colour-code-g-309295.html 0.6 2026-06-21T05:09:50+08:00 daily https://www.pharmasources.com/industryinsights/impact-pioneers-honored-for-groundbreaki-309296.html 0.6 2026-06-26T22:28:08+08:00 daily https://www.pharmasources.com/industryinsights/now-that-lilly-has-a-cheaper-generic-hum-309297.html 0.6 2026-06-22T04:56:40+08:00 daily https://www.pharmasources.com/industryinsights/louisianas-netflix-deal-for-hepatitis-c--309298.html 0.6 2026-01-30T21:32:59+08:00 daily https://www.pharmasources.com/industryinsights/a-third-cancer-causing-impurity-detected-309299.html 0.6 2026-06-21T06:22:01+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-invests-100m-in-its-biovect-309300.html 0.6 2026-06-22T03:10:45+08:00 daily https://www.pharmasources.com/industryinsights/elsevier-launches-assessment-capabilitie-309301.html 0.6 2026-08-07T02:49:39+08:00 daily https://www.pharmasources.com/industryinsights/potential-new-treatment-for-heart-attack-309302.html 0.6 2026-08-09T02:54:54+08:00 daily https://www.pharmasources.com/industryinsights/catalent-invests-27m-to-commercialize-zy-309303.html 0.6 2026-08-08T11:54:29+08:00 daily https://www.pharmasources.com/industryinsights/aprecia-cmic-enter-3dp-pact-in-japan-309304.html 0.6 2026-08-06T23:36:55+08:00 daily https://www.pharmasources.com/industryinsights/ict-opens-us-office-announces-executive--309305.html 0.6 2026-08-06T23:46:02+08:00 daily https://www.pharmasources.com/industryinsights/basi-appoints-key-executive-309306.html 0.6 2026-06-21T02:13:50+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-batch-variability-in-spray-c-309307.html 0.6 2026-08-07T23:00:21+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-launches-smart-inventory-track-309308.html 0.6 2026-06-22T05:15:15+08:00 daily https://www.pharmasources.com/industryinsights/cdc-gi-respiratory-illnesses-more-likely-309309.html 0.6 2026-06-21T00:32:27+08:00 daily https://www.pharmasources.com/industryinsights/suven-plans-to-buy-us-based-rising-pharm-309310.html 0.6 2026-06-21T09:02:02+08:00 daily https://www.pharmasources.com/industryinsights/beneficiaries-give-a-thumbs-up-to-janaus-309311.html 0.6 2026-07-07T11:16:28+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-calls-vertex-an-extreme-outl-309312.html 0.6 2026-06-20T15:57:50+08:00 daily https://www.pharmasources.com/industryinsights/name-of-amazon-jpmorgan-berkshire-hathaw-309313.html 0.6 2026-07-18T06:03:35+08:00 daily https://www.pharmasources.com/industryinsights/beam-therapeutics-raises-135m-to-advance-309314.html 0.6 2026-08-07T00:53:26+08:00 daily https://www.pharmasources.com/industryinsights/celgenes-fedratinib-gets-fda-priority-re-309315.html 0.6 2026-08-07T00:42:40+08:00 daily https://www.pharmasources.com/industryinsights/beigene-and-ambrx-form-rd-alliance-for-n-309316.html 0.6 2026-08-07T00:40:02+08:00 daily https://www.pharmasources.com/industryinsights/vertex-reports-preliminary-data-for-trip-309317.html 0.6 2026-08-07T00:15:38+08:00 daily https://www.pharmasources.com/industryinsights/scott-gottlieb-resigns-as-fda-commission-309318.html 0.6 2026-08-07T00:01:34+08:00 daily https://www.pharmasources.com/industryinsights/probiotic-sanitation-cuts-antimicrobial--309319.html 0.6 2026-08-06T23:54:59+08:00 daily https://www.pharmasources.com/industryinsights/secondhand-smoke-exposure-linked-to-chro-309320.html 0.6 2026-08-06T23:46:25+08:00 daily https://www.pharmasources.com/industryinsights/acc-long-term-outcomes-for-mi-similar-at-309321.html 0.6 2026-08-06T23:56:59+08:00 daily https://www.pharmasources.com/industryinsights/persistent-prolonged-opioid-use-occurs-a-309322.html 0.6 2026-08-07T00:41:09+08:00 daily https://www.pharmasources.com/industryinsights/yo-yo-dieting-can-take-a-toll-on-your-he-309323.html 0.6 2026-08-07T01:10:57+08:00 daily https://www.pharmasources.com/industryinsights/allergans-rapastinel-fails-to-hit-key-ta-309324.html 0.6 2026-08-07T01:19:36+08:00 daily https://www.pharmasources.com/industryinsights/vertex-three-drug-cf-combo-hits-phiii-ta-309325.html 0.6 2026-07-22T17:51:04+08:00 daily https://www.pharmasources.com/industryinsights/86-of-britain-believe-nhs-faces-a-major--309326.html 0.6 2026-08-06T23:46:42+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-new-prognostic-test--309327.html 0.6 2026-08-06T23:56:52+08:00 daily https://www.pharmasources.com/industryinsights/west-opens-new-digital-technology-centre-309328.html 0.6 2026-08-07T12:03:15+08:00 daily https://www.pharmasources.com/industryinsights/avita-medical-to-commercialize-wounds-tr-309329.html 0.6 2026-08-07T12:29:42+08:00 daily https://www.pharmasources.com/industryinsights/santen-to-raise-disease-awareness-during-309330.html 0.6 2026-08-07T13:16:30+08:00 daily https://www.pharmasources.com/industryinsights/philips-acquires-carestream-health-biz-t-309331.html 0.6 2026-08-08T03:31:05+08:00 daily https://www.pharmasources.com/industryinsights/ambrx-beigene-to-develop-next-generation-309332.html 0.6 2026-08-08T04:37:02+08:00 daily https://www.pharmasources.com/industryinsights/clients-shrug-as-fda-slams-canadian-firm-309333.html 0.6 2026-08-09T07:36:27+08:00 daily https://www.pharmasources.com/industryinsights/patient-advocate-urges-bio-to-boot-catal-309334.html 0.6 2026-06-21T09:53:02+08:00 daily https://www.pharmasources.com/industryinsights/andapharm-repeat-violations-lead-to-fda--309335.html 0.6 2026-06-21T02:45:40+08:00 daily https://www.pharmasources.com/industryinsights/gsks-tesaro-taps-actor-scott-foley-for-o-309336.html 0.6 2026-06-22T19:29:38+08:00 daily https://www.pharmasources.com/industryinsights/gottliebs-quick-goodbye-triggers-investo-309337.html 0.6 2026-07-22T14:45:06+08:00 daily https://www.pharmasources.com/industryinsights/activist-starboard-steps-up-revolt-on-br-309338.html 0.6 2026-07-01T16:59:24+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-pfizer-return-to-the-top-of-p-309339.html 0.6 2026-06-20T21:14:51+08:00 daily https://www.pharmasources.com/industryinsights/teva-plant-tagged-with-warning-letter-fo-309340.html 0.6 2026-06-21T04:58:51+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-commissioner-scott-go-309341.html 0.6 2026-06-20T15:52:30+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-and-ark-biosciences-sign-cmc-de-309342.html 0.6 2026-07-02T17:09:41+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019031-309343.html 0.6 2026-06-20T15:56:35+08:00 daily https://www.pharmasources.com/industryinsights/continuous-manufacturing-method-used-to--309344.html 0.6 2026-06-21T10:09:13+08:00 daily https://www.pharmasources.com/industryinsights/industry-experts-combine-to-create-safer-309345.html 0.6 2026-06-21T00:03:36+08:00 daily https://www.pharmasources.com/industryinsights/akili-shionogi-to-develop-digital-therap-309346.html 0.6 2026-06-21T10:20:32+08:00 daily https://www.pharmasources.com/industryinsights/computer-designed-vaccine-elicits-potent-309347.html 0.6 2026-06-23T23:40:40+08:00 daily https://www.pharmasources.com/industryinsights/china-unveils-final-rules-for-nasdaq-sty-309348.html 0.6 2026-06-21T15:47:09+08:00 daily https://www.pharmasources.com/industryinsights/glaxos-viiv-touts-more-two-drug-hiv-succ-309349.html 0.6 2026-06-22T23:29:56+08:00 daily https://www.pharmasources.com/industryinsights/allergan-activists-ready-for-disruptive--309350.html 0.6 2026-06-20T20:19:53+08:00 daily https://www.pharmasources.com/industryinsights/shkreli-running-his-drug-company-from-pr-309351.html 0.6 2026-06-20T14:53:01+08:00 daily https://www.pharmasources.com/industryinsights/allergan-investors-rooting-for-a-breakup-309352.html 0.6 2026-06-21T21:44:27+08:00 daily https://www.pharmasources.com/industryinsights/louisianas-netflix-deal-for-hepatitis-c--309353.html 0.6 2026-07-04T03:27:20+08:00 daily https://www.pharmasources.com/industryinsights/medicines-australia-honors-talent-in-pha-309354.html 0.6 2026-06-24T05:28:16+08:00 daily https://www.pharmasources.com/industryinsights/advent-access-to-join-stanford-startx-co-309355.html 0.6 2026-06-21T13:09:44+08:00 daily https://www.pharmasources.com/industryinsights/aslan-signs-news-commercialisation-agree-309356.html 0.6 2026-06-22T07:56:52+08:00 daily https://www.pharmasources.com/industryinsights/senseonics-teams-up-with-glooko-for-effe-309357.html 0.6 2026-07-30T15:18:41+08:00 daily https://www.pharmasources.com/industryinsights/in-a-first-ever-head-to-head-biologic-cl-309358.html 0.6 2026-06-21T08:20:19+08:00 daily https://www.pharmasources.com/industryinsights/pp-biotech-obtains-us-patent-for-its-pla-309359.html 0.6 2026-07-31T10:58:35+08:00 daily https://www.pharmasources.com/industryinsights/trinity-biotech-announces-q4-and-fy-2018-309360.html 0.6 2026-06-30T14:04:48+08:00 daily https://www.pharmasources.com/industryinsights/som-biotech-closes-a-financing-round-of--309361.html 0.6 2026-06-20T18:53:39+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-gains-expanded-approval-309362.html 0.6 2026-08-07T11:51:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-panel-recommends-against-us-309363.html 0.6 2026-06-20T20:59:44+08:00 daily https://www.pharmasources.com/industryinsights/amags-confirmatory-study-of-makena-to-re-309364.html 0.6 2026-06-22T11:12:54+08:00 daily https://www.pharmasources.com/industryinsights/china-moves-to-expand-cancer-medicine-ac-309365.html 0.6 2026-06-21T10:01:12+08:00 daily https://www.pharmasources.com/industryinsights/drug-access-delays-a-threat-to-future-ph-309366.html 0.6 2026-02-28T14:21:16+08:00 daily https://www.pharmasources.com/industryinsights/significant-changes-to-happen-to-the-pha-309367.html 0.6 2026-08-07T02:30:41+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-receives-two-approvals-from--309368.html 0.6 2026-08-07T02:22:08+08:00 daily https://www.pharmasources.com/industryinsights/indian-defence-lab-develops-combat-drugs-309369.html 0.6 2026-08-07T01:19:40+08:00 daily https://www.pharmasources.com/industryinsights/three-winners-of-2019-sandoz-healthcare--309370.html 0.6 2026-08-07T01:10:47+08:00 daily https://www.pharmasources.com/industryinsights/pall-broadley-james-partner-on-su-techno-309371.html 0.6 2026-08-07T00:01:29+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-testing-facilities-complete--309372.html 0.6 2026-07-20T03:03:17+08:00 daily https://www.pharmasources.com/industryinsights/la-jolla-pharmaceutical-appoints-cco-309373.html 0.6 2026-08-07T00:02:42+08:00 daily https://www.pharmasources.com/industryinsights/uhlmann-appoints-regional-sales-manager-309374.html 0.6 2026-08-07T01:27:48+08:00 daily https://www.pharmasources.com/industryinsights/usfda-concludes-inspection-of-unichem-la-309375.html 0.6 2026-08-07T00:39:57+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-announces-results-of-digital-inno-309376.html 0.6 2026-08-07T01:19:28+08:00 daily https://www.pharmasources.com/industryinsights/takedas-entyvio-outperforms-abbvies-humi-309377.html 0.6 2026-08-07T01:31:42+08:00 daily https://www.pharmasources.com/industryinsights/merck-co-pens-340m-pain-drug-deal-with-k-309378.html 0.6 2026-08-07T01:43:00+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-first-checkpoint-inhibitor-ok-309379.html 0.6 2026-08-07T13:16:53+08:00 daily https://www.pharmasources.com/industryinsights/seres-therapeutics-announces-microbiome--309380.html 0.6 2026-08-09T02:39:02+08:00 daily https://www.pharmasources.com/industryinsights/tenax-therapeutics-enrolls-first-patient-309381.html 0.6 2026-08-09T06:51:34+08:00 daily https://www.pharmasources.com/industryinsights/roches-i-o-drug-tecentriq-picks-up-key-f-309382.html 0.6 2026-08-07T01:27:38+08:00 daily https://www.pharmasources.com/industryinsights/xencor-announces-closing-of-research-col-309383.html 0.6 2026-06-22T05:40:32+08:00 daily https://www.pharmasources.com/industryinsights/vitruvias-therapeutics-inc-launches-shan-309384.html 0.6 2026-06-21T06:05:45+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-imbrium-therapeutics-announce--309385.html 0.6 2025-11-13T08:51:59+08:00 daily https://www.pharmasources.com/industryinsights/envigo-launches-pathway-an-optimized-saf-309386.html 0.6 2026-06-22T00:57:46+08:00 daily https://www.pharmasources.com/industryinsights/catalent-invests-over-27-million-to-comm-309387.html 0.6 2026-06-21T20:47:37+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-imfda-filing-acceptance-of-new-309388.html 0.6 2026-07-27T22:49:32+08:00 daily https://www.pharmasources.com/industryinsights/piramal-critical-care-announces-the-us-l-309389.html 0.6 2026-06-22T07:02:53+08:00 daily https://www.pharmasources.com/industryinsights/smc-says-no-to-novartis-kymriah-for-adul-309390.html 0.6 2026-07-21T20:14:14+08:00 daily https://www.pharmasources.com/industryinsights/bridge-medicines-enters-agreement-with-w-309391.html 0.6 2026-08-07T23:40:06+08:00 daily https://www.pharmasources.com/industryinsights/lucence-diagnostics-to-develop-ai-tools--309392.html 0.6 2026-06-21T09:00:06+08:00 daily https://www.pharmasources.com/industryinsights/takedas-entyvio-bests-abbvies-humira-in--309393.html 0.6 2026-07-04T13:10:00+08:00 daily https://www.pharmasources.com/industryinsights/allergan-files-anti-cgrp-migraine-drug-i-309394.html 0.6 2026-06-21T08:03:01+08:00 daily https://www.pharmasources.com/industryinsights/govt-offers-56m-for-research-into-public-309395.html 0.6 2026-06-24T11:16:10+08:00 daily https://www.pharmasources.com/industryinsights/clinical-stage-biotech-company-inventisb-309396.html 0.6 2026-06-20T19:54:07+08:00 daily https://www.pharmasources.com/industryinsights/darolutamide-submitted-for-eu-approval-309397.html 0.6 2026-06-21T04:56:12+08:00 daily https://www.pharmasources.com/industryinsights/nice-updates-high-blood-pressure-guideli-309398.html 0.6 2026-06-20T18:55:44+08:00 daily https://www.pharmasources.com/industryinsights/nice-updates-high-blood-pressure-guideli-309399.html 0.6 2026-06-22T12:21:42+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-reduced-hypoglycaemia-after--309400.html 0.6 2026-06-21T01:14:55+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-reduced-hypoglycaemia-after--309401.html 0.6 2026-07-08T08:00:33+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-joins-super-crowded-next-gene-309402.html 0.6 2026-06-21T04:51:56+08:00 daily https://www.pharmasources.com/industryinsights/roches-i-o-drug-tecentriq-picks-up-key-f-309403.html 0.6 2026-06-24T03:37:15+08:00 daily https://www.pharmasources.com/industryinsights/celgene-files-for-eu-approval-of-ozanimo-309404.html 0.6 2026-06-20T14:24:30+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-dupixent-gains-expande-309405.html 0.6 2026-06-22T19:38:42+08:00 daily https://www.pharmasources.com/industryinsights/at-second-time-of-asking-pfizers-trazime-309406.html 0.6 2026-06-21T16:35:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-trazimera-trastuzumab-qyyp--309407.html 0.6 2026-07-12T16:17:32+08:00 daily https://www.pharmasources.com/industryinsights/scottish-medicines-consortium-tisagenlec-309408.html 0.6 2026-06-21T01:54:37+08:00 daily https://www.pharmasources.com/industryinsights/apellis-pharmaceuticals-announces-closin-309409.html 0.6 2026-07-09T04:08:53+08:00 daily https://www.pharmasources.com/industryinsights/us-company-claims-irish-firm-amgen-infri-309410.html 0.6 2026-07-18T15:56:19+08:00 daily https://www.pharmasources.com/industryinsights/oncoceutics-licenses-rights-for-its-anti-309411.html 0.6 2026-06-21T05:06:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-nda-for-lemborexant-to-treat-309412.html 0.6 2026-06-20T14:57:04+08:00 daily https://www.pharmasources.com/industryinsights/lucence-diagnostics-to-develop-ai-tools--309413.html 0.6 2026-06-27T08:11:26+08:00 daily https://www.pharmasources.com/industryinsights/ossio-secures-22-m-in-financing-309414.html 0.6 2026-06-21T16:02:18+08:00 daily https://www.pharmasources.com/industryinsights/natera-and-bgi-genomics-announce-50m-par-309415.html 0.6 2026-06-25T17:44:14+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-fdas-accelerated-approval-to--309416.html 0.6 2026-04-27T15:34:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-designation-to-p-309417.html 0.6 2026-07-08T03:37:34+08:00 daily https://www.pharmasources.com/industryinsights/variantata-trust-collaborate-for-advance-309418.html 0.6 2026-07-08T20:54:56+08:00 daily https://www.pharmasources.com/industryinsights/vitruvias-sinotherapeutics-launch-approv-309419.html 0.6 2026-06-20T20:18:56+08:00 daily https://www.pharmasources.com/industryinsights/co-diagnostics-gets-ce-mark-for-zika-den-309420.html 0.6 2026-06-20T14:55:03+08:00 daily https://www.pharmasources.com/industryinsights/project-launched-to-tackle-lab-inefficie-309421.html 0.6 2026-06-21T09:05:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-a-new-generic-valsartan-309422.html 0.6 2026-07-21T03:02:08+08:00 daily https://www.pharmasources.com/industryinsights/hhs-confirms-sharpless-to-serve-as-actin-309423.html 0.6 2026-06-22T11:10:55+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-grabs-biogen-biologics-plant-in-309424.html 0.6 2026-07-07T21:27:58+08:00 daily https://www.pharmasources.com/industryinsights/dupont-launches-new-plant-protein-nugget-309425.html 0.6 2026-06-21T03:03:42+08:00 daily https://www.pharmasources.com/industryinsights/barry-callebaut-opens-beijing-chocolate--309426.html 0.6 2026-08-05T18:19:28+08:00 daily https://www.pharmasources.com/industryinsights/french-biotech-cellectis-picks-us-for-co-309427.html 0.6 2026-06-21T09:15:20+08:00 daily https://www.pharmasources.com/industryinsights/cstone-received-ind-approval-in-china-fo-309428.html 0.6 2026-08-06T23:21:34+08:00 daily https://www.pharmasources.com/industryinsights/hematogenix-launches-fda-approved-compan-309429.html 0.6 2026-06-21T07:16:12+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-services-announces--309430.html 0.6 2026-01-12T03:16:21+08:00 daily https://www.pharmasources.com/industryinsights/cellectis-to-build-mfg-facility-in-north-309431.html 0.6 2026-07-08T21:54:09+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-seres-in-cancer-research-tie-309432.html 0.6 2026-08-03T06:15:29+08:00 daily https://www.pharmasources.com/industryinsights/envigo-launches-pathway-309433.html 0.6 2026-06-22T05:53:35+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-services-expands-309434.html 0.6 2026-06-20T21:50:31+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-sparc-enter-dna-encoded-libra-309435.html 0.6 2026-07-17T21:01:35+08:00 daily https://www.pharmasources.com/industryinsights/secura-bio-acquires-global-rights-to-far-309436.html 0.6 2026-06-21T05:13:01+08:00 daily https://www.pharmasources.com/industryinsights/third-sartorius-research-xchange-forum-2-309437.html 0.6 2026-07-20T14:05:08+08:00 daily https://www.pharmasources.com/industryinsights/national-cancer-institute-chief-norman-s-309438.html 0.6 2026-06-21T22:03:49+08:00 daily https://www.pharmasources.com/industryinsights/sparc-inks-research-collaboration-pact-w-309439.html 0.6 2026-06-21T20:27:02+08:00 daily https://www.pharmasources.com/industryinsights/regeneronsanofi-wins-us-approval-for-exp-309440.html 0.6 2026-07-03T22:43:11+08:00 daily https://www.pharmasources.com/industryinsights/lillys-combo-therapy-succeeds-in-late-st-309441.html 0.6 2026-06-21T03:01:45+08:00 daily https://www.pharmasources.com/industryinsights/uk-prioritises-transport-of-medical-prod-309442.html 0.6 2026-08-06T18:04:08+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-sell-biologics-production-site-309443.html 0.6 2026-03-01T01:56:16+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-seres-therapeutics-to-st-309444.html 0.6 2026-06-21T05:08:49+08:00 daily https://www.pharmasources.com/industryinsights/microsoft-unveils-new-platform-to-boost--309445.html 0.6 2025-12-13T12:52:46+08:00 daily https://www.pharmasources.com/industryinsights/who-launches-its-most-far-reaching-strat-309446.html 0.6 2026-06-21T06:10:49+08:00 daily https://www.pharmasources.com/industryinsights/takedas-entyvio-achieves-superior-remiss-309447.html 0.6 2026-06-21T01:05:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-a-new-generic-diovan-valsar-309448.html 0.6 2026-07-20T05:10:11+08:00 daily https://www.pharmasources.com/industryinsights/model-can-predict-survival-in-nonmetasta-309449.html 0.6 2026-05-02T23:10:08+08:00 daily https://www.pharmasources.com/industryinsights/mri-method-that-measures-iron-in-brain-s-309450.html 0.6 2026-06-21T08:16:17+08:00 daily https://www.pharmasources.com/industryinsights/are-some-birth-control-methods-doomed-to-309451.html 0.6 2026-08-09T06:51:40+08:00 daily https://www.pharmasources.com/industryinsights/common-household-chemicals-harm-sperm-in-309452.html 0.6 2026-08-09T02:52:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rocklatan-309453.html 0.6 2026-08-09T00:10:05+08:00 daily https://www.pharmasources.com/industryinsights/emmaus-life-sciences-signs-agreement-wit-309454.html 0.6 2026-08-08T07:54:42+08:00 daily https://www.pharmasources.com/industryinsights/booster-for-medical-imaging-ai-in-india-309455.html 0.6 2026-08-09T23:54:43+08:00 daily https://www.pharmasources.com/industryinsights/ireland-to-lead-7-m-parkinsons-research--309456.html 0.6 2026-06-21T12:25:28+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-to-acquire-biogen-in-a-890-m-de-309457.html 0.6 2026-06-21T11:58:08+08:00 daily https://www.pharmasources.com/industryinsights/lance-goudzwaard-appointed-as-chief-comm-309458.html 0.6 2026-06-27T12:31:07+08:00 daily https://www.pharmasources.com/industryinsights/yunhu-technology-secures-tens-of-million-309459.html 0.6 2026-07-24T21:48:21+08:00 daily https://www.pharmasources.com/industryinsights/atos-inks-aud-124m-contract-with-wa-heal-309460.html 0.6 2026-08-09T20:12:38+08:00 daily https://www.pharmasources.com/industryinsights/medicen-supports-four-healthcare-winners-309461.html 0.6 2026-06-20T20:06:44+08:00 daily https://www.pharmasources.com/industryinsights/oxford-nanopore-launches-flongle-for-qui-309462.html 0.6 2026-06-21T06:03:47+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-services-announces--309463.html 0.6 2026-06-20T21:03:47+08:00 daily https://www.pharmasources.com/industryinsights/medtec-china-2019-swells-up-by-21-309464.html 0.6 2026-06-22T01:53:31+08:00 daily https://www.pharmasources.com/industryinsights/who-launches-new-global-influenza-strate-309465.html 0.6 2026-06-20T19:19:56+08:00 daily https://www.pharmasources.com/industryinsights/cstone-receives-ind-approval-in-china-fo-309466.html 0.6 2026-08-04T04:41:34+08:00 daily https://www.pharmasources.com/industryinsights/on-a-roll-dupixent-marches-into-teen-ecz-309467.html 0.6 2026-06-21T12:55:29+08:00 daily https://www.pharmasources.com/industryinsights/foquest-receives-approval-for-expanded-i-309468.html 0.6 2026-07-15T22:08:16+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-announces-rd-collaborat-309469.html 0.6 2026-06-21T03:05:45+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-announces-strategic-rev-309470.html 0.6 2026-06-21T10:55:08+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-ceo-insists-propose-309471.html 0.6 2026-07-09T07:28:01+08:00 daily https://www.pharmasources.com/industryinsights/prescription-drug-prices-arent-rising-th-309472.html 0.6 2026-06-22T12:47:48+08:00 daily https://www.pharmasources.com/industryinsights/rocket-pharmaceuticals-announces-first-p-309473.html 0.6 2026-07-28T03:36:05+08:00 daily https://www.pharmasources.com/industryinsights/pharmacy-benefit-managers-next-up-to-tes-309474.html 0.6 2026-07-09T15:59:15+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-disease-servier-and-oncodesig-309475.html 0.6 2026-06-22T04:55:40+08:00 daily https://www.pharmasources.com/industryinsights/european-firms-fuel-growth-in-patent-app-309476.html 0.6 2026-06-21T12:12:50+08:00 daily https://www.pharmasources.com/industryinsights/new-cholesterol-lowering-drug-could-help-309477.html 0.6 2026-06-21T00:18:05+08:00 daily https://www.pharmasources.com/industryinsights/when-a-cells-fingerprint-can-be-a-weapon-309478.html 0.6 2026-06-22T05:59:34+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-notches-win-in-breast-c-309479.html 0.6 2026-06-22T06:03:02+08:00 daily https://www.pharmasources.com/industryinsights/sparc-inks-research-collaboration-pact-w-309480.html 0.6 2026-06-08T18:00:22+08:00 daily https://www.pharmasources.com/industryinsights/regeneronsanofi-wins-us-approval-for-exp-309481.html 0.6 2026-06-22T11:43:30+08:00 daily https://www.pharmasources.com/industryinsights/short-regimen-noninferior-for-rifampin-r-309482.html 0.6 2026-07-09T15:37:26+08:00 daily https://www.pharmasources.com/industryinsights/mumps-causes-quarantine-of-over-2200-imm-309483.html 0.6 2026-07-07T12:22:49+08:00 daily https://www.pharmasources.com/industryinsights/adding-bempedoic-acid-to-statin-therapy--309484.html 0.6 2026-07-21T09:27:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-generic-valsartan-to-ea-309485.html 0.6 2026-06-27T13:25:43+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-ceo-walmsley-snags-a-pay-309486.html 0.6 2026-06-28T12:11:24+08:00 daily https://www.pharmasources.com/industryinsights/head-of-national-cancer-institute-named--309487.html 0.6 2026-07-08T12:02:06+08:00 daily https://www.pharmasources.com/industryinsights/opioid-rxs-decreasing-but-not-for-all-do-309488.html 0.6 2026-06-20T14:45:02+08:00 daily https://www.pharmasources.com/industryinsights/even-distant-relatives-history-could-up--309489.html 0.6 2026-06-20T20:02:34+08:00 daily https://www.pharmasources.com/industryinsights/flavored-e-cigarettes-hold-greatest-appe-309490.html 0.6 2026-07-05T09:53:28+08:00 daily https://www.pharmasources.com/industryinsights/are-inactive-ingredients-in-your-drugs-r-309491.html 0.6 2026-06-21T06:45:59+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutics-enters-into-commercial-309492.html 0.6 2026-08-09T09:26:20+08:00 daily https://www.pharmasources.com/industryinsights/x4-pharmaceuticals-completes-merger-with-309493.html 0.6 2026-08-08T14:47:18+08:00 daily https://www.pharmasources.com/industryinsights/sungen-pharma-and-athenex-pharmaceutical-309494.html 0.6 2026-08-07T13:16:06+08:00 daily https://www.pharmasources.com/industryinsights/hematogenix-introduces-the-fda-approved--309495.html 0.6 2026-08-07T12:30:16+08:00 daily https://www.pharmasources.com/industryinsights/us-senate-invites-pharmacy-benefit-manag-309496.html 0.6 2026-08-07T12:03:20+08:00 daily https://www.pharmasources.com/industryinsights/irish-scientists-secure-eu-funding-for-p-309497.html 0.6 2026-08-07T01:39:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-biosimilar-to-roches-herceptin-r-309498.html 0.6 2026-08-07T01:31:50+08:00 daily https://www.pharmasources.com/industryinsights/medicine-as-a-service-should-be-the-new--309499.html 0.6 2026-08-07T01:28:14+08:00 daily https://www.pharmasources.com/industryinsights/finalists-announced-for-the-2019-pharmat-309500.html 0.6 2026-08-08T20:00:40+08:00 daily https://www.pharmasources.com/industryinsights/lillys-cyramza-hits-first-line-nsclc-tri-309501.html 0.6 2026-08-07T07:30:46+08:00 daily https://www.pharmasources.com/industryinsights/chemistry-professionals-say-no-deal-brex-309502.html 0.6 2026-08-07T00:59:16+08:00 daily https://www.pharmasources.com/industryinsights/smith-nephew-buys-osiris-in-regenerative-309503.html 0.6 2026-08-07T00:40:47+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-exercises-option-to-acquire-myon-309504.html 0.6 2026-08-07T00:15:34+08:00 daily https://www.pharmasources.com/industryinsights/bioplan-benchmarks-the-state-of-biopharm-309505.html 0.6 2026-08-07T00:02:52+08:00 daily https://www.pharmasources.com/industryinsights/emergent-awarded-us-department-of-state--309506.html 0.6 2026-08-06T23:55:54+08:00 daily https://www.pharmasources.com/industryinsights/gtx-and-oncternal-enter-merger-309507.html 0.6 2026-08-06T23:47:59+08:00 daily https://www.pharmasources.com/industryinsights/west-opens-digital-technology-center-309508.html 0.6 2026-08-06T21:35:29+08:00 daily https://www.pharmasources.com/industryinsights/goodwin-biotechnology-expands-capacity-309509.html 0.6 2026-08-06T20:08:02+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-use-generative-modelling-ai-tec-309510.html 0.6 2026-08-06T21:54:02+08:00 daily https://www.pharmasources.com/industryinsights/janssen-seeks-usfda-nod-for-darzalex-to--309511.html 0.6 2026-08-07T13:17:55+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-nod-to-market-ge-309512.html 0.6 2026-08-07T15:25:46+08:00 daily https://www.pharmasources.com/industryinsights/lupin-responds-to-us-fdas-oai-letter-309513.html 0.6 2026-08-09T04:32:08+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sandoz-chief-exits-with-de-inte-309514.html 0.6 2026-08-09T06:51:29+08:00 daily https://www.pharmasources.com/industryinsights/scientists-clarify-what-probiotics-are-a-309515.html 0.6 2026-06-20T14:54:05+08:00 daily https://www.pharmasources.com/industryinsights/highlighting-advantages-of-the-whole-ind-309516.html 0.6 2026-07-05T13:37:07+08:00 daily https://www.pharmasources.com/industryinsights/chinese-drug-regulator-self-defeating-wh-309517.html 0.6 2026-08-04T07:01:19+08:00 daily https://www.pharmasources.com/industryinsights/chinese-drug-regulator-self-defeating-wh-309518.html 0.6 2026-08-02T19:35:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-jubilant-tablet-plant-in-india-309519.html 0.6 2026-08-08T16:43:33+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-chalks-up-another-talc-l-309520.html 0.6 2026-06-27T01:47:39+08:00 daily https://www.pharmasources.com/industryinsights/bms-deal-quest-gets-a-boost-as-celgene-s-309521.html 0.6 2026-06-30T22:45:34+08:00 daily https://www.pharmasources.com/industryinsights/allergan-pulls-ads-from-fox-show-after-h-309522.html 0.6 2026-07-05T00:26:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-drops-warning-letter-on-lupin-steril-309523.html 0.6 2026-06-20T22:01:41+08:00 daily https://www.pharmasources.com/industryinsights/merck-limits-orders-for-bladder-cancer-d-309524.html 0.6 2026-04-13T23:37:41+08:00 daily https://www.pharmasources.com/industryinsights/could-a-patent-dispute-over-celgene-ms-h-309525.html 0.6 2026-06-22T10:11:52+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-plant-that-is-closing-gets-farewe-309526.html 0.6 2026-08-08T13:55:40+08:00 daily https://www.pharmasources.com/industryinsights/ibm-research-to-use-ml-for-detecting-alz-309527.html 0.6 2026-07-17T08:13:33+08:00 daily https://www.pharmasources.com/industryinsights/chugais-hemlibra-receives-approval-for-s-309528.html 0.6 2026-06-20T15:05:25+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-announces-150m-equity-investment-309529.html 0.6 2026-08-10T00:53:12+08:00 daily https://www.pharmasources.com/industryinsights/aprecia-cmic-to-bring-3dp-pharmaceutical-309530.html 0.6 2026-06-21T11:01:14+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-clin-309531.html 0.6 2026-02-27T20:28:30+08:00 daily https://www.pharmasources.com/industryinsights/stryker-acquires-orthospace-in-a-110m-de-309532.html 0.6 2026-04-13T01:03:53+08:00 daily https://www.pharmasources.com/industryinsights/bayers-ph-iii-clinical-trial-of-nifurtim-309533.html 0.6 2026-06-20T20:17:06+08:00 daily https://www.pharmasources.com/industryinsights/dornier-launches-dornier-optivision-next-309534.html 0.6 2026-06-21T23:08:47+08:00 daily https://www.pharmasources.com/industryinsights/zydus-set-to-market-generic-anti-diabeti-309535.html 0.6 2026-04-07T05:36:46+08:00 daily https://www.pharmasources.com/industryinsights/alipay-nus-enterprise-social-innovation--309536.html 0.6 2026-06-20T14:41:49+08:00 daily https://www.pharmasources.com/industryinsights/hematogenix-launches-fda-approved-compan-309537.html 0.6 2026-03-08T21:37:14+08:00 daily https://www.pharmasources.com/industryinsights/resmed-completes-acquisition-of-hb-healt-309538.html 0.6 2026-06-21T09:54:15+08:00 daily https://www.pharmasources.com/industryinsights/cxa-group-raises-25m-for-apac-expansion-309539.html 0.6 2026-08-07T14:26:47+08:00 daily https://www.pharmasources.com/industryinsights/celgene-survives-alvogens-attempt-for-in-309540.html 0.6 2026-08-08T19:30:59+08:00 daily https://www.pharmasources.com/industryinsights/matinas-biopharma-announces-proposed-pub-309541.html 0.6 2026-08-09T07:59:16+08:00 daily https://www.pharmasources.com/industryinsights/florida-pharmaceutical-products-inks-agr-309542.html 0.6 2026-06-23T13:36:11+08:00 daily https://www.pharmasources.com/industryinsights/ardelyx-appoints-renowned-nephrologist-g-309543.html 0.6 2026-06-21T16:03:19+08:00 daily https://www.pharmasources.com/industryinsights/vivus-announces-marketing-approval-of-av-309544.html 0.6 2026-07-23T14:48:40+08:00 daily https://www.pharmasources.com/industryinsights/roches-mabthera-garners-eu-clearance-as--309545.html 0.6 2026-06-20T17:15:27+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-denies-defensive-st-309546.html 0.6 2026-06-29T05:28:52+08:00 daily https://www.pharmasources.com/industryinsights/viiv-builds-case-for-long-acting-hiv-dou-309547.html 0.6 2026-06-21T14:57:22+08:00 daily https://www.pharmasources.com/industryinsights/genfit-announces-launch-of-proposed-glob-309548.html 0.6 2026-07-04T07:05:35+08:00 daily https://www.pharmasources.com/industryinsights/c4-therapeutics-appoints-adam-crystal-md-309549.html 0.6 2026-08-07T23:03:12+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019318-309550.html 0.6 2026-06-21T11:22:37+08:00 daily https://www.pharmasources.com/industryinsights/celgene-dodges-alvogen-bid-to-overturn-r-309551.html 0.6 2026-06-21T03:05:42+08:00 daily https://www.pharmasources.com/industryinsights/asia-set-to-lead-the-way-on-healthcare-b-309552.html 0.6 2026-06-20T19:52:33+08:00 daily https://www.pharmasources.com/industryinsights/tha-olix-to-develop-rnai-therapies-for-a-309553.html 0.6 2026-07-01T15:56:05+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approves-new-indication-for-valve--309554.html 0.6 2026-07-07T17:55:31+08:00 daily https://www.pharmasources.com/industryinsights/inventisbio-closes-70m-series-c-financin-309555.html 0.6 2026-06-20T18:07:28+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-incorporates-ai-in-new-chromato-309556.html 0.6 2026-06-21T10:12:30+08:00 daily https://www.pharmasources.com/industryinsights/bayers-ph-iii-clinical-trial-of-nifurtim-309557.html 0.6 2026-06-20T17:59:22+08:00 daily https://www.pharmasources.com/industryinsights/celgenes-revlimid-tops-medicare-spending-309558.html 0.6 2026-06-20T15:14:26+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-has-a-blockbuster-market-not-fa-309559.html 0.6 2026-06-21T03:59:47+08:00 daily https://www.pharmasources.com/industryinsights/ex-pfizer-ceo-ian-read-sees-2018-pay-sla-309560.html 0.6 2026-07-26T05:56:21+08:00 daily https://www.pharmasources.com/industryinsights/jj-chief-gorsky-took-a-big-pay-hit-in-20-309561.html 0.6 2026-06-21T11:06:14+08:00 daily https://www.pharmasources.com/industryinsights/chinas-hitgen-in-collaboration-with-indi-309562.html 0.6 2026-06-22T04:52:37+08:00 daily https://www.pharmasources.com/industryinsights/helix-biopharma-corp-closes-private-plac-309563.html 0.6 2026-06-22T03:02:42+08:00 daily https://www.pharmasources.com/industryinsights/apple-watch-identified-atrial-fibrillati-309564.html 0.6 2026-06-08T19:43:12+08:00 daily https://www.pharmasources.com/industryinsights/praluent-alirocumab-now-approved-in-euro-309565.html 0.6 2026-08-09T04:32:17+08:00 daily https://www.pharmasources.com/industryinsights/rocket-pharmaceuticals-announces-present-309566.html 0.6 2026-08-08T20:03:03+08:00 daily https://www.pharmasources.com/industryinsights/with-single-gene-insertion-blind-mice-re-309567.html 0.6 2026-08-08T13:46:58+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-continues-to-deliver-reco-309568.html 0.6 2026-08-08T12:36:17+08:00 daily https://www.pharmasources.com/industryinsights/birth-control-pill-recalled-due-to-defec-309569.html 0.6 2026-08-08T10:41:01+08:00 daily https://www.pharmasources.com/industryinsights/no-deal-brexit-catastrophic-for-science--309570.html 0.6 2026-08-07T13:17:07+08:00 daily https://www.pharmasources.com/industryinsights/absorbable-antibiotic-envelope-cuts-card-309571.html 0.6 2026-08-06T23:46:08+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-introduces-milli-q-connec-309572.html 0.6 2026-08-06T22:53:32+08:00 daily https://www.pharmasources.com/industryinsights/sheba-lonza-collaborate-on-cell-therapy--309573.html 0.6 2026-08-06T21:47:14+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-adds-cto-role-309574.html 0.6 2026-08-06T20:07:25+08:00 daily https://www.pharmasources.com/industryinsights/paratek-pharma-management-change-309575.html 0.6 2026-08-06T21:55:07+08:00 daily https://www.pharmasources.com/industryinsights/napajen-pharma-and-astellas-pharma-estab-309576.html 0.6 2026-08-06T22:08:24+08:00 daily https://www.pharmasources.com/industryinsights/cro-inks-omnicomm-edc-agreement-309577.html 0.6 2026-08-06T23:47:12+08:00 daily https://www.pharmasources.com/industryinsights/pii-to-manufacture-busulfan-injection-dr-309578.html 0.6 2026-08-06T23:55:38+08:00 daily https://www.pharmasources.com/industryinsights/in-utero-ultrafine-particle-exposure-tie-309579.html 0.6 2026-06-20T19:12:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-update-on-mortality-risk-with-309580.html 0.6 2026-08-06T23:35:52+08:00 daily https://www.pharmasources.com/industryinsights/acc-adherence-to-statins-low-among-patie-309581.html 0.6 2026-08-06T23:32:23+08:00 daily https://www.pharmasources.com/industryinsights/az-farxiga-shows-cv-benefit-in-diabetes--309582.html 0.6 2026-08-06T23:36:33+08:00 daily https://www.pharmasources.com/industryinsights/gw-sells-priority-review-voucher-for-105-309583.html 0.6 2026-08-06T23:46:42+08:00 daily https://www.pharmasources.com/industryinsights/setback-for-allergys-birch-pollen-immuno-309584.html 0.6 2026-08-07T02:40:00+08:00 daily https://www.pharmasources.com/industryinsights/groundbreaking-study-finds-optimum-dosag-309585.html 0.6 2026-08-07T02:52:49+08:00 daily https://www.pharmasources.com/industryinsights/lewy-body-society-grants-1-million-for-d-309586.html 0.6 2026-06-21T23:50:43+08:00 daily https://www.pharmasources.com/industryinsights/cma-drops-anti-competitive-case-against--309587.html 0.6 2026-08-08T20:02:59+08:00 daily https://www.pharmasources.com/industryinsights/uveal-melanoma-study-announced-309588.html 0.6 2026-08-09T02:38:59+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-expand-praluents-label-309589.html 0.6 2026-08-09T07:56:40+08:00 daily https://www.pharmasources.com/industryinsights/study-warns-of-disinfectant-use-in-hospi-309590.html 0.6 2026-07-16T18:15:08+08:00 daily https://www.pharmasources.com/industryinsights/ccgs-failing-to-demonstrate-value-for-mo-309591.html 0.6 2026-06-21T07:38:13+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-saracatinib-orphan-drug-de-309592.html 0.6 2026-03-23T22:16:37+08:00 daily https://www.pharmasources.com/industryinsights/kings-college-signs-mental-health-deal-w-309593.html 0.6 2026-06-21T08:44:48+08:00 daily https://www.pharmasources.com/industryinsights/new-lung-cancer-indication-for-keytruda--309594.html 0.6 2026-06-21T05:52:00+08:00 daily https://www.pharmasources.com/industryinsights/nasa-calls-for-new-vaccinations-to-comba-309595.html 0.6 2026-06-21T10:05:10+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-effective-against-heart-fa-309596.html 0.6 2026-06-09T18:33:45+08:00 daily https://www.pharmasources.com/industryinsights/blackstone-to-acquire-anti-rheumatism-dr-309597.html 0.6 2026-07-14T12:21:09+08:00 daily https://www.pharmasources.com/industryinsights/novartis-joins-the-global-chagas-disease-309598.html 0.6 2026-06-21T00:57:52+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-mercks-keytruda-for-metastat-309599.html 0.6 2026-06-20T19:08:40+08:00 daily https://www.pharmasources.com/industryinsights/green-tea-cuts-obesity-health-risks-in-m-309600.html 0.6 2026-06-21T19:58:37+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-collaboration-with-iktos-309601.html 0.6 2026-06-21T11:52:13+08:00 daily https://www.pharmasources.com/industryinsights/lillys-combo-therapy-succeeds-in-the-lat-309602.html 0.6 2026-06-21T05:15:55+08:00 daily https://www.pharmasources.com/industryinsights/commonly-used-heart-drug-may-up-cardiac--309603.html 0.6 2026-08-03T17:49:25+08:00 daily https://www.pharmasources.com/industryinsights/amgen-taps-comedian-jay-leno-for-cholest-309604.html 0.6 2026-06-21T13:04:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-farxiga-chops-follow-up-cv--309605.html 0.6 2026-07-10T09:55:52+08:00 daily https://www.pharmasources.com/industryinsights/amarin-rolls-out-more-vascepa-heart-bene-309606.html 0.6 2026-06-21T19:09:40+08:00 daily https://www.pharmasources.com/industryinsights/bms-pfizers-eliquis-tops-warfarin-in-hig-309607.html 0.6 2026-06-13T14:32:42+08:00 daily https://www.pharmasources.com/industryinsights/more-trouble-for-samsung-biologics-prose-309608.html 0.6 2026-06-23T06:05:58+08:00 daily https://www.pharmasources.com/industryinsights/pharma-ad-police-issues-2019s-first-warn-309609.html 0.6 2026-06-21T16:03:19+08:00 daily https://www.pharmasources.com/industryinsights/theranica-raises-35m-to-bring-innovative-309610.html 0.6 2026-07-01T19:27:26+08:00 daily https://www.pharmasources.com/industryinsights/shineco-expands-to-capture-cannabis-mark-309611.html 0.6 2026-06-20T18:03:27+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-roches-mabthera-for-a-rare-a-309612.html 0.6 2026-07-05T00:35:02+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-to-invest-150-m-in-expandi-309613.html 0.6 2026-06-22T07:03:51+08:00 daily https://www.pharmasources.com/industryinsights/ono-pharma-twoxar-announce-drug-discover-309614.html 0.6 2026-06-20T14:45:09+08:00 daily https://www.pharmasources.com/industryinsights/eppendorf-presents-extended-spectrum-of--309615.html 0.6 2026-06-21T14:50:19+08:00 daily https://www.pharmasources.com/industryinsights/immunogenx-initiates-ph2-trial-for-its-l-309616.html 0.6 2026-03-20T18:23:12+08:00 daily https://www.pharmasources.com/industryinsights/orthos-vitros-xt-microslide-receives-ce--309617.html 0.6 2026-06-20T20:20:55+08:00 daily https://www.pharmasources.com/industryinsights/bionano-genomics-enters-into-debt-and-eq-309618.html 0.6 2026-06-28T09:14:22+08:00 daily https://www.pharmasources.com/industryinsights/bd-to-market-its-venovo-venous-stent-309619.html 0.6 2026-06-21T07:50:57+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-be-the-first-biologics-309620.html 0.6 2026-08-09T18:20:51+08:00 daily https://www.pharmasources.com/industryinsights/orphanion-enters-api-deal-with-lgm-pharm-309621.html 0.6 2026-06-20T21:57:31+08:00 daily https://www.pharmasources.com/industryinsights/c2-pharma-acquires-digoxin-api-portfolio-309622.html 0.6 2026-06-21T07:55:24+08:00 daily https://www.pharmasources.com/industryinsights/vgxi-achieves-tech-transfer-milestones-309623.html 0.6 2026-06-20T20:48:31+08:00 daily https://www.pharmasources.com/industryinsights/pall-enters-cell-and-gene-therapy-mfg-ti-309624.html 0.6 2026-06-21T04:56:42+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-genscript-to-accelerate-c-309625.html 0.6 2026-08-08T11:53:39+08:00 daily https://www.pharmasources.com/industryinsights/the-1st-chinese-produced-biosimilar-appr-309626.html 0.6 2026-07-07T13:09:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zulresso-brexanolone-for-th-309627.html 0.6 2026-06-21T12:24:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-against-marketer-of-una-309628.html 0.6 2026-06-20T22:57:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-tecentriq-for-extensive-stage-sm-309629.html 0.6 2026-06-21T01:04:50+08:00 daily https://www.pharmasources.com/industryinsights/american-academy-of-orthopaedic-surgeons-309630.html 0.6 2026-06-21T12:17:31+08:00 daily https://www.pharmasources.com/industryinsights/model-predicts-survival-in-transplant-in-309631.html 0.6 2026-07-13T13:22:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-homeopathic-company-about-ille-309632.html 0.6 2026-07-18T16:05:25+08:00 daily https://www.pharmasources.com/industryinsights/can-high-potency-pot-make-you-crazy-309633.html 0.6 2026-07-08T13:04:47+08:00 daily https://www.pharmasources.com/industryinsights/abbott-introduces-new-digital-service-in-309634.html 0.6 2026-07-07T15:15:54+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-raises-rs-150-crore-via-n-309635.html 0.6 2026-06-22T07:58:52+08:00 daily https://www.pharmasources.com/industryinsights/merck-collaborates-with-genscript-to-acc-309636.html 0.6 2026-06-20T23:58:37+08:00 daily https://www.pharmasources.com/industryinsights/eastgate-biotech-signs-strategic-allianc-309637.html 0.6 2026-06-21T00:02:43+08:00 daily https://www.pharmasources.com/industryinsights/needle-free-dominates-injectable-drug-de-309638.html 0.6 2026-06-21T09:07:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-label-for-allergans-antibact-309639.html 0.6 2026-07-01T17:17:18+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-files-for-regulator-309640.html 0.6 2026-06-21T04:20:04+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-settles-victoza-patent-disp-309641.html 0.6 2026-06-21T01:04:48+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-gardp-partner-to-identify-new-309642.html 0.6 2026-06-21T04:14:15+08:00 daily https://www.pharmasources.com/industryinsights/allergy-therapeutics-birch-pollen-produc-309643.html 0.6 2026-06-22T02:42:26+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-introduces-cubis-ii-modular-la-309644.html 0.6 2026-06-21T20:10:49+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharmas-bidose-nasal-drug-delivery-309645.html 0.6 2026-07-25T00:28:51+08:00 daily https://www.pharmasources.com/industryinsights/sotios-dcvacovca-significantly-improves--309646.html 0.6 2026-06-21T10:56:16+08:00 daily https://www.pharmasources.com/industryinsights/abzena-and-lipum-ab-sign-integrated-cmc--309647.html 0.6 2026-06-23T07:15:05+08:00 daily https://www.pharmasources.com/industryinsights/crinetics-pharmaceuticals-doses-first-pa-309648.html 0.6 2026-06-22T07:52:58+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-collaborate-with-genscript-to-a-309649.html 0.6 2026-08-03T14:36:00+08:00 daily https://www.pharmasources.com/industryinsights/go-for-a-run-or-eat-chocolate-a-choice-d-309650.html 0.6 2026-07-13T07:37:43+08:00 daily https://www.pharmasources.com/industryinsights/abbott-introduces-a-new-digital-service--309651.html 0.6 2026-08-08T06:14:24+08:00 daily https://www.pharmasources.com/industryinsights/c2-pharma-acquires-digoxin-api-portfolio-309652.html 0.6 2026-06-21T11:20:33+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-hospira-both-recall-injected-d-309653.html 0.6 2026-06-22T06:59:48+08:00 daily https://www.pharmasources.com/industryinsights/sage-wins-ok-for-depression-drug-zulress-309654.html 0.6 2026-06-21T14:37:02+08:00 daily https://www.pharmasources.com/industryinsights/without-smoking-gun-bms-celgene-deal-wil-309655.html 0.6 2026-06-20T22:59:41+08:00 daily https://www.pharmasources.com/industryinsights/fueling-the-pharmaceutical-industry-by-c-309656.html 0.6 2026-07-28T03:51:12+08:00 daily https://www.pharmasources.com/industryinsights/p-mec-china-to-arrive-in-june-as-shangha-309657.html 0.6 2026-08-10T00:17:02+08:00 daily https://www.pharmasources.com/industryinsights/service-rules-309658.html 0.6 2026-07-30T15:22:47+08:00 daily https://www.pharmasources.com/industryinsights/vertex-receives-approval-for-cf-drug-in--309659.html 0.6 2026-06-20T13:20:36+08:00 daily https://www.pharmasources.com/industryinsights/abbott-introduces-new-digital-service-in-309660.html 0.6 2026-03-01T05:19:53+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-gets-ema-gmp-certificates-309661.html 0.6 2026-06-20T22:52:08+08:00 daily https://www.pharmasources.com/industryinsights/connectedlife-partners-with-ocean-protoc-309662.html 0.6 2026-06-21T01:54:49+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-brings-new-automated-sampl-309663.html 0.6 2026-06-23T06:50:06+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-genscript-to-stimulate-ce-309664.html 0.6 2026-06-22T05:10:52+08:00 daily https://www.pharmasources.com/industryinsights/acell-enters-distribution-agreement-for--309665.html 0.6 2026-06-22T08:01:49+08:00 daily https://www.pharmasources.com/industryinsights/stanford-medicine-announces-results-of-u-309666.html 0.6 2026-08-09T05:02:26+08:00 daily https://www.pharmasources.com/industryinsights/check-cap-announces-appointment-of-mira--309667.html 0.6 2026-06-21T04:53:47+08:00 daily https://www.pharmasources.com/industryinsights/sage-wins-ok-for-depression-drug-zulress-309668.html 0.6 2026-06-22T04:57:39+08:00 daily https://www.pharmasources.com/industryinsights/bayer-animal-health-sale-could-rake-in-8-309669.html 0.6 2026-06-21T07:08:00+08:00 daily https://www.pharmasources.com/industryinsights/lillys-7m-tax-abatement-in-indianapolis--309670.html 0.6 2026-06-21T09:07:06+08:00 daily https://www.pharmasources.com/industryinsights/venclexta-trial-deaths-force-abbvie-roch-309671.html 0.6 2026-08-05T10:43:56+08:00 daily https://www.pharmasources.com/industryinsights/nls-pharmaceutics-announces-the-completi-309672.html 0.6 2026-07-14T15:59:44+08:00 daily https://www.pharmasources.com/industryinsights/stada-to-hire-hundreds-of-employees-309673.html 0.6 2026-08-06T19:59:04+08:00 daily https://www.pharmasources.com/industryinsights/sage-therapeutics-zulresso-becomes-first-309674.html 0.6 2026-08-05T09:51:02+08:00 daily https://www.pharmasources.com/industryinsights/early-stage-trial-shows-positive-results-309675.html 0.6 2026-06-21T10:57:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sunosi-solriamfetol-for-exc-309676.html 0.6 2026-06-21T05:01:46+08:00 daily https://www.pharmasources.com/industryinsights/trastuzumab-tied-to-higher-long-term-ris-309677.html 0.6 2026-03-30T12:59:45+08:00 daily https://www.pharmasources.com/industryinsights/antiepileptic-drugs-not-tied-to-dementia-309678.html 0.6 2026-07-27T19:41:35+08:00 daily https://www.pharmasources.com/industryinsights/pregnancy-adapted-algorithm-avoids-diagn-309679.html 0.6 2026-06-21T15:01:35+08:00 daily https://www.pharmasources.com/industryinsights/developing-easy-to-swallow-medicine-for--309680.html 0.6 2026-08-08T01:34:10+08:00 daily https://www.pharmasources.com/industryinsights/ready-to-use-glucagon-for-exercise-induc-309681.html 0.6 2026-06-30T07:49:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-roches-tecentriq-in-combina-309682.html 0.6 2026-06-22T19:00:09+08:00 daily https://www.pharmasources.com/industryinsights/algae-could-prevent-limb-amputation-309683.html 0.6 2026-06-22T10:15:17+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-nod-to-market-ge-309684.html 0.6 2026-07-13T07:01:49+08:00 daily https://www.pharmasources.com/industryinsights/hc-seeks-centres-reply-on-peta-plea-agai-309685.html 0.6 2026-06-22T06:54:54+08:00 daily https://www.pharmasources.com/industryinsights/bayer-animal-health-sale-can-rake-in-8b--309686.html 0.6 2026-07-24T10:29:50+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-309687.html 0.6 2026-06-21T12:02:12+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-collaborations-and-rare-d-309688.html 0.6 2026-08-04T00:53:21+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-secures-exclusive-option-to-acqui-309689.html 0.6 2026-06-21T04:47:50+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-hemoshear-therapeutics-extend-309690.html 0.6 2026-06-21T05:59:46+08:00 daily https://www.pharmasources.com/industryinsights/petra-pharma-announces-licensing-agreeme-309691.html 0.6 2026-06-21T01:14:57+08:00 daily https://www.pharmasources.com/industryinsights/alexion-and-zealand-pharma-announce-coll-309692.html 0.6 2026-03-25T15:33:50+08:00 daily https://www.pharmasources.com/industryinsights/valoremrx-collaborates-with-kroger-speci-309693.html 0.6 2026-06-08T21:45:58+08:00 daily https://www.pharmasources.com/industryinsights/biotech-firm-spiber-to-develop-artificia-309694.html 0.6 2026-06-21T05:09:49+08:00 daily https://www.pharmasources.com/industryinsights/phar-east-gathers-over-700-pharma-biotec-309695.html 0.6 2025-11-27T14:35:29+08:00 daily https://www.pharmasources.com/industryinsights/spag-makes-strategic-move-in-se-asia-309696.html 0.6 2026-06-21T21:53:09+08:00 daily https://www.pharmasources.com/industryinsights/new-who-recommendations-to-accelerate-pr-309697.html 0.6 2026-02-09T10:11:10+08:00 daily https://www.pharmasources.com/industryinsights/miltenyi-atlatl-build-cell-gene-therapy--309698.html 0.6 2026-07-21T06:00:33+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-faces-class-action-lawsuit-from-n-309699.html 0.6 2026-07-02T18:38:49+08:00 daily https://www.pharmasources.com/industryinsights/mercks-refreshed-hpv-vaccine-push-puts-m-309700.html 0.6 2026-04-25T02:38:29+08:00 daily https://www.pharmasources.com/industryinsights/c2-pharma-doubles-down-on-supplies-of-di-309701.html 0.6 2026-08-07T06:32:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-merck-kgaa-scrap-yet-another-bave-309702.html 0.6 2026-06-11T00:39:20+08:00 daily https://www.pharmasources.com/industryinsights/biogen-eisai-scrap-late-stage-studies-of-309703.html 0.6 2026-08-06T05:31:37+08:00 daily https://www.pharmasources.com/industryinsights/petra-pharma-announces-licensing-agreeme-309704.html 0.6 2026-06-21T13:01:30+08:00 daily https://www.pharmasources.com/industryinsights/trizell-ltd-announces-phase-3-pivotal-st-309705.html 0.6 2026-06-22T04:12:57+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-signs-cdo-deal-with-eu-309706.html 0.6 2026-06-21T16:14:32+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-gains-fda-approval--309707.html 0.6 2026-07-19T15:41:53+08:00 daily https://www.pharmasources.com/industryinsights/pdcline-pharma-enters-into-a-licensing-a-309708.html 0.6 2026-08-04T08:55:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-internal-probe-expert-panel-fin-309709.html 0.6 2026-06-21T04:01:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-doctors-myeloma-patients-of-do-309710.html 0.6 2026-08-05T16:50:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-stiff-arms-sanofi-and-lexicons-type--309711.html 0.6 2026-06-20T15:46:35+08:00 daily https://www.pharmasources.com/industryinsights/60p-launches-malaria-preventive-medicine-309712.html 0.6 2026-06-21T15:04:34+08:00 daily https://www.pharmasources.com/industryinsights/psychiatry-uk-taliaz-launch-online-servi-309713.html 0.6 2026-05-06T17:42:50+08:00 daily https://www.pharmasources.com/industryinsights/pdcline-pharma-enters-into-a-licensing-a-309714.html 0.6 2026-03-19T23:17:26+08:00 daily https://www.pharmasources.com/industryinsights/eisai-to-present-latest-research-on-alzh-309715.html 0.6 2026-06-20T22:19:04+08:00 daily https://www.pharmasources.com/industryinsights/hyphens-pharma-inks-mou-with-astar-for-d-309716.html 0.6 2026-06-21T20:34:37+08:00 daily https://www.pharmasources.com/industryinsights/philips-receives-recognition-for-design--309717.html 0.6 2026-02-04T15:35:22+08:00 daily https://www.pharmasources.com/industryinsights/nus-researchers-develop-self-healing-ele-309718.html 0.6 2026-07-05T00:02:58+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-wins-cmo-leadership-aw-309719.html 0.6 2026-07-10T07:39:07+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-developes-anti-tnfr2-programme-309720.html 0.6 2026-08-08T16:36:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-again-issues-complete-response-lette-309721.html 0.6 2026-06-21T08:43:36+08:00 daily https://www.pharmasources.com/industryinsights/eisai-biogen-to-advance-alzheimers-drug--309722.html 0.6 2026-08-08T23:36:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-new-steps-to-advance-natural-h-309723.html 0.6 2026-07-27T00:21:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-conatus-emricasan-fails-mid-sta-309724.html 0.6 2026-06-22T21:03:58+08:00 daily https://www.pharmasources.com/industryinsights/anti-tb-drugs-can-increase-risk-of-tb-re-309725.html 0.6 2026-08-07T05:07:18+08:00 daily https://www.pharmasources.com/industryinsights/legochem-biosciences-takeda-collaborate--309726.html 0.6 2026-08-07T02:31:13+08:00 daily https://www.pharmasources.com/industryinsights/duke-nus-study-shows-promise-for-heart-m-309727.html 0.6 2026-08-07T02:37:04+08:00 daily https://www.pharmasources.com/industryinsights/sosei-announces-launch-of-copd-medicatio-309728.html 0.6 2026-08-07T02:52:12+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-to-acquire-viral-vector-ma-309729.html 0.6 2026-07-07T12:07:11+08:00 daily https://www.pharmasources.com/industryinsights/eisai-starts-phase-iii-clinical-trial-fo-309730.html 0.6 2026-08-07T05:05:34+08:00 daily https://www.pharmasources.com/industryinsights/research-from-xjtlu-advances-rna-modific-309731.html 0.6 2026-08-07T04:57:15+08:00 daily https://www.pharmasources.com/industryinsights/inovio-announces-demonstration-of-100-im-309732.html 0.6 2026-07-23T21:36:36+08:00 daily https://www.pharmasources.com/industryinsights/alzprotect-partners-with-parexel-biotech-309733.html 0.6 2026-06-20T15:51:39+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharma-gets-us-fda-approval-for-a-d-309734.html 0.6 2026-07-06T13:39:08+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-shoulders-into-gene-therap-309735.html 0.6 2026-08-07T02:05:13+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019032-309736.html 0.6 2026-08-07T01:19:39+08:00 daily https://www.pharmasources.com/industryinsights/the-third-china-pharma-week-an-event-to--309737.html 0.6 2026-08-07T01:19:33+08:00 daily https://www.pharmasources.com/industryinsights/in-hiking-prices-drugmakers-show-some-si-309738.html 0.6 2026-08-07T13:18:44+08:00 daily https://www.pharmasources.com/industryinsights/pivotal-phase-iii-trial-launched-in-recu-309739.html 0.6 2026-08-08T00:54:04+08:00 daily https://www.pharmasources.com/industryinsights/new-technique-shows-promise-for-heart-mu-309740.html 0.6 2026-08-08T01:44:11+08:00 daily https://www.pharmasources.com/industryinsights/bayer-reaches-settlement-to-resolve-xare-309741.html 0.6 2026-08-08T02:37:51+08:00 daily https://www.pharmasources.com/industryinsights/usfda-nod-for-generic-version-of-viagra--309742.html 0.6 2026-08-08T03:25:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-sanofi-lexicon-add-on-pill-f-309743.html 0.6 2026-08-08T04:35:19+08:00 daily https://www.pharmasources.com/industryinsights/indian-government-notifies-new-rules-for-309744.html 0.6 2026-08-08T07:47:50+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-insulin-price-hike-critics--309745.html 0.6 2026-08-08T10:10:45+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-launch-of-generic-version-309746.html 0.6 2026-08-09T06:59:19+08:00 daily https://www.pharmasources.com/industryinsights/huakang-biomed-declares-first-annual-res-309747.html 0.6 2026-06-29T16:35:12+08:00 daily https://www.pharmasources.com/industryinsights/gcam-opens-new-plasma-collection-centre-309748.html 0.6 2026-06-21T22:13:56+08:00 daily https://www.pharmasources.com/industryinsights/lupin-yl-biologics-receive-pmda-approval-309749.html 0.6 2026-08-05T15:05:49+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-almirall-to-identify-novel-drug-t-309750.html 0.6 2026-06-22T14:55:56+08:00 daily https://www.pharmasources.com/industryinsights/pilloxa-initiates-a-strategic-partnershi-309751.html 0.6 2026-06-22T04:46:25+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-wins-recognition-for-biop-309752.html 0.6 2026-08-08T20:37:29+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-majority-cancer-patients-i-309753.html 0.6 2026-08-08T18:42:18+08:00 daily https://www.pharmasources.com/industryinsights/activist-investor-appaloosa-dismisses-al-309754.html 0.6 2026-08-08T14:47:25+08:00 daily https://www.pharmasources.com/industryinsights/bayer-johnson-johnson-to-pay-775-million-309755.html 0.6 2026-08-08T10:11:46+08:00 daily https://www.pharmasources.com/industryinsights/shares-in-proteostasis-therapeutics-plun-309756.html 0.6 2026-08-07T13:15:17+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-exclusively-launches-treprostinil-309757.html 0.6 2026-08-07T04:34:02+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-daratumumab-and-hepatitis-b-vir-309758.html 0.6 2026-08-07T22:17:00+08:00 daily https://www.pharmasources.com/industryinsights/cladribine-tablets-approved-as-the-first-309759.html 0.6 2026-08-07T02:09:47+08:00 daily https://www.pharmasources.com/industryinsights/pharmacosmos-phosphare-study-program-dem-309760.html 0.6 2026-08-07T02:04:57+08:00 daily https://www.pharmasources.com/industryinsights/aerie-pharmaceuticals-announces-four-app-309761.html 0.6 2026-08-06T23:56:46+08:00 daily https://www.pharmasources.com/industryinsights/trigr-therapeutics-completes-14-million--309762.html 0.6 2026-08-07T00:03:03+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-cimzia-certolizum-309763.html 0.6 2026-08-07T00:41:26+08:00 daily https://www.pharmasources.com/industryinsights/biofrontera-inc-usa-acquires-cutanea-lif-309764.html 0.6 2026-08-07T00:42:57+08:00 daily https://www.pharmasources.com/industryinsights/enterprise-therapeutics-strengthens-lead-309765.html 0.6 2026-08-07T00:59:10+08:00 daily https://www.pharmasources.com/industryinsights/alimera-sciences-announces-approval-rece-309766.html 0.6 2026-08-07T23:04:55+08:00 daily https://www.pharmasources.com/industryinsights/gelesis-presents-expanded-data-showing-i-309767.html 0.6 2026-08-08T00:58:25+08:00 daily https://www.pharmasources.com/industryinsights/gt-biopharma-restructures-management-tea-309768.html 0.6 2026-08-07T04:06:56+08:00 daily https://www.pharmasources.com/industryinsights/windmil-therapeutics-announces-key-appoi-309769.html 0.6 2026-06-21T14:57:23+08:00 daily https://www.pharmasources.com/industryinsights/enamine-lundbeck-extend-drug-discovery-p-309770.html 0.6 2026-06-22T06:57:47+08:00 daily https://www.pharmasources.com/industryinsights/three-further-losartan-batches-recalled-309771.html 0.6 2026-08-07T05:07:28+08:00 daily https://www.pharmasources.com/industryinsights/bridgit-a-new-tool-for-orphan-and-novel--309772.html 0.6 2026-06-20T16:00:21+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-announces-fda-and-e-309773.html 0.6 2026-08-08T00:48:11+08:00 daily https://www.pharmasources.com/industryinsights/iscr-welcomes-new-drugs-and-clinical-tri-309774.html 0.6 2026-08-07T11:15:14+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-launches-new-subsidiary-309775.html 0.6 2026-06-20T21:09:44+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-enters-into-strategic-partne-309776.html 0.6 2026-06-22T11:46:51+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-almirall-enter-research-collabora-309777.html 0.6 2026-07-04T23:53:04+08:00 daily https://www.pharmasources.com/industryinsights/teva-genedata-enter-biopharma-partnershi-309778.html 0.6 2026-06-23T21:37:36+08:00 daily https://www.pharmasources.com/industryinsights/lupin-yl-biologics-receive-nod-to-market-309779.html 0.6 2026-06-20T19:01:43+08:00 daily https://www.pharmasources.com/industryinsights/dr-thomas-ramdahl-joins-clarity-pharmace-309780.html 0.6 2026-06-20T22:05:44+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-immunology-blockbuster-to-be-sky-309781.html 0.6 2026-05-04T17:12:27+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-pharmaceutical-ab-publishes-20-309782.html 0.6 2026-06-22T12:52:41+08:00 daily https://www.pharmasources.com/industryinsights/transgene-and-bioinvent-extend-their-col-309783.html 0.6 2026-06-22T03:06:47+08:00 daily https://www.pharmasources.com/industryinsights/vect-horus-enters-into-collaboration-and-309784.html 0.6 2026-08-07T23:00:01+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-and-almirall-enter-dna-encoded-li-309785.html 0.6 2026-06-21T13:11:02+08:00 daily https://www.pharmasources.com/industryinsights/sourcinglinknet-enters-into-an-exclusive-309786.html 0.6 2026-04-22T00:10:52+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-plans-to-airlift-flu-vaccine-into-309787.html 0.6 2026-07-22T16:45:04+08:00 daily https://www.pharmasources.com/industryinsights/japanese-regulators-hand-first-global-ap-309788.html 0.6 2026-06-20T17:00:24+08:00 daily https://www.pharmasources.com/industryinsights/fudan-zhangjiang-to-be-the-first-applyin-309789.html 0.6 2026-07-22T17:49:53+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-az-forxiga-for-type-i-diabet-309790.html 0.6 2026-06-21T08:20:24+08:00 daily https://www.pharmasources.com/industryinsights/motif-bio-raises-27-million-via-share-pl-309791.html 0.6 2026-06-21T13:01:48+08:00 daily https://www.pharmasources.com/industryinsights/tiziana-submits-ind-for-foralumab-oral-f-309792.html 0.6 2026-06-21T02:56:33+08:00 daily https://www.pharmasources.com/industryinsights/eisai-biogen-move-alzheimers-treatment-i-309793.html 0.6 2026-06-21T00:58:46+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-buys-brammer-bio-for-17bn-309794.html 0.6 2026-06-21T14:01:30+08:00 daily https://www.pharmasources.com/industryinsights/rituximab-found-to-extend-progression-fr-309795.html 0.6 2026-06-22T20:55:16+08:00 daily https://www.pharmasources.com/industryinsights/communications-team-of-the-year-strength-309796.html 0.6 2026-06-23T11:44:25+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-team-up-with-patient-compliance-309797.html 0.6 2026-07-06T14:59:52+08:00 daily https://www.pharmasources.com/industryinsights/nearly-half-of-british-public-regret-not-309798.html 0.6 2026-06-21T16:07:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-oral-type-i-diabetes-drug-309799.html 0.6 2026-06-21T01:09:55+08:00 daily https://www.pharmasources.com/industryinsights/cardiff-uni-launches-medicines-discovery-309800.html 0.6 2026-06-21T09:04:05+08:00 daily https://www.pharmasources.com/industryinsights/venclexta-safety-warnings-in-multiple-my-309801.html 0.6 2026-06-21T09:56:02+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-trial-discontinued-due-to-ine-309802.html 0.6 2026-06-21T09:05:09+08:00 daily https://www.pharmasources.com/industryinsights/purdue-agrees-to-pay-270-million-to-okla-309803.html 0.6 2026-08-08T13:15:58+08:00 daily https://www.pharmasources.com/industryinsights/celgene-resubmits-ms-drug-ozanimod-to-fd-309804.html 0.6 2026-06-20T19:08:39+08:00 daily https://www.pharmasources.com/industryinsights/forxiga-approved-in-japan-for-type-1-dia-309805.html 0.6 2026-06-21T07:23:16+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-results-move-aimmunes-peanut-a-309806.html 0.6 2026-07-01T17:01:55+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-fda-approval-for-mayze-309807.html 0.6 2026-06-20T20:10:51+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-usfda-nod-for-erecti-309808.html 0.6 2026-07-01T03:27:28+08:00 daily https://www.pharmasources.com/industryinsights/lupins-pune-biotech-facility-receives-eu-309809.html 0.6 2026-06-21T05:06:46+08:00 daily https://www.pharmasources.com/industryinsights/many-nhs-partnerships-with-drug-companie-309810.html 0.6 2026-06-20T23:53:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-prepares-for-possible-device-shortag-309811.html 0.6 2026-06-22T13:00:10+08:00 daily https://www.pharmasources.com/industryinsights/cancer-immunotherapy-alliance-formed-by--309812.html 0.6 2026-06-07T20:00:20+08:00 daily https://www.pharmasources.com/industryinsights/device-safety-experts-to-fda-make-data-p-309813.html 0.6 2025-11-08T02:32:51+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ms-drug-gets-fda-approval-309814.html 0.6 2026-06-21T07:11:05+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommendation-for-steglatro-in-typ-309815.html 0.6 2026-08-09T13:08:54+08:00 daily https://www.pharmasources.com/industryinsights/raps-on-delayed-brexit-309816.html 0.6 2026-06-21T14:42:15+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-stas-new-drug-product-manufacturing-309817.html 0.6 2026-07-20T05:02:39+08:00 daily https://www.pharmasources.com/industryinsights/gore-launches-improject-plunger-for-pre--309818.html 0.6 2026-06-20T13:23:26+08:00 daily https://www.pharmasources.com/industryinsights/schreiner-medipharm-label-supports-ypsom-309819.html 0.6 2026-06-21T08:07:04+08:00 daily https://www.pharmasources.com/industryinsights/herma-debuts-next-gen-500-label-applicat-309820.html 0.6 2026-06-21T00:55:57+08:00 daily https://www.pharmasources.com/industryinsights/masthercell-announces-new-cell-gene-ther-309821.html 0.6 2026-06-20T16:59:13+08:00 daily https://www.pharmasources.com/industryinsights/asymchem-completes-hpapi-facility-inspec-309822.html 0.6 2026-06-20T14:32:42+08:00 daily https://www.pharmasources.com/industryinsights/bormioli-pharma-strengthens-us-presence-309823.html 0.6 2026-06-22T02:09:57+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-mfg-facility-passes-gmp-inspect-309824.html 0.6 2026-07-12T02:15:44+08:00 daily https://www.pharmasources.com/industryinsights/pci-invests-in-high-potent-tableting-and-309825.html 0.6 2026-06-24T03:47:15+08:00 daily https://www.pharmasources.com/industryinsights/how-hot-is-the-third-generation-egfr-tki-309826.html 0.6 2026-08-09T22:08:51+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-osimertinib-approaching-rmb-2-b-309827.html 0.6 2026-08-07T01:06:39+08:00 daily https://www.pharmasources.com/industryinsights/labconnect-appoints-medical-director-309828.html 0.6 2026-06-21T01:19:29+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-inks-deal-with-immunext-to-joi-309829.html 0.6 2026-06-21T07:11:05+08:00 daily https://www.pharmasources.com/industryinsights/new-clinical-data-on-ac-immunes-novel-ne-309830.html 0.6 2026-06-20T16:56:14+08:00 daily https://www.pharmasources.com/industryinsights/herceptin-has-been-excellent-over-the-tw-309831.html 0.6 2026-06-20T14:17:13+08:00 daily https://www.pharmasources.com/industryinsights/ose-immunotherapeutics-announces-new-res-309832.html 0.6 2026-06-20T23:57:38+08:00 daily https://www.pharmasources.com/industryinsights/owc-pharmaceutical-research-corp-to-coll-309833.html 0.6 2026-08-07T23:01:42+08:00 daily https://www.pharmasources.com/industryinsights/immuno-oncology-company-elicio-therapeut-309834.html 0.6 2026-06-22T12:05:07+08:00 daily https://www.pharmasources.com/industryinsights/axsome-therapeutics-receives-fda-breakth-309835.html 0.6 2026-02-04T09:29:25+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-chooses-veeva-development-clo-309836.html 0.6 2026-01-04T07:40:06+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-still-going-strong-at-the-sta-309837.html 0.6 2026-06-20T15:11:18+08:00 daily https://www.pharmasources.com/industryinsights/communications-team-of-the-year-strength-309838.html 0.6 2026-06-04T19:19:05+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-study-finds-progress-in-combating-309839.html 0.6 2026-06-22T00:51:41+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-announces-accelerate-309840.html 0.6 2026-06-21T10:21:21+08:00 daily https://www.pharmasources.com/industryinsights/discoveries-made-through-routine-researc-309841.html 0.6 2026-05-31T17:21:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-patients-with-309842.html 0.6 2026-07-09T06:18:55+08:00 daily https://www.pharmasources.com/industryinsights/researchers-target-metastasis-in-fight-a-309843.html 0.6 2026-06-20T14:33:13+08:00 daily https://www.pharmasources.com/industryinsights/as-remodulin-copies-roll-united-therapeu-309844.html 0.6 2026-08-09T06:59:22+08:00 daily https://www.pharmasources.com/industryinsights/restoring-a-sense-of-smell-with-stem-cel-309845.html 0.6 2026-08-07T13:57:58+08:00 daily https://www.pharmasources.com/industryinsights/pain-intensifies-for-abbvie-as-it-slashe-309846.html 0.6 2026-08-07T13:16:50+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019040-309847.html 0.6 2026-08-07T02:31:05+08:00 daily https://www.pharmasources.com/industryinsights/did-novartis-hand-out-kickbacks-or-host--309848.html 0.6 2026-08-07T02:36:58+08:00 daily https://www.pharmasources.com/industryinsights/better-8-years-late-than-never-merck-kga-309849.html 0.6 2026-06-21T15:57:24+08:00 daily https://www.pharmasources.com/industryinsights/impax-in-hot-water-for-pay-for-delay-dea-309850.html 0.6 2026-06-21T09:04:04+08:00 daily https://www.pharmasources.com/industryinsights/heritage-pharma-sues-over-container-of-r-309851.html 0.6 2026-06-20T19:18:52+08:00 daily https://www.pharmasources.com/industryinsights/one-year-after-mammoth-lung-cancer-win-m-309852.html 0.6 2026-06-29T12:02:29+08:00 daily https://www.pharmasources.com/industryinsights/how-the-gray-market-is-threatening-your--309853.html 0.6 2026-06-21T01:58:35+08:00 daily https://www.pharmasources.com/industryinsights/astellas-pads-xospatas-aml-lead-with-che-309854.html 0.6 2026-07-06T02:36:03+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-up-for-new-fda-nod-spurs-309855.html 0.6 2026-06-20T20:20:09+08:00 daily https://www.pharmasources.com/industryinsights/amgen-gsk-novartis-bi-spots-head-to-the--309856.html 0.6 2026-06-22T11:18:20+08:00 daily https://www.pharmasources.com/industryinsights/chi-med-astrazenecas-savolitinib-helps-s-309857.html 0.6 2026-06-23T19:46:28+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-opdivo-yervoy-duo--309858.html 0.6 2026-06-22T12:53:10+08:00 daily https://www.pharmasources.com/industryinsights/jj-launches-industry-first-tv-ad-with-dr-309859.html 0.6 2026-08-09T20:05:37+08:00 daily https://www.pharmasources.com/industryinsights/pharma-taps-new-ceo-just-as-it-unveils-a-309860.html 0.6 2026-07-03T15:35:13+08:00 daily https://www.pharmasources.com/industryinsights/bms-celgene-merger-chances-improve-with--309861.html 0.6 2026-07-06T14:18:45+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-nabs-key-lung-cancer-nod-in-chi-309862.html 0.6 2026-06-26T09:28:44+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-tees-up-its-first-gene-therapy--309863.html 0.6 2026-06-21T08:20:15+08:00 daily https://www.pharmasources.com/industryinsights/vr-app-lets-physicians-tackle-tough-case-309864.html 0.6 2026-06-20T16:02:25+08:00 daily https://www.pharmasources.com/industryinsights/novo-plunks-down-100m-to-ready-plant-for-309865.html 0.6 2026-07-15T04:47:58+08:00 daily https://www.pharmasources.com/industryinsights/amarins-vascepa-nabs-ada-backing-to-cut--309866.html 0.6 2026-06-20T14:51:05+08:00 daily https://www.pharmasources.com/industryinsights/fresh-off-new-farxiga-data-astrazeneca-d-309867.html 0.6 2026-06-21T07:12:13+08:00 daily https://www.pharmasources.com/industryinsights/nhs-prescribed-nearly-70m-antidepressant-309868.html 0.6 2026-06-20T18:57:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-green-light-for-mercks-mavenclad-309869.html 0.6 2026-08-06T14:42:43+08:00 daily https://www.pharmasources.com/industryinsights/no-deal-brexit-could-mean-temporary-medi-309870.html 0.6 2026-06-21T00:57:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-label-expansion-for-ucbs-cimzia-309871.html 0.6 2026-06-20T16:11:06+08:00 daily https://www.pharmasources.com/industryinsights/bluebirds-zynteglo-kicks-off-first-amste-309872.html 0.6 2026-06-21T03:19:59+08:00 daily https://www.pharmasources.com/industryinsights/jj-submits-snda-for-invokana-after-prema-309873.html 0.6 2026-06-21T00:59:45+08:00 daily https://www.pharmasources.com/industryinsights/boots-tests-behavioural-nudge-theory-for-309874.html 0.6 2026-08-06T20:24:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-predictimmunes-ibd-prognosis--309875.html 0.6 2026-06-21T16:46:18+08:00 daily https://www.pharmasources.com/industryinsights/bms-signs-deal-with-concerto-healthai-309876.html 0.6 2026-07-24T11:59:41+08:00 daily https://www.pharmasources.com/industryinsights/new-glioblastoma-cancer-vaccine-shows-pr-309877.html 0.6 2026-06-20T21:50:26+08:00 daily https://www.pharmasources.com/industryinsights/pharma-to-benefit-from-fda-digital-healt-309878.html 0.6 2026-08-08T01:50:54+08:00 daily https://www.pharmasources.com/industryinsights/big-pharma-accused-of-no-action-on-antib-309879.html 0.6 2026-06-21T01:10:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-strengthens-anti-inflammatory-d-309880.html 0.6 2026-08-09T04:25:59+08:00 daily https://www.pharmasources.com/industryinsights/the-discoveries-made-through-routine-res-309881.html 0.6 2026-06-20T17:54:22+08:00 daily https://www.pharmasources.com/industryinsights/european-approval-for-tevas-migraine-dru-309882.html 0.6 2026-06-21T06:19:09+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-breast-cancer-delay-drug-309883.html 0.6 2026-06-21T04:46:28+08:00 daily https://www.pharmasources.com/industryinsights/azs-selumetinib-granted-us-breakthrough--309884.html 0.6 2026-06-20T21:56:40+08:00 daily https://www.pharmasources.com/industryinsights/circassias-copd-drug-gets-fda-approval-309885.html 0.6 2026-06-21T20:00:40+08:00 daily https://www.pharmasources.com/industryinsights/acg-to-showcase-the-zro-200t-capsule-fil-309886.html 0.6 2026-06-23T03:52:20+08:00 daily https://www.pharmasources.com/industryinsights/new-pharma-azadyne-raises-15m-for-autoim-309887.html 0.6 2026-06-20T19:16:10+08:00 daily https://www.pharmasources.com/industryinsights/nhs-aims-for-one-link-worker-per-primary-309888.html 0.6 2026-08-03T05:27:42+08:00 daily https://www.pharmasources.com/industryinsights/az-imfinzi-to-be-funded-for-nhs-use-via--309889.html 0.6 2026-06-22T08:36:18+08:00 daily https://www.pharmasources.com/industryinsights/number-of-prescription-rises-but-cost-fa-309890.html 0.6 2026-06-21T11:58:08+08:00 daily https://www.pharmasources.com/industryinsights/antares-vision-to-introduce-verification-309891.html 0.6 2026-06-20T21:22:16+08:00 daily https://www.pharmasources.com/industryinsights/3m-drug-delivery-systems-relocates-uk-rd-309892.html 0.6 2026-08-06T12:00:37+08:00 daily https://www.pharmasources.com/industryinsights/triphase-accelerator-initiates-phase-i-t-309893.html 0.6 2026-06-21T00:00:51+08:00 daily https://www.pharmasources.com/industryinsights/evolution-research-acquires-finger-lakes-309894.html 0.6 2026-07-24T11:26:16+08:00 daily https://www.pharmasources.com/industryinsights/amneal-divests-creo-pharma-309895.html 0.6 2026-06-21T01:42:24+08:00 daily https://www.pharmasources.com/industryinsights/the-avexis-expands-world-leading-gene-th-309896.html 0.6 2026-07-06T20:40:53+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-support-creation-of-life--309897.html 0.6 2026-07-18T14:51:37+08:00 daily https://www.pharmasources.com/industryinsights/accuron-medtech-rebrands-to-advanced-med-309898.html 0.6 2026-06-21T23:11:01+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-nextcode-expands-laboratory-footpri-309899.html 0.6 2026-07-15T21:25:19+08:00 daily https://www.pharmasources.com/industryinsights/takeda-stridebio-to-advance-novel-gene-t-309900.html 0.6 2026-06-21T11:16:26+08:00 daily https://www.pharmasources.com/industryinsights/diseases-cost-the-african-region-24-tril-309901.html 0.6 2026-07-03T03:17:04+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-innovation-capital-raises-gbp1-309902.html 0.6 2025-10-22T18:43:43+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-to-host-the-third-china-pharma--309903.html 0.6 2026-06-20T15:56:30+08:00 daily https://www.pharmasources.com/industryinsights/celgene-receives-positive-chmp-opinion-f-309904.html 0.6 2026-08-06T02:19:07+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-acquires-icd-therap-309905.html 0.6 2026-06-21T21:58:39+08:00 daily https://www.pharmasources.com/industryinsights/standigm-raises-115m-in-series-b-round-309906.html 0.6 2026-07-19T17:27:24+08:00 daily https://www.pharmasources.com/industryinsights/pulmatrix-signs-binding-agreement-with-c-309907.html 0.6 2026-08-08T10:18:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-advances-policy-changes-to-modernize-309908.html 0.6 2026-06-21T07:00:58+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-receives-approval-in-chi-309909.html 0.6 2026-07-10T18:39:50+08:00 daily https://www.pharmasources.com/industryinsights/avexis-expands-world-leading-gene-therap-309910.html 0.6 2026-06-21T09:56:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-the-reintroduction-of-zelno-309911.html 0.6 2026-06-26T20:46:08+08:00 daily https://www.pharmasources.com/industryinsights/mobile-app-effective-in-delivering-cogni-309912.html 0.6 2026-08-07T20:41:57+08:00 daily https://www.pharmasources.com/industryinsights/pipeline-data-at-american-thoracic-socie-309913.html 0.6 2026-06-21T11:22:30+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-shares-surge-after-intrav-309914.html 0.6 2026-06-21T00:02:36+08:00 daily https://www.pharmasources.com/industryinsights/chordia-therapeutics-raises-approximatel-309915.html 0.6 2026-06-22T22:43:56+08:00 daily https://www.pharmasources.com/industryinsights/new-discoveries-on-bacterial-viruses-309916.html 0.6 2026-06-28T05:50:40+08:00 daily https://www.pharmasources.com/industryinsights/holobiome-announces-second-collaboration-309917.html 0.6 2026-06-21T12:06:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-approval-of-evoke-pharmas-gi-309918.html 0.6 2026-06-20T15:58:29+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-sangamo-report-positive-early-sta-309919.html 0.6 2026-06-21T12:17:29+08:00 daily https://www.pharmasources.com/industryinsights/fera-pharmaceuticals-announces-fda-appro-309920.html 0.6 2026-06-20T18:16:47+08:00 daily https://www.pharmasources.com/industryinsights/natural-gene-therapy-for-intractable-ski-309921.html 0.6 2026-06-22T02:15:57+08:00 daily https://www.pharmasources.com/industryinsights/selumetinib-granted-us-breakthrough-ther-309922.html 0.6 2026-06-21T11:11:18+08:00 daily https://www.pharmasources.com/industryinsights/liver-colon-cancer-cells-thwarted-by-com-309923.html 0.6 2026-08-07T02:37:13+08:00 daily https://www.pharmasources.com/industryinsights/sugar-could-be-sweet-solution-to-respira-309924.html 0.6 2026-08-07T02:30:58+08:00 daily https://www.pharmasources.com/industryinsights/lupin-appoints-christine-mundkur-as-inde-309925.html 0.6 2026-08-08T03:18:40+08:00 daily https://www.pharmasources.com/industryinsights/strides-to-launch-potassium-chloride-ext-309926.html 0.6 2026-08-07T01:52:07+08:00 daily https://www.pharmasources.com/industryinsights/ipa-appoints-sudarshan-jain-as-secretary-309927.html 0.6 2026-08-07T01:43:35+08:00 daily https://www.pharmasources.com/industryinsights/as-merck-research-laboratories-moves-int-309928.html 0.6 2026-08-07T01:21:31+08:00 daily https://www.pharmasources.com/industryinsights/aacr-bayer-posts-early-clinical-data-on--309929.html 0.6 2026-08-07T01:13:56+08:00 daily https://www.pharmasources.com/industryinsights/long-term-data-shows-promise-in-breast-c-309930.html 0.6 2026-08-07T01:14:45+08:00 daily https://www.pharmasources.com/industryinsights/23-million-funding-for-cutting-edge-heal-309931.html 0.6 2026-06-21T18:50:59+08:00 daily https://www.pharmasources.com/industryinsights/evoke-pharma-receives-complete-response--309932.html 0.6 2026-06-22T09:59:28+08:00 daily https://www.pharmasources.com/industryinsights/pall-artesyn-biosolutions-expand-single--309933.html 0.6 2026-08-07T04:26:36+08:00 daily https://www.pharmasources.com/industryinsights/integrated-solutions-for-continuous-manu-309934.html 0.6 2026-06-21T06:00:51+08:00 daily https://www.pharmasources.com/industryinsights/dr-gustavo-mahler-resigns-as-chief-execu-309935.html 0.6 2026-04-07T21:28:45+08:00 daily https://www.pharmasources.com/industryinsights/cytodyn-samsung-biologics-enter-mfg-agre-309936.html 0.6 2026-08-06T20:05:54+08:00 daily https://www.pharmasources.com/industryinsights/inovio-completes-enrollment-ahead-of-sch-309937.html 0.6 2026-06-21T01:11:52+08:00 daily https://www.pharmasources.com/industryinsights/sterling-pharma-aquires-civentichem-in-t-309938.html 0.6 2026-08-06T22:54:22+08:00 daily https://www.pharmasources.com/industryinsights/la-biomed-opens-medical-research-buildin-309939.html 0.6 2026-08-09T23:02:37+08:00 daily https://www.pharmasources.com/industryinsights/briacell-announces-clinical-trial-collab-309940.html 0.6 2026-08-06T17:44:52+08:00 daily https://www.pharmasources.com/industryinsights/xencor-and-astellas-enter-collaboration--309941.html 0.6 2026-07-28T10:28:15+08:00 daily https://www.pharmasources.com/industryinsights/puma-biotechnology-and-pierre-fabre-ente-309942.html 0.6 2026-06-20T09:22:53+08:00 daily https://www.pharmasources.com/industryinsights/pulmatrix-enters-into-binding-term-sheet-309943.html 0.6 2026-06-21T03:50:41+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-molecular-partners-announce-309944.html 0.6 2026-06-20T22:17:50+08:00 daily https://www.pharmasources.com/industryinsights/novartis-seeks-to-further-tap-into-chine-309945.html 0.6 2026-07-31T04:53:20+08:00 daily https://www.pharmasources.com/industryinsights/tevas-migraine-drug-secures-european-mar-309946.html 0.6 2026-06-21T06:14:57+08:00 daily https://www.pharmasources.com/industryinsights/springworks-therapeutics-raises-125m-for-309947.html 0.6 2026-06-20T20:03:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-astrazeneca-mercks-selumetini-309948.html 0.6 2026-06-26T22:44:29+08:00 daily https://www.pharmasources.com/industryinsights/penn-presents-positive-results-for-targe-309949.html 0.6 2026-06-21T07:16:20+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-buy-ifm-tre-for-up-to-157bn-309950.html 0.6 2026-06-21T17:58:48+08:00 daily https://www.pharmasources.com/industryinsights/takeda-collaborates-with-stridebio-to-de-309951.html 0.6 2026-06-20T14:56:09+08:00 daily https://www.pharmasources.com/industryinsights/first-gene-therapy-recommended-for-appro-309952.html 0.6 2026-06-20T15:40:29+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-astrazenecas-imfinzi-thr-309953.html 0.6 2026-06-21T12:17:32+08:00 daily https://www.pharmasources.com/industryinsights/xentech-sas-partners-with-gustave-roussy-309954.html 0.6 2026-06-27T14:51:59+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-rockwell-automation-enter--309955.html 0.6 2026-07-09T01:20:09+08:00 daily https://www.pharmasources.com/industryinsights/cure-pharmaceutical-to-acquire-chemistry-309956.html 0.6 2026-06-25T18:54:05+08:00 daily https://www.pharmasources.com/industryinsights/janssen-laying-off-4-dozen-employees-as--309957.html 0.6 2026-07-18T06:17:16+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-massive-humira-discounts-are-sti-309958.html 0.6 2026-06-22T04:02:41+08:00 daily https://www.pharmasources.com/industryinsights/ecri-institute-opens-international-medic-309959.html 0.6 2026-06-08T23:37:41+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-automated-detection--309960.html 0.6 2026-06-21T10:00:05+08:00 daily https://www.pharmasources.com/industryinsights/neurocore-and-their-feedback-therapy-309961.html 0.6 2026-06-22T05:51:34+08:00 daily https://www.pharmasources.com/industryinsights/tms-health-solutions-provides-an-innovat-309962.html 0.6 2025-12-15T12:22:39+08:00 daily https://www.pharmasources.com/industryinsights/enlightening-people-on-how-to-set-bounda-309963.html 0.6 2026-06-20T14:52:04+08:00 daily https://www.pharmasources.com/industryinsights/eric-lefkofksys-bloomberg-interview-reve-309964.html 0.6 2026-06-21T05:13:56+08:00 daily https://www.pharmasources.com/industryinsights/leaps-by-bayer-khloris-to-develop-breakt-309965.html 0.6 2026-06-22T12:51:19+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-approves-novartiss-cosentyx-for-pso-309966.html 0.6 2026-08-07T06:19:56+08:00 daily https://www.pharmasources.com/industryinsights/chugai-pharma-sells-ulcerlmin-business-t-309967.html 0.6 2026-06-21T20:05:44+08:00 daily https://www.pharmasources.com/industryinsights/takeda-takes-step-towards-eu-entyvio-ext-309968.html 0.6 2026-06-23T14:56:29+08:00 daily https://www.pharmasources.com/industryinsights/aptorum-group-limited-announces-appointm-309969.html 0.6 2026-07-02T16:32:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-asceniv-for-the-treatment-o-309970.html 0.6 2026-08-06T19:40:39+08:00 daily https://www.pharmasources.com/industryinsights/jonas-bergh-receives-first-esmo-breast-c-309971.html 0.6 2026-08-08T01:55:53+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-showcases-clinical-analyti-309972.html 0.6 2026-06-21T17:58:33+08:00 daily https://www.pharmasources.com/industryinsights/second-potential-male-birth-control-pill-309973.html 0.6 2026-07-18T17:38:19+08:00 daily https://www.pharmasources.com/industryinsights/lyrica-reclassified-after-being-linked-t-309974.html 0.6 2026-06-21T02:15:56+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-takeda-application-for-subcu-309975.html 0.6 2026-06-20T19:15:49+08:00 daily https://www.pharmasources.com/industryinsights/savolitinib-found-to-help-treatment-resi-309976.html 0.6 2026-06-20T22:59:40+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-double-diabetes-prevention-progra-309977.html 0.6 2026-06-20T16:56:15+08:00 daily https://www.pharmasources.com/industryinsights/roches-ipatasertib-combo-shows-early-pro-309978.html 0.6 2026-06-22T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/venue-announced-for-the-international-cl-309979.html 0.6 2026-07-04T10:03:05+08:00 daily https://www.pharmasources.com/industryinsights/igem-gets-further-funding-for-cancer-dru-309980.html 0.6 2026-06-20T18:03:27+08:00 daily https://www.pharmasources.com/industryinsights/holobiome-and-jj-collaborate-for-second--309981.html 0.6 2026-06-23T19:22:00+08:00 daily https://www.pharmasources.com/industryinsights/new-test-could-diagnose-nine-in-10-endom-309982.html 0.6 2026-06-21T10:15:48+08:00 daily https://www.pharmasources.com/industryinsights/novartis-adds-clinical-and-preclinical-a-309983.html 0.6 2026-06-23T04:07:02+08:00 daily https://www.pharmasources.com/industryinsights/pharmatimes-announce-brand-new-partnersh-309984.html 0.6 2026-06-21T09:53:12+08:00 daily https://www.pharmasources.com/industryinsights/oxford-genetics-wins-six-licensing-deals-309985.html 0.6 2026-06-21T08:01:59+08:00 daily https://www.pharmasources.com/industryinsights/first-bacterial-genome-created-entirely--309986.html 0.6 2026-06-30T12:40:16+08:00 daily https://www.pharmasources.com/industryinsights/nhs-improvement-makes-important-chief-pe-309987.html 0.6 2026-06-21T11:05:16+08:00 daily https://www.pharmasources.com/industryinsights/biocon-to-soon-expand-its-presence-in-bi-309988.html 0.6 2026-06-21T19:58:38+08:00 daily https://www.pharmasources.com/industryinsights/emcure-launches-generic-eribulin-for-tre-309989.html 0.6 2026-06-22T07:51:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-lays-out-plans-for-a-new-review-fram-309990.html 0.6 2026-06-22T16:49:00+08:00 daily https://www.pharmasources.com/industryinsights/napp-launches-pegfilgrastim-biosimilar-i-309991.html 0.6 2026-06-26T13:38:32+08:00 daily https://www.pharmasources.com/industryinsights/new-research-into-chest-pain-to-reduce-s-309992.html 0.6 2026-04-05T18:50:35+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-appoints-vp-of-sales-marketing-309993.html 0.6 2026-08-09T16:09:35+08:00 daily https://www.pharmasources.com/industryinsights/sharp-packaging-names-president-of-us-op-309994.html 0.6 2026-06-21T03:47:12+08:00 daily https://www.pharmasources.com/industryinsights/breaking-news-myoderm-announces-leadersh-309995.html 0.6 2026-06-21T17:00:24+08:00 daily https://www.pharmasources.com/industryinsights/combating-alzheimers-by-restoring-the-br-309996.html 0.6 2026-06-22T09:11:57+08:00 daily https://www.pharmasources.com/industryinsights/lonza-chr-hansen-set-up-microbiome-jv-309997.html 0.6 2026-08-09T04:28:43+08:00 daily https://www.pharmasources.com/industryinsights/pii-ast-form-aseptic-partnership-309998.html 0.6 2026-08-09T19:04:20+08:00 daily https://www.pharmasources.com/industryinsights/icer-says-price-for-biogens-spinraza-est-309999.html 0.6 2026-07-16T16:51:40+08:00 daily https://www.pharmasources.com/industryinsights/aveo-oncology-warns-of-regulatory-action-310000.html 0.6 2026-03-13T23:18:15+08:00 daily https://www.pharmasources.com/industryinsights/cignas-express-scripts-to-cap-out-of-poc-310001.html 0.6 2026-06-21T10:02:10+08:00 daily https://www.pharmasources.com/industryinsights/roche-confident-of-closing-spark-therape-310002.html 0.6 2026-06-22T03:51:17+08:00 daily https://www.pharmasources.com/industryinsights/physician-view-snap-poll-gastroenterolog-310003.html 0.6 2026-06-21T20:58:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approved-drug-effectively-treats-rar-310004.html 0.6 2026-06-24T22:08:14+08:00 daily https://www.pharmasources.com/industryinsights/israel-india-to-work-on-ocular-surface-d-310005.html 0.6 2026-06-21T02:54:52+08:00 daily https://www.pharmasources.com/industryinsights/a-ray-of-hope-for-organ-transplant-patie-310006.html 0.6 2026-07-04T15:59:10+08:00 daily https://www.pharmasources.com/industryinsights/duke-nus-researchers-win-top-accolades-a-310007.html 0.6 2026-06-23T09:20:16+08:00 daily https://www.pharmasources.com/industryinsights/harvest-one-enters-into-supply-agreement-310008.html 0.6 2026-06-22T14:18:25+08:00 daily https://www.pharmasources.com/industryinsights/itm-united-imaging-to-cover-chinese-and--310009.html 0.6 2026-08-08T03:39:12+08:00 daily https://www.pharmasources.com/industryinsights/singapore-recalls-3-brands-of-losartan-m-310010.html 0.6 2026-06-21T09:13:11+08:00 daily https://www.pharmasources.com/industryinsights/aivita-biomedical-guthy-renker-collabora-310011.html 0.6 2026-06-21T11:11:21+08:00 daily https://www.pharmasources.com/industryinsights/jj-completes-acquisition-of-auris-health-310012.html 0.6 2026-08-09T19:48:18+08:00 daily https://www.pharmasources.com/industryinsights/axcella-announces-patent-issuance-for-ax-310013.html 0.6 2026-06-20T22:06:43+08:00 daily https://www.pharmasources.com/industryinsights/veeda-clinical-research-achieves-iso-270-310014.html 0.6 2026-07-03T01:52:32+08:00 daily https://www.pharmasources.com/industryinsights/kerry-wentworth-appointed-to-massbio-boa-310015.html 0.6 2026-06-20T18:56:35+08:00 daily https://www.pharmasources.com/industryinsights/bms-clinging-to-opdivos-lung-cancer-shar-310016.html 0.6 2026-08-07T20:27:42+08:00 daily https://www.pharmasources.com/industryinsights/roche-forced-to-extend-spark-tender-offe-310017.html 0.6 2026-08-07T00:36:35+08:00 daily https://www.pharmasources.com/industryinsights/former-insys-sales-exec-to-shell-out-95m-310018.html 0.6 2026-08-07T00:02:43+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-plans-sales-layoffsagainin-primar-310019.html 0.6 2026-08-06T23:57:23+08:00 daily https://www.pharmasources.com/industryinsights/icer-says-price-for-biogens-spinraza-est-310020.html 0.6 2026-08-06T23:37:30+08:00 daily https://www.pharmasources.com/industryinsights/aveo-oncology-warns-of-regulatory-action-310021.html 0.6 2026-08-06T20:06:30+08:00 daily https://www.pharmasources.com/industryinsights/astellas-announces-key-senior-leadership-310022.html 0.6 2026-06-21T23:13:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approved-drug-effectively-treats-rar-310023.html 0.6 2026-08-06T17:49:26+08:00 daily https://www.pharmasources.com/industryinsights/liquidia-technologies-presents-phase-3-t-310024.html 0.6 2026-06-20T14:56:07+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-broadens-senior-leadership-team-310025.html 0.6 2026-08-07T09:55:54+08:00 daily https://www.pharmasources.com/industryinsights/pluristem-therapeutics-inc-announces-pro-310026.html 0.6 2026-04-16T07:35:38+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-completes-acquisition-of-us-rig-310027.html 0.6 2026-06-21T08:59:07+08:00 daily https://www.pharmasources.com/industryinsights/ly09004-approved-for-clinical-trials-in--310028.html 0.6 2026-07-21T21:48:51+08:00 daily https://www.pharmasources.com/industryinsights/dbv-technologies-announces-the-launch-of-310029.html 0.6 2026-06-21T10:02:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-sends-four-warning-letters-for-cgmp--310030.html 0.6 2026-07-02T23:55:12+08:00 daily https://www.pharmasources.com/industryinsights/brexit-will-have-minimal-impact-on-rd-ex-310031.html 0.6 2026-06-21T00:58:43+08:00 daily https://www.pharmasources.com/industryinsights/heart-drugs-free-from-carcinogens-identi-310032.html 0.6 2026-08-06T02:54:00+08:00 daily https://www.pharmasources.com/industryinsights/drug-linked-to-33-deaths-in-northern-ire-310033.html 0.6 2025-12-15T11:04:19+08:00 daily https://www.pharmasources.com/industryinsights/us-government-forces-chinese-divestiture-310034.html 0.6 2026-06-22T14:44:09+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-enhances-oncology-r-310035.html 0.6 2026-07-06T23:42:23+08:00 daily https://www.pharmasources.com/industryinsights/compound-that-kills-drug-resistant-fungi-310036.html 0.6 2026-06-21T05:47:39+08:00 daily https://www.pharmasources.com/industryinsights/drugs-from-bugs-joint-venture-310037.html 0.6 2026-06-20T23:03:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approved-use-of-metastatic-b-310038.html 0.6 2026-06-30T13:58:43+08:00 daily https://www.pharmasources.com/industryinsights/olon-completes-acquisition-of-mahad-plan-310039.html 0.6 2026-07-31T19:44:57+08:00 daily https://www.pharmasources.com/industryinsights/xcell-biosciences-launches-technology-ac-310040.html 0.6 2026-06-21T12:12:43+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019040-310041.html 0.6 2026-07-27T19:06:52+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-kk-gc-pharma-sign-pact-to-marke-310042.html 0.6 2026-06-23T02:23:56+08:00 daily https://www.pharmasources.com/industryinsights/congresswoman-dingell-honored-as-innovat-310043.html 0.6 2026-06-20T14:58:06+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-majority-cancer-patients-i-310044.html 0.6 2026-04-27T01:54:35+08:00 daily https://www.pharmasources.com/industryinsights/smartfuture-launches-health-kit-rental-s-310045.html 0.6 2026-05-03T17:23:27+08:00 daily https://www.pharmasources.com/industryinsights/astris-cervical-cancer-screening-system--310046.html 0.6 2026-06-20T19:01:35+08:00 daily https://www.pharmasources.com/industryinsights/singapores-war-on-diabetes-has-a-new-all-310047.html 0.6 2026-06-21T00:55:52+08:00 daily https://www.pharmasources.com/industryinsights/astris-cervical-cancer-screening-system--310048.html 0.6 2026-06-21T01:58:38+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-jiangsu-nhwa-team-up-with-biodextr-310049.html 0.6 2026-06-21T07:14:27+08:00 daily https://www.pharmasources.com/industryinsights/wuhan-university-joins-landing-enterpris-310050.html 0.6 2026-07-19T17:50:10+08:00 daily https://www.pharmasources.com/industryinsights/evogene-to-develop-medical-cannabis-prod-310051.html 0.6 2026-06-20T22:13:32+08:00 daily https://www.pharmasources.com/industryinsights/japan-grants-sakigake-designation-to-eis-310052.html 0.6 2026-06-21T20:17:36+08:00 daily https://www.pharmasources.com/industryinsights/george-clinical-strengthens-asia-pacific-310053.html 0.6 2026-06-25T19:04:49+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-launches-infugem-in-the-us-310054.html 0.6 2026-06-30T16:41:14+08:00 daily https://www.pharmasources.com/industryinsights/everstone-to-sell-controlling-stake-in-r-310055.html 0.6 2026-08-09T22:30:11+08:00 daily https://www.pharmasources.com/industryinsights/smartfuture-launches-health-kit-rental-s-310056.html 0.6 2026-07-10T15:08:25+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-extends-clinical-trial-progra-310057.html 0.6 2026-06-21T06:13:22+08:00 daily https://www.pharmasources.com/industryinsights/technology-collaboration-to-enhance-inno-310058.html 0.6 2026-08-08T01:04:15+08:00 daily https://www.pharmasources.com/industryinsights/eppendorf-ag-increases-sales-and-earning-310059.html 0.6 2026-06-21T06:09:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-declares-40-generics-free-of-carcino-310060.html 0.6 2026-06-30T23:28:10+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-uses-real-world-data-to-score-ibr-310061.html 0.6 2026-06-21T03:14:53+08:00 daily https://www.pharmasources.com/industryinsights/takeda-scouts-buyers-for-latin-america-b-310062.html 0.6 2026-06-15T03:20:03+08:00 daily https://www.pharmasources.com/industryinsights/after-apotex-founders-murder-family-weig-310063.html 0.6 2026-06-20T20:59:38+08:00 daily https://www.pharmasources.com/industryinsights/the-top-15-pharma-companies-by-2018-reve-310064.html 0.6 2026-07-28T11:57:58+08:00 daily https://www.pharmasources.com/industryinsights/as-amgen-seeks-to-can-aimovig-collaborat-310065.html 0.6 2026-06-21T20:53:38+08:00 daily https://www.pharmasources.com/industryinsights/apotex-could-fetch-up-to-3-billion-as-so-310066.html 0.6 2026-07-02T23:46:02+08:00 daily https://www.pharmasources.com/industryinsights/optima-pharma-charit-initiate-cell-produ-310067.html 0.6 2026-06-21T03:59:41+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-launches-medtech-innovation-ac-310068.html 0.6 2026-06-22T03:48:36+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-launches-biocontinuum-buf-310069.html 0.6 2026-06-21T04:56:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-alnylam-amend-rare-disease-al-310070.html 0.6 2026-08-10T01:54:54+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-genovis-advance-bio-charac-310071.html 0.6 2026-06-22T03:58:46+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-alnylam-ink-rnai-alliance-310072.html 0.6 2026-08-09T14:34:17+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-appoints-cmo-310073.html 0.6 2026-08-09T06:37:23+08:00 daily https://www.pharmasources.com/industryinsights/avexis-buys-fourth-us-plant-310074.html 0.6 2026-08-07T17:15:54+08:00 daily https://www.pharmasources.com/industryinsights/lakepharma-enhances-mfg-operations-310075.html 0.6 2026-06-22T03:15:58+08:00 daily https://www.pharmasources.com/industryinsights/twist-bioscience-lakepharma-form-collabo-310076.html 0.6 2026-08-09T22:28:45+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-ceo-to-step-down-310077.html 0.6 2026-08-05T19:55:53+08:00 daily https://www.pharmasources.com/industryinsights/masy-bioservices-acquires-metrology-labo-310078.html 0.6 2026-06-21T03:11:49+08:00 daily https://www.pharmasources.com/industryinsights/sinovant-and-roivant-sciences-launch-cyt-310079.html 0.6 2026-08-08T07:39:52+08:00 daily https://www.pharmasources.com/industryinsights/astellas-makes-senior-level-appointments-310080.html 0.6 2026-08-09T03:41:00+08:00 daily https://www.pharmasources.com/industryinsights/catalent-expands-optimelt-capabilities-a-310081.html 0.6 2026-08-09T16:33:30+08:00 daily https://www.pharmasources.com/industryinsights/wests-asia-pacific-footprint-grows-310082.html 0.6 2026-08-09T19:03:12+08:00 daily https://www.pharmasources.com/industryinsights/wcg-acquires-analgesic-solutions-310083.html 0.6 2026-08-09T17:53:31+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-appoints-vp-of-sales-marketing-310084.html 0.6 2026-06-22T17:15:32+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-stem-cell-derived-kid-310085.html 0.6 2026-07-01T08:35:55+08:00 daily https://www.pharmasources.com/industryinsights/ally-bridge-lifetech-scientific-quantum--310086.html 0.6 2026-06-22T11:55:56+08:00 daily https://www.pharmasources.com/industryinsights/myriad-astrazeneca-and-merck-expand-comp-310087.html 0.6 2026-04-09T19:55:11+08:00 daily https://www.pharmasources.com/industryinsights/astris-cervical-cancer-screening-system--310088.html 0.6 2026-06-22T23:06:05+08:00 daily https://www.pharmasources.com/industryinsights/gsk-named-one-of-top-companies-to-work-f-310089.html 0.6 2026-06-20T17:32:52+08:00 daily https://www.pharmasources.com/industryinsights/novel-first-in-class-flip-inhibitors-for-310090.html 0.6 2026-08-05T21:55:07+08:00 daily https://www.pharmasources.com/industryinsights/proteonic-biotechnology-licenses-protein-310091.html 0.6 2026-06-21T02:06:44+08:00 daily https://www.pharmasources.com/industryinsights/bcg-digital-ventures-and-sartorius-help--310092.html 0.6 2026-06-20T22:01:41+08:00 daily https://www.pharmasources.com/industryinsights/tasly-pharmaceutical-group-taps-shuwen-b-310093.html 0.6 2026-08-04T22:55:35+08:00 daily https://www.pharmasources.com/industryinsights/celgene-seeks-fda-approval-for-luspaterc-310094.html 0.6 2026-07-09T01:39:32+08:00 daily https://www.pharmasources.com/industryinsights/jazz-alexion-and-lundbeck-to-pay-122m-to-310095.html 0.6 2026-06-21T12:54:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-ibrances-label-to-include-ma-310096.html 0.6 2026-06-22T01:56:31+08:00 daily https://www.pharmasources.com/industryinsights/gilead-submits-snda-to-fda-to-expand-hiv-310097.html 0.6 2026-06-22T11:09:01+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-bms-opdivo-yervoy-combin-310098.html 0.6 2026-06-21T10:13:17+08:00 daily https://www.pharmasources.com/industryinsights/agomab-secures-funds-to-support-regenera-310099.html 0.6 2026-06-15T16:57:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-amgen-dispute-over-migraine-310100.html 0.6 2026-08-05T09:44:47+08:00 daily https://www.pharmasources.com/industryinsights/roivant-and-sinovant-launch-biopharma-fi-310101.html 0.6 2026-06-21T01:13:55+08:00 daily https://www.pharmasources.com/industryinsights/viiv-announces-long-term-positive-result-310102.html 0.6 2026-06-20T22:14:34+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-nbe-therapeutics-anno-310103.html 0.6 2026-07-19T10:03:21+08:00 daily https://www.pharmasources.com/industryinsights/nih-initiates-first-clinical-trial-of-un-310104.html 0.6 2026-06-20T15:56:23+08:00 daily https://www.pharmasources.com/industryinsights/dyne-therapeutics-to-develop-muscle-dise-310105.html 0.6 2026-06-21T12:59:26+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-three-big-trend-310106.html 0.6 2026-08-06T23:46:52+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-iprogen-biotech-to-develop-a-s-310107.html 0.6 2026-08-07T01:52:00+08:00 daily https://www.pharmasources.com/industryinsights/genedesign-joins-ajinomoto-bio-pharma-310108.html 0.6 2026-08-07T01:19:00+08:00 daily https://www.pharmasources.com/industryinsights/acell-enters-chinese-distribution-agreem-310109.html 0.6 2026-08-07T01:11:40+08:00 daily https://www.pharmasources.com/industryinsights/englands-nice-rebuffs-pfizer-and-astella-310110.html 0.6 2026-08-07T01:18:58+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheims-ofev-takes-fiercem-310111.html 0.6 2026-08-07T01:27:49+08:00 daily https://www.pharmasources.com/industryinsights/amazon-alexas-first-hipaa-sanctioned-ski-310112.html 0.6 2026-08-07T01:36:44+08:00 daily https://www.pharmasources.com/industryinsights/on-the-heels-of-victory-in-new-jersey-jj-310113.html 0.6 2026-08-07T05:07:19+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcares-dovato-approved-in-us-a-310114.html 0.6 2026-06-20T20:10:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-clear-to-focus-on-prescription--310115.html 0.6 2026-07-05T07:18:04+08:00 daily https://www.pharmasources.com/industryinsights/shares-in-zogenix-plunge-after-fda-issue-310116.html 0.6 2026-06-21T08:42:16+08:00 daily https://www.pharmasources.com/industryinsights/united-therapeutics-scraps-development-o-310117.html 0.6 2026-06-21T17:00:27+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-announces-departure-of-jim-robi-310118.html 0.6 2026-06-20T15:41:57+08:00 daily https://www.pharmasources.com/industryinsights/immunomedics-announces-promotion-agreeme-310119.html 0.6 2026-06-20T21:47:24+08:00 daily https://www.pharmasources.com/industryinsights/kaleido-biosciences-announces-key-appoin-310120.html 0.6 2026-07-20T21:20:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-single-tablet-two-dru-310121.html 0.6 2026-06-21T21:42:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-evenity-310122.html 0.6 2026-06-21T05:11:52+08:00 daily https://www.pharmasources.com/industryinsights/genetic-testing-underused-in-breast-ovar-310123.html 0.6 2026-06-21T02:16:58+08:00 daily https://www.pharmasources.com/industryinsights/many-nps-unable-to-prescribe-meds-to-tre-310124.html 0.6 2026-06-21T06:07:58+08:00 daily https://www.pharmasources.com/industryinsights/digital-health-310125.html 0.6 2026-08-09T10:14:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-gsks-dovato-first-2-drug-regi-310126.html 0.6 2026-06-20T16:13:04+08:00 daily https://www.pharmasources.com/industryinsights/amgen-ceo-scores-10-raise-to-186-million-310127.html 0.6 2026-08-07T11:10:30+08:00 daily https://www.pharmasources.com/industryinsights/gsk-named-one-of-top-companies-to-work-f-310128.html 0.6 2026-07-05T08:31:24+08:00 daily https://www.pharmasources.com/industryinsights/continuous-wet-granulation-manufacturing-310129.html 0.6 2026-01-11T04:48:11+08:00 daily https://www.pharmasources.com/industryinsights/continuous-wet-granulation-manufacturing-310130.html 0.6 2026-08-05T14:21:50+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-fasenra-keeps-the-heat-on-g-310131.html 0.6 2026-06-22T02:52:36+08:00 daily https://www.pharmasources.com/industryinsights/medicaid-misclassification-bill-inspired-310132.html 0.6 2026-06-21T11:17:48+08:00 daily https://www.pharmasources.com/industryinsights/post-alcon-novartis-eyes-ma-in-ophthalmi-310133.html 0.6 2026-07-28T14:32:53+08:00 daily https://www.pharmasources.com/industryinsights/lonza-jv-to-produce-live-biotherapeutics-310134.html 0.6 2026-07-06T22:55:27+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-lands-first-in-class-c-310135.html 0.6 2026-06-21T10:46:52+08:00 daily https://www.pharmasources.com/industryinsights/under-fire-purdue-hunts-for-ad-agency-to-310152.html 0.6 2026-07-05T23:15:45+08:00 daily https://www.pharmasources.com/industryinsights/polish-researchers-develop-method-to-rec-310153.html 0.6 2026-08-06T05:46:56+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-spurs-long-responses-in-small-c-310154.html 0.6 2026-06-21T02:59:42+08:00 daily https://www.pharmasources.com/industryinsights/six-new-licensing-deals-for-drug-and-gen-310155.html 0.6 2026-06-21T04:03:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-amgen-ucbs-postmenopausal-o-310156.html 0.6 2026-06-21T00:02:37+08:00 daily https://www.pharmasources.com/industryinsights/bpsa-releases-guide-to-production-of-cel-310157.html 0.6 2026-06-25T12:09:22+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-and-elektrofi-expand-partners-310158.html 0.6 2026-06-21T21:54:00+08:00 daily https://www.pharmasources.com/industryinsights/immune-cells-fighting-blood-cancer-visua-310159.html 0.6 2026-06-20T23:20:09+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-new-drug-to-treat-310160.html 0.6 2026-06-21T18:07:27+08:00 daily https://www.pharmasources.com/industryinsights/cpi-gsk-az-to-establish-wet-granulation--310161.html 0.6 2026-06-21T02:12:53+08:00 daily https://www.pharmasources.com/industryinsights/nanna-theraputics-awarded-innovate-uk-gr-310162.html 0.6 2026-06-20T17:58:18+08:00 daily https://www.pharmasources.com/industryinsights/another-eu-patent-for-verona-in-copd-dru-310163.html 0.6 2026-08-02T08:03:42+08:00 daily https://www.pharmasources.com/industryinsights/gsks-hiv-drug-dovato-gets-fda-approval-310166.html 0.6 2026-07-04T15:38:46+08:00 daily https://www.pharmasources.com/industryinsights/diversifying-drug-development-with-a-met-310167.html 0.6 2026-06-21T01:54:35+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccine-to-thank-for-89-decline-in-c-310168.html 0.6 2026-08-08T21:45:32+08:00 daily https://www.pharmasources.com/industryinsights/news-fda-finds-another-carcinogenic-impu-310169.html 0.6 2026-08-07T09:23:00+08:00 daily https://www.pharmasources.com/industryinsights/no-association-found-between-trazodone-a-310170.html 0.6 2026-08-09T03:03:17+08:00 daily https://www.pharmasources.com/industryinsights/late-stage-pipeline-drugs-could-compete--310171.html 0.6 2026-06-23T04:27:35+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-enhances-oncology-r-310172.html 0.6 2026-06-20T20:47:20+08:00 daily https://www.pharmasources.com/industryinsights/benzodiazepines-could-decrease-mortality-310173.html 0.6 2026-06-18T05:32:51+08:00 daily https://www.pharmasources.com/industryinsights/nulta-partners-with-phonepe-and-tiss-to--310174.html 0.6 2026-06-20T18:06:33+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-collaborates-with-junsh-310175.html 0.6 2026-08-05T18:53:54+08:00 daily https://www.pharmasources.com/industryinsights/aum-biosciences-wins-apac-biotech-entrep-310176.html 0.6 2026-06-20T19:59:39+08:00 daily https://www.pharmasources.com/industryinsights/japan-approves-rakuten-medicals-asp-1929-310177.html 0.6 2026-07-12T22:43:02+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-bio-nbe-therapeutics-announce-adc-p-310178.html 0.6 2026-08-05T12:56:57+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-jiangsu-nhwa-team-up-with-biodextr-310179.html 0.6 2026-08-08T22:45:42+08:00 daily https://www.pharmasources.com/industryinsights/george-clinical-establishes-new-presence-310180.html 0.6 2026-08-07T01:54:13+08:00 daily https://www.pharmasources.com/industryinsights/australia-conducts-trial-to-test-new-bra-310181.html 0.6 2026-08-08T22:30:49+08:00 daily https://www.pharmasources.com/industryinsights/gsks-dovato-chalks-up-first-2-drug-regim-310182.html 0.6 2026-07-09T00:12:40+08:00 daily https://www.pharmasources.com/industryinsights/with-biosims-closing-in-amgen-ceo-bradwa-310183.html 0.6 2026-08-04T13:32:09+08:00 daily https://www.pharmasources.com/industryinsights/manufacturing-problems-persist-for-aurob-310184.html 0.6 2026-06-21T00:02:40+08:00 daily https://www.pharmasources.com/industryinsights/pbms-tell-us-senate-hearing-that-pharmac-310185.html 0.6 2026-07-04T23:27:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-amgen-ucbs-postmenopausal-o-310186.html 0.6 2026-06-21T01:56:39+08:00 daily https://www.pharmasources.com/industryinsights/poxel-sumitomo-dainippons-experimental-t-310187.html 0.6 2026-07-04T09:49:05+08:00 daily https://www.pharmasources.com/industryinsights/indivior-indicted-in-us-over-marketing-p-310188.html 0.6 2026-06-22T01:45:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-merck-cos-parp-inhibitor-lyn-310189.html 0.6 2026-05-04T02:11:31+08:00 daily https://www.pharmasources.com/industryinsights/uniqure-receives-fda-fast-track-designat-310190.html 0.6 2026-07-04T13:26:00+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-expands-insulin-savings-programme-310191.html 0.6 2026-08-03T01:02:35+08:00 daily https://www.pharmasources.com/industryinsights/novartis-continues-to-reimagine-itself-a-310192.html 0.6 2026-06-21T11:21:25+08:00 daily https://www.pharmasources.com/industryinsights/routemap-designed-to-help-innovators-nav-310193.html 0.6 2026-06-22T09:45:18+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-gains-eu-approval-for-type-of-m-310194.html 0.6 2026-07-29T13:35:42+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-and-astellas-announce-p-310195.html 0.6 2026-06-20T21:09:52+08:00 daily https://www.pharmasources.com/industryinsights/amgens-evenity-fda-approved-for-osteopor-310196.html 0.6 2026-06-22T01:08:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-refuses-zogenixs-seizure-drug-fintep-310197.html 0.6 2026-08-09T08:41:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-green-lights-amgen-and-ucbs-evenity--310198.html 0.6 2026-07-05T00:22:08+08:00 daily https://www.pharmasources.com/industryinsights/europe-approves-lynparza-in-her2--gbrcam-310199.html 0.6 2026-04-23T09:30:52+08:00 daily https://www.pharmasources.com/industryinsights/epilepsy-society-calls-for-review-of-uk--310200.html 0.6 2026-06-22T08:07:50+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-and-sanofi-close-research-phase--310201.html 0.6 2026-06-21T00:08:45+08:00 daily https://www.pharmasources.com/industryinsights/verubecestat-atabecestat-not-beneficial--310202.html 0.6 2026-06-21T16:06:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-patients-should-not-abruptly-stop-ta-310203.html 0.6 2026-07-14T14:24:57+08:00 daily https://www.pharmasources.com/industryinsights/new-china-based-biotechs-fueling-growth--310204.html 0.6 2026-06-21T08:20:33+08:00 daily https://www.pharmasources.com/industryinsights/cdc-still-no-source-as-e-coli-outbreak-g-310205.html 0.6 2026-07-26T11:45:48+08:00 daily https://www.pharmasources.com/industryinsights/sterling-pharma-to-acquire-civentichem-i-310206.html 0.6 2026-07-09T10:54:11+08:00 daily https://www.pharmasources.com/industryinsights/ttp-spin-out-to-commercialise-next-gener-310207.html 0.6 2026-07-05T11:31:47+08:00 daily https://www.pharmasources.com/industryinsights/new-yorkers-must-be-vaccinated-or-face-a-310208.html 0.6 2026-06-30T22:47:03+08:00 daily https://www.pharmasources.com/industryinsights/biospectra-announces-advancement-in-carb-310209.html 0.6 2026-07-06T17:33:30+08:00 daily https://www.pharmasources.com/industryinsights/kymab-announces-merck-exec-simon-sturge--310210.html 0.6 2026-06-21T13:47:00+08:00 daily https://www.pharmasources.com/industryinsights/whats-in-your-pellet-biospectra-announce-310211.html 0.6 2026-06-17T12:37:45+08:00 daily https://www.pharmasources.com/industryinsights/flamma-announces-the-successful-cfda-ins-310212.html 0.6 2026-08-07T01:02:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-ibrance-for-advance-310213.html 0.6 2026-06-21T12:22:46+08:00 daily https://www.pharmasources.com/industryinsights/flamma-opens-new-cgmp-kilo-lab-suite-in--310214.html 0.6 2026-07-20T11:16:36+08:00 daily https://www.pharmasources.com/industryinsights/catalent-expands-optimelt-hot-melt-extru-310215.html 0.6 2026-08-07T05:58:07+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivoyervoy-recommended-for-untreat-310216.html 0.6 2026-06-20T21:57:39+08:00 daily https://www.pharmasources.com/industryinsights/celgene-submits-application-to-fda-for-o-310217.html 0.6 2026-08-08T19:54:55+08:00 daily https://www.pharmasources.com/industryinsights/chargepoint-launches-aseptic-processing--310218.html 0.6 2026-08-07T06:03:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-two-drug-hiv-therapy-for-pr-310219.html 0.6 2026-08-07T11:28:59+08:00 daily https://www.pharmasources.com/industryinsights/chargepoint-technology-launches-single-u-310220.html 0.6 2026-08-07T06:03:53+08:00 daily https://www.pharmasources.com/industryinsights/puromill-resins-featured-in-pharma-intel-310221.html 0.6 2026-08-07T12:18:18+08:00 daily https://www.pharmasources.com/industryinsights/indivior-indicted-in-us-over-marketing-p-310222.html 0.6 2026-08-07T11:55:09+08:00 daily https://www.pharmasources.com/industryinsights/curcumin-and-pomegrantes---new-hope-for--310223.html 0.6 2026-08-07T13:17:50+08:00 daily https://www.pharmasources.com/industryinsights/alvogen-business-partners-obtain-first-e-310224.html 0.6 2026-08-09T06:59:33+08:00 daily https://www.pharmasources.com/industryinsights/basf-launches-three-new-active-ingredien-310225.html 0.6 2026-06-22T01:46:32+08:00 daily https://www.pharmasources.com/industryinsights/gt-biopharma-receives-institutional-revi-310226.html 0.6 2026-06-21T01:38:04+08:00 daily https://www.pharmasources.com/industryinsights/hpv-therapy-ino-3106-demonstrates-clinic-310227.html 0.6 2026-06-20T22:13:58+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-pfizer-announce-phase-12-interim-310228.html 0.6 2026-06-24T06:56:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-homeopathic-firms-for-putting--310229.html 0.6 2026-07-20T16:07:06+08:00 daily https://www.pharmasources.com/industryinsights/more-alzheimers-drug-trial-failures-are--310230.html 0.6 2026-06-21T07:03:01+08:00 daily https://www.pharmasources.com/industryinsights/migraine-pain-linked-to-raised-suicide-r-310231.html 0.6 2026-06-21T08:46:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-evenity-romosozumab-aqqg-fo-310232.html 0.6 2026-07-25T22:30:57+08:00 daily https://www.pharmasources.com/industryinsights/a-new-molecule-to-improve-treatment-for--310233.html 0.6 2026-06-28T08:18:37+08:00 daily https://www.pharmasources.com/industryinsights/celgene-corporation-and-acceleron-pharma-310234.html 0.6 2026-06-23T01:48:54+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-india-centre-takes-its-innovatio-310235.html 0.6 2026-07-23T02:01:18+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-new-vaccine-to-teach-310236.html 0.6 2026-02-23T22:03:37+08:00 daily https://www.pharmasources.com/industryinsights/viivs-two-drug-regimen-dovato-gets-fda-a-310237.html 0.6 2026-06-22T00:57:45+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-daiichi-sankyo-sign-69bn-310238.html 0.6 2026-08-04T11:28:38+08:00 daily https://www.pharmasources.com/industryinsights/nationalised-drug-firms-may-address-supe-310239.html 0.6 2026-06-21T19:15:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novartis-oral-multiple-scle-310240.html 0.6 2026-06-21T20:04:40+08:00 daily https://www.pharmasources.com/industryinsights/blue-brain-project-clarifies-neurons-str-310241.html 0.6 2026-06-21T08:12:06+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-immunext-enter-autoimmune-dise-310242.html 0.6 2026-04-12T13:25:44+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-jiangsu-nhwa-team-up-with-biodextr-310243.html 0.6 2026-06-21T07:12:04+08:00 daily https://www.pharmasources.com/industryinsights/the-government-of-armenia-signs-strategi-310244.html 0.6 2026-06-21T15:59:21+08:00 daily https://www.pharmasources.com/industryinsights/concerto-healthai-collaborates-with-pfiz-310245.html 0.6 2026-06-21T09:52:04+08:00 daily https://www.pharmasources.com/industryinsights/sectra-signs-13-year-contract-with-nsw-h-310246.html 0.6 2026-06-22T19:14:34+08:00 daily https://www.pharmasources.com/industryinsights/novena-global-healthcare-makes-strategic-310247.html 0.6 2026-06-08T16:11:46+08:00 daily https://www.pharmasources.com/industryinsights/new-partnerships-reinforce-novena-global-310248.html 0.6 2026-06-21T02:58:09+08:00 daily https://www.pharmasources.com/industryinsights/edigene-raises-15-m-in-series-b-funding-310249.html 0.6 2026-06-21T11:02:07+08:00 daily https://www.pharmasources.com/industryinsights/six-indian-institutes-establish-joint-do-310250.html 0.6 2026-06-21T18:51:47+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodts-inomax-receives-approval-i-310251.html 0.6 2026-08-05T22:45:32+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-collaborates-with-roche--310252.html 0.6 2026-06-21T07:14:39+08:00 daily https://www.pharmasources.com/industryinsights/nus-provides-new-insights-into-neuronal--310253.html 0.6 2026-06-21T22:01:40+08:00 daily https://www.pharmasources.com/industryinsights/china-based-innovation-cdmos-and-paralle-310254.html 0.6 2026-06-02T01:40:38+08:00 daily https://www.pharmasources.com/industryinsights/fed-up-with-the-blame-game-on-insulin-pr-310255.html 0.6 2026-06-20T19:53:31+08:00 daily https://www.pharmasources.com/industryinsights/greater-competition-on-insulin-products--310256.html 0.6 2026-07-23T08:25:08+08:00 daily https://www.pharmasources.com/industryinsights/intas-launches-trastuzumab-biosimilar-to-310257.html 0.6 2026-06-21T20:02:38+08:00 daily https://www.pharmasources.com/industryinsights/synspira-therapeutics-receives-orphan-de-310258.html 0.6 2026-06-29T08:48:01+08:00 daily https://www.pharmasources.com/industryinsights/biodelivery-sciences-international-inc-a-310259.html 0.6 2026-06-21T22:03:46+08:00 daily https://www.pharmasources.com/industryinsights/biodelivery-sciences-acquires-us-commerc-310260.html 0.6 2026-06-20T19:17:55+08:00 daily https://www.pharmasources.com/industryinsights/teva-canada-announces-the-approval-of-tr-310261.html 0.6 2026-06-20T14:24:33+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodts-inomax-nitric-oxide-gas-fo-310262.html 0.6 2026-08-07T05:01:15+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-launches-clinical--310263.html 0.6 2026-08-07T04:49:04+08:00 daily https://www.pharmasources.com/industryinsights/isotype-specific-secondary-antibodies-fo-310264.html 0.6 2026-08-10T01:36:10+08:00 daily https://www.pharmasources.com/industryinsights/esmo-drives-eu-level-action-to-tackle-sh-310265.html 0.6 2026-08-07T04:27:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-first-line-nsclc-label-for-m-310266.html 0.6 2026-08-07T21:57:32+08:00 daily https://www.pharmasources.com/industryinsights/intercept-reports-additional-positive-da-310267.html 0.6 2026-08-07T00:39:41+08:00 daily https://www.pharmasources.com/industryinsights/positive-scientific-advice-from-european-310268.html 0.6 2026-08-07T00:42:40+08:00 daily https://www.pharmasources.com/industryinsights/icer-posts-draft-scoping-document-for-th-310269.html 0.6 2026-08-07T09:03:13+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-issues-notice-of-complianc-310270.html 0.6 2026-08-07T01:06:52+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-drives-differentiated-portfolio-w-310271.html 0.6 2026-08-07T01:14:15+08:00 daily https://www.pharmasources.com/industryinsights/cdc-superbug-fungus-has-sickened-600-ame-310272.html 0.6 2026-08-07T13:17:13+08:00 daily https://www.pharmasources.com/industryinsights/millions-on-insomnia-drug-would-sleep-th-310273.html 0.6 2026-08-07T22:35:54+08:00 daily https://www.pharmasources.com/industryinsights/rfxcel-enhances-pharmaceutical-track-and-310274.html 0.6 2026-08-08T00:50:21+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-use-concerto-healthai-technolo-310275.html 0.6 2026-08-08T03:09:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-osteoporo-310276.html 0.6 2026-06-23T07:17:08+08:00 daily https://www.pharmasources.com/industryinsights/big-pharma-blamed-for-skyrocketing-us-dr-310277.html 0.6 2026-06-22T01:00:48+08:00 daily https://www.pharmasources.com/industryinsights/merck-recognised-with-interphex-exhibito-310278.html 0.6 2026-06-20T17:04:23+08:00 daily https://www.pharmasources.com/industryinsights/brexit-will-have-minimal-effect-on-rd-ex-310279.html 0.6 2026-08-07T05:16:30+08:00 daily https://www.pharmasources.com/industryinsights/intercept-sputters-as-it-reveals-full-oc-310280.html 0.6 2026-08-07T00:02:18+08:00 daily https://www.pharmasources.com/industryinsights/merck-elevates-its-biocontinuum-platform-310281.html 0.6 2026-06-22T09:13:56+08:00 daily https://www.pharmasources.com/industryinsights/3m-drug-delivery-systems-relocates-uk-rd-310282.html 0.6 2026-01-20T02:08:26+08:00 daily https://www.pharmasources.com/industryinsights/nobel-laureate-behind-bristol-myers-i-o--310283.html 0.6 2026-07-25T10:54:07+08:00 daily https://www.pharmasources.com/industryinsights/opioid-crisis-cost-us-government-nearly--310284.html 0.6 2026-08-09T02:19:10+08:00 daily https://www.pharmasources.com/industryinsights/top-novel-drug-approvals-february-2019-310285.html 0.6 2026-08-09T07:36:37+08:00 daily https://www.pharmasources.com/industryinsights/new-generic-valsartan-approved-to-addres-310286.html 0.6 2026-08-09T00:37:54+08:00 daily https://www.pharmasources.com/industryinsights/pharma-firms-accused-of-illegal-agreemen-310287.html 0.6 2026-08-08T22:51:26+08:00 daily https://www.pharmasources.com/industryinsights/darolutamide-nda-to-treat-non-metastatic-310288.html 0.6 2026-08-08T21:48:48+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-resistance-sensing-m-310289.html 0.6 2026-08-08T20:00:23+08:00 daily https://www.pharmasources.com/industryinsights/china-based-innovation-cdmos-and-paralle-310290.html 0.6 2026-08-08T18:26:42+08:00 daily https://www.pharmasources.com/industryinsights/catalent-opens-second-clinical-supply-fa-310291.html 0.6 2026-08-07T13:19:09+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-hires-cancer-drug-developmen-310292.html 0.6 2026-08-06T23:48:12+08:00 daily https://www.pharmasources.com/industryinsights/spry-health-announces-fda-clearance-of-g-310293.html 0.6 2026-08-06T21:59:56+08:00 daily https://www.pharmasources.com/industryinsights/werum-it-solutions-to-boost-paperless-ph-310294.html 0.6 2026-08-06T20:00:58+08:00 daily https://www.pharmasources.com/industryinsights/synaffix-announces-license-agreement-wit-310295.html 0.6 2026-08-07T03:06:23+08:00 daily https://www.pharmasources.com/industryinsights/kaken-pharma-hitgen-to-develop-a-novel-c-310296.html 0.6 2026-08-07T13:19:01+08:00 daily https://www.pharmasources.com/industryinsights/sectra-inks-13-year-contract-with-nsw-he-310297.html 0.6 2026-08-08T07:47:28+08:00 daily https://www.pharmasources.com/industryinsights/catalent-opens-second-clinical-supply-fa-310298.html 0.6 2026-08-08T10:13:48+08:00 daily https://www.pharmasources.com/industryinsights/phebra-to-collaborate-with-university-of-310299.html 0.6 2026-08-08T12:18:43+08:00 daily https://www.pharmasources.com/industryinsights/israel-cannabis-sign-mou-for-co-investme-310300.html 0.6 2026-08-08T14:03:37+08:00 daily https://www.pharmasources.com/industryinsights/wuhan-to-build-guanggu-nanda-health-indu-310301.html 0.6 2026-08-09T07:36:48+08:00 daily https://www.pharmasources.com/industryinsights/ortoma-signs-exclusivity-agreement-to-be-310302.html 0.6 2026-06-25T05:25:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-ai-enabled-roi-radiat-310303.html 0.6 2026-06-20T20:04:35+08:00 daily https://www.pharmasources.com/industryinsights/luqa-pharmaceuticals-and-ferrer-internac-310304.html 0.6 2026-07-16T16:11:14+08:00 daily https://www.pharmasources.com/industryinsights/tracon-terminates-phase-iii-trial-for-tr-310305.html 0.6 2026-06-21T11:51:02+08:00 daily https://www.pharmasources.com/industryinsights/migraine-drug-developer-biohaven-conside-310306.html 0.6 2026-06-20T21:03:40+08:00 daily https://www.pharmasources.com/industryinsights/marketing-authorisation-for-xonvea-in-ir-310307.html 0.6 2026-06-21T05:15:56+08:00 daily https://www.pharmasources.com/industryinsights/acquisition-of-marketing-approval-for-vy-310308.html 0.6 2026-06-21T02:49:30+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-celgene-shareholder-310309.html 0.6 2026-08-06T19:50:57+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-balversa-becomes-first--310310.html 0.6 2026-06-21T06:25:14+08:00 daily https://www.pharmasources.com/industryinsights/clovis-ends-mid-stage-trial-of-bladder-c-310311.html 0.6 2026-06-21T03:06:44+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharmaceuticals-appoints-cco-310312.html 0.6 2026-08-05T23:36:17+08:00 daily https://www.pharmasources.com/industryinsights/paragon-opens-new-biomanufacturing-facil-310313.html 0.6 2026-06-21T05:57:41+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-celularity-enter-supply-chain-p-310314.html 0.6 2026-08-05T08:08:29+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-accelerates-cell-line-devt-time-310315.html 0.6 2026-06-21T06:24:42+08:00 daily https://www.pharmasources.com/industryinsights/catalent-inaugurates-second-shanghai-fac-310316.html 0.6 2026-08-07T12:54:00+08:00 daily https://www.pharmasources.com/industryinsights/evonik-commissions-catalyst-plant-in-ind-310317.html 0.6 2026-08-05T22:35:50+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-completes-highly-potent-api-mfg--310318.html 0.6 2026-08-05T20:23:46+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-continues-its-lung-cancer-land--310319.html 0.6 2026-06-21T00:16:49+08:00 daily https://www.pharmasources.com/industryinsights/pps-bioanalytix-announce-merger-agreemen-310320.html 0.6 2026-08-05T23:09:25+08:00 daily https://www.pharmasources.com/industryinsights/evotec-indivumed-enter-research-collabor-310321.html 0.6 2026-07-04T19:27:00+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-chdi-extend-partnership-310322.html 0.6 2026-06-28T14:18:17+08:00 daily https://www.pharmasources.com/industryinsights/ymc-acquires-chromacon-biz-310323.html 0.6 2026-08-06T17:50:24+08:00 daily https://www.pharmasources.com/industryinsights/japanese-pharma-market-set-for-strong-gr-310324.html 0.6 2026-06-21T14:46:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-identifies-hundreds-of-devices-affec-310325.html 0.6 2026-06-21T07:06:59+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-nhwa-and-cdmo-biodextris-enter-res-310326.html 0.6 2026-06-26T20:05:45+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-fuji-pharma-sign-commercializat-310327.html 0.6 2026-07-02T11:23:46+08:00 daily https://www.pharmasources.com/industryinsights/bioatla-beigene-enter-development-pact-310328.html 0.6 2026-08-07T19:07:26+08:00 daily https://www.pharmasources.com/industryinsights/somalogic-janssen-enter-agreement-310329.html 0.6 2026-06-21T02:15:10+08:00 daily https://www.pharmasources.com/industryinsights/three-key-challenges-for-wide-scale-ai-a-310330.html 0.6 2026-08-09T03:20:02+08:00 daily https://www.pharmasources.com/industryinsights/the-classic-miracle-drug-has-fallen-off--310331.html 0.6 2026-08-04T07:57:41+08:00 daily https://www.pharmasources.com/industryinsights/the-govt-of-eg-us-energy-companies-sanar-310332.html 0.6 2026-08-07T12:21:59+08:00 daily https://www.pharmasources.com/industryinsights/acquisition-of-marketing-approval-for-vy-310333.html 0.6 2026-08-08T21:17:16+08:00 daily https://www.pharmasources.com/industryinsights/marketing-authorisation-for-xonvea-in-ir-310334.html 0.6 2026-07-09T09:48:00+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-announces-acquisi-310335.html 0.6 2026-06-21T12:59:28+08:00 daily https://www.pharmasources.com/industryinsights/suven-gets-us-courts-approval-to-buy-ass-310336.html 0.6 2026-06-22T01:52:31+08:00 daily https://www.pharmasources.com/industryinsights/luqa-pharmaceuticals-and-ferrer-internac-310337.html 0.6 2026-07-15T20:30:37+08:00 daily https://www.pharmasources.com/industryinsights/amag-pharmaceuticals-appoints-new-member-310338.html 0.6 2026-08-08T00:09:57+08:00 daily https://www.pharmasources.com/industryinsights/fibrocell-castle-creek-enter-collaborati-310339.html 0.6 2026-06-20T19:06:41+08:00 daily https://www.pharmasources.com/industryinsights/swissfillon-frh-announce-partnership-310340.html 0.6 2026-06-21T12:03:13+08:00 daily https://www.pharmasources.com/industryinsights/sharp-gets-mhra-approval-for-clinical-se-310341.html 0.6 2026-07-24T13:42:17+08:00 daily https://www.pharmasources.com/industryinsights/hovione-acquires-rights-for-inhaler-devi-310342.html 0.6 2026-06-21T04:12:04+08:00 daily https://www.pharmasources.com/industryinsights/exploristics-surges-ahead-with-1m-invest-310343.html 0.6 2026-06-21T21:11:16+08:00 daily https://www.pharmasources.com/industryinsights/global-collaboration-to-innovate-more-na-310344.html 0.6 2026-06-21T10:15:46+08:00 daily https://www.pharmasources.com/industryinsights/acg-is-well-geared-up-to-constantly-meet-310345.html 0.6 2026-08-09T00:01:18+08:00 daily https://www.pharmasources.com/industryinsights/evolving-role-of-packaging-development-t-310346.html 0.6 2026-08-07T13:55:13+08:00 daily https://www.pharmasources.com/industryinsights/almac-expands-global-analytical-services-310347.html 0.6 2026-08-08T19:17:36+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-acquire-paragon-for-12b-310348.html 0.6 2026-08-07T05:07:35+08:00 daily https://www.pharmasources.com/industryinsights/vertex-takes-a-risk-based-approach-to-ua-310349.html 0.6 2026-08-07T02:31:40+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019041-310350.html 0.6 2026-08-07T02:18:48+08:00 daily https://www.pharmasources.com/industryinsights/ema-restricts-use-of-multiple-sclerosis--310351.html 0.6 2026-08-07T02:30:42+08:00 daily https://www.pharmasources.com/industryinsights/newage-industries-celebrates-its-65th-an-310352.html 0.6 2026-08-07T02:33:25+08:00 daily https://www.pharmasources.com/industryinsights/developing-the-production-of-the-radiois-310353.html 0.6 2026-08-07T05:30:49+08:00 daily https://www.pharmasources.com/industryinsights/examining-the-course-of-back-pain-over-t-310354.html 0.6 2026-06-24T11:47:29+08:00 daily https://www.pharmasources.com/industryinsights/investigational-cream-could-help-patient-310355.html 0.6 2026-06-23T00:08:22+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-used-to-detect-e-310356.html 0.6 2026-06-20T14:42:06+08:00 daily https://www.pharmasources.com/industryinsights/blood-pressure-and-heart-medication-reca-310357.html 0.6 2026-04-05T19:40:37+08:00 daily https://www.pharmasources.com/industryinsights/deloitte-finds-pharma-returns-on-rd-reac-310358.html 0.6 2026-08-09T08:01:20+08:00 daily https://www.pharmasources.com/industryinsights/ocrelizumab-reccommended-for-relapsing-r-310359.html 0.6 2026-08-06T23:55:18+08:00 daily https://www.pharmasources.com/industryinsights/record-year-for-pharma-packaging-and-dru-310360.html 0.6 2026-08-06T23:46:54+08:00 daily https://www.pharmasources.com/industryinsights/monsanto-liable-for-french-farmers-ill-h-310361.html 0.6 2026-08-07T00:03:02+08:00 daily https://www.pharmasources.com/industryinsights/high-dose-vitamin-d-shows-benefit-in-pat-310362.html 0.6 2026-06-21T12:56:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-targeted-therapy-for--310363.html 0.6 2026-06-21T01:00:43+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-shareholders-approv-310364.html 0.6 2026-08-02T20:59:11+08:00 daily https://www.pharmasources.com/industryinsights/active-pharmaceutical-ingredient-market--310365.html 0.6 2026-06-29T09:21:21+08:00 daily https://www.pharmasources.com/industryinsights/catalent-pulls-off-12b-deal-for-gene-the-310366.html 0.6 2026-07-09T04:54:22+08:00 daily https://www.pharmasources.com/industryinsights/hovione-technology-announces-acquisition-310367.html 0.6 2026-06-21T08:00:59+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trials-breaking-the-taboo-310368.html 0.6 2026-06-22T03:48:43+08:00 daily https://www.pharmasources.com/industryinsights/genomics-england-completes-first-phase-o-310369.html 0.6 2026-06-23T05:04:53+08:00 daily https://www.pharmasources.com/industryinsights/ai-could-identify-existing-drugs-to-help-310370.html 0.6 2026-06-21T04:19:07+08:00 daily https://www.pharmasources.com/industryinsights/enesi-and-barda-to-co-develop-flu-vaccin-310371.html 0.6 2026-06-21T07:49:58+08:00 daily https://www.pharmasources.com/industryinsights/half-a-million-gp-hours-freed-for-patien-310372.html 0.6 2026-06-21T15:02:27+08:00 daily https://www.pharmasources.com/industryinsights/bms-celgene-shareholders-back-mega-merge-310373.html 0.6 2026-06-29T10:45:14+08:00 daily https://www.pharmasources.com/industryinsights/az-finds-lack-of-lung-cancer-info-availa-310374.html 0.6 2026-06-20T17:56:40+08:00 daily https://www.pharmasources.com/industryinsights/data-show-jjs-invokana-may-slow-or-preve-310375.html 0.6 2026-06-21T02:04:38+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-temporarily-restricting-l-310376.html 0.6 2026-06-20T15:10:23+08:00 daily https://www.pharmasources.com/industryinsights/gilead-announces-novo-nordisk-nash-partn-310377.html 0.6 2026-06-21T03:00:40+08:00 daily https://www.pharmasources.com/industryinsights/concerning-levels-of-non-alcoholic-fatty-310378.html 0.6 2026-06-20T16:58:16+08:00 daily https://www.pharmasources.com/industryinsights/the-creative-engagement-group-strengthen-310379.html 0.6 2026-03-27T11:47:13+08:00 daily https://www.pharmasources.com/industryinsights/balversa-receives-us-fda-approval-for-th-310380.html 0.6 2026-06-20T20:53:43+08:00 daily https://www.pharmasources.com/industryinsights/rayvios-new-xr-308-nm-uvb-led-can-lower--310381.html 0.6 2026-06-08T02:55:29+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-to-host-medtec-china-mdit-forum-310382.html 0.6 2026-06-22T00:04:45+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-launches-tarlige-tablets--310383.html 0.6 2026-08-01T08:28:55+08:00 daily https://www.pharmasources.com/industryinsights/at-who-forum-on-medicines-countries-and--310384.html 0.6 2026-06-21T16:20:42+08:00 daily https://www.pharmasources.com/industryinsights/cstone-receives-ind-approval-in-china-fo-310385.html 0.6 2026-07-21T02:55:42+08:00 daily https://www.pharmasources.com/industryinsights/chinese-cdmo-genscript-starts-constructi-310386.html 0.6 2026-07-23T19:27:17+08:00 daily https://www.pharmasources.com/industryinsights/insilico-opens-office-in-singapore-to-ex-310387.html 0.6 2026-06-20T21:59:37+08:00 daily https://www.pharmasources.com/industryinsights/ta-associates-announces-partnership-with-310388.html 0.6 2026-06-21T12:49:15+08:00 daily https://www.pharmasources.com/industryinsights/permobil-to-launch-its-new-f-series-in-j-310389.html 0.6 2026-06-21T05:40:43+08:00 daily https://www.pharmasources.com/industryinsights/phebra-to-collaborate-with-university-of-310390.html 0.6 2026-01-26T13:22:07+08:00 daily https://www.pharmasources.com/industryinsights/wuhan-to-build-guanggu-nanda-health-indu-310391.html 0.6 2026-08-06T23:47:11+08:00 daily https://www.pharmasources.com/industryinsights/tessa-therapeutics-collaborates-with-msd-310392.html 0.6 2026-08-06T21:47:27+08:00 daily https://www.pharmasources.com/industryinsights/biotechpharma-expands-manufacturing-capa-310393.html 0.6 2026-08-06T20:07:08+08:00 daily https://www.pharmasources.com/industryinsights/amag-pharmaceuticals-appoints-vp-310394.html 0.6 2026-08-04T01:17:05+08:00 daily https://www.pharmasources.com/industryinsights/achaogen-seeks-near-term-sale-through-ba-310396.html 0.6 2026-06-21T13:02:32+08:00 daily https://www.pharmasources.com/industryinsights/ms-pharma-acquires-genepharm-310397.html 0.6 2026-06-22T12:00:56+08:00 daily https://www.pharmasources.com/industryinsights/ex-gsk-immunology-chief-to-lead-flagship-310398.html 0.6 2026-06-21T00:02:39+08:00 daily https://www.pharmasources.com/industryinsights/stealthy-insitro-opens-upstarting-with-g-310399.html 0.6 2026-04-13T19:56:40+08:00 daily https://www.pharmasources.com/industryinsights/vetters-skokie-site-nears-completion-310400.html 0.6 2026-03-17T20:43:45+08:00 daily https://www.pharmasources.com/industryinsights/mitotech-a-dry-eye-treatment-aimed-at-mi-310401.html 0.6 2026-06-20T18:18:53+08:00 daily https://www.pharmasources.com/industryinsights/researchers-build-3d-printed-heart-out-o-310402.html 0.6 2026-07-06T23:50:19+08:00 daily https://www.pharmasources.com/industryinsights/lachman-consultants-names-compliance-ser-310403.html 0.6 2026-08-08T23:30:59+08:00 daily https://www.pharmasources.com/industryinsights/qiagen-launches-first-fgfr-based-cancer--310404.html 0.6 2026-06-23T18:22:44+08:00 daily https://www.pharmasources.com/industryinsights/fibrocell-castle-creek-ink-rare-disease--310405.html 0.6 2026-08-07T19:24:19+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-i-mab-biopharma-ink-long--310406.html 0.6 2026-07-24T08:11:52+08:00 daily https://www.pharmasources.com/industryinsights/a-better-crispr-rna-hairpins-could-impro-310407.html 0.6 2026-08-08T14:23:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-reports-high-contamination-rates-in--310408.html 0.6 2026-06-22T05:11:48+08:00 daily https://www.pharmasources.com/industryinsights/cevec-expands-aav-production-platform-310409.html 0.6 2026-06-29T18:32:33+08:00 daily https://www.pharmasources.com/industryinsights/bringing-car-t-to-solid-tumors-with-help-310410.html 0.6 2026-03-20T08:59:17+08:00 daily https://www.pharmasources.com/industryinsights/rexahn-biosense-enter-license-agreement-310411.html 0.6 2026-06-20T18:02:20+08:00 daily https://www.pharmasources.com/industryinsights/intensive-bp-lowering-may-up-cognitive-d-310412.html 0.6 2026-06-22T19:00:04+08:00 daily https://www.pharmasources.com/industryinsights/global-innovative-drugs-speeding-up-to-e-310413.html 0.6 2026-08-06T21:54:05+08:00 daily https://www.pharmasources.com/industryinsights/mixed-effects-observed-for-workplace-wel-310414.html 0.6 2026-03-25T18:31:19+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-evidence-lacking-for-elevated-lea-310415.html 0.6 2026-06-20T14:53:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-halts-all-sales-of-pelvic-mesh-produ-310416.html 0.6 2026-06-22T07:45:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-balversa-erdafitinib-for-th-310417.html 0.6 2026-06-21T07:45:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dovato-dolutegravirlamivudi-310418.html 0.6 2026-06-20T18:57:36+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-provides-update-on-ongoin-310419.html 0.6 2026-06-22T11:08:52+08:00 daily https://www.pharmasources.com/industryinsights/immunocores-lead-asset-tebentafusp-gains-310420.html 0.6 2026-07-24T20:39:33+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-initiates-phase-3-protect-310421.html 0.6 2026-06-08T04:58:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-orders-important-safety-labeling-cha-310422.html 0.6 2026-06-21T09:00:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-avaclyr-for-the-treatment-o-310423.html 0.6 2026-06-16T10:36:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ibrance-palbociclib-for-the-310424.html 0.6 2026-06-20T18:20:57+08:00 daily https://www.pharmasources.com/industryinsights/vetters-skokie-facility-expansion-nears--310425.html 0.6 2026-06-20T19:21:29+08:00 daily https://www.pharmasources.com/industryinsights/ambr-15-fermentation-and-ambr-250-high-t-310426.html 0.6 2026-06-21T05:50:17+08:00 daily https://www.pharmasources.com/industryinsights/eur-3-million-in-series-a-for-the-growth-310427.html 0.6 2026-06-18T01:49:03+08:00 daily https://www.pharmasources.com/industryinsights/implandata-successfully-gains-ce-mark-fo-310428.html 0.6 2026-06-20T16:00:21+08:00 daily https://www.pharmasources.com/industryinsights/alzprotect-starts-collaboration-with-par-310429.html 0.6 2026-06-23T03:17:32+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-the-influence-of-particle-si-310430.html 0.6 2026-08-01T08:01:19+08:00 daily https://www.pharmasources.com/industryinsights/ab2-bio-announces-readiness-for-recruitm-310431.html 0.6 2026-08-01T12:01:32+08:00 daily https://www.pharmasources.com/industryinsights/lead-pharma-announces-start-of-phase-i-c-310432.html 0.6 2026-08-09T10:03:29+08:00 daily https://www.pharmasources.com/industryinsights/domainex-and-spirochem-enter-a-fragment--310433.html 0.6 2026-06-21T20:56:14+08:00 daily https://www.pharmasources.com/industryinsights/cellesce-announces-license-agreement-wit-310434.html 0.6 2026-08-07T10:13:50+08:00 daily https://www.pharmasources.com/industryinsights/deuterium-depletion-is-a-disruptive-inno-310435.html 0.6 2026-06-21T11:56:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-fda-filing-acceptance-310436.html 0.6 2026-07-26T13:53:17+08:00 daily https://www.pharmasources.com/industryinsights/cosmo-pharmaceuticals-announces-submissi-310437.html 0.6 2026-06-22T12:08:00+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-successfully-completed-fi-310438.html 0.6 2026-07-21T12:56:41+08:00 daily https://www.pharmasources.com/industryinsights/review-progress-of-the-first-batch-of-cl-310439.html 0.6 2026-06-23T02:10:11+08:00 daily https://www.pharmasources.com/industryinsights/aprea-receives-fast-track-designation-or-310440.html 0.6 2026-06-21T11:08:19+08:00 daily https://www.pharmasources.com/industryinsights/viracta-receives-orphan-drug-designation-310441.html 0.6 2026-06-21T11:21:33+08:00 daily https://www.pharmasources.com/industryinsights/use-of-genzymes-ms-drug-lemtrada-restric-310442.html 0.6 2026-08-04T01:59:21+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-make-redundancies-at-plant-in-ste-310443.html 0.6 2026-06-21T02:23:23+08:00 daily https://www.pharmasources.com/industryinsights/ai-uses-patient-data-to-administer-less--310444.html 0.6 2026-06-22T01:54:32+08:00 daily https://www.pharmasources.com/industryinsights/china-introduces-new-laws-to-ensure-stea-310445.html 0.6 2026-06-20T19:00:32+08:00 daily https://www.pharmasources.com/industryinsights/leicester-to-support-chronic-lung-diseas-310446.html 0.6 2026-06-28T19:47:03+08:00 daily https://www.pharmasources.com/industryinsights/manufacturing-small-batches-of-biopharma-310447.html 0.6 2026-08-03T06:10:28+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-disease-patients-often-show-p-310448.html 0.6 2026-06-24T01:18:44+08:00 daily https://www.pharmasources.com/industryinsights/vetters-skokie-facility-expansion-nears--310449.html 0.6 2026-06-25T10:44:01+08:00 daily https://www.pharmasources.com/industryinsights/medidata-launches-acorn-aitm-and-appoint-310450.html 0.6 2026-08-06T14:51:15+08:00 daily https://www.pharmasources.com/industryinsights/tickets-available-for-the-20th-internati-310451.html 0.6 2026-06-23T15:45:22+08:00 daily https://www.pharmasources.com/industryinsights/new-data-reinforce-effectiveness-of-nova-310452.html 0.6 2026-07-04T08:14:58+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-licenses-discovery-programme-to--310453.html 0.6 2026-06-19T07:43:47+08:00 daily https://www.pharmasources.com/industryinsights/trial-results-show-promise-for-chemo-fre-310454.html 0.6 2026-08-07T17:43:49+08:00 daily https://www.pharmasources.com/industryinsights/landmark-day-for-akcea-as-nice-recommend-310455.html 0.6 2026-06-21T21:59:49+08:00 daily https://www.pharmasources.com/industryinsights/novartis-wet-amd-drug-gets-fda-filing-310456.html 0.6 2026-06-20T16:59:13+08:00 daily https://www.pharmasources.com/industryinsights/10-killed-in-explosion-at-chinese-pharma-310457.html 0.6 2026-07-15T08:30:50+08:00 daily https://www.pharmasources.com/industryinsights/novartis-speedy-brolucizumab-review-tees-310458.html 0.6 2026-08-06T23:46:41+08:00 daily https://www.pharmasources.com/industryinsights/ionis-tegsedi-gets-a-uk-boost-after-nice-310459.html 0.6 2026-06-20T22:02:44+08:00 daily https://www.pharmasources.com/industryinsights/jj-under-accelerating-generic-and-biosim-310460.html 0.6 2026-04-24T02:54:59+08:00 daily https://www.pharmasources.com/industryinsights/struggling-insys-swaps-ceos-as-subsys-ma-310461.html 0.6 2026-06-20T22:58:42+08:00 daily https://www.pharmasources.com/industryinsights/amgen-prices-bone-drug-evenity-on-par-wi-310462.html 0.6 2026-06-25T15:56:30+08:00 daily https://www.pharmasources.com/industryinsights/chinas-genscript-starts-on-plasmid-virus-310463.html 0.6 2026-07-09T08:48:55+08:00 daily https://www.pharmasources.com/industryinsights/klick-health-spills-its-secrets-in-new-p-310464.html 0.6 2026-07-06T02:22:13+08:00 daily https://www.pharmasources.com/industryinsights/gileads-first-big-tv-push-for-triple-com-310465.html 0.6 2026-07-02T22:25:09+08:00 daily https://www.pharmasources.com/industryinsights/feds-oppose-white-coat-kickbacks-suit-ou-310466.html 0.6 2026-06-27T18:35:20+08:00 daily https://www.pharmasources.com/industryinsights/teva-ceo-kre-schultz-nabs-whopping-33m-i-310467.html 0.6 2026-06-24T17:37:58+08:00 daily https://www.pharmasources.com/industryinsights/direct-eye-injections-best-treat-uveitic-310468.html 0.6 2026-07-01T14:51:49+08:00 daily https://www.pharmasources.com/industryinsights/further-advances-in-cell-based-influenza-310469.html 0.6 2026-06-27T18:48:57+08:00 daily https://www.pharmasources.com/industryinsights/orgenesis-excellabio-enter-cell-therapy--310470.html 0.6 2026-07-08T10:04:06+08:00 daily https://www.pharmasources.com/industryinsights/biomanufacturing-sector-set-to-boost-its-310471.html 0.6 2026-07-07T23:13:08+08:00 daily https://www.pharmasources.com/industryinsights/recro-teva-extend-license-and-supply-agr-310472.html 0.6 2026-04-21T12:35:14+08:00 daily https://www.pharmasources.com/industryinsights/ology-wins-two-dod-awards-310473.html 0.6 2026-06-22T07:03:51+08:00 daily https://www.pharmasources.com/industryinsights/therapeuticsmd-announces-commercial-avai-310474.html 0.6 2026-06-21T04:18:04+08:00 daily https://www.pharmasources.com/industryinsights/durvalumab-improves-survival-of-non-smal-310475.html 0.6 2026-07-23T10:03:58+08:00 daily https://www.pharmasources.com/industryinsights/adare-acquires-egalets-parvulet-technolo-310476.html 0.6 2026-06-21T12:01:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-statu-310477.html 0.6 2026-06-21T10:58:11+08:00 daily https://www.pharmasources.com/industryinsights/niaid-plan-for-in-depth-tuberculosis-res-310478.html 0.6 2026-06-20T15:00:12+08:00 daily https://www.pharmasources.com/industryinsights/paragon-to-build-second-gmp-mfg-facility-310479.html 0.6 2026-07-03T04:49:21+08:00 daily https://www.pharmasources.com/industryinsights/stealth-biotherapeutics-announces-positi-310480.html 0.6 2026-07-03T03:38:58+08:00 daily https://www.pharmasources.com/industryinsights/biotechpharma-to-expand-process-developm-310481.html 0.6 2026-08-06T20:07:38+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-facility-targets-development-and-310482.html 0.6 2026-06-27T11:33:54+08:00 daily https://www.pharmasources.com/industryinsights/cell-therapy-rejected-for-aggressive-adu-310483.html 0.6 2026-08-06T20:47:40+08:00 daily https://www.pharmasources.com/industryinsights/discover-roquettes-latest-biopharmaceuti-310484.html 0.6 2026-08-07T05:30:50+08:00 daily https://www.pharmasources.com/industryinsights/aluminium-could-aid-delivery-of-chemothe-310485.html 0.6 2026-06-30T01:36:29+08:00 daily https://www.pharmasources.com/industryinsights/new-micro-platform-improves-understandin-310486.html 0.6 2026-08-08T01:00:13+08:00 daily https://www.pharmasources.com/industryinsights/roches-drugs-new-and-old-team-up-for-maj-310487.html 0.6 2026-06-23T15:45:27+08:00 daily https://www.pharmasources.com/industryinsights/smart-pills-could-dumb-down-medical-care-310488.html 0.6 2026-06-28T15:55:04+08:00 daily https://www.pharmasources.com/industryinsights/device-offers-inexpensive-and-quick-scre-310489.html 0.6 2026-06-20T21:15:57+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-improves-diagnos-310490.html 0.6 2026-06-21T07:21:15+08:00 daily https://www.pharmasources.com/industryinsights/contract-manufacturing-markets-are-being-310491.html 0.6 2026-08-03T01:30:58+08:00 daily https://www.pharmasources.com/industryinsights/spc-manufacturing-waiver-is-good-news-fo-310492.html 0.6 2026-03-26T20:44:41+08:00 daily https://www.pharmasources.com/industryinsights/some-patients-with-imminently-fatal-canc-310493.html 0.6 2026-06-21T01:10:57+08:00 daily https://www.pharmasources.com/industryinsights/cdc-raw-tuna-linked-to-salmonella-outbre-310494.html 0.6 2026-07-19T13:45:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-maker-of-childrens-otc-drugs-a-310495.html 0.6 2026-06-21T15:56:18+08:00 daily https://www.pharmasources.com/industryinsights/most-diabetes-phone-apps-lack-education--310496.html 0.6 2026-06-21T10:08:16+08:00 daily https://www.pharmasources.com/industryinsights/more-than-half-of-internal-medicine-grad-310497.html 0.6 2026-06-21T11:53:27+08:00 daily https://www.pharmasources.com/industryinsights/more-sports-experience-may-reduce-impact-310498.html 0.6 2026-06-21T18:58:42+08:00 daily https://www.pharmasources.com/industryinsights/egg-allergy-dont-let-that-stop-you-from--310499.html 0.6 2026-06-20T23:17:56+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-might-prove-a-cure-for-bubb-310500.html 0.6 2026-02-08T18:29:23+08:00 daily https://www.pharmasources.com/industryinsights/weekly-infusion-may-be-effective-easier--310501.html 0.6 2026-06-22T21:01:08+08:00 daily https://www.pharmasources.com/industryinsights/buyer-beware-when-purchasing-medical-tes-310502.html 0.6 2026-06-21T05:05:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-monotherapy-label--310503.html 0.6 2026-03-23T05:08:37+08:00 daily https://www.pharmasources.com/industryinsights/zogenix-receives-refusal-to-file-letter--310504.html 0.6 2026-06-20T16:04:24+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-kirin-announces-fda-acceptance-of--310505.html 0.6 2026-07-23T08:04:30+08:00 daily https://www.pharmasources.com/industryinsights/avexis-data-reinforce-effectiveness-of-z-310506.html 0.6 2026-08-02T04:59:18+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivery-to-the-heart-with-tannin-a-310507.html 0.6 2026-06-21T22:00:40+08:00 daily https://www.pharmasources.com/industryinsights/radiance-could-be-the-key-to-faster-vira-310508.html 0.6 2026-06-20T23:00:40+08:00 daily https://www.pharmasources.com/industryinsights/drug-prices-increased-twice-as-fast-duri-310509.html 0.6 2025-12-18T17:47:28+08:00 daily https://www.pharmasources.com/industryinsights/vetters-skokie-facility-expansion-nears--310510.html 0.6 2026-03-19T10:02:39+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-acquire-gene-therapy-leader--310511.html 0.6 2026-06-22T01:49:29+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-expands-functional-film-coating-310512.html 0.6 2026-06-20T19:05:38+08:00 daily https://www.pharmasources.com/industryinsights/soft-gel-production-starts-310513.html 0.6 2026-08-06T00:15:44+08:00 daily https://www.pharmasources.com/industryinsights/pulmatrix-and-cipla-collaborate-to-devel-310514.html 0.6 2026-06-21T10:04:10+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-insitro-team-up-to-develop-tr-310515.html 0.6 2026-08-07T01:42:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-presentation-of-data-fr-310516.html 0.6 2026-06-22T01:35:21+08:00 daily https://www.pharmasources.com/industryinsights/albireo-announces-fda-clearance-of-ind-t-310517.html 0.6 2026-08-07T00:53:15+08:00 daily https://www.pharmasources.com/industryinsights/tg-therapeutics-receives-orphan-drug-des-310518.html 0.6 2026-08-07T00:42:13+08:00 daily https://www.pharmasources.com/industryinsights/egg-allergy-dont-let-that-stop-you-from--310519.html 0.6 2026-03-11T02:52:24+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-signs-major-cancer-drug-deal-310520.html 0.6 2026-08-06T23:56:53+08:00 daily https://www.pharmasources.com/industryinsights/regular-infusions-of-a-novel-antibody-ma-310521.html 0.6 2026-08-06T20:06:04+08:00 daily https://www.pharmasources.com/industryinsights/biotechpharma-to-expand-process-developm-310522.html 0.6 2026-08-06T18:36:33+08:00 daily https://www.pharmasources.com/industryinsights/europe-africa-partnership-spearheads-dev-310523.html 0.6 2026-08-06T21:54:36+08:00 daily https://www.pharmasources.com/industryinsights/cdc-recent-decline-seen-in-high-grade-ce-310524.html 0.6 2026-08-06T22:08:03+08:00 daily https://www.pharmasources.com/industryinsights/anti-inflammatory-add-on-may-be-benefici-310525.html 0.6 2026-08-06T23:46:57+08:00 daily https://www.pharmasources.com/industryinsights/trial-results-unclear-for-benefit-of-lon-310526.html 0.6 2026-08-06T23:57:04+08:00 daily https://www.pharmasources.com/industryinsights/interns-spend-most-of-their-time-in-indi-310527.html 0.6 2026-06-22T21:09:21+08:00 daily https://www.pharmasources.com/industryinsights/sixty-people-charged-in-massive-opioid-p-310528.html 0.6 2026-06-21T22:52:46+08:00 daily https://www.pharmasources.com/industryinsights/no-one-size-fits-all-diet-for-diabetics--310529.html 0.6 2026-06-20T16:14:30+08:00 daily https://www.pharmasources.com/industryinsights/whether-to-preserve-fertility-is-tough-d-310530.html 0.6 2026-06-21T02:59:43+08:00 daily https://www.pharmasources.com/industryinsights/the-falsified-medicines-directive-steps--310531.html 0.6 2026-06-23T10:55:58+08:00 daily https://www.pharmasources.com/industryinsights/electromagnetic-imaging-using-portable-m-310532.html 0.6 2026-06-21T07:04:58+08:00 daily https://www.pharmasources.com/industryinsights/ultra-thin-meta-lens-enables-full-colour-310533.html 0.6 2026-06-21T03:03:07+08:00 daily https://www.pharmasources.com/industryinsights/stc-biologics-completes-new-gmp-mfg-faci-310534.html 0.6 2026-08-06T20:08:26+08:00 daily https://www.pharmasources.com/industryinsights/centogene-appoints-ai-director-310535.html 0.6 2026-06-20T16:55:12+08:00 daily https://www.pharmasources.com/industryinsights/tau-bio-logic-announces-humanization-of--310536.html 0.6 2026-06-21T12:10:21+08:00 daily https://www.pharmasources.com/industryinsights/aprecia-appoints-ceo-310537.html 0.6 2026-06-22T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/tb-alliance-mylan-announce-collaboration-310538.html 0.6 2026-06-22T06:47:44+08:00 daily https://www.pharmasources.com/industryinsights/natoli-engineering-releases-20192020-cat-310539.html 0.6 2026-06-20T23:59:39+08:00 daily https://www.pharmasources.com/industryinsights/greenfield-global-plans-for-new-european-310540.html 0.6 2026-06-20T15:52:26+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-receives-fda-approval-of-fast--310541.html 0.6 2026-06-23T01:18:47+08:00 daily https://www.pharmasources.com/industryinsights/encube-ethicals-announces-new-mfg-facili-310542.html 0.6 2026-06-21T15:48:22+08:00 daily https://www.pharmasources.com/industryinsights/indalo-therapeutics-initiates-phase-1-tr-310543.html 0.6 2026-06-21T22:54:00+08:00 daily https://www.pharmasources.com/industryinsights/ciprofloxacin-dramatically-affects-the-m-310545.html 0.6 2026-06-21T08:44:59+08:00 daily https://www.pharmasources.com/industryinsights/bacterial-therapy-shows-early-promise-in-310546.html 0.6 2026-06-22T04:00:43+08:00 daily https://www.pharmasources.com/industryinsights/pharma-firms-step-up-plans-to-beat-brexi-310547.html 0.6 2026-07-27T10:05:02+08:00 daily https://www.pharmasources.com/industryinsights/holistic-approach-to-data-management-for-310548.html 0.6 2026-06-20T16:51:25+08:00 daily https://www.pharmasources.com/industryinsights/parker-bioscience-filtration-appoints-gm-310549.html 0.6 2026-06-21T20:58:38+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-johnson-johnson-310550.html 0.6 2026-07-23T15:08:47+08:00 daily https://www.pharmasources.com/industryinsights/puretech-health-announces-collaboration--310551.html 0.6 2026-05-06T16:42:07+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-to-launch-globa-310552.html 0.6 2026-08-07T10:54:45+08:00 daily https://www.pharmasources.com/industryinsights/sk-biopharmaceuticals-and-twoxar-sign-co-310553.html 0.6 2026-06-21T19:08:39+08:00 daily https://www.pharmasources.com/industryinsights/rotavirus-vaccine-cuts-infant-diarrhoea--310554.html 0.6 2026-06-22T08:02:48+08:00 daily https://www.pharmasources.com/industryinsights/recro-pharma-announces-six-year-extensio-310555.html 0.6 2026-06-22T01:53:33+08:00 daily https://www.pharmasources.com/industryinsights/benzodiazepines-associated-with-an-incre-310556.html 0.6 2026-06-28T23:28:00+08:00 daily https://www.pharmasources.com/industryinsights/doxorubicin-disrupts-the-immune-system-t-310557.html 0.6 2026-06-21T10:04:18+08:00 daily https://www.pharmasources.com/industryinsights/ms-pharma-announces-acquisition-of-genep-310558.html 0.6 2026-06-21T01:50:34+08:00 daily https://www.pharmasources.com/industryinsights/cardiac-monitoring-for-high-risk-breast--310559.html 0.6 2026-06-21T01:11:56+08:00 daily https://www.pharmasources.com/industryinsights/aimovig-approved-by-eu-for-migraine-prev-310560.html 0.6 2026-07-09T00:23:23+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drugs-aid-macrophages-to-contro-310561.html 0.6 2026-06-22T03:01:31+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-and-envigo-sign-innovative-agree-310562.html 0.6 2026-07-28T04:24:44+08:00 daily https://www.pharmasources.com/industryinsights/why-are-bace-inhibitors-failing-clinical-310563.html 0.6 2026-07-20T12:06:45+08:00 daily https://www.pharmasources.com/industryinsights/the-natural-history-museum-uses-linkam-t-310564.html 0.6 2026-07-09T13:55:24+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-and-wuxi-biologics-annou-310565.html 0.6 2026-07-19T22:00:20+08:00 daily https://www.pharmasources.com/industryinsights/direct-anticoagulants-associated-with-in-310566.html 0.6 2026-07-16T11:37:49+08:00 daily https://www.pharmasources.com/industryinsights/roche-throws-in-the-towel-on-tecentriq-b-310567.html 0.6 2026-06-22T02:57:35+08:00 daily https://www.pharmasources.com/industryinsights/old-guard-generics-players-yield-us-lead-310568.html 0.6 2026-07-08T17:13:34+08:00 daily https://www.pharmasources.com/industryinsights/consumer-watchdog-petitions-fda-for-blac-310569.html 0.6 2026-06-21T11:08:20+08:00 daily https://www.pharmasources.com/industryinsights/hiv-drugmakers-viiv-gilead-top-2018-phar-310570.html 0.6 2026-06-20T19:55:48+08:00 daily https://www.pharmasources.com/industryinsights/lonza-plagued-by-supply-problems-after-c-310571.html 0.6 2026-07-16T06:23:31+08:00 daily https://www.pharmasources.com/industryinsights/allergans-new-concierge-platform-regi-fi-310572.html 0.6 2026-07-04T17:34:43+08:00 daily https://www.pharmasources.com/industryinsights/united-therapeutics-teamed-with-pumpmake-310573.html 0.6 2026-06-21T07:10:05+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-sales-ease-boehringers-pat-310574.html 0.6 2026-06-20T23:44:27+08:00 daily https://www.pharmasources.com/industryinsights/avalue-technology-launches-iot-based-hea-310575.html 0.6 2026-06-20T23:21:12+08:00 daily https://www.pharmasources.com/industryinsights/golden-meditech-hkbu-team-up-to-conduct--310576.html 0.6 2026-06-21T04:18:59+08:00 daily https://www.pharmasources.com/industryinsights/medshift-to-expand-in-australia-nz-310577.html 0.6 2026-06-24T07:42:08+08:00 daily https://www.pharmasources.com/industryinsights/act-genomics-to-provide-cancer-genomic-p-310578.html 0.6 2026-06-23T03:11:18+08:00 daily https://www.pharmasources.com/industryinsights/aidoc-raises-27-million-to-expand-its-ai-310579.html 0.6 2026-06-24T19:35:11+08:00 daily https://www.pharmasources.com/industryinsights/vonage-unveils-advanced-services-and-api-310580.html 0.6 2026-07-18T07:22:11+08:00 daily https://www.pharmasources.com/industryinsights/china-sxt-pharma-announces-pricing-of-a--310581.html 0.6 2026-06-24T13:17:24+08:00 daily https://www.pharmasources.com/industryinsights/india-to-be-one-of-the-worlds-fastest-gr-310582.html 0.6 2026-06-22T19:17:56+08:00 daily https://www.pharmasources.com/industryinsights/cmd-llc-wins-au1-million-grant-award-fro-310583.html 0.6 2026-06-21T22:10:53+08:00 daily https://www.pharmasources.com/industryinsights/merck-launches-drug-compound-to-treat-an-310584.html 0.6 2026-07-06T08:34:24+08:00 daily https://www.pharmasources.com/industryinsights/nagasaki-university-nec-initiate-program-310585.html 0.6 2026-08-06T13:44:35+08:00 daily https://www.pharmasources.com/industryinsights/jackson-immunoresearch-launches-secondar-310586.html 0.6 2026-06-29T12:45:02+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-announces-phase-iii-trial-o-310587.html 0.6 2026-06-22T00:51:46+08:00 daily https://www.pharmasources.com/industryinsights/fingerprint-database-could-help-pinpoint-310588.html 0.6 2026-06-21T09:04:02+08:00 daily https://www.pharmasources.com/industryinsights/nice-final-guidance-published-for-cimzia-310589.html 0.6 2026-06-21T09:47:07+08:00 daily https://www.pharmasources.com/industryinsights/public-unaware-they-have-a-choice-of-hos-310590.html 0.6 2026-07-17T18:03:36+08:00 daily https://www.pharmasources.com/industryinsights/puretech-health-boehringer-ingelheim-ent-310591.html 0.6 2026-07-10T11:48:51+08:00 daily https://www.pharmasources.com/industryinsights/new-data-reinforce-effectiveness-of-nova-310592.html 0.6 2026-06-20T15:11:16+08:00 daily https://www.pharmasources.com/industryinsights/liposomal-bupivacaine-shows-safety-in-pa-310593.html 0.6 2026-07-15T14:05:48+08:00 daily https://www.pharmasources.com/industryinsights/maxinovels-orally-active-pd-l1-inhibitor-310594.html 0.6 2026-07-14T18:48:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-final-approval-for-tevas-gene-310595.html 0.6 2026-06-21T08:06:31+08:00 daily https://www.pharmasources.com/industryinsights/almost-half-of-young-asthma-patients-mis-310596.html 0.6 2026-04-12T23:39:28+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-eli-lillys-tanezumab-yields-mixed-310597.html 0.6 2026-06-20T14:53:09+08:00 daily https://www.pharmasources.com/industryinsights/minimally-invasive-surgery-has-some-bene-310598.html 0.6 2026-06-24T05:56:03+08:00 daily https://www.pharmasources.com/industryinsights/navidea-biopharmaceuticals-announces-rev-310599.html 0.6 2026-06-21T10:03:14+08:00 daily https://www.pharmasources.com/industryinsights/scientists-advance-creation-of-artificia-310600.html 0.6 2026-08-09T20:59:43+08:00 daily https://www.pharmasources.com/industryinsights/researchers-use-gene-editing-with-crispr-310601.html 0.6 2026-06-20T15:13:21+08:00 daily https://www.pharmasources.com/industryinsights/neurotrope-announces-inducement-grant-to-310602.html 0.6 2026-08-07T03:11:10+08:00 daily https://www.pharmasources.com/industryinsights/new-programme-increases-use-of-hiv-medic-310603.html 0.6 2026-06-20T14:37:00+08:00 daily https://www.pharmasources.com/industryinsights/largest-oral-hpv-study-in-england-shows--310604.html 0.6 2026-08-01T11:08:33+08:00 daily https://www.pharmasources.com/industryinsights/technique-to-identify-charge-distributio-310605.html 0.6 2026-07-28T21:14:44+08:00 daily https://www.pharmasources.com/industryinsights/identifying-mutations-that-give-bacteria-310606.html 0.6 2026-06-21T12:23:52+08:00 daily https://www.pharmasources.com/industryinsights/triple-pill-lowers-blood-pressure-more-e-310607.html 0.6 2026-07-16T19:25:13+08:00 daily https://www.pharmasources.com/industryinsights/more-than-40-percent-of-women-with-asthm-310608.html 0.6 2026-06-21T22:50:51+08:00 daily https://www.pharmasources.com/industryinsights/peak-scientific-reveals-dedicated-gas-so-310609.html 0.6 2026-06-22T23:43:44+08:00 daily https://www.pharmasources.com/industryinsights/prostate-cancer-treatment-reduced-from-3-310610.html 0.6 2026-07-03T01:03:53+08:00 daily https://www.pharmasources.com/industryinsights/successful-kidney-transplants-from-hepat-310611.html 0.6 2026-06-21T17:54:22+08:00 daily https://www.pharmasources.com/industryinsights/sensitive-blood-tests-diagnose-heart-att-310612.html 0.6 2026-06-21T11:15:25+08:00 daily https://www.pharmasources.com/industryinsights/stem-cells-to-grow-new-immune-system-in--310613.html 0.6 2026-07-15T16:06:36+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-crispr-could-help-treat-lung-310614.html 0.6 2026-08-08T01:37:03+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-can-detect-early-stage-pancre-310615.html 0.6 2026-06-22T16:59:01+08:00 daily https://www.pharmasources.com/industryinsights/public-trust-in-use-of-big-data-for-heal-310616.html 0.6 2026-06-21T09:56:16+08:00 daily https://www.pharmasources.com/industryinsights/advantapure-introduces-new-case-studies--310617.html 0.6 2026-06-21T01:53:43+08:00 daily https://www.pharmasources.com/industryinsights/saliva-diagnostics-will-saliva-translate-310618.html 0.6 2026-06-21T03:48:00+08:00 daily https://www.pharmasources.com/industryinsights/nucleation-identification-benefits-from--310619.html 0.6 2026-06-20T19:57:36+08:00 daily https://www.pharmasources.com/industryinsights/developing-a-new-radioactive-marker-for--310620.html 0.6 2026-06-20T15:16:01+08:00 daily https://www.pharmasources.com/industryinsights/mouse-model-shows-success-of-senolytic-d-310621.html 0.6 2026-07-31T11:52:39+08:00 daily https://www.pharmasources.com/industryinsights/theres-a-downside-to-vigorous-interval-t-310622.html 0.6 2026-06-22T12:51:55+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-drug-could-boost-hormone-t-310623.html 0.6 2026-07-02T01:08:33+08:00 daily https://www.pharmasources.com/industryinsights/aortic-valve-disease-does-its-damage-slo-310624.html 0.6 2026-06-21T03:12:51+08:00 daily https://www.pharmasources.com/industryinsights/rapid-zika-detection-test-uses-smartphon-310625.html 0.6 2026-06-14T20:20:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-naloxone-nasa-310626.html 0.6 2026-06-20T22:52:02+08:00 daily https://www.pharmasources.com/industryinsights/phenformin-mtor-inhibitor-combination-sh-310627.html 0.6 2026-06-20T17:11:27+08:00 daily https://www.pharmasources.com/industryinsights/statins-safe-effective-in-rheumatoid-art-310628.html 0.6 2026-07-24T11:10:52+08:00 daily https://www.pharmasources.com/industryinsights/biomrieux-launches-endozyme-ii-go-an-inn-310629.html 0.6 2026-06-21T04:11:56+08:00 daily https://www.pharmasources.com/industryinsights/increased-screen-time-in-preschool-tied--310630.html 0.6 2026-07-05T10:24:52+08:00 daily https://www.pharmasources.com/industryinsights/chinas-genscript-starts-on-plasmid-virus-310631.html 0.6 2026-07-09T10:25:12+08:00 daily https://www.pharmasources.com/industryinsights/cannabinoid-topical-cream-for-treatment--310632.html 0.6 2026-06-21T01:03:46+08:00 daily https://www.pharmasources.com/industryinsights/atrasentan-tied-to-lower-risk-for-kidney-310633.html 0.6 2026-06-22T02:55:59+08:00 daily https://www.pharmasources.com/industryinsights/micropacemaker-demonstrates-improved-app-310634.html 0.6 2026-06-22T06:47:39+08:00 daily https://www.pharmasources.com/industryinsights/do-hospitals-have-flus-spread-under-cont-310635.html 0.6 2026-06-20T20:56:38+08:00 daily https://www.pharmasources.com/industryinsights/chi-med-files-application-to-list-in-hon-310636.html 0.6 2026-06-21T14:54:20+08:00 daily https://www.pharmasources.com/industryinsights/uk-nice-recommends-use-of-akceas-tegsedi-310637.html 0.6 2026-06-21T00:10:44+08:00 daily https://www.pharmasources.com/industryinsights/of-mice-and-men-new-light-and-sound-comb-310638.html 0.6 2026-06-23T01:03:05+08:00 daily https://www.pharmasources.com/industryinsights/janssens-bladder-cancer-drug-balversa-re-310639.html 0.6 2026-06-23T01:09:31+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-announces-significant-discover-310640.html 0.6 2026-05-03T19:49:36+08:00 daily https://www.pharmasources.com/industryinsights/dnanexus-sutter-health-and-upmc-launch-m-310641.html 0.6 2026-06-21T06:20:23+08:00 daily https://www.pharmasources.com/industryinsights/viela-bio-receives-fda-breakthrough-ther-310642.html 0.6 2026-06-22T11:52:00+08:00 daily https://www.pharmasources.com/industryinsights/flus-response-to-xofluza-explored-310643.html 0.6 2026-03-23T02:27:04+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019042-310644.html 0.6 2026-08-07T04:07:01+08:00 daily https://www.pharmasources.com/industryinsights/repurposing-cancer-drugs-may-lead-to-a-n-310645.html 0.6 2026-06-23T07:53:03+08:00 daily https://www.pharmasources.com/industryinsights/teva-launches-generic-androgel-310646.html 0.6 2026-04-01T05:53:54+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-lilly-announce-top-line-resul-310647.html 0.6 2026-06-21T02:11:47+08:00 daily https://www.pharmasources.com/industryinsights/roche-reports-a-strong-start-in-2019-and-310648.html 0.6 2026-03-27T20:47:24+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-buy-gene-therapy-manufacture-310649.html 0.6 2026-06-20T15:14:30+08:00 daily https://www.pharmasources.com/industryinsights/enesi-pharma-partners-with-us-barda-on-n-310650.html 0.6 2026-06-20T21:51:30+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-74bn-celgene-takeover-gets-310651.html 0.6 2026-04-27T22:34:35+08:00 daily https://www.pharmasources.com/industryinsights/agroceutical-products-daffodils-a-boon-t-310652.html 0.6 2026-06-22T01:37:24+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-slash-costs-of-certain-insulin-310653.html 0.6 2026-06-22T09:00:41+08:00 daily https://www.pharmasources.com/industryinsights/askbio-secures-235m-investment-to-accele-310654.html 0.6 2026-08-06T17:38:17+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-to-commercialise-shionogis-rizmoi-310655.html 0.6 2026-08-07T06:47:09+08:00 daily https://www.pharmasources.com/industryinsights/merck-heaps-early-pressure-on-bristol-my-310656.html 0.6 2026-08-05T23:27:16+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lynparza-gets-ec-approval-f-310657.html 0.6 2026-07-24T06:41:08+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-alnylam-partner-on-eye-and-310658.html 0.6 2026-06-20T19:18:52+08:00 daily https://www.pharmasources.com/industryinsights/centene-to-fund-washington-universitys-p-310659.html 0.6 2026-06-21T10:07:21+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-concludes-option-phase-of-rare-di-310660.html 0.6 2026-06-21T09:03:02+08:00 daily https://www.pharmasources.com/industryinsights/editas-and-bluerock-partner-to-develop-e-310661.html 0.6 2026-08-07T05:05:57+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-pfizers-nsclc-drug-vizimpro-310662.html 0.6 2026-08-07T00:39:50+08:00 daily https://www.pharmasources.com/industryinsights/chinas-nmpa-approves-novartis-cosentyx-a-310663.html 0.6 2026-08-07T00:03:21+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-announces-promising-early-result-310664.html 0.6 2026-08-06T23:56:01+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-resubmits-bla-for-biosimilar-pegf-310665.html 0.6 2026-08-06T23:46:33+08:00 daily https://www.pharmasources.com/industryinsights/bayer-invests-in-khloris-anti-cancer-vac-310666.html 0.6 2026-08-08T07:25:14+08:00 daily https://www.pharmasources.com/industryinsights/puma-licences-breast-cancer-therapy-to-p-310667.html 0.6 2026-06-21T05:42:26+08:00 daily https://www.pharmasources.com/industryinsights/zentiva-buys-amneal-subsidiary-creo-phar-310668.html 0.6 2026-08-06T22:42:27+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-and-gilead-announce-positive-p-310669.html 0.6 2026-08-06T22:31:52+08:00 daily https://www.pharmasources.com/industryinsights/mdxhealths-selectmdx-test-successfully-s-310670.html 0.6 2026-08-06T22:21:00+08:00 daily https://www.pharmasources.com/industryinsights/celonic-ag-appoints-soenke-brunswieck-as-310671.html 0.6 2026-08-06T22:09:14+08:00 daily https://www.pharmasources.com/industryinsights/tfs-international-to-strengthen-strategi-310672.html 0.6 2026-08-06T20:03:36+08:00 daily https://www.pharmasources.com/industryinsights/aduro-biotech-appoints-cmo-310673.html 0.6 2026-08-07T12:03:13+08:00 daily https://www.pharmasources.com/industryinsights/oakrum-pharma-biophore-india-ink-mfg-pac-310674.html 0.6 2026-08-08T01:01:53+08:00 daily https://www.pharmasources.com/industryinsights/bio-techne-elpiscience-enter-strategic-a-310675.html 0.6 2026-08-09T06:59:30+08:00 daily https://www.pharmasources.com/industryinsights/lilly-avidity-biosciences-enter-global-r-310676.html 0.6 2026-07-29T02:16:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-reveals-promising-interim-phase-310677.html 0.6 2026-08-07T02:30:08+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-ucbs-cimzia-in-severe-pl-310678.html 0.6 2026-08-07T13:17:40+08:00 daily https://www.pharmasources.com/industryinsights/cbd-could-be-used-to-deliver-drugs-into--310679.html 0.6 2026-07-30T22:40:17+08:00 daily https://www.pharmasources.com/industryinsights/doctors-cure-bubble-boy-syndrome-using-m-310680.html 0.6 2026-08-03T10:18:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-lillys-painkiller-tanezumab-shows-310681.html 0.6 2026-08-01T02:15:46+08:00 daily https://www.pharmasources.com/industryinsights/imperial-college-london-researchers-deve-310682.html 0.6 2026-06-21T20:00:41+08:00 daily https://www.pharmasources.com/industryinsights/ms-pharma-ink-deal-for-acquisition-of-ge-310683.html 0.6 2026-08-07T02:05:30+08:00 daily https://www.pharmasources.com/industryinsights/can-ai-help-doctors-treat-depression-the-310684.html 0.6 2026-08-07T06:07:01+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-akceas-tegsedi-for-rare--310685.html 0.6 2026-08-07T01:51:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-keytruda-label-to-include-st-310686.html 0.6 2026-08-07T01:19:36+08:00 daily https://www.pharmasources.com/industryinsights/biogeneration-ventures-fund-iii-reaches--310687.html 0.6 2026-07-30T16:24:15+08:00 daily https://www.pharmasources.com/industryinsights/redesigned-car-t-eliminates-dangerous-cy-310688.html 0.6 2026-08-07T01:10:42+08:00 daily https://www.pharmasources.com/industryinsights/janssens-symtuza-around-90-effective-in--310689.html 0.6 2026-08-07T00:59:33+08:00 daily https://www.pharmasources.com/industryinsights/throat-lozenges-could-be-contributing-to-310690.html 0.6 2026-08-07T01:14:03+08:00 daily https://www.pharmasources.com/industryinsights/traffic-pollution-linked-to-four-million-310691.html 0.6 2026-08-07T15:32:31+08:00 daily https://www.pharmasources.com/industryinsights/biosimilars-that-have-entered-phase-iii--310692.html 0.6 2026-08-07T12:03:55+08:00 daily https://www.pharmasources.com/industryinsights/hot-battle-which-to-be-the-next-hanlikan-310693.html 0.6 2026-08-07T00:53:05+08:00 daily https://www.pharmasources.com/industryinsights/torrent-recalls-more-than-1m-bottles-of--310694.html 0.6 2026-08-07T12:25:56+08:00 daily https://www.pharmasources.com/industryinsights/corning-valor-glass-a-glass-package-desi-310695.html 0.6 2026-08-07T13:16:56+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-is-far-from-the-lebron-jam-310696.html 0.6 2026-08-07T22:33:29+08:00 daily https://www.pharmasources.com/industryinsights/federal-judge-scolds-purdue-endo-and-mal-310697.html 0.6 2026-08-07T15:07:09+08:00 daily https://www.pharmasources.com/industryinsights/old-guard-generics-players-yield-us-lead-310698.html 0.6 2026-08-09T06:59:21+08:00 daily https://www.pharmasources.com/industryinsights/path-and-mmv-launch-5-year-global-initia-310699.html 0.6 2026-06-13T17:55:25+08:00 daily https://www.pharmasources.com/industryinsights/national-experts-chart-roadmap-for-ai-in-310700.html 0.6 2026-07-17T00:01:29+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-sale-of-legacy-antibioti-310701.html 0.6 2026-07-27T20:18:33+08:00 daily https://www.pharmasources.com/industryinsights/alembics-ophthalmic-solution-gets-usfda--310702.html 0.6 2026-06-20T20:10:45+08:00 daily https://www.pharmasources.com/industryinsights/circle-dna-launches-next-gen-consumer-ge-310703.html 0.6 2026-06-21T14:50:23+08:00 daily https://www.pharmasources.com/industryinsights/rapid-medical-raises-20m-in-new-funding-310704.html 0.6 2026-06-21T22:54:38+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-increases-focus-on--310705.html 0.6 2026-02-04T23:38:57+08:00 daily https://www.pharmasources.com/industryinsights/israel-finland-collaborate-to-promote-di-310706.html 0.6 2026-06-23T19:37:48+08:00 daily https://www.pharmasources.com/industryinsights/elpiscience-bio-techne-to-develop-anti-c-310707.html 0.6 2026-06-21T11:54:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mercks-keytruda-in-combinat-310708.html 0.6 2026-06-23T06:55:41+08:00 daily https://www.pharmasources.com/industryinsights/m3-acquires-majority-share-in-dailyround-310709.html 0.6 2026-06-26T08:05:08+08:00 daily https://www.pharmasources.com/industryinsights/merck-foundation-african-minister-of-hea-310710.html 0.6 2026-08-08T23:32:37+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-increases-focus-on--310711.html 0.6 2025-11-16T17:41:55+08:00 daily https://www.pharmasources.com/industryinsights/malawi-launches-pilot-of-worlds-first-ma-310712.html 0.6 2026-07-12T12:58:53+08:00 daily https://www.pharmasources.com/industryinsights/lillys-taltz-meets-endpoints-in-phase-ii-310713.html 0.6 2026-07-01T11:44:05+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-closes-1bn-clementia-pharmaceutica-310714.html 0.6 2026-08-06T18:33:05+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-gets-fda-approval-to-tre-310715.html 0.6 2026-07-28T09:20:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-status-to-genfit-310716.html 0.6 2026-06-21T00:01:37+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-partners-puretech-to-develop--310717.html 0.6 2026-06-21T09:04:06+08:00 daily https://www.pharmasources.com/industryinsights/los-angeles-county-measles-outbreak-unde-310718.html 0.6 2026-06-22T05:18:36+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-urges-asymptomatic-bacteriuria-sc-310719.html 0.6 2026-06-23T16:33:20+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-tv-video-watching-high-sta-310720.html 0.6 2026-06-20T16:55:17+08:00 daily https://www.pharmasources.com/industryinsights/malawi-first-country-to-immunize-childre-310721.html 0.6 2026-06-21T19:16:46+08:00 daily https://www.pharmasources.com/industryinsights/obesity-may-impact-the-form-and-structur-310722.html 0.6 2026-06-13T07:45:26+08:00 daily https://www.pharmasources.com/industryinsights/asthma-myths-that-can-hurt-you-310723.html 0.6 2026-06-26T22:19:07+08:00 daily https://www.pharmasources.com/industryinsights/untrained-caregivers-bear-burden-of-care-310724.html 0.6 2026-07-12T02:22:56+08:00 daily https://www.pharmasources.com/industryinsights/video-games-dont-hamper-boys-social-skil-310725.html 0.6 2026-08-07T23:39:16+08:00 daily https://www.pharmasources.com/industryinsights/can-pregnancy-put-a-damper-on-your-caree-310726.html 0.6 2026-04-25T08:50:23+08:00 daily https://www.pharmasources.com/industryinsights/keytrudainlyta-combo-scores-fda-approval-310727.html 0.6 2026-06-20T20:23:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-permits-marketing-of-first-medical-d-310728.html 0.6 2026-06-21T04:01:48+08:00 daily https://www.pharmasources.com/industryinsights/personalizing-precision-medicine-with-co-310729.html 0.6 2026-06-22T04:56:46+08:00 daily https://www.pharmasources.com/industryinsights/intelgenx-to-promote-oral-films-cdmo-ser-310730.html 0.6 2026-06-21T16:06:25+08:00 daily https://www.pharmasources.com/industryinsights/cphi-na-partners-with-ibio-310731.html 0.6 2026-06-21T01:49:28+08:00 daily https://www.pharmasources.com/industryinsights/cphi-na-keynotes-former-senator-jeff-fla-310732.html 0.6 2026-06-20T21:57:35+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-sells-two-legacy-drugs-and-man-310733.html 0.6 2026-08-07T19:20:18+08:00 daily https://www.pharmasources.com/industryinsights/catalent-invests-14m-at-germany-softgel--310734.html 0.6 2026-06-21T02:53:37+08:00 daily https://www.pharmasources.com/industryinsights/more-evidence-that-blood-tests-can-detec-310735.html 0.6 2026-06-21T12:11:22+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-opens-qc-lab-in-italy-310736.html 0.6 2026-06-20T21:04:44+08:00 daily https://www.pharmasources.com/industryinsights/fulcrum-acquires-global-rights-of-invest-310737.html 0.6 2026-06-30T18:37:07+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-insitro-ink-drug-discovery-de-310738.html 0.6 2026-06-20T20:09:39+08:00 daily https://www.pharmasources.com/industryinsights/chinese-cdmo-genscript-breaks-ground-310739.html 0.6 2026-08-06T19:46:53+08:00 daily https://www.pharmasources.com/industryinsights/teva-launches-generic-version-of-vesicar-310740.html 0.6 2026-08-04T02:52:45+08:00 daily https://www.pharmasources.com/industryinsights/teva-scraps-development-of-cgrp-inhibito-310741.html 0.6 2026-08-06T00:18:16+08:00 daily https://www.pharmasources.com/industryinsights/top-10-small-molecule-drugs-a-half-were--310742.html 0.6 2026-06-23T19:57:28+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-ono-and-lifearc-to-id-310743.html 0.6 2026-06-21T09:09:29+08:00 daily https://www.pharmasources.com/industryinsights/lees-pharm-and-regenerx-develop-ophthalm-310744.html 0.6 2026-06-26T17:22:09+08:00 daily https://www.pharmasources.com/industryinsights/verastem-oncology-announces-amendment-to-310745.html 0.6 2026-06-30T05:22:05+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-inks-pain-medicine-development-d-310746.html 0.6 2026-06-21T04:57:42+08:00 daily https://www.pharmasources.com/industryinsights/teva-abandons-ajovy-trial-for-cluster-he-310747.html 0.6 2026-06-23T05:19:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-orphan-drug-designation-granted-for--310748.html 0.6 2026-06-21T21:01:38+08:00 daily https://www.pharmasources.com/industryinsights/skyrizi-gets-us-approval-for-psoriasis-310749.html 0.6 2026-07-02T20:13:41+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-roll-out-mental-health-job-coache-310750.html 0.6 2026-08-06T07:42:01+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-avidity-biosciences-announce-3-310751.html 0.6 2026-06-20T23:58:35+08:00 daily https://www.pharmasources.com/industryinsights/pharmatimes-introduces-a-brand-new-categ-310752.html 0.6 2026-01-25T19:25:30+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-recruited-in-global-amd-tr-310753.html 0.6 2026-06-24T07:20:27+08:00 daily https://www.pharmasources.com/industryinsights/nhs-set-to-fund-brain-surgery-for-deaf-c-310754.html 0.6 2026-06-21T18:08:32+08:00 daily https://www.pharmasources.com/industryinsights/positive-results-for-eli-lillys-taltz-in-310755.html 0.6 2026-08-07T01:51:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-permits-marketing-of-first-non-drug--310756.html 0.6 2026-08-07T02:04:53+08:00 daily https://www.pharmasources.com/industryinsights/new-breast-cancer-blood-test-could-help--310757.html 0.6 2026-08-07T02:18:38+08:00 daily https://www.pharmasources.com/industryinsights/landmark-study-links-air-pollution-to-un-310758.html 0.6 2026-08-08T07:34:02+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-focus-on-new-drugs-in-china-unl-310759.html 0.6 2026-08-07T02:30:44+08:00 daily https://www.pharmasources.com/industryinsights/macrogen-exosome-plus-to-jointly-develop-310760.html 0.6 2026-08-07T02:36:53+08:00 daily https://www.pharmasources.com/industryinsights/velabs-collaborates-with-chiome-for-gpcr-310761.html 0.6 2026-08-07T02:40:37+08:00 daily https://www.pharmasources.com/industryinsights/astar-nea-ncid-develop-diagnostic-test-f-310762.html 0.6 2026-06-20T18:55:39+08:00 daily https://www.pharmasources.com/industryinsights/astar-duke-nus-unveils-the-map-to-design-310763.html 0.6 2026-06-24T08:32:09+08:00 daily https://www.pharmasources.com/industryinsights/malaria-vaccine-pilot-launched-in-malawi-310764.html 0.6 2026-06-21T04:21:14+08:00 daily https://www.pharmasources.com/industryinsights/recovery-force-receives-18m-grant-from-n-310765.html 0.6 2026-06-20T21:01:41+08:00 daily https://www.pharmasources.com/industryinsights/gracell-bio-develops-technology-for-hema-310766.html 0.6 2026-06-24T01:11:23+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-avidity-biosciences-enter-into-310767.html 0.6 2026-06-21T04:00:51+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-licenses-lead-stage-molecules-to-310768.html 0.6 2026-06-22T03:50:31+08:00 daily https://www.pharmasources.com/industryinsights/nus-researchers-find-new-biomarkers-asso-310769.html 0.6 2026-08-05T21:33:33+08:00 daily https://www.pharmasources.com/industryinsights/eisai-selected-as-a-competitive-it-strat-310770.html 0.6 2026-08-07T18:56:15+08:00 daily https://www.pharmasources.com/industryinsights/speedx-receives-funding-from-us-venture--310771.html 0.6 2026-08-09T18:45:33+08:00 daily https://www.pharmasources.com/industryinsights/biotech-startup-rwdc-raises-22-m-in-a3-r-310772.html 0.6 2026-04-17T00:02:51+08:00 daily https://www.pharmasources.com/industryinsights/mfine-raises-172-m-to-create-largest-vir-310773.html 0.6 2026-08-06T17:54:33+08:00 daily https://www.pharmasources.com/industryinsights/1998-to-2015-saw-increase-in-outpatient--310774.html 0.6 2026-06-21T00:15:52+08:00 daily https://www.pharmasources.com/industryinsights/nusinersen-promising-for-later-onset-spi-310775.html 0.6 2026-06-21T05:55:48+08:00 daily https://www.pharmasources.com/industryinsights/new-york-city-measles-cases-increase-to--310776.html 0.6 2026-06-21T11:53:19+08:00 daily https://www.pharmasources.com/industryinsights/many-seniors-will-be-unable-to-afford-ca-310777.html 0.6 2026-06-21T15:16:54+08:00 daily https://www.pharmasources.com/industryinsights/cdc-provides-clarification-of-opioid-pre-310778.html 0.6 2026-08-05T17:18:30+08:00 daily https://www.pharmasources.com/industryinsights/wellness-programs-take-hold-in-american--310779.html 0.6 2026-06-20T23:59:39+08:00 daily https://www.pharmasources.com/industryinsights/young-adults-with-autism-need-jobs-but-r-310780.html 0.6 2026-07-07T22:50:01+08:00 daily https://www.pharmasources.com/industryinsights/e-coli-outbreak-tied-to-ground-beef-expa-310781.html 0.6 2026-06-20T14:05:37+08:00 daily https://www.pharmasources.com/industryinsights/could-common-food-preservative-make-peop-310782.html 0.6 2026-06-09T04:12:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-skyrizi-risankizumab-rzaa-f-310783.html 0.6 2026-08-08T20:16:37+08:00 daily https://www.pharmasources.com/industryinsights/medicinova-announces-plans-to-move-forwa-310784.html 0.6 2026-08-07T09:19:03+08:00 daily https://www.pharmasources.com/industryinsights/drug-prices-come-under-fire-as-us-pharma-310785.html 0.6 2026-07-20T01:39:32+08:00 daily https://www.pharmasources.com/industryinsights/slam-microscopy-could-enable-real-time-d-310786.html 0.6 2026-06-21T08:22:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-the-inclusion-of-new-eviden-310787.html 0.6 2026-03-21T22:07:39+08:00 daily https://www.pharmasources.com/industryinsights/new-data-show-blueprint-identifies-estro-310788.html 0.6 2026-06-20T23:47:39+08:00 daily https://www.pharmasources.com/industryinsights/velabs-therapeutics-to-cooperate-with-ch-310789.html 0.6 2026-06-20T15:59:23+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-combo-wins-fda-approval-for-rcc-310790.html 0.6 2026-06-22T11:02:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-brings-in-glaxosmithklines-rich-310791.html 0.6 2026-06-21T13:56:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-lifts-annual-profit-outlook-as--310792.html 0.6 2026-06-21T23:39:51+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-boehringer-ingelheims-il-23-inhib-310793.html 0.6 2026-08-06T10:33:42+08:00 daily https://www.pharmasources.com/industryinsights/medicare-proposal-will-increase-payments-310794.html 0.6 2026-06-21T11:14:24+08:00 daily https://www.pharmasources.com/industryinsights/biogen-posts-20-percent-increase-in-firs-310795.html 0.6 2026-08-04T00:36:15+08:00 daily https://www.pharmasources.com/industryinsights/physician-views-snap-poll---asking-us-op-310796.html 0.6 2026-06-20T13:21:28+08:00 daily https://www.pharmasources.com/industryinsights/alkindi-granted-orphan-drug-designation--310797.html 0.6 2026-07-06T03:41:02+08:00 daily https://www.pharmasources.com/industryinsights/feraccru-granted-major-extension-to-appr-310798.html 0.6 2026-06-25T10:30:23+08:00 daily https://www.pharmasources.com/industryinsights/knopp-biosciences-receives-fda-orphan-dr-310799.html 0.6 2026-06-20T21:24:47+08:00 daily https://www.pharmasources.com/industryinsights/scientists-design-new-skin-cell-culture--310800.html 0.6 2026-06-21T06:45:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-brings-in-glaxosmithklines-rich-310801.html 0.6 2026-07-15T11:29:28+08:00 daily https://www.pharmasources.com/industryinsights/rna-based-therapy-cures-lung-cancer-310802.html 0.6 2026-08-08T05:53:10+08:00 daily https://www.pharmasources.com/industryinsights/repurposing-leukaemia-drugs-may-prevent--310803.html 0.6 2026-06-21T12:12:28+08:00 daily https://www.pharmasources.com/industryinsights/3d-simulation-gives-authentic-representa-310804.html 0.6 2026-06-22T02:56:47+08:00 daily https://www.pharmasources.com/industryinsights/calcium-supplements-may-boost-risk-of-ab-310805.html 0.6 2026-06-21T13:03:29+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-predicts-effectiveness-of-pal-310806.html 0.6 2026-06-21T04:20:15+08:00 daily https://www.pharmasources.com/industryinsights/anti-tnf-therapy-may-help-reduce-risk-of-310807.html 0.6 2026-06-20T18:18:57+08:00 daily https://www.pharmasources.com/industryinsights/delivering-cancer-treatment-on-a-nanodis-310808.html 0.6 2026-06-21T03:03:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-nda-for-alks-5461-for-major--310809.html 0.6 2026-07-28T21:16:02+08:00 daily https://www.pharmasources.com/industryinsights/contrast-enhanced-subharmonic-imaging-de-310810.html 0.6 2026-06-20T20:54:34+08:00 daily https://www.pharmasources.com/industryinsights/study-examines-antipsychotic-medication--310811.html 0.6 2026-06-21T13:04:33+08:00 daily https://www.pharmasources.com/industryinsights/how-did-gonorrhoea-become-a-drug-resista-310812.html 0.6 2026-07-28T00:20:42+08:00 daily https://www.pharmasources.com/industryinsights/oral-sirolimus-alters-the-course-of-dipn-310813.html 0.6 2026-08-08T00:57:14+08:00 daily https://www.pharmasources.com/industryinsights/metformin-may-help-with-nicotine-withdra-310814.html 0.6 2026-06-21T19:11:10+08:00 daily https://www.pharmasources.com/industryinsights/sygnature-and-silcsbio-team-up-310815.html 0.6 2026-06-22T00:41:36+08:00 daily https://www.pharmasources.com/industryinsights/527000-uk-children-unvaccinated-with-fir-310816.html 0.6 2026-06-21T02:07:45+08:00 daily https://www.pharmasources.com/industryinsights/new-research-could-spot-people-most-susc-310817.html 0.6 2026-07-20T12:02:28+08:00 daily https://www.pharmasources.com/industryinsights/new-accelerator-to-give-250000-to-50-sta-310818.html 0.6 2026-07-20T04:40:09+08:00 daily https://www.pharmasources.com/industryinsights/new-interactive-service-set-to-tackle-mi-310819.html 0.6 2026-06-23T05:44:50+08:00 daily https://www.pharmasources.com/industryinsights/novartis-recruits-gsk-exec-as-new-sandoz-310820.html 0.6 2026-06-21T02:16:51+08:00 daily https://www.pharmasources.com/industryinsights/pharmatimes-is-excited-to-announce-the-l-310821.html 0.6 2026-06-21T19:57:35+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-healthcares-digital-ad-spend--310822.html 0.6 2026-03-20T08:59:26+08:00 daily https://www.pharmasources.com/industryinsights/valsartan-mess-to-spawn-the-latest-surge-310823.html 0.6 2026-06-20T20:18:01+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-shakes-up-psoriasis-field-with-bl-310824.html 0.6 2026-06-27T10:49:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-launches-global-assessment-of-m-310825.html 0.6 2026-07-10T07:53:28+08:00 daily https://www.pharmasources.com/industryinsights/south-florida-drugmaker-opens-sterile-dr-310826.html 0.6 2026-06-21T09:02:01+08:00 daily https://www.pharmasources.com/industryinsights/novartis-nabs-gsk-executive-for-sandoz-c-310827.html 0.6 2026-07-10T03:05:52+08:00 daily https://www.pharmasources.com/industryinsights/cosentyx-entresto-again-drive-growth-at--310828.html 0.6 2026-06-21T10:07:13+08:00 daily https://www.pharmasources.com/industryinsights/landmark-malaria-vaccine-pilot-programme-310829.html 0.6 2026-06-20T22:08:43+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-medication-provides-improve-310830.html 0.6 2026-06-22T07:58:51+08:00 daily https://www.pharmasources.com/industryinsights/il-18-inhibitor-drug-holds-great-potenti-310831.html 0.6 2026-06-21T05:00:44+08:00 daily https://www.pharmasources.com/industryinsights/ziplines-drone-delivery-of-medical-produ-310832.html 0.6 2026-08-07T12:01:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-breakthrough-status-to-la-jol-310833.html 0.6 2026-06-20T19:13:32+08:00 daily https://www.pharmasources.com/industryinsights/sharp-expands-us-operations-310834.html 0.6 2026-06-21T03:12:53+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-completes-wisconsin-mfg-fac-310835.html 0.6 2026-06-21T22:08:58+08:00 daily https://www.pharmasources.com/industryinsights/goodwin-biotechnology-readies-for-expans-310836.html 0.6 2026-06-22T00:56:11+08:00 daily https://www.pharmasources.com/industryinsights/telstar-completes-gmp-production-freeze--310837.html 0.6 2026-08-10T01:03:12+08:00 daily https://www.pharmasources.com/industryinsights/la-jolla-pharma-gets-breakthrough-design-310838.html 0.6 2026-06-21T05:15:56+08:00 daily https://www.pharmasources.com/industryinsights/study-of-selonsertib-in-bridging-fibrosi-310839.html 0.6 2026-06-21T00:17:14+08:00 daily https://www.pharmasources.com/industryinsights/adc-therapeutics-adagene-ink-license-agr-310840.html 0.6 2026-06-25T18:26:44+08:00 daily https://www.pharmasources.com/industryinsights/portola-pharmaceuticals-rd-exec-to-retir-310841.html 0.6 2026-07-12T12:28:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-of-skyrizi-for-moderate-to--310842.html 0.6 2026-06-30T17:04:18+08:00 daily https://www.pharmasources.com/industryinsights/salix-announes-license-agreement-with-mi-310843.html 0.6 2026-06-20T21:10:44+08:00 daily https://www.pharmasources.com/industryinsights/progress-of-diabetes-treatment-with-tcm--310844.html 0.6 2026-07-16T20:57:20+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-pharma-connect-online-matchma-310845.html 0.6 2026-06-20T16:02:18+08:00 daily https://www.pharmasources.com/industryinsights/bayers-q1-sales-boosted-by-performance-o-310847.html 0.6 2026-06-24T05:36:02+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-raises-annual-earnings-guidance-d-310848.html 0.6 2026-07-06T21:11:53+08:00 daily https://www.pharmasources.com/industryinsights/precigen-opens-gene-and-cell-therapy-man-310849.html 0.6 2026-08-08T00:51:33+08:00 daily https://www.pharmasources.com/industryinsights/symic-bio-announces-closing-of-investmen-310850.html 0.6 2026-06-20T23:09:50+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-first-pat-310851.html 0.6 2026-06-26T05:14:35+08:00 daily https://www.pharmasources.com/industryinsights/sharp-invests-21m-to-expand-us-packaging-310852.html 0.6 2026-07-21T11:00:11+08:00 daily https://www.pharmasources.com/industryinsights/43m-donated-to-paths-visualise-no-malari-310853.html 0.6 2026-06-21T05:01:48+08:00 daily https://www.pharmasources.com/industryinsights/sirios-ayanda-launches-probiotic-softgel-310854.html 0.6 2026-07-07T03:22:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-facts-fda-and-partners-investig-310855.html 0.6 2026-06-21T12:09:18+08:00 daily https://www.pharmasources.com/industryinsights/company-diverts-more-than-92-million-uni-310856.html 0.6 2026-06-21T07:54:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-of-skyrizi-for-moderate-to--310857.html 0.6 2026-06-21T01:59:41+08:00 daily https://www.pharmasources.com/industryinsights/vial-switch-improves-life-saving-antivir-310858.html 0.6 2026-08-08T02:30:59+08:00 daily https://www.pharmasources.com/industryinsights/cdc-drinking-alcohol-not-uncommon-among--310859.html 0.6 2026-06-22T02:10:56+08:00 daily https://www.pharmasources.com/industryinsights/surge-of-indian-biosimilars-market-forec-310860.html 0.6 2026-08-07T21:13:17+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-reports-first-quart-310861.html 0.6 2026-06-21T17:10:27+08:00 daily https://www.pharmasources.com/industryinsights/new-insight-into-melatonin-could-lead-to-310862.html 0.6 2026-06-21T09:13:12+08:00 daily https://www.pharmasources.com/industryinsights/taking-the-difficulty-out-of-api-process-310863.html 0.6 2026-06-21T03:19:01+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-company-and-its-former-ex-310864.html 0.6 2026-06-21T12:58:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-pediatr-310865.html 0.6 2026-06-22T11:08:55+08:00 daily https://www.pharmasources.com/industryinsights/combination-immunotherapy-improves-survi-310866.html 0.6 2026-07-02T23:37:31+08:00 daily https://www.pharmasources.com/industryinsights/ionising-radiation-found-to-soften-tumou-310867.html 0.6 2026-06-21T15:59:22+08:00 daily https://www.pharmasources.com/industryinsights/lc-msms-used-to-identify-novel-prostagla-310868.html 0.6 2026-06-20T14:55:14+08:00 daily https://www.pharmasources.com/industryinsights/treating-menopause-symptoms-reduces-abdo-310869.html 0.6 2026-06-20T18:18:00+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-use-increases-risk-of-severe--310870.html 0.6 2026-07-27T00:32:28+08:00 daily https://www.pharmasources.com/industryinsights/kineret-reduces-inflammation-in-stroke-p-310871.html 0.6 2026-06-20T15:53:38+08:00 daily https://www.pharmasources.com/industryinsights/crystallographic-method-accelerates-drug-310872.html 0.6 2026-06-22T06:53:22+08:00 daily https://www.pharmasources.com/industryinsights/nih-scientists-say-advanced-vaccines-cou-310873.html 0.6 2026-06-21T10:02:16+08:00 daily https://www.pharmasources.com/industryinsights/outlook-therapeutics-names-clinical-svp-310874.html 0.6 2026-06-20T22:02:44+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-withdraw-cancer-drug-lartruvo-f-310875.html 0.6 2026-06-21T11:08:24+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-astellas-to-pay-125m-to-settle-310876.html 0.6 2026-08-06T23:56:50+08:00 daily https://www.pharmasources.com/industryinsights/kite-pharma-expands-mfg-facility-in-md-310877.html 0.6 2026-08-06T23:47:09+08:00 daily https://www.pharmasources.com/industryinsights/almac-launches-site-storage-temp-complia-310878.html 0.6 2026-08-06T23:56:49+08:00 daily https://www.pharmasources.com/industryinsights/precigen-opens-cell-therapy-mfg-facility-310879.html 0.6 2026-08-07T00:01:39+08:00 daily https://www.pharmasources.com/industryinsights/catalent-accelerates-formulation-and-sup-310880.html 0.6 2026-08-07T00:40:38+08:00 daily https://www.pharmasources.com/industryinsights/for-kids-obesity-and-mental-health-woes--310881.html 0.6 2026-08-06T02:16:35+08:00 daily https://www.pharmasources.com/industryinsights/breast-milk-has-biggest-benefit-for-pree-310882.html 0.6 2026-08-07T01:19:35+08:00 daily https://www.pharmasources.com/industryinsights/breast-milk-has-biggest-benefit-for-pree-310883.html 0.6 2026-08-07T01:11:07+08:00 daily https://www.pharmasources.com/industryinsights/gsk-receives-us-approval-of-benlysta-for-310884.html 0.6 2026-08-07T13:19:45+08:00 daily https://www.pharmasources.com/industryinsights/cdc-first-confirmed-id-of-kissing-bug-in-310885.html 0.6 2026-08-09T19:47:02+08:00 daily https://www.pharmasources.com/industryinsights/longer-duration-of-antibiotic-use-tied-t-310886.html 0.6 2026-03-29T03:10:27+08:00 daily https://www.pharmasources.com/industryinsights/significant-number-of-referred-patients--310887.html 0.6 2026-02-16T13:42:56+08:00 daily https://www.pharmasources.com/industryinsights/reneuron-climbs-on-updated-vision-loss-c-310888.html 0.6 2026-06-20T15:53:24+08:00 daily https://www.pharmasources.com/industryinsights/hundreds-quarantined-for-measles-at-two--310889.html 0.6 2026-06-24T13:24:25+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-dumps-amgen-partnered-drug-a-310890.html 0.6 2026-06-22T03:13:48+08:00 daily https://www.pharmasources.com/industryinsights/using-the-innate-immune-system-to-treat--310891.html 0.6 2026-07-08T01:39:54+08:00 daily https://www.pharmasources.com/industryinsights/single-cell-sequencer-mission-bio-adds-3-310892.html 0.6 2026-07-09T03:32:37+08:00 daily https://www.pharmasources.com/industryinsights/psychostimulant-use-pervasive-in-young-a-310893.html 0.6 2026-06-21T09:20:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-current-healths-hospital-to-h-310894.html 0.6 2026-07-04T11:38:06+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-snaps-up-envigos-nonclinical-bus-310895.html 0.6 2026-06-20T23:58:05+08:00 daily https://www.pharmasources.com/industryinsights/mintcom-founder-launches-visual-er-manag-310896.html 0.6 2026-03-01T05:24:14+08:00 daily https://www.pharmasources.com/industryinsights/va-doctors-prescribing-unnecessary-antib-310897.html 0.6 2026-06-21T12:04:30+08:00 daily https://www.pharmasources.com/industryinsights/gileads-selonsertib-flunks-another-nash--310898.html 0.6 2026-06-21T01:11:52+08:00 daily https://www.pharmasources.com/industryinsights/jjs-quest-to-detect-lung-cancer-before-i-310899.html 0.6 2026-06-21T06:10:57+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-picks-immuno-oncology-bispecific-310900.html 0.6 2026-08-03T11:11:38+08:00 daily https://www.pharmasources.com/industryinsights/most-states-restrict-pregnant-womens-adv-310901.html 0.6 2026-06-21T06:01:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-duobrii-halobetasol-propion-310902.html 0.6 2026-07-23T15:33:26+08:00 daily https://www.pharmasources.com/industryinsights/ponatinib-is-found-to-be-effective-again-310903.html 0.6 2026-06-20T14:27:44+08:00 daily https://www.pharmasources.com/industryinsights/injectable-self-assembled-nanomaterials--310904.html 0.6 2026-06-21T07:54:28+08:00 daily https://www.pharmasources.com/industryinsights/blood-and-urine-tests-developed-to-indic-310905.html 0.6 2026-06-20T18:15:42+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-cuts-time-to-diagnosis-for-ca-310906.html 0.6 2026-06-20T22:13:56+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-whats-next-for--310907.html 0.6 2026-08-06T23:57:01+08:00 daily https://www.pharmasources.com/industryinsights/cdc-first-confirmed-id-of-kissing-bug-in-310908.html 0.6 2026-06-22T11:59:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-pediatr-310909.html 0.6 2026-06-21T10:21:21+08:00 daily https://www.pharmasources.com/industryinsights/gsk-commits-100m-to-increase-vaccine-man-310910.html 0.6 2026-07-09T22:35:49+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-withdraw-cancer-drug-lartruvo-f-310911.html 0.6 2026-07-05T08:04:55+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-meets-primary-trial-endpoint-as-310912.html 0.6 2026-06-20T23:13:50+08:00 daily https://www.pharmasources.com/industryinsights/after-the-alzheimers-crash-should-biogen-310913.html 0.6 2026-06-24T13:53:01+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-expands-immunology-portfolio-in-t-310914.html 0.6 2026-08-07T02:52:18+08:00 daily https://www.pharmasources.com/industryinsights/drug-prices-come-under-fire-as-us-pharma-310915.html 0.6 2026-08-06T23:47:36+08:00 daily https://www.pharmasources.com/industryinsights/significant-number-of-referred-patients--310916.html 0.6 2026-08-06T22:08:40+08:00 daily https://www.pharmasources.com/industryinsights/just-20-of-physicians-say-ai-has-changed-310917.html 0.6 2026-08-06T20:06:27+08:00 daily https://www.pharmasources.com/industryinsights/blood-samples-to-help-choose-early-phase-310918.html 0.6 2026-08-07T05:30:46+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-files-for-eu-approval-of-oz-310919.html 0.6 2026-06-21T13:00:30+08:00 daily https://www.pharmasources.com/industryinsights/experts-deeply-concerned-about-nhs-long--310920.html 0.6 2026-06-21T08:18:15+08:00 daily https://www.pharmasources.com/industryinsights/uk-regulatory-approval-for-scib1-phase-i-310921.html 0.6 2026-06-21T00:54:44+08:00 daily https://www.pharmasources.com/industryinsights/apac-biz-leaders-team-up-with-world-econ-310922.html 0.6 2026-06-20T23:40:40+08:00 daily https://www.pharmasources.com/industryinsights/bd-launches-patient-safety-programme-pri-310923.html 0.6 2026-06-21T02:59:40+08:00 daily https://www.pharmasources.com/industryinsights/nccs-raises-awareness-about-hereditary-c-310924.html 0.6 2026-06-20T20:44:39+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-receives-075-m-under-mitsubish-310925.html 0.6 2026-06-20T17:53:38+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-selects-oncology-candidate-built-310926.html 0.6 2026-08-03T11:12:07+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-sells-its-nihonbashi-buil-310927.html 0.6 2026-06-27T02:25:35+08:00 daily https://www.pharmasources.com/industryinsights/eps-international-and-george-clinical-pu-310928.html 0.6 2026-06-20T22:00:41+08:00 daily https://www.pharmasources.com/industryinsights/salix-partners-with-mitsubishi-tanabe-ph-310929.html 0.6 2026-08-08T17:53:17+08:00 daily https://www.pharmasources.com/industryinsights/eppendorf-with-worldwide-setting-program-310930.html 0.6 2026-08-08T15:49:49+08:00 daily https://www.pharmasources.com/industryinsights/tableu-mapbox-exasol-and-alteryx-commit--310931.html 0.6 2026-08-08T13:46:46+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-and-biotech-sectors-to-dr-310932.html 0.6 2026-06-26T16:15:05+08:00 daily https://www.pharmasources.com/industryinsights/start-codon-to-deliver-premier-life-scie-310933.html 0.6 2026-08-07T13:56:39+08:00 daily https://www.pharmasources.com/industryinsights/nir-identifies-breast-cancer-patients-wh-310934.html 0.6 2026-08-07T13:19:00+08:00 daily https://www.pharmasources.com/industryinsights/biktarvy-approved-for-the-treatment-of-h-310935.html 0.6 2026-06-27T23:15:26+08:00 daily https://www.pharmasources.com/industryinsights/e-skin-mimics-the-function-and-mechanica-310936.html 0.6 2026-08-07T04:22:05+08:00 daily https://www.pharmasources.com/industryinsights/tsg12-provides-a-non-toxic-therapeutic-t-310937.html 0.6 2026-08-07T04:04:14+08:00 daily https://www.pharmasources.com/industryinsights/54-million-funding-to-transform-health-t-310938.html 0.6 2026-08-07T03:54:49+08:00 daily https://www.pharmasources.com/industryinsights/primaquine-methylene-blue-combination-bl-310939.html 0.6 2026-06-21T10:54:31+08:00 daily https://www.pharmasources.com/industryinsights/strengthened-guidance-on-follow-up-and-r-310940.html 0.6 2026-06-25T09:34:52+08:00 daily https://www.pharmasources.com/industryinsights/robotic-method-isolates-high-producing-c-310941.html 0.6 2026-06-22T01:06:56+08:00 daily https://www.pharmasources.com/industryinsights/new-technology-for-accelerated-wound-hea-310942.html 0.6 2026-06-20T14:48:27+08:00 daily https://www.pharmasources.com/industryinsights/gilsons-combined-gx-241-liquid-handler-a-310943.html 0.6 2026-06-21T07:17:14+08:00 daily https://www.pharmasources.com/industryinsights/measuring-molecular-interactions-using-l-310944.html 0.6 2026-06-20T23:56:36+08:00 daily https://www.pharmasources.com/industryinsights/sodium-benzoate-enhances-schizophrenia-t-310945.html 0.6 2026-08-05T23:00:50+08:00 daily https://www.pharmasources.com/industryinsights/lab-on-a-chip-for-tracking-single-bacter-310946.html 0.6 2026-06-23T06:23:42+08:00 daily https://www.pharmasources.com/industryinsights/ibuprofen-in-the-first-three-months-of-p-310947.html 0.6 2026-07-16T12:55:40+08:00 daily https://www.pharmasources.com/industryinsights/in-air-microfluidics-produces-3d-printed-310948.html 0.6 2026-06-20T22:57:45+08:00 daily https://www.pharmasources.com/industryinsights/tofacitinib-uv-b-light-therapy-combinati-310949.html 0.6 2026-06-21T19:00:39+08:00 daily https://www.pharmasources.com/industryinsights/microbubbles-make-breast-cancer-more-sus-310950.html 0.6 2026-02-28T19:21:36+08:00 daily https://www.pharmasources.com/industryinsights/sofosbuvir-found-to-be-effective-against-310951.html 0.6 2026-06-21T08:34:50+08:00 daily https://www.pharmasources.com/industryinsights/statistical-computing-tool-visualises-em-310952.html 0.6 2026-06-23T00:49:09+08:00 daily https://www.pharmasources.com/industryinsights/for-obese-people-commuting-by-car-can-be-310953.html 0.6 2026-06-21T14:41:12+08:00 daily https://www.pharmasources.com/industryinsights/how-much-does-your-kid-weigh-chances-are-310954.html 0.6 2026-06-21T12:07:17+08:00 daily https://www.pharmasources.com/industryinsights/zonisamide-may-help-those-with-dementia--310955.html 0.6 2026-06-21T03:04:45+08:00 daily https://www.pharmasources.com/industryinsights/metrohm-acquires-innovative-photonic-sol-310956.html 0.6 2026-06-21T07:11:03+08:00 daily https://www.pharmasources.com/industryinsights/cannabidiol-may-help-to-reduce-seizures--310957.html 0.6 2026-06-22T04:06:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-takes-top-spot-in-pharma-market-c-310958.html 0.6 2026-07-25T12:09:53+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-supplements-could-ease-painful-310959.html 0.6 2026-06-20T23:15:59+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-orphan-drug-designation-for-gi-310960.html 0.6 2026-08-09T15:10:21+08:00 daily https://www.pharmasources.com/industryinsights/romil-ups-ultra-lc-solvents-and-eluant-m-310961.html 0.6 2026-06-22T23:11:15+08:00 daily https://www.pharmasources.com/industryinsights/robotic-implant-aids-the-treatment-of-oe-310962.html 0.6 2026-01-11T20:22:51+08:00 daily https://www.pharmasources.com/industryinsights/fosmidomycin-piperaquine-combination-pro-310963.html 0.6 2026-06-20T21:07:02+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-allergopharma-plans-to-invest-310964.html 0.6 2026-08-01T21:23:19+08:00 daily https://www.pharmasources.com/industryinsights/prescription-labels-provide-insufficient-310965.html 0.6 2026-06-21T07:14:14+08:00 daily https://www.pharmasources.com/industryinsights/stem-cells-rebuild-neurons-protective-sh-310966.html 0.6 2026-07-03T12:20:23+08:00 daily https://www.pharmasources.com/industryinsights/how-are-the-first-lung-cancer-patients-t-310967.html 0.6 2026-08-05T23:55:49+08:00 daily https://www.pharmasources.com/industryinsights/questions-about-bms-celgene-integration--310968.html 0.6 2026-06-20T18:55:41+08:00 daily https://www.pharmasources.com/industryinsights/new-phase-3-data-paints-fuller-picture-f-310969.html 0.6 2025-12-12T10:25:32+08:00 daily https://www.pharmasources.com/industryinsights/primaquine-methylene-blue-combination-bl-310970.html 0.6 2026-06-22T00:35:33+08:00 daily https://www.pharmasources.com/industryinsights/nir-identifies-breast-cancer-patients-wh-310971.html 0.6 2026-08-09T07:59:50+08:00 daily https://www.pharmasources.com/industryinsights/sofosbuvir-found-to-be-effective-against-310972.html 0.6 2026-08-07T13:19:11+08:00 daily https://www.pharmasources.com/industryinsights/china-national-medical-products-administ-310973.html 0.6 2026-08-06T22:21:46+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019042-310974.html 0.6 2026-08-08T00:43:41+08:00 daily https://www.pharmasources.com/industryinsights/6000-non-smokers-die-of-lung-cancer-each-310975.html 0.6 2026-08-06T22:21:07+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-talzenna-leads-latest-chmp-highli-310976.html 0.6 2026-08-06T22:31:57+08:00 daily https://www.pharmasources.com/industryinsights/praulent-gets-fda-nod-for-heart-attack-a-310977.html 0.6 2026-08-06T23:32:27+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-victoza-found-to-cut-blood-310978.html 0.6 2026-08-07T23:46:21+08:00 daily https://www.pharmasources.com/industryinsights/zynquista-approved-in-eu-for-certain-pat-310979.html 0.6 2026-08-07T02:33:35+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-receives-075-m-under-mitsubish-310980.html 0.6 2026-08-07T02:39:41+08:00 daily https://www.pharmasources.com/industryinsights/santen-glaukos-collaborate-for-exclusive-310981.html 0.6 2026-08-07T02:51:55+08:00 daily https://www.pharmasources.com/industryinsights/teva-pharmaceuticals-issues-voluntary-na-310982.html 0.6 2026-08-07T05:05:51+08:00 daily https://www.pharmasources.com/industryinsights/illumina-reports-financial-results-for-f-310983.html 0.6 2026-06-24T09:15:59+08:00 daily https://www.pharmasources.com/industryinsights/nccs-raises-awareness-about-hereditary-c-310984.html 0.6 2026-06-21T06:00:46+08:00 daily https://www.pharmasources.com/industryinsights/acadia-pharma-initiates-ph3-clarity-prog-310985.html 0.6 2026-07-09T19:20:09+08:00 daily https://www.pharmasources.com/industryinsights/china-puts-focus-on-tackling-biomedical--310986.html 0.6 2026-06-20T15:42:43+08:00 daily https://www.pharmasources.com/industryinsights/asian-malaria-endgame-under-threat-310987.html 0.6 2026-06-21T15:14:47+08:00 daily https://www.pharmasources.com/industryinsights/smartgraft-technology-enters-australia-310988.html 0.6 2026-06-22T02:59:38+08:00 daily https://www.pharmasources.com/industryinsights/japanese-scientists-reveal-potential-of--310989.html 0.6 2026-07-08T01:03:09+08:00 daily https://www.pharmasources.com/industryinsights/iqvia-changing-healthcare-with-ai-ml-310990.html 0.6 2026-06-22T04:14:52+08:00 daily https://www.pharmasources.com/industryinsights/pharmapod-partners-with-fip-to-improve-p-310991.html 0.6 2026-06-21T03:40:28+08:00 daily https://www.pharmasources.com/industryinsights/alivecor-expands-into-chinese-heart-heal-310992.html 0.6 2026-06-21T00:57:52+08:00 daily https://www.pharmasources.com/industryinsights/application-to-ema-filed-for-the-approva-310993.html 0.6 2026-07-29T10:03:09+08:00 daily https://www.pharmasources.com/industryinsights/legal-ruling-confirms-that-routine-disco-310994.html 0.6 2026-06-20T14:04:13+08:00 daily https://www.pharmasources.com/industryinsights/combination-therapy-favourable-in-long-t-310995.html 0.6 2026-06-21T14:57:21+08:00 daily https://www.pharmasources.com/industryinsights/nicotinamide-riboside-repairs-features-o-310996.html 0.6 2026-08-07T01:19:39+08:00 daily https://www.pharmasources.com/industryinsights/medical-cannabis-significantly-safer-for-310997.html 0.6 2026-08-07T01:10:50+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivering-capsules-could-sustain-t-310998.html 0.6 2026-08-07T00:43:03+08:00 daily https://www.pharmasources.com/industryinsights/cancer-fighting-nano-robots-programmed-t-310999.html 0.6 2026-08-07T00:40:08+08:00 daily https://www.pharmasources.com/industryinsights/bm32-vaccine-developed-against-rhinitis-311000.html 0.6 2026-08-07T00:03:23+08:00 daily https://www.pharmasources.com/industryinsights/ultra-thin-optical-fibers-offer-new-way--311001.html 0.6 2026-08-06T23:54:18+08:00 daily https://www.pharmasources.com/industryinsights/triclosan-may-help-fight-drug-resistant--311002.html 0.6 2026-08-06T20:08:34+08:00 daily https://www.pharmasources.com/industryinsights/report-calls-into-question-effectiveness-311003.html 0.6 2026-08-06T23:54:41+08:00 daily https://www.pharmasources.com/industryinsights/3f4ap-tracer-can-measure-demyelination-i-311004.html 0.6 2026-08-09T23:54:22+08:00 daily https://www.pharmasources.com/industryinsights/rare-melanoma-type-highly-responsive-to--311005.html 0.6 2026-08-07T01:27:43+08:00 daily https://www.pharmasources.com/industryinsights/project-hercules-to-lead-way-in-duchenne-311006.html 0.6 2026-08-07T01:18:57+08:00 daily https://www.pharmasources.com/industryinsights/3d-printing-technique-creates-super-soft-311007.html 0.6 2026-08-07T01:11:16+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-powerful-technique-to-311008.html 0.6 2026-08-07T00:42:51+08:00 daily https://www.pharmasources.com/industryinsights/skin-patch-offers-solution-to-antibiotic-311009.html 0.6 2026-08-07T00:41:12+08:00 daily https://www.pharmasources.com/industryinsights/advances-in-pet-settle-debate-over-sprea-311010.html 0.6 2026-08-07T00:01:38+08:00 daily https://www.pharmasources.com/industryinsights/cardiff-met-develops-new-cancer-treatmen-311011.html 0.6 2026-08-06T23:55:24+08:00 daily https://www.pharmasources.com/industryinsights/kisqali-receives-breakthrough-therapy-de-311012.html 0.6 2026-08-06T23:45:35+08:00 daily https://www.pharmasources.com/industryinsights/silver-nanoparticles-improve-molecular-d-311013.html 0.6 2026-08-06T23:37:40+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-significantly-reverses-mem-311014.html 0.6 2026-08-06T23:41:09+08:00 daily https://www.pharmasources.com/industryinsights/heroin-vaccine-could-tackle-opioid-addic-311015.html 0.6 2026-08-06T23:45:49+08:00 daily https://www.pharmasources.com/industryinsights/researchers-define-alzheimers-like-brain-311016.html 0.6 2026-08-06T23:54:43+08:00 daily https://www.pharmasources.com/industryinsights/amgen-ignites-a-social-fitness-movement--311017.html 0.6 2026-08-06T23:58:05+08:00 daily https://www.pharmasources.com/industryinsights/possible-link-between-autism-and-antidep-311018.html 0.6 2026-08-07T12:11:18+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-new-am-311019.html 0.6 2026-08-07T13:17:06+08:00 daily https://www.pharmasources.com/industryinsights/amal-therapeutics-enters-clinical-collab-311020.html 0.6 2026-08-08T07:57:55+08:00 daily https://www.pharmasources.com/industryinsights/implandata-successfully-gains-ce-mark-fo-311021.html 0.6 2026-08-08T08:59:22+08:00 daily https://www.pharmasources.com/industryinsights/walnuts-may-help-lower-blood-pressure-fo-311022.html 0.6 2026-08-08T10:05:13+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-starts-artificial-intelligen-311023.html 0.6 2026-08-08T13:46:41+08:00 daily https://www.pharmasources.com/industryinsights/regis-technologies-2019-fda-inspection-y-311024.html 0.6 2026-08-08T12:18:40+08:00 daily https://www.pharmasources.com/industryinsights/can-pharma-expect-more-skilled-worker-vi-311025.html 0.6 2026-08-08T17:53:28+08:00 daily https://www.pharmasources.com/industryinsights/new-cell-culture-microbioreactor-system--311026.html 0.6 2026-08-08T20:05:20+08:00 daily https://www.pharmasources.com/industryinsights/novel-colorectal-cancer-vaccine-shows-po-311027.html 0.6 2026-08-08T15:50:05+08:00 daily https://www.pharmasources.com/industryinsights/micro-sphere-partnership-to-further-supp-311028.html 0.6 2026-08-09T07:15:45+08:00 daily https://www.pharmasources.com/industryinsights/long-lasting-opioid-treatment-recommende-311030.html 0.6 2026-06-21T11:13:47+08:00 daily https://www.pharmasources.com/industryinsights/brexits-trick-or-treat-on-patient-safety-311031.html 0.6 2026-06-22T10:56:47+08:00 daily https://www.pharmasources.com/industryinsights/catalent-invests-14-million-at-its-eberb-311032.html 0.6 2026-07-06T05:45:39+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-astellas-pharma-us-agree-to-se-311033.html 0.6 2026-08-02T22:38:14+08:00 daily https://www.pharmasources.com/industryinsights/hikma-introduces-100th-injectable-medici-311034.html 0.6 2026-06-21T16:40:22+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-syapse-enter-precision-medicin-311035.html 0.6 2026-06-21T04:17:00+08:00 daily https://www.pharmasources.com/industryinsights/100-million-is-to-be-invested-to-increas-311036.html 0.6 2026-08-03T07:30:36+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-transgene-to-develop-can-311037.html 0.6 2026-06-23T08:21:42+08:00 daily https://www.pharmasources.com/industryinsights/genkyotex-reports-mixed-efficacy-phase-i-311038.html 0.6 2026-06-20T18:17:52+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dengue-vaccine-secures-fda-appro-311039.html 0.6 2026-08-04T22:41:00+08:00 daily https://www.pharmasources.com/industryinsights/takeda-opens-drug-research-facility-in-c-311040.html 0.6 2026-06-20T17:00:19+08:00 daily https://www.pharmasources.com/industryinsights/heroin-vaccine-blocks-lethal-overdose-311041.html 0.6 2026-06-21T13:00:30+08:00 daily https://www.pharmasources.com/industryinsights/merck-increases-measles-vaccine-producti-311042.html 0.6 2026-08-07T14:43:56+08:00 daily https://www.pharmasources.com/industryinsights/gore-to-debut-gore-improject-plunger-for-311043.html 0.6 2026-08-08T19:21:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-label-of-first-universal-hep-311044.html 0.6 2026-06-21T17:16:52+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-signs-cancer-drug-deal-with-eirge-311045.html 0.6 2026-06-22T01:44:28+08:00 daily https://www.pharmasources.com/industryinsights/cabozantinib-shows-promise-as-first-line-311046.html 0.6 2026-06-22T07:01:54+08:00 daily https://www.pharmasources.com/industryinsights/eisai-acquires-rights-to-lemborexant-fro-311047.html 0.6 2026-06-22T21:10:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-forms-drug-discovery-allianc-311048.html 0.6 2026-04-15T21:33:28+08:00 daily https://www.pharmasources.com/industryinsights/comprehensive-tumor-profiling-promises-n-311049.html 0.6 2026-06-20T13:20:38+08:00 daily https://www.pharmasources.com/industryinsights/seed-financing-311050.html 0.6 2026-08-09T17:53:24+08:00 daily https://www.pharmasources.com/industryinsights/un-report-outlines-plan-to-address-antim-311051.html 0.6 2026-08-07T22:20:30+08:00 daily https://www.pharmasources.com/industryinsights/five-hepatitis-c-drugs-to-become-availab-311052.html 0.6 2026-06-20T17:57:20+08:00 daily https://www.pharmasources.com/industryinsights/niclosamide-could-lead-the-fight-against-311053.html 0.6 2026-06-21T01:57:07+08:00 daily https://www.pharmasources.com/industryinsights/single-dose-vaccine-could-provide-faster-311054.html 0.6 2026-06-20T19:18:02+08:00 daily https://www.pharmasources.com/industryinsights/gene-based-zika-vaccine-is-safe-and-immu-311055.html 0.6 2026-06-22T08:16:59+08:00 daily https://www.pharmasources.com/industryinsights/bioengineered-ovaries-found-to-be-more-e-311056.html 0.6 2026-06-20T17:52:38+08:00 daily https://www.pharmasources.com/industryinsights/lithium-chloride-prevents-brain-damage-l-311057.html 0.6 2026-06-21T02:55:56+08:00 daily https://www.pharmasources.com/industryinsights/simple-blood-test-may-predict-mri-diseas-311058.html 0.6 2026-07-08T13:51:07+08:00 daily https://www.pharmasources.com/industryinsights/highlights-of-cphi-china-2019-that-you-c-311059.html 0.6 2026-08-08T22:50:59+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-2019double-exhibition-in-the--311060.html 0.6 2026-07-12T12:42:40+08:00 daily https://www.pharmasources.com/industryinsights/pac-1-temozolomide-combination-shows-pro-311061.html 0.6 2026-06-21T08:59:02+08:00 daily https://www.pharmasources.com/industryinsights/antimalarial-drugs-could-support-existin-311062.html 0.6 2026-06-21T07:09:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-adds-boxed-warning-for-risk-of-serio-311063.html 0.6 2026-07-19T19:29:37+08:00 daily https://www.pharmasources.com/industryinsights/eisai-continues-alzheimers-research-adds-311064.html 0.6 2026-06-21T11:19:30+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-art-prevents-hiv-transmissio-311065.html 0.6 2026-06-20T19:18:55+08:00 daily https://www.pharmasources.com/industryinsights/the-superbug-that-has-swept-the-globe-br-311066.html 0.6 2026-06-21T04:56:42+08:00 daily https://www.pharmasources.com/industryinsights/big-pharma-can-only-see-the-benefit-of-r-311067.html 0.6 2026-06-20T19:11:44+08:00 daily https://www.pharmasources.com/industryinsights/sagent-pharmaceuticals-issues-voluntary--311068.html 0.6 2026-06-22T09:50:39+08:00 daily https://www.pharmasources.com/industryinsights/global-polyethylene-compound-market-esti-311069.html 0.6 2026-06-21T10:02:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ivosidenib-as-first-line-tr-311070.html 0.6 2026-06-21T02:59:48+08:00 daily https://www.pharmasources.com/industryinsights/anti-malaria-drug-shows-promise-as-zika--311071.html 0.6 2026-06-21T03:14:59+08:00 daily https://www.pharmasources.com/industryinsights/does-hormone-therapy-for-prostate-cancer-311072.html 0.6 2026-06-20T18:03:26+08:00 daily https://www.pharmasources.com/industryinsights/testosterone-supplements-not-all-theyre--311073.html 0.6 2026-07-24T14:07:01+08:00 daily https://www.pharmasources.com/industryinsights/primary-care-constitutes-minority-of-res-311074.html 0.6 2026-07-08T14:33:11+08:00 daily https://www.pharmasources.com/industryinsights/cardio-oncology-services-growing-in-numb-311075.html 0.6 2026-06-20T22:17:00+08:00 daily https://www.pharmasources.com/industryinsights/microbial-toxins-found-in-electronic-cig-311076.html 0.6 2026-06-30T23:24:57+08:00 daily https://www.pharmasources.com/industryinsights/aua-atenolol-linked-to-drop-in-low--inte-311077.html 0.6 2026-06-21T05:03:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-qternmet-xr-311078.html 0.6 2026-06-20T14:42:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dengvaxia-311079.html 0.6 2026-06-21T03:43:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mavyret-glecaprevir-and-pib-311080.html 0.6 2026-06-30T19:44:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-eticovo-311081.html 0.6 2026-06-23T01:08:24+08:00 daily https://www.pharmasources.com/industryinsights/neratinib-defeats-the-ras-genes-notoriou-311082.html 0.6 2026-06-20T18:58:42+08:00 daily https://www.pharmasources.com/industryinsights/experimental-ebola-vaccines-elicit-year--311083.html 0.6 2026-08-06T20:05:34+08:00 daily https://www.pharmasources.com/industryinsights/pi3k-inhibitors-show-hope-for-rare-bone--311084.html 0.6 2026-08-07T05:28:41+08:00 daily https://www.pharmasources.com/industryinsights/biopure-q-clamp-is-compatible-with-a-wid-311085.html 0.6 2026-08-07T05:30:55+08:00 daily https://www.pharmasources.com/industryinsights/microcapsules-to-enhance-the-efficiency--311086.html 0.6 2026-06-20T17:08:24+08:00 daily https://www.pharmasources.com/industryinsights/tk216-vincristine-combination-for-ewing--311087.html 0.6 2026-08-04T15:13:54+08:00 daily https://www.pharmasources.com/industryinsights/important-finding-by-chinese-scientists--311088.html 0.6 2026-08-06T23:56:02+08:00 daily https://www.pharmasources.com/industryinsights/computer-model-shows-an-optimal-anti-amy-311089.html 0.6 2026-08-06T22:09:17+08:00 daily https://www.pharmasources.com/industryinsights/proposed-guidelines-for-handling-car-t-c-311090.html 0.6 2026-08-06T20:06:46+08:00 daily https://www.pharmasources.com/industryinsights/ala-artemisinin-combination-therapy-for--311091.html 0.6 2026-06-21T13:01:32+08:00 daily https://www.pharmasources.com/industryinsights/mri-effective-in-detecting-postpartum-br-311092.html 0.6 2026-08-06T22:21:23+08:00 daily https://www.pharmasources.com/industryinsights/good-news-for-azs-next-phase-of-growth-i-311093.html 0.6 2026-08-09T19:15:12+08:00 daily https://www.pharmasources.com/industryinsights/one-vaccine-injection-could-carry-many-d-311094.html 0.6 2026-08-06T23:47:25+08:00 daily https://www.pharmasources.com/industryinsights/z-endoxifen-shows-promise-for-breast-can-311095.html 0.6 2026-06-22T04:15:10+08:00 daily https://www.pharmasources.com/industryinsights/gsk-chases-trelegy-asthma-nod-with-mixed-311096.html 0.6 2026-06-21T15:52:28+08:00 daily https://www.pharmasources.com/industryinsights/mri-can-measure-kidney-scarring-and-pred-311097.html 0.6 2026-07-22T15:51:32+08:00 daily https://www.pharmasources.com/industryinsights/researchers-define-alzheimers-like-brain-311098.html 0.6 2026-06-21T10:04:13+08:00 daily https://www.pharmasources.com/industryinsights/new-imaging-technique-may-predict-the-sp-311099.html 0.6 2026-07-24T12:02:11+08:00 daily https://www.pharmasources.com/industryinsights/smc-recommends-three-new-medicines-for-r-311100.html 0.6 2026-06-20T18:50:30+08:00 daily https://www.pharmasources.com/industryinsights/can-pharma-expect-more-skilled-worker-vi-311101.html 0.6 2026-06-20T16:11:47+08:00 daily https://www.pharmasources.com/industryinsights/regis-technologies-2019-fda-inspection-y-311102.html 0.6 2026-06-21T02:44:43+08:00 daily https://www.pharmasources.com/industryinsights/merck-has-supplies-in-hand-as-measles-ca-311103.html 0.6 2026-06-20T17:57:30+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dengue-vaccine-secures-fda-appro-311104.html 0.6 2026-07-30T14:25:46+08:00 daily https://www.pharmasources.com/industryinsights/manufacturing-growth-sees-surging-demand-311105.html 0.6 2026-06-21T17:14:41+08:00 daily https://www.pharmasources.com/industryinsights/tessa-therapeutics-baylor-college-of-med-311106.html 0.6 2026-06-20T21:07:20+08:00 daily https://www.pharmasources.com/industryinsights/dariohealth-partners-with-the-american-d-311107.html 0.6 2026-05-06T16:47:54+08:00 daily https://www.pharmasources.com/industryinsights/meet-eppendorf-at-labvolution-2019-disco-311108.html 0.6 2026-06-20T19:12:01+08:00 daily https://www.pharmasources.com/industryinsights/prima-temp-announces-new-leadership-inve-311109.html 0.6 2026-06-22T15:24:28+08:00 daily https://www.pharmasources.com/industryinsights/medi-futures-signs-mou-with-suhb-for-cli-311110.html 0.6 2026-08-08T21:19:47+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-signs-contract-with-gi-311111.html 0.6 2026-08-07T05:58:15+08:00 daily https://www.pharmasources.com/industryinsights/axt-offers-organ-on-chip-systems-in-asia-311112.html 0.6 2026-08-09T01:30:53+08:00 daily https://www.pharmasources.com/industryinsights/polyu-develops-novel-3d-ultrasound-imagi-311113.html 0.6 2026-06-22T14:34:45+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-cttq-unite-to-discover-de-311114.html 0.6 2026-06-21T05:13:19+08:00 daily https://www.pharmasources.com/industryinsights/jci-selects-hbmsu-to-improve-quality-and-311115.html 0.6 2026-07-07T03:12:32+08:00 daily https://www.pharmasources.com/industryinsights/delopen-announces-its-scientific-advisor-311116.html 0.6 2026-06-30T05:40:37+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-to-enhance-biometrics-servic-311117.html 0.6 2026-07-28T10:50:16+08:00 daily https://www.pharmasources.com/industryinsights/nccs-reveals-potential-of-a-new-genomic--311118.html 0.6 2026-06-20T22:15:49+08:00 daily https://www.pharmasources.com/industryinsights/new-menb-awareness-drive-backs-up-vaccin-311119.html 0.6 2026-06-23T17:05:15+08:00 daily https://www.pharmasources.com/industryinsights/real-patients-are-all-the-rage-in-pharma-311120.html 0.6 2026-06-21T00:01:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-speeds-bayers-jj-pfizer-showdown-wit-311121.html 0.6 2026-07-03T16:17:17+08:00 daily https://www.pharmasources.com/industryinsights/teva-amid-massive-restructuring-closes-i-311122.html 0.6 2026-06-22T01:12:03+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-avastin-lung-cancer-com-311123.html 0.6 2026-06-20T19:12:02+08:00 daily https://www.pharmasources.com/industryinsights/indivior-slashes-sales-projections-almos-311124.html 0.6 2026-06-20T22:02:41+08:00 daily https://www.pharmasources.com/industryinsights/insys-founder-kapoor-found-guilty-in-lan-311125.html 0.6 2026-06-22T02:59:39+08:00 daily https://www.pharmasources.com/industryinsights/endo-ceo-campanelli-nabs-almost-20m-in-2-311126.html 0.6 2026-08-07T05:05:36+08:00 daily https://www.pharmasources.com/industryinsights/non-invasive-technique-for-probing-cells-311127.html 0.6 2026-06-22T07:15:27+08:00 daily https://www.pharmasources.com/industryinsights/lonza-pharmabiotech-launches-ibex-soluti-311128.html 0.6 2026-06-20T15:07:25+08:00 daily https://www.pharmasources.com/industryinsights/new-gasket-and-braided-hose-range-from-b-311129.html 0.6 2026-06-20T18:51:32+08:00 daily https://www.pharmasources.com/industryinsights/rainins-calibration-service-helps-ensure-311130.html 0.6 2026-01-16T06:44:10+08:00 daily https://www.pharmasources.com/industryinsights/growth-in-next-generation-sequencing-inf-311131.html 0.6 2026-06-21T20:49:37+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-3-drugs-for-treating-plaqu-311132.html 0.6 2026-02-28T13:16:50+08:00 daily https://www.pharmasources.com/industryinsights/camo-releases-new-approach-to-modeling-a-311133.html 0.6 2026-06-22T08:07:51+08:00 daily https://www.pharmasources.com/industryinsights/eu-approval-for-regeneron-and-sanofis-rh-311134.html 0.6 2026-07-06T16:13:50+08:00 daily https://www.pharmasources.com/industryinsights/novartis-bristol-myers-squibb-to-collabo-311135.html 0.6 2026-04-25T21:36:47+08:00 daily https://www.pharmasources.com/industryinsights/atlantic-develops-tablet-formulations-of-311136.html 0.6 2026-06-21T08:13:08+08:00 daily https://www.pharmasources.com/industryinsights/quantum-dots-to-shine-bright-with-romil--311137.html 0.6 2026-04-13T17:29:03+08:00 daily https://www.pharmasources.com/industryinsights/new-canadian-clinical-guideline-for-phys-311138.html 0.6 2026-06-21T03:40:31+08:00 daily https://www.pharmasources.com/industryinsights/syrris-to-launch-titan-continuous-proces-311139.html 0.6 2026-06-22T02:57:55+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-kali-care-to-develop-medica-311140.html 0.6 2026-06-21T03:40:15+08:00 daily https://www.pharmasources.com/industryinsights/braeburn-and-camurus-phase-iii-opioid-us-311141.html 0.6 2026-06-21T04:00:44+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-new-formulation-tablets-rec-311142.html 0.6 2026-08-07T23:26:34+08:00 daily https://www.pharmasources.com/industryinsights/cherwell-laboratories-to-highlight-clean-311143.html 0.6 2026-06-21T16:45:31+08:00 daily https://www.pharmasources.com/industryinsights/sirt-is-better-tolerated-than-sorafenib--311144.html 0.6 2026-06-21T00:13:51+08:00 daily https://www.pharmasources.com/industryinsights/nanoscale-diamond-racetrack-becomes-brea-311145.html 0.6 2026-06-21T09:56:04+08:00 daily https://www.pharmasources.com/industryinsights/raman-scattering-for-non-invasive-prosta-311146.html 0.6 2026-06-21T13:00:39+08:00 daily https://www.pharmasources.com/industryinsights/enzyme-indicators-new-technology-for-dec-311147.html 0.6 2026-06-20T22:02:40+08:00 daily https://www.pharmasources.com/industryinsights/dolomite-microfluidics-mitos-p-pumps-ena-311148.html 0.6 2026-07-08T07:49:17+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-enrols-last-patient-in-311149.html 0.6 2026-06-21T22:57:44+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-globally-co-commercialise-am-311150.html 0.6 2026-06-12T05:46:47+08:00 daily https://www.pharmasources.com/industryinsights/rainin-terrarack-benefits-cell-different-311151.html 0.6 2026-03-24T18:29:49+08:00 daily https://www.pharmasources.com/industryinsights/aesica-adds-development-capability-with--311152.html 0.6 2026-06-21T11:07:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatments-vyndaqel-taf-311153.html 0.6 2026-06-20T21:18:30+08:00 daily https://www.pharmasources.com/industryinsights/newer-diabetes-drugs-linked-to-flesh-eat-311154.html 0.6 2026-06-21T13:10:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-french-soft-ripened-cheese-possibly--311155.html 0.6 2026-06-21T01:59:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatments-for-heart-failur-311156.html 0.6 2026-06-21T03:48:31+08:00 daily https://www.pharmasources.com/industryinsights/world-asthma-day-can-fevipiprant-revolut-311157.html 0.6 2026-07-29T21:32:01+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-increase-patient-centric-dos-311158.html 0.6 2026-06-20T18:10:28+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-acquisition-enhances-its-bio-311159.html 0.6 2026-07-22T18:52:23+08:00 daily https://www.pharmasources.com/industryinsights/sgs-implements-veeva-vault-clinical-tria-311160.html 0.6 2026-07-08T02:38:11+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-syapse-enter-precision-medicin-311161.html 0.6 2026-07-09T00:10:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatments-for-heart-di-311162.html 0.6 2026-06-21T09:00:59+08:00 daily https://www.pharmasources.com/industryinsights/researchers-define-alzheimers-like-brain-311163.html 0.6 2026-06-21T02:08:42+08:00 daily https://www.pharmasources.com/industryinsights/enhance-your-workflow-efficiency-with-ra-311164.html 0.6 2026-07-07T16:46:33+08:00 daily https://www.pharmasources.com/industryinsights/intellicyt-cy-clone-plus-311165.html 0.6 2026-06-20T18:21:58+08:00 daily https://www.pharmasources.com/industryinsights/nice-asks-bms-for-more-data-before-appro-311166.html 0.6 2026-06-20T15:26:45+08:00 daily https://www.pharmasources.com/industryinsights/shimadzus-new-triple-quadrupole-gcms-ach-311167.html 0.6 2026-06-20T16:02:27+08:00 daily https://www.pharmasources.com/industryinsights/waters-adds-metlin-msms-library-to-proge-311168.html 0.6 2026-04-06T07:06:37+08:00 daily https://www.pharmasources.com/industryinsights/high-efficacy-0-adverse-effects-in-hemp--311169.html 0.6 2026-06-20T16:00:14+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-acquires-core-i-311170.html 0.6 2026-06-21T06:00:09+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-to-purchase-abide-therapeutics--311171.html 0.6 2026-06-21T14:31:19+08:00 daily https://www.pharmasources.com/industryinsights/skyhawk-and-takeda-partner-to-develop-sm-311172.html 0.6 2026-06-21T08:13:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-drugs-for-transthyr-311173.html 0.6 2026-06-21T05:00:45+08:00 daily https://www.pharmasources.com/industryinsights/radiology-residents-often-miss-child-abu-311174.html 0.6 2026-06-20T20:15:12+08:00 daily https://www.pharmasources.com/industryinsights/oral-aspirin-does-not-up-fit-test-sensit-311175.html 0.6 2026-06-21T16:58:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ruzurgi-for-children-with-r-311176.html 0.6 2026-06-27T14:51:23+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-healthcare-pfizers-biosimilar--311177.html 0.6 2026-06-21T10:06:14+08:00 daily https://www.pharmasources.com/industryinsights/burden-of-heart-failure-related-cvd-mort-311178.html 0.6 2026-06-21T11:01:14+08:00 daily https://www.pharmasources.com/industryinsights/cdc-pregnancy-related-deaths-occur-befor-311179.html 0.6 2026-08-08T05:20:04+08:00 daily https://www.pharmasources.com/industryinsights/custom-to-build-20-million-pharmaceutica-311180.html 0.6 2026-06-21T08:54:54+08:00 daily https://www.pharmasources.com/industryinsights/shame-around-mental-illness-may-be-fadin-311181.html 0.6 2026-06-20T14:54:05+08:00 daily https://www.pharmasources.com/industryinsights/many-pregnancy-related-maternal-deaths-o-311182.html 0.6 2026-06-21T05:16:59+08:00 daily https://www.pharmasources.com/industryinsights/smaller-and-faster-mira-m-3-handheld-ram-311183.html 0.6 2026-04-09T20:06:49+08:00 daily https://www.pharmasources.com/industryinsights/military-tourniquets-might-save-kids-liv-311184.html 0.6 2026-06-21T13:07:37+08:00 daily https://www.pharmasources.com/industryinsights/weight-before-pregnancy-most-important-t-311185.html 0.6 2026-07-17T09:48:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ruzurgi-amifampridine-for-c-311186.html 0.6 2026-06-22T03:46:40+08:00 daily https://www.pharmasources.com/industryinsights/novartis-presents-first-of-its-kind-algo-311187.html 0.6 2026-07-27T15:41:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatments-vyndaqel-taf-311188.html 0.6 2026-08-08T03:02:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-qternmet-xr-dapagliflozin-s-311189.html 0.6 2026-07-22T20:57:09+08:00 daily https://www.pharmasources.com/industryinsights/agios-announces-fda-approval-of-tibsovo--311190.html 0.6 2026-07-21T10:04:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dengvaxia-dengue-vaccine-fo-311191.html 0.6 2026-06-21T01:43:24+08:00 daily https://www.pharmasources.com/industryinsights/researchers-define-alzheimers-like-brain-311192.html 0.6 2026-07-08T19:21:07+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-therapeutics-receives-complete-r-311193.html 0.6 2026-06-22T01:39:19+08:00 daily https://www.pharmasources.com/industryinsights/avexis-presented-robust-data-at-aan-demo-311194.html 0.6 2026-06-21T05:14:54+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-311195.html 0.6 2026-06-21T08:04:04+08:00 daily https://www.pharmasources.com/industryinsights/celgene-corporation-and-bluebird-bio-ann-311196.html 0.6 2026-06-20T23:09:45+08:00 daily https://www.pharmasources.com/industryinsights/oral-aspirin-does-not-up-fit-test-sensit-311197.html 0.6 2026-06-20T16:58:16+08:00 daily https://www.pharmasources.com/industryinsights/esact-inaugural-innovation-award-to-hono-311198.html 0.6 2026-06-20T18:57:37+08:00 daily https://www.pharmasources.com/industryinsights/wise-enrols-first-patient-in-pivotal-cli-311199.html 0.6 2026-06-22T09:05:48+08:00 daily https://www.pharmasources.com/industryinsights/report-shows-us-brand-name-drug-prices-h-311200.html 0.6 2026-07-09T07:07:37+08:00 daily https://www.pharmasources.com/industryinsights/eu-approval-for-sanofis-type-2-diabetes--311201.html 0.6 2026-06-21T13:05:04+08:00 daily https://www.pharmasources.com/industryinsights/future-proofing-311202.html 0.6 2026-06-21T10:05:14+08:00 daily https://www.pharmasources.com/industryinsights/astells-autoclave-fills-unmet-medical-an-311203.html 0.6 2026-06-24T22:25:58+08:00 daily https://www.pharmasources.com/industryinsights/the-buzz-about-nanosponge-sers-and-trace-311204.html 0.6 2026-06-21T14:56:56+08:00 daily https://www.pharmasources.com/industryinsights/linkam-launches-a-new-platform-to-replic-311205.html 0.6 2026-07-03T22:40:14+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-infinity-to-col-311206.html 0.6 2026-07-31T06:28:37+08:00 daily https://www.pharmasources.com/industryinsights/ruzurgii-feature-drug-approved-for-autoi-311207.html 0.6 2026-06-21T22:12:51+08:00 daily https://www.pharmasources.com/industryinsights/alternate-methods-result-in-more-precise-311208.html 0.6 2026-06-21T09:07:09+08:00 daily https://www.pharmasources.com/industryinsights/dupixent-approved-for-severe-asthma-by-e-311209.html 0.6 2026-07-04T01:37:44+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-announces-fda-approval-of-ind--311210.html 0.6 2026-06-22T06:04:08+08:00 daily https://www.pharmasources.com/industryinsights/par-pharmaceutical-issues-recall-of-one--311211.html 0.6 2026-03-19T22:14:14+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-announces-additional-positive--311212.html 0.6 2026-07-19T13:32:30+08:00 daily https://www.pharmasources.com/industryinsights/radcliffe-group-ltd-appoints-non-executi-311213.html 0.6 2026-06-20T18:10:28+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-announces-fam--trastuzuma-311214.html 0.6 2026-06-21T05:10:49+08:00 daily https://www.pharmasources.com/industryinsights/targovax-announces-completed-enrollment--311215.html 0.6 2026-07-17T04:20:25+08:00 daily https://www.pharmasources.com/industryinsights/aklrd-nordic-bioscience-collaborate-to-s-311216.html 0.6 2026-06-21T05:47:39+08:00 daily https://www.pharmasources.com/industryinsights/preablation-bariatric-surgery-linked-to--311217.html 0.6 2026-06-21T00:04:44+08:00 daily https://www.pharmasources.com/industryinsights/prices-will-soon-be-included-in-tv-drug--311218.html 0.6 2026-06-22T02:58:43+08:00 daily https://www.pharmasources.com/industryinsights/less-invasive-mastectomy-an-option-for-m-311219.html 0.6 2026-06-21T15:10:35+08:00 daily https://www.pharmasources.com/industryinsights/scientology-cruise-ship-passengers-crew--311220.html 0.6 2026-06-21T00:03:38+08:00 daily https://www.pharmasources.com/industryinsights/window-for-safe-use-of-clot-buster-tpa-w-311221.html 0.6 2026-06-21T21:58:40+08:00 daily https://www.pharmasources.com/industryinsights/after-concussions-some-ex-athletes-show--311222.html 0.6 2026-06-21T15:14:59+08:00 daily https://www.pharmasources.com/industryinsights/an-antibiotic-alternative-using-a-virus--311223.html 0.6 2026-06-21T06:17:07+08:00 daily https://www.pharmasources.com/industryinsights/new-treatment-guideline-focuses-on-toure-311224.html 0.6 2026-08-06T20:20:33+08:00 daily https://www.pharmasources.com/industryinsights/gilead-announces-topline-data-from-phase-311225.html 0.6 2026-07-24T13:55:21+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-establish-an-access-program-for-311226.html 0.6 2026-07-04T07:27:20+08:00 daily https://www.pharmasources.com/industryinsights/haseeb-ahmad-has-been-named-as-the-new-p-311227.html 0.6 2026-06-21T00:57:51+08:00 daily https://www.pharmasources.com/industryinsights/haseeb-ahmad-has-been-named-as-the-new-p-311228.html 0.6 2026-06-29T02:43:20+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-introduces-new--311229.html 0.6 2026-06-21T20:59:39+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-introduces-new--311230.html 0.6 2026-04-16T01:42:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-treatments-for-heart--311231.html 0.6 2026-06-20T23:56:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-treatments-for-heart--311232.html 0.6 2026-06-21T04:00:42+08:00 daily https://www.pharmasources.com/industryinsights/new-digital-filter-aims-to-improve-chemi-311233.html 0.6 2026-06-23T03:14:24+08:00 daily https://www.pharmasources.com/industryinsights/new-digital-filter-aims-to-improve-chemi-311234.html 0.6 2026-06-21T15:48:17+08:00 daily https://www.pharmasources.com/industryinsights/about-one-third-of-the-revenues-generate-311235.html 0.6 2026-06-21T14:53:19+08:00 daily https://www.pharmasources.com/industryinsights/verve-therapeutics-to-develop-cardiovasc-311236.html 0.6 2026-06-22T07:57:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-paediatric-lems-drug-311237.html 0.6 2026-06-21T22:50:54+08:00 daily https://www.pharmasources.com/industryinsights/bicycle-and-ddf-collaborate-on-drug-deve-311238.html 0.6 2026-06-21T13:11:35+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-acquire-takedas-dry-eye-trea-311239.html 0.6 2026-07-22T18:01:46+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sector-posts-47-deals-worth-77-bn-311240.html 0.6 2026-08-05T23:05:34+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-daiichi-sankyos-trastuzumab--311241.html 0.6 2026-06-20T19:50:25+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-buy-therachon-for-340-million--311242.html 0.6 2026-06-21T05:03:44+08:00 daily https://www.pharmasources.com/industryinsights/gilead-partners-with-goldfinch-bio-to-de-311243.html 0.6 2026-06-13T17:18:07+08:00 daily https://www.pharmasources.com/industryinsights/us-finalises-rule-requiring-drugmakers-t-311244.html 0.6 2026-06-22T09:32:10+08:00 daily https://www.pharmasources.com/industryinsights/ifm-therapeutics-and-novartis-complete-p-311245.html 0.6 2026-06-21T10:02:07+08:00 daily https://www.pharmasources.com/industryinsights/mustang-bio-announces-city-of-hope-opens-311246.html 0.6 2026-06-21T04:19:03+08:00 daily https://www.pharmasources.com/industryinsights/amerigen-announces-fda-approval-for-gene-311247.html 0.6 2026-06-21T06:17:05+08:00 daily https://www.pharmasources.com/industryinsights/protagonist-therapeutics-expands-ptg-200-311248.html 0.6 2026-06-21T11:08:18+08:00 daily https://www.pharmasources.com/industryinsights/innovative-cellular-therapeutics-announc-311249.html 0.6 2026-08-07T04:30:55+08:00 daily https://www.pharmasources.com/industryinsights/vibegron-effective-and-safe-for-treating-311250.html 0.6 2026-08-07T04:21:43+08:00 daily https://www.pharmasources.com/industryinsights/scholar-rock-announces-initiation-of-pat-311251.html 0.6 2026-08-07T04:04:00+08:00 daily https://www.pharmasources.com/industryinsights/prometic-strengthens-its-leadership-with-311252.html 0.6 2026-08-07T03:55:19+08:00 daily https://www.pharmasources.com/industryinsights/physical-therapy-superior-to-steroid-inj-311253.html 0.6 2026-08-09T00:37:24+08:00 daily https://www.pharmasources.com/industryinsights/emd-millipore-introduces-drypour-packagi-311254.html 0.6 2026-08-06T06:30:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-identifies-harm-reported-from-sudden-311255.html 0.6 2026-08-06T22:08:41+08:00 daily https://www.pharmasources.com/industryinsights/waylivra-granted-conditional-marketing-a-311256.html 0.6 2026-08-06T22:00:11+08:00 daily https://www.pharmasources.com/industryinsights/amr-could-cause-10-million-deaths-per-ye-311257.html 0.6 2026-08-06T22:08:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-vyndaqel-vyndamax-win-us-nod-for-311258.html 0.6 2026-08-07T13:16:46+08:00 daily https://www.pharmasources.com/industryinsights/eu-approval-for-palynziq-in-adult-phenyl-311259.html 0.6 2026-06-22T09:56:41+08:00 daily https://www.pharmasources.com/industryinsights/az-calquence-trial-to-stop-early-after-h-311260.html 0.6 2026-08-08T03:25:18+08:00 daily https://www.pharmasources.com/industryinsights/final-week-to-book-tickets-for-the-inter-311261.html 0.6 2026-08-08T02:55:44+08:00 daily https://www.pharmasources.com/industryinsights/prostate-cancer-mutation-found-to-triple-311262.html 0.6 2026-08-07T13:19:12+08:00 daily https://www.pharmasources.com/industryinsights/vectura-wins-patent-litigation-battle-ag-311263.html 0.6 2026-08-07T00:39:55+08:00 daily https://www.pharmasources.com/industryinsights/roche-launches-her2-biomarker-test-for-b-311264.html 0.6 2026-08-06T23:57:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-hits-acacia-with-another-rejection-c-311265.html 0.6 2026-08-06T23:54:12+08:00 daily https://www.pharmasources.com/industryinsights/nhs-improvements-to-give-patients-faster-311266.html 0.6 2026-08-06T23:47:44+08:00 daily https://www.pharmasources.com/industryinsights/the-price-of-access-can-the-nhs-afford-o-311267.html 0.6 2026-08-06T23:56:36+08:00 daily https://www.pharmasources.com/industryinsights/new-report-reveals-priorities-for-local--311268.html 0.6 2026-06-21T21:01:39+08:00 daily https://www.pharmasources.com/industryinsights/gilead-goldfinch-to-team-up-against-kidn-311269.html 0.6 2026-08-07T13:57:45+08:00 daily https://www.pharmasources.com/industryinsights/az-daiichi-her-2-drug-shows-promise-in-m-311270.html 0.6 2026-08-08T10:49:48+08:00 daily https://www.pharmasources.com/industryinsights/eisai-dementia-research-institute-join-f-311271.html 0.6 2026-08-08T12:07:41+08:00 daily https://www.pharmasources.com/industryinsights/ocrevus-finally-available-on-nhs-311272.html 0.6 2026-08-08T13:17:55+08:00 daily https://www.pharmasources.com/industryinsights/eu-approval-for-palynziq-in-adult-phenyl-311273.html 0.6 2026-08-09T07:56:40+08:00 daily https://www.pharmasources.com/industryinsights/industry-key-to-boosting-health-and-medi-311274.html 0.6 2026-07-03T23:59:55+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-opens-new-manufacturing-faci-311275.html 0.6 2026-06-21T07:00:03+08:00 daily https://www.pharmasources.com/industryinsights/promethera-biosciences-makes-progress-in-311276.html 0.6 2026-06-21T01:01:49+08:00 daily https://www.pharmasources.com/industryinsights/wise-enrolls-first-patient-in-pivotal-cl-311277.html 0.6 2026-06-21T11:49:57+08:00 daily https://www.pharmasources.com/industryinsights/rapid-medical-announces-fda-approval-for-311278.html 0.6 2026-07-04T15:46:27+08:00 daily https://www.pharmasources.com/industryinsights/nucleai-announces-partnership-with-prote-311279.html 0.6 2026-06-20T14:50:07+08:00 daily https://www.pharmasources.com/industryinsights/henlius-biosimilar-hlx02-gets-nda-accept-311280.html 0.6 2026-07-20T17:09:05+08:00 daily https://www.pharmasources.com/industryinsights/promethera-biosciences-completes-397-m-s-311281.html 0.6 2026-04-16T04:34:06+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-calquence-phase-iii-ascend--311282.html 0.6 2026-07-02T03:46:56+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo--astrazenecas-breast-canc-311283.html 0.6 2026-06-20T23:57:37+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-eli-lilly-has-announc-311284.html 0.6 2026-06-22T08:59:46+08:00 daily https://www.pharmasources.com/industryinsights/dupixents-on-a-roll-in-eczema-and-asthma-311285.html 0.6 2026-06-27T19:20:28+08:00 daily https://www.pharmasources.com/industryinsights/mercks-gardasil-blockbuster-sales-prompt-311286.html 0.6 2026-06-20T20:59:38+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sees-saudi-arabia-as-promising--311287.html 0.6 2026-06-20T15:11:19+08:00 daily https://www.pharmasources.com/industryinsights/takeda-sells-shires-xiidra-transfers-400-311288.html 0.6 2026-08-04T16:59:08+08:00 daily https://www.pharmasources.com/industryinsights/dont-worry-about-our-19b-bond-issue-bms--311289.html 0.6 2026-07-22T17:23:20+08:00 daily https://www.pharmasources.com/industryinsights/rejected-by-the-fda-ionis-and-akceas-way-311290.html 0.6 2026-08-09T22:26:15+08:00 daily https://www.pharmasources.com/industryinsights/novartis-blockbuster-to-be-mayzent-helps-311291.html 0.6 2026-06-25T11:41:49+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-tees-up-pga-champ-day-to-pus-311292.html 0.6 2026-07-17T14:10:54+08:00 daily https://www.pharmasources.com/industryinsights/amarin-defends-vascepas-cv-prevention-da-311293.html 0.6 2026-06-20T20:55:49+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-ironwoods-ibs-c-push-links--311294.html 0.6 2026-07-11T11:16:48+08:00 daily https://www.pharmasources.com/industryinsights/dupixents-on-a-roll-in-eczema-and-asthma-311295.html 0.6 2026-06-23T00:30:58+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-for-huntington-lowers-levels-of-311296.html 0.6 2026-06-23T11:28:19+08:00 daily https://www.pharmasources.com/industryinsights/genetic-therapy-heals-damage-caused-by-h-311297.html 0.6 2026-07-11T16:03:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-childre-311298.html 0.6 2026-06-20T14:04:22+08:00 daily https://www.pharmasources.com/industryinsights/trastuzumab-deruxtecan-demonstrated-clin-311299.html 0.6 2026-07-28T03:56:14+08:00 daily https://www.pharmasources.com/industryinsights/generic-version-of-truvada-available-in--311300.html 0.6 2026-06-21T10:47:14+08:00 daily https://www.pharmasources.com/industryinsights/is-the-county-you-call-home-a-potential--311301.html 0.6 2026-06-22T13:00:57+08:00 daily https://www.pharmasources.com/industryinsights/acs-sets-goal-to-cut-cancer-mortality-40-311302.html 0.6 2026-08-07T04:41:34+08:00 daily https://www.pharmasources.com/industryinsights/cdc-hiv-racial-disparity-measure-decreas-311303.html 0.6 2026-08-06T19:09:19+08:00 daily https://www.pharmasources.com/industryinsights/2018-saw-more-employed-physicians-than-s-311304.html 0.6 2026-06-20T19:05:47+08:00 daily https://www.pharmasources.com/industryinsights/summer-is-tough-for-asthma-sufferers-311305.html 0.6 2026-06-22T22:13:12+08:00 daily https://www.pharmasources.com/industryinsights/brief-ems-training-saves-lives-after-bra-311306.html 0.6 2026-06-24T12:43:40+08:00 daily https://www.pharmasources.com/industryinsights/hepatitis-a-infections-soaring-cdc-311307.html 0.6 2026-06-24T01:58:02+08:00 daily https://www.pharmasources.com/industryinsights/nut-intake-in-first-trimester-may-benefi-311308.html 0.6 2026-06-23T19:00:26+08:00 daily https://www.pharmasources.com/industryinsights/new-ultra-convenient-solid-phase-extract-311309.html 0.6 2026-06-22T19:17:42+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-divest-dry-eye-drug-to-novarti-311310.html 0.6 2026-07-06T22:04:38+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gets-ec-approval-for-dupixent-to--311311.html 0.6 2026-07-31T19:30:57+08:00 daily https://www.pharmasources.com/industryinsights/who-calls-for-expanded-ebola-vaccination-311312.html 0.6 2026-06-21T03:10:52+08:00 daily https://www.pharmasources.com/industryinsights/researchers-define-alzheimers-like-brain-311313.html 0.6 2026-06-21T22:06:55+08:00 daily https://www.pharmasources.com/industryinsights/provectus-appoints-coo-311314.html 0.6 2026-07-10T04:22:32+08:00 daily https://www.pharmasources.com/industryinsights/crown-bioscience-opens-new-san-diego-cen-311315.html 0.6 2025-12-02T13:20:35+08:00 daily https://www.pharmasources.com/industryinsights/bayer-invests-150m-to-build-cell-culture-311316.html 0.6 2026-06-21T04:00:54+08:00 daily https://www.pharmasources.com/industryinsights/intelgenx-aquestive-enter-ed-collaborati-311317.html 0.6 2026-06-24T10:57:14+08:00 daily https://www.pharmasources.com/industryinsights/gilead-goldfinch-enter-kidney-collaborat-311318.html 0.6 2026-08-04T09:07:46+08:00 daily https://www.pharmasources.com/industryinsights/cytrx-announces-patent-issued-for-aldoxo-311319.html 0.6 2026-06-24T01:14:08+08:00 daily https://www.pharmasources.com/industryinsights/research-point-global-and-wuxi-cds-to-re-311320.html 0.6 2026-07-25T00:30:15+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-biosys-selects-cdd-vault-to-com-311321.html 0.6 2026-06-20T19:49:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-takedas-bla-for-a-subcutaneo-311322.html 0.6 2026-06-21T03:57:40+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-announces-top-line-result-311323.html 0.6 2026-06-20T22:56:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-document-regarding-extendin-311324.html 0.6 2026-08-02T16:10:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-acquire-xiidra-311325.html 0.6 2026-06-21T07:18:23+08:00 daily https://www.pharmasources.com/industryinsights/haseeb-ahmad-named-new-abpi-president-311326.html 0.6 2026-07-05T10:25:55+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-opdivo-fails-to-hi-311327.html 0.6 2026-06-20T14:35:26+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-ocrevus-in-primary-pro-311328.html 0.6 2026-06-22T05:05:42+08:00 daily https://www.pharmasources.com/industryinsights/bayer-joins-sensyne-health-consortium-fo-311329.html 0.6 2026-06-21T04:12:55+08:00 daily https://www.pharmasources.com/industryinsights/successful-digital-health-hub-pilot-show-311330.html 0.6 2026-07-29T11:56:59+08:00 daily https://www.pharmasources.com/industryinsights/az-transgene-to-collaborate-on-immunothe-311331.html 0.6 2026-06-22T06:01:39+08:00 daily https://www.pharmasources.com/industryinsights/spectrum-announces-asset-purchase-and-li-311332.html 0.6 2026-08-09T20:05:43+08:00 daily https://www.pharmasources.com/industryinsights/c3j-therapeutics-and-ampliphi-bioscience-311333.html 0.6 2026-06-20T21:01:42+08:00 daily https://www.pharmasources.com/industryinsights/lupin-and-aptissen-announce-exclusive-di-311334.html 0.6 2026-06-20T18:06:24+08:00 daily https://www.pharmasources.com/industryinsights/icers-evidence-report-finds-esketamine-m-311335.html 0.6 2026-06-21T23:03:45+08:00 daily https://www.pharmasources.com/industryinsights/icers-evidence-report-finds-esketamine-m-311336.html 0.6 2026-06-21T22:57:46+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bios-analyst-day-highlights-com-311337.html 0.6 2026-06-20T20:06:47+08:00 daily https://www.pharmasources.com/industryinsights/intelgenx-and-aquestive-therapeutics-ent-311338.html 0.6 2026-08-09T06:51:53+08:00 daily https://www.pharmasources.com/industryinsights/bicycle-hires-clinical-leader-ahead-of-i-311339.html 0.6 2026-08-09T02:38:53+08:00 daily https://www.pharmasources.com/industryinsights/personalizing-viral-phages-to-fight-resi-311340.html 0.6 2026-08-08T07:33:40+08:00 daily https://www.pharmasources.com/industryinsights/advice-for-medtech-startups-dont-do-your-311341.html 0.6 2026-08-08T06:16:35+08:00 daily https://www.pharmasources.com/industryinsights/adimab-broadens-rd-partnerships-with-a-t-311342.html 0.6 2026-08-08T04:31:04+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-hit-with-fda-rejection-of-contem-311343.html 0.6 2026-08-07T13:57:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-pushes-for-stronger-warnings-on-inso-311344.html 0.6 2026-08-08T18:00:43+08:00 daily https://www.pharmasources.com/industryinsights/2m-nhs-investment-into-leadership-develo-311345.html 0.6 2026-08-07T00:53:27+08:00 daily https://www.pharmasources.com/industryinsights/potential-first-ever-targeted-therapy-de-311346.html 0.6 2026-08-07T00:45:40+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-receives-regulatory-approval-from-311347.html 0.6 2026-08-07T00:43:12+08:00 daily https://www.pharmasources.com/industryinsights/pi-cardia-completes-first-in-human-studi-311348.html 0.6 2026-08-07T00:40:13+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-acquire-xiidra-in-a-53b-deal-311349.html 0.6 2026-08-07T00:15:54+08:00 daily https://www.pharmasources.com/industryinsights/abg-leads-pulmonxs-65-million-financing-311350.html 0.6 2026-08-07T00:01:31+08:00 daily https://www.pharmasources.com/industryinsights/mlp-care-announces-strong-revenue-growth-311351.html 0.6 2026-08-06T23:55:12+08:00 daily https://www.pharmasources.com/industryinsights/moh-confirms-imported-case-of-monkeypox--311352.html 0.6 2026-08-07T00:02:45+08:00 daily https://www.pharmasources.com/industryinsights/aslan-signs-agreement-with-korean-gastri-311353.html 0.6 2026-08-07T00:40:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-heart-murmur-detection-devi-311354.html 0.6 2026-08-07T21:53:18+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-opdivo-fails-brain-tumor-t-311355.html 0.6 2026-08-07T13:15:01+08:00 daily https://www.pharmasources.com/industryinsights/novartis-says-it-is-ready-to-meet-even-u-311356.html 0.6 2026-08-08T03:08:43+08:00 daily https://www.pharmasources.com/industryinsights/as-merck-ebola-vaccine-runs-short-in-con-311357.html 0.6 2026-06-22T08:01:48+08:00 daily https://www.pharmasources.com/industryinsights/gileads-3b-truvada-will-face-generics-a--311358.html 0.6 2026-08-09T13:05:00+08:00 daily https://www.pharmasources.com/industryinsights/mylan-investors-are-fed-up-with-manageme-311359.html 0.6 2026-06-21T01:55:54+08:00 daily https://www.pharmasources.com/industryinsights/roches-ocrevus-continues-winning-streak--311360.html 0.6 2026-06-22T05:56:46+08:00 daily https://www.pharmasources.com/industryinsights/researchers-warn-about-gangrene-cases-in-311361.html 0.6 2026-08-06T03:17:03+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-daiichis-her2-adc-hits-g-311362.html 0.6 2026-06-20T22:43:44+08:00 daily https://www.pharmasources.com/industryinsights/chinas-wuxi-apptec-buys-up-us-pharmapace-311363.html 0.6 2026-06-22T10:59:53+08:00 daily https://www.pharmasources.com/industryinsights/takeda-taps-skyhawks-rna-targeting-tech--311364.html 0.6 2026-06-20T20:57:44+08:00 daily https://www.pharmasources.com/industryinsights/precise-efficient-matchmaking-by-cphi-ch-311365.html 0.6 daily https://www.pharmasources.com/industryinsights/teva-and-other-generic-drugmakers-inflat-311366.html 0.6 2026-06-22T10:08:12+08:00 daily https://www.pharmasources.com/industryinsights/skin-cancer-awareness-month-overcoming-d-311367.html 0.6 2026-08-09T20:36:30+08:00 daily https://www.pharmasources.com/industryinsights/clinical-catch-up-from-last-week-may-5-1-311368.html 0.6 2026-06-21T22:02:40+08:00 daily https://www.pharmasources.com/industryinsights/deep-branch-bios-peter-rowe-wants-to-sav-311369.html 0.6 2026-06-20T17:51:17+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019051-311370.html 0.6 2026-06-20T19:56:49+08:00 daily https://www.pharmasources.com/industryinsights/exclusive-servier-establishes-first-us-t-311371.html 0.6 2026-06-21T09:51:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-childre-311372.html 0.6 2026-03-29T12:40:08+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-fails-in-phase-iii-glioblasto-311373.html 0.6 2026-08-08T14:23:11+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-donate-24m-bottles-of-truvada--311374.html 0.6 2026-06-21T11:00:24+08:00 daily https://www.pharmasources.com/industryinsights/researchers-warn-about-gangrene-cases-in-311375.html 0.6 2026-06-22T05:02:46+08:00 daily https://www.pharmasources.com/industryinsights/genetic-therapy-heals-damage-caused-by-h-311376.html 0.6 2026-08-09T19:38:59+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-seizure-drug-in-u-311377.html 0.6 2026-08-07T17:22:29+08:00 daily https://www.pharmasources.com/industryinsights/tv-pharma-ads-now-required-to-include-pr-311378.html 0.6 2026-06-21T15:50:23+08:00 daily https://www.pharmasources.com/industryinsights/masimo-and-mindray-announce-expanded-par-311379.html 0.6 2026-06-22T04:41:54+08:00 daily https://www.pharmasources.com/industryinsights/eisai-to-sell-anti-rheumatic-injection-i-311380.html 0.6 2026-06-21T00:11:58+08:00 daily https://www.pharmasources.com/industryinsights/aimed-and-bcs-collaborate-to-launch-aime-311381.html 0.6 2026-06-22T06:56:47+08:00 daily https://www.pharmasources.com/industryinsights/the-seventh-himss-elsevier-digital-healt-311382.html 0.6 2026-06-21T03:58:50+08:00 daily https://www.pharmasources.com/industryinsights/how-pharma-40-can-improve-product-safety-311383.html 0.6 2026-06-23T00:52:37+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-to-acquire-vertfilex-f-311384.html 0.6 2026-06-20T17:16:40+08:00 daily https://www.pharmasources.com/industryinsights/takeda-sells-surgical-patch-to-ethicon-f-311385.html 0.6 2026-06-29T12:57:30+08:00 daily https://www.pharmasources.com/industryinsights/aslan-signs-agreement-with-korean-gastri-311386.html 0.6 2026-06-22T11:57:47+08:00 daily https://www.pharmasources.com/industryinsights/take2-licenses-technology-for-nasopharyn-311387.html 0.6 2026-06-21T15:58:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-final-guidance-on-considerati-311388.html 0.6 2026-08-09T04:34:51+08:00 daily https://www.pharmasources.com/industryinsights/based-on-china-to-go-international-the-t-311389.html 0.6 2026-08-07T13:18:11+08:00 daily https://www.pharmasources.com/industryinsights/super-blockbuster-trastuzumab-311390.html 0.6 2026-08-08T15:47:50+08:00 daily https://www.pharmasources.com/industryinsights/cdc-us-measles-cases-in-2019-reach-839-311391.html 0.6 2026-08-07T13:18:24+08:00 daily https://www.pharmasources.com/industryinsights/industry-review-on-uk-drug-discovery-emp-311392.html 0.6 2026-08-08T01:01:34+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-invest-150m-in-building-biologi-311393.html 0.6 2026-08-08T01:35:55+08:00 daily https://www.pharmasources.com/industryinsights/us-states-file-lawsuit-against-20-drugma-311394.html 0.6 2026-08-09T00:31:21+08:00 daily https://www.pharmasources.com/industryinsights/doctors-turning-to-antibiotic-alternativ-311395.html 0.6 2026-08-09T03:34:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-buy-takedas-dry-eye-drug-xii-311396.html 0.6 2026-08-09T06:51:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-finds-testing-issues-at-torrent-plan-311397.html 0.6 2026-08-08T10:02:14+08:00 daily https://www.pharmasources.com/industryinsights/nanoviricides-announces-completion-of-pr-311398.html 0.6 2026-08-08T08:03:55+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-acquire-xiidra-expanding-fro-311399.html 0.6 2026-08-08T03:08:43+08:00 daily https://www.pharmasources.com/industryinsights/bone-cells-suppress-cancer-metastases-311400.html 0.6 2026-08-07T15:08:04+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-announces-finalists-311401.html 0.6 2026-08-07T13:17:16+08:00 daily https://www.pharmasources.com/industryinsights/california-couple-awarded-362-billion-in-311402.html 0.6 2026-08-06T23:55:05+08:00 daily https://www.pharmasources.com/industryinsights/quitting-smoking-while-pregnant-tied-to--311403.html 0.6 2026-08-07T00:41:43+08:00 daily https://www.pharmasources.com/industryinsights/glucosamine-joint-pain-supplement-could--311404.html 0.6 2026-08-07T01:15:46+08:00 daily https://www.pharmasources.com/industryinsights/taxing-sweetened-beverages-reduces-volum-311405.html 0.6 2026-08-07T01:21:50+08:00 daily https://www.pharmasources.com/industryinsights/tool-predicts-seizure-risk-during-after--311406.html 0.6 2026-08-07T13:17:05+08:00 daily https://www.pharmasources.com/industryinsights/american-academy-of-neurology-may-4-10-311407.html 0.6 2026-08-08T03:30:40+08:00 daily https://www.pharmasources.com/industryinsights/post-hospital-low-blood-sugar-a-danger-t-311408.html 0.6 2026-08-08T07:56:01+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-why-are-women-with-diabetes-at--311409.html 0.6 2026-06-22T11:53:50+08:00 daily https://www.pharmasources.com/industryinsights/lessons-learned-from-early-eu-fmd-adopte-311410.html 0.6 2026-08-08T08:59:21+08:00 daily https://www.pharmasources.com/industryinsights/catalent-achieves-global-iso-accreditati-311411.html 0.6 2026-08-07T02:30:40+08:00 daily https://www.pharmasources.com/industryinsights/us-drugmakers-allegedly-collude-on-gener-311412.html 0.6 2026-08-06T23:45:58+08:00 daily https://www.pharmasources.com/industryinsights/the-cleanroom-technology-conference-311413.html 0.6 2026-08-07T14:59:21+08:00 daily https://www.pharmasources.com/industryinsights/new-guidance-issued-for-3d-printed-medic-311414.html 0.6 2026-08-06T23:57:37+08:00 daily https://www.pharmasources.com/industryinsights/ghana-launches-the-worlds-largest-vaccin-311415.html 0.6 2026-08-07T00:02:56+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-tests-injectable-vs-oral--311416.html 0.6 2026-08-07T00:40:55+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-produce-new-clinical-st-311417.html 0.6 2026-08-07T05:08:27+08:00 daily https://www.pharmasources.com/industryinsights/sensid-inks-distribution-agreement-with--311418.html 0.6 2026-06-21T05:01:47+08:00 daily https://www.pharmasources.com/industryinsights/lilly-secures-fda-approval-for-cyramza-t-311419.html 0.6 2026-06-20T20:42:28+08:00 daily https://www.pharmasources.com/industryinsights/zealand-announces-confirmatory-phase-iii-311420.html 0.6 2026-06-20T20:12:48+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-fda-on-policy-advancement-311421.html 0.6 2026-06-21T04:21:06+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-buckles-in-abbvie-patent-figh-311422.html 0.6 2026-06-21T13:02:29+08:00 daily https://www.pharmasources.com/industryinsights/seven-indian-pharma-companies-among-the--311423.html 0.6 2026-06-29T03:31:31+08:00 daily https://www.pharmasources.com/industryinsights/medical-affairs-2025-excellence-in-the-e-311424.html 0.6 2026-08-07T10:23:58+08:00 daily https://www.pharmasources.com/industryinsights/solid-tanks-as-safety-scare-again-rocks--311425.html 0.6 2026-06-22T10:14:16+08:00 daily https://www.pharmasources.com/industryinsights/prophylactic-antibiotic-use-could-halve--311426.html 0.6 2026-06-20T22:51:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-end-controversial-311427.html 0.6 2026-06-21T08:46:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-indication-for-eylea-to-cove-311428.html 0.6 2026-06-20T18:06:21+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-spending-varies-dramatical-311429.html 0.6 2026-04-07T21:36:54+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-recommended-on-nhs-in-scot-311431.html 0.6 2026-07-31T02:16:26+08:00 daily https://www.pharmasources.com/industryinsights/uk-gps-are-underequipped-to-handle-growi-311432.html 0.6 2026-06-23T02:15:24+08:00 daily https://www.pharmasources.com/industryinsights/stroke-drug-cocktail-normalizes-brain-fl-311433.html 0.6 2026-06-21T22:56:41+08:00 daily https://www.pharmasources.com/industryinsights/us-sees-300-increase-in-the-number-of-ca-311435.html 0.6 2026-06-21T07:23:33+08:00 daily https://www.pharmasources.com/industryinsights/heart-disease-deaths-increase-for-first--311436.html 0.6 2026-06-21T09:59:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-broadened-indication-for-xe-311437.html 0.6 2026-02-28T16:43:50+08:00 daily https://www.pharmasources.com/industryinsights/gilead-struck-anti-competitive-deals-to--311438.html 0.6 2026-06-20T16:00:18+08:00 daily https://www.pharmasources.com/industryinsights/roivant-announces-positive-results-from--311439.html 0.6 2026-06-21T06:58:55+08:00 daily https://www.pharmasources.com/industryinsights/lipocine-announces-tlando-nda-pdufa-acti-311440.html 0.6 2026-08-06T05:32:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-eylea-311441.html 0.6 2026-06-20T20:44:25+08:00 daily https://www.pharmasources.com/industryinsights/tolero-announces-first-patient-dosed-in--311442.html 0.6 2026-06-20T20:10:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-bavencio-avelumab-plus-inly-311443.html 0.6 2026-06-22T05:51:32+08:00 daily https://www.pharmasources.com/industryinsights/vaccination-personal-choice-or-public-he-311444.html 0.6 2026-06-06T19:05:57+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-will-test-long-acting-hiv-311445.html 0.6 2026-06-22T00:59:52+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-vaccitech-sign-license-agr-311446.html 0.6 2026-06-20T16:15:00+08:00 daily https://www.pharmasources.com/industryinsights/why-agencies-and-in-house-pharma-profess-311447.html 0.6 2026-06-20T18:00:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approval-for-bavencio-combo-in-advan-311448.html 0.6 2026-06-22T04:57:06+08:00 daily https://www.pharmasources.com/industryinsights/bmj-publishes-subclinical-hypothyroidism-311449.html 0.6 2026-06-20T20:10:46+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-eylea-wins-fda-approval-311450.html 0.6 2026-06-22T12:02:48+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-sprinraza-for-5q-spinal--311451.html 0.6 2026-06-23T11:32:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-recalls-liquid-version-of-anemi-311452.html 0.6 2026-06-21T13:17:19+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-eylea-pads-its-armor-with-dia-311453.html 0.6 2026-06-21T19:54:38+08:00 daily https://www.pharmasources.com/industryinsights/huge-growth-in-middle-east-manufacturing-311454.html 0.6 2026-06-20T23:03:46+08:00 daily https://www.pharmasources.com/industryinsights/bgi-genomics-pryzm-health-to-advance-pre-311455.html 0.6 2026-06-21T08:59:05+08:00 daily https://www.pharmasources.com/industryinsights/olix-pharma-expands-ocular-disease-pipel-311456.html 0.6 2026-06-23T06:24:01+08:00 daily https://www.pharmasources.com/industryinsights/peritech-pharma-receives-new-patents-in--311457.html 0.6 2026-08-07T19:32:54+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-launches-hypertension-dru-311458.html 0.6 2026-08-10T00:45:12+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-mobile-image-recogni-311459.html 0.6 2026-02-07T09:42:14+08:00 daily https://www.pharmasources.com/industryinsights/unsw-study-predicts-more-than-50-rise-in-311460.html 0.6 2026-06-21T12:04:19+08:00 daily https://www.pharmasources.com/industryinsights/nih-facilitates-first-tribal-data-sharin-311461.html 0.6 2026-06-21T17:44:24+08:00 daily https://www.pharmasources.com/industryinsights/varian-partners-with-proton-therapy-311462.html 0.6 2026-06-20T19:58:45+08:00 daily https://www.pharmasources.com/industryinsights/takedas-bla-for-vedolizumab-gets-approva-311463.html 0.6 2026-08-07T05:01:14+08:00 daily https://www.pharmasources.com/industryinsights/iqvia-launches-dedicated-solutions-for-m-311464.html 0.6 2026-06-22T02:01:52+08:00 daily https://www.pharmasources.com/industryinsights/philips-announces-collaboration-with-med-311465.html 0.6 2026-06-20T14:44:03+08:00 daily https://www.pharmasources.com/industryinsights/zebra-medical-vision-receives-fda-approv-311466.html 0.6 2026-06-22T10:57:52+08:00 daily https://www.pharmasources.com/industryinsights/dyadic-serum-institute-of-india-collabor-311467.html 0.6 2026-06-21T00:01:44+08:00 daily https://www.pharmasources.com/industryinsights/wearable-injectors-and-connected-devices-311468.html 0.6 2026-06-21T01:04:47+08:00 daily https://www.pharmasources.com/industryinsights/researchers-block-protein-that-plays-a-k-311469.html 0.6 2026-03-25T19:11:26+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-miscarriage-up-with-benzodiazep-311470.html 0.6 2026-06-21T06:14:58+08:00 daily https://www.pharmasources.com/industryinsights/two-thirds-of-sunscreens-fail-safety-tes-311471.html 0.6 2026-06-21T09:00:02+08:00 daily https://www.pharmasources.com/industryinsights/habitual-glucosamine-use-linked-to-reduc-311472.html 0.6 2026-06-21T01:11:55+08:00 daily https://www.pharmasources.com/industryinsights/healthy-lifestyle-recommended-for-reduci-311473.html 0.6 2026-06-21T08:57:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-tattoo-inks-recalled-due-to-bacteria-311474.html 0.6 2025-11-15T15:48:38+08:00 daily https://www.pharmasources.com/industryinsights/low-fat-diet-could-be-a-weapon-against-b-311475.html 0.6 2026-06-21T18:57:40+08:00 daily https://www.pharmasources.com/industryinsights/huhn-scientists-working-on-hearing-aid-t-311476.html 0.6 2026-08-10T01:01:26+08:00 daily https://www.pharmasources.com/industryinsights/anthrax-is-a-risk-on-every-continent-311477.html 0.6 2026-08-07T21:49:08+08:00 daily https://www.pharmasources.com/industryinsights/curbing-a-skin-oil-might-help-curb-acne--311478.html 0.6 2026-08-09T21:45:23+08:00 daily https://www.pharmasources.com/industryinsights/tufts-csdd-study-on-the-vendor-qualifica-311479.html 0.6 2026-06-20T14:51:15+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-vaccitech-ink-cell-line-licens-311480.html 0.6 2026-06-20T20:03:42+08:00 daily https://www.pharmasources.com/industryinsights/adaptimmune-alpine-immune-sciences-enter-311481.html 0.6 2026-06-22T04:54:43+08:00 daily https://www.pharmasources.com/industryinsights/codexis-novartis-ink-tech-transfer-and-l-311482.html 0.6 2026-06-22T08:58:43+08:00 daily https://www.pharmasources.com/industryinsights/aphena-pharma-solutions-invests-7m-for-e-311483.html 0.6 2026-06-21T01:11:52+08:00 daily https://www.pharmasources.com/industryinsights/chiasma-lonza-advance-commercial-supply--311484.html 0.6 2026-06-20T22:57:44+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-chia-tai-tianqing-enter-b-311485.html 0.6 2026-03-28T03:49:10+08:00 daily https://www.pharmasources.com/industryinsights/legacy-plans-for-lyophilization-boom-311486.html 0.6 2026-06-21T15:38:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tracelink-dscsa-pilot-submi-311487.html 0.6 2026-03-25T18:39:31+08:00 daily https://www.pharmasources.com/industryinsights/lsne-receives-gmp-certification-by-brazi-311488.html 0.6 2026-06-22T05:01:39+08:00 daily https://www.pharmasources.com/industryinsights/frontage-names-sridhar-krishnan-svp-glob-311489.html 0.6 2026-06-21T07:57:58+08:00 daily https://www.pharmasources.com/industryinsights/cellectar-gains-fda-fast-track-for-clr-1-311490.html 0.6 2026-07-20T01:03:59+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-appoints-gm-311491.html 0.6 2026-08-09T06:51:27+08:00 daily https://www.pharmasources.com/industryinsights/intelgenx-appoints-andr-godin-as-preside-311492.html 0.6 2026-08-09T03:44:46+08:00 daily https://www.pharmasources.com/industryinsights/biogens-spinraza-gets-a-boost-from-nice--311493.html 0.6 2026-08-09T02:39:06+08:00 daily https://www.pharmasources.com/industryinsights/antares-vision-introduces-data-monitorin-311494.html 0.6 2026-08-07T13:17:42+08:00 daily https://www.pharmasources.com/industryinsights/vibalogics-increases-capacity-for-virus--311495.html 0.6 2026-08-07T13:56:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-buys-dry-eye-drug-from-takeda-f-311496.html 0.6 2026-06-20T16:41:04+08:00 daily https://www.pharmasources.com/industryinsights/bormioli-pharma-offers-green-plastic-pac-311497.html 0.6 2026-07-28T16:47:38+08:00 daily https://www.pharmasources.com/industryinsights/researchers-block-protein-that-plays-a-k-311498.html 0.6 2026-06-22T01:06:58+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-launches-inhalation-offering-311499.html 0.6 2026-06-21T03:56:50+08:00 daily https://www.pharmasources.com/industryinsights/skyhawk-takeda-to-develop-neurological-d-311500.html 0.6 2026-06-21T09:04:03+08:00 daily https://www.pharmasources.com/industryinsights/aldevron-readies-for-expansion-311501.html 0.6 2026-06-22T16:58:58+08:00 daily https://www.pharmasources.com/industryinsights/bioduro-continues-expansion-with-leaders-311502.html 0.6 2026-06-21T17:45:11+08:00 daily https://www.pharmasources.com/industryinsights/amgen-syapse-enter-precision-medicine-pa-311503.html 0.6 2026-06-22T09:53:52+08:00 daily https://www.pharmasources.com/industryinsights/micro-sphere-partners-with-ptm-consultin-311504.html 0.6 2026-06-21T04:57:45+08:00 daily https://www.pharmasources.com/industryinsights/acgs-new-91m-brazil-facility-311505.html 0.6 2026-07-31T15:25:20+08:00 daily https://www.pharmasources.com/industryinsights/swissfillon-completes-successful-fda-ins-311506.html 0.6 2026-06-20T20:55:50+08:00 daily https://www.pharmasources.com/industryinsights/dalton-pharma-services-completes-pai-ins-311507.html 0.6 2026-06-21T16:03:28+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-completes-first-fda-routi-311508.html 0.6 2026-07-27T00:08:19+08:00 daily https://www.pharmasources.com/industryinsights/ispe-releases-good-practice-guide-proces-311509.html 0.6 2026-08-06T20:05:11+08:00 daily https://www.pharmasources.com/industryinsights/celgenes-pomalyst-secures-breakthrough-d-311510.html 0.6 2026-08-06T21:54:16+08:00 daily https://www.pharmasources.com/industryinsights/two-daiichi-sankyo-drugs-dealt-a-thumbs--311511.html 0.6 2026-08-06T23:46:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-mercks-inlyta-combo-becomes-first-311512.html 0.6 2026-08-06T23:56:06+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-agree-to-pay-for-biogens-750-311513.html 0.6 2026-06-21T13:06:29+08:00 daily https://www.pharmasources.com/industryinsights/bms-blockbuster-opdivo-falls-short-at-ph-311514.html 0.6 2026-08-06T09:31:54+08:00 daily https://www.pharmasources.com/industryinsights/odac-votes-no-on-quizartinib-as-relapsed-311515.html 0.6 2026-08-06T13:00:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-bavencio-plus-axitinib-comb-311516.html 0.6 2026-03-18T03:55:47+08:00 daily https://www.pharmasources.com/industryinsights/novartis-slow-rolling-kymriah-wins-cover-311517.html 0.6 2026-03-29T00:05:25+08:00 daily https://www.pharmasources.com/industryinsights/pti-announces-vp-global-sales-appointmen-311518.html 0.6 2026-06-20T16:07:38+08:00 daily https://www.pharmasources.com/industryinsights/biogens-spinraza-gets-a-boost-from-nice--311519.html 0.6 2026-04-09T09:54:34+08:00 daily https://www.pharmasources.com/industryinsights/novartis-issues-recall-of-promacta-125-m-311520.html 0.6 2026-06-21T12:59:28+08:00 daily https://www.pharmasources.com/industryinsights/haemonetics-receives-fda-clearance-for-e-311521.html 0.6 2026-06-30T13:53:59+08:00 daily https://www.pharmasources.com/industryinsights/roivant-announces-positive-results-from--311522.html 0.6 2026-07-03T17:32:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-panel-votes-against-daiichi-311523.html 0.6 2026-08-08T14:54:47+08:00 daily https://www.pharmasources.com/industryinsights/ben-gurion-university-introduces-novel-c-311524.html 0.6 2026-07-07T12:02:34+08:00 daily https://www.pharmasources.com/industryinsights/connecticut-ag-leads-coalition-in-antitr-311525.html 0.6 2026-08-06T17:47:42+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-enrolled-in-regenerx-jv-ph-311526.html 0.6 2026-06-29T13:32:58+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-boehringer-settle-humira-bios-311527.html 0.6 2026-06-25T11:30:15+08:00 daily https://www.pharmasources.com/industryinsights/sep-363856-receives-fda-breakthrough-the-311528.html 0.6 2026-06-26T11:15:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-anticoagulant-blood-t-311529.html 0.6 2026-06-26T11:31:14+08:00 daily https://www.pharmasources.com/industryinsights/once-per-month-hiv-drugs-could-soon-be-a-311530.html 0.6 2026-07-02T13:20:20+08:00 daily https://www.pharmasources.com/industryinsights/product-hub-high-throughput-experimentat-311531.html 0.6 2026-08-09T14:12:10+08:00 daily https://www.pharmasources.com/industryinsights/reducing-analysis-time-with-the-thermo-s-311532.html 0.6 2026-06-20T21:00:44+08:00 daily https://www.pharmasources.com/industryinsights/creating-a-modern-landscape-311533.html 0.6 2026-06-21T08:07:11+08:00 daily https://www.pharmasources.com/industryinsights/single-use-trays-for-bulk-lyophilisation-311534.html 0.6 2026-06-22T08:58:45+08:00 daily https://www.pharmasources.com/industryinsights/tuberculosis-fighting-the-disease-with-a-311535.html 0.6 2026-06-20T16:57:21+08:00 daily https://www.pharmasources.com/industryinsights/cphi-north-america-fps-confirm-their-pre-311536.html 0.6 2026-04-01T00:14:31+08:00 daily https://www.pharmasources.com/industryinsights/north-carolina-sues-electronic-cigarette-311537.html 0.6 2026-06-21T13:13:15+08:00 daily https://www.pharmasources.com/industryinsights/recs-updated-for-tb-screening-treatment--311538.html 0.6 2026-06-21T00:14:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-venetoclax-for-chronic-smal-311539.html 0.6 2026-06-21T04:53:41+08:00 daily https://www.pharmasources.com/industryinsights/americans-increasingly-open-about-mental-311540.html 0.6 2026-06-20T19:18:59+08:00 daily https://www.pharmasources.com/industryinsights/avelumab-43-axitinib-approved-for-treatm-311541.html 0.6 2026-04-14T07:00:42+08:00 daily https://www.pharmasources.com/industryinsights/heroin-ods-have-started-declining-in-som-311542.html 0.6 2026-06-22T06:07:42+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-commenced-construction-of-311543.html 0.6 2026-06-27T03:22:35+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-abrocitinib-smashes-primary-and--311544.html 0.6 2026-07-04T07:35:08+08:00 daily https://www.pharmasources.com/industryinsights/immunogen-shares-plummet-by-32-after-fda-311545.html 0.6 2026-06-21T00:02:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-greenlights-roche-and-abbvies-vencle-311546.html 0.6 2026-06-21T03:58:58+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kymriah-to-be-covered-by-japans-311547.html 0.6 2026-06-20T22:48:04+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-invest-100-million-into-limerick-m-311548.html 0.6 2026-06-20T22:13:54+08:00 daily https://www.pharmasources.com/industryinsights/mda-awards-26-grants-totaling-more-than--311549.html 0.6 2026-07-04T16:26:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-venetoclax-for-cll-and-sll-311550.html 0.6 2026-08-08T20:40:34+08:00 daily https://www.pharmasources.com/industryinsights/is-the-pharma-sector-ready-for-a-no-deal-311551.html 0.6 2026-08-07T02:49:49+08:00 daily https://www.pharmasources.com/industryinsights/hdl-therapeutics-announces-positive-data-311552.html 0.6 2026-06-21T10:21:21+08:00 daily https://www.pharmasources.com/industryinsights/rigel-enrolls-first-patient-in-phase-3-c-311553.html 0.6 2026-07-05T03:14:37+08:00 daily https://www.pharmasources.com/industryinsights/bayer-presents-new-analyses-for-vitrakvi-311554.html 0.6 2026-04-20T01:10:11+08:00 daily https://www.pharmasources.com/industryinsights/lonza-synpromics-enter-biomanufacturing--311555.html 0.6 2026-06-21T07:15:20+08:00 daily https://www.pharmasources.com/industryinsights/wellspring-biosciences-announces-ind-app-311556.html 0.6 2026-06-20T20:16:01+08:00 daily https://www.pharmasources.com/industryinsights/horseshoe-crabs-and-the-biomedical-indus-311557.html 0.6 2026-06-22T02:58:39+08:00 daily https://www.pharmasources.com/industryinsights/red-cross-needs-type-o-blood-to-ease-sho-311558.html 0.6 2026-06-20T17:03:22+08:00 daily https://www.pharmasources.com/industryinsights/pool-chemicals-harm-thousands-every-summ-311559.html 0.6 2026-06-21T06:04:46+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-buys-gsk-api-site-for-100m-311560.html 0.6 2026-06-20T16:11:41+08:00 daily https://www.pharmasources.com/industryinsights/civica-rx-and-xellia-join-forces-to-redu-311561.html 0.6 2026-06-20T16:16:00+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-build-mfg-center-in-so-311562.html 0.6 2026-07-20T07:03:51+08:00 daily https://www.pharmasources.com/industryinsights/sekisui-invests-19m-in-microbial-biophar-311563.html 0.6 2026-06-21T05:02:47+08:00 daily https://www.pharmasources.com/industryinsights/nelson-labs-supporting-internal-quality--311564.html 0.6 2026-07-08T23:22:04+08:00 daily https://www.pharmasources.com/industryinsights/its-not-just-about-the-science-311565.html 0.6 2026-07-07T02:46:03+08:00 daily https://www.pharmasources.com/industryinsights/sepha-visionscan-non-destructive-determi-311566.html 0.6 2026-07-02T19:07:45+08:00 daily https://www.pharmasources.com/industryinsights/dont-let-difficult-substances-control-yo-311567.html 0.6 2026-06-26T01:38:51+08:00 daily https://www.pharmasources.com/industryinsights/less-pain-more-car-crashes-legalized-mar-311568.html 0.6 2026-08-07T05:06:15+08:00 daily https://www.pharmasources.com/industryinsights/adma-announces-it-will-reintroduce-bivig-311569.html 0.6 2026-08-06T23:48:26+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-submits-new-drug-appli-311570.html 0.6 2026-08-06T23:45:02+08:00 daily https://www.pharmasources.com/industryinsights/esperion-announces-us-fda-acceptance-of--311571.html 0.6 2026-08-06T23:35:55+08:00 daily https://www.pharmasources.com/industryinsights/cristal-therapeutics-to-present-data-at--311572.html 0.6 2026-08-07T15:01:03+08:00 daily https://www.pharmasources.com/industryinsights/breastfeeding-brings-a-heart-bonus-for-m-311573.html 0.6 2026-08-08T19:04:32+08:00 daily https://www.pharmasources.com/industryinsights/swallowed-batteries-should-be-removed-to-311574.html 0.6 2026-08-06T23:46:07+08:00 daily https://www.pharmasources.com/industryinsights/many-lives-could-be-saved-if-all-hospita-311575.html 0.6 2026-08-06T23:54:28+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-care-app-can-reduce-in-person-o-311576.html 0.6 2026-08-07T00:41:07+08:00 daily https://www.pharmasources.com/industryinsights/private-insurers-pay-241-percent-of-what-311577.html 0.6 2026-08-07T03:03:15+08:00 daily https://www.pharmasources.com/industryinsights/pool-chemical-injuries-led-to-13500-ed-v-311578.html 0.6 2026-08-07T16:21:06+08:00 daily https://www.pharmasources.com/industryinsights/love-the-smell-of-a-cup-o-joe-heres-what-311579.html 0.6 2026-08-07T21:56:20+08:00 daily https://www.pharmasources.com/industryinsights/for-women-with-hiv-daily-life-can-impede-311580.html 0.6 2026-08-08T08:00:57+08:00 daily https://www.pharmasources.com/industryinsights/faulty-barcode-scans-could-cost-the-phar-311581.html 0.6 2026-08-08T08:59:02+08:00 daily https://www.pharmasources.com/industryinsights/lonza-launches-capsugel-zephyr-dpi-portf-311582.html 0.6 2026-08-08T10:14:11+08:00 daily https://www.pharmasources.com/industryinsights/cytek-biosciences-achieves-iso-90012015--311583.html 0.6 2026-08-08T11:48:34+08:00 daily https://www.pharmasources.com/industryinsights/wellspring-biosciences-janssen-receive-i-311584.html 0.6 2026-08-08T13:11:38+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-calamp-enter-strategic-collabor-311585.html 0.6 2026-08-09T02:39:05+08:00 daily https://www.pharmasources.com/industryinsights/market-for-single-use-bioprocessing-syst-311586.html 0.6 2026-08-09T06:51:25+08:00 daily https://www.pharmasources.com/industryinsights/complete-response-letter-from-fda-for-ba-311587.html 0.6 2026-06-20T17:03:18+08:00 daily https://www.pharmasources.com/industryinsights/veritas-announces-the-completion-of-clin-311588.html 0.6 2026-06-20T15:41:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-positive-top-line-resul-311589.html 0.6 2026-06-22T13:06:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-lifts-partial-clinical-hold-on-phase-311590.html 0.6 2026-06-20T19:44:22+08:00 daily https://www.pharmasources.com/industryinsights/pooled-analyses-of-the-roxadustat-global-311591.html 0.6 2026-06-22T12:12:58+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-announces-outcome-of-fda--311592.html 0.6 2026-07-22T00:50:44+08:00 daily https://www.pharmasources.com/industryinsights/novartis-issues-voluntary-nationwide-rec-311593.html 0.6 2026-06-21T02:11:51+08:00 daily https://www.pharmasources.com/industryinsights/vivimed-life-sciences-pvt-ltd-issues-vol-311594.html 0.6 2026-06-28T06:16:18+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-drummers-death-inspires-grief-s-311595.html 0.6 2026-06-20T18:18:54+08:00 daily https://www.pharmasources.com/industryinsights/sugary-drinks-and-fruit-juice-may-increa-311596.html 0.6 2026-06-30T16:22:13+08:00 daily https://www.pharmasources.com/industryinsights/suicides-increase-among-us-kids-but-more-311597.html 0.6 2026-06-20T17:48:30+08:00 daily https://www.pharmasources.com/industryinsights/could-hypnotherapy-be-alternative-to-opi-311598.html 0.6 2026-06-20T18:44:18+08:00 daily https://www.pharmasources.com/industryinsights/colon-cancer-increasingly-striking-the-y-311599.html 0.6 2025-11-10T00:38:20+08:00 daily https://www.pharmasources.com/industryinsights/myovant-sciences-announces-positive-phas-311600.html 0.6 2026-07-28T16:04:08+08:00 daily https://www.pharmasources.com/industryinsights/cellectar-receives-fda-fast-track-design-311601.html 0.6 2026-06-22T04:01:39+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019520-311602.html 0.6 2026-08-07T01:02:18+08:00 daily https://www.pharmasources.com/industryinsights/researcher-proposes-glaucoma-screening-i-311603.html 0.6 2026-06-21T13:02:29+08:00 daily https://www.pharmasources.com/industryinsights/new-open-source-solution-for-the-robust--311604.html 0.6 2026-07-02T11:47:41+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-molecular-destruction-co-311605.html 0.6 2026-06-21T00:54:48+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-frazier-healthcare-partners-a-311606.html 0.6 2026-06-08T20:06:32+08:00 daily https://www.pharmasources.com/industryinsights/parvus-therapeutics-genetech-collaborate-311607.html 0.6 2026-06-21T09:02:58+08:00 daily https://www.pharmasources.com/industryinsights/takeda-announces-results-of-phase-3b-var-311608.html 0.6 2026-06-21T12:50:14+08:00 daily https://www.pharmasources.com/industryinsights/gulf-medical-university-inks-mou-with-ch-311609.html 0.6 2026-06-23T03:42:01+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-fails-to-hold-up-influenz-311610.html 0.6 2026-06-22T08:52:18+08:00 daily https://www.pharmasources.com/industryinsights/farrer-park-hospital-introduces-robotic--311611.html 0.6 2026-06-21T00:07:39+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-to-acquire-gsk-api-site-fo-311612.html 0.6 2026-06-26T05:52:20+08:00 daily https://www.pharmasources.com/industryinsights/study-demonstrates-clinical-utility-of-l-311613.html 0.6 2026-02-15T13:40:08+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-revlimid-as-multiple-mye-311614.html 0.6 2026-06-21T20:52:04+08:00 daily https://www.pharmasources.com/industryinsights/emas-prac-to-review-xeljanz-and-recommen-311615.html 0.6 2026-07-28T16:18:02+08:00 daily https://www.pharmasources.com/industryinsights/europeans-at-risk-of-chronic-digestive-d-311616.html 0.6 2026-06-20T15:10:25+08:00 daily https://www.pharmasources.com/industryinsights/record-number-of-patients-taking-part-in-311617.html 0.6 2026-06-20T15:56:35+08:00 daily https://www.pharmasources.com/industryinsights/owlstone-medical-actelion-team-up-for-pu-311618.html 0.6 2026-06-21T14:43:14+08:00 daily https://www.pharmasources.com/industryinsights/az-symbicort-reduces-rate-of-asthma-atta-311619.html 0.6 2026-07-04T16:49:15+08:00 daily https://www.pharmasources.com/industryinsights/more-data-needed-for-blister-packages-in-311620.html 0.6 2026-06-23T02:21:13+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-that-clinical-research-in-en-311621.html 0.6 2026-06-21T02:58:41+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-novartis-misled-consumers-says-f-311622.html 0.6 2026-06-21T04:52:38+08:00 daily https://www.pharmasources.com/industryinsights/emerging-nmr-techniques-as-advanced-tool-311623.html 0.6 2026-06-20T17:17:01+08:00 daily https://www.pharmasources.com/industryinsights/endotoxin-definition-and-standardisation-311624.html 0.6 2026-08-08T07:33:34+08:00 daily https://www.pharmasources.com/industryinsights/the-role-of-an-integrated-lims-solution--311625.html 0.6 2026-08-07T20:44:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nayzilam-midazolam-nasal-sp-311626.html 0.6 2026-06-24T12:16:52+08:00 daily https://www.pharmasources.com/industryinsights/statin-use-reduces-dementia-risk-after-c-311627.html 0.6 2026-06-20T17:51:40+08:00 daily https://www.pharmasources.com/industryinsights/mometasone-tiotropium-do-not-top-placebo-311628.html 0.6 2026-06-21T07:13:09+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-signed-letter-of-intent-f-311629.html 0.6 2026-06-28T12:21:03+08:00 daily https://www.pharmasources.com/industryinsights/cphi-p-mec-china-will-have-a-grand-openi-311630.html 0.6 2026-06-20T16:47:50+08:00 daily https://www.pharmasources.com/industryinsights/mustaches-are-more-than-just-manly-they--311631.html 0.6 2026-06-21T11:57:14+08:00 daily https://www.pharmasources.com/industryinsights/postoperative-infection-rate-similar-acr-311632.html 0.6 2026-06-20T16:38:14+08:00 daily https://www.pharmasources.com/industryinsights/racial-disparity-seen-in-prescriptions-f-311633.html 0.6 2026-07-17T08:29:08+08:00 daily https://www.pharmasources.com/industryinsights/wasdell-strengthens-offering-with-honeyw-311634.html 0.6 2026-06-20T17:51:20+08:00 daily https://www.pharmasources.com/industryinsights/catalent-completes-paragon-acquisition-311635.html 0.6 2026-06-07T22:07:18+08:00 daily https://www.pharmasources.com/industryinsights/cantargia-patheon-biologics-sign-supply--311636.html 0.6 2026-07-08T14:20:28+08:00 daily https://www.pharmasources.com/industryinsights/avid-names-richard-hancock-interim-presi-311637.html 0.6 2026-06-21T15:54:26+08:00 daily https://www.pharmasources.com/industryinsights/pci-readies-for-growth-with-upper-manage-311638.html 0.6 2026-08-08T07:41:42+08:00 daily https://www.pharmasources.com/industryinsights/roches-personalised-medicine-entrectinib-311639.html 0.6 2026-08-07T13:55:51+08:00 daily https://www.pharmasources.com/industryinsights/why-so-many-older-women-develop-utis-311640.html 0.6 2026-08-07T18:15:07+08:00 daily https://www.pharmasources.com/industryinsights/investment-risks-and-logic-of-the-bio-me-311641.html 0.6 2026-08-07T13:17:32+08:00 daily https://www.pharmasources.com/industryinsights/vaping-habit-might-make-you-more-prone-t-311642.html 0.6 2026-08-07T19:39:30+08:00 daily https://www.pharmasources.com/industryinsights/investment-risks-and-logic-of-the-bio-me-311643.html 0.6 2026-08-08T01:01:03+08:00 daily https://www.pharmasources.com/industryinsights/highly-potent-active-pharmaceutical-ingr-311644.html 0.6 2026-08-08T16:49:03+08:00 daily https://www.pharmasources.com/industryinsights/nearly-half-of-juul-twitter-followers-ar-311645.html 0.6 2026-06-21T09:55:06+08:00 daily https://www.pharmasources.com/industryinsights/agile-therapeutics-resubmits-new-drug-ap-311646.html 0.6 2026-08-08T20:00:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gattex-teduglutide-for-chil-311647.html 0.6 2026-08-09T08:00:52+08:00 daily https://www.pharmasources.com/industryinsights/varian-to-acquire-cancer-treatment-servi-311648.html 0.6 2026-06-20T15:12:17+08:00 daily https://www.pharmasources.com/industryinsights/microsoft-provides-grant-to-develop-epil-311649.html 0.6 2026-06-21T11:59:10+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-signs-vaccine-manufacturi-311650.html 0.6 2026-08-06T18:12:57+08:00 daily https://www.pharmasources.com/industryinsights/merck-joins-transvac2-programme-to-advan-311651.html 0.6 2026-06-20T19:11:50+08:00 daily https://www.pharmasources.com/industryinsights/takeda-frazier-healthcare-partners-to-la-311652.html 0.6 2026-08-09T16:06:46+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-fasenra-offers-severe-asthm-311653.html 0.6 2026-08-05T23:59:27+08:00 daily https://www.pharmasources.com/industryinsights/after-oklahoma-payout-purdue-faces-5-new-311654.html 0.6 2026-06-21T20:14:52+08:00 daily https://www.pharmasources.com/industryinsights/lawmakers-clash-as-gilead-ceo-takes-cong-311655.html 0.6 2026-06-29T06:38:47+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-falls-short-in-late-stage--311656.html 0.6 2026-06-21T22:53:39+08:00 daily https://www.pharmasources.com/industryinsights/ai-could-spot-lung-cancer-before-radiolo-311657.html 0.6 2026-06-23T15:19:39+08:00 daily https://www.pharmasources.com/industryinsights/positive-phase-i-results-for-allergys-ac-311658.html 0.6 2026-06-21T08:02:02+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-ends-phase-iii-brain-tumour-study-311659.html 0.6 2026-06-20T20:47:24+08:00 daily https://www.pharmasources.com/industryinsights/ech-makes-moves-toward-facilitating-medi-311660.html 0.6 2026-04-18T23:42:26+08:00 daily https://www.pharmasources.com/industryinsights/steriline-products-and-solutions-robotic-311661.html 0.6 2026-08-08T09:24:56+08:00 daily https://www.pharmasources.com/industryinsights/steriline-products-and-solutions-isolato-311662.html 0.6 2026-08-06T23:37:40+08:00 daily https://www.pharmasources.com/industryinsights/agendia-and-imegen-announce-an-exclusive-311663.html 0.6 2026-08-06T23:46:19+08:00 daily https://www.pharmasources.com/industryinsights/ime-medical-electrospinning-launches-med-311664.html 0.6 2026-08-06T23:55:24+08:00 daily https://www.pharmasources.com/industryinsights/poor-broadband-penetration-in-rural-area-311665.html 0.6 2026-08-09T14:55:33+08:00 daily https://www.pharmasources.com/industryinsights/bill-would-raise-us-legal-age-to-buy-tob-311666.html 0.6 2026-06-21T11:01:15+08:00 daily https://www.pharmasources.com/industryinsights/homemade-sunscreen-recipes-commonly-shar-311667.html 0.6 2026-06-21T01:12:54+08:00 daily https://www.pharmasources.com/industryinsights/q-fever-a-bigger-threat-to-humans-than-t-311668.html 0.6 2026-06-22T03:02:41+08:00 daily https://www.pharmasources.com/industryinsights/favorable-trends-seen-in-lipids-apolipop-311669.html 0.6 2026-06-21T21:55:38+08:00 daily https://www.pharmasources.com/industryinsights/four-clinical-phenotypes-identified-for--311670.html 0.6 2026-07-01T02:47:00+08:00 daily https://www.pharmasources.com/industryinsights/wheres-the-best-place-for-your-childs-sp-311671.html 0.6 2026-08-08T01:07:05+08:00 daily https://www.pharmasources.com/industryinsights/respivant-sciences-announces-dosing-of-f-311672.html 0.6 2026-06-20T21:56:37+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-potentially-fatal-buildup-of-pr-311673.html 0.6 2026-06-22T08:52:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-fragmin-dalteparin-sodium-a-311674.html 0.6 2026-06-30T13:42:31+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-us-fda-approval-of-venc-311675.html 0.6 2026-07-05T09:58:06+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-announces-topline-res-311676.html 0.6 2026-06-20T23:52:38+08:00 daily https://www.pharmasources.com/industryinsights/inovio-first-to-advance-lassa-fever-cand-311677.html 0.6 2026-06-21T21:52:35+08:00 daily https://www.pharmasources.com/industryinsights/first-sublingual-ketamine-drug-for-treat-311678.html 0.6 2026-06-21T01:51:32+08:00 daily https://www.pharmasources.com/industryinsights/diet-for-blood-pressure-may-also-reduce--311679.html 0.6 2026-06-22T01:43:37+08:00 daily https://www.pharmasources.com/industryinsights/array-biopharma-announces-braftovi-mekto-311680.html 0.6 2026-08-07T01:13:03+08:00 daily https://www.pharmasources.com/industryinsights/your-dna-might-determine-whether-youre-a-311681.html 0.6 2026-06-24T02:20:20+08:00 daily https://www.pharmasources.com/industryinsights/are-diy-sunscreens-dangerous-311682.html 0.6 2026-06-20T14:51:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-peloton-therapeutics-311683.html 0.6 2026-03-28T04:12:09+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-granted-exclusive-worldwide-righ-311684.html 0.6 2026-06-20T16:17:54+08:00 daily https://www.pharmasources.com/industryinsights/epo-revokes-regenlab-prp-patent-311685.html 0.6 2026-06-22T06:06:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nayzilam-to-treat-seizure-a-311686.html 0.6 2026-06-22T11:00:45+08:00 daily https://www.pharmasources.com/industryinsights/compugen-doses-first-patient-in-com701op-311687.html 0.6 2026-06-08T21:23:38+08:00 daily https://www.pharmasources.com/industryinsights/intec-pharma-granted-european-patent-311688.html 0.6 2026-06-21T09:15:12+08:00 daily https://www.pharmasources.com/industryinsights/eisai-announces-vice-president-us-medica-311689.html 0.6 2026-06-25T12:30:35+08:00 daily https://www.pharmasources.com/industryinsights/wellspring-biosciences-announces-ind-cle-311690.html 0.6 2026-06-21T06:54:53+08:00 daily https://www.pharmasources.com/industryinsights/stryker-receives-fda-premarket-approval--311691.html 0.6 2026-06-20T20:59:46+08:00 daily https://www.pharmasources.com/industryinsights/catalent-closes-12bn-acquisition-of-para-311692.html 0.6 2026-06-22T14:45:46+08:00 daily https://www.pharmasources.com/industryinsights/flexipharm-austrading-launches-apml-ther-311693.html 0.6 2026-06-23T12:18:19+08:00 daily https://www.pharmasources.com/industryinsights/schrdinger-raises-110m-to-develop-drug-d-311694.html 0.6 2026-06-20T20:46:30+08:00 daily https://www.pharmasources.com/industryinsights/charity-lifearc-sells-rights-to-keytruda-311695.html 0.6 2026-06-21T04:12:54+08:00 daily https://www.pharmasources.com/industryinsights/roche-receives-fda-approval-for-venclext-311696.html 0.6 2026-06-21T00:26:57+08:00 daily https://www.pharmasources.com/industryinsights/parvus-and-genentech-to-develop-treatmen-311697.html 0.6 2026-06-21T05:00:49+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-frazier-team-up-to-launch-bio-311698.html 0.6 2026-06-29T10:23:51+08:00 daily https://www.pharmasources.com/industryinsights/gsk-expands-bispecific-antibodies-deal-w-311699.html 0.6 2026-08-03T21:06:57+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-fragmin-approved-by-the-fda-for--311700.html 0.6 2026-07-15T12:18:00+08:00 daily https://www.pharmasources.com/industryinsights/new-uk-programme-to-address-cancer-resis-311701.html 0.6 2026-06-22T17:07:00+08:00 daily https://www.pharmasources.com/industryinsights/biogens-sma-drug-spinraza-to-be-availabl-311702.html 0.6 2026-06-21T18:03:54+08:00 daily https://www.pharmasources.com/industryinsights/vertex-and-kymera-to-identify-protein-de-311703.html 0.6 2025-11-22T07:32:20+08:00 daily https://www.pharmasources.com/industryinsights/cleaner-air-linked-to-lower-asthma-rates-311704.html 0.6 2026-01-23T11:18:14+08:00 daily https://www.pharmasources.com/industryinsights/for-many-with-mild-asthma-popular-rx-may-311705.html 0.6 2026-06-20T18:15:42+08:00 daily https://www.pharmasources.com/industryinsights/cholesterol-levels-improving-among-us-ki-311706.html 0.6 2026-07-18T01:48:41+08:00 daily https://www.pharmasources.com/industryinsights/earlier-bedtimes-help-kids-fight-obesity-311707.html 0.6 2026-06-21T06:55:50+08:00 daily https://www.pharmasources.com/industryinsights/could-cbd-treat-opioid-addiction-311708.html 0.6 2026-06-21T10:09:12+08:00 daily https://www.pharmasources.com/industryinsights/half-price-version-of-humalog-insulin-no-311709.html 0.6 2026-02-15T07:59:43+08:00 daily https://www.pharmasources.com/industryinsights/cdc-seniors-use-various-strategies-to-re-311710.html 0.6 2026-06-20T16:58:24+08:00 daily https://www.pharmasources.com/industryinsights/suboptimal-diet-accounted-for-80000-canc-311711.html 0.6 2026-06-21T08:11:09+08:00 daily https://www.pharmasources.com/industryinsights/cdc-cancer-death-rates-decreased-heart-d-311712.html 0.6 2026-06-20T19:56:31+08:00 daily https://www.pharmasources.com/industryinsights/steriline-products-and-solutions-intelli-311713.html 0.6 2026-06-21T00:01:12+08:00 daily https://www.pharmasources.com/industryinsights/women-with-copd-have-worse-qol-increased-311714.html 0.6 2026-04-02T02:49:31+08:00 daily https://www.pharmasources.com/industryinsights/watchful-waiting-less-likely-for-black-p-311715.html 0.6 2026-06-22T02:55:37+08:00 daily https://www.pharmasources.com/industryinsights/aggressive-approach-to-pancreatic-cysts--311716.html 0.6 2026-06-22T04:42:33+08:00 daily https://www.pharmasources.com/industryinsights/unfiltered-cigarettes-are-most-deadly-311717.html 0.6 2026-06-21T15:46:25+08:00 daily https://www.pharmasources.com/industryinsights/how-does-room-temperature-affect-test-sc-311718.html 0.6 2026-06-21T02:17:25+08:00 daily https://www.pharmasources.com/industryinsights/fewer-deaths-tied-to-dirty-air-but-threa-311719.html 0.6 2026-07-07T12:46:04+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-need-a-break-a-vacation-really--311720.html 0.6 2026-07-05T02:43:53+08:00 daily https://www.pharmasources.com/industryinsights/rising-rx-drug-costs-continue-to-create--311721.html 0.6 2026-08-09T18:01:54+08:00 daily https://www.pharmasources.com/industryinsights/blood-banks-could-help-screen-for-heredi-311722.html 0.6 2026-06-22T05:12:08+08:00 daily https://www.pharmasources.com/industryinsights/copd-may-strike-women-harder-than-men-311723.html 0.6 2026-06-20T14:59:03+08:00 daily https://www.pharmasources.com/industryinsights/kids-of-opioid-using-parents-may-be-more-311724.html 0.6 2026-06-20T16:56:11+08:00 daily https://www.pharmasources.com/industryinsights/take-a-new-view-of-aging-311725.html 0.6 2026-04-05T23:18:08+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-anti-clotting-meds-safe-after-bl-311726.html 0.6 2026-06-20T19:13:43+08:00 daily https://www.pharmasources.com/industryinsights/women-with-sleep-apnea-may-have-higher-c-311727.html 0.6 2026-06-25T12:46:06+08:00 daily https://www.pharmasources.com/industryinsights/healthy-food-may-boost-mood-311728.html 0.6 2026-06-20T20:57:42+08:00 daily https://www.pharmasources.com/industryinsights/federal-court-enters-consent-decree-agai-311729.html 0.6 2026-06-21T03:50:42+08:00 daily https://www.pharmasources.com/industryinsights/epibone-receives-fda-clearance-to-start--311730.html 0.6 2026-06-22T04:16:56+08:00 daily https://www.pharmasources.com/industryinsights/closed-icu-model-may-reduce-hospital-acq-311731.html 0.6 2026-07-06T18:59:54+08:00 daily https://www.pharmasources.com/industryinsights/halozyme-announces-argenx-has-selected-s-311732.html 0.6 2026-06-21T05:15:56+08:00 daily https://www.pharmasources.com/industryinsights/mirikizumab-met-primary-secondary-endpoi-311733.html 0.6 2026-07-06T10:23:33+08:00 daily https://www.pharmasources.com/industryinsights/89bio-reports-positive-top-line-data-fro-311734.html 0.6 2026-08-06T00:54:32+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-releases-interim-data-from-ongoi-311735.html 0.6 2026-06-22T09:37:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-anticoagulant-for-ped-311736.html 0.6 2026-06-21T22:53:43+08:00 daily https://www.pharmasources.com/industryinsights/celgene-receives-ec-approval-for-two-tri-311737.html 0.6 2026-03-17T23:45:17+08:00 daily https://www.pharmasources.com/industryinsights/idmc-recommends-stopping-depatuxizumab-m-311738.html 0.6 2026-07-29T08:00:42+08:00 daily https://www.pharmasources.com/industryinsights/genentech-announces-fda-approval-for-ven-311739.html 0.6 2026-08-07T22:30:56+08:00 daily https://www.pharmasources.com/industryinsights/ligand-licenses-ver250840-to-cumulus-onc-311740.html 0.6 2026-06-21T20:00:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gattex-for-children-with-sh-311741.html 0.6 2026-06-21T08:04:02+08:00 daily https://www.pharmasources.com/industryinsights/new-opioid-with-faster-results-and-less--311742.html 0.6 2026-07-13T10:07:33+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-files-lawsuit-against-us-he-311743.html 0.6 2026-06-20T16:59:13+08:00 daily https://www.pharmasources.com/industryinsights/evotec-to-acquire-biologics-company-just-311744.html 0.6 2026-07-18T14:14:51+08:00 daily https://www.pharmasources.com/industryinsights/merck-signs-1bn-deal-to-buy-peloton-ther-311745.html 0.6 2026-06-22T05:51:34+08:00 daily https://www.pharmasources.com/industryinsights/nih-awards-t3d-therapeutics-9m-to-fund-a-311746.html 0.6 2026-06-21T09:59:11+08:00 daily https://www.pharmasources.com/industryinsights/mercks-threat-to-pfizers-lucrative-prevn-311747.html 0.6 2026-06-21T06:12:00+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-acquires-therachon-to-broaden-its-311748.html 0.6 2026-06-21T20:15:59+08:00 daily https://www.pharmasources.com/industryinsights/us-incident-cases-of-hepatitis-a-increas-311749.html 0.6 2026-06-25T15:47:12+08:00 daily https://www.pharmasources.com/industryinsights/volume-overload-present-in-patients-on-p-311750.html 0.6 2026-06-21T04:57:51+08:00 daily https://www.pharmasources.com/industryinsights/california-bill-to-tighten-vaccine-exemp-311751.html 0.6 2026-06-22T00:46:57+08:00 daily https://www.pharmasources.com/industryinsights/most-patients-at-high-risk-of-opiate-ove-311752.html 0.6 2026-06-21T00:56:02+08:00 daily https://www.pharmasources.com/industryinsights/us-lawmakers-say-who-opioid-guidelines-t-311753.html 0.6 2026-07-19T06:51:26+08:00 daily https://www.pharmasources.com/industryinsights/open-communication-helps-teens-manage-ty-311754.html 0.6 2026-06-21T08:08:31+08:00 daily https://www.pharmasources.com/industryinsights/infant-pain-heightened-after-opioid-expo-311755.html 0.6 2026-06-21T07:14:10+08:00 daily https://www.pharmasources.com/industryinsights/can-the-bacteria-in-your-belly-ease-your-311756.html 0.6 2026-06-21T06:19:11+08:00 daily https://www.pharmasources.com/industryinsights/high-deductible-health-plans-can-harm-co-311757.html 0.6 2026-06-28T23:35:28+08:00 daily https://www.pharmasources.com/industryinsights/2-in-3-adults-who-use-e-cigs-want-to-sto-311758.html 0.6 2026-06-21T21:54:40+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-with-grit-and-gratitude-stroke--311759.html 0.6 2026-07-07T15:01:31+08:00 daily https://www.pharmasources.com/industryinsights/bipolar-disorder-a-risk-factor-for-parki-311760.html 0.6 2026-06-21T01:11:58+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-abcuro-signed-glymaxx-impr-311761.html 0.6 2026-08-09T11:41:38+08:00 daily https://www.pharmasources.com/industryinsights/mirikizimab-moved-to-phase-iii-after-pos-311762.html 0.6 2026-06-28T19:59:07+08:00 daily https://www.pharmasources.com/industryinsights/single-vaccination-approach-developed-to-311763.html 0.6 2026-06-20T14:59:05+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-cleanroom-monitoring-soft-311764.html 0.6 2026-06-22T07:08:56+08:00 daily https://www.pharmasources.com/industryinsights/platform-launched-to-facilitate-licensed-311765.html 0.6 2026-08-03T10:34:27+08:00 daily https://www.pharmasources.com/industryinsights/connect-2-cleanrooms-and-elis-cleanroom--311766.html 0.6 2026-08-06T20:27:02+08:00 daily https://www.pharmasources.com/industryinsights/janssens-invokana-secures-fda-priority-r-311767.html 0.6 2026-04-01T07:11:01+08:00 daily https://www.pharmasources.com/industryinsights/amgen-offers-167m-to-acquire-nuevolution-311768.html 0.6 2026-06-22T03:59:39+08:00 daily https://www.pharmasources.com/industryinsights/ilc-dovers-new-cork-manufacturing-plant--311769.html 0.6 2026-07-07T20:22:55+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-new-opioid-with-fast-311770.html 0.6 2026-06-21T03:02:49+08:00 daily https://www.pharmasources.com/industryinsights/lannett-announces-board-of-directors-app-311771.html 0.6 2026-06-23T04:13:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-of-invokana-s-311772.html 0.6 2026-06-20T19:59:30+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-announces-collaboration-with-n-311773.html 0.6 2026-07-04T05:50:22+08:00 daily https://www.pharmasources.com/industryinsights/immunovant-initiates-dosing-in-ascend-go-311774.html 0.6 2026-06-22T19:09:11+08:00 daily https://www.pharmasources.com/industryinsights/federal-judge-enters-consent-decree-agai-311775.html 0.6 2026-06-21T23:54:39+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-trial-of-oncosecs-311776.html 0.6 2026-06-21T08:00:06+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-mouth-bacteria-found-in-stroke--311777.html 0.6 2026-06-22T08:53:42+08:00 daily https://www.pharmasources.com/industryinsights/new-gene-variants-for-type-2-diabetes-fo-311778.html 0.6 2026-06-21T01:03:48+08:00 daily https://www.pharmasources.com/industryinsights/poor-diet-might-raise-your-cancer-risk-311779.html 0.6 2026-06-21T10:06:14+08:00 daily https://www.pharmasources.com/industryinsights/many-dehumanize-people-with-obesity-311780.html 0.6 2026-06-21T12:18:32+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-green-light-for-brain-bleed-stro-311781.html 0.6 2026-07-09T10:00:36+08:00 daily https://www.pharmasources.com/industryinsights/aprinoia-therapeutics-awarded-grant-from-311782.html 0.6 2026-06-22T01:06:59+08:00 daily https://www.pharmasources.com/industryinsights/new-data-show-symbicort-reduces-attacks--311783.html 0.6 2026-07-16T03:05:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-phase-ii-data-for-new-inhaled-c-311784.html 0.6 2026-08-07T15:35:40+08:00 daily https://www.pharmasources.com/industryinsights/benralizumab-not-effective-reducing-exac-311785.html 0.6 2026-07-11T03:31:20+08:00 daily https://www.pharmasources.com/industryinsights/cipla-releases-financial-results-for-fy1-311786.html 0.6 2026-06-23T10:20:07+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-nod-for-acid-ref-311787.html 0.6 2026-06-21T10:53:23+08:00 daily https://www.pharmasources.com/industryinsights/ipec-federation-publishes-its-position-o-311788.html 0.6 2026-06-21T05:00:50+08:00 daily https://www.pharmasources.com/industryinsights/bial-launches-cold-chain-dedicated-servi-311789.html 0.6 2026-06-20T22:59:41+08:00 daily https://www.pharmasources.com/industryinsights/optel-chosen-for-us-fdas-dscsa-pilot-pro-311790.html 0.6 2026-06-21T10:18:31+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2018052-311791.html 0.6 2026-06-21T16:18:40+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-developing-a-design-space-fo-311792.html 0.6 2026-07-20T04:00:19+08:00 daily https://www.pharmasources.com/industryinsights/vulnerable-children-stuck-in-mental-heal-311793.html 0.6 2026-06-21T08:16:19+08:00 daily https://www.pharmasources.com/industryinsights/scancell-cr-uk-publish-joint-vaccine-upd-311794.html 0.6 2026-06-20T17:54:31+08:00 daily https://www.pharmasources.com/industryinsights/cma-accuses-four-pharmas-of-anticompetit-311795.html 0.6 2026-06-29T01:06:15+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-receives-12b-in-keytruda-royalti-311796.html 0.6 2026-06-21T11:22:27+08:00 daily https://www.pharmasources.com/industryinsights/az-her2-drug-hits-mid-stage-trial-endpoi-311797.html 0.6 2026-06-22T10:54:05+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-undergo-ambitious-tech-overhaul-311798.html 0.6 2026-06-21T23:57:41+08:00 daily https://www.pharmasources.com/industryinsights/gsk-updates-its-sales-rep-incentives-311799.html 0.6 2026-06-21T07:09:03+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-guidance-issued-for-akceas-te-311800.html 0.6 2026-06-21T02:59:49+08:00 daily https://www.pharmasources.com/industryinsights/zolgensma-wins-fda-green-light-in-child--311801.html 0.6 2026-06-20T19:01:39+08:00 daily https://www.pharmasources.com/industryinsights/new-molecular-diagnostics-business-launc-311802.html 0.6 2026-06-21T12:56:44+08:00 daily https://www.pharmasources.com/industryinsights/santhera-submits-maa-to-ema-for-puldysa-311803.html 0.6 2026-06-21T11:57:18+08:00 daily https://www.pharmasources.com/industryinsights/theresa-may-failed-to-tackle-countrys-bi-311804.html 0.6 2026-06-20T15:15:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approval-for-novartis-piqray-311805.html 0.6 2026-06-21T00:56:46+08:00 daily https://www.pharmasources.com/industryinsights/insilico-ark-initiate-health-span-and-lo-311806.html 0.6 2026-07-03T20:36:19+08:00 daily https://www.pharmasources.com/industryinsights/new-data-highlights-value-of-janssens-sp-311807.html 0.6 2026-06-21T17:12:46+08:00 daily https://www.pharmasources.com/industryinsights/t-fit-insulation-presents-leading-produc-311808.html 0.6 2026-06-21T04:59:46+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-prestige-biopharmas-maa-for--311809.html 0.6 2026-06-21T07:11:07+08:00 daily https://www.pharmasources.com/industryinsights/amprions-pmca-technology-receives-breakt-311810.html 0.6 2026-06-22T02:40:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-permits-marketing-of-first-diagnosti-311811.html 0.6 2026-06-22T12:04:01+08:00 daily https://www.pharmasources.com/industryinsights/translational-research-led-by-singapore--311812.html 0.6 2026-06-21T01:59:36+08:00 daily https://www.pharmasources.com/industryinsights/cellect-biotechnology-reports-q1-2019-re-311813.html 0.6 2025-10-28T04:06:20+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-technique-for-better--311814.html 0.6 2026-06-20T15:04:25+08:00 daily https://www.pharmasources.com/industryinsights/a-nutrition-pathway-to-stamp-out-the-sta-311815.html 0.6 2026-06-21T12:30:29+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-smartphone-app-to-di-311816.html 0.6 2026-06-20T21:10:45+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-establish-comprehensive-311817.html 0.6 2026-06-21T10:54:19+08:00 daily https://www.pharmasources.com/industryinsights/calecim-to-expand-skin-care-products-in--311818.html 0.6 2025-11-01T16:52:26+08:00 daily https://www.pharmasources.com/industryinsights/menicon-launches-holistic-approach-for-m-311819.html 0.6 2026-06-22T22:17:23+08:00 daily https://www.pharmasources.com/industryinsights/b-dot-medical-to-develop-ultra-compact-p-311820.html 0.6 2026-06-21T12:00:20+08:00 daily https://www.pharmasources.com/industryinsights/stay-healthy-with-smart-diabetic-friendl-311821.html 0.6 2026-06-21T09:04:00+08:00 daily https://www.pharmasources.com/industryinsights/emcure-injected-schizophrenia-drug-recal-311822.html 0.6 2026-06-21T07:09:02+08:00 daily https://www.pharmasources.com/industryinsights/novartis-slaps-2m-plus-price-tag-on-newl-311823.html 0.6 2026-06-18T08:21:21+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-a-world-leader-in-biop-311824.html 0.6 2026-07-16T23:24:41+08:00 daily https://www.pharmasources.com/industryinsights/mass-exodus-of-amgen-sales-reps-sparks-l-311825.html 0.6 2026-08-06T02:42:13+08:00 daily https://www.pharmasources.com/industryinsights/trump-to-unveil-executive-order-to-force-311826.html 0.6 2026-03-29T03:02:29+08:00 daily https://www.pharmasources.com/industryinsights/biogens-board-expansion-hits-snag-as-cat-311827.html 0.6 2026-06-21T03:02:47+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ceo-touts-25-potentialand-diver-311828.html 0.6 2026-06-21T17:11:31+08:00 daily https://www.pharmasources.com/industryinsights/allergan-puts-vraylar-on-blockbuster-tra-311829.html 0.6 2026-06-21T04:00:45+08:00 daily https://www.pharmasources.com/industryinsights/novartis-grabs-blockbuster-cancer-nod-fo-311830.html 0.6 2026-07-21T15:56:18+08:00 daily https://www.pharmasources.com/industryinsights/chinas-driving-sales-growth-ahead-of-the-311831.html 0.6 2026-07-15T12:23:05+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithklines-booming-shingrix-after--311832.html 0.6 2026-06-23T15:49:38+08:00 daily https://www.pharmasources.com/industryinsights/chugai-ponies-up-1b-to-combine-rd-operat-311833.html 0.6 2026-06-25T09:09:16+08:00 daily https://www.pharmasources.com/industryinsights/lilly-oncology-suffers-another-blow-as-v-311834.html 0.6 2026-06-20T13:21:44+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-to-build-dedicated-vaccine-facility-311835.html 0.6 2026-07-23T12:47:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-sends-warning-letter-to-canadian-otc-311836.html 0.6 2026-06-21T04:00:44+08:00 daily https://www.pharmasources.com/industryinsights/patent-litigation-for-adalimumab-resolve-311837.html 0.6 2026-06-21T07:06:58+08:00 daily https://www.pharmasources.com/industryinsights/four-drug-companies-accused-of-illegal-m-311838.html 0.6 2026-06-22T07:08:54+08:00 daily https://www.pharmasources.com/industryinsights/vetter-works-towards-a-sustainable-energ-311839.html 0.6 2026-06-21T10:19:24+08:00 daily https://www.pharmasources.com/industryinsights/european-medicines-agency-accepts-market-311840.html 0.6 2026-08-08T15:51:58+08:00 daily https://www.pharmasources.com/industryinsights/rate-of-opioid-prescribing-high-for-teen-311841.html 0.6 2026-08-08T10:38:36+08:00 daily https://www.pharmasources.com/industryinsights/work-burnout-gaming-addiction-classified-311842.html 0.6 2026-08-08T07:58:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-permits-marketing-of-test-to-detect--311843.html 0.6 2026-08-08T09:47:17+08:00 daily https://www.pharmasources.com/industryinsights/decreased-air-pollutants-linked-to-less--311844.html 0.6 2026-06-21T11:02:10+08:00 daily https://www.pharmasources.com/industryinsights/meds-for-weight-management-underutilized-311845.html 0.6 2026-08-08T20:03:11+08:00 daily https://www.pharmasources.com/industryinsights/polyethylene-glycol-loxenatide-the-first-311846.html 0.6 2026-08-07T13:17:58+08:00 daily https://www.pharmasources.com/industryinsights/the-global-glp-1r-agonist-market-rapidly-311847.html 0.6 2026-08-07T13:14:57+08:00 daily https://www.pharmasources.com/industryinsights/do-you-have-the-fainting-gene-311848.html 0.6 2026-08-08T14:38:48+08:00 daily https://www.pharmasources.com/industryinsights/though-donut-hole-is-shrinking-medicare--311849.html 0.6 2026-08-09T22:07:26+08:00 daily https://www.pharmasources.com/industryinsights/women-in-cardiac-arrest-less-likely-to-r-311850.html 0.6 2026-06-21T07:18:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-gene-therapy-zolgensm-311851.html 0.6 2026-06-21T01:44:27+08:00 daily https://www.pharmasources.com/industryinsights/idifarma-welcomes-director-of-operations-311852.html 0.6 2026-06-21T00:57:47+08:00 daily https://www.pharmasources.com/industryinsights/jacobs-to-provide-construction-for-wuxi--311853.html 0.6 2026-08-08T22:42:33+08:00 daily https://www.pharmasources.com/industryinsights/masy-opens-north-carolina-office-311854.html 0.6 2026-08-07T12:04:13+08:00 daily https://www.pharmasources.com/industryinsights/central-pharma-partners-with-veratrak-311855.html 0.6 2026-06-21T00:05:39+08:00 daily https://www.pharmasources.com/industryinsights/vineti-opens-new-regional-hq-in-maryland-311856.html 0.6 2026-07-06T19:13:41+08:00 daily https://www.pharmasources.com/industryinsights/santhera-chiesi-group-enter-raxone-licen-311857.html 0.6 2026-06-21T11:13:26+08:00 daily https://www.pharmasources.com/industryinsights/catalent-launches-onebio-suite-311858.html 0.6 2026-06-21T09:54:28+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-abcuro-ink-glymaxx-pact-311859.html 0.6 2026-06-21T09:08:14+08:00 daily https://www.pharmasources.com/industryinsights/sgs-opens-biologics-testing-facility-in--311860.html 0.6 2026-06-20T18:16:51+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-to-invest-50m-to-expand-bi-311861.html 0.6 2026-06-20T20:02:41+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-inks-strategic-loi-with-g-311862.html 0.6 2026-08-08T23:21:59+08:00 daily https://www.pharmasources.com/industryinsights/teva-agrees-to-85m-settlement-in-oklahom-311863.html 0.6 2026-06-12T02:36:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gene-therapy-zolgensma-gets-fda-311864.html 0.6 2026-06-21T02:59:45+08:00 daily https://www.pharmasources.com/industryinsights/new-discovery-offers-hope-for-global-str-311865.html 0.6 2026-06-22T12:57:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-pi3k-inhibitor-for-br-311866.html 0.6 2026-06-21T14:50:22+08:00 daily https://www.pharmasources.com/industryinsights/protalix-biotherapeutics-appoints-presid-311867.html 0.6 2026-01-31T08:22:26+08:00 daily https://www.pharmasources.com/industryinsights/evotec-to-acquire-just-biotherapeutics-i-311868.html 0.6 2026-06-21T12:57:55+08:00 daily https://www.pharmasources.com/industryinsights/calidi-biotherapeutics-announces-collabo-311869.html 0.6 2026-06-21T09:50:48+08:00 daily https://www.pharmasources.com/industryinsights/armas-micro-labs-announce-collaboration--311870.html 0.6 2026-06-21T03:07:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-revlimid-lenalidomide-in-co-311871.html 0.6 2026-04-13T06:15:39+08:00 daily